<SEC-DOCUMENT>0001110803-25-000019.txt : 20250212
<SEC-HEADER>0001110803-25-000019.hdr.sgml : 20250212
<ACCEPTANCE-DATETIME>20250212162155
ACCESSION NUMBER:		0001110803-25-000019
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		123
CONFORMED PERIOD OF REPORT:	20241229
FILED AS OF DATE:		20250212
DATE AS OF CHANGE:		20250212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ILLUMINA, INC.
		CENTRAL INDEX KEY:			0001110803
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				330804655
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1229

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35406
		FILM NUMBER:		25615152

	BUSINESS ADDRESS:	
		STREET 1:		5200 ILLUMINA WAY
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		8582024500

	MAIL ADDRESS:	
		STREET 1:		5200 ILLUMINA WAY
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ILLUMINA INC
		DATE OF NAME CHANGE:	20000331
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ilmn-20241229.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3be010a1-b4e2-4eb6-8721-f9b45bdbb770,g:4f5b8127-d86a-4b2f-b09c-147b6f0d2a9f,d:64df1cccf2dd452496bdff4e9d30a288-->
<html xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ilmn="http://www.illumina.com/20241229" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ilmn-20241229</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-32">0001110803</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-33">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-34">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-35">false</ix:nonNumeric><ix:nonNumeric contextRef="c-13" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="f-232">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="c-88" name="ilmn:StandardProductWarrantyDescriptionTerm" id="f-489">P6M</ix:nonNumeric><ix:nonNumeric contextRef="c-147" name="ilmn:RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" id="f-594">P3M</ix:nonNumeric><ix:nonNumeric contextRef="c-149" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-607">1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-848">http://fasb.org/us-gaap/2024#GoodwillAndIntangibleAssetImpairment</ix:nonNumeric><ix:nonNumeric contextRef="c-12" name="us-gaap:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-849">http://fasb.org/us-gaap/2024#GoodwillAndIntangibleAssetImpairment</ix:nonNumeric><ix:nonNumeric contextRef="c-283" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-986">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-314" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-1101">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1239">http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1240">http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-423" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1605">478</ix:nonNumeric><ix:nonNumeric contextRef="c-426" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1606">568</ix:nonNumeric><ix:nonNumeric contextRef="c-429" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1607">403</ix:nonNumeric><ix:nonNumeric contextRef="c-432" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1608">366</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ilmn-20241229.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="fund"><xbrli:measure>ilmn:fund</xbrli:measure></xbrli:unit><xbrli:unit id="day"><xbrli:measure>ilmn:day</xbrli:measure></xbrli:unit><xbrli:unit id="reporting_unit"><xbrli:measure>ilmn:reporting_unit</xbrli:measure></xbrli:unit><xbrli:unit id="one_year_extension"><xbrli:measure>ilmn:one_year_extension</xbrli:measure></xbrli:unit><xbrli:unit id="consecutive_fiscal_quarter"><xbrli:measure>ilmn:consecutive_fiscal_quarter</xbrli:measure></xbrli:unit><xbrli:unit id="award"><xbrli:measure>ilmn:award</xbrli:measure></xbrli:unit><xbrli:unit id="lawsuit"><xbrli:measure>ilmn:lawsuit</xbrli:measure></xbrli:unit><xbrli:unit id="movant"><xbrli:measure>ilmn:movant</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>ilmn:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2022-01-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-24</xbrli:startDate><xbrli:endDate>2024-06-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ilmn:InvestmentPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ilmn:IssueSizeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ilmn:IndustryCreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ilmn:InvestmentPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ilmn:BuildingandLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ilmn:BuildingandLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:AsiaPacificMiddleEastAndAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:AsiaPacificMiddleEastAndAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:AsiaPacificMiddleEastAndAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ilmn:HelixHoldingsILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ilmn:ContingentPaymentRightsAxis">ilmn:PaymentRightsOfOneBillionEachTwelveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ilmn:ContingentPaymentRightsAxis">ilmn:PaymentRightsOfOneBillionEachTwelveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ilmn:ContingentPaymentRightsAxis">ilmn:PaymentRightsOfAboveOneBillionEachTwelveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ilmn:ContingentPaymentRightsAxis">ilmn:PaymentRightsOfAboveOneBillionEachTwelveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-02</xbrli:startDate><xbrli:endDate>2024-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-03</xbrli:startDate><xbrli:endDate>2023-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-04</xbrli:startDate><xbrli:endDate>2022-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ilmn:MeasurementInputRevenueRiskPremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ilmn:MeasurementInputCalculationTrailingPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2022-01-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ilmn:MeasurementInputCashFlowPeriodMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-03</xbrli:startDate><xbrli:endDate>2023-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-03</xbrli:startDate><xbrli:endDate>2023-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-03</xbrli:startDate><xbrli:endDate>2023-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-03</xbrli:startDate><xbrli:endDate>2023-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-04</xbrli:startDate><xbrli:endDate>2022-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ilmn:LicensedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ilmn:LicensedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ilmn:FluentBioSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ilmn:FluentBioSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ilmn:FluentBioSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-30</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-09</xbrli:startDate><xbrli:endDate>2024-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-17</xbrli:startDate><xbrli:endDate>2024-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-09</xbrli:startDate><xbrli:endDate>2024-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ilmn:SwinglineBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ilmn:SwinglineBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TheCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2015StockAndIncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2015StockAndIncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2015StockAndIncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:MarketBasedPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityClassifiedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityClassifiedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityClassifiedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2000EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2000EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2000EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2000EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-30</xbrli:startDate><xbrli:endDate>2025-02-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfGoodsSoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfGoodsSoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfGoodsSoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ilmn:AssetImpairmentChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ilmn:AssetImpairmentChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ilmn:AssetImpairmentChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:FosterCityCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:SanDiegoCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:AcquisitionOfGrailInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:AcquisitionOfGrailInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:AcquisitionOfGrailInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-11</xbrli:startDate><xbrli:endDate>2023-11-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-01-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:CompleteGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:CompleteGenomicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:CompleteGenomicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:CompleteGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InlandRevenueSingaporeIRASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InlandRevenueSingaporeIRASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InlandRevenueSingaporeIRASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ilmn:SeniorLevelEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-03</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:FrancesArnoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:FrancesArnoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-30</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:FrancesArnoldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:JakobWedelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:JakobWedelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-30</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:JakobWedelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:ScottDaviesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:ScottDaviesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-30</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:ScottDaviesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:PatriciaLeckmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:PatriciaLeckmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-30</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:PatriciaLeckmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001110803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-30</xbrli:startDate><xbrli:endDate>2024-12-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i64df1cccf2dd452496bdff4e9d30a288_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">Form&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.364%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.753%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December 29</ix:nonNumeric>, 2024</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.364%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.753%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-35406</ix:nonNumeric> </span></div><div style="text-align:center"><img src="ilmn-20241229_g1.jpg" alt="ilmnlogoa19.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:135px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">Illumina, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:1pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.627%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" rowspan="4" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">33-0804655</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">5200 Illumina Way</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">CA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">92122</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">858</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">202-4500</ix:nonNumeric>  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.388%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, $0.01&#160;par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">ILMN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:  None</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#254;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.016%"><tr><td style="width:1.0%"/><td style="width:15.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.395%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.550%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.920%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-26">&#9745;</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-27">o</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-28">&#254;</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of February&#160;7, 2025, there were <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-29">158.4</ix:nonFraction>&#160;million shares (excluding 41.8&#160;million&#160;shares held in treasury) of the registrant&#8217;s common stock outstanding. The aggregate market value of the common stock held by non-affiliates of the registrant as of June&#160;30, 2024 (the last business day of the registrant&#8217;s most recently completed second quarter), based on the closing price for the common stock on The Nasdaq Global Select Market on June&#160;28, 2024 (the last trading day before June&#160;30, 2024), was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="f-30">14.7</ix:nonFraction>&#160;billion. This excludes an aggregate of 18.3&#160;million shares of common stock held by officers and directors and each person known by the registrant to own 10% or more of the outstanding common stock. Exclusion of shares held by any person should not be construed to indicate that such person possesses the power, directly or indirectly, to direct or cause the direction of the management or policies of the registrant, or that the registrant is controlled by or under common control with such person.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-31" escape="true"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s proxy statement for the 2025 annual meeting of stockholders are incorporated by reference into Items&#160;10 through 14 of Part&#160;III of this Report.</span></div></ix:nonNumeric><div style="margin-bottom:1pt;margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_7"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE FISCAL YEAR ENDED DECEMBER&#160;29, 2024 </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BUSINESS &amp; MARKET INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_13">Business Overview</a></span></div></td><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_25">28</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_31">Market Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_31">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_34">Share Repurchases and Sales</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_34">30</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION &amp; ANALYSIS</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_37">Management&#8217;s Overview and Outlook</a></span></div></td><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_37">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_43">Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_43">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_46">Liquidity and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_46">38</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_52">Critical Accounting Policies and Estimates</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_52">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_55">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_55">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_58">Recent Accounting Pronouncements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_58">46</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED FINANCIAL STATEMENTS</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_64">Index to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_64">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_67">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_67">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_73">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_73">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_76">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_76">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_79">Consolidated Statements of Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_79">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_82">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_82">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_85">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_85">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_88">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_88">55</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER KEY INFORMATION</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_148">Controls and Procedures</a></span></div></td><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_148">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_151">Adoptions, Modifications or Terminations of Trading Plans</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_151">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_160">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_160">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_163">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_163">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_166">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_166">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_169">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_169">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_172">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_172">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_175">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_175">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_181">Form 10-K Cross-Reference Index</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_181">105</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Form 10-K Cross-Reference Index&#8221; within Other Key Information for a cross-reference to the parts and items requirements of the Securities and Exchange Commission Annual Report on Form 10-K.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_10"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consideration Regarding Forward-Looking Statements</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This annual report on Form 10-K contains, and our officers and representatives may from time to time make, &#8220;forward-looking statements&#8221; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as: &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;goal,&#8221; &#8220;seek,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;likely,&#8221; &#8220;may,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; or similar words or phrases, or the negatives of these words, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward looking. Examples of forward-looking statements include, among others, statements we make regarding:</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations as to our future financial performance, results of operations, or other operational results or metrics;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the benefits that we expect will result from our business activities and certain transactions we have completed, or may complete, such as product introductions, increased revenue, decreased expenses, and avoided expenses and expenditures; </span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations of the effect on our financial condition of claims, litigation, contingent liabilities, and governmental investigations, proceedings, and regulations; </span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our strategies or expectations for product development, market position, financial results, and reserves;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully implement cost reduction plans in a timely manner and the possibility that costs associated with our cost reduction plans are greater than we anticipate;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks relating to the recent divestiture of GRAIL, Inc. (f/k/a GRAIL, LLC) (GRAIL); and</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other expectations, beliefs, plans, strategies, anticipated developments, and other matters that are not historical facts.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations and beliefs regarding prospects and growth for our business and the markets in which we operate;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and mix of customer orders among our products and services;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges inherent in developing, manufacturing, and launching new products and services, including expanding manufacturing operations and reliance on third-party suppliers for critical components;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty regarding the impact of our recent inclusion by the China Ministry of Commerce announcement that Illumina is included on its &#8220;unreliable entities list&#8221;;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any reductions or potential reductions in funding for the National Institutes of Health, or targeted cancellations by the U.S. federal government of certain grants or contracts, could negatively impact our customers and reduce demand for our products and services; </span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of recently launched or pre-announced products and services on existing products and services;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty regarding, or potential changes in, diplomatic and trade relationships, for example, as a result of the recent change in the U.S. government administration;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks and uncertainties regarding legal and regulatory proceedings;</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of tariffs recently imposed by the U.S. government and its trading partners in response, other possible tariffs or trade protection measures, import or export licensing requirements, new or different customs duties, trade embargoes and sanctions and other trade barriers;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with contracts or other agreements containing provisions that might be implicated by the divestiture of GRAIL, including our ability to fully realize the anticipated economic benefits of our commercial arrangements with GRAIL and our obligations with respect to contingent value rights (the CVRs) issued by us in connection with the GRAIL acquisition, which may adversely affect us and our business and/or the market value of the CVRs;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk of additional litigation arising against us in connection with the GRAIL acquisition;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the assumptions underlying our critical accounting policies and estimates;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our assessments and estimates that determine our effective tax rate;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our assessments and beliefs regarding the outcome of pending legal proceedings and any liability that we may incur as a result of those proceedings, as well as the cost and potential diversion of management resources associated with these proceedings;</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty, or adverse economic and business conditions, including as a result of slowing or uncertain economic growth, public health crisis, or armed conflict; and</span></div><div style="margin-bottom:10pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors detailed in our filings with the Securities and Exchange Commission (SEC), including the risks, uncertainties, and assumptions described in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">Risk Factors</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Business &amp; Market Information section of this report, or in information disclosed in public conference calls, the date and time of which are released beforehand.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any forward-looking statement made by us in this annual report on Form 10-K is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation, and do not intend, to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, or to review or confirm analysts&#8217; expectations, or to provide interim reports or updates on the progress of any current financial quarter, in each case whether as a result of new information, future developments, or otherwise.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all amendments to those reports are available free of charge on our website, www.illumina.com. The information on our website is not incorporated by reference into this report. Such reports are made available as soon as reasonably practicable after filing with, or furnishing to, the SEC. The SEC also maintains an Internet site at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that electronically file with the SEC. Copies of our annual report on Form 10-K will be made available, free of charge, upon written request. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assign, BaseSpace, BeadArray, Bluebee, BlueFuse, BlueGnome, cBot, Clarity LIMS, CircLigase, COVIDSeq, DesignStudio, DRAGEN, DRAGEN ORA, Emedgene, Enancio, FastTrack, Flow, Fluent Biosciences, Genetic Energy, GenomeStudio, Genomics Suite, Golden Gate, HiSeq, iHope, Illumina, Illumina Connected Analytics, Illumina Propel Certified, Infinium, iScan, iSelect, iSeq, MiniSeq, MiSeq, MiSeq FGx, Nextera, NextSeq, NovaSeq, Partek, Pattern Visualization System, PIPseq, Powered by Illumina, Praxis, Ribo-Zero, SureCell, The Analytical Spreadsheet, TruGenome, TruSeq, TruSight, Turning Data Into Discovery, Verifi, Verinata, Verinata Health, VeriSeq, XLEAP-SBS, the pumpkin orange color, and the Genetic Energy / streaming bases design are trademarks or registered trademarks of Illumina, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;GRAIL,&#8221; the GRAIL logos, and other trade names, trademarks, or service marks of GRAIL are the property of GRAIL. The &#8220;Galleri&#8221; mark and logo are registered in numerous countries including the United States and the United Kingdom.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applications to register the &#8220;Galleri&#8221; mark and logo, the &#8220;GRAIL&#8221; mark and the logo, and marks associated with GRAIL are also pending in a variety of countries.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this annual report on Form&#160;10-K to &#8220;Illumina,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Illumina, Inc. and its consolidated subsidiaries.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year is the 52 or 53&#160;weeks ending the Sunday closest to December&#160;31, with quarters of 13 or 14&#160;weeks ending the Sunday closest to March&#160;31, June&#160;30, September&#160;30, and December&#160;31. References to 2024, 2023, and 2022 refer to fiscal years ended December&#160;29, 2024, December&#160;31, 2023, and January&#160;1, 2023, respectively, which were all 52 weeks.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_13"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BUSINESS &amp; MARKET INFORMATION </span></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BUSINESS OVERVIEW</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global leader in sequencing- and array-based solutions for genetic and genomic analysis. Our products and services serve customers in a wide range of markets, enabling the adoption of genomic solutions in research and clinical settings. We were incorporated in California in April 1998 and reincorporated in Delaware in July 2000. Our principal executive offices are located at 5200 Illumina Way, San Diego, California 92122.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers include leading genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Our portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis and addresses the range of genomic complexity, price points, and throughput, enabling customers to select the best solution for their research or clinical application.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;24, 2024, we completed the separation (the Spin-Off) of GRAIL into a new public company through the distribution of 26,547,021 shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The distribution reflected approximately 85.5% of the outstanding common stock of GRAIL as of 5:00 p.m. New York time on June 13, 2024, the record date for the distribution (the Record Date). We retained approximately 14.5% of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL&#8217;s assets, liabilities, results of operations and cash flows have not been reclassified. Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Genetics Primer</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The instruction set for all living cells is encoded in deoxyribonucleic acid, or DNA. The complete set of DNA for any organism is referred to as its genome. DNA contains small regions called genes, which comprise a string of nucleotide bases labeled A, C, G, and T, representing adenine, cytosine, guanine, and thymine, respectively. These nucleotide bases occur in a precise order known as the DNA sequence. When a gene is &#8220;expressed,&#8221; a copy of a portion of its DNA sequence called messenger RNA (mRNA) is used as a template to direct the synthesis of a particular protein.  Proteins, in turn, direct all cellular function. The illustration below is a simplified gene expression schematic.  </span></div><div style="margin-top:13pt;text-align:center;text-indent:22.5pt"><img src="ilmn-20241229_g2.gif" alt="a201510kgenegraphica01a01a26.gif" style="height:245px;margin-bottom:5pt;vertical-align:text-bottom;width:248px"/></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variations among organisms are due, in large part, to differences in their DNA sequences. Changes can result from insertions, deletions, inversions, translocations, or duplications of nucleotide bases. These changes may result in certain genes becoming overexpressed (excessive protein production), underexpressed (reduced protein production), or silenced altogether, sometimes triggering changes in cellular function. The most common form of variation in humans is called a single nucleotide polymorphism (SNP), which is a base change in a single position in a DNA sequence. Another type of variation, copy number variations (CNVs), occur when there are fewer or more copies of certain genes, segments of a gene, or stretches of DNA. In humans, genetic variation accounts for many of the physical differences we see (e.g., height, hair, eye color, etc.). Genetic variations also can have medical consequences affecting disease susceptibility, including predisposition to complex genetic diseases such as cancer, </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diabetes, cardiovascular disease, and Alzheimer&#8217;s disease. They can affect individuals&#8217; response to certain drug treatments, causing them to respond well, experience adverse side effects, or not respond at all.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scientists are studying these variations and their consequences in humans, as well as in a broad range of animals, plants, and microorganisms. Such research takes place in government, university, pharmaceutical, biotechnology, and agrigenomics laboratories around the world, where scientists expand our knowledge of the biological functions essential for life. Beginning at the genetic level, our tools are used to elucidate the relationship between gene sequence and biological processes. Researchers who investigate human and non-human genetic variation to understand the mechanisms of disease are enabling the development of more effective diagnostics and therapeutics.  They also provide greater insight into genetic variation in plants (e.g., food and biofuel crops) and animals (e.g., livestock and domestic), enabling improvements in crop yields and animal breeding programs.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By empowering genetic analysis and facilitating a deeper understanding of genetic variation and function, our tools advance disease research, drug development, and the creation of molecular diagnostic tests. We believe that this will trigger a fundamental shift in the practice of medicine and health care, and that the increased emphasis on preventive and predictive molecular medicine will usher in the era of precision health care.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Principal Markets</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We target the markets and customers outlined below.  </span></div><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Applied</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our core business has been in the life sciences research market. This includes laboratories associated with universities, research centers, and government institutions, along with biotechnology and pharmaceutical companies. Researchers at these institutions use our products and services for basic and translational research across a spectrum of scientific applications, including targeted, exome, and whole-genome sequencing; genetic variation; gene expression; epigenetics; and metagenomics. Next-generation sequencing (NGS) technologies are being adopted due to their ability to cost-effectively sequence large sample sizes quickly and accurately, generating vast amounts of high-quality data. Both private and public funding drive this research, along with global initiatives to characterize genetic variation. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products also serve various applied markets including consumer genomics and agrigenomics. For example, in consumer genomics, our customers use our technologies to provide personalized genetic data and analysis to individual consumers. In agrigenomics, government and corporate researchers use our products and services to explore the genetic and biological basis for productivity and nutritional constitution in crops and livestock.  Researchers can identify natural and novel genomic variation and deploy genome-wide marker-based applications to accelerate breeding and production of healthier and higher-yielding crops and livestock.</span></div><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on enabling translational and clinical markets through the introduction of best-in-class sequencing technology. Further, we are developing sample-to-answer solutions to catalyze adoption in the clinical setting, including in reproductive and genetic health and oncology. In reproductive health, our primary focus is driving noninvasive prenatal testing (NIPT) adoption globally through our technology, which identifies fetal chromosomal abnormalities by analyzing cell-free DNA in maternal blood. Our NGS technology is also accelerating rare and undiagnosed disease research to discover the genetic causes of inherited disorders by assessing many genes simultaneously. Using NGS can reduce costs compared to traditional methods of disease diagnosis, which are often expensive and inconclusive while requiring extensive testing.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancer is a disease of the genome, and the goal of cancer genomics is to identify genomic changes that transform a normal cell into a cancerous one. Understanding these genomic changes will improve diagnostic accuracy, increase understanding of the prognosis, and enable oncologists to target therapies to individuals. Customers in the translational and clinical oncology markets use our products to perform research that may help identify individuals who are genetically predisposed to cancer and to identify molecular changes in a tumor. We believe that circulating tumor DNA (ctDNA) will become an important clinical tool for managing oncology patients during all stages of tumor progression. Our technology is being used to research the implications of ctDNA in treatment determination, treatment monitoring, minimal residual disease, and asymptomatic screening. For example, GRAIL&#8217;s Galleri blood test for early-stage cancer detection is enabled by our sequencing technology.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Principal Products, Services, and Technologies</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unique technology platforms support the scale of experimentation necessary for population-scale studies, genome-wide discovery, target selection, and validation studies (see Figure 1 below). Customers use our products to analyze the genome at all levels of complexity, from targeted panels to whole-genome sequencing. A large and dynamic Illumina user community has published hundreds of thousands of customer-authored scientific papers using our technologies. Through rapid innovation, we are changing the economics of genetic research, enabling projects that were previously considered impossible, and supporting clinical advances towards precision medicine. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our product sales consist of sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation, based on our proprietary technologies. We also perform various services for our customers. In 2024, 2023, and 2022, instrument sales represented 12%, 16%, and 16%, respectively, of total consolidated revenue; consumable sales represented 72%, 68%, and 70%, respectively, of total consolidated revenue; and services represented 16%, 16%, and 14%, respectively, of total consolidated revenue. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 1: Illumina Platform Overview: </span></div><div style="margin-top:13pt"><img src="ilmn-20241229_g3.jpg" alt="ir-annual-report-instrument-comparison-2025.jpg" style="height:263px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sequencing </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DNA sequencing is the process of determining the order of nucleotide bases (A, C, G, or T) in a DNA sample. Our portfolio of sequencing platforms represents a family of systems that we believe set the standard for productivity, cost-effectiveness, and accuracy among NGS technologies. Customers use our platforms to perform whole-genome, de novo, exome and RNA sequencing, and targeted resequencing of specific gene regions and genes.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whole-genome sequencing determines the complete DNA sequence of an organism. In de novo sequencing, the goal is to sequence and assemble the genome of that sample without using information from prior sequencing of that species. In targeted resequencing, a portion of the sequence of an organism is compared to a standard or reference sequence from previously sequenced samples to identify genetic variation. Understanding the similarities and differences in DNA sequence between and within species helps us understand the function of the structures encoded in the DNA.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our DNA sequencing technology is based on our proprietary reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis (SBS) biochemistry. SBS tracks the addition of labeled nucleotides as the DNA chain is copied in a massively parallel fashion. In 2023, we launched XLEAP-SBS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a faster, higher quality, and more robust version of our SBS chemistry that delivers the highest level of data accuracy and performance.  Our XLEAP-SBS sequencing technology provides researchers with a broad range of applications and the ability to sequence more than 20,000 human genomes per year per instrument.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sequencing platforms can generate between 500 megabases (Mb) and 16.0 terabases (Tb) (equivalent to approximately 128 human genomes) of genomic data in a single run, depending on the instrument and application.  </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are different price points per gigabase (Gb) for each instrument, and for different applications, which range from small-genome, amplicon, and targeted gene-panel sequencing to population-scale whole human genome sequencing. Since we launched our first sequencing system in 2007, our systems have significantly reduced the cost of sequencing. In 2023, we launched the NovaSeq</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> X Plus, a production-scale sequencing system that can sequence a human genome for as little as $200. In 2024, we launched the benchtop MiSeq i100 series, our fastest, simplest sequencing system, featuring room temperature reagents, empowering every lab, everywhere.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Illumina informatics products play a critical role in supporting our sequencing applications and customers&#8217; needs across a range of activities, including sample preparation, instrument control and management, and post-run analysis. Our BaseSpace Informatics Suite integrates directly with our sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive meaningful results. It facilitates data sharing, provides data-storage solutions and streamlines analysis through a growing number of applications developed by us and the bioinformatics community. Our DRAGEN Bio-IT Platform is used for secondary analysis and analyzes sequencing data from a variety of experiment types, including whole genomes, whole exomes, germline and somatic datasets, and RNA sequencing experiments with industry leading accuracy, speed and efficiency. Additionally, Illumina Connected Analytics is an integrated bioinformatics solution that provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, 2023, and 2022, total sequencing revenue comprised </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91% </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of total consolidated revenue for all periods.</span></div><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Arrays</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arrays are used for a broad range of DNA and RNA analysis applications, including SNP genotyping, CNV analysis, gene expression analysis, and methylation analysis, and enable the detection of millions of known genetic markers on a single array. Arrays are the primary technology used in consumer genomics applications.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform many assays simultaneously. This facilitates large-scale analysis of genetic variation and biological function in a unique, high-throughput, cost-effective, and flexible manner. Using our BeadArray technology, we achieve high-throughput analysis via a high density of test sites per array and the ability to format arrays in various configurations. To serve the needs of multiple markets and market segments, we can vary the size, shape, and format of the substrate into which the beads self-assemble and create specific bead types for different applications. Our iScan System and our NextSeq 550 System can be used to image arrays.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, 2023, and 2022, total array revenue comprised 9% of total consolidated revenue for all periods.</span></div><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumables</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed various library preparation and sequencing kits to simplify workflows and accelerate analysis.  Our sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. In January 2025, we launched Illumina Single Cell 3&#8217; RNA Prep, a simple, end-to-end single cell workflow allowing transcriptome studies of hundreds to millions of cells. Our sequencing kits maximize the ability of our customers to characterize the target genome accurately and are sold in various configurations, addressing a wide range of applications.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers use our array-based genotyping consumables for a wide range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer. Customers can select from a range of human, animal, and agriculturally relevant genome panels or create their own custom arrays to investigate millions of genetic markers targeting any species.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Services</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer support services to customers who have purchased our products. In addition, we provide whole-genome sequencing, genotyping, NIPT, and product support services. Human whole-genome sequencing services are provided through our CLIA-certified, CAP-accredited laboratory. Using our services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). We also provide NIPT services through our partner laboratories that direct samples to us on a test send-out basis in our CLIA-certified, CAP-accredited laboratory.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GRAIL</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRAIL&#8217;s multi-cancer early detection test, Galleri, is designed as a screening test for adults with an elevated risk for cancer, such as those aged 50 or older, and was commercially launched in 2021 as a laboratory developed test.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an extensive intellectual property portfolio. As of December&#160;29, 2024, excluding GRAIL which was spun-off on June&#160;24, 2024, we owned or had exclusive licenses to 1,337 issued U.S. patents and 1,119 pending U.S. patent applications and 8,027 issued patents outside the U.S. and 5,668 pending patent applications outside the U.S. Our issued and pending patents cover various aspects of our arrays, assays, oligo synthesis, sequencing technology, instruments, digital microfluidics, software, bioinformatics, and chemical-detection technologies, and our issued patents have terms that expire between 2025 and 2049. We continue to file new patent applications to protect the full range of our technologies. We have filed or have been granted counterparts for many of these patents and applications in foreign countries. We protect our trade secrets, know-how, copyrights, and trademarks. Our success depends in part on obtaining patent protection for our products and processes, preserving trade secrets, patents, obtaining copyrights and trademarks, operating without infringing the proprietary rights of third parties, and acquiring licenses for technology or products. In addition, we invest in technological innovation, and we seek beneficial licensing opportunities to develop and maintain our competitive position. We are party to various exclusive and nonexclusive license agreements and other arrangements with third parties that grant us rights to use key aspects of our sequencing and array technologies, assay methods, chemical detection methods, reagent kits, and scanning equipment. We have additional nonexclusive license agreements with various third parties for other components of our products. In most cases, the agreements remain in effect over the term of the underlying patents, may be terminated at our request without further obligation, and require that we pay customary royalties.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically made substantial investments in research and development and we expect to continue to make investments in research and development during 2025 to support business growth and our innovation pipeline. Our research and development efforts prioritize continuous innovation coupled with product evolution. Research and development expense in 2024, 2023, and 2022 was $1,169 million, $1,354 million, and $1,321 million, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing and Distribution</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market and distribute our products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region. In addition, we sell through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. We expect to continue making commercial investments in 2025 and beyond as we launch new products and expand our potential commercial base in alignment with our strategy.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture sequencing and array platforms and reagent kits. In 2024, we continued to increase our manufacturing capability, and we expect to increase our manufacturing capability again in 2025 to meet customer demand. To address increasing product complexity and volume, we continue to automate manufacturing processes to accelerate throughput and improve quality and yield. We are committed to providing medical devices and related services that consistently meet customer and applicable regulatory requirements. We adhere to health and safety standards required by federal, state, and local health ordinances, such as standards for the use, handling, and disposal of hazardous substances. Our key manufacturing and distribution facilities operate under a quality management system certified to ISO 13485.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raw Materials</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing operations require a wide variety of raw materials, electronic and mechanical components, chemical and biochemical materials, and other supplies. Multiple commercial sources provide many of our components and supplies, but there are some raw materials and components that we obtain from single-source suppliers. To manage potential risks arising from single-source suppliers, we believe that, if necessary, we could redesign our products using alternative components or for use with alternative reagents or develop an internal supply capability. In addition, while we attempt to keep our inventory at minimal levels, we purchase incremental inventory as circumstances warrant to protect our supply chain. If the capabilities of our suppliers and component manufacturers are limited or stopped, due to pandemics, disasters, quality, regulatory, or other reasons, it could negatively impact our ability to manufacture our products.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that our products and services provide significant advantages over products and services currently available from other sources, we expect continued intense competition. Our competitors offer products, services, and software for sequencing, SNP genotyping, gene expression, proteomics, and molecular diagnostics markets. In some cases, we compete for the resources our customers allocate for purchasing a wide range of sequencing and non-sequencing products used to analyze genetic variation and associated biological functions, some of which are complementary or adjacent to our own but not directly competitive; in other cases, our products face direct competition as customers choose among sequencing and non-sequencing products that are designed to address the same use case or answer the same biological question. Some of our competitors have, or will have, substantially greater financial, technical, research, artificial intelligence capabilities, and other resources than we do, along with larger, more established marketing, sales, distribution, and service organizations. In addition, they may have greater name recognition than we do in the markets we address, and in some cases a larger installed base of systems. We expect new competitors to emerge and the intensity of competition to increase. To compete effectively, we must scale our organization and infrastructure appropriately and demonstrate that our products have superior throughput, cost, and accuracy.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment and Geographic Information</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one reportable segment, Core Illumina, as of December&#160;29, 2024. Prior to the Spin-Off of GRAIL into a separate, independent publicly traded company on June&#160;24, 2024, our reportable segments included both Core Illumina and GRAIL. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_136">12. Segment and Geographic Information</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details on our reportable segments.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently sell our products to a number of customers outside the United States, including customers in other areas of North America, Latin America, Europe, China, and the Asia-Pacific region. Shipments to customers outside the United States totaled $2,084 million, or 48%, of total consolidated revenue in 2024, compared to $2,145 million, or 48%, and $2,294 million, or 50%, in 2023 and 2022, respectively. We consider the U.S. dollar to be the functional currency of our international operations due to the primary activities of our foreign subsidiaries. We expect that sales to international customers will continue to be an important and growing source of revenue. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_91">1. Organization and Significant Accounting Policies</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_94">3. Revenue</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Consolidated Financial Statements section of this report for further information concerning our foreign and domestic operations.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Backlog</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our backlog was $657 million and $653 million as of December&#160;29, 2024 and December&#160;31, 2023, respectively, and consists of orders believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The timing of shipments depends on several factors, including agreed upon shipping schedules, which may span multiple quarters, and whether the product is catalog or custom. We expect 78% of our backlog as of December&#160;29, 2024 to be shipped in 2025, 10% in 2026, and the remainder thereafter. Although we generally recognize revenue when control of our products and services is transferred to our customers, some customer contracts might require us to defer revenue recognition beyond the transfer of control.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_16"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Properties</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table, excluding GRAIL which was spun-off on June&#160;24, 2024, summarizes the facilities we leased as of December&#160;29, 2024, including location and size of each principal facility and designated use. We believe our facilities are adequate for our current and near-term needs, and we will be able to locate additional facilities, as needed.</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:27.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.921%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.709%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Square Feet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease <br/>Expiration Dates</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San&#160;Diego, CA</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860,000&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office, Lab, Manufacturing, and Distribution</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030&#160;&#8211; 2031</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office, Lab, Manufacturing, and Distribution</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027&#160;&#8211; 2037</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Francisco Bay Area, CA </span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,000&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office, Lab, and Manufacturing</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025&#160;&#8211; 2033</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cambridge, United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office, Lab, and Manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025&#160;&#8211; 2038</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madison, WI</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,000&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office, Lab, and Manufacturing</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eindhoven, the Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and Distribution</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,000&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and Lab</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 &#8211; 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and Lab</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 &#8211; 2029</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,000&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and Lab</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 &#8211; 2030</span></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To continue as a leader in genomics, we need to harness the world&#8217;s best talent and give them the opportunity to thrive. We are committed to attracting, retaining, developing, and supporting our people to enable everyone to fully contribute to our mission and deliver on the transformative power of genomics. We drive innovation by embracing new perspectives and making Illumina a place where everyone can belong. Our key human capital objectives include: attract extraordinary talent, invest in our people, support employee health, safety, and well-being, and engage our people and communities. Additional information is included in our annual Corporate Social Responsibility (CSR) Report, located on our website at www.illumina.com/csr. Information on our website, including the CSR Report, shall not be deemed incorporated by reference into this Annual Report. Our annual CSR Report is guided by the reporting frameworks of the Global Reporting Initiative (GRI), Sustainable Accounting Standards Board (SASB), and the Task Force for Climate related Financial Disclosures (TCFD).</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, excluding GRAIL which was spun-off on June&#160;24, 2024, our global workforce was comprised of approximately 8,970 full time employees, 60 part time employees, and 1,340 contingent workers. The regional representation includes approximately 5,250 employees in the Americas, 1,290 employees in Europe, 2,190 employees in Africa, Middle East and Asia, and 300 employees in Greater China. The global voluntary turnover rate for 2024 was 7%. Additional details about our workforce for 2024 will be available in our annual CSR Report, which we expect to publish in May 2025 on our website at www.illumina.com/csr.</span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_19"></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybersecurity</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-36" continuedAt="f-36-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-37" escape="true">Our cybersecurity risk management strategy is <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-38">integrated</ix:nonNumeric> into our established enterprise risk management program, which includes defined risk, assessment, mitigation, and reporting processes.</ix:nonNumeric> Our information security team has deployed multiple technical and operational processes to aid in our ability to continuously identify and respond to cybersecurity threats and incidents. Our cybersecurity incident management process includes impact assessment, containment, mitigation and recovery strategies.</span></div></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-36-1"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our continuous monitoring of our information systems, we <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-39">utilize third parties</ix:nonNumeric> to provide external threat intelligence and evaluation of incident notifications in order to identify potential threats or incidents that could impact us. We also evaluate our cybersecurity program against the National Institute of Standards and Technology&#8217;s Cybersecurity Framework. For all suspected cybersecurity incidents, the information security team conducts a preliminary assessment to determine the potential severity and impact extent of the incident and, where appropriate, a materiality assessment is made. Upon a confirmed cybersecurity incident, the information security team initiates an incident response process with goals to contain, respond, recover, protect and minimize any impacts caused by the incident. The response process includes deployment of a variety of short term and long-term technical and procedural actions as appropriate. Further, <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-40">we have established a third party risk management program to monitor suppliers who have access to our information.</ix:nonNumeric></span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-43" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-42" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-41" escape="true">Our Audit Committee, a committee of our Board of Directors, is responsible for governing management&#8217;s review and assessment of our cybersecurity and other information technology risks, controls, and procedures, including management&#8217;s incident resolution process and any specific cybersecurity issues that could affect the adequacy of our internal controls.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-44" escape="true">Our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-45">Chief Information Officer</ix:nonNumeric> provides regular updates to the Audit Committee and to the Board of Directors, including a review of any security risk events and improvements in our security controls.</ix:nonNumeric></span></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-47" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-46" escape="true">Our information security team, under the Chief Information Officer, is led by our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-48">Chief Information Security Officer (CISO)</ix:nonNumeric> and is responsible for assessing and managing risks from cybersecurity threats.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-49" escape="true">Our CISO has over 20 years of information security experience, including as a leader of information security programs at other large enterprises, and is supported by a team of professionals focused on information security.</ix:nonNumeric> Our information security team regularly meets to review our cybersecurity posture, the broader cybersecurity landscape and any identified cybersecurity incidents. Our information security team has procedures in place for investigating suspected cybersecurity incidents, as well as monitoring cybersecurity risks and ongoing mitigation strategies, the status of prevention, detection, and mitigation controls and any planned future control enhancement</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-50">We believe that risks from prior cybersecurity threats to information systems owned and used by us, including as a result of any previous cybersecurity incidents, have not materially affected our business to date.</ix:nonNumeric> We can provide no assurance that there will not be incidents in the future or that they will not materially affect us, including our business strategy, results of operations, or financial condition. We maintain a cybersecurity insurance policy which may mitigate certain financial impacts of a cybersecurity inciden</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to &#8220;Risks Relating to Information Technology Security and Continuity&#8221; within the </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">Risk Factors</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Business &amp; Market Information Section of this report.</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Matters</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global corporate citizen, we recognize the importance of the environment to a healthy, sustainable future for our business, our patients, and communities. We are committed to the protection of our employees and the environment with an approach to continuously strengthen our environmental stewardship. We believe that we are in material compliance with current applicable laws and regulations. However, we could be held liable for damages and fines should contamination of the environment or individual exposures to hazardous substances occur. In addition, we cannot predict how changes in these laws and regulations, or the development of new laws and regulations, will affect our business operations or the cost of compliance. Further, regulators are considering, and in some cases have implemented, new environmental disclosure rules. For example, California has recently enacted new climate-related disclosure rules and requirements. The cost of complying with any new disclosure regimes is uncertain. In addition, climate change may impact our business by increasing operating costs due to additional regulatory requirements, physical risks to our facilities, energy limitations, and disruptions to our supply chain. These potential risks are accounted for in our business planning, including investment in renewable energy, reducing energy and water consumption, greenhouse gas emissions, and waste production. As part of our climate action plan, we established emission reduction targets in line with a 1.5 degree pathway, established Net Zero emission commitments by 2050, and had those targets verified by the Sciences Based Target Initiative. Additional information is included in our annual CSR Report located on our website at www.Illumina.com/csr.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand product lines to address the diagnosis of disease, regulation by governmental authorities in the U.S. and other countries will become an increasingly significant factor in development, testing, production, and marketing activities. Products that we develop in the molecular diagnostic markets, depending on their intended use, may be regulated as medical devices or in vitro diagnostic products (IVDs) by the FDA and comparable agencies in other countries. In the U.S., certain of our products may require FDA clearance following a pre-market notification process, also known as a 510(k) clearance, or premarket approval (PMA) from the FDA. The usually shorter 510(k) clearance process, which we used for the FDA-cleared assays that are run on our FDA-regulated MiSeqDx instrument, generally takes from three to six months after submission, but it can take significantly longer. The longer PMA process, which we used for our FDA-approved TruSight Comprehensive Oncology panel that is run on our NextSeq550 Dx instrument, is typically much more costly and uncertain. It can take from 9 to 18 months after a complete filing, but it can take significantly longer and requires conducting clinical studies that are generally more extensive than those required for 510(k) clearance. All of the products that are currently regulated by the FDA as medical devices and IVDs are also subject to the FDA Quality System Regulation (QSR). Obtaining the requisite regulatory approvals, including the FDA quality system inspections that are required for PMA approval, can be expensive and may involve considerable delay. In the U.S., the products we develop for oncology and non-invasive prenatal testing will be regulated by the PMA process. We cannot be certain which of our other planned molecular diagnostic products will be subject to the shorter 510(k) clearance process, or which of these will need to go through the PMA process.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory approval process for such products may be significantly delayed, may be significantly more expensive than anticipated, and may conclude without such products being approved by the FDA. Without timely regulatory approval, we will not be able to launch or successfully commercialize such products, which would adversely affect our earnings and competitive position. Many of the products that we are developing are the first of their kind. The regulatory approval pathways for such products do not currently exist and therefore have a high degree of uncertainty.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to the current regulatory framework, including the imposition of additional or new regulations, could arise at any time during the development or marketing of our products. This may negatively affect our ability to obtain or maintain FDA or comparable regulatory clearance or approval of our products. In addition, regulatory agencies may introduce new requirements that may change the regulatory requirements for us or our customers, or both. For example, the final rule published by the FDA in 2024 allows the FDA to regulate laboratory developed tests (LDTs). Under the final rule, our customers will be required to either submit their current test for FDA approval or find an IVD manufacturer to supply them with IVDs. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our products labeled as &#8220;For Research Use Only,&#8221; or RUO, are used, or could be used, for the diagnosis of disease, the regulatory requirements related to marketing, selling, and supporting such products could be uncertain. This is true even if such use by our customers occurs without our consent. If the FDA or other regulatory authorities assert that any of our RUO products are subject to regulatory clearance or approval, our business, financial condition, or results of operations could be adversely affected.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products sold as medical devices or IVDs in Europe are now regulated under the In Vitro Diagnostics Regulation (EU) 2017/746, the IVDR, that went into full enforcement in May 2022. These regulations include requirements for both presentation and review of performance data and quality-system requirements.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our products are currently available through laboratories that are certified under the Clinical Laboratory Improvements Amendments (CLIA) of 1988. These products are commonly called &#8220;laboratory developed tests,&#8221; or LDTs. For a number of years, the FDA has exercised its regulatory enforcement discretion not to regulate LDTs as medical devices if created and used within a single laboratory. However, as mentioned above, the FDA published a final rule in 2024 that phases out the enforcement discretion over a 4 year time period. The final rule is effective as of the 2024 publication. While this rule is being challenged in the U.S. court system, if the final rule stands in its current form, laboratories will be required to submit LDTs for FDA approval and will be required to implement a fully compliant Quality Management System (QMS).</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification of CLIA laboratories includes standards in the areas of personnel qualifications, administration, and participation in proficiency testing, patient test management, and quality control procedures. CLIA also mandates that, for high complexity labs such as ours, to operate as a lab, we must have an accreditation by an organization recognized by CLIA such as the College of Pathologists (CAP), which we have obtained and must maintain. If we were to lose our CLIA certification or CAP accreditation, our business, financial condition, or results of operations could be adversely affected. In addition, state laboratory licensing and inspection requirements may also apply to our products, which, in some cases, are more stringent than CLIA requirements.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_22"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RISK FACTORS</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report and other documents we file with the SEC contain forward-looking statements that are based on current expectations, estimates, forecasts and projections about us, our future performance, our business, our beliefs and our management&#8217;s assumptions. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. You should carefully consider the risks and uncertainties our business faces. The risks described below are not the only ones we face. Our business is also subject to the risks that affect many other companies, such as employment relations, general economic conditions, geopolitical events and international operations. Further, additional risks not currently known to us or that we currently believe are immaterial may in the future materially and adversely affect our business, operations, liquidity and stock price.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Our Sales of Products and Services, Marketing and Research and Development</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our success depends upon the continued emergence and growth of markets for analysis of genetic variation, and continued substantial increases in the use of sequencing as the cost of sequencing declines.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The usefulness of our technologies depends in part upon the availability of genetic data and its usefulness in clinical, research, and consumer applications. We are focusing on markets for analysis of genetic variation or biological function, namely sequencing, genotyping, and gene expression profiling. These markets are relatively new and emerging, and they may not develop as quickly as we anticipate, or reach what we expect to be their full potential.  Other methods of analysis of genetic variation and biological function may emerge and displace the methods we are developing. In addition, a reduction or delay in research and development budgets and government funding may adversely affect our business. For example, changes in the regulatory environment affecting life sciences and pharmaceutical companies, and reduced allocations to government agencies that fund research and development activities, such as the U.S. National Institutes of Health, or NIH, or targeted cancellations by the U.S. federal government of certain grants or contracts, could adversely affect our business or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The introduction of next-generation sequencing technologies, including ours, has reduced the cost of sequencing by a factor of more than 10,000 and reduced the sequencing time per Gb by a factor of approximately 12,000 over the last 20 years. Consequently, demand for sequencing-related products and services has increased substantially as new applications are enabled and more sequencing is done in connection with existing applications. If, as we expect, the cost of sequencing continues to fall, we cannot be sure that the demand for related products and services will increase at least proportionately as new applications are enabled or more sequencing is done in connection with existing applications. In the future, if demand for our products and services due to lower sequencing costs is less than we expect, our business, financial condition, and results of operations will be adversely affected.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products may be used to provide genetic information about humans, agricultural crops, other food sources, and other living organisms. The information obtained from our products could be used in a variety of applications, which may have underlying ethical, legal, and social concerns regarding privacy and the appropriate uses of the resulting information, including preimplantation genetic screening of embryos, prenatal genetic testing, genetic engineering or modification of agricultural products, or testing genetic predisposition for certain medical conditions, particularly for those that have no known cure. Our customers&#8217; implementation of our products to provide their own products and services may raise such concerns and affect our own reputation. U.S. and international governmental authorities could, for social or other purposes, call for limits on or regulation of the use of genetic testing or prohibit testing for genetic predisposition to certain conditions, particularly for those that have no known cure. Similarly, such concerns may lead individuals to refuse to use genetics tests, even if permissible. These and other ethical, legal, and social concerns about genetic testing may limit market acceptance of our technology for certain applications or reduce the potential markets for our technology, either of which could have an adverse effect on our business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We face intense competition, which could render our products obsolete, result in significant price reductions, or substantially limit the volume of products that we sell.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with third parties that design, manufacture, and market products and services for analysis of genetic variation and biological function and other applications using a wide range of technologies. We have faced, and expect to continue to face, increased pricing pressure from competitors who offer sequencing products and we have experienced lengthened sales cycles with many customers due to competition. In some cases, we compete for the resources our customers allocate for purchasing a wide range of sequencing and non-sequencing products, some of which are complementary or adjacent to our own but not directly competitive; in other cases, our products face direct </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">competition as customers choose among sequencing and non-sequencing products that are designed to address the same use case or answer the same biological question. For example, complementary third-party sequencing technologies address use cases to which our products are not as well suited. If we are unable to develop or acquire new technologies that address these complementary sequencing applications, our rate of growth and our ability to grow the overall market for sequencing could be adversely affected. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to face increased competition as existing companies develop new or improved products and as new companies enter the market with new technologies. One or more of our competitors may render one or more of our technologies obsolete or uneconomical. Some of our competitors have greater financial and personnel resources, broader product lines, more focused product lines, a more established customer base, more experience and broader reach in clinical markets, and more experience in research and development than we do.  Furthermore, life sciences, clinical genomics, and pharmaceutical companies, which are our potential customers and strategic partners, could also develop competing products. We believe that customers in our markets display a significant amount of loyalty to their initial supplier of a particular product; therefore, it may be difficult to generate sales to potential customers who have purchased products from competitors. To the extent we are unable to be the first to develop or supply new products, our competitive position may suffer.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for clinical and diagnostic products, in particular, is currently limited and highly competitive, with several large companies having significant market share, intellectual property portfolios, and regulatory expertise. For example, the market for noninvasive prenatal testing is rapidly developing, and if our competitors are able to develop and commercialize products superior to or less expensive than ours or are able to obtain regulatory clearances before we do, our business could be adversely impacted. Established clinical and diagnostic companies also have an installed base of instruments in several markets, including clinical and reference laboratories, which could deter acceptance of our products. In addition, some of these companies have formed alliances with genomics companies that provide them access to genetic information that may be incorporated into their diagnostic tests, potentially creating a competitive advantage for them.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">China&#8217;s Ministry of Commerce has added Illumina to its List of Unreliable Entities, which could result in fines or restrictions on our ability to do business in China and could have a material adverse effect on our revenue and results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 4, 2025, China&#8217;s Ministry of Commerce (MOFCOM) announced that it had added Illumina to its List of Unreliable Entities under the Provisions of the List of Unreliable Entities (the UEL Provisions). Under the UEL Provisions, potential penalties for companies placed on the List of Unreliable Entities can include monetary fines, restrictions or prohibitions on the sale of goods in China, engaging in import and export activities related to China, making investments in, or extracting investments from, China, denial of entry of our relevant personnel into China, restrictions or revocation of work permits, stay or residence status of our relevant personnel in China, or other measures.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MOFCOM has not announced what penalties will be imposed on us and we cannot currently predict the duration of our inclusion on the List of Unreliable Entities or any actions that may ultimately be taken by MOFCOM. The decision to place us on the List of Unreliable Entities and any future decision to take action to impose and enforce penalties or restrictions against us could have a material adverse effect on our revenue and results of operations. Furthermore, if, as a result of any such penalties or restrictions, we were to cease entirely or curtail operations in China, we could incur material impairment charges related to any such exit or disposal activities. Our revenue from the Greater China region, which includes China, Taiwan, and Hong Kong, was $308 million in 2024. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_94">3. Revenue</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we do not successfully manage the development, manufacturing, and launch of new products or</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">services, including product transitions, our financial results could be adversely</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">affected.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face risks associated with launching new products and pre-announcing products and services when the products or services have not been fully developed or tested. In addition, we may experience difficulty in managing or forecasting customer reactions, purchasing decisions, transition requirements, or programs with respect to newly-launched products (or products in development), which could adversely affect sales of our existing products. If our products and services are not able to deliver the performance or results expected by our target markets or are not delivered on a timely basis, our reputation and credibility may suffer. If we encounter development challenges or discover errors in our products late in our development cycle, we may delay the product launch date. The expenses or losses associated with unsuccessful product development or launch activities, or a lack of market acceptance of our new products, could adversely affect our business, financial condition, or results of operations.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we announce future products or integrate new products into our portfolio, such as new instruments or instrument platforms, we face numerous risks relating to product transitions and the evolution of our product portfolio. We may be unable to accurately forecast new product demand and the impact of new products on the demand for current or established products. We may experience challenges relating to managing excess and obsolete inventories, managing new or higher product cost structures, and managing different sales and support requirements.  Announcements of currently planned or other new products may cause customers to defer or stop purchasing our current or established products until new products become available. In addition, customers may defer or stop purchasing our current or established products as they assess the features and technological characteristics of new products, as compared to our current or established products, before making a financial commitment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our continued growth is dependent on continuously developing and commercializing new</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">products.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our target markets are characterized by rapid technological change, changes in customer needs, existing and emerging competition, strong price competition, and frequent new product introductions. Accordingly, our continued growth depends on developing and commercializing new products and services, including improving our existing products and services, in order to address evolving market requirements on a timely basis. If we fail to innovate or adequately invest in new technologies, we could lose our competitive position in the markets that we serve.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we fail to introduce new and innovative products, or such products are not accepted in the market or suffer significant delays in development, our financial results may suffer. An inability, for technological or other reasons, to successfully develop and introduce new products on a timely basis could reduce our growth rate or otherwise have an adverse effect on our business.  </span></div><div style="margin-bottom:10pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, we have experienced, and are likely to experience in the future, delays in the development and introduction of new products. There can be no assurance that we will keep pace with the rapid rate of change in our markets or that our new products will adequately meet the requirements of the marketplace, achieve market acceptance, or compete successfully with third-party technologies. Some of the factors affecting our ability to develop and successfully commercialize new products and services include:</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the functionality and performance of new and existing products and services;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of introduction of new products or services relative to competing products and services;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability, quality, and price relative to competing products and services;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">scientists&#8217; and customers&#8217; opinions of the utility of new products or services;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">citation of new products or services in published research;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory trends and approvals; and</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to acquire or otherwise gain access to third party technologies, products, or businesses.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As we develop, market, or sell diagnostic tests, we may encounter delays in receipt, or limits in the amount, of reimbursement approvals and public health funding, which will impact our ability to grow revenues in the healthcare market.</span></div><div style="margin-bottom:10pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physicians and patients may not order diagnostic tests that we develop, market, sell, or enable, such as our prenatal tests, unless third-party payors, such as managed care organizations as well as government payors such as Medicare and Medicaid and governmental payors outside of the United States, pay a substantial portion of the test price. Third-party payors are often reluctant to reimburse healthcare providers for the use of medical tests that involve new technologies or provide novel diagnostic information. In addition, third-party payors are increasingly limiting reimbursement coverage for medical diagnostic products and, in many instances, are exerting pressure on diagnostic product suppliers to reduce their prices. Reimbursement by a payor may depend on a number of factors, including a payor's determination that tests using our technologies are: not experimental or investigational; medically necessary; appropriate for the specific patient; cost-effective; supported by peer-reviewed publications; and included in clinical practice guidelines.  </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since each third-party payor often makes independent reimbursement decisions and may also make decisions on an individual patient basis, obtaining such approvals is a time-consuming and costly process that requires Illumina and/or our customers to provide scientific and clinical data supporting the clinical benefits of each of our products. As a result, there can be no assurance that reimbursement approvals will be obtained. This process can delay the broad market introduction of new products, and could have a negative effect on our results of operations. As a result, third-party reimbursement may not be consistent or financially adequate to cover the cost of diagnostic products that we develop, market, or sell. This could limit our ability to sell our products or cause us to reduce prices, which would adversely affect our results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if tests are reimbursed, third-party payors may withdraw their coverage policies, cancel their contracts with our customers at any time, review and adjust the rate of reimbursement, require co-payments from patients, or stop paying for tests, which would reduce our revenues. In addition, insurers, including managed care organizations as well as government payors such as Medicare and Medicaid, have increased their efforts to control the cost, utilization, and delivery of healthcare services. These measures have resulted in reduced payment rates and decreased utilization for the clinical laboratory industry. Reductions in the reimbursement rate of payors may occur in the future.  Reductions in the prices at which our tests are reimbursed could have a negative impact on our results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Uncertainties with respect to the development, deployment, and use of artificial intelligence in our business and products may result in harm to our business and reputation.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incorporated, and expect to continue to incorporate, artificial intelligence (AI) into our business activities and our product and service offerings. As with many innovations, AI presents risks and challenges that could adversely impact our business. The development, adoption, and use of AI technologies are still in their early stages and ineffective or inadequate AI development or deployment practices could result in unintended consequences. For example, AI algorithms may be flawed or may be based on datasets that are biased or insufficient. In addition, any disruption or failure in the AI functionality we incorporate into our business activities, products or services could adversely impact our business or result in delays or errors in our offerings. Conversely, any failure to successfully develop and deploy AI in our business activities, products and services could adversely affect our competitiveness (particularly if our competitors successfully deploy AI in their businesses, products, and services), and the development and deployment of AI will require additional investment and increase our costs. There also may be real or perceived social harm, unfairness, or other outcomes that undermine public confidence in the use and deployment of AI. Any of the foregoing may result in decreased demand for our products or harm to our reputation, business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legal and regulatory landscape surrounding AI technologies is rapidly evolving and uncertain, including in the areas of intellectual property, cybersecurity, and privacy and data protection. Compliance with new or changing laws, regulations or industry standards relating to AI may impose significant costs and may limit our ability to develop, deploy, or use AI technologies. Failure to appropriately respond to this evolving landscape may result in legal liability, regulatory action, or brand and reputational harm.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Supply Chain, Manufacturing, and Quality</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We depend on third-party manufacturers and suppliers for some of our products, or sub-assemblies, components, and materials used in our products, and if shipments from these manufacturers or suppliers are delayed or interrupted, or if the quality of the products, components, or materials supplied do not meet our requirements, we may not be able to launch, manufacture, or ship our products in a timely manner, or at all.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The complex nature of our products requires customized, precision-manufactured sub-assemblies, components, and materials that currently are available from a limited number of sources, and, in the case of some sub-assemblies, components, and materials, from only a single source. If deliveries from these vendors are delayed or interrupted for any reason, or if we are otherwise unable to secure a sufficient supply, we may not be able to obtain these sub-assemblies, components, or materials on a timely basis or in sufficient quantities or at satisfactory qualities. We may need to enter into contractual relationships with manufacturers for commercial-scale production of some of our products, in whole or in part, or develop these capabilities internally, and there can be no assurance that we will be able to do this on a timely basis, in sufficient quantities, satisfactory quality, or on commercially reasonable terms. In addition, the lead time needed to establish a relationship with a new supplier, and qualify their supply, can be lengthy, and we may experience delays in meeting demand in the event we must switch to a new supplier. The time and effort required to qualify a new supplier could result in additional costs, diversion of resources, or reduced manufacturing yields, any of which would negatively impact our operating results. Accordingly, we may not be able to establish or maintain reliable, high-volume manufacturing at commercially reasonable costs. In addition, the manufacture or </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shipment of our products may be delayed or interrupted if the quality of the products, sub-assemblies, components, or materials supplied by our vendors does not meet our requirements. Current or future social and environmental regulations or critical issues, such as those relating to the sourcing of minerals from conflict-affected areas such as the Democratic Republic of the Congo or the need to eliminate environmentally sensitive materials from our products, could restrict the supply of components and materials used in production or increase our costs. Any delay or interruption to our manufacturing process or in shipping our products could result in lost revenue, which would adversely affect our business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In the past, defects have been discovered in our products, as a result of which we have incurred costs and our products have been subject to recalls. If defects are discovered in our products in the future, we may incur additional unforeseen costs, our products may be subject to recalls, customers may not purchase our products, our reputation may suffer, and ultimately our sales and operating earnings could be negatively impacted.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products incorporate complex, precision-manufactured mechanical parts, electrical components, optical components, and fluidics, as well as computer software and complex surface chemistry, biochemistry and reagents, any of which may contain or result in errors or failures, especially when first introduced. In the course of conducting our business, we must adequately address quality issues associated with our products and services, including defects in our engineering, software development, product cybersecurity, design, and manufacturing processes, as well as defects in third-party components included in our products. In addition, new products or enhancements may contain undetected errors or performance problems that, despite testing, are discovered only after commercial shipment. Defects or errors in our products have resulted in shipment holds, product recalls, negative publicity and adverse financial impacts in the past. The costs incurred in correcting any defects or errors may be substantial and could adversely affect our operating margins. Identifying the root cause of quality issues, particularly those affecting reagents and third-party components, may be difficult, which increases the time needed to address quality issues as they arise, and increases the risk that similar problems could recur. Because our products are designed to be used to perform complex genomic analysis and our instruments can be, and often are, connected to the internet, which presents product cybersecurity risk, we expect that our customers will have an increased sensitivity to such defects. If we do not meet applicable regulatory or quality standards, our products may be, and in the past have been, subject to recall, and, under certain circumstances, we may be required to, and have in the past been required to, notify applicable regulatory authorities about a recall. Quality issues may also result in, and have in the past resulted in, additional regulatory and governmental scrutiny. If our products are subject to recall or shipment holds, our reputation, business, financial condition, or results of operations could be adversely affected.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to increase our manufacturing or service capacity and develop and maintain operation of our manufacturing or service capability, we may not be able to launch or support our products or services in a timely manner, or at all.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to increase our manufacturing and service capacity to meet the anticipated demand for our products.  Although we have consistently increased our manufacturing and service capacity, and we believe we have plans in place sufficient to ensure we have adequate capacity to meet our current business plans, there are uncertainties inherent in expanding our manufacturing and service capabilities, and we may not be able to sufficiently increase our capacity in a timely manner. For example, manufacturing and product quality issues may arise as we increase production rates at our manufacturing facilities and launch new products. Also, we may not manufacture the right product mix to meet customer demand, especially as we introduce new products. As a result, we may experience difficulties in meeting customer, collaborator, and internal demand, in which case we could lose customers or be required to delay new product introductions, and demand for our products could decline. Additionally, in the past, we have experienced variations in manufacturing conditions and quality control issues that have temporarily reduced or suspended production of certain products. Due to the intricate nature of manufacturing complex instruments, consumables, and products that contain DNA and enzymes, we may encounter similar or previously unknown manufacturing difficulties in the future that could significantly reduce production yields, impact our ability to launch or sell these products (or to produce them economically), or prevent us from achieving expected performance levels, any of which could adversely affect our business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">An interruption in our ability to manufacture our products or an inability to obtain key components or raw materials due to a catastrophic disaster, infectious disease, or infrastructure failure could adversely affect our business.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently manufacture in a limited number of locations. Our manufacturing facilities are located in San Diego and the San Francisco Bay Area in California; Madison, Wisconsin; Cambridge, United Kingdom; and Singapore. These </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">areas are subject to natural disasters such as earthquakes, wildfires, or floods. If a natural disaster were to damage one of our facilities significantly or if other events, such as the outbreak of a serious infectious disease, were to cause our operations to fail or be significantly curtailed, we may be unable to manufacture our products, provide our services, or develop new products. In addition, if the capabilities of our suppliers and component manufacturers are limited or stopped, due to the outbreak of a serious infectious disease, natural or other disasters, quality, regulatory, or other reasons, it could negatively impact our ability to manufacture our products.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our product manufacturing and distribution processes are automated and are controlled by information management systems, including significant network and storage infrastructure. If either our information management systems or our network or storage infrastructure were to fail for an extended period of time, our ability to manufacture our products on a timely basis could be adversely impacted and we could be prevented from achieving our expected shipments in any given period.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Our Strategic Collaborations</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to maintain and successfully manage our strategic collaborations, our future results may be adversely impacted.</span></div><div style="margin-bottom:10pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Strategic collaborations require significant management attention and operational resources. If we are unable to successfully manage or meet milestones related to our strategic collaborations, or if our partners do not perform as we expect, our future results may be adversely impacted. Furthermore, dependence on collaborative arrangements may also subject us to other risks, including:</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to relinquish important rights, including intellectual property, marketing and distribution rights;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may disagree with our partners as to rights to intellectual property, the direction of research programs, or commercialization activities;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our revenues may be lower than if we were to develop and commercialize such products ourselves;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a collaboration partner could develop and market a product that is competitive with either products developed under the collaboration or other of our products, either independently or in collaboration with others, including our competitors; </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our partners could become unable or less willing to expend their resources in support of our collaboration;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborations could expose us to additional regulatory risks; and</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unsuccessful at managing multiple simultaneous collaborations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, disagreements with a partner or former partner could develop, and any conflict with a partner or former partner could reduce our ability to enter into future collaboration agreements and negatively impact our relationships with one or more existing partners.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Relating to the Protection of Our Intellectual Property</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any inability to effectively protect our proprietary technologies could harm our competitive position.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proprietary positions of companies developing tools for the life sciences, genomics, forensics, agricultural, and pharmaceutical industries, including our proprietary position, generally are uncertain and involve complex legal and factual questions. Our success depends to a large extent on our ability to develop proprietary products and technologies and to obtain patents and maintain adequate protection of our intellectual property in the United States and other countries. The laws of some foreign countries do not protect proprietary rights to the same extent as the laws of the United States, and many companies have encountered significant challenges in establishing and enforcing their proprietary rights outside of the United States. These challenges can be caused by the absence of rules and methods for the establishment and enforcement of intellectual property rights outside of the United States.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be able to protect our proprietary rights from unauthorized use by third parties only to the extent that our proprietary technologies are covered by valid and enforceable patents or are effectively maintained as trade secrets.  Any finding that our patents or applications are unenforceable could harm our ability to prevent others from practicing the related technology, and a finding that others have inventorship or ownership rights to our patents and applications could require us to obtain certain rights to practice related technologies, which may not be available on favorable terms, if at all. Furthermore, as issued patents expire, including those related to our sequencing-by-synthesis technology, we may lose some competitive advantage as others develop, market, and sell competing products, which could negatively affect our revenue.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our existing patents and any future patents we obtain may not be sufficiently broad to prevent others from practicing our technologies or from developing competing products and may therefore fail to provide us with any competitive advantage. We may need to initiate lawsuits to protect or enforce our patents, or litigate against third-party claims, which would be expensive, and, if we lose, may cause us to lose some of our intellectual property rights and reduce our ability to compete in the marketplace. Furthermore, these lawsuits may divert the attention of our management and technical personnel. There is also the risk that others may independently develop similar or alternative technologies or design around our patented technologies. In that regard, certain patent applications in the United States may be maintained in secrecy until the patents issue, and publication of discoveries in the scientific or patent literature tend to lag behind actual discoveries by several months.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely upon trade secrets and proprietary know-how protection for our confidential and proprietary information, and we have taken security measures to protect this information. These measures, however, may not provide adequate protection for our trade secrets, know-how, or other confidential information. Additionally, the use of artificial intelligence (AI) based software is increasingly common. Use of AI based software may lead to the inadvertent release of confidential proprietary information which may impact our ability to realize the benefit of our intellectual property.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Related to Acquisitions, Including the Acquisition of GRAIL</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our acquisitions expose us to risks that could adversely affect our business, and we may not achieve the anticipated benefits of acquisitions of businesses or technologies.</span></div><div style="margin-bottom:10pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategy to develop and identify new products, services, and technologies, we have made, and may continue to make, acquisitions of technologies, products, or businesses. Acquisitions involve numerous risks and operational, financial, and managerial challenges, including the following, any of which could materially and adversely affect our business, financial condition, or results of operations:</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges, costs, delays, and uncertainty associated with obtaining any required regulatory approvals;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in integrating new operations, technologies, products, and personnel;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of synergies or the inability to realize expected synergies and cost-savings;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lengthy, expensive, and time and resource-intensive regulatory review processes, the outcomes of which can be unpredictable;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in managing geographically dispersed operations;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">underperformance of any acquired technology, product, or business relative to our expectations and the price we paid;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative near-term impacts on financial results after an acquisition, including acquisition-related earnings charges;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential loss of key employees, customers, and strategic partners of acquired companies;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">claims by terminated employees and shareholders of acquired companies or other third parties related to the transaction;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the issuance of dilutive securities, assumption or incurrence of additional debt obligations or expenses, or use of substantial portions of our cash;  </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management&#8217;s attention and company resources from existing operations of the business;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inconsistencies in standards, controls, procedures, and policies;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impairment of intangible assets as a result of technological advancements, or worse-than-expected performance of acquired companies; and  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assumption of, or exposure to, known or unknown contingent liabilities or liabilities that are difficult to identify or accurately quantify.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the successful integration of acquired businesses requires significant efforts and expense across all operational areas, including sales and marketing, research and development, manufacturing, finance, legal, and information technologies. There can be no assurance that any of the acquisitions we make will be successful or will be, or will remain, profitable. Our failure to successfully address the above risks may prevent us from achieving the anticipated benefits from any acquisition in a reasonable time frame, or at all.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">On June 24, 2024, we completed the separation of GRAIL into a separate, independent publicly traded company. As of September 6, 2024, all previously disclosed regulatory proceedings in the United States and European Union related to our acquisition of GRAIL (the Acquisition) have come to an end. Litigation, regulation, and other proceedings related to or resulting from the Acquisition have resulted in operational restrictions and increased costs and could result in similar additional future consequences or further result in loss of revenues.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the Acquisition was subject to various legal challenges, including by the FTC and European Commission. As a result, we have been a party to a number of regulatory and administrative proceedings regarding the Acquisition. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 24, 2024, we completed the separation (the Spin-Off) of GRAIL into a separate, independent publicly traded company as described in note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Consolidated Financial Statements. We incurred significant costs to complete the Spin-Off, including significant legal, financial advisory, regulatory and other professional services fees and additional expenses, and assumed certain liabilities in connection therewith. The Spin-Off also may result in loss of revenue and other adverse effects on our business, financial condition and results of operations. In addition, we have experienced and might continue to experience negative impacts on our stock price. We cannot predict what other adverse consequences to, among other things, our reputation, our relationships with governmental or regulatory authorities, or our ability to successfully complete future transactions, our ability to attract, retain and motivate customers, key personnel and those with whom we conduct business may result.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we have and may continue to become subject to stockholder inspection demands under Delaware law, investigations initiated by regulators and law firms, and derivative or other similar litigation that can be expensive, divert management attention and human and financial capital to less productive uses and result in potential reputational damage. The GRAIL acquisition and subsequent litigation resulted in (i) the announcement of an investigation by the SEC and others by law firms of possible securities law violations; (ii) stockholder inspection demands seeking to investigate possible breaches of fiduciary duties, corporate wrongdoing or a lack of independence of the members of the Board, including a complaint filed in the Delaware Court of Chancery seeking to inspect books and records captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pavers and Road Builders Benefit Funds v. Illumina, Inc.;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (iii) the filing of securities class actions in the United States District Court for the Southern District of California: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kangas v. Illumina, Inc. et al., Roy v. Illumina, Inc. et al., and Louisiana Sheriffs&#8217; Pension &amp; Relief Fund v. Illumina, Inc. et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; (iv) the filing of a stockholder derivative complaint in the United States District Court for the Southern District of California captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warner v. deSouza et al.;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (v) the filing of a stockholder derivative complaint in the United States District Court for the District of Delaware captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wang v. deSouza et al.;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (vi) the filing of two securities class actions in the Superior Court of the State of California, County of San Mateo: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loren Scott Mar v. Illumina, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Scott Zerzanek v. Illumina, Inc. et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; (vii) the filing of a stockholder derivative and class action complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Icahn Partners LP, et al. v. deSouza, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; (viii) the filing of a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Omaha Police and Firefighters Retirement System v. deSouza, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; (ix) the filing of a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Roseville General Employees Retirement System, et al. v. deSouza, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; and (x) the filing of a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thomas P. DiNapoli v. John Thompson et al</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.; and (xi) the filing of a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pavers and Road Builders Benefit Funds v. John Thompson et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_127">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Consolidated Financial Statements for further details. In the event that any of the matters described above </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">result in one or more adverse judgments or settlements, we may experience an adverse impact on our financial condition, results of operations or stock price.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Spin-Off could result in substantial tax liability. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received a private letter ruling from the Internal Revenue Service (the IRS) and a written opinion of tax counsel substantially to the effect that, for U.S. federal income tax purposes, the Spin-Off and certain related transactions qualified for non-recognition of gain and loss under Sections 355 and 368 of the U.S. Internal Revenue Code of 1986, as amended.  If the factual assumptions or representations made in the request for the private letter ruling prove to have been inaccurate or incomplete in any material respect, then we will not be able to rely on the ruling. Furthermore, the IRS does not rule on whether a distribution such as the Spin-Off satisfies certain requirements necessary to obtain tax-free treatment under Section 355 of the Code. The private letter ruling was based on representations by us and GRAIL that those requirements were satisfied, and any inaccuracy in those representations could invalidate the ruling. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the opinion of tax counsel relied on, among other things, the continuing validity of the private letter ruling and various assumptions and representations as to factual matters made by GRAIL and us which, if inaccurate or incomplete in any material respect, would jeopardize the conclusions reached by such counsel in its opinion. The opinion is not binding on the IRS or the courts, and there can be no assurance that the IRS or the courts would not challenge the conclusions stated in the opinion or that any such challenge would not prevail.  If, notwithstanding the private letter ruling and opinion of tax counsel, the IRS determines that the Spin-Off and certain related transactions did not qualify for tax-free treatment for U.S. federal income tax purposes, the resulting tax liability to the Company and its shareholders could be substantial.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Following the Spin-Off, we remain the obligor on the contingent value rights (the CVRs) we issued in connection with the GRAIL Acquisition.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Spin-Off, we remain the obligor on the CVRs and, accordingly, continue to be required to record in our financial statements the estimated future liabilities associated with the CVRs. Since we no longer own GRAIL, it may be more difficult for us to estimate these future liabilities. We also may have difficulty complying with our obligations with respect to the CVRs if we are unable to obtain timely and accurate information from GRAIL. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Spin-Off could adversely affect the market value of the CVRs.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business of GRAIL may be adversely affected by the Spin-Off, which could adversely affect the market value of the CVRs.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Litigation</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation, other proceedings, or third-party claims of intellectual property infringement could require us to spend significant time and money and could prevent us from selling our products or services.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in part on our non-infringement of the patents or proprietary rights of third parties. Third parties have asserted and may in the future assert that we are employing their proprietary technology without authorization.  As we enter new markets or introduce new products, we expect that competitors will likely claim that our products infringe their intellectual property rights as part of a business strategy to impede our successful competition. In addition, third parties may have obtained and may in the future obtain patents allowing them to claim that the use of our technologies infringes these patents. We could incur substantial costs and divert the attention of our management and technical personnel in defending ourselves against any of these claims. Any adverse ruling or perception of an adverse ruling in defending ourselves against these claims could have an adverse impact on our stock price, which may be disproportionate to the actual impact of the ruling itself. Furthermore, parties making claims against us may be able to obtain injunctive or other relief, which effectively could block our ability to develop further, commercialize, or sell products or services, and could result in the award of substantial damages against us. In the event of a successful infringement claim against us, we may be required to pay damages and obtain one or more licenses from third parties or be prohibited from selling certain products or services. In addition, we may be unable to obtain these licenses at a reasonable cost, if at all. We could therefore incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our gross margins and earnings per share. In addition, we could encounter delays in product introductions while we attempt to develop alternative methods or products. Defense of any lawsuit or failure to obtain any of these licenses on favorable terms could prevent us from commercializing </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products, and the prohibition of sale of any of our products or services could adversely affect our ability to grow or maintain profitability.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If product or service liability lawsuits are successfully brought against us, we may face reduced demand for our products and incur significant liabilities.</span></div><div style="margin-bottom:10pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and services are used for sensitive applications, and we face an inherent risk of exposure to product or service liability claims if our products or services are alleged to have caused harm, resulted in false negatives or false positives, or do not perform in accordance with specifications. Product liability claims filed against us or against third parties to whom we may have an obligation could be costly and time-consuming to defend and result in substantial damages or reputational risk. We cannot be certain that we would be able to successfully defend any product or service liability lawsuit brought against us. Regardless of merit or eventual outcome, product or service liability claims may result in: decreased demand for our products; injury to our reputation; increased product liability insurance costs; costs of related litigation; and substantial monetary awards to plaintiffs.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we carry product and service liability insurance, if we become the subject of a successful product or service liability lawsuit, our insurance may not cover all substantial liabilities, which could have an adverse effect on our business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Government Regulation</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in, or failure to comply with, competition laws could adversely affect our business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governments are actively enforcing competition laws and regulations, and some jurisdictions also allow competitors or consumers to assert claims of anti-competitive conduct. U.S. and foreign antitrust authorities have previously brought enforcement actions and may continue to scrutinize our business (see note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_127">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Regulators have been asserting expansive and sometimes novel interpretations of the scope of existing competition laws, which reduces predictability with respect to compliance. Further, any new requirements or restrictions, or proposed requirements or restrictions, could result in adverse publicity or fines, whether or not valid or subject to appeal.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental agencies and regulators may, among other things, prohibit future acquisitions, divestitures, or combinations we seek to make, impose significant fines or penalties, require divestiture of certain assets, or impose other restrictions that limit or require us to modify our operations, including limitations on our contractual relationships with customers or restrictions on our pricing policies. Such rulings or uncertainty regarding regulatory interpretations of industry business practices may alter the way in which we do business and, therefore, may continue to increase our costs or liabilities or reduce demand for our products, which could adversely affect our business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Antitrust enforcement agencies (including the U.S. Department of Justice (DOJ) and the FTC and their non-U.S. equivalents) may continue to closely scrutinize pricing policies or merger activity, with a particular focus on the healthcare sector, and there can be no assurance that our pricing policies or proposed, completed, or future mergers, acquisitions, and divestitures will not be the subject of an investigation or enforcement action by the DOJ, the FTC, or another antitrust enforcement agency. Changes in antitrust laws globally, or in their interpretation, administration, or enforcement, may limit our future acquisitions, divestitures, operations, and growth.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our products, if used for the diagnosis of disease, could be subject to government regulation, and the regulatory approval and maintenance process for such products may be expensive, time-consuming, and uncertain both in timing and in outcome. Since our strategy includes an emphasis on increasing our participation in clinical markets, we will be increasingly exposed to these risks.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are not subject to FDA clearance or approval if they are not intended to be used for the diagnosis, treatment or prevention of disease. However, as we implement our strategy to increase our participation in clinical markets by expanding our product line to encompass products that are intended to be used for the diagnosis of disease, such as our FDA-regulated MiSeqDx and NextSeq550Dx, certain of our products will become subject to regulation by the FDA, or comparable international agencies, including requirements for regulatory clearance or approval of such products before they can be marketed. Such regulatory approval processes or clearances may be expensive, time-consuming, and uncertain, and our failure to obtain or comply with such approvals and clearances </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could have an adverse effect on our business, financial condition, or operating results. Our failure to obtain such clearance or approval in a timely manner, or our competitors&#8217; success in obtaining clearance or approval before we do for products that are competitive with our planned offerings, may result in material adverse business consequences because the investment and time required to seek and obtain clearance or approval for clinical products are substantial. In addition, changes to the current regulatory framework, including the imposition of additional or new regulations, could arise at any time during the development or marketing of our products, which may negatively affect our ability to obtain or maintain FDA or comparable regulatory approval of our products, if required. Diagnostic products are regulated as medical devices by the FDA and comparable international agencies and may require either clearance from the FDA following the 510(k) pre-market notification process or pre-market approval from the FDA, in each case prior to marketing. Obtaining the requisite regulatory approvals can be expensive and may involve considerable delay. If we fail to obtain, or experience significant delays in obtaining, regulatory approvals for diagnostic products that we develop, we may not be able to launch or successfully commercialize such products in a timely manner, or at all.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if our products labeled as &#8220;For Research Use Only. Not for use in diagnostic procedures,&#8221; or RUO, are used, or could be used, for the diagnosis of disease, the regulatory requirements related to marketing, selling, and supporting such products could change or be uncertain, even if such use by our customers is without our consent. If the FDA or other regulatory authorities assert that any of our RUO products are subject to regulatory clearance or approval, our business, financial condition, or results of operations could be adversely affected.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In April 2024, the FDA issued the Final Rule relating to Laboratory Development Tests (LDTs). Newly developed LDT products may be subject to regulatory clearance or approval, and could result in adverse impacts to our business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our in vitro diagnostic products, or IVDs, are currently available through laboratories that are certified under the Clinical Laboratory Improvements Amendments (CLIA) of 1988. These IVD products are commonly called &#8220;laboratory developed tests,&#8221; or LDTs. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a number of years, the FDA has exercised its regulatory enforcement discretion to not regulate LDTs as medical devices if created and used within a single laboratory. On April 29, 2024, the FDA released final regulations under 21 CFR Part 809 under the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act) amending the regulations to make explicit that LDTs offered as IVDs are devices under the FD&amp;C Act including when the manufacturer of the IVD is a laboratory (the LDT Rule). </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LDT Rule also provides that the FDA intends to exercise enforcement discretion with regard to premarket review and most quality system requirements for certain categories of IVDs, including currently marketed IVDs offered as LDTs that were first marketed prior to April 29, 2024. The FDA has included additional enforcement discretion policies within the rule for LDTs approved by the New York State&#8217;s Clinical Laboratory Evaluation Program (NYS CLEP).</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of revenue from products currently offered by our laboratories do not fall within the scope of the LDT Rule. With one exception, the LDTs currently offered as IVDs by our laboratories that fall within the purview of the LDT Rule are approved by NYS CLEP and were first marketed prior to the release of the LDT Rule.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the specifics of how the FDA intends to implement the Final Rule and uncertainties remain as to whether and how newly developed LDT products that are now require regulatory clearance or approval may impact our business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Information Technology Security and Continuity</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Despite using commercially reasonable measures to secure our systems, networks, and products, security breaches, including with respect to cybersecurity, and other disruptions could compromise our information, products, and services, disrupt our or our customers&#8217; operations, and expose us to liability, which could cause our business and reputation to suffer.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect sensitive data, including intellectual property, our proprietary business information (and that of our customers), and personally identifiable information of our customers, vendors and employees and store it in our data centers and on our networks. Our customers also collect sensitive data and personally identifiable information using our products. The secure maintenance of information is important to our operations and business strategy. Despite our information systems&#8217; security measures and the security measures built </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">into our products, our information technology infrastructure and our products may in the future be, and have in the past been, impacted by cyber-attacks, employee error, malfeasance, or other disruptions.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and users of our products may face, and in the past have faced, cyber-attacks, including from nation state actors or advanced persistent threats who attempt to penetrate our or our customers&#8217; network security, including our data centers; sabotage or otherwise disable our research, products, and services, including instruments at our customers&#8217; sites; misappropriate our or our customers' and partners' proprietary information, which may include personally identifiable information; or cause interruptions of our or our customers&#8217; internal operations, systems and services, including through ransomware attacks. Any such breach could compromise our or our customers&#8217; networks and the information stored there could be accessed, publicly disclosed, lost, or exfiltrated. Any such access, disruption, disclosure, or other loss of information could result in an adverse impact on our or our customers&#8217; business, legal claims or proceedings, liability under laws that protect the privacy of personal information, and damage to our reputation.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disruption of critical information technology systems could have an adverse effect on our operations, business, customer relations, and financial condition.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends, in part, on the continued and uninterrupted performance of our IT systems, which are used extensively in virtually all aspects of our business. IT systems may be vulnerable to damage from a variety of sources, including telecommunications or network failures, power loss, natural disasters, human acts, terrorist attacks, computer viruses, computer denial-of-service attacks, ransomware attacks, unauthorized access to customer or employee data or company trade secrets, and other attempts to harm our systems. Certain of our systems are not redundant, and our disaster recovery planning is not sufficient for every eventuality. Further, the development of artificial intelligence is creating unforeseen, more sophisticated attacks. Despite any precautions we may take, such problems could result in, among other consequences, disruption of our operations, which could harm our reputation and financial results.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continuously adjust our workflow and business practices and add additional functionality to our enterprise software, problems could arise that we have not foreseen, including interruptions in service, loss of data, inaccurate data, or reduced functionality. Such problems could adversely impact our ability to run our business in a timely manner.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Relating to Public Health Crises</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are unable to predict the extent to which public health crises may adversely impact our business operations and financial performance.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to risks associated with public health crises. For example, the COVID-19 pandemic significantly curtailed the movement of people, goods and services worldwide, including in the regions in which we sell our products and services and conduct our business operations. How a future public health crisis may impact our business activity could (1) negatively impact the demand for our products and services, (2) restrict our sales operations, marketing efforts, and customer field support, (3) impede the shipping and delivery of our products to customers (4) disrupt our supply chain, and (5) limit our ability to conduct research and product development and other important business activities. We continue to monitor our operations and applicable government mandates and recommendations, and we have made modifications to our operations because of the COVID-19 pandemic. In the event of a public health crisis, we may incur increased costs and experience delays in sales, purchases, deliveries and other business activities associated with the invocation by customers, suppliers, service providers, and other business partners of contractual provisions they may claim are triggered by such an event. Additionally, concerns over the economic impact of a public health crisis like the COVID-19 pandemic could cause volatility in financial and other capital markets which may adversely impact the fair value of our marketable securities.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Risk Factors</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Doing business internationally, especially in emerging markets, creates operational risk for our business.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conducting and launching operations on an international scale requires close coordination of activities across multiple jurisdictions and consumes significant management resources. If we fail to coordinate and manage these activities effectively, including the risks noted below, our business, financial condition, or results of operations could be adversely affected. We have sales offices located internationally throughout Europe, the Asia-Pacific region, and </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brazil, as well as manufacturing and research facilities in Singapore and the United Kingdom. Shipments to customers outside the United States comprised 48%, 48%, and 50% of our total revenue in 2024, 2023, and 2022, respectively.</span></div><div style="margin-bottom:10pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the following risks and challenges associated with conducting business globally, particularly in emerging international markets, where we expect a growing proportion of our business to be located:</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">longer payment cycles and difficulties in collecting accounts receivable outside of the United States;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">longer sales cycles due to the volume of transactions taking place through public tenders;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges in staffing and managing foreign operations;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tariffs and other trade barriers;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of consistency, and unexpected changes, in legislative or regulatory requirements of foreign countries into which we sell our products;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased risk of governmental and regulatory scrutiny and investigations;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the burden of complying with a wide variety of foreign laws, regulations, and legal standards;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating in locations with a higher incidence of corruption and fraudulent business practices;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">import and export requirements, tariffs, taxes, and other trade barriers;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">weak or no protection of intellectual property rights;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">possible enactment of laws regarding the management of and access to data and public networks and websites;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential negative impact of a global health crisis, such as the outbreak of a serious infectious disease, to our commercial or manufacturing operations, including the loss of productivity from our own workforce and consequences of any restrictions on the movement of people or materials;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">possible future limitations on foreign-owned businesses;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty regarding, or potential changes in, diplomatic and trade relationships, for example, as a result of the recent change in the U.S. government administration; </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of tariffs recently imposed by the U.S. government and its trading partners in response, other possible tariffs or trade protection measures, import or export licensing requirements, new or different customs duties, trade embargoes and sanctions and other trade barriers;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant taxes; and  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general geopolitical risks beyond our control, including political, social and economic instability, changes in diplomatic and trade relations as a result of the recent change in the U.S. government administration or for other reasons, and security concerns in general.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we must comply with complex foreign and U.S. laws and regulations, such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and other local laws prohibiting corrupt payments to governmental officials, anti-competition regulations and sanctions imposed by the U.S. Office of Foreign Assets Control and other similar laws and regulations. Violations of these laws and regulations could result in fines and penalties, criminal sanctions, restrictions on our business conduct and on our ability to offer our products in one or more countries, and could also materially affect our brand, our ability to attract and retain employees, our international operations, our business and our operating results. Although we have implemented policies and procedures designed to ensure compliance with these laws and regulations, there can be no assurance that our employees, contractors, or agents will not violate our policies.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to expand our business into multiple international markets, our success will depend, in large part, on our ability to anticipate and effectively manage these and other risks associated with our international operations. Any of these risks could harm our international operations and negatively impact our sales, adversely affecting our business, results of operations, financial condition and growth prospects.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The armed conflict between Russia and Ukraine, the international sanctions imposed on Russia, and the restrictions imposed on exports to Russia will likely continue to negatively affect our business. Armed conflict in the Middle East or elsewhere could also negatively impact us.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the armed conflict between Russia and Ukraine, doing business in the Ukraine may not be practicable. In addition, the U.S. and other countries have imposed sanctions on Russia, including its major financial institutions and certain other businesses and individuals, as well as restrictions on exports to Russia. These sanctions and export restrictions have increased in magnitude over time. Russia has responded in kind, and the continuation of the conflict may result in additional sanctions and export restrictions being enacted by the U.S. or other countries. The impact of these sanctions and export restrictions, along with the spillover effect of ongoing civil, political and economic disturbances on surrounding areas, has affected our ability to ship products into the region, and has reduced our sales. Sanctions or export restrictions currently prohibit our ability to collect or pay liabilities owed by or to certain Russian entities or to supply products and services, directly or indirectly, into Russia. The impact of the Russia-Ukraine conflict, and armed conflict in the Middle East or elsewhere on general economic conditions is currently unknown and could in the future have a negative effect on our results of operations, cash flows, financial condition or growth prospects.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are exposed to risks associated with transactions denominated in foreign currency.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2024, more than half of our international sales were denominated in foreign currencies, while the majority of our purchases of raw materials were denominated in U.S. dollars. Changes in the value of the relevant currencies may affect the cost of certain items required in our operations. Changes in currency exchange rates may also affect the relative prices at which we are able to sell products in the same market. Our revenues from international customers may be negatively impacted as increases in the U.S. dollar relative to our international customers local currency could make our products more expensive, impacting our ability to compete. Our costs of materials from international suppliers may increase if, in order to continue doing business with us, they raise their prices as the value of the U.S. dollar decreases relative to their local currency. Foreign policies and actions regarding currency valuation could result in actions by the United States and other countries to offset the effects of such fluctuations. Recent global financial conditions have led to a high level of volatility in foreign currency exchange rates and that level of volatility may continue, which could adversely affect our business, financial condition, or results of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to risks related to taxation in multiple jurisdictions.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in both the United States and numerous foreign jurisdictions. Significant judgments based on interpretations of existing tax laws or regulations are required in determining the provision for income taxes.  Our effective income tax rate could be adversely affected by various factors, including, but not limited to, changes in the mix of earnings in tax jurisdictions with different statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in existing tax policies, laws, regulations, or rates (including the implementation of global minimum tax rates in certain jurisdictions), changes in the level of non-deductible expenses (including share-based compensation), location of operations, changes in our future levels of research and development spending, mergers and acquisitions, or the result of examinations by various tax authorities. Although we believe our tax estimates are reasonable, if the U.S. Internal Revenue Service or other taxing authority disagrees with the positions taken on our tax returns, we could have additional tax liability, including interest and penalties. If material, payment of such additional amounts upon final adjudication of any disputes could have a material impact on our results of operations and financial position.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our operating results may vary significantly from period to period.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is subject to fluctuations due to the timing of sales of high-value products and services, the effects of new product launches and related promotions, the timing and availability of our customers&#8217; funding, the impact of seasonal spending patterns, the timing and size of research projects our customers perform, changes in overall spending levels in the life sciences industry, and other unpredictable factors that may affect customer ordering patterns. In particular, collaboration agreements and large-scale government funded projects such as population genomic projects are the result of lengthy and complex negotiations, and the timing of revenue recognition in connection with these agreements </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and projects may be subject to significant uncertainty because of the long-term nature of development and collaboration projects, as well as sample availability for population genomics projects.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the difficulty in predicting the timing and magnitude of sales for our products and services, we may experience quarter-to-quarter fluctuations in revenue resulting in the potential for a sequential decline in quarterly revenue. As a substantial portion of our quarterly revenue is typically recognized in the last month of the quarter with a concentration of orders in the final weeks, our manufacturing and shipping operations may experience increased pressure and demand during the time period shortly before the end of a fiscal quarter; delays related to our manufacturing and shipping operations during this time period could delay the recognition of revenue.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we receive large orders that have a significant effect on our operating results in the period in which the order is recognized as revenue. The timing of such orders is difficult to predict, and the timing of revenue recognition from such orders may affect period-to-period changes in net sales. As a result, our operating results could vary materially from quarter-to-quarter based on the receipt of such orders and their ultimate recognition as revenue.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adverse economic or market conditions may harm our business.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Worsening economic conditions, including inflation, increasing interest rates, decreasing economic activity, volatility in equity and credit markets or other changes in the economic environment, may adversely affect our business, financial condition, or results of operations. For example, we depend on third-party manufacturers and suppliers for some of our products, or sub-assemblies, components, and materials used in our products, and the suppliers of these inputs may seek to raise prices in the current inflationary economic environment. If our costs increase and we are unable to successfully pass along those increased costs to our customers, our revenue and or operating profitability may be adversely affected. In addition, we have a variable-interest-rate credit facility (see note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_109">6. Debt and Other Commitments</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), under which we have no currently outstanding debt, and we may in the future raise additional debt or refinance existing debt. Our cost of borrowing in the future may be higher than it has been to date because interest rates have risen and may continue to increase. An increased cost of borrowing may adversely affect our financial condition and results of operations.</span></div><div><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_25"></div><div style="margin-bottom:0.3pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div style="margin-bottom:0.3pt;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See discussion of legal proceedings in note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_127">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Consolidated Financial Statements section of this report, which is incorporated by reference herein.</span></div><div style="margin-bottom:0.3pt;text-indent:24.75pt"><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_31"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MARKET INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock has been quoted on The Nasdaq Global Select Market under the symbol &#8220;ILMN&#8221; since July&#160;28, 2000. The following table sets forth, for the fiscal periods indicated, the quarterly high and low sales prices per share of our common stock as reported on The Nasdaq Global Select Market.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Low</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Quarter</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">145.50</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123.54</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.55&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.00&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Quarter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136.02</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98.27</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Quarter</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137.18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">103.57</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.64&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.37&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth Quarter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156.66</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">125.06</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below compares the cumulative total stockholder returns on our common stock for the last five fiscal years with the cumulative total stockholder returns on the Nasdaq Composite Index, the Nasdaq Biotechnology Index, and the S&amp;P 500 Index for the same period. The graph assumes that $100 was invested on December 29, 2019 in our common stock and in each index and that all dividends were reinvested. No cash dividends have been declared on our common stock. Stockholder returns over the indicated period should not be considered indicative of future stockholder returns.  </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compare 5-Year Cumulative Total Return among Illumina, Nasdaq Composite Index, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nasdaq Biotechnology Index, and S&amp;P 500 Index</span></div><div style="text-align:center"><img src="ilmn-20241229_g4.jpg" alt="1061" style="height:400px;margin-bottom:5pt;vertical-align:text-bottom;width:682px"/></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;7, 2025, we had 497 record holders of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never paid cash dividends and have no present intention to pay cash dividends in the foreseeable future.  </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_34"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SHARE REPURCHASES AND SALES</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer</span></div><div style="margin-bottom:13pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2024, our Board of Directors authorized a new share repurchase program, which cancels and supersedes all prior and available repurchase authorizations, to repurchase up to $1.5&#160;billion of our outstanding common stock. The repurchases may be completed through open market purchases, pursuant to Rule 10b5-1 or Rule 10b-18, or through an accelerated share repurchase program. We did not repurchase any shares under the prior program during 2024. Shares repurchased in open market transactions pursuant to the new program during 2024 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In thousands, except price per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;<br/>&#160;<br/>Total Number <br/>of Shares<br/>Purchased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid per Share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Purchased as Part of Publicly</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Announced Program</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">that May Yet Be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchased Under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">the Program</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Quarter</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.71&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401,684&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth Quarter </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.90&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384,404&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Average price paid per share excludes the excise tax on share repurchases imposed as part of the Inflation Reduction Act of 2022. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Repurchases during the fourth quarter of 2024 were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In thousands, except price per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;<br/>&#160;<br/>Total Number <br/>of Shares<br/>Purchased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid per Share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Purchased as Part of Publicly</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Announced Program</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">that May Yet Be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchased Under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">the Program</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2024 - October 27, 2024</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.72&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,388,718&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2024 - November 24, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 25, 2024 - December 29, 2024</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384,404&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Average price paid per share excludes the excise tax on share repurchases imposed as part of the Inflation Reduction Act of 2022. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales of Unregistered Securities</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no sales of unregistered securities in 2024.</span></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_37"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION &amp; ANALYSIS</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Management&#8217;s Discussion and Analysis (MD&amp;A) will help readers understand our results of operations, financial condition, and cash flow. It is provided in addition to the accompanying consolidated financial statements and notes.  This MD&amp;A is organized as follows:  </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Management&#8217;s Overview and Outlook.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> High level discussion of our operating results and significant known trends that affect our business.</span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Results of Operations.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Detailed discussion of our revenues and expenses.</span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Liquidity and Capital Resources. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussion of key aspects of our consolidated statements of cash flows, changes in our financial position, and our financial commitments.</span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Critical Accounting Policies and Estimates.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Discussion of critical accounting policies and the significant assumptions, estimates, and judgments we make in applying such policies.</span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Quantitative and Qualitative Disclosure about Market Risk.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Discussion of our financial instruments&#8217; exposure to market risk.</span></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Recent Accounting Pronouncements. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summary of recent accounting pronouncements applicable to our consolidated financial statements. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This MD&amp;A generally discusses 2024 and 2023 items and year-to-year comparisons between 2024 and 2023. Discussions of 2022 items and year-to-year comparisons between 2023 and 2022 that are not included in this Form 10-K can be found in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000111080324000010/ilmn-20231231.htm">Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the fiscal year ended 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This MD&amp;A discussion contains forward-looking statements that involve risks and uncertainties. See </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_10">Consideration Regarding Forward-Looking Statements</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> preceding the Business &amp; Market Overview section of this report for additional factors relating to such statements. See </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">Risk Factors</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Business &amp; Market Information section of this report for a discussion of certain risk factors applicable to our business, financial condition, and results of operations. Operating results are not necessarily indicative of results that may occur in future periods. </span></div><div><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_40"></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S OVERVIEW AND OUTLOOK</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This overview and outlook provide a high-level discussion of our operating results and significant known trends that affect our business. We believe an understanding of these trends is important to understanding our financial results for the periods being reported herein as well as our future financial performance. This summary is not intended to be exhaustive, nor is it intended to be a substitute for the detailed discussion and analysis provided elsewhere.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About Illumina</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets.&#160;Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Our customers include leading genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Our comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. This portfolio of leading-edge sequencing and array-based solutions addresses a range of genomic complexity and throughput, enabling researchers and clinical practitioners to select the best solution for their scientific challenge.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;24, 2024, we completed the Spin-Off of GRAIL into a separate, independent publicly traded company through the distribution of approximately 85.5% of the outstanding shares of common stock of GRAIL to Illumina stockholders on a pro rata basis. We retained approximately 14.5% of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL&#8217;s assets, liabilities, results of operations and cash flows have not been reclassified. In connection with the Spin-Off, Illumina&#8217;s stockholders received one share of GRAIL common stock for every six shares of Illumina common stock held on the Record Date. Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one reportable segment, Core Illumina, as of December&#160;29, 2024. Prior to the Spin-Off of GRAIL on June&#160;24, 2024, our reportable segments included both Core Illumina and GRAIL. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_136">12. Segment and Geographic Information</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Consolidated Financial Statements section of this report for details on our reportable segments.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results have been, and will continue to be, impacted by several significant trends, which are described below. While these trends are important to understanding and evaluating our financial results, this discussion should be read in conjunction with our consolidated financial statements and the notes thereto within the Consolidated Financial Statements section of this report, and the other transactions, events, and trends discussed in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">Risk Factors</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Business &amp; Market Information section of this report.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Overview </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2023, macroeconomic factors such as inflation, exchange rate fluctuations and concerns about an economic downturn, competitive challenges in our China region, and the sanctions imposed on Russia as a result of the armed conflict between Russia and Ukraine have impacted both Illumina directly and our customers&#8217; behavior. For example, some customers experienced supply chain pressures that delayed their lab expansions and others are managing inventory and capital more conservatively. We expect these factors to continue to have an impact on our sales and results of operations in 2025, the size and duration of which is significantly uncertain. In February 2025, we were added to China&#8217;s Ministry of Commerce List of Unreliable Entities, the implications of which are currently uncertain. See the risk factor &#8220;China&#8217;s Ministry of Commerce has added Illumina to its List of Unreliable Entities&#8221; in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">Risk Factors</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Business &amp; Market Information section of this report for additional information.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2024, we made significant progress towards our strategic goals to accelerate growth and expand operating margins. We focused on operational excellence initiatives, to improve productivity and achieve cost savings, and on our capital allocation strategy, including obtaining authorization for a new share repurchase program. We expect to continue to make further progress towards these goals in 2025, including a focus on returning to revenue growth. </span></div><div style="margin-bottom:10pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial highlights for 2024 included the following: </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.2pt">Revenue decreased 3% in 2024 to $4.4 billion compared to $4.5 billion in 2023 primarily due to a decrease in sequencing instruments revenue, driven by fewer shipments of our high-throughput and mid-throughput instruments, offset by increases in sequencing consumables revenue. </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.2pt">Gross profit as a percentage of revenue (gross margin) was 65.4% in 2024 compared to 60.9% in 2023.  The increase in gross margin was driven primarily by execution of our operational excellence initiatives that continue to deliver cost savings, including freight, and improve productivity, a more favorable revenue mix towards sequencing consumables, and a decrease in warranty and field service costs. This was partially offset by higher strategic partnership revenue that is lower margin. Our gross margin depends on many factors, including: market conditions that may impact our pricing; sales mix changes among consumables, instruments, services, and development and licensing revenue; product mix changes between established products and new products; excess and obsolete inventories; royalties; our cost structure for manufacturing operations relative to volume; freight costs; and product support obligations. </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss from operations was $0.8 billion in 2024 compared to $1.1 billion in 2023. The decrease was due to a decrease in operating expense of $119 million and an increase in gross profit of $117&#160;million. The decrease in operating expense included a $476 million favorable impact in legal contingency and settlement, as a result of the European Commission withdrawing, in September 2024, its previously imposed fine, a decrease of $323 million in GRAIL operating expenses, as a result of the Spin-Off in Q2 2024, an increase in the gains recognized on our GRAIL contingent consideration liability of $290 million, and a decrease in restructuring charges of $86&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offset by an increase in goodwill and intangible impairment of $1,062 million. We continue to focus on our cost reduction initiatives to accelerate progress toward higher margins and create flexibility for further investment in high-growth areas.</span></div><div style="margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our effective tax rate was (3.8)% and (3.9)% in 2024 and 2023, respectively. In 2024, the variance from the U.S. federal statutory tax rate of 21% was primarily because of the income tax expense impact of the impairment of goodwill, which is nondeductible for tax purposes, the income tax expense impact of the reversal of the European Commission fine related to the GRAIL acquisition, which is excluded from taxable income, the income tax expense impact of research and development expense capitalization for tax purposes, and the income tax expense impact of GRAIL pre-acquisition net operating losses on GILTI, the utilization of U.S. foreign tax credits, and the Pillar Two global minimum top-up tax. This was partially offset by the mix of earnings in jurisdictions with lower statutory tax rates than the U.S. federal statutory tax rate, such as in Singapore.</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We ended 2024 with cash, cash equivalents, and short-term investments totaling $1,220 million, of which approximately $439 million was held by our foreign subsidiaries. </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_43"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To enhance comparability, the following table sets forth audited consolidated statement of operations data for 2024, 2023, and 2022, stated as a percentage of total revenue.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.963%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service and other revenue</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expense:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal contingency and settlement</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10.4)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">84.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19.1)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.2)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6.7)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(27.0)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.6)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28.0)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.1)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Percentages may not recalculate due to rounding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.371%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024-2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,169</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,670</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">662</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Core Illumina revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,332</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,372</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,504&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core Illumina consumables revenue increased in 2024 primarily due to an increase in sequencing consumables revenue of $59 million, driven primarily by an increase in NovaSeq X consumables, partially offset by decreases in consumables across our other high-throughput instruments, as customers transition to NovaSeq X, and across our mid-throughput instruments. Core Illumina instruments revenue decreased in 2024 primarily due to a decrease in sequencing instruments revenue of $203 million, driven by fewer shipments of our high-throughput instruments, following the first year of NovaSeq X shipments in 2023, and fewer shipments of our mid-throughput instruments, as capital and cash flow constraints continue to impact our customer&#8217;s purchasing behavior.</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core Illumina service and other revenue increased in 2024 primarily due to increased revenue from strategic partnerships and extended maintenance service contracts, partially offset by decreased revenues from genotyping services and development and licensing agreements.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in GRAIL revenue in 2024 was due to the Spin-Off in Q2 2024.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Margin</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"><tr><td style="width:1.0%"/><td style="width:55.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024-2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit (loss):</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,856</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(38)</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated gross profit</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,861</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,744</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin:</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</span></td><td colspan="3" style="background-color:#dddddd;padding:0 12.25pt 0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated gross margin</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 12.25pt 0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.98pt">Not meaningful.</span></div><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in Core Illumina gross margin in 2024 was driven primarily by a favorable impact from the execution of our operational excellence initiatives that continue to deliver cost savings, including freight, and improve productivity, a more favorable revenue mix towards sequencing consumables, and a decrease in warranty and field service costs, partially offset by higher strategic partnership revenue that is lower margin. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in GRAIL gross loss in 2024 was due to the Spin-Off in Q2 2024.</span></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expense</span></div><div><span><br/></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:56.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024-2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">988</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">189</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated research and development</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,169</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative:</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">900</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">192</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated selling, general and administrative</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,092</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible impairment:</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,886</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,065&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated goodwill and intangible impairment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,889</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal contingency and settlement:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(456)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(476)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,380)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7.75pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated operating expense</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,694</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7.75pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core Illumina R&amp;D expense decreased by $42 million, or 4%, in 2024 primarily due to decreases in headcount and employee compensation costs, and restructuring charges of $25&#160;million, as we focus on cost reduction initiatives. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core Illumina SG&amp;A expense decreased by $348 million, or 28%, in 2024 primarily due to an increase in the gains recognized on our GRAIL contingent consideration liability of $290 million, a decrease in proxy contest charges of $30 million, and decreases in restructuring charges of $61&#160;million, facility related costs, and employee compensation costs, as we continue to exit certain of our facilities and focus on our cost reduction initiatives. The decrease was partially offset by an increase in share-based compensation expense related to PSU awards.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The decrease in GRAIL R&amp;D and SG&amp;A expense in 2024 was due to the Spin-Off in Q2 2024.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRAIL goodwill and intangible impairment in 2024 consisted of goodwill impairment of $1,466&#160;million and IPR&amp;D impairment of $420&#160;million as a result of impairment tests performed in Q2 2024. Core Illumina goodwill and intangible impairment for 2024 consisted of an IPR&amp;D impairment recorded in Q1 2024. GRAIL goodwill and intangible impairment for 2023 consisted of goodwill impairment of $712&#160;million and IPR&amp;D impairment of $109&#160;million as a result of an interim impairment test performed in Q3 2023. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_106">5. </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_106">Goodwill, Intangible Assets, and Acquisitions</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core Illumina legal contingency and settlement in 2024 primarily consisted of a gain recognized in Q3 2024 of $489&#160;million for the reversal of the EC fine accrual, and related accrued interest, following the European Commission&#8217;s decision to withdraw its previously imposed fine. Core Illumina legal contingency and settlement for 2023 primarily consisted of an adjustment to our accrual for the fine previously imposed by the European Commission and other patent litigation settlement activity. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_127">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details.</span></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div><span><br/></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.371%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024-2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(292)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(346)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net primarily relates to the Core Illumina segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consisted primarily of interest on our money market funds, which decreased in 2024 primarily due to a lower cash balance throughout the year, as compared to prior year, partially offset by an increase in average interest rates. Interest expense consisted primarily of interest on our outstanding term debt, including on our delayed draw term loan, and a loss on debt extinguishment of $5&#160;million related to the repayment of our delayed draw term loan. The increase in other expense, net in 2024 was primarily driven by an increase in net losses recognized on our strategic investments of $272&#160;million, which included an unrealized loss of $309&#160;million on our retained investment in GRAIL subsequent to the Spin-Off. This was offset by a favorable net impact related to foreign currency activity, as compared to the prior year, and an increase of $5&#160;million in the gains recognized on our Helix contingent value right, which was settled in Q3 2024.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:56.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024-2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,179)</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,117)</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,223)</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt 0 7pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,161)</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3.8)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, the variance from the U.S. federal statutory tax rate of 21% was primarily because of the $308 million income tax expense impact from the impairment of goodwill, which is nondeductible for tax purposes, $90&#160;million income tax expense impact of GRAIL pre-acquisition net operating losses on GILTI, the utilization of U.S. foreign tax credits, and the Pillar Two global minimum top-up tax, and the $52&#160;million income tax expense impact of capitalizing research and development expenses for tax purposes. The income tax rate in 2024 was favorably impacted by the $99&#160;million income tax expense impact of the reversal of the European Commission fine related to the GRAIL acquisition, which is excluded from taxable income, and by the mix of earnings in jurisdictions with lower statutory tax rates than the U.S. federal statutory tax rate, such as in Singapore.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, the variance from the U.S. federal statutory tax rate of 21% was primarily because of the $149&#160;million income tax expense impact from the impairment of goodwill, which is nondeductible for tax purposes, the $86&#160;million income tax expense impact of capitalizing research and development expense for tax purposes, and the $61&#160;million income tax expense impact of GRAIL pre-acquisition net operating losses on GILTI and the utilization of the U.S. foreign tax credits. The income tax expense in 2023 was also favorably impacted by the mix of earnings in jurisdictions with lower statutory tax rates than the U.S. federal statutory tax rate, such as in Singapore. </span></div><div style="margin-bottom:10pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future effective tax rate may vary from the U.S. federal statutory tax rate due to the mix of earnings in tax jurisdictions with different statutory tax rates and the other factors discussed in the risk factor &#8220;We are subject to risks related to taxation in multiple jurisdictions&#8221; in </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">Risk Factors</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Business &amp; Market Information section of this report, including future tax legislation that changes existing tax policies, laws, regulations, or rates.</span></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_46"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, we had $1,127 million in cash and cash equivalents, of which approximately $439 million was held by our foreign subsidiaries. Cash and cash equivalents increased by $79 million from the prior year due primarily to factors described in the &#8220;Cash Flow Summary&#8221; below. Our primary source of liquidity, other than our holdings of cash, cash equivalents, and investments, has been cash flows from operations and, from time to time, issuances of debt. In 2024, we received net proceeds from the issuance of our 2026 Term Notes of $497&#160;million and repaid our delayed draw term loan of $750&#160;million. Our ability to generate cash from operations, supplemented with the issuance of debt and/or liquidation of our short-term investments, provides us with the financial flexibility we need to meet operating, investing, and financing needs. In connection with the Spin-Off, we derecognized GRAIL&#8217;s cash and cash equivalents of $968&#160;million, which included the required Disposal Funding (see note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). As of December&#160;29, 2024, we had $93 million in short-term investments, comprised of marketable equity securities.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, the European Commission withdrew its previously imposed fine of &#8364;432&#160;million. Accordingly, we reversed the related accrual and recognized a net gain of $481&#160;million in Q3 2024. The guarantees we provided in October 2023 to satisfy the obligation in lieu of cash payment while we appealed the European Commission&#8217;s jurisdictional and fine decisions are no longer outstanding. Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_127">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2024, we entered into a 364-day Delayed Draw Credit Facility, which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $750&#160;million. On June 20, 2024, we borrowed $750&#160;million on the Delayed Draw Credit Facility. The delayed draw term loan incurred interest at a rate of 6.7%. On September 9, 2024, we repaid the full principal amount outstanding under the Delayed Draw Credit Facility, as well as accrued interest, in an aggregate amount of $761&#160;million and terminated the Delayed Draw Credit Agreement.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2024, we issued $500&#160;million aggregate principal amount of 2026 Term Notes. We received net proceeds of $497&#160;million, which were used to repay a portion of the outstanding debt under the Delayed Draw Credit Agreement. The 2026 Term Notes, which mature on September 9, 2026, accrue interest at a rate of 4.650% per annum, payable semi-annually on March 9 and September 9 of each year, beginning on March 9, 2025. We may redeem for cash all or any portion of the 2026 Term Notes, at our option, at any time prior to maturity. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we issued $500&#160;million aggregate principal amount of 2025 Term Notes and $500&#160;million aggregate principal amount of 2027 Term Notes. The 2025 Term Notes, which mature on December 12, 2025, and the 2027 Term Notes, which mature on December 13, 2027, accrue interest at a rate of 5.800% and 5.750% per annum, respectively, payable semi-annually in June and December of each year. In March 2021, we issued $500&#160;million aggregate principal amount of 2031 Term Notes, which mature on March 23, 2031 and accrue interest at a rate of 2.550% per annum, payable semi-annually in March and September of each year. We may redeem for cash all or any portion of the 2025, 2027, or 2031 Term Notes, at our option, at any time prior to maturity.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we entered into the Revolving Credit Agreement, which provides us with a $750&#160;million senior unsecured five-year revolving credit facility, including a $40&#160;million sublimit for swingline borrowings and a $50&#160;million sublimit for letters of credit. The credit facility matures, and all amounts outstanding become due and payable in full, on January 4, 2028, subject to two one-year extensions at our option, the consent of the extending lenders, and certain other conditions. As of December&#160;29, 2024, there were no outstanding borrowings.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, the fair value of our contingent consideration liability related to GRAIL was $71&#160;million, of which $70&#160;million was included in other long-term liabilities. The contingent value rights entitle the holders to receive future cash payments on a quarterly basis (Covered Revenue Payments) representing a pro rata portion of certain GRAIL-related revenues (Covered Revenues) each year through August 2033. This reflects a 2.5% payment right to the first $1&#160;billion of revenue each year for 12 years. Revenue above $1&#160;billion each year is subject to a 9% contingent payment right during this same period. In 2024, we paid $1.1&#160;million in aggregate Covered Revenue Payments related to Covered Revenues for the period Q4 2023 through Q3 2024 of $117&#160;million in aggregate.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2024, our Board of Directors authorized a new share repurchase program, which cancels and supersedes all prior and available repurchase authorizations, to repurchase up to $1.5&#160;billion of our outstanding common stock. The repurchases may be completed through open market purchases, pursuant to Rule 10b5-1 or Rule 10b-18, or through an accelerated share repurchase program. Authorizations to repurchase up to $1.4 billion of our outstanding common stock remained available as of December&#160;29, 2024. Subsequent to December&#160;29, 2024 and through February 11, 2025, we repurchased an additional 1.0 million shares of our common stock for $126 million.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $3 million (plus recallable distributions of approximately $10 million), $46 million, and $47 million, respectively, remaining in our capital commitments to three venture capital investment funds as of December&#160;29, 2024 that are callable through April 2026, July 2029, and December 2034, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of the 2017 Tax Cuts and Jobs Act resulted in a one-time transition tax on earnings of certain foreign subsidiaries which we elected to pay in installments. As of December&#160;29, 2024, we owed $39&#160;million, which we expect to pay within the next year.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other short-term and long-term material cash requirements, from known contractual obligations as of December&#160;29, 2024, include operating lease liabilities, uncertain tax positions, and amounts due under our executive deferred compensation plan, as discussed in the Consolidated Financial Statements section of this report.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our current cash, cash equivalents, and short-term investments, together with cash provided by operating activities and available borrowing capacity under the Revolving Credit Facility, are sufficient to fund our near-term capital and operating needs for at least the next 12 months. Operating needs include the planned costs to operate our business, including amounts required to fund working capital and capital expenditures. Our primary short-term needs for capital, which are subject to change, may include:  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">support of commercialization efforts related to our current and future products;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquisitions of equipment and other fixed assets for use in our current and future manufacturing and research and development facilities;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the continued advancement of research and development efforts;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential strategic acquisitions and investments;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">repayment of debt obligations;</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">repurchases of our outstanding common stock; and</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the evolving needs of our facilities, including costs of leasing and building out facilities.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our revenue and results of operations, as well as the status of each of our new product development programs, will significantly impact our cash management decisions. Our future capital requirements and the adequacy of our available funds will depend on many factors, including:</span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully commercialize and further develop our technologies and create innovative products in our markets;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">scientific progress in our research and development programs and the magnitude of those programs;  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competing technological and market developments; and  </span></div><div style="margin-bottom:10pt;margin-top:13pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement our product and service offerings. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flow Summary</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.988%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.899%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">837</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(570)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities in 2024 consisted of a net loss of $1,223 million, plus net adjustments of $2,543 million, less net changes in operating assets and liabilities of $483 million. The primary adjustments to net loss included goodwill and intangible impairment of $1,889 million, share-based compensation expense of $370 million, depreciation and amortization expense of $354 million, net loss on strategic investments of $312 million, and property and equipment and right-of-use asset impairment of $46 million, offset by change in fair value of contingent consideration liabilities of $315 million and deferred income taxes of $112 million. Cash flow impact from changes in net operating assets and liabilities were primarily driven by decreases in accrued liabilities and inventory, offset by increases in accounts receivable, operating lease right-of-use assets and liabilities, net, and other long-term liabilities.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities in 2023 consisted of net adjustments of $1,729&#160;million, less a net loss of $1,161&#160;million and net changes in operating assets and liabilities of $90&#160;million. The primary adjustments to net loss included goodwill and intangible impairment of $827&#160;million, depreciation and amortization expense of $432&#160;million, share-based compensation of $380&#160;million, property and equipment and right-of-use asset impairment of $100&#160;million, and net loss on strategic investments of $40&#160;million, offset by deferred income taxes of $33&#160;million and change in fair value of contingent consideration liabilities of $24&#160;million. Cash flow impact from changes in net operating assets and liabilities were primarily driven by increases in accounts receivable and inventory and a decrease in accounts payable.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities totaled $178 million in 2024. We invested $128 million in capital expenditures, net of proceeds received from sales, primarily associated with investments in facilities, paid $81 million for an acquisition, net of cash acquired, and other intangible assets, and purchased strategic investments, net of distributions, of $52 million. This was offset by the receipt of $83 million related to the settlement of our Helix contingent value right.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities totaled $231&#160;million in 2023. We invested $195&#160;million in capital expenditures, primarily associated with our investment in facilities, paid $30&#160;million for an acquisition, net of cash acquired, and other intangible assets, and used $6&#160;million for net purchases of strategic investments.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities totaled $570 million in 2024. We deconsolidated cash and cash equivalents of $968&#160;million, as a result of the GRAIL Spin-Off, repaid our delayed draw term loan of $750&#160;million, used $116&#160;million to repurchase our common stock, and used $32 million to pay taxes related to net share settlement of equity awards. This was offset by net borrowings on the Delayed Draw Credit Facility of $744&#160;million, net proceeds received from the issuance of our 2026 Term Notes of $497&#160;million, and proceeds received from the sale of shares under our employee stock purchase plan of $56 million.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities totaled $1,210&#160;million in 2023. We repaid our 2023 Term Notes, with an aggregate principal amount of $500&#160;million, repaid our 2023 Convertible Notes, with an aggregate principal amount of $750&#160;million, and used $40&#160;million to pay taxes related to net share settlement of equity awards. This was offset by $67&#160;million received in proceeds from the sale of shares under our employee stock purchase plan and the issuance of common stock through the exercise of stock options.</span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_52"></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S.&#160;generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Management bases its estimates on historical experience, market and other conditions, and various other assumptions it believes to be reasonable. Although these estimates are based on management&#8217;s best knowledge of current events and actions that may impact us in the future, the estimation process is, by its nature, uncertain given that estimates depend on events over which we may not have control. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Though macroeconomic factors such as inflation, exchange rate fluctuations and concerns about an economic downturn&#160;present additional uncertainty, we continue to use the best information available to inform our critical accounting estimates. If market and other conditions change from those that we anticipate, our financial statements may be materially affected. In addition, if our assumptions change, we may need to revise our estimates, or take other corrective actions, either of which may also have a material effect on our consolidated financial statements.  </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the following critical accounting policies and estimates have a higher degree of inherent uncertainty and require our most significant judgments. In addition, had we used estimates different from any of these, our consolidated financial statements could have been materially different from those presented. Members of our senior management have discussed the development and selection of our critical accounting policies and estimates, and our disclosure regarding them, with the audit committee of our board of directors. Our accounting policies are more fully described in note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_91">1. Organization and Significant Accounting Policies</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Consolidated Financial Statements.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated from the sale of products and services. Product revenue consists of sales of instruments and consumables used in genetic analysis. Service and other revenue consists of revenue generated from genotyping and sequencing services, instrument service contracts, development and licensing agreements, and, prior to the Spin-Off of GRAIL on June&#160;24, 2024, cancer detection testing services related to the GRAIL business.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of our products and services is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. Revenue recognition for contracts with multiple deliverables is based on the separate satisfaction of each distinct performance obligation within the contract. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of a good or service to the customer, meaning the customer has the ability to use and obtain the benefit of the good or service. The contract price is allocated to each performance obligation in proportion to its standalone selling price. We determine our best estimate of standalone selling price using average selling prices over a rolling 12-month period coupled with an assessment of current market conditions. If the product or service has no history of sales or if the sales volume is not sufficient, we rely upon prices set by management, adjusted for applicable discounts.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized generally upon delivery to the end customer, which is when control of the product is deemed to be transferred. Invoicing typically occurs upon shipment and payment is typically due within 30 days from invoice. In instances where right of payment or transfer of title is contingent upon customer acceptance of the product, revenue is deferred until all acceptance criteria have been met. Revenue from genotyping and sequencing services, including cancer detection testing services related to the GRAIL business prior to the Spin-Off, is recognized when earned, which is generally at the time the genotyping or sequencing analysis data is made available to the customer. Revenue from instrument service contracts is recognized as the services are rendered, typically evenly over the contract term. Revenue from development and licensing agreements generally includes upfront and periodic licensing fees, contract research and development services, or payments for development and regulatory milestones. Revenue for these agreements is recognized when each distinct performance obligation is satisfied.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of discounts, distributor commissions, and sales taxes collected on behalf of governmental authorities. Employee sales commissions are recorded as selling, general and administrative expense when incurred as the amortization period for such costs, if capitalized, would have been one year or less.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain markets, products and services are sold to customers through distributors. In most sales through distributors, the product is delivered directly to customers by us. The terms of sales transactions through distributors are consistent with the terms of direct sales to customers. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory Valuation</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost or net realizable value. We regularly review inventory for excess and obsolete products and components, taking into account product life cycles, quality issues, historical experience, and usage forecasts. We record write-downs of inventory for potentially excess, obsolete, or impaired goods in order to state inventory at net realizable value. We make assumptions about future demand, market conditions, and the release of new products that may supersede old ones. However, if actual market conditions are less favorable than anticipated, additional inventory write-downs could be required.  </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various lawsuits and claims arising in the ordinary course of business, including actions with respect to intellectual property, employment, and contractual matters. In connection with these matters, we assess, on a regular basis, the probability and range of possible loss based on the developments in these matters. A liability is recorded in the consolidated financial statements if it is believed to be probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review outstanding legal matters to determine the adequacy of the liabilities accrued and related disclosures in consideration of many factors, which include, but are not limited to, past history, scientific and other evidence, and the specifics and status of each matter. We may change our estimates if our assessment of the various factors changes and the amount of ultimate loss may differ from our estimates, resulting in a material effect on our business, financial condition, results of operations, and/or cash flows.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the acquisition method of accounting, we allocate the fair value of the total consideration transferred to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the date of acquisition. The fair values assigned, defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between willing market participants, are based on estimates and assumptions determined by management. These valuations require us to make estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill. Costs that we incur to complete the business combination, such as legal and other professional fees, are expensed as they are incurred.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain acquisitions, contingent consideration can be earned by the sellers upon completion of certain future performance milestones. In these cases, a liability is recorded on the acquisition date, as a component of accrued liabilities and/or other long-term liabilities, for an estimate of the acquisition-date fair value of the contingent consideration. We generally use a Monte Carlo simulation or an income approach to estimate the fair value of contingent consideration. Estimates and assumptions used in a Monte Carlo simulation include forecasted revenues, a revenue risk premium, a revenue volatility estimate, an operational leverage ratio and a counterparty credit spread. An income approach utilizes inputs such as anticipated future cash flows, risk-free adjusted discount rates, and nonperformance risk, as well as management judgment regarding the probability of achieving certain future milestones. Future changes in our estimates could result in expenses or gains. Changes in the fair value of contingent consideration subsequent to the acquisition date are recognized in selling, general and administrative expense.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically use a discounted cash flow method to value acquired intangible assets. This method requires management judgment to forecast future operating results and establish residual growth rates and discount factors. The estimates we use to value and amortize intangible assets are consistent with the plans and estimates that we use to manage our business and are based on available historical information and industry estimates and averages. If the subsequent actual results and updated projections of the underlying business activity change compared with the assumptions and projections used to develop these values, we could experience impairment charges. In addition, we have estimated the economic lives of the acquired assets, which are used to calculate depreciation and amortization expense. If our estimates of the economic lives change, depreciation or amortization expense could be accelerated or extended. We capitalize in-process research and development (IPR&amp;D) with an indefinite life until completion or abandonment of the associated research and development efforts. Upon reaching the end of the research and development project (i.e., upon commercialization), the IPR&amp;D asset is amortized over its estimated useful life. If the research and development project is abandoned, the IPR&amp;D asset is expensed in the period of abandonment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the initial accounting for a business combination is incomplete by the end of a reporting period that falls within the measurement period (not to exceed one year from the date of acquisition), we report provisional amounts in our consolidated financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. We record these adjustments to the provisional amounts with a corresponding offset to goodwill. Any adjustments identified after the measurement period are recorded in the consolidated statements of operations.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Intangible Assets with Indefinite Lives&#160;&#8212; Impairment Assessment</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other intangible assets with indefinite useful lives (i.e., IPR&amp;D) are not amortized, however they are tested annually for impairment, in the second quarter of our fiscal year, and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment test include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with our reporting structure and availability of discrete financial information. During the goodwill impairment review, we assess qualitative factors to determine whether it is more likely than not that the fair values of our reporting units are less than the carrying amounts, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and our overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair values of our reporting units are less than the carrying amounts, then no additional assessment is deemed necessary. Otherwise, we proceed to compare the estimated fair values of the reporting units with the carrying values, including goodwill. If the carrying amounts of the reporting units exceed the fair values, we record an impairment loss based on the difference. If a quantitative assessment is performed, the evaluation includes management estimates of cash flow projections based on internal future projections and/or use of a market approach by looking at market values of comparable companies. Key assumptions include, but are not limited to, future revenue growth, operating margins, capital expenditures, terminal growth rates and discount rates. We also consider our market capitalization as a part of our analysis. We may elect to bypass the qualitative assessment in a period and proceed to perform the quantitative goodwill impairment test.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D impairment test is performed by comparing the fair value of the asset to its carrying amount. When testing indefinite-lived intangibles for impairment, we may assess qualitative factors to determine whether it is more likely than not that the asset is impaired. Alternatively, we may bypass this qualitative assessment and perform a quantitative impairment test. We estimate the fair value of IPR&amp;D using a discounted cash flow model, which requires the use of significant estimates and assumptions, including, but not limited to, estimating the timing of future cash flows, growth rates, and discount rates. If the IPR&amp;D is impaired, the carrying value of the IPR&amp;D is written down to the revised fair value with the related impairment charge recognized in the period in which the impairment occurs. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets and Other Long-Lived Assets&#160;&#8212; Impairment Assessment</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform regular reviews to determine if any event has occurred that may indicate that the carrying values of our intangible assets with finite lives and other long-lived assets are impaired. If indicators of impairment exist, we assess the recoverability of the affected assets by determining whether their carrying amounts exceed their undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss if the carrying value exceeds the fair value. Factors that may indicate potential impairment include a significant decline in our stock price and market capitalization compared to net book value, significant changes in the ability of an asset to generate positive cash flows and the pattern of utilization of a particular asset.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to estimate the fair values of identifiable intangible assets with finite lives and other long-lived assets, we estimate the present value of future cash flows from those assets. The key assumptions that we use in our cash flow model are the amount and timing of estimated future cash flows to be generated by the asset over an extended period of time and a rate of return that considers the relative risk of achieving the cash flows, the time value of money, and other factors that a willing market participant would consider. Management judgment is required to estimate the amount and timing of future cash flows and the relative risk of achieving those cash flows.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review our operating lease right-of-use (ROU) assets for impairment whenever events or changes in circumstances indicate that the carrying value of the ROU asset may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. We consider a triggering event to reassess an ROU asset&#8217;s asset group to have occurred if we exit a portion of or the full facility or enter into a sublease. Factors that may indicate potential impairment include a significant decrease in the market price of an underlying leased asset group. If we conclude that the carrying value of affected assets will not be recovered, we estimate the fair value of the assets and record an impairment in an amount equal to the excess of the carrying value over the fair value. We estimate the present value of future cash flows from our assets in order to determine the fair value. There is uncertainty in the projected future cash flows used in our impairment review analysis, which requires the use of estimates and assumptions. </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions and estimates about future values and remaining useful lives are complex and often subjective. They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts. For example, if our future operating results do not meet current forecasts or if we experience a sustained decline in our market capitalization that is determined to be indicative of a reduction in fair value of our reporting units, we may be required to record future impairment charges for purchased intangible assets with finite lives. Impairment charges could materially decrease our future results of operations and result in lower asset values on our balance sheet.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect our best assessment of estimated future taxes to be paid. Judgments and estimates based on interpretations of existing tax laws or regulations in the United States and the numerous foreign jurisdictions where we are subject to income tax are required in determining our provision for income taxes. Changes in tax laws, regulations, or statutory tax rates (including the implementation of global minimum tax rates in certain jurisdictions), and estimates of our future taxable income could impact the deferred tax assets and liabilities provided for in the consolidated financial statements and would require an adjustment to the provision for income taxes.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating our ability to recover deferred tax assets within the jurisdiction which they arise, we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, our history of earnings and reliability of our forecasts, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the impact of a tax position in our consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Tax authorities regularly examine our returns in the jurisdictions in which we do business and we regularly assess the tax risk of our return filing positions. Due to the complexity of some of the uncertainties, the ultimate resolution may result in payments that are materially different from our current estimate of the tax liability. These differences, as well as any interest and penalties, will be reflected in the provision for income taxes in the period in which they are determined.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_55"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current investment policy with respect to our cash, cash equivalents and short-term investments focuses on maintaining acceptable levels of interest rate risk and liquidity. To achieve these objectives, our policy allows us to maintain a portfolio of cash equivalents and short-term investments in a variety of securities, including money market funds, U.S. Treasury debt and corporate debt securities. Our policy also limits the amount of credit exposure to any one issuer and type of instrument. Under our current policies, we do not use interest rate derivative instruments to manage exposure to interest rate changes. As of December&#160;29, 2024, our cash equivalents consisted primarily of U.S. government money market funds that invest in very liquid investments, namely, cash, government securities and purchase agreements that are collateralized fully with government securities. U.S. government money market funds provide same day liquidity and have a net asset value of $1.00. We have historically maintained a relatively short average maturity for our investment portfolio, and we believe a hypothetical 100 basis point adverse move in interest rates along the entire interest rate yield curve would not materially affect the fair value of our interest-sensitive financial instruments. Other than convertible notes, we held no debt securities as of December&#160;29, 2024.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, we issued $500&#160;million of 4.650% notes due 2026. In December 2022, we issued $500&#160;million of 5.800% notes due 2025 and $500&#160;million of 5.750% notes due 2027. In March 2021, we issued $500&#160;million of 2.550% notes due 2031. We carry the notes at the principal amount, less unamortized discount and debt issuance costs, on our consolidated balance sheets. As the notes have fixed annual interest rates, we do not have economic interest rate exposure or financial statement risk associated with changes in interest rates. The fair value of the notes, however, may fluctuate when interest rates change. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_109">6. Debt and Other Commitments</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct a portion of our business in currencies other than our U.S. dollar functional currency. These transactions give rise to cash flows and monetary assets and liabilities that are denominated in currencies other than the U.S. dollar; the value of these amounts are exposed to changes in currency exchange rates from the time the transactions are forecasted or originated until the time the cash settlement is converted into U.S. dollars. Our foreign currency exposures are primarily concentrated in the euro, Japanese yen, Australian dollar, Canadian dollar, Singapore dollar, Chinese Yuan Renminbi, and British pound. We use forward exchange contracts to manage these foreign currency risks and to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. We only use derivative financial instruments to reduce foreign currency exchange rate risks; we do not hold any derivative financial instruments for trading or speculative purposes. The counterparties to these forward exchange contracts expose us to credit-related risks in the event of their non-performance. We mitigate this risk by actively monitoring credit ratings and only selecting major financial institutions as counterparties. Additionally, our risk of credit-related loss is limited to the fair value of these financial contracts, which were not material to our financial position.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our forward exchange contracts used to manage foreign currency risks related to monetary assets and liabilities have terms of one month or less. Realized and unrealized gains or losses on the fair value of these financial contracts are included in the determination of net income (loss), as they have not been designated for hedge accounting. These contracts, which settle monthly, effectively fix the exchange rate at which these specific monetary assets and liabilities will be settled, so that gains or losses on the forward contracts offset the gains or losses from changes in the value of the underlying monetary assets and liabilities. As of December&#160;29, 2024, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases was $477 million. Our forward exchange contracts used to hedge portions of our foreign currency exposure associated with forecasted revenue transactions have terms of up to 24 months. These derivative financial instruments are designated as cash flow hedges. Gains and losses on these financial contracts, which settle monthly, are generally recorded to revenue in the same period the underlying hedged transactions are recorded. As of December&#160;29, 2024, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases was $621 million.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_58"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a summary of recent accounting pronouncements applicable to our consolidated financial statements refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_91">1. Organization and Significant Accounting Policies</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Consolidated Financial Statements section of this report, which is incorporated herein by reference. </span></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_64"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONSOLIDATED FINANCIAL STATEMENTS</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_67">Report of Independent Registered Public Accounting Firm (PCAOB ID: </a></span><span style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-51">42</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_67">)</a></span></div></td><td colspan="3" style="border-top:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_67">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_73">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_73">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_76">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_76">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_79">Consolidated Statements of Comprehensive </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_79">Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_79">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_82">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_82">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_85">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_85">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_88">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_88">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_91">1. Organization and Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_91">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">2. GRAIL Spin-Off</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_94">3. Revenue</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_94">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_100">4. Investments and Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_100">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_106">5. </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_106">Goodwill, </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_106">Intangible Assets, and Acquisitions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_106">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_109">6. Debt and Other Commitments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_109">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_118">7. Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_118">77</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_121">8. Supplemental Balance Sheet </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_121">Details</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_121">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_127">9. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_127">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_130">10. Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_130">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_133">11. Employee Benefit Plans</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_133">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_136">12. Segment and Geographic Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_136">92</a></span></div></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_67"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the Stockholders and the Board of Directors of Illumina, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Illumina, Inc. (the Company) as of December&#160;29, 2024 and December&#160;31, 2023, the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;29, 2024, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;29, 2024 and December&#160;31, 2023, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;29, 2024, in conformity with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December&#160;29, 2024, based on criteria established in Internal Control</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:107%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February&#160;12, 2025 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.836%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">GRAIL Contingent Consideration</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the August 18, 2021 acquisition of GRAIL, the Company recognized a contingent consideration liability at the estimated fair value on the acquisition date. The Company uses a Monte Carlo simulation model to determine the fair value of the contingent consideration liability each reporting period. As disclosed in Note 4 of the consolidated financial statements, the fair value of the contingent consideration liability as of December 29, 2024 is $71 million. The Company recognized a $315 million gain in the current year as a result of the change in the fair value of the contingent consideration liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing the valuation of the contingent consideration liability was complex and required significant auditor judgment due to the estimation uncertainty in evaluating the reasonableness of a significant assumption, which is the revenue risk premium. A significant emphasis is placed on the appropriateness of the estimate considerations used by management to determine the fair value of the GRAIL contingent consideration due to the sensitivity of the fair value to changes in the revenue risk premium. The revenue risk premium is forward-looking and could be affected by future economic and market conditions.</span></div></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.836%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.964%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of internal controls over the Company's process for determining the fair value of the contingent consideration liability related to GRAIL. This included controls over management&#8217;s development of the above-described assumption used in the valuation model applied.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In testing the valuation of the contingent consideration liability, we performed audit procedures that included, among others, evaluating the Company&#8217;s use of the Monte Carlo simulation model and testing the significant assumption used in the model, as described above. We evaluated the completeness and accuracy of underlying data used in supporting the assumption and estimate. In addition, we involved valuation specialists to assist in evaluating the Company&#8217;s use of the Monte Carlo simulation model and selection of the revenue risk premium. Our valuation specialists evaluated the revenue risk premium by comparing it against a range that was independently developed using publicly available market data for comparable entities. </span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Impairment assessment of GRAIL in-process research and development (IPR&amp;D)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company tests indefinite-lived intangible assets for impairment annually, as of May, or more frequently if events or circumstances indicate it is more likely than not that the fair value of an asset is less than its carrying amount. The Company identified a triggering event that occurred in the three months ended June 30, 2024 that required an interim impairment test. GRAIL IPR&amp;D was tested for impairment by comparing its fair value to its carrying value. As disclosed in Note 5 of the consolidated financial statements, as a result of the interim impairment assessment, the Company recorded an impairment loss of $420 million related to GRAIL IPR&amp;D. The carrying value of IPR&amp;D following the impairment assessment was $140 million. The Company divested GRAIL on June 24, 2024.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing the Company&#8217;s IPR&amp;D impairment assessment was complex and required significant auditor judgment due to the significant estimation uncertainty in determining the fair value of GRAIL IPR&amp;D. Management used an income approach to estimate the fair value of GRAIL IPR&amp;D. A significant emphasis is placed on the appropriateness of the estimate considerations used by management to determine the fair value of GRAIL IPR&amp;D due to the sensitivity of the fair value to the underlying assumptions. The significant assumptions include forecasted revenues for GRAIL IPR&amp;D and the discount rate used to discount future cash flows. These significant assumptions related to the fair value of GRAIL IPR&amp;D are forward-looking and could be affected by future economic and market conditions.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of internal controls over the Company's process for determining the fair value of GRAIL IPR&amp;D. This included controls over management&#8217;s development of the above-described assumptions used in the valuation model applied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In testing the valuation of GRAIL IPR&amp;D, we performed audit procedures that included, among others, evaluating the Company&#8217;s use of the income approach and testing the significant assumptions used in the model, as described above. We evaluated the completeness and accuracy of underlying data used in supporting the assumptions and estimates. We evaluated the reasonableness of projected revenue growth used within the valuation against industry trends, market trends, and other market information. In addition, we involved valuation specialists to assist in evaluating the Company&#8217;s use of the income approach and selection of the discount rate. Our valuation specialists evaluated the discount rate by comparing it against a discount rate range that was independently developed using publicly available market data for comparable entities.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-52">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2000.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-53">San&#160;Diego, California</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;12, 2025 </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_73"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except par value)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="12" style="background-color:#dddddd;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-54">1,127</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-55">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-56">93</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-57">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-58">735</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-59">734</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="f-60">547</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="f-61">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-62">244</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-63">234</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-64">2,746</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-65">2,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-66">815</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-67">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-68">419</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-69">544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-70">1,113</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-71">2,545</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-72">295</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-73">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-74">567</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-75">56</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-76">348</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-77">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-78">6,303</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-79">10,111</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-80">221</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-81">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="f-82">827</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-83">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term debt, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:NotesPayableCurrent" scale="6" id="f-84">499</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:NotesPayableCurrent" format="ixt:fixed-zero" scale="6" id="f-85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-86">1,547</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-87">1,570</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-88">554</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-89">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term debt</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-90">1,490</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-91">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-92">339</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-93">620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies </span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-94"></ix:nonFraction></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-95"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-96"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-97">0.01</ix:nonFraction></ix:nonFraction>&#160;par value, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-98"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-99">10</ix:nonFraction></ix:nonFraction> million&#160;shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-100"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-101"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-102"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-103">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;29, 2024 and December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-104">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-106"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-107">0.01</ix:nonFraction></ix:nonFraction>&#160;par value, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-108"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-109">320</ix:nonFraction></ix:nonFraction>&#160;million&#160;shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="f-110">200</ix:nonFraction>&#160;million shares issued and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-111">159</ix:nonFraction>&#160;million outstanding at December&#160;29, 2024; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="f-112">199</ix:nonFraction>&#160;million&#160;shares issued and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-113">159</ix:nonFraction>&#160;million outstanding at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="f-114">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="f-115">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-116">7,525</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-117">9,555</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-118">22</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-119">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-120">1,242</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-121">19</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-6" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="f-122">41</ix:nonFraction>&#160;million shares and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-6" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="f-123">40</ix:nonFraction>&#160;million shares at December&#160;29, 2024 and December&#160;31, 2023, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="f-124">3,934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="f-125">3,792</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-126">2,373</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-127">5,745</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-128">6,303</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-129">10,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_76"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.988%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-130">3,656</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-131">3,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-132">3,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-133">716</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-134">717</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-135">631</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-136">4,372</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-137">4,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-138">4,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-139">1,017</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-140">1,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-141">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service and other revenue</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-142">367</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-143">392</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-144">295</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="f-145">127</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="f-146">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="f-147">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-148">1,511</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-149">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-150">1,612</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-151">2,861</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-152">2,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-153">2,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expense:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-154">1,169</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-155">1,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-156">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-157">1,092</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-158">1,612</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-159">1,297</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="6" id="f-160">1,889</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="f-161">827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="6" id="f-162">3,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal contingency and settlement</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="f-163">456</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="f-164">20</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="f-165">619</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-166">3,694</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-167">3,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-168">7,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-169">833</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-170">1,069</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-171">4,179</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-172">46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-173">58</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-174">11</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-175">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-176">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-177">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-178">292</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-179">29</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-180">142</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-181">346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-182">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-183">157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-184">1,179</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-185">1,117</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-186">4,336</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-187">44</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-188">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-189">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-190">1,223</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-191">1,161</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-192">4,404</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-193">7.69</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-194">7.34</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-195">28.00</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-196">7.69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-197">7.34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-198">28.00</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing loss per share:</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-199">159</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-200">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-201">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="2" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-202">159</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="2" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-203">158</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="2" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-204">157</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="margin-top:19pt"><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_79"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.988%"><tr><td style="width:1.0%"/><td style="width:54.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-205">1,223</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-206">1,161</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-207">4,404</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on cash flow hedges, net of deferred tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-208">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-209">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-210">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive loss</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-211">1,200</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-212">1,165</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-213">4,418</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_82"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="margin-top:1pt;text-align:center"><span><br/></span></div><div style="margin-bottom:1pt;margin-top:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.678%"><tr><td style="width:1.0%"/><td style="width:40.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.314%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.314%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.182%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.314%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.314%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.314%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.358%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.314%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.314%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.046%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid-In</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Comprehensive</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Accumulated</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deficit)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-214">197</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-215">2</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-216">8,938</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-217">17</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-218">5,485</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-18" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-219">40</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-220">3,702</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-221">10,740</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-222">4,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-223">4,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on cash flow hedges, net of deferred tax</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-224">14</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-225">14</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock, net of repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="-6" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares" scale="6" id="f-226">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue" scale="6" id="f-227">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" sign="-" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue" scale="6" id="f-228">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue" scale="6" id="f-229">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-230">299</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-231">299</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-232">Cumulative-effect adjustment from adoption of ASU 2020-06, net of deferred tax</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-233">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-234">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-235">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-236">198</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-237">2</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-238">9,207</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-239">3</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-240">1,142</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-32" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-241">40</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-242">3,755</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-243">6,599</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-244">1,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-245">1,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on cash flow hedges, net of deferred tax</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-246">4</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-247">4</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock, net of repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-6" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares" scale="6" id="f-248">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue" scale="6" id="f-249">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-6" sign="-" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue" scale="6" id="f-250">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue" scale="6" id="f-251">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-252">275</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-253">275</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of liability-classified awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="ilmn:ReclassificationLiabilityAwards" scale="6" id="f-254">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="ilmn:ReclassificationLiabilityAwards" scale="6" id="f-255">9</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-256">199</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-257">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-258">9,555</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-259">1</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-260">19</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-43" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-261">40</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-262">3,792</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-263">5,745</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-264">1,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-265">1,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gain on cash flow hedges, net of deferred tax</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-266">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="f-267">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance of common stock, net of repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="-6" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares" scale="6" id="f-268">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue" scale="6" id="f-269">51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-48" decimals="-3" sign="-" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares" scale="6" id="f-270">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-6" sign="-" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue" scale="6" id="f-271">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue" scale="6" id="f-272">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-273">318</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-274">318</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Spin-Off of GRAIL (see </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">Note 2</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="ilmn:AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" format="ixt:num-dot-decimal" scale="6" id="f-275">2,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ilmn:AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" format="ixt:num-dot-decimal" scale="6" id="f-276">2,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 29, 2024</span></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-49" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-277">200</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-278">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-279">7,525</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-280">22</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-281">1,242</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-53" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-282">41</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-283">3,934</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-284">2,373</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_85"></div><hr style="page-break-after:always"/><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.963%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.963%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ILLUMINA, INC.<br/>CONSOLIDATED STATEMENTS OF CASH FLOWS<br/>(In millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-285">1,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-286">1,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-287">4,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#DDDDDD;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#DDDDDD;padding:0 1pt"/><td colspan="3" style="background-color:#DDDDDD;padding:0 1pt"/><td colspan="3" style="background-color:#DDDDDD;padding:0 1pt"/><td colspan="3" style="background-color:#DDDDDD;padding:0 1pt"/><td colspan="3" style="background-color:#DDDDDD;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:Depreciation" scale="6" id="f-288">224</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:Depreciation" scale="6" id="f-289">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:Depreciation" scale="6" id="f-290">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-291">130</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-292">197</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-293">179</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-294">370</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-295">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-296">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-297">112</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-298">33</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-299">23</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net losses on strategic investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="ilmn:GainLossOnStrategicInvestmentsNoncash" scale="6" id="f-300">312</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="ilmn:GainLossOnStrategicInvestmentsNoncash" scale="6" id="f-301">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="ilmn:GainLossOnStrategicInvestmentsNoncash" scale="6" id="f-302">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-303">315</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-304">24</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-305">205</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss on Helix contingent value right</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ilmn:ContingentValueRightUnrealizedGainLossNoncash" scale="6" id="f-306">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="ilmn:ContingentValueRightUnrealizedGainLossNoncash" scale="6" id="f-307">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="ilmn:ContingentValueRightUnrealizedGainLossNoncash" scale="6" id="f-308">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and intangible (IPR&amp;D) impairment</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="6" id="f-309">1,889</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="f-310">827</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="6" id="f-311">3,914</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment and right-of-use asset impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ilmn:PropertyAndEquipmentAndRightOfUseAssetImpairment" scale="6" id="f-312">46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="ilmn:PropertyAndEquipmentAndRightOfUseAssetImpairment" scale="6" id="f-313">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="ilmn:PropertyAndEquipmentAndRightOfUseAssetImpairment" scale="6" id="f-314">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-315">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-316">17</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-317">8</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-318">25</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-319">40</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-320">12</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-321">19</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-322">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-323">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-324">14</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-325">11</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-326">16</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ilmn:IncreaseDecreaseOfOperatingLeasesNet" scale="6" id="f-327">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="ilmn:IncreaseDecreaseOfOperatingLeasesNet" scale="6" id="f-328">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="ilmn:IncreaseDecreaseOfOperatingLeasesNet" scale="6" id="f-329">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="f-330">15</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="f-331">5</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="f-332">19</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-333">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-334">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-335">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-336">440</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-337">15</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="f-338">381</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="f-339">28</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="f-340">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="6" id="f-341">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-342">837</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-343">478</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-344">392</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net purchases of property and equipment</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-345">128</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-346">195</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-347">286</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net purchases of strategic investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ilmn:PurchasesSalesForStrategicInvestments" scale="6" id="f-348">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="ilmn:PurchasesSalesForStrategicInvestments" scale="6" id="f-349">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="ilmn:PurchasesSalesForStrategicInvestments" scale="6" id="f-350">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for acquisitions and intangible assets, net of cash acquired</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-351">81</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-352">30</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-353">265</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash received for Helix contingent value right</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" scale="6" id="f-354">83</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="f-355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" format="ixt:fixed-zero" scale="6" id="f-356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-357">178</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-358">231</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-359">591</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from debt, net of issuance costs</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-360">1,241</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="f-361">1</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-362">991</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on debt obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="f-363">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-364">1,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="6" id="f-365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on contingent consideration liabilities</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" scale="6" id="f-366">1</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" scale="6" id="f-367">1</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-368">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-369">56</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-370">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-371">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-372">32</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-373">40</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-374">54</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-375">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="f-376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="f-377">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GRAIL cash deconsolidated as a result of spin-off</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ilmn:CashDeconsolidatedFinancingActivities" scale="6" id="f-378">968</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="ilmn:CashDeconsolidatedFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="ilmn:CashDeconsolidatedFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-381">570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-382">1,210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-383">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-384">10</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-386">22</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-387">79</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-388">963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-389">779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-390">1,048</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-391">2,011</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-392">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-393">1,127</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-394">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-395">2,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-396">83</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-397">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-398">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-399">105</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-400">65</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-401">122</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="f-402">132</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="f-403">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="f-404">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment included in accounts payable and accrued liabilities</span></div></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-405">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-406">12</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-407">16</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GRAIL net assets, excluding cash and cash equivalents, deconsolidated as a result of spin-off</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ilmn:NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-408">1,770</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="ilmn:NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="ilmn:NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:15.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_88"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Illumina,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Illumina, Inc. and its consolidated subsidiaries.</span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_91"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="f-411" continuedAt="f-411-1" escape="true"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.  ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a provider of sequencing- and array-based solutions, serving customers in the research, clinical and applied markets.&#160;Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Our customers include leading genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;24, 2024, we completed the separation (the Spin-Off) of GRAIL into a new public company through the distribution of <ix:nonFraction unitRef="shares" contextRef="c-55" decimals="INF" name="ilmn:DiscontinuedOperationNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-412">26,547,021</ix:nonFraction> shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The distribution reflected approximately <ix:nonFraction unitRef="number" contextRef="c-55" decimals="3" name="ilmn:DiscontinuedOperationPercentOfInterestDisposedOf" scale="-2" id="f-413">85.5</ix:nonFraction>% of the outstanding common stock of GRAIL as of 5:00 p.m. New York time on June 13, 2024, the record date for the distribution (the Record Date). We retained approximately <ix:nonFraction unitRef="number" contextRef="c-55" decimals="3" name="us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" scale="-2" id="f-414">14.5</ix:nonFraction>% of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL&#8217;s assets, liabilities, results of operations and cash flows have not been reclassified.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-415" continuedAt="f-415-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-415-1">The consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (GAAP) and include our accounts, our wholly-owned subsidiaries, and majority-owned or controlled companies. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation.</ix:continuation>  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="f-416" continuedAt="f-416-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entities (VIEs)</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-416-1">We evaluate our ownership, contractual and other interests in entities that are not wholly-owned to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously perform this assessment, as changes to existing relationships or future transactions may result in the consolidation or deconsolidation of a VIE. As of December&#160;29, 2024, there were no VIEs for which we were the primary beneficiary and for which we were required to consolidate.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-417" continuedAt="f-417-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-417-1">The preparation of the consolidated financial statements requires that management make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures of contingent assets and liabilities. Though macroeconomic factors such as inflation, exchange rate fluctuations and concerns about an economic downturn&#160;present additional uncertainty, we continue to use the best information available to inform our critical accounting estimates. Actual results could differ from those estimates.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FiscalPeriod" id="f-418" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year is the 52 or 53&#160;weeks ending the Sunday closest to December&#160;31, with quarters of 13 or 14&#160;weeks ending the Sunday closest to March&#160;31, June&#160;30, September&#160;30, and December&#160;31. References to 2024, 2023, and 2022 refer to fiscal years ended December&#160;29, 2024, December&#160;31, 2023, and January&#160;1, 2023, respectively, which were all 52 weeks.</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-411-1" continuedAt="f-411-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-419" continuedAt="f-419-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Functional Currency</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-419-1">The U.S. dollar is the functional currency of our international operations. We re-measure foreign subsidiaries&#8217; monetary assets and liabilities to the U.S. dollar and record the net gains or losses resulting from re-measurement in other expense, net in the consolidated statements of operations.</ix:continuation>  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-420" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customers</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact our operating results. A portion of our customers consist of university and research institutions that management believes are, to some degree, directly or indirectly supported by the United States Government. A significant change in current research funding, particularly with respect to funding of the U.S. National Institutes of Health or targeted cancellations by the U.S. federal government of certain grants or contracts, could have an adverse impact on future revenues and results of operations.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised <ix:nonFraction unitRef="number" contextRef="c-56" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-421">48</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-57" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-422">48</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="c-58" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-423">50</ix:nonFraction>% of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented <ix:nonFraction unitRef="number" contextRef="c-59" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-424">53</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-60" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-425">55</ix:nonFraction>% of our gross trade accounts receivable balance as of December&#160;29, 2024 and December&#160;31, 2023, respectively.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no customers that provided more than 10% of total consolidated revenue in 2024, 2023, and 2022. We perform regular reviews of customer activity and associated credit risks and do not require collateral or enter into netting arrangements. Historically, we have not experienced significant credit losses from accounts receivable. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to risks related to our financial instruments, including cash and cash equivalents, investments, and accounts receivable. Most of our cash and cash equivalents as of December&#160;29, 2024 were deposited with U.S. financial institutions, either domestically or with their foreign branches. Our investment policy restricts the amount of credit exposure to any one issuer to <ix:nonFraction unitRef="number" contextRef="c-61" decimals="INF" name="ilmn:ConcentrationRiskThreshold" scale="-2" id="f-426">5</ix:nonFraction>% of the portfolio or <ix:nonFraction unitRef="number" contextRef="c-62" decimals="INF" name="ilmn:ConcentrationRiskThreshold" scale="-2" id="f-427">5</ix:nonFraction>% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to <ix:nonFraction unitRef="number" contextRef="c-63" decimals="INF" name="ilmn:ConcentrationRiskThreshold" scale="-2" id="f-428">30</ix:nonFraction>% of the portfolio at the time of purchase. There is no limit to the percentage of the portfolio that may be maintained in debt securities, U.S.&#160;government-sponsored entities, U.S.&#160;Treasury securities, and money market funds. Historically, we have not experienced significant credit losses from financial instruments. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Suppliers</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require customized products and components that currently are available from a limited number of sources. We source certain key products and components included in our products from single vendors. Historically, we have not experienced significant issues sourcing materials to build our products.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-429" continuedAt="f-429-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segments</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-429-1">We report segment information based on the management approach, which designates the internal reporting used by the Chief Operating Decision Maker (CODM) for making decisions and assessing performance as the source of our reportable segments. Our CODM allocates resources and assesses the performance of segments using information about their revenue and net income (loss). Our CODM does not evaluate our segments using asset information.</ix:continuation> </span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-411-2" continuedAt="f-411-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-430" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2024</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard requires a company to disclose incremental segment information on an annual and interim basis, including significant segment expenses and measures of profit or loss that are regularly provided to the CODM. The standard does not change how an entity identifies its operating segments. The standard was effective for us beginning in fiscal year 2024 and interim periods within fiscal year 2025. We adopted the standard on its effective date in fiscal year 2024 and applied the amendments retrospectively to all prior periods presented in the consolidated financial statements. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_136">12. Segment and Geographic Information</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2022</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options (Subtopic 470-20)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard reduces the number of accounting models for convertible debt instruments, amends the accounting for certain contracts in an entity&#8217;s own equity, and modifies how certain convertible instruments and contracts that may be settled in cash or shares impact the calculation of diluted earnings per share. Specifically, the guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments and requires the use of the if-converted method to calculate diluted earnings per share. We adopted the standard on its effective date in the first quarter of 2022 using a modified retrospective approach by recognizing a cumulative-effect adjustment to retained earnings on January 3, 2022. As a result of the adoption of ASU 2020-06, we increased retained earnings and decreased additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-431">61</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-432">93</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Pending Adoption</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses -</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard requires a company to provide disaggregated disclosures, in the notes to the financial statements, of specified categories of expenses that are included in line items on the face of the income statement. The standard is effective for us beginning in fiscal year 2027 and interim periods within fiscal year 2028, with early adoption permitted. The new standard is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2024-03 on the consolidated financial statements and related disclosures.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) - Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard requires a company to expand its existing income tax disclosures, specifically related to the rate reconciliation and income taxes paid. The standard is effective for us beginning in fiscal year 2025, with early adoption permitted, and is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2023-09 on the consolidated financial statements and related disclosures.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-433" continuedAt="f-433-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated from the sale of products and services. Product revenue consists of sales of instruments and consumables used in genetic analysis. Service and other revenue consists of revenue generated from genotyping and sequencing services, instrument service contracts, development and licensing agreements, and, prior to the Spin-Off of GRAIL on June&#160;24, 2024, cancer detection testing services related to the GRAIL business.</span></div></ix:nonNumeric></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-411-3" continuedAt="f-411-4"><ix:continuation id="f-433-1" continuedAt="f-433-2"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of our products and services is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. Revenue recognition for contracts with multiple deliverables is based on the separate satisfaction of each distinct performance obligation within the contract. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of a good or service to the customer, meaning the customer has the ability to use and obtain the benefit of the good or service. The contract price is allocated to each performance obligation in proportion to its standalone selling price. We determine our best estimate of standalone selling price using average selling prices over a rolling 12-month period coupled with an assessment of current market conditions. If the product or service has no history of sales or if the sales volume is not sufficient, we rely upon prices set by management, adjusted for applicable discounts.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized generally upon delivery to the end customer, which is when control of the product is deemed to be transferred. Invoicing typically occurs upon shipment and payment is typically due within <ix:nonNumeric contextRef="c-6" name="ilmn:RevenueFromContractWithCustomerPaymentTerm" format="ixt-sec:durday" id="f-434">30</ix:nonNumeric> days from invoice. In instances where right of payment or transfer of title is contingent upon the customer&#8217;s acceptance of the product, revenue is deferred until all acceptance criteria have been met. Revenue from genotyping and sequencing services, including cancer detection testing services related to the GRAIL business, is recognized when earned, which is generally at the time the genotyping or sequencing analysis data is made available to the customer. Revenue from instrument service contracts is recognized as the services are rendered, typically evenly over the contract term. Revenue from development and licensing agreements generally includes upfront and periodic licensing fees, contract research and development services, or payments for development and regulatory milestones.  Revenue for these agreements is recognized when each distinct performance obligation is satisfied.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of discounts, distributor commissions, and sales taxes collected on behalf of governmental authorities. Employee sales commissions are recorded as selling, general and administrative expense when incurred as the amortization period for such costs, if capitalized, would have been one year or less.</span></div></ix:continuation><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-433-2" continuedAt="f-433-3">In certain markets, products and services are sold to customers through distributors. In most sales through distributors, the product is delivered directly to customers by us. The terms of sales transactions through distributors are consistent with the terms of direct sales to customers.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-435" continuedAt="f-435-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss per Share</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-435-1">Basic loss per share is computed based on the weighted average number of common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. In loss periods, basic and diluted loss per share are identical since the effect of potentially dilutive common shares is antidilutive and therefore excluded. Potentially dilutive common shares from equity awards are determined using the average share price for each period under the treasury stock method. In addition, proceeds from exercise of equity awards and the average amount of unrecognized compensation expense for equity awards are assumed to be used to repurchase shares. Potentially dilutive common shares issuable upon conversion of convertible senior notes are determined using the if-converted method.</ix:continuation> </span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-411-4" continuedAt="f-411-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="f-436" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average shares used to calculate basic and diluted loss per share were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:60.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in calculating basic loss per share</span></div></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-437">159</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-438">158</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-439">157</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in calculating diluted loss per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-440">159</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-441">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-442">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity awards</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-443">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-66" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-444">3</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-67" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-445">2</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-68" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="f-446">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-69" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-447">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-70" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-448">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded due to antidilutive effect</span></div></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-449">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-450">4</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-451">4</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-452" continuedAt="f-452-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of assets and liabilities are based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize use of observable inputs and minimize use of unobservable inputs. We use a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:</span></div><div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;1&#160;&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Quoted prices in active markets for identical assets or liabilities.  </span></div><div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;2&#160;&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Inputs, other than Level&#160;1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.  </span></div><div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;3&#160;&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.  </span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-452-1">The carrying amounts of financial instruments such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate the related fair values due to the short-term maturities of these instruments.</ix:continuation>  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-453" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents and Investments</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are comprised of short-term, highly-liquid investments with original maturities of 90 days or less.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsPolicy" id="f-454" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have strategic investments in privately-held companies (non-marketable equity securities) and publicly traded companies (marketable equity securities). Our marketable equity securities are measured at fair value. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Equity investments are classified as current, short-term investments, or noncurrent, recorded in other assets, based on the nature of the securities and their availability for use in current operations. Realized and unrealized gains and losses on our equity investments are recorded in other expense, net in the consolidated statements of operations. Our equity investments are assessed for impairment quarterly. Impairment losses, equal to the difference between the carrying value and the fair value of the investment, are recorded in other expense, net. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the equity method to account for investments through which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded in other assets, and our share of net income or loss is recognized on a one quarter lag in other expense, net.</span></div></ix:nonNumeric></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-411-5" continuedAt="f-411-6"><ix:nonNumeric contextRef="c-1" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="f-455" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. Receivables are considered past due based on the contractual payment terms. We reserve a percentage of our trade receivable balance based on collection history and current economic trends that we expect will impact the level of credit losses over the life of our receivables. These reserves are re-evaluated on a regular basis and adjusted, as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-456" continuedAt="f-456-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-456-1">Inventory is stated at the lower of cost or net realizable value, on a first-in, first-out basis. Inventory includes raw materials and finished goods that may be used in the research and development process, and such items are expensed as consumed or capitalized as property and equipment and depreciated. Inventory write-downs for slow-moving, excess, and obsolete inventories are estimated based on product life cycles, quality issues, historical experience, and usage forecasts.</ix:continuation>  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-457" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, using the straight-line method. Depreciation of leasehold improvements is recorded over the shorter of the lease term or the estimated useful life of the related assets. Maintenance and repairs are expensed as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred to develop internal-use software during the application development stage are recorded at cost as computer software. Costs incurred in the development of such internal-use software, including external direct costs of materials and services and applicable compensation costs of employees devoted to specific software application development, are capitalized. Costs incurred outside of the application development stage are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-458" continuedAt="f-458-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of the major classes of property and equipment are generally as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-71" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-459">4</ix:nonNumeric> to <ix:nonNumeric contextRef="c-72" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-460">20</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-73" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-461">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c-74" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-462">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-75" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-463">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c-76" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-464">9</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-77" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-465">7</ix:nonNumeric> years</span></div></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-466" continuedAt="f-466-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have various non-cancellable operating lease agreements for office, lab, manufacturing, and distribution facilities. These leases have remaining lease terms of <ix:nonNumeric contextRef="c-78" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="f-467">1</ix:nonNumeric> year to <ix:nonNumeric contextRef="c-79" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="f-468">14</ix:nonNumeric> years, which represent the non-cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised. We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from <ix:nonNumeric contextRef="c-78" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="f-469">2</ix:nonNumeric> years to <ix:nonNumeric contextRef="c-79" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="f-470">20</ix:nonNumeric> years. Our lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms, as well as payments for common-area-maintenance and administrative services. We often receive customary incentives from our landlords, such as reimbursements for tenant improvements and rent abatement periods, which effectively reduce the total lease payments owed for these leases. Leases are classified as operating or financing at commencement. As of December&#160;29, 2024, we do not have any financing leases.</span></div></ix:nonNumeric></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-411-6" continuedAt="f-411-7"><ix:continuation id="f-466-1"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and liabilities on our consolidated balance sheets represent the present value of our remaining lease payments over the remaining lease terms, less any impairments recorded for right-of-use assets. We do not allocate lease payments to non-lease components; therefore, fixed payments for common-area-maintenance and administrative services are included in our operating lease right-of-use assets and liabilities. We use our incremental borrowing rate to calculate the present value of our lease payments, as the implicit rates in our leases are not readily determinable. Operating lease costs consist primarily of the fixed lease payments included in our operating lease liabilities and are recorded on a straight-line basis over the lease terms. We sublease certain real estate to third parties and this sublease income is also recorded on a straight-line basis.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationsPolicy" id="f-471" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the acquisition method of accounting, we allocate the fair value of the total consideration transferred to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the date of acquisition. These valuations require us to make estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill. Costs that we incur to complete the business combination, such as legal and other professional fees, are expensed as they are incurred.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain acquisitions, contingent consideration can be earned by the sellers upon completion of certain future performance milestones. In these cases, a liability is recorded on the acquisition date, as a component of accrued liabilities and/or other long-term liabilities, for an estimate of the acquisition-date fair value of the contingent consideration. These estimates require management judgment, including probabilities of achieving certain future milestones. Changes in the fair value of the contingent consideration subsequent to the acquisition date are recognized in selling, general and administrative expense in our consolidated statements of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the initial accounting for a business combination is incomplete by the end of a reporting period that falls within the measurement period (not to exceed a year from the date of acquisition), we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. We record these adjustments to the provisional amounts with a corresponding offset to goodwill. Any adjustments identified after the measurement period are recorded in the consolidated statements of operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="f-472" continuedAt="f-472-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill, Intangible Assets and Other Long-Lived Assets</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired, including intangible assets and capitalized in-process research and development (IPR&amp;D), and liabilities assumed are measured at fair value as of the acquisition date. Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of the net assets acquired. Intangible assets acquired in a business combination that are used for IPR&amp;D activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project (i.e., upon commercialization), the IPR&amp;D asset is amortized over its estimated useful life. If the relevant research and development project is abandoned, the IPR&amp;D asset is expensed in the period of abandonment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and IPR&amp;D are not amortized; however, they are reviewed for impairment at least annually during the second quarter, or more frequently if an event occurs indicating the potential for impairment. Goodwill and IPR&amp;D are considered to be impaired if the carrying value of the reporting unit or IPR&amp;D asset exceeds its respective fair value.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with our reporting structure and availability of discrete financial information. During the goodwill impairment review, we assess qualitative factors to determine whether it is more likely than not that the fair values of our reporting units are less than the carrying amounts, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and our overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair values of our reporting units are less than the carrying amounts, then no additional assessment is deemed necessary. Otherwise, we proceed to compare the estimated fair values of the reporting units with the carrying values, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, we record an impairment loss based on the difference. We may elect to bypass the qualitative assessment in a period and proceed to perform the quantitative goodwill impairment test.  </span></div></ix:nonNumeric></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-411-7" continuedAt="f-411-8"><ix:continuation id="f-472-1" continuedAt="f-472-2"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D impairment test is performed by comparing the fair value of the asset to its carrying amount. When testing indefinite-lived intangibles for impairment, we may assess qualitative factors to determine whether it is more likely than not that the asset is impaired. Alternatively, we may bypass this qualitative assessment and perform a quantitative impairment test. If the IPR&amp;D asset is impaired, the carrying value of the IPR&amp;D is written down to the revised fair value with the related impairment charge recognized in the period in which the impairment occurs. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our identifiable intangible assets with a finite life are typically comprised of acquired developed technologies, licensed technologies, customer relationships, license agreements, and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#8217; respective estimated useful lives.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform regular reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss in an amount equal to the excess of the carrying value over the fair value. Factors that may indicate potential impairment include a significant decline in our stock price and market capitalization compared to the net book value, significant changes in the ability of a particular asset to generate positive cash flows for our strategic business objectives, and the pattern of utilization of a particular asset.  </span></div></ix:continuation><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-472-2">We review our operating lease right-of-use assets for impairment whenever events or changes in circumstances indicate the carrying value of the right-of-use asset may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. We consider a triggering event to reassess a right-of-use asset&#8217;s asset group to have occurred if we exit a portion of or the full facility or enter into a sublease. Factors that may indicate potential impairment include a significant decrease in the market price of an underlying leased asset group. If we conclude the carrying value of affected assets will not be recovered, we estimate the fair value of the assets and record an impairment in an amount equal to the excess of the carrying value over the fair value.</ix:continuation>  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-473" continuedAt="f-473-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign exchange rate risks in the normal course of business and use derivative financial instruments to partially offset this exposure. We do not use derivative financial instruments for speculative or trading purposes. Foreign exchange contracts are carried at fair value in other current assets, other assets, accrued liabilities, or other long-term liabilities, as appropriate, on the consolidated balance sheets. The cash flows associated with such foreign exchange contracts, or derivative financial instruments, are classified as cash flows from operating activities in the consolidated statements of cash flows, which is the same category as the hedged transaction.</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-473-1">We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these derivatives are recognized in other expense, net, along with the re-measurement gain or loss on the foreign currency denominated assets or liabilities. As of December&#160;29, 2024, we had foreign exchange forward contracts in place to hedge exposures in the euro, Japanese yen, Australian dollar, Canadian dollar, Singapore dollar, Chinese Yuan Renminbi, and British pound.</ix:continuation> As of December&#160;29, 2024 and December&#160;31, 2023, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases were $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-474">477</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-475">926</ix:nonFraction> million, respectively. In September 2024, as a result of the European Commission withdrawing its previously imposed fine, the related forward contracts we previously entered into for a total notional amount of &#8364;<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-476">432</ix:nonFraction>&#160;million were terminated.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-411-8" continuedAt="f-411-9"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durmonth" id="f-477">24</ix:nonNumeric> months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other comprehensive income (loss) and are reclassified to revenue in the same period the underlying hedged transactions are recorded. We regularly review the effectiveness of our cash flow hedges and consider them to be ineffective if it becomes probable that the forecasted transactions will not occur in the identified period. Changes in fair value of the ineffective portions of our cash flow hedges, if any, are recognized in other expense, net. As of December&#160;29, 2024, we had foreign currency forward contracts in place to hedge exposures associated with forecasted revenue transactions denominated in the euro, Japanese yen, Australian dollar, Canadian dollar, and Chinese Yuan Renminbi. As of December&#160;29, 2024 and December&#160;31, 2023, the total notional amounts of outstanding cash flow hedge contracts in place for these foreign currency purchases were $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-478">621</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-479">628</ix:nonFraction> million, respectively. We reclassified $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-480">15</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-481">18</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-482">53</ix:nonFraction>&#160;million to revenue in 2024, 2023, and 2022, respectively. As of December&#160;29, 2024, the fair value of foreign currency forward contracts was $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="f-483">27</ix:nonFraction>&#160;million, recorded in total assets. As of December&#160;31, 2023, the fair value of foreign currency forward contracts recorded in total assets and total liabilities was $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-484">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="f-485">9</ix:nonFraction> million, respectively. Estimated gains reported in accumulated other comprehensive income (loss) expected to be reclassified into earnings within the next 12 months are $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="f-486">27</ix:nonFraction> million as of December&#160;29, 2024. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:StandardProductWarrantyPolicy" id="f-487" continuedAt="f-487-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranties</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-487-1">We generally provide a <ix:nonNumeric contextRef="c-87" name="ilmn:StandardProductWarrantyDescriptionTerm" format="ixt-sec:durwordsen" id="f-488">one-year</ix:nonNumeric> warranty on instruments. Additionally, we provide a warranty on consumables through the expiration date, which generally ranges from <span style="-sec-ix-hidden:f-489">six</span> to <ix:nonNumeric contextRef="c-89" name="ilmn:StandardProductWarrantyDescriptionTerm" format="ixt-sec:durwordsen" id="f-490">twelve months</ix:nonNumeric> after the manufacture date. At the time revenue is recognized, an accrual is established for estimated warranty expenses based on historical experience as well as anticipated product performance. We periodically review the warranty reserve for adequacy and adjust the warranty accrual, if necessary, based on actual experience and estimated costs to be incurred. Warranty expense is recorded as a component of cost of product revenue.</ix:continuation>  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-491" continuedAt="f-491-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is incurred related to restricted stock, employee stock purchase plan (ESPP), stock options, and, prior to the GRAIL Spin-Off on June&#160;24, 2024, cash-based equity incentive awards. Forfeitures are accounted for, as incurred, as a reversal of share-based compensation expense related to awards that will not vest.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock units (RSU) and performance stock units (PSU) are both considered restricted stock. The determination of the amount of share-based compensation expense for our PSU requires the use of certain estimates and assumptions that affect the amount of share-based compensation expense recognized in our consolidated statements of operations. The fair value of restricted stock and performance stock units that do not include a market condition is determined by the closing market price of our common stock on the date of grant. PSU that do not include a market condition represent a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any increase or decrease in share-based compensation expense resulting from an adjustment in the estimated shares to be released is treated as a cumulative catch-up in the period of adjustment. The fair value of performance stock units that include a market condition is determined on the date of grant using a Monte Carlo simulation, which includes assumptions for expected volatility, risk-free interest rate and dividend yield. These unobservable inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. Share-based compensation expense is recognized based on the fair value on a straight-line basis over the requisite service periods of the awards. Compensation expense for PSU that include a market condition is recognized over the requisite service period regardless of whether the market conditions are achieved.</span></div></ix:nonNumeric></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-411-9" continuedAt="f-411-10"><ix:continuation id="f-491-1"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchased under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. The expected volatility is generally determined by weighing the historical and implied volatility of our common stock. The historical volatility is generally commensurate with the estimated expected term. The implied volatility is calculated from the implied market volatility of exchange-traded call options on our common stock. The expected term is generally based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-492">0</ix:nonFraction>% given that we have never declared or paid cash dividends on our common stock and do not anticipate paying such cash dividends. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash-based equity incentive awards were classified as liability awards, as such awards were to be settled in cash. In connection with the Spin-Off of GRAIL, these awards were assumed by GRAIL. For purposes of valuation and performance measurement of the awards, GRAIL&#8217;s stand-alone value calculation, as estimated by GRAIL based on its analysis and on input from independent valuation advisors and analyses, was used. The fair value of the awards was recorded over the respective vesting periods of the awards, with recognition of a corresponding liability recorded in accrued liabilities in the consolidated balance sheets. The awards were remeasured to fair value at each reporting date until the awards were settled, with changes in fair value recognized in share-based compensation expense.</span></div></ix:continuation><ix:continuation id="f-433-3" continuedAt="f-433-4"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Expenses</span></div></ix:continuation><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-433-4">Shipping and handling expenses are included in cost of product revenue.</ix:continuation>  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-493" continuedAt="f-493-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-493-1">Research and development expenses include personnel expenses, contractor fees, facilities-related costs, material costs, and license fees. Expenditures relating to research and development are expensed in the period incurred.</ix:continuation>  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="f-494" continuedAt="f-494-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-494-1">Advertising costs are expensed as incurred</ix:continuation> and were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="f-495">37</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="f-496">36</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AdvertisingExpense" scale="6" id="f-497">53</ix:nonFraction> million in 2024, 2023, and 2022, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="ilmn:RestructuringPolicyTextBlock" id="f-498" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and accrue liabilities associated with employee separation costs, which primarily consist of severance pay and other separation costs such as outplacement services and benefits, at fair value as of the date the plan is approved and when such costs are reasonably estimable. The fair value measurement of restructuring related liabilities requires certain assumptions and estimates to be made, such as the retention period of certain employees. It is our policy to use the best estimates based on facts and circumstances available at the time of measurement, review the assumptions and estimates periodically, and adjust the liabilities when necessary.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-499" continuedAt="f-499-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise, we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.  </span></div></ix:nonNumeric></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-499-1"><ix:continuation id="f-411-10">The impact of a tax position is recognized in the consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected in income tax expense.</ix:continuation></ix:continuation>  </span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_1657"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="f-500" continuedAt="f-500-1" escape="true"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.  GRAIL SPIN-OFF</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 24, 2024, we completed the Spin-Off of GRAIL into a separate, independent publicly traded company through the distribution of <ix:nonFraction unitRef="shares" contextRef="c-55" decimals="INF" name="ilmn:DiscontinuedOperationNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-501">26,547,021</ix:nonFraction> shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The GRAIL common stock distributed in the Spin-Off consisted of approximately <ix:nonFraction unitRef="number" contextRef="c-55" decimals="3" name="ilmn:DiscontinuedOperationPercentOfInterestDisposedOf" scale="-2" id="f-502">85.5</ix:nonFraction>% of the outstanding common stock of GRAIL as of the Record Date. The Spin-Off was structured as a tax-free spin-off and Illumina stockholders received one share of GRAIL common stock for every <ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="ilmn:DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff" format="ixt-sec:numwordsen" scale="0" id="f-503">six</ix:nonFraction> shares of Illumina common stock held on the Record Date. We retained approximately <ix:nonFraction unitRef="number" contextRef="c-55" decimals="3" name="us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" scale="-2" id="f-504">14.5</ix:nonFraction>% of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL&#8217;s assets, liabilities, results of operations and cash flows have not been reclassified. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Spin-Off, we contributed to GRAIL an amount, in cash, to cover <ix:nonNumeric contextRef="c-55" name="us-gaap:DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal" format="ixt-sec:duryear" id="f-505">2.5</ix:nonNumeric> years of GRAIL&#8217;s operations (the Disposal Funding), which was determined to be $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal" format="ixt:num-dot-decimal" scale="6" id="f-506">974</ix:nonFraction>&#160;million, less the cash and cash equivalents held by GRAIL.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="f-507" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of GRAIL&#8217;s assets and liabilities included as part of the disposal group were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:87.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.158%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="f-508">968</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="f-509">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="f-510">22</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="f-511">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="f-512">80</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="ilmn:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" scale="6" id="f-513">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-514">2,201</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="f-515">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="f-516">12</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" scale="6" id="f-517">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="ilmn:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" scale="6" id="f-518">62</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long term-liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" scale="6" id="f-519">469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL net assets</span></div></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets" format="ixt:num-dot-decimal" scale="6" id="f-520">2,738</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of GRAIL net assets recorded to short-term investments</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets" scale="6" id="f-521">397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of GRAIL net assets recorded to additional paid-in capital</span></div></td><td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets" format="ixt:num-dot-decimal" scale="6" id="f-522">2,341</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional adjustments recorded to additional paid-in capital as a result of the GRAIL Spin-Off:</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-contingent indemnification liability (see </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_118">Note 7</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" scale="6" id="f-523">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax adjustment for difference between the book and tax values of our retained investment in GRAIL</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" scale="6" id="f-524">57</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recorded to additional paid-in capital as a result of the GRAIL Spin-Off</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="ilmn:DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-525">2,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Includes IPR&amp;D with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-526">140</ix:nonFraction>&#160;million after impairment. Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_106">5. Goodwill, Intangible</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_106"> Assets, and Acquisitions</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_136">12. Segment and Geographic Information</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for GRAIL&#8217;s results of operations, prior to the Spin-Off, included in our consolidated statements of operations for the periods presented within.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In planning for and executing the Spin-Off, we incurred $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" name="ilmn:DiscontinuedOperationTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="f-527">53</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="ilmn:DiscontinuedOperationTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="f-528">17</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in separation-related transaction costs in 2024 and 2023, respectively, recognized in selling, general, and administrative expense. The costs primarily related to financial advisory, legal, regulatory and other professional services fees directly related to the Spin-Off. </span></div></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-500-1"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Spin-Off, Illumina and GRAIL entered into various agreements to effect the Spin-Off and provide a framework for GRAIL&#8217;s relationship with Illumina after the Spin-Off, including a separation and distribution agreement, an employee matters agreement, a tax matters agreement, an amended supply and commercialization agreement and a stockholder&#8217;s and registration rights agreement (the Agreements). The Agreements determine the treatment of the assets, employees, liabilities and obligations (including certain tax-related assets and liabilities) of Illumina attributable to periods prior to, at and after GRAIL&#8217;s separation and also govern certain relationships between Illumina and GRAIL after the Spin-Off.</span></div></ix:continuation><div id="i64df1cccf2dd452496bdff4e9d30a288_94"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-529" continuedAt="f-529-1" escape="true"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.  REVENUE</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated from the sale of products and services. Product revenue consists of sales of instruments and consumables used in genetic analysis. Service and other revenue consists of revenue generated from genotyping and sequencing services, instrument service contracts, development and licensing agreements, and prior to the Spin-Off of GRAIL on June&#160;24, 2024, cancer detection testing services related to the GRAIL business. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-530" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue by Source</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sequencing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Microarray</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sequencing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Microarray</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sequencing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Microarray</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-531">2,858</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-532">297</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-533">3,155</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-534">2,790</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-535">293</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-536">3,083</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-537">2,919</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-538">306</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-539">3,225</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-540">484</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-541">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-542">501</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-543">685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-544">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-545">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-546">709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-547">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-548">728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-549">3,342</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-550">314</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-551">3,656</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-552">3,475</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-553">312</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-554">3,787</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-555">3,628</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-556">325</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-557">3,953</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-558">651</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-559">65</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-560">716</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-561">637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-562">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-563">717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-564">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-565">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-566">631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-567">3,993</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-568">379</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-569">4,372</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-570">4,112</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-571">392</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-572">4,504</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-573">4,171</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-574">413</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-575">4,584</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue by Geographic Area</span></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.963%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Based on region of destination (in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-576">2,441</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-577">2,521</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-578">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-579">1,185</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-580">1,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-581">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-582">308</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-583">384</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-584">472</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific, Middle East and Africa</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-585">438</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-586">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-587">544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-588">4,372</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-589">4,504</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-590">4,584</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">We implemented a new global commercial structure in Q1 2023 to improve operating efficiencies and better align with local markets. We integrated Asia-Pacific and Japan with emerging markets across the Middle East, Africa, Turkey, and Commonwealth of Independent States (CIS). Beginning in Q1 2023, and going forward, we report regional results for the following regions: Americas, Europe, Greater China, and Asia-Pacific, Middle East and Africa (AMEA). Prior period amounts have been reclassified to conform to this new presentation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">Americas revenue included United States revenue of $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-591">2,288</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-592">2,359</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-593">2,290</ix:nonFraction>&#160;million in 2024, 2023 and 2022, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">Region includes revenue from China, Taiwan, and Hong Kong.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">Region includes revenue from Russia and Turkey.</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly enter into contracts with multiple performance obligations. These contracts are believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The timing of shipments depends on several factors, including agreed upon shipping schedules, which may span multiple quarters. Most performance obligations are generally satisfied within a short time frame, approximately <span style="-sec-ix-hidden:f-594">three</span> to <ix:nonNumeric contextRef="c-148" name="ilmn:RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" format="ixt-sec:durwordsen" id="f-595">six months</ix:nonNumeric>, after the contract execution date. As of December&#160;29, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-596">657</ix:nonFraction> million, of which approximately <ix:nonFraction unitRef="number" contextRef="c-149" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="f-597">78</ix:nonFraction>% is expected to be converted to revenue in 2025, approximately <ix:nonFraction unitRef="number" contextRef="c-150" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="f-598">10</ix:nonFraction>% in the following <ix:nonNumeric contextRef="c-150" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="f-599">twelve months</ix:nonNumeric>, and the remainder thereafter.</span></div></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-529-1" continuedAt="f-529-2"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets, which consist of revenue recognized and performance obligations satisfied or partially satisfied in advance of customer billing, as of December&#160;29, 2024 and December&#160;31, 2023, were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="f-600">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="f-601">18</ix:nonFraction> million, respectively, all of which were short-term and recorded in prepaid expenses and other current assets.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-529-2">Contract liabilities, which consist of deferred revenue and customer deposits, as of December&#160;29, 2024 and December&#160;31, 2023, were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-602">327</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-603">329</ix:nonFraction> million, respectively, of which the short-term portions of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-604">260</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-605">252</ix:nonFraction> million, respectively, were recorded in accrued liabilities and the remaining long-term portions were recorded in other long-term liabilities. Revenue recorded in 2024 included $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-606">245</ix:nonFraction> million of previously deferred revenue that was included in contract liabilities as of December&#160;31, 2023.</ix:continuation> </span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_100"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-608" continuedAt="f-608-1" escape="true"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.  INVESTMENTS AND FAIR VALUE MEASUREMENTS</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategic Investments</span></div><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Equity Securities</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of marketable equity securities. As of December&#160;29, 2024 and December&#160;31, 2023, the fair value of our marketable equity securities totaled $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-609">93</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-610">6</ix:nonFraction> million, respectively. The increase in our marketable equity securities relates to the investment we retained in GRAIL subsequent to the Spin-Off, which was initially recorded as $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets" scale="6" id="f-611">397</ix:nonFraction> million, representing <ix:nonFraction unitRef="number" contextRef="c-55" decimals="3" name="us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" scale="-2" id="f-612">14.5</ix:nonFraction>% of GRAIL&#8217;s net assets disposed of at Spin-Off. Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details. We recorded an <ix:nonNumeric contextRef="c-1" name="ilmn:DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" id="f-613">unrealized loss</ix:nonNumeric> of $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" sign="-" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" scale="6" id="f-614">309</ix:nonFraction> million in 2024, subsequent to the Spin-Off, based on the fair value of our investment in GRAIL as of December&#160;29, 2024.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesTextBlock" id="f-615" escape="true"><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and (losses) recognized in other expense, net on marketable equity securities were as follows:</span></div><div style="margin-top:13pt;padding-left:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:66.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) recognized during the period on marketable equity securities</span></div></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="f-616">310</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="f-617">2</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="f-618">81</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net (losses) recognized during the period on marketable equity securities sold during the period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-619">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="f-620">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (losses) recognized during the period on marketable equity securities still held at the reporting date</span></div></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="f-622">310</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:fixed-zero" scale="6" id="f-623">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="f-624">81</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Marketable Equity Securities</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024 and December&#160;31, 2023, non-marketable equity securities, without readily determinable fair values, included in other assets, were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="f-625">26</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="f-626">28</ix:nonFraction> million, respectively. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Venture Funds</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in <ix:nonFraction unitRef="fund" contextRef="c-151" decimals="INF" name="ilmn:NumberOfInvestmentFunds" format="ixt-sec:numwordsen" scale="0" id="f-627">three</ix:nonFraction> venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="f-628">201</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="f-629">168</ix:nonFraction> million as of December&#160;29, 2024 and December&#160;31, 2023, respectively. We recorded a net gain of $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="f-630">5</ix:nonFraction>&#160;million in 2024, and net losses of $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="f-631">33</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="f-632">25</ix:nonFraction>&#160;million in 2023 and 2022, respectively, in other expense, net.</span></div></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-608-1" continuedAt="f-608-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherCommitmentsTableTextBlock" id="f-633" escape="true"><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitments to the Funds are as follows:</span></div><div style="margin-top:13pt;padding-left:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.965%"><tr><td style="width:1.0%"/><td style="width:36.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital commitments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Callable through date</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remaining callable as of December&#160;29, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fund I</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:OtherCommitment" scale="6" id="f-634">100</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2026</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="ilmn:RemainingCapitalCommitment" scale="6" id="f-635">3</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fund II</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-6" name="us-gaap:OtherCommitment" scale="6" id="f-636">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-6" name="ilmn:RemainingCapitalCommitment" scale="6" id="f-637">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fund III</span></div></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-6" name="us-gaap:OtherCommitment" scale="6" id="f-638">60</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2034</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-6" name="ilmn:RemainingCapitalCommitment" scale="6" id="f-639">47</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Fund I also had recallable distributions of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="ilmn:RecallableDistributionsCommitment" format="ixt:num-dot-decimal" scale="6" id="f-640">10</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from transactions with our strategic investees was $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-641">20</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-642">69</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-643">113</ix:nonFraction> million in 2024, 2023, and 2022, respectively. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-644" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy&#160;for assets and liabilities measured at fair value on a recurring basis:</span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"><tr><td style="width:1.0%"/><td style="width:28.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (cash equivalents)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-645">931</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-646">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-647">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-648">931</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-649">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-650">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-651">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-652">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="f-653">93</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="f-654">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="f-655">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="f-656">93</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="f-657">6</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="f-658">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="f-659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="f-660">6</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="ilmn:OtherInvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-661">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="ilmn:OtherInvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-662">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="ilmn:OtherInvestmentsFairValueDisclosure" scale="6" id="f-663">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="ilmn:OtherInvestmentsFairValueDisclosure" scale="6" id="f-664">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="ilmn:OtherInvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-665">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="ilmn:OtherInvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-666">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="ilmn:OtherInvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-667">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="ilmn:OtherInvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helix contingent value right</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="ilmn:ContingentValueRightFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-669">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="ilmn:ContingentValueRightFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-670">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="ilmn:ContingentValueRightFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-671">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="ilmn:ContingentValueRightFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="ilmn:ContingentValueRightFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="ilmn:ContingentValueRightFairValueDisclosure" scale="6" id="f-674">68</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="ilmn:ContingentValueRightFairValueDisclosure" scale="6" id="f-675">68</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-676">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-677">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-678">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-679">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-681">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-683">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-684">1,024</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-685">70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-686">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-687">1,111</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-688">780</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-689">61</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-690">68</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-691">909</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-692">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-693">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-694">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-695">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-696">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-697">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-698">387</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-699">387</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" format="ixt:fixed-zero" scale="6" id="f-700">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-701">65</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" format="ixt:fixed-zero" scale="6" id="f-702">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-703">65</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" format="ixt:fixed-zero" scale="6" id="f-704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-705">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" format="ixt:fixed-zero" scale="6" id="f-706">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-707">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-708">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-709">65</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-710">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-711">138</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-712">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-713">59</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-714">387</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-715">446</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable equity securities are measured at fair value based on quoted trade prices in active markets. Other investments, included in other assets, consist of convertible notes, for which we elected the fair value option. Fair value is derived using a probability-weighted scenario approach. Changes in fair value are recognized in other expense, net. Deferred compensation plan assets consist primarily of investments in life insurance contracts carried at cash surrender value, which reflects the net asset value of the underlying publicly traded mutual funds. We corroborate the fair value of our holdings, comparing valuations obtained from our investment service provider to valuations reported by our asset custodians, validating pricing sources and models, and reviewing key model inputs. </span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-608-2" continuedAt="f-608-3"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Helix Contingent Value Right</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the deconsolidation of Helix Holdings I, LLC (Helix) in April 2019, we received a contingent value right with a <ix:nonNumeric contextRef="c-170" name="ilmn:BusinessAcquisitionContingentValueRightsTerm" format="ixt-sec:durwordsen" id="f-716">7-year</ix:nonNumeric> term that entitled us to consideration dependent upon the outcome of Helix&#8217;s future financing and/or liquidity events. We elected the fair value option to measure the contingent value right received from Helix. Changes in the estimated fair value are recognized in other expense, net. We estimated the fair value of the contingent value right using a Monte Carlo simulation. Estimates and assumptions used in the Monte Carlo simulation included probabilities related to the timing and outcome of future financing and/or liquidity events, assumptions regarding collectability and volatility, and an estimated equity value of Helix. These unobservable inputs represented a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. On July 31, 2024, we received cash of $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-717">83</ix:nonFraction> million to settle the contingent value right early. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-718" continuedAt="f-718-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Helix contingent value right were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.676%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="f-719">65</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-720">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="f-721">58</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-722">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="f-723">68</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="f-724">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received to settle</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="f-725">83</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="f-726">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Liabilities</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reassess the fair value of contingent consideration related to acquisitions on a quarterly basis, with changes in the fair value, subsequent to the acquisition date, recognized in selling, general and administrative expense. The contingent value rights issued as part of the GRAIL acquisition entitle the holders to receive future cash payments on a quarterly basis (Covered Revenue Payments) representing a pro rata portion of certain GRAIL-related revenues (Covered Revenues) each year for a <ix:nonNumeric contextRef="c-178" name="ilmn:BusinessAcquisitionContingentValueRightsTerm" format="ixt-sec:duryear" id="f-727">12</ix:nonNumeric>-year period (through August 2033). As defined in the </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000095015721000850/ex4-1.htm">Contingent Value Rights Agreement</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, this will reflect a <ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="ilmn:BusinessAcquisitionContingentValueRightsProRataOnePercentage" scale="-2" id="f-728">2.5</ix:nonFraction>% payment right to the first $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-9" name="ilmn:BusinessAcquisitionContingentValueRightsRevenueThreshold" format="ixt:num-dot-decimal" scale="9" id="f-729">1</ix:nonFraction>&#160;billion of revenue each year for <ix:nonNumeric contextRef="c-178" name="ilmn:BusinessAcquisitionContingentValueRightsTerm" format="ixt-sec:duryear" id="f-730">12</ix:nonNumeric> years. Revenue above $<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-9" name="ilmn:BusinessAcquisitionContingentValueRightsRevenueThreshold" format="ixt:num-dot-decimal" scale="9" id="f-731">1</ix:nonFraction>&#160;billion each year will be subject to a <ix:nonFraction unitRef="number" contextRef="c-182" decimals="2" name="ilmn:BusinessAcquisitionContingentValueRightsProRataTwoPercentage" scale="-2" id="f-732">9</ix:nonFraction>% contingent payment right during this same period. Covered Revenues for the periods Q4 2023 through Q3 2024, Q4 2022 through Q3 2023, and Q4 2021 through Q3 2022 were $<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-6" name="ilmn:CoveredRevenuesOfGRAILContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-733">117</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="ilmn:CoveredRevenuesOfGRAILContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-734">85</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="ilmn:CoveredRevenuesOfGRAILContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-735">42</ix:nonFraction>&#160;million, respectively, driven primarily by sales of GRAIL&#8217;s Galleri test. Covered Revenue Payments relating to such periods were $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="f-736">1.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="f-737">803,000</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="f-738">396,000</ix:nonFraction> in 2024, 2023, and 2022, respectively. A portion of the Covered Revenue Payments in 2022 were applied to reimburse us for certain expenses. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our contingent consideration liability related to GRAIL was $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-739">71</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-740">387</ix:nonFraction>&#160;million as of December&#160;29, 2024 and December&#160;31, 2023, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-741">70</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-742">385</ix:nonFraction>&#160;million, respectively, was included in other long-term liabilities, with the remaining balances included in accrued liabilities. We use a Monte Carlo simulation to estimate the fair value of the GRAIL contingent consideration liability. Estimates and assumptions used in the Monte Carlo simulation include forecasted revenues for GRAIL, a revenue risk premium, a revenue volatility estimate, an operational leverage ratio and a counterparty credit spread. These unobservable inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. Subsequent to the Spin-Off, we no longer have access to GRAIL management&#8217;s forecasts. Therefore, we must rely on information made public by GRAIL&#8217;s management and, beginning in Q4 2024, information published in analyst reports to estimate forecasted revenues through August 2033. In August 2024, GRAIL publicly announced a corporate restructure, including a reduction in headcount and planned hires and a substantial decrease in certain R&amp;D projects and investments. To estimate the liability as of December&#160;29, 2024, we selected a revenue risk premium of <ix:nonFraction unitRef="number" contextRef="c-189" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-743">9</ix:nonFraction>%, which was derived from reconciling our forecasted revenues for GRAIL to GRAIL&#8217;s market capitalization based on a <ix:nonFraction unitRef="day" contextRef="c-190" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="f-744">60</ix:nonFraction>-day trailing average. The significant decrease in the contingent consideration liability from December&#160;31, 2023 was due to a decrease in the forecasted revenues, following revised revenue projections announced by GRAIL in May 2024 and the restructuring announcement in August 2024.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-608-3"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in estimating the fair value of the contingent consideration liability related to GRAIL are inherently subject to uncertainty and we note that small changes in these assumptions could have a significant impact on the concluded value. For example, an increase or decrease of 20%, in each year, to the forecasted revenues would have resulted in an increase of $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease" format="ixt:num-dot-decimal" scale="6" id="f-745">17</ix:nonFraction>&#160;million and a decrease of $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" sign="-" name="ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-746">18</ix:nonFraction>&#160;million, respectively, in the liability as of December&#160;29, 2024. Additionally, an increase or decrease of 250 basis points to the selected revenue risk premium would have resulted in a decrease of $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" sign="-" name="ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease" format="ixt:num-dot-decimal" scale="6" id="f-747">12</ix:nonFraction>&#160;million and an increase of $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease" format="ixt:num-dot-decimal" scale="6" id="f-748">15</ix:nonFraction>&#160;million, respectively. We expect certain levels of volatility in the GRAIL contingent consideration liability are possible in future periods.</span></div><ix:continuation id="f-718-1"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the estimated fair value of our contingent consideration liabilities were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="f-749">615</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="f-750">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-751">205</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="f-752">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-753">24</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="f-754">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="f-755">387</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="f-756">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-757">315</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="f-758">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="f-759">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_106"></div><ix:nonNumeric contextRef="c-1" name="ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-760" continuedAt="f-760-1" escape="true"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.  GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS</span></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-761" continuedAt="f-761-1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></ix:nonNumeric></div><ix:continuation id="f-761-1"><div style="margin-bottom:1pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-762">3,239</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="f-763">712</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-764">18</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-765">2,545</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-766">1,466</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-767">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-768">1,113</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"> The balance as of January&#160;1, 2023 includes accumulated impairment of $<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-6" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-769">3,914</ix:nonFraction>&#160;million related to our GRAIL reporting unit.</span></div></ix:continuation><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2024 Impairment of Goodwill</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is reviewed for impairment annually, during the second quarter of our fiscal year, or more frequently if an event occurs indicating the potential for impairment. In May 2024, we performed our annual goodwill impairment test for our <ix:nonFraction unitRef="reporting_unit" contextRef="c-199" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="f-770">two</ix:nonFraction> reporting units: Core Illumina and GRAIL. We performed a quantitative test for both reporting units. GRAIL&#8217;s carrying value exceeded its fair value, estimated as $<ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-6" name="ilmn:GoodwillAmountThatExceedsCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-771">580</ix:nonFraction>&#160;million, and we recorded a goodwill impairment of $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-772">1,466</ix:nonFraction>&#160;million in Q2 2024. There was no impairment for Core Illumina, as its fair value exceeded its carrying value.</span></div></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-760-1" continuedAt="f-760-2"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the investment bankers&#8217; enterprise value estimates included estimated revenues for a <ix:nonFraction unitRef="number" contextRef="c-199" decimals="INF" name="ilmn:GoodwillImpairmentMeasurementInput" format="ixt-sec:numwordsen" scale="0" id="f-773">two</ix:nonFraction> year period based on assumed growth rates and implied revenue multiples for comparable companies. These estimates and assumptions represent a Level 3 measurement as they are supported by little or no market activity and reflect our own assumptions in measuring fair value. An increase in estimated enterprise values for GRAIL of 100% would still have resulted in a full impairment of goodwill. In prior periods, we used a combination of both an income (discounted cash flow) and market approach to determine the fair value of GRAIL. The income approach utilized estimated cash flows for GRAIL based on a long-range plan, for a <ix:nonFraction unitRef="number" contextRef="c-202" decimals="INF" name="ilmn:GoodwillImpairmentMeasurementInput" scale="0" id="f-774">15</ix:nonFraction> year period, which contemplated FDA approval. Based on this approach, in Q3 2023, we estimated the fair value of GRAIL to be $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-8" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="f-775">3.6</ix:nonFraction>&#160;billion and using this same approach in Q4 2023 suggested no further decrement in fair value. Initial analyst coverage of GRAIL from December 2023 into the spring of 2024 suggested that GRAIL could be valued between $<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-9" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="f-776">3</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-9" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="f-777">4</ix:nonFraction>&#160;billion. By May 2024, prior to the consummation of the GRAIL Spin-Off, additional information about GRAIL had become available in GRAIL&#8217;s amended Form 10 filings and a publicly available management presentation, which included updated disclosure about GRAIL&#8217;s business and anticipated near term financial trends. Prior to the consummation of the GRAIL Spin-Off, the amount of GRAIL&#8217;s Disposal Funding, $<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-6" name="us-gaap:DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal" format="ixt:num-dot-decimal" scale="6" id="f-778">974</ix:nonFraction>&#160;million, was also disclosed. Analyst and banker valuation estimates then began to estimate fair values between $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-6" name="ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets" format="ixt:num-dot-decimal" scale="6" id="f-779">400</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-6" name="ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets" format="ixt:num-dot-decimal" scale="6" id="f-780">770</ix:nonFraction>&#160;million, consistent with the impairment recorded in Q2 2024.     </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of Core Illumina, we used a combination of both an income and market approach consistent with prior periods. The income approach utilized estimated discounted cash flows for the reporting unit, while the market approach utilized comparable company information. Estimates and assumptions used in the income approach included projected cash flows and a discount rate and represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated GRAIL&#8217;s IPR&amp;D intangible asset for potential impairment, in May 2024, as part of our annual test. We also concluded that the when-issued trading activity for GRAIL&#8217;s common stock, in June 2024, represented a triggering event that required an additional impairment test be performed. The carrying value of the IPR&amp;D asset exceeded its estimated fair value and we recorded an impairment of $<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-781">420</ix:nonFraction>&#160;million in Q2 2024. The fair value of GRAIL&#8217;s IPR&amp;D was determined by the income approach, using a discounted cash flow model. Estimates and assumptions used in the income approach, which represent a Level 3 measurement, included projected cash flows and a discount rate of <ix:nonFraction unitRef="number" contextRef="c-210" decimals="3" name="ilmn:IntangibleAssetsImpairmentMeasurementInput" scale="-2" id="f-782">46.5</ix:nonFraction>%. The discount rate was derived from reconciling GRAIL&#8217;s long-range plan, which contemplated FDA approval and estimated cash flows for a <ix:nonFraction unitRef="number" contextRef="c-211" decimals="INF" name="ilmn:IntangibleAssetsImpairmentMeasurementInput" scale="0" id="f-783">15</ix:nonFraction> year period, to observed market values of GRAIL based on when-issued trading activity. An increase of 300 basis points to the discount rate used in our analysis would have resulted in additional impairment of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ilmn:SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints" format="ixt:num-dot-decimal" scale="6" id="f-784">20</ix:nonFraction>&#160;million. There is substantial risk inherent in forecasting revenues and spend associated with research and development, including assumptions around the timing and level of resources and investment to be made, which were made more challenging in light of the Spin-Off and related Disposal Funding.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a recoverability test for GRAIL&#8217;s definite-lived intangible assets, which included developed technology and trade name, noting no impairment. No impairment was noted for Core Illumina definite-lived intangible assets.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Impairment of Goodwill</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q3 2023, we concluded that the sustained decrease in the Company&#8217;s stock price and overall market capitalization during the quarter was a triggering event indicating the fair values of our reporting units might be less than their carrying amounts and that an interim impairment test was required. Based on our analysis, we concluded GRAIL&#8217;s carrying value exceeded its fair value and recorded a goodwill impairment of $<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-785">712</ix:nonFraction>&#160;million, primarily due to the decrease in the Company&#8217;s consolidated market capitalization and a higher discount rate selected for the fair value calculation of GRAIL. There was no impairment for Core Illumina, as its fair value exceeded its carrying value.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-760-2" continuedAt="f-760-3"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed our interim goodwill impairment test using a combination of both an income and a market approach to determine the fair value of each reporting unit. The income approach utilized the estimated discounted cash flows for each reporting unit, while the market approach utilized comparable company information. Estimates and assumptions used in the income approach included projected cash flows for both GRAIL and Core Illumina and a discount rate for each reporting unit. Discount rates were determined using a weighted average cost of capital for risk factors specific to each reporting unit and other market and industry data. For GRAIL, the selected discount rate was <ix:nonFraction unitRef="number" contextRef="c-212" decimals="2" name="ilmn:GoodwillImpairmentDiscountedCashFlowModelDiscountRate" scale="-2" id="f-786">24.0</ix:nonFraction>%. An increase of <ix:nonFraction unitRef="number" contextRef="c-213" decimals="INF" name="ilmn:GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" scale="-4" id="f-787">50</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="c-214" decimals="INF" name="ilmn:GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" scale="-4" id="f-788">100</ix:nonFraction> basis points to the discount rate would have resulted in additional impairment of $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-6" name="ilmn:GoodwillPotentialImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-789">200</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-6" name="ilmn:GoodwillPotentialImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-790">350</ix:nonFraction>&#160;million. The estimates and assumptions used in our assessment represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. In order to further validate the reasonableness of the fair values concluded for our reporting units, a reconciliation to market capitalization was performed by estimating a reasonable implied control premium and other market factors.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with our interim goodwill impairment test, we also evaluated GRAIL&#8217;s IPR&amp;D intangible asset for potential impairment. We performed our impairment test by comparing the carrying value of the IPR&amp;D intangible asset to its estimated fair value, which was determined by the income approach, using a discounted cash flow model. Estimates and assumptions used in the income approach, which represent a Level 3 measurement, included projected cash flows and a selected discount rate of <ix:nonFraction unitRef="number" contextRef="c-217" decimals="2" name="ilmn:GoodwillImpairmentDiscountedCashFlowModelDiscountRate" scale="-2" id="f-791">19.0</ix:nonFraction>%. Based on our analysis, the carrying value of GRAIL&#8217;s IPR&amp;D intangible asset exceeded its estimated fair value and we recorded an impairment of $<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-792">109</ix:nonFraction>&#160;million in Q3 2023, primarily due to a decrease in projected cash flows and a higher discount rate selected for the fair value calculation of the IPR&amp;D asset. We also performed a recoverability test for the definite-lived intangible assets assigned to GRAIL, which included developed technology and trade name, and to Core Illumina and noted no impairment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q4 2023, we concluded, among other events, that our formal announcement to divest GRAIL represented a triggering event that required an additional interim impairment test be performed. As a result of our analysis, no impairment was recorded for Core Illumina or GRAIL. The fair value of GRAIL exceeded its carrying value by approximately $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-6" name="us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-793">950</ix:nonFraction>&#160;million and the selected discount rate used in the analysis was <ix:nonFraction unitRef="number" contextRef="c-219" decimals="INF" name="ilmn:GoodwillImpairmentTestDiscountRate" scale="-2" id="f-794">23.0</ix:nonFraction>%. An increase of 100 basis points to the discount rate would still have resulted in <ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-6" name="ilmn:GoodwillPotentialImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-795">no</ix:nonFraction> impairment for GRAIL. We also performed a recoverability test for the definite-lived intangible assets assigned to GRAIL and Core Illumina and noted no impairment. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Impairment of Goodwill</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 13, 2022, the EU General Court ruled that the European Commission had jurisdiction under the EU Merger Regulation to review our acquisition of GRAIL. Additionally, on September 6, 2022, the European Commission issued its decision prohibiting the acquisition. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_127">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These decisions, along with a continued and significant decrease in the Company&#8217;s stock price and market capitalization, required us to perform an interim impairment test in Q3 2022. Based on our analysis, we concluded GRAIL&#8217;s carrying value exceeded its fair value and recorded a goodwill impairment of $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-796">3,914</ix:nonFraction>&#160;million, primarily due to the negative impact of capital market conditions and a higher discount rate selected for the fair value calculation of GRAIL. There was no impairment for Core Illumina. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed our interim goodwill impairment test using a combination of both an income and a market approach to determine the fair value of each reporting unit. The income approach utilized the estimated discounted cash flows for each reporting unit, while the market approach utilized comparable company information. Estimates and assumptions used in the income approach included projected cash flows for both GRAIL and Core Illumina and a discount rate for each reporting unit. Discount rates were determined using a weighted average cost of capital for risk factors specific to each reporting unit and other market and industry data. For GRAIL, the discount rate selected was <ix:nonFraction unitRef="number" contextRef="c-221" decimals="3" name="ilmn:GoodwillImpairmentDiscountedCashFlowModelDiscountRate" scale="-2" id="f-797">22.0</ix:nonFraction>%. In order to further validate the reasonableness of the fair values concluded for our reporting units, a reconciliation to market capitalization was performed by estimating a reasonable implied control premium and other market factors.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with our interim goodwill impairment test, we also evaluated GRAIL&#8217;s IPR&amp;D intangible asset for potential impairment. We performed our impairment test by comparing the carrying value of the IPR&amp;D intangible asset to its estimated fair value, which was determined by the income approach, using a discounted cash flow model. Estimates and assumptions used in the income approach included projected cash flows and a discount rate. Based on our analysis, the carrying value of the IPR&amp;D intangible asset did not exceed its estimated fair value and no impairment was recorded. We also performed a recoverability test for the definite-lived intangible assets assigned to GRAIL, which included developed technology and trade name, and to Core Illumina and noted no impairment.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-760-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-798" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.982%"><tr><td style="width:1.0%"/><td style="width:17.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible Assets,<br/>Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible Assets,<br/>Net</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-799">465</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-800">305</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-801">160</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-802">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-803">585</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-6" name="ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="6" id="f-804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-805">2,222</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensed technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-806">234</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-807">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-808">120</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-809">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-810">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-6" name="ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="6" id="f-811">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-812">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-813">19</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-814">13</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-815">6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-816">14</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-817">13</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" name="ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="6" id="f-818">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-819">1</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-820">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-821">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-822">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-823">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-824">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" name="ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="6" id="f-825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-826">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Database</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-827">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-828">5</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-829">7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-830">12</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-831">3</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-6" name="ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="6" id="f-832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-833">9</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-834">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-835">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="f-836">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-837">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-838">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-6" name="ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="6" id="f-839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-840">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangible assets, net</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-841">748</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-842">453</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-843">295</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-844">3,164</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-845">761</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment" format="ixt:fixed-zero" scale="6" id="f-846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-847">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-848"><span style="-sec-ix-hidden:f-849">In-process research and development (IPR&amp;D)</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-6" name="ilmn:IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" format="ixt:fixed-zero" scale="6" id="f-850">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="f-851">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-6" name="ilmn:IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" scale="6" id="f-852">705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-6" name="ilmn:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" scale="6" id="f-853">115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="f-854">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="f-855">748</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-856">453</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-857">295</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-858">3,869</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-859">761</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="ilmn:IntangibleAssetsExcludingGoodwillAccumulatedImpairment" scale="6" id="f-860">115</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-861">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant decrease in developed technologies, trade name, and IPR&amp;D reflect the GRAIL intangible assets disposed of in connection with the Spin-Off. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_1657">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details. Also, in Q1 2024, we placed into service (reflected in developed technologies), with a useful life of <ix:nonNumeric contextRef="c-236" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-862">10</ix:nonNumeric> years, the $<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-6" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="6" id="f-863">35</ix:nonFraction>&#160;million IPR&amp;D intangible asset we acquired in 2021, net of impairments recognized in 2024 and 2023 of $<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-864">3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-865">6</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="f-866">42</ix:nonFraction>&#160;million, with a useful life of <ix:nonNumeric contextRef="c-240" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-867">7</ix:nonNumeric> years, and a customer relationship asset of $<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="f-868">2</ix:nonFraction>&#160;million, with a useful life of <ix:nonNumeric contextRef="c-241" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-869">11</ix:nonNumeric> years. We are still finalizing the allocation of the purchase price as it relates to the completion of certain tax returns. We expect to finalize the valuation as soon as practicable, but no later than one year after the acquisition. As a result of an acquisition in Q4 2023, we recorded a developed technology asset of $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="f-870">19</ix:nonFraction>&#160;million, with a useful life of <ix:nonNumeric contextRef="c-242" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-871">10</ix:nonNumeric> years. We finalized the allocation of the purchase price in Q4 2024 with no material adjustments to provisional amounts. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-872" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future annual amortization of finite-lived intangible assets is shown in the following table. Actual amortization expense to be reported in future periods could differ from these estimates as a result of acquisitions, divestitures, and asset impairments, among other factors.</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Annual Amortization</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="f-873">69</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="f-874">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="f-875">55</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="f-876">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="f-877">23</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="ilmn:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive" scale="6" id="f-878">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-879">295</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_109"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-880" continuedAt="f-880-1" escape="true"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.  DEBT AND OTHER COMMITMENTS</span></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-881" continuedAt="f-881-1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Term Debt Obligations</span></ix:nonNumeric></div><ix:continuation id="f-881-1"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.328%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.371%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.330%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2025 Term Notes outstanding</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-882">500</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-883">500</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2026 Term Notes outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-884">500</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:fixed-zero" scale="6" id="f-885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2027 Term Notes outstanding</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-886">500</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-887">500</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2031 Term Notes outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-888">500</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-889">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discounts and debt issuance costs</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="f-890">11</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="f-891">11</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of term debt</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-892">1,989</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-893">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-894">499</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="f-895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term debt, non-current</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-896">1,490</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-897">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of term debt outstanding (Level 2)</span></div></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-898">1,940</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-899">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense recognized on our term notes and delayed draw term loan, which included amortization of debt discounts and issuance costs, was $<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-6" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="f-900">99</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-6" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="f-901">74</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-6" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="f-902">21</ix:nonFraction>&#160;million in 2024, 2023 and 2022, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-245" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-903">4.650</ix:nonFraction>% Term Notes due 2026 (2026 Term Notes)</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2024, we issued $<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-904">500</ix:nonFraction>&#160;million aggregate principal amount of 2026 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-905">497</ix:nonFraction>&#160;million, which were used to repay a portion of the outstanding debt under the Delayed Draw Credit Agreement. The 2026 Term Notes, which mature on September 9, 2026, accrue interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-258" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-906">4.650</ix:nonFraction>% per annum, payable semi-annually on March 9 and September 9 of each year, beginning on March 9, 2025. We may redeem for cash all or any portion of the 2026 Term Notes, at our option, at any time prior to maturity at make-whole premium redemption prices as defined in the form of the notes.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-260" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-907">5.800</ix:nonFraction>% Term Notes due 2025 (2025 Term Notes) and <ix:nonFraction unitRef="number" contextRef="c-261" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-908">5.750</ix:nonFraction>% Term Notes due 2027 (2027 Term Notes)</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we issued $<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-909">500</ix:nonFraction>&#160;million aggregate principal amount of 2025 Term Notes and $<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-910">500</ix:nonFraction>&#160;million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-911">991</ix:nonFraction>&#160;million. The 2025 Notes, which mature on December 12, 2025, and the 2027 Notes, which mature on December 13, 2027, accrue interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-260" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-912">5.800</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-261" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-913">5.750</ix:nonFraction>% per annum, respectively, payable semi-annually. Interest for the 2025 Notes is payable on June 12 and December 12 of each year and interest for the 2027 Notes is payable on June 13 and December 13 of each year, beginning in June 2023.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may redeem for cash all or any portion of the 2025 or 2027 Term Notes, at our option, at any time prior to maturity. Prior to November 12, 2025 for the 2025 Notes and prior to November 13, 2027 for the 2027 Notes, the notes are redeemable at make-whole premium redemption prices as defined in the applicable forms of note. After November 12, 2025 and November 13, 2027, respectively, the notes are redeemable at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="c-255" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-914">100</ix:nonFraction>% of the principal to be redeemed, plus accrued and unpaid interest up to, but excluding, the redemption date. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-263" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-915">0.550</ix:nonFraction>% Term Notes due 2023 (2023 Term Notes) and <ix:nonFraction unitRef="number" contextRef="c-264" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-916">2.550</ix:nonFraction>% Term Notes due 2031 (2031 Term Notes)</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we issued $<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-917">500</ix:nonFraction>&#160;million aggregate principal amount of 2023 Term Notes and $<ix:nonFraction unitRef="usd" contextRef="c-264" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-918">500</ix:nonFraction>&#160;million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-919">992</ix:nonFraction>&#160;million. The 2023 Notes matured and were repaid in cash on March 23, 2023. The 2031 Notes, which mature on March 23, 2031, accrue interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-264" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-920">2.550</ix:nonFraction>% per annum, payable semi-annually on March 23 and September 23 of each year. We may redeem for cash all or any portion of the 2031 Term Notes, at our option, at any time prior to maturity. Prior to December 23, 2030, the notes are redeemable at make-whole premium redemption prices as defined in the form of the notes. After December 23, 2030, the notes are redeemable at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="c-265" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-921">100</ix:nonFraction>% of the principal to be redeemed, plus accrued and unpaid interest up to, but excluding, the redemption date.</span></div></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-880-1" continuedAt="f-880-2"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delayed Draw Term Loan due 2025</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2024, we entered into a <ix:nonNumeric contextRef="c-266" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="f-922">364</ix:nonNumeric>-day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-923">750</ix:nonFraction>&#160;million (the Delayed Draw Credit Facility). On June 20, 2024, we borrowed $<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-924">750</ix:nonFraction>&#160;million on the credit facility in order to provide a portion of the Disposal Funding to GRAIL as part of the Spin-Off. The delayed draw term loan incurred interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-267" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-925">6.7</ix:nonFraction>%. On September 9, 2024, we repaid the full principal outstanding on the Delayed Draw Credit Facility, as well as accrued interest, in an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-926">761</ix:nonFraction>&#160;million and terminated the Delayed Draw Credit Agreement. We recognized a loss on debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="INF" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-927">5</ix:nonFraction>&#160;million in 2024, included in interest expense in the consolidated statements of operations, related to the write-off of unamortized debt issuance costs.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-271" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-928">0</ix:nonFraction>% Convertible Senior Notes due 2023 (2023 Convertible Notes)</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we issued $<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-929">750</ix:nonFraction>&#160;million aggregate principal amount of 2023 Convertible Notes. The notes were convertible into cash, shares of common stock or a combination of cash and shares of common stock, at our election, based on conversion rates as defined in the indenture. The 2023 Convertible Notes matured on August 15, 2023, at which time the principal was repaid in cash. We did not issue any shares of common stock. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability component to be estimated by estimating the fair value of a similar liability that does not have an associated conversion feature. Because at issuance we had no outstanding non-convertible public debt, we determined that market-traded senior, unsecured corporate bonds represented a similar liability without a conversion option. Based on market data available for publicly traded, senior, unsecured corporate bonds issued by companies in our industry, and with similar maturities to the 2023 Convertible Notes, we estimated an implied interest rate of&#160;<ix:nonFraction unitRef="number" contextRef="c-272" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-930">3.7</ix:nonFraction>%, assuming no conversion option. The estimated implied interest rate was applied to the 2023 Convertible Notes, which resulted in a fair value of the liability component in aggregate of&#160;$<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-931">624</ix:nonFraction>&#160;million&#160;upon issuance, calculated as the present value of implied future payments based on the&#160;$<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-932">750</ix:nonFraction>&#160;million&#160;aggregate principal amount. The&#160;$<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="ilmn:AdditionalPaidInCapitalBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-933">126</ix:nonFraction>&#160;million&#160;difference ($<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-934">93</ix:nonFraction>&#160;million, net of tax) between the aggregate principal amount of&#160;$<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-935">750</ix:nonFraction>&#160;million&#160;and the estimated fair value of the liability component was recorded in additional paid-in capital as the 2023 Convertible Notes were not considered redeemable. As of January 3, 2022, we adopted ASU 2020-06, which removed the requirement to separate the embedded conversion feature from the notes and requires the notes to be accounted for as a single liability measured at amortized cost. Accordingly, we reclassified the unamortized debt discount from additional paid-in capital to convertible senior notes in the consolidated balance sheets on January 3, 2022. This resulted in an increase to retained earnings and a decrease to additional paid-in capital of $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-936">61</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-937">93</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense recognized on our 2023 Convertible Notes was immaterial in both 2023 and 2022.</span></div><div style="margin-top:13pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revolving Credit Agreement</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2023, we entered into a new credit agreement (the Revolving Credit Agreement), which provides us with a $<ix:nonFraction unitRef="usd" contextRef="c-273" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-938">750</ix:nonFraction>&#160;million senior unsecured <ix:nonNumeric contextRef="c-274" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-939">five-year</ix:nonNumeric> revolving credit facility, including a $<ix:nonFraction unitRef="usd" contextRef="c-275" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-940">40</ix:nonFraction>&#160;million sublimit for swingline borrowings and a $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-941">50</ix:nonFraction>&#160;million sublimit for letters of credit (the Revolving Credit Facility). Proceeds of the loans under the Revolving Credit Facility may be used to finance working capital needs and for general corporate purposes. The credit agreement dated as of March 8, 2021 and the commitments thereunder were terminated as of January 4, 2023.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility matures, and all amounts outstanding become due and payable in full, on January 4, 2028, subject to <ix:nonFraction unitRef="one_year_extension" contextRef="c-274" decimals="INF" name="ilmn:DebtInstrumentNumberOfOneYearExtensions" format="ixt-sec:numwordsen" scale="0" id="f-942">two</ix:nonFraction> <ix:nonNumeric contextRef="c-274" name="ilmn:DebtInstrumentExtensionTerm" format="ixt-sec:durwordsen" id="f-943">one-year</ix:nonNumeric> extensions at our option, the consent of the extending lenders and certain other conditions. We may prepay amounts borrowed and terminate commitments under the Revolving Credit Facility at any time without premium or penalty. As of December&#160;29, 2024, there were no borrowings or letters of credit outstanding under the credit facility, and we were in compliance with all financial and operating covenants.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-880-2" continuedAt="f-880-3"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans under the Revolving Credit Facility will have a variable interest rate based on either the term secured overnight financing rate (SOFR) or the alternate base rate, plus an applicable rate that varies with our debt rating and, in the case of loans bearing interest based on term SOFR, a credit spread adjustment equal to <ix:nonFraction unitRef="number" contextRef="c-277" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-944">0.10</ix:nonFraction>% per annum. The Revolving Credit Agreement includes an option for us to elect to increase commitments under the credit facility or enter into one or more tranches of term loans in the aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-6" name="ilmn:DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-945">250</ix:nonFraction>&#160;million, subject to consent of the lenders providing the additional commitments or loans and certain other conditions.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Agreement contains financial and operating covenants. Pursuant to the Revolving Credit Agreement, we are required to maintain a ratio of total debt to adjusted annual earnings before interest, taxes, depreciation and amortization (EBITDA), calculated based on the <ix:nonFraction unitRef="consecutive_fiscal_quarter" contextRef="c-277" decimals="INF" name="ilmn:DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio" format="ixt-sec:numwordsen" scale="0" id="f-946">four</ix:nonFraction> consecutive fiscal quarters ending with the most recent fiscal quarter, of not greater than <ix:nonFraction unitRef="number" contextRef="c-278" decimals="INF" name="ilmn:DebtInstrumentCovenantMinimumDebtToEBITDARatio" scale="0" id="f-947">3.50</ix:nonFraction> to 1.00 as of the end of each fiscal quarter. Upon the consummation of any Qualified Acquisition (as defined in the Revolving Credit Agreement) and us providing notice to the Administrative Agent, the ratio increases to <ix:nonFraction unitRef="number" contextRef="c-278" decimals="INF" name="ilmn:DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" scale="0" id="f-948">4.00</ix:nonFraction> to 1.00 for the fiscal quarter in which the acquisition is consummated and the <ix:nonFraction unitRef="consecutive_fiscal_quarter" contextRef="c-277" decimals="INF" name="ilmn:DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition" format="ixt-sec:numwordsen" scale="0" id="f-949">three</ix:nonFraction> consecutive fiscal quarters thereafter. The operating covenants include, among other things, limitations on (i) the incurrence of indebtedness by our subsidiaries, (ii) liens on our and our subsidiaries assets, and (iii) certain fundamental changes and the disposition of assets by us and our subsidiaries. The Credit Agreement contains other customary covenants, representations and warranties, and events of default.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-950" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, the maturities of our operating lease liabilities were as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-951">105</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-952">105</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-953">103</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-954">84</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-955">81</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-956">275</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total remaining lease payments</span></div></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-957">753</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-958">120</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-959">633</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-960">79</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-961">554</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-962">8.0</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-963">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-964" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of our lease costs were as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="f-965">93</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="f-966">116</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="f-967">112</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="f-968">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="f-969">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="f-970">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="f-971">25</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="f-972">27</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="f-973">20</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="f-974">99</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="f-975">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="f-976">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Variable lease costs include non-fixed maintenance charges and property taxes.</span></div></ix:nonNumeric></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-880-3"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Obligations</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we enter into agreements to purchase goods or services that are not cancelable without penalty, primarily related to licensing and supply arrangements. For those agreements with variable terms, we do not estimate the total obligation beyond any minimum quantities or pricing as of the reporting date. Licensing agreements under which we commit to minimum royalty payments, some of which are subject to adjustment, may be terminated prior to the expiration of underlying intellectual property under certain circumstances. Annual minimum payments for noncancelable purchase obligations as of December&#160;29, 2024 totaled $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:PurchaseObligation" scale="6" id="f-977">212</ix:nonFraction> million, approximately half of which are due within the next twelve months.</span></div></ix:continuation><div id="i64df1cccf2dd452496bdff4e9d30a288_118"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="f-978" continuedAt="f-978-1" escape="true"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.  STOCKHOLDERS' EQUITY</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2015 Stock and Incentive Compensation Plan (the 2015 Stock Plan) and the New Hire Stock and Incentive Plan allow for the issuance of stock options, performance stock options, restricted stock units and awards and performance stock units. In 2023, the Company&#8217;s stockholders approved an amended and restated version of the 2015 Stock Plan and increased the maximum number of shares authorized for issuance by <ix:nonFraction unitRef="shares" contextRef="c-279" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-979">8.0</ix:nonFraction>&#160;million shares. In connection with the GRAIL Spin-Off, all unvested RSU and PSU were equitably adjusted pursuant to the plan to preserve their intrinsic value and the number of shares reserved for issuance under the 2015 Stock Plan was increased by <ix:nonFraction unitRef="shares" contextRef="c-280" decimals="-3" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-980">160,000</ix:nonFraction> shares. As of December&#160;29, 2024, approximately <ix:nonFraction unitRef="shares" contextRef="c-281" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-981">5.4</ix:nonFraction> million&#160;shares remained available for future grants under the 2015 Stock Plan. There is no set number of shares reserved for issuance under the New Hire Stock and Incentive Plan.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue restricted stock units (RSU) and performance stock units (PSU), both of which are considered restricted stock. We grant restricted stock pursuant to the 2015 Stock Plan and satisfy such grants through the issuance of either new shares or shares from treasury stock. RSU are share awards that, upon vesting, will deliver to the holder shares of our common stock. RSU generally vest over a <ix:nonNumeric contextRef="c-282" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-982">four-year</ix:nonNumeric> period with equal vesting annually. We issue <ix:nonFraction unitRef="award" contextRef="c-4" decimals="INF" name="ilmn:ShareBasedCompensationNumberOfPerformanceStockUnitAwards" format="ixt-sec:numwordsen" scale="0" id="f-983">three</ix:nonFraction> different PSU awards. We issue PSU for which the number of shares issuable at the end of a <ix:nonNumeric contextRef="c-283" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-984">three-year</ix:nonNumeric> performance period is based on our performance relative to specified earnings per share targets (EPS PSU) and, during 2024, we began to issue PSU for which the number of shares issuable at the end of a <ix:nonNumeric contextRef="c-283" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-985">three-year</ix:nonNumeric> performance period is based on our performance relative to specified operating margin targets (OM PSU). During 2023, we began to issue PSU with a market condition that vest based on the Company&#8217;s relative total shareholder return as compared to a peer group of companies measured over a <span style="-sec-ix-hidden:f-986">three-fiscal</span> year performance period (rTSR PSU). Depending on the actual performance over the measurement period, an rTSR PSU award recipient could receive up to <ix:nonFraction unitRef="number" contextRef="c-284" decimals="INF" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout" scale="-2" id="f-987">175</ix:nonFraction>% of the granted award. Shares issuable under all PSU awards are subject to continued employment through the vesting period. </span></div></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-978-1" continuedAt="f-978-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="f-989" continuedAt="f-989-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" id="f-988" continuedAt="f-988-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock activity was as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.825%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.828%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted <br/>Stock Units <br/>(RSU)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(PSU) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant-<br/>Date Fair Value per Share</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Units in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSU</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-285" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="6" id="f-990">1,130</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-286" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-991">328</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-285" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-992">345.66</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-286" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-993">466.42</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-287" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-994">1,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-288" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-995">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-287" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-996">302.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-288" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-997">479.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-287" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="f-998">707</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-288" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-999">99</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-287" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1000">341.56</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-288" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1001">492.55</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-287" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="f-1002">182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-288" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-1003">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-287" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1004">341.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-288" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1005">411.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-289" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="6" id="f-1006">1,611</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-290" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1007">74</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-289" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1008">311.23</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-290" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1009">446.74</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-291" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1010">2,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-292" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1011">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-291" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1012">195.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-292" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1013">239.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-291" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="f-1014">987</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-292" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="3" id="f-1015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-291" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1016">268.08</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-292" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-1017">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-291" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="f-1018">458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-292" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-1019">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-291" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1020">253.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-292" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1021">299.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-293" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="6" id="f-1022">2,198</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-294" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="3" id="f-1023">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-293" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1024">236.32</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-294" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-1025">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-282" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1026">2,788</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-283" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1027">729</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-282" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1028">133.73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-283" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1029">164.38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested adjustment for GRAIL Spin-Off</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-282" decimals="-3" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" scale="6" id="f-1030">107</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-283" decimals="-3" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" scale="3" id="f-1031">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-282" decimals="2" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-1032">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-283" decimals="2" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-1033">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-282" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="f-1034">771</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-283" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="3" id="f-1035">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-282" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1036">249.70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-283" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-1037">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-282" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="f-1038">443</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-283" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-1039">41</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-282" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1040">195.11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-283" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1041">167.68</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-295" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="6" id="f-1042">3,879</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-296" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1043">700</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-295" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1044">158.60</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-296" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1045">164.87</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div></ix:nonNumeric></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="f-989-1" continuedAt="f-989-2"><ix:continuation id="f-988-1" continuedAt="f-988-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"><ix:continuation id="f-989-2"><ix:continuation id="f-988-2">For EPS and OM PSU, the number of units reflect the estimated number of shares to be issued at the end of the performance period. For rTSR PSU, the number of units reflect the estimated number of shares to be issued based on performance as of the current reporting period. Awarded units are presented net of performance adjustments.</ix:continuation></ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-1047" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" id="f-1046" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax intrinsic value and fair value of vested restricted stock was as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.963%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax intrinsic value of outstanding restricted stock:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="f-1048">525</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="f-1049">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="f-1050">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="f-1051">95</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:fixed-zero" scale="6" id="f-1052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" scale="6" id="f-1053">15</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of restricted stock vested:</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1054">116</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1055">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1056">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="6" id="f-1057">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="6" id="f-1058">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1059">49</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability-Classified RSU</span></div><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q1 2023, we granted RSU that were to be settled in cash if stockholder approval to increase our share reserve under the amended and restated 2015 Stock Plan was not obtained. In Q2 2023, the Company&#8217;s stockholders approved an amended and restated version of the 2015 Stock Plan and increased the maximum number of shares authorized for issuance. Upon such approval, all RSU previously accounted for as liability-classified awards, approximately <ix:nonFraction unitRef="shares" contextRef="c-297" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1060">557,000</ix:nonFraction> RSU, were reclassified to stockholders equity and accounted for prospectively as equity awards. There were <ix:nonFraction unitRef="shares" contextRef="c-298" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="f-1061"><ix:nonFraction unitRef="shares" contextRef="c-299" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="f-1062">no</ix:nonFraction></ix:nonFraction> RSU liability-classified awards outstanding as of December&#160;29, 2024 or December&#160;31, 2023.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-978-2" continuedAt="f-978-3"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-1063" continuedAt="f-1063-1" escape="true"><div style="margin-top:13pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity was as follows:  </span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Units in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock Options</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise&#160;Price</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-300" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-1064">8</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-300" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1065">66.42</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-301" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-1066">17</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-301" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1067">85.54</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-302" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-1068">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-302" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1069">330.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-303" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="6" id="f-1070">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-303" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1071">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-302" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-1072">1</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-302" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1073">6.55</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-303" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="6" id="f-1074">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-303" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-304" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-1076">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-304" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1077">319.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-305" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-1078">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-305" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1079">85.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-306" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-1080">8</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-306" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1081">71.09</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-307" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-1082">1</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-307" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1083">16.69</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-306" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="f-1084">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-306" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-1085">330.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-307" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:fixed-zero" scale="3" id="f-1086">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-307" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1087">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-308" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-1088">35</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-308" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1089">330.25</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-309" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="f-1090">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-309" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1091">87.74</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-310" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="f-1092">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-310" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-1093">330.25</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-311" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="f-1094">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-311" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-1095">87.74</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-312" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:fixed-zero" scale="3" id="f-1096">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-312" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1097">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-313" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:fixed-zero" scale="3" id="f-1098">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-313" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1099">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="f-1063-1" continuedAt="f-1063-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"><ix:continuation id="f-1063-2">In connection with the GRAIL acquisition, we issued replacement performance stock options to GRAIL employees in 2021. The number of units reflected awards that had been granted and for which it was assumed to be probable that the underlying performance goals would be achieved. In connection with the GRAIL Spin-Off, all outstanding performance stock options were assumed by GRAIL.</ix:continuation> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was immaterial in both 2023 and 2022. None exercised in 2024. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Liability-Classified Awards</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the GRAIL Spin-Off, we granted cash-based equity incentive awards to GRAIL employees, which were accounted for as liability-classified awards. In connection with the Spin-Off, these awards were assumed by GRAIL. For purposes of valuation and performance measurement of the awards, GRAIL&#8217;s stand-alone value calculation, as estimated by GRAIL based on its analysis and on input from independent valuation advisors and analyses, was used. The awards generally had terms of <ix:nonNumeric contextRef="c-314" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-1100">four years</ix:nonNumeric> and vested in <span style="-sec-ix-hidden:f-1101">four</span> equal installments on each anniversary of the grant date, subject to continued employment through the vesting period. </span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-978-3" continuedAt="f-978-4"><ix:nonNumeric contextRef="c-1" name="ilmn:ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" id="f-1102" escape="true"><div style="margin-bottom:13pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash-based equity incentive award activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" scale="6" id="f-1103">184</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" scale="6" id="f-1104">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and paid in cash</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" scale="6" id="f-1105">41</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" scale="6" id="f-1106">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" scale="6" id="f-1107">23</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" scale="6" id="f-1108">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" scale="6" id="f-1109">116</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and paid in cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" scale="6" id="f-1110">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" scale="6" id="f-1111">32</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-6" sign="-" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" scale="6" id="f-1112">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" scale="6" id="f-1113">292</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" scale="6" id="f-1114">67</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and paid in cash</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" scale="6" id="f-1115">54</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" scale="6" id="f-1116">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" sign="-" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" scale="6" id="f-1117">9</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derecognition for GRAIL Spin-Off</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition" scale="6" id="f-1118">283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" format="ixt:fixed-zero" scale="6" id="f-1119">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">The estimated liability immediately prior to the Spin-Off, recorded in accrued liabilities, was $<ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-6" name="ilmn:AccruedLiabilityClassifiedAwardsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1120">53</ix:nonFraction>&#160;million, which was disposed of as part of GRAIL&#8217;s net assets. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_40">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional details.</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized share-based compensation expense on these cash-based equity incentive awards of $<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1121">52</ix:nonFraction>&#160;million in 2024, prior to the Spin-Off, and $<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1122">95</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1123">67</ix:nonFraction>&#160;million in 2023 and 2022, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of GRAIL, we assumed a performance-based award for which vesting was based on GRAIL&#8217;s future revenues and had an aggregate potential value of up to $<ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-6" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" format="ixt:num-dot-decimal" scale="6" id="f-1124">78</ix:nonFraction>&#160;million. Prior to the Spin-Off of GRAIL, it was not probable that the performance conditions associated with the award would be achieved and, therefore, no share-based compensation expense was recognized in the consolidated statements of operations. In connection with the Spin-Off, this award was assumed by GRAIL. For a period of <ix:nonNumeric contextRef="c-95" name="us-gaap:DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal" format="ixt-sec:duryear" id="f-1125">2.5</ix:nonNumeric> years following the Spin-Off, we are obligated to indemnify GRAIL for cash payments that become earned and payable related to this award. The indemnification is accounted for in accordance with ASC 460. As of December&#160;29, 2024, we recognized a non-contingent liability of $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" format="ixt:num-dot-decimal" scale="6" id="f-1126">1</ix:nonFraction>&#160;million for this indemnification, with a corresponding charge to additional paid-in capital.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2000 Employee Stock Purchase Plan, or ESPP, permits eligible employees to purchase common stock at a discount through payroll deductions during defined offering periods. The price at which stock is purchased under the ESPP is equal to <ix:nonFraction unitRef="number" contextRef="c-321" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-1127">85</ix:nonFraction>% of the fair market value of the common stock on the first day of the offering period or purchase date, whichever is lower. The initial offering period commenced in July 2000. During 2024, 2023, and 2022, approximately <ix:nonFraction unitRef="shares" contextRef="c-321" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="6" id="f-1128">0.5</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="c-322" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="6" id="f-1129">0.4</ix:nonFraction> million, and <ix:nonFraction unitRef="shares" contextRef="c-323" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="6" id="f-1130">0.3</ix:nonFraction> million shares, respectively, were issued under the ESPP. As of December&#160;29, 2024, approximately <ix:nonFraction unitRef="shares" contextRef="c-324" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-1131">12.4</ix:nonFraction> million&#160;shares remained available for issuance under the ESPP, which includes an increase of <ix:nonFraction unitRef="shares" contextRef="c-321" decimals="-5" name="ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease" scale="6" id="f-1132">0.5</ix:nonFraction> million shares pursuant to the terms of the ESPP to account for the GRAIL Spin-Off.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-978-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="f-1133" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for the specified reporting periods and the resulting estimates of weighted-average fair value per share for stock purchased under the ESPP were as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.271%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-325" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-1134">4.35</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-325" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-1135">5.54</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonFraction unitRef="number" contextRef="c-326" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-1136">0.78</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-326" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-1137">5.54</ix:nonFraction>% </span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-327" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-1138">0.06</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-327" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-1139">2.98</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-325" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-1140">41</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-325" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-1141">49</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonFraction unitRef="number" contextRef="c-326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-1142">41</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-1143">51</ix:nonFraction>% </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-1144">37</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-1145">51</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-328" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1146">0.5</ix:nonNumeric> - <ix:nonNumeric contextRef="c-329" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1147">1.1</ix:nonNumeric> year</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="c-330" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1148">0.5</ix:nonNumeric> - <ix:nonNumeric contextRef="c-331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1149">1.1</ix:nonNumeric> year </span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-332" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1150">0.5</ix:nonNumeric> - <ix:nonNumeric contextRef="c-333" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1151">1.0</ix:nonNumeric> year</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-325" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:num-dot-decimal" id="f-1152">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-326" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:num-dot-decimal" id="f-1153">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-327" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:num-dot-decimal" id="f-1154">0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value per share</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-325" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="f-1155">37.24</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="f-1156">49.87</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="f-1157">50.22</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2024, our Board of Directors authorized a new share repurchase program, which cancels and supersedes all prior and available repurchase authorizations, to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-334" decimals="INF" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="f-1158">1.5</ix:nonFraction>&#160;billion of our outstanding common stock. The repurchases may be completed through open market purchases, pursuant to Rule 10b5-1 or Rule 10b-18, or through an accelerated share repurchase program. Authorizations to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-7" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="f-1159">1.4</ix:nonFraction> billion of our outstanding common stock remained available as of December&#160;29, 2024. We did <ix:nonFraction unitRef="shares" contextRef="c-336" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="f-1160"><ix:nonFraction unitRef="shares" contextRef="c-337" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="f-1161">not</ix:nonFraction></ix:nonFraction> repurchase&#160;any shares during 2023 or 2022.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="f-1162" escape="true"><div style="margin-bottom:13pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share repurchase activity during 2024 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions, except shares in thousands</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares repurchased</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="f-1163">904</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of shares repurchased</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-1164">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Total cost of shares repurchased includes the 1% excise tax imposed as part of the Inflation Reduction Act of 2022, which is calculated based on share repurchases, net of certain share issuances.</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;29, 2024 and through February 11, 2025, we repurchased an additional <ix:nonFraction unitRef="shares" contextRef="c-338" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1165">1.0</ix:nonFraction> million shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-1166">126</ix:nonFraction> million.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-1167" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense, which includes expense for both equity and liability-classified awards, reported in our consolidated statements of operations was as follows:  </span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.963%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1168">25</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1169">29</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1170">26</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1171">6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1172">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1173">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1174">146</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1175">155</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1176">153</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1177">194</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1178">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1179">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, before taxes</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1180">371</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1181">380</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1182">366</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1183">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1184">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1185">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of taxes</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1186">288</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1187">293</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1188">283</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, unrecognized compensation cost, related to restricted stock and ESPP shares issued to date, of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-1189">565</ix:nonFraction> million was expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1190">2.5</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_121"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-1191" continuedAt="f-1191-1" escape="true"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.  SUPPLEMENTAL BALANCE SHEET DETAILS</span></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-1192" continuedAt="f-1192-1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></ix:nonNumeric></div><ix:continuation id="f-1192-1"><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, gross</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="f-1193">744</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="f-1194">741</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-1195">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-1196">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-1197">735</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-1198">734</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-1199" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:InventoryRawMaterials" scale="6" id="f-1200">225</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:InventoryRawMaterials" scale="6" id="f-1201">276</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="f-1202">404</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="f-1203">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:InventoryFinishedGoods" scale="6" id="f-1204">31</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:InventoryFinishedGoods" scale="6" id="f-1205">30</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:InventoryGross" scale="6" id="f-1206">660</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:InventoryGross" scale="6" id="f-1207">708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserve</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:InventoryValuationReserves" scale="6" id="f-1208">113</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:InventoryValuationReserves" scale="6" id="f-1209">121</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="f-1210">547</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="f-1211">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:continuation id="f-458-1"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1212">772</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1213">803</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1214">683</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1215">684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1216">478</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1217">463</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1218">53</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1219">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1220">44</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1221">44</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1222">39</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1223">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1224">2,069</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1225">2,145</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1226">1,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1227">1,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-1228">815</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-1229">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-1230" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal contingencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="f-1231">26</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="f-1232">484</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-1233">260</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-1234">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation expenses</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-1235">252</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-1236">223</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="f-1237">101</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="f-1238">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1239"><span style="-sec-ix-hidden:f-1240">Operating lease liabilities, current portion</span></span></span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1241">79</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1242">86</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified equity incentive awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="ilmn:AccruedLiabilityClassifiedAwardsCurrent" format="ixt:fixed-zero" scale="6" id="f-1243">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="ilmn:AccruedLiabilityClassifiedAwardsCurrent" scale="6" id="f-1244">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, including warranties</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-1245">109</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-1246">146</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="f-1247">827</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1248">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_127">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional details.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">See table below for changes in the reserve for product warranties.</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-1191-1" continuedAt="f-1191-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="f-1249" escape="true"><div style="margin-bottom:6pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the reserve for product warranties were as follows:  </span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:ProductWarrantyAccrual" scale="6" id="f-1250">22</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="f-1251">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repairs and replacements</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="f-1252">27</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:ProductWarrantyAccrual" scale="6" id="f-1253">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to cost of product revenue</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="f-1254">42</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repairs and replacements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="f-1255">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:ProductWarrantyAccrual" scale="6" id="f-1256">21</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="f-1257">42</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repairs and replacements</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="f-1258">45</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:ProductWarrantyAccrual" scale="6" id="f-1259">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q2 2023, we implemented a cost reduction initiative that included workforce reductions, the consolidation of certain facilities and other actions to reduce expenses, all as part of a plan to realign operating expenses while maintaining focus on our innovation roadmap and sustainable long-term growth. In both 2024 and 2023, we recorded restructuring charges primarily consisting of asset impairments related to exit activities at certain of our leased facilities.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="f-1260" continuedAt="f-1260-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the pre-tax restructuring charges is as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:47.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.015%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.446%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.025%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative charges recorded since inception</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee separation costs</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1261">12</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1262">48</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1263">60</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1264">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1265">100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1266">146</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other costs</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1267">4</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1268">4</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1269">8</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1270">62</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1271">152</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="f-1272">214</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">For 2024, relates to impairment of right-of-use assets and leasehold improvements for Foster City campus and other property in San Diego. </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For 2023, primarily relates to impairment of right-of-use assets and leasehold improvements for our i3 and Foster City campuses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">For 2024, $<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="f-1273">59</ix:nonFraction>&#160;million was recorded in SG&amp;A expense, $<ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="f-1274">2</ix:nonFraction>&#160;million in R&amp;D expense, and remainder in cost of revenue.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For 2023, $<ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="f-1275">122</ix:nonFraction>&#160;million was recorded in SG&amp;A expense, $<ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="f-1276">24</ix:nonFraction>&#160;million in R&amp;D expense, and remainder in cost of revenue.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total restructuring charges primarily relate to our Core Illumina segment.</span></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, we recorded right-of-use asset impairments of $<ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-6" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-1277">12</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-6" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-1278">19</ix:nonFraction>&#160;million related to our campus in Foster City, California and another property in San Diego, California, respectively. In 2023, we recorded right-of-use asset impairments of $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-1279">38</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="ilmn:OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="f-1280">21</ix:nonFraction>&#160;million related to our i3 campus in San Diego and our campus in Foster City, respectively. The impairments were determined by comparing the fair values of the impacted right-of-use assets to the carrying values of the assets as of the impairment measurement date. The fair values of the right-of-use assets were estimated using the discounted future cash flows method, which includes estimates and assumptions for future sublease rental rates that reflect current sublease market conditions, as well as discount rates. The estimates and assumptions used in our assessments represent Level 3 measurements because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. In 2024, we recorded $<ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-6" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-1281">14</ix:nonFraction>&#160;million of leasehold improvement impairments related to our Foster City campus and, in 2023, we recorded $<ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-6" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-1282">16</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-6" name="ilmn:OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="f-1283">22</ix:nonFraction>&#160;million of leasehold improvement impairments related to our i3 and Foster City campuses, respectively. The right-of-use asset and leasehold improvement impairments were recognized in selling, general and administrative expense. We continue to evaluate our options for the rest of our Foster City campus, for which, as of December&#160;29, 2024, we had remaining assets, consisting primarily of right-of-use assets and leasehold improvements, of $<ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-1284"><ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-6" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="f-1285">100</ix:nonFraction></ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-1260-1"><ix:continuation id="f-1191-2"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the restructuring liability is as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Separation Costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded in accrued liabilities as of January&#160;1, 2023</span></div></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-1286">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-1287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="6" id="f-1288">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="ilmn:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" id="f-1289">Expense recorded</ix:nonNumeric></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1290">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1291">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1292">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-1293">31</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-1294">3</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-1295">34</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded in accrued liabilities as of December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1296">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1297">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1298">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recorded</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1299">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1300">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1301">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-1302">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-1303">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="f-1304">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to accrual</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-1305">3</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-1306">1</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="f-1307">4</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded in accrued liabilities as of December&#160;29, 2024</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1308">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1309">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1310">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:1pt;margin-top:1pt"><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_127"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="f-1311" continuedAt="f-1311-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.  LEGAL PROCEEDINGS</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various lawsuits and claims arising in the ordinary course of business, including actions with respect to intellectual property, employment, and contractual matters. In connection with these matters, we assess, on a regular basis, the probability and range of possible loss based on the developments in these matters. A liability is recorded in the consolidated financial statements if it is believed to be probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review outstanding legal matters to determine the adequacy of the liabilities accrued and related disclosures in consideration of many factors, which include, but are not limited to, past history, scientific and other evidence, and the specifics and status of each matter. We may change our estimates if our assessment of the various factors changes and the amount of ultimate loss may differ from our estimates, resulting in a material effect on our business, financial condition, results of operations, and/or cash flows.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of GRAIL</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 6, 2024, all previously disclosed regulatory proceedings in the United States and European Union related to our acquisition of GRAIL have been resolved (as further described below).</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 19, 2021, the European Commission sought and subsequently accepted a request for a referral of the GRAIL acquisition for European Union merger review, submitted by a Member State of the European Union (France), and joined by several other EEA Member States (Belgium, Greece, Iceland, the Netherlands and Norway), under Article 22(1) of Council Regulation (EC) No 139/2004 (the EU Merger Regulation). The European Commission had never solicited referrals to take jurisdiction over an acquisition of a U.S. company that had no revenue in Europe. On April 28, 2021, we filed an action in the General Court of the European Union (the EU General Court) asking for annulment of the European Commission&#8217;s assertion of jurisdiction to review the acquisition under Article 22 of the EU Merger Regulation, as the acquisition does not meet the jurisdictional criteria under the EU Merger Regulation or under the national merger control laws of any Member State of the European Union. On July 13, 2022, the EU General Court reached a decision in favor of the European Commission, holding that the European Commission has jurisdiction under the EU Merger Regulation to review the acquisition. On September 22, 2022, we filed an appeal in the Court of Justice of the European Union (the EU Court of Justice) asking for annulment of the EU General Court&#8217;s judgment. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 12, 2023, the European Commission adopted a decision requiring Illumina to unwind its acquisition of GRAIL (the EC Divestment Decision). On December 17, 2023, we announced that we would divest GRAIL. On June&#160;24, 2024, we completed the separation (the Spin-Off) of GRAIL into a separate, independent publicly traded company through the distribution of approximately <ix:nonFraction unitRef="number" contextRef="c-55" decimals="3" name="ilmn:DiscontinuedOperationPercentOfInterestDisposedOf" scale="-2" id="f-1312">85.5</ix:nonFraction>% of the outstanding GRAIL common stock to Illumina stockholders on a pro rata basis.</span></div></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-1311-1" continuedAt="f-1311-2"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2024, the EU Court of Justice ruled in our favor, confirming that the European Commission had unlawfully asserted jurisdiction over our acquisition of GRAIL, and hence annulling the EU General Court&#8217;s judgment and the European Commission&#8217;s decisions accepting the referral of the GRAIL acquisition for EU merger review (the EU Court of Justice Judgment). The EU Court of Justice Judgment concludes these proceedings and is not subject to further appeals. In view of this judgment, on September 6, 2024, the European Commission issued a decision (the Withdrawal Decision) withdrawing all of its prior decisions, including (1) its July 22, 2021 decision opening an investigation of Illumina&#8217;s proposed acquisition of GRAIL, (2) its September 6, 2022 decision prohibiting Illumina&#8217;s acquisition of GRAIL, (3) its October 29, 2021 and October 28, 2022 decisions concerning interim measures, (4) the EC Divestment Decision, and (5) its July 12, 2023 decision fining Illumina &#8364;<ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-1313">432</ix:nonFraction>&#160;million and GRAIL for closing the acquisition before approval by the European Commission. The Withdrawal Decision resolves all ongoing regulatory proceedings in the European Union. The European Commission has also been ordered to pay Illumina&#8217;s costs incurred in connection with the GRAIL-related proceedings before the EU Court of Justice and the EU General Court.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the European Commission withdrawing its previously imposed fine, we recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="f-1314">481</ix:nonFraction>&#160;million in Q3 2024. We recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-6" name="us-gaap:LitigationSettlementGain" format="ixt:num-dot-decimal" scale="6" id="f-1315">489</ix:nonFraction>&#160;million in operating expense, resulting from reversal of the accrued fine and related accrued interest, offset by a loss of $<ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-6" name="us-gaap:LitigationSettlementLoss" format="ixt:num-dot-decimal" scale="6" id="f-1316">8</ix:nonFraction>&#160;million, recognized in other expense, net, for the reversal of associated foreign currency fluctuations. The fine accrued interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-385" decimals="3" name="ilmn:LitigationSettlementFinePercentageRate" scale="-2" id="f-1317">5.5</ix:nonFraction>% per annum while it was outstanding. The guarantees we provided in October 2023 to satisfy the obligation in lieu of cash payment while we appealed the European Commission&#8217;s jurisdictional and fine decisions are no longer outstanding. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 15, 2024, the U.S. Federal Trade Commission dismissed the previously disclosed administrative complaint in light of the completion of the Spin-Off.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SEC Inquiry Letter</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, we were informed that the staff of the SEC was conducting an investigation relating to Illumina and was requesting documents and communications primarily related to Illumina&#8217;s acquisition of GRAIL and certain statements and disclosures concerning GRAIL, its products and its acquisition, and related to the conduct and compensation of certain members of Illumina and GRAIL management, among other things. Illumina is cooperating with the SEC in this investigation.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Shareholder Derivative Complaints</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 17, 2023, a stockholder derivative and class action complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Icahn Partners LP, et al. v. deSouza, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, purportedly brought on behalf of Illumina and public holders of Illumina&#8217;s common stock, was filed in the Delaware Court of Chancery against certain current and former directors (including our former Chief Executive Officer). We are named as a nominal defendant in the complaint. The lawsuit alleges the named directors breached their fiduciary duties by knowingly causing Illumina to unlawfully close the GRAIL acquisition, concealing material facts related to the GRAIL acquisition and making inadequate disclosures. Before the filing of the complaint, the purported stockholders did not make a demand that our Board of Directors pursue the claims asserted therein. The complaint seeks damages, costs and expenses, including attorney fees, the certification and consolidation of a putative class, the issuance of amended disclosures, the removal of conflicted directors and declaratory and other equitable relief. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the defendants filed a motion to dismiss the complaint, which has not yet been briefed. On the same day, Illumina-joined by the director defendants-moved to strike portions of the complaint that contain improperly included confidential and privileged information. On January 16, 2024, the Court granted the motion to strike. On December 5, 2023, the plaintiffs moved to expedite the proceedings with respect to their direct claims. The director defendants opposed that motion and Illumina joined their opposition. On January 19, 2024, the Court denied plaintiffs&#8217; motion to expedite. On January 23, 2024, the plaintiffs filed a motion for reargument of the Court&#8217;s January 16 opinion, which the Court denied on February 19, 2024. On February 29, 2024, the plaintiffs filed an application to the trial court to certify the orders granting the motion to strike and denying the motion for reargument for interlocutory appeal. The Court refused the application on March 20, 2024. On March 14, 2024, the plaintiffs filed an application for interlocutory appeal with the Supreme Court of Delaware, which the Court denied on April 11, 2024.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-1311-2" continuedAt="f-1311-3"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Omaha Police and Firefighters Retirement System v. deSouza, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors. On April 16, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Roseville General Employees Retirement System, et al. v. deSouza, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors and officers. On August 16, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thomas P. DiNapoli v. John Thompson et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors. We are named as a nominal defendant in the complaints. The lawsuits allege the named directors and officers breached their fiduciary duties by knowingly causing Illumina to unlawfully close the GRAIL acquisition. The stockholders previously made requests to inspect certain books and records under Delaware law, and they purport to base their complaint in part on documents obtained from Illumina in response to those requests. Before the filing of the complaint, the purported stockholders did not make a demand that our Board of Directors pursue the claim asserted therein. The complaints seek damages against the individual defendants, costs and expenses, including attorney fees and other equitable relief. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2024, the defendants filed a motion to dismiss the complaint in the lawsuit filed by City of Omaha Police and Firefighters Retirement System. The motion has not yet been briefed. On May 16, 2024, the defendants filed a motion to dismiss the complaint in the lawsuit filed by City of Roseville General Employees Retirement System, et al. The motion has not yet been briefed. On September 16, 2024, the defendants filed a motion to dismiss the complaint in the lawsuit filed by Thomas DiNapoli. The motion has not yet been briefed.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Pavers and Road Builders Benefit Funds v. deSouza, et al., </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors and officers. Like the complaints described above, the lawsuits allege the named directors and officers breached their fiduciary duties by knowingly causing Illumina to unlawfully close the GRAIL acquisition. The stockholder previously made requests to inspect certain books and records under Delaware law and litigated a books and records action against the Company (described below), and it purports to base its complaint in part on documents obtained from Illumina in response to those requests and that litigation. Before the filing of the complaint, the purported stockholder did not make a demand that our Board of Directors pursue the claim asserted therein. The complaint seeks damages against the individual defendants and other equitable relief.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the fact that these lawsuits are in an early stage, we cannot predict the ultimate outcome of the suits. We deny the allegations in the complaints and intend to vigorously defend the litigations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Elaine Wang, et al. v. deSouza, et al.,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> purportedly brought on behalf of the Company was filed in the United States District Court for the District of Delaware (District of Delaware) against certain current and former directors. The Company was named as a nominal defendant in the complaint. The lawsuit alleged that the named directors breached their fiduciary duties by knowingly causing the Company to unlawfully close the GRAIL acquisition. Before the filing of the complaint, the purported stockholder did not make a demand that our Board of Directors pursue the asserted claims therein. The complaint sought, among other things, restitution to the Company for the alleged damages caused by the named defendants. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michael Warner, et al. v. deSouza, et al.,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> purportedly brought on behalf of Illumina was also filed in the United States District Court for the Southern District of California against certain current and former directors. We were named as a nominal defendant in the complaint. The lawsuit alleged that the named directors breached their fiduciary duties by knowingly causing us to unlawfully close the GRAIL acquisition. Before the filing of the complaint, the purported stockholder did not make a demand that our Board of Directors pursue the asserted claims therein. The complaint sought, among other things, restitution to Illumina for the alleged damages caused by the named defendants. On March 28, 2024, the parties submitted a Joint Motion to Transfer the lawsuit to the District of Delaware, which the Court granted on March 29, 2024, and the Court transferred the lawsuit to the District of Delaware on the same day.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-1311-3" continuedAt="f-1311-4"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Elaine Wang, et al. v. deSouza, et al. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michael Warner, et al. v. deSouza, et al. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were voluntarily dismissed on April 29, 2024, and May 1, 2024, respectively. On May 1, 2024, Michael Warner sent a litigation demand to our Board of Directors requesting that a civil action for monetary damages be brought by the Board of Directors on behalf of Illumina against officers and directors involved with the GRAIL acquisition. On July 30, 2024, the Board unanimously determined that it was in the best interest of the Company and its shareholders to defer a final decision on the demand given, among other things, the pending stockholder lawsuits described herein and the similarity of issues raised in the demand and those lawsuits. Our Board will monitor the stockholder lawsuits and revisit the demand as warranted as the lawsuits progress. On June 3, 2024, Elaine Wang made requests to inspect certain books and records under Delaware law and the Company sent a production of documents in response to that demand. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2024, an additional stockholder, Jane Davidson, sent a litigation demand to our Board of Directors requesting that a civil action for breaches of fiduciary duty, indemnification, contribution and other appropriate claims be brought by the Board of Directors on behalf of Illumina against officers and directors involved with the GRAIL acquisition. On October 29, 2024, the Board unanimously determined that it was in the best interest of the Company and its shareholders to defer a final decision on the demand given, among other things, the pending stockholder lawsuits described herein and the similarity of issues raised in the demand and those lawsuits. Our Board will monitor the stockholder lawsuits and revisit the demand as warranted as the lawsuits progress.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:113%">Securities Class Actions</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Securities Class Actions. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 11, 2023, the first of <ix:nonFraction unitRef="lawsuit" contextRef="c-386" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="f-1318">three</ix:nonFraction> securities class action complaints was filed against Illumina and certain of its current and former executive officers in the United States District Court for the Southern District of California. The first-filed case is captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kangas v. Illumina, Inc. et al</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., the second-filed case is captioned</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Roy v. Illumina, Inc. et al.,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the third-filed case is captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Louisiana Sheriffs&#8217; Pension &amp; Relief Fund v. Illumina, Inc. et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (collectively, the Actions). The complaints generally allege, among other things, that defendants made materially false and misleading statements and omitted material facts relating to Illumina&#8217;s acquisition of GRAIL. The complaints seek unspecified damages, interest, fees, and costs. On January 9, 2024, <ix:nonFraction unitRef="movant" contextRef="c-387" decimals="INF" name="ilmn:CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions" format="ixt-sec:numwordsen" scale="0" id="f-1319">four</ix:nonFraction> movants filed motions to consolidate the Actions and to appoint a lead plaintiff (Lead Plaintiff Motions). On April 11, 2024, the Court issued an order consolidating the Actions into a single action (captioned in re Illumina, Inc. Securities Litigation No. 23-cv-2082-LL-MMP), and appointed Universal-Investment-Gesellschaft mbH, UI BVK Kapitalverwaltungsgesellschaft mbH, and ACATIS Investment Kapitalverwaltungsgesellschaft mbH as lead plaintiffs (the Lead Plaintiffs). On June 21, 2024, the Lead Plaintiffs filed their consolidated amended complaint. The complaint alleges that Illumina and GRAIL and certain of their current and former directors and officers violated Sections 10(b) and 20(a) of the Securities Exchange Act and SEC Rule 10b-5 in connection with Illumina&#8217;s acquisition of GRAIL. On September 13, 2024, the Lead Plaintiffs filed a second amended consolidated complaint. On November 12, 2024, the Company and other defendants filed a motion to dismiss the second amended consolidated complaint. On December 20, 2024, the Lead Plaintiffs filed their opposition to the motion to dismiss. The defendants&#8217; final reply brief was filed on February 3, 2025. No hearing date has been set.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Securities Class Actions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On February 2, 2024, the first of <ix:nonFraction unitRef="lawsuit" contextRef="c-388" decimals="INF" name="ilmn:CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions" format="ixt-sec:numwordsen" scale="0" id="f-1320">two</ix:nonFraction> additional securities class actions was filed against Illumina, certain of its officers and directors, and several other individuals and entities in the Superior Court of the State of California, County of San Mateo, captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loren Scott Mar v. Illumina, et al. and Scott Zerzanek v. Illumina, Inc. et al</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Both complaints generally allege, among other things, that defendants made materially false and misleading statements and omitted material facts in the November 2020 and February 2021 registration statements and prospectus relating to Illumina&#8217;s acquisition of GRAIL. The complaints seek unspecified damages, interest, fees, and costs. On March 29, 2024, the parties to the actions filed a Joint Stipulation to Consolidate the actions and to appoint co-lead counsel for plaintiffs, which the Court granted on April 5, 2024. On August 12, 2024, the Plaintiffs filed their consolidated complaint. On September 6, 2024, Illumina and the other named defendants filed a motion to stay the litigation. On October 4, 2024, the plaintiffs opposed the motion to stay. At a hearing held on December 6, 2024, the Court declined to stay the litigation. The defendants&#8217; demurrer is due February 28, 2025. Plaintiffs&#8217; oppositions to the demurrer are due April 30, 2025, and defendants&#8217; final reply briefs are due May 30, 2025. A hearing is set for June 20, 2025.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the fact that the lawsuits are in an early stage, we cannot predict the ultimate outcome of the suits. We deny the allegations in the complaints and intend to vigorously defend the litigation.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-1311-4"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">DOJ Civil Investigative Demand</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 18, 2024, we received a civil investigative demand (CID) from the U.S. Department of Justice, requiring production of certain documents and information in the course of a False Claims Act investigation to determine whether there is or has been a violation of 31 U.S.C. &#167; 3729. The False Claims Act investigation concerns allegations that the Company caused the submission of false claims to Medicare and other federal government programs because it misrepresented its compliance with cybersecurity requirements to the Food and Drug Administration and other federal agencies that purchase its devices. The Company is cooperating with the government. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Books and Records Action</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2024, a stockholder filed a complaint in the Delaware Court of Chancery captioned Pavers and Road Builders Benefit Funds v. Illumina, Inc. seeking to inspect certain books and records related to the GRAIL transaction, including certain materials and minutes from meetings of our Board of Directors, which have been withheld because the Company contends they are non-responsive to the request or subject to the attorney-client privilege. Illumina previously provided documents to the stockholder in response to a demand made by letter under Delaware law, but the stockholder seeks additional and unredacted materials through this action. On March 11, 2024, Illumina filed an answer to the complaint, denying that the stockholder was entitled to inspection. We deny that the stockholder is entitled to review the documents and intend to vigorously defend the litigation. The trial took place on June 7, 2024. On July 16, 2024, the Court issued a decision requiring the Company to produce certain additional documents to plaintiff. On July 26, 2024, the stockholder filed a motion seeking in camera review of certain documents that the Company maintains are not subject to the Court&#8217;s July 16, 2024 order to produce documents. The Court granted the motion on August 19, 2024, and the Company filed the documents for in camera review on August 29, 2024. On October 7, 2024, the Court ruled that the Company need not produce the documents subject to the motion for in camera review because they are privileged under the attorney opinion work product doctrine. On December 11, 2024, the Court entered its final order and judgment. On December 23, 2024, the plaintiff in this action filed a derivative complaint, described above.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BGI Genomics Co. Ltd. and its Affiliates</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, we were engaged in litigation in various U.S. jurisdictions with BGI Genomics Co. Ltd (BGI) and certain of its affiliates, including Complete Genomics, Inc. (CGI) since June of 2019. On July 14, 2022, we entered into a Settlement and License Agreement with BGI and CGI (the Agreement). Pursuant to the terms of the Agreement, we agreed to pay CGI a one time payment of $<ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="f-1321">325</ix:nonFraction>&#160;million. We allocated the $<ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="f-1322">325</ix:nonFraction>&#160;million payment on a relative fair value basis, resulting in $<ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-6" name="ilmn:LossContingencyLicenseGrantedIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-1323">180</ix:nonFraction>&#160;million capitalized as an intangible asset in 2022 for the value of the license, which is amortized over a period of <ix:nonNumeric contextRef="c-391" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="f-1324">6.5</ix:nonNumeric> years on a straight-line basis, $<ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-6" name="ilmn:PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed" format="ixt:num-dot-decimal" scale="6" id="f-1325">150</ix:nonFraction>&#160;million allocated to the release of past damages claimed, and a $<ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-6" name="us-gaap:FormerGainContingencyRecognizedInCurrentPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1326">5</ix:nonFraction>&#160;million gain for damages awarded to us. The fair value of the license was estimated using a discounted cash flow model, which included assumptions for projected revenues covered by the license, an estimated royalty rate and a discount rate. The fair value of the past damages claimed was estimated based on applicable historical revenues and an estimated royalty rate. These inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value.</span></div></ix:continuation><div style="margin-top:13pt"><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_130"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1327" continuedAt="f-1327-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.  INCOME TAXES</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-1328" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes summarized by region was as follows:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.963%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="f-1329">1,834</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="f-1330">1,735</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="f-1331">4,942</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-1332">655</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-1333">618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-1334">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss before income taxes</span></div></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1335">1,179</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1336">1,117</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1337">4,336</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><div><span><br/></span></div><ix:continuation id="f-1327-1" continuedAt="f-1327-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1338" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.963%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1339">6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1340">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1341">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1342">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1343">6</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1344">27</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1345">137</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1346">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1347">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1348">161</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1349">78</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1350">91</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1351">59</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1352">13</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1353">40</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1354">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1355">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1356">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1357">2</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1358">5</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1359">16</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1360">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1361">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1362">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax provision</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1363">44</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1364">44</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1365">68</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1366" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes reconciles to the amount computed by applying the federal statutory rate to loss before income taxes as follows:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.963%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="f-1367">248</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="f-1368">235</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="f-1369">911</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="f-1370">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="f-1371">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="f-1372">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and other credits</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="f-1373">32</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="f-1374">42</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="f-1375">46</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="f-1376">29</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="f-1377">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="f-1378">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of R&amp;D expense capitalization</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" scale="6" id="f-1379">52</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" scale="6" id="f-1380">86</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" scale="6" id="f-1381">87</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of net operating losses on GILTI, U.S. foreign tax credits, and Pillar Two global minimum top-up tax</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount" scale="6" id="f-1382">90</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount" scale="6" id="f-1383">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount" scale="6" id="f-1384">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign operations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-1385">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-1386">50</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-1387">81</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="f-1388">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="f-1389">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="f-1390">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual of European Commission fine</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="ilmn:EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" scale="6" id="f-1391">99</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="ilmn:EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" scale="6" id="f-1392">3</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="ilmn:EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" scale="6" id="f-1393">96</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" scale="6" id="f-1394">308</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" scale="6" id="f-1395">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" scale="6" id="f-1396">822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of acquisition related items</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="ilmn:EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" scale="6" id="f-1397">46</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="ilmn:EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" scale="6" id="f-1398">8</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="ilmn:EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" scale="6" id="f-1399">27</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="f-1400">9</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="f-1401">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="f-1402">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax provision</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1403">44</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1404">44</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1405">68</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to account for the global intangible low-taxed income (GILTI) as a period cost in our consolidated financial statements. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of foreign operations primarily represents the difference between the actual provision for income taxes for our legal entities that operate in jurisdictions that have statutory tax rates that differ from the U.S. federal statutory tax rate of 21%. The most significant tax benefits from foreign operations were from our earnings in Singapore, which had a statutory tax rate of 17% in 2024. The impact of foreign operations also includes the impacts of GILTI, U.S. foreign tax credits, and the Pillar Two global minimum top-up tax of non-U.S. earnings before the tax impact of net operating losses, and uncertain tax positions related to foreign items.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of R&amp;D expense capitalization is primarily the income tax expense impact of capitalizing research and development expenses for tax purposes on GILTI and the utilization of the U.S. foreign tax credits. </span></div></ix:continuation><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-1327-2" continuedAt="f-1327-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of net operating losses on GILTI, U.S. foreign tax credits, and the Pillar Two global minimum top-up tax is primarily the income tax expense impact of GRAIL pre-acquisition net operating losses on GILTI, the utilization of the U.S. foreign tax credits, and the Pillar Two global minimum top-up tax.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The impact of acquisition related items includes the income tax expense impact of transaction costs, acquisition related compensation, and changes to the contingent value rights associated with the GRAIL acquisition.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1406" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of deferred tax assets and liabilities were as follows:  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-1407">189</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-1408">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="f-1409">252</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="f-1410">211</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="6" id="f-1411">40</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="6" id="f-1412">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="f-1413">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="f-1414">15</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized U.S. R&amp;D expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="f-1415">181</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="f-1416">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other amortization</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" scale="6" id="f-1417">42</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" scale="6" id="f-1418">115</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="ilmn:DeferredTaxAssetsOperatingLeaseLiabilities" scale="6" id="f-1419">112</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="ilmn:DeferredTaxAssetsOperatingLeaseLiabilities" scale="6" id="f-1420">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="f-1421">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="f-1422">4</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsInvestments" scale="6" id="f-1423">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsInvestments" scale="6" id="f-1424">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-1425">63</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-1426">56</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="f-1427">953</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-1428">1,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance on deferred tax assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1429">278</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1430">251</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="f-1431">675</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="f-1432">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased intangible amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="f-1433">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="f-1434">734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="ilmn:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" scale="6" id="f-1435">57</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="ilmn:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" scale="6" id="f-1436">88</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="f-1437">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="f-1438">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-1439">117</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-1440">847</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="f-1441">558</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="f-1442">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence, including operating results and forecasted ranges of future taxable income. Based on the available evidence as of December&#160;29, 2024, we were not able to conclude it is more likely than not certain deferred tax assets will be realized. Therefore, a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1443">278</ix:nonFraction> million was recorded against certain U.S. and foreign deferred tax assets. &#160;&#160;&#160;&#160;</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, we had net operating loss carryforwards for federal and state tax purposes of $<ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1444">74</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1445">1,872</ix:nonFraction> million, respectively, which will begin to expire in 2036 and 2025, respectively, unless utilized prior. We also had federal and state tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-1446">140</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-1447">239</ix:nonFraction> million, which will begin to expire in 2031 and 2027, respectively, unless utilized prior.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section&#160;382 and 383 of the Internal Revenue Code, utilization of net operating losses and credits may be subject to annual limitations in the event of any significant future changes in its ownership structure. These annual limitations may result in the expiration of net operating losses and credits prior to utilization. The deferred tax assets as of December&#160;29, 2024 are net of any previous limitations due to Section&#160;382 and 383.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing operations in Singapore operate under various tax holidays and incentives, which will begin to expire in 2028. These tax holidays and incentives resulted in a $<ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-6" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" scale="6" id="f-1448">33</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-6" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" scale="6" id="f-1449">75</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-6" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" scale="6" id="f-1450">56</ix:nonFraction> million decrease to the provision for income taxes in 2024, 2023, and 2022, respectively. These tax holidays and incentives resulted in a decrease in diluted loss per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-396" decimals="2" name="us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare" scale="0" id="f-1451">0.20</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-397" decimals="2" name="us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare" scale="0" id="f-1452">0.47</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-398" decimals="2" name="us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare" scale="0" id="f-1453">0.35</ix:nonFraction>, in 2024, 2023, and 2022, respectively.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:continuation id="f-1327-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, we asserted that $<ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-6" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="f-1454">1,806</ix:nonFraction> million of foreign earnings would not be indefinitely reinvested, and accordingly, recorded a deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="f-1455">24</ix:nonFraction> million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-1456" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gross amount of our uncertain tax positions:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.963%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1457">210</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1458">153</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1459">131</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1460">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1461">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1462">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1463">2</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1464">2</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1465">3</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1466">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1467">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1468">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to lapse of statute of limitations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-1469">1</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-1470">10</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-1471">29</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1472">232</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1473">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1474">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the balance of uncertain tax positions as of December&#160;29, 2024 and December&#160;31, 2023, was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1475">202</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1476">156</ix:nonFraction>&#160;million, respectively, of net unrecognized tax benefits that, if recognized, would reduce the effective income tax rate in future periods.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any interest and penalties related to uncertain tax positions are reflected in the provision for income taxes. We recognized expense of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1477">6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1478">2</ix:nonFraction>&#160;million in 2024 and 2023, respectively, and income of $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1479">3</ix:nonFraction>&#160;million in 2022, related to potential interest and penalties on uncertain tax positions. We recorded a liability for potential interest and penalties of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1480">13</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1481">6</ix:nonFraction>&#160;million as of December&#160;29, 2024 and December&#160;31, 2023, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tax years 1997 to 2023 remain subject to future examination by the major tax jurisdictions in which we are subject to tax. The Internal Revenue Service completed an examination of the U.S. Corporation Income Tax Returns for tax years 2017, 2018, and 2020. Given the uncertainty of potential adjustments from examination as well as the potential expiration of the statute of limitations, it is reasonably possible that the balance of unrecognized tax benefits could change significantly over the next 12 months. Due to the number of years remaining that are subject to examination, we are unable to estimate the full range of possible adjustments to the balance of gross unrecognized tax benefits.</span></div></ix:continuation><div><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_133"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="f-1482" continuedAt="f-1482-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.  EMPLOYEE BENEFIT PLANS</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Plan</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a 401(k) savings plan covering substantially all of our employees in the United States. Our contributions to the plan are discretionary. During 2024, 2023, and 2022, we made matching contributions of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-1483">34</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-1484">36</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-1485">30</ix:nonFraction> million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Illumina, Inc. Deferred Compensation Plan (the Plan) allows senior level employees to contribute up to <ix:nonFraction unitRef="number" contextRef="c-400" decimals="INF" name="ilmn:DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent" scale="-2" id="f-1486">60</ix:nonFraction>% of their base salary and <ix:nonFraction unitRef="number" contextRef="c-400" decimals="INF" name="ilmn:DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" scale="-2" id="f-1487">100</ix:nonFraction>% of their variable cash compensation, and members of the board of directors to contribute up to <ix:nonFraction unitRef="number" contextRef="c-401" decimals="INF" name="ilmn:DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" scale="-2" id="f-1488">100</ix:nonFraction>% of their director fees and equity awards. Under the Plan, we credit the participants&#8217; contributions with earnings that reflect the performance of certain independent investment funds. On a discretionary basis, we may also make employer contributions to participant accounts in any amount determined by us. The vesting schedules of employer contributions are at the sole discretion of the Compensation Committee. However, all employer contributions shall become <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="ilmn:DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents" scale="-2" id="f-1489">100</ix:nonFraction>% vested upon the occurrence of the participant&#8217;s disability, death or retirement or a change in control of Illumina. The benefits under this plan are unsecured. Participants are generally eligible to receive payment of their vested benefit at the end of their elected deferral period or after termination of their employment for any reason or at a later date to comply with the restrictions of Section&#160;409A. </span></div></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1482-1">We established a rabbi trust for the benefit of the participants under the Plan and have included the assets of the rabbi trust in other assets in the consolidated balance sheets. As of December&#160;29, 2024 and December&#160;31, 2023, the assets of the trust were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-1490">70</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-1491">61</ix:nonFraction> million, respectively, and our liabilities, included in accrued liabilities, were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent" scale="6" id="f-1492">65</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent" scale="6" id="f-1493">59</ix:nonFraction> million, respectively. Changes in the values of the assets held by the trust are recorded in other expense, net, and changes in the values of the deferred compensation liabilities are recorded in operating expense.</ix:continuation> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_136"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1494" continuedAt="f-1494-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.  SEGMENT AND GEOGRAPHIC INFORMATION</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reportable Segment Information</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, we have <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1495">one</ix:nonFraction> reportable segment, Core Illumina. Prior to the Spin-Off of GRAIL, on June&#160;24, 2024, our reportable segments included both Core Illumina and GRAIL. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_40">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details. We continue to disclose certain historical information for GRAIL prior to the Spin-Off. Segment information is consistent with how our Chief Operating Decision Maker (CODM), who is our Chief Executive Officer, reviews financial information, makes operating decisions, allocates resources, and assesses performance. We also consider the way budgets and forecasts are prepared and reviewed and the basis on which executive compensation is determined.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Core Illumina: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core Illumina&#8217;s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina sells products and provides services to GRAIL, and vice versa, in accordance with contractual agreements between the entities.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRAIL: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRAIL is a healthcare company focused on early detection of multiple cancers. Prior to the Spin-Off of GRAIL into a separate, independent public company, GRAIL was required to be held and operated separately and independently from Illumina pursuant to the transitional measures ordered by the European Commission. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1496" continuedAt="f-1496-1" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CODM allocates resources and evaluates business performance based on revenues and net income (loss). Net income (loss) is used in the annual budgeting and monthly forecasting processes and to monitor and assess budgeted/forecasted versus actual results. Our CODM does not evaluate segments using asset information. The accounting policies for segments are the same as those described in the summary of significant accounting policies. </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><ix:continuation id="f-1496-1"><ix:continuation id="f-1494-1" continuedAt="f-1494-2"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present selected financial information with respect to segments for the periods presented:</span></div><div style="margin-bottom:6pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.043%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina:</span></div></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1497">4,332</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1498">4,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1499">4,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1500">1,424</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1501">1,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1502">1,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-1503">988</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1504">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-1505">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:SellingAndMarketingExpense" scale="6" id="f-1506">638</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:SellingAndMarketingExpense" scale="6" id="f-1507">648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:SellingAndMarketingExpense" scale="6" id="f-1508">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-1509">262</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-1510">600</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-1511">326</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible impairment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="f-1512">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="f-1513">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="6" id="f-1514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal contingency and settlement</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="f-1515">456</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="f-1516">20</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="f-1517">619</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1518">1,473</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1519">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1520">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL:</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1521">55</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1522">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1523">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-1524">2,360</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-1525">1,714</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-1526">4,712</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated other expense, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1527">346</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1528">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1529">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated provision for income taxes</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1530">44</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1531">44</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1532">68</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment eliminations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-1533">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="f-1534">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-1535">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net loss</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1536">1,223</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1537">1,161</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1538">4,404</ix:nonFraction>)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Core Illumina revenue for 2024, 2023, and 2022 included intercompany revenue of $<ix:nonFraction unitRef="usd" contextRef="c-411" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-1539">15</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-1540">26</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-1541">24</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">GRAIL operating expenses are inclusive of cost of revenue, research and development, selling and marketing, general and administrative, and goodwill and intangible impairment for the comparative periods prior to the Spin-Off on June&#160;24, 2024.</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.963%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1542">280</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1543">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1544">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1545">74</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1546">159</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1547">154</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1548">354</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1549">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1550">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1551">137</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1552">183</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1553">262</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1554">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1555">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1556">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" format="ixt:fixed-zero" scale="6" id="f-1557">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-6" sign="-" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1558">1</ix:nonFraction>)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" format="ixt:fixed-zero" scale="6" id="f-1559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1560">142</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1561">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1562">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:3pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ILLUMINA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8212; (Continued)</span></div></div><div style="margin-top:1pt"><span><br/></span></div><ix:continuation id="f-1494-2"><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geographic Data</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="f-1563" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, consisting of property and equipment and operating lease right-of-use assets, were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="f-1564">750</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-1565">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="f-1566">279</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-417" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="f-1567">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="f-1568">124</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="f-1569">136</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="f-1570">81</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="f-1571">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets, net</span></div></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-1572">1,234</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dddddd;padding:0 1pt"/><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-1573">1,551</ix:nonFraction>&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_94">3. Revenue</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for revenue by geographic area.</span></div></ix:continuation><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_148"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We design our internal controls to provide reasonable assurance that (1) our transactions are properly authorized; (2) our assets are safeguarded against unauthorized or improper use; and (3) our transactions are properly recorded and reported in conformity with U.S. generally accepted accounting principles. We also maintain internal controls and procedures to ensure that we comply with applicable laws and our established financial policies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2024, we continued to monitor and evaluate the design and operating effectiveness of key controls. There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that materially affected or are reasonably likely to materially affect internal control over financial reporting.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, under the supervision and with the participation of our chief executive officer (CEO) and chief financial officer (CFO), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (Exchange Act)), as of the end of the period covered by this Annual Report on Form 10-K. Based on such evaluation, our CEO and CFO have concluded that as of December&#160;29, 2024, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (SEC), and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. </span></div><div style="margin-top:13pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f). Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on this evaluation, our management has concluded that our internal control over financial reporting was effective as of December&#160;29, 2024. The effectiveness of our internal control over financial reporting as of December&#160;29, 2024 has been audited by Ernst &amp; Young LLP, an independent registered public accounting firm, as stated in their report which is included herein.</span></div><div><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:109%">To the Stockholders and the Board of Directors of Illumina, Inc.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:109%">Opinion on Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:109%">We have audited Illumina, Inc.&#8217;s internal control over financial reporting as of December&#160;29, 2024, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Illumina, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December&#160;29, 2024, based on the COSO criteria.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:109%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December&#160;29, 2024 and December&#160;31, 2023, the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;29, 2024, and the related notes and our report dated February&#160;12, 2025 expressed an unqualified opinion thereon.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:109%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:109%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:109%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:109%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:109%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:109%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:109%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San&#160;Diego, California</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;12, 2025 </span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ADOPTIONS, MODIFICATIONS OR TERMINATIONS OF TRADING PLANS</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarterly period ended December&#160;29, 2024, the following directors and officers adopted, modified or terminated 10b5-1 plans:</span></div><div style="margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><ix:nonNumeric contextRef="c-422" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1574" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On <ix:nonNumeric contextRef="c-423" name="ecd:TrdArrAdoptionDate" id="f-1575">November 6, 2024</ix:nonNumeric>, <ix:nonNumeric contextRef="c-423" name="ecd:TrdArrIndName" id="f-1576">Frances Arnold</ix:nonNumeric>, a member of our <ix:nonNumeric contextRef="c-423" name="ecd:TrdArrIndTitle" id="f-1577">Board of Directors</ix:nonNumeric>, <ix:nonNumeric contextRef="c-423" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1578">entered</ix:nonNumeric> in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on <ix:nonNumeric contextRef="c-423" name="ecd:TrdArrExpirationDate" id="f-1579">February 27, 2026</ix:nonNumeric> and provides for the sale of up to <ix:nonFraction unitRef="shares" contextRef="c-424" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" scale="0" id="f-1580">120</ix:nonFraction> shares.</span></ix:nonNumeric></div><div style="margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><ix:nonNumeric contextRef="c-425" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1581" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On <ix:nonNumeric contextRef="c-426" name="ecd:TrdArrAdoptionDate" id="f-1582">November 7, 2024</ix:nonNumeric>, <ix:nonNumeric contextRef="c-426" name="ecd:TrdArrIndName" id="f-1583">Jakob Wedel</ix:nonNumeric>, our <ix:nonNumeric contextRef="c-426" name="ecd:TrdArrIndTitle" id="f-1584">Chief Strategy and Corporate Development Officer</ix:nonNumeric>, <ix:nonNumeric contextRef="c-426" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1585">entered</ix:nonNumeric> in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on <ix:nonNumeric contextRef="c-426" name="ecd:TrdArrExpirationDate" id="f-1586">May 29, 2026</ix:nonNumeric> and provides for the sale of up to <ix:nonFraction unitRef="shares" contextRef="c-427" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-1587">3,182</ix:nonFraction> shares.</span></ix:nonNumeric></div><div style="margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><ix:nonNumeric contextRef="c-428" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1588" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On <ix:nonNumeric contextRef="c-429" name="ecd:TrdArrAdoptionDate" id="f-1589">November 8, 2024</ix:nonNumeric>, <ix:nonNumeric contextRef="c-429" name="ecd:TrdArrIndName" id="f-1590">Scott Davies</ix:nonNumeric>, our <ix:nonNumeric contextRef="c-429" name="ecd:TrdArrIndTitle" id="f-1591">Interim General Counsel</ix:nonNumeric>, <ix:nonNumeric contextRef="c-429" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1592">entered</ix:nonNumeric> in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on <ix:nonNumeric contextRef="c-429" name="ecd:TrdArrExpirationDate" id="f-1593">December 16, 2025</ix:nonNumeric> and provides for the sale of up to <ix:nonFraction unitRef="shares" contextRef="c-430" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-1594">3,301</ix:nonFraction> shares.</span></ix:nonNumeric></div><div style="margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><ix:nonNumeric contextRef="c-431" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1595" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On <ix:nonNumeric contextRef="c-432" name="ecd:TrdArrAdoptionDate" id="f-1596">November 13, 2024</ix:nonNumeric>, <ix:nonNumeric contextRef="c-432" name="ecd:TrdArrIndName" id="f-1597">Patricia Leckman</ix:nonNumeric>, our <ix:nonNumeric contextRef="c-432" name="ecd:TrdArrIndTitle" id="f-1598">Chief People Officer</ix:nonNumeric>, <ix:nonNumeric contextRef="c-432" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1599">entered</ix:nonNumeric> in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on <ix:nonNumeric contextRef="c-432" name="ecd:TrdArrExpirationDate" id="f-1600">November 14, 2025</ix:nonNumeric> and provides for the sale of up to <ix:nonFraction unitRef="shares" contextRef="c-433" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-1601">1,615</ix:nonFraction> shares.</span></ix:nonNumeric></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as disclosed above, during the quarterly period ended December&#160;29, 2024, none of the Company&#8217;s directors or officers adopted, modified or terminated any &#8220;<ix:nonNumeric contextRef="c-434" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1602">Rule 10b5-1 trading arrangement</ix:nonNumeric>&#8221; or any &#8220;<ix:nonNumeric contextRef="c-434" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1603"><ix:nonNumeric contextRef="c-434" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1604">non-Rule 10b5-1 trading arrangement</ix:nonNumeric></ix:nonNumeric>,&#8221; in each case as such term is defined in Item 408 of Regulation S-K. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_160"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning our directors is incorporated by reference from the section entitled &#8220;Proposal&#160;One: Election of Directors,&#8221; &#8220;Information About Directors,&#8221; &#8220;Director Compensation,&#8221; and &#8220;Board of Directors and Corporate Governance&#8221; to be contained in our definitive Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC no later than April&#160;28, 2025.  </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning our executive officers is incorporated by reference from the section entitled &#8220;Executive Officers&#8221; to be contained in our definitive Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC no later than April&#160;28, 2025.  </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Governance</span></div><div><span><br/></span></div><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Section&#160;16(a) of the Exchange Act </span></div><div style="padding-left:13.5pt"><span><br/></span></div><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning compliance with Section&#160;16(a) of the Securities Exchange Act of 1934 is incorporated by reference from the section entitled &#8220;Section&#160;16(a) Beneficial Ownership Reporting Compliance&#8221; to be contained in our definitive Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC no later than April&#160;28, 2025.  </span></div><div style="padding-left:13.5pt;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee Financial Expert </span></div><div style="padding-left:13.5pt;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning the audit committee financial expert as defined by the SEC rules adopted pursuant to the Sarbanes-Oxley Act of 2002 is incorporated by reference from the section entitled &#8220;Board of Directors and Corporate Governance&#8221; to be contained in our definitive Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC no later than April&#160;28, 2025.  </span></div><div style="padding-left:13.5pt"><span><br/></span></div><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code of Conduct</span></div><div style="padding-left:13.5pt;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a code of conduct for our directors, officers, and employees, which is available on our website at www.illumina.com in the Corporate Governance portal of the Investor Information section under &#8220;Company.&#8221; A copy of the Code of Conduct is available in print free of charge to any stockholder who requests a copy. Interested parties may address a written request for a printed copy of the Code of Ethics to: Corporate Secretary, Illumina, Inc., 5200 Illumina Way, San Diego, California 92122. We intend to satisfy the disclosure requirement regarding any amendment to, or a waiver from, a provision of the Code of Ethics for our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, by posting such information on our website. The information on, or that can be accessed from, our website is not incorporated by reference into this report.  </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_163"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning executive compensation is incorporated by reference from the sections entitled &#8220;Compensation Discussion and Analysis,&#8221; &#8220;Director Compensation,&#8221; and &#8220;Executive Compensation&#8221; to be contained in our definitive Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC no later than April&#160;28, 2025.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_166"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning the security ownership of certain beneficial owners and management and information covering securities authorized for issuance under equity compensation plans is incorporated by reference from the sections entitled &#8220;Stock Ownership of Principal Stockholders and Management,&#8221; &#8220;Executive Compensation,&#8221; and &#8220;Equity Compensation Plan Information&#8221; to be contained in our definitive Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC no later than April&#160;28, 2025.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_169"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning certain relationships and related transactions, and director independence is incorporated by reference from the sections entitled &#8220;Proposal&#160;One: Election of Directors,&#8221; &#8220;Information About Directors,&#8221; &#8220;Director Compensation,&#8221; &#8220;Executive Compensation,&#8221; and &#8220;Certain Relationships and Related Party Transactions&#8221; to be contained in our definitive Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC no later than April&#160;28, 2025.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_172"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning principal accountant fees and services is incorporated by reference from the sections entitled &#8220;Proposal&#160;Two: Ratification of Appointment of Independent Registered Public Accounting Firm&#8221; and &#8220;Independent Registered Public Accountants&#8221; to be contained in our definitive Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC no later than April&#160;28, 2025.  </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i64df1cccf2dd452496bdff4e9d30a288_175"></div><div style="-sec-extract:summary;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBITS, FINANCIAL STATEMENT SCHEDULES</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibits</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits listed in the accompanying </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_178">Index to Exhibits</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below are filed or incorporated by reference as part of this report.</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_64">Index to Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Consolidated Financial Statements section of this report.</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Financial Statement Schedules</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All financial schedules have been omitted as the required information is not applicable, not material, or because the information required is included in the consolidated financial statements and notes thereto included in the </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_64">Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this report.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_178"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Index to Exhibits</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.126%"><tr><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Herewith</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080322000041/exhibit31amendedrestatedce.htm">Amended and Restated Certificate of Incorporation</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/11/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1110803/000111080324000044/ilmn-20240630.htm">Amended and Restated Bylaws</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/7/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000101287000003639/0001012870-00-003639-0005.txt">Specimen Common Stock Certificate</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-33922</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/3/2000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080321000015/ex45descriptionofregistran.htm">Description of Illumina, Inc.&#8217;s securities registered pursuant to Section 12 of the Exchange Act of 1934</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/17/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312521078737/d261878dex46.htm">Indenture, dated as of March 12, 2021, by and between Illumina, Inc. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee  (incorporated by reference to Exhibit 4.6 to Illumina&#8217;s Registration Statement on Form S-3 (File No. 333-254195) </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-54195</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/12/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312521089600/d117662dex42.htm">Form of Officer&#8217;s Certificate setting forth the terms and forms of the 2023 Notes and 2031 Notes.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/22/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000095015721000850/ex4-1.htm">Contingent Value Rights Agreement by and among Illumina, Inc., Computershare Trust Company, N.A., as Trustee and Shareholder Representative Services LLC dated as of August 18, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/18/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312522303832/d384400dex42.htm">Form of Officer&#8217;s Certificate setting forth the terms and forms of the 2025 Notes and 2027 Notes</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/13/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639208000474/a42420exv10w55.htm">Form of Indemnification Agreement between Illumina and each of its directors and executive officers</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/25/2008</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639209000092/a51300exv10w34.htm">Form of Change in Control Severance Agreement between Illumina and each of its executive officers</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/26/2009</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080323000064/ex1012000esppasamendedandr.htm">2000 Employee Stock Purchase Plan, as amended and restated through May 2, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/10/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000095012310018433/a55310exv10w7.htm">New Hire Stock and Incentive Plan, as amended and restated through October&#160;28, 2009</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/26/2010</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639207000368/a29658exv10w5.htm">License Agreement, effective as of May&#160;6, 1998, between Tufts University and Illumina</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/3/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639207000897/a35845exv99w3.htm">The Solexa Unapproved Company Share Option Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/26/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639207000897/a35845exv99w4.htm">The Solexa Share Option Plan for Consultants</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/26/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639207000897/a35845exv99w5.htm">Solexa Limited Enterprise Management Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/26/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639209000092/a51300exv10w25.htm">Amended and Restated Solexa 2005 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/26/2009</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639209000092/a51300exv10w26.htm">Amended and Restated Solexa 1992 Stock Option Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/26/2009</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080323000013/exhibit101amendedandrestat.htm">Amended and Restated 2015 Stock and Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/7/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.126%"><tr><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080323000013/exhibit104formofrestricted.htm">Form of Restricted Stock Unit Agreement for Employees Under Amended and Restated 2015 Stock and Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/7/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080323000013/exhibit102formofperformanc.htm">Form of Performance Stock Unit Agreement (Relative TSR) for Employees Under Amended and Restated 2015 Stock and Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/7/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080323000013/exhibit103formofperformanc.htm">Form of Performance Stock Unit Agreement (Adjusted EPS) for Employees Under Amended and Restated 2015 Stock and Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/7/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080323000023/formofoptionagreementforem.htm">Form of Option Agreement for Employees Under 2015 Stock and Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/17/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639207000368/a29658exv10w41.htm">Amended and Restated Lease between BMR-9885 Towne Centre Drive LLC and Illumina for the 9885 Towne Centre Drive property, dated January&#160;26, 2007</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/3/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000093639207000368/a29658exv10w42.htm">Lease between BMR-9885 Towne Centre Drive LLC and Illumina for the 9865 Towne Centre Drive property, dated January&#160;26, 2007</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">000-30361</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/3/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080312000104/amendedandrestatedlease.htm">Amended and Restated Lease Agreement, dated March&#160;27, 2012, between ARE-SD Region No.&#160;32, LLC and Illumina</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/3/2012</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080315000064/ex1023.htm">First Amendment to Amended and Restated Lease Agreement, dated March&#160;27, 2012, between ARE-SD Region No.&#160;32, LLC and Illumina</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/18/2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080315000064/ex1024.htm">Second Amendment to Amended and Restated Lease Agreement, dated March&#160;27, 2012, between ARE-SD Region No.&#160;32, LLC and Illumina</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/18/2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080318000009/arelease.htm">Amended and Restated Second Amendment to Amended and Restated Lease Agreement, dated March&#160;27, 2012, between ARE-SD Region No.&#160;32, LLC and Illumina</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/13/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000119312512043693/d295981dex99e6.htm">Deferred Compensation Plan, effective December 1, 2007</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14D-9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">005-60457</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99(e)(6)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/7/2012</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080315000064/ex1026.htm">Lease between BMR-Lincoln Centre LP and Illumina, dated December 30, 2014</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/18/2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080315000064/ex1027.htm">Pooled Patents Agreement between Illumina and Sequenom, Inc., dated December 2, 2014 (with certain confidential portions omitted)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/18/2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080318000009/firstamendmenttopooledpate.htm">First Amendment to Pooled Patents Agreement between Illumina and Sequenom, Inc., effective as of April 21, 2016</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/13/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080318000009/secondamendmenttopooledpat.htm">Second Amendment to Pooled Patents Agreement between Illumina and Sequenom, Inc., effective as of April 17, 2017</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/13/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.126%"><tr><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080318000009/thirdamendmenttopooledpate.htm">Third Amendment to Pooled Patents Agreement between Illumina and Sequenom, Inc., effective as of August 28, 2017 (with certain confidential portions omitted)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/13/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080320000018/exhibit1025fourthamend.htm">Fourth Amendment to Pooled Patents Agreement between Illumina and Sequenom, Inc., effective as of March 15, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/11/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080320000018/exhibit1026fifthamendm.htm">Fifth Amendment to Pooled Patents Agreement between Illumina and Sequenom, Inc., effective as of April 12, 2019 (with certain confidential portions omitted)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/11/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080320000060/exhibit1036sixthamendm.htm">Sixth Amendment to Pooled Patents Agreement between Illumina and Sequenom, Inc., effective as of May 8, 2020 (with certain confidential portions omitted)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/30/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080315000140/ex101grantaparkagreementfo.htm">Agreement for Lease between Granta Park Park Jco 1 Limited and Illumina, dated June 25, 2015</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/31/2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080316000175/fy1510-kex1029.htm">Third Amendment to Lease between ARE-SD Region No. 32, LLC and Illumina, dated September 2, 2015</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2016</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080316000175/fy1510-kex1030.htm">First Amendment to Lease between BMR-Lincoln Center LP and Illumina, dated February 23, 2016</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2016</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080317000014/ex1028fourthamendmenttoale.htm">Fourth Amendment to Lease between ARE-SD Region No. 32, LLC and Illumina, dated April 14, 2016</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/14/2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080317000014/ex1029secondamendmentbmr-l.htm">Second Amendment to Lease between BMR-Lincoln Center LP and Illumina dated August 15, 2016</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/14/2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080317000014/ex1030deedofvariationgrant.htm">Deed of Variation to the Agreement for Lease between Granta Park Jco 1 Limited and Illumina dated October 24, 2016</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/14/2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1110803/000111080318000015/fy1810-qex101bmrxlincolnce.htm">Third Amendment to Lease between BMR-Lincoln Center LP and Illumina dated January 18, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/25/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.39</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080321000046/formofinsurancemattersagre.htm">Form of Insurance Matters Agreement</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/5/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312523001536/d443370dex101.htm">Credit Agreement, dated as of January 4, 2023, among the Company, as the borrower, the lenders from time to time party thereto, Bank of America, N.A., as administrative agent, an issuing bank and the swingline lender, and the other issuing banks from time to time party thereto</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/4/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.41</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080324000024/ex101kreevesseparationagre.htm">Separation Agreement and Release of All Claims by and between Illumina, Inc. and Kathryne Reeves, dates of March 19, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/3/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312524167025/d851030dex101.htm">Tax Matters Agreement, dated June 21, 2024, between GRAIL, LLC and Illumina, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/24/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312524167025/d851030dex102.htm">Employee Matters Agreement, dated June 21, 2024, between GRAIL, LLC and Illumina, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/24/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.126%"><tr><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312524167025/d851030dex103.htm">Stockholder and Registration Rights Agreement, Dated June 21, 2024, between GRAIL, LLC and Illumina, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/24/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312524167025/d851030dex104.htm">Fourth Amendment to the Amended and Restated Supply and Commercialization Agreement, dated June 21, 2024, by and between Illumina, Inc. and GRAIL, LLC*</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/24/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312524162068/d840320dex101.htm">364-Day Delayed Draw Credit Agreement, dated as of June 17, 2024, among the Company, as the borrower, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312524162068/d840320dex101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312524162068/d840320dex101.htm">Fourth Amendment to the Amended and Restated Supply and Commercialization Agreement, dated June 21, 2024, by and between Illumina, Inc. and GRAIL, LLC*</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/17/2024</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.57</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080324000044/ex106jgoswamiretentionagre.htm">Retention Agreement by and between Joydeep Goswami and Illumina, Inc. dated as of April 8, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/7/2024</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.58</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080324000044/ex107jgoswamiseparationagr.htm">Separation Agreement and General Release of All Claims by and between Joydeep Goswami and Illumina, Inc. dated as of July 2, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/7/2024</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.59</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312524215883/d888510dex11.htm">Underwriting Agreement, dated September 4, 2024, between the Company and J.P. Morgan Securities LLC and Goldman Sachs &amp; Co. LLC, as representatives of the several underwriters named therein</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/9/2024</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000119312524215883/d888510dex42.htm">Officer&#8217;s Certificate, dated September 9, 2024, setting forth the terms and form of the Notes</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/9/2024</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.61</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000095015724001364/ex10-1.htm">Advisory Agreement between Illumina, Inc. and Charles Dadswell, dated October 3, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/3/2024</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+10.62</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000095015724001364/ex10-2.htm">Separation Agreement between Illumina, Inc. and Charles Dadswell, dated October 3, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/3/2024</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+19.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex191insidertradingpolicy.htm"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-1609">Insider Trading Policy, Adopted July 30, 2024</ix:nonNumeric></a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy2410-kex211subsidiariesq4.htm">Subsidiaries of Illumina</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex231consentfy2410-kq4.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney (included on the signature page)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex311.htm">Certification of Jacob Thaysen pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex312.htm">Certification of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex312.htm">Ankur</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex312.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex312.htm">Dhingra</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex312.htm"> pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex321.htm">Certification of Jacob Thaysen pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex322.htm">Certification of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex322.htm">Ankur Dhingra</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fy24q4ex322.htm"> pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.126%"><tr><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+97.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1110803/000111080324000010/ex97compensationrecoverycl.htm">Compensation Recovery/Clawback Policy - Adopted May 2, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35406</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/16/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - formatted in Inline XBRL and included as Exhibit 101</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.507%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or corporate plan or arrangement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portions of this exhibit omitted pursuant to Item 601(b)(2) and Item 601(b)(10) of Regulation S-K, as applicable. The Company agrees to furnish a supplemental and unredacted copy of any omitted schedule to the Securities and Exchange Commission upon its request.</span></div></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Information</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No Annual Report to stockholders or proxy materials has been furnished to stockholders as of the date of this report. The Annual Report to stockholders and proxy material will be furnished to our stockholders after the filing of this Annual Report on Form&#160;10-K and we will furnish such material to the SEC at that time.</span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_181"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM 10-K CROSS-REFERENCE INDEX</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:14.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:67.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.128%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART&#160;I</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_13">Item 1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">Item 1A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_22">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unresolved Staff Comments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_19">Item 1C</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_19">Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_19">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_16">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_16">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_16">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_25">Item 3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_25">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART&#160;II</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_31">Item 5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_31">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_31">28</a></span><span style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">;</span><span style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#070dff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_34">30</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_37">Item 7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_37">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_37">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_55">Item 7A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_55">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_55">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_64">Item 8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_64">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_64">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_148">Item 9A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_148">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_148">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_151">Item 9B</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_151">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_151">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART&#160;III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_160">Item 10</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_160">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_160">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_163">Item 11</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_163">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_163">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_166">Item 12</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_166">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_166">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_169">Item 13</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_169">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_169">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_172">Item 14</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_172">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_172">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART&#160;IV</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_175">Item 15</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_175">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_175">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_184">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_184">106</a></span></div></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="i64df1cccf2dd452496bdff4e9d30a288_184"></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, on February&#160;12, 2025.  </span></div><div style="margin-top:25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:39.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.806%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ILLUMINA, INC.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;JACOB THAYSEN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacob Thaysen<br/>Chief Executive Officer</span></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:33.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i64df1cccf2dd452496bdff4e9d30a288_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;12, 2025 </span></div><div style="margin-top:19pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Jacob Thaysen and Ankur Dhingra, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form&#160;10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their, his, or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.  </span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form&#160;10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.  </span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.701%"><tr><td style="width:1.0%"/><td style="width:33.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;JACOB THAYSEN</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer, Director<br/>(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacob Thaysen</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  ANKUR DHINGRA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ankur Dhingra</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  SCOTT ERICKSEN</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and Chief Accounting Officer <br/>(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott Ericksen</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  STEPHEN P. MACMILLAN</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Chair of the Board of Directors </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen P. MacMillan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  FRANCES ARNOLD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frances Arnold, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  CAROLINE DORSA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Caroline Dorsa</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  ROBERT S. EPSTEIN</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert S. Epstein, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  SCOTT GOTTLIEB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott Gottlieb, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  GARY S. GUTHART</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gary S. Guthart, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  PHILIP SCHILLER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Philip Schiller</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  SUSAN SIEGEL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Susan Siegel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  ANNA RICHO</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anna Richo</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  SCOTT B. ULLEM</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 12, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott B. Ullem</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>2
<FILENAME>ex191insidertradingpolicy.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ie7d0af1e04024830916c5a081b69a565_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">ILLUMINA, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Insider Trading Compliance Program</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:35.99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To take an active role in the prevention of insider trading violations by its officers, directors, employees and other related individuals, Illumina has adopted the policies and procedures described in this Memorandum.</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">I.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:29.9pt;text-decoration:underline">Adoption of Insider Trading Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="padding-left:36pt;text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:35.99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Illumina has adopted the Insider Trading Policy attached as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), which prohibits trading based on Material Non-Public Information (as defined in the Policy). The Policy covers officers, directors and all other employees of, or consultants to, Illumina, as well as family members of such persons, and others, in each case where such persons have or may have access to such information. This Policy also applies to any entities controlled by individuals subject to the Policy, including any corporations, partnerships, or trusts, and transactions by these entities should be treated for the purposes of the Policy and applicable securities laws as if they were for the individual&#8217;s own account. The Policy (or a summary thereof) is to be delivered to all new employees and consultants on the commencement of their relationships with Illumina, and is to be circulated to all employees at least annually.</font></div><div style="padding-left:36pt;text-indent:35.99pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">II.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:27.69pt;text-decoration:underline">Designation of Certain Persons</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:35.99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Illumina has determined that (1) the members of Illumina&#8217;s Board of Directors and those officers who are subject to the reporting and penalty provisions of Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), and the rules and regulations promulgated thereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Section 16 Individuals</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), (2) those employees having a title of &#8220;Senior Vice President&#8221; or above who are not Section 16 Individuals (collectively, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Senior Executives,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221; and (3) those persons listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, are required to obtain the preclearances described in this Policy, in that Illumina believes such persons have, or are likely to have, frequent access to Material Non- public Information. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit B </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">may be amended by Illumina from time to time. Under special circumstances, certain persons not listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit B </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">may come to have access to Material Non- Public Information for a period of time and will be listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit B </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">during such period. In addition, during such period, such persons are also required to obtain the preclearance described in Section 4 under &#8220;Specific Policies&#8221; below.</font></div><div style="padding-left:36pt;text-indent:35.99pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">III.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:24.92pt;text-decoration:underline">Appointment of Compliance Person.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Illumina has appointed its General Counsel as the Insider Trading Compliance Officer.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">IV.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:23.8pt;text-decoration:underline">Duties of the Insider Trading Compliance Officer</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The duties of the Insider Trading Compliance Officer shall include, but not be limited to, the following&#58;</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Preclearance of all Qualified Trading Plans (as defined in the Policy) for Section 16 Individuals and Senior Executives.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Preclearance of all open market purchases or sales involving Illumina&#8217;s securities by those persons listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">Granting exemptions from the requirement that Section 16 Individuals and Senior Executives execute purchases or sales of Illumina&#8217;s securities pursuant to Qualified Trading Plans.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">Assistance in the preparation of Section 16 reports (Forms 3, 4 and 5) for all Section 16 Individuals.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">E.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Distribution of periodic reminders to all Section 16 Individuals regarding their obligations to report.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revised in July 2024</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">F.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:27.13pt">Performance of cross-checks of available materials, which may include Forms 3, 4, and 5, Form 144, officers and directors questionnaires, and reports received from Illumina&#8217;s stock administrator and transfer agent, to determine trading activity by officers, directors and others who have, or may have, access to Material Non-Public Information.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">G.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:25.46pt">Distribution of the Policy (and&#47;or a summary thereof) to all employees, including Section 16 Individuals, on at least an annual basis, and provision of the Policy and other appropriate materials to new officers, directors and others who have, or may have, access to Material Non-Public Information.</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">H.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">Assisting Illumina&#8217;s Board of Directors in implementation of this Program and the Policy.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">I.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:30.46pt">Determining the persons who should be listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">J.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.23pt">Determining whether a Temporary Blackout Period (as defined in the Policy) should be implemented or terminated and the persons who should be subject to any Temporary Blackout Period.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revised in July 2024</font></div></div></div><div id="ie7d0af1e04024830916c5a081b69a565_47"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit A</font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ILLUMINA, INC.</font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Insider Trading Policy and </font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Guidelines with Respect to Certain Transactions in Company Securities</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">_________________</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Policy provides guidelines to employees, officers, and directors of Illumina, Inc. and its subsidiaries (&#8220;Illumina&#8221; or the &#8220;Company&#8221;) with respect to transactions in Illumina&#8217;s securities.</font></div><div style="text-indent:5.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Applicability of Policy</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Policy applies to all transactions in Illumina&#8217;s securities, including common stock, options for common stock and any other securities Illumina may issue from time to time, such as preferred stock, warrants, convertible debentures, and contingent value rights, as well as to derivative securities relating to Illumina&#8217;s stock, whether or not issued by Illumina, such as put and call options and collars. This Policy applies to all officers of Illumina, all members of Illumina&#8217;s Board of Directors, and all employees of, and consultants and contractors to, Illumina, and any person who receives Material Non- Public Information from any such individual (collectively, &#8220;Insiders&#8221;). This Policy also applies to any entities controlled by individuals subject to the Policy, including any corporations, partnerships, or trusts, and transactions by these entities should be treated for the purposes of this Policy and applicable securities laws as if they were for the individual&#8217;s own account. In addition, this Policy applies to all transactions by Insiders in Illumina&#8217;s securities regardless of how or where the securities are held (e.g., a Company provided brokerage account or private brokerage account). Where specifically stated, this Policy also applies to transactions by Illumina in its securities.</font></div><div style="text-indent:5.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Statement of Policy</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Federal and state securities laws (especially Rule 10b-5 under the Exchange Act prohibit the purchase or sale of a company&#8217;s securities by persons who are aware of Material Non-Public Information (as defined herein). These laws also prohibit persons who are aware of such Material Non-Public Information from disclosing this information to others who may trade. Companies and their controlling persons are also subject to liability if they fail to take reasonable steps to prevent insider trading by company personnel.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Securities and Exchange Commission (the &#8220;SEC&#8221;) has created an exception from these restrictions on purchases or sales of a company&#8217;s securities pursuant to Qualified Trading Plans (as defined below) that meet certain requirements. These Qualified Trading Plans are also known as Rule 10b5-1 plans.</font></div><div style="text-indent:5.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">General Policy</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">It is the policy of Illumina to prohibit the unauthorized disclosure of any non-public information acquired in the work-place and the use of Material Non-Public Information in securities trading.</font></div><div style="text-indent:5.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Specific Policies</font></div><div><font><br></font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">No Trading or Causing Trading While in Possession of Material Non-Public Information.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No Insider may&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">purchase or sell, or offer to purchase or sell, any Company security, whether or not issued by Illumina, while in possession of Material Non-Public Information&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">communicate Material Non-Public Information to (&#34;tip&#34;) any other person, including family members and friends, or otherwise disclose such information without Illumina&#8217;s authorization&#59;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revised in July 2024</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">purchase or sell any security of any other company (including all significant collaborators, customers, partners, suppliers, or competitors of Illumina) while in possession of Material Non-Public Information that may materially affect the value of such other company&#8217;s securities if such Material Non-Public Information was obtained in the course of his or her involvement with Illumina&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">communicate any Material Non-Public Information about any other company that was obtained in the course of his or her involvement with Illumina to any other person, including family members and friends, or otherwise disclose such information without Illumina&#8217;s authorization.</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">Trading by Section 16 Individuals and Senior Executives Limited to Qualified Trading Plans.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 16 Individuals and Senior Executives may only engage in transactions involving the purchase or sale of Illumina&#8217;s securities, including any offer to purchase or offer to sell, pursuant to a Qualified Trading Plan. The requirement to engage in such transactions only pursuant to a Qualified Trading Plan applies to transactions executed by the Section 16 Individuals and Senior</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Executives, but does not apply to transactions executed by others (including members of the immediate family or household of Section 16 Individuals or Senior Executives). Illumina recognizes that there may be situations where imposition of this requirement would create practical difficulties, such as where a Section 16 Individual or Senior Executive possesses investment power over Company securities owned by others, including minor children, for whom a Qualified Trading Plan might not be available or suitable. In such circumstances, the Insider Trading Compliance Officer is authorized to grant exemptions from this requirement to facilitate transactions that are otherwise implemented in accordance with this Policy.</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">Trading Window.</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">It is Illumina&#8217;s belief that all Insiders have the ability from time to time to come into possession of Material Non-Public Information. To ensure compliance with this Policy and applicable federal and state securities laws, Illumina and all Insiders are prohibited from conducting transactions involving the purchase or sale of Illumina's securities during the &#8220;Blackout Periods&#8221; set forth below, except pursuant to a Qualified Trading Plan.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:9.3pt">Quarterly Blackout Periods</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Trading in Illumina's securities is prohibited during the period beginning at the close of the market on the 23rd calendar day prior to the last day of the fiscal quarter and ending at 4&#58;00 p.m. (Eastern time) on the first Trading Day following the date of public disclosure of the financial results for the prior fiscal quarter or year. During these periods, Illumina and all Insiders generally possess or are presumed to possess Material Non-Public Information about Illumina's financial results. As used herein, the term &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Trading Day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; shall mean a day on which national stock exchanges are open for trading.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:10pt">Temporary Blackout Periods</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. From time to time, other types of Material Non- Public Information regarding Illumina (such as negotiation of mergers, acquisitions, or dispositions&#59; new product developments&#59; or investigations or audits) may be pending and not be publicly disclosed. While such Material Non-Public Information is pending, Illumina may impose special, temporary blackout periods (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Temporary Blackout Periods</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) during which all or certain Insiders are prohibited from trading in Illumina's securities. If Illumina imposes a special blackout period, it will notify the affected individuals. Following the termination of any Temporary Blackout Period, Illumina will notify the affected individuals.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, transactions involving the purchase or sale of Illumina&#8217;s securities by members of the immediate family or household of any Insider may result in that person&#8217;s transactions being attributable to such Insider. Accordingly, transactions by members of the immediate family or household of any Insider should be treated for the purposes of this Policy as if they were for the account of such Insider. Illumina strongly encourages that all members of the immediate family or household of any Insider refrain from effecting transactions in Company securities (that are outside of a Qualified Trading Plan) during a Blackout Period.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revised in July 2024</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Open orders, such as limit orders or stop orders, that are not under a Qualified Trading Plan must be cancelled before a quarterly Blackout Period begins or immediately after becoming subject to any Temporary Blackout Period.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Illumina&#8217;s Chief Executive Officer is authorized to approve, with the advice of Illumina&#8217;s General Counsel, a proposed sale by an Insider of Illumina&#8217;s securities in the public market outside a Qualified Trading Plan and during a Blackout Period, but only in the case of extreme hardship and only where circumstances indicate that such proposed sale would not violate applicable law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any period that is not during a Blackout Period for any applicable Insider is referred to as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Trading Window</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,&#8221; with respect to such Insider.</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">Preclearance of Trades or Qualified Trading Plans by Section 16 Individuals, Senior Executives, and Those Persons Listed on Exhibit B.</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.78pt;text-decoration:underline">Section 16 Individuals and Senior Executives</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Any Section 16 Individual or Senior Executive who intends to establish or modify a Qualified Trading Plan must first comply with Illumina&#8217;s preclearance process and should contact Illumina&#8217;s Insider Trading Compliance Officer prior to establishing any Qualified Trading Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.78pt;text-decoration:underline">Persons listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Illumina has determined that any person listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit B </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">who intends to trade in Illumina&#8217;s securities, even during a Trading Window, must first comply with Illumina&#8217;s preclearance process and should contact Illumina&#8217;s Insider Trading Compliance Officer prior to commencing any trade in Illumina&#8217;s securities.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Other Individuals</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Illumina may also find it necessary, from time to time, to require compliance with the preclearance process from certain other Insiders.</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">Individual Responsibility.</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Every Insider has the individual responsibility to comply with this Policy against insider trading. An Insider may, from time to time, have to forego a proposed transaction in Illumina&#8217;s securities even if he or she planned to make the transaction before learning of the Material Non- Public Information and even though the Insider believes he or she may suffer an economic loss or forego anticipated profit by waiting.</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">Confidentiality of Non-Public Information.</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-public information relating to Illumina is the property of Illumina and the unauthorized disclosure or unauthorized use of such information is forbidden. In particular, any exchange or discussion of information concerning Illumina in social media, &#8220;chat rooms,&#8221; on &#8220;message boards,&#8221; through e-mail or any similar electronic format is forbidden.</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">Short Sales, Hedging, and Trading in Common Stock Derivative Securities.</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Insiders shall not purchase financial instruments (including prepaid variable forward contracts, equity swaps, collars, and exchange funds), or otherwise engage in transactions, that hedge or offset, or are designed to hedge or offset, any decrease in the market value of Illumina&#8217;s equity securities&#59; engage in short sales or pledging of Illumina&#8217;s securities&#59; or enter into any transactions with put or call options or any other derivative security on Illumina&#8217;s common stock.</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Potential Criminal and Civil Liability and&#47;or Disciplinary Action</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">Liability for Insider Trading.</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Penalties for violation of these policies and procedures may involve any appropriate remedy, including termination of employment. In addition, the SEC and criminal prosecutors vigorously enforce insider trading laws. SEC penalties include fines of up to three times the gains or losses avoided and can be imposed upon the trader and the tipper. The SEC has been granted broad authority to seek &#8220;any equitable relief that may be appropriate or necessary for the benefit of investors&#8221; for violations of any provisions of the securities laws. The SEC also may bar a violator from future service as a director or officer of a public company. Federal criminal authorities may seek penalties that include fines of up to $5,000,000 and 20 years in prison. In addition, current law authorizes enforcement authorities to award substantial dollar &#8220;bounties&#8221; to persons who provide information leading to the imposition of an insider </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revised in July 2024</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">trading penalty. Finally, private lawsuits also may be brought against illegal traders by persons who traded without access to the material, non-public information and incurred losses.</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">Liability for Tipping.</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Insiders may also be liable for improper transactions by any person (commonly referred to as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">tippee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) to whom they have disclosed Material Non-Public Information regarding Illumina or to whom they have made recommendations or expressed opinions on the basis of such information as to trading in Illumina&#8217;s securities. The SEC has imposed large penalties even when the disclosing person did not profit from the trading. The SEC, the stock exchanges, and the Financial Industry Regulatory Authority, Inc. use sophisticated electronic surveillance techniques to uncover insider trading.</font></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.17pt">Possible Disciplinary Actions.</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Employees of Illumina who violate this Policy shall also be subject to disciplinary action by Illumina, which may include ineligibility for future participation in Illumina&#8217;s equity incentive plans or termination of employment. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Applicability of Policy to Material Non-Public Information Regarding Other Companies</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Policy and the guidelines described herein also apply to Material Non-Public Information relating to other companies, including Illumina&#8217;s customers, vendors or suppliers (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">business partners</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), when that information is obtained in the course of employment with, or other services performed on behalf of, Illumina. Civil and criminal penalties, and termination of employment, may result from trading on Material Non-Public Information regarding Illumina&#8217;s business partners. All employees should treat Material Non-Public Information about Illumina&#8217;s business partners with the same care required with respect to information related directly to Illumina. The fact that information has been disclosed to a few members of the public does not make it public for insider trading purposes. To be &#8220;public&#8221; the information must have been disseminated in a manner designed to reach investors generally, and the investors must be given the opportunity to absorb the information.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Definition of Material Non-Public Information</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Material Non-Public Information is information, whether negative or positive, that is reasonably likely to be considered important to an investor in making an investment decision to purchase, sell, or hold Illumina&#8217;s securities, that has not been previously disclosed to the general public and that is otherwise not available to the general public. While it may be difficult under this standard to determine whether particular information is material, there are various categories of information that are particularly sensitive and, as a general rule, should always be considered material. Examples of such information may include&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Financial results</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Projections of future earnings or losses</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Significant changes in Illumina&#8217;s prospects</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">News of a pending or proposed merger</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">News of the disposition of a subsidiary</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Impending bankruptcy or financial liquidity problems</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Gain or loss of a substantial customer or supplier</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Changes in dividend policy</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">New product announcements of a significant nature</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Significant product defects or modifications</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Significant pricing changes</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Stock splits</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revised in July 2024</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">New equity or debt offerings</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Acquisitions</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Significant litigation exposure due to actual or threatened litigation</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Significant cybersecurity incidents</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Changes in senior management.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Certain Exceptions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For purposes of this Policy, Illumina considers the exercise of stock options for cash under Illumina&#8217;s stock option plans or the purchase of shares under Illumina&#8217;s employee stock purchase plan (but </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the sale of any such shares) to be exempt from this Policy, since the other party to the transaction is Illumina itself and, with respect to stock options, the price does not vary with the market but is fixed by the terms of the option agreement or the stock option plan. Similarly, the following transactions undertaken to satisfy tax obligations are likewise exempt from this Policy&#58; the vesting of restricted stock units and the net issuance of shares (which effectively involves disposing vested shares to Illumina) and automatic open market sale (where employees cannot designate sale price or exact number of shares to sell).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, for purposes of this Policy, Illumina considers that bona fide gifts of Illumina&#8217;s securities are exempt from this Policy&#59; provided that (a) if the Insider is currently subject to a Blackout Period, the donee must expressly agree not to sell or transfer the shares received until the applicable Blackout Period is lifted and communicated to the donee by the Insider, and (b) if the Insider is a Section 16 Individual, all such bona fide gifts must be reported to the Insider Trading</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Compliance Officer within 24 hours of making the gift in order to facilitate compliance with applicable reporting requirements.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Qualified Trading Plans</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Purchases or sales of Illumina&#8217;s securities made pursuant to a Qualified Trading Plan are exempt from the restrictions on trading while in possession of Material Non-Public Information and are exempt from the limitations imposed during Blackout Periods. For purposes of this exception, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Qualified Trading Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; is a written plan for (a) with respect to individuals, purchasing or selling Company securities, and (b) with respect to Illumina, purchasing Company securities, which meets each of the following requirements&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.28pt">the terms of the plan are approved in advance by Illumina&#8217;s Insider Trading Compliance Officer&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.28pt">the plan is not adopted during a Blackout Period&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.28pt">the plan is adopted when Illumina or individual, as applicable, is not in possession of Material Non-Public Information&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(4)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.28pt">for Section 16 Individuals, trading under the plan does not commence until the later of (a) 90 days after the plan is adopted or modified and (b) two business days following the disclosure of Illumina&#8217;s financial results in a Form 10-Q or Form 10-K for the fiscal quarter in which the plan was adopted or modified&#59; for any person other than Section 16 Individuals (not including the Company) trading under the plan does not commence until 30 days after the plan has been adopted or modified&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(5)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.28pt">the plan is adhered to strictly&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(6)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.28pt">the plan either (a) specifies the amount of securities to be purchased or sold and the date on which the securities are to be purchased or sold, (b) includes a written formula or algorithm, or computer program, for determining the amount of securities to be purchased or sold and the price at which and the date on which the securities are to be purchased or sold, or (c) does not permit any insider to exercise any subsequent influence over how, when, or whether to effect sales&#59; provided, in addition, that any other person who, </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revised in July 2024</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">pursuant to the contract, instruction, or plan, did exercise such influence must not have been aware of the Material Non-Public Information when doing so&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(7)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.28pt">the plan must be effective for a period of at least one year&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(8)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.28pt">the plan is entered into in good faith and not as part of a plan or scheme to evade prohibitions of Section &#167; 240.10b5-1(c)(1)(C) of the Code of Federal Regulations (&#8220;Rule 10b5-1&#8221;) and contains a representation to that effect&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(9)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.28pt">the plan conforms to the rules restricting overlapping and single-trade plans included in Rule 10b5-1&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(10)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:4.72pt">at the time the plan is adopted, there are no other plans in effect that allow for trades during the same period covered by the new plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All individual plans must be set up using the standard legal template Illumina has previously negotiated with a designated broker.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following the adoption, termination, or modification of any Qualified Trading Plan, Illumina will&#58; (1) disclose in its next Form 10-Q (or Form 10-K for the fourth fiscal quarter) whether, during the most recently completed fiscal quarter any Section 16 Individual has adopted, modified, or terminated a Qualified Trading Plan, and (2) provide a description of the material terms of the Qualified Trading Plan, other than pricing terms.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Additional Information - Section 16 Individuals</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All Section 16 Individuals must also comply with the reporting obligations and limitations on short-swing transactions set forth in Section 16 of the Exchange Act. The practical effect of these provisions is that any Section 16 Individual who purchases and sells Illumina&#8217;s securities in a non- exempt transaction within a six-month period must disgorge all profits to Illumina whether or not he&#47;she had knowledge of any Material Non-Public Information. Under these provisions, and so long as certain other criteria are met, neither the receipt of an option under Illumina&#8217;s option plans, nor the exercise of that option, nor the receipt of stock upon vesting of a restricted stock unit or under Illumina&#8217;s employee stock purchase plan is subject to the disgorgement provisions&#59; however, the sale of any such shares is generally subject to the disgorgement provisions under Section 16.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Inquiries</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Please direct your questions as to any of the matters discussed in this Policy to Illumina&#8217;s Insider Trading Compliance Officer.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revised in July 2024</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>fy2410-kex211subsidiariesq4.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ia499a513aae142bea8b62a62dfb0ca25_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%">SUBSIDIARIES OF THE COMPANY</font></div><div style="margin-bottom:13pt;margin-top:13pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a list of subsidiaries of Illumina, Inc. as of December&#160;29, 2024, omitting subsidiaries which, considered in the aggregate, would not constitute a significant subsidiary</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-indent:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Subsidiary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-indent:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Doing Business As</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Liquid Logic Inc.</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Liquid Logic Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BlueBee Holding BV</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BlueBee Holding BV</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conexio Genomics Pty Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conexio Genomics Pty Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emedgene Technologies Ltd </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emedgene</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fluent Biosciences Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fluent Biosciences Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDbyDNA Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IDbyDNA Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina AB</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina AB</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Australia Pty. Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Australia Pty. Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Austria GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Austria GmbH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Belgium BV</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Belgium BVBA</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Brasil Produtos de Biotecnologia Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Cambridge, Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Cambridge, Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Canada ULC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Canada ULC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina (China) Scientific Co Ltd</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina China (Scientific) Co Ltd</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina (China) Scientific Co., Ltd. &#8211; Beijing Branch</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina (China) Scientific Co., Ltd. &#8211; Beijing Branch</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina (China) Scientific Co., Ltd. &#8211; Guangzhou Branch</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina (China) Scientific Co., Ltd. &#8211; Guangzhou Branch</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Colombia S.A.S.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Colombia S.A.S.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Commercial South Africa (Pty)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Africa</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Commercial South Africa (Pty)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Denmark ApS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Denmark ApS</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Diagnostics (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Diagnostics (Shanghai) Co., Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Finland Oy</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Finland Oy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina France Holding Sarl</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina France Holding Sarl</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina France Sarl</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina France Sarl</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina GmbH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Hong Kong Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Hong Kong Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina India Biotechnology Private Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina India Biotechnology Private Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Ireland Commercial Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Ireland Commercial Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Italy S.r.l.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Italy S.r.l.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Korea Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Republic of Korea</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Korea Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina K.K.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina K.K.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina M&#233;xico Productos de Biotecnolog&#237;a, S. de R.L. de C.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina M&#233;xico Productos de Biotecnolog&#237;a, S. de R.L. de C.V.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Middle East FZE</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Arab Emirates</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Middle East FZE</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Netherlands B.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Netherlands B.V.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina New Zealand Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina New Zealand Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Norway AS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norway</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Norway AS</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Productos de Espana, S.L.U.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Productos de Espana, S.L.U.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Shanghai (Trading) Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Shanghai (Trading) Co., Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Singapore Pte. Ltd</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Software, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Software, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Switzerland GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Switzerland GmbH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina US Manufacturing Operations, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina US Manufacturing Operations, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Taiwan Biotechnology Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Taiwan Biotechnology Co., Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Turkey Biyoteknoloji Limited Sirketii</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illumina Turkey Biyoteknoloji Limited Sirketii</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verinata Health, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verinata Health, Inc.</font></td></tr></table></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*All listed subsidiaries are wholly-owned, direct or indirect, subsidiaries of Illumina, Inc.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ex231consentfy2410-kq4.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="if4bdda771e08473f9286102b941393e2_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font><br></font></div><div style="padding-left:31.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Registration Statement (Form S-3 No. 333-281921) of Illumina, Inc., </font></div><div style="padding-left:31.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Registration Statement (Form S-8 No. 333-270187) of Illumina, Inc., and</font></div><div style="padding-left:31.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Registration Statement (Form S-8 No. 333-206215) of Illumina, Inc.&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">of our reports dated February&#160;12, 2025, with respect to the consolidated financial statements of Illumina, Inc. and the effectiveness of internal control over financial reporting of Illumina, Inc. included in this Annual Report (Form 10-K) of Illumina, Inc. for the year ended December&#160;29, 2024.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">San Diego, California </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%">February&#160;12, 2025</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>fy24q4ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i63aeb47ffeda4d939c7360663f239dde_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF JACOB THAYSEN PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jacob Thaysen, certify that&#58;</font></div><div style="margin-top:6pt"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.157%"><tr><td style="width:1.0%"></td><td style="width:4.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form 10-K of Illumina, Inc.&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;12, 2025 </font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.949%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JACOB THAYSEN</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacob Thaysen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>fy24q4ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i0d50c2075c564e6ebca5b590737c5680_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF ANKUR DHINGRA PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ankur Dhingra, certify that&#58;</font></div><div style="margin-top:6pt"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.573%"><tr><td style="width:1.0%"></td><td style="width:4.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form 10-K of Illumina, Inc.&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;12, 2025 </font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ANKUR DHINGRA </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ankur Dhingra </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>fy24q4ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i1fea2325fa834c91b47630d5e9077bae_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF JACOB THAYSEN PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of Illumina, Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;29, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Jacob Thaysen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;12, 2025 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JACOB THAYSEN</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacob Thaysen</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanying the Report is not deemed filed with the Securities and Exchange Commission for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such Section, and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before, on or after the date of the Report), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>fy24q4ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i95e377b1f4a54899be82d62e32a0e349_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF ANKUR DHINGRA PURSUANT TO 18 U.S.C.SECTION 1350, AS ADOPTED </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of Illumina, Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;29, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Ankur Dhingra, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;12, 2025 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ANKUR DHINGRA</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ankur Dhingra</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanying the Report is not deemed filed with the Securities and Exchange Commission for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such Section, and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before, on or after the date of the Report), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>ilmn-20241229.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3be010a1-b4e2-4eb6-8721-f9b45bdbb770,g:4f5b8127-d86a-4b2f-b09c-147b6f0d2a9f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ilmn="http://www.illumina.com/20241229" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.illumina.com/20241229">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20241229_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20241229_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20241229_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20241229_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.illumina.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.illumina.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>9952157 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GRAILSPINOFF" roleURI="http://www.illumina.com/role/GRAILSPINOFF">
        <link:definition>9952158 - Disclosure - GRAIL SPIN-OFF</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.illumina.com/role/REVENUE">
        <link:definition>9952159 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>9952160 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLINTANGIBLEASSETSANDACQUISITIONS" roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONS">
        <link:definition>9952161 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDOTHERCOMMITMENTS" roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTS">
        <link:definition>9952162 - Disclosure - DEBT AND OTHER COMMITMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITY">
        <link:definition>9952163 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILS" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILS">
        <link:definition>9952164 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGS" roleURI="http://www.illumina.com/role/LEGALPROCEEDINGS">
        <link:definition>9952165 - Disclosure - LEGAL PROCEEDINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.illumina.com/role/INCOMETAXES">
        <link:definition>9952166 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANS" roleURI="http://www.illumina.com/role/EMPLOYEEBENEFITPLANS">
        <link:definition>9952167 - Disclosure - EMPLOYEE BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATION" roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATION">
        <link:definition>9952168 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>9955511 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>9955512 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GRAILSPINOFFTables" roleURI="http://www.illumina.com/role/GRAILSPINOFFTables">
        <link:definition>9955513 - Disclosure - GRAIL SPIN-OFF (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.illumina.com/role/REVENUETables">
        <link:definition>9955514 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>9955515 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables" roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables">
        <link:definition>9955516 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDOTHERCOMMITMENTSTables" roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSTables">
        <link:definition>9955517 - Disclosure - DEBT AND OTHER COMMITMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>9955518 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILSTables" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables">
        <link:definition>9955519 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.illumina.com/role/INCOMETAXESTables">
        <link:definition>9955520 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONTables" roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables">
        <link:definition>9955521 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails">
        <link:definition>9955522 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Business Overview (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails">
        <link:definition>9955523 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Concentrations of Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails">
        <link:definition>9955524 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Recently Adopted Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails">
        <link:definition>9955525 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails">
        <link:definition>9955526 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails">
        <link:definition>9955527 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Lives of Major Classes of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails">
        <link:definition>9955528 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails">
        <link:definition>9955529 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails">
        <link:definition>9955530 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Warranties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeShareBasedCompensationDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeShareBasedCompensationDetails">
        <link:definition>9955531 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeAdvertisingCostsDetails" roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeAdvertisingCostsDetails">
        <link:definition>9955532 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Advertising Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GRAILSPINOFFNarrativeDetails" roleURI="http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails">
        <link:definition>9955533 - Disclosure - GRAIL SPIN-OFF - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails" roleURI="http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails">
        <link:definition>9955534 - Disclosure - GRAIL SPIN-OFF - Assets and Liabilities Included as Part of the Disposal Group (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEScheduleofDisaggregationofRevenueDetails" roleURI="http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails">
        <link:definition>9955535 - Disclosure - REVENUE - Schedule of Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENarrativeRemainingPerformanceObligationDetails" roleURI="http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails">
        <link:definition>9955536 - Disclosure - REVENUE - Narrative - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENarrativeRemainingPerformanceObligationDetails_1" roleURI="http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails_1">
        <link:definition>9955536 - Disclosure - REVENUE - Narrative - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENarrativeContractAssetsandLiabilitiesDetails" roleURI="http://www.illumina.com/role/REVENUENarrativeContractAssetsandLiabilitiesDetails">
        <link:definition>9955537 - Disclosure - REVENUE - Narrative - Contract Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>9955538 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails" roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails">
        <link:definition>9955539 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Marketable Equity Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails" roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails">
        <link:definition>9955540 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Other Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails" roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails">
        <link:definition>9955541 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Hierarchy&#160;for Assets and Liabilities Measured at Fair Value Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails" roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails">
        <link:definition>9955542 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Changes in Estimated Fair Value of Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails" roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails">
        <link:definition>9955543 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS- Contingent Consideration Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails" roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails">
        <link:definition>9955544 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Changes in Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails" roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails">
        <link:definition>9955545 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails" roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails">
        <link:definition>9955546 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails" roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails">
        <link:definition>9955547 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Estimated Annual Amortization of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails" roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails">
        <link:definition>9955548 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Debt Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDOTHERCOMMITMENTSNarrativeDetails" roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails">
        <link:definition>9955549 - Disclosure - DEBT AND OTHER COMMITMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>9955550 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>9955550 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails" roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails">
        <link:definition>9955551 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>9955552 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails">
        <link:definition>9955553 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails">
        <link:definition>9955554 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Restricted Stock Activity and Related Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails">
        <link:definition>9955555 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Pre-tax Intrinsic Values and Total Fair Value of Vested Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails">
        <link:definition>9955556 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stock Option Activity Under all Stock Option Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails">
        <link:definition>9955557 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Liability-Classified Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails">
        <link:definition>9955558 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Cash-Based Equity Incentive Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails">
        <link:definition>9955559 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Employee Stock Purchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails">
        <link:definition>9955560 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Assumptions used to Estimate the Weighted-Average Fair Value Per Share for Stock Purchase under the Employee Stock Purchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails">
        <link:definition>9955561 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivityDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivityDetails">
        <link:definition>9955562 - Disclosure - STOCKHOLDERS&#8217; EQUITY - Schedule of Share Repurchase Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails">
        <link:definition>9955563 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share-Based Compensation Expense for all Stock Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeShareBasedCompensationDetails" roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareBasedCompensationDetails">
        <link:definition>9955564 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails">
        <link:definition>9955565 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails">
        <link:definition>9955566 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails">
        <link:definition>9955567 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails">
        <link:definition>9955568 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails">
        <link:definition>9955569 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Changes in Reserve for Product Warranties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails">
        <link:definition>9955570 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Restructuring Charge (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails">
        <link:definition>9955571 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Narrative - Restructuring (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails" roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails">
        <link:definition>9955572 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Charges and Total Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGSDetails" roleURI="http://www.illumina.com/role/LEGALPROCEEDINGSDetails">
        <link:definition>9955573 - Disclosure - LEGAL PROCEEDINGS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails" roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails">
        <link:definition>9955574 - Disclosure - INCOME TAXES - Schedule of (Loss) Income before Income Taxes by Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>9955575 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails" roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails">
        <link:definition>9955576 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Provision for (Loss) Income Taxes to Amount Computed by Applying the Federal Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955577 - Disclosure - INCOME TAXES - Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.illumina.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>9955578 - Disclosure - INCOME TAXES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails" roleURI="http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails">
        <link:definition>9955579 - Disclosure - INCOME TAXES - Schedule of the Gross Amount of Uncertain Tax Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSDetails" roleURI="http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails">
        <link:definition>9955580 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails">
        <link:definition>9955581 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails" roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails">
        <link:definition>9955582 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Operating Performance and Assets by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails">
        <link:definition>9955583 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails" roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails">
        <link:definition>9955584 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Net Long-lived Assets Consisting of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ilmn_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares" abstract="false" name="StockIssuedDuringPeriodNetOfRepurchasesShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue" abstract="false" name="StockIssuedDuringPeriodNetOfRepurchasesValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_ReclassificationLiabilityAwards" abstract="false" name="ReclassificationLiabilityAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" abstract="false" name="AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_GainLossOnStrategicInvestmentsNoncash" abstract="false" name="GainLossOnStrategicInvestmentsNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_ContingentValueRightUnrealizedGainLossNoncash" abstract="false" name="ContingentValueRightUnrealizedGainLossNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment" abstract="false" name="PropertyAndEquipmentAndRightOfUseAssetImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_IncreaseDecreaseOfOperatingLeasesNet" abstract="false" name="IncreaseDecreaseOfOperatingLeasesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_PurchasesSalesForStrategicInvestments" abstract="false" name="PurchasesSalesForStrategicInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_CashDeconsolidatedFinancingActivities" abstract="false" name="CashDeconsolidatedFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" abstract="false" name="NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock" abstract="false" name="BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="ilmn_RestructuringPolicyTextBlock" abstract="false" name="RestructuringPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" abstract="false" name="ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="ilmn_GRAILInc.Member" abstract="true" name="GRAILInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction" abstract="false" name="DiscontinuedOperationNumberOfSharesIssuedInTransaction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ilmn_DiscontinuedOperationPercentOfInterestDisposedOf" abstract="false" name="DiscontinuedOperationPercentOfInterestDisposedOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ilmn_IndustryCreditConcentrationRiskMember" abstract="true" name="IndustryCreditConcentrationRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_InvestmentPortfolioMember" abstract="true" name="InvestmentPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_IssueSizeMember" abstract="true" name="IssueSizeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_ConcentrationRiskThreshold" abstract="false" name="ConcentrationRiskThreshold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ilmn_RevenueFromContractWithCustomerPaymentTerm" abstract="false" name="RevenueFromContractWithCustomerPaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ilmn_BuildingandLeaseholdImprovementsMember" abstract="true" name="BuildingandLeaseholdImprovementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_StandardProductWarrantyDescriptionTerm" abstract="false" name="StandardProductWarrantyDescriptionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff" abstract="false" name="DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ilmn_DiscontinuedOperationTransactionCosts" abstract="false" name="DiscontinuedOperationTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_GRAILIncMember" abstract="true" name="GRAILIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNetAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_SequencingMember" abstract="true" name="SequencingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_MicroarrayMember" abstract="true" name="MicroarrayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_AsiaPacificMiddleEastAndAfricaMember" abstract="true" name="AsiaPacificMiddleEastAndAfricaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" abstract="false" name="RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ilmn_VentureCapitalInvestmentFundTheFundMember" abstract="true" name="VentureCapitalInvestmentFundTheFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_HelixHoldingsILLCMember" abstract="true" name="HelixHoldingsILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_HelixContingentConsiderationMember" abstract="true" name="HelixContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_ContingentPaymentRightsAxis" abstract="true" name="ContingentPaymentRightsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ilmn_ContingentPaymentRightsDomain" abstract="true" name="ContingentPaymentRightsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember" abstract="true" name="PaymentRightsOfOneBillionEachTwelveYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember" abstract="true" name="PaymentRightsOfAboveOneBillionEachTwelveYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_MeasurementInputRevenueRiskPremiumMember" abstract="true" name="MeasurementInputRevenueRiskPremiumMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_MeasurementInputCalculationTrailingPeriodMember" abstract="true" name="MeasurementInputCalculationTrailingPeriodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" abstract="false" name="DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ilmn_NumberOfInvestmentFunds" abstract="false" name="NumberOfInvestmentFunds" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ilmn_BusinessAcquisitionContingentValueRightsTerm" abstract="false" name="BusinessAcquisitionContingentValueRightsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage" abstract="false" name="BusinessAcquisitionContingentValueRightsProRataOnePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold" abstract="false" name="BusinessAcquisitionContingentValueRightsRevenueThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage" abstract="false" name="BusinessAcquisitionContingentValueRightsProRataTwoPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability" abstract="false" name="CoveredRevenuesOfGRAILContingentConsiderationLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease" abstract="false" name="SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease" abstract="false" name="SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease" abstract="false" name="SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease" abstract="false" name="SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_VentureCapitalInvestmentFundTheFundOneMember" abstract="true" name="VentureCapitalInvestmentFundTheFundOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_VentureCapitalInvestmentFundTheFundTwoMember" abstract="true" name="VentureCapitalInvestmentFundTheFundTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_VentureCapitalInvestmentFundTheFundThreeMember" abstract="true" name="VentureCapitalInvestmentFundTheFundThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_RemainingCapitalCommitment" abstract="false" name="RemainingCapitalCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_RecallableDistributionsCommitment" abstract="false" name="RecallableDistributionsCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_OtherInvestmentsFairValueDisclosure" abstract="false" name="OtherInvestmentsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_ContingentValueRightFairValueDisclosure" abstract="false" name="ContingentValueRightFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_BusinessCombinationContingentConsiderationLiabilityMember" abstract="true" name="BusinessCombinationContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_MeasurementInputCashFlowPeriodMemberMember" abstract="true" name="MeasurementInputCashFlowPeriodMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_FluentBioSciencesMember" abstract="true" name="FluentBioSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_GoodwillAmountThatExceedsCarryingValue" abstract="false" name="GoodwillAmountThatExceedsCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_GoodwillImpairmentMeasurementInput" abstract="false" name="GoodwillImpairmentMeasurementInput" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ilmn_IntangibleAssetsImpairmentMeasurementInput" abstract="false" name="IntangibleAssetsImpairmentMeasurementInput" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints" abstract="false" name="SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate" abstract="false" name="GoodwillImpairmentDiscountedCashFlowModelDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" abstract="false" name="GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ilmn_GoodwillPotentialImpairmentLoss" abstract="false" name="GoodwillPotentialImpairmentLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_GoodwillImpairmentTestDiscountRate" abstract="false" name="GoodwillImpairmentTestDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ilmn_LicensedTechnologyMember" abstract="true" name="LicensedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" abstract="false" name="IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" abstract="false" name="IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment" abstract="false" name="IntangibleAssetsExcludingGoodwillAccumulatedImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_TermNotesMember" abstract="true" name="TermNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_TermNotesDue2025Member" abstract="true" name="TermNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_TermNotesDue2026Member" abstract="true" name="TermNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_TermNotesDue2027Member" abstract="true" name="TermNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_TermNotesDue2031Member" abstract="true" name="TermNotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_TermNotesDue2023Member" abstract="true" name="TermNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_DelayedDrawCreditFacilityDue2025Member" abstract="true" name="DelayedDrawCreditFacilityDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_RevolvingCreditAgreementMember" abstract="true" name="RevolvingCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_TheCreditAgreementMember" abstract="true" name="TheCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_SwinglineBorrowingsMember" abstract="true" name="SwinglineBorrowingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_AdditionalPaidInCapitalBeforeTax" abstract="false" name="AdditionalPaidInCapitalBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_DebtInstrumentNumberOfOneYearExtensions" abstract="false" name="DebtInstrumentNumberOfOneYearExtensions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ilmn_DebtInstrumentExtensionTerm" abstract="false" name="DebtInstrumentExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" abstract="false" name="DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio" abstract="false" name="DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio" abstract="false" name="DebtInstrumentCovenantMinimumDebtToEBITDARatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" abstract="false" name="DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition" abstract="false" name="DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ilmn_A2015StockAndIncentiveCompensationPlanMember" abstract="true" name="A2015StockAndIncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ilmn_MarketBasedPerformanceStockUnitsMember" abstract="true" name="MarketBasedPerformanceStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards" abstract="false" name="ShareBasedCompensationNumberOfPerformanceStockUnitAwards" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember" abstract="true" name="ShareBasedPaymentArrangementPerformanceStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_LiabilityClassifiedRestrictedStockUnitsMember" abstract="true" name="LiabilityClassifiedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_LiabilityBasedAwardsMember" abstract="true" name="LiabilityBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_AccruedLiabilityClassifiedAwardsCurrent" abstract="false" name="AccruedLiabilityClassifiedAwardsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_A2000EmployeeStockPurchasePlanMember" abstract="true" name="A2000EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ilmn_CostOfGoodsSoldMember" abstract="true" name="CostOfGoodsSoldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_CostOfServicesMember" abstract="true" name="CostOfServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_AssetImpairmentChargesMember" abstract="true" name="AssetImpairmentChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_FosterCityCaliforniaMember" abstract="true" name="FosterCityCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_SanDiegoCaliforniaMember" abstract="true" name="SanDiegoCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" abstract="false" name="OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" abstract="false" name="RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ilmn_AcquisitionOfGrailInc.Member" abstract="true" name="AcquisitionOfGrailInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_CompleteGenomicsMember" abstract="true" name="CompleteGenomicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_LitigationSettlementFinePercentageRate" abstract="false" name="LitigationSettlementFinePercentageRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions" abstract="false" name="CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions" abstract="false" name="CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ilmn_LossContingencyLicenseGrantedIntangibleAssets" abstract="false" name="LossContingencyLicenseGrantedIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed" abstract="false" name="PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" abstract="false" name="EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_DeferredTaxAssetsOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ilmn_SeniorLevelEmployeeMember" abstract="true" name="SeniorLevelEmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent" abstract="false" name="DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" abstract="false" name="DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents" abstract="false" name="DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ilmn_CoreIlluminaMember" abstract="true" name="CoreIlluminaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ilmn_FrancesArnoldMember" abstract="true" name="FrancesArnoldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_JakobWedelMember" abstract="true" name="JakobWedelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_ScottDaviesMember" abstract="true" name="ScottDaviesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ilmn_PatriciaLeckmanMember" abstract="true" name="PatriciaLeckmanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>ilmn-20241229_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3be010a1-b4e2-4eb6-8721-f9b45bdbb770,g:4f5b8127-d86a-4b2f-b09c-147b6f0d2a9f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_dab9d6ce-63b3-49a6-a531-058c9f5c156f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_02efe828-5394-436b-afb6-7a63d8c913ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dab9d6ce-63b3-49a6-a531-058c9f5c156f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_02efe828-5394-436b-afb6-7a63d8c913ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_41ae4c7c-5e39-4f29-be5f-6758162aa5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dab9d6ce-63b3-49a6-a531-058c9f5c156f" xlink:to="loc_us-gaap_LongTermNotesPayable_41ae4c7c-5e39-4f29-be5f-6758162aa5c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_558a4baf-5b9b-4e3d-9b8b-74acfe3405d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dab9d6ce-63b3-49a6-a531-058c9f5c156f" xlink:to="loc_us-gaap_LiabilitiesCurrent_558a4baf-5b9b-4e3d-9b8b-74acfe3405d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9539750f-f0e3-4a65-9888-a48aa9cc3066" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dab9d6ce-63b3-49a6-a531-058c9f5c156f" xlink:to="loc_us-gaap_StockholdersEquity_9539750f-f0e3-4a65-9888-a48aa9cc3066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_75fec5a2-f03e-4119-b9d4-84bb4d534fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dab9d6ce-63b3-49a6-a531-058c9f5c156f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_75fec5a2-f03e-4119-b9d4-84bb4d534fb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_510c78d4-5900-43dc-9016-aa18a8189d54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_dab9d6ce-63b3-49a6-a531-058c9f5c156f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_510c78d4-5900-43dc-9016-aa18a8189d54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1e996d9e-87a9-4f88-add5-ebc59be1ca6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_eaed9434-9dfe-47d2-9be1-1572a579b41e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1e996d9e-87a9-4f88-add5-ebc59be1ca6f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_eaed9434-9dfe-47d2-9be1-1572a579b41e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_c7540624-32ec-4ffd-8912-24bd748e997c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1e996d9e-87a9-4f88-add5-ebc59be1ca6f" xlink:to="loc_us-gaap_NotesPayableCurrent_c7540624-32ec-4ffd-8912-24bd748e997c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_59a88681-ab32-4699-b87a-97582763b0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1e996d9e-87a9-4f88-add5-ebc59be1ca6f" xlink:to="loc_us-gaap_AccountsPayableCurrent_59a88681-ab32-4699-b87a-97582763b0d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e79e0f4d-fb02-44d3-988d-4a4e15c49b67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4161e321-87ca-4044-8b65-9896ffab919d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e79e0f4d-fb02-44d3-988d-4a4e15c49b67" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4161e321-87ca-4044-8b65-9896ffab919d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_a8501492-fb11-45eb-82eb-7f059637fe7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e79e0f4d-fb02-44d3-988d-4a4e15c49b67" xlink:to="loc_us-gaap_ShortTermInvestments_a8501492-fb11-45eb-82eb-7f059637fe7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ecc1bebb-1a56-45a6-a9ff-83524bba7d59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e79e0f4d-fb02-44d3-988d-4a4e15c49b67" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ecc1bebb-1a56-45a6-a9ff-83524bba7d59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1e5634b4-bf07-428b-a059-42f181cdcae1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e79e0f4d-fb02-44d3-988d-4a4e15c49b67" xlink:to="loc_us-gaap_InventoryNet_1e5634b4-bf07-428b-a059-42f181cdcae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ab14b05f-9bc8-4582-9543-69f3c0c7285d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e79e0f4d-fb02-44d3-988d-4a4e15c49b67" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ab14b05f-9bc8-4582-9543-69f3c0c7285d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8652fd9e-e1c5-4b2a-83f6-e1406b913255" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b4e7a913-f59b-4b77-8880-227df3d5b560" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8652fd9e-e1c5-4b2a-83f6-e1406b913255" xlink:to="loc_us-gaap_PreferredStockValue_b4e7a913-f59b-4b77-8880-227df3d5b560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bb386bcb-a1f1-444b-9e8e-13a4b014131b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8652fd9e-e1c5-4b2a-83f6-e1406b913255" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bb386bcb-a1f1-444b-9e8e-13a4b014131b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3ad70804-5119-48aa-a35d-a83580583e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8652fd9e-e1c5-4b2a-83f6-e1406b913255" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3ad70804-5119-48aa-a35d-a83580583e7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_66731258-bceb-4eb4-b9ad-ddbfc6186931" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8652fd9e-e1c5-4b2a-83f6-e1406b913255" xlink:to="loc_us-gaap_TreasuryStockCommonValue_66731258-bceb-4eb4-b9ad-ddbfc6186931" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_caac8356-5528-42f7-a5fd-deb44ff2665a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8652fd9e-e1c5-4b2a-83f6-e1406b913255" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_caac8356-5528-42f7-a5fd-deb44ff2665a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4fb8ddd4-623c-4c53-9be0-f8298282f5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8652fd9e-e1c5-4b2a-83f6-e1406b913255" xlink:to="loc_us-gaap_CommonStockValue_4fb8ddd4-623c-4c53-9be0-f8298282f5f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9207c3dc-3310-469a-8fe2-23b707b1889f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1ba4012f-3422-4349-a206-2bf7aa256b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9207c3dc-3310-469a-8fe2-23b707b1889f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1ba4012f-3422-4349-a206-2bf7aa256b8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a536be26-c22d-46f7-9509-62b8748957ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9207c3dc-3310-469a-8fe2-23b707b1889f" xlink:to="loc_us-gaap_AssetsCurrent_a536be26-c22d-46f7-9509-62b8748957ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_970ee4b4-dd98-4c63-bd75-be09f0997ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9207c3dc-3310-469a-8fe2-23b707b1889f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_970ee4b4-dd98-4c63-bd75-be09f0997ce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_56487b1b-da1d-49c7-96ae-39dfd3a48cad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9207c3dc-3310-469a-8fe2-23b707b1889f" xlink:to="loc_us-gaap_Goodwill_56487b1b-da1d-49c7-96ae-39dfd3a48cad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8255a618-48c9-4936-8ab9-745d35f1a096" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9207c3dc-3310-469a-8fe2-23b707b1889f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8255a618-48c9-4936-8ab9-745d35f1a096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c0c6c90c-4300-411d-9de9-37ef17095338" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9207c3dc-3310-469a-8fe2-23b707b1889f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c0c6c90c-4300-411d-9de9-37ef17095338" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a3d80e8c-596c-4147-8b06-2da73deea2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9207c3dc-3310-469a-8fe2-23b707b1889f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a3d80e8c-596c-4147-8b06-2da73deea2dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_adce33d5-d2f7-40d0-9f71-5f91f9a25a75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7ff8c589-5632-4ea0-a371-ee2f2a1b43ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_adce33d5-d2f7-40d0-9f71-5f91f9a25a75" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7ff8c589-5632-4ea0-a371-ee2f2a1b43ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_68df1c87-eb34-4bb3-951e-6d993a47681e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_adce33d5-d2f7-40d0-9f71-5f91f9a25a75" xlink:to="loc_us-gaap_CostOfRevenue_68df1c87-eb34-4bb3-951e-6d993a47681e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_afa164cf-6d2a-4206-a2d9-99057ce09496" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3bb695a4-c2eb-4220-a88e-ea0e0d2aa283" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_afa164cf-6d2a-4206-a2d9-99057ce09496" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3bb695a4-c2eb-4220-a88e-ea0e0d2aa283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e8384ebb-b2ea-446a-9e65-04102f856d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_afa164cf-6d2a-4206-a2d9-99057ce09496" xlink:to="loc_us-gaap_OperatingIncomeLoss_e8384ebb-b2ea-446a-9e65-04102f856d2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c7dbe672-66b4-4405-b1c1-927351ceb291" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d611e84f-69a1-4c94-b6f2-673fe1a2c262" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c7dbe672-66b4-4405-b1c1-927351ceb291" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d611e84f-69a1-4c94-b6f2-673fe1a2c262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_4988cc97-8f18-4edd-adf4-513a28283f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c7dbe672-66b4-4405-b1c1-927351ceb291" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_4988cc97-8f18-4edd-adf4-513a28283f6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f25c0946-6e5d-435d-abe6-463da7dd1040" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c7dbe672-66b4-4405-b1c1-927351ceb291" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f25c0946-6e5d-435d-abe6-463da7dd1040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_9495f313-fdbd-45f3-9549-7c2cae485a89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c7dbe672-66b4-4405-b1c1-927351ceb291" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_9495f313-fdbd-45f3-9549-7c2cae485a89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_acb118d5-3ba2-4074-bf2b-8a48c35a41d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb71a1f5-e678-4118-b8c5-eb51685a4aee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_acb118d5-3ba2-4074-bf2b-8a48c35a41d7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb71a1f5-e678-4118-b8c5-eb51685a4aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_313f0b64-14af-40e2-8ec2-c6ba49745b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_acb118d5-3ba2-4074-bf2b-8a48c35a41d7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_313f0b64-14af-40e2-8ec2-c6ba49745b2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_a33463ac-8d7d-4d57-b5b5-613e18b22587" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_754a2511-a8c9-4398-bc78-f62b7767f7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue_a33463ac-8d7d-4d57-b5b5-613e18b22587" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_754a2511-a8c9-4398-bc78-f62b7767f7b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_4749701c-8aa8-4b43-9234-1a21cc56c705" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue_a33463ac-8d7d-4d57-b5b5-613e18b22587" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_4749701c-8aa8-4b43-9234-1a21cc56c705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dab32a0f-2094-402e-a7fa-07a558252283" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1bf55c33-11db-4453-b618-00ac2e481e86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dab32a0f-2094-402e-a7fa-07a558252283" xlink:to="loc_us-gaap_OperatingExpenses_1bf55c33-11db-4453-b618-00ac2e481e86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c129f883-c638-4d55-9a29-0f54d15e1e45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_dab32a0f-2094-402e-a7fa-07a558252283" xlink:to="loc_us-gaap_GrossProfit_c129f883-c638-4d55-9a29-0f54d15e1e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6e79c2c9-ef5c-4f90-8997-bee7320d807e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_26052fe5-e253-4bbe-8066-24d127e22d49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_6e79c2c9-ef5c-4f90-8997-bee7320d807e" xlink:to="loc_us-gaap_InterestExpenseNonoperating_26052fe5-e253-4bbe-8066-24d127e22d49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0e31859c-6eb1-4937-935d-f811d87ecd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_6e79c2c9-ef5c-4f90-8997-bee7320d807e" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0e31859c-6eb1-4937-935d-f811d87ecd9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6c862409-cc9d-4c3d-ba01-ca5c2fc0f64b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_6e79c2c9-ef5c-4f90-8997-bee7320d807e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6c862409-cc9d-4c3d-ba01-ca5c2fc0f64b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_78e5d423-f101-4b56-b342-90b5630d93c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e84a31b2-04ab-49bc-93fc-30f4c04531a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_78e5d423-f101-4b56-b342-90b5630d93c3" xlink:to="loc_us-gaap_NetIncomeLoss_e84a31b2-04ab-49bc-93fc-30f4c04531a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_6e8244b4-690f-4e86-ab55-92a5c49d1eea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_78e5d423-f101-4b56-b342-90b5630d93c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_6e8244b4-690f-4e86-ab55-92a5c49d1eea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bc5bc11-83b4-4f11-bcfa-02d19b3b9bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f514df8c-dc90-42d5-a482-3728f94c3874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bc5bc11-83b4-4f11-bcfa-02d19b3b9bb0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f514df8c-dc90-42d5-a482-3728f94c3874" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CashDeconsolidatedFinancingActivities_ee3c0a6a-4fa3-41e2-91b0-c4d16a3d297f" xlink:href="ilmn-20241229.xsd#ilmn_CashDeconsolidatedFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bc5bc11-83b4-4f11-bcfa-02d19b3b9bb0" xlink:to="loc_ilmn_CashDeconsolidatedFinancingActivities_ee3c0a6a-4fa3-41e2-91b0-c4d16a3d297f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_f12966aa-452c-4564-9bed-580c3d1ef310" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bc5bc11-83b4-4f11-bcfa-02d19b3b9bb0" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_f12966aa-452c-4564-9bed-580c3d1ef310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7c93a74f-1642-46e5-8280-1145a11f9a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bc5bc11-83b4-4f11-bcfa-02d19b3b9bb0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7c93a74f-1642-46e5-8280-1145a11f9a7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_7af4a8c0-fe13-46d9-83bf-7850a30926c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bc5bc11-83b4-4f11-bcfa-02d19b3b9bb0" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_7af4a8c0-fe13-46d9-83bf-7850a30926c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a2f77c55-331e-4a1e-ab24-e07eec89cb73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bc5bc11-83b4-4f11-bcfa-02d19b3b9bb0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a2f77c55-331e-4a1e-ab24-e07eec89cb73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9710e5a1-01f8-4aca-ba24-fe466581278c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bc5bc11-83b4-4f11-bcfa-02d19b3b9bb0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9710e5a1-01f8-4aca-ba24-fe466581278c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_11c2f70c-755f-4e40-8e0d-f03828434c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bc5bc11-83b4-4f11-bcfa-02d19b3b9bb0" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_11c2f70c-755f-4e40-8e0d-f03828434c7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_16365764-ef9f-454e-b806-674fe3f011cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01adf3e8-16c2-4ae9-8fe0-9b095503c82e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_16365764-ef9f-454e-b806-674fe3f011cd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01adf3e8-16c2-4ae9-8fe0-9b095503c82e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0746fce5-e93e-4a16-8391-252baf4d532a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_16365764-ef9f-454e-b806-674fe3f011cd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0746fce5-e93e-4a16-8391-252baf4d532a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4dfeab7-bd8b-4db9-bf69-71baace84743" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_16365764-ef9f-454e-b806-674fe3f011cd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4dfeab7-bd8b-4db9-bf69-71baace84743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5233c99e-18c6-40ec-9e84-4798da9d3472" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_16365764-ef9f-454e-b806-674fe3f011cd" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5233c99e-18c6-40ec-9e84-4798da9d3472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_076cda7c-2122-4c18-ba66-50801392c537" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_076cda7c-2122-4c18-ba66-50801392c537" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_aeb77220-f272-4a17-9a75-de003b51b2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_aeb77220-f272-4a17-9a75-de003b51b2a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2ed524bf-d15e-440a-a30a-df502fe38e87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2ed524bf-d15e-440a-a30a-df502fe38e87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_acba6a84-9a95-4f11-ba37-82867db95432" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_acba6a84-9a95-4f11-ba37-82867db95432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_51245477-2955-42a7-bdc4-7abec8171508" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_51245477-2955-42a7-bdc4-7abec8171508" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2a78dab5-4f61-4f6f-9530-030715cf7e84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2a78dab5-4f61-4f6f-9530-030715cf7e84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a09ff4e7-1477-4d8c-b2dc-a1aac43f2833" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a09ff4e7-1477-4d8c-b2dc-a1aac43f2833" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_5b566c52-bf79-45c2-b9b2-656020d862ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_5b566c52-bf79-45c2-b9b2-656020d862ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IncreaseDecreaseOfOperatingLeasesNet_afde9366-da02-4dd5-9d21-13e6b4905055" xlink:href="ilmn-20241229.xsd#ilmn_IncreaseDecreaseOfOperatingLeasesNet"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_ilmn_IncreaseDecreaseOfOperatingLeasesNet_afde9366-da02-4dd5-9d21-13e6b4905055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentValueRightUnrealizedGainLossNoncash_b90c11de-f477-47d3-b036-efeb597b0622" xlink:href="ilmn-20241229.xsd#ilmn_ContingentValueRightUnrealizedGainLossNoncash"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_ilmn_ContingentValueRightUnrealizedGainLossNoncash_b90c11de-f477-47d3-b036-efeb597b0622" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e317236e-ba50-42cc-aea1-b84fb9d3732c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e317236e-ba50-42cc-aea1-b84fb9d3732c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment_07c146bf-9b55-4ec7-99c3-fd046566b550" xlink:href="ilmn-20241229.xsd#ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment_07c146bf-9b55-4ec7-99c3-fd046566b550" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GainLossOnStrategicInvestmentsNoncash_38231f85-119f-4cfc-9555-67b3c9bbf328" xlink:href="ilmn-20241229.xsd#ilmn_GainLossOnStrategicInvestmentsNoncash"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_ilmn_GainLossOnStrategicInvestmentsNoncash_38231f85-119f-4cfc-9555-67b3c9bbf328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a2793644-5806-4141-b316-ac0f6a9565e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_ShareBasedCompensation_a2793644-5806-4141-b316-ac0f6a9565e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c17a1fe8-8b51-417b-95e2-1762f43f9e81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_Depreciation_c17a1fe8-8b51-417b-95e2-1762f43f9e81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7d11116b-22ad-430c-8fcb-92e86af48303" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7d11116b-22ad-430c-8fcb-92e86af48303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0e68755e-d7ed-458f-80e5-a40a0a78bed4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_NetIncomeLoss_0e68755e-d7ed-458f-80e5-a40a0a78bed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1f7580fd-ba53-4cc3-91ee-9d71f9bec9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1f7580fd-ba53-4cc3-91ee-9d71f9bec9e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6502eb8a-2f12-49bc-aa52-890bb51e1756" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_802807ee-2160-435a-88c8-762bd68ac713" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6502eb8a-2f12-49bc-aa52-890bb51e1756" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce1943a1-a8be-4657-90e1-ccfd6862595f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PurchasesSalesForStrategicInvestments_ce15ccb8-ea17-4554-a128-6bc48bf1ffee" xlink:href="ilmn-20241229.xsd#ilmn_PurchasesSalesForStrategicInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce1943a1-a8be-4657-90e1-ccfd6862595f" xlink:to="loc_ilmn_PurchasesSalesForStrategicInvestments_ce15ccb8-ea17-4554-a128-6bc48bf1ffee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_4611cfe0-3270-4d72-8b8c-d8e68373b3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce1943a1-a8be-4657-90e1-ccfd6862595f" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_4611cfe0-3270-4d72-8b8c-d8e68373b3f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_01fc288b-a6af-4675-8e52-5cc2ab65a8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce1943a1-a8be-4657-90e1-ccfd6862595f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_01fc288b-a6af-4675-8e52-5cc2ab65a8e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5b8a124c-e2ba-40e8-9063-91df772c5088" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce1943a1-a8be-4657-90e1-ccfd6862595f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5b8a124c-e2ba-40e8-9063-91df772c5088" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1683c7c7-2337-4d78-b7db-6c2a7aa2995c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dfcb9b54-870f-4b0e-949c-17a4253e80e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1683c7c7-2337-4d78-b7db-6c2a7aa2995c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dfcb9b54-870f-4b0e-949c-17a4253e80e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_48027efc-b2f4-4eca-8922-4a460e1812bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_48027efc-b2f4-4eca-8922-4a460e1812bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_fd13abf3-3175-43be-b0bc-6bd6a3275738" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_fd13abf3-3175-43be-b0bc-6bd6a3275738" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_b522d5d1-c5cd-4e86-8d49-9ae9d57948d5" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_b522d5d1-c5cd-4e86-8d49-9ae9d57948d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_46e4e147-e98b-46b8-a4a4-3f668a7b9909" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_46e4e147-e98b-46b8-a4a4-3f668a7b9909" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_1fb385d6-2bb5-4636-87f5-0c2959d38170" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_1fb385d6-2bb5-4636-87f5-0c2959d38170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_1f85674f-274f-42e9-a4dc-d5e0222c454c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_1f85674f-274f-42e9-a4dc-d5e0222c454c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_cb2d5ab0-343b-4d28-9c1d-9dc4a215329b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_cb2d5ab0-343b-4d28-9c1d-9dc4a215329b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e9cb34e2-6ef8-40d1-b401-7a68564ea1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e9cb34e2-6ef8-40d1-b401-7a68564ea1c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_e0451fee-8c41-4b0a-b765-29bc3e4d60a8" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_e0451fee-8c41-4b0a-b765-29bc3e4d60a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_139014ac-01a9-42ad-bde6-afd812633c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_139014ac-01a9-42ad-bde6-afd812633c4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_5a04f6a3-ace3-4e3c-bc90-b8efe6eabe6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_5a04f6a3-ace3-4e3c-bc90-b8efe6eabe6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_46350529-99d4-42b5-832d-3214af3434e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_08c4fccd-037c-49d7-bc84-403e0ff683d1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_46350529-99d4-42b5-832d-3214af3434e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_348a8b5a-05ec-4d95-aa1e-d57cdf593e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_db79b3ef-b842-4178-a975-4bc55357896c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss_348a8b5a-05ec-4d95-aa1e-d57cdf593e2a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_db79b3ef-b842-4178-a975-4bc55357896c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_e356b631-c446-4721-bcad-4b27bac1f192" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss_348a8b5a-05ec-4d95-aa1e-d57cdf593e2a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_e356b631-c446-4721-bcad-4b27bac1f192" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c384d481-144d-4c33-9c58-3356804da047" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_628b4eb7-7c74-4b15-b8af-b81e7f6a4a70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c384d481-144d-4c33-9c58-3356804da047" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_628b4eb7-7c74-4b15-b8af-b81e7f6a4a70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_49bc8678-73c3-4e4d-86d1-846ba85f6252" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c384d481-144d-4c33-9c58-3356804da047" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_49bc8678-73c3-4e4d-86d1-846ba85f6252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_1a915b08-9340-4c6d-afa5-f902db84acac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c384d481-144d-4c33-9c58-3356804da047" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_1a915b08-9340-4c6d-afa5-f902db84acac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentValueRightFairValueDisclosure_1fd52206-774d-4f8c-be12-2c5b75855e95" xlink:href="ilmn-20241229.xsd#ilmn_ContingentValueRightFairValueDisclosure"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c384d481-144d-4c33-9c58-3356804da047" xlink:to="loc_ilmn_ContingentValueRightFairValueDisclosure_1fd52206-774d-4f8c-be12-2c5b75855e95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OtherInvestmentsFairValueDisclosure_2234180f-0d51-40b0-bb8a-528d03edcdf0" xlink:href="ilmn-20241229.xsd#ilmn_OtherInvestmentsFairValueDisclosure"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c384d481-144d-4c33-9c58-3356804da047" xlink:to="loc_ilmn_OtherInvestmentsFairValueDisclosure_2234180f-0d51-40b0-bb8a-528d03edcdf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d4d473e0-37ed-4439-95c8-df87c71a0385" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_04877e8c-2166-4b07-88fe-e1a3c6b0d8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_d4d473e0-37ed-4439-95c8-df87c71a0385" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_04877e8c-2166-4b07-88fe-e1a3c6b0d8fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_947d72bc-c811-420f-83af-6cc4c3e86584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_d4d473e0-37ed-4439-95c8-df87c71a0385" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_947d72bc-c811-420f-83af-6cc4c3e86584" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e7236db7-7f18-49cb-94a9-57647d331c50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3dbdc82b-2851-4632-9938-47afeaf08f37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e7236db7-7f18-49cb-94a9-57647d331c50" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3dbdc82b-2851-4632-9938-47afeaf08f37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6c54307e-2e91-4102-b585-d1fa1637f654" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e7236db7-7f18-49cb-94a9-57647d331c50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6c54307e-2e91-4102-b585-d1fa1637f654" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_c6e74946-8cbb-4df9-b531-b17d99b1f415" xlink:href="ilmn-20241229.xsd#ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment_1971f16f-bf8c-4ce4-82a6-8dbc3e9d825d" xlink:href="ilmn-20241229.xsd#ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_c6e74946-8cbb-4df9-b531-b17d99b1f415" xlink:to="loc_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment_1971f16f-bf8c-4ce4-82a6-8dbc3e9d825d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_aa4d020d-73fe-4305-a47f-f11e9857bc57" xlink:href="ilmn-20241229.xsd#ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_c6e74946-8cbb-4df9-b531-b17d99b1f415" xlink:to="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_aa4d020d-73fe-4305-a47f-f11e9857bc57" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4185cf7b-4536-4840-830b-fb23747da559" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive_f7d3a8e3-b53e-4430-ab9c-99609766472f" xlink:href="ilmn-20241229.xsd#ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4185cf7b-4536-4840-830b-fb23747da559" xlink:to="loc_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive_f7d3a8e3-b53e-4430-ab9c-99609766472f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a62d3e2d-a4d7-433c-9d7a-add107f9e434" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4185cf7b-4536-4840-830b-fb23747da559" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a62d3e2d-a4d7-433c-9d7a-add107f9e434" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_23494d1b-002b-49ab-8022-502d23827e96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4185cf7b-4536-4840-830b-fb23747da559" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_23494d1b-002b-49ab-8022-502d23827e96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2052c943-c9fd-469b-94ed-4dd9191aff65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4185cf7b-4536-4840-830b-fb23747da559" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2052c943-c9fd-469b-94ed-4dd9191aff65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_aae2401f-fa98-43af-9adf-fb8c798c8414" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4185cf7b-4536-4840-830b-fb23747da559" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_aae2401f-fa98-43af-9adf-fb8c798c8414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a3cdc6ee-35c2-440e-b5b6-8b5e030dac80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4185cf7b-4536-4840-830b-fb23747da559" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a3cdc6ee-35c2-440e-b5b6-8b5e030dac80" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8414443e-c321-4105-860b-80e7af321987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1de2dabf-2cae-44ee-9e7b-0d9aefe087a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8414443e-c321-4105-860b-80e7af321987" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1de2dabf-2cae-44ee-9e7b-0d9aefe087a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_db50b27e-e01e-44e3-b3cf-da2afd001805" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8414443e-c321-4105-860b-80e7af321987" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_db50b27e-e01e-44e3-b3cf-da2afd001805" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_caa7ff99-4c08-4d0b-a3fa-c0d964bd08b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9bda89dd-2a2d-4928-98e3-02b04cb91e73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_caa7ff99-4c08-4d0b-a3fa-c0d964bd08b8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9bda89dd-2a2d-4928-98e3-02b04cb91e73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6e47203b-0a96-4c15-9531-49172a12f14e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_caa7ff99-4c08-4d0b-a3fa-c0d964bd08b8" xlink:to="loc_us-gaap_OperatingLeaseLiability_6e47203b-0a96-4c15-9531-49172a12f14e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a1d4c835-7ee2-4764-a461-b1d776bf2401" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_72de3055-229b-4cf3-9eb3-78d8020b0d88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a1d4c835-7ee2-4764-a461-b1d776bf2401" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_72de3055-229b-4cf3-9eb3-78d8020b0d88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0e0a1b08-99ca-4f75-b696-17081a0e0ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a1d4c835-7ee2-4764-a461-b1d776bf2401" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0e0a1b08-99ca-4f75-b696-17081a0e0ac6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0fe14e25-067d-4434-93c7-9cf5a799c944" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_68c61004-b43e-4331-97f2-6a35b35b391c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0fe14e25-067d-4434-93c7-9cf5a799c944" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_68c61004-b43e-4331-97f2-6a35b35b391c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9335ef33-87e2-49d8-ae68-32366e3cfe71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0fe14e25-067d-4434-93c7-9cf5a799c944" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9335ef33-87e2-49d8-ae68-32366e3cfe71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4a3398e0-85a6-449f-81a9-d3e0aa471030" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0fe14e25-067d-4434-93c7-9cf5a799c944" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4a3398e0-85a6-449f-81a9-d3e0aa471030" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_237e93ab-eb18-48c8-a7f5-8cc93a6d1a38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0fe14e25-067d-4434-93c7-9cf5a799c944" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_237e93ab-eb18-48c8-a7f5-8cc93a6d1a38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8fdf9946-8442-4c4b-8f20-d3dbd52793a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0fe14e25-067d-4434-93c7-9cf5a799c944" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8fdf9946-8442-4c4b-8f20-d3dbd52793a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e769dfa0-28d8-4108-a669-ecd47e36d4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0fe14e25-067d-4434-93c7-9cf5a799c944" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e769dfa0-28d8-4108-a669-ecd47e36d4ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e6fac285-b6e7-4939-ba12-df5b062f7001" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_6c15e451-bf7c-413f-a76c-6ca3b22503ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e6fac285-b6e7-4939-ba12-df5b062f7001" xlink:to="loc_us-gaap_SubleaseIncome_6c15e451-bf7c-413f-a76c-6ca3b22503ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_eda32a8b-47b1-4745-9b32-bef2819ad5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e6fac285-b6e7-4939-ba12-df5b062f7001" xlink:to="loc_us-gaap_VariableLeaseCost_eda32a8b-47b1-4745-9b32-bef2819ad5b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_18c17fd9-af62-4278-ac32-a0aed89ae156" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e6fac285-b6e7-4939-ba12-df5b062f7001" xlink:to="loc_us-gaap_OperatingLeaseCost_18c17fd9-af62-4278-ac32-a0aed89ae156" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_c73c7188-f8fa-46ae-bd9e-62a3ef15bcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_943d9deb-7f08-46a4-afd2-cc758f34ac1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_c73c7188-f8fa-46ae-bd9e-62a3ef15bcc0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_943d9deb-7f08-46a4-afd2-cc758f34ac1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_99cc139d-e5d5-4d47-b771-244857e19f97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_c73c7188-f8fa-46ae-bd9e-62a3ef15bcc0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_99cc139d-e5d5-4d47-b771-244857e19f97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6e7881a1-589a-4fdf-9492-423a6492d567" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_3bf2b047-c5e7-4b3c-a978-0aacefc0c6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_6e7881a1-589a-4fdf-9492-423a6492d567" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_3bf2b047-c5e7-4b3c-a978-0aacefc0c6e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_4bf6b47c-0591-43d3-ae32-03eb75a24005" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_6e7881a1-589a-4fdf-9492-423a6492d567" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_4bf6b47c-0591-43d3-ae32-03eb75a24005" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_039d95c6-b04d-40e3-a3a3-41f647b5ed24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_e15fbc27-5ba0-4e46-bcb6-700258fdf59b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_039d95c6-b04d-40e3-a3a3-41f647b5ed24" xlink:to="loc_us-gaap_InventoryFinishedGoods_e15fbc27-5ba0-4e46-bcb6-700258fdf59b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_d491ad2f-c656-4d55-92a2-3b8f65e0b5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_039d95c6-b04d-40e3-a3a3-41f647b5ed24" xlink:to="loc_us-gaap_InventoryRawMaterials_d491ad2f-c656-4d55-92a2-3b8f65e0b5ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_afda21f7-09be-4439-8e45-874d90af2624" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_039d95c6-b04d-40e3-a3a3-41f647b5ed24" xlink:to="loc_us-gaap_InventoryWorkInProcess_afda21f7-09be-4439-8e45-874d90af2624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9db6f65b-7839-4cd0-8a21-c23dbe9a94b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_3a27168b-4b55-4ba0-b4fc-62d44d28087d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9db6f65b-7839-4cd0-8a21-c23dbe9a94b3" xlink:to="loc_us-gaap_InventoryValuationReserves_3a27168b-4b55-4ba0-b4fc-62d44d28087d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_4f2bfc31-7da3-402f-a064-16230c25bf95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9db6f65b-7839-4cd0-8a21-c23dbe9a94b3" xlink:to="loc_us-gaap_InventoryGross_4f2bfc31-7da3-402f-a064-16230c25bf95" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_41634632-00ee-4259-83ee-6259fcc955b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3b815fd8-ebf2-4710-9885-5cb524cae1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_41634632-00ee-4259-83ee-6259fcc955b9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3b815fd8-ebf2-4710-9885-5cb524cae1ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f509ab83-a254-4874-99c8-368f0bcf61d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_41634632-00ee-4259-83ee-6259fcc955b9" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f509ab83-a254-4874-99c8-368f0bcf61d8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3c7eb09d-0bfb-40eb-b218-c49c48fcf7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_2c650a49-ae36-4305-b3f8-712908868230" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3c7eb09d-0bfb-40eb-b218-c49c48fcf7fb" xlink:to="loc_us-gaap_TaxesPayableCurrent_2c650a49-ae36-4305-b3f8-712908868230" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent_397a4d2e-a56c-45a4-a643-48caac0529d0" xlink:href="ilmn-20241229.xsd#ilmn_AccruedLiabilityClassifiedAwardsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3c7eb09d-0bfb-40eb-b218-c49c48fcf7fb" xlink:to="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent_397a4d2e-a56c-45a4-a643-48caac0529d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f27a7c7d-6119-447d-8607-bdbcef3b9da2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3c7eb09d-0bfb-40eb-b218-c49c48fcf7fb" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f27a7c7d-6119-447d-8607-bdbcef3b9da2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_d5809ba0-f8d5-4679-a5da-75eacab44ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3c7eb09d-0bfb-40eb-b218-c49c48fcf7fb" xlink:to="loc_us-gaap_LitigationReserveCurrent_d5809ba0-f8d5-4679-a5da-75eacab44ab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_70bb97a1-35de-4b47-81e8-4ee30d47e05f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3c7eb09d-0bfb-40eb-b218-c49c48fcf7fb" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_70bb97a1-35de-4b47-81e8-4ee30d47e05f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3b647168-2415-486d-a06e-183fa3c61145" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3c7eb09d-0bfb-40eb-b218-c49c48fcf7fb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3b647168-2415-486d-a06e-183fa3c61145" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_03d42039-9e8a-4033-b8f2-77288eda42c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3c7eb09d-0bfb-40eb-b218-c49c48fcf7fb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_03d42039-9e8a-4033-b8f2-77288eda42c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_502f406f-fa04-4f0b-b14f-1850fe40a16b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_94656ee0-0ca2-4b3a-81e3-a7928556e925" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_502f406f-fa04-4f0b-b14f-1850fe40a16b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_94656ee0-0ca2-4b3a-81e3-a7928556e925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f4660317-27d6-4b2e-a0e3-e1d7e232c524" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_502f406f-fa04-4f0b-b14f-1850fe40a16b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f4660317-27d6-4b2e-a0e3-e1d7e232c524" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b476125b-c339-41cb-b535-d93ab3e8b5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4711f595-f02f-4599-999e-063389fbb5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b476125b-c339-41cb-b535-d93ab3e8b5f8" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4711f595-f02f-4599-999e-063389fbb5ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_420ea02e-6a72-4a72-ac6b-f3e163328f45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b476125b-c339-41cb-b535-d93ab3e8b5f8" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_420ea02e-6a72-4a72-ac6b-f3e163328f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_dcb729e4-e25e-4d4e-a373-4d34894fa69c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b476125b-c339-41cb-b535-d93ab3e8b5f8" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_dcb729e4-e25e-4d4e-a373-4d34894fa69c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f96866b8-294a-4c5a-9d83-c20375c0233a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_23a6be26-9eea-45aa-aa30-fc6b992b383d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_f96866b8-294a-4c5a-9d83-c20375c0233a" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_23a6be26-9eea-45aa-aa30-fc6b992b383d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_71b0254a-ac1d-4db3-89f5-949e2ee087cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_f96866b8-294a-4c5a-9d83-c20375c0233a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_71b0254a-ac1d-4db3-89f5-949e2ee087cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ca0a3c6e-0ca8-4698-a243-6bc3b682f06c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b649724c-35a7-4011-8c1e-f0a37f99d645" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ca0a3c6e-0ca8-4698-a243-6bc3b682f06c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b649724c-35a7-4011-8c1e-f0a37f99d645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_75866aca-8239-4830-bced-47875a104e19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ca0a3c6e-0ca8-4698-a243-6bc3b682f06c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_75866aca-8239-4830-bced-47875a104e19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_08adc971-ff67-4a8b-b034-e8628dbfe51a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ca0a3c6e-0ca8-4698-a243-6bc3b682f06c" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_08adc971-ff67-4a8b-b034-e8628dbfe51a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount_bdc6e151-6104-4e78-b28e-96546ec52822" xlink:href="ilmn-20241229.xsd#ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount_bdc6e151-6104-4e78-b28e-96546ec52822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7b4200f7-0b18-44a6-978e-b20a809da8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7b4200f7-0b18-44a6-978e-b20a809da8ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine_6227b0f0-8faa-4862-8ddd-41f202dcc74a" xlink:href="ilmn-20241229.xsd#ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine_6227b0f0-8faa-4862-8ddd-41f202dcc74a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_76bfde9d-e0db-4b60-ac74-2d3b3466dc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_76bfde9d-e0db-4b60-ac74-2d3b3466dc1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_59072e57-91f2-4627-af51-cade3e1000b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_59072e57-91f2-4627-af51-cade3e1000b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_e802edea-2b54-457f-83e1-2c01645938e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_e802edea-2b54-457f-83e1-2c01645938e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5525878f-bfd3-46fb-8bd6-577774799ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5525878f-bfd3-46fb-8bd6-577774799ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_0d8958dd-8b24-4e6a-909d-f43968023c27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_0d8958dd-8b24-4e6a-909d-f43968023c27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_564ccd59-0641-41db-8342-1491bd634f87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_564ccd59-0641-41db-8342-1491bd634f87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_e162c272-b341-4c6b-8120-a337ddb2ef59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_e162c272-b341-4c6b-8120-a337ddb2ef59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_7cea8f95-8f7e-421e-9e67-988f5746a045" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_7cea8f95-8f7e-421e-9e67-988f5746a045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ccec5d64-4569-4eda-abf1-b89b3e6f3376" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_bb024511-a66e-4137-855b-db6a1f8be258" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ccec5d64-4569-4eda-abf1-b89b3e6f3376" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_85befdaf-31d2-47cc-8ba6-0c731ba242a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_4c68dab8-06dc-4ffe-8596-9972d21499b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_85befdaf-31d2-47cc-8ba6-0c731ba242a7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_4c68dab8-06dc-4ffe-8596-9972d21499b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_f8ee39b7-0bee-41f6-b869-ac257c2be6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_85befdaf-31d2-47cc-8ba6-0c731ba242a7" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_f8ee39b7-0bee-41f6-b869-ac257c2be6d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f8190a5f-5bb6-4411-8e7c-96ccb38a2c30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f8190a5f-5bb6-4411-8e7c-96ccb38a2c30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_934b49a5-a024-47d3-ab5e-2544ac6cbce8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_934b49a5-a024-47d3-ab5e-2544ac6cbce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_4127aa17-1c99-4edc-aff4-745d65998cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_4127aa17-1c99-4edc-aff4-745d65998cd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_b6f78bff-896c-410d-9d1c-dce0096c494a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_b6f78bff-896c-410d-9d1c-dce0096c494a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_6a5197e7-1c8c-4718-bd8b-6f46704538c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_6a5197e7-1c8c-4718-bd8b-6f46704538c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_e0917852-6882-409f-ae0f-e0eb3d5f73cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_e0917852-6882-409f-ae0f-e0eb3d5f73cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_0f30c412-ca0e-4cf3-b257-4dc22daf5692" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_0f30c412-ca0e-4cf3-b257-4dc22daf5692" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities_e79107ea-252f-4ca4-889c-c36c65571e11" xlink:href="ilmn-20241229.xsd#ilmn_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities_e79107ea-252f-4ca4-889c-c36c65571e11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_961c0a28-902f-4b5f-b19d-3215393df44e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_961c0a28-902f-4b5f-b19d-3215393df44e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_af0fe115-b8b6-404d-9b23-15372e880b88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_16d00a81-5593-4f88-9394-8e523469e571" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_af0fe115-b8b6-404d-9b23-15372e880b88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e169a1af-0afc-4ccb-949d-2e5546a5767f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f44d3371-ac15-48ff-9a5c-c9b49d09bf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e169a1af-0afc-4ccb-949d-2e5546a5767f" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_f44d3371-ac15-48ff-9a5c-c9b49d09bf9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cb8f0e33-e40f-4147-a22b-c67fd5c6f82c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e169a1af-0afc-4ccb-949d-2e5546a5767f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cb8f0e33-e40f-4147-a22b-c67fd5c6f82c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5ee0c5fe-3394-458b-beeb-66809910f0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5c31f5be-fa75-40af-95de-8134ac90babb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ee0c5fe-3394-458b-beeb-66809910f0f6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5c31f5be-fa75-40af-95de-8134ac90babb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_b44f04b1-443f-43d2-ad8b-56a3a4443cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ee0c5fe-3394-458b-beeb-66809910f0f6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_b44f04b1-443f-43d2-ad8b-56a3a4443cb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_90777bb1-270b-486f-9662-46c995c72174" xlink:href="ilmn-20241229.xsd#ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ee0c5fe-3394-458b-beeb-66809910f0f6" xlink:to="loc_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_90777bb1-270b-486f-9662-46c995c72174" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_199aa6ba-3631-456a-bf28-178e852b3b18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_199aa6ba-3631-456a-bf28-178e852b3b18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_9091fab9-b6a7-496c-a5e4-c89d981f3bed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_9091fab9-b6a7-496c-a5e4-c89d981f3bed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_48ffaf49-f4c3-4b9b-9c53-bb8035375d30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_48ffaf49-f4c3-4b9b-9c53-bb8035375d30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ff7a4d91-0465-496d-9496-2ab64842bb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_CostOfRevenue_ff7a4d91-0465-496d-9496-2ab64842bb5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_977e84ae-bfa3-4dc7-b3bb-9da58cf93124" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_977e84ae-bfa3-4dc7-b3bb-9da58cf93124" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_abd8cacd-1c7a-4298-a227-3b9ac3bf3745" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_SellingAndMarketingExpense_abd8cacd-1c7a-4298-a227-3b9ac3bf3745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0a4d2b16-f2be-4b3a-b420-cc47fb2849d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0a4d2b16-f2be-4b3a-b420-cc47fb2849d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ad34e80d-2ba1-4c4f-ba24-c056658d3ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ad34e80d-2ba1-4c4f-ba24-c056658d3ca8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_62463852-cd72-4041-ac8d-3115076ea82f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_OperatingExpenses_62463852-cd72-4041-ac8d-3115076ea82f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_078cc4ed-a272-4254-bfe0-dfefb85e2821" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_42616028-7428-4046-a81a-95dff2ab4b20" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_078cc4ed-a272-4254-bfe0-dfefb85e2821" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>ilmn-20241229_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3be010a1-b4e2-4eb6-8721-f9b45bdbb770,g:4f5b8127-d86a-4b2f-b09c-147b6f0d2a9f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_34658f7c-7ca6-42fb-830c-62cd6c24c8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_StatementTable_34658f7c-7ca6-42fb-830c-62cd6c24c8a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7a09e44f-ce9f-4aff-b5e0-8bf5830970e5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_34658f7c-7ca6-42fb-830c-62cd6c24c8a0" xlink:to="loc_srt_ProductOrServiceAxis_7a09e44f-ce9f-4aff-b5e0-8bf5830970e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7a09e44f-ce9f-4aff-b5e0-8bf5830970e5_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7a09e44f-ce9f-4aff-b5e0-8bf5830970e5" xlink:to="loc_srt_ProductsAndServicesDomain_7a09e44f-ce9f-4aff-b5e0-8bf5830970e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e7d88ca8-f97b-483d-bc0e-af8de6b30145" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7a09e44f-ce9f-4aff-b5e0-8bf5830970e5" xlink:to="loc_srt_ProductsAndServicesDomain_e7d88ca8-f97b-483d-bc0e-af8de6b30145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_acd0e8e1-b535-4571-ae35-b51a9aafc2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e7d88ca8-f97b-483d-bc0e-af8de6b30145" xlink:to="loc_us-gaap_ProductMember_acd0e8e1-b535-4571-ae35-b51a9aafc2b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_bbcf1b31-532e-4d3c-8d41-321479a2a866" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e7d88ca8-f97b-483d-bc0e-af8de6b30145" xlink:to="loc_us-gaap_ServiceMember_bbcf1b31-532e-4d3c-8d41-321479a2a866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_dea6a299-a08c-48f5-a42d-d8c78dd01a47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_RevenuesAbstract_dea6a299-a08c-48f5-a42d-d8c78dd01a47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_496a3a5f-2a1e-4e73-add0-f8bc4fe165e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_dea6a299-a08c-48f5-a42d-d8c78dd01a47" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_496a3a5f-2a1e-4e73-add0-f8bc4fe165e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f6feb124-54ad-4217-8a87-b2c74f447a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f6feb124-54ad-4217-8a87-b2c74f447a2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_021b4316-a55e-4754-9f75-d41c011ef0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_021b4316-a55e-4754-9f75-d41c011ef0b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_491ba360-8566-4f9d-bffa-537f8d42855f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:to="loc_us-gaap_CostOfRevenue_491ba360-8566-4f9d-bffa-537f8d42855f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0d11cdec-660f-45c7-a9b3-861b8f7fe531" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_GrossProfit_0d11cdec-660f-45c7-a9b3-861b8f7fe531" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_27063e21-6496-46d4-9bdb-ea7dad724dac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_27063e21-6496-46d4-9bdb-ea7dad724dac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a3f1b044-94f6-4dbb-8481-fc92f47cd7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a3f1b044-94f6-4dbb-8481-fc92f47cd7c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b5c471bb-da71-4748-82c2-c5528e93dbce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b5c471bb-da71-4748-82c2-c5528e93dbce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_5ffba6b2-140d-46a3-a892-f2a0e6deea7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_5ffba6b2-140d-46a3-a892-f2a0e6deea7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2d759a04-bed7-425e-902a-ba2482cbc37a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_OperatingExpenses_2d759a04-bed7-425e-902a-ba2482cbc37a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0ede059d-b0f3-4862-b52e-ec7b721f3843" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_OperatingIncomeLoss_0ede059d-b0f3-4862-b52e-ec7b721f3843" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5402199d-e1e4-412e-864f-dc474cce949e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5402199d-e1e4-412e-864f-dc474cce949e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_5a021f6a-4bf9-4d1e-ae2b-0c654a0e78e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:to="loc_us-gaap_InterestExpenseNonoperating_5a021f6a-4bf9-4d1e-ae2b-0c654a0e78e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ce2700d9-6c0f-4000-8d85-42dd383af050" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ce2700d9-6c0f-4000-8d85-42dd383af050" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_8d28b474-daaa-4c13-90a1-3bb0bd1e6f26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_8d28b474-daaa-4c13-90a1-3bb0bd1e6f26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4afd66dd-3698-4721-9ead-4f4877851dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4afd66dd-3698-4721-9ead-4f4877851dc1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_aed449fd-f0d6-4913-b05a-d8396fed9a12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_aed449fd-f0d6-4913-b05a-d8396fed9a12" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54e3f1f7-e3ca-466e-85d8-2766b7073e57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_NetIncomeLoss_54e3f1f7-e3ca-466e-85d8-2766b7073e57" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c2338114-2097-4098-9eb0-f7fb3f3dd326" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_EarningsPerShareAbstract_c2338114-2097-4098-9eb0-f7fb3f3dd326" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6eeb81de-06a5-4efd-8a6b-9c73950fad42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c2338114-2097-4098-9eb0-f7fb3f3dd326" xlink:to="loc_us-gaap_EarningsPerShareBasic_6eeb81de-06a5-4efd-8a6b-9c73950fad42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c71d3cfe-fd6e-41d4-b462-e26bb5d6ff01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c2338114-2097-4098-9eb0-f7fb3f3dd326" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c71d3cfe-fd6e-41d4-b462-e26bb5d6ff01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_3b38e0ad-4bc8-442c-af5b-5630d03efb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_3b38e0ad-4bc8-442c-af5b-5630d03efb8c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c5d8083a-919f-4e46-8bfa-608b74819749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_3b38e0ad-4bc8-442c-af5b-5630d03efb8c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c5d8083a-919f-4e46-8bfa-608b74819749" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85393e69-b886-4643-87b2-43fb901e507a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_3b38e0ad-4bc8-442c-af5b-5630d03efb8c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85393e69-b886-4643-87b2-43fb901e507a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4ec8003f-200a-44b8-89ca-fb6c80cbe596" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1ac02cf1-3d40-4170-b31a-1358b4c5ceaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4ec8003f-200a-44b8-89ca-fb6c80cbe596" xlink:to="loc_us-gaap_StatementTable_1ac02cf1-3d40-4170-b31a-1358b4c5ceaf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_67277aba-a219-4e5a-9eb6-6111f798beb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1ac02cf1-3d40-4170-b31a-1358b4c5ceaf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_67277aba-a219-4e5a-9eb6-6111f798beb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_67277aba-a219-4e5a-9eb6-6111f798beb0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67277aba-a219-4e5a-9eb6-6111f798beb0" xlink:to="loc_us-gaap_EquityComponentDomain_67277aba-a219-4e5a-9eb6-6111f798beb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67277aba-a219-4e5a-9eb6-6111f798beb0" xlink:to="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_61720b5f-708d-414d-b0b8-8f8e4a9c877b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_CommonStockMember_61720b5f-708d-414d-b0b8-8f8e4a9c877b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9ca67993-3503-4d02-9aef-d6684adaadb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9ca67993-3503-4d02-9aef-d6684adaadb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a10370d2-eb22-4d7f-8a1c-b2098f4fd536" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a10370d2-eb22-4d7f-8a1c-b2098f4fd536" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_38db657a-2bfd-4efa-8df0-8803e1dd2fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_RetainedEarningsMember_38db657a-2bfd-4efa-8df0-8803e1dd2fd6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_869cc1d1-0e57-4e0b-8bd2-b3dfd243ac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_TreasuryStockCommonMember_869cc1d1-0e57-4e0b-8bd2-b3dfd243ac8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3efeb97-1a43-4ab9-86e3-c299bdb8187a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1ac02cf1-3d40-4170-b31a-1358b4c5ceaf" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3efeb97-1a43-4ab9-86e3-c299bdb8187a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d3efeb97-1a43-4ab9-86e3-c299bdb8187a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3efeb97-1a43-4ab9-86e3-c299bdb8187a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d3efeb97-1a43-4ab9-86e3-c299bdb8187a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cc800dd3-039f-4817-b1da-4a49ebb0c754" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3efeb97-1a43-4ab9-86e3-c299bdb8187a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cc800dd3-039f-4817-b1da-4a49ebb0c754" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3b7861e8-3770-4cfe-85ed-fa7e464acffe" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cc800dd3-039f-4817-b1da-4a49ebb0c754" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3b7861e8-3770-4cfe-85ed-fa7e464acffe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4ec8003f-200a-44b8-89ca-fb6c80cbe596" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_36a9e743-b00d-4e3c-9265-019bad2daee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_36a9e743-b00d-4e3c-9265-019bad2daee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1f3de638-a23d-4348-b372-2f72f582416b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_StockholdersEquity_1f3de638-a23d-4348-b372-2f72f582416b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_bb25d115-7024-4ac2-8ede-7695fcfae069" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_TreasuryStockCommonShares_bb25d115-7024-4ac2-8ede-7695fcfae069" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1abb7a63-5591-4222-9577-5a471647d42a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_NetIncomeLoss_1abb7a63-5591-4222-9577-5a471647d42a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_879759d8-9834-4a8f-b78d-3beabcc4e781" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_879759d8-9834-4a8f-b78d-3beabcc4e781" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares_922f4889-59b3-46ba-9006-bef9418a6521" xlink:href="ilmn-20241229.xsd#ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares_922f4889-59b3-46ba-9006-bef9418a6521" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue_789908a7-49d9-4896-a992-0574f831e8db" xlink:href="ilmn-20241229.xsd#ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue_789908a7-49d9-4896-a992-0574f831e8db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6085454a-2383-429d-aa1e-bbf8c7663551" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6085454a-2383-429d-aa1e-bbf8c7663551" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ReclassificationLiabilityAwards_78032bed-3045-467a-b755-9a335389a04e" xlink:href="ilmn-20241229.xsd#ilmn_ReclassificationLiabilityAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_ilmn_ReclassificationLiabilityAwards_78032bed-3045-467a-b755-9a335389a04e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation_539f64c9-bf2b-421c-8b26-6d15ac57dd24" xlink:href="ilmn-20241229.xsd#ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation_539f64c9-bf2b-421c-8b26-6d15ac57dd24" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ce07d8ac-30bc-4f34-8c85-2cf308fec0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6dd58a65-8396-4e6a-9a57-4c107ed2a914" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1bf16d81-95ca-4359-94d8-71c31c71f7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_f954dd18-9bfd-41e7-9ef0-302b858ee217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4ec8003f-200a-44b8-89ca-fb6c80cbe596" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_f954dd18-9bfd-41e7-9ef0-302b858ee217" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2255372d-fb2e-41e2-a8d7-dd743028ecce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2255372d-fb2e-41e2-a8d7-dd743028ecce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2e03d82a-87b5-410a-a748-bdeb530c50a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2255372d-fb2e-41e2-a8d7-dd743028ecce" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2e03d82a-87b5-410a-a748-bdeb530c50a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2e03d82a-87b5-410a-a748-bdeb530c50a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2e03d82a-87b5-410a-a748-bdeb530c50a5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2e03d82a-87b5-410a-a748-bdeb530c50a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f2818637-dc4e-4486-bb02-0cca45c155b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2e03d82a-87b5-410a-a748-bdeb530c50a5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f2818637-dc4e-4486-bb02-0cca45c155b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_19378ba8-6324-49ab-abeb-b44395c37a72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f2818637-dc4e-4486-bb02-0cca45c155b1" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_19378ba8-6324-49ab-abeb-b44395c37a72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_219fb7da-28e5-404b-a4e0-4dc0fbd7bd63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2255372d-fb2e-41e2-a8d7-dd743028ecce" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_219fb7da-28e5-404b-a4e0-4dc0fbd7bd63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_219fb7da-28e5-404b-a4e0-4dc0fbd7bd63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_219fb7da-28e5-404b-a4e0-4dc0fbd7bd63" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_219fb7da-28e5-404b-a4e0-4dc0fbd7bd63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9afa4375-4342-4b01-b71d-18c6053db71d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_219fb7da-28e5-404b-a4e0-4dc0fbd7bd63" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9afa4375-4342-4b01-b71d-18c6053db71d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_ace639e1-f0ad-45e7-875e-4350ea7f2093" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9afa4375-4342-4b01-b71d-18c6053db71d" xlink:to="loc_ilmn_GRAILInc.Member_ace639e1-f0ad-45e7-875e-4350ea7f2093" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_a43b578c-d2f7-48fa-bc7c-781c7461b5d7" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:to="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_a43b578c-d2f7-48fa-bc7c-781c7461b5d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_12e05723-7cd4-4c3c-be27-ea09b6fff3d2" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationPercentOfInterestDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:to="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_12e05723-7cd4-4c3c-be27-ea09b6fff3d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_2c0677b3-6b2e-4cd4-a4dd-4ee33bb41a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:to="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_2c0677b3-6b2e-4cd4-a4dd-4ee33bb41a6d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_862e5dc5-6ede-4dda-832e-71186b848f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_862e5dc5-6ede-4dda-832e-71186b848f6b" xlink:to="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d45a7d95-3a36-4676-aede-0af834755954" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:to="loc_srt_StatementGeographicalAxis_d45a7d95-3a36-4676-aede-0af834755954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d45a7d95-3a36-4676-aede-0af834755954_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d45a7d95-3a36-4676-aede-0af834755954" xlink:to="loc_srt_SegmentGeographicalDomain_d45a7d95-3a36-4676-aede-0af834755954_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a1725608-045e-4d21-a01c-272e461d1eb5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d45a7d95-3a36-4676-aede-0af834755954" xlink:to="loc_srt_SegmentGeographicalDomain_a1725608-045e-4d21-a01c-272e461d1eb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ed1785b3-5f0f-4d39-bba4-9b050390af00" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a1725608-045e-4d21-a01c-272e461d1eb5" xlink:to="loc_country_US_ed1785b3-5f0f-4d39-bba4-9b050390af00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_8469f3a0-f48d-4b6c-8901-32a7137239ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a1725608-045e-4d21-a01c-272e461d1eb5" xlink:to="loc_us-gaap_NonUsMember_8469f3a0-f48d-4b6c-8901-32a7137239ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7fb0e7ae-f057-4248-a732-046fcc61b5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7fb0e7ae-f057-4248-a732-046fcc61b5e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7fb0e7ae-f057-4248-a732-046fcc61b5e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7fb0e7ae-f057-4248-a732-046fcc61b5e7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7fb0e7ae-f057-4248-a732-046fcc61b5e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7fb0e7ae-f057-4248-a732-046fcc61b5e7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_f427d14b-64e0-4301-a2b4-5f40bcb1b08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_f427d14b-64e0-4301-a2b4-5f40bcb1b08a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_d8571831-c4a7-4df0-aa85-d7f9bd6a6323" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_d8571831-c4a7-4df0-aa85-d7f9bd6a6323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_55e4ed04-26a8-4816-ae58-80b045c097da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_55e4ed04-26a8-4816-ae58-80b045c097da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndustryCreditConcentrationRiskMember_008a2d64-b40d-41bc-8562-b2c972a77bf0" xlink:href="ilmn-20241229.xsd#ilmn_IndustryCreditConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:to="loc_ilmn_IndustryCreditConcentrationRiskMember_008a2d64-b40d-41bc-8562-b2c972a77bf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_285ea465-8951-429b-a17b-503e954c24a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_285ea465-8951-429b-a17b-503e954c24a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_285ea465-8951-429b-a17b-503e954c24a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_285ea465-8951-429b-a17b-503e954c24a9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_285ea465-8951-429b-a17b-503e954c24a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_285ea465-8951-429b-a17b-503e954c24a9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_cd5de9b1-91f9-4e72-be6f-dbb080aa1e56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:to="loc_us-gaap_SalesRevenueNetMember_cd5de9b1-91f9-4e72-be6f-dbb080aa1e56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_68617c01-40f4-495d-a206-d51ec495d5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:to="loc_us-gaap_AccountsReceivableMember_68617c01-40f4-495d-a206-d51ec495d5ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_InvestmentPortfolioMember_b57c1beb-641b-4fd7-9b05-9999d6147d4e" xlink:href="ilmn-20241229.xsd#ilmn_InvestmentPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:to="loc_ilmn_InvestmentPortfolioMember_b57c1beb-641b-4fd7-9b05-9999d6147d4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IssueSizeMember_44fb7dbb-4586-4ccc-8ded-8532b13522d2" xlink:href="ilmn-20241229.xsd#ilmn_IssueSizeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:to="loc_ilmn_IssueSizeMember_44fb7dbb-4586-4ccc-8ded-8532b13522d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_6bd520f7-af9f-4b10-a8ad-b1e395171ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_862e5dc5-6ede-4dda-832e-71186b848f6b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_6bd520f7-af9f-4b10-a8ad-b1e395171ac7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConcentrationRiskThreshold_aa3bd890-1524-4d93-80c8-3b4c16e02637" xlink:href="ilmn-20241229.xsd#ilmn_ConcentrationRiskThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_862e5dc5-6ede-4dda-832e-71186b848f6b" xlink:to="loc_ilmn_ConcentrationRiskThreshold_aa3bd890-1524-4d93-80c8-3b4c16e02637" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a2cb0729-236d-4390-ba8c-ae5ba910a638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_166dd36a-a5f2-4b4f-9b20-e30b5cccdb92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a2cb0729-236d-4390-ba8c-ae5ba910a638" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_166dd36a-a5f2-4b4f-9b20-e30b5cccdb92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_92dc9aed-ccc7-4dea-a107-91985327fc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_166dd36a-a5f2-4b4f-9b20-e30b5cccdb92" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_92dc9aed-ccc7-4dea-a107-91985327fc4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_92dc9aed-ccc7-4dea-a107-91985327fc4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_92dc9aed-ccc7-4dea-a107-91985327fc4c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_92dc9aed-ccc7-4dea-a107-91985327fc4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7eae2a4b-5439-4658-b2a9-e329de7bff77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_92dc9aed-ccc7-4dea-a107-91985327fc4c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7eae2a4b-5439-4658-b2a9-e329de7bff77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_a4458bcb-d3a4-4831-8c6b-16d8e1e6239f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_7eae2a4b-5439-4658-b2a9-e329de7bff77" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_a4458bcb-d3a4-4831-8c6b-16d8e1e6239f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_43a637a2-35cf-4275-a2be-0f157ba8e91c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_166dd36a-a5f2-4b4f-9b20-e30b5cccdb92" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_43a637a2-35cf-4275-a2be-0f157ba8e91c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_43a637a2-35cf-4275-a2be-0f157ba8e91c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_43a637a2-35cf-4275-a2be-0f157ba8e91c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_43a637a2-35cf-4275-a2be-0f157ba8e91c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_568b850d-e310-4061-995d-1cab5a574eb2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_43a637a2-35cf-4275-a2be-0f157ba8e91c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_568b850d-e310-4061-995d-1cab5a574eb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_90326172-f6ea-4be6-a666-d9769fc79bec" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_568b850d-e310-4061-995d-1cab5a574eb2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_90326172-f6ea-4be6-a666-d9769fc79bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8d15bb4f-18cb-48e7-b62e-cd40c487d18c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a2cb0729-236d-4390-ba8c-ae5ba910a638" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8d15bb4f-18cb-48e7-b62e-cd40c487d18c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2409623c-b82e-489d-b32f-fc11b3e27869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a2cb0729-236d-4390-ba8c-ae5ba910a638" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2409623c-b82e-489d-b32f-fc11b3e27869" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_44990014-237f-41b6-8b8d-a67d14d217d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_b00cc1b8-afb8-4045-85e8-aa59515bdb99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_44990014-237f-41b6-8b8d-a67d14d217d7" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_b00cc1b8-afb8-4045-85e8-aa59515bdb99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_73af2f7c-eb5e-4fd8-bc69-f269807ca3ac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_b00cc1b8-afb8-4045-85e8-aa59515bdb99" xlink:to="loc_srt_ProductOrServiceAxis_73af2f7c-eb5e-4fd8-bc69-f269807ca3ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_73af2f7c-eb5e-4fd8-bc69-f269807ca3ac_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_73af2f7c-eb5e-4fd8-bc69-f269807ca3ac" xlink:to="loc_srt_ProductsAndServicesDomain_73af2f7c-eb5e-4fd8-bc69-f269807ca3ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_64331b88-abde-48b0-ae79-1e43e677aba0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_73af2f7c-eb5e-4fd8-bc69-f269807ca3ac" xlink:to="loc_srt_ProductsAndServicesDomain_64331b88-abde-48b0-ae79-1e43e677aba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c73ec565-90b5-4f46-a0a5-36cdd155bd05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64331b88-abde-48b0-ae79-1e43e677aba0" xlink:to="loc_us-gaap_ProductMember_c73ec565-90b5-4f46-a0a5-36cdd155bd05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevenueFromContractWithCustomerPaymentTerm_e1581ab6-da7e-4791-8531-1157a8717bb2" xlink:href="ilmn-20241229.xsd#ilmn_RevenueFromContractWithCustomerPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_44990014-237f-41b6-8b8d-a67d14d217d7" xlink:to="loc_ilmn_RevenueFromContractWithCustomerPaymentTerm_e1581ab6-da7e-4791-8531-1157a8717bb2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_449ad973-7d7a-4468-b3a7-6f40c0e2fc81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0743ba17-b1f9-4576-bb44-7abb8d6460ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_449ad973-7d7a-4468-b3a7-6f40c0e2fc81" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0743ba17-b1f9-4576-bb44-7abb8d6460ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74a267ee-aee9-4260-ad51-af779b7f24b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0743ba17-b1f9-4576-bb44-7abb8d6460ee" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74a267ee-aee9-4260-ad51-af779b7f24b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_74a267ee-aee9-4260-ad51-af779b7f24b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74a267ee-aee9-4260-ad51-af779b7f24b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_74a267ee-aee9-4260-ad51-af779b7f24b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bcfd4136-4533-4828-addf-51da2b73350e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74a267ee-aee9-4260-ad51-af779b7f24b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bcfd4136-4533-4828-addf-51da2b73350e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_1647e4c8-6b75-4169-a26c-256ca7841838" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bcfd4136-4533-4828-addf-51da2b73350e" xlink:to="loc_us-gaap_StockCompensationPlanMember_1647e4c8-6b75-4169-a26c-256ca7841838" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_e44c8c73-b0bf-43ec-9881-ea93b24c00b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bcfd4136-4533-4828-addf-51da2b73350e" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_e44c8c73-b0bf-43ec-9881-ea93b24c00b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1681aac0-8db2-401a-b634-d7a22e9edb06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_449ad973-7d7a-4468-b3a7-6f40c0e2fc81" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1681aac0-8db2-401a-b634-d7a22e9edb06" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_715bc13a-2609-46c5-90c3-7281d816b768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a1e2b0b7-fb2e-4e74-aa80-53fc1789377d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_715bc13a-2609-46c5-90c3-7281d816b768" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a1e2b0b7-fb2e-4e74-aa80-53fc1789377d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5eef79c2-cfe8-441f-b09c-06d12f3dad3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a1e2b0b7-fb2e-4e74-aa80-53fc1789377d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5eef79c2-cfe8-441f-b09c-06d12f3dad3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5eef79c2-cfe8-441f-b09c-06d12f3dad3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5eef79c2-cfe8-441f-b09c-06d12f3dad3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5eef79c2-cfe8-441f-b09c-06d12f3dad3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5eef79c2-cfe8-441f-b09c-06d12f3dad3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BuildingandLeaseholdImprovementsMember_19042cb1-ca84-47ae-89cd-1915928fea2b" xlink:href="ilmn-20241229.xsd#ilmn_BuildingandLeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:to="loc_ilmn_BuildingandLeaseholdImprovementsMember_19042cb1-ca84-47ae-89cd-1915928fea2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_bc4adf60-38d0-49a9-8b5f-d19fcbb3e729" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_bc4adf60-38d0-49a9-8b5f-d19fcbb3e729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_60aee23f-9bc2-4945-aeba-57d2a6ea32ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:to="loc_us-gaap_ComputerEquipmentMember_60aee23f-9bc2-4945-aeba-57d2a6ea32ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_fb545571-247f-4937-aa45-f373c3052fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_fb545571-247f-4937-aa45-f373c3052fbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fb959ed9-712c-42c7-a079-0ce3cfdbdde2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a1e2b0b7-fb2e-4e74-aa80-53fc1789377d" xlink:to="loc_srt_RangeAxis_fb959ed9-712c-42c7-a079-0ce3cfdbdde2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb959ed9-712c-42c7-a079-0ce3cfdbdde2_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fb959ed9-712c-42c7-a079-0ce3cfdbdde2" xlink:to="loc_srt_RangeMember_fb959ed9-712c-42c7-a079-0ce3cfdbdde2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bd7b6e13-acbb-4a45-afc2-6cc1026139b8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fb959ed9-712c-42c7-a079-0ce3cfdbdde2" xlink:to="loc_srt_RangeMember_bd7b6e13-acbb-4a45-afc2-6cc1026139b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_45661416-2c29-45a4-b37a-dd347eb1e4b4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bd7b6e13-acbb-4a45-afc2-6cc1026139b8" xlink:to="loc_srt_MinimumMember_45661416-2c29-45a4-b37a-dd347eb1e4b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f48517b-2ddd-48f4-abfb-01be47c4c9d8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bd7b6e13-acbb-4a45-afc2-6cc1026139b8" xlink:to="loc_srt_MaximumMember_1f48517b-2ddd-48f4-abfb-01be47c4c9d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_fa3cacdd-a4c9-4915-99fa-b4228616f0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_715bc13a-2609-46c5-90c3-7281d816b768" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_fa3cacdd-a4c9-4915-99fa-b4228616f0b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_950dc95e-1e79-41c6-9de6-b857c1bb2a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5086a3ca-603b-4be1-97a5-cb7f5b23f633" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_950dc95e-1e79-41c6-9de6-b857c1bb2a7d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5086a3ca-603b-4be1-97a5-cb7f5b23f633" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b5123ee-c647-493f-9bd9-2c7529a76858" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5086a3ca-603b-4be1-97a5-cb7f5b23f633" xlink:to="loc_srt_RangeAxis_6b5123ee-c647-493f-9bd9-2c7529a76858" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b5123ee-c647-493f-9bd9-2c7529a76858_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6b5123ee-c647-493f-9bd9-2c7529a76858" xlink:to="loc_srt_RangeMember_6b5123ee-c647-493f-9bd9-2c7529a76858_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a5568a9-59ea-4cdf-b651-4151bd7cee08" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6b5123ee-c647-493f-9bd9-2c7529a76858" xlink:to="loc_srt_RangeMember_5a5568a9-59ea-4cdf-b651-4151bd7cee08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_742039bc-7e70-4058-b852-1a3b74853e3c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5a5568a9-59ea-4cdf-b651-4151bd7cee08" xlink:to="loc_srt_MinimumMember_742039bc-7e70-4058-b852-1a3b74853e3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5eb6f2d0-0a9c-4c38-9ab2-9b628f4c8d8b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5a5568a9-59ea-4cdf-b651-4151bd7cee08" xlink:to="loc_srt_MaximumMember_5eb6f2d0-0a9c-4c38-9ab2-9b628f4c8d8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_df79824c-04c7-4f33-b8b9-b6c53ea143a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_950dc95e-1e79-41c6-9de6-b857c1bb2a7d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_df79824c-04c7-4f33-b8b9-b6c53ea143a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9eb8f979-841f-4e96-9aee-2a6fcaccece6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_950dc95e-1e79-41c6-9de6-b857c1bb2a7d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9eb8f979-841f-4e96-9aee-2a6fcaccece6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_49bbe5c4-a770-42ed-9378-6e41c9378813" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_49bbe5c4-a770-42ed-9378-6e41c9378813" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_49bbe5c4-a770-42ed-9378-6e41c9378813_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_49bbe5c4-a770-42ed-9378-6e41c9378813" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_49bbe5c4-a770-42ed-9378-6e41c9378813_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_12a8a5ba-7889-4790-8433-5e5add0344f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_49bbe5c4-a770-42ed-9378-6e41c9378813" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_12a8a5ba-7889-4790-8433-5e5add0344f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f369fad1-1dde-4261-bc1e-a3ce5bada451" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_12a8a5ba-7889-4790-8433-5e5add0344f3" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f369fad1-1dde-4261-bc1e-a3ce5bada451" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_38751b19-75c8-4b76-862e-da512c366b36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:to="loc_us-gaap_HedgingDesignationAxis_38751b19-75c8-4b76-862e-da512c366b36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_38751b19-75c8-4b76-862e-da512c366b36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_38751b19-75c8-4b76-862e-da512c366b36" xlink:to="loc_us-gaap_HedgingDesignationDomain_38751b19-75c8-4b76-862e-da512c366b36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d4a9c80c-be5b-44ad-ab93-310d1d52c9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_38751b19-75c8-4b76-862e-da512c366b36" xlink:to="loc_us-gaap_HedgingDesignationDomain_d4a9c80c-be5b-44ad-ab93-310d1d52c9c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9c1371ac-90c4-4982-b08a-e0a13d5d1f02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_d4a9c80c-be5b-44ad-ab93-310d1d52c9c4" xlink:to="loc_us-gaap_NondesignatedMember_9c1371ac-90c4-4982-b08a-e0a13d5d1f02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_90ccbfa5-5a86-43fc-9b0c-2b023a9ab57d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_d4a9c80c-be5b-44ad-ab93-310d1d52c9c4" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_90ccbfa5-5a86-43fc-9b0c-2b023a9ab57d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c298263c-7d4f-448a-8bd7-087c31728455" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c298263c-7d4f-448a-8bd7-087c31728455" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c298263c-7d4f-448a-8bd7-087c31728455_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c298263c-7d4f-448a-8bd7-087c31728455" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c298263c-7d4f-448a-8bd7-087c31728455_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e88153b1-9897-4bc7-8e2a-debd13cf8372" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c298263c-7d4f-448a-8bd7-087c31728455" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e88153b1-9897-4bc7-8e2a-debd13cf8372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_fb3e668e-3e8d-4ad5-aa3c-411070eead3c" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e88153b1-9897-4bc7-8e2a-debd13cf8372" xlink:to="loc_ilmn_GRAILInc.Member_fb3e668e-3e8d-4ad5-aa3c-411070eead3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_affc7c61-3f42-46d5-b490-31c0fa753d03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_affc7c61-3f42-46d5-b490-31c0fa753d03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_73bac583-a972-4698-bb0f-c8a81ebdadf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_73bac583-a972-4698-bb0f-c8a81ebdadf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_374d4285-ea4d-449a-a579-764d866de19b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_DerivativeTermOfContract_374d4285-ea4d-449a-a579-764d866de19b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_f2c926a0-a07f-4b98-b687-2b61b8be57e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_f2c926a0-a07f-4b98-b687-2b61b8be57e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_3299ae6c-6db5-4b32-bfc7-10e2c0aa851e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_DerivativeAssets_3299ae6c-6db5-4b32-bfc7-10e2c0aa851e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_e2fbb741-2783-4cb5-a6d6-933261156eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_DerivativeLiabilities_e2fbb741-2783-4cb5-a6d6-933261156eb2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_77934eb2-eae5-41f2-bd68-66870ab28bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_77934eb2-eae5-41f2-bd68-66870ab28bb1" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityLineItems_a038516e-ed47-44fc-a3cc-ec34db3049b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityTable_ea6f1031-c084-4853-b691-1c8f8a8e83d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_a038516e-ed47-44fc-a3cc-ec34db3049b0" xlink:to="loc_us-gaap_ProductWarrantyLiabilityTable_ea6f1031-c084-4853-b691-1c8f8a8e83d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_25759db6-87ad-4f7f-b76c-b2f3817be0f0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_ea6f1031-c084-4853-b691-1c8f8a8e83d9" xlink:to="loc_srt_ProductOrServiceAxis_25759db6-87ad-4f7f-b76c-b2f3817be0f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_25759db6-87ad-4f7f-b76c-b2f3817be0f0_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_25759db6-87ad-4f7f-b76c-b2f3817be0f0" xlink:to="loc_srt_ProductsAndServicesDomain_25759db6-87ad-4f7f-b76c-b2f3817be0f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bad056b1-aae1-43d5-b8fe-8c904e0a782a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_25759db6-87ad-4f7f-b76c-b2f3817be0f0" xlink:to="loc_srt_ProductsAndServicesDomain_bad056b1-aae1-43d5-b8fe-8c904e0a782a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_InstrumentsMember_d0d6f4ab-5bc3-4ae3-8355-f55f4444dd68" xlink:href="ilmn-20241229.xsd#ilmn_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bad056b1-aae1-43d5-b8fe-8c904e0a782a" xlink:to="loc_ilmn_InstrumentsMember_d0d6f4ab-5bc3-4ae3-8355-f55f4444dd68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConsumablesMember_d1c5a58b-7c86-4c7b-afc0-e694f1ded247" xlink:href="ilmn-20241229.xsd#ilmn_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bad056b1-aae1-43d5-b8fe-8c904e0a782a" xlink:to="loc_ilmn_ConsumablesMember_d1c5a58b-7c86-4c7b-afc0-e694f1ded247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_90186752-84bc-463a-9da5-cc78acf14deb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_ea6f1031-c084-4853-b691-1c8f8a8e83d9" xlink:to="loc_srt_RangeAxis_90186752-84bc-463a-9da5-cc78acf14deb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_90186752-84bc-463a-9da5-cc78acf14deb_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_90186752-84bc-463a-9da5-cc78acf14deb" xlink:to="loc_srt_RangeMember_90186752-84bc-463a-9da5-cc78acf14deb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a8a05c02-ee09-4ac4-b488-e245e6f6072e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_90186752-84bc-463a-9da5-cc78acf14deb" xlink:to="loc_srt_RangeMember_a8a05c02-ee09-4ac4-b488-e245e6f6072e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5ec44b4b-6ef4-4572-8e7d-33f91f0c2403" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a8a05c02-ee09-4ac4-b488-e245e6f6072e" xlink:to="loc_srt_MinimumMember_5ec44b4b-6ef4-4572-8e7d-33f91f0c2403" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7c651b3d-ec36-4ba9-9756-010e113b9031" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a8a05c02-ee09-4ac4-b488-e245e6f6072e" xlink:to="loc_srt_MaximumMember_7c651b3d-ec36-4ba9-9756-010e113b9031" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_StandardProductWarrantyDescriptionTerm_4959b6f7-b2a6-496f-8051-76f7d22eff77" xlink:href="ilmn-20241229.xsd#ilmn_StandardProductWarrantyDescriptionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_a038516e-ed47-44fc-a3cc-ec34db3049b0" xlink:to="loc_ilmn_StandardProductWarrantyDescriptionTerm_4959b6f7-b2a6-496f-8051-76f7d22eff77" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GRAILSPINOFFNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81c07330-5941-4919-ad95-7de990083cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81c07330-5941-4919-ad95-7de990083cf5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_27117a53-610f-4c12-bf0e-95bbda38e4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81c07330-5941-4919-ad95-7de990083cf5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_27117a53-610f-4c12-bf0e-95bbda38e4c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_27117a53-610f-4c12-bf0e-95bbda38e4c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_27117a53-610f-4c12-bf0e-95bbda38e4c0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_27117a53-610f-4c12-bf0e-95bbda38e4c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_73778846-64ea-4af6-bcd4-4f7dfb417164" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_27117a53-610f-4c12-bf0e-95bbda38e4c0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_73778846-64ea-4af6-bcd4-4f7dfb417164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_ad8927dd-1888-47c8-a0a7-03581f869635" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_73778846-64ea-4af6-bcd4-4f7dfb417164" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_ad8927dd-1888-47c8-a0a7-03581f869635" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04cc2b0f-2a55-414c-88e0-7866f1cf5f52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81c07330-5941-4919-ad95-7de990083cf5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04cc2b0f-2a55-414c-88e0-7866f1cf5f52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04cc2b0f-2a55-414c-88e0-7866f1cf5f52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04cc2b0f-2a55-414c-88e0-7866f1cf5f52" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04cc2b0f-2a55-414c-88e0-7866f1cf5f52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6340c026-993e-4bb8-9dd5-b85d21bc031c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04cc2b0f-2a55-414c-88e0-7866f1cf5f52" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6340c026-993e-4bb8-9dd5-b85d21bc031c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_16f52f63-461d-4f9f-81b1-b716d0db0800" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6340c026-993e-4bb8-9dd5-b85d21bc031c" xlink:to="loc_ilmn_GRAILInc.Member_16f52f63-461d-4f9f-81b1-b716d0db0800" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_36af430d-8f5b-4a67-8105-a0b5daf3f9f1" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_36af430d-8f5b-4a67-8105-a0b5daf3f9f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_3f573977-75dd-41ba-b541-6425bd5d6758" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationPercentOfInterestDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_3f573977-75dd-41ba-b541-6425bd5d6758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff_cf1f55a4-225b-4b56-855b-14032a2e79c1" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff_cf1f55a4-225b-4b56-855b-14032a2e79c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_53f93e6c-e073-4f8b-a657-8269e366ab78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_53f93e6c-e073-4f8b-a657-8269e366ab78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_f982ba72-d148-4e0c-a4f4-f31e9fa941d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_f982ba72-d148-4e0c-a4f4-f31e9fa941d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_09e1a6d1-25e8-46d0-908b-b56666245746" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_09e1a6d1-25e8-46d0-908b-b56666245746" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationTransactionCosts_b44267ee-0e4a-4b5a-b9a0-12062017b5cd" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_ilmn_DiscontinuedOperationTransactionCosts_b44267ee-0e4a-4b5a-b9a0-12062017b5cd" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f2377c7-fbae-4c74-8f6a-ab4cbfdce411" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f2377c7-fbae-4c74-8f6a-ab4cbfdce411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6f2377c7-fbae-4c74-8f6a-ab4cbfdce411_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f2377c7-fbae-4c74-8f6a-ab4cbfdce411" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6f2377c7-fbae-4c74-8f6a-ab4cbfdce411_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326108cd-efa0-4b25-85b9-a90b3e74b0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f2377c7-fbae-4c74-8f6a-ab4cbfdce411" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326108cd-efa0-4b25-85b9-a90b3e74b0f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_344b0cc1-7fc7-4f25-a54c-076bb8e3dc39" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326108cd-efa0-4b25-85b9-a90b3e74b0f0" xlink:to="loc_ilmn_GRAILInc.Member_344b0cc1-7fc7-4f25-a54c-076bb8e3dc39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_064a7904-1df1-4235-87d4-56d58996b940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_064a7904-1df1-4235-87d4-56d58996b940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_064a7904-1df1-4235-87d4-56d58996b940_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_064a7904-1df1-4235-87d4-56d58996b940" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_064a7904-1df1-4235-87d4-56d58996b940_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_38305c8c-9069-4e45-ad4b-77e4aa1bd4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_064a7904-1df1-4235-87d4-56d58996b940" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_38305c8c-9069-4e45-ad4b-77e4aa1bd4d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_3ea1ebc5-c04d-4d61-a2a5-7f484f0a07a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_38305c8c-9069-4e45-ad4b-77e4aa1bd4d8" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_3ea1ebc5-c04d-4d61-a2a5-7f484f0a07a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a4e8b86-5716-4c98-862d-3bfeaf15ed95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a4e8b86-5716-4c98-862d-3bfeaf15ed95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7a4e8b86-5716-4c98-862d-3bfeaf15ed95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a4e8b86-5716-4c98-862d-3bfeaf15ed95" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7a4e8b86-5716-4c98-862d-3bfeaf15ed95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9ba55b9a-8082-4d7e-b954-c22cdb6c2942" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a4e8b86-5716-4c98-862d-3bfeaf15ed95" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9ba55b9a-8082-4d7e-b954-c22cdb6c2942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_53abb7ff-727a-4a25-b350-d44cc63a6d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ba55b9a-8082-4d7e-b954-c22cdb6c2942" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_53abb7ff-727a-4a25-b350-d44cc63a6d8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b52e01cd-50d1-4052-8e55-34706263a4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ba55b9a-8082-4d7e-b954-c22cdb6c2942" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b52e01cd-50d1-4052-8e55-34706263a4ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_63cdd094-761e-4edf-aa21-f85dc59a37c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_63cdd094-761e-4edf-aa21-f85dc59a37c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_63cdd094-761e-4edf-aa21-f85dc59a37c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_63cdd094-761e-4edf-aa21-f85dc59a37c6" xlink:to="loc_us-gaap_SegmentDomain_63cdd094-761e-4edf-aa21-f85dc59a37c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fabdb79a-74f8-4b74-811b-b81a7c7b06c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_63cdd094-761e-4edf-aa21-f85dc59a37c6" xlink:to="loc_us-gaap_SegmentDomain_fabdb79a-74f8-4b74-811b-b81a7c7b06c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILIncMember_15ce1144-08df-4f6c-a13d-ff137420134b" xlink:href="ilmn-20241229.xsd#ilmn_GRAILIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fabdb79a-74f8-4b74-811b-b81a7c7b06c3" xlink:to="loc_ilmn_GRAILIncMember_15ce1144-08df-4f6c-a13d-ff137420134b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5e8c3cda-84e1-4306-96f2-0daf94416774" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5e8c3cda-84e1-4306-96f2-0daf94416774" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5e8c3cda-84e1-4306-96f2-0daf94416774_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5e8c3cda-84e1-4306-96f2-0daf94416774" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5e8c3cda-84e1-4306-96f2-0daf94416774_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_64c74205-494e-435b-8705-277c4db27287" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5e8c3cda-84e1-4306-96f2-0daf94416774" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_64c74205-494e-435b-8705-277c4db27287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_cebd034f-9d23-4c52-a23e-337b7d4af439" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_64c74205-494e-435b-8705-277c4db27287" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_cebd034f-9d23-4c52-a23e-337b7d4af439" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2c41cff1-f9e7-4ab6-bb8c-b68aa3729a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2c41cff1-f9e7-4ab6-bb8c-b68aa3729a5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_ed5a337d-d054-4971-ab3a-b8ad6bb599c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_ed5a337d-d054-4971-ab3a-b8ad6bb599c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_4aa1ac2c-2dc3-4500-8ed5-acc7a3a5bd64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_4aa1ac2c-2dc3-4500-8ed5-acc7a3a5bd64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3f3b120f-9546-492d-bdd1-33bb336df6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3f3b120f-9546-492d-bdd1-33bb336df6e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6af9132a-e532-4f87-adfa-49318964454d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6af9132a-e532-4f87-adfa-49318964454d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_db0f0f26-867f-47f3-b71d-0bf8afbce085" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_db0f0f26-867f-47f3-b71d-0bf8afbce085" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_448391c2-20a0-4ab5-8e58-b9f661450a87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_448391c2-20a0-4ab5-8e58-b9f661450a87" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_6a73bf9b-0794-4338-a0dc-e595408a1494" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_6a73bf9b-0794-4338-a0dc-e595408a1494" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_256c870f-0bfe-45e3-b617-7889a3034389" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_256c870f-0bfe-45e3-b617-7889a3034389" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_85fc1694-b828-4892-973d-78ed335945b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_85fc1694-b828-4892-973d-78ed335945b4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_15084072-9892-461e-b223-b7cb820c3636" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_15084072-9892-461e-b223-b7cb820c3636" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_0690e2a8-6599-4e16-b740-9476cbcf54bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_0690e2a8-6599-4e16-b740-9476cbcf54bd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_ef7ef119-5e70-49f7-932f-0b1294416705" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_ef7ef119-5e70-49f7-932f-0b1294416705" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_b8da15cd-1529-4a18-b3cb-a0a359bfc97a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_b8da15cd-1529-4a18-b3cb-a0a359bfc97a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_49da1e7e-8ca6-463c-824a-e60428a015cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:to="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_49da1e7e-8ca6-463c-824a-e60428a015cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital_d139c745-5800-4812-9335-8eb551e15a32" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital_d139c745-5800-4812-9335-8eb551e15a32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c5118f24-bcdf-478c-b835-d1cd0fa1fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c5118f24-bcdf-478c-b835-d1cd0fa1fd92" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#REVENUEScheduleofDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3808897d-447f-46ce-9cf2-02a6d117145e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3808897d-447f-46ce-9cf2-02a6d117145e" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3db97ade-417c-40b0-857c-8e09cc5ab276" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3db97ade-417c-40b0-857c-8e09cc5ab276" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3db97ade-417c-40b0-857c-8e09cc5ab276_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3db97ade-417c-40b0-857c-8e09cc5ab276" xlink:to="loc_us-gaap_SegmentDomain_3db97ade-417c-40b0-857c-8e09cc5ab276_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7fb8aa6-3150-47ff-920c-37f12b113b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3db97ade-417c-40b0-857c-8e09cc5ab276" xlink:to="loc_us-gaap_SegmentDomain_d7fb8aa6-3150-47ff-920c-37f12b113b6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SequencingMember_9a06faaa-5ef9-4338-882b-96fad966afed" xlink:href="ilmn-20241229.xsd#ilmn_SequencingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d7fb8aa6-3150-47ff-920c-37f12b113b6c" xlink:to="loc_ilmn_SequencingMember_9a06faaa-5ef9-4338-882b-96fad966afed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MicroarrayMember_e4207b9c-1cf0-40af-b00c-a61e14431dbe" xlink:href="ilmn-20241229.xsd#ilmn_MicroarrayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d7fb8aa6-3150-47ff-920c-37f12b113b6c" xlink:to="loc_ilmn_MicroarrayMember_e4207b9c-1cf0-40af-b00c-a61e14431dbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e506593c-ce67-47ff-97e4-365300ae9d06" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:to="loc_srt_ProductOrServiceAxis_e506593c-ce67-47ff-97e4-365300ae9d06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e506593c-ce67-47ff-97e4-365300ae9d06_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e506593c-ce67-47ff-97e4-365300ae9d06" xlink:to="loc_srt_ProductsAndServicesDomain_e506593c-ce67-47ff-97e4-365300ae9d06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_da5568a6-54eb-4ebf-b4bf-3471e3007aac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e506593c-ce67-47ff-97e4-365300ae9d06" xlink:to="loc_srt_ProductsAndServicesDomain_da5568a6-54eb-4ebf-b4bf-3471e3007aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_4caa1626-93b8-4044-9ff3-0e92733ce814" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_da5568a6-54eb-4ebf-b4bf-3471e3007aac" xlink:to="loc_us-gaap_ProductMember_4caa1626-93b8-4044-9ff3-0e92733ce814" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConsumablesMember_e0650685-2593-4422-b1af-8bfcf851454c" xlink:href="ilmn-20241229.xsd#ilmn_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_4caa1626-93b8-4044-9ff3-0e92733ce814" xlink:to="loc_ilmn_ConsumablesMember_e0650685-2593-4422-b1af-8bfcf851454c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_InstrumentsMember_de840877-b77f-48f3-b379-b72d1a20aac2" xlink:href="ilmn-20241229.xsd#ilmn_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_4caa1626-93b8-4044-9ff3-0e92733ce814" xlink:to="loc_ilmn_InstrumentsMember_de840877-b77f-48f3-b379-b72d1a20aac2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_e8454b94-d81f-4970-883a-13eb89e0a5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_da5568a6-54eb-4ebf-b4bf-3471e3007aac" xlink:to="loc_us-gaap_ServiceMember_e8454b94-d81f-4970-883a-13eb89e0a5eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7155151a-ddea-4012-8031-49d2949120c5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:to="loc_srt_StatementGeographicalAxis_7155151a-ddea-4012-8031-49d2949120c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7155151a-ddea-4012-8031-49d2949120c5_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7155151a-ddea-4012-8031-49d2949120c5" xlink:to="loc_srt_SegmentGeographicalDomain_7155151a-ddea-4012-8031-49d2949120c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7155151a-ddea-4012-8031-49d2949120c5" xlink:to="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_bbdfd87c-bbfd-4ac1-97ca-9597ff39f34f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_srt_AmericasMember_bbdfd87c-bbfd-4ac1-97ca-9597ff39f34f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c4bd48e3-4f89-486f-a53f-4d629f43dec0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_srt_EuropeMember_c4bd48e3-4f89-486f-a53f-4d629f43dec0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_2c53269d-6310-4dc7-80c8-237fc62789a0" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_country_CN_2c53269d-6310-4dc7-80c8-237fc62789a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AsiaPacificMiddleEastAndAfricaMember_7a70fae5-65bc-4945-a740-7f39688d1802" xlink:href="ilmn-20241229.xsd#ilmn_AsiaPacificMiddleEastAndAfricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_ilmn_AsiaPacificMiddleEastAndAfricaMember_7a70fae5-65bc-4945-a740-7f39688d1802" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9c7f9976-12f4-42ae-aaf0-106e04093d17" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_country_US_9c7f9976-12f4-42ae-aaf0-106e04093d17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3f0284a6-1abd-4fca-b77f-fa5f0809e01a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3808897d-447f-46ce-9cf2-02a6d117145e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3f0284a6-1abd-4fca-b77f-fa5f0809e01a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#REVENUENarrativeRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_475cbc35-c784-43a3-b183-32cba4e90fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_475cbc35-c784-43a3-b183-32cba4e90fa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:to="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c3302acf-ed44-41be-b0ec-b09509dfccf6_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:to="loc_srt_RangeMember_c3302acf-ed44-41be-b0ec-b09509dfccf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:to="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8a1a807-d3c9-469b-aee7-5f6f4dd5eab3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:to="loc_srt_MinimumMember_b8a1a807-d3c9-469b-aee7-5f6f4dd5eab3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2b0b840c-05d3-42e1-8c74-55873438b159" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:to="loc_srt_MaximumMember_2b0b840c-05d3-42e1-8c74-55873438b159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame_6beadd3f-df6e-4c99-89a3-7d55938e6b2d" xlink:href="ilmn-20241229.xsd#ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame_6beadd3f-df6e-4c99-89a3-7d55938e6b2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_48db4ee9-454c-4d49-81f5-4b20b81bf804" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_48db4ee9-454c-4d49-81f5-4b20b81bf804" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_de42d419-4906-4453-b1a6-c616e8abd800" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_de42d419-4906-4453-b1a6-c616e8abd800" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d13518dc-ea00-4093-9b62-64a570e44918" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d13518dc-ea00-4093-9b62-64a570e44918" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="ilmn-20241229.xsd#REVENUENarrativeRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:to="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c3302acf-ed44-41be-b0ec-b09509dfccf6_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:to="loc_srt_RangeMember_c3302acf-ed44-41be-b0ec-b09509dfccf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:to="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8a1a807-d3c9-469b-aee7-5f6f4dd5eab3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:to="loc_srt_MinimumMember_b8a1a807-d3c9-469b-aee7-5f6f4dd5eab3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2b0b840c-05d3-42e1-8c74-55873438b159" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:to="loc_srt_MaximumMember_2b0b840c-05d3-42e1-8c74-55873438b159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame_6beadd3f-df6e-4c99-89a3-7d55938e6b2d" xlink:href="ilmn-20241229.xsd#ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame_6beadd3f-df6e-4c99-89a3-7d55938e6b2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_48db4ee9-454c-4d49-81f5-4b20b81bf804" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_48db4ee9-454c-4d49-81f5-4b20b81bf804" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_de42d419-4906-4453-b1a6-c616e8abd800" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_de42d419-4906-4453-b1a6-c616e8abd800" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d13518dc-ea00-4093-9b62-64a570e44918" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d13518dc-ea00-4093-9b62-64a570e44918" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1cd6126c-c6bd-40fe-8a34-b2543df2a147" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1cd6126c-c6bd-40fe-8a34-b2543df2a147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1cd6126c-c6bd-40fe-8a34-b2543df2a147_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1cd6126c-c6bd-40fe-8a34-b2543df2a147" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1cd6126c-c6bd-40fe-8a34-b2543df2a147_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7ac1bbc1-c70f-441d-9508-a605e1c032b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1cd6126c-c6bd-40fe-8a34-b2543df2a147" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7ac1bbc1-c70f-441d-9508-a605e1c032b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_284ce6e4-2876-4044-abc6-f80473b7670d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7ac1bbc1-c70f-441d-9508-a605e1c032b9" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_284ce6e4-2876-4044-abc6-f80473b7670d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_251f98f7-823b-4b64-a5ec-9ead81a7c377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_251f98f7-823b-4b64-a5ec-9ead81a7c377" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_251f98f7-823b-4b64-a5ec-9ead81a7c377_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_251f98f7-823b-4b64-a5ec-9ead81a7c377" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_251f98f7-823b-4b64-a5ec-9ead81a7c377_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fe31e226-3fbf-4805-aba1-1c3aeb892912" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_251f98f7-823b-4b64-a5ec-9ead81a7c377" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fe31e226-3fbf-4805-aba1-1c3aeb892912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_89accd75-9162-49a9-9785-3520ca862f01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fe31e226-3fbf-4805-aba1-1c3aeb892912" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_89accd75-9162-49a9-9785-3520ca862f01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b03cc9fe-4674-4b71-ac3d-a2f10d220f95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b03cc9fe-4674-4b71-ac3d-a2f10d220f95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b03cc9fe-4674-4b71-ac3d-a2f10d220f95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b03cc9fe-4674-4b71-ac3d-a2f10d220f95" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b03cc9fe-4674-4b71-ac3d-a2f10d220f95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d53fb27c-d085-4d6f-8389-4a33895bb1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b03cc9fe-4674-4b71-ac3d-a2f10d220f95" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d53fb27c-d085-4d6f-8389-4a33895bb1e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_94c8811e-81a0-4d30-8d73-15283013e85f" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d53fb27c-d085-4d6f-8389-4a33895bb1e5" xlink:to="loc_ilmn_GRAILInc.Member_94c8811e-81a0-4d30-8d73-15283013e85f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff4a8740-09b6-4378-b297-83221fd0d035" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff4a8740-09b6-4378-b297-83221fd0d035" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ff4a8740-09b6-4378-b297-83221fd0d035_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff4a8740-09b6-4378-b297-83221fd0d035" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ff4a8740-09b6-4378-b297-83221fd0d035_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ed79f77f-d945-4832-b210-ecfe8368ae2e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff4a8740-09b6-4378-b297-83221fd0d035" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ed79f77f-d945-4832-b210-ecfe8368ae2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundMember_93d9311e-ff4c-4512-adf7-ce56723271c7" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed79f77f-d945-4832-b210-ecfe8368ae2e" xlink:to="loc_ilmn_VentureCapitalInvestmentFundTheFundMember_93d9311e-ff4c-4512-adf7-ce56723271c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba03ba2d-cefa-44ba-a84d-1895bdfdb11f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba03ba2d-cefa-44ba-a84d-1895bdfdb11f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ba03ba2d-cefa-44ba-a84d-1895bdfdb11f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba03ba2d-cefa-44ba-a84d-1895bdfdb11f" xlink:to="loc_us-gaap_RelatedPartyDomain_ba03ba2d-cefa-44ba-a84d-1895bdfdb11f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2ce5cc50-13d8-4367-9950-04f4bd187533" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba03ba2d-cefa-44ba-a84d-1895bdfdb11f" xlink:to="loc_us-gaap_RelatedPartyDomain_2ce5cc50-13d8-4367-9950-04f4bd187533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember_9dd35283-6643-4395-9655-c3adc10c2633" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_2ce5cc50-13d8-4367-9950-04f4bd187533" xlink:to="loc_us-gaap_InvesteeMember_9dd35283-6643-4395-9655-c3adc10c2633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_162d7916-08a9-44b6-a08f-621ef4d500a0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_dei_LegalEntityAxis_162d7916-08a9-44b6-a08f-621ef4d500a0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_162d7916-08a9-44b6-a08f-621ef4d500a0_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_162d7916-08a9-44b6-a08f-621ef4d500a0" xlink:to="loc_dei_EntityDomain_162d7916-08a9-44b6-a08f-621ef4d500a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1a722c39-1d09-4be3-b12c-571be83d50b0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_162d7916-08a9-44b6-a08f-621ef4d500a0" xlink:to="loc_dei_EntityDomain_1a722c39-1d09-4be3-b12c-571be83d50b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_HelixHoldingsILLCMember_6e023411-9435-4c91-9763-3633cec15fb4" xlink:href="ilmn-20241229.xsd#ilmn_HelixHoldingsILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1a722c39-1d09-4be3-b12c-571be83d50b0" xlink:to="loc_ilmn_HelixHoldingsILLCMember_6e023411-9435-4c91-9763-3633cec15fb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_7e2ac1a6-bdae-43d3-9e35-3263d9162ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_7e2ac1a6-bdae-43d3-9e35-3263d9162ef3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7e2ac1a6-bdae-43d3-9e35-3263d9162ef3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_7e2ac1a6-bdae-43d3-9e35-3263d9162ef3" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7e2ac1a6-bdae-43d3-9e35-3263d9162ef3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6aa7b0f1-713d-4028-989a-fe54e51a51c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_7e2ac1a6-bdae-43d3-9e35-3263d9162ef3" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6aa7b0f1-713d-4028-989a-fe54e51a51c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_HelixContingentConsiderationMember_fdf45e43-2657-497e-94a5-96f6f3163472" xlink:href="ilmn-20241229.xsd#ilmn_HelixContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6aa7b0f1-713d-4028-989a-fe54e51a51c5" xlink:to="loc_ilmn_HelixContingentConsiderationMember_fdf45e43-2657-497e-94a5-96f6f3163472" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e085aa3-b3c0-4c3d-adaa-64236208fc80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e085aa3-b3c0-4c3d-adaa-64236208fc80" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e085aa3-b3c0-4c3d-adaa-64236208fc80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e085aa3-b3c0-4c3d-adaa-64236208fc80" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e085aa3-b3c0-4c3d-adaa-64236208fc80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3067185d-51d2-4d33-abe4-8637ede940ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e085aa3-b3c0-4c3d-adaa-64236208fc80" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3067185d-51d2-4d33-abe4-8637ede940ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_91da245a-f4d9-40c5-b712-da0e05f2ceaf" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3067185d-51d2-4d33-abe4-8637ede940ed" xlink:to="loc_ilmn_GRAILInc.Member_91da245a-f4d9-40c5-b712-da0e05f2ceaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentPaymentRightsAxis_5cd4c1b1-5dc4-4b9a-8567-e76ee2a3884d" xlink:href="ilmn-20241229.xsd#ilmn_ContingentPaymentRightsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_ilmn_ContingentPaymentRightsAxis_5cd4c1b1-5dc4-4b9a-8567-e76ee2a3884d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentPaymentRightsDomain_5cd4c1b1-5dc4-4b9a-8567-e76ee2a3884d_default" xlink:href="ilmn-20241229.xsd#ilmn_ContingentPaymentRightsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ilmn_ContingentPaymentRightsAxis_5cd4c1b1-5dc4-4b9a-8567-e76ee2a3884d" xlink:to="loc_ilmn_ContingentPaymentRightsDomain_5cd4c1b1-5dc4-4b9a-8567-e76ee2a3884d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentPaymentRightsDomain_8f72bce1-9d5d-4b01-81c4-df4633268562" xlink:href="ilmn-20241229.xsd#ilmn_ContingentPaymentRightsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ilmn_ContingentPaymentRightsAxis_5cd4c1b1-5dc4-4b9a-8567-e76ee2a3884d" xlink:to="loc_ilmn_ContingentPaymentRightsDomain_8f72bce1-9d5d-4b01-81c4-df4633268562" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember_72bdcf2d-ed14-44b3-a6ed-6789d8cfdb33" xlink:href="ilmn-20241229.xsd#ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ilmn_ContingentPaymentRightsDomain_8f72bce1-9d5d-4b01-81c4-df4633268562" xlink:to="loc_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember_72bdcf2d-ed14-44b3-a6ed-6789d8cfdb33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember_f4cf733d-c1c3-4ad6-ae99-34e1d2991213" xlink:href="ilmn-20241229.xsd#ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ilmn_ContingentPaymentRightsDomain_8f72bce1-9d5d-4b01-81c4-df4633268562" xlink:to="loc_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember_f4cf733d-c1c3-4ad6-ae99-34e1d2991213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cccb5479-3bc6-46c5-95c1-188dfbfa6154" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cccb5479-3bc6-46c5-95c1-188dfbfa6154" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_cccb5479-3bc6-46c5-95c1-188dfbfa6154_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cccb5479-3bc6-46c5-95c1-188dfbfa6154" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_cccb5479-3bc6-46c5-95c1-188dfbfa6154_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_e3fd0f2e-2808-496c-a2a5-245d82cfcaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cccb5479-3bc6-46c5-95c1-188dfbfa6154" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_e3fd0f2e-2808-496c-a2a5-245d82cfcaf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MeasurementInputRevenueRiskPremiumMember_05d35ccf-ea23-42ed-ab43-6e702a2ce2db" xlink:href="ilmn-20241229.xsd#ilmn_MeasurementInputRevenueRiskPremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e3fd0f2e-2808-496c-a2a5-245d82cfcaf0" xlink:to="loc_ilmn_MeasurementInputRevenueRiskPremiumMember_05d35ccf-ea23-42ed-ab43-6e702a2ce2db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MeasurementInputCalculationTrailingPeriodMember_9c23b411-ee1e-44f7-a294-feab871f3164" xlink:href="ilmn-20241229.xsd#ilmn_MeasurementInputCalculationTrailingPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e3fd0f2e-2808-496c-a2a5-245d82cfcaf0" xlink:to="loc_ilmn_MeasurementInputCalculationTrailingPeriodMember_9c23b411-ee1e-44f7-a294-feab871f3164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_ec148ae9-2207-413c-a6a0-2a05cc3b5547" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_ShortTermInvestments_ec148ae9-2207-413c-a6a0-2a05cc3b5547" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_739e8e53-adad-4278-8ab3-936dc3d9ec36" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_739e8e53-adad-4278-8ab3-936dc3d9ec36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_8b951b6c-d8b9-4cfd-91b7-26a0e2b22093" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_8b951b6c-d8b9-4cfd-91b7-26a0e2b22093" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_e7831c2c-56a4-48de-8998-0eede8ad044b" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_e7831c2c-56a4-48de-8998-0eede8ad044b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_5971b46f-fff6-4fae-acb9-1e83684b6a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_5971b46f-fff6-4fae-acb9-1e83684b6a1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_82e26e81-0b01-4eed-8190-c02866e1df12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_82e26e81-0b01-4eed-8190-c02866e1df12" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_NumberOfInvestmentFunds_e898a8a2-03f0-421f-846f-4a101115a54b" xlink:href="ilmn-20241229.xsd#ilmn_NumberOfInvestmentFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_NumberOfInvestmentFunds_e898a8a2-03f0-421f-846f-4a101115a54b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_e7ada20b-ac41-4971-8d0a-386e3f6d0b49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_EquityMethodInvestments_e7ada20b-ac41-4971-8d0a-386e3f6d0b49" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_5fd6d83d-a046-4529-a27c-622dee660c10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_5fd6d83d-a046-4529-a27c-622dee660c10" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9bea9a87-68d0-4a1c-a468-7d1d22dc3691" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9bea9a87-68d0-4a1c-a468-7d1d22dc3691" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsTerm_6349c83b-1881-4a90-9d0f-c51ed8327197" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_BusinessAcquisitionContingentValueRightsTerm_6349c83b-1881-4a90-9d0f-c51ed8327197" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_fc50e2a0-e43c-4b2c-b5a2-902c43480e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_fc50e2a0-e43c-4b2c-b5a2-902c43480e7a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage_5f024b41-b8ad-4923-bcd4-c36a52089965" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage_5f024b41-b8ad-4923-bcd4-c36a52089965" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold_ca2fb748-1d3b-4150-b87d-d0ee88174260" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold_ca2fb748-1d3b-4150-b87d-d0ee88174260" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage_f00ec4e7-78de-45ba-b318-37353b78b0e1" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage_f00ec4e7-78de-45ba-b318-37353b78b0e1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability_3537bcf1-d047-41ac-8726-d359e97e02b1" xlink:href="ilmn-20241229.xsd#ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability_3537bcf1-d047-41ac-8726-d359e97e02b1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_5df259fc-2c8f-4f81-a394-3b843564e749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_5df259fc-2c8f-4f81-a394-3b843564e749" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_11aa34c9-0c50-44f9-94e6-89c459f3bb92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_11aa34c9-0c50-44f9-94e6-89c459f3bb92" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_cfcf8c14-b41d-4e85-8845-5033fa0a28f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_cfcf8c14-b41d-4e85-8845-5033fa0a28f2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_8224972b-681b-4c2b-887b-cc2d95285e80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_8224972b-681b-4c2b-887b-cc2d95285e80" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease_c70e21bc-a231-4c8d-b34c-2b20280b3af8" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease_c70e21bc-a231-4c8d-b34c-2b20280b3af8" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease_a2197017-5296-4076-b39e-325892a9aa65" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease_a2197017-5296-4076-b39e-325892a9aa65" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease_baffc085-61ae-4872-ae93-992e84b4936f" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease_baffc085-61ae-4872-ae93-992e84b4936f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease_25ba91b6-e64f-4583-8c46-b1e3ee4ead22" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease_25ba91b6-e64f-4583-8c46-b1e3ee4ead22" xlink:type="arc" order="23"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_3fd21f35-7f5c-49e6-8572-9a79f2d24608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_3fd21f35-7f5c-49e6-8572-9a79f2d24608" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9849a578-66e4-4c5b-8b44-e0123101f05e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3fd21f35-7f5c-49e6-8572-9a79f2d24608" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9849a578-66e4-4c5b-8b44-e0123101f05e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9849a578-66e4-4c5b-8b44-e0123101f05e_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9849a578-66e4-4c5b-8b44-e0123101f05e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9849a578-66e4-4c5b-8b44-e0123101f05e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9849a578-66e4-4c5b-8b44-e0123101f05e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundOneMember_63d486af-1174-4cae-b285-29ab812d9158" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:to="loc_ilmn_VentureCapitalInvestmentFundTheFundOneMember_63d486af-1174-4cae-b285-29ab812d9158" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundTwoMember_3bd215af-bbfb-45a2-81a7-fd0b4e27ff8d" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:to="loc_ilmn_VentureCapitalInvestmentFundTheFundTwoMember_3bd215af-bbfb-45a2-81a7-fd0b4e27ff8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundThreeMember_d9cd143a-a940-4c8a-8da7-9e47a2efd82b" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:to="loc_ilmn_VentureCapitalInvestmentFundTheFundThreeMember_d9cd143a-a940-4c8a-8da7-9e47a2efd82b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_6e2101e1-2d2d-4970-a7e7-7d17dc1ef507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:to="loc_us-gaap_OtherCommitment_6e2101e1-2d2d-4970-a7e7-7d17dc1ef507" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RemainingCapitalCommitment_a937ddd1-9989-4000-922e-6e2ce6711d35" xlink:href="ilmn-20241229.xsd#ilmn_RemainingCapitalCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:to="loc_ilmn_RemainingCapitalCommitment_a937ddd1-9989-4000-922e-6e2ce6711d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RecallableDistributionsCommitment_ab2a2e50-2599-46dc-9193-972e956b5c6b" xlink:href="ilmn-20241229.xsd#ilmn_RecallableDistributionsCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:to="loc_ilmn_RecallableDistributionsCommitment_ab2a2e50-2599-46dc-9193-972e956b5c6b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acee7562-71ee-4ecd-b50e-639c29d6e869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7230e8a2-cd28-4b6b-86fa-397239b84974" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acee7562-71ee-4ecd-b50e-639c29d6e869" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7230e8a2-cd28-4b6b-86fa-397239b84974" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ef99543d-65f0-470f-b8c8-1362cd752676" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7230e8a2-cd28-4b6b-86fa-397239b84974" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ef99543d-65f0-470f-b8c8-1362cd752676" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ef99543d-65f0-470f-b8c8-1362cd752676_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ef99543d-65f0-470f-b8c8-1362cd752676" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ef99543d-65f0-470f-b8c8-1362cd752676_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e8a76d4-17a2-4859-94b9-40b6bd4823a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ef99543d-65f0-470f-b8c8-1362cd752676" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e8a76d4-17a2-4859-94b9-40b6bd4823a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_227fb4f2-1722-479c-ad71-3083f350eaac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e8a76d4-17a2-4859-94b9-40b6bd4823a5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_227fb4f2-1722-479c-ad71-3083f350eaac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2c14a7c-217b-4de3-8a58-f1f6aadf61d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7230e8a2-cd28-4b6b-86fa-397239b84974" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2c14a7c-217b-4de3-8a58-f1f6aadf61d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a2c14a7c-217b-4de3-8a58-f1f6aadf61d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2c14a7c-217b-4de3-8a58-f1f6aadf61d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a2c14a7c-217b-4de3-8a58-f1f6aadf61d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2c14a7c-217b-4de3-8a58-f1f6aadf61d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4bb1c046-f4bb-4b49-bef1-149bc7496aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4bb1c046-f4bb-4b49-bef1-149bc7496aa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_dee565ac-594e-4338-8cc7-159f8227ec30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_dee565ac-594e-4338-8cc7-159f8227ec30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_607fc505-5aeb-4c98-a700-5dd2e1e425d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_607fc505-5aeb-4c98-a700-5dd2e1e425d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acee7562-71ee-4ecd-b50e-639c29d6e869" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d887241f-d407-455a-aa29-d65895c0037d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d887241f-d407-455a-aa29-d65895c0037d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_f275162b-a600-41fc-8080-d09c0ffa3de2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_f275162b-a600-41fc-8080-d09c0ffa3de2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OtherInvestmentsFairValueDisclosure_393a349d-3c72-4996-ac94-2116f27e25ca" xlink:href="ilmn-20241229.xsd#ilmn_OtherInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_ilmn_OtherInvestmentsFairValueDisclosure_393a349d-3c72-4996-ac94-2116f27e25ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentValueRightFairValueDisclosure_30da0a04-097d-4709-ba71-779ba08ce18f" xlink:href="ilmn-20241229.xsd#ilmn_ContingentValueRightFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_ilmn_ContingentValueRightFairValueDisclosure_30da0a04-097d-4709-ba71-779ba08ce18f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_51dbc92e-1ad2-4350-a3b2-f7e85bf8bfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_51dbc92e-1ad2-4350-a3b2-f7e85bf8bfd0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_88c12588-9918-4a5a-b699-935ad176c887" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_88c12588-9918-4a5a-b699-935ad176c887" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acee7562-71ee-4ecd-b50e-639c29d6e869" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_da48d199-4f2a-4959-9682-f3d6741b872c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_da48d199-4f2a-4959-9682-f3d6741b872c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_0e7436bb-8431-4336-a352-e237bdbfa26a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_0e7436bb-8431-4336-a352-e237bdbfa26a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_3b19f4af-d4a0-4af8-810b-00ec71a010f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_3b19f4af-d4a0-4af8-810b-00ec71a010f8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c56c6dfe-4155-4124-b21d-7b3698be29ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_31c95d27-c56f-4f19-917c-24e366949622" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c56c6dfe-4155-4124-b21d-7b3698be29ee" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_31c95d27-c56f-4f19-917c-24e366949622" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_8f03b74e-64d7-4a2c-b3af-08cd745b3a71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_31c95d27-c56f-4f19-917c-24e366949622" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_8f03b74e-64d7-4a2c-b3af-08cd745b3a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_8f03b74e-64d7-4a2c-b3af-08cd745b3a71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_8f03b74e-64d7-4a2c-b3af-08cd745b3a71" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_8f03b74e-64d7-4a2c-b3af-08cd745b3a71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0513fdbf-9ced-49c7-a917-9f1edd70fde6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_8f03b74e-64d7-4a2c-b3af-08cd745b3a71" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0513fdbf-9ced-49c7-a917-9f1edd70fde6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_HelixContingentConsiderationMember_38c219cd-1712-4fd1-8def-001aa3ef8a39" xlink:href="ilmn-20241229.xsd#ilmn_HelixContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0513fdbf-9ced-49c7-a917-9f1edd70fde6" xlink:to="loc_ilmn_HelixContingentConsiderationMember_38c219cd-1712-4fd1-8def-001aa3ef8a39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c56c6dfe-4155-4124-b21d-7b3698be29ee" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4495b560-28c4-4c5f-8dd8-201ca51b375a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4495b560-28c4-4c5f-8dd8-201ca51b375a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_d2817697-9393-4a25-89d9-65f384395685" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_d2817697-9393-4a25-89d9-65f384395685" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_55c1a57e-cb42-4e11-82a0-10ad07d2bcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_55c1a57e-cb42-4e11-82a0-10ad07d2bcaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_7b5f9125-a6b2-4a4b-a6d8-68f795eb3cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_34e4d9da-f96a-4aeb-8cf2-f08780e3b638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b2a34e2f-2472-4218-9826-14c9975bfa56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_34e4d9da-f96a-4aeb-8cf2-f08780e3b638" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b2a34e2f-2472-4218-9826-14c9975bfa56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_c5255db8-58ae-4c62-b8df-261120732f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b2a34e2f-2472-4218-9826-14c9975bfa56" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_c5255db8-58ae-4c62-b8df-261120732f8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c5255db8-58ae-4c62-b8df-261120732f8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c5255db8-58ae-4c62-b8df-261120732f8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c5255db8-58ae-4c62-b8df-261120732f8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b45c4229-3b3f-480c-a59c-4bd6776ad905" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c5255db8-58ae-4c62-b8df-261120732f8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b45c4229-3b3f-480c-a59c-4bd6776ad905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessCombinationContingentConsiderationLiabilityMember_8a699b4c-e816-4993-b047-701b388acfaf" xlink:href="ilmn-20241229.xsd#ilmn_BusinessCombinationContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b45c4229-3b3f-480c-a59c-4bd6776ad905" xlink:to="loc_ilmn_BusinessCombinationContingentConsiderationLiabilityMember_8a699b4c-e816-4993-b047-701b388acfaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_45813c58-3b7f-49f3-a887-7db5e7f84bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b2a34e2f-2472-4218-9826-14c9975bfa56" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_45813c58-3b7f-49f3-a887-7db5e7f84bf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_45813c58-3b7f-49f3-a887-7db5e7f84bf6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_45813c58-3b7f-49f3-a887-7db5e7f84bf6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_45813c58-3b7f-49f3-a887-7db5e7f84bf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1a314607-f3f2-475a-b210-85e5f3711ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_45813c58-3b7f-49f3-a887-7db5e7f84bf6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1a314607-f3f2-475a-b210-85e5f3711ec4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_57bd9cb3-d382-4d27-b7e8-023690b4b452" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1a314607-f3f2-475a-b210-85e5f3711ec4" xlink:to="loc_ilmn_GRAILInc.Member_57bd9cb3-d382-4d27-b7e8-023690b4b452" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_34e4d9da-f96a-4aeb-8cf2-f08780e3b638" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_238f5788-074a-4471-bf9c-66f80519ca60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_238f5788-074a-4471-bf9c-66f80519ca60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78995685-8159-4cf9-bc99-d25f807ce4de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78995685-8159-4cf9-bc99-d25f807ce4de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7dcd3b8a-636b-4f78-ac64-d0d4e9a092da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7dcd3b8a-636b-4f78-ac64-d0d4e9a092da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d06a1d4e-bc22-4543-a07f-ae8ade5e8bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d06a1d4e-bc22-4543-a07f-ae8ade5e8bcc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_00bf88bf-ee56-4a20-ada5-de1b475d661d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5af12e6c-7f0d-4f37-a01e-ecfb48724b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f5827f5e-3f74-42cc-8fd9-228bbce2ae8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_5af12e6c-7f0d-4f37-a01e-ecfb48724b7f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f5827f5e-3f74-42cc-8fd9-228bbce2ae8d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5ec731ab-7c8e-48d0-897a-6dec26e03f85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f5827f5e-3f74-42cc-8fd9-228bbce2ae8d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5ec731ab-7c8e-48d0-897a-6dec26e03f85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5ec731ab-7c8e-48d0-897a-6dec26e03f85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5ec731ab-7c8e-48d0-897a-6dec26e03f85" xlink:to="loc_us-gaap_SegmentDomain_5ec731ab-7c8e-48d0-897a-6dec26e03f85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_20dc2b26-5438-4f20-88da-8e6d749e7626" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5ec731ab-7c8e-48d0-897a-6dec26e03f85" xlink:to="loc_us-gaap_SegmentDomain_20dc2b26-5438-4f20-88da-8e6d749e7626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILIncMember_1b6f5535-3aeb-4aa6-a151-2d332413ed6b" xlink:href="ilmn-20241229.xsd#ilmn_GRAILIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_20dc2b26-5438-4f20-88da-8e6d749e7626" xlink:to="loc_ilmn_GRAILIncMember_1b6f5535-3aeb-4aa6-a151-2d332413ed6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5af12e6c-7f0d-4f37-a01e-ecfb48724b7f" xlink:to="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_80948c36-0442-47dc-a453-f2b4028d1bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:to="loc_us-gaap_Goodwill_80948c36-0442-47dc-a453-f2b4028d1bfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0d328674-bd52-4c12-b21b-588269b73481" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0d328674-bd52-4c12-b21b-588269b73481" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6c99bd14-d295-42ea-9275-05b1a99b27f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6c99bd14-d295-42ea-9275-05b1a99b27f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97a46589-aa24-402a-b6de-29cb8131d8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_988a0117-e2bd-45ee-91c0-00a74d9068f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_988a0117-e2bd-45ee-91c0-00a74d9068f9" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f4878350-7c3d-45f4-baf3-e035c34fadf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f4878350-7c3d-45f4-baf3-e035c34fadf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f4878350-7c3d-45f4-baf3-e035c34fadf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f4878350-7c3d-45f4-baf3-e035c34fadf3" xlink:to="loc_us-gaap_SegmentDomain_f4878350-7c3d-45f4-baf3-e035c34fadf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_766bfa45-0691-47bd-afb1-881766b5bcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f4878350-7c3d-45f4-baf3-e035c34fadf3" xlink:to="loc_us-gaap_SegmentDomain_766bfa45-0691-47bd-afb1-881766b5bcf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_2f6249e3-7aa1-4f1f-90df-fca781de6a2c" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_766bfa45-0691-47bd-afb1-881766b5bcf7" xlink:to="loc_ilmn_GRAILInc.Member_2f6249e3-7aa1-4f1f-90df-fca781de6a2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0742dee7-e1c4-426d-89cf-18c4c5daadaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0742dee7-e1c4-426d-89cf-18c4c5daadaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_0742dee7-e1c4-426d-89cf-18c4c5daadaa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0742dee7-e1c4-426d-89cf-18c4c5daadaa" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_0742dee7-e1c4-426d-89cf-18c4c5daadaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0742dee7-e1c4-426d-89cf-18c4c5daadaa" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MeasurementInputCashFlowPeriodMemberMember_01231637-8e6f-4f0e-b564-fd8051e00278" xlink:href="ilmn-20241229.xsd#ilmn_MeasurementInputCashFlowPeriodMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:to="loc_ilmn_MeasurementInputCashFlowPeriodMemberMember_01231637-8e6f-4f0e-b564-fd8051e00278" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b4b03293-a72f-4fbe-87ee-9dbf110ec694" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b4b03293-a72f-4fbe-87ee-9dbf110ec694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1cb778a9-90a9-480d-9bf5-c2199b5a1c21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1cb778a9-90a9-480d-9bf5-c2199b5a1c21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_eb8482f9-107a-4093-8f28-adaf72bdd3de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_ValuationTechniqueAxis_eb8482f9-107a-4093-8f28-adaf72bdd3de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_eb8482f9-107a-4093-8f28-adaf72bdd3de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_eb8482f9-107a-4093-8f28-adaf72bdd3de" xlink:to="loc_us-gaap_ValuationTechniqueDomain_eb8482f9-107a-4093-8f28-adaf72bdd3de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_618ea2eb-c4d1-4514-af38-153461ddb0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_eb8482f9-107a-4093-8f28-adaf72bdd3de" xlink:to="loc_us-gaap_ValuationTechniqueDomain_618ea2eb-c4d1-4514-af38-153461ddb0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_2ee4bd07-2573-49ca-916e-baf3c16a0950" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_618ea2eb-c4d1-4514-af38-153461ddb0c1" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_2ee4bd07-2573-49ca-916e-baf3c16a0950" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_58e0a979-104c-45b0-ac7d-9b40c5083489" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_srt_RangeAxis_58e0a979-104c-45b0-ac7d-9b40c5083489" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58e0a979-104c-45b0-ac7d-9b40c5083489_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_58e0a979-104c-45b0-ac7d-9b40c5083489" xlink:to="loc_srt_RangeMember_58e0a979-104c-45b0-ac7d-9b40c5083489_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c79c3953-695b-4b97-afc5-3670c1bd136b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_58e0a979-104c-45b0-ac7d-9b40c5083489" xlink:to="loc_srt_RangeMember_c79c3953-695b-4b97-afc5-3670c1bd136b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a68a4c6a-976b-4d09-ab58-e55c8f2f921f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c79c3953-695b-4b97-afc5-3670c1bd136b" xlink:to="loc_srt_MinimumMember_a68a4c6a-976b-4d09-ab58-e55c8f2f921f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e14325d3-a22d-455a-ab0c-18a8c22388d5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c79c3953-695b-4b97-afc5-3670c1bd136b" xlink:to="loc_srt_MaximumMember_e14325d3-a22d-455a-ab0c-18a8c22388d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_749c3726-b3d5-466d-9901-4399ec2afb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_749c3726-b3d5-466d-9901-4399ec2afb3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_749c3726-b3d5-466d-9901-4399ec2afb3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_749c3726-b3d5-466d-9901-4399ec2afb3c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_749c3726-b3d5-466d-9901-4399ec2afb3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9ec106f8-0f02-47ad-962e-e39b8dde0f57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_749c3726-b3d5-466d-9901-4399ec2afb3c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9ec106f8-0f02-47ad-962e-e39b8dde0f57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_a692d7a3-f141-42f0-bcdb-1ee04d4aad69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9ec106f8-0f02-47ad-962e-e39b8dde0f57" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_a692d7a3-f141-42f0-bcdb-1ee04d4aad69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_85e966bf-c3a1-4a99-80ef-d87ca01df1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_85e966bf-c3a1-4a99-80ef-d87ca01df1d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_85e966bf-c3a1-4a99-80ef-d87ca01df1d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_85e966bf-c3a1-4a99-80ef-d87ca01df1d7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_85e966bf-c3a1-4a99-80ef-d87ca01df1d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9eddc4cf-3886-4122-95b7-9492e7c9710c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_85e966bf-c3a1-4a99-80ef-d87ca01df1d7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9eddc4cf-3886-4122-95b7-9492e7c9710c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILIncMember_2778a47d-7e1f-4bf3-8cb1-d3d1278fc9ac" xlink:href="ilmn-20241229.xsd#ilmn_GRAILIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9eddc4cf-3886-4122-95b7-9492e7c9710c" xlink:to="loc_ilmn_GRAILIncMember_2778a47d-7e1f-4bf3-8cb1-d3d1278fc9ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_33719427-1ebb-47db-bf98-bbb0cce10b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_33719427-1ebb-47db-bf98-bbb0cce10b3d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_33719427-1ebb-47db-bf98-bbb0cce10b3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_33719427-1ebb-47db-bf98-bbb0cce10b3d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_33719427-1ebb-47db-bf98-bbb0cce10b3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_37a615c4-75c4-4739-8bcd-78e702f88ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_33719427-1ebb-47db-bf98-bbb0cce10b3d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_37a615c4-75c4-4739-8bcd-78e702f88ba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_aa42516e-80fe-42ff-a68d-a2e787af5651" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_37a615c4-75c4-4739-8bcd-78e702f88ba7" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_aa42516e-80fe-42ff-a68d-a2e787af5651" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3284f4c6-d808-47e4-a75e-25911bc00bea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3284f4c6-d808-47e4-a75e-25911bc00bea" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3284f4c6-d808-47e4-a75e-25911bc00bea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3284f4c6-d808-47e4-a75e-25911bc00bea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3284f4c6-d808-47e4-a75e-25911bc00bea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a58f0e7-0383-4cfa-ac92-dee3c942b1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3284f4c6-d808-47e4-a75e-25911bc00bea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a58f0e7-0383-4cfa-ac92-dee3c942b1d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILIncMember_87735db7-4e8b-41e9-9893-eb7c3a405d4c" xlink:href="ilmn-20241229.xsd#ilmn_GRAILIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a58f0e7-0383-4cfa-ac92-dee3c942b1d9" xlink:to="loc_ilmn_GRAILIncMember_87735db7-4e8b-41e9-9893-eb7c3a405d4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_3f3af474-c998-446d-a0e4-6bb2b79d5ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a58f0e7-0383-4cfa-ac92-dee3c942b1d9" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_3f3af474-c998-446d-a0e4-6bb2b79d5ed5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8ac27266-c6c7-4ab3-9264-4d9fe8d76277" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8ac27266-c6c7-4ab3-9264-4d9fe8d76277" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8ac27266-c6c7-4ab3-9264-4d9fe8d76277_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8ac27266-c6c7-4ab3-9264-4d9fe8d76277" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8ac27266-c6c7-4ab3-9264-4d9fe8d76277_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1a2eba74-aad4-4b2d-8518-723d3f8cdea3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8ac27266-c6c7-4ab3-9264-4d9fe8d76277" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1a2eba74-aad4-4b2d-8518-723d3f8cdea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_8fcb3ab2-ea9d-485c-8533-f20b302687cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1a2eba74-aad4-4b2d-8518-723d3f8cdea3" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_8fcb3ab2-ea9d-485c-8533-f20b302687cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a0d3d66f-48df-4d94-9136-c26d13cd1e17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1a2eba74-aad4-4b2d-8518-723d3f8cdea3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a0d3d66f-48df-4d94-9136-c26d13cd1e17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_81449882-1595-4dd5-92f0-1bc60d3f9757" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_AssetAcquisitionAxis_81449882-1595-4dd5-92f0-1bc60d3f9757" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_81449882-1595-4dd5-92f0-1bc60d3f9757_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_81449882-1595-4dd5-92f0-1bc60d3f9757" xlink:to="loc_us-gaap_AssetAcquisitionDomain_81449882-1595-4dd5-92f0-1bc60d3f9757_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_cd7fb9e1-b683-4f7c-98e0-098abb1f607c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_81449882-1595-4dd5-92f0-1bc60d3f9757" xlink:to="loc_us-gaap_AssetAcquisitionDomain_cd7fb9e1-b683-4f7c-98e0-098abb1f607c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FluentBioSciencesMember_a3262da5-ab0a-4e90-9c53-d2a7e23c691f" xlink:href="ilmn-20241229.xsd#ilmn_FluentBioSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_cd7fb9e1-b683-4f7c-98e0-098abb1f607c" xlink:to="loc_ilmn_FluentBioSciencesMember_a3262da5-ab0a-4e90-9c53-d2a7e23c691f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_f70c3420-68da-441b-a516-f64cb5f312e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_NumberOfReportingUnits_f70c3420-68da-441b-a516-f64cb5f312e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillAmountThatExceedsCarryingValue_4bd40a2c-2ff7-4c0b-be9f-cf5d81f1c1b0" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillAmountThatExceedsCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillAmountThatExceedsCarryingValue_4bd40a2c-2ff7-4c0b-be9f-cf5d81f1c1b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ab9c97c0-f8ed-4684-90ee-c68adb60004f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ab9c97c0-f8ed-4684-90ee-c68adb60004f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentMeasurementInput_b152d40c-abfe-4007-a919-6223e665f954" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillImpairmentMeasurementInput_b152d40c-abfe-4007-a919-6223e665f954" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d27080a4-be27-45dd-9210-82c366c17468" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_Goodwill_d27080a4-be27-45dd-9210-82c366c17468" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_647a181e-dfac-46f3-a9e3-a8da75018620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_647a181e-dfac-46f3-a9e3-a8da75018620" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_dc7313df-e16e-4224-a6d3-a2e6adc61612" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_dc7313df-e16e-4224-a6d3-a2e6adc61612" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_21a95668-a6fc-476d-805f-a1b256a408da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_21a95668-a6fc-476d-805f-a1b256a408da" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IntangibleAssetsImpairmentMeasurementInput_c0ff53fb-b8fb-49d0-a711-bee4c08b8a5e" xlink:href="ilmn-20241229.xsd#ilmn_IntangibleAssetsImpairmentMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_IntangibleAssetsImpairmentMeasurementInput_c0ff53fb-b8fb-49d0-a711-bee4c08b8a5e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints_ea5870e5-4f67-4cf5-95c4-24c973568d7f" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints_ea5870e5-4f67-4cf5-95c4-24c973568d7f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate_604ef5e5-550f-4df9-9a9c-593724230435" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate_604ef5e5-550f-4df9-9a9c-593724230435" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate_b63ddbbf-f17e-411e-a4b3-92dd327f09ef" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate_b63ddbbf-f17e-411e-a4b3-92dd327f09ef" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillPotentialImpairmentLoss_2b8e3cda-e037-4f59-a6df-c6eca69d4a7c" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillPotentialImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillPotentialImpairmentLoss_2b8e3cda-e037-4f59-a6df-c6eca69d4a7c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_df8ff233-8b8f-4c04-b41f-f816a4adadb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_df8ff233-8b8f-4c04-b41f-f816a4adadb3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentTestDiscountRate_30646b0c-d602-425d-98bf-39982a358983" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentTestDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillImpairmentTestDiscountRate_30646b0c-d602-425d-98bf-39982a358983" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e13c17ba-81b4-45d3-9ab9-5e66964925ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e13c17ba-81b4-45d3-9ab9-5e66964925ff" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_fa403914-09ae-47a9-805c-8aa52beab083" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_fa403914-09ae-47a9-805c-8aa52beab083" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_e4ce292f-dd6a-443a-95e5-094550804e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_e4ce292f-dd6a-443a-95e5-094550804e07" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c4754f59-e50c-4797-b39c-e37dc0b64286" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c4754f59-e50c-4797-b39c-e37dc0b64286" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e76cefcd-bd40-4a47-bb9d-0d17c703abea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c4754f59-e50c-4797-b39c-e37dc0b64286" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e76cefcd-bd40-4a47-bb9d-0d17c703abea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e76cefcd-bd40-4a47-bb9d-0d17c703abea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e76cefcd-bd40-4a47-bb9d-0d17c703abea" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e76cefcd-bd40-4a47-bb9d-0d17c703abea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fedffdba-03c3-4cdd-a46e-be2b0080a0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e76cefcd-bd40-4a47-bb9d-0d17c703abea" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fedffdba-03c3-4cdd-a46e-be2b0080a0ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_cc17adac-5f87-4537-bcd5-1eb8a115c612" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fedffdba-03c3-4cdd-a46e-be2b0080a0ae" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_cc17adac-5f87-4537-bcd5-1eb8a115c612" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e29810fb-7951-48ae-a935-51b76ff54bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c4754f59-e50c-4797-b39c-e37dc0b64286" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e29810fb-7951-48ae-a935-51b76ff54bf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e29810fb-7951-48ae-a935-51b76ff54bf2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e29810fb-7951-48ae-a935-51b76ff54bf2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e29810fb-7951-48ae-a935-51b76ff54bf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e29810fb-7951-48ae-a935-51b76ff54bf2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_20c74662-2211-4f90-a220-49d552af549e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_20c74662-2211-4f90-a220-49d552af549e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LicensedTechnologyMember_2c473e5a-48da-48c6-a90d-304c2cb88e7a" xlink:href="ilmn-20241229.xsd#ilmn_LicensedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_ilmn_LicensedTechnologyMember_2c473e5a-48da-48c6-a90d-304c2cb88e7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_1405fad7-bcd6-4db2-9d5d-887c1a76f9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_LicensingAgreementsMember_1405fad7-bcd6-4db2-9d5d-887c1a76f9e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ff2873ea-7927-4765-ab9c-040aec15de56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ff2873ea-7927-4765-ab9c-040aec15de56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_b9410fc9-ccea-4198-ad6e-8535d53d7549" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_DatabasesMember_b9410fc9-ccea-4198-ad6e-8535d53d7549" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_600be75d-70ea-4e42-8e2c-164c79e5b8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_TradeNamesMember_600be75d-70ea-4e42-8e2c-164c79e5b8f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_70c62d41-52a9-4b39-a07e-a6ac8ff0f124" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_70c62d41-52a9-4b39-a07e-a6ac8ff0f124" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0e7ed39e-4277-4e0e-adfc-be2b06958f87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0e7ed39e-4277-4e0e-adfc-be2b06958f87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment_b2346c35-bfdf-49ba-9c24-91c02f2cd249" xlink:href="ilmn-20241229.xsd#ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment_b2346c35-bfdf-49ba-9c24-91c02f2cd249" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8f0a8c3-9b75-4ed9-85a4-29da511cf0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8f0a8c3-9b75-4ed9-85a4-29da511cf0b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross_1dee4aed-880f-42bf-b2b2-89c00c2f83b7" xlink:href="ilmn-20241229.xsd#ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross_1dee4aed-880f-42bf-b2b2-89c00c2f83b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_417ddfb4-18f8-48dc-9c4d-573e63c75560" xlink:href="ilmn-20241229.xsd#ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_417ddfb4-18f8-48dc-9c4d-573e63c75560" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4cd6c56c-767d-4afe-84fb-e7e700130834" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4cd6c56c-767d-4afe-84fb-e7e700130834" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bb594d46-662b-40e9-b2b0-ed8f007737f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bb594d46-662b-40e9-b2b0-ed8f007737f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_739130c4-70f4-4f7c-ac7f-2bcc39a2a289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_1c2a9961-e3c3-45b6-9097-09e4d1ba7d3d" xlink:href="ilmn-20241229.xsd#ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:to="loc_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_1c2a9961-e3c3-45b6-9097-09e4d1ba7d3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0c52e780-f9f6-445a-8f63-5d82520ab13c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0c52e780-f9f6-445a-8f63-5d82520ab13c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_a30b2dc7-d123-466d-9430-4ee8d550a320" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_a30b2dc7-d123-466d-9430-4ee8d550a320" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fd8310d8-90d9-4f8d-b8c0-6ea19fd594f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fd8310d8-90d9-4f8d-b8c0-6ea19fd594f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fd8310d8-90d9-4f8d-b8c0-6ea19fd594f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fd8310d8-90d9-4f8d-b8c0-6ea19fd594f8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fd8310d8-90d9-4f8d-b8c0-6ea19fd594f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_63c465a8-3484-449d-81b4-39cdbbbef1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fd8310d8-90d9-4f8d-b8c0-6ea19fd594f8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_63c465a8-3484-449d-81b4-39cdbbbef1b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesMember_e939f110-656f-4d75-ad21-4b03464ee340" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_63c465a8-3484-449d-81b4-39cdbbbef1b0" xlink:to="loc_ilmn_TermNotesMember_e939f110-656f-4d75-ad21-4b03464ee340" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b4354f8d-e5d1-483a-b869-5b21a92f6686" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:to="loc_us-gaap_DebtInstrumentAxis_b4354f8d-e5d1-483a-b869-5b21a92f6686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b4354f8d-e5d1-483a-b869-5b21a92f6686_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b4354f8d-e5d1-483a-b869-5b21a92f6686" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b4354f8d-e5d1-483a-b869-5b21a92f6686_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b4354f8d-e5d1-483a-b869-5b21a92f6686" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2025Member_8ea475c6-c899-4a3f-85df-30205450eda7" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:to="loc_ilmn_TermNotesDue2025Member_8ea475c6-c899-4a3f-85df-30205450eda7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2026Member_77af24b3-ddd2-4f0a-a7fc-e6dd1d27ea25" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:to="loc_ilmn_TermNotesDue2026Member_77af24b3-ddd2-4f0a-a7fc-e6dd1d27ea25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2027Member_65055c5f-8fa4-45a5-a173-f804ba8c7734" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:to="loc_ilmn_TermNotesDue2027Member_65055c5f-8fa4-45a5-a173-f804ba8c7734" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2031Member_8a5dacf8-36e0-4275-9052-98280970275c" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:to="loc_ilmn_TermNotesDue2031Member_8a5dacf8-36e0-4275-9052-98280970275c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11336454-ba94-43af-af25-422b360b018c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11336454-ba94-43af-af25-422b360b018c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11336454-ba94-43af-af25-422b360b018c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11336454-ba94-43af-af25-422b360b018c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11336454-ba94-43af-af25-422b360b018c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7f81c8e7-7874-4ce3-806e-343324f1a8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11336454-ba94-43af-af25-422b360b018c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7f81c8e7-7874-4ce3-806e-343324f1a8b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b1ec14a7-a153-4e78-8da3-325a50bbf468" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7f81c8e7-7874-4ce3-806e-343324f1a8b9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b1ec14a7-a153-4e78-8da3-325a50bbf468" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_260d6ec8-016d-4a7b-8288-9ae13bbadbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_260d6ec8-016d-4a7b-8288-9ae13bbadbcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9d95f27c-0a01-45a8-bd71-194fc91b7008" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9d95f27c-0a01-45a8-bd71-194fc91b7008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fa401ea6-7750-4d4d-aff7-46c15ad398d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_LongTermDebt_fa401ea6-7750-4d4d-aff7-46c15ad398d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_606fb720-9d62-4cc2-b6d0-839e62e02d75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_LongTermDebtCurrent_606fb720-9d62-4cc2-b6d0-839e62e02d75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ed2c7a9b-8833-427d-a016-bd8921c77915" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ed2c7a9b-8833-427d-a016-bd8921c77915" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_95640705-7137-4818-a57d-eb0aa4197baf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_DebtInstrumentFairValue_95640705-7137-4818-a57d-eb0aa4197baf" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a26e8c8e-df57-440b-a4f3-7376488b7db5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a26e8c8e-df57-440b-a4f3-7376488b7db5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a26e8c8e-df57-440b-a4f3-7376488b7db5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a26e8c8e-df57-440b-a4f3-7376488b7db5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a26e8c8e-df57-440b-a4f3-7376488b7db5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a26e8c8e-df57-440b-a4f3-7376488b7db5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesMember_a227f123-8866-43f5-bc5c-8234c04e80d7" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:to="loc_ilmn_TermNotesMember_a227f123-8866-43f5-bc5c-8234c04e80d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_44bc92a4-ffa0-46c4-939a-d6ed90dd1cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:to="loc_us-gaap_ConvertibleDebtMember_44bc92a4-ffa0-46c4-939a-d6ed90dd1cb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_66536a09-4b82-4fa3-8ae4-a1c237c9f124" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:to="loc_us-gaap_LineOfCreditMember_66536a09-4b82-4fa3-8ae4-a1c237c9f124" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_8ead484b-07a6-4aef-9fe2-943f9cdee94c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:to="loc_us-gaap_UnsecuredDebtMember_8ead484b-07a6-4aef-9fe2-943f9cdee94c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_46298b61-115a-4907-923f-450281be7156" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_us-gaap_DebtInstrumentAxis_46298b61-115a-4907-923f-450281be7156" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_46298b61-115a-4907-923f-450281be7156_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_46298b61-115a-4907-923f-450281be7156" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_46298b61-115a-4907-923f-450281be7156_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_46298b61-115a-4907-923f-450281be7156" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2026Member_0c6e2287-6642-40cd-8aad-88e2fefe8bf4" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2026Member_0c6e2287-6642-40cd-8aad-88e2fefe8bf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2025Member_5c93a2a5-d8af-4a6c-b4fd-7f87ccd40063" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2025Member_5c93a2a5-d8af-4a6c-b4fd-7f87ccd40063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2027Member_330dc20c-4f85-49a6-9073-a7b004e86253" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2027Member_330dc20c-4f85-49a6-9073-a7b004e86253" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2023Member_a1061da1-e45a-4936-94e1-edca1617c42c" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2023Member_a1061da1-e45a-4936-94e1-edca1617c42c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2031Member_c0f6e38a-a2f7-4de6-87cd-a7615940bd65" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2031Member_c0f6e38a-a2f7-4de6-87cd-a7615940bd65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DelayedDrawCreditFacilityDue2025Member_9da02170-fb71-45a0-a2f1-d8b33a6a018a" xlink:href="ilmn-20241229.xsd#ilmn_DelayedDrawCreditFacilityDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_DelayedDrawCreditFacilityDue2025Member_9da02170-fb71-45a0-a2f1-d8b33a6a018a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConvertibleSeniorNotesDue2023Member_1f0ae683-a475-4314-b182-565f03769abb" xlink:href="ilmn-20241229.xsd#ilmn_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_ConvertibleSeniorNotesDue2023Member_1f0ae683-a475-4314-b182-565f03769abb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevolvingCreditAgreementMember_f9896849-d492-43ae-ae5f-1aa60bdb6a2a" xlink:href="ilmn-20241229.xsd#ilmn_RevolvingCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_RevolvingCreditAgreementMember_f9896849-d492-43ae-ae5f-1aa60bdb6a2a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TheCreditAgreementMember_18e429a9-ae6f-493a-8d47-8070376c3468" xlink:href="ilmn-20241229.xsd#ilmn_TheCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TheCreditAgreementMember_18e429a9-ae6f-493a-8d47-8070376c3468" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e5b621cf-a15e-4bde-a535-e8c0d55db933" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e5b621cf-a15e-4bde-a535-e8c0d55db933" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e5b621cf-a15e-4bde-a535-e8c0d55db933_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e5b621cf-a15e-4bde-a535-e8c0d55db933" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e5b621cf-a15e-4bde-a535-e8c0d55db933_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_551ad062-b741-4ec0-b743-6cc425f324a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e5b621cf-a15e-4bde-a535-e8c0d55db933" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_551ad062-b741-4ec0-b743-6cc425f324a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9bd0227a-ace9-4b0f-8b84-c4be4647c614" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_551ad062-b741-4ec0-b743-6cc425f324a7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9bd0227a-ace9-4b0f-8b84-c4be4647c614" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_93e0162c-d67d-4fc6-b4c2-0414e6896294" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_93e0162c-d67d-4fc6-b4c2-0414e6896294" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_93e0162c-d67d-4fc6-b4c2-0414e6896294_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_93e0162c-d67d-4fc6-b4c2-0414e6896294" xlink:to="loc_us-gaap_TypeOfAdoptionMember_93e0162c-d67d-4fc6-b4c2-0414e6896294_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5b5a4c0a-52ac-4b94-80f4-061ed405ad6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_93e0162c-d67d-4fc6-b4c2-0414e6896294" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5b5a4c0a-52ac-4b94-80f4-061ed405ad6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_ca2c02f7-9e4f-4771-82e2-6e9831ab0437" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_5b5a4c0a-52ac-4b94-80f4-061ed405ad6a" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_ca2c02f7-9e4f-4771-82e2-6e9831ab0437" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c9c6a6a2-cda2-4014-8d5c-3d3c723e67c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_us-gaap_CreditFacilityAxis_c9c6a6a2-cda2-4014-8d5c-3d3c723e67c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c9c6a6a2-cda2-4014-8d5c-3d3c723e67c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c9c6a6a2-cda2-4014-8d5c-3d3c723e67c5" xlink:to="loc_us-gaap_CreditFacilityDomain_c9c6a6a2-cda2-4014-8d5c-3d3c723e67c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c9c6a6a2-cda2-4014-8d5c-3d3c723e67c5" xlink:to="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7f91f2eb-2813-40af-b7b7-a2d6bd75f6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7f91f2eb-2813-40af-b7b7-a2d6bd75f6e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SwinglineBorrowingsMember_748530a8-fd7f-455e-8934-7c9b237b57b1" xlink:href="ilmn-20241229.xsd#ilmn_SwinglineBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:to="loc_ilmn_SwinglineBorrowingsMember_748530a8-fd7f-455e-8934-7c9b237b57b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_f129face-859b-4275-9752-57ef325f5753" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:to="loc_us-gaap_LetterOfCreditMember_f129face-859b-4275-9752-57ef325f5753" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_83a331cb-b0cc-4553-8dc7-6135258c449e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_InterestExpenseDebt_83a331cb-b0cc-4553-8dc7-6135258c449e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5b2f8770-59f9-4508-b5bc-46bdfb1663f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5b2f8770-59f9-4508-b5bc-46bdfb1663f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8cfa24e1-7834-41c5-9c51-c77091463e10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8cfa24e1-7834-41c5-9c51-c77091463e10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_bad35ccf-bc09-4a83-82e7-40b564166005" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_bad35ccf-bc09-4a83-82e7-40b564166005" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_247e726c-774a-4544-8c87-281a5cbbcc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_247e726c-774a-4544-8c87-281a5cbbcc1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e5d12463-3636-4100-a3b6-ee0630f7b75a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentTerm_e5d12463-3636-4100-a3b6-ee0630f7b75a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8d4c126b-6eb2-4bd6-b521-d215b6d1828c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8d4c126b-6eb2-4bd6-b521-d215b6d1828c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9ae6f45f-d428-4f68-9c39-1d28f21528c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9ae6f45f-d428-4f68-9c39-1d28f21528c9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_293ed6bc-494b-459e-b258-8bd2bf534239" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_293ed6bc-494b-459e-b258-8bd2bf534239" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_d512e62b-bacf-45dc-9aae-795199fd97a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_d512e62b-bacf-45dc-9aae-795199fd97a7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AdditionalPaidInCapitalBeforeTax_e1318868-381f-4830-80f8-d35669c8b2a8" xlink:href="ilmn-20241229.xsd#ilmn_AdditionalPaidInCapitalBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_AdditionalPaidInCapitalBeforeTax_e1318868-381f-4830-80f8-d35669c8b2a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_9af31205-5222-40a0-bbac-f0cd723a8bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_AdditionalPaidInCapital_9af31205-5222-40a0-bbac-f0cd723a8bf7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e9ba0853-2e05-4079-97e1-713d4e2b1937" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e9ba0853-2e05-4079-97e1-713d4e2b1937" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e78d9411-f8f0-4953-964c-36c281ad334e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e78d9411-f8f0-4953-964c-36c281ad334e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentNumberOfOneYearExtensions_c9101b5c-575a-4c81-b03a-bc40b40b3a48" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentNumberOfOneYearExtensions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentNumberOfOneYearExtensions_c9101b5c-575a-4c81-b03a-bc40b40b3a48" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentExtensionTerm_cfd66aa9-0022-4e63-b6f8-ffc0857c9d4d" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentExtensionTerm_cfd66aa9-0022-4e63-b6f8-ffc0857c9d4d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_eb1fb795-4e8b-47be-95ff-675923d7915b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_eb1fb795-4e8b-47be-95ff-675923d7915b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings_1c0fd6e7-d4a5-43ff-bb5d-af6c3958ecc4" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings_1c0fd6e7-d4a5-43ff-bb5d-af6c3958ecc4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio_9d2a6b5b-ad3d-4f82-8460-6805af0cecb4" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio_9d2a6b5b-ad3d-4f82-8460-6805af0cecb4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio_6c7ca8f0-285a-4cc1-9567-fc84abffa112" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio_6c7ca8f0-285a-4cc1-9567-fc84abffa112" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition_f0db4f3e-46ea-4227-a71a-4ef5d394bab5" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition_f0db4f3e-46ea-4227-a71a-4ef5d394bab5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition_1af5eb9a-07b8-4f39-a3ef-1a13f86089d4" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition_1af5eb9a-07b8-4f39-a3ef-1a13f86089d4" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_1683600b-f1f6-4f39-8b82-f728699fd095" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_PurchaseObligation_1683600b-f1f6-4f39-8b82-f728699fd095" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48c21c3-9629-4ddc-b72a-4bf07323a61e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48c21c3-9629-4ddc-b72a-4bf07323a61e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e1906243-ef16-4dc0-b8b0-6b7754f8cf27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48c21c3-9629-4ddc-b72a-4bf07323a61e" xlink:to="loc_us-gaap_PlanNameAxis_e1906243-ef16-4dc0-b8b0-6b7754f8cf27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e1906243-ef16-4dc0-b8b0-6b7754f8cf27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_e1906243-ef16-4dc0-b8b0-6b7754f8cf27" xlink:to="loc_us-gaap_PlanNameDomain_e1906243-ef16-4dc0-b8b0-6b7754f8cf27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ceae2e1d-81ce-431a-80a6-87ba05c3c921" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_e1906243-ef16-4dc0-b8b0-6b7754f8cf27" xlink:to="loc_us-gaap_PlanNameDomain_ceae2e1d-81ce-431a-80a6-87ba05c3c921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_A2015StockAndIncentiveCompensationPlanMember_29abb05c-e7a2-4611-9102-9793bd845878" xlink:href="ilmn-20241229.xsd#ilmn_A2015StockAndIncentiveCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ceae2e1d-81ce-431a-80a6-87ba05c3c921" xlink:to="loc_ilmn_A2015StockAndIncentiveCompensationPlanMember_29abb05c-e7a2-4611-9102-9793bd845878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_92285086-787c-460a-90f7-799b0dfe0d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_92285086-787c-460a-90f7-799b0dfe0d4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment_79e15d85-a5b0-4dc4-9267-91be3f83670f" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment_79e15d85-a5b0-4dc4-9267-91be3f83670f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_681ba48e-d8b6-4ac3-83a1-76a12186f504" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_681ba48e-d8b6-4ac3-83a1-76a12186f504" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36c9c4d4-6fda-4bad-8034-57e8dc887ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36c9c4d4-6fda-4bad-8034-57e8dc887ecd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_62d44b07-1304-4daf-aedc-87d0376b12e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36c9c4d4-6fda-4bad-8034-57e8dc887ecd" xlink:to="loc_us-gaap_AwardTypeAxis_62d44b07-1304-4daf-aedc-87d0376b12e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62d44b07-1304-4daf-aedc-87d0376b12e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_62d44b07-1304-4daf-aedc-87d0376b12e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62d44b07-1304-4daf-aedc-87d0376b12e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_62d44b07-1304-4daf-aedc-87d0376b12e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e4e5286c-b674-456d-99b8-aa3c30c2f7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e4e5286c-b674-456d-99b8-aa3c30c2f7b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_cb4b46a6-eed6-472e-b2cb-bde2592373df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:to="loc_us-gaap_PerformanceSharesMember_cb4b46a6-eed6-472e-b2cb-bde2592373df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MarketBasedPerformanceStockUnitsMember_09932ac4-99c0-4769-909e-979f6bf1bdee" xlink:href="ilmn-20241229.xsd#ilmn_MarketBasedPerformanceStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:to="loc_ilmn_MarketBasedPerformanceStockUnitsMember_09932ac4-99c0-4769-909e-979f6bf1bdee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4239a55a-2e11-4302-bcef-559b0749b0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4239a55a-2e11-4302-bcef-559b0749b0ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards_a1e97f55-e7fc-4370-9cb5-4997563d9edf" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:to="loc_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards_a1e97f55-e7fc-4370-9cb5-4997563d9edf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout_fcf0a73c-c547-48f7-8e73-dd5670eb4663" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout_fcf0a73c-c547-48f7-8e73-dd5670eb4663" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2fe47f02-ab4e-4f05-8d1d-6f6cea659595" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46804a6c-6edd-4f8f-8472-e1cd6dc9c4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2fe47f02-ab4e-4f05-8d1d-6f6cea659595" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46804a6c-6edd-4f8f-8472-e1cd6dc9c4b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d5e95130-cf98-4dc6-ac28-7176ec5f5482" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46804a6c-6edd-4f8f-8472-e1cd6dc9c4b0" xlink:to="loc_us-gaap_AwardTypeAxis_d5e95130-cf98-4dc6-ac28-7176ec5f5482" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5e95130-cf98-4dc6-ac28-7176ec5f5482_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d5e95130-cf98-4dc6-ac28-7176ec5f5482" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5e95130-cf98-4dc6-ac28-7176ec5f5482_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d5e95130-cf98-4dc6-ac28-7176ec5f5482" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f326c1dc-1221-4595-841d-2afbeb70fdba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f326c1dc-1221-4595-841d-2afbeb70fdba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bfef2ea8-dfa0-441b-b9a8-ecf4d7cdfc54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:to="loc_us-gaap_PerformanceSharesMember_bfef2ea8-dfa0-441b-b9a8-ecf4d7cdfc54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MarketBasedPerformanceStockUnitsMember_78c5d843-7344-4ad8-9eb6-a6e4ecfd3a7d" xlink:href="ilmn-20241229.xsd#ilmn_MarketBasedPerformanceStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:to="loc_ilmn_MarketBasedPerformanceStockUnitsMember_78c5d843-7344-4ad8-9eb6-a6e4ecfd3a7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2fe47f02-ab4e-4f05-8d1d-6f6cea659595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fecdb16c-c5ed-48ed-9bf3-e059041f08cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fecdb16c-c5ed-48ed-9bf3-e059041f08cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4004442e-128b-44db-ae06-25ac0051e980" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4004442e-128b-44db-ae06-25ac0051e980" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_4b228463-8811-4056-9062-bbe29a399674" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_4b228463-8811-4056-9062-bbe29a399674" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7ff8c35e-091d-498f-99b4-5f4fca89b683" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7ff8c35e-091d-498f-99b4-5f4fca89b683" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_48428ed0-4d95-4b07-aa41-d7584614bc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_48428ed0-4d95-4b07-aa41-d7584614bc9c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fa5203e0-20af-4008-9bb1-ef407ebcfc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2fe47f02-ab4e-4f05-8d1d-6f6cea659595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3809a802-2120-406e-8bd6-44039c893f97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3809a802-2120-406e-8bd6-44039c893f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_be8dbaf7-9634-4a0b-8ec6-477e87ebca7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_be8dbaf7-9634-4a0b-8ec6-477e87ebca7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_470ea0ae-f305-42ad-8689-b82b46bbbd96" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_470ea0ae-f305-42ad-8689-b82b46bbbd96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e6cbed78-58ce-4179-884a-9a9d73fd0d97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e6cbed78-58ce-4179-884a-9a9d73fd0d97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_043e047f-f258-420b-bd88-36a2ef13a34a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_043e047f-f258-420b-bd88-36a2ef13a34a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7584c313-cf40-435b-a595-e82259bd766a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c2b3c2b-8c03-4eaf-86a0-fc26df42ed32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b015ff49-67b3-4bc5-bc0c-048d518203c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c2b3c2b-8c03-4eaf-86a0-fc26df42ed32" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b015ff49-67b3-4bc5-bc0c-048d518203c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b80892f2-ca6e-42ce-b3c6-97fced25b8db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b015ff49-67b3-4bc5-bc0c-048d518203c0" xlink:to="loc_us-gaap_AwardTypeAxis_b80892f2-ca6e-42ce-b3c6-97fced25b8db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b80892f2-ca6e-42ce-b3c6-97fced25b8db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b80892f2-ca6e-42ce-b3c6-97fced25b8db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b80892f2-ca6e-42ce-b3c6-97fced25b8db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff3d5ee3-5211-46ce-bd3c-25f7a8378391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b80892f2-ca6e-42ce-b3c6-97fced25b8db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff3d5ee3-5211-46ce-bd3c-25f7a8378391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ffe37987-6fe3-4c85-a7cb-507f46e5b2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff3d5ee3-5211-46ce-bd3c-25f7a8378391" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ffe37987-6fe3-4c85-a7cb-507f46e5b2c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_59621cbe-17b1-4f95-a979-efd1301b47a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff3d5ee3-5211-46ce-bd3c-25f7a8378391" xlink:to="loc_us-gaap_PerformanceSharesMember_59621cbe-17b1-4f95-a979-efd1301b47a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2bde2fb5-3892-4d7b-bb3b-3ba861981868" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c2b3c2b-8c03-4eaf-86a0-fc26df42ed32" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2bde2fb5-3892-4d7b-bb3b-3ba861981868" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_411e5eff-5ae1-46d7-a355-51e855cec38b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c2b3c2b-8c03-4eaf-86a0-fc26df42ed32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_411e5eff-5ae1-46d7-a355-51e855cec38b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f340dba5-5d71-4fa0-a1e2-de57750806a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bcece378-2067-4a27-9699-efaa151a77ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f340dba5-5d71-4fa0-a1e2-de57750806a1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bcece378-2067-4a27-9699-efaa151a77ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_97779db5-0ca2-45c6-aa6b-6cc7bb0b9397" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bcece378-2067-4a27-9699-efaa151a77ab" xlink:to="loc_us-gaap_AwardTypeAxis_97779db5-0ca2-45c6-aa6b-6cc7bb0b9397" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97779db5-0ca2-45c6-aa6b-6cc7bb0b9397_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_97779db5-0ca2-45c6-aa6b-6cc7bb0b9397" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_97779db5-0ca2-45c6-aa6b-6cc7bb0b9397_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a84c298-8882-418e-8bc0-10a27d4ac427" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_97779db5-0ca2-45c6-aa6b-6cc7bb0b9397" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a84c298-8882-418e-8bc0-10a27d4ac427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1e2bd662-59aa-4a3e-9a6b-69a6ea938872" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a84c298-8882-418e-8bc0-10a27d4ac427" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1e2bd662-59aa-4a3e-9a6b-69a6ea938872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember_bc943934-bfd0-4992-bde5-6a2391b6ab85" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a84c298-8882-418e-8bc0-10a27d4ac427" xlink:to="loc_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember_bc943934-bfd0-4992-bde5-6a2391b6ab85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f340dba5-5d71-4fa0-a1e2-de57750806a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_28003912-daec-4f80-ad4a-cf58cb6acd93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_28003912-daec-4f80-ad4a-cf58cb6acd93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_34a53f1d-9340-4767-aa68-f2e6f7362d78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_34a53f1d-9340-4767-aa68-f2e6f7362d78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a14af4fa-316d-4e9a-9e67-79ec7210df8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a14af4fa-316d-4e9a-9e67-79ec7210df8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3f4bf510-f001-4ba9-a2c1-fdd6338369f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3f4bf510-f001-4ba9-a2c1-fdd6338369f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cad9a24d-e826-462a-b62b-7055a3343a67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f340dba5-5d71-4fa0-a1e2-de57750806a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1cf039e2-d0b9-4791-9c1c-9a302c5d8865" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1cf039e2-d0b9-4791-9c1c-9a302c5d8865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7be9e3f3-f807-43a8-bdff-629991659c74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7be9e3f3-f807-43a8-bdff-629991659c74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ef5f00dd-5912-43d4-9281-19eadda4f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ef5f00dd-5912-43d4-9281-19eadda4f53e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3868e559-7588-4de0-a15c-0ed805d8283a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3868e559-7588-4de0-a15c-0ed805d8283a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5425c121-54ea-45cf-b47d-a9819a36eff3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0509c577-9611-4585-8982-376d160f9a37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:to="loc_us-gaap_AwardTypeAxis_0509c577-9611-4585-8982-376d160f9a37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0509c577-9611-4585-8982-376d160f9a37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0509c577-9611-4585-8982-376d160f9a37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0509c577-9611-4585-8982-376d160f9a37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_134d57e1-c6e2-43e7-9076-c1444fafbc20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0509c577-9611-4585-8982-376d160f9a37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_134d57e1-c6e2-43e7-9076-c1444fafbc20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LiabilityClassifiedRestrictedStockUnitsMember_399861dc-f5eb-466f-851a-c504962d09fd" xlink:href="ilmn-20241229.xsd#ilmn_LiabilityClassifiedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_134d57e1-c6e2-43e7-9076-c1444fafbc20" xlink:to="loc_ilmn_LiabilityClassifiedRestrictedStockUnitsMember_399861dc-f5eb-466f-851a-c504962d09fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LiabilityBasedAwardsMember_e9354d41-4ab9-424d-80ae-d103f5c2fe15" xlink:href="ilmn-20241229.xsd#ilmn_LiabilityBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_134d57e1-c6e2-43e7-9076-c1444fafbc20" xlink:to="loc_ilmn_LiabilityBasedAwardsMember_e9354d41-4ab9-424d-80ae-d103f5c2fe15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5ffcacb5-41c5-4bb6-b278-1abb1ec75600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5ffcacb5-41c5-4bb6-b278-1abb1ec75600" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5ffcacb5-41c5-4bb6-b278-1abb1ec75600_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5ffcacb5-41c5-4bb6-b278-1abb1ec75600" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5ffcacb5-41c5-4bb6-b278-1abb1ec75600_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e72b7596-6d20-4c2e-99f3-f6f7b18c946f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5ffcacb5-41c5-4bb6-b278-1abb1ec75600" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e72b7596-6d20-4c2e-99f3-f6f7b18c946f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_1f5b6482-b4dd-41c9-82c6-0cabab9bfb83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e72b7596-6d20-4c2e-99f3-f6f7b18c946f" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_1f5b6482-b4dd-41c9-82c6-0cabab9bfb83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0159b87-607d-4b88-b941-6d35d35f7f22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0159b87-607d-4b88-b941-6d35d35f7f22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e0159b87-607d-4b88-b941-6d35d35f7f22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0159b87-607d-4b88-b941-6d35d35f7f22" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e0159b87-607d-4b88-b941-6d35d35f7f22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ffac35c-11b6-4fc2-83d3-af764eb08402" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0159b87-607d-4b88-b941-6d35d35f7f22" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ffac35c-11b6-4fc2-83d3-af764eb08402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_3eadc198-1c30-44cf-8cb8-eaf82a1b4469" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ffac35c-11b6-4fc2-83d3-af764eb08402" xlink:to="loc_ilmn_GRAILInc.Member_3eadc198-1c30-44cf-8cb8-eaf82a1b4469" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_724c762c-c768-4049-a445-3c6b4c57abef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_724c762c-c768-4049-a445-3c6b4c57abef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a015f812-9b0f-49de-828f-ee86c7b39fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a015f812-9b0f-49de-828f-ee86c7b39fa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_be0cc7f0-3e6c-4a6e-a52a-fb0c42315bad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_be0cc7f0-3e6c-4a6e-a52a-fb0c42315bad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_bfbd29b9-fc77-4782-b7a5-9cf74980c45f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_bfbd29b9-fc77-4782-b7a5-9cf74980c45f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested_07d5b35c-d80d-4116-9f10-10b6b55047e3" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested_07d5b35c-d80d-4116-9f10-10b6b55047e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_db48157b-bc55-4e82-bb85-f7003243edc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_db48157b-bc55-4e82-bb85-f7003243edc5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_4632a626-f86d-499e-a02c-4e910750bafd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_4632a626-f86d-499e-a02c-4e910750bafd" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd80df5-00db-4ec6-bb01-a13d29fad3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a663a4-ef59-4c69-87e0-7ef273c1ce7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd80df5-00db-4ec6-bb01-a13d29fad3c3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a663a4-ef59-4c69-87e0-7ef273c1ce7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e72332cc-721d-4680-9ead-145fe57f03e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a663a4-ef59-4c69-87e0-7ef273c1ce7e" xlink:to="loc_us-gaap_AwardTypeAxis_e72332cc-721d-4680-9ead-145fe57f03e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e72332cc-721d-4680-9ead-145fe57f03e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e72332cc-721d-4680-9ead-145fe57f03e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e72332cc-721d-4680-9ead-145fe57f03e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ca36e9d9-5948-45db-afc0-eb051066b83c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e72332cc-721d-4680-9ead-145fe57f03e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ca36e9d9-5948-45db-afc0-eb051066b83c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LiabilityBasedAwardsMember_47f5dfc1-9054-4de9-bea8-11789111726e" xlink:href="ilmn-20241229.xsd#ilmn_LiabilityBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ca36e9d9-5948-45db-afc0-eb051066b83c" xlink:to="loc_ilmn_LiabilityBasedAwardsMember_47f5dfc1-9054-4de9-bea8-11789111726e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd80df5-00db-4ec6-bb01-a13d29fad3c3" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_302314b4-7f76-42e3-a66c-63055184a105" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_302314b4-7f76-42e3-a66c-63055184a105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue_27a709f8-54bb-47cb-9c3c-ae74f442dafb" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue_27a709f8-54bb-47cb-9c3c-ae74f442dafb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue_e56e97d7-13a2-4ee8-ab2f-96afc5599e77" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue_e56e97d7-13a2-4ee8-ab2f-96afc5599e77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue_0e67d127-af41-4eb2-8847-61e24adfd470" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue_0e67d127-af41-4eb2-8847-61e24adfd470" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue_a8aaca8c-743a-4653-8d7a-335f632f9bfb" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue_a8aaca8c-743a-4653-8d7a-335f632f9bfb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition_722a913a-6f94-466f-80e8-7d086fe5be80" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition_722a913a-6f94-466f-80e8-7d086fe5be80" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_f1171605-c853-4fba-b42e-c7d31cdec067" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent_42d5a098-6c4b-45b5-b03b-5228975342b1" xlink:href="ilmn-20241229.xsd#ilmn_AccruedLiabilityClassifiedAwardsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd80df5-00db-4ec6-bb01-a13d29fad3c3" xlink:to="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent_42d5a098-6c4b-45b5-b03b-5228975342b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91a64fdc-3e4c-4404-bd20-99015e5d722b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91a64fdc-3e4c-4404-bd20-99015e5d722b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_90fe864d-e2fb-4e2d-a4df-8bf3034f5747" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91a64fdc-3e4c-4404-bd20-99015e5d722b" xlink:to="loc_us-gaap_AwardTypeAxis_90fe864d-e2fb-4e2d-a4df-8bf3034f5747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90fe864d-e2fb-4e2d-a4df-8bf3034f5747_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_90fe864d-e2fb-4e2d-a4df-8bf3034f5747" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90fe864d-e2fb-4e2d-a4df-8bf3034f5747_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c7e34ea2-07ff-49a7-a672-31b3c9adb493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_90fe864d-e2fb-4e2d-a4df-8bf3034f5747" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c7e34ea2-07ff-49a7-a672-31b3c9adb493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_285f8112-f551-4766-aef9-699af371a034" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c7e34ea2-07ff-49a7-a672-31b3c9adb493" xlink:to="loc_us-gaap_EmployeeStockMember_285f8112-f551-4766-aef9-699af371a034" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5fa04b31-ef55-499b-8865-ee9a40282732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91a64fdc-3e4c-4404-bd20-99015e5d722b" xlink:to="loc_us-gaap_PlanNameAxis_5fa04b31-ef55-499b-8865-ee9a40282732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5fa04b31-ef55-499b-8865-ee9a40282732_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5fa04b31-ef55-499b-8865-ee9a40282732" xlink:to="loc_us-gaap_PlanNameDomain_5fa04b31-ef55-499b-8865-ee9a40282732_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6b48cf6f-97bc-4f1b-af16-b24894552c80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5fa04b31-ef55-499b-8865-ee9a40282732" xlink:to="loc_us-gaap_PlanNameDomain_6b48cf6f-97bc-4f1b-af16-b24894552c80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_A2000EmployeeStockPurchasePlanMember_12fa9af1-f89e-4587-b155-2a0bbe20f6e4" xlink:href="ilmn-20241229.xsd#ilmn_A2000EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6b48cf6f-97bc-4f1b-af16-b24894552c80" xlink:to="loc_ilmn_A2000EmployeeStockPurchasePlanMember_12fa9af1-f89e-4587-b155-2a0bbe20f6e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cd95d54d-6099-4fb0-8acb-682023d6c6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cd95d54d-6099-4fb0-8acb-682023d6c6c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_35e54afd-aaeb-46ab-a413-739d376a50ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_35e54afd-aaeb-46ab-a413-739d376a50ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0c6a4b77-5f81-4e4d-98f2-aa1545ca9fab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0c6a4b77-5f81-4e4d-98f2-aa1545ca9fab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease_c0466ac5-9f4b-43c4-bd70-c264dd27dc88" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease_c0466ac5-9f4b-43c4-bd70-c264dd27dc88" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_26066f84-34b2-42ad-8f38-e1e6709be9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_26066f84-34b2-42ad-8f38-e1e6709be9e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ef4b0936-f606-4b57-950e-f89cae4d4847" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_26066f84-34b2-42ad-8f38-e1e6709be9e8" xlink:to="loc_us-gaap_AwardTypeAxis_ef4b0936-f606-4b57-950e-f89cae4d4847" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef4b0936-f606-4b57-950e-f89cae4d4847_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ef4b0936-f606-4b57-950e-f89cae4d4847" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef4b0936-f606-4b57-950e-f89cae4d4847_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e737951-d543-4c1c-a695-a87f3e90181f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ef4b0936-f606-4b57-950e-f89cae4d4847" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e737951-d543-4c1c-a695-a87f3e90181f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_0de0b053-99ea-40ec-816a-335f221fca1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e737951-d543-4c1c-a695-a87f3e90181f" xlink:to="loc_us-gaap_EmployeeStockMember_0de0b053-99ea-40ec-816a-335f221fca1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6cdbeab5-5d14-46a7-9d6e-19c7961ec09e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_26066f84-34b2-42ad-8f38-e1e6709be9e8" xlink:to="loc_srt_RangeAxis_6cdbeab5-5d14-46a7-9d6e-19c7961ec09e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6cdbeab5-5d14-46a7-9d6e-19c7961ec09e_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6cdbeab5-5d14-46a7-9d6e-19c7961ec09e" xlink:to="loc_srt_RangeMember_6cdbeab5-5d14-46a7-9d6e-19c7961ec09e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_30c25c44-e5e4-4c33-a6a3-2af45037624e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6cdbeab5-5d14-46a7-9d6e-19c7961ec09e" xlink:to="loc_srt_RangeMember_30c25c44-e5e4-4c33-a6a3-2af45037624e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_25f7d1af-445a-4276-b841-8fe7cd977f11" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_30c25c44-e5e4-4c33-a6a3-2af45037624e" xlink:to="loc_srt_MinimumMember_25f7d1af-445a-4276-b841-8fe7cd977f11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1dd14924-ff87-483d-be09-5483a1cd8857" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_30c25c44-e5e4-4c33-a6a3-2af45037624e" xlink:to="loc_srt_MaximumMember_1dd14924-ff87-483d-be09-5483a1cd8857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_108ec055-31f0-41fc-a78a-33f7b939ce05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_108ec055-31f0-41fc-a78a-33f7b939ce05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_89c6e351-3a15-48d1-91e3-5b6c8224a5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_89c6e351-3a15-48d1-91e3-5b6c8224a5eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3b0cb680-9ec1-47e9-a1fc-d67fb5fe3cad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3b0cb680-9ec1-47e9-a1fc-d67fb5fe3cad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0c5bd6ed-93a9-41ad-a77a-2d0d5f0df558" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0c5bd6ed-93a9-41ad-a77a-2d0d5f0df558" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6bde24c0-f25a-4e67-897d-c82fb2f9edd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6bde24c0-f25a-4e67-897d-c82fb2f9edd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_23172334-ab32-4382-ab77-d7bea8766aed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_23172334-ab32-4382-ab77-d7bea8766aed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_12a717c5-343c-4808-833f-dd4a10dcef00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_12a717c5-343c-4808-833f-dd4a10dcef00" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f540648e-f3bd-403e-bc35-f03f8436f182" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f540648e-f3bd-403e-bc35-f03f8436f182" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8d238911-1679-42b5-bce3-c6c26c0adad9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f540648e-f3bd-403e-bc35-f03f8436f182" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8d238911-1679-42b5-bce3-c6c26c0adad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8d238911-1679-42b5-bce3-c6c26c0adad9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8d238911-1679-42b5-bce3-c6c26c0adad9" xlink:to="loc_us-gaap_ClassOfStockDomain_8d238911-1679-42b5-bce3-c6c26c0adad9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_05361f21-3021-4409-9848-7115eac032f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8d238911-1679-42b5-bce3-c6c26c0adad9" xlink:to="loc_us-gaap_ClassOfStockDomain_05361f21-3021-4409-9848-7115eac032f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c9422416-6b7c-4e4c-abe7-1c19db6f8c98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_05361f21-3021-4409-9848-7115eac032f2" xlink:to="loc_us-gaap_CommonStockMember_c9422416-6b7c-4e4c-abe7-1c19db6f8c98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9f2cf3f1-ef6b-4b64-a88b-f3951eda8bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f540648e-f3bd-403e-bc35-f03f8436f182" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9f2cf3f1-ef6b-4b64-a88b-f3951eda8bd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9f2cf3f1-ef6b-4b64-a88b-f3951eda8bd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9f2cf3f1-ef6b-4b64-a88b-f3951eda8bd0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9f2cf3f1-ef6b-4b64-a88b-f3951eda8bd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_107d808b-1d8e-4bcc-bba2-625c71e2fb35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9f2cf3f1-ef6b-4b64-a88b-f3951eda8bd0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_107d808b-1d8e-4bcc-bba2-625c71e2fb35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5b03e17b-eff7-4a57-bb48-0e69074c7a08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_107d808b-1d8e-4bcc-bba2-625c71e2fb35" xlink:to="loc_us-gaap_SubsequentEventMember_5b03e17b-eff7-4a57-bb48-0e69074c7a08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_3cf71aa0-e86b-44af-b423-bdaef4b3e6e3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_3cf71aa0-e86b-44af-b423-bdaef4b3e6e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_89519034-2588-44ab-a73b-e16e0bb15a07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_89519034-2588-44ab-a73b-e16e0bb15a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_a7873ded-5a14-485d-a914-f76652ae245f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_a7873ded-5a14-485d-a914-f76652ae245f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_2b25986e-b749-4b86-9c20-811afef4fb73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_2b25986e-b749-4b86-9c20-811afef4fb73" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08f222a9-fa43-4867-8b90-7c80ecfa7d10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08f222a9-fa43-4867-8b90-7c80ecfa7d10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_22a791c0-bbd5-44b2-a2b5-46e7d9e942e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08f222a9-fa43-4867-8b90-7c80ecfa7d10" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_22a791c0-bbd5-44b2-a2b5-46e7d9e942e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_22a791c0-bbd5-44b2-a2b5-46e7d9e942e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_22a791c0-bbd5-44b2-a2b5-46e7d9e942e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_22a791c0-bbd5-44b2-a2b5-46e7d9e942e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_22a791c0-bbd5-44b2-a2b5-46e7d9e942e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CostOfGoodsSoldMember_82aee70b-86d3-49ea-947b-298c692e0097" xlink:href="ilmn-20241229.xsd#ilmn_CostOfGoodsSoldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:to="loc_ilmn_CostOfGoodsSoldMember_82aee70b-86d3-49ea-947b-298c692e0097" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CostOfServicesMember_f975bf42-e5ba-416a-a246-2c3f76ca97e3" xlink:href="ilmn-20241229.xsd#ilmn_CostOfServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:to="loc_ilmn_CostOfServicesMember_f975bf42-e5ba-416a-a246-2c3f76ca97e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_48033da3-7fbb-459e-9090-983dd62a8fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_48033da3-7fbb-459e-9090-983dd62a8fc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_320e08bd-869b-4fb2-a6bc-f40c8cad2a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_320e08bd-869b-4fb2-a6bc-f40c8cad2a2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_18901d7d-35df-4f14-b285-b172291b5bee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_18901d7d-35df-4f14-b285-b172291b5bee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_ba8ccf13-77ce-4a31-b891-0dd114264c20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_ba8ccf13-77ce-4a31-b891-0dd114264c20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_eac54327-8661-4e18-8d5b-d1bdd95afa7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_eac54327-8661-4e18-8d5b-d1bdd95afa7a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1219446f-5588-4723-be43-180b7afdf523" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1219446f-5588-4723-be43-180b7afdf523" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bff7540-71c6-491f-a4b8-206ba1e3a98b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1219446f-5588-4723-be43-180b7afdf523" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bff7540-71c6-491f-a4b8-206ba1e3a98b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bff7540-71c6-491f-a4b8-206ba1e3a98b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bff7540-71c6-491f-a4b8-206ba1e3a98b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bff7540-71c6-491f-a4b8-206ba1e3a98b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bff7540-71c6-491f-a4b8-206ba1e3a98b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_24b61899-bca6-4f15-9615-e0a9a6c2dc88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_24b61899-bca6-4f15-9615-e0a9a6c2dc88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_7f5d748b-768e-4bef-8faf-ee107b65d090" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_EquipmentMember_7f5d748b-768e-4bef-8faf-ee107b65d090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_f35d358a-c4f4-42d9-8dbf-149d46a54a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_ComputerEquipmentMember_f35d358a-c4f4-42d9-8dbf-149d46a54a0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_8ceba1f0-de20-4169-a2ba-85c07aa57873" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_8ceba1f0-de20-4169-a2ba-85c07aa57873" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_dece326b-766b-4064-8adf-2eac9d9947b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_BuildingMember_dece326b-766b-4064-8adf-2eac9d9947b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_2b85c80a-c74a-46c0-bb68-92e167eae355" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_ConstructionInProgressMember_2b85c80a-c74a-46c0-bb68-92e167eae355" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ed39489d-ae1a-4bfe-b839-698a4726bbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ed39489d-ae1a-4bfe-b839-698a4726bbc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ca383e2d-a626-445c-b895-c68685f8ba3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ca383e2d-a626-445c-b895-c68685f8ba3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_37e36fb1-db93-4fb6-95b9-67a27770ae28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_37e36fb1-db93-4fb6-95b9-67a27770ae28" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_97a54db6-2126-45b7-a19a-bbc6756de983" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97165ede-0449-4bd6-ae1f-915a8ef31eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_97a54db6-2126-45b7-a19a-bbc6756de983" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97165ede-0449-4bd6-ae1f-915a8ef31eb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0868273d-c503-42c5-8ea6-2a5c6572c328" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97165ede-0449-4bd6-ae1f-915a8ef31eb6" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0868273d-c503-42c5-8ea6-2a5c6572c328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0868273d-c503-42c5-8ea6-2a5c6572c328_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0868273d-c503-42c5-8ea6-2a5c6572c328" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0868273d-c503-42c5-8ea6-2a5c6572c328_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0868273d-c503-42c5-8ea6-2a5c6572c328" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_fed462c5-c4b0-4adf-a39e-0e2ec3e5c2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:to="loc_us-gaap_EmployeeSeveranceMember_fed462c5-c4b0-4adf-a39e-0e2ec3e5c2e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AssetImpairmentChargesMember_5cc51e16-5d55-4bfe-a824-23469ece9337" xlink:href="ilmn-20241229.xsd#ilmn_AssetImpairmentChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:to="loc_ilmn_AssetImpairmentChargesMember_5cc51e16-5d55-4bfe-a824-23469ece9337" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_13df8902-c1a0-42e9-8bc0-7d52a9367ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:to="loc_us-gaap_OtherRestructuringMember_13df8902-c1a0-42e9-8bc0-7d52a9367ee1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_071bf2dc-c458-402e-bb45-8dec2bfed77f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97165ede-0449-4bd6-ae1f-915a8ef31eb6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_071bf2dc-c458-402e-bb45-8dec2bfed77f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_071bf2dc-c458-402e-bb45-8dec2bfed77f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_071bf2dc-c458-402e-bb45-8dec2bfed77f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_071bf2dc-c458-402e-bb45-8dec2bfed77f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5d2a90a6-4e09-4c7b-a2f0-36298c6e662a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_071bf2dc-c458-402e-bb45-8dec2bfed77f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5d2a90a6-4e09-4c7b-a2f0-36298c6e662a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_81b16574-a8d0-40af-a5d3-6204d755b297" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d2a90a6-4e09-4c7b-a2f0-36298c6e662a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_81b16574-a8d0-40af-a5d3-6204d755b297" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f181205d-77da-4aae-925a-fe2491b82028" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d2a90a6-4e09-4c7b-a2f0-36298c6e662a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f181205d-77da-4aae-925a-fe2491b82028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_e01be741-cd07-4506-aac0-9c862e46501f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_97a54db6-2126-45b7-a19a-bbc6756de983" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_e01be741-cd07-4506-aac0-9c862e46501f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cc51c42d-ada4-40c6-9ff4-ffff6b62ac69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cc51c42d-ada4-40c6-9ff4-ffff6b62ac69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8a4c8bb9-983b-488f-b1ff-25b79750ba69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cc51c42d-ada4-40c6-9ff4-ffff6b62ac69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8a4c8bb9-983b-488f-b1ff-25b79750ba69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a4c8bb9-983b-488f-b1ff-25b79750ba69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8a4c8bb9-983b-488f-b1ff-25b79750ba69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8a4c8bb9-983b-488f-b1ff-25b79750ba69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31bd9c1c-30b3-4758-87af-41527a9905a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8a4c8bb9-983b-488f-b1ff-25b79750ba69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31bd9c1c-30b3-4758-87af-41527a9905a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4026e4c5-3a60-4f68-a74e-9c957a308bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31bd9c1c-30b3-4758-87af-41527a9905a1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4026e4c5-3a60-4f68-a74e-9c957a308bf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0d1e7cbf-a3a8-487f-9a3b-0ef5e5683ae2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cc51c42d-ada4-40c6-9ff4-ffff6b62ac69" xlink:to="loc_srt_StatementGeographicalAxis_0d1e7cbf-a3a8-487f-9a3b-0ef5e5683ae2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0d1e7cbf-a3a8-487f-9a3b-0ef5e5683ae2_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0d1e7cbf-a3a8-487f-9a3b-0ef5e5683ae2" xlink:to="loc_srt_SegmentGeographicalDomain_0d1e7cbf-a3a8-487f-9a3b-0ef5e5683ae2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0d1e7cbf-a3a8-487f-9a3b-0ef5e5683ae2" xlink:to="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_a045d64c-8a91-4b25-a26f-61f485c3406d" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:to="loc_stpr_CA_a045d64c-8a91-4b25-a26f-61f485c3406d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FosterCityCaliforniaMember_ab0b0d32-cadc-4e14-8daf-d97263fdf9eb" xlink:href="ilmn-20241229.xsd#ilmn_FosterCityCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:to="loc_ilmn_FosterCityCaliforniaMember_ab0b0d32-cadc-4e14-8daf-d97263fdf9eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SanDiegoCaliforniaMember_f5d1a2e2-e3ef-41e8-9974-84322b1eaa50" xlink:href="ilmn-20241229.xsd#ilmn_SanDiegoCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:to="loc_ilmn_SanDiegoCaliforniaMember_f5d1a2e2-e3ef-41e8-9974-84322b1eaa50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_43fdc8df-ff28-4c35-a806-e4ef2af19f03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_43fdc8df-ff28-4c35-a806-e4ef2af19f03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements_3b62db07-acee-4750-9411-f90362f1c89b" xlink:href="ilmn-20241229.xsd#ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:to="loc_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements_3b62db07-acee-4750-9411-f90362f1c89b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3a9f8729-3457-4a99-b702-da6dd71412c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3a9f8729-3457-4a99-b702-da6dd71412c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_1db2f096-3d7b-4725-b050-5e9b935e61ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_1db2f096-3d7b-4725-b050-5e9b935e61ee" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1d01411d-1170-4750-9736-0837546cc679" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_013f7dc2-e3c0-42ff-b808-fb8da233d14b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d01411d-1170-4750-9736-0837546cc679" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_013f7dc2-e3c0-42ff-b808-fb8da233d14b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_fc0eb0b6-47d5-4dd5-ab67-f6196e431f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_013f7dc2-e3c0-42ff-b808-fb8da233d14b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_fc0eb0b6-47d5-4dd5-ab67-f6196e431f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_fc0eb0b6-47d5-4dd5-ab67-f6196e431f99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_fc0eb0b6-47d5-4dd5-ab67-f6196e431f99" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_fc0eb0b6-47d5-4dd5-ab67-f6196e431f99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c3f12f5b-239c-4237-89b6-d5e6e4d95d65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_fc0eb0b6-47d5-4dd5-ab67-f6196e431f99" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c3f12f5b-239c-4237-89b6-d5e6e4d95d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_5b6018c5-9808-445c-81e8-ac85ddf9eaba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c3f12f5b-239c-4237-89b6-d5e6e4d95d65" xlink:to="loc_us-gaap_EmployeeSeveranceMember_5b6018c5-9808-445c-81e8-ac85ddf9eaba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_7949f6a4-e35b-4793-8627-80128d569e10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c3f12f5b-239c-4237-89b6-d5e6e4d95d65" xlink:to="loc_us-gaap_OtherRestructuringMember_7949f6a4-e35b-4793-8627-80128d569e10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d01411d-1170-4750-9736-0837546cc679" xlink:to="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_fec69f94-fcca-4315-b737-eda0bb1d818c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:to="loc_us-gaap_RestructuringReserve_fec69f94-fcca-4315-b737-eda0bb1d818c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3d4255e7-0042-43cc-be89-1f291b026be1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:to="loc_us-gaap_RestructuringCharges_3d4255e7-0042-43cc-be89-1f291b026be1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_3c767b9f-608e-4b25-9bf8-d5f144dfd9c8" xlink:href="ilmn-20241229.xsd#ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCharges_3d4255e7-0042-43cc-be89-1f291b026be1" xlink:to="loc_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_3c767b9f-608e-4b25-9bf8-d5f144dfd9c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_00559ee0-bce1-4539-b529-600623eee11a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:to="loc_us-gaap_PaymentsForRestructuring_00559ee0-bce1-4539-b529-600623eee11a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_972c6d9e-e515-469d-888a-d95f52d839a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_972c6d9e-e515-469d-888a-d95f52d839a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9c358cb5-d665-489b-8f8b-091a81dd26f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/LEGALPROCEEDINGSDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#LEGALPROCEEDINGSDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/LEGALPROCEEDINGSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d9bd12e0-79c1-4e6a-91d3-2d2d33ff212d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d9bd12e0-79c1-4e6a-91d3-2d2d33ff212d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9bd12e0-79c1-4e6a-91d3-2d2d33ff212d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d9bd12e0-79c1-4e6a-91d3-2d2d33ff212d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9bd12e0-79c1-4e6a-91d3-2d2d33ff212d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_44a36b31-8c39-4779-b495-b779d04b8cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d9bd12e0-79c1-4e6a-91d3-2d2d33ff212d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_44a36b31-8c39-4779-b495-b779d04b8cfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_9b98e0d1-80bc-47be-a56b-deb043011b06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_44a36b31-8c39-4779-b495-b779d04b8cfa" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_9b98e0d1-80bc-47be-a56b-deb043011b06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8632f44c-ffdd-4781-b14a-5b85105aeac8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8632f44c-ffdd-4781-b14a-5b85105aeac8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8632f44c-ffdd-4781-b14a-5b85105aeac8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8632f44c-ffdd-4781-b14a-5b85105aeac8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8632f44c-ffdd-4781-b14a-5b85105aeac8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7354df4d-6121-4fe6-82a9-641b08ce37e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8632f44c-ffdd-4781-b14a-5b85105aeac8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7354df4d-6121-4fe6-82a9-641b08ce37e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_14a63b80-481b-4144-a512-bf9ee4f26faa" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7354df4d-6121-4fe6-82a9-641b08ce37e0" xlink:to="loc_ilmn_GRAILInc.Member_14a63b80-481b-4144-a512-bf9ee4f26faa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b416fee6-2249-42cf-bd38-709ecd22dc24" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:to="loc_srt_LitigationCaseAxis_b416fee6-2249-42cf-bd38-709ecd22dc24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b416fee6-2249-42cf-bd38-709ecd22dc24_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_b416fee6-2249-42cf-bd38-709ecd22dc24" xlink:to="loc_srt_LitigationCaseTypeDomain_b416fee6-2249-42cf-bd38-709ecd22dc24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c1e413c1-f32c-4a0a-812b-0bc19e4d4f41" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_b416fee6-2249-42cf-bd38-709ecd22dc24" xlink:to="loc_srt_LitigationCaseTypeDomain_c1e413c1-f32c-4a0a-812b-0bc19e4d4f41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AcquisitionOfGrailInc.Member_0745b0f8-d596-47f2-84fb-37f354ec437e" xlink:href="ilmn-20241229.xsd#ilmn_AcquisitionOfGrailInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c1e413c1-f32c-4a0a-812b-0bc19e4d4f41" xlink:to="loc_ilmn_AcquisitionOfGrailInc.Member_0745b0f8-d596-47f2-84fb-37f354ec437e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CompleteGenomicsMember_7383c7a5-ff09-4359-a0ff-b247e63cbb45" xlink:href="ilmn-20241229.xsd#ilmn_CompleteGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c1e413c1-f32c-4a0a-812b-0bc19e4d4f41" xlink:to="loc_ilmn_CompleteGenomicsMember_7383c7a5-ff09-4359-a0ff-b247e63cbb45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ef7f044-0d20-4347-9cc0-833026ad7e74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ef7f044-0d20-4347-9cc0-833026ad7e74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef7f044-0d20-4347-9cc0-833026ad7e74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ef7f044-0d20-4347-9cc0-833026ad7e74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef7f044-0d20-4347-9cc0-833026ad7e74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0a3c75d7-6987-46fc-b296-fb4beab4950d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ef7f044-0d20-4347-9cc0-833026ad7e74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0a3c75d7-6987-46fc-b296-fb4beab4950d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_02855814-9b7f-40de-9f4b-e8ea324e6731" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0a3c75d7-6987-46fc-b296-fb4beab4950d" xlink:to="loc_us-gaap_LicenseMember_02855814-9b7f-40de-9f4b-e8ea324e6731" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_ef281ecf-8bd9-4891-a76c-9ed33ea0fdaf" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationPercentOfInterestDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_ef281ecf-8bd9-4891-a76c-9ed33ea0fdaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_27e78741-4257-4fb9-8c5c-e7aceacb00de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_27e78741-4257-4fb9-8c5c-e7aceacb00de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_58970c13-b05c-4a74-903c-c795ba745ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_58970c13-b05c-4a74-903c-c795ba745ca7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementGain_24a89875-8a34-4849-917f-2e49d2301d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_LitigationSettlementGain_24a89875-8a34-4849-917f-2e49d2301d1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementLoss_0b880d2a-9c22-4ef9-ac43-20205fcbca0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_LitigationSettlementLoss_0b880d2a-9c22-4ef9-ac43-20205fcbca0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LitigationSettlementFinePercentageRate_1c7075eb-82f3-455f-b29c-7c9458633d9d" xlink:href="ilmn-20241229.xsd#ilmn_LitigationSettlementFinePercentageRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_LitigationSettlementFinePercentageRate_1c7075eb-82f3-455f-b29c-7c9458633d9d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_b33b3fc1-fbed-437c-9121-5d40694b4971" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_b33b3fc1-fbed-437c-9121-5d40694b4971" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions_22c2587d-f3c4-4e4d-9a8e-6684eb795503" xlink:href="ilmn-20241229.xsd#ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions_22c2587d-f3c4-4e4d-9a8e-6684eb795503" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions_68853cb3-191b-423c-b371-6e15ad9026d5" xlink:href="ilmn-20241229.xsd#ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions_68853cb3-191b-423c-b371-6e15ad9026d5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_44799b55-da6e-411f-afba-91217ff4b4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_44799b55-da6e-411f-afba-91217ff4b4d1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LossContingencyLicenseGrantedIntangibleAssets_498f0d18-dcc1-4b26-82a7-9124f20fe3fe" xlink:href="ilmn-20241229.xsd#ilmn_LossContingencyLicenseGrantedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_LossContingencyLicenseGrantedIntangibleAssets_498f0d18-dcc1-4b26-82a7-9124f20fe3fe" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_58637bba-bddd-4cab-8264-eafa9f232c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_58637bba-bddd-4cab-8264-eafa9f232c6e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed_08abcf3f-2273-469b-a16f-f02122e5fe08" xlink:href="ilmn-20241229.xsd#ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed_08abcf3f-2273-469b-a16f-f02122e5fe08" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod_3d533b10-244c-48c8-b618-60a6e50a23b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FormerGainContingencyRecognizedInCurrentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod_3d533b10-244c-48c8-b618-60a6e50a23b6" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f7366b2d-d73b-49a1-aa14-9734055b3eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f7366b2d-d73b-49a1-aa14-9734055b3eb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f7366b2d-d73b-49a1-aa14-9734055b3eb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f7366b2d-d73b-49a1-aa14-9734055b3eb1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f7366b2d-d73b-49a1-aa14-9734055b3eb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f7366b2d-d73b-49a1-aa14-9734055b3eb1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_7a91c7e4-4292-4496-a4ab-7de5298f5024" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:to="loc_us-gaap_DomesticCountryMember_7a91c7e4-4292-4496-a4ab-7de5298f5024" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_e6b668f2-ffaf-4a6a-86b3-4ba2ddbb2cea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_e6b668f2-ffaf-4a6a-86b3-4ba2ddbb2cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_ac326a79-00a9-421a-aad2-7eafee420176" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:to="loc_us-gaap_ForeignCountryMember_ac326a79-00a9-421a-aad2-7eafee420176" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_7efca287-3a89-4e00-90b9-036924bb9ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_7efca287-3a89-4e00-90b9-036924bb9ba1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_7efca287-3a89-4e00-90b9-036924bb9ba1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7efca287-3a89-4e00-90b9-036924bb9ba1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_7efca287-3a89-4e00-90b9-036924bb9ba1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_861c1780-561b-45cc-a680-46d48cef47b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7efca287-3a89-4e00-90b9-036924bb9ba1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_861c1780-561b-45cc-a680-46d48cef47b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_ebacf578-221b-47f2-bee5-f85b7fc0bae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_861c1780-561b-45cc-a680-46d48cef47b3" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_ebacf578-221b-47f2-bee5-f85b7fc0bae7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InlandRevenueSingaporeIRASMember_3ba570df-5f28-458f-917c-85e4856c66bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InlandRevenueSingaporeIRASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_861c1780-561b-45cc-a680-46d48cef47b3" xlink:to="loc_us-gaap_InlandRevenueSingaporeIRASMember_3ba570df-5f28-458f-917c-85e4856c66bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_2abc3b7b-414c-4657-9c10-0848f0f00c76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:to="loc_us-gaap_TaxPeriodAxis_2abc3b7b-414c-4657-9c10-0848f0f00c76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_2abc3b7b-414c-4657-9c10-0848f0f00c76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_2abc3b7b-414c-4657-9c10-0848f0f00c76" xlink:to="loc_us-gaap_TaxPeriodDomain_2abc3b7b-414c-4657-9c10-0848f0f00c76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_b40fbeae-844f-410a-a593-702fd0b3f06a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_2abc3b7b-414c-4657-9c10-0848f0f00c76" xlink:to="loc_us-gaap_TaxPeriodDomain_b40fbeae-844f-410a-a593-702fd0b3f06a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2017Member_9ee5119b-9e16-4a19-bdbb-662e890556d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxYear2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_b40fbeae-844f-410a-a593-702fd0b3f06a" xlink:to="loc_us-gaap_TaxYear2017Member_9ee5119b-9e16-4a19-bdbb-662e890556d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a271e189-ece5-46a4-a73b-7a913114c3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a271e189-ece5-46a4-a73b-7a913114c3a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_96ac8133-a5ae-41ce-85ca-ae16e301fa73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_OperatingLossCarryforwards_96ac8133-a5ae-41ce-85ca-ae16e301fa73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_04a03a87-2fbf-4f0d-bb96-2d73131fbe33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_04a03a87-2fbf-4f0d-bb96-2d73131fbe33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_825b8018-4d38-4202-83db-332872cbc521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_825b8018-4d38-4202-83db-332872cbc521" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_5cb2392f-762a-411b-83e7-1309fa85a5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_5cb2392f-762a-411b-83e7-1309fa85a5c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_858cdeed-873d-46a5-99c1-db5b49e0cf48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_858cdeed-873d-46a5-99c1-db5b49e0cf48" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_4b166a4c-adc4-4451-9160-33fd1f5d26fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_4b166a4c-adc4-4451-9160-33fd1f5d26fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_877cb41d-1d75-4c96-a926-22508d43cb74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_877cb41d-1d75-4c96-a926-22508d43cb74" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_60088e0d-cc12-4e35-9f95-4890690290d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_60088e0d-cc12-4e35-9f95-4890690290d3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ae448118-a2b7-4f22-819e-f6fc381749cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ae448118-a2b7-4f22-819e-f6fc381749cb" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#EMPLOYEEBENEFITPLANSDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_7ee5035e-776a-410b-9e7a-0f274d355628" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_7ee5035e-776a-410b-9e7a-0f274d355628" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_385b9cd7-c52d-491c-839a-9f59b67383ba" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_7ee5035e-776a-410b-9e7a-0f274d355628" xlink:to="loc_srt_TitleOfIndividualAxis_385b9cd7-c52d-491c-839a-9f59b67383ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_385b9cd7-c52d-491c-839a-9f59b67383ba_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_385b9cd7-c52d-491c-839a-9f59b67383ba" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_385b9cd7-c52d-491c-839a-9f59b67383ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_429c5e62-e3dd-4950-aa64-716cfee3ffac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_385b9cd7-c52d-491c-839a-9f59b67383ba" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_429c5e62-e3dd-4950-aa64-716cfee3ffac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SeniorLevelEmployeeMember_75639f2e-9e0d-44bf-b6aa-816dfb19ad5b" xlink:href="ilmn-20241229.xsd#ilmn_SeniorLevelEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_429c5e62-e3dd-4950-aa64-716cfee3ffac" xlink:to="loc_ilmn_SeniorLevelEmployeeMember_75639f2e-9e0d-44bf-b6aa-816dfb19ad5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_aebec8d9-d061-4a24-a465-15690a463058" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_429c5e62-e3dd-4950-aa64-716cfee3ffac" xlink:to="loc_srt_DirectorMember_aebec8d9-d061-4a24-a465-15690a463058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_f6d71f97-e1ad-412f-8401-505aa018da51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_f6d71f97-e1ad-412f-8401-505aa018da51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent_1d35e06b-a7f3-422f-bd32-90d88466154c" xlink:href="ilmn-20241229.xsd#ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent_1d35e06b-a7f3-422f-bd32-90d88466154c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent_fc22438a-b474-4caa-8cb7-68745ff5a848" xlink:href="ilmn-20241229.xsd#ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent_fc22438a-b474-4caa-8cb7-68745ff5a848" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents_71cac006-1905-4803-987f-c69cf161f96f" xlink:href="ilmn-20241229.xsd#ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents_71cac006-1905-4803-987f-c69cf161f96f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_670c4814-7803-4c46-a43d-e99f33b00d96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_670c4814-7803-4c46-a43d-e99f33b00d96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent_f629530d-d80e-4a16-a019-e234cb267202" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent_f629530d-d80e-4a16-a019-e234cb267202" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_98ac94fe-0c32-4ee4-9fb2-c543dc330307" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_98ac94fe-0c32-4ee4-9fb2-c543dc330307" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4312df3f-11dc-4104-aa95-7d1dda9246b9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_98ac94fe-0c32-4ee4-9fb2-c543dc330307" xlink:to="loc_srt_ConsolidationItemsAxis_4312df3f-11dc-4104-aa95-7d1dda9246b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4312df3f-11dc-4104-aa95-7d1dda9246b9_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_4312df3f-11dc-4104-aa95-7d1dda9246b9" xlink:to="loc_srt_ConsolidationItemsDomain_4312df3f-11dc-4104-aa95-7d1dda9246b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4e9aa3f5-035f-4840-9c4b-8ce272ea1459" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_4312df3f-11dc-4104-aa95-7d1dda9246b9" xlink:to="loc_srt_ConsolidationItemsDomain_4e9aa3f5-035f-4840-9c4b-8ce272ea1459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d0025dba-db98-4f9a-82ec-6ff929338a36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4e9aa3f5-035f-4840-9c4b-8ce272ea1459" xlink:to="loc_us-gaap_OperatingSegmentsMember_d0025dba-db98-4f9a-82ec-6ff929338a36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_1a389e8b-f99b-4bc2-ad34-4a355eaec17e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4e9aa3f5-035f-4840-9c4b-8ce272ea1459" xlink:to="loc_us-gaap_IntersegmentEliminationMember_1a389e8b-f99b-4bc2-ad34-4a355eaec17e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a0a5f13e-a137-45ff-83e0-65331245fce0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_98ac94fe-0c32-4ee4-9fb2-c543dc330307" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a0a5f13e-a137-45ff-83e0-65331245fce0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a0a5f13e-a137-45ff-83e0-65331245fce0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a0a5f13e-a137-45ff-83e0-65331245fce0" xlink:to="loc_us-gaap_SegmentDomain_a0a5f13e-a137-45ff-83e0-65331245fce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d21cc4f5-ace3-43d1-9be1-229eb3726af1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a0a5f13e-a137-45ff-83e0-65331245fce0" xlink:to="loc_us-gaap_SegmentDomain_d21cc4f5-ace3-43d1-9be1-229eb3726af1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CoreIlluminaMember_c7f41ed8-3c63-494b-a0df-2da185e0cfde" xlink:href="ilmn-20241229.xsd#ilmn_CoreIlluminaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d21cc4f5-ace3-43d1-9be1-229eb3726af1" xlink:to="loc_ilmn_CoreIlluminaMember_c7f41ed8-3c63-494b-a0df-2da185e0cfde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_5d97f862-d42c-4453-b606-adb9f5c89882" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d21cc4f5-ace3-43d1-9be1-229eb3726af1" xlink:to="loc_ilmn_GRAILInc.Member_5d97f862-d42c-4453-b606-adb9f5c89882" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d0b811d-19ac-435c-b048-ca1d9f3ca6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d0b811d-19ac-435c-b048-ca1d9f3ca6a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0b2a5d06-24f7-4c38-9c2f-d6b2882ddf65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_OperatingExpenses_0b2a5d06-24f7-4c38-9c2f-d6b2882ddf65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_279ee58a-0208-4987-87ff-5128470ce065" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_CostOfRevenue_279ee58a-0208-4987-87ff-5128470ce065" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f69d4a23-b57e-40a8-a05e-a9ac8b203e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f69d4a23-b57e-40a8-a05e-a9ac8b203e8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_deeba645-3630-4961-b72f-59097c234c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_SellingAndMarketingExpense_deeba645-3630-4961-b72f-59097c234c3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ce49193a-c990-441c-b63b-4d2a5463e0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ce49193a-c990-441c-b63b-4d2a5463e0b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_593baf2a-613c-49d4-99af-00e2da84738c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_593baf2a-613c-49d4-99af-00e2da84738c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_6ad780d7-774e-4dd0-864e-f9cd7237c336" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_6ad780d7-774e-4dd0-864e-f9cd7237c336" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1f5351c9-4ba5-4353-b075-5afdae5b11da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1f5351c9-4ba5-4353-b075-5afdae5b11da" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d4914df7-d8b6-470e-9ae6-c943ef69eb26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d4914df7-d8b6-470e-9ae6-c943ef69eb26" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e32e1f1f-da86-48c3-9d82-0446a435de0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_NetIncomeLoss_e32e1f1f-da86-48c3-9d82-0446a435de0e" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_79fd5ffa-ca90-4898-9b73-31d12ed9d451" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_14d3b00d-8fe2-428a-98a4-9f3a313ccbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_79fd5ffa-ca90-4898-9b73-31d12ed9d451" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_14d3b00d-8fe2-428a-98a4-9f3a313ccbc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b7f61241-dc69-4c74-bb46-c5330c918dee" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_14d3b00d-8fe2-428a-98a4-9f3a313ccbc6" xlink:to="loc_srt_ConsolidationItemsAxis_b7f61241-dc69-4c74-bb46-c5330c918dee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b7f61241-dc69-4c74-bb46-c5330c918dee_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b7f61241-dc69-4c74-bb46-c5330c918dee" xlink:to="loc_srt_ConsolidationItemsDomain_b7f61241-dc69-4c74-bb46-c5330c918dee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_14865071-f70c-47ac-8d86-90b889fbfb1e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b7f61241-dc69-4c74-bb46-c5330c918dee" xlink:to="loc_srt_ConsolidationItemsDomain_14865071-f70c-47ac-8d86-90b889fbfb1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_14713fa9-331b-4c56-813c-c8813c62cde1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_14865071-f70c-47ac-8d86-90b889fbfb1e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_14713fa9-331b-4c56-813c-c8813c62cde1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e52ffd31-c5f2-4442-8a9a-dc41cd300ace" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_14865071-f70c-47ac-8d86-90b889fbfb1e" xlink:to="loc_us-gaap_OperatingSegmentsMember_e52ffd31-c5f2-4442-8a9a-dc41cd300ace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a7667e39-ca9d-43c4-9f1e-01fff644224f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_14d3b00d-8fe2-428a-98a4-9f3a313ccbc6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a7667e39-ca9d-43c4-9f1e-01fff644224f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7667e39-ca9d-43c4-9f1e-01fff644224f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7667e39-ca9d-43c4-9f1e-01fff644224f" xlink:to="loc_us-gaap_SegmentDomain_a7667e39-ca9d-43c4-9f1e-01fff644224f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5c5e954b-1e6c-42d4-9476-ffaa200b00ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7667e39-ca9d-43c4-9f1e-01fff644224f" xlink:to="loc_us-gaap_SegmentDomain_5c5e954b-1e6c-42d4-9476-ffaa200b00ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CoreIlluminaMember_3321e97a-c6b0-4658-91f4-caf088e1ca19" xlink:href="ilmn-20241229.xsd#ilmn_CoreIlluminaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5c5e954b-1e6c-42d4-9476-ffaa200b00ea" xlink:to="loc_ilmn_CoreIlluminaMember_3321e97a-c6b0-4658-91f4-caf088e1ca19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_3e9be4c4-3cd8-4ee7-ab64-b289f3e01841" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5c5e954b-1e6c-42d4-9476-ffaa200b00ea" xlink:to="loc_ilmn_GRAILInc.Member_3e9be4c4-3cd8-4ee7-ab64-b289f3e01841" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0234c8ac-fb90-4b69-9fe2-e22c8abd0970" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_79fd5ffa-ca90-4898-9b73-31d12ed9d451" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0234c8ac-fb90-4b69-9fe2-e22c8abd0970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_566ed7e3-5e28-4aef-a460-6355939bcc68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_79fd5ffa-ca90-4898-9b73-31d12ed9d451" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_566ed7e3-5e28-4aef-a460-6355939bcc68" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_63e5fd6b-0f6f-4517-aae1-651d1d5ff97c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_04c1147b-0fd8-4175-8430-e051759ce0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_63e5fd6b-0f6f-4517-aae1-651d1d5ff97c" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_04c1147b-0fd8-4175-8430-e051759ce0cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_780a8815-eb08-4c0f-b59e-7d6c2ac367f8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_04c1147b-0fd8-4175-8430-e051759ce0cb" xlink:to="loc_srt_StatementGeographicalAxis_780a8815-eb08-4c0f-b59e-7d6c2ac367f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_780a8815-eb08-4c0f-b59e-7d6c2ac367f8_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_780a8815-eb08-4c0f-b59e-7d6c2ac367f8" xlink:to="loc_srt_SegmentGeographicalDomain_780a8815-eb08-4c0f-b59e-7d6c2ac367f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_780a8815-eb08-4c0f-b59e-7d6c2ac367f8" xlink:to="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2c4f709a-70b6-41a5-92ff-f338080c7e42" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:to="loc_country_US_2c4f709a-70b6-41a5-92ff-f338080c7e42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_3f7ebd36-8a86-4e4e-bc43-6335d16a302f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SG"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:to="loc_country_SG_3f7ebd36-8a86-4e4e-bc43-6335d16a302f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_bb3f89e7-0533-416c-9efd-79dd147c04ec" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:to="loc_country_GB_bb3f89e7-0533-416c-9efd-79dd147c04ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OtherCountriesMember_d0d50ca1-d5d5-49ff-bf6e-682b680b6a8b" xlink:href="ilmn-20241229.xsd#ilmn_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:to="loc_ilmn_OtherCountriesMember_d0d50ca1-d5d5-49ff-bf6e-682b680b6a8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_c082bd8d-8d1c-4f57-b8ee-ba659d990621" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_63e5fd6b-0f6f-4517-aae1-651d1d5ff97c" xlink:to="loc_us-gaap_NoncurrentAssets_c082bd8d-8d1c-4f57-b8ee-ba659d990621" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="691"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="41"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FrancesArnoldMember_51d3aa6d-0115-40e5-ad14-d37e30e09803" xlink:href="ilmn-20241229.xsd#ilmn_FrancesArnoldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ilmn_FrancesArnoldMember_51d3aa6d-0115-40e5-ad14-d37e30e09803" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_JakobWedelMember_6ad384ec-7bb0-4417-9474-413552d7f613" xlink:href="ilmn-20241229.xsd#ilmn_JakobWedelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ilmn_JakobWedelMember_6ad384ec-7bb0-4417-9474-413552d7f613" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ScottDaviesMember_7ffdab63-0888-4808-a2d4-fe160f875460" xlink:href="ilmn-20241229.xsd#ilmn_ScottDaviesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ilmn_ScottDaviesMember_7ffdab63-0888-4808-a2d4-fe160f875460" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PatriciaLeckmanMember_13164d4d-56cd-45b7-803e-8bbfbf079b31" xlink:href="ilmn-20241229.xsd#ilmn_PatriciaLeckmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ilmn_PatriciaLeckmanMember_13164d4d-56cd-45b7-803e-8bbfbf079b31" xlink:type="arc" order="5"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>ilmn-20241229_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3be010a1-b4e2-4eb6-8721-f9b45bdbb770,g:4f5b8127-d86a-4b2f-b09c-147b6f0d2a9f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease_63299592-54e6-4ae1-8f95-a2f495f77462_terseLabel_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of change of additional 250 basis points, decrease in liability</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease_label_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Increase</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease_documentation_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease" xlink:to="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a346cf73-1055-4aaa-b8ff-115d1c63f8fa_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_aa533e63-9917-4580-b3f4-70ebee0f1b2f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_baa9940a-58c7-4fef-a3d7-f58f8d20f085_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dollar amount remaining in authorized stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Remaining Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_04425d4c-de99-4753-8b0f-01514da1d938_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Annual Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c5096853-d7e6-4c30-a2b1-1aa2949cb5b3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock_7f2890cd-bf4b-4cc5-a64d-8449e8dbcd3d_terseLabel_en-US" xlink:label="lab_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS</link:label>
    <link:label id="lab_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination And Goodwill And Intangible Assets Disclosure [Text Block]</link:label>
    <link:label id="lab_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock_documentation_en-US" xlink:label="lab_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination And Goodwill And Intangible Assets Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="ilmn-20241229.xsd#ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_c02391fe-02ed-4802-8d92-5ef6eda36984_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_79899e52-af21-485a-a925-f3862609d9d6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2e98c249-d1f0-493d-b1df-c7ebbededff0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_929dddde-2950-47cb-bf8c-de5cc4709069_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development (IPR&amp;D)</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_1286c4c8-434c-442c-a0d8-df22a0f032c1_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_26e4a428-9f5a-4c4e-9c38-ee86369e2b21_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_d26654bf-3719-4b8d-819e-f39438769876_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_A2015StockAndIncentiveCompensationPlanMember_aea7e25a-3147-4339-ba3b-25060a5f778f_terseLabel_en-US" xlink:label="lab_ilmn_A2015StockAndIncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2015 Stock Plan</link:label>
    <link:label id="lab_ilmn_A2015StockAndIncentiveCompensationPlanMember_label_en-US" xlink:label="lab_ilmn_A2015StockAndIncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2015 Stock and Incentive Compensation Plan [Member]</link:label>
    <link:label id="lab_ilmn_A2015StockAndIncentiveCompensationPlanMember_documentation_en-US" xlink:label="lab_ilmn_A2015StockAndIncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2015 Stock and Incentive Compensation Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_A2015StockAndIncentiveCompensationPlanMember" xlink:href="ilmn-20241229.xsd#ilmn_A2015StockAndIncentiveCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_A2015StockAndIncentiveCompensationPlanMember" xlink:to="lab_ilmn_A2015StockAndIncentiveCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d331be1f-dcbc-4a98-8794-f6f0397859fc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_a051df14-da50-4875-a94e-2ecdce6ca119_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Net (losses) recognized during the period on marketable equity securities sold during the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_LossContingencyLicenseGrantedIntangibleAssets_2a1c09f4-4975-4cfb-b3bb-335ae738b562_terseLabel_en-US" xlink:label="lab_ilmn_LossContingencyLicenseGrantedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License granted intangible assets</link:label>
    <link:label id="lab_ilmn_LossContingencyLicenseGrantedIntangibleAssets_label_en-US" xlink:label="lab_ilmn_LossContingencyLicenseGrantedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, License Granted Intangible Assets</link:label>
    <link:label id="lab_ilmn_LossContingencyLicenseGrantedIntangibleAssets_documentation_en-US" xlink:label="lab_ilmn_LossContingencyLicenseGrantedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, License Granted Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LossContingencyLicenseGrantedIntangibleAssets" xlink:href="ilmn-20241229.xsd#ilmn_LossContingencyLicenseGrantedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_LossContingencyLicenseGrantedIntangibleAssets" xlink:to="lab_ilmn_LossContingencyLicenseGrantedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9507ea03-641b-4015-8946-82d169625f11_negatedLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Related income tax benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9cd6d277-ff87-4d52-9dd5-6dca7ef2b1aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_46dcfd62-2ba0-4a06-9852-de5ee8aa2741_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate_7c1a024e-08fe-4d0d-8cc9-f84fe953090d_terseLabel_en-US" xlink:label="lab_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of discount rate (as a percent)</link:label>
    <link:label id="lab_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate_label_en-US" xlink:label="lab_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill Impairment, Discounted cash flow model, Discount rate</link:label>
    <link:label id="lab_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate_documentation_en-US" xlink:label="lab_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill Impairment, Discounted cash flow model, Discount rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate" xlink:to="lab_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_0b3eb94a-1b89-42b4-b74b-0c08da03eb13_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_PatriciaLeckmanMember_label_en-US" xlink:label="lab_ilmn_PatriciaLeckmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patricia Leckman [Member]</link:label>
    <link:label id="lab_ilmn_PatriciaLeckmanMember_documentation_en-US" xlink:label="lab_ilmn_PatriciaLeckmanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Patricia Leckman</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PatriciaLeckmanMember" xlink:href="ilmn-20241229.xsd#ilmn_PatriciaLeckmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_PatriciaLeckmanMember" xlink:to="lab_ilmn_PatriciaLeckmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_5ee9388f-56a9-45d3-95fa-eeeb122e3869_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_35b49ad6-642b-47a4-b59d-9b807ac63ed2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_3f6150c2-63f9-43b0-aaf8-aeabf8dee74e_totalLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net (losses) recognized during the period on marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_a4c8958d-0ef7-4242-bb10-becf5adb0604_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">(Loss) Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_b7d80dc1-4ed5-4b98-9255-767574719083_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital_a8eac5c8-00a9-4473-8868-f4593402321c_terseLabel_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total recorded to additional paid-in capital as a result of the GRAIL Spin-Off</link:label>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital_label_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Adjustment To Additional Paid In Capital</link:label>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital_documentation_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Adjustment To Additional Paid In Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital" xlink:to="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_9b111b16-9e35-4b57-9ab5-15fa2808a22f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INVESTMENTS AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_dcc46027-c47b-4232-93ee-fea56619443c_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_02da87bf-da1c-4c9f-b514-b6ad1ba993b7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f1ef5aa5-d7ee-4a1d-abbb-c3b0a3dcfe36_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_41a5f163-fe4f-4a8f-8c8c-0176749cc877_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_1ebfb14f-8f59-4eca-b8df-c426008fdf6e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_bf12828b-e24e-49a5-844a-560a0d3d6c55_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value in excess of carrying amount (more than)</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit, Amount of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:to="lab_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_d5cb0c1a-2014-430e-ae7d-03332ee0e44f_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_51e506c0-7576-41fe-9de9-cc419d0d5d3e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_efc14dea-5ff2-4acc-b343-28cebf1241f2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_RecallableDistributionsCommitment_02fd50a3-1cd7-4b29-b82e-bd6be69f119f_terseLabel_en-US" xlink:label="lab_ilmn_RecallableDistributionsCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recallable distributions</link:label>
    <link:label id="lab_ilmn_RecallableDistributionsCommitment_label_en-US" xlink:label="lab_ilmn_RecallableDistributionsCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recallable Distributions Commitment</link:label>
    <link:label id="lab_ilmn_RecallableDistributionsCommitment_documentation_en-US" xlink:label="lab_ilmn_RecallableDistributionsCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Recallable Distributions Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RecallableDistributionsCommitment" xlink:href="ilmn-20241229.xsd#ilmn_RecallableDistributionsCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_RecallableDistributionsCommitment" xlink:to="lab_ilmn_RecallableDistributionsCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_f70d55b8-ee46-4df9-8a30-4bed800d454f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_d8632292-0935-4742-8d5f-c687f805e02d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_IntangibleAssetsImpairmentMeasurementInput_cbec8d99-dca2-468a-b9ee-d0bb812501d1_terseLabel_en-US" xlink:label="lab_ilmn_IntangibleAssetsImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets impairment measurement input</link:label>
    <link:label id="lab_ilmn_IntangibleAssetsImpairmentMeasurementInput_label_en-US" xlink:label="lab_ilmn_IntangibleAssetsImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Impairment Measurement Input</link:label>
    <link:label id="lab_ilmn_IntangibleAssetsImpairmentMeasurementInput_documentation_en-US" xlink:label="lab_ilmn_IntangibleAssetsImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intangible Assets Impairment Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IntangibleAssetsImpairmentMeasurementInput" xlink:href="ilmn-20241229.xsd#ilmn_IntangibleAssetsImpairmentMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_IntangibleAssetsImpairmentMeasurementInput" xlink:to="lab_ilmn_IntangibleAssetsImpairmentMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_19b51f02-88c0-454c-a2e3-45cc94df8acd_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_536c0161-c4a8-4445-b72a-88d9555e1654_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_GoodwillImpairmentTestDiscountRate_4837244a-26aa-46b8-ae97-a44caf7526b6_terseLabel_en-US" xlink:label="lab_ilmn_GoodwillImpairmentTestDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination impairment test percentage</link:label>
    <link:label id="lab_ilmn_GoodwillImpairmentTestDiscountRate_label_en-US" xlink:label="lab_ilmn_GoodwillImpairmentTestDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Test, Discount Rate</link:label>
    <link:label id="lab_ilmn_GoodwillImpairmentTestDiscountRate_documentation_en-US" xlink:label="lab_ilmn_GoodwillImpairmentTestDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Test, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentTestDiscountRate" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentTestDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_GoodwillImpairmentTestDiscountRate" xlink:to="lab_ilmn_GoodwillImpairmentTestDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ContingentPaymentRightsDomain_4e27561a-a6e2-45e4-83ad-0b987316e02e_terseLabel_en-US" xlink:label="lab_ilmn_ContingentPaymentRightsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Payment Rights [Domain]</link:label>
    <link:label id="lab_ilmn_ContingentPaymentRightsDomain_label_en-US" xlink:label="lab_ilmn_ContingentPaymentRightsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Payment Rights [Domain]</link:label>
    <link:label id="lab_ilmn_ContingentPaymentRightsDomain_documentation_en-US" xlink:label="lab_ilmn_ContingentPaymentRightsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Payment Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentPaymentRightsDomain" xlink:href="ilmn-20241229.xsd#ilmn_ContingentPaymentRightsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ContingentPaymentRightsDomain" xlink:to="lab_ilmn_ContingentPaymentRightsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_AsiaPacificMiddleEastAndAfricaMember_ecf3a105-e9a8-40ad-8b84-0d6f6a6cfb1f_terseLabel_en-US" xlink:label="lab_ilmn_AsiaPacificMiddleEastAndAfricaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asia-Pacific, Middle East and Africa</link:label>
    <link:label id="lab_ilmn_AsiaPacificMiddleEastAndAfricaMember_label_en-US" xlink:label="lab_ilmn_AsiaPacificMiddleEastAndAfricaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asia-Pacific, Middle East and Africa [Member]</link:label>
    <link:label id="lab_ilmn_AsiaPacificMiddleEastAndAfricaMember_documentation_en-US" xlink:label="lab_ilmn_AsiaPacificMiddleEastAndAfricaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asia-Pacific, Middle East and Africa</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AsiaPacificMiddleEastAndAfricaMember" xlink:href="ilmn-20241229.xsd#ilmn_AsiaPacificMiddleEastAndAfricaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_AsiaPacificMiddleEastAndAfricaMember" xlink:to="lab_ilmn_AsiaPacificMiddleEastAndAfricaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_cc0fabbc-b2e0-4b84-8b1a-a0b9cd6a3c1d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7e27cdf9-45ad-48d7-bdd1-5856865141d1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2ebf8d70-05cd-4614-a887-d540de314229_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_486aa850-6990-4408-a8c8-7ced66751460_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_278d8811-7c81-463b-abe6-63c2e60273d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefit [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefit [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:to="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_5bec63e6-3c59-4c64-a060-559059eb4773_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross_75db3303-cd55-46d8-a104-74247323e29c_terseLabel_en-US" xlink:label="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development (IPR&amp;D)</link:label>
    <link:label id="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross_label_en-US" xlink:label="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill), Gross</link:label>
    <link:label id="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross_documentation_en-US" xlink:label="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill), Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" xlink:href="ilmn-20241229.xsd#ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" xlink:to="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_fa20ad97-f8b4-4eb8-b1ce-b475af5cede8_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_f8e85fa2-3330-42aa-9b76-d6d84cba2095_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_TermNotesDue2025Member_afb360c5-03d9-4728-8e59-2a0a00bfae4f_terseLabel_en-US" xlink:label="lab_ilmn_TermNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025 Term Notes</link:label>
    <link:label id="lab_ilmn_TermNotesDue2025Member_label_en-US" xlink:label="lab_ilmn_TermNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Notes Due 2025 [Member]</link:label>
    <link:label id="lab_ilmn_TermNotesDue2025Member_documentation_en-US" xlink:label="lab_ilmn_TermNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2025Member" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_TermNotesDue2025Member" xlink:to="lab_ilmn_TermNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_cad9522f-b381-4f02-8e76-e3b939902a2b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_0f025f79-5b58-44bc-8f98-f36704bae6fe_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_193001d0-122b-41f9-ad15-2630d10b29ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_7aa0a72c-e929-4b6c-8c88-327af18c3b3f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bdf95c20-337c-43ec-b5f9-8dd9b37a7b72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_051e33f4-e0bd-457f-b686-a4efde0b4a36_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_74a48801-2cd6-442c-bb5a-6b04061b1cc4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_45fc1f77-5c40-44f3-829a-7ca6c3bf5def_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_937098ac-2041-4770-9dfc-3647964ce189_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9b4e8a3f-e0a5-4bdd-922a-0d4cef8658ac_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potentially dilutive shares excluded due to antidilutive effect</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_a953239c-d508-437a-a4f0-219c86aaac37_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-contingent indemnification liability (see Note 7)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Amounts of Material Contingent Liabilities Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:to="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_784349f4-d51f-412c-8745-75c3a2813178_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_9269bfbc-c6b4-44b1-9d3d-dfe4f518de71_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_IncreaseDecreaseOfOperatingLeasesNet_a9eff1ee-f387-415c-9350-fcceb29db2eb_negatedTerseLabel_en-US" xlink:label="lab_ilmn_IncreaseDecreaseOfOperatingLeasesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_ilmn_IncreaseDecreaseOfOperatingLeasesNet_label_en-US" xlink:label="lab_ilmn_IncreaseDecreaseOfOperatingLeasesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Of Operating Leases, Net</link:label>
    <link:label id="lab_ilmn_IncreaseDecreaseOfOperatingLeasesNet_documentation_en-US" xlink:label="lab_ilmn_IncreaseDecreaseOfOperatingLeasesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Of Operating Leases, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IncreaseDecreaseOfOperatingLeasesNet" xlink:href="ilmn-20241229.xsd#ilmn_IncreaseDecreaseOfOperatingLeasesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_IncreaseDecreaseOfOperatingLeasesNet" xlink:to="lab_ilmn_IncreaseDecreaseOfOperatingLeasesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_48165ea8-ac57-466f-8b58-90a2ff53d373_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_015aa762-ea6e-4b74-a265-02273f034a2b_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_2d4e2100-0e2d-4901-a2d4-53acead14eaa_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_b40ffd58-315a-405a-b13a-de080de5f7bf_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_14894611-43ac-4d7d-9446-d7183e947166_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment for contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b3b099f8-28ed-4fd0-9609-35f8af7930b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_0e7ebb22-2cc0-417d-a8fc-91612c52f6d6_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program authorized amount</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_125b8721-a150-4834-9a96-40f2dd284a03_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repairs and replacements</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_3be19863-6541-4a36-b2f4-10921dc5d723_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_4c66861c-a993-4480-987b-ab79f70a3d97_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_bdcc0998-a08a-4062-afac-cbbae809ea96_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_571ab5eb-e7ad-4c37-84b2-10f99da5797b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_c07390bd-29bb-4a93-8951-14ce1b22cae3_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_92047546-34f0-4007-9851-505ea3624767_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_020afc1c-ade2-4af7-91b3-56e9cdf0b152_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_bd7c80b4-0c03-4235-a558-1d277c3be109_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cdf3def2-b98e-47cb-9bd7-aadf9743df18_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryGross_84979139-5d3d-4ba5-a748-f875a3343ef8_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Inventory, gross</link:label>
    <link:label id="lab_us-gaap_InventoryGross_label_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryGross" xlink:to="lab_us-gaap_InventoryGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_7b951cb9-154e-4243-b7cd-0cffb3803fd2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_143cd148-5f44-4312-9456-434547d4e773_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_878a8edc-2878-49a3-b3b5-b37acd0929e6_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_af3e5621-965b-47e0-8301-7d60cbfdfd99_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive_25d19697-f25a-4958-8233-bc94da2c3f6e_terseLabel_en-US" xlink:label="lab_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive_label_en-US" xlink:label="lab_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Five</link:label>
    <link:label id="lab_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive_documentation_en-US" xlink:label="lab_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive" xlink:href="ilmn-20241229.xsd#ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive" xlink:to="lab_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_1ac8a5ff-3df6-4952-99cf-074ccc53719a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total long-lived assets, net</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease_e2dab949-01fc-4fbb-a39f-464233644b7c_terseLabel_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in 20% of revenue, decrease in liability</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease_label_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent Decrease, Decrease</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease_documentation_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent Decrease, Decrease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease" xlink:to="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_d3a82a5f-632f-4ec9-adb7-610b49089d3a_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_74213526-95e5-460e-a6db-d4a006016a72_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3751799b-1212-493d-a729-2cc03e277a27_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f9c0429e-eaba-47c6-97b3-91cb4da67332_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3c8a28ce-4e87-49ee-b592-e8bece6cd4d5_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life (in years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_da0836f5-ac84-4ae4-88be-feafb1e70f23_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Functional Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_421b0fd3-ced1-4e0e-a3b6-824c2d13253b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e27c5dc-669f-471f-996e-67b08c17c578_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c2ac18c5-8e22-46bd-b60b-6d40800044a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f80130db-3df3-494c-a6b0-d468e9d35a7d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8ad96c84-2576-4275-b1f5-3049d70edafa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_64ea9725-3401-4a0b-842d-51064f0588c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_98aa55f5-9c3d-420c-91aa-45b6878f9ff0_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_6617bc92-42a3-4572-abf0-7259365b2222_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share repurchase activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_FrancesArnoldMember_label_en-US" xlink:label="lab_ilmn_FrancesArnoldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Frances Arnold [Member]</link:label>
    <link:label id="lab_ilmn_FrancesArnoldMember_documentation_en-US" xlink:label="lab_ilmn_FrancesArnoldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Frances Arnold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FrancesArnoldMember" xlink:href="ilmn-20241229.xsd#ilmn_FrancesArnoldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_FrancesArnoldMember" xlink:to="lab_ilmn_FrancesArnoldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_18fe1b76-e98d-4a7f-bdcd-b354402a0cf8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_158ed775-5b3c-42d0-b556-df23856ec9c3_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_611e6c6b-e7f7-4f42-811d-d3dcd979958c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_ba0137a0-b9e1-4ab2-b046-6554580a11e9_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b842fcbe-a529-4b62-a15f-5e403a1baff2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a6cbf3db-5ff1-492e-a126-b2c00270f9ae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise&#160;Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_4a0a0b8c-a89f-434d-b1c8-7352136f656c_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Intangible Assets and Other Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_16dc602b-11ad-445d-80ed-6c4c2763ddcb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decreases related to lapse of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0de243a8-c328-44fd-b952-1c5b3fff3d3a_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4ddf81bc-ed43-4769-b72d-fa2dd96db6ec_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6c457a5d-1b96-4958-a5c5-77ec83d7aa60_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares used in calculating diluted earnings (loss) per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_MeasurementInputCalculationTrailingPeriodMember_6eaf4ec4-4cef-4427-adb0-986049d78aa1_terseLabel_en-US" xlink:label="lab_ilmn_MeasurementInputCalculationTrailingPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Calculation Trailing Period</link:label>
    <link:label id="lab_ilmn_MeasurementInputCalculationTrailingPeriodMember_label_en-US" xlink:label="lab_ilmn_MeasurementInputCalculationTrailingPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Calculation Trailing Period [Member]</link:label>
    <link:label id="lab_ilmn_MeasurementInputCalculationTrailingPeriodMember_documentation_en-US" xlink:label="lab_ilmn_MeasurementInputCalculationTrailingPeriodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Calculation Trailing Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MeasurementInputCalculationTrailingPeriodMember" xlink:href="ilmn-20241229.xsd#ilmn_MeasurementInputCalculationTrailingPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_MeasurementInputCalculationTrailingPeriodMember" xlink:to="lab_ilmn_MeasurementInputCalculationTrailingPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ConvertibleSeniorNotesDue2023Member_c9616792-a603-41a6-9d5b-a0f6b4b55f6e_terseLabel_en-US" xlink:label="lab_ilmn_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023 Notes</link:label>
    <link:label id="lab_ilmn_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_ilmn_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Senior Notes Due 2023 [Member]</link:label>
    <link:label id="lab_ilmn_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_ilmn_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Senior Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConvertibleSeniorNotesDue2023Member" xlink:href="ilmn-20241229.xsd#ilmn_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_ilmn_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_faf726ed-bb4c-4730-958c-b65cb74e6679_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c1a9bb7e-5f50-4c64-b5b8-95857564e9f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_bcdedfe1-f599-4fdd-829b-93fcd4ece420_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_ff21b893-69eb-4347-902c-756d17c69e5f_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_67e32b26-b033-4b75-8901-7cb74e869ede_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of net operating losses on GILTI, U.S. foreign tax credits, and Pillar Two global minimum top-up tax</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, GILTI, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_a36ded70-4a20-468a-9b6e-d2efb52669e6_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_87f8b949-2d67-4296-802d-86fe9dee6073_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_32e1ed0c-b185-4865-86cc-5f1f78202d1c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_ba5f416d-c41a-4967-8e89-b8e082db7940_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9059c393-adbb-4a4b-b8b9-1096c749cb99_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_51ad46f3-a6a5-4d49-8360-54176b6ae166_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_7693b994-bfd9-499e-9e1d-193464b83344_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments on debt obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_6efbe46c-73d4-4b8c-8c54-6b99474edf35_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_37d17bb5-a395-47cb-87e0-5cc1c5632cc9_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total product revenue</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxYear2017Member_2ed4424f-ed0c-451b-a775-eb61e051c2c6_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2017</link:label>
    <link:label id="lab_us-gaap_TaxYear2017Member_label_en-US" xlink:label="lab_us-gaap_TaxYear2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Year 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2017Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxYear2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2017Member" xlink:to="lab_us-gaap_TaxYear2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount_8c776a92-bcc6-4269-af64-c7e358c760d1_negatedTerseLabel_en-US" xlink:label="lab_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of acquisition related items</link:label>
    <link:label id="lab_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount_label_en-US" xlink:label="lab_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Acquisitions Related Items, Amount</link:label>
    <link:label id="lab_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount_documentation_en-US" xlink:label="lab_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Acquisitions Related Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" xlink:href="ilmn-20241229.xsd#ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" xlink:to="lab_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3b8ca726-c18f-4f44-86eb-e00eddd79401_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_1595b59e-cb75-46df-ba97-47e9e4909f82_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal contingencies</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_eabf822e-5593-49b4-90e7-0b24a630e928_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_64c92e54-2af0-468a-861d-0a1f5d7d8b8e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_acdbc48e-89dc-457f-9390-426858adbc92_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f67dfeff-8871-458b-a1ae-d3eb27ced4b4_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_6db8d65f-b450-4771-8054-be5f701cb622_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability-classified awards (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_106cf78c-2365-49d2-bef1-ad4174705652_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_25eb7894-0b60-4004-b6b3-fb99ab78b974_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected dividends</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_948837d4-dea1-4ec1-b580-5905b8d1b3d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of R&amp;D expense capitalization</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_98611cf8-ee08-4e00-acd9-aba7bb98829c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5b634b43-e165-4258-92c4-7bc2f1ef0bfd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective interest rate used to measure fair value of convertible senior note</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_e4a9d9aa-4989-4d8c-a6d8-60f7c8afa7b0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_680ea516-5396-487f-9db1-7d5cbb2d0b0e_negatedTerseLabel_en-US" xlink:label="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_label_en-US" xlink:label="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite Lived Intangible Assets (Excluding Goodwill), Accumulated Impairment</link:label>
    <link:label id="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_documentation_en-US" xlink:label="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indefinite Lived Intangible Assets (Excluding Goodwill), Accumulated Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:href="ilmn-20241229.xsd#ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:to="lab_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_000fe6ff-5c5a-406c-8798-a5baa0475964_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Operating Performance and Assets by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_SwinglineBorrowingsMember_be7ccca0-d827-4b10-a1c7-7b79c8e86c25_terseLabel_en-US" xlink:label="lab_ilmn_SwinglineBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Swingline Borrowings</link:label>
    <link:label id="lab_ilmn_SwinglineBorrowingsMember_label_en-US" xlink:label="lab_ilmn_SwinglineBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Swingline Borrowings [Member]</link:label>
    <link:label id="lab_ilmn_SwinglineBorrowingsMember_documentation_en-US" xlink:label="lab_ilmn_SwinglineBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Swingline Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SwinglineBorrowingsMember" xlink:href="ilmn-20241229.xsd#ilmn_SwinglineBorrowingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_SwinglineBorrowingsMember" xlink:to="lab_ilmn_SwinglineBorrowingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_acbe1e04-81ea-4f5c-a681-f1d359364e0f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff_77bbea0c-125d-402a-8d87-ae2cc426e5aa_terseLabel_en-US" xlink:label="lab_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of parent shares converted into one share of spin-off (in shares)</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff_label_en-US" xlink:label="lab_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Number Of Parent Shares Converted Into One Share Of Spin-Off</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff_documentation_en-US" xlink:label="lab_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Number Of Parent Shares Converted Into One Share Of Spin-Off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff" xlink:to="lab_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityTable_77dc876d-29a3-457d-bec3-33ea50b7c9a5_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Warranty Liability [Table]</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityTable_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Warranty Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable" xlink:to="lab_us-gaap_ProductWarrantyLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_ca23eca0-24f1-41a7-8bf1-765823de8654_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Annual Amortization of Finite-lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsTerm_e226e95c-da8b-420f-83c5-cf045885029b_terseLabel_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent value right, terms</link:label>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsTerm_label_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Value Rights, Term</link:label>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsTerm_documentation_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Value Rights, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsTerm" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_BusinessAcquisitionContingentValueRightsTerm" xlink:to="lab_ilmn_BusinessAcquisitionContingentValueRightsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_6ab4c643-e92f-42c7-80e3-c3f79ca6fe75_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8a4297e7-900b-4a37-9109-b9f0f3855cc1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_33368df1-d992-4133-93cb-748116e79ffb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2a171a38-b0a8-42ed-bd40-9cf6d2044aa0_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_483df4dd-0c98-44a7-a180-aa9cb288f75c_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_89b2f2e6-6819-4aaa-bfad-89524c74cdd2_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0bfdcf4b-63d0-42b0-9e47-6164b1bc54ab_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_aae9390c-bb67-498e-9adf-859cde6ce6ce_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_10d66e9c-4d63-45e0-b959-6510531e1583_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Legal contingency and settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_579d9ccd-e1a1-48af-8605-0bf16523b980_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal contingency and settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) from Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_2a1c4638-e537-444e-9eb2-1ce27d8e7947_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_7bdff734-c606-45a1-89da-b8f5e3060515_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_eaa47643-5c60-4a63-8f40-52dfa636d1c1_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0e1fc18a-374a-4fe8-af4c-cc95dc4eccc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities Included as Part of the Disposal Group</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_52d70d44-aa2e-4665-8dcf-a82e0af9c992_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_616eb4d2-ccca-41a2-87e2-e7cefb01f0cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_c41ca62d-16ba-450b-8e6d-548d0fa42c70_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and intangible impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_24794ae0-dbd0-4353-8ff8-d8f4c8545411_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operation, equity method investment retained after disposal, ownership interest after disposal</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Equity Method Investment Retained after Disposal, Ownership Interest after Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:to="lab_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_OtherCountriesMember_4577c2b2-0097-4d19-895f-63843efb11f9_verboseLabel_en-US" xlink:label="lab_ilmn_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other countries</link:label>
    <link:label id="lab_ilmn_OtherCountriesMember_label_en-US" xlink:label="lab_ilmn_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_ilmn_OtherCountriesMember_documentation_en-US" xlink:label="lab_ilmn_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OtherCountriesMember" xlink:href="ilmn-20241229.xsd#ilmn_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_OtherCountriesMember" xlink:to="lab_ilmn_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_02812004-b3b7-41d7-bd49-1582c84f9b8d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_eb8094e4-6913-468c-9770-96464d65da7d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f0679048-fba2-48ae-9acf-ee3aa08b26c4_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_8bbb908d-b19d-4eef-a0f3-a5779254c69a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redemption price</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_a5fe69bb-ecef-4453-b618-93d559ace179_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_505a8e8a-a690-4ed8-a4ab-aad9aacb32df_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e322a508-ae07-457f-9095-f3435d8cfc67_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition and Shipping and Handling Expenses</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_c4020eca-547e-4156-ade7-830fdf5a533d_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_8a31ea50-b283-406e-93ed-4bfd0322de26_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_4207364c-1673-4096-924f-3eeb673a9e66_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue:</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_aaaef812-aaa8-461c-bfa3-4cb644eff6c7_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_e0534a04-7dd1-4ca4-a4a2-26ee1ec07f8f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_label_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_f061f538-4f69-4067-9187-d5879381062d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_69980f1f-2a2a-4406-8122-ac0d5d859a7b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_d4608068-450d-4998-923a-b0dd7d097889_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue_87d70ce6-f775-46a3-a88e-f1f30414c811_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Change In Fair Value</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Change In Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_24aba435-6bae-4893-ac42-410c909e4fa2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_29328be6-9538-421e-b42e-0bb7919ec98c_terseLabel_en-US" xlink:label="lab_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:href="ilmn-20241229.xsd#ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_626a369e-9a77-4ea5-a1f9-a441d677a10c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term debt</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_5b462aaf-0e98-4eb2-9922-efd09ac4eb6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in estimated fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_b096e527-045d-4c1d-97c9-3aa946a51929_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and other credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_c95c2421-e42d-47e2-8a56-158776e5bb09_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_be9b04c7-0ecb-4173-8d61-9129e25454c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements_735802b4-43ae-49de-b9c8-b0dcddf80977_terseLabel_en-US" xlink:label="lab_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets and leasehold improvements</link:label>
    <link:label id="lab_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements_label_en-US" xlink:label="lab_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset and Leasehold Improvements</link:label>
    <link:label id="lab_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements_documentation_en-US" xlink:label="lab_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset and Leasehold Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" xlink:href="ilmn-20241229.xsd#ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" xlink:to="lab_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_AdditionalPaidInCapitalBeforeTax_ca34c966-693e-41ab-a123-c5ad274a43c9_terseLabel_en-US" xlink:label="lab_ilmn_AdditionalPaidInCapitalBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid in capital, before tax</link:label>
    <link:label id="lab_ilmn_AdditionalPaidInCapitalBeforeTax_label_en-US" xlink:label="lab_ilmn_AdditionalPaidInCapitalBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid In Capital Before Tax</link:label>
    <link:label id="lab_ilmn_AdditionalPaidInCapitalBeforeTax_documentation_en-US" xlink:label="lab_ilmn_AdditionalPaidInCapitalBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional Paid In Capital Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AdditionalPaidInCapitalBeforeTax" xlink:href="ilmn-20241229.xsd#ilmn_AdditionalPaidInCapitalBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_AdditionalPaidInCapitalBeforeTax" xlink:to="lab_ilmn_AdditionalPaidInCapitalBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_91017505-0843-4a87-b658-325ab00202aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of restricted stock vested:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a34783fc-3994-4a84-b217-b6ee5acf2cce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_be676afb-1651-4901-8b41-683c05d8128b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_79f0cee1-3d72-4780-b97c-6389a07e61ab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_455129c2-c743-486e-a51f-14b09e4bf217_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_31c20633-44f4-4b3f-8905-c937946427c3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional amount of outstanding forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_672a8b45-92ae-4c0f-aff2-75c9a63bf1bb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative assets related to terminated acquisition</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_ff74182f-df70-41be-820a-0322c8025766_terseLabel_en-US" xlink:label="lab_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued in transaction</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Number Of Shares Issued In Transaction</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_documentation_en-US" xlink:label="lab_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Number Of Shares Issued In Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction" xlink:to="lab_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_5faabec0-42d3-440a-b35f-392c0225ebdd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_547cf3c9-24f0-485a-b7c1-2842c997ae5d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average period of unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59906650-40d8-40cb-8236-736c93c897a4_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83766a91-3eb1-4069-883f-34815d16ec2c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_781a8444-f315-4596-b27c-0394c46328bf_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_9079b434-dab7-48c4-8fd1-230b0fe75677_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_47146340-4b9a-4257-9483-624db393f676_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e8ef066f-836d-4967-89b1-411a25bdb20b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_eb3bddcb-d8db-4e9d-b2a9-fc57942a2a1f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_08133ad3-4d34-42d6-a194-ecab83a94e7c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_861d7d95-a61c-4610-b969-1a6be30fac1e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Securities and Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_8f08e68c-a4f7-4356-bd79-b0f62862e0ed_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2adcbfff-d96d-4dda-b4cb-5bb27a439090_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_4cf58f13-622f-443e-83d5-9c3fd20e2063_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_a83f71c3-c40f-4dbc-beb3-5259ae59d965_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_3dbc7232-0321-464e-8e68-21e88640e524_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expense recorded</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0578bd91-924f-4b7a-99eb-ad5e7e0967ff_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a88ec9c5-7d66-49c9-a512-b5ac35d16c2a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_010cba3a-4803-4a04-b510-35391b3b5b4a_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease_e4cde6ee-53c3-4898-8fd8-d4191086203c_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for grant, period increase</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Number Of Shares Available For Grant, Period Increase</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Number Of Shares Available For Grant, Period Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage_2d6ea442-e6dd-47c6-89ec-6abace1a2596_terseLabel_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent payment rights, first percentage</link:label>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage_label_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Value Rights, Pro Rata One, Percentage</link:label>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage_documentation_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Value Rights, Pro Rata One, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage" xlink:to="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate_ac4f41dd-cb12-4ac9-af28-6b72541131aa_terseLabel_en-US" xlink:label="lab_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment increase in discounted cash flow model discount rate</link:label>
    <link:label id="lab_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate_label_en-US" xlink:label="lab_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill Impairment Increase In Discounted Cash Flow Model Discount Rate</link:label>
    <link:label id="lab_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate_documentation_en-US" xlink:label="lab_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill Impairment Increase In Discounted Cash Flow Model Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" xlink:to="lab_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_3b21ddb3-35b4-41ce-9f84-4e530edc66dd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_360a8b7e-db81-4218-a9b9-e05c5efa800f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c92e9f5b-a183-45e3-890e-bbe76a5e4362_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityLineItems_a8000580-d5d4-40e4-a607-5635d4756839_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Warranty Liability [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyLiabilityLineItems_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Warranty Liability [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems" xlink:to="lab_us-gaap_ProductWarrantyLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2d060b46-1662-406b-bffb-7cf40fb7c79b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at period start (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e5a3ee9f-d7c1-404d-b519-08a552d2a8b9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at period end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_05cf204e-6ab4-429f-8b20-8a6a317b5a3a_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_eebfdae6-1266-4a99-843c-30e42e133814_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency, new claims filed, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_72c3196b-e5d1-4305-964e-205bcddd069d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ff75ccb4-e543-4003-96a7-fa0c17dff073_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at period start (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_aefe005b-f541-4605-b01f-1e15b4041dfc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at period end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_3d26faf5-89d0-43d9-b087-49299514db5b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2dd673dd-2dc1-4788-966a-6319dff4a5e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_a172bc82-496b-4759-870f-d916e700529f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_463a8fd9-cf4c-4543-9b1e-5980519320c7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_093ddbc3-4e08-4a99-bbee-fc76413f25a5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at period start (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50c9e1bf-5022-48ba-b7a1-aa3952eae100_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at period end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability_d21b4e87-ea82-4209-b18c-55999ec70513_terseLabel_en-US" xlink:label="lab_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covered revenues of GRAIL, contingent consideration liability</link:label>
    <link:label id="lab_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability_label_en-US" xlink:label="lab_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covered Revenues of GRAIL, Contingent Consideration Liability</link:label>
    <link:label id="lab_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability_documentation_en-US" xlink:label="lab_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covered Revenues of GRAIL, Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability" xlink:href="ilmn-20241229.xsd#ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability" xlink:to="lab_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_b0c8181b-6b29-4a20-ba08-c2cb1b1134a8_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_BusinessCombinationContingentConsiderationLiabilityMember_e71eb80a-6fe9-49a6-80dd-cfc9361a400b_terseLabel_en-US" xlink:label="lab_ilmn_BusinessCombinationContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_ilmn_BusinessCombinationContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_ilmn_BusinessCombinationContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability [Member]</link:label>
    <link:label id="lab_ilmn_BusinessCombinationContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_ilmn_BusinessCombinationContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessCombinationContingentConsiderationLiabilityMember" xlink:href="ilmn-20241229.xsd#ilmn_BusinessCombinationContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_BusinessCombinationContingentConsiderationLiabilityMember" xlink:to="lab_ilmn_BusinessCombinationContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_GRAILInc.Member_5be033ec-79e0-40c4-b223-eaf6ac696582_terseLabel_en-US" xlink:label="lab_ilmn_GRAILInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GRAIL</link:label>
    <link:label id="lab_ilmn_GRAILInc.Member_label_en-US" xlink:label="lab_ilmn_GRAILInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GRAIL, Inc. [Member]</link:label>
    <link:label id="lab_ilmn_GRAILInc.Member_documentation_en-US" xlink:label="lab_ilmn_GRAILInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GRAIL, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_GRAILInc.Member" xlink:to="lab_ilmn_GRAILInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_efb8cfed-c7c6-4ac6-bb28-1c41a8c7d51f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_4f5372db-47ab-46de-8b18-0b3fba3056f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assumptions used to Estimate the Weighted-Average Fair Value Per Share for Stock Purchase under the Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementGain_13c102f5-8055-47fe-9d32-11528e492b6a_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation settlement, gain</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementGain_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementGain" xlink:to="lab_us-gaap_LitigationSettlementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_16a74252-7109-4fc4-b007-68e922c64431_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Awarded (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_35dae8b4-9d02-477e-a48c-ec0df4c328c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average grant-date fair value per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment_c9021059-546f-4cf2-9ee8-2dc99bf3786f_negatedTerseLabel_en-US" xlink:label="lab_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment_label_en-US" xlink:label="lab_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite Lived Intangible Assets, Accumulated Impairment</link:label>
    <link:label id="lab_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment_documentation_en-US" xlink:label="lab_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finite Lived Intangible Assets, Accumulated Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:href="ilmn-20241229.xsd#ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:to="lab_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_b00110ee-8e1c-45d4-ad53-6c4b84f9c5f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_a5b28a99-7a97-4cd8-a4bb-24db68608bf4_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_095cd6c3-ddbd-4bb0-9a7a-6e6b8b3b949f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3e72f356-beba-4154-8457-7a180ba38e3b_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundMember_4c8a19be-afea-4521-8ad5-f2ddc09f2664_terseLabel_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Venture Capital Investment Fund (the Fund)</link:label>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundMember_label_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Venture Capital Investment Fund (the Fund) [Member]</link:label>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundMember_documentation_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Venture Capital Investment Fund (the Fund)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundMember" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_VentureCapitalInvestmentFundTheFundMember" xlink:to="lab_ilmn_VentureCapitalInvestmentFundTheFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue_1586dc68-8d62-4eca-a0c8-a8ad58459b4e_negatedTerseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cancelled</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Forfeited, Value</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Forfeited, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTableTextBlock_9a59d1eb-0f4b-4fe7-8c3c-c39d41d9e03d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTableTextBlock" xlink:to="lab_us-gaap_OtherCommitmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_20f0cd85-b391-440b-8c46-aa8ff600ccd5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_9a6c1174-3b48-4a95-ba51-ba10def584d9_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_69b2e7f0-9190-40d6-b0a6-c4fe25d38625_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_f8370a09-e772-4c05-9172-217df40a27fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase to net income per diluted share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Holiday, Income Tax Benefits Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:to="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_LitigationSettlementFinePercentageRate_d94c86fc-767c-403f-aeb8-66fa9c556266_terseLabel_en-US" xlink:label="lab_ilmn_LitigationSettlementFinePercentageRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, fine percentage rate</link:label>
    <link:label id="lab_ilmn_LitigationSettlementFinePercentageRate_label_en-US" xlink:label="lab_ilmn_LitigationSettlementFinePercentageRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Fine Percentage Rate</link:label>
    <link:label id="lab_ilmn_LitigationSettlementFinePercentageRate_documentation_en-US" xlink:label="lab_ilmn_LitigationSettlementFinePercentageRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Fine Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LitigationSettlementFinePercentageRate" xlink:href="ilmn-20241229.xsd#ilmn_LitigationSettlementFinePercentageRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_LitigationSettlementFinePercentageRate" xlink:to="lab_ilmn_LitigationSettlementFinePercentageRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_5913d2b0-6f1f-458a-9380-82645543af03_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, operating lease, remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvesteeMember_ab5316f0-3f43-4ef5-b1f2-5dd62875e0ec_terseLabel_en-US" xlink:label="lab_us-gaap_InvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investee</link:label>
    <link:label id="lab_us-gaap_InvesteeMember_label_en-US" xlink:label="lab_us-gaap_InvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvesteeMember" xlink:to="lab_us-gaap_InvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_f4cb33bc-f4ac-4d67-86e6-aa6c5f455104_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost; 41&#160;million shares and 40&#160;million shares at December&#160;29, 2024 and December&#160;31, 2023, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DebtInstrumentNumberOfOneYearExtensions_ddaa2bf7-c132-442e-90fd-3d64f87cbbcb_terseLabel_en-US" xlink:label="lab_ilmn_DebtInstrumentNumberOfOneYearExtensions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, number of one year extensions</link:label>
    <link:label id="lab_ilmn_DebtInstrumentNumberOfOneYearExtensions_label_en-US" xlink:label="lab_ilmn_DebtInstrumentNumberOfOneYearExtensions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number of One Year Extensions</link:label>
    <link:label id="lab_ilmn_DebtInstrumentNumberOfOneYearExtensions_documentation_en-US" xlink:label="lab_ilmn_DebtInstrumentNumberOfOneYearExtensions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number of One Year Extensions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentNumberOfOneYearExtensions" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentNumberOfOneYearExtensions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DebtInstrumentNumberOfOneYearExtensions" xlink:to="lab_ilmn_DebtInstrumentNumberOfOneYearExtensions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_37889f9d-fd42-4239-a848-98a2297e628f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds (cash equivalents)</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_LiabilityClassifiedRestrictedStockUnitsMember_de659fbd-837e-45a8-8fe8-63fdf59c48e9_terseLabel_en-US" xlink:label="lab_ilmn_LiabilityClassifiedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Classified Restricted Stock Units</link:label>
    <link:label id="lab_ilmn_LiabilityClassifiedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_ilmn_LiabilityClassifiedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Classified Restricted Stock Units [Member]</link:label>
    <link:label id="lab_ilmn_LiabilityClassifiedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_ilmn_LiabilityClassifiedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liability Classified Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LiabilityClassifiedRestrictedStockUnitsMember" xlink:href="ilmn-20241229.xsd#ilmn_LiabilityClassifiedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_LiabilityClassifiedRestrictedStockUnitsMember" xlink:to="lab_ilmn_LiabilityClassifiedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f36d3877-60df-4be3-94c2-86c1e24ee397_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d160a67d-5e80-413f-b1ef-c217a58e54a6_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_acbbbe50-8552-4292-a9f5-7f26f6a64264_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance on deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_6d303302-94bd-43ca-96c3-bf3d0189a3fd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance on deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_d4d0e4de-14f3-4dbc-851e-f52ef110415b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_ced3d48f-244d-478f-a818-1f431a50b666_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_SanDiegoCaliforniaMember_85c3e3c0-74ea-484b-9d35-471ab188859c_terseLabel_en-US" xlink:label="lab_ilmn_SanDiegoCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">San Diego, California</link:label>
    <link:label id="lab_ilmn_SanDiegoCaliforniaMember_label_en-US" xlink:label="lab_ilmn_SanDiegoCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">San Diego, California [Member]</link:label>
    <link:label id="lab_ilmn_SanDiegoCaliforniaMember_documentation_en-US" xlink:label="lab_ilmn_SanDiegoCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">San Diego, California</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SanDiegoCaliforniaMember" xlink:href="ilmn-20241229.xsd#ilmn_SanDiegoCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_SanDiegoCaliforniaMember" xlink:to="lab_ilmn_SanDiegoCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_a355e072-dfe9-4678-8522-8f4a7a018b5a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_df186efa-e721-49db-9119-741696220de8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_24956a1b-1b03-4154-9ad5-19c1be5eddec_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_1868e077-59c7-4900-998f-1ee4cdef200b_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ee5407a6-0be8-4367-bbc3-79b991446423_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5123bead-6d59-4e74-95d5-ed4073ec651c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Specified percentage of the fair market value of the common stock on the first or last day of the offering period whichever is lower at which stock is purchased</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f85fc09e-8229-4604-a7ed-a23ef0da584e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_cd293f70-0a1c-4c37-8b24-62f4ca4f24fd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4be62d85-f9c6-485b-b115-a3f82b141419_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_6970a71c-de0c-432d-88ab-68201a4a59ab_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Net Long-lived Assets Consisting of Property and Equipment by Region</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_5977d989-ea7b-4f39-8d77-dff4a802d2f7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5d081344-2754-4723-a5e4-4f6f6329396e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_32ded2df-868e-4298-9324-485ee36d9858_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_72746a3d-ecc1-4a4d-a2f3-d4bc90b8889e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Estimated Fair Value of Acquisition Related Contingent Consideration Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_9a1660c7-be15-4a08-b91f-4ccce371e0ef_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_GoodwillAmountThatExceedsCarryingValue_7293a335-93de-40b6-a3ad-ca740cf06d29_terseLabel_en-US" xlink:label="lab_ilmn_GoodwillAmountThatExceedsCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill amount that exceeds carrying value</link:label>
    <link:label id="lab_ilmn_GoodwillAmountThatExceedsCarryingValue_label_en-US" xlink:label="lab_ilmn_GoodwillAmountThatExceedsCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill Amount That Exceeds Carrying Value</link:label>
    <link:label id="lab_ilmn_GoodwillAmountThatExceedsCarryingValue_documentation_en-US" xlink:label="lab_ilmn_GoodwillAmountThatExceedsCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill Amount That Exceeds Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillAmountThatExceedsCarryingValue" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillAmountThatExceedsCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_GoodwillAmountThatExceedsCarryingValue" xlink:to="lab_ilmn_GoodwillAmountThatExceedsCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_84ffc52b-0076-4650-9179-f75f53b8d1be_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_53432e1c-76a9-4323-bc6b-19f49bd91157_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_55608583-d81d-4313-bd9f-ccc6acc2fe90_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_69487003-988d-468a-b329-e09a6119073a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability recorded for potential interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember_01407c6c-3547-4e9f-aa22-f7d6f4c51911_terseLabel_en-US" xlink:label="lab_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment Rights Of Above One Billion Each Twelve Years</link:label>
    <link:label id="lab_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember_label_en-US" xlink:label="lab_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment Rights Of Above One Billion Each Twelve Years [Member]</link:label>
    <link:label id="lab_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember_documentation_en-US" xlink:label="lab_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment Rights Of Above One Billion Each Twelve Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember" xlink:href="ilmn-20241229.xsd#ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember" xlink:to="lab_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_978896ba-7ac4-45f2-8e44-041196431935_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additions charged to cost of product revenue</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_bb206b15-b20b-42ec-9ad5-1d35b5c81eb1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_07adbce7-9091-4beb-9dc0-a8665f556239_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEGMENT AND GEOGRAPHIC INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1521ceca-fdcf-4a07-b750-7c3d538fc992_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in estimated fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5867ee60-5058-4aa2-ad66-4f55c7305a8c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_f5a38548-7bf8-45a9-8298-97de617f01a0_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ContingentPaymentRightsAxis_d0569ca3-d747-44a6-8837-45098164eca5_terseLabel_en-US" xlink:label="lab_ilmn_ContingentPaymentRightsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Payment Rights [Axis]</link:label>
    <link:label id="lab_ilmn_ContingentPaymentRightsAxis_label_en-US" xlink:label="lab_ilmn_ContingentPaymentRightsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Payment Rights [Axis]</link:label>
    <link:label id="lab_ilmn_ContingentPaymentRightsAxis_documentation_en-US" xlink:label="lab_ilmn_ContingentPaymentRightsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Payment Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentPaymentRightsAxis" xlink:href="ilmn-20241229.xsd#ilmn_ContingentPaymentRightsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ContingentPaymentRightsAxis" xlink:to="lab_ilmn_ContingentPaymentRightsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_3fbbb69d-b69b-4f15-b2be-6a0a1cf6dd00_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b42271d9-c91b-4d55-8332-5409cce6f748_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of (Loss) Income before Income Taxes by Region</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_0a13b8dd-fcfb-4eee-8fd1-4aeadfdb9f13_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_c810e34e-d9f5-4fab-ac2d-04078070c14d_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_5c2d3405-85f1-4b4d-be6e-1263ba9c7058_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_a258dfe4-6368-4326-b9ae-f1614369d6f9_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IRS</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_6c9b8cfa-d1e6-4a1f-a305-ee3f971d35c2_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entities (VIEs)</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_91c354a9-10cb-4588-a37d-7eb250ed08f1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_6645ce72-b8ad-47e0-9209-fd783f01ad42_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_404e9c71-257d-4527-be62-5751c02e69a4_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_e98a9869-e23a-4604-a966-2d4b90d07f73_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_bb441ef2-a772-4d99-a1db-c95b0a4de664_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_TermNotesDue2026Member_a2be1b23-b823-4757-90a7-9c4174571ad3_terseLabel_en-US" xlink:label="lab_ilmn_TermNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026 Term Notes</link:label>
    <link:label id="lab_ilmn_TermNotesDue2026Member_label_en-US" xlink:label="lab_ilmn_TermNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Notes Due 2026 [Member]</link:label>
    <link:label id="lab_ilmn_TermNotesDue2026Member_documentation_en-US" xlink:label="lab_ilmn_TermNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2026Member" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_TermNotesDue2026Member" xlink:to="lab_ilmn_TermNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_TermNotesMember_477e3e8c-fc9a-4991-9ac1-652f5fbc0369_terseLabel_en-US" xlink:label="lab_ilmn_TermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term Notes</link:label>
    <link:label id="lab_ilmn_TermNotesMember_label_en-US" xlink:label="lab_ilmn_TermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Notes [Member]</link:label>
    <link:label id="lab_ilmn_TermNotesMember_documentation_en-US" xlink:label="lab_ilmn_TermNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesMember" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_TermNotesMember" xlink:to="lab_ilmn_TermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_GRAILIncMember_07df48fb-f316-4a5b-bdb6-14ecce69dee2_terseLabel_en-US" xlink:label="lab_ilmn_GRAILIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GRAIL Inc</link:label>
    <link:label id="lab_ilmn_GRAILIncMember_label_en-US" xlink:label="lab_ilmn_GRAILIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GRAIL Inc [Member]</link:label>
    <link:label id="lab_ilmn_GRAILIncMember_documentation_en-US" xlink:label="lab_ilmn_GRAILIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GRAIL Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILIncMember" xlink:href="ilmn-20241229.xsd#ilmn_GRAILIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_GRAILIncMember" xlink:to="lab_ilmn_GRAILIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_11da46f2-2ecd-498a-8e50-07a54c39c383_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_LicensedTechnologyMember_ee8ccff6-2efa-4a11-9740-ae586c216f81_terseLabel_en-US" xlink:label="lab_ilmn_LicensedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Licensed technologies</link:label>
    <link:label id="lab_ilmn_LicensedTechnologyMember_label_en-US" xlink:label="lab_ilmn_LicensedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licensed Technology [Member]</link:label>
    <link:label id="lab_ilmn_LicensedTechnologyMember_documentation_en-US" xlink:label="lab_ilmn_LicensedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Licensed Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LicensedTechnologyMember" xlink:href="ilmn-20241229.xsd#ilmn_LicensedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_LicensedTechnologyMember" xlink:to="lab_ilmn_LicensedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ContingentValueRightUnrealizedGainLossNoncash_0f4c759d-aba2-4aea-9886-ff29a4a270ca_negatedTerseLabel_en-US" xlink:label="lab_ilmn_ContingentValueRightUnrealizedGainLossNoncash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">(Gain) loss on Helix contingent value right</link:label>
    <link:label id="lab_ilmn_ContingentValueRightUnrealizedGainLossNoncash_label_en-US" xlink:label="lab_ilmn_ContingentValueRightUnrealizedGainLossNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Value Right, Unrealized Gain (Loss), Noncash</link:label>
    <link:label id="lab_ilmn_ContingentValueRightUnrealizedGainLossNoncash_documentation_en-US" xlink:label="lab_ilmn_ContingentValueRightUnrealizedGainLossNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Value Right, Unrealized Gain (Loss), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentValueRightUnrealizedGainLossNoncash" xlink:href="ilmn-20241229.xsd#ilmn_ContingentValueRightUnrealizedGainLossNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ContingentValueRightUnrealizedGainLossNoncash" xlink:to="lab_ilmn_ContingentValueRightUnrealizedGainLossNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_0f211273-4d06-463e-a72a-89860de5766d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability for undistributed foreign earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_9b8e6fef-4bf6-4089-81e9-f9c48007dc1a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term debt, non-current</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9b3556a7-40a0-49f5-b5aa-4fd9f3cff91e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cd3f99d3-e0ff-435e-99c6-bc4afd2b39e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant- Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_da5d5a3a-e80f-4667-aee8-27306def12a7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_IndustryCreditConcentrationRiskMember_ba5190bb-e767-4a90-9864-b78fe61ae352_terseLabel_en-US" xlink:label="lab_ilmn_IndustryCreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Industry Credit Concentration Risk</link:label>
    <link:label id="lab_ilmn_IndustryCreditConcentrationRiskMember_label_en-US" xlink:label="lab_ilmn_IndustryCreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Industry Credit Concentration Risk [Member]</link:label>
    <link:label id="lab_ilmn_IndustryCreditConcentrationRiskMember_documentation_en-US" xlink:label="lab_ilmn_IndustryCreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Industry Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndustryCreditConcentrationRiskMember" xlink:href="ilmn-20241229.xsd#ilmn_IndustryCreditConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_IndustryCreditConcentrationRiskMember" xlink:to="lab_ilmn_IndustryCreditConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_95a48e48-d2ee-4ba3-834a-0ba83003dc68_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_82f891d2-68f3-4d4d-ad4c-867063024cd6_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Expected Term</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_84aa0cc9-9be2-4d77-a9a3-cb0211498d1c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_d8304fcb-464a-461d-b537-f374c8b1ad24_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_20fa8829-221a-4563-996e-2db0afcafec4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_3f534a85-b06d-4806-9e7d-45192085a90d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_RevolvingCreditAgreementMember_ca8b48ff-7cba-4c2d-b851-d737f04228fa_terseLabel_en-US" xlink:label="lab_ilmn_RevolvingCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Agreement</link:label>
    <link:label id="lab_ilmn_RevolvingCreditAgreementMember_label_en-US" xlink:label="lab_ilmn_RevolvingCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Agreement [Member]</link:label>
    <link:label id="lab_ilmn_RevolvingCreditAgreementMember_documentation_en-US" xlink:label="lab_ilmn_RevolvingCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revolving Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevolvingCreditAgreementMember" xlink:href="ilmn-20241229.xsd#ilmn_RevolvingCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_RevolvingCreditAgreementMember" xlink:to="lab_ilmn_RevolvingCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_83a27081-d2a3-41e9-ae73-fcced3129342_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_eaf9ee6f-6658-4b31-a63d-918a1d21be8f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_d8f8a3ac-1afe-45f8-b6f4-86de10b72910_terseLabel_en-US" xlink:label="lab_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensive Income Extensible Enumeration Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_f3d5f1f7-28a7-4304-9f5d-5d3f2aaeef32_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_3f4c7303-e903-4cd9-badf-b17fe3f75642_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain to be reclassified into earnings within the next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_f41f5fb6-7c42-4b0b-b68a-85e1c16ea933_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_0130efb8-75db-4a3f-9770-5571b197948e_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_f8d2ead4-b23f-4628-8e5b-a6cf920cb8e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_6a25094c-adf8-406b-ae77-2c8d8286b83d_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net unrealized (losses) recognized during the period on marketable equity securities still held at the reporting date</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment_b1a2b1c5-9553-4caf-af3b-e772fd5055cf_terseLabel_en-US" xlink:label="lab_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment and right-of-use asset impairment</link:label>
    <link:label id="lab_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment_label_en-US" xlink:label="lab_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and Equipment and Right-of-Use Asset Impairment</link:label>
    <link:label id="lab_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment_documentation_en-US" xlink:label="lab_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Property and Equipment and Right-of-Use Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment" xlink:href="ilmn-20241229.xsd#ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment" xlink:to="lab_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_571fc63b-fcef-4f83-a26a-660354e5859a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_30feb636-9b06-4cb5-988b-4a0cd8b8cd43_verboseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">PSU</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_cc44ee97-9765-42a6-a74e-31eee8dae0d3_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PSU</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_020de671-5ed1-4ef1-9e7f-05db96f61b47_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation plan liability</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Liability, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_GoodwillPotentialImpairmentLoss_e5ea494d-5871-4fe3-a0fb-c73c96cca7ca_terseLabel_en-US" xlink:label="lab_ilmn_GoodwillPotentialImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill potential impairment loss</link:label>
    <link:label id="lab_ilmn_GoodwillPotentialImpairmentLoss_label_en-US" xlink:label="lab_ilmn_GoodwillPotentialImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill Potential Impairment Loss</link:label>
    <link:label id="lab_ilmn_GoodwillPotentialImpairmentLoss_documentation_en-US" xlink:label="lab_ilmn_GoodwillPotentialImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill Potential Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillPotentialImpairmentLoss" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillPotentialImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_GoodwillPotentialImpairmentLoss" xlink:to="lab_ilmn_GoodwillPotentialImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e7971ba4-0a12-4bc4-b237-875fafbe1ec7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_AuditInformationAbstract_label_en-US" xlink:label="lab_ilmn_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_ilmn_AuditInformationAbstract_documentation_en-US" xlink:label="lab_ilmn_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AuditInformationAbstract" xlink:href="ilmn-20241229.xsd#ilmn_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_AuditInformationAbstract" xlink:to="lab_ilmn_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_9822c3df-80c8-4113-845c-d19d365852bc_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_5496c4b9-5077-4339-80c6-a4b90aef6fac_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">DEBT AND OTHER COMMITMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7b85b6e-1a3e-47ea-8be1-f57734b502fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_7d47d1c2-aeda-4fae-89ee-ad35f92c787f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal amount of notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_e2fad8b4-a34f-4c28-b1b6-5db8f0f529ae_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance as of beginning of period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_3fbc46c6-6a0b-4fa6-9e31-b94279b58890_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance as of end of period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_bb17ca8e-74d5-4700-a17f-3a800cdbeacc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6b8aa029-7229-4817-9d63-09aa281f81cb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_22c102ae-5407-483e-937b-8b855c59f24d_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_d33cdab4-c3af-4642-bd63-94ab8c6ad5df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Pre-tax Intrinsic Values of Vested Restricted Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DelayedDrawCreditFacilityDue2025Member_9eb23218-6ed3-4e52-8d61-20a9bb7314fd_terseLabel_en-US" xlink:label="lab_ilmn_DelayedDrawCreditFacilityDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Delayed Draw Credit Facility Due 2025</link:label>
    <link:label id="lab_ilmn_DelayedDrawCreditFacilityDue2025Member_label_en-US" xlink:label="lab_ilmn_DelayedDrawCreditFacilityDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Delayed Draw Credit Facility Due 2025 [Member]</link:label>
    <link:label id="lab_ilmn_DelayedDrawCreditFacilityDue2025Member_documentation_en-US" xlink:label="lab_ilmn_DelayedDrawCreditFacilityDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Delayed Draw Credit Facility Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DelayedDrawCreditFacilityDue2025Member" xlink:href="ilmn-20241229.xsd#ilmn_DelayedDrawCreditFacilityDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DelayedDrawCreditFacilityDue2025Member" xlink:to="lab_ilmn_DelayedDrawCreditFacilityDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_4c2c7ea4-075b-45b0-a6e8-f1ab60496460_verboseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fiscal Year</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_CashDeconsolidatedFinancingActivities_f8309bc8-49c5-47a8-a5e2-550d8ae38f0a_negatedTerseLabel_en-US" xlink:label="lab_ilmn_CashDeconsolidatedFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">GRAIL cash deconsolidated as a result of spin-off</link:label>
    <link:label id="lab_ilmn_CashDeconsolidatedFinancingActivities_label_en-US" xlink:label="lab_ilmn_CashDeconsolidatedFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Deconsolidated Financing Activities</link:label>
    <link:label id="lab_ilmn_CashDeconsolidatedFinancingActivities_documentation_en-US" xlink:label="lab_ilmn_CashDeconsolidatedFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Deconsolidated Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CashDeconsolidatedFinancingActivities" xlink:href="ilmn-20241229.xsd#ilmn_CashDeconsolidatedFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_CashDeconsolidatedFinancingActivities" xlink:to="lab_ilmn_CashDeconsolidatedFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_2ab4fbee-e6db-488e-868b-2954a3eeafa4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c11696e0-85e1-4b69-8397-8f7717eec522_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill fair value recorded impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_StandardProductWarrantyDescriptionTerm_8fcb73a9-6b7a-42c4-8758-926ea33636c0_terseLabel_en-US" xlink:label="lab_ilmn_StandardProductWarrantyDescriptionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warranty period</link:label>
    <link:label id="lab_ilmn_StandardProductWarrantyDescriptionTerm_label_en-US" xlink:label="lab_ilmn_StandardProductWarrantyDescriptionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty Description, Term</link:label>
    <link:label id="lab_ilmn_StandardProductWarrantyDescriptionTerm_documentation_en-US" xlink:label="lab_ilmn_StandardProductWarrantyDescriptionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Describes the approximate term of the product warranty.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_StandardProductWarrantyDescriptionTerm" xlink:href="ilmn-20241229.xsd#ilmn_StandardProductWarrantyDescriptionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_StandardProductWarrantyDescriptionTerm" xlink:to="lab_ilmn_StandardProductWarrantyDescriptionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_80542ef6-1a3d-4869-a2a2-48f72963205e_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_04964be5-d0ea-4751-87b5-1e90f3f07c0b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6018af82-32d1-4af9-b787-22402ca0dd88_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_156af8bf-e629-4362-a73b-172cad7b29e4_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6d81e63a-51c2-4d82-b119-095e0aced45a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_8c176851-514e-4b46-ad9b-0b1e48ae9768_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_bf50240a-94d8-4371-880a-c41b283a7c43_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity awards</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f2ae9009-d311-42e9-9169-ff54106ac447_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options and Performance Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_TermNotesDue2023Member_c33e6511-ac39-4b84-9e2d-672174747501_terseLabel_en-US" xlink:label="lab_ilmn_TermNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023 Term Notes</link:label>
    <link:label id="lab_ilmn_TermNotesDue2023Member_label_en-US" xlink:label="lab_ilmn_TermNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Notes Due 2023 [Member]</link:label>
    <link:label id="lab_ilmn_TermNotesDue2023Member_documentation_en-US" xlink:label="lab_ilmn_TermNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Notes Due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2023Member" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_TermNotesDue2023Member" xlink:to="lab_ilmn_TermNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_9256a037-5262-48aa-ba3b-49b1228562a4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_24e28fcf-3e23-49e5-ac90-44002cca964e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_a0e4f90d-7851-4db3-8a0a-6cf099481605_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:to="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_1ed54c68-1f8d-477f-a6a2-e56ce4fab5f3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_HelixHoldingsILLCMember_c5c94775-8e04-400b-8578-f0eff0ff9955_terseLabel_en-US" xlink:label="lab_ilmn_HelixHoldingsILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Helix Holdings I, LLC</link:label>
    <link:label id="lab_ilmn_HelixHoldingsILLCMember_label_en-US" xlink:label="lab_ilmn_HelixHoldingsILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Helix Holdings I, LLC [Member]</link:label>
    <link:label id="lab_ilmn_HelixHoldingsILLCMember_documentation_en-US" xlink:label="lab_ilmn_HelixHoldingsILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Helix Holdings I, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_HelixHoldingsILLCMember" xlink:href="ilmn-20241229.xsd#ilmn_HelixHoldingsILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_HelixHoldingsILLCMember" xlink:to="lab_ilmn_HelixHoldingsILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions_22a1cc22-1746-4cd6-9732-05867af28595_terseLabel_en-US" xlink:label="lab_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies, number of additional securities class actions</link:label>
    <link:label id="lab_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions_label_en-US" xlink:label="lab_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Number Of Additional Securities Class Actions</link:label>
    <link:label id="lab_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions_documentation_en-US" xlink:label="lab_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Number Of Additional Securities Class Actions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions" xlink:href="ilmn-20241229.xsd#ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions" xlink:to="lab_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_a343284a-d5d2-48cd-8c5c-43bee6dd6c43_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints_18310fac-42f1-4bb1-98d4-f6cf5dd7fc0f_terseLabel_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sensitivity analysis of intangible assets impairment additional charges impact of 300 basis points</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints_label_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Intangible Assets Impairment Additional Charges Impact Of 300 Basis Points</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints_documentation_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Intangible Assets Impairment Additional Charges Impact Of 300 Basis Points</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints" xlink:to="lab_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_6bb32188-89c1-42a2-9118-ff9ed22d4413_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout_e4e37c6a-f16d-4de0-9f86-f9663fd4bee6_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, maximum award payout</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Award Payout</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Award Payout</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_HelixContingentConsiderationMember_f4c7a70d-8892-4943-a88b-49218d37326a_terseLabel_en-US" xlink:label="lab_ilmn_HelixContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Helix Contingent Consideration</link:label>
    <link:label id="lab_ilmn_HelixContingentConsiderationMember_label_en-US" xlink:label="lab_ilmn_HelixContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Helix Contingent Consideration [Member]</link:label>
    <link:label id="lab_ilmn_HelixContingentConsiderationMember_documentation_en-US" xlink:label="lab_ilmn_HelixContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Helix Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_HelixContingentConsiderationMember" xlink:href="ilmn-20241229.xsd#ilmn_HelixContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_HelixContingentConsiderationMember" xlink:to="lab_ilmn_HelixContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_288e35e7-c025-48ad-b6c1-d7d2c4de7727_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_a80839d7-acae-42d7-88ed-340d4273af85_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_6481b92c-241f-44aa-8002-56b29aaf234f_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_38de2768-003e-47fd-a97a-cb174050e19b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_03b22b09-4d00-4930-93f3-5350160d8867_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DatabasesMember_9a758ee0-8d6c-43d1-838a-8f6f8913191c_terseLabel_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Database</link:label>
    <link:label id="lab_us-gaap_DatabasesMember_label_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Database Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DatabasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DatabasesMember" xlink:to="lab_us-gaap_DatabasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_7b4059b3-e91e-4936-84ed-d9ab2d11f5db_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_8576144e-ea50-4f13-a650-86c6119d0d4c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e5723c66-d119-4432-bc51-8730767c8e4c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5c6fc5c5-4a63-4bcd-b6d7-c65dbeed1ac8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_RevenueFromContractWithCustomerPaymentTerm_21ef7a47-e08e-48c0-b386-8800071c7afa_terseLabel_en-US" xlink:label="lab_ilmn_RevenueFromContractWithCustomerPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment period from invoice</link:label>
    <link:label id="lab_ilmn_RevenueFromContractWithCustomerPaymentTerm_label_en-US" xlink:label="lab_ilmn_RevenueFromContractWithCustomerPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue From Contract With Customer, Payment Term</link:label>
    <link:label id="lab_ilmn_RevenueFromContractWithCustomerPaymentTerm_documentation_en-US" xlink:label="lab_ilmn_RevenueFromContractWithCustomerPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue From Contract With Customer, Payment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevenueFromContractWithCustomerPaymentTerm" xlink:href="ilmn-20241229.xsd#ilmn_RevenueFromContractWithCustomerPaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_RevenueFromContractWithCustomerPaymentTerm" xlink:to="lab_ilmn_RevenueFromContractWithCustomerPaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ccfc8a9d-cc93-4fd8-9d77-dbe4d0863a2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Provision for (Loss) Income Taxes to Amount Computed by Applying the Federal Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_26847ddd-3688-4908-b99f-08795485acc8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6c11b0b2-f76e-4a0c-ada1-23881b19a3cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_RemainingCapitalCommitment_1764fb0a-004d-4e9f-a897-3faa45773f5c_verboseLabel_en-US" xlink:label="lab_ilmn_RemainingCapitalCommitment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Remaining callable</link:label>
    <link:label id="lab_ilmn_RemainingCapitalCommitment_label_en-US" xlink:label="lab_ilmn_RemainingCapitalCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remaining Capital Commitment</link:label>
    <link:label id="lab_ilmn_RemainingCapitalCommitment_documentation_en-US" xlink:label="lab_ilmn_RemainingCapitalCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remaining Capital Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RemainingCapitalCommitment" xlink:href="ilmn-20241229.xsd#ilmn_RemainingCapitalCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_RemainingCapitalCommitment" xlink:to="lab_ilmn_RemainingCapitalCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_fcc2cdf3-8125-4ec4-92ae-d32950a4760b_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1ab85b66-bac5-4ef8-859a-4f125585f534_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_9fcceebf-abe6-44b7-8293-4412acb8fabf_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt, fair value</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_98a988fe-7d94-45ec-889a-dec99e11d187_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4158dac3-459b-4331-8e3b-b00fcd390abc_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_aab6d1b8-2b34-40ba-a073-3116d00c2d7e_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue_d0cef9e9-e040-4616-bd72-c6d70bc187c8_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Granted, Value</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Granted, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_RestructuringPolicyTextBlock_e94e4991-b434-4617-9c72-d86b0f017aa9_terseLabel_en-US" xlink:label="lab_ilmn_RestructuringPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_ilmn_RestructuringPolicyTextBlock_label_en-US" xlink:label="lab_ilmn_RestructuringPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring [Policy Text Block]</link:label>
    <link:label id="lab_ilmn_RestructuringPolicyTextBlock_documentation_en-US" xlink:label="lab_ilmn_RestructuringPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RestructuringPolicyTextBlock" xlink:href="ilmn-20241229.xsd#ilmn_RestructuringPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_RestructuringPolicyTextBlock" xlink:to="lab_ilmn_RestructuringPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7353ac5a-0d61-466d-b57e-5b7ad0fbd18e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_bd1fc652-4265-4b5c-bbad-1caec00ccb72_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Revenue from External Customer, Product and Service [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Revenue from External Customer, Product and Service [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b6d54b78-3e0e-4f9f-939e-8fc4c348deca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_fc5e0aa3-bce5-49cc-9d50-21f56322cf18_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_8506bc2e-94d1-47ea-b360-2e8ffa414a24_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_d5338871-9011-41d6-939a-3dcc538cb0ee_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares used in computing loss per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c763f50a-18bc-4fa9-abd6-1e231141512c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e6f357fd-5082-4caf-afee-5b28152deaa5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_OtherInvestmentsFairValueDisclosure_87fd96ff-b6eb-4ed3-b34e-44cf5b2c4484_terseLabel_en-US" xlink:label="lab_ilmn_OtherInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_ilmn_OtherInvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_ilmn_OtherInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Investments Fair Value Disclosure</link:label>
    <link:label id="lab_ilmn_OtherInvestmentsFairValueDisclosure_documentation_en-US" xlink:label="lab_ilmn_OtherInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Investments Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OtherInvestmentsFairValueDisclosure" xlink:href="ilmn-20241229.xsd#ilmn_OtherInvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_OtherInvestmentsFairValueDisclosure" xlink:to="lab_ilmn_OtherInvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_IssueSizeMember_7ba2f498-4021-4a12-8be8-4a8a5a62fb35_terseLabel_en-US" xlink:label="lab_ilmn_IssueSizeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue Size</link:label>
    <link:label id="lab_ilmn_IssueSizeMember_label_en-US" xlink:label="lab_ilmn_IssueSizeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issue Size [Member]</link:label>
    <link:label id="lab_ilmn_IssueSizeMember_documentation_en-US" xlink:label="lab_ilmn_IssueSizeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issue Size [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IssueSizeMember" xlink:href="ilmn-20241229.xsd#ilmn_IssueSizeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_IssueSizeMember" xlink:to="lab_ilmn_IssueSizeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_5aecce62-4307-435b-8601-310e51b76910_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Inventory reserve</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3fa870cb-049a-4134-8f5b-a1058f830b9b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_ff732cfd-b2fb-43bc-a89b-46d1e50c804b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_A2000EmployeeStockPurchasePlanMember_55c774bd-cbf3-4823-bc80-e72c73783d6f_terseLabel_en-US" xlink:label="lab_ilmn_A2000EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_ilmn_A2000EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_ilmn_A2000EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2000 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_ilmn_A2000EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_ilmn_A2000EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2000 Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_A2000EmployeeStockPurchasePlanMember" xlink:href="ilmn-20241229.xsd#ilmn_A2000EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_A2000EmployeeStockPurchasePlanMember" xlink:to="lab_ilmn_A2000EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_946350bf-58c5-42f2-9d57-7e994b89bb1e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decreases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_247f8baa-8218-445f-b329-4deaebbf2c5d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_73f1c335-88a4-46a7-8a17-54290ce47e6a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Activity and Related Information, Performance Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation_3cbbba2a-0c55-43ba-8407-69214b778870_negatedTerseLabel_en-US" xlink:label="lab_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Spin-Off of GRAIL (see Note 2)</link:label>
    <link:label id="lab_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation_label_en-US" xlink:label="lab_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To Additional Paid In Capital, Decrease From Deconsolidation</link:label>
    <link:label id="lab_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation_documentation_en-US" xlink:label="lab_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustment To Additional Paid In Capital, Decrease From Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" xlink:href="ilmn-20241229.xsd#ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" xlink:to="lab_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings_47a8ddb0-a404-45ad-b249-fb6334d58cf0_terseLabel_en-US" xlink:label="lab_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, face amount, optional increase in additional borrowings</link:label>
    <link:label id="lab_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings_label_en-US" xlink:label="lab_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount, Optional Increase In Additional Borrowings</link:label>
    <link:label id="lab_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings_documentation_en-US" xlink:label="lab_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount, Optional Increase In Additional Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" xlink:to="lab_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame_7491f5e7-98b9-467b-8fd3-a57893c26615_terseLabel_en-US" xlink:label="lab_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product or service delivery period</link:label>
    <link:label id="lab_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame_label_en-US" xlink:label="lab_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Multiple-Deliverable Arrangements, Delivery Time Frame</link:label>
    <link:label id="lab_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame_documentation_en-US" xlink:label="lab_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Multiple-Deliverable Arrangements, Delivery Time Frame</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" xlink:href="ilmn-20241229.xsd#ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" xlink:to="lab_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_94c39f17-5870-4b0c-be6e-35974bde7bb4_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_d9fdca10-ff4b-460b-8081-abdc31061527_totalLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_01a468c8-9ed8-4820-9ac9-6ced13d7fc66_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_62ff9ea9-3803-4a3b-9ced-6ad74f1f57b5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_FluentBioSciencesMember_5884af50-8d8c-4f22-9303-c77bbfae6054_terseLabel_en-US" xlink:label="lab_ilmn_FluentBioSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fluent Bio Sciences</link:label>
    <link:label id="lab_ilmn_FluentBioSciencesMember_label_en-US" xlink:label="lab_ilmn_FluentBioSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fluent Bio Sciences [Member]</link:label>
    <link:label id="lab_ilmn_FluentBioSciencesMember_documentation_en-US" xlink:label="lab_ilmn_FluentBioSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fluent Bio Sciences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FluentBioSciencesMember" xlink:href="ilmn-20241229.xsd#ilmn_FluentBioSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_FluentBioSciencesMember" xlink:to="lab_ilmn_FluentBioSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_6bb534f8-ed07-4f8f-bd93-2449ee8c7f34_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dd6134bf-5fcb-4ce8-b265-e5022f7c3282_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_254abd10-4354-407d-bfac-f82e53ddef5c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7b1683f1-329d-43b6-9035-15f40742a2fe_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5ca5229c-6990-4bc7-bc28-f77ec84e4af0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_JakobWedelMember_label_en-US" xlink:label="lab_ilmn_JakobWedelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Jakob Wedel [Member]</link:label>
    <link:label id="lab_ilmn_JakobWedelMember_documentation_en-US" xlink:label="lab_ilmn_JakobWedelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Jakob Wedel</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_JakobWedelMember" xlink:href="ilmn-20241229.xsd#ilmn_JakobWedelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_JakobWedelMember" xlink:to="lab_ilmn_JakobWedelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_cc38f5b3-057d-44cf-acaf-08db72728efe_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_2c222cf8-fcd7-4ca0-b1e4-c51a7d423ddf_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9de20351-d3d6-418e-976d-1b00a1bf9cc1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b434b4be-ab2d-408d-9f9e-82986e7233b3_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_4fac8bb1-bdd9-4c92-9785-878a9948d43b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent_e30e41dd-2f7e-4ddb-b79d-65c9178085b7_terseLabel_en-US" xlink:label="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of base salary available for contribution to the deferred compensation plan</link:label>
    <link:label id="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent_label_en-US" xlink:label="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Base Salary, Percent</link:label>
    <link:label id="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent_documentation_en-US" xlink:label="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Base Salary, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent" xlink:href="ilmn-20241229.xsd#ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent" xlink:to="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_68f1ef52-21e0-4e2d-afef-66d95d4137d9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_TheCreditAgreementMember_9e86f69f-5542-4560-a6a5-a8c3dafc5582_terseLabel_en-US" xlink:label="lab_ilmn_TheCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_ilmn_TheCreditAgreementMember_label_en-US" xlink:label="lab_ilmn_TheCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Credit Agreement [Member]</link:label>
    <link:label id="lab_ilmn_TheCreditAgreementMember_documentation_en-US" xlink:label="lab_ilmn_TheCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TheCreditAgreementMember" xlink:href="ilmn-20241229.xsd#ilmn_TheCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_TheCreditAgreementMember" xlink:to="lab_ilmn_TheCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundThreeMember_595a115c-d7bc-487f-86f7-eb7b4ef88875_terseLabel_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fund III</link:label>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundThreeMember_label_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Venture Capital Investment Fund (the Fund), Three [Member]</link:label>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundThreeMember_documentation_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Venture Capital Investment Fund (the Fund), Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundThreeMember" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_VentureCapitalInvestmentFundTheFundThreeMember" xlink:to="lab_ilmn_VentureCapitalInvestmentFundTheFundThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_9544cfa5-da9f-4c6c-a324-cd36c26d3ff4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_ea091721-57c5-42e0-8afe-d92314ae9ac0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_8daeb224-3550-4d37-995f-8088a9732fdd_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_92ea42e5-57e0-4c09-a4db-fb28e1a0120c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated capital expenditures</link:label>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_label_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment, Expenditure, Addition to Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:to="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_348dbb03-70f6-45dd-9f9d-3ac62592e43e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease_7e4b15ad-2b36-4853-83fd-b0cbd62c70b3_terseLabel_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in 20% of revenue, increase in liability</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease_label_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent, Increase</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease_documentation_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease" xlink:to="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_88f1ee1f-1ed6-4b35-9599-7c20a2af46f4_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term debt, current portion</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_f773f158-7a2e-4f3f-935d-24687db9cd5b_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_97acd708-eb22-4961-b129-9c05ad92df4b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax positions that would reduce annual effective tax rate, if recognized</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_60de11ca-9763-465f-9e48-4b72bef2692a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASU 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a20a2ef8-41cc-4c45-88b3-1c7208e3ce28_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e8b0f961-23b8-4988-8b0b-f9d7199b24b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation vesting performance period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_ed537642-8914-497b-8934-20a10471a441_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_f421b65c-eb37-4889-9777-ba5533ca23a8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_AcquisitionOfGrailInc.Member_aed205ec-a89d-4f97-8b99-b98427cb08ec_terseLabel_en-US" xlink:label="lab_ilmn_AcquisitionOfGrailInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition Of Grail, Inc.</link:label>
    <link:label id="lab_ilmn_AcquisitionOfGrailInc.Member_label_en-US" xlink:label="lab_ilmn_AcquisitionOfGrailInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition Of Grail, Inc. [Member]</link:label>
    <link:label id="lab_ilmn_AcquisitionOfGrailInc.Member_documentation_en-US" xlink:label="lab_ilmn_AcquisitionOfGrailInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquisition Of Grail, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AcquisitionOfGrailInc.Member" xlink:href="ilmn-20241229.xsd#ilmn_AcquisitionOfGrailInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_AcquisitionOfGrailInc.Member" xlink:to="lab_ilmn_AcquisitionOfGrailInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_75bdc00c-95f3-4492-9a55-ed3c29b4e008_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_cc301925-6ea6-4a69-aa3d-89809fa2676a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_MeasurementInputCashFlowPeriodMemberMember_91bb20e8-a7a2-4ee0-931c-774bc4f7d82a_terseLabel_en-US" xlink:label="lab_ilmn_MeasurementInputCashFlowPeriodMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Cash Flow Period Member</link:label>
    <link:label id="lab_ilmn_MeasurementInputCashFlowPeriodMemberMember_label_en-US" xlink:label="lab_ilmn_MeasurementInputCashFlowPeriodMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Cash Flow Period Member [Member]</link:label>
    <link:label id="lab_ilmn_MeasurementInputCashFlowPeriodMemberMember_documentation_en-US" xlink:label="lab_ilmn_MeasurementInputCashFlowPeriodMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input Cash Flow Period Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MeasurementInputCashFlowPeriodMemberMember" xlink:href="ilmn-20241229.xsd#ilmn_MeasurementInputCashFlowPeriodMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_MeasurementInputCashFlowPeriodMemberMember" xlink:to="lab_ilmn_MeasurementInputCashFlowPeriodMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bf13d3bf-aac7-48ce-9714-4428e56f2040_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_496c4bd2-a091-4d42-8a07-8ca21ef6f427_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense, net of taxes</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_CompleteGenomicsMember_5c803335-9ec3-4725-aa71-0650fe01bc92_terseLabel_en-US" xlink:label="lab_ilmn_CompleteGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Complete Genomics</link:label>
    <link:label id="lab_ilmn_CompleteGenomicsMember_label_en-US" xlink:label="lab_ilmn_CompleteGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Complete Genomics [Member]</link:label>
    <link:label id="lab_ilmn_CompleteGenomicsMember_documentation_en-US" xlink:label="lab_ilmn_CompleteGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Complete Genomics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CompleteGenomicsMember" xlink:href="ilmn-20241229.xsd#ilmn_CompleteGenomicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_CompleteGenomicsMember" xlink:to="lab_ilmn_CompleteGenomicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8a495ddb-3a21-49d5-b267-53fa7cfd9f87_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_26eda518-0a1b-4d9a-add7-cc93d4382c20_verboseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LEGAL PROCEEDINGS</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_64382fb5-1b0e-45cf-a08b-85ea6266c46b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_56164159-46c3-4e5c-8b52-142dbd2cbf92_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5ad868d2-497f-4dd6-9f0e-2b8c34662a26_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_fcb6fc10-4da2-4686-8491-56f5c3ad209c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_ae08aae2-0b55-4939-857d-fd512c6571f0_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_0b4cbcad-b7ab-4cc5-a94f-db58e8c293b7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_201cc424-72bd-4f18-b263-5594cc1d087f_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spinoff</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale, Spinoff [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_587f48ab-a0b8-425b-b183-2737104fb3c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_34f24482-a530-4067-ba20-748283bd7bd1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_504293f4-2f68-4796-b8ff-35cd10946ec5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_4f668268-e581-4733-84d8-b1bd455413fc_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ContingentValueRightFairValueDisclosure_ef7ce0c0-ddf4-4cd8-9d61-edc759538acf_terseLabel_en-US" xlink:label="lab_ilmn_ContingentValueRightFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Helix contingent value right</link:label>
    <link:label id="lab_ilmn_ContingentValueRightFairValueDisclosure_label_en-US" xlink:label="lab_ilmn_ContingentValueRightFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Value Right, Fair Value Disclosure</link:label>
    <link:label id="lab_ilmn_ContingentValueRightFairValueDisclosure_documentation_en-US" xlink:label="lab_ilmn_ContingentValueRightFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Value Right, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentValueRightFairValueDisclosure" xlink:href="ilmn-20241229.xsd#ilmn_ContingentValueRightFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ContingentValueRightFairValueDisclosure" xlink:to="lab_ilmn_ContingentValueRightFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_b681cdc8-e4ce-400e-8fd8-c60cbe3e67e5_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_e1b27487-22c3-47d4-b281-b9800f920ee6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_bcadc8de-7bbd-4bd3-b272-009dec78d1fc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a44b23ae-d54d-4dd5-92f8-0e6f30ff93a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_4069a4be-e899-43b5-84a4-f5af7a6af2ed_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_e4f4c9a7-e6aa-43c7-b6dd-3658d837b375_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_a2ce6932-0a78-4a35-a08b-c17fdb018352_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_eec33d96-0130-4ae4-ad5b-b8ed8077ce15_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3dad3984-af9f-4615-85cf-8056c6aad4bf_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent_8e61297d-5cd2-473c-8ff7-406e86b654a3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation liability</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Cash-Based Arrangements, Liability, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ConcentrationRiskThreshold_3a055791-9966-4e6a-8b66-fc9650c34229_terseLabel_en-US" xlink:label="lab_ilmn_ConcentrationRiskThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum investment portfolio credit exposure</link:label>
    <link:label id="lab_ilmn_ConcentrationRiskThreshold_label_en-US" xlink:label="lab_ilmn_ConcentrationRiskThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Threshold</link:label>
    <link:label id="lab_ilmn_ConcentrationRiskThreshold_documentation_en-US" xlink:label="lab_ilmn_ConcentrationRiskThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Concentration Risk, Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConcentrationRiskThreshold" xlink:href="ilmn-20241229.xsd#ilmn_ConcentrationRiskThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ConcentrationRiskThreshold" xlink:to="lab_ilmn_ConcentrationRiskThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_300d178e-03d2-4628-8844-30a51a10aa7b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_67bd9580-d671-4a1b-a09f-fe22af50def8_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_a1842963-dc27-4f76-8527-d1487bae7f59_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a21889ff-ed4e-43aa-a47d-c48d9ec01adb_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6b5fd88e-33ba-4eee-8376-816fe868543d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue_69c39eb4-8c5b-4af3-a03e-6c4ad7036554_negatedTerseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested and paid in cash</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Vested And Paid In Cash, Value</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Vested And Paid In Cash, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_dcd9d47e-c8da-4cf6-8e1f-e785fbdf6e89_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_78724734-c056-4a0d-88e0-26c92cba518c_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_07616f6d-8b49-4663-a227-577d1bb40007_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_c8674d02-f009-4649-a555-0ddf6a14772f_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_7c13996f-ad71-4e07-91eb-953e7c10432a_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_5a2a0e51-b309-4e67-abbd-edfb007d733c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_CostOfGoodsSoldMember_2e3c51b0-792d-4c7c-9e60-3411b431e037_verboseLabel_en-US" xlink:label="lab_ilmn_CostOfGoodsSoldMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of product revenue</link:label>
    <link:label id="lab_ilmn_CostOfGoodsSoldMember_label_en-US" xlink:label="lab_ilmn_CostOfGoodsSoldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost Of Goods Sold [Member]</link:label>
    <link:label id="lab_ilmn_CostOfGoodsSoldMember_documentation_en-US" xlink:label="lab_ilmn_CostOfGoodsSoldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost Of Goods Sold [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CostOfGoodsSoldMember" xlink:href="ilmn-20241229.xsd#ilmn_CostOfGoodsSoldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_CostOfGoodsSoldMember" xlink:to="lab_ilmn_CostOfGoodsSoldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_3f7a3773-e338-4056-8a4b-91ffb7a7fbca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of discontinued operation, net of tax</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_132d845f-79a4-4927-acf0-c1f41b7ef045_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed Technology Rights</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_47275994-65f0-482b-be33-435b41b228e5_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Developed technologies</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_0bca60ea-4253-4006-984b-a37335f1fa99_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_a1c5ef81-19e6-475c-8981-571be2142872_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_20f8b694-b209-4556-b408-4f05c0e834f4_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLossAbstract_bd6480ae-5299-49e9-a1fe-0f7d2f3290cc_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities, Gain (Loss) [Abstract]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLossAbstract_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Security, Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract" xlink:to="lab_us-gaap_MarketableSecuritiesGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_50b4e2f3-f368-4968-8f08-df41343f270d_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period of continuing involvement after disposal</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Period of Continuing Involvement after Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal" xlink:to="lab_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_db99d3b0-9b18-4854-9e85-f6d1f81561b3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_87a0d08e-e30a-4d0b-ae3d-b8f5972f106d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to accrual</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_ed061385-5df4-4199-a5ee-85168c3b2eab_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_eb98f65d-9d63-4a14-89f2-69e36ff09c34_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EMPLOYEE BENEFIT PLANS</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_7a873287-8377-4943-9259-415d63c8063c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f9fc7eee-01d1-40c2-8d84-8c6a4ea76e88_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_a1cf1096-9fb2-41e0-8e67-4732f0ed35e8_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_38517792-2421-4bf7-b7fa-bfff34b8a063_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InlandRevenueSingaporeIRASMember_4e8ae345-0be0-4e72-8708-3dac0322b53f_terseLabel_en-US" xlink:label="lab_us-gaap_InlandRevenueSingaporeIRASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Singapore</link:label>
    <link:label id="lab_us-gaap_InlandRevenueSingaporeIRASMember_label_en-US" xlink:label="lab_us-gaap_InlandRevenueSingaporeIRASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inland Revenue, Singapore (IRAS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InlandRevenueSingaporeIRASMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InlandRevenueSingaporeIRASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InlandRevenueSingaporeIRASMember" xlink:to="lab_us-gaap_InlandRevenueSingaporeIRASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_ef38f98a-5531-470c-99e2-d269c7297be2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_49358ae9-c3ea-481c-ae9c-bf78810a811f_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundOneMember_f0eefc53-46b8-43d2-857a-6ae43cf9f46c_terseLabel_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fund I</link:label>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundOneMember_label_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Venture Capital Investment Fund (the Fund), One [Member]</link:label>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundOneMember_documentation_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Venture Capital Investment Fund (the Fund) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundOneMember" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_VentureCapitalInvestmentFundTheFundOneMember" xlink:to="lab_ilmn_VentureCapitalInvestmentFundTheFundOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_207485b9-e39d-4ff4-b725-e74fe77c9c99_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod_5df058b9-3e38-4d56-9343-4b35dcfb4457_terseLabel_en-US" xlink:label="lab_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Former gain contingency, recognized in current period</link:label>
    <link:label id="lab_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod_label_en-US" xlink:label="lab_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FormerGainContingencyRecognizedInCurrentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod" xlink:to="lab_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_79da9d74-e3a9-4f8c-b979-9a64f6489763_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_9d0e5385-02d4-46b8-ad3c-5b97d4fbbaa5_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_9bd07064-7b92-48e8-80d7-791dcf6c5a44_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_906b3b47-c74e-418d-852a-a35d46b2cd4b_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_ffe1806f-247b-49a9-a3ac-e87fb7d4c9e1_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities_7f7a6e34-1eda-444a-8780-8c775e0df64e_terseLabel_en-US" xlink:label="lab_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities_label_en-US" xlink:label="lab_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:label id="lab_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="ilmn-20241229.xsd#ilmn_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="lab_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_81f5ecdd-edbd-4894-9ae3-dae5c542f23d_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_302e227e-ac45-4f11-911b-0fc5b8e0532b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_579acc88-a656-4c68-87bf-ed6f3467c0ab_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_c45ae08b-df94-49a8-b1f0-6922a09029b7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_11842d99-6f01-4a12-a059-f38c233052b8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_52488470-e5d3-46d7-b78a-4781d1e0b340_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2b3d0269-6639-4e64-bdda-dbb7be817de5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8a39062b-231a-42ef-8957-ea367516bae5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b348ae4d-6fc1-4c6f-9af2-f98e647d08d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_fa99729a-b1b7-4e08-9acc-c4a2f1ed83fc_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_d3b69ca9-2aea-4de8-8afe-e6ce9f39592d_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested adjustment (in shares)</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ConsumablesMember_001c9928-37a6-4137-aa9e-58f27d853bad_terseLabel_en-US" xlink:label="lab_ilmn_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_ilmn_ConsumablesMember_label_en-US" xlink:label="lab_ilmn_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_ilmn_ConsumablesMember_documentation_en-US" xlink:label="lab_ilmn_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConsumablesMember" xlink:href="ilmn-20241229.xsd#ilmn_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ConsumablesMember" xlink:to="lab_ilmn_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_1e86390b-73de-4fe6-a2c7-121031e0efcd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_d363f5f2-3b6d-497d-b577-b07381b2a56b_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_cea72f78-5f1d-4dd9-8ed3-4ffb822cd837_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_1ab304e6-8443-46d5-9175-40d52e39b61d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash received for Helix contingent value right</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_1f08b0a3-aa00-4475-9ab6-a03c2b8c9505_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_0261656a-db64-4dfe-8741-5681118f2137_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c693e59c-48c0-4c4f-b951-f0f1d056f03a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_26ecf372-b4b0-43b5-b3a2-bdaaa1dd6989_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration percent</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_GainLossOnStrategicInvestmentsNoncash_bb41428c-94be-41c4-906c-b9794ff10afd_negatedTerseLabel_en-US" xlink:label="lab_ilmn_GainLossOnStrategicInvestmentsNoncash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net losses on strategic investments</link:label>
    <link:label id="lab_ilmn_GainLossOnStrategicInvestmentsNoncash_label_en-US" xlink:label="lab_ilmn_GainLossOnStrategicInvestmentsNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Strategic Investments, Noncash</link:label>
    <link:label id="lab_ilmn_GainLossOnStrategicInvestmentsNoncash_documentation_en-US" xlink:label="lab_ilmn_GainLossOnStrategicInvestmentsNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Strategic Investments, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GainLossOnStrategicInvestmentsNoncash" xlink:href="ilmn-20241229.xsd#ilmn_GainLossOnStrategicInvestmentsNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_GainLossOnStrategicInvestmentsNoncash" xlink:to="lab_ilmn_GainLossOnStrategicInvestmentsNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_TermNotesDue2027Member_565be272-181d-4eb6-ad67-d436f5555987_terseLabel_en-US" xlink:label="lab_ilmn_TermNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027 Term Notes</link:label>
    <link:label id="lab_ilmn_TermNotesDue2027Member_label_en-US" xlink:label="lab_ilmn_TermNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Notes Due 2027 [Member]</link:label>
    <link:label id="lab_ilmn_TermNotesDue2027Member_documentation_en-US" xlink:label="lab_ilmn_TermNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Notes Due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2027Member" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_TermNotesDue2027Member" xlink:to="lab_ilmn_TermNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_b85cd19c-0eab-4419-a177-73cefffffa6d_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer hardware and software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_62a6c100-5fd1-469e-a148-930ec9037b0c_verboseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Computer hardware and software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_AssetImpairmentChargesMember_52e9b6ec-a071-4277-b84f-d4079055807e_terseLabel_en-US" xlink:label="lab_ilmn_AssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset impairment charges</link:label>
    <link:label id="lab_ilmn_AssetImpairmentChargesMember_label_en-US" xlink:label="lab_ilmn_AssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges [Member]</link:label>
    <link:label id="lab_ilmn_AssetImpairmentChargesMember_documentation_en-US" xlink:label="lab_ilmn_AssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AssetImpairmentChargesMember" xlink:href="ilmn-20241229.xsd#ilmn_AssetImpairmentChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_AssetImpairmentChargesMember" xlink:to="lab_ilmn_AssetImpairmentChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio_7036a578-19fe-4230-89f0-ef81130f9889_terseLabel_en-US" xlink:label="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of consecutive fiscal quarters, minimum debt to EBITDA ratio</link:label>
    <link:label id="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio_label_en-US" xlink:label="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt to EBITDA Ratio</link:label>
    <link:label id="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio_documentation_en-US" xlink:label="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt to EBITDA Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio" xlink:to="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_dbebdb54-56aa-4345-ac29-409a5b75bcad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative liabilities related to terminated acquisition</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_355b8028-b1c0-483d-b0d0-964e1d2d69ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_InstrumentsMember_c139ca37-6f57-40ba-a7e5-387b8bfd06a3_verboseLabel_en-US" xlink:label="lab_ilmn_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_ilmn_InstrumentsMember_2abaed8d-e4ad-428d-9f74-a62f35df749a_terseLabel_en-US" xlink:label="lab_ilmn_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_ilmn_InstrumentsMember_label_en-US" xlink:label="lab_ilmn_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_ilmn_InstrumentsMember_documentation_en-US" xlink:label="lab_ilmn_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_InstrumentsMember" xlink:href="ilmn-20241229.xsd#ilmn_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_InstrumentsMember" xlink:to="lab_ilmn_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage_332600b2-d836-426c-b431-33b430a29a5f_terseLabel_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent payment rights, second percentage</link:label>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage_label_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Value Rights, Pro Rata Two, Percentage</link:label>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage_documentation_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Value Rights, Pro Rata Two, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage" xlink:to="lab_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_f26cd999-1279-41a1-ac4b-188bcdcb47d8_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_7a7d8b64-e1be-48cc-b873-6b718bcc73b6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and intangible impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_13d45436-4edc-4bbf-9652-dc6a3e91de44_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and intangible (IPR&amp;D) impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_642c8153-84f8-48ff-ad30-6479f693a68d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_LiabilityBasedAwardsMember_8a4b434b-b296-4987-9f1d-0d9eb774a741_terseLabel_en-US" xlink:label="lab_ilmn_LiabilityBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability-Based Awards</link:label>
    <link:label id="lab_ilmn_LiabilityBasedAwardsMember_label_en-US" xlink:label="lab_ilmn_LiabilityBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability-Based Awards [Member]</link:label>
    <link:label id="lab_ilmn_LiabilityBasedAwardsMember_documentation_en-US" xlink:label="lab_ilmn_LiabilityBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liability-Based Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LiabilityBasedAwardsMember" xlink:href="ilmn-20241229.xsd#ilmn_LiabilityBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_LiabilityBasedAwardsMember" xlink:to="lab_ilmn_LiabilityBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2c6c2a29-8b20-4e36-83a4-843850fba3bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for acquisitions and intangible assets, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_967b76a4-6db1-4e87-980a-fc3caea176f6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_151080ef-f2fe-4f0d-ae8f-a248e3d880b4_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_3ac81751-03a8-4713-ba5f-36606313831c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_32d67a00-6c64-4e25-b0d8-70582ea88bab_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_09d906b2-273c-4d9c-96f8-9ac105a50c0f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_c0184c3e-a865-4e1b-8bf4-1355032887a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_1edccf56-5cf9-4a6a-b718-31ea64acb297_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_950d4c6f-ace5-4afd-b8ca-dca3cf2469ee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss) hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d68d5a3e-a095-40b9-8ef9-f752ca7bb25d_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8fd4c1ec-04fc-4919-ad3a-f04242b090e2_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_5dbcbb2e-5731-45bd-95c0-658432fbaf28_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6476e743-6eaf-422c-a9c2-c188609a6f4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1c666f42-5411-4ddb-ae47-bade25df4aa4_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6437f106-0ff5-434f-b006-8047a4e28a2a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_bd74c2d2-8499-4abb-829d-7d790363004e_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net carrying amount of term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_591cbf63-d620-466d-8c33-55e3c3044a2e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade accounts receivable, gross</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions_bc782b52-4e0d-4d11-b8dc-b4d8ccdebc5e_terseLabel_en-US" xlink:label="lab_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies, number of movants filed motions consolidate actions</link:label>
    <link:label id="lab_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions_label_en-US" xlink:label="lab_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Number Of Movants Filed Motions Consolidate Actions</link:label>
    <link:label id="lab_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions_documentation_en-US" xlink:label="lab_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Number Of Movants Filed Motions Consolidate Actions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions" xlink:href="ilmn-20241229.xsd#ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions" xlink:to="lab_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_0e1d84b5-1907-456f-bd8b-d1d7ca3a7418_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_PurchasesSalesForStrategicInvestments_3d9154ba-c380-46ab-b9ca-b7fa6aa0c409_negatedTerseLabel_en-US" xlink:label="lab_ilmn_PurchasesSalesForStrategicInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net purchases of strategic investments</link:label>
    <link:label id="lab_ilmn_PurchasesSalesForStrategicInvestments_label_en-US" xlink:label="lab_ilmn_PurchasesSalesForStrategicInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">(Purchases) Sales For Strategic Investments</link:label>
    <link:label id="lab_ilmn_PurchasesSalesForStrategicInvestments_documentation_en-US" xlink:label="lab_ilmn_PurchasesSalesForStrategicInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">(Purchases) Sales For Strategic Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PurchasesSalesForStrategicInvestments" xlink:href="ilmn-20241229.xsd#ilmn_PurchasesSalesForStrategicInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_PurchasesSalesForStrategicInvestments" xlink:to="lab_ilmn_PurchasesSalesForStrategicInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e82d9326-c83f-4889-a605-dc082791e458_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_5f1d7be8-c3cf-4ffe-815e-7722a9ea10ad_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation plan assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_e3f64958-beaf-4c83-bd48-1b3f25b07470_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax adjustment for difference between the book and tax values of our retained investment in GRAIL</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:to="lab_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_00954b8d-8111-49e1-a558-3a8b34f48f16_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development (IPR&amp;D)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_BuildingandLeaseholdImprovementsMember_307d57b1-3d37-47d4-9e32-5b1bb7ac0dec_terseLabel_en-US" xlink:label="lab_ilmn_BuildingandLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buildings and leasehold improvements</link:label>
    <link:label id="lab_ilmn_BuildingandLeaseholdImprovementsMember_label_en-US" xlink:label="lab_ilmn_BuildingandLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building and Leasehold Improvements [Member]</link:label>
    <link:label id="lab_ilmn_BuildingandLeaseholdImprovementsMember_documentation_en-US" xlink:label="lab_ilmn_BuildingandLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Building and Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BuildingandLeaseholdImprovementsMember" xlink:href="ilmn-20241229.xsd#ilmn_BuildingandLeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_BuildingandLeaseholdImprovementsMember" xlink:to="lab_ilmn_BuildingandLeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_4bffc507-4109-4eac-9bdb-c2681726f71b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_70457760-5f63-4a08-bafd-6ab688c19f1d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_320ad1b1-bcde-4f4f-affe-0078896c0dcd_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outside the United States</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_00d870c6-a89e-4478-81f4-a7e3b2ed9cf2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_fd8869fa-2f15-4b20-9b95-0001b6921bd6_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_7d5bb661-ec2c-4f91-afb4-f62642fd198f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_165a781f-91fe-4240-9f12-1de13f7a4c02_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_MarketBasedPerformanceStockUnitsMember_c612e9c9-894a-44ab-b603-cb4862ea9298_terseLabel_en-US" xlink:label="lab_ilmn_MarketBasedPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Based Performance Stock Units</link:label>
    <link:label id="lab_ilmn_MarketBasedPerformanceStockUnitsMember_label_en-US" xlink:label="lab_ilmn_MarketBasedPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Based Performance Stock Units [Member]</link:label>
    <link:label id="lab_ilmn_MarketBasedPerformanceStockUnitsMember_documentation_en-US" xlink:label="lab_ilmn_MarketBasedPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Based Performance Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MarketBasedPerformanceStockUnitsMember" xlink:href="ilmn-20241229.xsd#ilmn_MarketBasedPerformanceStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_MarketBasedPerformanceStockUnitsMember" xlink:to="lab_ilmn_MarketBasedPerformanceStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1c05c8dc-b817-4375-85df-ac636099cd1c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_862fc3b8-6d34-46ab-b8e5-4ba48e11ab70_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_14feccb7-de00-4d01-9f1a-080cd45fc250_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested_3466a481-4b34-4faf-935e-2c1d17a52c74_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregated potential value</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Award, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Award, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_2dba22fa-6f00-4abe-8fc0-89b5e83c2407_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa16d87a-a245-4573-a778-c52d29716f88_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc421cb1-58ee-468d-a0fa-996c02f07e12_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_28b91b6e-1ec5-4e7e-abfc-1cb7ada8f5e6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition_e4b5c29e-a909-4e10-8f57-29513950ce96_terseLabel_en-US" xlink:label="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, covenant, minimum debt to EBITDA ratio upon consummation of acquisition</link:label>
    <link:label id="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition_label_en-US" xlink:label="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition</link:label>
    <link:label id="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition_documentation_en-US" xlink:label="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:to="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition_69dfbfa5-bbdc-48c7-b052-66b284be98ab_terseLabel_en-US" xlink:label="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of consecutive fiscal quarters, minimum debt to EBITDA ratio upon consummation of acquisition</link:label>
    <link:label id="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition_label_en-US" xlink:label="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition</link:label>
    <link:label id="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition_documentation_en-US" xlink:label="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:to="lab_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_4aec18dc-912c-457f-99f1-9a1e5817da5e_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_215cdd85-36a7-4f3d-b7bc-0720291a2ee3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_9a1d939b-9405-4502-8e63-deca40a1bd18_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_0850c269-2438-4b8f-825c-256ceab8e308_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_e56ae467-d07a-42f9-b817-963b1b43c8f3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_50d8698a-008a-4ee1-a0a1-4cf96c6b8a4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_5c68b17a-6853-4332-87bf-abc0c26d8773_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_0babb723-30a7-4cb2-b63f-7c383941229f_negatedTerseLabel_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_label_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Liability</link:label>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_documentation_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:to="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_79009d3c-b909-4a6f-bfb0-0c140d0d877c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Pronouncements Adopted and Accounting Pronouncements Pending Adoption</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_f2a684c9-3e99-402e-bfe3-017e48f1b0c1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_bc4f4e20-7094-41d4-b996-5eba52bb8e66_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warranties</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_34004012-acc8-4112-8961-cb04c17f8cf9_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe85a30a-fe09-4682-be8f-a26ec3cadec8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dfd34f82-7d00-4962-a9c6-2f29abd69a08_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_1d1e92bd-029f-4ac0-9262-31ea3fc731ea_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings Per Share, Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_b1203c30-21d8-465d-bfe7-c29c61893702_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_94f85216-4351-43c1-8d92-693bd59cd04b_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_5351f7af-472a-4528-b5e2-411f8c078d15_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember_cc4b096e-04d7-44e2-9362-0838ffcb5b07_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Stock Options</link:label>
    <link:label id="lab_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember_label_en-US" xlink:label="lab_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Performance Stock Option [Member]</link:label>
    <link:label id="lab_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember_documentation_en-US" xlink:label="lab_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Performance Stock Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember" xlink:to="lab_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_c39ba794-e83b-4d10-9a91-59fd371e8c3f_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_117a75ad-b115-4d62-b8dd-397e7f0126a0_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2bf6b76f-f42a-4835-b81f-6847fa740e8c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_4865d93a-310f-414c-916f-360688cb28c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments on contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Merger Related Costs, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:to="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_06995897-f807-461a-b822-c1283e7a71a8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee separation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_3779bdf5-8564-4feb-a968-57c902b30987_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee Separation Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_d9b49784-df4f-4cad-a025-52fe88187de9_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Greater China</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_23b32edd-2e3b-40ac-8b64-7d922fb041d4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_a2104742-4750-41c2-a76e-703dd9b3142e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue risk premium</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_bdcf6efc-eae4-42aa-b5ae-8744d2949372_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_b39fd8ef-fb41-42c1-bc49-48e7d5261f7f_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_d4c2355d-6583-463e-a3a2-3cb960fbacb8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_148e81f4-cdf8-4454-b36f-e4c04da09fdc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_68a98145-3027-457d-90aa-730ae85b0eb9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_938970e7-6c81-451b-b2cd-f5976f15d5e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_17e4eb58-0a55-4cf9-9a1b-38afe23f0ed4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other long term-liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_60e5031c-b6e1-4a92-b318-f806de6f19ac_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_MeasurementInputRevenueRiskPremiumMember_c1e4c621-311f-4168-97de-18826e7849cb_terseLabel_en-US" xlink:label="lab_ilmn_MeasurementInputRevenueRiskPremiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Risk Premium</link:label>
    <link:label id="lab_ilmn_MeasurementInputRevenueRiskPremiumMember_label_en-US" xlink:label="lab_ilmn_MeasurementInputRevenueRiskPremiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Revenue Risk Premium [Member]</link:label>
    <link:label id="lab_ilmn_MeasurementInputRevenueRiskPremiumMember_documentation_en-US" xlink:label="lab_ilmn_MeasurementInputRevenueRiskPremiumMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Revenue Risk Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MeasurementInputRevenueRiskPremiumMember" xlink:href="ilmn-20241229.xsd#ilmn_MeasurementInputRevenueRiskPremiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_MeasurementInputRevenueRiskPremiumMember" xlink:to="lab_ilmn_MeasurementInputRevenueRiskPremiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_18e28665-d7d9-49a0-82d6-35a374b0346f_totalLabel_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">GRAIL net assets</link:label>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_b1e44eed-49ca-4cd9-907b-48f6be0e0d5f_terseLabel_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GRAIL net assets</link:label>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_label_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Net Assets</link:label>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_documentation_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:to="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_8636e942-2ae7-4a55-8b85-8455abca6561_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized U.S. R&amp;D expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, In-Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_f82440ec-528f-407b-b990-6fa98148f69b_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d593e980-a8f9-4b57-bca4-2a16011bb633_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Consolidated other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_88e96650-ad5c-4803-9e5d-908cf7488388_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_235e9d67-d21b-4071-b518-c606b1030623_verboseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Service and other revenue</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_88f838c7-2eff-4cda-b72a-8c21ac260e0c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_42b2204a-4744-429f-986b-5ffcf152561a_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d54d26e1-d683-42bf-874c-ab7ebef1d870_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio_08e5117d-c6e2-4ebd-9504-6f2c7c041656_terseLabel_en-US" xlink:label="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, covenant, minimum debt to EBITDA ratio</link:label>
    <link:label id="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio_label_en-US" xlink:label="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Minimum Debt to EBITDA Ratio</link:label>
    <link:label id="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio_documentation_en-US" xlink:label="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Minimum Debt to EBITDA Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio" xlink:to="lab_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_11071f88-8c5b-4d99-94e2-ed7171f80b5b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_17d7f3bc-03b5-463f-ab68-3f4d630eb8f4_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segment</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_bd33341a-b733-46e1-9134-325ee0fac37a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_e5b6a8d9-6ad0-4018-afa7-e21486e4bad6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_0e5be5df-1cf3-4be5-8e7d-3696b44392d7_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_70c9f056-67bc-4ad0-996d-9bc47f649252_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use asset impairment</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine_a8cc8630-757c-44e1-98d2-bb53f11c380d_terseLabel_en-US" xlink:label="lab_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrual of European Commission fine</link:label>
    <link:label id="lab_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine_label_en-US" xlink:label="lab_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Accrual of Potential Fine</link:label>
    <link:label id="lab_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine_documentation_en-US" xlink:label="lab_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Accrual of Potential Fine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" xlink:href="ilmn-20241229.xsd#ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" xlink:to="lab_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_d4bdc8e3-e011-4868-9a11-8abd53064b55_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9faa2e34-ffba-482a-bb0c-5a69f54e57b1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_424c116d-d4a6-4c6e-8fc7-3cbbe65376df_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Activity and Related Information, Restricted Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_25ffd1df-d713-4f86-8485-a0061a4147c0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a0bedd85-ccf8-40af-9b9f-5ba177e3d3cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_2754d209-8a54-446c-9403-62962e62041f_periodStartLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_8166803e-04f1-480f-ae64-a7bd3c1e4a5a_periodEndLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Outstanding, Value</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Outstanding, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d586e12a-a044-49bd-9bdf-e994f7f61007_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ec8692ba-3d63-4608-9b36-18e405080471_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_5b494a2b-825f-46e5-bb1c-5f6cec7eb7d4_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_7c015611-472c-4407-ac7a-c4ff1bfecb2f_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_45ca4b5f-db6e-4b06-a16b-d9c4acbc683e_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_058d99c1-f2d9-4cd6-af54-a0b16508af10_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ff4c7f9b-61b5-4de0-a1fc-0d294f289cbd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_20bf581e-18d8-4a61-861f-c80282ca882f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c6806ea7-06e0-4e51-b6d9-5bddb6bb0352_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating expense:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_33973539-416f-4ae9-aff9-8087bdc4a7e8_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Useful Lives of Major Classes of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_a7e9d630-6873-48a8-8c91-7382f8050577_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_148142f8-560a-4acd-b38e-11ff2709e688_negatedLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_800cf5c6-7cc8-4a2b-a4f3-f091e1280377_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative term</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_f691a506-56ff-4bd1-93ab-83cfbcf06bc3_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_97e995b7-c415-497f-8f4b-0c83bdf6426e_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unamortized discounts and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_399e4dda-ffef-4c58-a490-9eabc2ea4a02_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_b0fabf67-ac3c-46e9-bfa4-5951f63e39c4_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United Kingdom</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_80b72994-92ec-43ca-8e42-1bcdeaa684de_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock_c3cdaae3-b2f7-4e0e-a04b-6698e8774bb9_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash-Based Equity Incentive Award Activity</link:label>
    <link:label id="lab_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock_label_en-US" xlink:label="lab_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Liability-Classified Awards, Activity [Table Text Block]</link:label>
    <link:label id="lab_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock_documentation_en-US" xlink:label="lab_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Liability-Classified Awards, Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" xlink:to="lab_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_c2578bb8-c47f-4b56-9e81-d7f885ef7429_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_955ab3f9-c7c6-44f7-b292-bca62e73fd11_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Total Fair Value of Vested Restricted Stock</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_94b9ac49-a4ee-4f00-b823-21aa331ee597_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e3905512-9dc6-4b7d-83ea-1fb0f7640102_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Significant Components of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_FosterCityCaliforniaMember_70d1c108-1678-4d5a-9cb0-31e75cbae9bf_terseLabel_en-US" xlink:label="lab_ilmn_FosterCityCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foster City, California</link:label>
    <link:label id="lab_ilmn_FosterCityCaliforniaMember_label_en-US" xlink:label="lab_ilmn_FosterCityCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foster City, California [Member]</link:label>
    <link:label id="lab_ilmn_FosterCityCaliforniaMember_documentation_en-US" xlink:label="lab_ilmn_FosterCityCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foster City, California</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FosterCityCaliforniaMember" xlink:href="ilmn-20241229.xsd#ilmn_FosterCityCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_FosterCityCaliforniaMember" xlink:to="lab_ilmn_FosterCityCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ScottDaviesMember_label_en-US" xlink:label="lab_ilmn_ScottDaviesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scott Davies [Member]</link:label>
    <link:label id="lab_ilmn_ScottDaviesMember_documentation_en-US" xlink:label="lab_ilmn_ScottDaviesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Scott Davies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ScottDaviesMember" xlink:href="ilmn-20241229.xsd#ilmn_ScottDaviesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ScottDaviesMember" xlink:to="lab_ilmn_ScottDaviesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_7f8a8671-381e-4203-bc89-b9a13ebf3f00_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_CostOfServicesMember_3444c378-b47c-4325-af44-46c761ca9425_terseLabel_en-US" xlink:label="lab_ilmn_CostOfServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of service and other revenue</link:label>
    <link:label id="lab_ilmn_CostOfServicesMember_label_en-US" xlink:label="lab_ilmn_CostOfServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost Of Services [Member]</link:label>
    <link:label id="lab_ilmn_CostOfServicesMember_documentation_en-US" xlink:label="lab_ilmn_CostOfServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost Of Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CostOfServicesMember" xlink:href="ilmn-20241229.xsd#ilmn_CostOfServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_CostOfServicesMember" xlink:to="lab_ilmn_CostOfServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_a6a52806-ff90-4cba-839e-59397015254a_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue_310e6209-22fa-4dc3-a961-37e0654334ba_terseLabel_en-US" xlink:label="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of repurchases</link:label>
    <link:label id="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue_label_en-US" xlink:label="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Net Of Repurchases, Value</link:label>
    <link:label id="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue_documentation_en-US" xlink:label="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Net Of Repurchases, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue" xlink:href="ilmn-20241229.xsd#ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue" xlink:to="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_aed312a5-7681-4635-b96c-100b04f13dd1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8bcaedf2-164f-4e98-a1e9-e7a0b4b2d82c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_0e919701-38f7-48a8-947f-d591bcb5fa9e_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_bc3a04b2-1cce-471d-9f29-cd64803bc424_terseLabel_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditConcentrationRiskMember" xlink:to="lab_us-gaap_CreditConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_52ed6448-8fe5-444f-8a2c-b3b6509a7ca9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_39e96758-c13f-4220-aeff-cca179e110a7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of term debt outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a8a01e41-e114-4402-8648-33fdcbbd6e2f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_ed54ef7d-ffcc-4a17-8efb-4b1b62636916_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_acabafac-94be-4a44-9ad6-00a4a5d6aaaa_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f5c815df-0871-4c46-a043-c243120dddc1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8ba5cb74-bdb6-4a28-9191-8e4d50ac459d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_829a9f80-3e6c-47ff-b029-dff7f70ff087_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards [Roll Forward]</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards [Roll Forward]</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed_5c5f0175-c645-4eb0-8789-5673c3d859f1_terseLabel_en-US" xlink:label="lab_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for legal settlements, amount allocated to release of past damages claimed</link:label>
    <link:label id="lab_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed_label_en-US" xlink:label="lab_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Legal Settlements, Amount Allocated to Release of Past Damages Claimed</link:label>
    <link:label id="lab_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed_documentation_en-US" xlink:label="lab_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments for Legal Settlements, Amount Allocated to Release of Past Damages Claimed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed" xlink:href="ilmn-20241229.xsd#ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed" xlink:to="lab_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_f757ffaa-a9e4-4524-86af-9c73554a938d_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Undistributed earnings of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cebb2c84-db14-436a-af9c-0ebe7ccbb52c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_42f2c7cc-2fc2-4673-a205-58d8bd0d2473_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease_606e7c6a-b11c-46d6-9ee2-1187d5892b20_terseLabel_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of change of additional 250 basis points, increase in liability</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease_label_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Decrease</link:label>
    <link:label id="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease_documentation_en-US" xlink:label="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Decrease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease" xlink:to="lab_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_7dec2225-f04f-4d38-925f-e95e4cb4c93f_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f9d65521-5e2f-4647-bb7c-5c76818cd472_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_fe35bbf5-4429-4174-9809-381aceff778c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_eaa1290f-d1a6-4914-8978-d1d98707bc47_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_87394f64-45f8-43ba-8a82-157f13611cb8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_1d51eeb2-1ef2-47ad-b58f-a338c42b4d24_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember_4ea838de-e7fa-47ff-93f4-c1e16f939b05_terseLabel_en-US" xlink:label="lab_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment Rights Of One Billion Each Twelve Years</link:label>
    <link:label id="lab_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember_label_en-US" xlink:label="lab_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment Rights Of One Billion, Each Twelve Years [Member]</link:label>
    <link:label id="lab_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember_documentation_en-US" xlink:label="lab_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment Rights Of One Billion, Each Twelve Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember" xlink:href="ilmn-20241229.xsd#ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember" xlink:to="lab_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_69636f9a-f8ba-4af4-8496-658ecbe148fe_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on equity method investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_74a02114-5e34-4a1e-9c74-d4b2b6eb4cd8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_f4329761-3f8b-4e6c-8ee5-9bc8d4c4eff7_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_b67b9465-4702-48ea-b9dc-1d8655fd9fc3_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_79bdb9a2-7880-4ee2-8bc3-33a3cbe61a72_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9de05acf-e6c5-4504-8472-ee4d8293db85_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundTwoMember_10c557ef-6958-4054-89dd-60a658c37e82_terseLabel_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fund II</link:label>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundTwoMember_label_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Venture Capital Investment Fund (the Fund), Two [Member]</link:label>
    <link:label id="lab_ilmn_VentureCapitalInvestmentFundTheFundTwoMember_documentation_en-US" xlink:label="lab_ilmn_VentureCapitalInvestmentFundTheFundTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Venture Capital Investment Fund (the Fund), Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundTwoMember" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_VentureCapitalInvestmentFundTheFundTwoMember" xlink:to="lab_ilmn_VentureCapitalInvestmentFundTheFundTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b816cb86-bac5-4df2-9c21-e523035a438f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1b5a9f0c-83b5-4ca4-8eb6-ceba578e3c65_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_704c15e7-6639-4767-bdfe-a43a511537d4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_e19dfef5-15cc-46b4-92c5-4ddddeecc470_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-tax intrinsic value of outstanding restricted stock:</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_d19a97c7-4e06-4061-9eb6-813173770a68_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8d28b314-a296-4248-bc8e-00753d21759a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0c92d5cc-62d4-43ab-8894-a33c91651db2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_ecf67c9f-f935-4835-86f7-e4741b35d76b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold_18e2c3fc-ce68-4884-8343-4d9286bbfc3a_terseLabel_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business acquisition, contingent value rights, revenue threshold</link:label>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold_label_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Value Rights, Revenue Threshold</link:label>
    <link:label id="lab_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold_documentation_en-US" xlink:label="lab_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Contingent Value Rights, Revenue Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold" xlink:to="lab_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_b6ee5cec-86e5-4581-99ce-ef6de130007d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease to the provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Holiday, Aggregate Dollar Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:to="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_8840ad3b-a619-43ff-953c-412ee84bd57d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_cf0ad0f1-7ed5-4b31-abb0-b5a45150b4e5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_54e603f4-a346-42fb-8a30-640562b05439_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_fb218e72-21c9-4fc7-a2b8-2d403a7e79d3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_CoreIlluminaMember_9ac092d2-3878-4efe-9d05-4203afb4a2a0_terseLabel_en-US" xlink:label="lab_ilmn_CoreIlluminaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Core Illumina</link:label>
    <link:label id="lab_ilmn_CoreIlluminaMember_label_en-US" xlink:label="lab_ilmn_CoreIlluminaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Core Illumina [Member]</link:label>
    <link:label id="lab_ilmn_CoreIlluminaMember_documentation_en-US" xlink:label="lab_ilmn_CoreIlluminaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Core Illumina [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CoreIlluminaMember" xlink:href="ilmn-20241229.xsd#ilmn_CoreIlluminaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_CoreIlluminaMember" xlink:to="lab_ilmn_CoreIlluminaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d300eff6-4001-4022-b6a1-0747854d7661_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b37001d1-ce0c-478e-b9fe-3722955cf941_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_527912e6-7535-48ee-a44e-edcf66157722_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_InvestmentPortfolioMember_36fd6d6f-4f6a-48f0-ae92-57d16c5ffa33_terseLabel_en-US" xlink:label="lab_ilmn_InvestmentPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment Portfolio</link:label>
    <link:label id="lab_ilmn_InvestmentPortfolioMember_label_en-US" xlink:label="lab_ilmn_InvestmentPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Portfolio [Member]</link:label>
    <link:label id="lab_ilmn_InvestmentPortfolioMember_documentation_en-US" xlink:label="lab_ilmn_InvestmentPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment Portfolio [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_InvestmentPortfolioMember" xlink:href="ilmn-20241229.xsd#ilmn_InvestmentPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_InvestmentPortfolioMember" xlink:to="lab_ilmn_InvestmentPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_43097d92-201a-4edc-a0c8-e5dc466415d6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_3643f9ed-10e3-4c59-8b4d-385b1f595097_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense recognized</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards_42f9f54f-4438-4cc4-a252-a700039893d3_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of PSU awards</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Number Of Performance Stock Unit Awards</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Number Of Performance Stock Unit Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards" xlink:to="lab_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_70a9fab9-d319-4c2a-8186-4cd3961720e6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_70b507a4-a1cf-49da-9aae-5244c54c1317_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ReclassificationLiabilityAwards_b43464b1-e0ca-4e42-b6ca-81116ec1f282_terseLabel_en-US" xlink:label="lab_ilmn_ReclassificationLiabilityAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of liability-classified awards</link:label>
    <link:label id="lab_ilmn_ReclassificationLiabilityAwards_label_en-US" xlink:label="lab_ilmn_ReclassificationLiabilityAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification, Liability Awards</link:label>
    <link:label id="lab_ilmn_ReclassificationLiabilityAwards_documentation_en-US" xlink:label="lab_ilmn_ReclassificationLiabilityAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification, Liability Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ReclassificationLiabilityAwards" xlink:href="ilmn-20241229.xsd#ilmn_ReclassificationLiabilityAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ReclassificationLiabilityAwards" xlink:to="lab_ilmn_ReclassificationLiabilityAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_81340db2-73c8-44e8-b067-477006cd592e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration asset settlement</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_949d11fb-3675-456d-ae1a-b5e7ed6f7433_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash received to settle</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares_ccd02590-c1c6-4694-945e-f91fe935c17f_terseLabel_en-US" xlink:label="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of repurchases (in shares)</link:label>
    <link:label id="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares_label_en-US" xlink:label="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Net Of Repurchases, Shares</link:label>
    <link:label id="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares_documentation_en-US" xlink:label="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Net Of Repurchases, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares" xlink:href="ilmn-20241229.xsd#ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares" xlink:to="lab_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_cceef483-3c53-457e-8606-61258ba67c1a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_d7038417-084f-4b60-9372-29dcce8a2ba0_negatedTerseLabel_en-US" xlink:label="lab_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease Right-of-use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:href="ilmn-20241229.xsd#ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:to="lab_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_d4a19302-7bec-4886-9aa5-e707286a9706_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_82db9b00-8138-4ac2-95c1-0a50497f801b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_99c7fe02-c7ba-4e73-ba17-fd1afba01b35_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_SequencingMember_afe854ed-f965-4c85-8626-2249b6321a22_terseLabel_en-US" xlink:label="lab_ilmn_SequencingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sequencing</link:label>
    <link:label id="lab_ilmn_SequencingMember_label_en-US" xlink:label="lab_ilmn_SequencingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sequencing [Member]</link:label>
    <link:label id="lab_ilmn_SequencingMember_documentation_en-US" xlink:label="lab_ilmn_SequencingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sequencing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SequencingMember" xlink:href="ilmn-20241229.xsd#ilmn_SequencingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_SequencingMember" xlink:to="lab_ilmn_SequencingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2ae5dcd3-aef1-41fa-99d5-4b0f5671c376_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_e2c25899-0e7e-4710-af79-5f64a268aa1c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_15c39d16-0e10-405a-b119-94971bdc4b22_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_30c2d536-4c83-483f-bf04-60869fb2721a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b06b46b5-ddbd-432f-95ea-43c39bfd56f7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_0c583bef-b4f3-455d-9a60-2f83366a7ed2_terseLabel_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:to="lab_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_GoodwillImpairmentMeasurementInput_f3666150-929c-4549-a90d-6b082f8003a8_terseLabel_en-US" xlink:label="lab_ilmn_GoodwillImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment measurement input</link:label>
    <link:label id="lab_ilmn_GoodwillImpairmentMeasurementInput_label_en-US" xlink:label="lab_ilmn_GoodwillImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill Impairment Measurement Input</link:label>
    <link:label id="lab_ilmn_GoodwillImpairmentMeasurementInput_documentation_en-US" xlink:label="lab_ilmn_GoodwillImpairmentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill Impairment Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentMeasurementInput" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_GoodwillImpairmentMeasurementInput" xlink:to="lab_ilmn_GoodwillImpairmentMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f9e3ed4a-2021-4bdf-93da-b303acecd82f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Strategic equity investments, without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents_263f66d6-eed2-49b3-be35-82e95dc96c76_terseLabel_en-US" xlink:label="lab_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GRAIL net assets, excluding cash and cash equivalents, deconsolidated as a result of spin-off</link:label>
    <link:label id="lab_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents_label_en-US" xlink:label="lab_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non cash Or Par tNon cash Spin off Net Assets Excluding Cash And Cash Equivalents</link:label>
    <link:label id="lab_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents_documentation_en-US" xlink:label="lab_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non cash Or Par tNon cash Spin off Net Assets Excluding Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" xlink:href="ilmn-20241229.xsd#ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" xlink:to="lab_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_e4cfea31-87ac-4944-80f0-f338bd79b489_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_1086fe2e-47aa-4b98-b76b-b61e55871ef1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_eb2c4b2f-1fbf-4b06-87a2-fb56c8d6c72d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_cc008ae3-262d-4d33-b943-1e900bee7eb2_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Technique, Discounted Cash Flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_870f0946-d684-4992-b5c6-bd4147e29cd4_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ce023aed-c55b-4954-b411-c66422676b72_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_707ddfaf-a759-49ae-9314-2f72b31ba330_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_093ac29d-061f-4ed2-9116-14c8025717b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_TermNotesDue2031Member_176b7211-c2a7-47db-964d-dc079eb56a60_terseLabel_en-US" xlink:label="lab_ilmn_TermNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2031 Term Notes</link:label>
    <link:label id="lab_ilmn_TermNotesDue2031Member_label_en-US" xlink:label="lab_ilmn_TermNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Notes Due 2031 [Member]</link:label>
    <link:label id="lab_ilmn_TermNotesDue2031Member_documentation_en-US" xlink:label="lab_ilmn_TermNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Notes Due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2031Member" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_TermNotesDue2031Member" xlink:to="lab_ilmn_TermNotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_677a710d-7139-4819-a7b3-be9b79d6a4ea_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8324470d-599c-4c31-aecf-fc364bcbfd64_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_7369ca4a-6ed0-4754-95bf-ae70e4b2dd55_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_79a78461-939e-43d0-8916-f5fadb225276_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9bd44b98-cd7c-4bdd-9166-398b01ad9e7f_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b477e557-2a42-47ed-a944-f2e9c9d9b309_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_0652351f-7e53-47f2-a5e4-93fa7d6929e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Reserve for Product Warranties</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4edeab24-c425-4071-8705-0783b144dff9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of foreign operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_f6da2e7f-050f-43a1-8b64-d477160a13b4_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_56a95a13-a0c4-43a6-9e19-cd59afa0f562_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_44ff97fb-68a9-4b75-9b6c-d5a3c648558b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-lived intangible assets, remaining amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_463a530a-0a25-441c-93db-4f2ad2a84d2d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_fdd97864-dfda-4e95-91b9-7d62e6a8e1b8_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_0896c8e2-642c-4a87-b33b-52cda52aa5bf_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_707f748a-c1d0-44af-bcc5-30b7964222c2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2f13321e-956b-4a40-a34f-e9ffc12fab6b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Expense for all Stock Awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_444804cb-3ca1-423b-a709-c658b9af935d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition_d57e4b0f-8d4e-492d-965e-7a77f6c0b1d5_negatedTerseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Derecognition for GRAIL Spin-Off</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Derecognition</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Derecognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_260a9434-2912-429c-bd62-5fc3d96c4ebb_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_06982544-49c6-431a-9e44-9462aca922f4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_3803c24c-aac2-4712-b6d8-da2ff784d946_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.01&#160;par value, 320&#160;million&#160;shares authorized; 200&#160;million shares issued and 159&#160;million outstanding at December&#160;29, 2024; 199&#160;million&#160;shares issued and 159&#160;million outstanding at December&#160;31, 2023</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_17e52a74-5661-4dfa-807c-b6bf9f0f3700_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_131a1553-09b3-4dc6-9d32-73ec4f001391_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accruals and reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_1469e749-c9f3-4ef8-8902-35d9adb9e9a7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_76099e98-2638-4472-8c5e-653ea5eea885_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_05e8f109-94b3-4e07-813d-bf8625dd6b09_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_d9e561bf-c7c2-471a-b084-61aa2cc9dc42_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of continuing cash flows after disposal</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Amount of Continuing Cash Flows after Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal" xlink:to="lab_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_fbb93c57-8d11-4337-bddc-6fec03b8e3ae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_b151648f-b9ab-40a6-94d4-594055241ebf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_f0945e9a-320d-4efd-b803-9563211f4779_terseLabel_en-US" xlink:label="lab_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of interest disposed</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_label_en-US" xlink:label="lab_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Percent Of Interest Disposed Of</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_documentation_en-US" xlink:label="lab_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Percent Of Interest Disposed Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationPercentOfInterestDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf" xlink:to="lab_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ebd92163-ba28-4006-be4e-b0dd5ce93c4c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_93bb9d45-cd57-4bca-9209-412d4d9e540d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_6adbe5a1-6c9b-4ec1-a01f-8e5fad4d4095_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_8a7bea72-66a5-4591-8622-74b4fb5b1f94_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.01&#160;par value, 10 million&#160;shares authorized; no shares issued and outstanding at December&#160;29, 2024 and December&#160;31, 2023</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_566a74e3-b605-4843-8beb-d6f29f2040b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b0f5f4f1-da7c-435d-8fa3-1fa8ed3af0b7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_9339ca25-3f7b-465d-a7a1-1616ab144869_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_abdd77cb-a333-4c73-a8da-1c5fd222c977_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent_ec842f00-d760-484e-80de-2c9c5460bd2d_terseLabel_en-US" xlink:label="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of all other forms of compensation available for contribution to the deferred compensation plan</link:label>
    <link:label id="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent_label_en-US" xlink:label="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Other Compensation, Percent</link:label>
    <link:label id="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent_documentation_en-US" xlink:label="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Other Compensation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" xlink:href="ilmn-20241229.xsd#ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" xlink:to="lab_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_6ebe88da-8ec4-4b8c-8b18-52e8b7bfaa86_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_14c1c12e-5d2b-473f-b3ec-0cd765c8573b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_fbf23801-9b5a-41f9-9390-02ff987152a3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_032dc12f-075f-44fa-af6f-edf0416072c5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b2210290-a425-46f9-89b9-475eb1f17e64_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_ab5e9935-f76a-422a-97b8-c3e9e869b793_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:to="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_99a7aad0-fc87-40e7-8403-a2c4368d8d85_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d41df7a9-1c42-4b17-8dbd-b988ef8c5f1d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4ed7ba8a-1a3c-4eb2-8bb1-7b2287ae048a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_58a78a5c-4928-4878-98cf-9e4f3ef559fb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0582a1f3-4653-488b-a28d-1c7912bf5b21_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_88e997db-3c36-4579-99d6-8c6302b697fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchased intangible amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_da034221-9e17-4eb6-aaba-429c20a21512_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_25115fc2-16ba-4d8e-b38e-1a995512ef9a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentrations of Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a766219e-f1da-495f-bf29-efcd389f7cb7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_AccruedLiabilityClassifiedAwardsCurrent_a6509b73-72eb-4e45-88bb-abed185c85c5_terseLabel_en-US" xlink:label="lab_ilmn_AccruedLiabilityClassifiedAwardsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability-classified equity incentive awards</link:label>
    <link:label id="lab_ilmn_AccruedLiabilityClassifiedAwardsCurrent_label_en-US" xlink:label="lab_ilmn_AccruedLiabilityClassifiedAwardsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liability-Classified Awards, Current</link:label>
    <link:label id="lab_ilmn_AccruedLiabilityClassifiedAwardsCurrent_documentation_en-US" xlink:label="lab_ilmn_AccruedLiabilityClassifiedAwardsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Liability-Classified Awards, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent" xlink:href="ilmn-20241229.xsd#ilmn_AccruedLiabilityClassifiedAwardsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent" xlink:to="lab_ilmn_AccruedLiabilityClassifiedAwardsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f7feae34-ca8a-48ff-8453-6b7d5ab5180a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Awarded (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_631bd492-d10b-4568-81b4-132bdb62fbb6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_d77e199b-f450-43ea-8dd9-ffa7815a9130_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_32e2e896-8505-4d42-b586-c268165555e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_country_SG_98f9861b-6e36-4f52-adc4-3029cdc9a257_verboseLabel_en-US" xlink:label="lab_country_SG" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Singapore</link:label>
    <link:label id="lab_country_SG_label_en-US" xlink:label="lab_country_SG" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SINGAPORE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SG"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_SG" xlink:to="lab_country_SG" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_f0e2b011-7a67-4866-bab0-ac30a92d1f4b_negatedTotalLabel_en-US" xlink:label="lab_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_label_en-US" xlink:label="lab_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets (Excluding Goodwill), Accumulated Impairment</link:label>
    <link:label id="lab_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_documentation_en-US" xlink:label="lab_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intangible Assets (Excluding Goodwill), Accumulated Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:href="ilmn-20241229.xsd#ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:to="lab_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_13c8827b-e8c4-4fdd-9c0e-5c7d6134aa9a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_31a8b17e-c7d7-428a-8e4b-3aee323fbee9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_80ab3be9-a963-4145-9607-7a452a1c9265_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_81b1a69f-fb10-4fc2-991a-a7a6f9cdd96b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Activity Under all Stock Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_abef175f-6c74-47b7-949c-e924cea45b33_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_447b00b7-1df8-467f-8845-edc0140fb5eb_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense, before taxes</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_NumberOfInvestmentFunds_475576af-f879-48ed-8fab-9f086b9d419a_terseLabel_en-US" xlink:label="lab_ilmn_NumberOfInvestmentFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of venture capital investment funds</link:label>
    <link:label id="lab_ilmn_NumberOfInvestmentFunds_label_en-US" xlink:label="lab_ilmn_NumberOfInvestmentFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Investment Funds</link:label>
    <link:label id="lab_ilmn_NumberOfInvestmentFunds_documentation_en-US" xlink:label="lab_ilmn_NumberOfInvestmentFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Investment Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_NumberOfInvestmentFunds" xlink:href="ilmn-20241229.xsd#ilmn_NumberOfInvestmentFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_NumberOfInvestmentFunds" xlink:to="lab_ilmn_NumberOfInvestmentFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d28d3396-b0b5-4d0e-9a9d-08c1e727f980_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GRAIL SPIN-OFF</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_405f1c30-2ee1-4415-97a9-fbf4fc42ff39_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential interest penalties (income) on uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_71d31316-bc16-4c59-b2cc-318d0bcd961e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_a912284a-1014-4ae9-bcec-afdea92125d5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Matching contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_4d0b4109-920f-4c89-88fb-588b34732b66_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_62bb9763-3173-4212-a21b-a1e94dd47324_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_0939da3a-cebb-4988-83d0-98e298bde115_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ee468bcb-63d2-40a3-8a64-48f617fa1476_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DebtInstrumentExtensionTerm_8c74b65a-35a4-45d4-be5b-1f4326adf448_terseLabel_en-US" xlink:label="lab_ilmn_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, extension term</link:label>
    <link:label id="lab_ilmn_DebtInstrumentExtensionTerm_label_en-US" xlink:label="lab_ilmn_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:label id="lab_ilmn_DebtInstrumentExtensionTerm_documentation_en-US" xlink:label="lab_ilmn_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentExtensionTerm" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DebtInstrumentExtensionTerm" xlink:to="lab_ilmn_DebtInstrumentExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_c0399802-ffbd-48ca-bfdb-a19119db5155_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_3a7ba395-3009-4f4f-be5a-6745e4b3cc66_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional adjustments recorded to additional paid-in capital as a result of the GRAIL Spin-Off:</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_c16cfa18-4be9-40cd-8af0-1ae751585101_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_27c2b696-e714-4f46-a2fd-52806b39d5c3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b5b66b43-475b-443e-823d-b233cb05f421_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_MicroarrayMember_b8526c7d-d0e7-4744-b772-b1aad0638495_terseLabel_en-US" xlink:label="lab_ilmn_MicroarrayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Microarray</link:label>
    <link:label id="lab_ilmn_MicroarrayMember_label_en-US" xlink:label="lab_ilmn_MicroarrayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Microarray [Member]</link:label>
    <link:label id="lab_ilmn_MicroarrayMember_documentation_en-US" xlink:label="lab_ilmn_MicroarrayMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Microarray [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MicroarrayMember" xlink:href="ilmn-20241229.xsd#ilmn_MicroarrayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_MicroarrayMember" xlink:to="lab_ilmn_MicroarrayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_6d018f6b-bb0c-4e8d-9838-4cfff575840b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total cost of shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_9ead59d1-7daf-4ab6-a6ce-e7be1e156997_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_95140345-671d-48d2-8028-f55a19499f5e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4dae19f8-c176-4521-b6fb-3f962a4c7fcc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, including warranties</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_7a459f2c-83f0-4e5a-9390-45a983dc2448_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e505f904-e26c-4ba2-a80b-69b0ecf431b2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d15999b8-d67f-4cc5-a6ad-ba1f7fb43824_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a03286e5-c8ac-4066-8727-38085a4a25a9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78233892-fbd7-4f1b-a364-635e6ee3bfa1_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total remaining lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_SeniorLevelEmployeeMember_385a5f95-58a7-43ac-883b-e41b888c4e70_terseLabel_en-US" xlink:label="lab_ilmn_SeniorLevelEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Level Employee</link:label>
    <link:label id="lab_ilmn_SeniorLevelEmployeeMember_label_en-US" xlink:label="lab_ilmn_SeniorLevelEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Level Employee [Member]</link:label>
    <link:label id="lab_ilmn_SeniorLevelEmployeeMember_documentation_en-US" xlink:label="lab_ilmn_SeniorLevelEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Level Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SeniorLevelEmployeeMember" xlink:href="ilmn-20241229.xsd#ilmn_SeniorLevelEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_SeniorLevelEmployeeMember" xlink:to="lab_ilmn_SeniorLevelEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a0a97689-2b53-43b3-820e-87582b81862d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at period start (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3e26c2d2-3977-4d0e-93a9-1f0e342f927e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at period end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_0ffda91e-734a-4357-94cd-4c2b084d8f1b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_523d7f29-aee3-4585-8de4-9c3a5f4675fd_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SUPPLEMENTAL BALANCE SHEET DETAILS</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment_3a51f435-d653-4b02-9547-8dc67fa1c39f_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for grant</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Period Adjustment</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Period Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e9876c16-3f11-4321-af20-a225bce8d9c6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_085926b8-eb8f-44c7-ad52-a0786af3a318_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized, previously deferred</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3539f59e-33be-4317-9983-ecdeb49db698_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_93d377b4-ac7b-40a8-8121-1144904711ed_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_e18d3ea8-cefd-4e93-8d05-71bc8e31b5ab_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_da99698e-6186-4288-a7dd-3849edee00b9_terseLabel_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested adjustment (in dollars per share)</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_8823c5f8-9db5-4f01-acf3-7f5dbd7f0626_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase obligation</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_b451bddd-d811-4f4c-9b49-e8b6e41568ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d5aca82b-b1e7-4064-b2d8-7d0e078ddebf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_0bfae196-0e10-4ad7-94be-d0d43ba8f6a0_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_a88ba6e1-3334-471d-8dc4-c4cee42a2ca5_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_a40b358e-552a-4af2-95fc-f3edf6b5a6e3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_b2e4e0d7-1caa-4614-bbc2-f43d600ac605_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_93c5d6c7-8d72-4a03-a400-e2d57964cfeb_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net long-lived assets consisting of property and equipment by region [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0c711f6a-ffab-4fcf-be55-592ebd24058e_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">RSU</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_7f60a3f2-e5e5-45cd-be23-2f0ee96b7802_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSU</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac3cba47-6be1-4dd8-8765-c6a4379913fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents_173012e6-fddf-404b-a194-39e55ae291fa_terseLabel_en-US" xlink:label="lab_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contribution vesting percent upon the occurrence of participant's disability, death or retirement or change in control of the Company</link:label>
    <link:label id="lab_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents_label_en-US" xlink:label="lab_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Vesting Percent, Specified Events</link:label>
    <link:label id="lab_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents_documentation_en-US" xlink:label="lab_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Compensation Arrangement With Individual, Vesting Percent, Specified Events</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents" xlink:href="ilmn-20241229.xsd#ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents" xlink:to="lab_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementLoss_630ed503-1b47-4aba-a1b5-4c7168479e76_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation settlement, loss</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementLoss_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementLoss" xlink:to="lab_us-gaap_LitigationSettlementLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_562e43bc-104b-4fbd-b89c-d15d4a9e6285_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ilmn_DiscontinuedOperationTransactionCosts_a9ee0e71-b388-4912-b2a1-7801b4bc3407_terseLabel_en-US" xlink:label="lab_ilmn_DiscontinuedOperationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Separation-related transaction costs</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationTransactionCosts_label_en-US" xlink:label="lab_ilmn_DiscontinuedOperationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Transaction Costs</link:label>
    <link:label id="lab_ilmn_DiscontinuedOperationTransactionCosts_documentation_en-US" xlink:label="lab_ilmn_DiscontinuedOperationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationTransactionCosts" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ilmn_DiscontinuedOperationTransactionCosts" xlink:to="lab_ilmn_DiscontinuedOperationTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_8ee27bbf-b57a-4d92-8478-b39436894725_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_0ddfa9f0-ac00-466d-a65e-5a0fc1482f69_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_256dfd51-6fee-42c3-9509-c8a3acbf50ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_1fb34f3d-259b-41f8-bc16-5212d9e9df8d_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_ee5686a0-07c4-4353-9a3c-80439c33f0ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on cash flow hedges, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_741776fb-9f45-4131-8a0a-e57167c1c4f9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unrealized loss on cash flow hedges, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>ilmn-20241229_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3be010a1-b4e2-4eb6-8721-f9b45bdbb770,g:4f5b8127-d86a-4b2f-b09c-147b6f0d2a9f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.illumina.com/role/CoverPage" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7f3457a2-634d-41d1-a6ee-6ea776eeba99" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_DocumentType_7f3457a2-634d-41d1-a6ee-6ea776eeba99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_70b82a3e-8394-4c96-8508-3e545d8b7e64" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_DocumentAnnualReport_70b82a3e-8394-4c96-8508-3e545d8b7e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7590a1f0-7dc0-4fd1-9a60-7defa1d6eeb2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_DocumentPeriodEndDate_7590a1f0-7dc0-4fd1-9a60-7defa1d6eeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_def048f3-0a9f-46d2-b448-a55face94cc1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_CurrentFiscalYearEndDate_def048f3-0a9f-46d2-b448-a55face94cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a77e41f9-9868-413c-a8fb-77d1918ab16c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_DocumentTransitionReport_a77e41f9-9868-413c-a8fb-77d1918ab16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_39b29f96-f8aa-48b1-b487-f078b7392539" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityFileNumber_39b29f96-f8aa-48b1-b487-f078b7392539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a365e196-d5e5-4f51-abe2-e09aea7f8f34" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityRegistrantName_a365e196-d5e5-4f51-abe2-e09aea7f8f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f2165e79-0191-4c5d-8fc6-6a40740fd179" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f2165e79-0191-4c5d-8fc6-6a40740fd179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d98fb2e3-6c5d-41ad-aded-666fb05e5410" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityTaxIdentificationNumber_d98fb2e3-6c5d-41ad-aded-666fb05e5410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_55447fa6-c3de-472d-bcc8-33ca3a9e67f2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityAddressAddressLine1_55447fa6-c3de-472d-bcc8-33ca3a9e67f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a2f5f8f9-ee71-48e2-a7fd-9cc6d30bd806" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityAddressCityOrTown_a2f5f8f9-ee71-48e2-a7fd-9cc6d30bd806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f8879ae3-a96e-452c-a301-55b192d7aeef" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityAddressStateOrProvince_f8879ae3-a96e-452c-a301-55b192d7aeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_fbae1dda-8633-44d5-bbfb-c1dde6c54659" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityAddressPostalZipCode_fbae1dda-8633-44d5-bbfb-c1dde6c54659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e98f0e63-5f9e-4cee-b87c-18a53c7a9c64" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_CityAreaCode_e98f0e63-5f9e-4cee-b87c-18a53c7a9c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f0913e89-49d8-42d0-8b32-158af5f4ce39" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_LocalPhoneNumber_f0913e89-49d8-42d0-8b32-158af5f4ce39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ab95af7a-98b3-44a8-be17-2e35bf5926e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_Security12bTitle_ab95af7a-98b3-44a8-be17-2e35bf5926e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4aec80e5-2842-4911-a438-431ffea76d5d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_TradingSymbol_4aec80e5-2842-4911-a438-431ffea76d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_86382e0b-d357-4148-86f2-ac2a1fe2e90c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_SecurityExchangeName_86382e0b-d357-4148-86f2-ac2a1fe2e90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a701d333-a37b-45dc-853e-251971203fcc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a701d333-a37b-45dc-853e-251971203fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_3c8622d0-0d3c-4268-a806-944cf970e1e4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityVoluntaryFilers_3c8622d0-0d3c-4268-a806-944cf970e1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_1cddfc02-3b55-4a08-869f-e72fe5f90735" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityCurrentReportingStatus_1cddfc02-3b55-4a08-869f-e72fe5f90735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_2534fb1b-633f-472b-b33b-f17dc891ad43" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityInteractiveDataCurrent_2534fb1b-633f-472b-b33b-f17dc891ad43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a16bd204-3b41-4e39-9d1c-45441cde8d61" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityFilerCategory_a16bd204-3b41-4e39-9d1c-45441cde8d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4516ee53-9924-4ed2-882f-460242f0535d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntitySmallBusiness_4516ee53-9924-4ed2-882f-460242f0535d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1ce00b57-141c-4d06-b7ed-920faa9390fb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityEmergingGrowthCompany_1ce00b57-141c-4d06-b7ed-920faa9390fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_198822c2-b448-4e90-ad9a-50124bc378ee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_IcfrAuditorAttestationFlag_198822c2-b448-4e90-ad9a-50124bc378ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_7a5f3559-3927-431f-b634-749c924852dc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_7a5f3559-3927-431f-b634-749c924852dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f642f80e-24e2-4922-b0c5-428e7cd42d82" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityShellCompany_f642f80e-24e2-4922-b0c5-428e7cd42d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_8101b34c-09e1-4751-8eca-678ef24b6f68" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_8101b34c-09e1-4751-8eca-678ef24b6f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_6289057f-53da-40e3-86e5-00194d733d0e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityPublicFloat_6289057f-53da-40e3-86e5-00194d733d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_89040a87-0651-4b38-b72c-94a6fc6324f7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_89040a87-0651-4b38-b72c-94a6fc6324f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a00aec90-fb75-40e3-9e9b-10fad725c149" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_EntityCentralIndexKey_a00aec90-fb75-40e3-9e9b-10fad725c149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7fc6902f-7263-4a83-b0be-f6a44dbf427e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_DocumentFiscalYearFocus_7fc6902f-7263-4a83-b0be-f6a44dbf427e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_70583bf8-04ce-4b33-b554-ae2a88b8389d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_DocumentFiscalPeriodFocus_70583bf8-04ce-4b33-b554-ae2a88b8389d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8f5eb8b3-13aa-4201-936f-a88037b0f722" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a66b511e-9823-4a19-b186-9ea70ed91fa8" xlink:to="loc_dei_AmendmentFlag_8f5eb8b3-13aa-4201-936f-a88037b0f722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/AuditInformation" xlink:type="simple" xlink:href="ilmn-20241229.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AuditInformationAbstract_d2f63a7d-57e5-481e-8d7a-f61fd2b5f5b8" xlink:href="ilmn-20241229.xsd#ilmn_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_759ec5a3-78a2-4c85-b95b-d9efe17d2396" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_AuditInformationAbstract_d2f63a7d-57e5-481e-8d7a-f61fd2b5f5b8" xlink:to="loc_dei_AuditorFirmId_759ec5a3-78a2-4c85-b95b-d9efe17d2396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_8a09bd11-ba08-40ca-9be9-371449f73b76" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_AuditInformationAbstract_d2f63a7d-57e5-481e-8d7a-f61fd2b5f5b8" xlink:to="loc_dei_AuditorName_8a09bd11-ba08-40ca-9be9-371449f73b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_0d657b7d-f950-4f70-90d9-d8d1c77e46ab" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_AuditInformationAbstract_d2f63a7d-57e5-481e-8d7a-f61fd2b5f5b8" xlink:to="loc_dei_AuditorLocation_0d657b7d-f950-4f70-90d9-d8d1c77e46ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2241f804-4f50-4eda-a3b4-dcb5a826dff1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2241f804-4f50-4eda-a3b4-dcb5a826dff1" xlink:to="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7346305a-0916-4fef-b825-4674c32bb65e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7346305a-0916-4fef-b825-4674c32bb65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11dacd46-8447-47b9-ba19-ccd94d8d3ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7346305a-0916-4fef-b825-4674c32bb65e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11dacd46-8447-47b9-ba19-ccd94d8d3ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_dd50d88f-f460-45cf-b217-37b2597723c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7346305a-0916-4fef-b825-4674c32bb65e" xlink:to="loc_us-gaap_ShortTermInvestments_dd50d88f-f460-45cf-b217-37b2597723c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f087a8ce-688f-4eab-8f0b-2df8937d7279" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7346305a-0916-4fef-b825-4674c32bb65e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f087a8ce-688f-4eab-8f0b-2df8937d7279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ee0cad2c-4b10-476f-ab62-056f8a4b0cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7346305a-0916-4fef-b825-4674c32bb65e" xlink:to="loc_us-gaap_InventoryNet_ee0cad2c-4b10-476f-ab62-056f8a4b0cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3145ae83-2f64-4e4a-b3ee-73e2653ddd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7346305a-0916-4fef-b825-4674c32bb65e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3145ae83-2f64-4e4a-b3ee-73e2653ddd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b3b97d72-0cc1-4148-9179-2db83f08120e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7346305a-0916-4fef-b825-4674c32bb65e" xlink:to="loc_us-gaap_AssetsCurrent_b3b97d72-0cc1-4148-9179-2db83f08120e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_57c99e30-6a19-4897-8539-90114196f480" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_57c99e30-6a19-4897-8539-90114196f480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_461e3843-b453-41e8-9819-8e3741338c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_461e3843-b453-41e8-9819-8e3741338c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2ebf57c7-d8f6-4143-b6b1-bc1c53b828bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:to="loc_us-gaap_Goodwill_2ebf57c7-d8f6-4143-b6b1-bc1c53b828bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_646e577b-9998-49e9-a8c6-e0e70ee78462" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_646e577b-9998-49e9-a8c6-e0e70ee78462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_07470b46-526f-4031-9821-fabb9cb54e03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_07470b46-526f-4031-9821-fabb9cb54e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_af2ea9a5-2ada-4c25-8e91-63eb22b5f358" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_af2ea9a5-2ada-4c25-8e91-63eb22b5f358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_61f206f8-3853-435a-b53b-63fd34067a39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dfd5e13f-1a45-4131-9081-89072458d968" xlink:to="loc_us-gaap_Assets_61f206f8-3853-435a-b53b-63fd34067a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_377345e2-6e51-4020-8ec9-72eddf6d4767" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2241f804-4f50-4eda-a3b4-dcb5a826dff1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_377345e2-6e51-4020-8ec9-72eddf6d4767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b6016b76-aaea-4c29-9ac9-4d44b5f5a4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_377345e2-6e51-4020-8ec9-72eddf6d4767" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b6016b76-aaea-4c29-9ac9-4d44b5f5a4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2b20f143-d40d-4c20-9514-67a3d083a23e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b6016b76-aaea-4c29-9ac9-4d44b5f5a4d7" xlink:to="loc_us-gaap_AccountsPayableCurrent_2b20f143-d40d-4c20-9514-67a3d083a23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6b0ec848-ab01-4a2e-a734-6fa7699d358a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b6016b76-aaea-4c29-9ac9-4d44b5f5a4d7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6b0ec848-ab01-4a2e-a734-6fa7699d358a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_6c1b7a9b-c59c-4214-9e23-88cb16aabd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b6016b76-aaea-4c29-9ac9-4d44b5f5a4d7" xlink:to="loc_us-gaap_NotesPayableCurrent_6c1b7a9b-c59c-4214-9e23-88cb16aabd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_98f66d6c-57f8-46ad-b74c-3a2859243688" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b6016b76-aaea-4c29-9ac9-4d44b5f5a4d7" xlink:to="loc_us-gaap_LiabilitiesCurrent_98f66d6c-57f8-46ad-b74c-3a2859243688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_21033a59-2fd7-4000-b76c-4c38a1aa8242" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_377345e2-6e51-4020-8ec9-72eddf6d4767" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_21033a59-2fd7-4000-b76c-4c38a1aa8242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_1f0f7f78-ae94-49ad-ad55-33efec39fd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_377345e2-6e51-4020-8ec9-72eddf6d4767" xlink:to="loc_us-gaap_LongTermNotesPayable_1f0f7f78-ae94-49ad-ad55-33efec39fd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_dc63ea3d-81ad-4f75-847d-3d734b7cae3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_377345e2-6e51-4020-8ec9-72eddf6d4767" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_dc63ea3d-81ad-4f75-847d-3d734b7cae3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_dab7cf20-324d-46fa-9eee-104d5cce7e42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_377345e2-6e51-4020-8ec9-72eddf6d4767" xlink:to="loc_us-gaap_CommitmentsAndContingencies_dab7cf20-324d-46fa-9eee-104d5cce7e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c8754fb-2ee0-44ad-9ead-9c29758dd851" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_377345e2-6e51-4020-8ec9-72eddf6d4767" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c8754fb-2ee0-44ad-9ead-9c29758dd851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b9205381-0b66-4560-a5d9-71ac5226b7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c8754fb-2ee0-44ad-9ead-9c29758dd851" xlink:to="loc_us-gaap_PreferredStockValue_b9205381-0b66-4560-a5d9-71ac5226b7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_78eebac4-2294-41b3-ab61-32615ebf2721" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c8754fb-2ee0-44ad-9ead-9c29758dd851" xlink:to="loc_us-gaap_CommonStockValue_78eebac4-2294-41b3-ab61-32615ebf2721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1f28defe-9bc2-4216-8e6a-3b50a02f3ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c8754fb-2ee0-44ad-9ead-9c29758dd851" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1f28defe-9bc2-4216-8e6a-3b50a02f3ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_990fa943-8337-427e-9640-f9d266a5e325" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c8754fb-2ee0-44ad-9ead-9c29758dd851" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_990fa943-8337-427e-9640-f9d266a5e325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fdc34a9f-aeec-49a5-9a79-1a613fa14192" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c8754fb-2ee0-44ad-9ead-9c29758dd851" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fdc34a9f-aeec-49a5-9a79-1a613fa14192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_2c63ffc1-93bc-4ada-a70b-32530327c15a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c8754fb-2ee0-44ad-9ead-9c29758dd851" xlink:to="loc_us-gaap_TreasuryStockCommonValue_2c63ffc1-93bc-4ada-a70b-32530327c15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_02fe24f1-d73e-4f1d-86cd-b7b67d403036" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1c8754fb-2ee0-44ad-9ead-9c29758dd851" xlink:to="loc_us-gaap_StockholdersEquity_02fe24f1-d73e-4f1d-86cd-b7b67d403036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f149cc94-6ba7-4a05-902c-bbef6eaeb794" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_377345e2-6e51-4020-8ec9-72eddf6d4767" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f149cc94-6ba7-4a05-902c-bbef6eaeb794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_706654a9-cfb6-4507-9fb1-68fcf9fdb871" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_706654a9-cfb6-4507-9fb1-68fcf9fdb871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5914c04e-6ebe-4fe6-a0ec-5d21713782f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5914c04e-6ebe-4fe6-a0ec-5d21713782f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6924e291-6302-4837-83ad-ea5fe9bd1353" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6924e291-6302-4837-83ad-ea5fe9bd1353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_83602fa6-60ad-4fde-9b79-fda25e779ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_83602fa6-60ad-4fde-9b79-fda25e779ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_faddc8ac-feb6-4f4d-a701-ec7740b80040" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_faddc8ac-feb6-4f4d-a701-ec7740b80040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b96a8549-7501-40e6-aef1-6fe34e599c08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b96a8549-7501-40e6-aef1-6fe34e599c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d657ab49-a8af-40c1-93ac-831cbe4927f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:to="loc_us-gaap_CommonStockSharesIssued_d657ab49-a8af-40c1-93ac-831cbe4927f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_26c26cf8-039c-4a52-8f81-01e2f72ab7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_26c26cf8-039c-4a52-8f81-01e2f72ab7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_166d6dc1-15c4-4875-b7c0-c14b565e154b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bef57ce4-5268-450f-970d-6aca127c3ae1" xlink:to="loc_us-gaap_TreasuryStockCommonShares_166d6dc1-15c4-4875-b7c0-c14b565e154b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_aa561574-5004-4652-b929-288865472714" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_34658f7c-7ca6-42fb-830c-62cd6c24c8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aa561574-5004-4652-b929-288865472714" xlink:to="loc_us-gaap_StatementTable_34658f7c-7ca6-42fb-830c-62cd6c24c8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7a09e44f-ce9f-4aff-b5e0-8bf5830970e5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34658f7c-7ca6-42fb-830c-62cd6c24c8a0" xlink:to="loc_srt_ProductOrServiceAxis_7a09e44f-ce9f-4aff-b5e0-8bf5830970e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e7d88ca8-f97b-483d-bc0e-af8de6b30145" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7a09e44f-ce9f-4aff-b5e0-8bf5830970e5" xlink:to="loc_srt_ProductsAndServicesDomain_e7d88ca8-f97b-483d-bc0e-af8de6b30145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_acd0e8e1-b535-4571-ae35-b51a9aafc2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e7d88ca8-f97b-483d-bc0e-af8de6b30145" xlink:to="loc_us-gaap_ProductMember_acd0e8e1-b535-4571-ae35-b51a9aafc2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_bbcf1b31-532e-4d3c-8d41-321479a2a866" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e7d88ca8-f97b-483d-bc0e-af8de6b30145" xlink:to="loc_us-gaap_ServiceMember_bbcf1b31-532e-4d3c-8d41-321479a2a866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34658f7c-7ca6-42fb-830c-62cd6c24c8a0" xlink:to="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_dea6a299-a08c-48f5-a42d-d8c78dd01a47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_RevenuesAbstract_dea6a299-a08c-48f5-a42d-d8c78dd01a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_496a3a5f-2a1e-4e73-add0-f8bc4fe165e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_dea6a299-a08c-48f5-a42d-d8c78dd01a47" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_496a3a5f-2a1e-4e73-add0-f8bc4fe165e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f6feb124-54ad-4217-8a87-b2c74f447a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f6feb124-54ad-4217-8a87-b2c74f447a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_021b4316-a55e-4754-9f75-d41c011ef0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_021b4316-a55e-4754-9f75-d41c011ef0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_491ba360-8566-4f9d-bffa-537f8d42855f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_4ff54c22-f0be-446c-b2eb-753f3d865f7d" xlink:to="loc_us-gaap_CostOfRevenue_491ba360-8566-4f9d-bffa-537f8d42855f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0d11cdec-660f-45c7-a9b3-861b8f7fe531" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_GrossProfit_0d11cdec-660f-45c7-a9b3-861b8f7fe531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_27063e21-6496-46d4-9bdb-ea7dad724dac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_27063e21-6496-46d4-9bdb-ea7dad724dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a3f1b044-94f6-4dbb-8481-fc92f47cd7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a3f1b044-94f6-4dbb-8481-fc92f47cd7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b5c471bb-da71-4748-82c2-c5528e93dbce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b5c471bb-da71-4748-82c2-c5528e93dbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_5ffba6b2-140d-46a3-a892-f2a0e6deea7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_5ffba6b2-140d-46a3-a892-f2a0e6deea7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2d759a04-bed7-425e-902a-ba2482cbc37a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_85f1ba8d-fa2a-4623-8ddb-0c91e58bc398" xlink:to="loc_us-gaap_OperatingExpenses_2d759a04-bed7-425e-902a-ba2482cbc37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0ede059d-b0f3-4862-b52e-ec7b721f3843" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_OperatingIncomeLoss_0ede059d-b0f3-4862-b52e-ec7b721f3843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5402199d-e1e4-412e-864f-dc474cce949e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5402199d-e1e4-412e-864f-dc474cce949e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_5a021f6a-4bf9-4d1e-ae2b-0c654a0e78e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:to="loc_us-gaap_InterestExpenseNonoperating_5a021f6a-4bf9-4d1e-ae2b-0c654a0e78e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ce2700d9-6c0f-4000-8d85-42dd383af050" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ce2700d9-6c0f-4000-8d85-42dd383af050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_8d28b474-daaa-4c13-90a1-3bb0bd1e6f26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d0120734-08ad-4e5a-82b4-32c649f15314" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_8d28b474-daaa-4c13-90a1-3bb0bd1e6f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4afd66dd-3698-4721-9ead-4f4877851dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4afd66dd-3698-4721-9ead-4f4877851dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_aed449fd-f0d6-4913-b05a-d8396fed9a12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_aed449fd-f0d6-4913-b05a-d8396fed9a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54e3f1f7-e3ca-466e-85d8-2766b7073e57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_NetIncomeLoss_54e3f1f7-e3ca-466e-85d8-2766b7073e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c2338114-2097-4098-9eb0-f7fb3f3dd326" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_EarningsPerShareAbstract_c2338114-2097-4098-9eb0-f7fb3f3dd326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6eeb81de-06a5-4efd-8a6b-9c73950fad42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c2338114-2097-4098-9eb0-f7fb3f3dd326" xlink:to="loc_us-gaap_EarningsPerShareBasic_6eeb81de-06a5-4efd-8a6b-9c73950fad42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c71d3cfe-fd6e-41d4-b462-e26bb5d6ff01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c2338114-2097-4098-9eb0-f7fb3f3dd326" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c71d3cfe-fd6e-41d4-b462-e26bb5d6ff01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_3b38e0ad-4bc8-442c-af5b-5630d03efb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba1478d-0a74-4440-8cdc-d37c4ffdb6c0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_3b38e0ad-4bc8-442c-af5b-5630d03efb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c5d8083a-919f-4e46-8bfa-608b74819749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_3b38e0ad-4bc8-442c-af5b-5630d03efb8c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c5d8083a-919f-4e46-8bfa-608b74819749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85393e69-b886-4643-87b2-43fb901e507a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_3b38e0ad-4bc8-442c-af5b-5630d03efb8c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85393e69-b886-4643-87b2-43fb901e507a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_09b7ec95-59e2-4f40-93a4-fa44bc28e905" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e1101a3a-f706-4189-816c-f450a31d794f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_09b7ec95-59e2-4f40-93a4-fa44bc28e905" xlink:to="loc_us-gaap_NetIncomeLoss_e1101a3a-f706-4189-816c-f450a31d794f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_f960855c-18e1-4feb-9bfc-1b8ce26de661" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_09b7ec95-59e2-4f40-93a4-fa44bc28e905" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_f960855c-18e1-4feb-9bfc-1b8ce26de661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_210147b5-0d57-4155-b97d-a7da90e7b1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_09b7ec95-59e2-4f40-93a4-fa44bc28e905" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_210147b5-0d57-4155-b97d-a7da90e7b1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_789c79a7-e2db-4888-b0b1-9305110d43d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1ac02cf1-3d40-4170-b31a-1358b4c5ceaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_789c79a7-e2db-4888-b0b1-9305110d43d5" xlink:to="loc_us-gaap_StatementTable_1ac02cf1-3d40-4170-b31a-1358b4c5ceaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_67277aba-a219-4e5a-9eb6-6111f798beb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ac02cf1-3d40-4170-b31a-1358b4c5ceaf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_67277aba-a219-4e5a-9eb6-6111f798beb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67277aba-a219-4e5a-9eb6-6111f798beb0" xlink:to="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_61720b5f-708d-414d-b0b8-8f8e4a9c877b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_CommonStockMember_61720b5f-708d-414d-b0b8-8f8e4a9c877b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9ca67993-3503-4d02-9aef-d6684adaadb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9ca67993-3503-4d02-9aef-d6684adaadb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a10370d2-eb22-4d7f-8a1c-b2098f4fd536" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a10370d2-eb22-4d7f-8a1c-b2098f4fd536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_38db657a-2bfd-4efa-8df0-8803e1dd2fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_RetainedEarningsMember_38db657a-2bfd-4efa-8df0-8803e1dd2fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_869cc1d1-0e57-4e0b-8bd2-b3dfd243ac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_601f1907-74c1-492a-997d-9999ff59308e" xlink:to="loc_us-gaap_TreasuryStockCommonMember_869cc1d1-0e57-4e0b-8bd2-b3dfd243ac8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3efeb97-1a43-4ab9-86e3-c299bdb8187a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ac02cf1-3d40-4170-b31a-1358b4c5ceaf" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3efeb97-1a43-4ab9-86e3-c299bdb8187a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cc800dd3-039f-4817-b1da-4a49ebb0c754" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3efeb97-1a43-4ab9-86e3-c299bdb8187a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cc800dd3-039f-4817-b1da-4a49ebb0c754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3b7861e8-3770-4cfe-85ed-fa7e464acffe" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cc800dd3-039f-4817-b1da-4a49ebb0c754" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3b7861e8-3770-4cfe-85ed-fa7e464acffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4ec8003f-200a-44b8-89ca-fb6c80cbe596" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ac02cf1-3d40-4170-b31a-1358b4c5ceaf" xlink:to="loc_us-gaap_StatementLineItems_4ec8003f-200a-44b8-89ca-fb6c80cbe596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4ec8003f-200a-44b8-89ca-fb6c80cbe596" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_36a9e743-b00d-4e3c-9265-019bad2daee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_36a9e743-b00d-4e3c-9265-019bad2daee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1f3de638-a23d-4348-b372-2f72f582416b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_StockholdersEquity_1f3de638-a23d-4348-b372-2f72f582416b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_bb25d115-7024-4ac2-8ede-7695fcfae069" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_TreasuryStockCommonShares_bb25d115-7024-4ac2-8ede-7695fcfae069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1abb7a63-5591-4222-9577-5a471647d42a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_NetIncomeLoss_1abb7a63-5591-4222-9577-5a471647d42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_879759d8-9834-4a8f-b78d-3beabcc4e781" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_879759d8-9834-4a8f-b78d-3beabcc4e781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares_922f4889-59b3-46ba-9006-bef9418a6521" xlink:href="ilmn-20241229.xsd#ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares_922f4889-59b3-46ba-9006-bef9418a6521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue_789908a7-49d9-4896-a992-0574f831e8db" xlink:href="ilmn-20241229.xsd#ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue_789908a7-49d9-4896-a992-0574f831e8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6085454a-2383-429d-aa1e-bbf8c7663551" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6085454a-2383-429d-aa1e-bbf8c7663551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ReclassificationLiabilityAwards_78032bed-3045-467a-b755-9a335389a04e" xlink:href="ilmn-20241229.xsd#ilmn_ReclassificationLiabilityAwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_ilmn_ReclassificationLiabilityAwards_78032bed-3045-467a-b755-9a335389a04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation_539f64c9-bf2b-421c-8b26-6d15ac57dd24" xlink:href="ilmn-20241229.xsd#ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation_539f64c9-bf2b-421c-8b26-6d15ac57dd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ce07d8ac-30bc-4f34-8c85-2cf308fec0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ce07d8ac-30bc-4f34-8c85-2cf308fec0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6dd58a65-8396-4e6a-9a57-4c107ed2a914" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_StockholdersEquity_6dd58a65-8396-4e6a-9a57-4c107ed2a914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1bf16d81-95ca-4359-94d8-71c31c71f7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_12f6a10f-6802-4941-b092-3f5d62ac5509" xlink:to="loc_us-gaap_TreasuryStockCommonShares_1bf16d81-95ca-4359-94d8-71c31c71f7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_f954dd18-9bfd-41e7-9ef0-302b858ee217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4ec8003f-200a-44b8-89ca-fb6c80cbe596" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_f954dd18-9bfd-41e7-9ef0-302b858ee217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c84e5687-0688-4cea-a938-dcd4efdaa8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8bc6028d-4c12-48e9-a5b4-22d877b2af44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c84e5687-0688-4cea-a938-dcd4efdaa8c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8bc6028d-4c12-48e9-a5b4-22d877b2af44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0d53d48a-c97b-40ef-ae44-0ed34bd83d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8bc6028d-4c12-48e9-a5b4-22d877b2af44" xlink:to="loc_us-gaap_NetIncomeLoss_0d53d48a-c97b-40ef-ae44-0ed34bd83d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8bc6028d-4c12-48e9-a5b4-22d877b2af44" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f4b0da00-5e02-4507-a53e-0fe164470e36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_us-gaap_Depreciation_f4b0da00-5e02-4507-a53e-0fe164470e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_632d5eae-d71f-4184-af87-a9c018209a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_632d5eae-d71f-4184-af87-a9c018209a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ccb99fa7-3fe4-449f-a061-717680bec941" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_us-gaap_ShareBasedCompensation_ccb99fa7-3fe4-449f-a061-717680bec941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6179ec82-3dcb-48a4-8b81-e775111b464e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6179ec82-3dcb-48a4-8b81-e775111b464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GainLossOnStrategicInvestmentsNoncash_52bf5801-d35e-4448-8202-f018e2bbf042" xlink:href="ilmn-20241229.xsd#ilmn_GainLossOnStrategicInvestmentsNoncash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_ilmn_GainLossOnStrategicInvestmentsNoncash_52bf5801-d35e-4448-8202-f018e2bbf042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ccf0af05-abec-41d1-8709-e45d1e7b571c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ccf0af05-abec-41d1-8709-e45d1e7b571c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentValueRightUnrealizedGainLossNoncash_8bc2b440-83c2-45f4-b5dd-76e6a100e22a" xlink:href="ilmn-20241229.xsd#ilmn_ContingentValueRightUnrealizedGainLossNoncash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_ilmn_ContingentValueRightUnrealizedGainLossNoncash_8bc2b440-83c2-45f4-b5dd-76e6a100e22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_013def19-5fe9-4cd6-a903-4d25a1e190dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_013def19-5fe9-4cd6-a903-4d25a1e190dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment_49cbbc8f-52a9-4565-b37c-38b22f5d9843" xlink:href="ilmn-20241229.xsd#ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment_49cbbc8f-52a9-4565-b37c-38b22f5d9843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_819329d4-e5f8-4dbc-8b75-f752abb71e17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_819329d4-e5f8-4dbc-8b75-f752abb71e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1cc53efd-09b4-492b-b98e-23b045ef71b2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1b71d5b8-bf70-414e-8465-0ecfefe2aafc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1b71d5b8-bf70-414e-8465-0ecfefe2aafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1fe24044-945d-4a5b-837c-0bc67f87d50b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1fe24044-945d-4a5b-837c-0bc67f87d50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_328e6f87-4e10-4b78-a2c5-99e85b82d2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_328e6f87-4e10-4b78-a2c5-99e85b82d2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IncreaseDecreaseOfOperatingLeasesNet_de9c7b6f-011a-437e-bdbb-996f50fd7522" xlink:href="ilmn-20241229.xsd#ilmn_IncreaseDecreaseOfOperatingLeasesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:to="loc_ilmn_IncreaseDecreaseOfOperatingLeasesNet_de9c7b6f-011a-437e-bdbb-996f50fd7522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8767e92d-3b23-4f13-8b9c-248f27a40204" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8767e92d-3b23-4f13-8b9c-248f27a40204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_638422b0-ef28-40eb-8b6e-21fe8223cd63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_638422b0-ef28-40eb-8b6e-21fe8223cd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ea66c8ef-4ab9-4c52-a6e8-997dc3b873e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ea66c8ef-4ab9-4c52-a6e8-997dc3b873e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_4bec628b-63f3-4c1e-9d21-bdabbf0d2dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_938916e4-8f4f-4138-9ce2-e8c0bad226a3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_4bec628b-63f3-4c1e-9d21-bdabbf0d2dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_887a0686-dde9-4277-b884-0c458e6873f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8bc6028d-4c12-48e9-a5b4-22d877b2af44" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_887a0686-dde9-4277-b884-0c458e6873f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_79f57a4f-c8ad-4e07-b8a6-346a0411848f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c84e5687-0688-4cea-a938-dcd4efdaa8c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_79f57a4f-c8ad-4e07-b8a6-346a0411848f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_79ad2eab-b359-4bf0-908a-8eeea8d02f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_79f57a4f-c8ad-4e07-b8a6-346a0411848f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_79ad2eab-b359-4bf0-908a-8eeea8d02f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PurchasesSalesForStrategicInvestments_e8b60912-586e-451e-9523-bed32b3aed85" xlink:href="ilmn-20241229.xsd#ilmn_PurchasesSalesForStrategicInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_79f57a4f-c8ad-4e07-b8a6-346a0411848f" xlink:to="loc_ilmn_PurchasesSalesForStrategicInvestments_e8b60912-586e-451e-9523-bed32b3aed85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_51ad98cf-2b10-476e-9c37-192a4b2a15d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_79f57a4f-c8ad-4e07-b8a6-346a0411848f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_51ad98cf-2b10-476e-9c37-192a4b2a15d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_a24f81e2-1965-4745-85e2-afd1248ee24a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_79f57a4f-c8ad-4e07-b8a6-346a0411848f" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_a24f81e2-1965-4745-85e2-afd1248ee24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d816d109-173f-4124-a27e-4300287b2131" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c84e5687-0688-4cea-a938-dcd4efdaa8c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d816d109-173f-4124-a27e-4300287b2131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c84e5687-0688-4cea-a938-dcd4efdaa8c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4fec0992-1216-4939-908a-8d69fa12ae76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4fec0992-1216-4939-908a-8d69fa12ae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2f124acc-6273-443c-b234-b03da287bf75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2f124acc-6273-443c-b234-b03da287bf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_780c6e49-955a-45fd-b1ce-cf5d4c56ba48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_780c6e49-955a-45fd-b1ce-cf5d4c56ba48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_a8f3875c-ea07-4c29-84b4-122010729a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_a8f3875c-ea07-4c29-84b4-122010729a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a750f14c-10f8-42d7-8753-0cb3913f7991" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a750f14c-10f8-42d7-8753-0cb3913f7991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_027c9a2c-eafd-40cf-a466-0cb4b68a949d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_027c9a2c-eafd-40cf-a466-0cb4b68a949d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_bd9dc6da-89d0-4b49-b69d-58633c68058c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_bd9dc6da-89d0-4b49-b69d-58633c68058c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CashDeconsolidatedFinancingActivities_37c9a59b-1bed-4930-83a3-e96b4ac421d2" xlink:href="ilmn-20241229.xsd#ilmn_CashDeconsolidatedFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:to="loc_ilmn_CashDeconsolidatedFinancingActivities_37c9a59b-1bed-4930-83a3-e96b4ac421d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16fcea3c-3ef4-41d7-b471-47340ca3afc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3ff25ec-9bdf-4117-9343-525c263889b2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16fcea3c-3ef4-41d7-b471-47340ca3afc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17b431b5-2c71-431c-8005-141b15c3afae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c84e5687-0688-4cea-a938-dcd4efdaa8c3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17b431b5-2c71-431c-8005-141b15c3afae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3f4dcb4b-d36c-47ff-acc7-9cf722dd8eca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c84e5687-0688-4cea-a938-dcd4efdaa8c3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3f4dcb4b-d36c-47ff-acc7-9cf722dd8eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a3d0883a-eeb6-4ca8-8525-f8d258496971" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c84e5687-0688-4cea-a938-dcd4efdaa8c3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a3d0883a-eeb6-4ca8-8525-f8d258496971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5dcd9d49-cec8-4cf6-9edd-95fbe227f83f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c84e5687-0688-4cea-a938-dcd4efdaa8c3" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5dcd9d49-cec8-4cf6-9edd-95fbe227f83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_ea43fc9a-ac26-482a-bcf8-4b6fef455a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5dcd9d49-cec8-4cf6-9edd-95fbe227f83f" xlink:to="loc_us-gaap_InterestPaidNet_ea43fc9a-ac26-482a-bcf8-4b6fef455a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_35fc56a5-dcb5-4e38-9637-92f8ebab9c31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5dcd9d49-cec8-4cf6-9edd-95fbe227f83f" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_35fc56a5-dcb5-4e38-9637-92f8ebab9c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_c909fcdf-9b3e-4684-bc92-cc6c6ee92934" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5dcd9d49-cec8-4cf6-9edd-95fbe227f83f" xlink:to="loc_us-gaap_OperatingLeasePayments_c909fcdf-9b3e-4684-bc92-cc6c6ee92934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_06f459cf-86da-4304-8773-78b6f152cd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5dcd9d49-cec8-4cf6-9edd-95fbe227f83f" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_06f459cf-86da-4304-8773-78b6f152cd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents_482e900f-82bf-4b74-b763-33424a50093f" xlink:href="ilmn-20241229.xsd#ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5dcd9d49-cec8-4cf6-9edd-95fbe227f83f" xlink:to="loc_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents_482e900f-82bf-4b74-b763-33424a50093f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_63377f05-2bb1-4ce4-939d-0bce8a6238b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_df65e9d4-0dee-4e19-9b17-d57f306092d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63377f05-2bb1-4ce4-939d-0bce8a6238b2" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_df65e9d4-0dee-4e19-9b17-d57f306092d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GRAILSPINOFF" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GRAILSPINOFF"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GRAILSPINOFF" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_cb33c0a9-82b1-4a83-a1c7-314e064174eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_5bd97995-f013-41a1-a669-deb588e8fbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_cb33c0a9-82b1-4a83-a1c7-314e064174eb" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_5bd97995-f013-41a1-a669-deb588e8fbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/REVENUE" xlink:type="simple" xlink:href="ilmn-20241229.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8202211f-7359-4b9d-bc2d-2a0b95a3d22b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5b78a6c4-3889-4400-990f-ad8b94366a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8202211f-7359-4b9d-bc2d-2a0b95a3d22b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5b78a6c4-3889-4400-990f-ad8b94366a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_511eaa63-c82f-43ef-8519-e040b0d7e20a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_0fcedc36-6795-4c6e-b65f-fbf414857620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_511eaa63-c82f-43ef-8519-e040b0d7e20a" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_0fcedc36-6795-4c6e-b65f-fbf414857620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_27d15645-d90a-4a91-b44a-c98a04a019a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock_cd7443bd-6b99-44ad-8e7c-000abaab7a52" xlink:href="ilmn-20241229.xsd#ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_27d15645-d90a-4a91-b44a-c98a04a019a2" xlink:to="loc_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock_cd7443bd-6b99-44ad-8e7c-000abaab7a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bc2fcb7f-5a96-4d29-802d-564208f80328" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_89b33afe-2780-45c6-ad94-d0581170cc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bc2fcb7f-5a96-4d29-802d-564208f80328" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_89b33afe-2780-45c6-ad94-d0581170cc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_365ae3d3-8efd-4363-b7a7-423f95b7c12d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_c7b79c5f-d253-47f5-bdd2-a262fa75a9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_365ae3d3-8efd-4363-b7a7-423f95b7c12d" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_c7b79c5f-d253-47f5-bdd2-a262fa75a9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9f02fa5f-11e9-4de0-b12b-ae2102332485" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_863878da-5190-442b-886c-2bee38c21f70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9f02fa5f-11e9-4de0-b12b-ae2102332485" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_863878da-5190-442b-886c-2bee38c21f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/LEGALPROCEEDINGS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#LEGALPROCEEDINGS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/LEGALPROCEEDINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ddcc3969-6674-4b43-aa55-b1026f2c3b29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_bb493231-fc99-4ea4-9dcf-04a30613cf59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ddcc3969-6674-4b43-aa55-b1026f2c3b29" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_bb493231-fc99-4ea4-9dcf-04a30613cf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXES" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d5325855-163e-402f-9ffe-5ed6e80faaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_b6d4b466-b57d-407d-a5f3-aaf3cc6acd31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d5325855-163e-402f-9ffe-5ed6e80faaa6" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_b6d4b466-b57d-407d-a5f3-aaf3cc6acd31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/EMPLOYEEBENEFITPLANS" xlink:type="simple" xlink:href="ilmn-20241229.xsd#EMPLOYEEBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/EMPLOYEEBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_3c1c7076-e0e0-439b-98dd-29c2283c6863" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_ef04f2bc-05b7-4986-be63-aa47d20acf71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_3c1c7076-e0e0-439b-98dd-29c2283c6863" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_ef04f2bc-05b7-4986-be63-aa47d20acf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATION"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e406836d-298a-4fc3-8647-4b53769a8fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_8daad5a7-f53b-4b0f-aab1-d6b3e9d9fc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e406836d-298a-4fc3-8647-4b53769a8fa1" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_8daad5a7-f53b-4b0f-aab1-d6b3e9d9fc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_afb83ffc-9b25-41b9-abe5-b4ab2e236b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_afb83ffc-9b25-41b9-abe5-b4ab2e236b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_a2d23b76-bdf6-4e10-b39a-fd3fa58194d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_a2d23b76-bdf6-4e10-b39a-fd3fa58194d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_0ec75f75-465a-4191-a8b0-cae3c814c694" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_UseOfEstimates_0ec75f75-465a-4191-a8b0-cae3c814c694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_6be1998a-4447-4e19-a3b5-e84bad503359" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_FiscalPeriod_6be1998a-4447-4e19-a3b5-e84bad503359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_8a25bfb9-63fb-4e0a-91a3-ce4670c90156" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_8a25bfb9-63fb-4e0a-91a3-ce4670c90156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_0cf50f3a-f21e-498a-9116-5562d67a3c03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_0cf50f3a-f21e-498a-9116-5562d67a3c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2fc55809-ceaa-4576-97c6-e797cd9a1f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2fc55809-ceaa-4576-97c6-e797cd9a1f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3a1b9c4f-2213-4d1d-ab11-2da48f6a4faf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3a1b9c4f-2213-4d1d-ab11-2da48f6a4faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_ef0783d5-1c99-4435-a32f-a8afb2b69149" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_ef0783d5-1c99-4435-a32f-a8afb2b69149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_285f7460-cc99-454b-b79b-284147298ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_285f7460-cc99-454b-b79b-284147298ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b0d1614f-2d3a-46a0-87fb-c98180a2e376" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b0d1614f-2d3a-46a0-87fb-c98180a2e376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d0f8747d-0162-427c-a0a8-5396b992b498" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d0f8747d-0162-427c-a0a8-5396b992b498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_2d8ede02-3dd2-486f-80bb-d25251199468" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_2d8ede02-3dd2-486f-80bb-d25251199468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_2e52b74d-a78d-454b-af14-feb57f271bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_2e52b74d-a78d-454b-af14-feb57f271bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_4641fcc4-bf45-46d7-a8cf-1a1b90ec3ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_4641fcc4-bf45-46d7-a8cf-1a1b90ec3ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_41e24aed-d998-4a70-b2b6-e7edb89da53c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_41e24aed-d998-4a70-b2b6-e7edb89da53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_6a0a470b-1fd0-41f5-aa2a-34b008896e60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_6a0a470b-1fd0-41f5-aa2a-34b008896e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_1a90fd4a-bbcc-4a20-9e15-ab2e2cd7b402" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_1a90fd4a-bbcc-4a20-9e15-ab2e2cd7b402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_f38789aa-3759-4888-af69-46a3285d3ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_f38789aa-3759-4888-af69-46a3285d3ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_fb7fd70e-40e3-41ba-a01f-ad73768569f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_fb7fd70e-40e3-41ba-a01f-ad73768569f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_7bd18ac9-2226-45cf-aec9-c25fa560f792" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_7bd18ac9-2226-45cf-aec9-c25fa560f792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ba20cb34-eb18-47ce-bb7e-343f8bbced4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ba20cb34-eb18-47ce-bb7e-343f8bbced4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_99ceb316-1d49-4032-8f9e-fcbaf7c95058" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_99ceb316-1d49-4032-8f9e-fcbaf7c95058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_e4e0b7d5-31b8-4e26-9bde-6b231db13d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_e4e0b7d5-31b8-4e26-9bde-6b231db13d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RestructuringPolicyTextBlock_43dab9dc-7aec-4590-ad13-d144ad8c724d" xlink:href="ilmn-20241229.xsd#ilmn_RestructuringPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_ilmn_RestructuringPolicyTextBlock_43dab9dc-7aec-4590-ad13-d144ad8c724d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_8c4034f7-d747-4cc1-bf52-f1f4438f3157" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf5a8f32-3bda-440d-948a-cd1bb97f4f0e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_8c4034f7-d747-4cc1-bf52-f1f4438f3157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d0accc99-8c38-46ba-89a5-114b3e42eb20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_206bfdbb-8b26-40ad-a83e-b35ea88950d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d0accc99-8c38-46ba-89a5-114b3e42eb20" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_206bfdbb-8b26-40ad-a83e-b35ea88950d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5b7140bc-147c-4fce-a665-81edea635c82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d0accc99-8c38-46ba-89a5-114b3e42eb20" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5b7140bc-147c-4fce-a665-81edea635c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GRAILSPINOFFTables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GRAILSPINOFFTables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GRAILSPINOFFTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e0170ea8-e585-40c3-a434-c72aa210aa5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_3f7a74c2-5900-49c4-8969-9c6797bbfc74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e0170ea8-e585-40c3-a434-c72aa210aa5c" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_3f7a74c2-5900-49c4-8969-9c6797bbfc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/REVENUETables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6081e297-e5a8-48cd-b2ce-15fe6134efc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_d66d3a76-0d14-4ce4-bc9d-e4e7ea1f857f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6081e297-e5a8-48cd-b2ce-15fe6134efc1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_d66d3a76-0d14-4ce4-bc9d-e4e7ea1f857f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_22d6f4d1-de46-446b-9252-9f911fa1a8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_c46fc23a-c243-45d8-a485-af4a940dd22a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_22d6f4d1-de46-446b-9252-9f911fa1a8fd" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_c46fc23a-c243-45d8-a485-af4a940dd22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTableTextBlock_e66ca042-446b-474f-b153-29f037d847c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_22d6f4d1-de46-446b-9252-9f911fa1a8fd" xlink:to="loc_us-gaap_OtherCommitmentsTableTextBlock_e66ca042-446b-474f-b153-29f037d847c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8fb9e5cf-72bb-4bf3-8e50-f81a59813e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_22d6f4d1-de46-446b-9252-9f911fa1a8fd" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8fb9e5cf-72bb-4bf3-8e50-f81a59813e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_64bb63c2-ec2a-4780-bbee-a7705c2d35e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_22d6f4d1-de46-446b-9252-9f911fa1a8fd" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_64bb63c2-ec2a-4780-bbee-a7705c2d35e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3ff1f7cc-5664-4d18-87b1-8529974f6392" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_d5f50cef-da7b-4b34-a879-af1634d8ee9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3ff1f7cc-5664-4d18-87b1-8529974f6392" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_d5f50cef-da7b-4b34-a879-af1634d8ee9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_d92e6f87-b4cb-4365-acab-6c80a38a8cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3ff1f7cc-5664-4d18-87b1-8529974f6392" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_d92e6f87-b4cb-4365-acab-6c80a38a8cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_731ff798-5341-4fba-9eed-7b01e99499b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3ff1f7cc-5664-4d18-87b1-8529974f6392" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_731ff798-5341-4fba-9eed-7b01e99499b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSTables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSTables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8807b4d5-cac5-4859-8c77-be36f76001b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_c5faa9a8-0052-473f-aec8-d8c02b3f28bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8807b4d5-cac5-4859-8c77-be36f76001b5" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_c5faa9a8-0052-473f-aec8-d8c02b3f28bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0b49a445-cd6f-4d38-a8a6-0c1f506e3436" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8807b4d5-cac5-4859-8c77-be36f76001b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0b49a445-cd6f-4d38-a8a6-0c1f506e3436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_fba6ea03-3cac-422d-8eff-6b5005447cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8807b4d5-cac5-4859-8c77-be36f76001b5" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_fba6ea03-3cac-422d-8eff-6b5005447cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_4d88ab6d-3bf4-4bff-9374-69b7fed0068a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_4d88ab6d-3bf4-4bff-9374-69b7fed0068a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_afa7d723-7298-4495-8529-d226bbdb6472" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:to="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_afa7d723-7298-4495-8529-d226bbdb6472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_48ba859f-2260-477b-8593-e6b60578c0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_48ba859f-2260-477b-8593-e6b60578c0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_3803baf0-119a-41b0-bf07-581a438cc682" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_3803baf0-119a-41b0-bf07-581a438cc682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_53de0b6b-beeb-4af4-a92a-82e0ae4c2018" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_53de0b6b-beeb-4af4-a92a-82e0ae4c2018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock_1c4d91bc-93d7-4d98-903a-29fba0747fed" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:to="loc_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock_1c4d91bc-93d7-4d98-903a-29fba0747fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_ab4d6f99-6124-406d-844b-a65ab921fdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_ab4d6f99-6124-406d-844b-a65ab921fdd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_fa5f88ad-2866-446e-9471-5a20bed22c23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_fa5f88ad-2866-446e-9471-5a20bed22c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9f204857-0cd3-4dfa-9623-37a750e8cfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3d1a6c8-c136-4069-98c5-399a568dbef5" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9f204857-0cd3-4dfa-9623-37a750e8cfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSTables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f67aae75-1781-4366-b921-9971408bc714" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_5c9a72f4-a13e-42e9-857f-00f84ee1f15f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f67aae75-1781-4366-b921-9971408bc714" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_5c9a72f4-a13e-42e9-857f-00f84ee1f15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c6beb2ab-bbe7-47f9-82b0-7f4de770e0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f67aae75-1781-4366-b921-9971408bc714" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c6beb2ab-bbe7-47f9-82b0-7f4de770e0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ae709a04-26b0-4ff7-aab1-f6bc91cc7937" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f67aae75-1781-4366-b921-9971408bc714" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ae709a04-26b0-4ff7-aab1-f6bc91cc7937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_dcfe7592-d802-46b4-b479-1a7da2c23819" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f67aae75-1781-4366-b921-9971408bc714" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_dcfe7592-d802-46b4-b479-1a7da2c23819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_38df76bf-b505-4b5d-be7b-dc0308754528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f67aae75-1781-4366-b921-9971408bc714" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_38df76bf-b505-4b5d-be7b-dc0308754528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6e2bff53-0d9c-44a5-8d57-fabb43b2ca3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f67aae75-1781-4366-b921-9971408bc714" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6e2bff53-0d9c-44a5-8d57-fabb43b2ca3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_28143501-5372-4085-80bb-7cf79944cb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_f7a1c665-1864-4c66-82d5-659d71a8ebd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28143501-5372-4085-80bb-7cf79944cb5c" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_f7a1c665-1864-4c66-82d5-659d71a8ebd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d301213a-9319-47db-9ec5-b3cdc836125d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28143501-5372-4085-80bb-7cf79944cb5c" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d301213a-9319-47db-9ec5-b3cdc836125d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d8e22038-c92c-4cd5-8972-c4a5988fb5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28143501-5372-4085-80bb-7cf79944cb5c" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d8e22038-c92c-4cd5-8972-c4a5988fb5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a1133d77-80e2-4e64-acbb-0cc40b528a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28143501-5372-4085-80bb-7cf79944cb5c" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a1133d77-80e2-4e64-acbb-0cc40b528a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_f4745fb9-5f8e-4f3a-8585-b7177e6ff464" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_28143501-5372-4085-80bb-7cf79944cb5c" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_f4745fb9-5f8e-4f3a-8585-b7177e6ff464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7c3a287f-fd68-4351-8ae5-0ef664d13ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_a644f24b-2132-4e26-9ab9-7a8d7855f643" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c3a287f-fd68-4351-8ae5-0ef664d13ac5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_a644f24b-2132-4e26-9ab9-7a8d7855f643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_0d8ce82d-956e-4db7-bff9-1a50129e01d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c3a287f-fd68-4351-8ae5-0ef664d13ac5" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_0d8ce82d-956e-4db7-bff9-1a50129e01d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_120849bd-bbfe-4048-8fcb-30b49ce6c721" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2255372d-fb2e-41e2-a8d7-dd743028ecce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_120849bd-bbfe-4048-8fcb-30b49ce6c721" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2255372d-fb2e-41e2-a8d7-dd743028ecce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2e03d82a-87b5-410a-a748-bdeb530c50a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2255372d-fb2e-41e2-a8d7-dd743028ecce" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2e03d82a-87b5-410a-a748-bdeb530c50a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f2818637-dc4e-4486-bb02-0cca45c155b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2e03d82a-87b5-410a-a748-bdeb530c50a5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f2818637-dc4e-4486-bb02-0cca45c155b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_19378ba8-6324-49ab-abeb-b44395c37a72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f2818637-dc4e-4486-bb02-0cca45c155b1" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_19378ba8-6324-49ab-abeb-b44395c37a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_219fb7da-28e5-404b-a4e0-4dc0fbd7bd63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2255372d-fb2e-41e2-a8d7-dd743028ecce" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_219fb7da-28e5-404b-a4e0-4dc0fbd7bd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9afa4375-4342-4b01-b71d-18c6053db71d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_219fb7da-28e5-404b-a4e0-4dc0fbd7bd63" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9afa4375-4342-4b01-b71d-18c6053db71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_ace639e1-f0ad-45e7-875e-4350ea7f2093" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9afa4375-4342-4b01-b71d-18c6053db71d" xlink:to="loc_ilmn_GRAILInc.Member_ace639e1-f0ad-45e7-875e-4350ea7f2093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2255372d-fb2e-41e2-a8d7-dd743028ecce" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_a43b578c-d2f7-48fa-bc7c-781c7461b5d7" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:to="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_a43b578c-d2f7-48fa-bc7c-781c7461b5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_12e05723-7cd4-4c3c-be27-ea09b6fff3d2" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationPercentOfInterestDisposedOf"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:to="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_12e05723-7cd4-4c3c-be27-ea09b6fff3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_2c0677b3-6b2e-4cd4-a4dd-4ee33bb41a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_452379f6-a8d8-4a97-93a4-b22e92bba03a" xlink:to="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_2c0677b3-6b2e-4cd4-a4dd-4ee33bb41a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4ccdfcce-f8a1-42a1-b7c6-d8079bb41f76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4ccdfcce-f8a1-42a1-b7c6-d8079bb41f76" xlink:to="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d45a7d95-3a36-4676-aede-0af834755954" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:to="loc_srt_StatementGeographicalAxis_d45a7d95-3a36-4676-aede-0af834755954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a1725608-045e-4d21-a01c-272e461d1eb5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d45a7d95-3a36-4676-aede-0af834755954" xlink:to="loc_srt_SegmentGeographicalDomain_a1725608-045e-4d21-a01c-272e461d1eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ed1785b3-5f0f-4d39-bba4-9b050390af00" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a1725608-045e-4d21-a01c-272e461d1eb5" xlink:to="loc_country_US_ed1785b3-5f0f-4d39-bba4-9b050390af00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_8469f3a0-f48d-4b6c-8901-32a7137239ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a1725608-045e-4d21-a01c-272e461d1eb5" xlink:to="loc_us-gaap_NonUsMember_8469f3a0-f48d-4b6c-8901-32a7137239ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7fb0e7ae-f057-4248-a732-046fcc61b5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7fb0e7ae-f057-4248-a732-046fcc61b5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7fb0e7ae-f057-4248-a732-046fcc61b5e7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_f427d14b-64e0-4301-a2b4-5f40bcb1b08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_f427d14b-64e0-4301-a2b4-5f40bcb1b08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_d8571831-c4a7-4df0-aa85-d7f9bd6a6323" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_d8571831-c4a7-4df0-aa85-d7f9bd6a6323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_55e4ed04-26a8-4816-ae58-80b045c097da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_55e4ed04-26a8-4816-ae58-80b045c097da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndustryCreditConcentrationRiskMember_008a2d64-b40d-41bc-8562-b2c972a77bf0" xlink:href="ilmn-20241229.xsd#ilmn_IndustryCreditConcentrationRiskMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_bef0a9ff-a9ff-4e12-afe6-3e7f5ce775ad" xlink:to="loc_ilmn_IndustryCreditConcentrationRiskMember_008a2d64-b40d-41bc-8562-b2c972a77bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_285ea465-8951-429b-a17b-503e954c24a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_285ea465-8951-429b-a17b-503e954c24a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_285ea465-8951-429b-a17b-503e954c24a9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_cd5de9b1-91f9-4e72-be6f-dbb080aa1e56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:to="loc_us-gaap_SalesRevenueNetMember_cd5de9b1-91f9-4e72-be6f-dbb080aa1e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_68617c01-40f4-495d-a206-d51ec495d5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:to="loc_us-gaap_AccountsReceivableMember_68617c01-40f4-495d-a206-d51ec495d5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_InvestmentPortfolioMember_b57c1beb-641b-4fd7-9b05-9999d6147d4e" xlink:href="ilmn-20241229.xsd#ilmn_InvestmentPortfolioMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:to="loc_ilmn_InvestmentPortfolioMember_b57c1beb-641b-4fd7-9b05-9999d6147d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IssueSizeMember_44fb7dbb-4586-4ccc-8ded-8532b13522d2" xlink:href="ilmn-20241229.xsd#ilmn_IssueSizeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_063e73fe-02d9-4287-807f-057355d54544" xlink:to="loc_ilmn_IssueSizeMember_44fb7dbb-4586-4ccc-8ded-8532b13522d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_862e5dc5-6ede-4dda-832e-71186b848f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_63d8d908-b896-4f3d-a04d-e2ad2b8a2d3d" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_862e5dc5-6ede-4dda-832e-71186b848f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_6bd520f7-af9f-4b10-a8ad-b1e395171ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_862e5dc5-6ede-4dda-832e-71186b848f6b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_6bd520f7-af9f-4b10-a8ad-b1e395171ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConcentrationRiskThreshold_aa3bd890-1524-4d93-80c8-3b4c16e02637" xlink:href="ilmn-20241229.xsd#ilmn_ConcentrationRiskThreshold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_862e5dc5-6ede-4dda-832e-71186b848f6b" xlink:to="loc_ilmn_ConcentrationRiskThreshold_aa3bd890-1524-4d93-80c8-3b4c16e02637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_59e9567a-ef88-41dd-b230-9177826f0e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_166dd36a-a5f2-4b4f-9b20-e30b5cccdb92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e9567a-ef88-41dd-b230-9177826f0e0c" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_166dd36a-a5f2-4b4f-9b20-e30b5cccdb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_92dc9aed-ccc7-4dea-a107-91985327fc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_166dd36a-a5f2-4b4f-9b20-e30b5cccdb92" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_92dc9aed-ccc7-4dea-a107-91985327fc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7eae2a4b-5439-4658-b2a9-e329de7bff77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_92dc9aed-ccc7-4dea-a107-91985327fc4c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7eae2a4b-5439-4658-b2a9-e329de7bff77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_a4458bcb-d3a4-4831-8c6b-16d8e1e6239f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_7eae2a4b-5439-4658-b2a9-e329de7bff77" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_a4458bcb-d3a4-4831-8c6b-16d8e1e6239f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_43a637a2-35cf-4275-a2be-0f157ba8e91c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_166dd36a-a5f2-4b4f-9b20-e30b5cccdb92" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_43a637a2-35cf-4275-a2be-0f157ba8e91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_568b850d-e310-4061-995d-1cab5a574eb2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_43a637a2-35cf-4275-a2be-0f157ba8e91c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_568b850d-e310-4061-995d-1cab5a574eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_90326172-f6ea-4be6-a666-d9769fc79bec" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_568b850d-e310-4061-995d-1cab5a574eb2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_90326172-f6ea-4be6-a666-d9769fc79bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a2cb0729-236d-4390-ba8c-ae5ba910a638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_166dd36a-a5f2-4b4f-9b20-e30b5cccdb92" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a2cb0729-236d-4390-ba8c-ae5ba910a638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8d15bb4f-18cb-48e7-b62e-cd40c487d18c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a2cb0729-236d-4390-ba8c-ae5ba910a638" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8d15bb4f-18cb-48e7-b62e-cd40c487d18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2409623c-b82e-489d-b32f-fc11b3e27869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a2cb0729-236d-4390-ba8c-ae5ba910a638" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2409623c-b82e-489d-b32f-fc11b3e27869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_185ebc61-9bc1-4318-8085-c56276726d39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_b00cc1b8-afb8-4045-85e8-aa59515bdb99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_185ebc61-9bc1-4318-8085-c56276726d39" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_b00cc1b8-afb8-4045-85e8-aa59515bdb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_73af2f7c-eb5e-4fd8-bc69-f269807ca3ac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_b00cc1b8-afb8-4045-85e8-aa59515bdb99" xlink:to="loc_srt_ProductOrServiceAxis_73af2f7c-eb5e-4fd8-bc69-f269807ca3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_64331b88-abde-48b0-ae79-1e43e677aba0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_73af2f7c-eb5e-4fd8-bc69-f269807ca3ac" xlink:to="loc_srt_ProductsAndServicesDomain_64331b88-abde-48b0-ae79-1e43e677aba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c73ec565-90b5-4f46-a0a5-36cdd155bd05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64331b88-abde-48b0-ae79-1e43e677aba0" xlink:to="loc_us-gaap_ProductMember_c73ec565-90b5-4f46-a0a5-36cdd155bd05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_44990014-237f-41b6-8b8d-a67d14d217d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_b00cc1b8-afb8-4045-85e8-aa59515bdb99" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_44990014-237f-41b6-8b8d-a67d14d217d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevenueFromContractWithCustomerPaymentTerm_e1581ab6-da7e-4791-8531-1157a8717bb2" xlink:href="ilmn-20241229.xsd#ilmn_RevenueFromContractWithCustomerPaymentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_44990014-237f-41b6-8b8d-a67d14d217d7" xlink:to="loc_ilmn_RevenueFromContractWithCustomerPaymentTerm_e1581ab6-da7e-4791-8531-1157a8717bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d4fdc71d-d6ec-4da2-af7c-bdb1a0a44fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf11e5b5-b40e-4a30-8562-7a51d5878e71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d4fdc71d-d6ec-4da2-af7c-bdb1a0a44fa9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf11e5b5-b40e-4a30-8562-7a51d5878e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13631249-65c4-46c8-9c9a-041c40e6206a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d4fdc71d-d6ec-4da2-af7c-bdb1a0a44fa9" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13631249-65c4-46c8-9c9a-041c40e6206a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0743ba17-b1f9-4576-bb44-7abb8d6460ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d4fdc71d-d6ec-4da2-af7c-bdb1a0a44fa9" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0743ba17-b1f9-4576-bb44-7abb8d6460ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74a267ee-aee9-4260-ad51-af779b7f24b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0743ba17-b1f9-4576-bb44-7abb8d6460ee" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74a267ee-aee9-4260-ad51-af779b7f24b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bcfd4136-4533-4828-addf-51da2b73350e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74a267ee-aee9-4260-ad51-af779b7f24b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bcfd4136-4533-4828-addf-51da2b73350e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_1647e4c8-6b75-4169-a26c-256ca7841838" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bcfd4136-4533-4828-addf-51da2b73350e" xlink:to="loc_us-gaap_StockCompensationPlanMember_1647e4c8-6b75-4169-a26c-256ca7841838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_e44c8c73-b0bf-43ec-9881-ea93b24c00b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bcfd4136-4533-4828-addf-51da2b73350e" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_e44c8c73-b0bf-43ec-9881-ea93b24c00b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_449ad973-7d7a-4468-b3a7-6f40c0e2fc81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0743ba17-b1f9-4576-bb44-7abb8d6460ee" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_449ad973-7d7a-4468-b3a7-6f40c0e2fc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1681aac0-8db2-401a-b634-d7a22e9edb06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_449ad973-7d7a-4468-b3a7-6f40c0e2fc81" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1681aac0-8db2-401a-b634-d7a22e9edb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_caccdec1-f2a5-4912-8f6d-02adb2ce3483" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a1e2b0b7-fb2e-4e74-aa80-53fc1789377d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_caccdec1-f2a5-4912-8f6d-02adb2ce3483" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a1e2b0b7-fb2e-4e74-aa80-53fc1789377d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5eef79c2-cfe8-441f-b09c-06d12f3dad3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a1e2b0b7-fb2e-4e74-aa80-53fc1789377d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5eef79c2-cfe8-441f-b09c-06d12f3dad3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5eef79c2-cfe8-441f-b09c-06d12f3dad3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BuildingandLeaseholdImprovementsMember_19042cb1-ca84-47ae-89cd-1915928fea2b" xlink:href="ilmn-20241229.xsd#ilmn_BuildingandLeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:to="loc_ilmn_BuildingandLeaseholdImprovementsMember_19042cb1-ca84-47ae-89cd-1915928fea2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_bc4adf60-38d0-49a9-8b5f-d19fcbb3e729" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_bc4adf60-38d0-49a9-8b5f-d19fcbb3e729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_60aee23f-9bc2-4945-aeba-57d2a6ea32ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:to="loc_us-gaap_ComputerEquipmentMember_60aee23f-9bc2-4945-aeba-57d2a6ea32ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_fb545571-247f-4937-aa45-f373c3052fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a77d7839-dc07-42d4-bfed-66298fab0963" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_fb545571-247f-4937-aa45-f373c3052fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fb959ed9-712c-42c7-a079-0ce3cfdbdde2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a1e2b0b7-fb2e-4e74-aa80-53fc1789377d" xlink:to="loc_srt_RangeAxis_fb959ed9-712c-42c7-a079-0ce3cfdbdde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bd7b6e13-acbb-4a45-afc2-6cc1026139b8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fb959ed9-712c-42c7-a079-0ce3cfdbdde2" xlink:to="loc_srt_RangeMember_bd7b6e13-acbb-4a45-afc2-6cc1026139b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_45661416-2c29-45a4-b37a-dd347eb1e4b4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bd7b6e13-acbb-4a45-afc2-6cc1026139b8" xlink:to="loc_srt_MinimumMember_45661416-2c29-45a4-b37a-dd347eb1e4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f48517b-2ddd-48f4-abfb-01be47c4c9d8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bd7b6e13-acbb-4a45-afc2-6cc1026139b8" xlink:to="loc_srt_MaximumMember_1f48517b-2ddd-48f4-abfb-01be47c4c9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_715bc13a-2609-46c5-90c3-7281d816b768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a1e2b0b7-fb2e-4e74-aa80-53fc1789377d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_715bc13a-2609-46c5-90c3-7281d816b768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_fa3cacdd-a4c9-4915-99fa-b4228616f0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_715bc13a-2609-46c5-90c3-7281d816b768" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_fa3cacdd-a4c9-4915-99fa-b4228616f0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a302ff0b-56d6-4563-aa14-ef0ef6bc1ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5086a3ca-603b-4be1-97a5-cb7f5b23f633" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a302ff0b-56d6-4563-aa14-ef0ef6bc1ee5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5086a3ca-603b-4be1-97a5-cb7f5b23f633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b5123ee-c647-493f-9bd9-2c7529a76858" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5086a3ca-603b-4be1-97a5-cb7f5b23f633" xlink:to="loc_srt_RangeAxis_6b5123ee-c647-493f-9bd9-2c7529a76858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a5568a9-59ea-4cdf-b651-4151bd7cee08" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6b5123ee-c647-493f-9bd9-2c7529a76858" xlink:to="loc_srt_RangeMember_5a5568a9-59ea-4cdf-b651-4151bd7cee08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_742039bc-7e70-4058-b852-1a3b74853e3c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5a5568a9-59ea-4cdf-b651-4151bd7cee08" xlink:to="loc_srt_MinimumMember_742039bc-7e70-4058-b852-1a3b74853e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5eb6f2d0-0a9c-4c38-9ab2-9b628f4c8d8b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5a5568a9-59ea-4cdf-b651-4151bd7cee08" xlink:to="loc_srt_MaximumMember_5eb6f2d0-0a9c-4c38-9ab2-9b628f4c8d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_950dc95e-1e79-41c6-9de6-b857c1bb2a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5086a3ca-603b-4be1-97a5-cb7f5b23f633" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_950dc95e-1e79-41c6-9de6-b857c1bb2a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_df79824c-04c7-4f33-b8b9-b6c53ea143a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_950dc95e-1e79-41c6-9de6-b857c1bb2a7d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_df79824c-04c7-4f33-b8b9-b6c53ea143a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9eb8f979-841f-4e96-9aee-2a6fcaccece6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_950dc95e-1e79-41c6-9de6-b857c1bb2a7d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9eb8f979-841f-4e96-9aee-2a6fcaccece6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d1b1f855-bdd2-4ca2-ab96-e2be0609c274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d1b1f855-bdd2-4ca2-ab96-e2be0609c274" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_49bbe5c4-a770-42ed-9378-6e41c9378813" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_49bbe5c4-a770-42ed-9378-6e41c9378813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_12a8a5ba-7889-4790-8433-5e5add0344f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_49bbe5c4-a770-42ed-9378-6e41c9378813" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_12a8a5ba-7889-4790-8433-5e5add0344f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f369fad1-1dde-4261-bc1e-a3ce5bada451" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_12a8a5ba-7889-4790-8433-5e5add0344f3" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f369fad1-1dde-4261-bc1e-a3ce5bada451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_38751b19-75c8-4b76-862e-da512c366b36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:to="loc_us-gaap_HedgingDesignationAxis_38751b19-75c8-4b76-862e-da512c366b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d4a9c80c-be5b-44ad-ab93-310d1d52c9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_38751b19-75c8-4b76-862e-da512c366b36" xlink:to="loc_us-gaap_HedgingDesignationDomain_d4a9c80c-be5b-44ad-ab93-310d1d52c9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9c1371ac-90c4-4982-b08a-e0a13d5d1f02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d4a9c80c-be5b-44ad-ab93-310d1d52c9c4" xlink:to="loc_us-gaap_NondesignatedMember_9c1371ac-90c4-4982-b08a-e0a13d5d1f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_90ccbfa5-5a86-43fc-9b0c-2b023a9ab57d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d4a9c80c-be5b-44ad-ab93-310d1d52c9c4" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_90ccbfa5-5a86-43fc-9b0c-2b023a9ab57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c298263c-7d4f-448a-8bd7-087c31728455" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c298263c-7d4f-448a-8bd7-087c31728455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e88153b1-9897-4bc7-8e2a-debd13cf8372" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c298263c-7d4f-448a-8bd7-087c31728455" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e88153b1-9897-4bc7-8e2a-debd13cf8372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_fb3e668e-3e8d-4ad5-aa3c-411070eead3c" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e88153b1-9897-4bc7-8e2a-debd13cf8372" xlink:to="loc_ilmn_GRAILInc.Member_fb3e668e-3e8d-4ad5-aa3c-411070eead3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_28d59644-cc54-4bd9-a1b2-58c75bc05a99" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_affc7c61-3f42-46d5-b490-31c0fa753d03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_affc7c61-3f42-46d5-b490-31c0fa753d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_73bac583-a972-4698-bb0f-c8a81ebdadf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_73bac583-a972-4698-bb0f-c8a81ebdadf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_374d4285-ea4d-449a-a579-764d866de19b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_DerivativeTermOfContract_374d4285-ea4d-449a-a579-764d866de19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_f2c926a0-a07f-4b98-b687-2b61b8be57e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_f2c926a0-a07f-4b98-b687-2b61b8be57e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_3299ae6c-6db5-4b32-bfc7-10e2c0aa851e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_DerivativeAssets_3299ae6c-6db5-4b32-bfc7-10e2c0aa851e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_e2fbb741-2783-4cb5-a6d6-933261156eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_DerivativeLiabilities_e2fbb741-2783-4cb5-a6d6-933261156eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_77934eb2-eae5-41f2-bd68-66870ab28bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f84bd63-e319-423a-ac20-fee0f2d103c4" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_77934eb2-eae5-41f2-bd68-66870ab28bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4a5d7999-bf55-46eb-8328-630087f57e04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityTable_ea6f1031-c084-4853-b691-1c8f8a8e83d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a5d7999-bf55-46eb-8328-630087f57e04" xlink:to="loc_us-gaap_ProductWarrantyLiabilityTable_ea6f1031-c084-4853-b691-1c8f8a8e83d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_25759db6-87ad-4f7f-b76c-b2f3817be0f0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_ea6f1031-c084-4853-b691-1c8f8a8e83d9" xlink:to="loc_srt_ProductOrServiceAxis_25759db6-87ad-4f7f-b76c-b2f3817be0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bad056b1-aae1-43d5-b8fe-8c904e0a782a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_25759db6-87ad-4f7f-b76c-b2f3817be0f0" xlink:to="loc_srt_ProductsAndServicesDomain_bad056b1-aae1-43d5-b8fe-8c904e0a782a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_InstrumentsMember_d0d6f4ab-5bc3-4ae3-8355-f55f4444dd68" xlink:href="ilmn-20241229.xsd#ilmn_InstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bad056b1-aae1-43d5-b8fe-8c904e0a782a" xlink:to="loc_ilmn_InstrumentsMember_d0d6f4ab-5bc3-4ae3-8355-f55f4444dd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConsumablesMember_d1c5a58b-7c86-4c7b-afc0-e694f1ded247" xlink:href="ilmn-20241229.xsd#ilmn_ConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bad056b1-aae1-43d5-b8fe-8c904e0a782a" xlink:to="loc_ilmn_ConsumablesMember_d1c5a58b-7c86-4c7b-afc0-e694f1ded247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_90186752-84bc-463a-9da5-cc78acf14deb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_ea6f1031-c084-4853-b691-1c8f8a8e83d9" xlink:to="loc_srt_RangeAxis_90186752-84bc-463a-9da5-cc78acf14deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a8a05c02-ee09-4ac4-b488-e245e6f6072e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_90186752-84bc-463a-9da5-cc78acf14deb" xlink:to="loc_srt_RangeMember_a8a05c02-ee09-4ac4-b488-e245e6f6072e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5ec44b4b-6ef4-4572-8e7d-33f91f0c2403" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a8a05c02-ee09-4ac4-b488-e245e6f6072e" xlink:to="loc_srt_MinimumMember_5ec44b4b-6ef4-4572-8e7d-33f91f0c2403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7c651b3d-ec36-4ba9-9756-010e113b9031" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a8a05c02-ee09-4ac4-b488-e245e6f6072e" xlink:to="loc_srt_MaximumMember_7c651b3d-ec36-4ba9-9756-010e113b9031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyLiabilityLineItems_a038516e-ed47-44fc-a3cc-ec34db3049b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyLiabilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityTable_ea6f1031-c084-4853-b691-1c8f8a8e83d9" xlink:to="loc_us-gaap_ProductWarrantyLiabilityLineItems_a038516e-ed47-44fc-a3cc-ec34db3049b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_StandardProductWarrantyDescriptionTerm_4959b6f7-b2a6-496f-8051-76f7d22eff77" xlink:href="ilmn-20241229.xsd#ilmn_StandardProductWarrantyDescriptionTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantyLiabilityLineItems_a038516e-ed47-44fc-a3cc-ec34db3049b0" xlink:to="loc_ilmn_StandardProductWarrantyDescriptionTerm_4959b6f7-b2a6-496f-8051-76f7d22eff77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeShareBasedCompensationDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_36bede76-423a-4661-bda8-1b1cf243703d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cd487ffc-9742-40ef-9ad7-6f770425b019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_36bede76-423a-4661-bda8-1b1cf243703d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cd487ffc-9742-40ef-9ad7-6f770425b019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeAdvertisingCostsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeAdvertisingCostsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeAdvertisingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f33f96cf-16a0-4fe3-8f98-18611d4e761d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_13ae8451-d873-473d-9b7e-d56d8cf332b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f33f96cf-16a0-4fe3-8f98-18611d4e761d" xlink:to="loc_us-gaap_AdvertisingExpense_13ae8451-d873-473d-9b7e-d56d8cf332b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GRAILSPINOFFNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_86e50973-38eb-4fde-8d5e-57cd572c09e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81c07330-5941-4919-ad95-7de990083cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_86e50973-38eb-4fde-8d5e-57cd572c09e7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81c07330-5941-4919-ad95-7de990083cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_27117a53-610f-4c12-bf0e-95bbda38e4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81c07330-5941-4919-ad95-7de990083cf5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_27117a53-610f-4c12-bf0e-95bbda38e4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_73778846-64ea-4af6-bcd4-4f7dfb417164" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_27117a53-610f-4c12-bf0e-95bbda38e4c0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_73778846-64ea-4af6-bcd4-4f7dfb417164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_ad8927dd-1888-47c8-a0a7-03581f869635" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_73778846-64ea-4af6-bcd4-4f7dfb417164" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_ad8927dd-1888-47c8-a0a7-03581f869635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04cc2b0f-2a55-414c-88e0-7866f1cf5f52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81c07330-5941-4919-ad95-7de990083cf5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04cc2b0f-2a55-414c-88e0-7866f1cf5f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6340c026-993e-4bb8-9dd5-b85d21bc031c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04cc2b0f-2a55-414c-88e0-7866f1cf5f52" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6340c026-993e-4bb8-9dd5-b85d21bc031c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_16f52f63-461d-4f9f-81b1-b716d0db0800" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6340c026-993e-4bb8-9dd5-b85d21bc031c" xlink:to="loc_ilmn_GRAILInc.Member_16f52f63-461d-4f9f-81b1-b716d0db0800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81c07330-5941-4919-ad95-7de990083cf5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_36af430d-8f5b-4a67-8105-a0b5daf3f9f1" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction_36af430d-8f5b-4a67-8105-a0b5daf3f9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_3f573977-75dd-41ba-b541-6425bd5d6758" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationPercentOfInterestDisposedOf"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_3f573977-75dd-41ba-b541-6425bd5d6758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff_cf1f55a4-225b-4b56-855b-14032a2e79c1" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff_cf1f55a4-225b-4b56-855b-14032a2e79c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_53f93e6c-e073-4f8b-a657-8269e366ab78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_53f93e6c-e073-4f8b-a657-8269e366ab78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_f982ba72-d148-4e0c-a4f4-f31e9fa941d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_f982ba72-d148-4e0c-a4f4-f31e9fa941d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_09e1a6d1-25e8-46d0-908b-b56666245746" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_09e1a6d1-25e8-46d0-908b-b56666245746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationTransactionCosts_b44267ee-0e4a-4b5a-b9a0-12062017b5cd" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationTransactionCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bbe63380-ec2b-4d46-996b-44ab24546dc7" xlink:to="loc_ilmn_DiscontinuedOperationTransactionCosts_b44267ee-0e4a-4b5a-b9a0-12062017b5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6724e024-9991-431b-a8ce-85750fa5c1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6724e024-9991-431b-a8ce-85750fa5c1d5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f2377c7-fbae-4c74-8f6a-ab4cbfdce411" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f2377c7-fbae-4c74-8f6a-ab4cbfdce411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326108cd-efa0-4b25-85b9-a90b3e74b0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f2377c7-fbae-4c74-8f6a-ab4cbfdce411" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326108cd-efa0-4b25-85b9-a90b3e74b0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_344b0cc1-7fc7-4f25-a54c-076bb8e3dc39" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326108cd-efa0-4b25-85b9-a90b3e74b0f0" xlink:to="loc_ilmn_GRAILInc.Member_344b0cc1-7fc7-4f25-a54c-076bb8e3dc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_064a7904-1df1-4235-87d4-56d58996b940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_064a7904-1df1-4235-87d4-56d58996b940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_38305c8c-9069-4e45-ad4b-77e4aa1bd4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_064a7904-1df1-4235-87d4-56d58996b940" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_38305c8c-9069-4e45-ad4b-77e4aa1bd4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_3ea1ebc5-c04d-4d61-a2a5-7f484f0a07a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_38305c8c-9069-4e45-ad4b-77e4aa1bd4d8" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_3ea1ebc5-c04d-4d61-a2a5-7f484f0a07a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a4e8b86-5716-4c98-862d-3bfeaf15ed95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a4e8b86-5716-4c98-862d-3bfeaf15ed95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9ba55b9a-8082-4d7e-b954-c22cdb6c2942" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a4e8b86-5716-4c98-862d-3bfeaf15ed95" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9ba55b9a-8082-4d7e-b954-c22cdb6c2942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_53abb7ff-727a-4a25-b350-d44cc63a6d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ba55b9a-8082-4d7e-b954-c22cdb6c2942" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_53abb7ff-727a-4a25-b350-d44cc63a6d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b52e01cd-50d1-4052-8e55-34706263a4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ba55b9a-8082-4d7e-b954-c22cdb6c2942" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b52e01cd-50d1-4052-8e55-34706263a4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_63cdd094-761e-4edf-aa21-f85dc59a37c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_63cdd094-761e-4edf-aa21-f85dc59a37c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fabdb79a-74f8-4b74-811b-b81a7c7b06c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_63cdd094-761e-4edf-aa21-f85dc59a37c6" xlink:to="loc_us-gaap_SegmentDomain_fabdb79a-74f8-4b74-811b-b81a7c7b06c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILIncMember_15ce1144-08df-4f6c-a13d-ff137420134b" xlink:href="ilmn-20241229.xsd#ilmn_GRAILIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fabdb79a-74f8-4b74-811b-b81a7c7b06c3" xlink:to="loc_ilmn_GRAILIncMember_15ce1144-08df-4f6c-a13d-ff137420134b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5e8c3cda-84e1-4306-96f2-0daf94416774" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5e8c3cda-84e1-4306-96f2-0daf94416774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_64c74205-494e-435b-8705-277c4db27287" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5e8c3cda-84e1-4306-96f2-0daf94416774" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_64c74205-494e-435b-8705-277c4db27287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_cebd034f-9d23-4c52-a23e-337b7d4af439" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_64c74205-494e-435b-8705-277c4db27287" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_cebd034f-9d23-4c52-a23e-337b7d4af439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b8ccd0e-7bb2-423b-b6bc-fe502c94f197" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2c41cff1-f9e7-4ab6-bb8c-b68aa3729a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2c41cff1-f9e7-4ab6-bb8c-b68aa3729a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_ed5a337d-d054-4971-ab3a-b8ad6bb599c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_ed5a337d-d054-4971-ab3a-b8ad6bb599c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_4aa1ac2c-2dc3-4500-8ed5-acc7a3a5bd64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_4aa1ac2c-2dc3-4500-8ed5-acc7a3a5bd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3f3b120f-9546-492d-bdd1-33bb336df6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3f3b120f-9546-492d-bdd1-33bb336df6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6af9132a-e532-4f87-adfa-49318964454d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6af9132a-e532-4f87-adfa-49318964454d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_db0f0f26-867f-47f3-b71d-0bf8afbce085" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_db0f0f26-867f-47f3-b71d-0bf8afbce085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_448391c2-20a0-4ab5-8e58-b9f661450a87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_448391c2-20a0-4ab5-8e58-b9f661450a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_6a73bf9b-0794-4338-a0dc-e595408a1494" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_6a73bf9b-0794-4338-a0dc-e595408a1494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_256c870f-0bfe-45e3-b617-7889a3034389" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_256c870f-0bfe-45e3-b617-7889a3034389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_85fc1694-b828-4892-973d-78ed335945b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_85fc1694-b828-4892-973d-78ed335945b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_15084072-9892-461e-b223-b7cb820c3636" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_15084072-9892-461e-b223-b7cb820c3636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_0690e2a8-6599-4e16-b740-9476cbcf54bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_0690e2a8-6599-4e16-b740-9476cbcf54bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_ef7ef119-5e70-49f7-932f-0b1294416705" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_ef7ef119-5e70-49f7-932f-0b1294416705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_33d67313-405d-457d-8aae-ede43b1ad8f7" xlink:to="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_b8da15cd-1529-4a18-b3cb-a0a359bfc97a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_b8da15cd-1529-4a18-b3cb-a0a359bfc97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_49da1e7e-8ca6-463c-824a-e60428a015cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:to="loc_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal_49da1e7e-8ca6-463c-824a-e60428a015cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital_d139c745-5800-4812-9335-8eb551e15a32" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital_d139c745-5800-4812-9335-8eb551e15a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c5118f24-bcdf-478c-b835-d1cd0fa1fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract_9723e73d-c996-49e6-ae71-20c8bc580911" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c5118f24-bcdf-478c-b835-d1cd0fa1fd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#REVENUEScheduleofDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f624ec30-271a-4519-84db-0804a9fb4dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f624ec30-271a-4519-84db-0804a9fb4dd0" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3db97ade-417c-40b0-857c-8e09cc5ab276" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3db97ade-417c-40b0-857c-8e09cc5ab276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7fb8aa6-3150-47ff-920c-37f12b113b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3db97ade-417c-40b0-857c-8e09cc5ab276" xlink:to="loc_us-gaap_SegmentDomain_d7fb8aa6-3150-47ff-920c-37f12b113b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SequencingMember_9a06faaa-5ef9-4338-882b-96fad966afed" xlink:href="ilmn-20241229.xsd#ilmn_SequencingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d7fb8aa6-3150-47ff-920c-37f12b113b6c" xlink:to="loc_ilmn_SequencingMember_9a06faaa-5ef9-4338-882b-96fad966afed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MicroarrayMember_e4207b9c-1cf0-40af-b00c-a61e14431dbe" xlink:href="ilmn-20241229.xsd#ilmn_MicroarrayMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d7fb8aa6-3150-47ff-920c-37f12b113b6c" xlink:to="loc_ilmn_MicroarrayMember_e4207b9c-1cf0-40af-b00c-a61e14431dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e506593c-ce67-47ff-97e4-365300ae9d06" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:to="loc_srt_ProductOrServiceAxis_e506593c-ce67-47ff-97e4-365300ae9d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_da5568a6-54eb-4ebf-b4bf-3471e3007aac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e506593c-ce67-47ff-97e4-365300ae9d06" xlink:to="loc_srt_ProductsAndServicesDomain_da5568a6-54eb-4ebf-b4bf-3471e3007aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_4caa1626-93b8-4044-9ff3-0e92733ce814" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_da5568a6-54eb-4ebf-b4bf-3471e3007aac" xlink:to="loc_us-gaap_ProductMember_4caa1626-93b8-4044-9ff3-0e92733ce814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConsumablesMember_e0650685-2593-4422-b1af-8bfcf851454c" xlink:href="ilmn-20241229.xsd#ilmn_ConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_4caa1626-93b8-4044-9ff3-0e92733ce814" xlink:to="loc_ilmn_ConsumablesMember_e0650685-2593-4422-b1af-8bfcf851454c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_InstrumentsMember_de840877-b77f-48f3-b379-b72d1a20aac2" xlink:href="ilmn-20241229.xsd#ilmn_InstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_4caa1626-93b8-4044-9ff3-0e92733ce814" xlink:to="loc_ilmn_InstrumentsMember_de840877-b77f-48f3-b379-b72d1a20aac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_e8454b94-d81f-4970-883a-13eb89e0a5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_da5568a6-54eb-4ebf-b4bf-3471e3007aac" xlink:to="loc_us-gaap_ServiceMember_e8454b94-d81f-4970-883a-13eb89e0a5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7155151a-ddea-4012-8031-49d2949120c5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:to="loc_srt_StatementGeographicalAxis_7155151a-ddea-4012-8031-49d2949120c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7155151a-ddea-4012-8031-49d2949120c5" xlink:to="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_bbdfd87c-bbfd-4ac1-97ca-9597ff39f34f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_srt_AmericasMember_bbdfd87c-bbfd-4ac1-97ca-9597ff39f34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c4bd48e3-4f89-486f-a53f-4d629f43dec0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_srt_EuropeMember_c4bd48e3-4f89-486f-a53f-4d629f43dec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_2c53269d-6310-4dc7-80c8-237fc62789a0" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CN"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_country_CN_2c53269d-6310-4dc7-80c8-237fc62789a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AsiaPacificMiddleEastAndAfricaMember_7a70fae5-65bc-4945-a740-7f39688d1802" xlink:href="ilmn-20241229.xsd#ilmn_AsiaPacificMiddleEastAndAfricaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_ilmn_AsiaPacificMiddleEastAndAfricaMember_7a70fae5-65bc-4945-a740-7f39688d1802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9c7f9976-12f4-42ae-aaf0-106e04093d17" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_92f7c209-49dc-4efa-a128-fd1a708edc4c" xlink:to="loc_country_US_9c7f9976-12f4-42ae-aaf0-106e04093d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3808897d-447f-46ce-9cf2-02a6d117145e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a67b5a22-86d0-4af9-8ab5-3f991a78bba6" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3808897d-447f-46ce-9cf2-02a6d117145e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3f0284a6-1abd-4fca-b77f-fa5f0809e01a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3808897d-447f-46ce-9cf2-02a6d117145e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3f0284a6-1abd-4fca-b77f-fa5f0809e01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#REVENUENarrativeRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e3368761-d0e0-417f-b26a-1623a7116208" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_84ad3877-99ec-4316-970c-e4dc2a53e07d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e3368761-d0e0-417f-b26a-1623a7116208" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_84ad3877-99ec-4316-970c-e4dc2a53e07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e3368761-d0e0-417f-b26a-1623a7116208" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_475cbc35-c784-43a3-b183-32cba4e90fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_475cbc35-c784-43a3-b183-32cba4e90fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:to="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c3302acf-ed44-41be-b0ec-b09509dfccf6" xlink:to="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8a1a807-d3c9-469b-aee7-5f6f4dd5eab3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:to="loc_srt_MinimumMember_b8a1a807-d3c9-469b-aee7-5f6f4dd5eab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2b0b840c-05d3-42e1-8c74-55873438b159" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bba0a636-131e-4e34-b4f2-e8f5e5896071" xlink:to="loc_srt_MaximumMember_2b0b840c-05d3-42e1-8c74-55873438b159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_82d0f702-a745-420f-ae37-2eac19ca8704" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame_6beadd3f-df6e-4c99-89a3-7d55938e6b2d" xlink:href="ilmn-20241229.xsd#ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame_6beadd3f-df6e-4c99-89a3-7d55938e6b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_48db4ee9-454c-4d49-81f5-4b20b81bf804" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_48db4ee9-454c-4d49-81f5-4b20b81bf804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_de42d419-4906-4453-b1a6-c616e8abd800" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_de42d419-4906-4453-b1a6-c616e8abd800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d13518dc-ea00-4093-9b62-64a570e44918" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_b6ddc171-8796-4c2b-be2b-6090ce889dee" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_d13518dc-ea00-4093-9b62-64a570e44918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/REVENUENarrativeContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#REVENUENarrativeContractAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/REVENUENarrativeContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_925e8e92-5675-4793-aced-c449de17559f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_d6397c93-531f-4b27-a1f2-7f851582bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_925e8e92-5675-4793-aced-c449de17559f" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_d6397c93-531f-4b27-a1f2-7f851582bbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e5568f04-a02c-476a-b25c-86778d9e92b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_925e8e92-5675-4793-aced-c449de17559f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e5568f04-a02c-476a-b25c-86778d9e92b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f9f2c937-3658-44b1-8b59-c728923e4dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_925e8e92-5675-4793-aced-c449de17559f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f9f2c937-3658-44b1-8b59-c728923e4dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f1d91e39-0da8-4b53-81da-ae0ab062dcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_925e8e92-5675-4793-aced-c449de17559f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f1d91e39-0da8-4b53-81da-ae0ab062dcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5f3a3239-dfa7-4217-9b95-4f32ff65402e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5f3a3239-dfa7-4217-9b95-4f32ff65402e" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1cd6126c-c6bd-40fe-8a34-b2543df2a147" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1cd6126c-c6bd-40fe-8a34-b2543df2a147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7ac1bbc1-c70f-441d-9508-a605e1c032b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1cd6126c-c6bd-40fe-8a34-b2543df2a147" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7ac1bbc1-c70f-441d-9508-a605e1c032b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_284ce6e4-2876-4044-abc6-f80473b7670d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7ac1bbc1-c70f-441d-9508-a605e1c032b9" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_284ce6e4-2876-4044-abc6-f80473b7670d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_251f98f7-823b-4b64-a5ec-9ead81a7c377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_251f98f7-823b-4b64-a5ec-9ead81a7c377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fe31e226-3fbf-4805-aba1-1c3aeb892912" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_251f98f7-823b-4b64-a5ec-9ead81a7c377" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fe31e226-3fbf-4805-aba1-1c3aeb892912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_89accd75-9162-49a9-9785-3520ca862f01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fe31e226-3fbf-4805-aba1-1c3aeb892912" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_89accd75-9162-49a9-9785-3520ca862f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b03cc9fe-4674-4b71-ac3d-a2f10d220f95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b03cc9fe-4674-4b71-ac3d-a2f10d220f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d53fb27c-d085-4d6f-8389-4a33895bb1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b03cc9fe-4674-4b71-ac3d-a2f10d220f95" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d53fb27c-d085-4d6f-8389-4a33895bb1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_94c8811e-81a0-4d30-8d73-15283013e85f" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d53fb27c-d085-4d6f-8389-4a33895bb1e5" xlink:to="loc_ilmn_GRAILInc.Member_94c8811e-81a0-4d30-8d73-15283013e85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff4a8740-09b6-4378-b297-83221fd0d035" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff4a8740-09b6-4378-b297-83221fd0d035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ed79f77f-d945-4832-b210-ecfe8368ae2e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ff4a8740-09b6-4378-b297-83221fd0d035" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ed79f77f-d945-4832-b210-ecfe8368ae2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundMember_93d9311e-ff4c-4512-adf7-ce56723271c7" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ed79f77f-d945-4832-b210-ecfe8368ae2e" xlink:to="loc_ilmn_VentureCapitalInvestmentFundTheFundMember_93d9311e-ff4c-4512-adf7-ce56723271c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba03ba2d-cefa-44ba-a84d-1895bdfdb11f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba03ba2d-cefa-44ba-a84d-1895bdfdb11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2ce5cc50-13d8-4367-9950-04f4bd187533" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba03ba2d-cefa-44ba-a84d-1895bdfdb11f" xlink:to="loc_us-gaap_RelatedPartyDomain_2ce5cc50-13d8-4367-9950-04f4bd187533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember_9dd35283-6643-4395-9655-c3adc10c2633" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2ce5cc50-13d8-4367-9950-04f4bd187533" xlink:to="loc_us-gaap_InvesteeMember_9dd35283-6643-4395-9655-c3adc10c2633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_162d7916-08a9-44b6-a08f-621ef4d500a0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_dei_LegalEntityAxis_162d7916-08a9-44b6-a08f-621ef4d500a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1a722c39-1d09-4be3-b12c-571be83d50b0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_162d7916-08a9-44b6-a08f-621ef4d500a0" xlink:to="loc_dei_EntityDomain_1a722c39-1d09-4be3-b12c-571be83d50b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_HelixHoldingsILLCMember_6e023411-9435-4c91-9763-3633cec15fb4" xlink:href="ilmn-20241229.xsd#ilmn_HelixHoldingsILLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1a722c39-1d09-4be3-b12c-571be83d50b0" xlink:to="loc_ilmn_HelixHoldingsILLCMember_6e023411-9435-4c91-9763-3633cec15fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_7e2ac1a6-bdae-43d3-9e35-3263d9162ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_7e2ac1a6-bdae-43d3-9e35-3263d9162ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6aa7b0f1-713d-4028-989a-fe54e51a51c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_7e2ac1a6-bdae-43d3-9e35-3263d9162ef3" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6aa7b0f1-713d-4028-989a-fe54e51a51c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_HelixContingentConsiderationMember_fdf45e43-2657-497e-94a5-96f6f3163472" xlink:href="ilmn-20241229.xsd#ilmn_HelixContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6aa7b0f1-713d-4028-989a-fe54e51a51c5" xlink:to="loc_ilmn_HelixContingentConsiderationMember_fdf45e43-2657-497e-94a5-96f6f3163472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e085aa3-b3c0-4c3d-adaa-64236208fc80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e085aa3-b3c0-4c3d-adaa-64236208fc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3067185d-51d2-4d33-abe4-8637ede940ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e085aa3-b3c0-4c3d-adaa-64236208fc80" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3067185d-51d2-4d33-abe4-8637ede940ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_91da245a-f4d9-40c5-b712-da0e05f2ceaf" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3067185d-51d2-4d33-abe4-8637ede940ed" xlink:to="loc_ilmn_GRAILInc.Member_91da245a-f4d9-40c5-b712-da0e05f2ceaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentPaymentRightsAxis_5cd4c1b1-5dc4-4b9a-8567-e76ee2a3884d" xlink:href="ilmn-20241229.xsd#ilmn_ContingentPaymentRightsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_ilmn_ContingentPaymentRightsAxis_5cd4c1b1-5dc4-4b9a-8567-e76ee2a3884d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentPaymentRightsDomain_8f72bce1-9d5d-4b01-81c4-df4633268562" xlink:href="ilmn-20241229.xsd#ilmn_ContingentPaymentRightsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ContingentPaymentRightsAxis_5cd4c1b1-5dc4-4b9a-8567-e76ee2a3884d" xlink:to="loc_ilmn_ContingentPaymentRightsDomain_8f72bce1-9d5d-4b01-81c4-df4633268562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember_72bdcf2d-ed14-44b3-a6ed-6789d8cfdb33" xlink:href="ilmn-20241229.xsd#ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ContingentPaymentRightsDomain_8f72bce1-9d5d-4b01-81c4-df4633268562" xlink:to="loc_ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember_72bdcf2d-ed14-44b3-a6ed-6789d8cfdb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember_f4cf733d-c1c3-4ad6-ae99-34e1d2991213" xlink:href="ilmn-20241229.xsd#ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ContingentPaymentRightsDomain_8f72bce1-9d5d-4b01-81c4-df4633268562" xlink:to="loc_ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember_f4cf733d-c1c3-4ad6-ae99-34e1d2991213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cccb5479-3bc6-46c5-95c1-188dfbfa6154" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cccb5479-3bc6-46c5-95c1-188dfbfa6154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_e3fd0f2e-2808-496c-a2a5-245d82cfcaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cccb5479-3bc6-46c5-95c1-188dfbfa6154" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_e3fd0f2e-2808-496c-a2a5-245d82cfcaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MeasurementInputRevenueRiskPremiumMember_05d35ccf-ea23-42ed-ab43-6e702a2ce2db" xlink:href="ilmn-20241229.xsd#ilmn_MeasurementInputRevenueRiskPremiumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e3fd0f2e-2808-496c-a2a5-245d82cfcaf0" xlink:to="loc_ilmn_MeasurementInputRevenueRiskPremiumMember_05d35ccf-ea23-42ed-ab43-6e702a2ce2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MeasurementInputCalculationTrailingPeriodMember_9c23b411-ee1e-44f7-a294-feab871f3164" xlink:href="ilmn-20241229.xsd#ilmn_MeasurementInputCalculationTrailingPeriodMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e3fd0f2e-2808-496c-a2a5-245d82cfcaf0" xlink:to="loc_ilmn_MeasurementInputCalculationTrailingPeriodMember_9c23b411-ee1e-44f7-a294-feab871f3164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_da46c25f-3fbf-4edc-b541-fc9c16aa01e0" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_ec148ae9-2207-413c-a6a0-2a05cc3b5547" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_ShortTermInvestments_ec148ae9-2207-413c-a6a0-2a05cc3b5547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_739e8e53-adad-4278-8ab3-936dc3d9ec36" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_739e8e53-adad-4278-8ab3-936dc3d9ec36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_8b951b6c-d8b9-4cfd-91b7-26a0e2b22093" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_8b951b6c-d8b9-4cfd-91b7-26a0e2b22093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_e7831c2c-56a4-48de-8998-0eede8ad044b" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_e7831c2c-56a4-48de-8998-0eede8ad044b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_5971b46f-fff6-4fae-acb9-1e83684b6a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_5971b46f-fff6-4fae-acb9-1e83684b6a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_82e26e81-0b01-4eed-8190-c02866e1df12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_82e26e81-0b01-4eed-8190-c02866e1df12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_NumberOfInvestmentFunds_e898a8a2-03f0-421f-846f-4a101115a54b" xlink:href="ilmn-20241229.xsd#ilmn_NumberOfInvestmentFunds"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_NumberOfInvestmentFunds_e898a8a2-03f0-421f-846f-4a101115a54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_e7ada20b-ac41-4971-8d0a-386e3f6d0b49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_EquityMethodInvestments_e7ada20b-ac41-4971-8d0a-386e3f6d0b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_5fd6d83d-a046-4529-a27c-622dee660c10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_5fd6d83d-a046-4529-a27c-622dee660c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9bea9a87-68d0-4a1c-a468-7d1d22dc3691" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9bea9a87-68d0-4a1c-a468-7d1d22dc3691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsTerm_6349c83b-1881-4a90-9d0f-c51ed8327197" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_BusinessAcquisitionContingentValueRightsTerm_6349c83b-1881-4a90-9d0f-c51ed8327197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_fc50e2a0-e43c-4b2c-b5a2-902c43480e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_fc50e2a0-e43c-4b2c-b5a2-902c43480e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage_5f024b41-b8ad-4923-bcd4-c36a52089965" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage_5f024b41-b8ad-4923-bcd4-c36a52089965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold_ca2fb748-1d3b-4150-b87d-d0ee88174260" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold_ca2fb748-1d3b-4150-b87d-d0ee88174260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage_f00ec4e7-78de-45ba-b318-37353b78b0e1" xlink:href="ilmn-20241229.xsd#ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage_f00ec4e7-78de-45ba-b318-37353b78b0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability_3537bcf1-d047-41ac-8726-d359e97e02b1" xlink:href="ilmn-20241229.xsd#ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability_3537bcf1-d047-41ac-8726-d359e97e02b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_5df259fc-2c8f-4f81-a394-3b843564e749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_5df259fc-2c8f-4f81-a394-3b843564e749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_11aa34c9-0c50-44f9-94e6-89c459f3bb92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_11aa34c9-0c50-44f9-94e6-89c459f3bb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_cfcf8c14-b41d-4e85-8845-5033fa0a28f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_cfcf8c14-b41d-4e85-8845-5033fa0a28f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_8224972b-681b-4c2b-887b-cc2d95285e80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_8224972b-681b-4c2b-887b-cc2d95285e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease_c70e21bc-a231-4c8d-b34c-2b20280b3af8" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease_c70e21bc-a231-4c8d-b34c-2b20280b3af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease_a2197017-5296-4076-b39e-325892a9aa65" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease_a2197017-5296-4076-b39e-325892a9aa65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease_baffc085-61ae-4872-ae93-992e84b4936f" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease_baffc085-61ae-4872-ae93-992e84b4936f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease_25ba91b6-e64f-4583-8c46-b1e3ee4ead22" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_5fead234-7e5e-48af-a3be-969e2fd78eca" xlink:to="loc_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease_25ba91b6-e64f-4583-8c46-b1e3ee4ead22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5f15e5f6-8d9f-4038-9c02-c14dd54cee1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLossAbstract_7080f0a5-e8b7-4fe4-80ad-2114cb9114cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5f15e5f6-8d9f-4038-9c02-c14dd54cee1b" xlink:to="loc_us-gaap_MarketableSecuritiesGainLossAbstract_7080f0a5-e8b7-4fe4-80ad-2114cb9114cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_7f4f0987-772e-440b-8160-76b0b1af7376" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_7080f0a5-e8b7-4fe4-80ad-2114cb9114cb" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_7f4f0987-772e-440b-8160-76b0b1af7376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_15dcb40b-fa1a-4d51-809a-183cd5d1a42b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_7080f0a5-e8b7-4fe4-80ad-2114cb9114cb" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_15dcb40b-fa1a-4d51-809a-183cd5d1a42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_83265c4f-0d04-4c15-a4bb-8ba5158ddfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossAbstract_7080f0a5-e8b7-4fe4-80ad-2114cb9114cb" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_83265c4f-0d04-4c15-a4bb-8ba5158ddfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_670949f6-e7dd-4c1a-9cc9-6bc9a166db07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_3fd21f35-7f5c-49e6-8572-9a79f2d24608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_670949f6-e7dd-4c1a-9cc9-6bc9a166db07" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_3fd21f35-7f5c-49e6-8572-9a79f2d24608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9849a578-66e4-4c5b-8b44-e0123101f05e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3fd21f35-7f5c-49e6-8572-9a79f2d24608" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9849a578-66e4-4c5b-8b44-e0123101f05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9849a578-66e4-4c5b-8b44-e0123101f05e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundOneMember_63d486af-1174-4cae-b285-29ab812d9158" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:to="loc_ilmn_VentureCapitalInvestmentFundTheFundOneMember_63d486af-1174-4cae-b285-29ab812d9158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundTwoMember_3bd215af-bbfb-45a2-81a7-fd0b4e27ff8d" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:to="loc_ilmn_VentureCapitalInvestmentFundTheFundTwoMember_3bd215af-bbfb-45a2-81a7-fd0b4e27ff8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_VentureCapitalInvestmentFundTheFundThreeMember_d9cd143a-a940-4c8a-8da7-9e47a2efd82b" xlink:href="ilmn-20241229.xsd#ilmn_VentureCapitalInvestmentFundTheFundThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6dd42cb0-02b3-45a7-ac7c-62096f1a22fb" xlink:to="loc_ilmn_VentureCapitalInvestmentFundTheFundThreeMember_d9cd143a-a940-4c8a-8da7-9e47a2efd82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_3fd21f35-7f5c-49e6-8572-9a79f2d24608" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_6e2101e1-2d2d-4970-a7e7-7d17dc1ef507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:to="loc_us-gaap_OtherCommitment_6e2101e1-2d2d-4970-a7e7-7d17dc1ef507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RemainingCapitalCommitment_a937ddd1-9989-4000-922e-6e2ce6711d35" xlink:href="ilmn-20241229.xsd#ilmn_RemainingCapitalCommitment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:to="loc_ilmn_RemainingCapitalCommitment_a937ddd1-9989-4000-922e-6e2ce6711d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RecallableDistributionsCommitment_ab2a2e50-2599-46dc-9193-972e956b5c6b" xlink:href="ilmn-20241229.xsd#ilmn_RecallableDistributionsCommitment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_d37782bd-f4b6-43f7-a175-4a78b1eb8ec2" xlink:to="loc_ilmn_RecallableDistributionsCommitment_ab2a2e50-2599-46dc-9193-972e956b5c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b33ef642-4289-43cf-96f2-46f99bbc3e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7230e8a2-cd28-4b6b-86fa-397239b84974" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b33ef642-4289-43cf-96f2-46f99bbc3e1d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7230e8a2-cd28-4b6b-86fa-397239b84974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ef99543d-65f0-470f-b8c8-1362cd752676" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7230e8a2-cd28-4b6b-86fa-397239b84974" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ef99543d-65f0-470f-b8c8-1362cd752676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e8a76d4-17a2-4859-94b9-40b6bd4823a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ef99543d-65f0-470f-b8c8-1362cd752676" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e8a76d4-17a2-4859-94b9-40b6bd4823a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_227fb4f2-1722-479c-ad71-3083f350eaac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e8a76d4-17a2-4859-94b9-40b6bd4823a5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_227fb4f2-1722-479c-ad71-3083f350eaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2c14a7c-217b-4de3-8a58-f1f6aadf61d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7230e8a2-cd28-4b6b-86fa-397239b84974" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2c14a7c-217b-4de3-8a58-f1f6aadf61d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2c14a7c-217b-4de3-8a58-f1f6aadf61d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4bb1c046-f4bb-4b49-bef1-149bc7496aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4bb1c046-f4bb-4b49-bef1-149bc7496aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_dee565ac-594e-4338-8cc7-159f8227ec30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_dee565ac-594e-4338-8cc7-159f8227ec30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_607fc505-5aeb-4c98-a700-5dd2e1e425d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bbc78e9-6a5b-4c1e-bdeb-1ca0afd8d95f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_607fc505-5aeb-4c98-a700-5dd2e1e425d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acee7562-71ee-4ecd-b50e-639c29d6e869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7230e8a2-cd28-4b6b-86fa-397239b84974" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acee7562-71ee-4ecd-b50e-639c29d6e869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acee7562-71ee-4ecd-b50e-639c29d6e869" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d887241f-d407-455a-aa29-d65895c0037d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d887241f-d407-455a-aa29-d65895c0037d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_f275162b-a600-41fc-8080-d09c0ffa3de2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_f275162b-a600-41fc-8080-d09c0ffa3de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OtherInvestmentsFairValueDisclosure_393a349d-3c72-4996-ac94-2116f27e25ca" xlink:href="ilmn-20241229.xsd#ilmn_OtherInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_ilmn_OtherInvestmentsFairValueDisclosure_393a349d-3c72-4996-ac94-2116f27e25ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ContingentValueRightFairValueDisclosure_30da0a04-097d-4709-ba71-779ba08ce18f" xlink:href="ilmn-20241229.xsd#ilmn_ContingentValueRightFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_ilmn_ContingentValueRightFairValueDisclosure_30da0a04-097d-4709-ba71-779ba08ce18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_51dbc92e-1ad2-4350-a3b2-f7e85bf8bfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_51dbc92e-1ad2-4350-a3b2-f7e85bf8bfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_88c12588-9918-4a5a-b699-935ad176c887" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_7ff95fdb-f673-4780-a39c-ed4ae0e6d01d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_88c12588-9918-4a5a-b699-935ad176c887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_acee7562-71ee-4ecd-b50e-639c29d6e869" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_da48d199-4f2a-4959-9682-f3d6741b872c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_da48d199-4f2a-4959-9682-f3d6741b872c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_0e7436bb-8431-4336-a352-e237bdbfa26a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_0e7436bb-8431-4336-a352-e237bdbfa26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_3b19f4af-d4a0-4af8-810b-00ec71a010f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b911459d-7052-47fb-b043-aa460449b596" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_3b19f4af-d4a0-4af8-810b-00ec71a010f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_04638580-c4be-4e71-bf39-6af01d5a72f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_31c95d27-c56f-4f19-917c-24e366949622" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04638580-c4be-4e71-bf39-6af01d5a72f5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_31c95d27-c56f-4f19-917c-24e366949622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_8f03b74e-64d7-4a2c-b3af-08cd745b3a71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_31c95d27-c56f-4f19-917c-24e366949622" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_8f03b74e-64d7-4a2c-b3af-08cd745b3a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0513fdbf-9ced-49c7-a917-9f1edd70fde6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_8f03b74e-64d7-4a2c-b3af-08cd745b3a71" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0513fdbf-9ced-49c7-a917-9f1edd70fde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_HelixContingentConsiderationMember_38c219cd-1712-4fd1-8def-001aa3ef8a39" xlink:href="ilmn-20241229.xsd#ilmn_HelixContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0513fdbf-9ced-49c7-a917-9f1edd70fde6" xlink:to="loc_ilmn_HelixContingentConsiderationMember_38c219cd-1712-4fd1-8def-001aa3ef8a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c56c6dfe-4155-4124-b21d-7b3698be29ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_31c95d27-c56f-4f19-917c-24e366949622" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c56c6dfe-4155-4124-b21d-7b3698be29ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c56c6dfe-4155-4124-b21d-7b3698be29ee" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4495b560-28c4-4c5f-8dd8-201ca51b375a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_4495b560-28c4-4c5f-8dd8-201ca51b375a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_d2817697-9393-4a25-89d9-65f384395685" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_d2817697-9393-4a25-89d9-65f384395685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_55c1a57e-cb42-4e11-82a0-10ad07d2bcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_55c1a57e-cb42-4e11-82a0-10ad07d2bcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_7b5f9125-a6b2-4a4b-a6d8-68f795eb3cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d835567e-5615-4d29-8781-bcd7702a61a4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_7b5f9125-a6b2-4a4b-a6d8-68f795eb3cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cc6424cb-ca5c-40d0-90b5-a75d6e166b42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b2a34e2f-2472-4218-9826-14c9975bfa56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cc6424cb-ca5c-40d0-90b5-a75d6e166b42" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b2a34e2f-2472-4218-9826-14c9975bfa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_c5255db8-58ae-4c62-b8df-261120732f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b2a34e2f-2472-4218-9826-14c9975bfa56" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_c5255db8-58ae-4c62-b8df-261120732f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b45c4229-3b3f-480c-a59c-4bd6776ad905" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c5255db8-58ae-4c62-b8df-261120732f8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b45c4229-3b3f-480c-a59c-4bd6776ad905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_BusinessCombinationContingentConsiderationLiabilityMember_8a699b4c-e816-4993-b047-701b388acfaf" xlink:href="ilmn-20241229.xsd#ilmn_BusinessCombinationContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b45c4229-3b3f-480c-a59c-4bd6776ad905" xlink:to="loc_ilmn_BusinessCombinationContingentConsiderationLiabilityMember_8a699b4c-e816-4993-b047-701b388acfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_45813c58-3b7f-49f3-a887-7db5e7f84bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b2a34e2f-2472-4218-9826-14c9975bfa56" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_45813c58-3b7f-49f3-a887-7db5e7f84bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1a314607-f3f2-475a-b210-85e5f3711ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_45813c58-3b7f-49f3-a887-7db5e7f84bf6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1a314607-f3f2-475a-b210-85e5f3711ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_57bd9cb3-d382-4d27-b7e8-023690b4b452" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1a314607-f3f2-475a-b210-85e5f3711ec4" xlink:to="loc_ilmn_GRAILInc.Member_57bd9cb3-d382-4d27-b7e8-023690b4b452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_34e4d9da-f96a-4aeb-8cf2-f08780e3b638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b2a34e2f-2472-4218-9826-14c9975bfa56" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_34e4d9da-f96a-4aeb-8cf2-f08780e3b638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_34e4d9da-f96a-4aeb-8cf2-f08780e3b638" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_238f5788-074a-4471-bf9c-66f80519ca60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_238f5788-074a-4471-bf9c-66f80519ca60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78995685-8159-4cf9-bc99-d25f807ce4de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_78995685-8159-4cf9-bc99-d25f807ce4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7dcd3b8a-636b-4f78-ac64-d0d4e9a092da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7dcd3b8a-636b-4f78-ac64-d0d4e9a092da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d06a1d4e-bc22-4543-a07f-ae8ade5e8bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d06a1d4e-bc22-4543-a07f-ae8ade5e8bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_00bf88bf-ee56-4a20-ada5-de1b475d661d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2e0cf2fa-4758-45c0-b0ca-86c0b0f8eff8" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_00bf88bf-ee56-4a20-ada5-de1b475d661d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f684a13-fd82-4ac6-9722-e730c6ed9fda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f5827f5e-3f74-42cc-8fd9-228bbce2ae8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f684a13-fd82-4ac6-9722-e730c6ed9fda" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f5827f5e-3f74-42cc-8fd9-228bbce2ae8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5ec731ab-7c8e-48d0-897a-6dec26e03f85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f5827f5e-3f74-42cc-8fd9-228bbce2ae8d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5ec731ab-7c8e-48d0-897a-6dec26e03f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_20dc2b26-5438-4f20-88da-8e6d749e7626" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5ec731ab-7c8e-48d0-897a-6dec26e03f85" xlink:to="loc_us-gaap_SegmentDomain_20dc2b26-5438-4f20-88da-8e6d749e7626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILIncMember_1b6f5535-3aeb-4aa6-a151-2d332413ed6b" xlink:href="ilmn-20241229.xsd#ilmn_GRAILIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_20dc2b26-5438-4f20-88da-8e6d749e7626" xlink:to="loc_ilmn_GRAILIncMember_1b6f5535-3aeb-4aa6-a151-2d332413ed6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5af12e6c-7f0d-4f37-a01e-ecfb48724b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f5827f5e-3f74-42cc-8fd9-228bbce2ae8d" xlink:to="loc_us-gaap_GoodwillLineItems_5af12e6c-7f0d-4f37-a01e-ecfb48724b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5af12e6c-7f0d-4f37-a01e-ecfb48724b7f" xlink:to="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_80948c36-0442-47dc-a453-f2b4028d1bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:to="loc_us-gaap_Goodwill_80948c36-0442-47dc-a453-f2b4028d1bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0d328674-bd52-4c12-b21b-588269b73481" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0d328674-bd52-4c12-b21b-588269b73481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6c99bd14-d295-42ea-9275-05b1a99b27f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6c99bd14-d295-42ea-9275-05b1a99b27f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97a46589-aa24-402a-b6de-29cb8131d8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:to="loc_us-gaap_Goodwill_97a46589-aa24-402a-b6de-29cb8131d8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_988a0117-e2bd-45ee-91c0-00a74d9068f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2d0b042a-b7c0-4e30-b3dc-cf550a70ec1b" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_988a0117-e2bd-45ee-91c0-00a74d9068f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_215a31f6-6f71-436f-b9c6-65f5698ab710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_215a31f6-6f71-436f-b9c6-65f5698ab710" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f4878350-7c3d-45f4-baf3-e035c34fadf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f4878350-7c3d-45f4-baf3-e035c34fadf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_766bfa45-0691-47bd-afb1-881766b5bcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f4878350-7c3d-45f4-baf3-e035c34fadf3" xlink:to="loc_us-gaap_SegmentDomain_766bfa45-0691-47bd-afb1-881766b5bcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_2f6249e3-7aa1-4f1f-90df-fca781de6a2c" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_766bfa45-0691-47bd-afb1-881766b5bcf7" xlink:to="loc_ilmn_GRAILInc.Member_2f6249e3-7aa1-4f1f-90df-fca781de6a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0742dee7-e1c4-426d-89cf-18c4c5daadaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0742dee7-e1c4-426d-89cf-18c4c5daadaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0742dee7-e1c4-426d-89cf-18c4c5daadaa" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MeasurementInputCashFlowPeriodMemberMember_01231637-8e6f-4f0e-b564-fd8051e00278" xlink:href="ilmn-20241229.xsd#ilmn_MeasurementInputCashFlowPeriodMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:to="loc_ilmn_MeasurementInputCashFlowPeriodMemberMember_01231637-8e6f-4f0e-b564-fd8051e00278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b4b03293-a72f-4fbe-87ee-9dbf110ec694" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b4b03293-a72f-4fbe-87ee-9dbf110ec694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1cb778a9-90a9-480d-9bf5-c2199b5a1c21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ab5fbd8c-131b-4f47-9771-dcaf28bab7ac" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1cb778a9-90a9-480d-9bf5-c2199b5a1c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_eb8482f9-107a-4093-8f28-adaf72bdd3de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_ValuationTechniqueAxis_eb8482f9-107a-4093-8f28-adaf72bdd3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_618ea2eb-c4d1-4514-af38-153461ddb0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_eb8482f9-107a-4093-8f28-adaf72bdd3de" xlink:to="loc_us-gaap_ValuationTechniqueDomain_618ea2eb-c4d1-4514-af38-153461ddb0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_2ee4bd07-2573-49ca-916e-baf3c16a0950" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_618ea2eb-c4d1-4514-af38-153461ddb0c1" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_2ee4bd07-2573-49ca-916e-baf3c16a0950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_58e0a979-104c-45b0-ac7d-9b40c5083489" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_srt_RangeAxis_58e0a979-104c-45b0-ac7d-9b40c5083489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c79c3953-695b-4b97-afc5-3670c1bd136b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_58e0a979-104c-45b0-ac7d-9b40c5083489" xlink:to="loc_srt_RangeMember_c79c3953-695b-4b97-afc5-3670c1bd136b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a68a4c6a-976b-4d09-ab58-e55c8f2f921f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c79c3953-695b-4b97-afc5-3670c1bd136b" xlink:to="loc_srt_MinimumMember_a68a4c6a-976b-4d09-ab58-e55c8f2f921f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e14325d3-a22d-455a-ab0c-18a8c22388d5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c79c3953-695b-4b97-afc5-3670c1bd136b" xlink:to="loc_srt_MaximumMember_e14325d3-a22d-455a-ab0c-18a8c22388d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_749c3726-b3d5-466d-9901-4399ec2afb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_749c3726-b3d5-466d-9901-4399ec2afb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9ec106f8-0f02-47ad-962e-e39b8dde0f57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_749c3726-b3d5-466d-9901-4399ec2afb3c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9ec106f8-0f02-47ad-962e-e39b8dde0f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_a692d7a3-f141-42f0-bcdb-1ee04d4aad69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9ec106f8-0f02-47ad-962e-e39b8dde0f57" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_a692d7a3-f141-42f0-bcdb-1ee04d4aad69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_85e966bf-c3a1-4a99-80ef-d87ca01df1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_85e966bf-c3a1-4a99-80ef-d87ca01df1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9eddc4cf-3886-4122-95b7-9492e7c9710c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_85e966bf-c3a1-4a99-80ef-d87ca01df1d7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9eddc4cf-3886-4122-95b7-9492e7c9710c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILIncMember_2778a47d-7e1f-4bf3-8cb1-d3d1278fc9ac" xlink:href="ilmn-20241229.xsd#ilmn_GRAILIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9eddc4cf-3886-4122-95b7-9492e7c9710c" xlink:to="loc_ilmn_GRAILIncMember_2778a47d-7e1f-4bf3-8cb1-d3d1278fc9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_33719427-1ebb-47db-bf98-bbb0cce10b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_33719427-1ebb-47db-bf98-bbb0cce10b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_37a615c4-75c4-4739-8bcd-78e702f88ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_33719427-1ebb-47db-bf98-bbb0cce10b3d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_37a615c4-75c4-4739-8bcd-78e702f88ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_aa42516e-80fe-42ff-a68d-a2e787af5651" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_37a615c4-75c4-4739-8bcd-78e702f88ba7" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_aa42516e-80fe-42ff-a68d-a2e787af5651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3284f4c6-d808-47e4-a75e-25911bc00bea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3284f4c6-d808-47e4-a75e-25911bc00bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a58f0e7-0383-4cfa-ac92-dee3c942b1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3284f4c6-d808-47e4-a75e-25911bc00bea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a58f0e7-0383-4cfa-ac92-dee3c942b1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILIncMember_87735db7-4e8b-41e9-9893-eb7c3a405d4c" xlink:href="ilmn-20241229.xsd#ilmn_GRAILIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a58f0e7-0383-4cfa-ac92-dee3c942b1d9" xlink:to="loc_ilmn_GRAILIncMember_87735db7-4e8b-41e9-9893-eb7c3a405d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_3f3af474-c998-446d-a0e4-6bb2b79d5ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a58f0e7-0383-4cfa-ac92-dee3c942b1d9" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_3f3af474-c998-446d-a0e4-6bb2b79d5ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8ac27266-c6c7-4ab3-9264-4d9fe8d76277" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8ac27266-c6c7-4ab3-9264-4d9fe8d76277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1a2eba74-aad4-4b2d-8518-723d3f8cdea3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8ac27266-c6c7-4ab3-9264-4d9fe8d76277" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1a2eba74-aad4-4b2d-8518-723d3f8cdea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_8fcb3ab2-ea9d-485c-8533-f20b302687cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1a2eba74-aad4-4b2d-8518-723d3f8cdea3" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_8fcb3ab2-ea9d-485c-8533-f20b302687cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a0d3d66f-48df-4d94-9136-c26d13cd1e17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1a2eba74-aad4-4b2d-8518-723d3f8cdea3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a0d3d66f-48df-4d94-9136-c26d13cd1e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_81449882-1595-4dd5-92f0-1bc60d3f9757" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_AssetAcquisitionAxis_81449882-1595-4dd5-92f0-1bc60d3f9757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_cd7fb9e1-b683-4f7c-98e0-098abb1f607c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_81449882-1595-4dd5-92f0-1bc60d3f9757" xlink:to="loc_us-gaap_AssetAcquisitionDomain_cd7fb9e1-b683-4f7c-98e0-098abb1f607c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FluentBioSciencesMember_a3262da5-ab0a-4e90-9c53-d2a7e23c691f" xlink:href="ilmn-20241229.xsd#ilmn_FluentBioSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_cd7fb9e1-b683-4f7c-98e0-098abb1f607c" xlink:to="loc_ilmn_FluentBioSciencesMember_a3262da5-ab0a-4e90-9c53-d2a7e23c691f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a48a32f0-7a0f-4afe-8bed-b4cdc79c7e1b" xlink:to="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_f70c3420-68da-441b-a516-f64cb5f312e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_NumberOfReportingUnits_f70c3420-68da-441b-a516-f64cb5f312e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillAmountThatExceedsCarryingValue_4bd40a2c-2ff7-4c0b-be9f-cf5d81f1c1b0" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillAmountThatExceedsCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillAmountThatExceedsCarryingValue_4bd40a2c-2ff7-4c0b-be9f-cf5d81f1c1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ab9c97c0-f8ed-4684-90ee-c68adb60004f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ab9c97c0-f8ed-4684-90ee-c68adb60004f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentMeasurementInput_b152d40c-abfe-4007-a919-6223e665f954" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentMeasurementInput"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillImpairmentMeasurementInput_b152d40c-abfe-4007-a919-6223e665f954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d27080a4-be27-45dd-9210-82c366c17468" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_Goodwill_d27080a4-be27-45dd-9210-82c366c17468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_647a181e-dfac-46f3-a9e3-a8da75018620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal_647a181e-dfac-46f3-a9e3-a8da75018620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_dc7313df-e16e-4224-a6d3-a2e6adc61612" xlink:href="ilmn-20241229.xsd#ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets_dc7313df-e16e-4224-a6d3-a2e6adc61612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_21a95668-a6fc-476d-805f-a1b256a408da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_21a95668-a6fc-476d-805f-a1b256a408da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IntangibleAssetsImpairmentMeasurementInput_c0ff53fb-b8fb-49d0-a711-bee4c08b8a5e" xlink:href="ilmn-20241229.xsd#ilmn_IntangibleAssetsImpairmentMeasurementInput"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_IntangibleAssetsImpairmentMeasurementInput_c0ff53fb-b8fb-49d0-a711-bee4c08b8a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints_ea5870e5-4f67-4cf5-95c4-24c973568d7f" xlink:href="ilmn-20241229.xsd#ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints_ea5870e5-4f67-4cf5-95c4-24c973568d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate_604ef5e5-550f-4df9-9a9c-593724230435" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate_604ef5e5-550f-4df9-9a9c-593724230435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate_b63ddbbf-f17e-411e-a4b3-92dd327f09ef" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate_b63ddbbf-f17e-411e-a4b3-92dd327f09ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillPotentialImpairmentLoss_2b8e3cda-e037-4f59-a6df-c6eca69d4a7c" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillPotentialImpairmentLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillPotentialImpairmentLoss_2b8e3cda-e037-4f59-a6df-c6eca69d4a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_df8ff233-8b8f-4c04-b41f-f816a4adadb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount_df8ff233-8b8f-4c04-b41f-f816a4adadb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GoodwillImpairmentTestDiscountRate_30646b0c-d602-425d-98bf-39982a358983" xlink:href="ilmn-20241229.xsd#ilmn_GoodwillImpairmentTestDiscountRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_ilmn_GoodwillImpairmentTestDiscountRate_30646b0c-d602-425d-98bf-39982a358983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e13c17ba-81b4-45d3-9ab9-5e66964925ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e13c17ba-81b4-45d3-9ab9-5e66964925ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_fa403914-09ae-47a9-805c-8aa52beab083" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_fa403914-09ae-47a9-805c-8aa52beab083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_e4ce292f-dd6a-443a-95e5-094550804e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f9e39ec1-c71c-4522-9e15-a5598137a062" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_e4ce292f-dd6a-443a-95e5-094550804e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5d1e58af-8606-4613-9b49-53616be8cf64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c4754f59-e50c-4797-b39c-e37dc0b64286" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5d1e58af-8606-4613-9b49-53616be8cf64" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c4754f59-e50c-4797-b39c-e37dc0b64286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e76cefcd-bd40-4a47-bb9d-0d17c703abea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c4754f59-e50c-4797-b39c-e37dc0b64286" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e76cefcd-bd40-4a47-bb9d-0d17c703abea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fedffdba-03c3-4cdd-a46e-be2b0080a0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e76cefcd-bd40-4a47-bb9d-0d17c703abea" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fedffdba-03c3-4cdd-a46e-be2b0080a0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_cc17adac-5f87-4537-bcd5-1eb8a115c612" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fedffdba-03c3-4cdd-a46e-be2b0080a0ae" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_cc17adac-5f87-4537-bcd5-1eb8a115c612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e29810fb-7951-48ae-a935-51b76ff54bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c4754f59-e50c-4797-b39c-e37dc0b64286" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e29810fb-7951-48ae-a935-51b76ff54bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e29810fb-7951-48ae-a935-51b76ff54bf2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_20c74662-2211-4f90-a220-49d552af549e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_20c74662-2211-4f90-a220-49d552af549e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LicensedTechnologyMember_2c473e5a-48da-48c6-a90d-304c2cb88e7a" xlink:href="ilmn-20241229.xsd#ilmn_LicensedTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_ilmn_LicensedTechnologyMember_2c473e5a-48da-48c6-a90d-304c2cb88e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_1405fad7-bcd6-4db2-9d5d-887c1a76f9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_LicensingAgreementsMember_1405fad7-bcd6-4db2-9d5d-887c1a76f9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ff2873ea-7927-4765-ab9c-040aec15de56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ff2873ea-7927-4765-ab9c-040aec15de56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_b9410fc9-ccea-4198-ad6e-8535d53d7549" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_DatabasesMember_b9410fc9-ccea-4198-ad6e-8535d53d7549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_600be75d-70ea-4e42-8e2c-164c79e5b8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c82e26ec-abbc-44fb-802b-49a8a0833efb" xlink:to="loc_us-gaap_TradeNamesMember_600be75d-70ea-4e42-8e2c-164c79e5b8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c4754f59-e50c-4797-b39c-e37dc0b64286" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_70c62d41-52a9-4b39-a07e-a6ac8ff0f124" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_70c62d41-52a9-4b39-a07e-a6ac8ff0f124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0e7ed39e-4277-4e0e-adfc-be2b06958f87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0e7ed39e-4277-4e0e-adfc-be2b06958f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment_b2346c35-bfdf-49ba-9c24-91c02f2cd249" xlink:href="ilmn-20241229.xsd#ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment_b2346c35-bfdf-49ba-9c24-91c02f2cd249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8f0a8c3-9b75-4ed9-85a4-29da511cf0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8f0a8c3-9b75-4ed9-85a4-29da511cf0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross_1dee4aed-880f-42bf-b2b2-89c00c2f83b7" xlink:href="ilmn-20241229.xsd#ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross_1dee4aed-880f-42bf-b2b2-89c00c2f83b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_417ddfb4-18f8-48dc-9c4d-573e63c75560" xlink:href="ilmn-20241229.xsd#ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_417ddfb4-18f8-48dc-9c4d-573e63c75560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4cd6c56c-767d-4afe-84fb-e7e700130834" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4cd6c56c-767d-4afe-84fb-e7e700130834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bb594d46-662b-40e9-b2b0-ed8f007737f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bb594d46-662b-40e9-b2b0-ed8f007737f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_739130c4-70f4-4f7c-ac7f-2bcc39a2a289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_739130c4-70f4-4f7c-ac7f-2bcc39a2a289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_1c2a9961-e3c3-45b6-9097-09e4d1ba7d3d" xlink:href="ilmn-20241229.xsd#ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:to="loc_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment_1c2a9961-e3c3-45b6-9097-09e4d1ba7d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0c52e780-f9f6-445a-8f63-5d82520ab13c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_19735695-2efa-4ce3-9e98-779ace41d227" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0c52e780-f9f6-445a-8f63-5d82520ab13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_a30b2dc7-d123-466d-9430-4ee8d550a320" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ba5882dc-e704-4c1c-a225-bf6d1e7e3bfa" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_a30b2dc7-d123-466d-9430-4ee8d550a320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b3bae1d2-5128-46f5-a855-0d611d3cc91c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7e6f0806-2197-46e6-9657-a3a41470e5da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b3bae1d2-5128-46f5-a855-0d611d3cc91c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7e6f0806-2197-46e6-9657-a3a41470e5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_37d8390a-1525-47b6-b799-dfe80e5896e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7e6f0806-2197-46e6-9657-a3a41470e5da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_37d8390a-1525-47b6-b799-dfe80e5896e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_98425fe0-2427-4d4a-8aed-de68b82bf609" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7e6f0806-2197-46e6-9657-a3a41470e5da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_98425fe0-2427-4d4a-8aed-de68b82bf609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_398a613f-2b44-4d58-94c9-a8a8e35b3070" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7e6f0806-2197-46e6-9657-a3a41470e5da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_398a613f-2b44-4d58-94c9-a8a8e35b3070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_95756b1b-276d-4bef-9334-e9e69a5c5107" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7e6f0806-2197-46e6-9657-a3a41470e5da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_95756b1b-276d-4bef-9334-e9e69a5c5107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_f710d511-d327-4b00-be18-09018b9c89ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7e6f0806-2197-46e6-9657-a3a41470e5da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_f710d511-d327-4b00-be18-09018b9c89ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive_60c89383-cfde-41cf-8a11-c447212dc3ed" xlink:href="ilmn-20241229.xsd#ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7e6f0806-2197-46e6-9657-a3a41470e5da" xlink:to="loc_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive_60c89383-cfde-41cf-8a11-c447212dc3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f1a3d263-968c-4b8e-95c9-0c6c6294120f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_7e6f0806-2197-46e6-9657-a3a41470e5da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f1a3d263-968c-4b8e-95c9-0c6c6294120f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f0973d0c-3bbd-4a74-8268-d30f8e187fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f0973d0c-3bbd-4a74-8268-d30f8e187fd6" xlink:to="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fd8310d8-90d9-4f8d-b8c0-6ea19fd594f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fd8310d8-90d9-4f8d-b8c0-6ea19fd594f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_63c465a8-3484-449d-81b4-39cdbbbef1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fd8310d8-90d9-4f8d-b8c0-6ea19fd594f8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_63c465a8-3484-449d-81b4-39cdbbbef1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesMember_e939f110-656f-4d75-ad21-4b03464ee340" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_63c465a8-3484-449d-81b4-39cdbbbef1b0" xlink:to="loc_ilmn_TermNotesMember_e939f110-656f-4d75-ad21-4b03464ee340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b4354f8d-e5d1-483a-b869-5b21a92f6686" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:to="loc_us-gaap_DebtInstrumentAxis_b4354f8d-e5d1-483a-b869-5b21a92f6686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b4354f8d-e5d1-483a-b869-5b21a92f6686" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2025Member_8ea475c6-c899-4a3f-85df-30205450eda7" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:to="loc_ilmn_TermNotesDue2025Member_8ea475c6-c899-4a3f-85df-30205450eda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2026Member_77af24b3-ddd2-4f0a-a7fc-e6dd1d27ea25" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:to="loc_ilmn_TermNotesDue2026Member_77af24b3-ddd2-4f0a-a7fc-e6dd1d27ea25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2027Member_65055c5f-8fa4-45a5-a173-f804ba8c7734" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:to="loc_ilmn_TermNotesDue2027Member_65055c5f-8fa4-45a5-a173-f804ba8c7734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2031Member_8a5dacf8-36e0-4275-9052-98280970275c" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2031Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_871af0c5-4fc9-4b16-808e-b690a3b41f7e" xlink:to="loc_ilmn_TermNotesDue2031Member_8a5dacf8-36e0-4275-9052-98280970275c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11336454-ba94-43af-af25-422b360b018c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11336454-ba94-43af-af25-422b360b018c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7f81c8e7-7874-4ce3-806e-343324f1a8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_11336454-ba94-43af-af25-422b360b018c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7f81c8e7-7874-4ce3-806e-343324f1a8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b1ec14a7-a153-4e78-8da3-325a50bbf468" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7f81c8e7-7874-4ce3-806e-343324f1a8b9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b1ec14a7-a153-4e78-8da3-325a50bbf468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4f528dbf-55a9-4c80-b905-1ee685fc4e1e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_260d6ec8-016d-4a7b-8288-9ae13bbadbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_260d6ec8-016d-4a7b-8288-9ae13bbadbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9d95f27c-0a01-45a8-bd71-194fc91b7008" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9d95f27c-0a01-45a8-bd71-194fc91b7008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fa401ea6-7750-4d4d-aff7-46c15ad398d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_LongTermDebt_fa401ea6-7750-4d4d-aff7-46c15ad398d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_606fb720-9d62-4cc2-b6d0-839e62e02d75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_LongTermDebtCurrent_606fb720-9d62-4cc2-b6d0-839e62e02d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ed2c7a9b-8833-427d-a016-bd8921c77915" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ed2c7a9b-8833-427d-a016-bd8921c77915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_95640705-7137-4818-a57d-eb0aa4197baf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9ba5af7-782d-47a2-85f4-26733f535ad8" xlink:to="loc_us-gaap_DebtInstrumentFairValue_95640705-7137-4818-a57d-eb0aa4197baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_179a16d0-f96e-4a21-b18d-9f94792dffbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_179a16d0-f96e-4a21-b18d-9f94792dffbf" xlink:to="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a26e8c8e-df57-440b-a4f3-7376488b7db5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a26e8c8e-df57-440b-a4f3-7376488b7db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a26e8c8e-df57-440b-a4f3-7376488b7db5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesMember_a227f123-8866-43f5-bc5c-8234c04e80d7" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:to="loc_ilmn_TermNotesMember_a227f123-8866-43f5-bc5c-8234c04e80d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_44bc92a4-ffa0-46c4-939a-d6ed90dd1cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:to="loc_us-gaap_ConvertibleDebtMember_44bc92a4-ffa0-46c4-939a-d6ed90dd1cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_66536a09-4b82-4fa3-8ae4-a1c237c9f124" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:to="loc_us-gaap_LineOfCreditMember_66536a09-4b82-4fa3-8ae4-a1c237c9f124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_8ead484b-07a6-4aef-9fe2-943f9cdee94c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc977c83-c1d3-4188-91fa-c43a75fd582d" xlink:to="loc_us-gaap_UnsecuredDebtMember_8ead484b-07a6-4aef-9fe2-943f9cdee94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_46298b61-115a-4907-923f-450281be7156" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_us-gaap_DebtInstrumentAxis_46298b61-115a-4907-923f-450281be7156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_46298b61-115a-4907-923f-450281be7156" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2026Member_0c6e2287-6642-40cd-8aad-88e2fefe8bf4" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2026Member_0c6e2287-6642-40cd-8aad-88e2fefe8bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2025Member_5c93a2a5-d8af-4a6c-b4fd-7f87ccd40063" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2025Member_5c93a2a5-d8af-4a6c-b4fd-7f87ccd40063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2027Member_330dc20c-4f85-49a6-9073-a7b004e86253" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2027Member_330dc20c-4f85-49a6-9073-a7b004e86253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2023Member_a1061da1-e45a-4936-94e1-edca1617c42c" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2023Member_a1061da1-e45a-4936-94e1-edca1617c42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TermNotesDue2031Member_c0f6e38a-a2f7-4de6-87cd-a7615940bd65" xlink:href="ilmn-20241229.xsd#ilmn_TermNotesDue2031Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TermNotesDue2031Member_c0f6e38a-a2f7-4de6-87cd-a7615940bd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DelayedDrawCreditFacilityDue2025Member_9da02170-fb71-45a0-a2f1-d8b33a6a018a" xlink:href="ilmn-20241229.xsd#ilmn_DelayedDrawCreditFacilityDue2025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_DelayedDrawCreditFacilityDue2025Member_9da02170-fb71-45a0-a2f1-d8b33a6a018a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ConvertibleSeniorNotesDue2023Member_1f0ae683-a475-4314-b182-565f03769abb" xlink:href="ilmn-20241229.xsd#ilmn_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_ConvertibleSeniorNotesDue2023Member_1f0ae683-a475-4314-b182-565f03769abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RevolvingCreditAgreementMember_f9896849-d492-43ae-ae5f-1aa60bdb6a2a" xlink:href="ilmn-20241229.xsd#ilmn_RevolvingCreditAgreementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_RevolvingCreditAgreementMember_f9896849-d492-43ae-ae5f-1aa60bdb6a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_TheCreditAgreementMember_18e429a9-ae6f-493a-8d47-8070376c3468" xlink:href="ilmn-20241229.xsd#ilmn_TheCreditAgreementMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9d49d73-313e-43ca-9ae2-3707ec3b7053" xlink:to="loc_ilmn_TheCreditAgreementMember_18e429a9-ae6f-493a-8d47-8070376c3468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e5b621cf-a15e-4bde-a535-e8c0d55db933" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e5b621cf-a15e-4bde-a535-e8c0d55db933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_551ad062-b741-4ec0-b743-6cc425f324a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e5b621cf-a15e-4bde-a535-e8c0d55db933" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_551ad062-b741-4ec0-b743-6cc425f324a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9bd0227a-ace9-4b0f-8b84-c4be4647c614" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_551ad062-b741-4ec0-b743-6cc425f324a7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9bd0227a-ace9-4b0f-8b84-c4be4647c614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_93e0162c-d67d-4fc6-b4c2-0414e6896294" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_93e0162c-d67d-4fc6-b4c2-0414e6896294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5b5a4c0a-52ac-4b94-80f4-061ed405ad6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_93e0162c-d67d-4fc6-b4c2-0414e6896294" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5b5a4c0a-52ac-4b94-80f4-061ed405ad6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_ca2c02f7-9e4f-4771-82e2-6e9831ab0437" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_5b5a4c0a-52ac-4b94-80f4-061ed405ad6a" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_ca2c02f7-9e4f-4771-82e2-6e9831ab0437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c9c6a6a2-cda2-4014-8d5c-3d3c723e67c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_us-gaap_CreditFacilityAxis_c9c6a6a2-cda2-4014-8d5c-3d3c723e67c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c9c6a6a2-cda2-4014-8d5c-3d3c723e67c5" xlink:to="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7f91f2eb-2813-40af-b7b7-a2d6bd75f6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7f91f2eb-2813-40af-b7b7-a2d6bd75f6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SwinglineBorrowingsMember_748530a8-fd7f-455e-8934-7c9b237b57b1" xlink:href="ilmn-20241229.xsd#ilmn_SwinglineBorrowingsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:to="loc_ilmn_SwinglineBorrowingsMember_748530a8-fd7f-455e-8934-7c9b237b57b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_f129face-859b-4275-9752-57ef325f5753" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2dc41f21-3ed2-4782-a9c6-b56ba4faa414" xlink:to="loc_us-gaap_LetterOfCreditMember_f129face-859b-4275-9752-57ef325f5753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_15415674-b744-4d52-b1aa-708b524e3374" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_83a331cb-b0cc-4553-8dc7-6135258c449e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_InterestExpenseDebt_83a331cb-b0cc-4553-8dc7-6135258c449e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5b2f8770-59f9-4508-b5bc-46bdfb1663f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5b2f8770-59f9-4508-b5bc-46bdfb1663f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8cfa24e1-7834-41c5-9c51-c77091463e10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8cfa24e1-7834-41c5-9c51-c77091463e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_bad35ccf-bc09-4a83-82e7-40b564166005" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_bad35ccf-bc09-4a83-82e7-40b564166005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_247e726c-774a-4544-8c87-281a5cbbcc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_247e726c-774a-4544-8c87-281a5cbbcc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e5d12463-3636-4100-a3b6-ee0630f7b75a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentTerm_e5d12463-3636-4100-a3b6-ee0630f7b75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8d4c126b-6eb2-4bd6-b521-d215b6d1828c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8d4c126b-6eb2-4bd6-b521-d215b6d1828c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9ae6f45f-d428-4f68-9c39-1d28f21528c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9ae6f45f-d428-4f68-9c39-1d28f21528c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_293ed6bc-494b-459e-b258-8bd2bf534239" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_293ed6bc-494b-459e-b258-8bd2bf534239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_d512e62b-bacf-45dc-9aae-795199fd97a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_d512e62b-bacf-45dc-9aae-795199fd97a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AdditionalPaidInCapitalBeforeTax_e1318868-381f-4830-80f8-d35669c8b2a8" xlink:href="ilmn-20241229.xsd#ilmn_AdditionalPaidInCapitalBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_AdditionalPaidInCapitalBeforeTax_e1318868-381f-4830-80f8-d35669c8b2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_9af31205-5222-40a0-bbac-f0cd723a8bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_AdditionalPaidInCapital_9af31205-5222-40a0-bbac-f0cd723a8bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e9ba0853-2e05-4079-97e1-713d4e2b1937" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e9ba0853-2e05-4079-97e1-713d4e2b1937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e78d9411-f8f0-4953-964c-36c281ad334e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e78d9411-f8f0-4953-964c-36c281ad334e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentNumberOfOneYearExtensions_c9101b5c-575a-4c81-b03a-bc40b40b3a48" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentNumberOfOneYearExtensions"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentNumberOfOneYearExtensions_c9101b5c-575a-4c81-b03a-bc40b40b3a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentExtensionTerm_cfd66aa9-0022-4e63-b6f8-ffc0857c9d4d" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentExtensionTerm"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentExtensionTerm_cfd66aa9-0022-4e63-b6f8-ffc0857c9d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_eb1fb795-4e8b-47be-95ff-675923d7915b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_eb1fb795-4e8b-47be-95ff-675923d7915b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings_1c0fd6e7-d4a5-43ff-bb5d-af6c3958ecc4" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings_1c0fd6e7-d4a5-43ff-bb5d-af6c3958ecc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio_9d2a6b5b-ad3d-4f82-8460-6805af0cecb4" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio_9d2a6b5b-ad3d-4f82-8460-6805af0cecb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio_6c7ca8f0-285a-4cc1-9567-fc84abffa112" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio_6c7ca8f0-285a-4cc1-9567-fc84abffa112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition_f0db4f3e-46ea-4227-a71a-4ef5d394bab5" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition_f0db4f3e-46ea-4227-a71a-4ef5d394bab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition_1af5eb9a-07b8-4f39-a3ef-1a13f86089d4" xlink:href="ilmn-20241229.xsd#ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition_1af5eb9a-07b8-4f39-a3ef-1a13f86089d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_1683600b-f1f6-4f39-8b82-f728699fd095" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d0aa7bd0-095d-4d52-95cb-072692df1577" xlink:to="loc_us-gaap_PurchaseObligation_1683600b-f1f6-4f39-8b82-f728699fd095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_14839e22-6877-4cea-a0ba-c1a49bb47c41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_14839e22-6877-4cea-a0ba-c1a49bb47c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_338f34e7-d684-4c4e-9dc8-2702b76f6501" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_338f34e7-d684-4c4e-9dc8-2702b76f6501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_09b292d2-2540-4d6f-88ae-09fcd5334b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_09b292d2-2540-4d6f-88ae-09fcd5334b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a6474935-6a26-4ce1-b65d-9707fe0613c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a6474935-6a26-4ce1-b65d-9707fe0613c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1ea605f9-558e-49b8-a12a-35f689c3c785" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1ea605f9-558e-49b8-a12a-35f689c3c785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_72c37551-4820-4683-a27e-8418f638f345" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_72c37551-4820-4683-a27e-8418f638f345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_72ca0132-4459-4ff4-a4d5-8ded7177509b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_72ca0132-4459-4ff4-a4d5-8ded7177509b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_aa52127a-e3cc-4e4d-9beb-443f8fe908bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_aa52127a-e3cc-4e4d-9beb-443f8fe908bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6aab3e54-6c12-4d9a-8775-e5a9027bc9be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_OperatingLeaseLiability_6aab3e54-6c12-4d9a-8775-e5a9027bc9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9198d7d5-8e47-45d4-a763-9d02c87e21fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9198d7d5-8e47-45d4-a763-9d02c87e21fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c7ef18db-419c-4ced-b8fd-1c762a2583f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c7ef18db-419c-4ced-b8fd-1c762a2583f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_70b8be3f-4710-4ddd-98d1-125f80a3bc8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_70b8be3f-4710-4ddd-98d1-125f80a3bc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_da09c821-cc29-4624-9bc5-f2ffeca9f69e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a0d91df1-759e-4318-9199-8254a59d9b66" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_da09c821-cc29-4624-9bc5-f2ffeca9f69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d00068e5-6325-45cf-8ae9-538da0c975d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_27587fa4-789c-4d0b-b165-8e587e1eca18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d00068e5-6325-45cf-8ae9-538da0c975d8" xlink:to="loc_us-gaap_OperatingLeaseCost_27587fa4-789c-4d0b-b165-8e587e1eca18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_b2617424-da89-48d4-8436-07939afe43b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d00068e5-6325-45cf-8ae9-538da0c975d8" xlink:to="loc_us-gaap_SubleaseIncome_b2617424-da89-48d4-8436-07939afe43b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_5de07ebc-3e3a-48c1-9e1a-6c83d0dd4db7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d00068e5-6325-45cf-8ae9-538da0c975d8" xlink:to="loc_us-gaap_VariableLeaseCost_5de07ebc-3e3a-48c1-9e1a-6c83d0dd4db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_0c7a72a0-0500-4785-9b0b-c710e5bc80ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d00068e5-6325-45cf-8ae9-538da0c975d8" xlink:to="loc_us-gaap_LeaseCost_0c7a72a0-0500-4785-9b0b-c710e5bc80ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_62d49b7c-4b6b-48ec-b7c6-f9a9cf0ebe29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48c21c3-9629-4ddc-b72a-4bf07323a61e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_62d49b7c-4b6b-48ec-b7c6-f9a9cf0ebe29" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48c21c3-9629-4ddc-b72a-4bf07323a61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e1906243-ef16-4dc0-b8b0-6b7754f8cf27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48c21c3-9629-4ddc-b72a-4bf07323a61e" xlink:to="loc_us-gaap_PlanNameAxis_e1906243-ef16-4dc0-b8b0-6b7754f8cf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ceae2e1d-81ce-431a-80a6-87ba05c3c921" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_e1906243-ef16-4dc0-b8b0-6b7754f8cf27" xlink:to="loc_us-gaap_PlanNameDomain_ceae2e1d-81ce-431a-80a6-87ba05c3c921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_A2015StockAndIncentiveCompensationPlanMember_29abb05c-e7a2-4611-9102-9793bd845878" xlink:href="ilmn-20241229.xsd#ilmn_A2015StockAndIncentiveCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ceae2e1d-81ce-431a-80a6-87ba05c3c921" xlink:to="loc_ilmn_A2015StockAndIncentiveCompensationPlanMember_29abb05c-e7a2-4611-9102-9793bd845878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a48c21c3-9629-4ddc-b72a-4bf07323a61e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_92285086-787c-460a-90f7-799b0dfe0d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_92285086-787c-460a-90f7-799b0dfe0d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment_79e15d85-a5b0-4dc4-9267-91be3f83670f" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment_79e15d85-a5b0-4dc4-9267-91be3f83670f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_681ba48e-d8b6-4ac3-83a1-76a12186f504" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0bfa084b-79ac-4633-90bd-06b3c9d11442" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_681ba48e-d8b6-4ac3-83a1-76a12186f504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_506402bd-c193-413a-a158-a431fa6c1b07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36c9c4d4-6fda-4bad-8034-57e8dc887ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_506402bd-c193-413a-a158-a431fa6c1b07" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36c9c4d4-6fda-4bad-8034-57e8dc887ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_62d44b07-1304-4daf-aedc-87d0376b12e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36c9c4d4-6fda-4bad-8034-57e8dc887ecd" xlink:to="loc_us-gaap_AwardTypeAxis_62d44b07-1304-4daf-aedc-87d0376b12e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_62d44b07-1304-4daf-aedc-87d0376b12e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e4e5286c-b674-456d-99b8-aa3c30c2f7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e4e5286c-b674-456d-99b8-aa3c30c2f7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_cb4b46a6-eed6-472e-b2cb-bde2592373df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:to="loc_us-gaap_PerformanceSharesMember_cb4b46a6-eed6-472e-b2cb-bde2592373df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MarketBasedPerformanceStockUnitsMember_09932ac4-99c0-4769-909e-979f6bf1bdee" xlink:href="ilmn-20241229.xsd#ilmn_MarketBasedPerformanceStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb07dc4e-0caa-4b43-bfd8-262a26b97d09" xlink:to="loc_ilmn_MarketBasedPerformanceStockUnitsMember_09932ac4-99c0-4769-909e-979f6bf1bdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_36c9c4d4-6fda-4bad-8034-57e8dc887ecd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4239a55a-2e11-4302-bcef-559b0749b0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4239a55a-2e11-4302-bcef-559b0749b0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards_a1e97f55-e7fc-4370-9cb5-4997563d9edf" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:to="loc_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards_a1e97f55-e7fc-4370-9cb5-4997563d9edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout_fcf0a73c-c547-48f7-8e73-dd5670eb4663" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d5fb168-1458-46b3-84be-2b91b023dd7a" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout_fcf0a73c-c547-48f7-8e73-dd5670eb4663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_09a886e6-c1ed-44eb-98e9-7fe9598ecf3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46804a6c-6edd-4f8f-8472-e1cd6dc9c4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_09a886e6-c1ed-44eb-98e9-7fe9598ecf3b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46804a6c-6edd-4f8f-8472-e1cd6dc9c4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d5e95130-cf98-4dc6-ac28-7176ec5f5482" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46804a6c-6edd-4f8f-8472-e1cd6dc9c4b0" xlink:to="loc_us-gaap_AwardTypeAxis_d5e95130-cf98-4dc6-ac28-7176ec5f5482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d5e95130-cf98-4dc6-ac28-7176ec5f5482" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f326c1dc-1221-4595-841d-2afbeb70fdba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f326c1dc-1221-4595-841d-2afbeb70fdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bfef2ea8-dfa0-441b-b9a8-ecf4d7cdfc54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:to="loc_us-gaap_PerformanceSharesMember_bfef2ea8-dfa0-441b-b9a8-ecf4d7cdfc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_MarketBasedPerformanceStockUnitsMember_78c5d843-7344-4ad8-9eb6-a6e4ecfd3a7d" xlink:href="ilmn-20241229.xsd#ilmn_MarketBasedPerformanceStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77045bb1-c818-41eb-810b-882d855fb95f" xlink:to="loc_ilmn_MarketBasedPerformanceStockUnitsMember_78c5d843-7344-4ad8-9eb6-a6e4ecfd3a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2fe47f02-ab4e-4f05-8d1d-6f6cea659595" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_46804a6c-6edd-4f8f-8472-e1cd6dc9c4b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2fe47f02-ab4e-4f05-8d1d-6f6cea659595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2fe47f02-ab4e-4f05-8d1d-6f6cea659595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fecdb16c-c5ed-48ed-9bf3-e059041f08cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fecdb16c-c5ed-48ed-9bf3-e059041f08cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4004442e-128b-44db-ae06-25ac0051e980" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4004442e-128b-44db-ae06-25ac0051e980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_4b228463-8811-4056-9062-bbe29a399674" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod_4b228463-8811-4056-9062-bbe29a399674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7ff8c35e-091d-498f-99b4-5f4fca89b683" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7ff8c35e-091d-498f-99b4-5f4fca89b683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_48428ed0-4d95-4b07-aa41-d7584614bc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_48428ed0-4d95-4b07-aa41-d7584614bc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fa5203e0-20af-4008-9bb1-ef407ebcfc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_56554564-746d-4d23-ad98-810cbd0724ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fa5203e0-20af-4008-9bb1-ef407ebcfc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2fe47f02-ab4e-4f05-8d1d-6f6cea659595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3809a802-2120-406e-8bd6-44039c893f97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3809a802-2120-406e-8bd6-44039c893f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_be8dbaf7-9634-4a0b-8ec6-477e87ebca7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_be8dbaf7-9634-4a0b-8ec6-477e87ebca7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_470ea0ae-f305-42ad-8689-b82b46bbbd96" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue_470ea0ae-f305-42ad-8689-b82b46bbbd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e6cbed78-58ce-4179-884a-9a9d73fd0d97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e6cbed78-58ce-4179-884a-9a9d73fd0d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_043e047f-f258-420b-bd88-36a2ef13a34a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_043e047f-f258-420b-bd88-36a2ef13a34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7584c313-cf40-435b-a595-e82259bd766a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a586519e-efb1-44b3-871f-a555f506935a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7584c313-cf40-435b-a595-e82259bd766a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7a0e5695-2554-4981-8432-f1bd36594a89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b015ff49-67b3-4bc5-bc0c-048d518203c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7a0e5695-2554-4981-8432-f1bd36594a89" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b015ff49-67b3-4bc5-bc0c-048d518203c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b80892f2-ca6e-42ce-b3c6-97fced25b8db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b015ff49-67b3-4bc5-bc0c-048d518203c0" xlink:to="loc_us-gaap_AwardTypeAxis_b80892f2-ca6e-42ce-b3c6-97fced25b8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff3d5ee3-5211-46ce-bd3c-25f7a8378391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b80892f2-ca6e-42ce-b3c6-97fced25b8db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff3d5ee3-5211-46ce-bd3c-25f7a8378391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ffe37987-6fe3-4c85-a7cb-507f46e5b2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff3d5ee3-5211-46ce-bd3c-25f7a8378391" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ffe37987-6fe3-4c85-a7cb-507f46e5b2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_59621cbe-17b1-4f95-a979-efd1301b47a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff3d5ee3-5211-46ce-bd3c-25f7a8378391" xlink:to="loc_us-gaap_PerformanceSharesMember_59621cbe-17b1-4f95-a979-efd1301b47a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c2b3c2b-8c03-4eaf-86a0-fc26df42ed32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b015ff49-67b3-4bc5-bc0c-048d518203c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c2b3c2b-8c03-4eaf-86a0-fc26df42ed32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2bde2fb5-3892-4d7b-bb3b-3ba861981868" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c2b3c2b-8c03-4eaf-86a0-fc26df42ed32" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2bde2fb5-3892-4d7b-bb3b-3ba861981868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_411e5eff-5ae1-46d7-a355-51e855cec38b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c2b3c2b-8c03-4eaf-86a0-fc26df42ed32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_411e5eff-5ae1-46d7-a355-51e855cec38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_45e1fd16-cfe5-4213-97fd-2adfaa774891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bcece378-2067-4a27-9699-efaa151a77ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_45e1fd16-cfe5-4213-97fd-2adfaa774891" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bcece378-2067-4a27-9699-efaa151a77ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_97779db5-0ca2-45c6-aa6b-6cc7bb0b9397" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bcece378-2067-4a27-9699-efaa151a77ab" xlink:to="loc_us-gaap_AwardTypeAxis_97779db5-0ca2-45c6-aa6b-6cc7bb0b9397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a84c298-8882-418e-8bc0-10a27d4ac427" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_97779db5-0ca2-45c6-aa6b-6cc7bb0b9397" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a84c298-8882-418e-8bc0-10a27d4ac427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1e2bd662-59aa-4a3e-9a6b-69a6ea938872" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a84c298-8882-418e-8bc0-10a27d4ac427" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1e2bd662-59aa-4a3e-9a6b-69a6ea938872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember_bc943934-bfd0-4992-bde5-6a2391b6ab85" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a84c298-8882-418e-8bc0-10a27d4ac427" xlink:to="loc_ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember_bc943934-bfd0-4992-bde5-6a2391b6ab85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f340dba5-5d71-4fa0-a1e2-de57750806a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bcece378-2067-4a27-9699-efaa151a77ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f340dba5-5d71-4fa0-a1e2-de57750806a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f340dba5-5d71-4fa0-a1e2-de57750806a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_28003912-daec-4f80-ad4a-cf58cb6acd93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_28003912-daec-4f80-ad4a-cf58cb6acd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_34a53f1d-9340-4767-aa68-f2e6f7362d78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_34a53f1d-9340-4767-aa68-f2e6f7362d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a14af4fa-316d-4e9a-9e67-79ec7210df8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a14af4fa-316d-4e9a-9e67-79ec7210df8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3f4bf510-f001-4ba9-a2c1-fdd6338369f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3f4bf510-f001-4ba9-a2c1-fdd6338369f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cad9a24d-e826-462a-b62b-7055a3343a67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af0701d2-0b28-4c15-8009-b8a50192d5b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cad9a24d-e826-462a-b62b-7055a3343a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f340dba5-5d71-4fa0-a1e2-de57750806a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1cf039e2-d0b9-4791-9c1c-9a302c5d8865" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1cf039e2-d0b9-4791-9c1c-9a302c5d8865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7be9e3f3-f807-43a8-bdff-629991659c74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7be9e3f3-f807-43a8-bdff-629991659c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ef5f00dd-5912-43d4-9281-19eadda4f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ef5f00dd-5912-43d4-9281-19eadda4f53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3868e559-7588-4de0-a15c-0ed805d8283a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3868e559-7588-4de0-a15c-0ed805d8283a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5425c121-54ea-45cf-b47d-a9819a36eff3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a676dd43-e8ff-4bd7-9ea9-fe209de4b55f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5425c121-54ea-45cf-b47d-a9819a36eff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f29b06f8-8156-4b71-ba1a-647102d9ca3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f29b06f8-8156-4b71-ba1a-647102d9ca3f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0509c577-9611-4585-8982-376d160f9a37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:to="loc_us-gaap_AwardTypeAxis_0509c577-9611-4585-8982-376d160f9a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_134d57e1-c6e2-43e7-9076-c1444fafbc20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0509c577-9611-4585-8982-376d160f9a37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_134d57e1-c6e2-43e7-9076-c1444fafbc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LiabilityClassifiedRestrictedStockUnitsMember_399861dc-f5eb-466f-851a-c504962d09fd" xlink:href="ilmn-20241229.xsd#ilmn_LiabilityClassifiedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_134d57e1-c6e2-43e7-9076-c1444fafbc20" xlink:to="loc_ilmn_LiabilityClassifiedRestrictedStockUnitsMember_399861dc-f5eb-466f-851a-c504962d09fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LiabilityBasedAwardsMember_e9354d41-4ab9-424d-80ae-d103f5c2fe15" xlink:href="ilmn-20241229.xsd#ilmn_LiabilityBasedAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_134d57e1-c6e2-43e7-9076-c1444fafbc20" xlink:to="loc_ilmn_LiabilityBasedAwardsMember_e9354d41-4ab9-424d-80ae-d103f5c2fe15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5ffcacb5-41c5-4bb6-b278-1abb1ec75600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5ffcacb5-41c5-4bb6-b278-1abb1ec75600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e72b7596-6d20-4c2e-99f3-f6f7b18c946f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5ffcacb5-41c5-4bb6-b278-1abb1ec75600" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e72b7596-6d20-4c2e-99f3-f6f7b18c946f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_1f5b6482-b4dd-41c9-82c6-0cabab9bfb83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e72b7596-6d20-4c2e-99f3-f6f7b18c946f" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_1f5b6482-b4dd-41c9-82c6-0cabab9bfb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0159b87-607d-4b88-b941-6d35d35f7f22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0159b87-607d-4b88-b941-6d35d35f7f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ffac35c-11b6-4fc2-83d3-af764eb08402" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0159b87-607d-4b88-b941-6d35d35f7f22" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ffac35c-11b6-4fc2-83d3-af764eb08402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_3eadc198-1c30-44cf-8cb8-eaf82a1b4469" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6ffac35c-11b6-4fc2-83d3-af764eb08402" xlink:to="loc_ilmn_GRAILInc.Member_3eadc198-1c30-44cf-8cb8-eaf82a1b4469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66935026-6d85-48cf-a28c-a37b5187f34e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_724c762c-c768-4049-a445-3c6b4c57abef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_724c762c-c768-4049-a445-3c6b4c57abef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a015f812-9b0f-49de-828f-ee86c7b39fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a015f812-9b0f-49de-828f-ee86c7b39fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_be0cc7f0-3e6c-4a6e-a52a-fb0c42315bad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_be0cc7f0-3e6c-4a6e-a52a-fb0c42315bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_bfbd29b9-fc77-4782-b7a5-9cf74980c45f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_bfbd29b9-fc77-4782-b7a5-9cf74980c45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested_07d5b35c-d80d-4116-9f10-10b6b55047e3" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested_07d5b35c-d80d-4116-9f10-10b6b55047e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_db48157b-bc55-4e82-bb85-f7003243edc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal_db48157b-bc55-4e82-bb85-f7003243edc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_4632a626-f86d-499e-a02c-4e910750bafd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_338af2dd-3629-4897-8405-1ad6fbf5b212" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_4632a626-f86d-499e-a02c-4e910750bafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3300735e-b331-4dbd-bf5b-1a966ae55fab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a663a4-ef59-4c69-87e0-7ef273c1ce7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3300735e-b331-4dbd-bf5b-1a966ae55fab" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a663a4-ef59-4c69-87e0-7ef273c1ce7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e72332cc-721d-4680-9ead-145fe57f03e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a663a4-ef59-4c69-87e0-7ef273c1ce7e" xlink:to="loc_us-gaap_AwardTypeAxis_e72332cc-721d-4680-9ead-145fe57f03e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ca36e9d9-5948-45db-afc0-eb051066b83c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e72332cc-721d-4680-9ead-145fe57f03e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ca36e9d9-5948-45db-afc0-eb051066b83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LiabilityBasedAwardsMember_47f5dfc1-9054-4de9-bea8-11789111726e" xlink:href="ilmn-20241229.xsd#ilmn_LiabilityBasedAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ca36e9d9-5948-45db-afc0-eb051066b83c" xlink:to="loc_ilmn_LiabilityBasedAwardsMember_47f5dfc1-9054-4de9-bea8-11789111726e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd80df5-00db-4ec6-bb01-a13d29fad3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28a663a4-ef59-4c69-87e0-7ef273c1ce7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd80df5-00db-4ec6-bb01-a13d29fad3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd80df5-00db-4ec6-bb01-a13d29fad3c3" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_302314b4-7f76-42e3-a66c-63055184a105" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_302314b4-7f76-42e3-a66c-63055184a105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue_27a709f8-54bb-47cb-9c3c-ae74f442dafb" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue_27a709f8-54bb-47cb-9c3c-ae74f442dafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue_e56e97d7-13a2-4ee8-ab2f-96afc5599e77" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue_e56e97d7-13a2-4ee8-ab2f-96afc5599e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue_0e67d127-af41-4eb2-8847-61e24adfd470" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue_0e67d127-af41-4eb2-8847-61e24adfd470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue_a8aaca8c-743a-4653-8d7a-335f632f9bfb" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue_a8aaca8c-743a-4653-8d7a-335f632f9bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition_722a913a-6f94-466f-80e8-7d086fe5be80" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition_722a913a-6f94-466f-80e8-7d086fe5be80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_f1171605-c853-4fba-b42e-c7d31cdec067" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward_b9d94296-a9a2-4994-bdf5-4fc3dc09acf8" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue_f1171605-c853-4fba-b42e-c7d31cdec067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent_42d5a098-6c4b-45b5-b03b-5228975342b1" xlink:href="ilmn-20241229.xsd#ilmn_AccruedLiabilityClassifiedAwardsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd80df5-00db-4ec6-bb01-a13d29fad3c3" xlink:to="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent_42d5a098-6c4b-45b5-b03b-5228975342b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e5644b69-470b-4e43-a58c-e9c247011a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91a64fdc-3e4c-4404-bd20-99015e5d722b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e5644b69-470b-4e43-a58c-e9c247011a3d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91a64fdc-3e4c-4404-bd20-99015e5d722b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_90fe864d-e2fb-4e2d-a4df-8bf3034f5747" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91a64fdc-3e4c-4404-bd20-99015e5d722b" xlink:to="loc_us-gaap_AwardTypeAxis_90fe864d-e2fb-4e2d-a4df-8bf3034f5747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c7e34ea2-07ff-49a7-a672-31b3c9adb493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_90fe864d-e2fb-4e2d-a4df-8bf3034f5747" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c7e34ea2-07ff-49a7-a672-31b3c9adb493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_285f8112-f551-4766-aef9-699af371a034" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c7e34ea2-07ff-49a7-a672-31b3c9adb493" xlink:to="loc_us-gaap_EmployeeStockMember_285f8112-f551-4766-aef9-699af371a034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5fa04b31-ef55-499b-8865-ee9a40282732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91a64fdc-3e4c-4404-bd20-99015e5d722b" xlink:to="loc_us-gaap_PlanNameAxis_5fa04b31-ef55-499b-8865-ee9a40282732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6b48cf6f-97bc-4f1b-af16-b24894552c80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5fa04b31-ef55-499b-8865-ee9a40282732" xlink:to="loc_us-gaap_PlanNameDomain_6b48cf6f-97bc-4f1b-af16-b24894552c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_A2000EmployeeStockPurchasePlanMember_12fa9af1-f89e-4587-b155-2a0bbe20f6e4" xlink:href="ilmn-20241229.xsd#ilmn_A2000EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6b48cf6f-97bc-4f1b-af16-b24894552c80" xlink:to="loc_ilmn_A2000EmployeeStockPurchasePlanMember_12fa9af1-f89e-4587-b155-2a0bbe20f6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91a64fdc-3e4c-4404-bd20-99015e5d722b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cd95d54d-6099-4fb0-8acb-682023d6c6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cd95d54d-6099-4fb0-8acb-682023d6c6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_35e54afd-aaeb-46ab-a413-739d376a50ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_35e54afd-aaeb-46ab-a413-739d376a50ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0c6a4b77-5f81-4e4d-98f2-aa1545ca9fab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0c6a4b77-5f81-4e4d-98f2-aa1545ca9fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease_c0466ac5-9f4b-43c4-bd70-c264dd27dc88" xlink:href="ilmn-20241229.xsd#ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c35699af-26af-491c-ba77-0b9c5fd76c48" xlink:to="loc_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease_c0466ac5-9f4b-43c4-bd70-c264dd27dc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b32a935d-eae8-485f-ab71-f2b9c916ceb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_26066f84-34b2-42ad-8f38-e1e6709be9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b32a935d-eae8-485f-ab71-f2b9c916ceb5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_26066f84-34b2-42ad-8f38-e1e6709be9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ef4b0936-f606-4b57-950e-f89cae4d4847" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_26066f84-34b2-42ad-8f38-e1e6709be9e8" xlink:to="loc_us-gaap_AwardTypeAxis_ef4b0936-f606-4b57-950e-f89cae4d4847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e737951-d543-4c1c-a695-a87f3e90181f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ef4b0936-f606-4b57-950e-f89cae4d4847" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e737951-d543-4c1c-a695-a87f3e90181f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_0de0b053-99ea-40ec-816a-335f221fca1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e737951-d543-4c1c-a695-a87f3e90181f" xlink:to="loc_us-gaap_EmployeeStockMember_0de0b053-99ea-40ec-816a-335f221fca1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6cdbeab5-5d14-46a7-9d6e-19c7961ec09e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_26066f84-34b2-42ad-8f38-e1e6709be9e8" xlink:to="loc_srt_RangeAxis_6cdbeab5-5d14-46a7-9d6e-19c7961ec09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_30c25c44-e5e4-4c33-a6a3-2af45037624e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6cdbeab5-5d14-46a7-9d6e-19c7961ec09e" xlink:to="loc_srt_RangeMember_30c25c44-e5e4-4c33-a6a3-2af45037624e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_25f7d1af-445a-4276-b841-8fe7cd977f11" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_30c25c44-e5e4-4c33-a6a3-2af45037624e" xlink:to="loc_srt_MinimumMember_25f7d1af-445a-4276-b841-8fe7cd977f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1dd14924-ff87-483d-be09-5483a1cd8857" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_30c25c44-e5e4-4c33-a6a3-2af45037624e" xlink:to="loc_srt_MaximumMember_1dd14924-ff87-483d-be09-5483a1cd8857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_26066f84-34b2-42ad-8f38-e1e6709be9e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_108ec055-31f0-41fc-a78a-33f7b939ce05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_108ec055-31f0-41fc-a78a-33f7b939ce05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_89c6e351-3a15-48d1-91e3-5b6c8224a5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_89c6e351-3a15-48d1-91e3-5b6c8224a5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3b0cb680-9ec1-47e9-a1fc-d67fb5fe3cad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3b0cb680-9ec1-47e9-a1fc-d67fb5fe3cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0c5bd6ed-93a9-41ad-a77a-2d0d5f0df558" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0c5bd6ed-93a9-41ad-a77a-2d0d5f0df558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6bde24c0-f25a-4e67-897d-c82fb2f9edd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6bde24c0-f25a-4e67-897d-c82fb2f9edd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_23172334-ab32-4382-ab77-d7bea8766aed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_23172334-ab32-4382-ab77-d7bea8766aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_12a717c5-343c-4808-833f-dd4a10dcef00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e3df6d-117a-4dab-91f6-5e21fa6faadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_12a717c5-343c-4808-833f-dd4a10dcef00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ae021c3f-e09a-4ac2-be7c-5ef08edf9bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f540648e-f3bd-403e-bc35-f03f8436f182" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ae021c3f-e09a-4ac2-be7c-5ef08edf9bf3" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f540648e-f3bd-403e-bc35-f03f8436f182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8d238911-1679-42b5-bce3-c6c26c0adad9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f540648e-f3bd-403e-bc35-f03f8436f182" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8d238911-1679-42b5-bce3-c6c26c0adad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_05361f21-3021-4409-9848-7115eac032f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8d238911-1679-42b5-bce3-c6c26c0adad9" xlink:to="loc_us-gaap_ClassOfStockDomain_05361f21-3021-4409-9848-7115eac032f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c9422416-6b7c-4e4c-abe7-1c19db6f8c98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_05361f21-3021-4409-9848-7115eac032f2" xlink:to="loc_us-gaap_CommonStockMember_c9422416-6b7c-4e4c-abe7-1c19db6f8c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9f2cf3f1-ef6b-4b64-a88b-f3951eda8bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f540648e-f3bd-403e-bc35-f03f8436f182" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9f2cf3f1-ef6b-4b64-a88b-f3951eda8bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_107d808b-1d8e-4bcc-bba2-625c71e2fb35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9f2cf3f1-ef6b-4b64-a88b-f3951eda8bd0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_107d808b-1d8e-4bcc-bba2-625c71e2fb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5b03e17b-eff7-4a57-bb48-0e69074c7a08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_107d808b-1d8e-4bcc-bba2-625c71e2fb35" xlink:to="loc_us-gaap_SubsequentEventMember_5b03e17b-eff7-4a57-bb48-0e69074c7a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f540648e-f3bd-403e-bc35-f03f8436f182" xlink:to="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_3cf71aa0-e86b-44af-b423-bdaef4b3e6e3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_3cf71aa0-e86b-44af-b423-bdaef4b3e6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_89519034-2588-44ab-a73b-e16e0bb15a07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_89519034-2588-44ab-a73b-e16e0bb15a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_a7873ded-5a14-485d-a914-f76652ae245f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_a7873ded-5a14-485d-a914-f76652ae245f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_2b25986e-b749-4b86-9c20-811afef4fb73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d176f805-4e1e-47fb-8a3d-19df2c634228" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_2b25986e-b749-4b86-9c20-811afef4fb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivityDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivityDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9a4c1c49-bc23-4785-9b12-951c104c968e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_76266524-a518-4575-aad0-ba52c98a0964" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9a4c1c49-bc23-4785-9b12-951c104c968e" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_76266524-a518-4575-aad0-ba52c98a0964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c2e840b0-d8d3-4403-8142-036169892d60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9a4c1c49-bc23-4785-9b12-951c104c968e" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c2e840b0-d8d3-4403-8142-036169892d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e6bb4176-1657-4fa8-b941-9409a101b461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08f222a9-fa43-4867-8b90-7c80ecfa7d10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e6bb4176-1657-4fa8-b941-9409a101b461" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08f222a9-fa43-4867-8b90-7c80ecfa7d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_22a791c0-bbd5-44b2-a2b5-46e7d9e942e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08f222a9-fa43-4867-8b90-7c80ecfa7d10" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_22a791c0-bbd5-44b2-a2b5-46e7d9e942e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_22a791c0-bbd5-44b2-a2b5-46e7d9e942e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CostOfGoodsSoldMember_82aee70b-86d3-49ea-947b-298c692e0097" xlink:href="ilmn-20241229.xsd#ilmn_CostOfGoodsSoldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:to="loc_ilmn_CostOfGoodsSoldMember_82aee70b-86d3-49ea-947b-298c692e0097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CostOfServicesMember_f975bf42-e5ba-416a-a246-2c3f76ca97e3" xlink:href="ilmn-20241229.xsd#ilmn_CostOfServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:to="loc_ilmn_CostOfServicesMember_f975bf42-e5ba-416a-a246-2c3f76ca97e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_48033da3-7fbb-459e-9090-983dd62a8fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_48033da3-7fbb-459e-9090-983dd62a8fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_320e08bd-869b-4fb2-a6bc-f40c8cad2a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_deb2ea6b-64b3-4d51-815a-1814af4354f2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_320e08bd-869b-4fb2-a6bc-f40c8cad2a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_08f222a9-fa43-4867-8b90-7c80ecfa7d10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_18901d7d-35df-4f14-b285-b172291b5bee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_18901d7d-35df-4f14-b285-b172291b5bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_ba8ccf13-77ce-4a31-b891-0dd114264c20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_ba8ccf13-77ce-4a31-b891-0dd114264c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_eac54327-8661-4e18-8d5b-d1bdd95afa7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db234474-855f-4b74-bd65-076838bebd4f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_eac54327-8661-4e18-8d5b-d1bdd95afa7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareBasedCompensationDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#STOCKHOLDERSEQUITYNarrativeShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3b99590b-f653-487f-8a6b-080bad483fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a67e76a1-3124-41e4-97f3-b11b94582bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3b99590b-f653-487f-8a6b-080bad483fb0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a67e76a1-3124-41e4-97f3-b11b94582bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b904059f-302a-443c-a154-485c976ae261" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3b99590b-f653-487f-8a6b-080bad483fb0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b904059f-302a-443c-a154-485c976ae261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4a796820-45ef-4ca3-ac0c-1c15c69efc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_84c3f120-8b49-499e-ab18-3ae8a94bbb70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4a796820-45ef-4ca3-ac0c-1c15c69efc9f" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_84c3f120-8b49-499e-ab18-3ae8a94bbb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2db786e4-823b-4520-927c-8b77adfb87d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4a796820-45ef-4ca3-ac0c-1c15c69efc9f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2db786e4-823b-4520-927c-8b77adfb87d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f5a63e3f-0e28-458e-842c-5bf6addadfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4a796820-45ef-4ca3-ac0c-1c15c69efc9f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f5a63e3f-0e28-458e-842c-5bf6addadfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c03a6f76-6fc7-484f-b4c5-cc0e961f24ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_196b16c4-f947-413a-bee9-3c0782d58d52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c03a6f76-6fc7-484f-b4c5-cc0e961f24ee" xlink:to="loc_us-gaap_InventoryRawMaterials_196b16c4-f947-413a-bee9-3c0782d58d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_fed40ebc-3e54-46f2-936e-05518b4e8cec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c03a6f76-6fc7-484f-b4c5-cc0e961f24ee" xlink:to="loc_us-gaap_InventoryWorkInProcess_fed40ebc-3e54-46f2-936e-05518b4e8cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_2d78aa5d-6f50-4f69-95f9-754994e4a2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c03a6f76-6fc7-484f-b4c5-cc0e961f24ee" xlink:to="loc_us-gaap_InventoryFinishedGoods_2d78aa5d-6f50-4f69-95f9-754994e4a2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_f0dd072a-81b9-4d8a-9860-bd344b137ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c03a6f76-6fc7-484f-b4c5-cc0e961f24ee" xlink:to="loc_us-gaap_InventoryGross_f0dd072a-81b9-4d8a-9860-bd344b137ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_9eef6e2e-8c73-4ebd-8fba-205986568c86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c03a6f76-6fc7-484f-b4c5-cc0e961f24ee" xlink:to="loc_us-gaap_InventoryValuationReserves_9eef6e2e-8c73-4ebd-8fba-205986568c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8404ab57-7e34-4a23-b94a-7d126aecd8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c03a6f76-6fc7-484f-b4c5-cc0e961f24ee" xlink:to="loc_us-gaap_InventoryNet_8404ab57-7e34-4a23-b94a-7d126aecd8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5ffc810f-d257-467c-a6dc-03621a44a16c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1219446f-5588-4723-be43-180b7afdf523" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5ffc810f-d257-467c-a6dc-03621a44a16c" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1219446f-5588-4723-be43-180b7afdf523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bff7540-71c6-491f-a4b8-206ba1e3a98b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1219446f-5588-4723-be43-180b7afdf523" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bff7540-71c6-491f-a4b8-206ba1e3a98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bff7540-71c6-491f-a4b8-206ba1e3a98b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_24b61899-bca6-4f15-9615-e0a9a6c2dc88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_24b61899-bca6-4f15-9615-e0a9a6c2dc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_7f5d748b-768e-4bef-8faf-ee107b65d090" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_EquipmentMember_7f5d748b-768e-4bef-8faf-ee107b65d090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_f35d358a-c4f4-42d9-8dbf-149d46a54a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_ComputerEquipmentMember_f35d358a-c4f4-42d9-8dbf-149d46a54a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_8ceba1f0-de20-4169-a2ba-85c07aa57873" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_8ceba1f0-de20-4169-a2ba-85c07aa57873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_dece326b-766b-4064-8adf-2eac9d9947b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_BuildingMember_dece326b-766b-4064-8adf-2eac9d9947b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_2b85c80a-c74a-46c0-bb68-92e167eae355" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f96bbdea-da80-4c59-a923-966a626d4732" xlink:to="loc_us-gaap_ConstructionInProgressMember_2b85c80a-c74a-46c0-bb68-92e167eae355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1219446f-5588-4723-be43-180b7afdf523" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ed39489d-ae1a-4bfe-b839-698a4726bbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ed39489d-ae1a-4bfe-b839-698a4726bbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ca383e2d-a626-445c-b895-c68685f8ba3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ca383e2d-a626-445c-b895-c68685f8ba3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_37e36fb1-db93-4fb6-95b9-67a27770ae28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_98cf09b3-6724-49cd-a301-b7f5c80f94a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_37e36fb1-db93-4fb6-95b9-67a27770ae28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47a5d3e3-fae0-4ebd-a245-92cbe207fb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_9136f479-f684-4d11-9bc5-b617e3ec96f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47a5d3e3-fae0-4ebd-a245-92cbe207fb9b" xlink:to="loc_us-gaap_LitigationReserveCurrent_9136f479-f684-4d11-9bc5-b617e3ec96f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_54d7518f-2c3d-4631-85f6-f6b699b752c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47a5d3e3-fae0-4ebd-a245-92cbe207fb9b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_54d7518f-2c3d-4631-85f6-f6b699b752c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_29cc9ea2-37c5-4444-b1a7-40c1ac9e7740" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47a5d3e3-fae0-4ebd-a245-92cbe207fb9b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_29cc9ea2-37c5-4444-b1a7-40c1ac9e7740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_80c89574-713b-4f5c-a767-70e34313b066" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47a5d3e3-fae0-4ebd-a245-92cbe207fb9b" xlink:to="loc_us-gaap_TaxesPayableCurrent_80c89574-713b-4f5c-a767-70e34313b066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_faa887cc-ae6e-431f-8efc-e75ed43d6020" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47a5d3e3-fae0-4ebd-a245-92cbe207fb9b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_faa887cc-ae6e-431f-8efc-e75ed43d6020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_a65a0653-0a2f-4241-9118-7d5e09861f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_faa887cc-ae6e-431f-8efc-e75ed43d6020" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_a65a0653-0a2f-4241-9118-7d5e09861f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent_f31825b2-a3cb-4895-b90e-be066cc51735" xlink:href="ilmn-20241229.xsd#ilmn_AccruedLiabilityClassifiedAwardsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47a5d3e3-fae0-4ebd-a245-92cbe207fb9b" xlink:to="loc_ilmn_AccruedLiabilityClassifiedAwardsCurrent_f31825b2-a3cb-4895-b90e-be066cc51735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a13b61ef-2082-45e7-8ffc-8aa6909c4a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47a5d3e3-fae0-4ebd-a245-92cbe207fb9b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a13b61ef-2082-45e7-8ffc-8aa6909c4a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3a4bb1b6-b8e8-4bd6-a164-0cb7c8d3a4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47a5d3e3-fae0-4ebd-a245-92cbe207fb9b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3a4bb1b6-b8e8-4bd6-a164-0cb7c8d3a4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc1c5ff7-932c-4d71-83f6-7693fd563ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_01db726a-45d0-472e-9392-da907bcedd00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc1c5ff7-932c-4d71-83f6-7693fd563ea6" xlink:to="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_01db726a-45d0-472e-9392-da907bcedd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_92f7d27a-f733-4f57-bdc5-9f0b52f8a304" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_01db726a-45d0-472e-9392-da907bcedd00" xlink:to="loc_us-gaap_ProductWarrantyAccrual_92f7d27a-f733-4f57-bdc5-9f0b52f8a304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_efcb1ef9-5143-495f-ae9d-6d9b2b36d819" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_01db726a-45d0-472e-9392-da907bcedd00" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_efcb1ef9-5143-495f-ae9d-6d9b2b36d819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_8308dc31-8eda-492f-8049-1e5252907af6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_01db726a-45d0-472e-9392-da907bcedd00" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_8308dc31-8eda-492f-8049-1e5252907af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_7b4feb48-46d9-4803-b8ea-ab60d5498c22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_01db726a-45d0-472e-9392-da907bcedd00" xlink:to="loc_us-gaap_ProductWarrantyAccrual_7b4feb48-46d9-4803-b8ea-ab60d5498c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_27d83c3f-cc0c-4b65-88e8-4ee7a13b8c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97165ede-0449-4bd6-ae1f-915a8ef31eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_27d83c3f-cc0c-4b65-88e8-4ee7a13b8c2e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97165ede-0449-4bd6-ae1f-915a8ef31eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0868273d-c503-42c5-8ea6-2a5c6572c328" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97165ede-0449-4bd6-ae1f-915a8ef31eb6" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0868273d-c503-42c5-8ea6-2a5c6572c328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0868273d-c503-42c5-8ea6-2a5c6572c328" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_fed462c5-c4b0-4adf-a39e-0e2ec3e5c2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:to="loc_us-gaap_EmployeeSeveranceMember_fed462c5-c4b0-4adf-a39e-0e2ec3e5c2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AssetImpairmentChargesMember_5cc51e16-5d55-4bfe-a824-23469ece9337" xlink:href="ilmn-20241229.xsd#ilmn_AssetImpairmentChargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:to="loc_ilmn_AssetImpairmentChargesMember_5cc51e16-5d55-4bfe-a824-23469ece9337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_13df8902-c1a0-42e9-8bc0-7d52a9367ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c4188362-02f5-4284-8849-458c21dd3912" xlink:to="loc_us-gaap_OtherRestructuringMember_13df8902-c1a0-42e9-8bc0-7d52a9367ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_071bf2dc-c458-402e-bb45-8dec2bfed77f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97165ede-0449-4bd6-ae1f-915a8ef31eb6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_071bf2dc-c458-402e-bb45-8dec2bfed77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5d2a90a6-4e09-4c7b-a2f0-36298c6e662a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_071bf2dc-c458-402e-bb45-8dec2bfed77f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5d2a90a6-4e09-4c7b-a2f0-36298c6e662a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_81b16574-a8d0-40af-a5d3-6204d755b297" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d2a90a6-4e09-4c7b-a2f0-36298c6e662a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_81b16574-a8d0-40af-a5d3-6204d755b297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f181205d-77da-4aae-925a-fe2491b82028" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d2a90a6-4e09-4c7b-a2f0-36298c6e662a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f181205d-77da-4aae-925a-fe2491b82028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_97a54db6-2126-45b7-a19a-bbc6756de983" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_97165ede-0449-4bd6-ae1f-915a8ef31eb6" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_97a54db6-2126-45b7-a19a-bbc6756de983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_e01be741-cd07-4506-aac0-9c862e46501f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_97a54db6-2126-45b7-a19a-bbc6756de983" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_e01be741-cd07-4506-aac0-9c862e46501f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc347dbe-f659-41b1-81d3-e726783e5479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cc51c42d-ada4-40c6-9ff4-ffff6b62ac69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc347dbe-f659-41b1-81d3-e726783e5479" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cc51c42d-ada4-40c6-9ff4-ffff6b62ac69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8a4c8bb9-983b-488f-b1ff-25b79750ba69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cc51c42d-ada4-40c6-9ff4-ffff6b62ac69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8a4c8bb9-983b-488f-b1ff-25b79750ba69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31bd9c1c-30b3-4758-87af-41527a9905a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8a4c8bb9-983b-488f-b1ff-25b79750ba69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31bd9c1c-30b3-4758-87af-41527a9905a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4026e4c5-3a60-4f68-a74e-9c957a308bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31bd9c1c-30b3-4758-87af-41527a9905a1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4026e4c5-3a60-4f68-a74e-9c957a308bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0d1e7cbf-a3a8-487f-9a3b-0ef5e5683ae2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cc51c42d-ada4-40c6-9ff4-ffff6b62ac69" xlink:to="loc_srt_StatementGeographicalAxis_0d1e7cbf-a3a8-487f-9a3b-0ef5e5683ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0d1e7cbf-a3a8-487f-9a3b-0ef5e5683ae2" xlink:to="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_a045d64c-8a91-4b25-a26f-61f485c3406d" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:to="loc_stpr_CA_a045d64c-8a91-4b25-a26f-61f485c3406d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FosterCityCaliforniaMember_ab0b0d32-cadc-4e14-8daf-d97263fdf9eb" xlink:href="ilmn-20241229.xsd#ilmn_FosterCityCaliforniaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:to="loc_ilmn_FosterCityCaliforniaMember_ab0b0d32-cadc-4e14-8daf-d97263fdf9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SanDiegoCaliforniaMember_f5d1a2e2-e3ef-41e8-9974-84322b1eaa50" xlink:href="ilmn-20241229.xsd#ilmn_SanDiegoCaliforniaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b72e6cf9-3b73-4551-989a-62dfdcea5597" xlink:to="loc_ilmn_SanDiegoCaliforniaMember_f5d1a2e2-e3ef-41e8-9974-84322b1eaa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cc51c42d-ada4-40c6-9ff4-ffff6b62ac69" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_43fdc8df-ff28-4c35-a806-e4ef2af19f03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_43fdc8df-ff28-4c35-a806-e4ef2af19f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements_3b62db07-acee-4750-9411-f90362f1c89b" xlink:href="ilmn-20241229.xsd#ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:to="loc_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements_3b62db07-acee-4750-9411-f90362f1c89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3a9f8729-3457-4a99-b702-da6dd71412c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3a9f8729-3457-4a99-b702-da6dd71412c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_1db2f096-3d7b-4725-b050-5e9b935e61ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0d9ef901-ef95-4155-9a26-a3516453ba8e" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_1db2f096-3d7b-4725-b050-5e9b935e61ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e98e7434-9178-4328-805f-0f2b8e8e9359" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_013f7dc2-e3c0-42ff-b808-fb8da233d14b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e98e7434-9178-4328-805f-0f2b8e8e9359" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_013f7dc2-e3c0-42ff-b808-fb8da233d14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_fc0eb0b6-47d5-4dd5-ab67-f6196e431f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_013f7dc2-e3c0-42ff-b808-fb8da233d14b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_fc0eb0b6-47d5-4dd5-ab67-f6196e431f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c3f12f5b-239c-4237-89b6-d5e6e4d95d65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_fc0eb0b6-47d5-4dd5-ab67-f6196e431f99" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c3f12f5b-239c-4237-89b6-d5e6e4d95d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_5b6018c5-9808-445c-81e8-ac85ddf9eaba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c3f12f5b-239c-4237-89b6-d5e6e4d95d65" xlink:to="loc_us-gaap_EmployeeSeveranceMember_5b6018c5-9808-445c-81e8-ac85ddf9eaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_7949f6a4-e35b-4793-8627-80128d569e10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c3f12f5b-239c-4237-89b6-d5e6e4d95d65" xlink:to="loc_us-gaap_OtherRestructuringMember_7949f6a4-e35b-4793-8627-80128d569e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1d01411d-1170-4750-9736-0837546cc679" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_013f7dc2-e3c0-42ff-b808-fb8da233d14b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_1d01411d-1170-4750-9736-0837546cc679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1d01411d-1170-4750-9736-0837546cc679" xlink:to="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_fec69f94-fcca-4315-b737-eda0bb1d818c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:to="loc_us-gaap_RestructuringReserve_fec69f94-fcca-4315-b737-eda0bb1d818c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3d4255e7-0042-43cc-be89-1f291b026be1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:to="loc_us-gaap_RestructuringCharges_3d4255e7-0042-43cc-be89-1f291b026be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_3c767b9f-608e-4b25-9bf8-d5f144dfd9c8" xlink:href="ilmn-20241229.xsd#ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCharges_3d4255e7-0042-43cc-be89-1f291b026be1" xlink:to="loc_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag_3c767b9f-608e-4b25-9bf8-d5f144dfd9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_00559ee0-bce1-4539-b529-600623eee11a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:to="loc_us-gaap_PaymentsForRestructuring_00559ee0-bce1-4539-b529-600623eee11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_972c6d9e-e515-469d-888a-d95f52d839a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_972c6d9e-e515-469d-888a-d95f52d839a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9c358cb5-d665-489b-8f8b-091a81dd26f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_90aa9515-cadd-408e-8e5a-07f3a77a0632" xlink:to="loc_us-gaap_RestructuringReserve_9c358cb5-d665-489b-8f8b-091a81dd26f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/LEGALPROCEEDINGSDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#LEGALPROCEEDINGSDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/LEGALPROCEEDINGSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c1b36532-991a-46a9-8a18-74f701fd4fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c1b36532-991a-46a9-8a18-74f701fd4fd1" xlink:to="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d9bd12e0-79c1-4e6a-91d3-2d2d33ff212d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d9bd12e0-79c1-4e6a-91d3-2d2d33ff212d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_44a36b31-8c39-4779-b495-b779d04b8cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d9bd12e0-79c1-4e6a-91d3-2d2d33ff212d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_44a36b31-8c39-4779-b495-b779d04b8cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_9b98e0d1-80bc-47be-a56b-deb043011b06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_44a36b31-8c39-4779-b495-b779d04b8cfa" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember_9b98e0d1-80bc-47be-a56b-deb043011b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8632f44c-ffdd-4781-b14a-5b85105aeac8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8632f44c-ffdd-4781-b14a-5b85105aeac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7354df4d-6121-4fe6-82a9-641b08ce37e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8632f44c-ffdd-4781-b14a-5b85105aeac8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7354df4d-6121-4fe6-82a9-641b08ce37e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_14a63b80-481b-4144-a512-bf9ee4f26faa" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7354df4d-6121-4fe6-82a9-641b08ce37e0" xlink:to="loc_ilmn_GRAILInc.Member_14a63b80-481b-4144-a512-bf9ee4f26faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b416fee6-2249-42cf-bd38-709ecd22dc24" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:to="loc_srt_LitigationCaseAxis_b416fee6-2249-42cf-bd38-709ecd22dc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c1e413c1-f32c-4a0a-812b-0bc19e4d4f41" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_b416fee6-2249-42cf-bd38-709ecd22dc24" xlink:to="loc_srt_LitigationCaseTypeDomain_c1e413c1-f32c-4a0a-812b-0bc19e4d4f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_AcquisitionOfGrailInc.Member_0745b0f8-d596-47f2-84fb-37f354ec437e" xlink:href="ilmn-20241229.xsd#ilmn_AcquisitionOfGrailInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c1e413c1-f32c-4a0a-812b-0bc19e4d4f41" xlink:to="loc_ilmn_AcquisitionOfGrailInc.Member_0745b0f8-d596-47f2-84fb-37f354ec437e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CompleteGenomicsMember_7383c7a5-ff09-4359-a0ff-b247e63cbb45" xlink:href="ilmn-20241229.xsd#ilmn_CompleteGenomicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c1e413c1-f32c-4a0a-812b-0bc19e4d4f41" xlink:to="loc_ilmn_CompleteGenomicsMember_7383c7a5-ff09-4359-a0ff-b247e63cbb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ef7f044-0d20-4347-9cc0-833026ad7e74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ef7f044-0d20-4347-9cc0-833026ad7e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0a3c75d7-6987-46fc-b296-fb4beab4950d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ef7f044-0d20-4347-9cc0-833026ad7e74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0a3c75d7-6987-46fc-b296-fb4beab4950d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_02855814-9b7f-40de-9f4b-e8ea324e6731" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0a3c75d7-6987-46fc-b296-fb4beab4950d" xlink:to="loc_us-gaap_LicenseMember_02855814-9b7f-40de-9f4b-e8ea324e6731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5d0e7d34-e900-4e50-81f9-040edf5d90ce" xlink:to="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_ef281ecf-8bd9-4891-a76c-9ed33ea0fdaf" xlink:href="ilmn-20241229.xsd#ilmn_DiscontinuedOperationPercentOfInterestDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf_ef281ecf-8bd9-4891-a76c-9ed33ea0fdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_27e78741-4257-4fb9-8c5c-e7aceacb00de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_27e78741-4257-4fb9-8c5c-e7aceacb00de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_58970c13-b05c-4a74-903c-c795ba745ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_58970c13-b05c-4a74-903c-c795ba745ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementGain_24a89875-8a34-4849-917f-2e49d2301d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_LitigationSettlementGain_24a89875-8a34-4849-917f-2e49d2301d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementLoss_0b880d2a-9c22-4ef9-ac43-20205fcbca0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_LitigationSettlementLoss_0b880d2a-9c22-4ef9-ac43-20205fcbca0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LitigationSettlementFinePercentageRate_1c7075eb-82f3-455f-b29c-7c9458633d9d" xlink:href="ilmn-20241229.xsd#ilmn_LitigationSettlementFinePercentageRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_LitigationSettlementFinePercentageRate_1c7075eb-82f3-455f-b29c-7c9458633d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_b33b3fc1-fbed-437c-9121-5d40694b4971" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_b33b3fc1-fbed-437c-9121-5d40694b4971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions_22c2587d-f3c4-4e4d-9a8e-6684eb795503" xlink:href="ilmn-20241229.xsd#ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions_22c2587d-f3c4-4e4d-9a8e-6684eb795503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions_68853cb3-191b-423c-b371-6e15ad9026d5" xlink:href="ilmn-20241229.xsd#ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions_68853cb3-191b-423c-b371-6e15ad9026d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_44799b55-da6e-411f-afba-91217ff4b4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_44799b55-da6e-411f-afba-91217ff4b4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_LossContingencyLicenseGrantedIntangibleAssets_498f0d18-dcc1-4b26-82a7-9124f20fe3fe" xlink:href="ilmn-20241229.xsd#ilmn_LossContingencyLicenseGrantedIntangibleAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_LossContingencyLicenseGrantedIntangibleAssets_498f0d18-dcc1-4b26-82a7-9124f20fe3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_58637bba-bddd-4cab-8264-eafa9f232c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_58637bba-bddd-4cab-8264-eafa9f232c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed_08abcf3f-2273-469b-a16f-f02122e5fe08" xlink:href="ilmn-20241229.xsd#ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed_08abcf3f-2273-469b-a16f-f02122e5fe08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod_3d533b10-244c-48c8-b618-60a6e50a23b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FormerGainContingencyRecognizedInCurrentPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0cb61717-410b-44cb-8614-0e36cc0f56cb" xlink:to="loc_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod_3d533b10-244c-48c8-b618-60a6e50a23b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eb587f6b-c004-496d-932c-17432fa35ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_cccfb6c8-086d-4ecd-ab73-27b0c904ef5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb587f6b-c004-496d-932c-17432fa35ddc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_cccfb6c8-086d-4ecd-ab73-27b0c904ef5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_edb6607e-e689-41cd-84c0-4a7dcc0aaa8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb587f6b-c004-496d-932c-17432fa35ddc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_edb6607e-e689-41cd-84c0-4a7dcc0aaa8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_68807d9d-1538-4e45-8a9f-d485cc064a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb587f6b-c004-496d-932c-17432fa35ddc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_68807d9d-1538-4e45-8a9f-d485cc064a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6778ab49-5a1d-46a9-90b7-2a5ef917c8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b7f6de2e-aa81-4b41-a2f8-0942bab5a5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6778ab49-5a1d-46a9-90b7-2a5ef917c8f6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b7f6de2e-aa81-4b41-a2f8-0942bab5a5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2a87d1e0-4df4-42bb-adf6-ab8f3e72eab3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b7f6de2e-aa81-4b41-a2f8-0942bab5a5d4" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2a87d1e0-4df4-42bb-adf6-ab8f3e72eab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_69928ae9-fed3-4963-9b90-02e8bfaef126" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b7f6de2e-aa81-4b41-a2f8-0942bab5a5d4" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_69928ae9-fed3-4963-9b90-02e8bfaef126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4109ae89-1872-4144-ad04-3a6ad8768d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b7f6de2e-aa81-4b41-a2f8-0942bab5a5d4" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4109ae89-1872-4144-ad04-3a6ad8768d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_897737c0-9727-4494-96ec-e6f81b0041ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b7f6de2e-aa81-4b41-a2f8-0942bab5a5d4" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_897737c0-9727-4494-96ec-e6f81b0041ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d1af51c7-5432-408e-88da-2a1aa7648aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6778ab49-5a1d-46a9-90b7-2a5ef917c8f6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d1af51c7-5432-408e-88da-2a1aa7648aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9be2b22f-dd9b-4d9d-abb9-a834fbff36a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d1af51c7-5432-408e-88da-2a1aa7648aeb" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9be2b22f-dd9b-4d9d-abb9-a834fbff36a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3196ab97-b649-4237-8fec-1167fda2f991" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d1af51c7-5432-408e-88da-2a1aa7648aeb" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3196ab97-b649-4237-8fec-1167fda2f991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_af7b4b22-3625-4672-be11-ef3e90a5a2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d1af51c7-5432-408e-88da-2a1aa7648aeb" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_af7b4b22-3625-4672-be11-ef3e90a5a2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0b9d2388-7a9b-496f-98ff-57c5e5b01422" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d1af51c7-5432-408e-88da-2a1aa7648aeb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0b9d2388-7a9b-496f-98ff-57c5e5b01422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_435b22cf-11e1-4d00-8ec1-4f78acf4a7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6778ab49-5a1d-46a9-90b7-2a5ef917c8f6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_435b22cf-11e1-4d00-8ec1-4f78acf4a7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_db0f57d9-a1cf-4e95-9a6a-160ed16a3dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_db0f57d9-a1cf-4e95-9a6a-160ed16a3dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_152dd6cc-7b52-4fc6-aa4c-7810e657b553" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_152dd6cc-7b52-4fc6-aa4c-7810e657b553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_4670a353-d069-4b26-a25b-5341d8ca9e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_4670a353-d069-4b26-a25b-5341d8ca9e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_79f652fe-474f-4c2c-824c-586b74dcdf56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_79f652fe-474f-4c2c-824c-586b74dcdf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_40ac36ab-ff77-410e-a75d-3cbf5533b481" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_40ac36ab-ff77-410e-a75d-3cbf5533b481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_00745ec2-f475-4b67-9131-5c605768f574" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_00745ec2-f475-4b67-9131-5c605768f574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_de20c4d9-6681-443d-94c4-33afe335849a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_de20c4d9-6681-443d-94c4-33afe335849a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_f95bb978-bade-41e8-a02f-1d93dac8817d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_f95bb978-bade-41e8-a02f-1d93dac8817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine_460a8e82-a4ac-490c-9759-82f0ff11200a" xlink:href="ilmn-20241229.xsd#ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine_460a8e82-a4ac-490c-9759-82f0ff11200a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_42281cb6-b717-47a3-80de-1c36c9dc72a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_42281cb6-b717-47a3-80de-1c36c9dc72a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount_620dd781-d94f-4ebc-b6e7-2ba7e1d8c84e" xlink:href="ilmn-20241229.xsd#ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount_620dd781-d94f-4ebc-b6e7-2ba7e1d8c84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_88bb1ec5-9390-44df-ad08-64a85a7fe1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_88bb1ec5-9390-44df-ad08-64a85a7fe1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_02544e1d-e155-48bb-8584-e28922ceb55d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e44a3f21-c29f-4f36-9b2c-7be453dcc377" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_02544e1d-e155-48bb-8584-e28922ceb55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_180015ad-70ef-4abe-87ea-1c0f81db6251" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_180015ad-70ef-4abe-87ea-1c0f81db6251" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d74a970c-3698-4e21-86aa-69cd8d2e4ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d74a970c-3698-4e21-86aa-69cd8d2e4ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_7ea39c80-4e08-46a4-8849-19280e2f99d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_7ea39c80-4e08-46a4-8849-19280e2f99d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_6dd1f493-0e52-4411-b0d4-27f5f2609a58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_6dd1f493-0e52-4411-b0d4-27f5f2609a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d9900b02-7e08-4bbb-a095-edd870548e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d9900b02-7e08-4bbb-a095-edd870548e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_dd1eb569-108d-4807-998d-ae954febbad0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_dd1eb569-108d-4807-998d-ae954febbad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_2576e140-2d22-44f8-a708-482db0420e10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_2576e140-2d22-44f8-a708-482db0420e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities_fe647c2f-9b47-4dca-bcc9-8957fbe569d3" xlink:href="ilmn-20241229.xsd#ilmn_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities_fe647c2f-9b47-4dca-bcc9-8957fbe569d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_92b052a3-4909-44b8-9c16-011a1459664a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_92b052a3-4909-44b8-9c16-011a1459664a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_b9ebc6bd-4a71-470c-8150-48dbf66bc16e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_b9ebc6bd-4a71-470c-8150-48dbf66bc16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_f43a0950-f855-4e9e-883b-f32e45f6d28c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_f43a0950-f855-4e9e-883b-f32e45f6d28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_caf2095c-c81f-48f5-9823-5425c9035fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_caf2095c-c81f-48f5-9823-5425c9035fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e87c16d1-1c10-4883-b57f-106ac1195b39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e87c16d1-1c10-4883-b57f-106ac1195b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_42694533-996c-4028-b804-e18ba4b03f90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_4d9bcb3a-be1e-4faa-9f08-b67c83e30312" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_42694533-996c-4028-b804-e18ba4b03f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_22835ca7-abb4-4c5b-bc63-74efcc3bc248" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_180015ad-70ef-4abe-87ea-1c0f81db6251" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_22835ca7-abb4-4c5b-bc63-74efcc3bc248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5b0baeef-26ee-431c-927f-00786938fa0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_22835ca7-abb4-4c5b-bc63-74efcc3bc248" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5b0baeef-26ee-431c-927f-00786938fa0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_4652e162-2708-4852-9510-c53c80d9f2d3" xlink:href="ilmn-20241229.xsd#ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_22835ca7-abb4-4c5b-bc63-74efcc3bc248" xlink:to="loc_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_4652e162-2708-4852-9510-c53c80d9f2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_ad2dcc9a-dbe6-47d8-808b-34456e256b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_22835ca7-abb4-4c5b-bc63-74efcc3bc248" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_ad2dcc9a-dbe6-47d8-808b-34456e256b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_f49c1fae-b175-4f50-942e-e8acd70b2042" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_22835ca7-abb4-4c5b-bc63-74efcc3bc248" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_f49c1fae-b175-4f50-942e-e8acd70b2042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c0a72afb-289c-48af-b984-1054018d1cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_22835ca7-abb4-4c5b-bc63-74efcc3bc248" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c0a72afb-289c-48af-b984-1054018d1cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_91ce571b-5c69-4e14-9fdd-63f65daa4680" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_91ce571b-5c69-4e14-9fdd-63f65daa4680" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f7366b2d-d73b-49a1-aa14-9734055b3eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f7366b2d-d73b-49a1-aa14-9734055b3eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f7366b2d-d73b-49a1-aa14-9734055b3eb1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_7a91c7e4-4292-4496-a4ab-7de5298f5024" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:to="loc_us-gaap_DomesticCountryMember_7a91c7e4-4292-4496-a4ab-7de5298f5024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_e6b668f2-ffaf-4a6a-86b3-4ba2ddbb2cea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_e6b668f2-ffaf-4a6a-86b3-4ba2ddbb2cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_ac326a79-00a9-421a-aad2-7eafee420176" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_81cc7dfc-54b9-4816-adea-08c5696bb419" xlink:to="loc_us-gaap_ForeignCountryMember_ac326a79-00a9-421a-aad2-7eafee420176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_7efca287-3a89-4e00-90b9-036924bb9ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_7efca287-3a89-4e00-90b9-036924bb9ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_861c1780-561b-45cc-a680-46d48cef47b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7efca287-3a89-4e00-90b9-036924bb9ba1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_861c1780-561b-45cc-a680-46d48cef47b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_ebacf578-221b-47f2-bee5-f85b7fc0bae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_861c1780-561b-45cc-a680-46d48cef47b3" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_ebacf578-221b-47f2-bee5-f85b7fc0bae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InlandRevenueSingaporeIRASMember_3ba570df-5f28-458f-917c-85e4856c66bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InlandRevenueSingaporeIRASMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_861c1780-561b-45cc-a680-46d48cef47b3" xlink:to="loc_us-gaap_InlandRevenueSingaporeIRASMember_3ba570df-5f28-458f-917c-85e4856c66bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_2abc3b7b-414c-4657-9c10-0848f0f00c76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:to="loc_us-gaap_TaxPeriodAxis_2abc3b7b-414c-4657-9c10-0848f0f00c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_b40fbeae-844f-410a-a593-702fd0b3f06a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_2abc3b7b-414c-4657-9c10-0848f0f00c76" xlink:to="loc_us-gaap_TaxPeriodDomain_b40fbeae-844f-410a-a593-702fd0b3f06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2017Member_9ee5119b-9e16-4a19-bdbb-662e890556d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxYear2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_b40fbeae-844f-410a-a593-702fd0b3f06a" xlink:to="loc_us-gaap_TaxYear2017Member_9ee5119b-9e16-4a19-bdbb-662e890556d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_e4165a6e-c4cd-4aa1-bbb2-4fa19dda4246" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a271e189-ece5-46a4-a73b-7a913114c3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a271e189-ece5-46a4-a73b-7a913114c3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_96ac8133-a5ae-41ce-85ca-ae16e301fa73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_OperatingLossCarryforwards_96ac8133-a5ae-41ce-85ca-ae16e301fa73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_04a03a87-2fbf-4f0d-bb96-2d73131fbe33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_04a03a87-2fbf-4f0d-bb96-2d73131fbe33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_825b8018-4d38-4202-83db-332872cbc521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_825b8018-4d38-4202-83db-332872cbc521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_5cb2392f-762a-411b-83e7-1309fa85a5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_5cb2392f-762a-411b-83e7-1309fa85a5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_858cdeed-873d-46a5-99c1-db5b49e0cf48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_858cdeed-873d-46a5-99c1-db5b49e0cf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_4b166a4c-adc4-4451-9160-33fd1f5d26fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_4b166a4c-adc4-4451-9160-33fd1f5d26fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_877cb41d-1d75-4c96-a926-22508d43cb74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_877cb41d-1d75-4c96-a926-22508d43cb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_60088e0d-cc12-4e35-9f95-4890690290d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_60088e0d-cc12-4e35-9f95-4890690290d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ae448118-a2b7-4f22-819e-f6fc381749cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_c1387118-d282-42a9-b3a4-df8867c59785" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ae448118-a2b7-4f22-819e-f6fc381749cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f5107377-9c47-4411-87ed-c3c27e874d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b97af463-4dad-41d0-b48a-026d5fb51d32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f5107377-9c47-4411-87ed-c3c27e874d1e" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b97af463-4dad-41d0-b48a-026d5fb51d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_694a31f7-0543-42c9-a4f0-8272464cf99c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b97af463-4dad-41d0-b48a-026d5fb51d32" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_694a31f7-0543-42c9-a4f0-8272464cf99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_7a5be456-b171-4a4b-bd06-dc6ccd22e5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b97af463-4dad-41d0-b48a-026d5fb51d32" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_7a5be456-b171-4a4b-bd06-dc6ccd22e5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_36276549-c941-44d6-931a-2025bc146444" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b97af463-4dad-41d0-b48a-026d5fb51d32" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_36276549-c941-44d6-931a-2025bc146444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_08a82f19-aa77-4874-9444-dd5d111d49a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b97af463-4dad-41d0-b48a-026d5fb51d32" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_08a82f19-aa77-4874-9444-dd5d111d49a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_7ee45c1b-d3e6-483b-bf51-1f573e6aa107" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b97af463-4dad-41d0-b48a-026d5fb51d32" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_7ee45c1b-d3e6-483b-bf51-1f573e6aa107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4873fde7-f241-42a5-aefd-a13f2fcd5d57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b97af463-4dad-41d0-b48a-026d5fb51d32" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4873fde7-f241-42a5-aefd-a13f2fcd5d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#EMPLOYEEBENEFITPLANSDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_8cea5cce-02a9-4621-b373-3eddf86f74ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_7ee5035e-776a-410b-9e7a-0f274d355628" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_8cea5cce-02a9-4621-b373-3eddf86f74ac" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_7ee5035e-776a-410b-9e7a-0f274d355628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_385b9cd7-c52d-491c-839a-9f59b67383ba" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_7ee5035e-776a-410b-9e7a-0f274d355628" xlink:to="loc_srt_TitleOfIndividualAxis_385b9cd7-c52d-491c-839a-9f59b67383ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_429c5e62-e3dd-4950-aa64-716cfee3ffac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_385b9cd7-c52d-491c-839a-9f59b67383ba" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_429c5e62-e3dd-4950-aa64-716cfee3ffac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_SeniorLevelEmployeeMember_75639f2e-9e0d-44bf-b6aa-816dfb19ad5b" xlink:href="ilmn-20241229.xsd#ilmn_SeniorLevelEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_429c5e62-e3dd-4950-aa64-716cfee3ffac" xlink:to="loc_ilmn_SeniorLevelEmployeeMember_75639f2e-9e0d-44bf-b6aa-816dfb19ad5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_aebec8d9-d061-4a24-a465-15690a463058" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_429c5e62-e3dd-4950-aa64-716cfee3ffac" xlink:to="loc_srt_DirectorMember_aebec8d9-d061-4a24-a465-15690a463058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_7ee5035e-776a-410b-9e7a-0f274d355628" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_f6d71f97-e1ad-412f-8401-505aa018da51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_f6d71f97-e1ad-412f-8401-505aa018da51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent_1d35e06b-a7f3-422f-bd32-90d88466154c" xlink:href="ilmn-20241229.xsd#ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent_1d35e06b-a7f3-422f-bd32-90d88466154c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent_fc22438a-b474-4caa-8cb7-68745ff5a848" xlink:href="ilmn-20241229.xsd#ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent_fc22438a-b474-4caa-8cb7-68745ff5a848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents_71cac006-1905-4803-987f-c69cf161f96f" xlink:href="ilmn-20241229.xsd#ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents_71cac006-1905-4803-987f-c69cf161f96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_670c4814-7803-4c46-a43d-e99f33b00d96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_670c4814-7803-4c46-a43d-e99f33b00d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent_f629530d-d80e-4a16-a019-e234cb267202" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_7d00db2b-7d63-4c33-839e-fbcbd956197f" xlink:to="loc_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent_f629530d-d80e-4a16-a019-e234cb267202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_402c57c3-59ea-4296-9bb7-3586cafe0056" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ab86f93d-0c98-4fab-8446-fa33bae932f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_402c57c3-59ea-4296-9bb7-3586cafe0056" xlink:to="loc_us-gaap_NumberOfReportableSegments_ab86f93d-0c98-4fab-8446-fa33bae932f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7a08660a-a2a3-4791-9926-3198ac2758fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_98ac94fe-0c32-4ee4-9fb2-c543dc330307" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7a08660a-a2a3-4791-9926-3198ac2758fe" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_98ac94fe-0c32-4ee4-9fb2-c543dc330307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4312df3f-11dc-4104-aa95-7d1dda9246b9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_98ac94fe-0c32-4ee4-9fb2-c543dc330307" xlink:to="loc_srt_ConsolidationItemsAxis_4312df3f-11dc-4104-aa95-7d1dda9246b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4e9aa3f5-035f-4840-9c4b-8ce272ea1459" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_4312df3f-11dc-4104-aa95-7d1dda9246b9" xlink:to="loc_srt_ConsolidationItemsDomain_4e9aa3f5-035f-4840-9c4b-8ce272ea1459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d0025dba-db98-4f9a-82ec-6ff929338a36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4e9aa3f5-035f-4840-9c4b-8ce272ea1459" xlink:to="loc_us-gaap_OperatingSegmentsMember_d0025dba-db98-4f9a-82ec-6ff929338a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_1a389e8b-f99b-4bc2-ad34-4a355eaec17e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4e9aa3f5-035f-4840-9c4b-8ce272ea1459" xlink:to="loc_us-gaap_IntersegmentEliminationMember_1a389e8b-f99b-4bc2-ad34-4a355eaec17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a0a5f13e-a137-45ff-83e0-65331245fce0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_98ac94fe-0c32-4ee4-9fb2-c543dc330307" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a0a5f13e-a137-45ff-83e0-65331245fce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d21cc4f5-ace3-43d1-9be1-229eb3726af1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a0a5f13e-a137-45ff-83e0-65331245fce0" xlink:to="loc_us-gaap_SegmentDomain_d21cc4f5-ace3-43d1-9be1-229eb3726af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CoreIlluminaMember_c7f41ed8-3c63-494b-a0df-2da185e0cfde" xlink:href="ilmn-20241229.xsd#ilmn_CoreIlluminaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d21cc4f5-ace3-43d1-9be1-229eb3726af1" xlink:to="loc_ilmn_CoreIlluminaMember_c7f41ed8-3c63-494b-a0df-2da185e0cfde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_5d97f862-d42c-4453-b606-adb9f5c89882" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d21cc4f5-ace3-43d1-9be1-229eb3726af1" xlink:to="loc_ilmn_GRAILInc.Member_5d97f862-d42c-4453-b606-adb9f5c89882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_98ac94fe-0c32-4ee4-9fb2-c543dc330307" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d0b811d-19ac-435c-b048-ca1d9f3ca6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d0b811d-19ac-435c-b048-ca1d9f3ca6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0b2a5d06-24f7-4c38-9c2f-d6b2882ddf65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_OperatingExpenses_0b2a5d06-24f7-4c38-9c2f-d6b2882ddf65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_279ee58a-0208-4987-87ff-5128470ce065" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_CostOfRevenue_279ee58a-0208-4987-87ff-5128470ce065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f69d4a23-b57e-40a8-a05e-a9ac8b203e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f69d4a23-b57e-40a8-a05e-a9ac8b203e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_deeba645-3630-4961-b72f-59097c234c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_SellingAndMarketingExpense_deeba645-3630-4961-b72f-59097c234c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ce49193a-c990-441c-b63b-4d2a5463e0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ce49193a-c990-441c-b63b-4d2a5463e0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_593baf2a-613c-49d4-99af-00e2da84738c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_593baf2a-613c-49d4-99af-00e2da84738c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_6ad780d7-774e-4dd0-864e-f9cd7237c336" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_6ad780d7-774e-4dd0-864e-f9cd7237c336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1f5351c9-4ba5-4353-b075-5afdae5b11da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1f5351c9-4ba5-4353-b075-5afdae5b11da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d4914df7-d8b6-470e-9ae6-c943ef69eb26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d4914df7-d8b6-470e-9ae6-c943ef69eb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e32e1f1f-da86-48c3-9d82-0446a435de0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4201a322-aa32-451e-b95f-8c47b9c21174" xlink:to="loc_us-gaap_NetIncomeLoss_e32e1f1f-da86-48c3-9d82-0446a435de0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_587bc49d-23e4-4c5a-99c4-59c8fc464c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_14d3b00d-8fe2-428a-98a4-9f3a313ccbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_587bc49d-23e4-4c5a-99c4-59c8fc464c1a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_14d3b00d-8fe2-428a-98a4-9f3a313ccbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b7f61241-dc69-4c74-bb46-c5330c918dee" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_14d3b00d-8fe2-428a-98a4-9f3a313ccbc6" xlink:to="loc_srt_ConsolidationItemsAxis_b7f61241-dc69-4c74-bb46-c5330c918dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_14865071-f70c-47ac-8d86-90b889fbfb1e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b7f61241-dc69-4c74-bb46-c5330c918dee" xlink:to="loc_srt_ConsolidationItemsDomain_14865071-f70c-47ac-8d86-90b889fbfb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_14713fa9-331b-4c56-813c-c8813c62cde1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_14865071-f70c-47ac-8d86-90b889fbfb1e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_14713fa9-331b-4c56-813c-c8813c62cde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e52ffd31-c5f2-4442-8a9a-dc41cd300ace" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_14865071-f70c-47ac-8d86-90b889fbfb1e" xlink:to="loc_us-gaap_OperatingSegmentsMember_e52ffd31-c5f2-4442-8a9a-dc41cd300ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a7667e39-ca9d-43c4-9f1e-01fff644224f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_14d3b00d-8fe2-428a-98a4-9f3a313ccbc6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a7667e39-ca9d-43c4-9f1e-01fff644224f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5c5e954b-1e6c-42d4-9476-ffaa200b00ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7667e39-ca9d-43c4-9f1e-01fff644224f" xlink:to="loc_us-gaap_SegmentDomain_5c5e954b-1e6c-42d4-9476-ffaa200b00ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_CoreIlluminaMember_3321e97a-c6b0-4658-91f4-caf088e1ca19" xlink:href="ilmn-20241229.xsd#ilmn_CoreIlluminaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5c5e954b-1e6c-42d4-9476-ffaa200b00ea" xlink:to="loc_ilmn_CoreIlluminaMember_3321e97a-c6b0-4658-91f4-caf088e1ca19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_GRAILInc.Member_3e9be4c4-3cd8-4ee7-ab64-b289f3e01841" xlink:href="ilmn-20241229.xsd#ilmn_GRAILInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5c5e954b-1e6c-42d4-9476-ffaa200b00ea" xlink:to="loc_ilmn_GRAILInc.Member_3e9be4c4-3cd8-4ee7-ab64-b289f3e01841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_79fd5ffa-ca90-4898-9b73-31d12ed9d451" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_14d3b00d-8fe2-428a-98a4-9f3a313ccbc6" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_79fd5ffa-ca90-4898-9b73-31d12ed9d451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0234c8ac-fb90-4b69-9fe2-e22c8abd0970" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_79fd5ffa-ca90-4898-9b73-31d12ed9d451" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0234c8ac-fb90-4b69-9fe2-e22c8abd0970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_566ed7e3-5e28-4aef-a460-6355939bcc68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_79fd5ffa-ca90-4898-9b73-31d12ed9d451" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_566ed7e3-5e28-4aef-a460-6355939bcc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ilmn-20241229.xsd#SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4cb34251-b436-4c0f-b9e5-8a60bfb9a840" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_04c1147b-0fd8-4175-8430-e051759ce0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4cb34251-b436-4c0f-b9e5-8a60bfb9a840" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_04c1147b-0fd8-4175-8430-e051759ce0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_780a8815-eb08-4c0f-b59e-7d6c2ac367f8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_04c1147b-0fd8-4175-8430-e051759ce0cb" xlink:to="loc_srt_StatementGeographicalAxis_780a8815-eb08-4c0f-b59e-7d6c2ac367f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_780a8815-eb08-4c0f-b59e-7d6c2ac367f8" xlink:to="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2c4f709a-70b6-41a5-92ff-f338080c7e42" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:to="loc_country_US_2c4f709a-70b6-41a5-92ff-f338080c7e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_3f7ebd36-8a86-4e4e-bc43-6335d16a302f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SG"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:to="loc_country_SG_3f7ebd36-8a86-4e4e-bc43-6335d16a302f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_bb3f89e7-0533-416c-9efd-79dd147c04ec" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:to="loc_country_GB_bb3f89e7-0533-416c-9efd-79dd147c04ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_OtherCountriesMember_d0d50ca1-d5d5-49ff-bf6e-682b680b6a8b" xlink:href="ilmn-20241229.xsd#ilmn_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7f040944-eae8-40b3-8869-295082c808d0" xlink:to="loc_ilmn_OtherCountriesMember_d0d50ca1-d5d5-49ff-bf6e-682b680b6a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_63e5fd6b-0f6f-4517-aae1-651d1d5ff97c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_04c1147b-0fd8-4175-8430-e051759ce0cb" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_63e5fd6b-0f6f-4517-aae1-651d1d5ff97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_c082bd8d-8d1c-4f57-b8ee-ba659d990621" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_63e5fd6b-0f6f-4517-aae1-651d1d5ff97c" xlink:to="loc_us-gaap_NoncurrentAssets_c082bd8d-8d1c-4f57-b8ee-ba659d990621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_FrancesArnoldMember" xlink:href="ilmn-20241229.xsd#ilmn_FrancesArnoldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ilmn_FrancesArnoldMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_JakobWedelMember" xlink:href="ilmn-20241229.xsd#ilmn_JakobWedelMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ilmn_JakobWedelMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_ScottDaviesMember" xlink:href="ilmn-20241229.xsd#ilmn_ScottDaviesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ilmn_ScottDaviesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ilmn_PatriciaLeckmanMember" xlink:href="ilmn-20241229.xsd#ilmn_PatriciaLeckmanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ilmn_PatriciaLeckmanMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ilmn-20241229_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ilmn-20241229_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !< 7 # 2(  A$! Q$!_\0
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MG]K3_DB6J?\ 7Q;_ /HU:^-OA+_R57P9_P!AJS_]'I7V"/G>I^EM>>_M!?\
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M2=6N9 ^HJ#:WA!_Y;1G!8\  L-KX XWXKT&I*/D?_AN74/\ H4;;_P #F_\
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M%=Z=<ZS."2;F\NY%;GL%C*K@>XS[FJT%J?/NF_MB?$&PSYYTO4?^OFT*]O\
MIFRU[-\,_P!K[0/%EY!IWB*T_P"$<OI-JK=-*'M7;@'+<&/)S]X$ =6K5\5?
MLC^ =<T]XM,M+CP_>#)2ZMIY)1G! #)(Q!7/)"[3QU&:^-?'W@74_ASXJO-"
MU:,"XMSE9$R4FC/*R*?[I'XC!!P10&I^CGCC07\5>#==T:*189=0L9K5)'SA
M6=&4$X[9/:O!/'5WIWBRZU2]U_68_"&MQZ;9P3Z%J-Y/;+</#/.T\+HG_'Q;
MR!MJO'O/.0!]T[_[(OQ$G\8> 9]'OI&EO="=(%D8')MW!,0)SR04=>!T5:]W
MI#."^'=G=:AKOB/Q//93:;:ZG]GM;*SN(3%*+> .!(RGD%WDDP& (4)GT'>T
M44AA7EG[17_(DV__ %^)_P"@M7J=>6?M%?\ (DV__7XG_H+5\_Q!_P BNO\
MX6>KE/\ O]'U1XM\,O\ D?M#_P"OE?Y&OKM:^1/AE_R/VA_]?*_R-?7:U\IP
M)_N=7_%^B/HN+/\ >X?X?U/(/VL/^2'ZS_UVMO\ T<M?&7PE_P"2J^#/^PU9
M_P#H]*^S?VL/^2'ZS_UVMO\ T<M?&7PE_P"2J^#/^PU9_P#H]*_34?#=3]+:
M\]_:"_Y(SXL_Z\S_ .A+7H5>??M!?\D7\6?]>9_]"6I*/SHK]6*_*>OU8JF2
MCYT_;<@#?#W0YLG<NJ!0.W,,A_\ 91^M>$?LL_\ )>/#'_;U_P"DLU>^?MM?
M\DUT;_L+)_Z)FKP/]EG_ )+QX8_[>O\ TEFHZ!U/T"HHHJ2CRC]J7_D@_B;_
M +=?_2J&OB?X4?\ )4O!W_89L_\ T>E?;'[4O_)!_$__ &Z_^E45?$_PH_Y*
MEX._[#-G_P"CTJD3U/TOKXH_;8_Y*II7_8%B_P#1\]?:]?%'[;'_ "532O\
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M/JCQ7X:L%\>Z&3_S\J/SX'ZU]>#[OX5\@?#G_D>M#_Z^X_YU]?K]VOD^!/\
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M-_#(\9^$=7T)K@VJW]N]N9PFXIN&,@9&?SKYW_X89M?^APF_\%Z__'*^I**
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@Z])JD=]"L3P-;"(!E;*MG>>Q;MWKUZBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ilmn-20241229_g2.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ilmn-20241229_g2.gif
M1TE&.#EA) $A >8  &EI:=C8V.SL[%A86&%A8?3T]%555=+2THZ.CM34U,7%
MQ<C(R'Y^?O+R\LS,S,;&QMO;V^;FYN'AX<K*RI&1D>CHZ./CX]#0T.KJZM;6
MUMS<W.3DY(J*BFYN;E%144%!08R,C(2$A(*"@GAX>(B(B'M[>TE)28" @$5%
M18:&ABXN+GIZ>C(R,EY>7G5U=7)R<FQL;&1D9'!P<'1T=#\_/TY.3F=G9S@X
M."LK*UM;6TQ,3!P<'#P\/"<G)_[^_K^_OY^?G_W]_9F9F9R<G)V=G9>7EZ2D
MI)J:FIN;FZ"@H**BHJ&AH<_/SYZ>GJJJJI.3DY24E*^OKZVMK=_?WZ:FIN_O
M[YB8F/S\_*6EI9*2DI65E:FIJ:.CHY:6EK"PL+N[NZZNKJ>GIZNKJZBHJ+BX
MN/KZ^KZ^OK.SL[R\O+:VMOO[^[>WM[2TM+*RLK6UM:RLK+&QL?;V]KFYN;V]
MO;JZNL'!P</#P\+"PL# P,[.SOGY^?CX^/#P\/?W]_'Q\?___R'Y!
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M);P@0PP8'.DE)@64,(,(%!S1 @\TQ!#$(5+44,-K.>B0PU-?UAF)#PO8$,,
M?GW0VAV'"-B"#3 0X($)%=BI:"1E"?E!#@S 4 ,(AUC0UP>8?C! D8MVNH@<
M!N3P @DP=)A#:H3H$4(, % WP@O#>2KK3AP8X$$.+A! PP E%F)&!RDTP90+
M,,YJ;"$3&-"" 7X9 ( %AS CPA!4(#"" \=F.T@0+=#P05LG"'3(%1R48,46
M68P@Q9K:9EM'!R$LD00),Z!WB ,CZ(<   S4UJZQ?+APPA!A6#L'(E4$UP&?
M+PSVK[%!E L%>2><D4C_"9B:$ ,'!3SL"*H *N!":$!T ! B4HRZ! <DT!F7
M#V4(8($$$?@!,BM[Z'%S>@*T  !;'P#072%YC(# %@BD($!<5PB0 !U;)'&$
M$%8(@<02;^ ! 1\[7Q)S 66P"Z :-M!  PJ3=5EI@6%P, .G1?D@ 1I$0)$%
M%%T4H7<17=B-MQ(*"-"U)#X4 $$%/@0Q]'^_,D $!RX,=$@!+>0   $=)!H5
M!EL\ 84615@]Q.BD#X&$$$5H\?D<#5SB@P *H-$ 'V)CZ(<(*3A!6G.']#%
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M)!&4X(0W> &39* #&N9@!C. P@S4_ (=UG"&*(AA#%QH @&?\( KQ$$ $:B
M!::@@2J [ DTN &V_/@'Q"TM" T07WH*L(*F\,D*M=L" W#(@&*Y) @+R((5
MB- $(VP!#%YPPQKH\ ,\W$$!&,6H'>R AQ_,@0YD8$,4P# &+  AE4\HP1LB
M ($'&,$!!W#  N2 !IGUY01OF4+'*J"! E3!G3("@PD^X $7C" !A#B""(!0
M! 9H[B53.((6C@ $+HQ!#'#_8(,TS5 '!3Q@ 0N8P 3 "E8%U,$,7Y"#&^ @
M!B,, 0%:R (#;* &/02@!E7@@P2JL <-I&$(.4 !\>:P  GHH0(2L)F1XA I
M"C1!!"%PV!\8T()-P.!]+TG#$^JW!"QLP9EP<$,::%J'!3@@#Q=@@FH=(%,%
MV.$':64#%Z P!!!8H0@4&  &KF"!#AP@"!>@@ ,:H $'P$$(=\A# BX @0!H
MH ()]-(43A :"GB #8,X 6!LT$B52*!O13C"Z8KP/"[8D @2,H(3VK &.\#T
M !=@[0(4\ ,ZK"P,24  %(2   8XX'5N.,(? K )/5BA V_8@ 2FT%P!Z--(
M/I@#_P-(,  >E*!$2V" "#H J);XH $!4 ("*  %)%B! AQ( QKPL 8GA("U
M7Y""%];0ABA@00IV.$!,8[<R(9PA#%U P!"><+3"': &:L! & P0AAB,X(K'
MV@,"KA,#!N1!$%B @A%( +>3].$+3R!! NPFA":85 LA:,,/[( &-JP@ 0&8
M@!A2<(0 Y(&^9 ##%GYP!RV0  HB8(,3D, !(IS8"GPHP!D^(!8)B   (1CB
ML2P@@A$8(0MC6-,;NK"$(K#2)'M(0!->X&0I+" Y5QL#%8X0@B38X0%UH(,(
M\J"! +"! PS80 0.L( Q+, .;:!""8SPAA/  0Q'X(#5H/^ @ "H@0XQ2,(?
M(!!D26<K @@0@H@Q4(8P9&$(6SG)%0Y0!!<P,0E#.1X"CL!,*30A!12PPUC-
M (('2$ "=D! !])97!G$=ZQ;P,(;$,"%-N27 D@H @<L=@ *N$ #(2#"$Q^V
M@2PHX0@@,("W"-!ED/@  R*H00["\()1",()64@.L;W@A3!$X0$P30 3-+"!
M"D3@WC^-0 (0<( CD( .OT8#%18^6PX,@9 <^(, G&"#HWJ,$ V( L900/5'
M238D<8"#BP9$!2688"@^&(+JGG#C,]#4#J8]0  @(($*"$  ?N!#W/F@@!"$
M"P!D< ";TV $(: N!:=SN 8F$ +_//CKZ8*H  %08 (/N.@#;Q@)!%Y0@[*5
M0(ADD $)%-<%+4@R#%+0*AX4L( \9  "4UBG!NK@@ +XH0!Q<&D)FAB F-HA
MSV%0 B0[?S>M'1[Q@LA #5 @<@/HX ,C" E"<V#AN_HG" $0@@$<4(8L>'X)
M80"#5LU ^@LD@->O=@,6!!"'"D"@ 1O@P!%L\ 4(Q'0!=4!#&KS@!-T+X0EM
M #XB(. !X@_ ^!_  ,94$0[@ 7^1 QI -8^Q!P<0!150?5TP!-@7>G1@!F@W
M4V\@!D[ !6(@ 04@  T7  [0 B:3 .[G  ^ !W,@!VWP!D:P!$> ?_K7.S+P
M 3I0 X_'_P$VX1$2H .OQ ,(@%@S8 :%H 9/4 02"'IM4(%W0 9#0 %<  9$
MP ![Y0<1$ !B0 (4-@!>, 6UAX(>Q8)2@ 5)( 10D 8S> @+@"E59P!<@ !L
M,'$9@0$_HP4?D 5[\'%G,"6$$ 1"T 5(D 1A\ 9NP$E.P %@P 3-]05"$ &)
MY@<2< !(, #!@7I?N !X@ 9K0']!888'DX:&< "*E ./)01)$ (V@%1>,0*/
MX@4$, 0W<0418&U_P 53!03$U@9BH!]N, 1,X%RI5P%5T  ^)8(D8 !D( &U
M%E^8N$V<" 1F&&Z@. @%8 1<0 %1< 51$ ('-@ =H $#* ]1@/\"F+(%0I #
M/9((:[!?RS0&1E $4H &9W &6S!S]Y8!9Z"#%; &%- !*\!. 9  >?!K]94&
M),4%1Z<%_C&-@N #!Q "1G T2O<".= "+^ "(1 !X6@.59 #0[4"$> &%/1I
MA9  FS4$ 00%4E"!<] &3;  &: !$O %3C "7G  #' @=: !$/!]#N!:*W@&
M4H!?<80$:L.09; 80! "7/ '/M &F*-^&D:+!!$$2< 6!G!%&D $*R"'A5
M71"!D)0%8+ &*_8#9I ':@<!%W!<'8  ,! #7<!@E_A:7[")3F $1!"#41!=
M#!D!(] A R!@?W %2[ "^B$"** $&SG_#A& CF[P LYA3#X@/T)  4_P!%T
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M +#G!Q4P!0K  7@P!5/0!B[PNG?  4GW!P5P $(CP%[@&B=01Q&1 TD !4^
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M8' '43 $#K &%88%7@!T3NH==H %*&5 !O3 $2T&#G!U%8T(?9 %+C!BW0P
M5U<%+Q"B6] %!$  1=T+>Q  1V5$<:#35B %FR&+(% "4=R0YAP'!=  =-T
M7_ F9+H(A;-K=[ &T:0  4!^4?TQ;( 4'#"B,;#_D V9DS+0 1V0 Q] !K^
M 2%P !'@!12 S5?P@:<&!Q6PE[_7"&.!!2;@!8,]# 0V(M9" %X ,OJJ+'U1
M R- O*;0!T8P T' RW5  EEP &K@ W:%8JLD"6H@ 6FP @,0VJ?M"GR@;R(@
M(@3@%H20 5K* QIC RT +:W@D CP G:P)A8P 4O0 6.P:WJSJ9-0!AJP!BU
M*<L=#&J !#* .P^2 TP;!$B .9'2 2- !"4-"7Y@!2L08QS@;%<@ 7,0!49
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M8N LD@$ ?4H(/E0"($ %0  "(U $>#X(-"("$.  6P '+O!_G?X(92 !4;
M/D ')"T->Y #9HX"8IZ&5U $V!T#DCH!B2 R(H C)+X"/R[H ? "%] ',%,&
M:;"?JD@)5[  JN@'$% $;& $3QX, A #9FX $_\O04 "&.XF**#L7WD$X<$%
M6% 7_PX)&9 &"5 'G9D 50 & ) #T#X)$@ %#>.4&^ $%,"TTA  'H\#)0#5
M^A<$7:#A)F "-8#OAZ !(\  64#P'. &E'#C[E[3#L#_ 3AN;I7^"$8DP&#
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M$!! @A"0"6IEB +:J""%,Y#A"VCX AG:\ 8L_Q!!"V30JN8CP8$2@$ +(R"
M"^3NC2"PP04BP$(*PO"S$22! T]@ #:)UH CQ%()6P #'-IPRRWL$FV\744$
M8%"3"^:[!"G@@*TYP,!N9$ &)R#!$(# @1 X800O8 ,Q( >O(P%#H 5]Q 54
M0 58H 1 < 1H@V*KP '7P'7-\WQD-E #\ 3UMPU^\ (N@ !+P%$(AP EP %W
MH F_4P%G\ 1%< 1# #A'T 5%\ 5+PPIR4 I#H#X%4 (G:'<&$ ;"MPIJH$,<
M0 %40 3QEP(RT (G\'J_HP<!0 =& #A-$ 9W( 'IUPH!(! NH#X;T $B  (<
MH(%<,(2IX ,.T (KT/\%6" $"& Z,' ?&H!S1*-(%; !;X:&D% %2S( ZF,&
M-@!]*1 ",C  1]"!TE  !- !67 $8] $G_<" + "B#=\TV L/+ ]09 %-J!_
M0@!Z \ !7,0-/B %.1 "0R %1\ !(# ",2 #$HB)VF #.* "I3@Z>E "OJ93
M,] "'C "-Z@8.? "73 &J),%+D  ,/ ;M.@-*5 *%B@Y&'!E4]:*OV4#EP4+
M04 $#4%:0$ !L&@#H_>,W* $ K&#O^, XS ")W ")= !.= "C+4-$@ #+E!S
M6W $(0   _ &EVB.NG ' D$9O^-%,X )U:0#.D  \Z4-/J %+< !M)<$"V;_
M !302@*Y#57 % #0/'CP/@CW @1@ CP ('/7 C. !%&P/S S )FWD=K %(#X
M.GL0 C5    0 S%@0SP0 S$)"YU# E0 !T @ C%0 ],HD]K &";P.P4P A^0
MDSR9 S2  D60B[I0!BT@ U8 !DY  :I4 G;(E*M@+!_P.S[0!#Q  P8  V'@
M '(@ 7S8"0XP "% !5Z !"4PC\-HEM*0*#10EXTB #G  R@P $5P 1%0!?FB
M#66@6%8@!F*0-!ZP!H#I#0/0%(I(-!L0 RC@ 0;0 C'P B%P!IVI"A!@ ")@
M!'LY QY  4^3F=.0 TVAE85C#T8@CRT  V>C!11 _VZNH 9"0 !/X 1.D (M
M0 #.2)O;0 !-L7VC$P05<!M&\0*/R #UV H2   SD 1@@ 0O4 ,*Y9S< )TW
MH)'J$V!1  ,(, 0,$)2A8 03*09.$ (#\ );:)ZZ@)[2N9XU!)Q/H)ZA@ $
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MF,@&!E "5Y@%+\"3[4(!2O &5$ ",0  =7"BM;H*&B 0(:("8\"I1(,&J80
M8Q &1A &3@ &4K $2>4S54"MM5H&QA(B!D"@F.A#7>EY%(  *3 "718=Y-JL
M[A:M1B63>Q  8$ " *"3#- $=E !J6FOQ *M'5"ON=D' E !RB"H!AL*!< 8
M-+#_C1%[L?:A G6!L1S;"I.ZI1T;LH]0 .4HLB9[LBB;LBJ[LBS;LB[[LC!K
M< ?0! @  FN@ %.@KC'+E).P 9VE 1I@!UJ@!6+   H0!WX0 % P!D5P!A"
M2#MKCD&  <>Q!%TPDC"0!"'P"R$P(C[ #G^  5[ !0D0 5 ;M9HG &=  4\
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MS$+ !8S\!6;P>+>\  ]04A1_!@NA\M<;IQL/(7M@S5;0!$0L!F#0!F>@#VP
M!S1\SV\5NT^<!G%L!GB #S\0R;L,!H;7QEF@ !*\\]GA!UL !44P!$G !5BP
M!<AIG]JZ!("<!8M'2W @\FL@!W)OQ6= R4Y@PQB?!4WPEUP/(7S@!$]@OTT
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MD( [@$$(:3A#X="@OKLX@ IT<( "/O2%!*SA!3>H@0SPH(,C\  $ 'A!#42
M@@%\  440 $):G"&/%2@ E,[11.HL(4M5+ M:C""%6)GA3?480TCZ( 1S*
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M #P'"  ZOV4+!H*I@"IL@ U-($(1CM $?)JB"$98@P(<8(>1)2"[HO%! :J
M!3 H  ('H(,2Z*D].$AA"5NX$WPUXP8T62 #^JW %(" "B*@(3X#'LT!E'"&
I.YBA5(KH@]9X%V'1;*JX5(B"!#I,G"!4X  )X -V2<SB%KN8(H$  #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ilmn-20241229_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ilmn-20241229_g3.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 7M#ZP# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 'R:7[/+G_5/_P!\FBS [?[=;_\ /Q%_WV/\:/MUO_S\1?\ ?8_QKB#;S?\
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M7,=Y8W42S07$+!DD1AE6!'4$$5YN,P-; RY:JWV9M3J1J*Z+U%%%<!J%%%%
M!65XI_Y%O4_^O=_Y5JUE>*/^1=U'_KW?^1H Y 1?NTX_A'3Z5W.DC;IEL/\
MIF/Y5QPC/EIQGY1_(5V6F_\ (/M_]P?RH M4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P 8%8>99>.@,C[QO?ZFNJTOP_\ %$8\VT\8#UWF[_J:_0W_ (1)_P#G[_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX22]\82++:Z9'HE[ \9.I"X(+NFTX3J3C)) Z#(/4^IO@;J4NL?"_P "7DH
M>72;(D+TXC4?TKWG/)KP3]DW3Y)?V?\ P*\Z2K+':O&5G0JP"SR@#! .   #
MTP!7NQY8T"1B>+-)N]6AMX[*.V,AD&^2XL8[H(%(96*NR\ J0,'.7!XV\Q+I
M^OQ722PW,,$(*&:W33XE:8J2'.X2?+O7:!D$KM]\"QXA\-P^(9M-DE('V&X^
MT*&>11G:0,;'7)!P?FR, @ 9)JO:^$8]/D+VCJF&5E626XD ()(P#,1@,2<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"_\ "P/#@ZZQ;?\ ?1_PH_X6)X;[ZS:_]]'_  KR!]%]JA;1..1^E [GLO\
MPL7PU_T&[7_OH_X4?\+&\-?]!NU_[Z/^%>+-H8_N4TZ"/[H_*@+GM?\ PL;P
MSG_D-VO_ 'T?\*#\1O#'_0:M/^^C_A7B?]A_[ _*@Z"#_#^E.P7/;!\2/#/_
M $&[3_OH_P"%)_PLCPQ_T'+3_OH_X5XE_8 7^#]*4Z /[OZ4@N>V?\+(\,?]
M!RT_[Z/^%'_"R/#''_$[M>?]H_X5XE_8 _NC\J5M!']S]* N>V?\+&\,[?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV;]_XDN98FR'0PJ P/!!(3/-=-#(D,21@G"@ ?*>WX5A[_%'_/[H?_@MG_\
MDFC?XH_Y_=#_ /!;/_\ )-3R^8&_]H7U/_?)_P *7[0OJW_?)_PKG]_BC_G]
MT/\ \%L__P DT;O%':]T+/OILY_]N:+:;C.@\]/]K_OD_P"%4Y+J\\X"(6QA
MP-WF&0-G'; (//KCBLO?XHY_TW0L=O\ B6S_ /R51O\ %'_/]H?_ (+I_P#Y
M)II=1&H]Q>C;M2U_VMTDG3GI\GT_7VI)I&DEL'8?.C$R>6"5!*D'!(!(SP"0
M/H*S-_BC_G]T/_P6S_\ R30'\3_\_NB?^"Z?_P"2:7+Y@;_VA/4_]\G_  I/
MM">I_P"^3_A6%N\2=[S1OPT^?_Y(IXD\0=[O23]+&4?^UZ.5=P^1HR:U91R%
M'N51U."I!Z^G2H_[?T__ )^T_7_"N2U+P1=:Q?RW=S=V1ED!5@EM,HVG/! G
MP>IQG)&:9:^ 'LY$=+N'<A+*6CE;!( .-TQZ@=.G?J34BN^QV4=_!?@F"590
MIP2N>":Q?&3B/0V.Q7_>J-K9QR?8@U:TC3Y--CE62592Y!!6,J!@8Z$FJ'C9
MLZ"?^NJ?SH*6QR]K:V]Q]^WC_ M_C5^/1+*3[T _!F_QJGI_05LP=J!$2^&]
M.*Y\CG/]X_XUE:QH]M;[/)CV<D'DGM[FNF1OE%4-1C$F?3([>U '*C3QZ4'3
MQZ?I6Y]GQ1]G'^10!A_V>/[M)_9X]*W?LPH^S"@#"_L]?3]*7^S1Z5N?9Z/L
M] &'_9X]/TI?[/'I6W]F%'V?'_ZJ ,3^SQZ4JZ>*V_LXH^SB@#(6P'I4T=B/
M2M/[./2GK'[4 5H;4+5R./%.5:E48% "HN*FCX-1@8IZM0 YCT_WA_.O8E^Z
M*\;SG;_O#^8KV1?NB@;'4444""BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'A;_ *"$G_@++_\ $UY2="']WOZ4?V"/[OZ4!<]5_P"%P>%?^@A+_P" LO\
M\32_\+@\+8_X_P"3_P !)?\ XFO)SH(]/TH_L$?W?TH#4]7_ .%P>%?^@A*/
M^W67_P")H_X7!X6_Y_Y?_ 27_P")KRC^P5_N_I1_8(_N_I0&IZNOQ@\*G_F(
M2?\ @)+_ /$T[_A;WA;M?R?^ LO_ ,37DW]A#^[^E.70A_=_2@-3U;_A;WA;
M_H(2?^ LO_Q-+_PMOPQ_S_R?^ LO_P 37E/]A_[/Z4J:%[?I0%SU3_A;/A@\
M"_D_\!9?_B:>OQ2\.-P+V3ZFVDQ_Z#7EB:&/2K$.B^U CU./XB:%+]V[<_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5\Q?M)<>/HO?3?_9C7T[7S)^TIQX\MO?3C_P"A&@#S?X>-U_WC7O\
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MW,D;$$QM&3DC@'((((R."09+/1;IM6&HZE?)<RPHT=M;V\7EQ0AL;VY)+,0
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MGT-(98^"O_(_^%?]^3_T$U]AU\>_!/\ Y*!X4_WI#_XX:^PJ "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8 <Y!^8?-TXZ5JQ-(T2F7[[<X (QGG!![CO[T^BI;8!12%L?X4N<^Q]",&D
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MY,_[Q_QKZD_X170_^@7#^;?XTG_")Z%_T"H/S;_&E_;V'_E97]EXGNOO_P"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\
MT_M-+M\::6?73I/_ $(U]+5\U_M.\>,=(_[!\G_H1H \G^'I_>/_ +U?0'AH
M_P"@I]*^?_AZ?WDG^]7OWAK_ (\4^E '!?%[_D):=C_GD_\ ,5Z;^SQD_#V8
M ?\ ,0F/Z+7GWQ9TV6X@M;J-"X@)60*,D*<<X]B*X;2_%FN:';FWTW5[RPMF
M8OY=O)M4L>IZ=3@?E0!]C;3Z'\J-I]#^5?(/_"QO%O\ T,FI?]_O_K4W_A8_
MBWMXEU/T_P!;_P#6H ^OZ*^0!\2/%N<?\)+J?_?W_P"M2_\ "R/%W_0RZE_W
M^'^% 'U_@^E)7R&OQ(\6G_F9=2_[^_\ UJD7XC>+/^ADU+_O]_\ 6H ^N*.?
M2ODM?B-XJ_Z&34C_ -MA_A4J_$/Q2?\ F9-1_P"_H_PH ^H+R^MA;740N%\\
MJT>W+*=V,8R!P1D<CH>:9IMS;6]A:6B2EYH8UC$;.TKY  Y8Y+''4DY/6OFA
M?B%XHX_XJ/4#]91_A5J+X@>)CU\07_\ W]_^M3UV ^H.AIVT^E?,L?C[Q)WU
MZ^_[^_\ UJG'CSQ'Q_Q/K[_O[_\ 6H0K'TGM/I1M/I7SG'XZ\0G_ )CE[_W\
M_P#K5;C\;:^W76[S_OY_]:BX6/H':?2I:\ 7QEKO_09O#_VT_P#K5:B\8ZXW
M76+O_OO_ .M1<+'NO/THP:\0'B[6_P#H+W7_ '\'^%/3Q9K6>=7NO^_G_P!:
MBX6/5?%W'A?4S_TR _45PO@[_D+'_KDW]*R)?$6IWD+03ZA/-$PPT;MD$=>>
M*W_!=C*)9+MT*1[=B%AC<2>2!Z>](>Q+XR;_ $&3Z&OGWQXW^A/7O_C1L6+_
M $-?/WCX_P"A/0!I? W_ )*-X7_W9C_XXU?8-?'_ ,"^?B1X9_W)C_XXU?8%
M !1110 4444 %%%% !1110 4444 %%%% !1110!\9_M\-_I6AKG_ )9Y_5J^
M6-'G,<B#-?8G[;7@'6O$EM8:O9PQ#2[*-5N+F:945"6(&0>>2P'U(KY"M]%D
MM6WO?Z;\IP5^VJ&_(X/Z5ZE"C4J13A&YS5*D(:2=CV[X=W9V+SV'>O3UNCM'
MTKPOP=XNTW1P@N+N'H!\LJD?J17<K\4M!Q_Q]K[@RQ__ !=>A'"U[:P?W'(\
M12OK)'=_:B32_:C7"_\ "TM"Z?:E_P"_D?\ \50WQ2T)?^7I>N/]9'_\75_5
MJ_\ (_N%]8H_SK[SN?M1]?UI?M1]:X/_ (6EH(7_ (^5QGG]Y'_\53C\4-"7
M_EY4=_\ 61__ !='U:O_ "/[@^LT?YU]YW1NSCJ:3[4?[U<-_P +0T+_ )^E
M//\ SUC_ #^_TI/^%I:$O/VD#_MI'_\ %4?5J_\ (_N#ZS1_G7WG=?:B>_?-
M'VH^M<+_ ,+2T+_GY';_ ):1_P#Q='_"TM"_Y^1_W\C_ /BJ/JU?^1_<'UBC
M_.OO.Z^U'UH-X?6N$_X6EH!&?M(QC/\ K(__ (J@_%30 ,_:1UQQ)&?Y-1]6
MK_R/[@^L4?YE]YW7VH^M+]J..M<&OQ5T!B!]HQWY=!_[-3O^%I:%_P _('UD
MC_\ BJ/JU?\ D?W#]O2_F7WG=?:_K2?:CZ]ZX4?%+0C_ ,O*]SS)'_\ %T?\
M+0T+K]I&/:2/_P"+H^K5_P"1_<+ZQ1_G7WG=_:CGK^=(;KWKAO\ A:.A'_EY
M7_OY'_\ %TO_  M#0O\ GZ7_ +^1_P#Q5'U:O_(_N#ZS1_G7WG<?:CGK1]I;
MU^G-<-_PM+0L9^TCL.9(\_\ H5'_  M+0N?])7CC_61__%T?5J_\C^X/K%'^
M=?>=S]J/K2?:CUSVKAO^%I:#_P _:],C]Y'_ /%?I1_PM+0O^?I?^_D?U_OT
M?5J_\C^X/K-'^=?>=S]J.?QJ&_NC]B?Z$UQC?%+0%SF[48XYDC'_ +-4-[\4
M] :W*"Z7)':1#U^C&E]6K_R/[AK$4OYU]YYE\0+DF\DY[UQ?@UMOQ&\/'_I^
MA/\ X\*Z?Q-)%KEPSVUY9@,3CS;E%/Y9KF;5(/"&O:/K>KZGIUGIEO>Q&2=K
MH-@!LG  )/ /0'I7%5H5HKFE%V7D=$*M.3M&5S[FG;$TB^C$?K46ZOA*^_X*
M,>)OMMQY7@[1WB\QMC&XE!*Y.#C'<5!_P\6\5_\ 0FZ/_P"!,M>,=MC[UW4I
M-?!/_#Q;Q7_T)NC_ /@3+1_P\6\5_P#0F:/_ .!,M 6/O7=[T;LU\%_\/%O%
M?_0F:-_X$RTG_#Q;Q7U_X0S1_P#P)EH"Q][9Q2;LU\%_\/&/%?\ T)NC_P#@
M3+2_\/%_%/\ T)FC_P#@3-0%C[SI-U?!O_#Q;Q3_ -"9H_\ X$RTG_#Q?Q5_
MT)FC_P#@3-0%C[SW4$^]?!G_  \6\4_]"9H__@3+1_P\6\5?]"9H_P#X$RT!
M8^WO$%C<:BMND&PA6R^X@=U(Q^1Z5CV^GZ_;V\%G'+Y,","98Y "$( *@$$Y
M!W'/N*^.?^'BWBG_ *$O1_\ P)FJ*?\ X*.>*8(RY\%Z.0.PN9: U/M#^S_$
M$:[5OY'##YG>12RG<0<<?W=OXY-6;2SUE-5M_/G9[",L&9I02Z_,5R !\P.W
M)[@')[5\2VW_  4<\4W40D3P9HX!Z;KF6K$'_!1+Q9+,D9\&:,"QP"+F6@+'
MZ 6K5ZE\-_\ D#S?]=C_ "%?G_\ "']K_P 2?$34+^UG\-Z79FUC60-%+(V[
M)(P<],8K[:_9]\4W7BGPU?2W=M';217&T+$Q((*@YYH$>J4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_#$LO_0"\.?^!S4?\,3R_P#0!\._^!S4 ?3A\7:!C_D.Z6/0_;(^#_WU2?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYO\ T!J^OZ^0?@+\WQ,\.^T$W_H)KZ^H **** "BBB@ HHHH **** "BBB@
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M5HVNR&19(K:)W49";57=CG:3CH2 /2N3$YTL11E2Y+7.JAEU2E44W/0^&O\
MAW:V/^1XA_\ !<W_ ,71_P .[3_T/$7_ (+F_P#BZ]G_ .%Q>,/^A&B_\&8_
M^)H_X7!XQ_Z$>+_P9C_XFOECW3QC_AW;_P!3Q#_X+F_^+H_X=V_]3Q#_ ."Y
MO_BZ]F_X7#XP_P"A&B_\&8_^(I&^,7C!<9\#0\G _P")F.O_ 'Q0!XU_P[N/
M_0\0_P#@N;_XNC_AW9Q_R/$7_@N;_P"+KV<_&#QA_P!"-#_X,Q_\31_PN'QC
M_P!"-#_X,Q_\30!XQ_P[M_ZGB+_P7-_\71_P[M_ZGB+_ ,%S?_%U[-_PN'QA
M_P!"-%_X,Q_\32_\+@\8?]"-#_X,Q_\ $T >+C_@G:?^AXB_\%S?_%TO_#NT
M_P#0\0_^"YO_ (NO9?\ A<GB\=? \7_@S'_Q-(/C)XO8\>!HO_!D/_B: /&O
M^'=IQ_R/$7_@N;_XNE_X=V_]3Q%_X+F_^+KVN/XL>-)?N^!(S_W$A_\ $U=A
M^(?CN;[O@.'\=44?^RT >#?\.[3_ -#Q#_X+F_\ BZKWW_!.22[MVC3QY"A/
M1CIS'_V>OHZ/Q=\09%R/ MICWU=1_P"RT_\ X2KXA_\ 0BV?_@X3_P")H ^:
M]/\ ^"<,UG:I$_CV!R!@LNFL/_9ZT;#_ ()Y&SOH)Y/&EO<I&V3"U@ZAAZ9#
MY'X5[Y=>+OB3#"#!\/K.X?< 4_MI%X/4Y*]O3O6=_P )]\7.?^+569XX_P"*
MBB_^(H'J9'PQ_90@\!ZM=WD>M0,+B%8C'#;R'D-G)+L?I@5]>?!3PX/#N@WL
M:W'V@23@YV;<84#U->#>'?$WC^[D(O\ P5:V">6&#+JR2_,3RN !T]>]?0'P
M?NM1NM!N6U&P2QD$^%6.82AA@9.0..>U COZ*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M51&SJ@P2 23M.  2> 3Q@5@1^(M<DBE)\)ZK%(J,RK)=66'8$ *")3C.202
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIK,%4DG ')-
M#J*\<\6?&:Y>ZDM]"$<=NAV_:Y5W-(0>J@\ =>2#D<X%<Q_PM+Q3_P!!=O\
MOQ%_\10!]%45\Z_\+2\4_P#07;_OQ%_\12_\+2\5?]!=O_ >+_XB@#Z)HKYV
M_P"%I>*?^@NW_?B+_P"(I/\ A:7BK_H+M_WXB_\ B* /HJBOG7_A:7BK_H+M
M_P!^(O\ XBC_ (6EXJ_Z"S?]^(O_ (B@#Z*HKYU_X6EXJ_Z"[?\ ?B+_ .(H
M_P"%I>*?^@NW_?B+_P"(H ^BJ*^=?^%I>*?^@NW_ 'XB_P#B*/\ A:7BG_H+
MM_WXB_\ B* /HJBOG7_A:7BK_H+M_P!^(O\ XBC_ (6EXI_Z"[?]^(O_ (B@
M#Z*HKYV_X6EXI_Z"[?\ ?B+_ .(I/^%I>*O^@LW_ 'XB_P#B* /HJBO#=!^,
MVKV,ZC5$CU*V)^9E0)*!Z@C"G'7! SZBO9M,U*WU;3X+RTE$]M,N]'7N#Z^A
M'((/(((- %RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/_?;\Z?'(^>7;\S0-G"^*/'$6H+HR66@>)KK[/JUM=S,NBS*%B0DL<D<D9'
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M\KO0.Q^I^ZEW5^6<7[6GQG>-6_X3N[&X9_X\[;_XU3Q^UG\9P?\ D>KK_P
MK;_XU0%C]2=U&ZORV/[67QG/_,]W?X65M_\ &J/^&LOC/G_D>[L_6RMO_C5
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M /?!_P *CDT5\QYB?[X_A/H?:NX\QO[[?F:CFD<^7\[??'<^AHN%CC_[%?\
MYY/_ -\'_"C^Q7_YY/\ ]\'_  KM/,;^^WYT>8W]]OS-%PL<7_8K_P#/)_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3Y3<?@:Y1M2N^?\ 2)!_P,_XUFZGK%XMO)LNIAD8^\3UXZ'B@#Q;]CC#7OB
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M\ZK9>AN(CQT^^M>L5Y+HOS:M8>OVB,_^/BO6J"0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KYI_:PTVTU+Q!X<6[MH[@+;3[=XY'(Y!&"#]#7TM7SG^
MU+_R,'AL_P#3O./U% '@/@GPY;R73B.\U*TVL0#;7KK^AR#7NWAGPG<R6H\K
MQ7XAML=EN(W'_CR&O'? ;?Z5-_O'^=>_^$6S:CZT 5+SPCJ:1G'C?7C_ +\=
MJW_M.N9OO#>I+(1_PF&K-_O6]M_\17I5\?W9KDM0/[P_6@#EO^$?U/\ Z&O4
M_P#P&M__ (BC_A']3_Z&S4__  &M_P#XBMK/-&Z@=C'7P_J>,?\ "6:G_P"
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M2_\ H:;#_P $Z?\ Q= %3_AA_P"$_P#SZ:Y_X-?_ +"C_AB'X3G_ )=-<_\
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M0K]0#D?C19C-^BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5A^*O%ECX/TTWM^[;>BQQ@%FZ9(R1P,CD]R ,D
M@'<KQ?\ :0;;:Z/Z%)\_]]P4 /;]I"T_@T29O<W '_LM)_PT= >FA2?^!0_^
M(KD?AO\ ">S\<^'Y]2N-4N;(QW#PE(40K@ '))!.>3^5=3:?L_Z/?6Z7%MXC
MO+BWD&5DC2)E8=,@@8//'%/06I-_PT9!_P! *3_P*'_Q%'_#14/_ $ 7_P#
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MZRO(M0MH[BW?S(9!E6Y!]P0>00<@@\@Y!KYM^('A.'P;K26,%S+=1M;K,7F
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M_42?[A_E7S!:MCX^ZR!U.C@=>/\ 7K7T_<?ZB3_</\J^7[<_\7^UC_L#\?\
M?]:DL[_<?J>G3_/I2^^:;Z?3O_GZTF>OIVH O:'\VL6!/)\^/)_X$*]:KR30
MSG6;#'_/>/K_ +PKUN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".2188V=R
M%11N8GH .IKSW7/$$^L2D M%:@X6,<9]V]3[=!^M=;XMF,.A7&TX+%5X]"1G
M],BO/: $Q[4M8^O^*K/PW+:)>).1<"0K)$@95* '#'(QN+!0>A8@$C(-5&^(
MWAK[/)+'J\5RD;,K+;*TK!E*AQA0>5WJ2.P.: .CHKG8_'VBQS/;WEVNG7JR
MO$+.X/[]BIQG8,D$\8!&2", Y%3S>+;2.SM+N*"ZN[:[9UAD@B)W%> ,'!!8
M@JJD D@C&<9 -ND/2N5_X6/I[3B-+2[D!@FN@Z",CR82HE;!<'Y2V,8R2#@'
M'/1:=JEIK%K]HLIUN8-[1^8H(&Y2588(!R""#QP01U!H 9J !MW^AKPM@/\
MA9ES@ ?Z)V'^W7NM]_Q[M]*\+?\ Y*9<?]>G7_@= '3T444 >L? '_5^(?\
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MPKUSX"_\>^M_[\/\FKR.O7/@+_J=;_WX?Y-0!ZO1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAXB^?QE$/2T3]7?_  KLH>(T'L/Y4 /HII;;Z_D:3>/]K_ODT /INVC?]?\
MODTGF#_:_P"^3_A0 ;?:F&.G>8/1O^^3_A2&5?1O^^#_ (4[B(F0=Z88_>IS
M(G]UO^^&_P *873T?_OVQ_I3"Q T>VF%?45.9$])/^_3?X5\@?MG?M?>*_@/
M\2/!O@[PMI>F2-K5G)?7&H:I%+(459!&$2,,@R<DEB2.V.]+0-3ZT9/Q%1M'
MGI7Q5K/[2GQ+30(KR/6+2WE*Y)CL(R"2/0YKSUOVOOBST_X22W_\%D'_ ,32
M&?HDZ=C5.:/;7Y\?\->?%C_H8[8_]PV#_P")IC?M;?%=NOB&V/\ W#(/_B:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M7SA^W-^T!>_ OX2I'H4_V?Q5X@F-AI]P,$VRA=TTX!ZE5P!Z,ZGG&" >X^)O
M'7ASP7'&_B#Q!I>AK("4.HWD=ONQUQO(S^%<Y_PT)\+_ /HHGA?_ ,'%O_\
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M?^ON'^9KPZOGSZ4*]<^ O^IUO_?A_DU>1YKUSX"_\>^M_P"_#_)J /5Z***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^>?VI_\ D)>&
M3_LSC]!7T-7SW^U1_P ?WA<_]=Q^BT >$^!_^/\ G]-Q_G7O?A _Z-7@?@?C
M4)_]X_SKWGP>W^CT ;U]_JZY*_/SFNKO_P#5FN2OS\Y^M %$FDW4TF@&JU D
M4U(K5#NIZMBI GC!=@H&68@ #U[5N;!:1")3DCEF]3W-4-#CWW#RGI$O'U/
M_K4EY)NR,]3@_2O0PM.^O<B<M+E>ZN#/PO\ J_3U]S5-N*G:H6KW(I15D<+O
M)W(6Z'Z'^59ND_\ ('LO^N2\5J,.#Z8/\JR]';S-%L'Q]Z%3C\*W6Q#6I(PJ
MUI.KR:5-W>V8_O(_ZCT(_6J\@J%J3BI*S!7B[H[>7Y3%>6SY. RL.C ]OH>E
M=!:W"75O'*GW6&0#U'J/PKC/"EV9;>>S<Y\O]Y'GT)Y'X'G\:W]#D,<EQ;YX
MSYBCZ\$?R->#BJ5K]T=T)<RN;J-ZU*K5 &Z5*IS7EFQ.K5*AJNK5*AH OV]3
ML?E-5[<U-)]TT <%X_;_ $?\:\#\?']ROUKWCX@?\>_XUX+X]_U2?44 >@?L
MU\_$M/;3'_\ 0EKZMKY4_9I&?B4?;2V_]"6OJN@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH \=^.'_(0T__ *Y?^S&O.(ONUZ/\<?\ D(:?_P!<C_,U
MYS'VH*+4(JQ5>&K%)B044M'\524)2TE% !1THHH **7::2@ HHHH 0=_J:=0
MO?ZT8H 2BE^E)0 444M "4444 %%%+0 E.7WIM.6J6XF2P=?Q]*W=&_X_K;_
M *Z C\ZPH?O5NZ)_Q_VV>GF#I]:9)SU%%% !4<W_ "S_ -\?R-25'-_RS_WQ
M_6@"2BBB@ HHHH 3TI:** "BBB@ HHHH *>.U,I] %VTKU;X<?\ (%E_ZZG^
M0KRJSZUZM\./^0++_P!=C_(4 =91110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>._M&_\@K2O]Z7^2U[%7C_ .T9_P @O2O]Z7^2U</B0T?&WC#_
M %I^O6F^#"?MB<]Q3_&0_>GZU!X./^FI]16DMS-GT1I#?\22?_KA)G_O@UR7
MP9!CTCP&C<%8K$$?@G%=1H[9T.?_ *X2<?\  #7,_"-O]$\$_P"[8C_T"I6Y
M)]D*O[QS_M?UJS4"_P"L/U/\ZL5D:(****!A11368(I)Z 9H 221(EWN<#UJ
MH;J65OW:;%]6&3^5(BF\DWMPH^ZOH/\ &KJH$& * *7EW+<^8WX "E\RYBZ_
M./\ :&/U%7J2@""&[2;C[K_W3_3UJQ52ZM0PWKPPY!%/M9_.4@_?7@T 6***
M* "BBB@""=0:\6^/QVW&A?[DO\UKVJ:O$OV@C_I&A?[DW\UK2&Y$MCR[X7KY
M<GC,YSOUQF_\E;<?TKF_B8V4D_'CWKHOAFW/B_\ [#+?^DUO7+_$QOOCZ]:9
MGU/#KS_CX>O3O@#_ ,E0\,?]?\7\Z\PNO^/@_6O3_@#_ ,E0\+_]?\7\Z:V-
MHGZ(T445B,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *\/_:@;_B5:*/5IOYQU[A7AW[4'_(,T3_>F_G%1U$RW^SW
M-]E^&=].<'R[V9\'..$4XX!].P/T-=A#XZLY+I8Y(S%'C+2 N^"1TP$YYXSG
MCK7*_LX_\D[G_P"PA+_Z"M>H^8_J?SK16ZHDQ_\ A+=*RB_:OOJ&7,;C()P#
MT[FM2X8I&?;/%2>8W]XU%,NZ-OI4RMT*CNKGD?Q#NI+N>WTZ-RLFH7,=DK \
M@.P!(]P,FO19+4K9_9;)A;[4$<!5<A ,!<#V  _QKS/XB?\ $M\1>&K^3B"W
MUFV:5CT"EMN?P+"O4/\ 5RX;D D$?H:F"M37G<Z\0]4EL8MUK1TVUCE/B_1[
M>)Y7B$DBH5WI@,@.[E@P(8<$9 QD<ZUO_:LUF+J+7;*>S>,3172P@H5ZY)!P
M5QSN!'Y<UR6C+?6NBZYI&GV=Q82ZCX@NK6&2. HL%N<%YQP  $#;3T+%0,YK
M;\3Z1=2::=+L-&E?2)7,=W''=*IE@2$!(T#-PK$*C#@X5N#NS5:G*3[KR;[/
M'_;VGW$TX%S"L*+NFMQR2H!.1ROS $8/;(IOBNS^W>'[U0,21(9XSZ,GS#]
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M/_)2/$W_ (*H_P#"OTI\OI_Q,(.> ?M"]^@'/>CRR91$+^(RE=PC$X+%<D9
MSDC((R,\@CJ*R^HYAO\ 6O\ R5?YE_6,-UH_B?FM_P ,8^*>?^+D>)O_  5)
M_A1_PQCXH_Z*/XE_\%2?X5^C%IKVDW[1+:>(]/N3+(8HUBNU8LX&2HP>H')'
M8=:N7$D=F8A/J<,1ED$4>Z<'<Y&=HP3SCG'8<]*7U',?^@O_ ,E7^8?6,-_S
MY_%GYM_\,8>*/^BC^)O_  5)_A1_PQCXH_Z*/XF_\%2?X5^DS%%D2,ZG;B1L
M[5-TN2 .<#/.!S42W5NUU';#5[8W,H<QQ"X&YPA <CGD*2 3T!(]:/J&8_\
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M_;E\-?L\^*QX2U?PUK6JWGV=;T7%@81%LD9L#YW!R""#QCISV'&_\/6? _\
MT(_B;_OJU_\ CM C[@HKX?\ ^'K/@?\ Z$?Q-_WU:_\ QVC_ (>L^!_^A'\3
M?]]6O_QV@#[@HKX?_P"'K/@?_H1_$W_?5K_\=H_X>L^!_P#H1_$W_?5K_P#'
M: /N"BOA_P#X>L^!_P#H1_$W_?5K_P#':/\ AZSX'_Z$?Q-_WU:__': /N"B
MOBS1_P#@J?\ #F\ODBU'POXHTNV8X-T(K>94]V59=V/]T$^U?4_PW^*/A7XO
M>&X]>\(:W:ZYICML:2W)#Q. "8Y$(#1N 0=K '!!QR* .LHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=U>N_ 7_ %&M_P"_#_)J\AW5Z]\!?^/?6_\ ?A_DU 'J]%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %?/?[57_ !]>%S[SC]%KZ$KY
M\_:J_P"/CPL?]J<?HM '@W@GC4IQ_M'^=>\>#_\ CW_*O!_!?_(2N/\ >/\
M.O=?"#?N?RH W[X_)7)7_P!XUU=\?D-<GJ'WS0!GDT!J1J3- #PU/4U$I_PI
MZU6H'0:*NW3;A_60#\A_]>J\N6<_3BIM';&DR_\ 74_R%0MRQKV<+\*,*FQ
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M^(_K0MC6)^A]%%%8C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O#?VH?^0?H?UF_G%7N5>&_M0?\>.ACU\__ -"A
MIH#2_9Q_Y)S-_P!A"7^2UZA7F'[.:[?AW+_V$)?Y+7I]40%)2T4 <+\2O"D?
MB+0[RT?*":,J'7JIQPP]P<$>XJO\//%K>*M%,=YB/7=.(MM2M^A$@'$H'=)
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M_;B _P"&P]&(ZG1K?./^NC?TH [SQ)G_ (1* 8_Y9C^5>2L?F//TKU?Q,?\
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M?FM+,(97 WOG))!R,DG_ /56EI/@GX=V-M)'9"W6UFNA*(UN7*K(T7E$*<Y
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ML]=TF12;NVTFW.!M2*Z$G/.03QTXQ@<Y/3'/K_\ PB.B?] FR_\  =/\*/\
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M7EPVZ>X\.Z?+(W/+&VC)//OFN]H **** "BBB@ HHHH **** "BBB@ HHHH
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M/_7:'_T UZY7SY\-_'-MX)CU$3P27)NY$8",@;=H(YSZYKM?^%ZZ=_T#Y_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY]_:
MK_UOA8_]-)O_ $%:^@J^?OVK/^96/_36;_T%: / O!G_ "$[C_>_K7NGA _N
M?RKPOP:?^)E<?[Q_G7N7@\_N: .AOO\ 5URE_P#>-=5>GY#7*WWWC0!FMUI.
MU*WZ4T&@!U.!IE*#0!T&C_\ ()E_ZZG^0J->=WUIVCM_Q*9_^NO]!38>=_L1
M_*O:POPHRF--1LN:F88J,]:[T8D##Y3]#_*LO0?^0#IW_7!?Y5KL/E/T/\JR
MM!7_ (D.G?\ 7!?Y5KT#J2R+4#+5F2H6%,5BSH?&KVWU/\C72VS?\3:+Z-_*
MN;T7_D+6_P!3_(UT5JW_ !-HO]UOY5P8K]#6&QOJ:F1JK(U3*>E?/FY.K<U*
MAJNIR*FC:@#1MST^M3RG]V:JVYZ58E;]V: /.OB WR"O"O'A^2/_ 'J]Q^(#
M?**\,\>-\L?^]3Z >H?LPKGX@WA]--'ZLM?4U?+G[+X_XK[4#_U#A_Z&*^HZ
M0!1110 4444 %%%% !1110 4444 %%%% !1110!X_P#'#_C_ --_ZY'^9KSB
M/[HKTCXX_P#']IW_ %S/\S7G$?0=J!]"S;U9:J]O5FEU#H- I>AI:*8!VHHH
MH$%%%% !UHHHH 0\&@M2T4#$7O\ 6EI%^\?J:6@0C=*-HI:* $^[0!BEHH 3
M.*/X:6B@K43FEHHH)$;I2J**5: )8?O5NZ+_ ,?UM_OC^=8<(^:M[1_^/ZU_
MWQ0!SM%%% !44W_+/_?'\C4M1S?\L_\ ?'\C0!)1110 4444 %%%&,4 %%%%
M !1110 4^F4^@"]9_P!*]4^'/_(%D_ZZG^0KRRTZ'TKU/X=?\@63_KJ?Y"@#
MJZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR']HC_D%Z7_ +TO
M\EKUZO(OVAO^07I?^]+_ "6KA\0'QOXT_P!8WUJAX3/^F+]16AXT_P!8>>]9
MOA3_ (_%^HK5K4AGT!HYSH<Y_P"F#]/]TUS/PE;]WX(^EE_-*Z71_P#D!S_]
M<)./^ FN8^$V O@H>]D/U2DMR3[67_6-_O&K%5E_UC?[W]:LU@:(****!A5:
M]C+Q9 Y4[L?SJS10!!:S"2,5/5&2-K5BZ<QGD@#I_P#6_E5B*Z20=>: ):*3
M<OK^M(TJKU- "LP49-4X?](NRW\*<G/N./\ &DDF>Y;RXQ]3Z?6K<,(AC"C\
M_6@"2BBB@ HHHH BF/%>%?M%?\?'A_\ W)OYK7NDW:O"OVC#_I6@?]<YOYK6
MM/<F6QY7\,&_Y&__ +#+#_R6MZYCXE<;S[' KI/AA_S-P_ZC+?\ I-!7-?$K
M^+CUJEN0>+77_'P?K7J/P!_Y*=X7_P"O^+^=>777_'P?K7J?P _Y*=X8_P"O
M^/\ G26S-(GZ&T445B,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *\._:;7=;Z",]K@X_X%#7N->/_M":3<ZE9Z1)
M;P/*L0F#;1DY)B. .YPK' YPK'H#30$O[/*[?AW+_P!A"7^2UZ77R_X;\:>)
M_"6GFPTNX-M;&0RE&M@QW'&3DC/8<5J_\+9\<?\ 00_\E$_PJB#Z+HKYU_X6
MMXV/_+__ .2B_P"%._X6OXW_ .?[_P E%_PH ^B*BGMTN%(<9_"OGIOBUXT4
MX;4<''0VJ?X4?\+:\:?]!$?^ J?X4%*ZU1[9>>$;2[)W(OXBJ:> +-6SL3\A
M7D/_  MCQI_T$1_X"K_A0/BQXT_Z" _\!5_PIWD;*M42M<]TLO#]M9XVH./0
M5I*H48 P*^>O^%L>,S_S$!_X"K_A3O\ A;'C/_H(#_P%7_"D92DY.[9]"TH8
MBOGM/BIXTDR4OMPS@E;13_2G_P#"SO&Y_P"7QO\ P$7_  H(/H)I-L;$ N5!
M(5>IP.@]S67:^(FNIHD_LG4H?,;;NFA4*O7DD,<#CJ,]1Q7B7_"SO&__ #^-
M_P" B_X4J_%#QN/^7QC_ -NB_P"%'09?^/ SXMLO^O)?_0VKU/X6L&\#:=CI
MNF_]'/7@>M:EK?B^_AGOTEN[M4$2;(-OR@DXP !U).:^@?AO;2V?@S3XI4V-
MF1A@Y!4R,58'T*D$?45+V&CIZ***0PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *K->1^8T:G>Z_> Z#ZU6\0:E_9.C7=V/OHN$_WB0!^I%9_A>,FS)8
MEW/)9CDD]R?<T ;!NF_N?K2?;6_NC\Z5H:C\NG85QWVYO^>?ZTTZ@W:,?]]?
M_6J,I2-'[46&9]_:_;;@RDE,@ @<CBJQTM?[[?I6N4]*C:/VI 97]EI_?:D_
MLM/[YK3:/\:85Q0,SO[+7/WS2?V>J_Q'ZYK1II4&@+F=]A'J?S_^M3#9C_:Z
M^M:#+_LU#(M ^A1-FH_B/Y__ %JC:!%]3^(_PJW)5>3K0)%:2-$R<'\__K5^
M:?[<UBEO^UWX=N!(S&ZT:)RK#[FV5E ![YQGMUK]*KIL+7YM_MTG/[67A+C_
M )@4?'_;=J!'5^*?^15A&?X!Q^'2O)FY8UZMXM;_ (I> $9^0#K[5Y.WWOY8
MH ]'_99_Y.<\.?\ 8$U'^<5?J3IW_'C#_NBORS_98/\ QD[X<]/[$U#^<5?J
M9IO_ !XP_P"[0!:HHHH Y/XIR>7\-_$TF-VS3IWV^N$)Q^E?)EM\>-.DM8]]
MKL)125\A2.@X!Q7V5XBT6'Q%H&HZ7.S+#>V\EN[(<, RE21[\U\ZQ_L2Z5'&
MJ?\ "3:H<#'^IB_PKZ3*L1A*4)+%/T/F\SH8NK4C+#[=3AQ\<-+;^!6] +<'
M\^.]'_"\-+/_ "SR<]K<?CQC]*]'TO\ 9#AT1IFL/%VJ6YE 60BW@.0#D#D'
MOZ5H?\,QWFXG_A-]5&3N(^R6^,^OW:]=XW+D_=V^?^1Y*P>86U_3_,\E/QRT
MQ6?Y >>UN,=.G3@5U7P<^)UOXP^*FA:?!;E"%GF,FT+]V(^@]ZTV_8JTQV9C
MXGU0ECN)\F+J>IZ5U?PO_9CT_P"&OC*V\01:S?7\MO%)$L,Z1JGSC!.0,GC/
MYUGB,9ESHS5-^\UIH:8?!YA&M%U/AN>Y44E+7Q!]L%>/?M._\DG\5_\ 8)NO
M_135[#7CW[3G_)*?%?\ V";K_P!$M0!^5NAD_P!@Z9_UZQ?^@"KN?YUGZ"0V
M@Z9Z?98?_0!5Z@!LGW&^AKWCPVW_ !3>C9YS86_'_;):\'?[C@9S@_RKW;PW
M_P BUHV,9^PVXS[>4M &B3Q_+_\ 71]./K29[>]&3P!_.@!>,<<?K_*CIUS_
M #_*D[8Z=.*.._/?- "[O3]?\_Y_.D]"/J.:3/7_ #_G\:!0!U?PI;_BYGA;
MWU.WP"/^F@K[ZKX#^%3?\7,\*?\ 83M\#V\P5]^4 %%%% !1110 4444 %%%
M% '-ZC_Q_3?[W]!56WS_ &UIN?[S?^@FK6H?\?TW^]_055M_^0UI_P#O-W_V
M30/H==1110(J:@MPUC<K9LD=V8V$+2@E0^/E)QVSC-<3:V/Q$AD03ZAI%Q&A
MW%EC96?);((QC@%,=.0>>@KB?VF?B#K7@63PV-)U"2P6Z-QYOEA<MM$>.2#T
MW'ICK7C2_'#QM):/=)K]PT*R"(X,>=Q&0,;>AP>?7BO7P^7U:U)5(M69XN(S
M.E0JNE)-M'U#-%\03#-)!/HHE+;8X9D<J%P,L6!Y;.0!C&,9.<U;O;?QDS:H
MMK=Z>@/SV+R*<@B12$? Z%-RD@$]".>:^4;SXY>-K&XEMY?$%PD\3%'4&/@C
MJ,[>U>M?%3XH:[X9_9P\/>)[;4I(-5NC8^;=!5W-Y@^;(QCGV IU<NJTI0B[
M>\[(5/-*52,Y)/W5<]&EL?'_ -EVB_TUY/[ZH5?H3D9!7.<+@C&!GK6IH/\
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M?VO=D"20*<97G!-? 2MW[XYK[&_9-\07NE_"-(K:141M1N6(,:MR6 ZD>PH
M^MY]4LO+/^FVW3_GNO\ C7BNKWEN/B-/+'-'.HM-I$#AR"6R,@'CH>OI6P?&
M&JMP9HB/>!?\*I/J\LDAD>"T=V&&9K9"2/0\<U<.5.\E=&555'!^S>I(VK1
MX\BY/NL8Q_Z%1_:R?\^UU_W[7_XJHHM4>&-(TMK-40!57[*AP!P!R,T[^V)?
M^?>S_P# 6/\ PKKYL-_*_O\ ^ >7[/,OYX?<_P#,D_M1?^?2[_[X7_XJE_M,
M?\^=W_W[7_XJF#6I5Z6]E_X"1G^E']N3_P#/O8_^ <?^%'-A_P"5_>'L\R_G
MC]S_ ,Q_]H?].EY_W[7_ .*IRZANS_HET/JB_P#Q51_VY/\ \^UC_P" <?\
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M/A_Y6'L\Q_GC]S_S.8-]C_EVN?\ O@?XTGV[_IVN?^^!_C74^7;_ //E9_\
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MKV\-\",I;CG7\*A9:L2=JA:NQ$6(7'RM]#_*LK0_^0#IO_7!/Y5L2?=/T/\
M*LC0?^0#IW_7!?Y5HMF%B:2HFJ>2H6ZTT%B;2?\ D*0'W/\ (UO6K?\ $VC^
MA_E6#I7_ "$H/J?Y&MNU;_B:1_1OY5QXC9^A<=#?C:IU:JJ-4Z-7SYJ6(VQ4
MJ-\U5@:FC;I_*@#2MZL2GY/PS56V-3R?</TH \V^(#=!7B'CH_+'_O"O:_B
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M)>Z\R5KB":'KM$DH8,2<Y  &,?R- &ND:QKA0%'H*=4/F_YS1YW^<T[ 345
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MWKMC(_U41&,8,:G^E)Y,/_/O;_\ ?E?\*7+V8<WD?$L&I>+QC=<ZV>.\LO\
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MK\SGQ'-[&?+O9GA_A[XDZAK7@^>__P"$NN([ZY96T]))&7,8'[QB.X#9#'L
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MXQU[$5T'GO\ WV_[Z- 7,$?$#P\?^8C)^-A=?_&J7_A/_#__ $$9/_ "Z_\
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M?R-2K3)OO1_[X_D: '44[@4%: &T4X+1MH ;13MM&V@!M%+2[: &T4[;1MH
M2GK3<<T\=J +MK]TUZG\._\ D"/_ -=3_(5Y;:_=KU/X>_\ (%?_ *ZG^0H
MZBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\D_:#_Y!>E_[TO\
MEKUNO)/VA&"Z7I>3CYI /KA:N'Q(#XZ\:_ZU_K69X4_X^D^O-;OC#2[VXD8Q
M6%U+SP8X&;^0K.\,Z+JD-T-^E7Z#/5K60#]16LDVR6>WZ3QHLX'_ #PD[_[!
MXKSSX5WTECX,\(WD!'FP6-I+&6&1N5%(R.XR!D5Z!I:W"Z3*AMYD=HF 5HV!
MR5(]*X?PKX<U#0_"^D:<;*[D^R6D4&XV[C.U0,XQQG%/V<C,]7_X7QXK/\=A
MZ_\ 'K_]>E'QV\5?W[#_ ,!?_KUYZ+&__P"?"Z_[\-_A3OL=[_SXW7_?EO\
M"CV3[#N>@_\ "]O%7]ZP_P# 7_Z]'_"]O%?]^P_\!?\ Z]>?_8K[_GRN?^_+
M?X4[[%>_\^5S_P!^6_PH]G+L',=__P +U\5_W[#_ ,!?_KTO_"]?%7]^P_\
M 7_Z]<!]AO?^?*Y_[]-_A2_8[W_GRN?^_3?X4O9R["YO,[__ (7MXK_O6/\
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M338WO_/E<_\ ?EO\*/9R[!S>9WG_  O7Q5_?L/I]E'^-<YXM\<ZIXT>V?4S
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M$I)_/M2Y/0"@9,&_+C/%4]2\0Z?HR@WEVD3'D1CYG/T YKC?$'CBXO+PZ9H
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M:P?^$HS_ ,NW_D3_ .M2'Q./^?7_ ,B?_6H'8W=GO^E1M'Z<?A6)_P ),O\
MSZ_^1/\ ZU-_X29/^?3_ ,BG_"F38V6B_'\*C:/\/PK(/B6/_GR_\BG_  II
M\31_\^7_ )%_^M1<+&HT?M4;1UF-XFCQ_P >?X>;_P#6J)O$L?\ SY_^1?\
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MJ_\ ^A;'_@P/_P :I#^VW?Y_Y%L?^# __&J /N[^WK+^\W_?- UVS8X#,3G
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M?AZX@NM5U%48@W'DE%2(D?P[G!([C)[5K3@JDK$RE;4[5?%5C-C[''=ZD"2
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M96XC7D]6;U-3[J""7<:3=[U'NHW4 8OA?"ZEXIP -VK9) QD_9;<9/O@ 9]
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M_P"^A7FPTRW_ .>?ZT[^S8!_!^M')YAS,]'\Z/\ OK_WT*7S$_O+^8KSD:;
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M,D9/)J]05J+FDHIIZTM1@3^=,)I>>::W2F0(U,8TK&F-0 C-ZFF-ZTXFHW-
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M.]?(BQ)_<7\A2A1Z#\JZ:-:--^]&Z.'%8:6(249N#\CZZ/@O]G7_ *'#5_\
MP(D/_M"FGP3^SN3QXSU@>PGD_P#C%?)( QT_2EVCTKK^M4?^?*/*_LK$?]!4
MSZS_ .$%_9Y/3QKK0]<32?\ QBC_ (0']GMNGC?6L]B)7_\ D>OD[:/2C:/2
ME]:H_P#/E#_LO$?]!4SZS7X>_L_?]#QK?_?U_P#Y'I?^%>_L_P#S?\5SK6<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M* "BBB@ HHHH **** "BBB@#R3XV_P#'[I__ %S/\S7G48PM>B_&S_C]T_\
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M^?\ ]:O,/^&3]/\ ^AVU[_OVG_Q5+_PRCI__ $.VO?\ ?M/_ (JCF?<#T_\
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M&T4ZB@+"?Q4\=J2G4!L7+;M7J'@#_D"/_P!=#_(5YA;]!7J'@#_D"M_UT/\
M(4".FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $ Q22?<;Z4ZN<
M\8>-++P?:QO>+(QF#!!&N1D 9SZ=1ZTUJP//H[S]V/I4,MZ*XZ;X@^'[%0+C
M6((2.#OCE'_LE5XOB-X;O'V0:_8R-V +C^:U[2E!=3/D.MFO1SS6;=:@!WJI
M]KBO(]\%[:R(>A\W'\Q5*XAED^Y/:G_MN*VC.G_,+E&WFH#GFN?O]1'-7[G2
M[R7[DEJ?^WA16->>&=6FSY?V,Y];M17;"K26\D0XE3^TA_>_6D_M)?7]:@/@
MG7/2S_\  Q/\:0^!]=]++_P,3_&NGVU'^=?>1ROL3_VDO][]:<-13U_6J_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX_YU?V31'W[1117*,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,Z+_ (0'5^.+;/I]KC_^*I?^%?ZP>UM[_P"E1_\ Q5<_]MF'_+5_S-'VZ?\
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MM-\1:7+J5G&NHVKN\RJJK*"220  /4UZ1SBI::W1I&I&:]UW'4444B@HHHH
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M7Z[U^1'_  5?_P"3GM+_ .Q6L_\ TINZN&Y,MCXQ84Q>_P#/%/;EO6FA=O\
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MV$_X(]J8_P!G'Q7G_H9WY_[=XJJZ9G9IO4^[O\FM^W_U$?\ N#^5<]716_\
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M/WGBD_[< _1J^BZ^=_V1Q_R-1_Z:0#_QUJ^B* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#R?XU?\?FG_\ 7,_S->>1?=KT3XT?\?EA_P!<S_,UY[#]
MVDQHM0U/4%O5C^&F'4/6C;1]WZTM 6&T4OO0U ]1,TI'%'O0U :B4O\ G%'X
M4;J U$HIU)]Z@5A%ZGZFBA>_U-.H'J(>>E)2GGI01Q0&HO--I1R:%H#4/\\4
MF,4O?BAJ U$HI3TH'2@5A*<M)WXIRT#U)8.&'\ZW-%_Y"%OG@;AGBL.W^\*W
M-%_X_P"#_>H%U,"C%%% @J*;K%_O_P!#4M1S=8O]\?R- $E%%% "&@#%+10
M4444 %%%% !1110 4^F4^@"Y;]1]*]/\!?\ (%/_ %T/\A7F-OVKT_P'_P @
M5O\ KH?Y"@#I**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR;X_
M?\@_2O\ >E_DM>LUY-\?O^/#2O\ >E_DM5'XD-;GRKXL7YVX[U@Z&O\ I8QZ
MUT/BI?F?ZU@Z*O\ I(^M:O<&>QZ)_P >*?2M'=6;HI_T-<>@Q6@&_P FI,R7
M=2@U&IIP- $JM^(IZM4-+NYH F#4N<5'NI=U $@:G5'NHW4 244RC=F@5A]%
M)NHW4!86BFY-(3ZT!8=FC=3:* L+FDW?SI"U)NJM1Z@_W3]*\Q\>?>?'/O7I
MC?=/TKS7QURS]>AZT(D\MD7]\?K7HGP3_P"2E^%_^O\ C_G7 NO[XX]:[_X+
M_P#)2_"__7_%V]ZO[):/OFBBBN4H**** "BBB@ HHHH **** "BBB@ HHHH
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M\D$^&_\ V+>G?^DT=>A5Y]^SS\WP$^&Y_P"I<T[_ -)HZ]!H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y3QQ9VMTME]IMH+D*6V^=$
MKXR!G&0<9_I75US/C3[MG]6_D* .1_L?3/\ H%V/_@)'_A1_8^E_] NQ_P#
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M;6DR)!=1R2,$C3+,S'@ #))^@K%@^]6@O_'K<?\ 7)__ $$T"/.O^%P>"?\
MH9]/_P"^S_A2_P#"X/!'_0SV'_?9_P *^/\ RZ/+% 'V!_PN#P3_ -#/I_\
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MVVZLA_TS;^=>4ZQ-F3\37J7Q2;;=6?\ US;^=>1ZI)NFH&C\L8[CRM0UL?\
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MGT *M+3:=0 HIU,I] "KUIZ?>7Z_UJ.I$^\OU_K0!%;G]R/JW_H1J7=44/\
MJQ]6_P#0C4E #@U29J&G*U $FZI <U#NIRF@"6GASMQ46ZE5J .6^(_W[/\
MZ]C_ %KZC^'OAGQGJFA^#I]%7.B^6PG;*^6"+B0R>8#\Q!4@+C/(/0\U\M_$
M;[UG_P!>Q_K7T'X=^%/Q@\8^&=*O_!6JZC9Z)Y+1B.VG=$\P2/N. <9.10!]
M%S>$BO(@..V4_P#K5QOB[PV56+*$8;GCZUYI_P ,^_M&_P#0?U@_]O4G^-1R
M?L[_ +1$PQ)K.K./1KAS_,T =9_8/3Y#^5*-"SP$Y^E<2_[,W[0+G/\ :^K#
M_=N9!_6F?\,Q_M ?]!C5_P#P*D_QH [K^P3W3\A2#0CT*?4XKAO^&8_V@/\
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MJ'G4>=1J!?\ .H\ZJ'G4>=1J!?\ .H\ZJ'G4>=1J!?\ .H\ZJ'G4>=1J!?\
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MYUU$?]A1^IKE8^5I,:+=O5C'_P"NH+?M5CC%,0AZ4?\ ZZ6C% QH[T!:=10
MFVC:*6B@04F,TM% !TI-HI:* &)W^IIVVA>_U-+0 4FVEHH 2C&:6B@!-M!6
MEHH 3_)H(XI:* #;^%*M)3EZ4 2P_>J]P+6X).%$,A))XQM.:HP]:O?N/L=S
M]JC:6V\B3S8U!)==IR !R21D8% 'YZ_VA:?\_=O_ -_5_P :/[1M/^?NW_[^
MK_C7M;?\,M;CCX3ZUMSQ_P 2"^Z?G2?\8M?]$GUK_P $%]_C0/0\5_M"T_Y^
M[?\ [^K_ (T?VA:?\_<'_?U?\:]N7_AECO\ "?6O_!#??XU(O_#*W_1)-;_#
M0;[_ !H#0\-_M"T_Y^[?_OZO^-']H6G_ #]V_P#W]7_&O<\?LJ?]$DUS_P $
M%]_C1_QBI_T237/_  07_P#C0&AX9_:-I_S]V_\ W]7_ !I?[0M/^?N#_O\
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M/_%&Z7W_ -%7\\4 ?N3^SY-CX#_#H?\ 4NZ>/_)>.N_\ZO,O@!-CX%_#P?\
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M!^<.?WLG^\W\S3J9_P MG_WV_F:?0 Y>E+2+2T %*.M)2KZT / IZTVE7K0
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M1<CG[;=?^C#0![C_ ,(G;^C_ /?UO\:/^$3M_1_^_K?XUU?R>E'R>E '*?\
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MH\77[H_E6<BXFS',)..AJ6L7SJMVVH#A9#]&_P :R-"_124M !1110 4444
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MI.I/&KI_\:I?^&L+C_H1I/\ P;I_\:KQ7RZ/+H"Q[3_PUC<_]"-)_P"#=/\
MXU2_\-8W _YD:3_P;I_\:KQ791L__70%CVG_ (:RN1T\#2?3^UT_^-4O_#65
MQ_T(LG_@W3_XU7BOET;* L>U?\-87/;P-)^.KI_\:H_X:RN!_P R-)_X-T_^
M-5XKLS2%#0%CVO\ X:QN.W@:3\=73_XU0/VL9_\ H1I?_!O'_P#&J\5V4;*
ML>U']K"X[>!I/QU=/_C51W7[74MC:O._@:4QJ,G;J\9/_HJO&MF*J:ZG_$DN
M/]TT!8]AT/\ ;DL-6NXK2/P5J"7<L@C6-K^/;@@Y);;Q@@#&.<Y[5]3:#K$5
MQ86-^=L0N;6.X6-V/ DC# $@'H& ) /? -?EKX)C"^+M/_ZZC^M?H/HOB)&T
M71D#XVZ=:*1GN((Q_2@+'IW]M[F)SU/K4L>L^_ZUP4>J;^C?K5F/4CZT%'H,
M.L>_ZU<CU4>O?UKSV'5#QS^M7HM5Z?-0!W2ZH/7]:D74@>]<7'JGO^M68]2]
M_P!:";'7+? U(E^1T8GV-<M'J'O5J&]]30(ZB*^$G!X-2^?[USBW9ZYYZ@@U
MH0W?F1@YYZ&K T_/]Z//]ZS_ #_>CS_>@#0\_P!Z//\ >L_S_>CS_>@#0\_W
MH\_WK/\ /]Z//]Z -#S_ 'H\_P!ZS_/]Z//]Z -#S_>CS_>L_P _WH\_WH T
M//\ >CS_ 'K/\_WH\_WH T//]Z//]ZS_ #_>CS_>@#0\_P!Z//\ >L_S_>CS
M_>@#0\_WH\_WK/\ /]Z3[1[C\Z -'S_>CS_>LMKY%ZN/P.:9_:2>] &OY_O1
MY_O6-_:@_N_K3?[84>G_ 'U2U V_/]Z//]ZPO[8]U_.F_P!MCU7_ #^-&H&_
MY_O4=PL-Y"8IXXYXFX*2*&4_4'BL,ZXOJO\ G\:0Z\!W4_C_ /7HU J:E\,/
M"6K$FXT2VR3DM#F(_FA%>/\ Q5^&%EX+N;;4-*C>/3KAO+,;.7\J0 D $DDA
M@">2<$'G! 'M/_"0J.I4?6N5^)6H0ZQX-OX"Z_(\,C'T431@G/; )Z4T]1J]
MSPV/5[RWP Z[,\C:,X^M<E_:7Q)73RG_  D'A][[[%(@F&E,$^U^;F.4IO/[
ML191DSG=A@<<5TOL1R.#FEVCTK2XW:YBMK7C4:@'_M/2OL'V]7,8L3YGV/R\
M/$&SCS1)\P?&-O!&:SUUCXEKI^U]<\/M?_82@E72V$?VSS01)MWY\HQ94IG(
M;D''%=0RKZ?C43!/2F2<[8_$CQ#/K&J6<LMJ$M-12T4BW )1X1(N3GKDGGN!
MC%7O^$_UC[/YWGVX'DF0?N1@;6P><]/Y5P=_!J5KXXUEX+.Z-O+XBT:19%B8
MHT;1%9F!QC:O1B.!QDBL,W>O/H.#I%\)5T76%P(&+>:ET#",8ZLHRHZD<C(I
M7%H>N?\ "<ZSYWE^?!_KA%_J!W7<.]1_\+ UCR!+]HMR/*\W_4CLVT]^E<):
MW&L)XGVFPN3;'7].4N8V"^2UI^\DSC&U6P">@/!P:P+RXUX>$_-CTR\^V?\
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MY<#=]UE^5%_A/))Z5L\=QFE*IZ56@$>F^)_$T4=S_:5[8W+M<RM!]FM/+6.
MG]W&V22SJOWFX!)X %7=&LM0\=>(++2(Y%66ZDP9 G$: $NQ&>< $@=S@=ZS
MIF&#BN]^ ^R'Q9?WQZ06+1DL!C+R)MP?7"/TZCZ53LD"U9ZO8_ [P19)&'T9
M;N15 ,EU+)(6P.I!.W)Z\ #T %=9HOAW1O#JD:7I=GI^1@FV@5"1Z$@ G\:H
M?\) /5:/^$@'JM<]V^I9T?G^]'G^]<Z-?!_N_G_]>E_MP?WE_P _C2U Z'S_
M 'H\_P!ZP/[:_P!W_/XT[^V!_>7\Z-0-WS_>CS_>L0:PIZ ?3=3O[4'<?K3
MV?/]Z//]ZR!J2-W(^HIZWJ-T<?GB@#4\_P!Z//\ >L_S_>CS_>@#0\_WH\_W
MK/\ /]Z//]Z -#S_ 'H\_P!ZS_/]Z//]Z -#S_>CS_>L_P _WH\_WH T//\
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MBK2_^?A_PMY/_B: ->EW5D?\)5I?_/Q)_P" \G_Q-'_"5:7_ ,_$G_@/)_\
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M%64G."+=.*[GS_>N8M=5M["WBMK<(EO"@CC51@!0   .,# '&.*G_MY?5?\
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M_@2_X4G_  E1_P"?>3_OM?\ "@#IJ='_ *P?A7,_\)8?^?>3_OI?\*4>+-K
M_9Y#@_WE_P * .AM?^/=/JW_ *$:EKF(_%7EH%^SR$ GHP[DGT]Z?_PEP_Y]
MI/\ OI?\* .DHKG/^$N'_/M)_P!]+2_\)<O_ #ZR?]]#_"@#M-#\0:EX9OQ?
M:1>RZ?>;3&)X2-VT]1R",' K8N?BEXOO+>T@G\0W;Q6@(@3Y0$SUZ $D\<G)
MX%>8R>+G&/*MN<\B1AC'MBF_\)A<?\^L7_?1H ]4NOBKXQU"SU2UN?$5Y<6^
MJ1F&]23:?/0@ J3C@$  X(R !7+5RH\8W'_/I'_WT:7_ (3"X_Y](O\ OHT
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M,\C[RGJ#5ND 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !11368(I)(  YS0 ZJ&I:Q;Z7'F5_G
M/W8U^\?P_K6#K?C:.'=#8$2/T,Q&5'T'?Z]/K7(S7LD\ADD<N[')9CS3L(W=
M2\03:DQ#'9%GB-3_ #]35#[0*SO/]Z//]ZH-31^T"C[0*SO/]Z//]Z U-'[0
M*/M K.\_WH\_WH#4T?M H^T"L[S_ 'H\_P!Z U-'[0*/M K.\_WH\_WH#4T?
MM H^T"L[S_>CS_>@-31^T"C[0*SO/]Z//]Z U-'[0*/M K.\_P!Z//\ >@-3
M1^T"C[0*SO/]Z//]Z U-'[0*/M K.\_WH\_WH#4T?M H^T"L[S_>CS_>@-31
M^T"C[0*SO/\ >CS_ 'H#4T?M H^T"L[S_>CS_>@-31^T"C[0*SO/]Z//]Z U
M-'[0*/M K.\_WH\_WH#4T?M H^T"L[S_ 'H\_P!Z U-'[0*/M K.\_WH\_WH
M#4T?M JI/K$<.?4#C/'-0^?[UR>I32%FQTR:E@CI)O%$<8YV_G_]>JO_  FD
M"N-\@"9&>G3O7G^H-<MG&>:Y^\CO#G&[-!5CS_QWH\DVI7+R#?(T\DC$<G!<
MD'Z$$$=JZKX1Z:L&KVS8Z#D54U33;B]7$\7F@#"E@01]",$?@14&EW>M^'9Q
M+97$T>WHK!9!_P"/J2?Q-(+'T)/;1-(?\*9_9B-SBO%I/BAXT#<7$?\ X!V_
M_P :J,?%;QPG2YC'_;E;_P#QJ@+'M)TM?2F'2T]*\;_X6UXY_P"?F/\ \ K?
M_P"-4?\ "V?'/_/S'_X!6_\ \:HN%CV(Z4#VJ-M)'_ZZ\?/Q8\<G_EYC_P#
M*W_^-4W_ (6GXX_Y^H__  #M_P#XU0&IZXVD#TJ%]('I7E!^*/C<_P#+S'Z?
M\>EO_P#&J3_A9_C?_GY3_P !+?\ ^-T7"QZ@^CC^[^E0/HX_N_I7FG_"S/&I
MZW$?_@);_P#QJD/Q)\9G_ENG_@);_P#QJ@+'HLFCKZ57DT53VKS\_$7QB?\
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M:;S&Y[G'-?,W[1U])=ZC!/':7=V"RDM;P-* !$B\X!QRA'X#U%?0FK6<LA?
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MS!RC?M _Y[QXX'^M7MT[]J7[2/\ GO'W_P"6J]^O?O3_ /AG7P'_ -"M;_\
M?3_XT?\ #._@7_H5K;_OI_\ &CF#E&BZ'_/>/M_RU7MT[]J7ST/_ "VB]?\
M6K_C3U_9[\#+T\+VX_X$_P#C3U^ '@I>GAFW'_ F_P :.87+YD?G)VEB_P"_
MJ_XTDDNQ=SNB#^\S #\R:MK\"?!R=/#EN/\ @3?XTJ_ OP4K CPO8YSD?N\\
MT^<?*<Y<>)-+R4&IVLCX)VP2"8\>R;B/Q%;'@_QQ%HK78CE.RX$7RM@'*&4Y
MQDD B0  X/!R!QG;7X4^'XP -*4 =!O8C^=6X?ASH\/^KTY1]&;_ !I.3:L"
MBEJ;-C\0!.HQ)^M:T/BSS.C_ *USL/A"TA^Y;;?HQJY'H:Q_=CQ^)J"S?3Q&
MYZ&I5\0L>]8:Z:R]!C\:F2Q?W/X4"-R/7BW>K$>N$GK^M8,=D_H:LQVK\<4
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MC</_ #S'Y4!8^ I?V38YNL#_ ($BFQ_LFF+_ %<EU'V^60_X5]__ /"-P_\
M/,?E1_PC</\ SS'Y4!8^!D_99N(^ES>^_P"\_P#K4+^RB'N!)(LTK\#<[$G
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ME_X;;^,?_0?\-_\ @A7_ !KO/^&2-)_YZ3T?\,D:3_STGH"QP?\ PVY\8_\
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M/J"*5@*+Y_\ K57D7=P1^5:)CSV8?04QH0.2,>Y%%AF++8HW;\Q5632HVSD
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M?P[5F0H%Y<Y/91TJS]H%585S2\_WH\_WK-^T"C[0* U-+S_>CS_>LW[0*/M
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M?V+!_?/Z_P"-']BP?WS^O^-/^T"C[0*+!J1_V+;_ -\_K_C3O['@_OG\"?\
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ME8.8\P_X5W!_SQ_2G#X=P#_ED/RKTW;%@#8..!@T?NO[@Z@\\T[!S'FR_#^
M8_=?CBI5\ P+_P LQ^5>BKY0_A_,DT!HQ_ /YT6"YY_'X'@7'[L?E5J+P7$O
M_+/Z<5VX:-6R%&:7S$_NK^5%@N<?'X3C7_EG^0JS'X;C7^#]*Z?S$_NK2^<.
M/;I3L%S CT%5R0F<=<"K$>CJ,?(>F0,9XK8^T"C[0*+"N9\>DCH$.?4C'\ZL
MKINQA\HQQW&*G^T"C[0*+!<<EGMQRH^@/7-68XXU'/)R2.>W:JGV@4?:!18+
MFEYV. <#L*//]ZS?M H^T"@-32\_WH\_WK-^T"C[0* U-+S_ 'H\_P!ZS?M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M .^C_A1_PN7P;_T,-G_WT?\ "OBBBC_53#?SL/\ 7S%_\^H_B?:__"Y?!O\
MT,-G_P!]'_"C_A<O@W_H8;/_ +Z/^%?%%%'^JF&_G8?Z^8O_ )]1_$^U_P#A
M<O@W_H8;/_OH_P"%'_"Y?!O_ $,-G_WT?\*^***/]5,-_.P_U\Q?_/J/XGVO
M_P +E\&_]##9_P#?1_PH_P"%R^#?^AAL_P#OH_X5\444?ZJ8;^=A_KYB_P#G
MU'\3[7_X7+X-_P"AAL_^^C_A1_PN7P;_ -##9_\ ?1_PKXHHH_U4PW\[#_7S
M%_\ /J/XGVO_ ,+E\&_]##9_]]'_  I?^%S>#!_S,5G_ -]'_"OB>BC_ %4P
MW\[#_7S%_P#/J/XGVO\ \+E\&_\ 0PV?_?1_PH_X7+X-_P"AAL_^^C_A7Q11
M1_JIAOYV'^OF+_Y]1_$^U_\ A<O@W_H8;/\ [Z/^%'_"Y?!O_0PV?_?1_P *
M^***/]5,-_.P_P!?,7_SZC^)]K_\+E\&_P#0PV?_ 'T?\*/^%R^#?^AAL_\
MOH_X5\444?ZJ8;^=A_KYB_\ GU'\3[7_ .%R^#?^AAL_^^C_ (4?\+E\&_\
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MH_U4PW\[#_7S%_\ /J/XGVO_ ,+E\&_]##9_]]'_  H_X7+X-_Z&&S_[Z/\
MA7Q111_JIAOYV'^OF+_Y]1_$^U_^%R^#?^AAL_\ OH_X4?\ "Y?!O_0PV?\
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MO_GU'\3[8_X7+X,_Z&*S_P"^C_A2?\+E\&_]##9_]]'_  KXHHH_U3P_\[_
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MM?\ X7+X-_Z&&S_[Z/\ A2_\+E\&?]#%9_\ ?1_PKXGHH_U4PW\[#_7S%_\
M/J/XGVO_ ,+E\&_]##9_]]'_  H_X7+X-_Z&&S_[Z/\ A7Q111_JIAOYV'^O
MF+_Y]1_$^U_^%R^#?^AAL_\ OH_X4?\ "Y?!O_0PV?\ WT?\*^***/\ 53#?
MSL/]?,7_ ,^H_B?:_P#PN7P;_P!##9_]]'_"C_A<O@W_ *&&S_[Z/^%?%%%'
M^JF&_G8?Z^8O_GU'\3[7_P"%R^#?^AAL_P#OH_X4?\+E\&_]##9_]]'_  KX
MHHH_U4PW\[#_ %\Q?_/J/XGVO_PN7P;_ -##9_\ ?1_PH_X7+X-_Z&&S_P"^
MC_A7Q111_JIAOYV'^OF+_P"?4?Q/M?\ X7+X-_Z&&S_[Z/\ A1_PN7P;_P!#
M#9_]]'_"OBBBC_53#?SL/]?,7_SZC^)]K_\ "Y?!O_0PV?\ WT?\*/\ A<O@
MW_H8;/\ [Z/^%?%%%'^JF&_G8?Z^8O\ Y]1_$^U_^%R^#?\ H8;/_OH_X4?\
M+E\&_P#0PV?_ 'T?\*^***/]5,-_.P_U\Q?_ #ZC^)]K_P#"Y?!O_0PV?_?1
M_P */^%R^#?^AAL_^^C_ (5\444?ZJ8;^=A_KYB_^?4?Q/M?_A<O@W_H8;/_
M +Z/^%'_  N7P;_T,-G_ -]'_"OBBBC_ %4PW\[#_7S%_P#/J/XGVO\ \+E\
M&_\ 0PV?_?1_PH_X7+X-_P"AAL_^^C_A7Q111_JIAOYV'^OF+_Y]1_$^U_\
MA<O@W_H8;/\ [Z/^%'_"Y?!O_0PV?_?1_P *^***/]5,-_.P_P!?,7_SZC^)
M]K_\+E\&_P#0PV?_ 'T?\*/^%R^#?^AAL_\ OH_X5\444?ZJ8;^=A_KYB_\
MGU'\3[7_ .%R^#?^AAL_^^C_ (4?\+E\&_\ 0PV?_?1_PKXHHH_U4PW\[#_7
MS%_\^H_B?:__  N7P;_T,-G_ -]'_"C_ (7+X-_Z&&S_ .^C_A7Q111_JIAO
MYV'^OF+_ .?4?Q/M?_A<O@W_ *&&S_[Z/^%'_"Y?!O\ T,-G_P!]'_"OBBBC
M_53#?SL/]?,7_P ^H_B?:_\ PN7P;_T,-G_WT?\ "C_A<O@W_H8;/_OH_P"%
M?%%%'^JF&_G8?Z^8O_GU'\3[7_X7+X-_Z&&S_P"^C_A1_P +E\&_]##9_P#?
M1_PKXHHH_P!5,-_.P_U\Q?\ SZC^)]K_ /"Y?!O_ $,-G_WT?\*/^%R^#?\
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MOBBBC_53#?SL/]?,7_SZC^)]K_\ "Y?!O_0PV?\ WT?\*/\ A<O@W_H8;/\
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M@_&3P<I(/B&S!S@@L<_RI/\ A<O@W_H8;/\ [Z/^%?%%%'^JF&_G8?Z^8O\
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M?\+E\&_]##9_]]'_  KXHHH_U4PW\[#_ %\Q?_/J/XGVO_PN7P;_ -##9_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444KHKE?8****9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444#"BBB@04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% PHHHH$%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444#"BBB@04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Z
ML_L^?\D1\#_]@FV_]%K7Y35^K/[/G_)$? __ &";;_T6M?!<7?P*7K^A^I<
M_P"]5?\ #^J/0J***_+S]N"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ^>_VXO^2$W7_7];_P#H1K\Z*_1?]N+_ )(3=?\ 7];_ /H1K\Z*
M_6^%?]Q?J_T/P+CC_D9Q_P *_4****^R/SP**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "NX^!^FVNL?%
M[PA8WUM#>6<^I0QRV\\8>.12<%64C!!]^*X>O0?V?_\ DMO@G_L*0?\ H0KB
MQS:PU1K?E?Y'IY:E+&T4U=.2_,^WOBN?@I\&/[+'B3P5HL9U(2F#[/H<$G^K
MV;L_+Q]]?UK@!\<?V;>_@_3S_P!RY#_\372?MB_!3Q7\7V\(GPQ9Q7G]GB[%
MQYMPD6WS/)VXW'G.QO\ )KYO_P"&+/BM_P! 6U_\#XO_ (JOSG+\/E]?#1GB
M<0XS=].;S/US-L1FF'QDZ6#PBE35K/DOT7ZD7[3'CCX;^,I/#I^'NCV^DBV%
MS]N$&G):;]WE>7G:!NQB3KTR?6O$17HN@?#Z]\'_ !X\-^$_$ME UU'K-A#>
M6C%9HF21XFVMU# HX&.>I%?9?Q2^$_PL^'^K6GCOQ!I.FZ?H6EV_E1:58V2(
M+NZ9B0610 Y"C 4Y'))P%Y^FEF-#*52PM-.:DKIWO>^Q\9#*<3GDJV,JN--Q
M:4E:R5M_N/SO]:/K7OWQV^,FG_M#W7A'0/"WA^XTN6UN9+>WMW" 2>:8U4 )
M]W!7D=.>M>X:II/PY_8W\#:;/>Z+!XE\77OW&E53+,XP7968'RHUR!\HR<KP
M3DCJJ9M.C"FITG[6>T+_ (W.2CD-.O5JRA77L:=KSMIZ)'PB/RHYZU]U> _C
M=\/?VHM6G\*^+/!MMIFIW49%F\DBS-+M!)"3!$=' &0!U //8_*_QV^$]Q\&
M_B'>Z"SO/8LHN+*X<<R0,3C/ &005/\ NY[UKA,S=:M+#5Z?)-:VWNO)G/C\
ME6'PZQF%JJK2;M=*S3\T>>]J2OOK_A4?PYG_ &</"VOZ_I&GZ9;VNEV.HZA?
M6=E&MU<@0HS1^8 &S(Q )SDY]\USWPI_:P\'Z]XDTWP3%\/+70M$U*9+.)HY
M8Y%+$A8Q)%Y:CDX!^8X]Z\^.>U*T)3H4')0OS:I))?F>H^&:5&I3IXK$J#J)
M<NC>_P"7J?$_M1Q7W-\9/"OPR_9O\2?\)LWA=-:U#5FV6.A,52T@D4$RRKE6
M"CYDXVG!SM SQU7PT\9^#_VOO!VN66K^$X=/N+ ) \>]97A5PQC>*7:K*05;
ML,8[Y-3+B"7LEB8T'[+J[K\NII'A6/MY8.>)2K;J-GJO7IZ'YW4M:7B;1)O#
M/B+5M'G/^D:?=RVDG0_,CE3R">X[&LWTKZZ$XSBIQV>J/@ZE.5.3A):IV$I:
M^F/V0?V?],^(<FH>+/%,"W'A[3G\J&UD;:D\P4,S2>J("IQT).#PI![+Q'^V
MGX+TF[N?#^C_  [M=4\-1R;=[21P1RXP"PA$3 CCC)R0 2!7S]?-I_6)8?"4
M74<=W=)(^KP^14_JL<7CJZI*?PJS;?W'QK25^D?P@^%?PG\6>%+CQ%HGAO2]
M2TW5[E[N*+4+"*62S.Q$:#Y@VT!D9MH.!O...3\,?!+X5W/QB^(%CX>MY&MK
M=@9[RZ52?)@4C<PX(R20HSQN89XI83.J6(5:4X\JI[W_ *\A8[AVO@Y4(PFI
MNKM;Y?YG!TO'%?<'C+XX?#O]E[5E\*>$?!D&K:E:*%O+E9EB9&(!PTVUV=R/
MO X X'L'Q^&? /[8GP]U+4M#T:'PSXST\;6\M5#)(0QC#E0!)&^"-Q 8$'TY
MP_MR<4J]6@XTF])7[]T=;X:IRE+#T<2I5XJ[C9].B?5GPW2]B*]<_9E\+VNJ
M?M">'M$U[3(+R 2W<5S8WL*R(62WF.&5@0<,H/(ZCU KZ&^-#?#/]G/QLFO'
MPE8ZWK>HPJ++1(8([:VLXDRK2G"L-S,< [<\'&,$GJQ6;*AB5A84W*4HW5G_
M %]YPX+(7BL)+&U:JA",N65^FW^>Q\.T$?E7Z'>!?$W@W]LCP9K<6K^%X["_
ML=L#,S++-!O5C')'+M4]0W&!TY!!KX,D\'ZA_P )I)X7AA:;5!?G35BP06E$
MA3!ZX^;\JO YI]9E4IUH<DX;J_3U,\RR5X.-*MAZGM(5-$[6U]#$ZT?SK[OU
M32?AS^QOX&TZ>]T6#Q+XOO?N-*JF69Q@NRLP/E1KD#Y1DY7()R1%X#^-WP]_
M:CU:?PKXL\&VVF:G=1G[(\DHF:7:"2$F"(R. ,@#J >>QX/[<J2BZ].@Y4D_
MBO\ H>K_ *LTHSCAJV*C&O):1L_N;/A2E_&O0OCM\)Y_@W\0[W06=I[ @7%E
M<..9(6)QG@#((*G_ '<]Z^M_^%1_#B?]G#PMK^OZ1I^F06NE6.I:A?6=E&MU
M<@1(6C\P -F1B ><G/OFNS%9S2P\*52,>:-3:QYN"X?KXNM7H2DH2I;W/@:B
MOMCX4_M8>#]>\2:;X)B^'=KH6BZE,EG$T<L<BEB0L8DB\M1R< _,<>]7_C)X
M5^&7[-_B/_A-G\+IK6H:LVRQT-BJ6D$B@F65<J0H^9.-IVG.T#/'&\[JTZWU
M>KAVI25XJZ=_\CT%PW0JX?ZU0Q2E"+]YV:M^K/ABBOT1^&GC/P?^U]X.URRU
MCPG#I]Q8!8'CWK*\*.&,;Q2[592"K=A@CODU\ >)-#E\->)-4T><?Z3I]W+:
M/@@_,CE#TSGD=LUZ&7YD\74J4:M/DG#=;GEYIDRP-*EB*%7VE.IL[6U]#-HK
M[3\*_#GP1^R[\+K/QAX[TN/7/%=\!Y%C,@<QNRY$**_ VC[[XR.0,\ VO!W[
M3'@/X^>(+7PCXP\"VNGQWV+:SGEF6X7>3\D>[RT:,D]"IZX'&:X99U.7-4H4
M'.G'>5_R74]&'#E./)2Q6)4*TUI&S?I=]#XBH_E7JW[1WP7/P5\?'3[622?1
M;V/[382R\L%R0R,>Y4]_0BO*:^AP^(IXJE&M3UBT?)XO"U<%7EAZRM*+#^&D
MI3[5]G^+/ /A7Q_^R#%XJT3PWI=AKEK9QW,UQI]E$DA>%@EQN*J#MP)&Q[ ]
MJY,;CE@I4U-74W:_8]#+<KGF4:KIRLX+FMW/C#L:*]Q_8[^']GX]^,$8U2QM
M=0TO3K.:ZGMKR(2Q29Q&H*L"#R^[D?P^N*Z_]MSX<Z%X7NO">N^&=.T[3]*U
M"WDA*Z9 D<3LI#H_R##;E<X/HHKGGFE.&/C@;:M;]CIIY)6J99+,[Z)[?<KG
MR]7M_P"S3XX^&_@UO$G_  L'2+?5?M0MQ8^?IR7?E[?-\S&X';G='TZX'I7J
M'[*/P]\+VWP9\5>-O%FB:;K$,<DKQ+J%K'+LC@CR=K.#@LQ8<?W1^%7]B#PC
MX>\?W_Q N->\/:5JGEM:20175E'*D&\W!81AE.T<*,#LHKS,PS&E6H8B$HOE
MIN*NG:[NMCVLKRBOA\3A*D91YJJDTFKI*SW_ $/F3QM?:=J7C37[S2(5@TFX
MU"XELXDC$82$R,8U"C[H"D#'08QVK&KNO&?A635OC=K_ (;T6TCB>X\0W%C9
MVL*A(TS<,B* .%4#'3@ =L5]C:\WP[_8S\%Z84T>/6O$MT,1R,BBYNG7&^0R
M$-Y:#(P!GJ  >3796S..%IT:=*#G.:7+'R\V>?A<EECJM>M6J*G3IM\TO/R1
M\4?"JRM]2^*'@^SNX([JUN-9LXIH)E#)(C3H&5@1@@@D$>A(KZ$_;L\$>'O!
MK>!_[ T+3M%%RM[YW]GVD<'F;?(V[M@&<;FZ^I]:Z7P#\8/A[^T-\0M%M=6\
M(1>%/$]M?17^G:A!.LAGEBD60QNX1,[@I&&!SDXP<9K?\%% %D^'^/2__P#;
M>O%^MUJV<8>-6#@TG=7OT?WGT/\ 9^'PV0XJI1J*I%N-G:SW7?5'QM17U!^S
M'\"?#UYX1U#XE^/ECD\.V8D:VM9\B.01Y#R./X@&!4+T)!SGBNHC_;<\&27@
MT27X=1)X4\[ DWQ$A,XWFW\O;G!S@/\ C7M5<VJ>UG2PE%U.7XG>R_X)X%#(
M:2HPK8ZNJ7/\*LVWY^2/C?OQ1S7T[^U9\ ]"\,Z'IOC_ ,$JJ>'=0V>=;0Y,
M4?F+NCECST5NF.Q(QC/'S%7J8'&4\=25:GZ-/='B9EE]7+,0Z%77JGT:[AZ9
MZ45UGPK^']U\4/'^C>&;5C$U]-B68#/E1*"TCX[D*&(!ZG ZD5]I>/OB)\//
MV0[/3=#T'PQ#J.NR1"1HU98Y?+Y7S)IRK'+$$  'H>@Q7#CLS^JU8X:C3YZD
ME>W_  3T<LR7Z[0GBZ]54Z4=+O77R1\K_LLZ'I_B3X\>%]/U6RMM2L)S<^;:
MW<2RQOBVE895@0>0",CL.]=5^VQX6T;PC\6-.LM#TJRT>T;1HI6@L8$A0N9I
MP6*J ,X4#/M7MOP+\?\ P]^-_P 3-.UFV\-1>#_&>C"6>..W=62]A>)XV!(5
M Q7S W*Y&."1FO)OV^N/C-I?_8#A_P#1]Q7@4\54KYS!3BX-1::OZGT]; 4<
M+P_4E2FJB<TU)=M/FO0I^+_B+\)=0_9[MM!TO0;6'QVMA8Q/?+I2)(9D:(S'
MSL9)8*_.><GUKYW[5]K?$GX=>%K#]C&RUZU\.:3;:VVD:5*=1BLHUN"[O;AV
M,@7=EMS9.>=QKC_V+O@7H?CY=4\5^([)-2L["X%K:V<W,32A5=F=?XL!D #9
M')ZXXZ<#F.'PF#JXA)V4WHW>[TV.3,,IQ6.Q^'PK<4W!.Z5DEKOYGRQ2]^>:
M^QS^W-X6T^ZFTJQ^',?_  CGFE=RSQQET!P&\CRMN2 ."WXU%^U?\%?"]]\/
M;7XF>#K2&QB98)KF*T01Q302A0DH08VL"R9VCG<2>F:[:><58U84L71Y%/9W
M3_X8X:V0494*E;!8A5'3^)6:T\NY\>]:2OHS]DC]G_3OB?=ZAXD\3Q[_  WI
M;^6(&<HMQ*!N;<PQ\B@@D9&=PSWKT#5?VUO!OA>_NM$\.?#RWN_#JOY7FI+'
M;),HX)$(B8;<YQD@D8R!6N(S6:KRP^$I.I*.^MDC##9'3>&CBL=75*,_AT;;
M^2Z'QI1Q7V/^T#\(?!?C_P"$2?%+P+:Q:8RPBYF@AB$231;MKAHQPLB'.2.#
MM;)/!KA/V1_V?=/^*%Y?^(_$T9D\.:8XC2W+%%N)0 Q#,/X5&"0#R2 >].&=
M4)826)FFN5V:ZW["J<.8F..A@Z<E+F5U+I;N?.=%?9^M?MI>"O".J7>@^'/
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M%:^JOVK/V=?!_P (OA[I>L:!#=QWEQJ<=J[7%P9!L:*5B #[HM>=?#_6-!^
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MF4"-67!Y^5LCG&:]<_:0T6U\-?LAW^DV%Q]JLK&STVV@GR#YD:3VZJV1P<@
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MDYKR\9F4Z-98;#TG.>[Z+[SW,!D]/$89XS%5E2IWMM=M^B/ARCM7WKX!\3>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU^V_^9.41^OY-B,OHO\ ><RDEW6G^1\>? ^2:/XR>!S;9\W^V;0'_=,RAO\
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M6_Z?]NU'_!.U@K?$') ^6PZ_]O-<?_--?/\ ]O/4NO\ 7"_E_P"XSYF^,?\
MR5[QQ_V';[_TH>N/KK_C%_R5WQQ_V'+[_P!*'KD*^[P?^[4_1?DC\OQ_^]U?
M\3_,^\?@48C^Q/KO]F*1?BPU838SDS8EVXR?[GE]*^#_ $KZ=_8]^/VD^ 5U
M'P?XIG2UT34)//@NYL>5#*5"NC\<*X"\G@$'/7-=;XG_ &+/!>H7ESX@TSXB
M6NC^&I)-RI)''-'%GDJLWFJ,=<9!(& <XKY/#XB.4XW$1Q2:4W=.S=_+\3[_
M !>#GGN786>":;IQY9)M*WGJ=K^P4+C_ (4SJGF[O*_MB?R<]-ODPYQ_P+=^
MM><_\$\[6T;Q%XRN'?%[':VT<2<<QLSESTSP5C_/Z8^B/V>M:\)7W@:]TOP1
M$_\ PC^B7CZ=%=.<F[<1QR/,>!]YI#]<9  ( ^%OV9?B]%\'_B5#J%]N.C7L
M1L[TJ,E$)!$@'4[6 )QS@GOBO(HTZF.CCU"-G+E=NN[=CWJ]2EEM3*_:S3C%
M25^FR7W7/9?B%X7_ &=+SQYXBGU[QGKMOK;ZA.;V&."8I'-YAWHI^S'*AL@8
M)& .36Y\(?''[/OP5U:_U#0O&VJ32WD/D2I>6EPZ;0P8$!;=>01U]"?6H?C'
M^R.WQ8\22>,O 6NZ4UEK'^DS1W4SF)I#]YXW17R&/)!Z$G'I3_"?P/\ !?[-
M/@W5-?\ B:^C^)-3N%V6U@T"SIE>=L2R+EG)(RV  ,9P,FDY86KA8TG7J2D[
M+D\^VW02ACJ..G66'I0@KOVEGMW^+J>??"37-*\2_MO0ZMHDWVG2[V_OKB";
M8R;@UK,2=K $<D]1FC]OMF_X7)I2YX&APX'UN)\_R'Y5S/[+>I+JW[47AZ_%
MO!9K<W%],+>V01Q1!K:8A%4# 49P!@=!72?M\L&^,VEX/']AP_\ H^XKV8T_
M99S0@NE-+\SYV5;VW#^)J.WO5;Z?([;_ ()U_>^('^[8?^W-><_#V"TN/VW)
M4O6VP#Q-J+@_]-%>=H^W]\+^=>B?\$[F"M\0,D#Y;#K_ -O-?/GCCQ%=>$?V
M@O$>MV.W[5I_B:ZNHMW0LER[ 'V.,'V)J(TW6S/&TH[RA9?<C5UH8?)\NJSV
MC-M_*3/5_P!OZ69OBUHL;9^SKHT;(.VXS3;L>^ OZ5XU\#Y)X_C)X(-OD2_V
MU: _[IF4-_XZ37V'\2/ _AW]LCP)I>O^%=7M[3Q%8)M\NX;(CW?>AF"_,N",
MJV#T. 0<C"^"?[**?!OQ WC3Q_KNEK'I*F6W2WE;R(V((\R1W5>F> !U(.>,
M5EALRP^&RQX2I=5$G'EMK=G3C,GQ.+SF..HV=*34N:^B2.;_ ."AD%HOB#P9
M-&W^G/:W*2KZ1ADV'\VD_*O0/BID?L&V'_8$T?\ ]#MJ^7/VEOBW%\8/B9<Z
MG9;AI%G&+.QW#!>-229",<;BS''7&,U]0_%9U_X8/L!D9_L31N,_]-+:N:KA
MYX:C@*=3?FO][3.JCBJ6+Q.:5:3TY&O6RL?''P;_ .2O>!_^P[8_^E"5]-?\
M%%/O?#[_ ';_ /\ ;:OF3X._\E=\#_\ 8<L?_2A*^FO^"B3!F^'V"#\M_P!/
M^W:O9QG_ ".\-Z/\F?.9>_\ C',9ZQ_-"_\ !.W[WQ!_W;#_ -N:\&UVWM;[
M]I[4;>^?R[*;QA)'.^0-L9O2&//'0GK7N_\ P3N8*WQ R0/EL/\ VYKYJ^+5
MQ);_ !D\9SPOMDCU^]=''8BX<@_@166'BYYQBXIVO%?DCHQ-14\BP$WK:3=O
MFS[H_:FTKX8ZI#X93XD:]J.BHGVAK%;&-V$IQ&)-VV)\$?)C./O'K7A-CX;_
M &8]-O;>[A\=^(%G@D65#Y$_#*00?^/;U KTW48] _;4^$>GQV^I0:9XSTH"
M1HI"?W4F K@KU,3D AAT('<$5P7@7]A/5]+\16U_XRUO1UT"S87$\=I)(YE5
M>2K%T4*I[GGC/UKP<)[##8=T<37G"<6[Q6WRTZGU&/6)QF+CB,'AJ=2$DFIM
M:KUU6QG?MC_&;P1\5]%\-1^%]6.IWEC/*9!]DFBV(ZJ.LB+GE1P/QKK]"\*?
MLO/HNGG4+C3Q?FWC-Q_Q-+L?O-HW<"3 YSTKQ']J#Q=X-\0>-(=/\#:1I>GZ
M1IJ-')=Z;:1PB[F)&YLHHW*N  ?4MC@YKQO':OI<+E?ML%2A"<Z=KO?77OL?
M(8S.E0S&M4JTJ=9NRVTT[7N?17[1VA_!73/!MA+\-Y;1]9.H(DXAO9YF\@QR
M$Y$C$ ;@G('H.AKT?]AO7K;Q7\/_ !CX"U!\Q_-,J@_,89D,<@'T*@\CJ_Y?
M%M>R_LC^-/\ A#?CEH?FNR6NJ;M-F"XY\S&SKC_EH$_7'H;Q^6N.63I<\I./
MO)RU>AGE>;QGG%.M[-0C+W6EHM=#UC]GG2KCX/\ P<^+OBJ\4P:E:O+I<+@$
M2I-"I48/\(\V51]4SV%5?$!_X69^PSI=]GSK_P +W2QR-)RP1',853Z".6,X
M_P!GO@9[W]M;4+#P5\(H]#TQ3 WB#5VNK@(?]9R99"QS_?\ +X]AZ5QW[">H
MZ?XAT7QMX(U>,75A<K'=_9I#\C*P,<GI@\18(YX!!XKYQ2G5PLLVDO>4T_DM
M#["2I4<;#(XR]QTY+_MZ7O7_  -?XU77_"H_V/\ PQX25PM_JT4$,B,N& )\
M^8@9X^;"G.?O>O(I?\$Z_O\ Q _W;#_VYKBOV[/&S:]\5+308G)M]#M%5DSQ
MYLN'8C_@'E"NU_X)W,%;X@Y('RV'7_MYK>K1<,AJ59?%4:D_G)'%1Q$:G$]*
MC#X*2<5\HO\ 4\\^'4=I-^VY,+T[8?\ A)M28$_\] TYC_\ ']OY_C6M^W]-
M,WQ:T:)L^0FC1LGIN,TP;] M>4^-?$MSX/\ VA/$>NV.TW.G^);JYC5NC%;E
MS@^QQCZ&OKOXI_#CP_\ M?>!=(\2>%-8M[?7+6/:GG-\JACEX)@,LK*<D'![
M]0V:Z:LE@L7A<95^#D2OV=CCP\'F& QN H/]YSN27=7_ . ?%7PGN+NW^*7A
M"2P >]75[3R5)P&8S* I]CT/U-?3W_!1/[WP_P _W;__ -MJ3X6_LTV_P'\1
M6OC+XB:YIL@LID33['3V9S-.YVJ?G"$L"P(4 ]R3Q1_P4296D\ ;2"-M_P!#
M_P!>].>,I8W.</*AK%*6MO)_D$,!6R[A[%1Q&DFXNU]M5^9Z7I6F^#_^&.M%
MM?$NIW6G^%Y=+LWO;RS!:5':2-B %1CCS3M/RG@G/<UX0/!_[+__ $//B ?]
MN\W_ ,BUU?[,GQ$\.?$SX3WGPA\57*VD[I)#9,SA#-&S;UV'IYB.<@=P!UP:
MYJ3]@'QA_:YC3Q#HO]E[^+AFE\[9GKY>S&<=M]<%&-/!UJU+%UY4WS-JVS3Z
M[/4]3%5*V/P^'K8+#PK1Y4G=:Q:Z;K0[#X@?&;X20_LZZEX \-^)[K4Y([/R
M;*.ZL[CS'82!U!=HE48([XQ@"OBVOJ7]I?\ X5U\-/ NG_#_ ,-:9I5_XGCV
M+?:NMK$US$JG+;I0N1(S <9X7(/4 _+-?49%2A"A*<$[2DW[V[\]EN?%\35Z
MM3$PIU7%RA%+W;V7EJWL?1'["L=J_P <'-P<2II4YM^O,FZ,'_QPOUK!_;(F
MED_:'\3+)G9&MJL?^[]FC/'XEJXOX,_$23X5_$K1?$84R06TI6YB R6A<%9
M/<*21[@5]>_'3]GO3OVD%T[QMX&US3S?SQ+'*\TC?9[B,#*DE59DD7(!!7I@
M'&WG@Q52.7YLL57^"4;7[/\ K\SU,#2EFF0RP>&UJ0GS6[JW]?<?-?[)<UW#
M^T%X2^Q+OD>69)%8X'E^1)OSR.@R<>H%=M^WW_R6;2_^P'#_ .C[BO4_@/\
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M]F566#S"GC,6K1G!+R3WL?/1P\<PRFK@, ^:5.HW:^KCLF?#^F?;OM#?V?\
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MZ^R2W]3Y:_; _P"3C/%_UM?_ $DAKQJO9?VP?^3C/%_^]:_^DD->-5]GE?\
MN-'_  Q_(_/,Z_Y&6(_QR_-A1117I'C!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^K/[/G_)$? _\
MV";;_P!%K7Y35^K/[/G_ "1'P/\ ]@FV_P#1:U\%Q=_ I>OZ'ZEP#_O57_#^
MJ/0J***_+S]N"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^
M>_VXO^2$W7_7];_^A&OSHK]%_P!N+_DA-U_U_6__ *$:_.BOUOA7_<7ZO]#\
M"XX_Y&<?\*_4****^R/SP**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-'NEN=/O)[&Y7[LUM*T;CZ$$$=!WJMS25#C&2LUH:*I*+4D]4;6N>,O$/BC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7ZL_L^?\ )$? _P#V";;_ -%K7Y35^K/[/O\ R1'P
M/_V";;_T6M?!<7?P*7K^A^I< _[U5_P_JCT*BBBOR\_;@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /GO\ ;B_Y(7<]O].M_P#T(U^=/K7Z
MG_'SPSIOBWP UAJMO]JM&NH6,?F,G(/'*D']:\K_ .&7?AE_T+7_ )/W7_QV
MON<DSO#Y=AG2JIMWOI;_ #/S#B/AG%YMC%B*$HI)):W_ ,F? =+^-???_#+O
MPR_Z%K_R?NO_ ([1_P ,N_#+_H6O_)^Z_P#CM?0?ZU8+^67X?YGRO^HN8_\
M/R'WO_(^!/QH_&OOO_AEWX9?]"U_Y/W7_P =H_X9=^&7_0M?^3]U_P#':/\
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MH_X9=^&7_0M?^3]U_P#':/\ 6K!?RR_#_,/]1<Q_Y^0^]_Y'P)^-'XU]]_\
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MZ_\ CM'^M6"_EE^'^8?ZBYC_ ,_(?>_\CX$_&C\:^^_^&7?AE_T+7_D_=?\
MQVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\ ,/\ 47,?^?D/O?\ D? GXT?C
M7WW_ ,,N_#+_ *%K_P G[K_X[1_PR[\,O^A:_P#)^Z_^.T?ZU8+^67X?YA_J
M+F/_ #\A][_R/@3\:/QK[[_X9=^&7_0M?^3]U_\ ':/^&7?AE_T+7_D_=?\
MQVC_ %JP7\LOP_S#_47,?^?D/O?^1\"?C1^-???_  R[\,O^A:_\G[K_ ..T
M?\,N_#+_ *%K_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\
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M&C\:^^_^&7?AE_T+7_D_=?\ QVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\
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M_P ,N_#+_H6O_)^Z_P#CM'^M6"_EE^'^8?ZBYC_S\A][_P CX$_&C\:^^_\
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M_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\ X9=^&7_0M?\
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MZ_\ CM'^M6"_EE^'^8?ZBYC_ ,_(?>_\CX$_&C\:^^_^&7?AE_T+7_D_=?\
MQVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\ ,/\ 47,?^?D/O?\ D? GXT?C
M7WW_ ,,N_#+_ *%K_P G[K_X[1_PR[\,O^A:_P#)^Z_^.T?ZU8+^67X?YA_J
M+F/_ #\A][_R/@3\:/QK[[_X9=^&7_0M?^3]U_\ ':/^&7?AE_T+7_D_=?\
MQVC_ %JP7\LOP_S#_47,?^?D/O?^1\"?C1^-???_  R[\,O^A:_\G[K_ ..T
M?\,N_#+_ *%K_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\
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M&C\:^^_^&7?AE_T+7_D_=?\ QVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\
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M_P ,N_#+_H6O_)^Z_P#CM'^M6"_EE^'^8?ZBYC_S\A][_P CX$_&C\:^^_\
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M_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\ X9=^&7_0M?\
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MZ_\ CM'^M6"_EE^'^8?ZBYC_ ,_(?>_\CX$_&C\:^^_^&7?AE_T+7_D_=?\
MQVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\ ,/\ 47,?^?D/O?\ D? GXT?C
M7WW_ ,,N_#+_ *%K_P G[K_X[1_PR[\,O^A:_P#)^Z_^.T?ZU8+^67X?YA_J
M+F/_ #\A][_R/@3\:/QK[[_X9=^&7_0M?^3]U_\ ':/^&7?AE_T+7_D_=?\
MQVC_ %JP7\LOP_S#_47,?^?D/O?^1\"?C1^-???_  R[\,O^A:_\G[K_ ..T
M?\,N_#+_ *%K_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\
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M&C\:^^_^&7?AE_T+7_D_=?\ QVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\
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M_P ,N_#+_H6O_)^Z_P#CM'^M6"_EE^'^8?ZBYC_S\A][_P CX$_&C\:^^_\
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M_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\ X9=^&7_0M?\
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MZ_\ CM'^M>"_EE^'^8?ZBYC_ ,_(?>_\CX$_&C\:^^_^&7?AE_T+7_D_=?\
MQVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\ ,/\ 47,?^?D/O?\ D? GXT?C
M7WW_ ,,N_#+_ *%K_P G[K_X[1_PR[\,O^A:_P#)^Z_^.T?ZU8+^67X?YA_J
M+F/_ #\A][_R/@3\:/QK[[_X9=^&7_0M?^3]U_\ ':/^&7?AE_T+7_D_=?\
MQVC_ %JP7\LOP_S#_47,?^?D/O?^1\"?C1^-???_  R[\,O^A:_\G[K_ ..T
M?\,N_#+_ *%K_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\
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M&C\:^^_^&7?AE_T+7_D_=?\ QVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\
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M_P ,N_#+_H6O_)^Z_P#CM'^M6"_EE^'^8?ZBYC_S\A][_P CX$_&C\:^^_\
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M_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\ X9=^&7_0M?\
MD_=?_':/^&7?AE_T+7_D_=?_ !VC_6K!?RR_#_,/]1<Q_P"?D/O?^1\"?C1^
M-???_#+OPR_Z%K_R?NO_ ([1_P ,N_#+_H6O_)^Z_P#CM'^M6"_EE^'^8?ZB
MYC_S\A][_P CX$_&C\:^^_\ AEWX9?\ 0M?^3]U_\=H_X9=^&7_0M?\ D_=?
M_':/]:L%_++\/\P_U%S'_GY#[W_D? GXT?C7WW_PR[\,O^A:_P#)^Z_^.T?\
M,N_#+_H6O_)^Z_\ CM'^M6"_EE^'^8?ZBYC_ ,_(?>_\CX$_&C\:^^_^&7?A
ME_T+7_D_=?\ QVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\ ,/\ 47,?^?D/
MO?\ D? GXT?C7WW_ ,,N_#+_ *%K_P G[K_X[4&H?LQ_#2&QN9$\-8=(V93]
MNNCR 2/^6E'^M6"_EE^'^8?ZBYC_ ,_(?>_\CX+_ !H_&ONKP_\ LT_#>^T>
MVGG\.;Y7!+-]NN1W(Z"4#M6C_P ,N_#+_H6O_)^Z_P#CM'^M6"_EE^'^8?ZB
MYC_S\A][_P CX$_&C\:^^_\ AEWX9?\ 0M?^3]U_\=H_X9=^&7_0M?\ D_=?
M_':/]:L%_++\/\P_U%S'_GY#[W_D? GXT?C7WW_PR[\,O^A:_P#)^Z_^.T?\
M,N_#+_H6O_)^Z_\ CM'^M6"_EE^'^8?ZBYC_ ,_(?>_\CX$_&C\:^^_^&7?A
ME_T+7_D_=?\ QVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\ ,/\ 47,?^?D/
MO?\ D? GXT?C7WW_ ,,N_#+_ *%K_P G[K_X[1_PR[\,O^A:_P#)^Z_^.T?Z
MU8+^67X?YA_J+F/_ #\A][_R/@3\:/QK[[_X9=^&7_0M?^3]U_\ ':/^&7?A
ME_T+7_D_=?\ QVC_ %JP7\LOP_S#_47,?^?D/O?^1\"?C1^-???_  R[\,O^
MA:_\G[K_ ..T?\,N_#+_ *%K_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(
M^!/QH_&OOO\ X9=^&7_0M?\ D_=?_':/^&7?AE_T+7_D_=?_ !VC_6K!?RR_
M#_,/]1<Q_P"?D/O?^1\"?C1^-???_#+OPR_Z%K_R?NO_ ([1_P ,N_#+_H6O
M_)^Z_P#CM'^M6"_EE^'^8?ZBYC_S\A][_P CX$_&C\:^^_\ AEWX9?\ 0M?^
M3]U_\=H_X9=^&7_0M?\ D_=?_':/]:L%_++\/\P_U%S'_GY#[W_D? GXT?C7
MWW_PR[\,O^A:_P#)^Z_^.T?\,N_#+_H6O_)^Z_\ CM'^M6"_EE^'^8?ZBYC_
M ,_(?>_\CX$_&C\:^^_^&7?AE_T+7_D_=?\ QVC_ (9=^&7_ $+7_D_=?_':
M/]:L%_++\/\ ,/\ 47,?^?D/O?\ D? GXT?C7WW_ ,,N_#+_ *%K_P G[K_X
M[1_PR[\,O^A:_P#)^Z_^.T?ZU8+^67X?YA_J+F/_ #\A][_R/@3\:/QK[[_X
M9=^&7_0M?^3]U_\ ':/^&7?AE_T+7_D_=?\ QVC_ %JP7\LOP_S#_47,?^?D
M/O?^1\"?C1^-???_  R[\,O^A:_\G[K_ ..T?\,N_#+_ *%K_P G[K_X[1_K
M5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\ X9=^&7_0M?\ D_=?_':/^&7?
MAE_T+7_D_=?_ !VC_6K!?RR_#_,/]1<Q_P"?D/O?^1\"?C1^-???_#+OPR_Z
M%K_R?NO_ ([1_P ,N_#+_H6O_)^Z_P#CM'^M6"_EE^'^8?ZBYC_S\A][_P C
MX$_&C\:^^_\ AEWX9?\ 0M?^3]U_\=H_X9=^&7_0M?\ D_=?_':/]:L%_++\
M/\P_U%S'_GY#[W_D? GXT?C7WW_PR[\,O^A:_P#)^Z_^.T?\,N_#+_H6O_)^
MZ_\ CM'^M6"_EE^'^8?ZBYC_ ,_(?>_\CX$_&C\:^^_^&7?AE_T+7_D_=?\
MQVC_ (9=^&7_ $+7_D_=?_':/]:L%_++\/\ ,/\ 47,?^?D/O?\ D? GXT?C
M7WW_ ,,N_#+_ *%K_P G[K_X[1_PR[\,O^A:_P#)^Z_^.T?ZU8+^67X?YA_J
M+F/_ #\A][_R/@3\:/QK[[_X9=^&7_0M?^3]U_\ ':/^&7?AE_T+7_D_=?\
MQVC_ %JP7\LOP_S#_47,?^?D/O?^1\"?C1^-???_  R[\,O^A:_\G[K_ ..T
M?\,N_#+_ *%K_P G[K_X[1_K5@OY9?A_F'^HN8_\_(?>_P#(^!/QH_&OOO\
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M %%S'_GY#[W_ )'P)^-'XU]]_P##+OPR_P"A:_\ )^Z_^.T?\,N_#+_H6O\
MR?NO_CM'^M6"_EE^'^8?ZBYC_P _(?>_\CX$_&C\:^^_^&7?AE_T+7_D_=?_
M !VC_AEWX9?]"U_Y/W7_ ,=H_P!:L%_++\/\P_U%S'_GY#[W_D? GXT?C7WW
M_P ,N_#+_H6O_)^Z_P#CM'_#+OPR_P"A:_\ )^Z_^.T?ZU8+^67X?YA_J+F/
M_/R'WO\ R/@3\:/QK[[_ .&7?AE_T+7_ )/W7_QVC_AEWX9?]"U_Y/W7_P =
MH_UJP7\LOP_S#_47,?\ GY#[W_D? GXT?C7WW_PR[\,O^A:_\G[K_P".T?\
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MP_U%S'_GY#[W_D? GXT?C7WW_P ,N_#+_H6O_)^Z_P#CM'_#+OPR_P"A:_\
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MYG/<XH9E2A"BFFGU_P"'/M.&>'L5DU>=2O)-25M+_P"2.HHHHKXP_10HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:?%?Z9>V^HV,V?+N;2598GP2IPRD@X((.#P01U%?*O[17[-^@> _A]>>(_"
MN-*-JJ0WUJ;EY$N86=5).XDY#%#C..,@ @5ZS^R;_P F_P#A;_M[_P#2N:@#
MTWQ!K4'AS0=1U:ZW?9K"VDNI=O7;&I8X]\ U\A^$]8^+?[3>H:KJ&E>*?^$3
MT:SD$:PVL\D(4G)"@Q@,Q QEF(ZC YP/K_6M)M]>T>_TR[4O:7L$EM,JG!*.
MI5@#]":^1;7X*_&+X"ZGJ$_@2\CUG2I\,Z1^62Z@G&^&3^,#NA)P<9ZB@"+5
M/&_Q2_9A\5Z9'XIUE_%GAZ^)),TS3&15(#A7D&]'4.#@D@Y&<XX^K(/B!X8N
MM0MM/3Q#IG]HW*H\-BUW&MPX= R8C)#<J00,9(.:^9X_VIKVPUBVTOXJ_#Z*
M#;TF-HP>,' +"*8'(/!)5ATXSP*A_:PTL>%_$W@;XF>'EC^S_N566!<(6CQ)
M >F,,FX 8Z(!@CH ?6U]?VVEV<]Y>W$-G:0J9);BXD"(B@9)9B0  .I)P*I:
M3XIT;7M-EU#3-7L-1T^$L)+JUN4EB3: 6!=20" 03D\ @UX9^UI\2+9/@?8)
MI\AQXH,)AR,-]GPLK'@X&?D!Y/#'ZUYO\:/A_KO@3]FOP5IUE',+)'-UK:P@
MC]]* Z>8.NU267)& 0N<'% 'U7:_$KPA>W@L[?Q5HD]V3M%O'J,+/GTVALY]
ML57^)_C2S\$^#=6NYM7L])OS97!L&NIHT,DZQDH$5SAF!Q\H!SD#!S7R/9Z/
M^S_XW\+Q6%GJ-[X*\0%5 O=3,LPW9!;?SY9'49!CZ@\8(KW37OA/I=U\ WM=
M?U./QN^BZ9=W&F:L-\0P(F,9&V5@VT  $D@@#CKD I_LO_&Z7QQX3N$\7>*-
M/G\1R:F\%K;3R06\\D7E1%0D:A2P+%\$ DD$9.,#VW6->TSP]:_:=5U&TTRV
MSCSKR=8DSZ98@9_&OE[]C#X:^&]?\(3>);_2TN-<T_672UO#+(IC"Q0LH #!
M3@NQY!Z^E<M9:EH'[0/QFU[4/'GB6UTGPMI+&*PL;J_CM1*NXJ@0LP/(4LQ7
M)R0,@$4 ?8NA^*=&\31O)H^KV&JQIC<UC<I,!GU*D@=*2]\6:)INL6VD7>L:
M?:ZK<@-!8SW4:3R@D@%$)#,"00" <D$=C7Q?\4X/"WP0\7:!XL^%?B6RN TC
M1W6EVFI+=* ,'!(=F*.,@AB<$ @Y(QJ?M%B3QU\>OAX-,NGL#K6D6*Q7"G#1
M+//,-P([A6/3OW[T ?6D/CWPS<ZM_9<7B/29=3W;/L27T1FW9QC8&W9SQC&<
MT[6_''ASPS.D&L>(-+TJ9AE8[Z]CA8CU 8@FOE#]ISX ^%/A;X!TK6_#<5U9
MW\5]';2R27#.9@RNP<Y. P*#!4 8)XS@CN?A_P#LQ^&/'GP[L==\4F]U3Q/K
MUJM_+JC7;[XVE&]=J@A3A2H(8'D'&!@  ^BK&^MM2M([FSN(KNVE&Z.:!PZ,
M.F002"/<&LG6?'OACP[=&UU7Q'I.EW QF&]OHH7Y (X9@>00?H:^8_V-[[6I
MO!WQ)T73[AC<6B1OIZLV%2XD29<C)P,F-#SQQS7EGPKF^&EK>:Q:?%C3]6.N
M-<L/M4CS!8@0-V]8R'WA@220P((X!'(!^@>FZI9:S:)=6%W!>VS?=FMI5D0_
M0@D'\ZLU\^?LX_#W0/#?B+5]5\%_$"/7?#UT")-$\C#PY.8V8EP0RC(!*#()
MKZ#H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ JKJG_(+O/^N+_P#H)JU575/^07>?]<7_ /03
M0!2\)_\ (OV?^Z?_ $(UKUD>$_\ D7[/_=/_ *$:UZ "OGK]J+XX:YX$U#1_
M"?A8K!K>J1B5KIE#-&C,8T5 00&9@W)'  QR<CZ%KPK]I+]GN\^+,VGZYH5]
M'9Z_I\1A$<Q*K,@8N@#@$JP8M@D8.[DC&: .$OO@;\<]/TZ35(/B/<7FHI'Y
MAT]-1N"&(&2JAAL)[ $ $]QUKN_V7OCM?_%;3=1TO7PG]OZ8%=IXXP@N(V)&
MXJ  K*0 0, Y&!UKSQ?BG\>_A7"R>(_#7]OV%N@#730>;A1P&,L!QD]RX)SU
MY)SZG^S]\8?"GQ2%Z-+T*W\/:[;QAKJUCC0%XR<;D=0"Z@X!! ()'!R#0!ZM
MK&O:9X>M?M.JZC::9;9QYUY.L29],L0,_C46A^*=&\31O)H^KV&JQIC<UC<I
M,!GU*D@=*^.K+4M _:!^,VO:AX\\2VND^%M)8Q6%C=7\=J)5W%4"%F!Y"EF*
MY.2!D BJ?Q3@\+?!#Q=H'BSX5^);*X#2-'=:7::DMTH P<$AV8HXR"&)P0"#
MDC !]P75W!8V\EQ<SQV]O&"SRRL%50.I). ![FL73?B!X7UIYTT_Q)I%^\"-
M)*MM?Q2&-5&2S ,< #DDX KY=^.'B*^^.7Q=\(^ M.NYK/0[J"WNY47!),D9
MF:0@'!*Q$8!) .X]ZZ[XF?LH^%/#W@'4-5\*B\TK7=)M)+J.Y-T[_:-BEG#@
MY +*& VA1DC(QD4 >^:=XPT'6-)N=5L=;TZ]TNUW>??6]W')#%M4,^]P2JX4
M@G)& 03Q4^A^(M*\369N]'U.SU6T#F,W%C<+,@8 $J64D9 ()&<\CUKY7_9X
M_P"32_B9_P!Q3_T@BKM_V(_^2/W?_86F_P#1<5 'M;>+="77QH3:SIXUMAD:
M:;J/[21M+9$>=WW06Z=!GIS5W4-2M-)M'N[^[ALK:,9>:XD"(OU)( _$U\LW
M7_)_%G_UR/\ Z;6K(^)VO67QD_:$G\+>(_$,&@>"]!+"07%W';K+(@ ?!8@%
MV=MHZD*I( ()H ^K=#\:>'O$TCQZ/KNF:K(H)9+&\CF( ZDA22.M2:UXLT3P
MU):QZOK&GZ5)=$K;K?74<)F((!"!B"Q!9<@9QD>HKXX^-7@_X?\ P]T_3/%/
MPO\ %=C;:W8W**UI8ZNET[*0?W@!=FR" ".5(8\ #!?^TYXTG\>>"_@_XCA"
MP7EY%=R%5QM68&W5L9SP'4XSVQF@#Z[U/Q]X8T74/L&H>(])L+WC_1KJ^BBE
MYY'R%@?TK=1UD0.A#HP!#*>"#T(-?-GC?]DWPEIOPMUF]=[RY\46ME+?2:Q-
M<NS33)&78%"=NUB#V+ 'J2.<SX _$R_\,?LL^)-:GD:YDT.ZN+>R60Y"Y2(Q
M@YZJ'F)QZ<#L* /H[7/&WAWPS*(M8U_3-*D8!@E]>1PD@\9 8@X]ZN:3K6G:
M_:?:],O[74;;)43VDRRID $C<I(S@@XSW%?*G[/7[/\ I'Q6\.S>.?';W6NW
M>J7$IACDN'1656*M(S*0Q)8,  0 %'!SQU7A/]GWQ'\)OC-::IX,N5/@RX"K
M>VMW='?M((=2N!N*G#*3R"<'/.0#J?A?I.I6?Q?\87-S\1;7Q+:3/<F+0(M3
M:=]/S< @-"6(CV#*' &"<>U>CV/C[PQJ6GW-_:>(])NK"U($]U!?1/%$3T#N
M&(4GMDC-?-W[.?\ R=)\4_\ KKJ'_I:M<#^RG\(]/^+#ZTGB">XET+3)(9/[
M-AE,2SS2!@&<K@X"H1@$'+<$<@@'VOH7B[0O% D.C:UI^KB, N;&ZCGVYX&=
MI./QK1NKN"QMY+BYGCM[>,%GEE8*J@=22< #W-?&/BCP1:? S]J+P1!X6EFM
M-/U2>V)MVD+;%EG,,D>2264KR-Q)!/7@&M_]HF^U/XK?';0/A?;7DUII2^6U
MTL?(9F4RO(1P#MB P#P#D]Z /I73OB!X7U@7)L/$FD7HMHVEG-O?12>4BC+,
M^&.T <DG '>KVA>)-(\46;W>C:I9:O;))Y3SV-PDR!P 2I920" 0<$YP0>XK
MYY^*G[*OA?P[\/\ 4=6\)"[TG6M*M)+CSS=._P!I15)D5P20"R;A\H .<$$$
MU=_87_Y)+JW_ &')O_1%O0!]%5D:YXQT#PPRKK&N:;I+,H95OKN.$D$D C<1
MD9!&?45IW'G?9Y?(V>=M/E^9G;NQQG';.,XYQ7R#IOPA\$>'O$VL:C\8_&FE
M:UJ\\NX6MMJ,@8,<[S*J@2 @E< $  $8(X !]8:)XFT?Q-"\ND:K8ZK$F-SV
M-PDRC.<9*D@9P<9ZX-,'BW0VUV31!K.G_P!L1KN?3Q=1_:%&T-DQYW ;2#DC
MH0>AKXHT74O"7A?]I7PH/ACJ%T=&NKB&WNE=G,9,DA5XUW@,RA2N-V2",@G
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M T@SW7IZ>::1)X7TGXK>)X_C1IVJWMXTYV.DCA5;<V2P5@Q4@J5*D@ < @C
M!][:/X@TOQ%;FXTK4;34[<'!ELYUF7/IE215^OF/X)_#OP9;_$P^(?AQ\0T;
M3MI$_AV2!C*\17!!+NKD!L,"4." "3W^G* "BBB@#!\1_P#(1T7_ *^?\*WJ
MP?$?_(1T7_KY_P *WJ "BBB@#R/]J'XB3?#OX4WLEE=/::OJ+K96DD,FV2,M
MDNZD'((0-@CD$KR#BO(OV7?B1XGTSXF77A'QCJNHW\NIV4=S:#4;IYS&_EB9
M0"Y) :)R2!W4#'&17^/5\?C%^T;X8\"6[M+IVG2+%<B/D;FQ)<'C^[&H'/0J
M?4U-^UUI<_@#XC>#O'^E1K$Z%8G"# \R%@R ]L,A*X]$/% 'UAJVL6&@Z?+?
MZG>V^G6,./,N;N58HDR0HRS$ 9) &3R2!U-9MYX\\-6&EVVIW/B'2;?3KH$V
M]Y+>Q+#* <'8Y8!L'C@FO,?VDM:M?$G[,>M:K9/YEG>P6-Q$W&=K7,)&<$C(
M!P0"<'->3? ?]FZR^*W@:R\1^,-0U"2!E:UTRSMY1&L4$;%=V2"1EPY   ZD
MYW< 'U@OBS1)->?0TUC3VUM!N;35NHS<J-H;)CSN VD')'0@]#2Z/XHT;Q%-
M=1:3J]CJ<MH5%Q'9W*3-"6S@.%)*YP<9QG!]#7QE\4/#>I^-/VOM9\/:7>2:
M?)J@M[>XN8_O);_8XFF(Y'5%(QD9SCO7J'B[]F-/"/P]U/2O!GB!=$@U*2!M
M7O-:NRJO%$)-JAE0!06DR0< @ =,@@'M4GQ0\&PW/V:3Q;H4=P3@1-J4(;/T
M+Y[5I:MXIT;0=-BU#4]7L-.T^8J([JZN4BB?<"5 =B 20"1@\@$U\H?\(+^S
MOX;\*_8M8\01ZEK20CS[_3[R69S* -PB$8,9!((&Y3P1D]",;X$Z#=_%#X$_
M$;PL9)+M+)H;O2XI 6:.;#L H!)&[RP,#(!8G!R<@'VGIVI6FL6,-[874%[9
MS+NBN+>021N/56!((]P:H1^,M DUXZ&FN::^MJ3G35NXS<@A=QS'G=PO/3IS
MTKPO]COXAPW'PAU.QU"8J/#4CN[, =ELP:0'CDX(E&#T  ![#B/V:]'U3Q]X
MD^)'Q#A&-5FCN8--+# 6YF#.,$G V@(O). _/'4 ^IM9\>^&/#MT;75?$>DZ
M7<#&8;V^BA?D CAF!Y!!^AK4TW5++6;1+JPNX+VV;[LUM*LB'Z$$@_G7Y^?"
MN;X:6MYK%I\6-/U8ZXURP^U2/,%B! W;UC(?>&!))# @C@$<_1/[./P]T#PW
MXBU?5?!?Q CUWP]= B31/(P\.3F-F)<$,HR 2@R": /H.BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH I
M:U_R![__ *]Y/_037=^!_P#D3]'_ .O:/^0KA-:_Y ]__P!>\G_H)KN_ _\
MR)^C_P#7M'_(4F4C=HHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 <5\7/\ D43_ -?$?\ZR:UOBY_R*)_Z^(_YUDU2)84444Q!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %8/C7_D7YO]]?YBMZL'QK_R+\W^^O\ ,4 ;5O\ \>\7^XO\JDJ.
MW_X]XO\ <7^524 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(!5@0<$ \CJ :-)T>PT'3XK#3+*WTZQASY=M:1+%$F26.$4 #)))P.22>IH
M^:?@O^U5X6\.?#NPT/Q9+=:;J^C0"T$?V9W\Y(QM0#:#M8* I#8&5SGGC=^!
MOQ5\:_&#XD:SJ:LUG\/[7>+>"2UC#.QP$3S ,E@,NV&(!P.A%>RZM\/_  OK
MUX;O4_#>D:C=D@FXN[&*5\CI\S*3Q@=^U;%C96VFVL=M:6\5K;1C"0P($11U
MP   !]!0!\K_ +!/_(/\:?\ 7:T_E+1^P3_R#_&G_7:T_E+7TSH'A'0O"JSK
MHFC:?HZSD&5=/M8X!(1G!;:!G&3C/3)]:- \(Z%X56==$T;3]'6<@RKI]K'
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MUY[\;?V@=-^#+6]I<Z==W^I7UM)+9B$*8MZD "0E@0,D<@$XS0!\F_">2_\
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MT1 C)))P9<%023A03T./M*JFF:39:+:"UT^SM["V4DB&UB6) 3U(  'Z5;H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2JKD3%0WS*C1X&&QDL0 ,@5]SUGZ+X=TKPW;F#2-,L]+@8@F.RMUA4XX&0H
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MQ)<_:-7\.:3JEQP#+>V,4S<# Y92>!Q]*TM,TFRT6T%KI]G;V%LI)$-K$L2
MGJ0  /TH MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% %+6O^0/?_P#7O)_Z":[OP/\ \B?H_P#U[1_R
M%<)K7_('O_\ KWD_]!-=WX'_ .1/T?\ Z]H_Y"DRD;M%%%2,**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#BOBY_R*)_Z^(_YUDUK?%S_D43
M_P!?$?\ .LFJ1+"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ K!\:_\B_-_OK_ #%;U8/C7_D7
MYO\ ?7^8H VK?_CWB_W%_E4E1V__ ![Q?[B_RJ2@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *JZI_R"[S_ *XO_P"@FK55=4_Y!=Y_UQ?_ -!- %+PG_R+]G_N
MG_T(UKUD>$_^1?L_]T_^A&M>@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#!\1_\ (1T7_KY_PK>K!\1_\A'1
M?^OG_"MZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@"EK7_('O_\ KWD_]!-=WX'_ .1/T?\ Z]H_Y"N$UK_D#W__ %[R?^@FN[\#
M_P#(GZ/_ ->T?\A292-VBBBI&%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!Q7Q:7S/">S.-US$,CW.*J?\ "H;7_H,ZE_W\'^%7OBM_R*H_
MZ^HO_0J[*G<#S_\ X5#:_P#09U+_ +^#_"C_ (5#:_\ 09U+_OX/\*] HHNP
M//\ _A4-K_T&=2_[^#_"C_A4-K_T&=2_[^#_  KT"BB[ \__ .%0VO\ T&=2
M_P"_@_PH_P"%0VO_ $&=2_[^#_"O0**+L#S_ /X5#:_]!G4O^_@_PH_X5#:_
M]!G4O^_@_P *] HHNP//_P#A4-K_ -!G4O\ OX/\*/\ A4-K_P!!G4O^_@_P
MKT"BB[ \_P#^%0VO_09U+_OX/\*/^%0VO_09U+_OX/\ "O0**+L#S_\ X5#:
M_P#09U+_ +^#_"C_ (5#:_\ 09U+_OX/\*] HHNP//\ _A4-K_T&=2_[^#_"
MC_A4-K_T&=2_[^#_  KT"BB[ \__ .%0VO\ T&=2_P"_@_PH_P"%0VO_ $&=
M2_[^#_"O0**+L#S_ /X5#:_]!G4O^_@_PH_X5#:_]!G4O^_@_P *] HHNP//
M_P#A4-K_ -!G4O\ OX/\*/\ A4-K_P!!G4O^_@_PKT"BB[ \_P#^%0VO_09U
M+_OX/\*/^%0VO_09U+_OX/\ "O0**+L#S_\ X5#:_P#09U+_ +^#_"C_ (5#
M:_\ 09U+_OX/\*] HHNP//\ _A4-K_T&=2_[^#_"C_A4-K_T&=2_[^#_  KT
M"BB[ \__ .%0VO\ T&=2_P"_@_PH_P"%0VO_ $&=2_[^#_"O0**+L#S_ /X5
M#:_]!G4O^_@_PKG_ !U\.X/#_ANXO4U*]N61E CG<%3E@.1CWKV"N-^+G_(C
MWG^_'_Z&*+NXK&=;_"2UDAC;^V-2&Y0<>8.X^E/_ .%0VO\ T&=2_P"_@_PK
MNK3_ (\X/]Q?Y5-1=C//_P#A4-K_ -!G4O\ OX/\*/\ A4-K_P!!G4O^_@_P
MKT"BB[ \_P#^%0VO_09U+_OX/\*/^%0VO_09U+_OX/\ "O0**+L#S_\ X5#:
M_P#09U+_ +^#_"C_ (5#:_\ 09U+_OX/\*] HHNP//\ _A4-K_T&=2_[^#_"
MC_A4-K_T&=2_[^#_  KT"BB[ \__ .%0VO\ T&=2_P"_@_PH_P"%0VO_ $&=
M2_[^#_"O0**+L#S_ /X5#:_]!G4O^_@_PH_X5#:_]!G4O^_@_P *] HHNP//
M_P#A4-K_ -!G4O\ OX/\*/\ A4-K_P!!G4O^_@_PKT"BB[ \_P#^%0VO_09U
M+_OX/\*/^%0VO_09U+_OX/\ "O0**+L#S_\ X5#:_P#09U+_ +^#_"C_ (5#
M:_\ 09U+_OX/\*] HHNP//\ _A4-K_T&=2_[^#_"C_A4-K_T&=2_[^#_  KT
M"BB[ \__ .%0VO\ T&=2_P"_@_PH_P"%0VO_ $&=2_[^#_"O0**+L#S_ /X5
M#:_]!G4O^_@_PH_X5#:_]!G4O^_@_P *] HHNP//_P#A4-K_ -!G4O\ OX/\
M*/\ A4-K_P!!G4O^_@_PKT"BB[ \_P#^%0VO_09U+_OX/\*/^%0VO_09U+_O
MX/\ "O0**+L#S_\ X5#:_P#09U+_ +^#_"C_ (5#:_\ 09U+_OX/\*] HHNP
M//\ _A4-K_T&=2_[^#_"C_A4-K_T&=2_[^#_  KT"BB[ \__ .%0VO\ T&=2
M_P"_@_PH_P"%0VO_ $&=2_[^#_"O0**+L#S_ /X5#:_]!G4O^_@_PH_X5#:_
M]!G4O^_@_P *] HHNP//_P#A4-K_ -!G4O\ OX/\*/\ A4-K_P!!G4O^_@_P
MKT"BB[ \_P#^%0VO_09U+_OX/\*/^%0VO_09U+_OX/\ "O0**+L#S_\ X5#:
M_P#09U+_ +^#_"C_ (5#:_\ 09U+_OX/\*] HHNP//\ _A4-K_T&=2_[^#_"
MC_A4-K_T&=2_[^#_  KT"BB[ \__ .%0VO\ T&=2_P"_@_PH_P"%0VO_ $&=
M2_[^#_"O0**+L#S_ /X5#:_]!G4O^_@_PH_X5#:_]!G4O^_@_P *] HHNP/'
MO^$#3_A./[%_M2_^S_8_M'F>8-V=V,=,8_"NA_X5#:_]!G4O^_@_PJQ_S6#_
M +A?_L]=Q1=BL>?_ /"H;7_H,ZE_W\'^%'_"H;7_ *#.I?\ ?P?X5Z!11=C/
M/_\ A4-K_P!!G4O^_@_PH_X5#:_]!G4O^_@_PKT"BB[ \_\ ^%0VO_09U+_O
MX/\ "C_A4-K_ -!G4O\ OX/\*] HHNP//_\ A4-K_P!!G4O^_@_PH_X5#:_]
M!G4O^_@_PKT"BB[ \_\ ^%0VO_09U+_OX/\ "C_A4-K_ -!G4O\ OX/\*] H
MHNP//_\ A4-K_P!!G4O^_@_PH_X5#:_]!G4O^_@_PKT"BB[ \_\ ^%0VO_09
MU+_OX/\ "C_A4-K_ -!G4O\ OX/\*] HHNP//_\ A4-K_P!!G4O^_@_PH_X5
M#:_]!G4O^_@_PKT"BB[ \_\ ^%0VO_09U+_OX/\ "C_A4-K_ -!G4O\ OX/\
M*] HHNP//_\ A4-K_P!!G4O^_@_PH_X5#:_]!G4O^_@_PKT"BB[ \_\ ^%0V
MO_09U+_OX/\ "C_A4-K_ -!G4O\ OX/\*] HHNP//_\ A4-K_P!!G4O^_@_P
MH_X5#:_]!G4O^_@_PKT"BB[ \_\ ^%0VO_09U+_OX/\ "C_A4-K_ -!G4O\
MOX/\*] HHNP//_\ A4-K_P!!G4O^_@_PH_X5#:_]!G4O^_@_PKT"BB[ \_\
M^%0VO_09U+_OX/\ "C_A4-K_ -!G4O\ OX/\*] HHNP//_\ A4-K_P!!G4O^
M_@_PH_X5#:_]!G4O^_@_PKT"BB[ \_\ ^%0VO_09U+_OX/\ "C_A4-K_ -!G
M4O\ OX/\*] HHNP//_\ A4-K_P!!G4O^_@_PH_X5#:_]!G4O^_@_PKT"BB[
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M_A7H%%%V!Y__ ,*AM?\ H,ZE_P!_!_A1_P *AM?^@SJ7_?P?X5Z!11=@>?\
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M_P#\*AM?^@SJ7_?P?X4?\*AM?^@SJ7_?P?X5Z!11=@>?_P#"H;7_ *#.I?\
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M?X5Z!11=@>?_ /"H;7_H,ZE_W\'^%'_"H;7_ *#.I?\ ?P?X5Z!11=@>?_\
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M_P#\*AM?^@SJ7_?P?X4?\*AM?^@SJ7_?P?X5Z!11=@>?_P#"H;7_ *#.I?\
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M?X5Z!11=@>?_ /"H;7_H,ZE_W\'^%'_"H;7_ *#.I?\ ?P?X5Z!11=@>?_\
M"H;7_H,ZE_W\'^%'_"H;7_H,ZE_W\'^%>@4478'G_P#PJ&U_Z#.I?]_!_A1_
MPJ&U_P"@SJ7_ '\'^%>@4478'G__  J&U_Z#.I?]_!_A1_PJ&U_Z#.I?]_!_
MA7H%%%V!Y_\ \*AM?^@SJ7_?P?X4?\*AM?\ H,ZE_P!_!_A7H%%%V!Y__P *
MAM?^@SJ7_?P?X4?\*AM?^@SJ7_?P?X5Z!11=@>?_ /"H;7_H,ZE_W\'^%'_"
MH;7_ *#.I?\ ?P?X5Z!11=@>?_\ "H;7_H,ZE_W\'^%'_"H;7_H,ZE_W\'^%
M>@4478'E_B'X9P:1H=]>QZMJ,DEO"TBJ\HP<#.#@=*?HGPO@U/1;"\DU?44>
MXMXY659!@%E!(&1TYKL/''_(GZQ_U[2?R-3>$?\ D5=%_P"O*'_T6M%V*QRW
M_"H;7_H,ZE_W\'^%'_"H;7_H,ZE_W\'^%>@4478SS_\ X5#:_P#09U+_ +^#
M_"C_ (5#:_\ 09U+_OX/\*] HHNP//\ _A4-K_T&=2_[^#_"C_A4-K_T&=2_
M[^#_  KT"BB[ \__ .%0VO\ T&=2_P"_@_PH_P"%0VO_ $&=2_[^#_"O0**+
ML#S_ /X5#:_]!G4O^_@_PH_X5#:_]!G4O^_@_P *] HHNP//_P#A4-K_ -!G
M4O\ OX/\*/\ A4-K_P!!G4O^_@_PKT"BB[ \_P#^%0VO_09U+_OX/\*/^%0V
MO_09U+_OX/\ "O0**+L#S_\ X5#:_P#09U+_ +^#_"C_ (5#:_\ 09U+_OX/
M\*] HHNP//\ _A4-K_T&=2_[^#_"C_A4-K_T&=2_[^#_  KT"BB[ \__ .%0
MVO\ T&=2_P"_@_PH_P"%0VO_ $&=2_[^#_"O0**+L#S_ /X5#:_]!G4O^_@_
MPH_X5#:_]!G4O^_@_P *] HHNP//_P#A4-K_ -!G4O\ OX/\*/\ A4-K_P!!
MG4O^_@_PKT"BB[ \_P#^%0VO_09U+_OX/\*/^%0VO_09U+_OX/\ "O0**+L#
MS_\ X5#:_P#09U+_ +^#_"C_ (5#:_\ 09U+_OX/\*] HHNP//\ _A4-K_T&
M=2_[^#_"C_A4-K_T&=2_[^#_  KT"BB[ \__ .%0VO\ T&=2_P"_@_PH_P"%
M0VO_ $&=2_[^#_"O0**+L#S_ /X5#:_]!G4O^_@_PH_X5#:_]!G4O^_@_P *
M] HHNP//_P#A4-K_ -!G4O\ OX/\*/\ A4-K_P!!G4O^_@_PKT"BB[ \_P#^
M%0VO_09U+_OX/\*/^%0VO_09U+_OX/\ "O0**+L#S_\ X5#:_P#09U+_ +^#
M_"JNK?"JVL]*O+A=6U%S% \@5I 0<*3@\=\5Z56=XB_Y%[5/^O67_P! -%V*
MQYQX0^&]OKGANROGU.^MVF4GRX9 %7#$8 Q[5L?\*AM?^@SJ7_?P?X5L_#7_
M )$;2O\ <;_T-JZ>B[N%CS__ (5#:_\ 09U+_OX/\*/^%0VO_09U+_OX/\*]
M HHNQGG_ /PJ&U_Z#.I?]_!_A1_PJ&U_Z#.I?]_!_A7H%%%V!Y__ ,*AM?\
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M_?P?X5Z!11=@>?\ _"H;7_H,ZE_W\'^%'_"H;7_H,ZE_W\'^%>@4478'G_\
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M '\'^%>@4478'G__  J&U_Z#.I?]_!_A1_PJ&U_Z#.I?]_!_A7H%%%V!Y_\
M\*AM?^@SJ7_?P?X4?\*AM?\ H,ZE_P!_!_A7H%%%V!Y__P *AM?^@SJ7_?P?
MX4?\*AM?^@SJ7_?P?X5Z!11=@>?_ /"H;7_H,ZE_W\'^%'_"H;7_ *#.I?\
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MU !117S9K?[5UQX0_:7U'P%KUE9V_A.-[:UCU95=9()YH(Y5,SEBFPLS+T7
M&22 : /I.BBO*=-^*VJWG[26K?#U[:S&D6?A]=5CN%5_M!E,L:%2=VTKB0GA
M0<@<T >K4444 %%%% !1110 45YG\7/C _P]O-%T'1M%E\4>,=<9TT[2(91$
M-J#+RRN<[$4=SUP>@!(Y2X\3?M!Z3 VH3^$?!NK6ZC>=+TZ_GCN\#D@.^4)Q
MP, \CH>E 'N]%<)\(?BWI7QA\+OJNFPW%C<V\[6M]IMXNV>SG7&Z-Q^.0>XZ
M@$$#NZ "BBB@ HHKR3X^:$)K/0-1AU76].N9=;TO39/[,UBZM$:":]C20%(I
M%4L5=AN(W $8(P, 'K=%?..L^*KGX3?&:_O;K6M4D\#:1I6GVE];7M[-=+#]
MI:[*7),C,2_FP11[B<D2XYP .H_9WOO$=U=>.H_$U_=W.H#5(+G[-<RLXLA<
M65O<&W0$D*L9E*@#CY<]220#V:BJ.L+J#:5=C2I+:/4C$WV9[Q&>$28.W>%(
M8KG&<$'TKSGX&?%^Y^(UGJND^(;*+1?&^@SFVU;2X\A0<G9-&&))C8=#D_4@
M@D ]4HKRSXW_ !>NOAY;Z5HWARSAUKQSKTXM])TN7)3J-\TNT@B-1R3D9]0
M2/1M)6_72[4:G);RZD(E%P]HC)"9,#<45B2%SG ))Q0!=HHHH **** "BBB@
M HKR^Z^)VIP?M&67P_6"T.D3>'#K#7!5_M'G>>T84'=M"X7.-N<]^U>H4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!P__ #6#_N%_^SUW%</_
M ,U@_P"X7_[/7<4P"BBN;^(WB*X\'_#WQ/K]I''-=Z5I=U?0QS9V,\43.H8
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M/QQ_:CO_ (+_ !JT#P[<Z9;77A.YTZ*]U&Z6.1KFW#SRQ%U(;;M78A(*DG)
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M(WG2&>$2/O)8J0"<#"C@<YKT^@ HHHH **** "BBB@ HHHH X?XG_P#,N_\
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MCXU>-?B#XBU?3?A9X9TW4--TBY:RNO$6O731VCSKC?'$D?S.%SRP..1P,@D
M]VHKY]U'XY>/OA)=64OQ3\*::GAVXE6WD\1>&)Y)8+5V. 98I!O"D]\CT 8D
M ^^PS1W$*2Q2+)$Z[ED4@JP/((/<&@"6BBB@ HHHH **** "BBB@ HHHH **
M*\P^#'Q.U3XCZE\0+?4;>TMX_#_B.ZT>U-JC@O%$0 SEF.6/<C ]J /3Z**^
M9_V4_P!J;5_C?KFL:-XET_3]-U".V6]T_P"P1R(L\(<I)G>[9*L4Y!YRW'%
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M "BBB@ KA_\ FL'_ '"__9Z[BN'_ .:P?]PO_P!GI@=Q1112 **** "BBB@
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M(,;ADC([9ZG#8 /6Z*** "BBB@ HHJAKFK0Z#HNH:G<?ZBRMY+F3']U%+']
M: +]%?.'@GQC^T/X\\)Z5XAL+/X;V]EJ=NMU!'=B_64(PRNX*Q )&#P3UKU?
MX9M\16AU#_A8*>&5EW)]C_X1LW&W;AM_F><>N=N,>^>U '<45\_R?$7XN^-?
M'7C&Q\!6O@Q=!T#4!IOG:^+OSY)A$C2<Q-M(#,1T&!@<\FNL\"O\:3XEM_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$-P?Q9\->)?V<?!\GCO0?B-XFU^+3+B$WFC^*;Q;V*\BDE5"J'8IC8;P<CH
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M.,D+CZ.LO'FE?$SX.W?B31IO-L+[2YW4-]Z)A&P:-QV96!!'J...:S/V7_\
MDWWP+_V#4_F:\;\6QO\ LL^--;@0&/X7^-HIPBJ#Y>DZBT38 [*C]AP !Z1\
M@%OX+_$Z/X1?L0^'_$1MQ>7D?VJ"RM,D?:+B2^G6-..V3DXYPIQ79:9\"_&W
MB;38-5\6?%3Q3I_B69!*UKX?N([6PM6(SY?E!3Y@7.,D@G&?>O%-/T^Z;]A7
MX=ZY;P/<Q>&]=&LW-NAYDACOKE7&.X'F GT )[5]JZ+K5EXBTBRU33KE+NPO
M(EG@N(SE71@""#[@T >!^']?\:>(HO'_ ,'_ !'K3Q^-;#3C=:/XDTXFTDO(
M&XCF.PC8RR%%8*0""1S@D]Y^S?X_G^(WP?T+4;Z21]8MT.GZB)<^8+F$['+Y
M_B8 ,?\ >KBO#=Q'XX_;(U_6-+<3Z9X9\-IHMY<Q\H;M[@R>6#W(4N#CH4(-
M8O\ PEL/[.?Q(^+=I<[8])U/3CXOTJ)N%>XP8YXA_M-+LP!CC'UH W-&\;:[
MK?Q4^*OBFRDU+5O#_A&Q.CZ=H=F\C1WM\B^;,1$N0T@;$8."<./04>%?@SXV
M\?\ A^QU_P ;_$GQ=HNNWR"Z_LGP]<KI]O8[AD0LFPEBH(!W'.00<XR:FES:
MI^SK^R'<ZXD7VKQ/]E_M.Z:9=Q-Y=2KEG'?R_,4$=Q'^-:_A'X"CQ=X?TS6/
M%WCWQ3XJNK^WCNI$@U:2TL<N@;]W%"5 7G@YR>#QTH L? ;QAX@C\<^/OAWX
MBUD^))_"\ML]IK$D86::">,N$EQP63@$]22<]!7 ?#?Q%X@_91LM4\)^)?!N
MMZWX92_FNK#Q'H< NE:-R"/.0$%2,'))SG( ( )I_!"'3M%^+7QXA^&\4$T5
MGIUM'I<;.\\3W20R @NSEI 9PV3NR<GGH:]L_9[^+*_&#X:Z?K-Q+;KK<>Z#
M4[2 %?L\ZL004))4$ ,,GO3 P(?C9\(?CYH=WX3G\06TJ:DH@ETR_P!]G,QW
M A5WA<L" 1M).1QTJ]\8?&EW\'_ ?AWP[X/MDN/$>J3V^@Z'#=,76,[0OFR$
MY)"*!DGN03D9I_[1G@?P)KOPS\0:AXOL;"+[/9RO#J4BJEQ%*%.P1R?>+%@
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M_;LN8M/E6<:3X6?3IY(R"OG+.)'7([KYH4CL00>10!]-4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !6%XX_Y$_6/^O:3^1K=K"\<?\ (GZQ_P!>
MTG\C0 >!_P#D3]'_ .O:/^0K=K"\#_\ (GZ/_P!>T?\ (5NT %?,OC[0;#Q1
M^VAI6D:I;)=Z?>^!I8)X).CHT]P"/8\]>O0CI7TU7SMKW_)]WAO_ +$Q_P#T
MHN* (?@7K]_\&_'ES\&/$]R\]LJM=^%-3G_Y>;4DDVY./OI@D#V8#@*#/\3?
M^3S/@W_V#]3_ /2>:NW^/_PA/Q7\'QC3IO[/\5:1+]OT345.UH+A<$+N[*V
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MX."0,CFNW\$Z5X&\4>++[XB^&+VUU74M0M5L+F^L;OS(V12I"L@. PVJ.0&
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M&,>U=Q^SG_R0?P%_V![;_P! %7_CG_R1/X@_]B]J'_I-)5#]G/\ Y(/X"_[
M]M_Z * .(\&C^WOVQOB%>3D2-H.AV.FVX;/R+,%G; Z9SGGK@D=S7M^N:3!K
MVBZAIERH>VO;>2VE4]"CJ5(/X$UX;!,/ 7[8E^;Y_(L/&VAQ"TF<X5[NV(4Q
M#L6\L$^OS #K7K/Q*\;67P[\"ZWXAOYD@AL;5Y%WG&^3!"(/4LQ 'N: /CSX
M=:M-XQ\$_LS>'KQ_,MSKM]<.C9(?[$Y:,'V ?;@\$>U?==?%,/A&[^$?P7^
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MMYFM>+M4M;&WMTY?RUE61Y".RKL7)/ W#ZABZ'NFGW7VVQM[C;M\Z-9-OID
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M$@>A%> ?%+_B[GQ ^+.LG][H/P_\)ZCIEIW5M0FMI?.89[JH9".Q5#QWM?\
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M'#P[J/[6GC:_TKP?#8MI7@F.4-K%Q&&6^OV /V-&.!L&T!CD@'D\%26!ZC\
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MRU/4%47MM+&65H)64 2!EEW*Y (*,",8->T_LG^)+77_ (%^&K>'$5YI,/\
M9E[:L,/!-$2I5QV) #8/9A7#?MB^*M/CUCX5^&A,KZI-XIL]1,*D%DAC8Q[B
M.VYI0 >Y4XZ4^H'TU1112 **** "BBB@ HHHH **** "BBB@ HHHH **** .
M-\>?\AKPG_V$1_2NRKC?'G_(:\)_]A$?TKLJ "BBB@ HK.T/7M,\2Z>E_I&H
MVFJV+LR+<V4ZS1DJ2" RDC(((//!XK/USX@>%_"]R+;6?$FD:3<-C$5]?Q0N
M<],!F!YX_.@#H:*J:?J5IJUHEU8W<%[;2<K-;R"1&^A!(-6Z "BBB@ HHHH
M***R?$>LW.A::;JUT6_UZ7>%^R::81*0<_-^]DC7 [_-GG@&@#6HKR%OVCM,
MMOAW_P )M>^%O$ECX?D%LUM--':L]R)W"H42.X8\$@D-M.#QD\5U6J_%?1-+
M\>>%?"?^D7>H^(XII[66V56ABCCB:0-(Q8$!PCA< Y*GIC- ':4456O;ZWTV
MUDN;NXBMK>,;GFF<(BCU))P!0!9HKG-&^(GA7Q'>&TTGQ-H^J70.#!97\4SY
MQG[JL3TKHZ "BBB@ HHI"0O)Z4 +12 AN1TI: "BBB@ HHHH **** "BBB@
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MA*^7H.I:W))8H%.0!& "0/0L>@KV6'3[:WL8[**VACLDC$*VZ(!&L8& @7&
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M,G &:[:B@#S+QY^S_P"&?'>O_P#"0+<:MX9\2&/R7UGP[?-9W4B   .0"&X
M&2"< #. !4O@'X#^&OA_KTNOQR:EKWB26/R6UK7KQKNZ"=U5C@*#SG: ><=.
M*](HH X+XE?!?PS\4IK&\U6&YM-8L,_8]8TNX:VO+?.>%D7J,DG!R 22!S7F
MWQ _9_\ #_A/X8^.=<O-3UWQ;K=KX=U(6VH>)M1>]DMLVL@)C! 521QD+GT/
M)S]#5GZUH]GXBT:_TK48?M.GW]O):W$)8J)(W4JZY!!&02,@@\\4 <1^SG_R
M0?P%_P!@>V_] %>CUE^'?#NG^$=!L-&TFW^RZ;8PK;V\&]GV1J, ;F)8\#J2
M36I0 4444 9'BKP];>+O#.KZ#>M(EGJEG-93M"0'$<J%&*D@@'#'!(/..M0^
M"_"=IX$\)Z1X>L)9I;+3+9+6&2Y(:5D4  L0 "<>@%;M% '*_$+X:>'OBEH:
MZ5XCL!>0(XFAD5C'-!(.DD;J058>QY[Y'%<+IW[+?A>/5K.]UW6O$WC-;*02
MVMEXEU9KNV@8# (C( ./1L@]\U[)10!2U?1[+7]+NM.U&UBO;"ZC,4]O.H9)
M$(P00>HQ7C;?LD^%?LYT^+Q#XPM_#AW#_A'8M=D&GE2<E=A!;;[;N]>XT4 9
MGAWP_IOA71;/2-'LH=.TRS0106T*X5%'I[Y)))Y)))))KS/7/V9?#.I:W?ZK
MH^K>(_!=SJ#^;>KX8U1K.*Y<G)9TP5R>^ ,\GJ<UZ_10!Q_PW^%7AWX5:7/8
M^'[-HC=2>==W<\AEN+J3GYI)&Y8\GCH,G &378444 >4^-OV=/#?C#Q1-XEM
MM1UWPEXAGC$=SJ7AG4#:2W"@8&_@@D 8SC)&,DX&*5S^RQX*O/#%_I5Q)J]Q
M>WL\5S-X@N+]I=3\R(DQL)F!QMR< #').,\U['10!P&D_!S2M)\<Z3XM.I:M
M?:SIVB#0EEOKA9?/A#E_,E)3<TI8DE@0#GI71>-/"=IX[\)ZOX>OY9HK+4[9
M[6:2V(6548$$J2" <>H-;M% ',6OP]T2/X?V?@RZM!J>@6^GQ:;]GO@',D,:
M*B[\ #=A0<@#D C&*\YM_P!D_P ,6L0L%\1^,#X=&%'ATZ[*+#9SE-@^;:0<
M8W5[;10!PW@WX0>'O /BS6-=T2*2S?4[6VLWL8]BVT,<"E4\M0H(R#SDG)]*
M[FBB@ HHHH **** "BBB@ HHHH X?XG_ /,N_P#84B_K7<5P_P 3_P#F7?\
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M#$CL<CBNX\ _#'2/AQ<>(9=)>XQK>HOJ<\,I39%(P *QA5&U  , Y^M=?10
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M^S0QL^U49BV[><@@!3P<YZUQFJ_M/^&;?4KVST31?$_C,6,I@N[KPUI+W=O
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M!@<#J3])_%;QL/AQ\-_$?B5E5WTVRDFB1NC28Q&I]BQ4?C7EWQR_Y..^ ?\
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M#T.$QGKAB.YR@.V\-_M+^%-:U^31-6M-9\%:H()+J.W\56)L3-#&"6="25(
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M<JPR?8YP0176T4 >/Z'^S-X>T[5;.]U?7O%/C!+*19;6S\2:LUU;0.N-I$6
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MT?\ (5-XN_Y%76O^O*;_ -%M4/@?_D3]'_Z]H_Y"GT W:***0!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 <;\5O^15'_7U%_Z%795QOQ6_
MY%4?]?47_H5=E0 4444 ?%^D^ ?$T7_!0*3Q$_AS5D\/_:)V&K-8RBUP=.9
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M.A) Z<4 >E_%SXP/\/;S1=!T;19?%'C'7&=-.TB&41#:@R\LKG.Q%'<]<'H
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M=U?0QS9V,\43.H8 @X)4 X(.*Z2N'^.?_)$_B#_V+VH?^DTE(#A?V8/VB_\
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M!ZK17S;K^H>)+[XI>%?@]'XTOO#MG:^'([^]UF*0-J.K3*WEE(Y90V#\ID)
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M8Y+<G(P/85@?M%?&ZV^"?P[OM4@GL9O$#%(]/T^Z8MYKLP!)16#%57<Q((Z
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MYR/,M0^!^W]JZS\-_P#"P/')\[PJU]_:QUK_ $]/]*=?)6;9Q%QG;CJ2<\T
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M0 !U)KGO@7X5D/[//AKP]X@TZ:W,ND_9+VPO(C&X5@RLCJ0""03D$=Z]3HH
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MYTS5[&\L=#\1:?ID-IJ3V[>2\B6Z_-&Q 5RDB@D ]1@XS7TK10!\Y>$/B/\
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MT>U^&&O>"_$5K>V=S=LNN+9AM+>,NS@^?NX+=  #G(]3CZ2HH ^</#\?BO\
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M/7KT(Z4 ?25G=PZA9P75M,EQ;3HLD4T3!D=6 (8$=000<CUKS'QA\5M5\/\
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M/[0_CSPGI7B&PL_AO;V6IVZW4$=V+]90C#*[@K$ D8/!/6O5_AFWQ%:'4/\
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MHRXC)^964 G:W.!VR 0"Y\1?C!JVG>-+;P-X&T2'Q%XNEM_M=R;N<Q6>G09
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MXB^.]*M_#]Q#8#2]'T.&[6Z:UC+;Y9'D3Y2['@$=B0<8&?:J /#;7]H;Q/\
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M **** "BBB@ HHHH **** "N-^+G_(CWG^_'_P"ABNRKC?BY_P B/>?[\?\
MZ&* .LM/^/.#_<7^535#:?\ 'G!_N+_*IJ "OG?X9?\ )YGQD_[!^F?^D\-?
M1%<7H?PKTG0/B7XD\;V\UX^K:_#!#=12.I@41(J*44*&!(49RQ'TH X;]H[X
M8ZIK5KIGCSP<#%X]\+$W%IL4DWL R9+9@,%@06('<EE&-Q->9_ GXE:=\6OV
ML-0\3::#''=>"E$UNQRT$RW$ DC/N&!Y[C![U]<UYEX._9^\*^ _BCKGCO1E
MN[75-8@>&XL_,7[*N]T=V10FX,S1@GYB.3@"@#B?V.;I-!\&Z_X#O&\O7_#&
ML7,%W"Y^=T=RT<WNK9(![[<]Q4O[9VHQWGPC_P"$/M<7'B#Q3?VMAIMHIR\C
M+/'(S8[* @!/0;AGK7;_ ! ^ _ACX@ZU%KDQU#0O$D2"--<T*[:TN]@Z*6&0
MP]-P)& !QQ4'@+]GWPQX#\0?\) 9M4\2^) GE+K/B*]:\N44YX0D +G)&0 <
M$C."<@')_M+:3)X2T?P7\0K,--=>"-1ADN74?/)8R[8;A0!W(*GV&XT[P5)'
M\3OVE/$GB>.476B>$=/BT73I%.8WN9AYMQ(I]54B,^Q%>R^(M!L_%&@ZEH^H
M1>;8ZA;R6L\?<HZE6 /8X)Y[5SOPE^$^B_!GPBGAW0FNIK7SY+F2XOG5YI9'
M(RS%54$@!5& .%&<GD@'D7A\:]^T#\2OB!:7_C'6?#7A[PSJ9TNWT70+@6DT
MNW<#--,!O*N5. "!QCC!SQ?[1'PX\$_#G6/AI!ITEW<>*KOQ18R&;4-1GNYV
MM5<AR1(Y"+O:/D 9(QV->X>-OV=/#?C#Q1-XEMM1UWPEXAGC$=SJ7AG4#:2W
M"@8&_@@D 8SC)&,DX&*5S^RQX*O/#%_I5Q)J]Q>WL\5S-X@N+]I=3\R(DQL)
MF!QMR< #').,\TP%MOC!J&E_M':GX!\0&SLM(O-.BO- F9"DER^%$D98L0S;
MA(0  <+CGOZKJNCZ?KUF]IJ5C;:C:./FM[N)94;ZJP(-<=XH^"?A;QUX1TSP
M_P")[6;Q!'IT:I!J%].S7H8  R><N&W-@%B, D#(X%<2?V2]">-K6;QKX\GT
MQ@%.F2:^_P!F( QC:%SC''6D!YGX+\)VR_%;XW^#?A\^WPI=>')(W@MI2UM;
M:G+'L58SR%.#)D \%2.B@"7]G7X-V7Q$^$NB:C:?$_XB:5/"AM+O2]-U[R(;
M.:,E6C6/RR4' 8 G.&![U]*> ?ASX<^&.@IH_AC2H=,L5.YECRSR-TW.YRSM
MQC)/0 =!BN,\4?LV^&M=\1WFOZ7J>O\ @O5[Y@]Y<^%]2:R^U$'.9% *DDDD
MD $DDG)-,#@;#X9^%O"7[0/@K3+KQCX_\8>*K>&YU"UCU75(KRVL(O+*LTP9
M R"3A1MZE1GC&=;]C>X71? VN>"+MO+UWPSK-U;7<,A_>.K.728^JMD@'OM^
ME>C_  W^#7AKX727UUI,%S<ZKJ!!O-6U*X:YN[C'0/(QSC@<  ' )YYK/^('
MP#\,_$#7H]?:74_#WB5(_)_MOP_>-:73)T"LP!#8  !8$@ #H,4@//OV[/%5
MAHOP$U+1YI5^WZS/;PVT.1N(CFCE=@/[H"8)[%AZU[[H/_(#T[_KVC_]!%?+
M_P"TI\$] ^'_ .SUXWU>*?4]=U^:.SA?6=>O&N[OR_ML!V!VP%7/)"@9[]!7
MU!H/_(#T[_KVC_\ 010!Y[^T!\6)?A;X/C72H#?^+=9F&GZ'8(H9I;EL -M[
MJN03V)*@XW5Y]+^R;'!\$(M)M+S_ (N)!<C78_$!;]Z=3X8_O.NPGY<GT#$$
MBO6;CX1Z/J'Q5M_'U]<7U]JUG:&TL;6XD4VMD#PSQ($!#L"P+%CPQ]!CN: /
M,O@'\6A\6O!*W%[#]@\2Z9(;#6M/8;6@N4X8[3R%;!(].1DE379^-O\ D3=>
M_P"O"X_]%M7.Z;\']&T7XI:EX[TZYOK#4]3MA;W]E Z"TNL8Q(Z%"?,&!\P8
M=_5L]AJEA'JFFW=E,66&XB:%RA^;:P(.,@\X)H ^<?V1OA3X)\2?L]>%-2U?
MP=H.JZA-]J\V[OM+@FFDQ=S*-SLA)PH &>@ ':O>?#OP^\+>$)7ET+PUI&B2
MOP[Z=810,WU**,U5^&/P[TSX4>!M,\*Z/+=3Z=I_F"*2]=6E.^1I&+%54'YG
M/0#C%=70!X#\<O\ DX[X!_\ 7SJW_HB&H_AS,FG_ +8'Q<M9V$<^H:=IEU;(
M>/,CC@2-R/7#$#BO4?%7PQTKQ=XS\(^)KV>[CU#PS)<26:0NHB<S(J.) 5)(
M 4$8(.?7I67\2O@;X;^*&HV.JWSZAI.O6*&.VUK1;MK6[B0DDJ' ((R20"#C
M)QC)R >6_M]^)[/2?@>=)ED7[;JU]"D,.?F*QL'=L>@PH)]6 [UWWQ4N_ GC
M+QCHOPS\::&^H/J]M)>V%Q.H6'S(\AD20.'64*"?E X(&><5FZI^R?X0USPW
MJ.EZKJ'B#6+V_6**;7-3U$W5_P"7'(L@C62165%+(,A5&>_08[KXD_"KPY\6
M-'AL/$-DTXMI?/M;J&0Q7%M(/XXY!RIZ9'0X&0<"@#Q/XE?"O5?@'X)U+Q?X
M%^(.O:?%HR"X.AZY=_;-/F0, 8E5P"A;. 022< 8SD?0?@W7)/$_A'0]8EMS
M:2ZA8P7;V[=8C)&K%3],X_"O,[7]EGPQ+>6\OB'7/%/C6WMW$D-CXDUB2ZMD
M8=#Y8"@X]&R#W!KV15"*    ,#% 'C_C[XP:C\/OCEX/T'5#9V?@O7[.2-;^
M="'6^4L0ADW;0I!C !'5NOIZU>64&H6[V]U!'<P.,-%,@96'H0>#6-XV\!Z#
M\1M!ET7Q'I<.K:=(P8Q3 @HPSAE8$,K#GE2#@D=S7ED?[)6@6B"WL?&?CK3=
M-QM_LVUU]UM]O8;2I.!Z9H X_2]"T7P5^V=ING> HHK&UO='N)?$NGZ><6T)
M&XQ,4'RHQ?R^!C 8$ ;CF:3Q=!^SE\5?BC;76V/1M:TU_%NF(W"M=*"D\0]6
M=]IQV 'X^T?#7X/>%/A)8SV_AK2UM)+EM]S=2.TMQ.>3EY&))Y)('09. ,UY
M'^TMX8T;XJ?%;X5^#)(UN=32]EU&^VG)AT] &D5QV$C(J@GNIXYH [3X$Z!-
M\,?@3:7NHV]Q>:Q/;S:]J4<2@SSW$H,S( 2 7 VH.0,J.>]<QX?^#?PT^-FC
MVWQ!\)2:QX/O-7#2O>^'[\V5P)-Q#"1%+('# YP.2223FOH6O&M0_9;\,-K%
M]J&@ZWXG\%&_E,UU;>&=6:T@F<]24P0,^BX [8H R?@WXC\4^&_C)XF^&6N^
M('\866GZ;%JEIJUQ&%N8 S*OD3D?>8[MP)Y(&>A #/V&6'_#.6A>US=C_P C
MM7I7PY^$OAKX6VMW'H5I(EQ>N)+R^NIGGN;IQG#22,23C)XZ#)(')KG_  /^
MSWHGPY\72:UH&M^(K*RDDFF/A\:B3I>^0$%O)VY)&<C+<8'I0!X)^S?\%H_$
MGA_7=&N?B+XZ\.:[H&K7-E?:5HNM?985(<E91'L)PXS\V<$J<5U/CCX/^%?"
M'C#P%IVN>/?B3XKU._UN&33=*N=9BNXUDB.XW$B2(,1H,[F4[@&('?'K/CS]
MG_PSX[U__A(%N-6\,^)#'Y+ZSX=OFL[J1   '(!#< #)!. !G  J7P#\!_#7
MP_UZ77XY-2U[Q)+'Y+:UKUXUW=!.ZJQP%!YSM /..G%,#B?A;_R=M\;?^O;1
M_P#TE6C]JG_D._!C_L>M._\ 0C7IVA?#+2O#OQ$\3^,K:>[;4_$4=M'=Q2.I
MA40QB-"@"A@2 ,Y8CZ4>/OAEI7Q%N_#-QJ4UW$_A_58=7M5M750\T1RH?*DE
M<]0"#[T@.AU[_D!ZC_U[2?\ H)KY6^!_B;PC9_LS?"WPMXTTAM2TGQ3=WNGI
M)+&C6T4PO)B@D8L"A8GY2H)!!/&,U]8WELMY9SV[DA)4:-MIYP00<?G7G>E_
ML_\ @^Q^$=K\-[NTFUGPY;;RGV^0&<.TKR[PZ!=K!G;!4# X[G(!PGB+]F]?
MA[H.HZK\/O'GB'P6^GP274=E/?FYTP!%+8>*3.%XP6).!DX/0^C_  )\>7WQ
M.^$OAKQ+J=LMKJ%_;EIHXP0I979"P'. VW<!DXW#FN1C_90\-W")::KXF\9Z
M_HJXVZ+J>NR/98'1=BA20/0GM7L6FZ=:Z/I]M8V-O':65M&L,,$*A4C11@*
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MGKLCV6!T78H4D#T)[4@//_B]X\OOB;^P;>^)M2MEM-0O[>T::.,84LNH1(6
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MLJ%';>V27()^9L]!G- &9^SG_P D'\!?]@>V_P#0!7$? W_DX[X^?]?.D_\
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M&=S*=P#$#OCUGQY^S_X9\=Z__P ) MQJWAGQ(8_)?6?#M\UG=2(   Y (;@
M9()P ,X %2^ ?@/X:^'^O2Z_')J6O>))8_);6M>O&N[H)W56. H/.=H!YQTX
MI@<+\ ;A/"_QD^,/A+4&\K5+K63KUJ)#\UQ;3C.4/<(=H/H6QV-==^TYXJL/
M"?P+\8R7TJH;[3I]/MXR?FEEFC:-0H[D;BQQV4GM6O\ $KX+^&?BE-8WFJPW
M-IK%AG['K&EW#6UY;YSPLB]1DDX.0"20.:\V^('[/_A_PG\,?'.N7FIZ[XMU
MNU\.ZD+;4/$VHO>R6V;60$Q@@*I(XR%SZ'DY0'?_ +.?_)!_ 7_8'MO_ $ 5
M?^+?Q0L?A/X2;5KFVEU"\GG2ST_38#^\O+I\B.)>#C."2<' !.">*H?LY_\
M)!_ 7_8'MO\ T 4OQ>^"6E?&3^PSJ.L:WHTVCW#7-K/HERD$BR$ !MS(Q!&.
M",$9/- ''^%?@7JOCC6K3Q?\7+Q-;U6-A-8^&83_ ,2S2\\@;<XFD'&6;(SD
M?, #7KWB_0_^$H\)ZUHQ;8-1L9[3=Z>9&R9_#->2?\,JQ_\ 16/BA_X48_\
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MP2\U+7;M/+N-:U>Z>ZO)5R#M+L>!D X4#.!G.!CT"@ HHHH X?XG_P#,N_\
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M.F2"< #. !3? _[/_AGP3X@3Q!)<:MXF\1QH8XM7\17[WMQ$I!!"$X5<@D9
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MP,,-YDP# 'W5!&A_W:U/B!\ _#7Q!\0P^(7FU3P_XDCC\D:UH%ZUG=,G968
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M -GKN*X?_FL'_<+_ /9Z8'<4444@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH P
MO''_ ")^L?\ 7M)_(U-X1_Y%71?^O*'_ -%K4/CC_D3]8_Z]I/Y&IO"/_(JZ
M+_UY0_\ HM: ->BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K.\1?
M\B]JG_7K+_Z :T:SO$7_ "+VJ?\ 7K+_ .@&@#)^&O\ R(VE?[C?^AM73US'
MPU_Y$;2O]QO_ $-JZ>@ KYVU[_D^[PW_ -B8_P#Z47%?1-<7=?"S2;WXK67Q
M >:\&M6FF'2DA61?LYB+L^XKMW;LNPR&QCM0!A?'_P"$)^*_@^,:=-_9_BK2
M)?M^B:BIVM!<+@A=W96P >P(4X.W%?/?@_XL-\6?VE?@W<:A;G3_ !+I=KJF
MGZSI[*5:"Y2WF#<'H&QD#L<CD@U]JUYG-^S]X5D^,UI\3H5N[3Q% C*T<$BB
MVG9HFB,CJ5)+;'(R& X!()SD \*\!_"F/Q)\;OBSH5]XY\8>$]776&U6&U\/
MZM]C2ZM9_G60KL.\KD*2.@('7-:7QJ^"7ACP7X-W>*_B/\4O$%EJ%U#90Z*N
MNQW#WLS."B+%)&%8@C=R>-N1S@5[?\2/@GX9^)UY9:AJ*7FGZY8@K::UI-RU
MK>0 YX$B]1R<!@0,G&,G.3X1_9S\->&?$5IX@O\ 4-=\8:[9 BTO_$^HM>26
MV>IC! 4'ISC(QD$&@1E?M%>.$\,^";7P3I5C'KWBOQ1'_96G:7. ^59=KSRC
MIL0$DD\9'H"1P'[/-G/^S/XVE^%GB9;8Q:\1?Z-X@ACV)>S!562W8G^)2/E!
M.>?]M17N&D?"'1M+^)FJ>/);B^U3Q!?0K;1R7TB-'90C_EG JH-BGN22>3S\
MS9E^*GPIT/XO>'8]*UK[3;^1.EU:WUC(([JUE4Y#Q.0=IQD'(/7U (!GFWQR
M(_X:-^ >?^?G5O\ T1#70?'7XM:K\(]:\"7NRU3PEJ&IFQUN\N(V8VP<+Y3A
M@0% Q(22#T'3ON?$3X*Z-\3]'T2TU;4-6AU#1W$MGK5A<B"^CDVA6<.J[0S8
M!.% R 0!6O8_#O3%\!IX2UB6[\5Z9Y1AFE\02_:I[D%BV9'(&2"1@C&,#&",
MT =&K0:A:AE,=Q;3("&!#(Z$9!]""/YU\O\ Q8\-:#X+_:0^%EQX(M;?2_%F
MHZ@T6JV6F (LU@0#+)+&HP,+O() SM)))4$=K'^R/X9TUC'H7BCQIX8L,D_V
M?H^NR10<]1A@QQ^-=?\ #7X#^#_A7>75_HUA)-K%T,3ZMJ$[7-U(#U!=CP#@
M9"@9P,YP* /G3]F_X+1^)/#^NZ-<_$7QUX<UW0-6N;*^TK1=:^RPJ0Y*RB/8
M3AQGYLX)4XKJ?''P?\*^$/&'@+3M<\>_$GQ7J=_K<,FFZ5<ZS%=QK)$=QN)$
MD08C09W,IW ,0.^/6?'G[/\ X9\=Z_\ \) MQJWAGQ(8_)?6?#M\UG=2(
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MC(!QD US_A3]G#PUX=\36GB'4=2U[QCK-F2UG=>)M1:]-J2>L:D!01Q@D$C
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M+O5+F2!M;UF&WC5YY9+A@TF58A255P&R<8C/6H+']FOP+XAL+?Q-X"U;7/!
MU2)+R*?PSJ300R!@&!,9++C!&57 XQ7NEU:Q7UM-;W$23P3(8Y(I%#*ZD$%2
M#P00<8/K7C*_LG^&M/:6+1/$OC'PSI4KM(^CZ/KDD-H2221L() .3P#0 []G
M7QKXDU75?'7A'Q+JD?B*Y\)ZA'9Q:Y'$(S=HZL0K@<>8FW#8Z$X))&3F_L,L
M/^&<M"]KF['_ )':O6/ /P[\/_#/01H_AO3DTZRWF5\,7>60\%W=B69C@<DG
M@ = !7(^!_V>]$^'/BZ36M UOQ%964DDTQ\/C42=+WR @MY.W)(SD9;C ]*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <;\5O^15'_7U%_P"A5V5<;\5O^15'_7U%_P"A5V5 !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7&_%S_D1[S_ 'X__0Q795QOQ<_Y$>\_WX__ $,4 =9:?\><
M'^XO\JFJ&T_X\X/]Q?Y5-0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &#XS\&:-\0O#-[X?\06?]H:1>;1/;F1X]^UU=?F0AAAE4\$=*V+>%+6
MWCAC&V.-0BKG. !P/RJ:B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MCEC6:-XW&Y'!5AZ@C!%<3\._@GX)^%$UU-X5\/P:5/=+MEG$DDLC+G.W?(S,
M%R < XX''%=U10 4444 %%%% !1110 4444 %%%% !1110 4444 </\ \U@_
M[A?_ +/7<5P__-8/^X7_ .SUW%, HHHI %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*X?_ )K!_P!PO_V>NXKA_P#FL'_<+_\ 9Z8'<4444@"BBB@ K@_%7P/\#>./
M%EGXEU_P]!JFLVD:Q0S7$DA0*K%E!C#;&P6)^93UKO** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@CD =#[UT58/C7_D7YO]]?YB@#2AUCQ;Y,>S5K8)M& ;=>F..U/_ +9\7_\
M07M?_ =?\*EM_P#CWB_W%_E4E %;^V?%_P#T%[7_ ,!U_P */[9\7_\ 07M?
M_ =?\*LT4 5O[9\7_P#07M?_  '7_"C^V?%__07M?_ =?\*LT4 5O[9\7_\
M07M?_ =?\*/[9\7_ /07M?\ P'7_  JS10!6_MGQ?_T%[7_P'7_"C^V?%_\
MT%[7_P !U_PJS10!6_MGQ?\ ]!>U_P# =?\ "C^V?%__ $%[7_P'7_"K-% %
M;^V?%_\ T%[7_P !U_PH_MGQ?_T%[7_P'7_"K-% %;^V?%__ $%[7_P'7_"C
M^V?%_P#T%[7_ ,!U_P *LT4 5O[9\7_]!>U_\!U_PH_MGQ?_ -!>U_\  =?\
M*LT4 5O[9\7_ /07M?\ P'7_  H_MGQ?_P!!>U_\!U_PJS10!6_MGQ?_ -!>
MU_\  =?\*/[9\7_]!>U_\!U_PJS10!6_MGQ?_P!!>U_\!U_PH_MGQ?\ ]!>U
M_P# =?\ "K-% %;^V?%__07M?_ =?\*/[9\7_P#07M?_  '7_"K-% %;^V?%
M_P#T%[7_ ,!U_P */[9\7_\ 07M?_ =?\*LT4 5O[9\7_P#07M?_  '7_"C^
MV?%__07M?_ =?\*LT4 5O[9\7_\ 07M?_ =?\*/[9\7_ /07M?\ P'7_  JS
M10!6_MGQ?_T%[7_P'7_"C^V?%_\ T%[7_P !U_PJS10!6_MGQ?\ ]!>U_P#
M=?\ "C^V?%__ $%[7_P'7_"K-% %;^V?%_\ T%[7_P !U_PH_MGQ?_T%[7_P
M'7_"K-% %;^V?%__ $%[7_P'7_"C^V?%_P#T%[7_ ,!U_P *LT4 5O[9\7_]
M!>U_\!U_PH_MGQ?_ -!>U_\  =?\*LT4 5O[9\7_ /07M?\ P'7_  H_MGQ?
M_P!!>U_\!U_PJS10!6_MGQ?_ -!>U_\  =?\*/[9\7_]!>U_\!U_PJS10!6_
MMGQ?_P!!>U_\!U_PH_MGQ?\ ]!>U_P# =?\ "K-% %;^V?%__07M?_ =?\*/
M[9\7_P#07M?_  '7_"K-% '-?VEK_P#PF'F_;H?[2^R[?.\D;=F<XQC&<]\5
MN?VSXO\ ^@O:_P#@.O\ A6-_S/'_ &Z_UKHJ *W]L^+_ /H+VO\ X#K_ (4?
MVSXO_P"@O:_^ Z_X59HH K?VSXO_ .@O:_\ @.O^%']L^+_^@O:_^ Z_X59H
MH K?VSXO_P"@O:_^ Z_X4?VSXO\ ^@O:_P#@.O\ A5FB@"M_;/B__H+VO_@.
MO^%']L^+_P#H+VO_ (#K_A5FB@"M_;/B_P#Z"]K_ . Z_P"%']L^+_\ H+VO
M_@.O^%6:* *W]L^+_P#H+VO_ (#K_A1_;/B__H+VO_@.O^%6:* *W]L^+_\
MH+VO_@.O^%']L^+_ /H+VO\ X#K_ (59HH K?VSXO_Z"]K_X#K_A1_;/B_\
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MO_@.O^%']L^+_P#H+VO_ (#K_A5FB@"M_;/B_P#Z"]K_ . Z_P"%']L^+_\
MH+VO_@.O^%6:* *W]L^+_P#H+VO_ (#K_A1_;/B__H+VO_@.O^%6:* *W]L^
M+_\ H+VO_@.O^%']L^+_ /H+VO\ X#K_ (59HH K?VSXO_Z"]K_X#K_A1_;/
MB_\ Z"]K_P" Z_X59HH K?VSXO\ ^@O:_P#@.O\ A1_;/B__ *"]K_X#K_A5
MFB@"M_;/B_\ Z"]K_P" Z_X4?VSXO_Z"]K_X#K_A5FB@"M_;/B__ *"]K_X#
MK_A1_;/B_P#Z"]K_ . Z_P"%6:* *W]L^+_^@O:_^ Z_X4?VSXO_ .@O:_\
M@.O^%6:* *W]L^+_ /H+VO\ X#K_ (4?VSXO_P"@O:_^ Z_X59HH K?VSXO_
M .@O:_\ @.O^%']L^+_^@O:_^ Z_X59HH K?VSXO_P"@O:_^ Z_X4?VSXO\
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MM<[_ ,SQ_P!NO]: -G^V?%__ $%[7_P'7_"C^V?%_P#T%[7_ ,!U_P *LT4
M5O[9\7_]!>U_\!U_PH_MGQ?_ -!>U_\  =?\*LT4 5O[9\7_ /07M?\ P'7_
M  H_MGQ?_P!!>U_\!U_PJS10!6_MGQ?_ -!>U_\  =?\*/[9\7_]!>U_\!U_
MPJS10!6_MGQ?_P!!>U_\!U_PH_MGQ?\ ]!>U_P# =?\ "K-% %;^V?%__07M
M?_ =?\*/[9\7_P#07M?_  '7_"K-% %;^V?%_P#T%[7_ ,!U_P */[9\7_\
M07M?_ =?\*LT4 5O[9\7_P#07M?_  '7_"C^V?%__07M?_ =?\*LT4 5O[9\
M7_\ 07M?_ =?\*/[9\7_ /07M?\ P'7_  JS10!6_MGQ?_T%[7_P'7_"C^V?
M%_\ T%[7_P !U_PJS10!6_MGQ?\ ]!>U_P# =?\ "C^V?%__ $%[7_P'7_"K
M-% %;^V?%_\ T%[7_P !U_PH_MGQ?_T%[7_P'7_"K-% %;^V?%__ $%[7_P'
M7_"C^V?%_P#T%[7_ ,!U_P *LT4 5O[9\7_]!>U_\!U_PH_MGQ?_ -!>U_\
M =?\*LT4 5O[9\7_ /07M?\ P'7_  H_MGQ?_P!!>U_\!U_PJS10!6_MGQ?_
M -!>U_\  =?\*/[9\7_]!>U_\!U_PJS10!6_MGQ?_P!!>U_\!U_PH_MGQ?\
M]!>U_P# =?\ "K-% %;^V?%__07M?_ =?\*/[9\7_P#07M?_  '7_"K-% %;
M^V?%_P#T%[7_ ,!U_P */[9\7_\ 07M?_ =?\*LT4 5O[9\7_P#07M?_  '7
M_"C^V?%__07M?_ =?\*LT4 5O[9\7_\ 07M?_ =?\*/[9\7_ /07M?\ P'7_
M  JS10!6_MGQ?_T%[7_P'7_"C^V?%_\ T%[7_P !U_PJS10!6_MGQ?\ ]!>U
M_P# =?\ "C^V?%__ $%[7_P'7_"K-% %;^V?%_\ T%[7_P !U_PK"_M+7_\
MA,/-^WP?VG]EV^=Y(V[,YQC&,Y[XKIJYW_F>/^W7^M &S_;/B_\ Z"]K_P"
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MMCJ,%O: $1QO &(&XYR2"3SGO6G_ &SXO_Z"]K_X#K_A5'PG_P B_9_[I_\
M0C6O0!6_MGQ?_P!!>U_\!U_PH_MGQ?\ ]!>U_P# =?\ "K-% %;^V?%__07M
M?_ =?\*/[9\7_P#07M?_  '7_"K-% %;^V?%_P#T%[7_ ,!U_P */[9\7_\
M07M?_ =?\*LT4 5O[9\7_P#07M?_  '7_"C^V?%__07M?_ =?\*LT4 5O[9\
M7_\ 07M?_ =?\*/[9\7_ /07M?\ P'7_  JS10!6_MGQ?_T%[7_P'7_"C^V?
M%_\ T%[7_P !U_PJS10!6_MGQ?\ ]!>U_P# =?\ "C^V?%__ $%[7_P'7_"K
M-% %;^V?%_\ T%[7_P !U_PH_MGQ?_T%[7_P'7_"K-% %;^V?%__ $%[7_P'
M7_"C^V?%_P#T%[7_ ,!U_P *LT4 5O[9\7_]!>U_\!U_PH_MGQ?_ -!>U_\
M =?\*LT4 5O[9\7_ /07M?\ P'7_  H_MGQ?_P!!>U_\!U_PJS10!6_MGQ?_
M -!>U_\  =?\*/[9\7_]!>U_\!U_PJS10!6_MGQ?_P!!>U_\!U_PH_MGQ?\
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M_ =?\*LT4 5O[9\7_P#07M?_  '7_"C^V?%__07M?_ =?\*LT4 5O[9\7_\
M07M?_ =?\*/[9\7_ /07M?\ P'7_  JS10!6_MGQ?_T%[7_P'7_"C^V?%_\
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MQ*Q\K"YP2%P<C!S@@D ]KHHKFOB1XR_X5[X'U?Q%]C^W_P!GQ"7[-YGE;_F
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M ,SQ_P!NO]:Z*N=_YGC_ +=?ZT =%1110 4444 %%%% !1110 4444 %%%%
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M,%48&3W('3GFO5;3Q=H][X53Q)%?Q'1&M?MGVPG"B(+N+'N, '((R""",C%
M&Q17BEM^T#X@\3YN_!_PSUC7]&.3%J%S<I9+, <%D# [AD$#!R<8P#D#>^'O
MQTL/&'B*3PUJND7_ (4\4HAD&EZDN#*H!):-P &  )Z#(!(R 2 #TVBBB@ H
MHKB/BQ\3!\+]+T6\.G?VG_:6K0:6$\_RO+\P.=^=K9QLZ8&<]10!V]%%% !1
M110 4444 %%%<9XR^(4OA/QEX/T)-(DOTU^::)[Q92JVHC"$$C8=V[=@ E>A
MY- '9T444 %%<GXJ^(^G^$?%GA;P_=V]S+=>(I)HK:2%5*1F,*27)((!WC&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN?M':/XH\-^9=>'_  [ITMM<ZIY96&>:02 1(2 6V^9DD< @]L$^I?\ "H/
M?_0D^'?_  50?_$5X_XZ\+Z;\&?B_P##N]\'0'1_[?U Z=J.G6S$03PEHP7V
M9P"N_/& " 0 0<@%7P_XTM_@%\6?'J>,[2\M-,\1ZB+ZRUN.!I8"A+D1L5!/
MRAP, $@@Y&""?6E\;>!OB]X?O]%LO$.FZC%J,#VS6ZRJ)L,I&1&V&R,Y!QU
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MWAOXUQZ+_:\7C?2;C5!'YQT)=)C%LQP3Y8GSN)/ !X!/<#FLWQAX@\0_%O\
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MA()-0?4=+G\*&QT[4+B P"5P)&&$8DJ2C(H4G(R!U(%?3;NL:%W(1%!)9CP
M.I)H ^>?AM\:?$/C7X:_%7Q'+<-;SZ6+N73(9(H\V86!I$0X4!RI Y8$G'/7
M%>K?!WQ!?^*OA?X;U?5)_M.H7EFLL\VQ4W,<Y.%  ^@ %>"?"J\MM:^%_P ?
M;O3D_P!#NY]3EME4<;&@D* ?@17M'[.\R3?!/P>R,' L54D>H)!'X$$?A0!0
MTWQMK,_[26J^%)+S=H4/A];Z.U\I!MF,L:EMP&X\,1@DCGI6')XU\;_%SQAK
M&G>!=1M?#7AK19S97&OSVJW3W-P/OK$A^4JN1U/((.>0!4\-:E!J'[9'B=()
M%D^R^&E@D*D$!A+;L1QW&X CL0:XG]G3PAXXU;P;J,6B?$<>&C9ZG<07>F'0
MX+ITF!&6+N0WS#'!&!@@=#0!Z7I'C;QA\.O'FD>&/'5[9Z[INN.T6F:_:VXM
MW\X8Q%+&N0"<C!'&6ZD [<'4OB/\0=4^//B_P-X<N+7R88+:2WGOH%,.GQF"
M-Y)#M7=(S,X"JQ(RW( !JKX_\ Z[#JW@Z+QI\7#>LVM6\FF6L?AJ-))+E3\N
M&A?<HP<$GY02">0*W/A^H_X:H^*C8&19:> V.<&"+(_0?E0!0\8>)_B/\#9M
M(UGQ!XEL_&?ABXNX[6^7^S4M)K;>3\R;#@@ '!)Y. 0,Y'4_$[XEZ[#XPT[P
M+X(MK6X\3WD)NKB\O"3!I]ODC>X')8GD ^W!W"L;]LC_ )(???\ 7Y;_ /H=
M,\,.-)_:V\917H\N75='MI=/:3C?&B1JZIZ_,C$X_NGT- $?BV3XM_"K1I/$
MTOB>P\;Z=9J);_2Y-+2T98^-YC>,DG;R<G& "<'&*TO%GQ5U"?QE\'O["O?(
MT/Q0;B6ZA:*-C+&(XF122"5(+D':0<Y!Z5ZCXH\267A#P]J.MZE(8[&Q@:>5
ME +849P 2,DG  SR2!WKQ#XB>((/%GQ.^ FLVD4\%M?2WEQ$ER@5]C1PE20"
M0,@@CD\$4 &I?$?X@ZI\>?%_@;PY<6ODPP6TEO/?0*8=/C,$;R2':NZ1F9P%
M5B1EN0 #3_&'B?XC_ V;2-9\0>);/QGX8N+N.UOE_LU+2:VWD_,FPX( !P2>
M3@$#.1?^'ZC_ (:H^*C8&19:> V.<&"+(_0?E2_MD?\ )#[[_K\M_P#T.@#I
M?B]\3M1\)W6C>&_#-G%J/C#7I&CLXIR?*@C49>:0#DA1D@< X)SA2#SVJ0?%
MOX=Z6_B2[\3Z?XSM+-3/?Z*NFI:MY(P7\B5>68#)&X#IT)P#!XND33OVMO!=
MQ=D);W>A36MJS\+YP:5B 3U)4@8ZY('<5[)X@U"RTG0=1O=1(&GV]O)+<E@"
M/+"DMD'KP#QWH \[_9J\;:S\0?A;:ZQKUY]NU&2YFC:41)'\JM@#"@#@=\9]
M<UTOQ@_Y)+XV_P"P'??^B'KSW]C?_DA]C_U^7'_H=>A?&#_DDOC;_L!WW_HA
MZ /%O@BWQ&\>?#?0H= UBT\%^'K"V^RQ7TEBMY<WDBC#L$<A0@;*@@Y)!SGH
M.S\*^/\ Q9X+^(5EX+^($]KJ8U=&?2->M(A"LS*,O%(@P V"",="0.=P(U/V
M9=0M-0^!_A8VC*1# T$JJ02LBR,&!'8D\X/8@]"*YWX_2)??$SX0:9;'?J8U
MP7A5.66WC*&0D=0" >3_ '3Z' !N?!?QQK>I>(?&?A/Q3>?;=;T._)AN&B2$
MS6D@!B8(H X R3CHZ_4R?%#QIK-M\0O GA#PY>"TN]4NFNM0D6-'9;*(98#>
M"HW?. 0,@J ,9P<+XDI_PKSX[>#/&:#RM.UL'P_J;#Y5W-S"SGIU Y.,"/K4
MWPI!\>?&+QSXWD_>65@P\/:8QY7;&0TS*3V+$$$<?,1ZT >TUXMJ7C+QG\1O
MB;X@\*>#]5LO"^G>'EB6]U2XM1=3RRR D!(V(4*,$9/<9S@@5[37B>K?#_PM
M\5O&FNZQX4\2:IX:\8:5,-/U&ZTPM%EEX D1@/,&$(!4@':,DX% #;'Q%\0?
M!OCJT\(>)]5M]9M->MKA=+\1VMDL,EM<*I($D8!3J5P"""6')&0.A_9_\?:G
MXW\&W,'B&3?XGT>]FT_4LHJ$NK$JQ10  00.  2I-<I_PE/C_P"$/C?POI'B
MC6K/QCX?U^\73H+Q;46UW!(<!2RK\I!+#)))(!)(.,RK)'\+/VD[LRNMMH7C
M2P,^]CMB2\MP2Y)/&2N2>A)D'MD Z'5?&NLZI\?M(\):/>"'1].TY]1UI4C1
MC(6^6*,LP)&"4;Y<$ACSQQYO\&?&WQ7^-7A$/;:_9Z'%:SM'<:Y/I\<TT[DD
MB.*$!8PJJ4R3R2P )P:[3]G&WE\11>*?B!>(PN?$^HLUOO&2MI"3'$ 3SC@C
M' (4'TJI^QLH7X(V1  +7MP20.IW8R?P 'X4 6/!_CCQCX4^+<'@+QG>VFO1
MZE:27>F:O;6PMW;9DE9$!VCA&.!D@XY(/'G6I^#?'*_M*Z9IS_$3?KLGA]IH
MM:_L2 >5#YT@\GR<[3R"=Q.?FQV%=]\0/^3IOA7_ ->>H?\ HB6C5_\ D\31
M/^Q4;_T?-0!SW[1&H:IX7\=?!F>-#X@UNWDNXD 40B[N"EN@) R%#.02!P 3
MCI70^)=)^,WAW0;WQ$GC32+^ZM(VNI-!CTE5MBB@LRI,3YA.!@ X)]0>J?&Y
M0WQN^"P(!'VV^/(SR%A(/X'FO7?%7_(LZO\ ]><W_H!H \RU+]H!(?@[H'BN
MRTS[9K>O,EII^DJV?,NRQ0KUR55E/(Y/RC()R*W_  C?QOMM,&K_ /"8Z/=Z
MHH\T^'6TQ%MFP"3&+@$/D],G S_$!S7A6GVM[)\,?@!+::H-# U/4(%U-X%F
M2WF>Z/EL48A3@JW!('4]J^@_^%;?%7_HLG_EKVG_ ,50!4O?VB[>/X%7'CN#
M3_\ B8PO]BDTV1B!%=[@I5C@':,AN,$C R">(YO#?QKCT7^UXO&^DW&J"/SC
MH2Z3&+9C@GRQ/G<2> #P">X'-<MX-L_ VA_#GQ;;^)_%A\4Z'KOB%K6[NAI<
MEI$M\P!8H%) &5#!UPH( '  KIX_@CXW\%6Y3P/\2;V.UB4+!I>OP+=0A1T4
M28)4#MM7(''U (O%WQGU>^_9DO/'.E*=#UU%A1D:(/Y$GVF.*0!9 00021D'
M 8=QFM#Q_P#$SQ#:W'@?PKX;-HGB7Q+ 96U"^7,5O&D89V"# 9C\Q Z#:1@Y
M&."\?_$F\^)W[)OB^_U.SCLM5L;V'3KN. DQ&6.ZMR67)) (<<9."#R:[KQ7
MX?\ !7Q&;PAX3UF]NK#Q2FG1ZAIEQ8EHIXU"@,4DVE<Y3)4\_*",<&@#,\7:
ME\4_@[:P>(K_ ,0VOCO0HY8TU"Q72TM)XD=@NZ(QD[L$@9)/)&01DCW6"9+F
M&.6)M\<BAE8#J",@_B#7@/BS3OB?\%/#MSX@L_&L?C#1=. EN=.UJU"S&/(!
MVS EF(!SR0!C@$\'W#PUK<?B;PYI6L11M%%J%I%=I&QR5$B!@#[@'% &C111
M0 4444 %%%% !6=XB_Y =[_UR;^5:-9WB+_D!WO_ %R;^5 !X=_Y =E_UR7^
M5:-9WAW_ ) =E_UR7^5:- !7%_%KX967Q3\(SZ7.PMK^,B>POE!W6TZ\JP(Y
MP>A'<'U ([2O+OCW\3+CP1X=M])T,?:?%^O2?8M,MDR74MA6EXZ!<C!/&XCJ
M < 'D-GXN\5_'V[LOA=J*?V5-I3N/%=]#,,W"PR! L>#U8@;L9&XY  !!]:^
M/6DV>@_L]^)-.T^W2ULK6P6*&",85%#J !^ ZGD]3S7FOB3X(7OP1\*>'_&?
MA4F]\3^'PTNLE2Q&I0N29L@\X7) X!VY)Y KN_B]XNT[QW^S/K^NZ5+YME>Z
M>KH3]Y3YBAE8=F4@@CU!ZT =M\'_ /DDO@G_ + =C_Z(2NNKD?@__P DE\$_
M]@.Q_P#1"5UU 'S-^R_\0_"_A+PKXHL];\0Z;I-V_B*ZF6"\NDB<H8X@& )!
M()4C/3(/I7LG_"[/A_\ ]#IH/_@PB_QKQ_\ 9;\!^&O%'A/Q3=ZSX=TG5[E/
M$=U$L]]8Q3.$$<1"AF4X ))P#C))[FO9_P#A3_@/_H2?#G_@I@_^(H T?&GB
M^S\%^#=4\17#K):V5JUP-K<2''R*",_>) !Z9(KYM_X5/?:I^S#?>()BY\6W
M=T?%AN& \S<"6 !//,66 X^9NGKU/[4-QJ'BZ\\*_"[P\D(OM7D^USK(66%+
M>('8'V@D(2K$X!(\L8YK=CTOXZ0V:6B/\/!;+&(A"$O-NT# 7&W&,<8]* /0
M/A?XTB^(7P_T/Q!&1NO+=3*H  69<K(O'8.& ]L5Y;\"9XX?C3\:_,D6/.HV
MN-S =[CUK*_9?DU/X=^+/%?PQU\VZ7EJRZE:+;,6A97"AQ&6 8C!C(!&1AL\
M@UD^ _A/X4^*'QJ^+O\ PD^E?VE]AU&#[/\ Z1+#LWF;?_JW7.=B]<XQQC)R
M ?2&N>+=&\,Z;/?ZIJEK96<*EGDEE & ,D 9R3Z  DG@ FO)/V/;&XMOA7>7
M,D#V]I?ZO<W5E&ZXQ 1&HP/3<C__ *JW+/\ 99^%UC<)/'X4B=U.0LUY<2K^
M*M(0?H0:[GQ-H5_J'A6?2_#^J#PQ>;8TMKV&U686ZJRD@1DA2"H*XXP#D=!0
M!N5\Y^*M>;X+_M$:SXO\0:?>3>&-<T^&UBU.UA,JVC*(P5;'(!,9)'4Y! ."
M!W?AWX<_$32]<LKO4?BK)J]A#*&GL6T*"(3J.J[PY*Y]0"15SX=_%(^.O%_C
M?PW>V$-C<Z#>&W2,R;FN8"6 D*D# ( )QD#<.>1D N^'_C)X"\<1M;Z?XETN
M\\T>6;6XD$3R C&/+D )!Z$ 'KBLC0_AE:?"?X3>*=&L+R:\M)(KR[3SP 8@
MT6-@QV&W(SSDFM+Q5\!_ 7C**0:AX9L$E<$?:+2(6\H)[[DP20>1G(]01Q7E
M/P;U"]LO#'Q=\)/J<VL:/X=,UOI]U<-O;8T<P,>[N%V#@< DXP#@ &A^S/\
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M)OB5I'Q$TS5$EGM;5[1OL+(\-TI# %W!.2N_C![ = *[^OF;Q5X-L/@7\9/
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MS\\90G(&.K'DD#&#D7])4-^V+K1*Y(\**03Z^?$/ZFC]LC_DA]]_U^6__H=
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MU!,D;G(!PNX@]<9 .=N.8^'9E_:4\<1>.-5MC;^$-!D\G2=)DD#&2Z 5GED
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M[<VS9/8"0+D^PS^56?A[\+].^'^M>)]3TV[>2WU^Z6\-J%410-\Q/EX['?\
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M"( M@;< G)R. .3G&*-!_:,^''B;5(].L/%-L]W(X2-)HI80S'H TB*I)Z
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M'(V[ $8FB8XXW!"5)P,Y]A@ ^G/&/C[P]\/]/2]\0ZK;Z7;NQ6,S$EG(Y(1
M"S$9!. <9YKEM/\ VC/AQJFEW^H6WB>![:Q027 :"5954L%#",H'89(!*@XR
M,X%>!?V&GQX_:WUG3]=#7&BZ$)0+,R$+Y<++&%'?#2N&(&"02..W7?M2? WP
MMI_PQO/$.AZ1::'J&E>63]AB$*S1LZQLKJH )^<')&3@@DYH ]5U'X_> ])\
M,Z1XAN]=,6CZLTJV=U]BN&$AC8JXP(RRX((^8#."1D<UW=C?0:G8V]Y;2"6V
MN(UEBD4$!U8 @C//((/-?*.G^!3XY_8?TQ8H_,O=,%UJ,& "<QW4Q<#//*%^
M!R3CKTKH?A+\9OL'[*>HZM)+G4?#D$FGJ2X+;CA;8D'H/WD:CJ#M..F  >R>
M$?BYX3\=:]J&C:%JW]H:A8!C<1K;RJJ!6"DAV0*>3@8)R.1D FNPKYV_8G\$
MG1?AY>^(;A&%WK=P=C,.?)B)52#UY<R$^H ^I^B: "BBB@ HHHH *P?&O_(O
MS?[Z_P Q6]6#XU_Y%^;_ 'U_F* -JW_X]XO]Q?Y5)4=O_P >\7^XO\JDH *\
M^^'7PF_X0SQ)XA\2ZIJ[>(/$>LR_O+YH/)6* 8VPHFYL*,#G/(51@8R?0:*
M*FK:7::YIEWI]] MS97430S0N.'5@00>_(/4<BO$[K]F2[NOA5<^ W\8/)I@
MU!;RQEET_<]K&"Q,1_>@."3D$;<$G@@@#W>B@#QS_A5?Q1_Z+-+_ .$Y;_\
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M05V]% 'E'[4<>G/\$]>-^^R2/RGLV4@/]I$B^6$YR23D''.TL>U=%\&?!9\
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M (($C(26&0"<C.1D$'!KV"SM(=/M(+:VC6"WAC6..-!@*J@  #T  'X5+10
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M _C3QKX@&IF]/B2XBN#;^1L^S[-_&[<=V?,/.!C'0YKNZ* "BBB@ KS3XA?
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M4$(R'J& )Y.<Y(.02#P-I\"_&FAQBTT3XN:Q::<H\N."^L8[MT0# 4.S#&
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M->V44 >=_%;X.6OQ&^'4'A&RO$T"SMY(6A:.W\Y46,$!0F]>,'&<\8[U@?\
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M8XK>\1_ [2-0^#=S\/-&E_L2PE6,+<F/SFW+*DI9QE=S,4Y.1C/&  *])HH
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MX&3C)Z#->-?$CQYX1D_:1FM_B!>K#H'AJQC^PV<D$L\4MW*J2%W558$A7QR
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M2,'G!.#6KX-\>>'_ (@::]_X=U6#5+9&V.T1(9#UPRD!E)'(R!D<BO*/V/\
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M,!L%<$A02"<$ @ ^A_%7C/1O!5O93ZS>?8HKV[CL;=O+=]\S@E%PH.,A3R<
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M35JJNJ?\@N\_ZXO_ .@F@"EX3_Y%^S_W3_Z$:UZR/"?_ "+]G_NG_P!"-:]
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M>NT44 <-\3/A)I?Q*6PN9;FZTC6].8R6.KZ>^R> GMGNI(!(.#QP1DYY.X^
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MB,Y ! X]22>@^'WA/_A!/!6C^'_M?V[^S[=8/M'E^7YF,\[<G'7ID_6NAHH
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MK;Q7;>?(XC7SX984)/ &]T"]^N<5Z1<7$5G;RSSRI!!$IDDDD8*J*!DDD\
M DD\ "OG?XK_ !>\'^//AIX@TO2O#>K^((H["4V]U%I$B6UJ50E9B[ >6J8#
M9P.!C&#BL+7-2O?&7PU^!_@ZYNI!9^)&C74&C8J\MO;B/*$^X(.3DDJ#S@Y
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M3@?G7G7Q.^&EE\0-3\.:O::O#HFNZ'>K<P7ZQ+,6C!R8F&]<J3@\D@<C!R:
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M^.F<'ZGK6EX(^.46L^ ?$FKZ[8?V5K/ACS8]6TY6)VR(I(*$]G(( )/((R0
M2 >JT5X;X6M?B[\2-#M_$;>,+#P9;WT?VBTTJWTB.Z(B8$IYCR$$$C!XSP>@
M/ W_ (/?$#7]6\0>*/!OBT6LGB/P_)$6N[(%8[J&5=R/MQ\I *D@8^\!@$'(
M!ZG17RY\*/B5\5_C+X2BM]$U"RL+BU=SJ/B*_M4.7+$I!#&J;20FTDD=P"0<
M;NUU/QUXW\5^+#X&\'7EG#>Z+;0_V_XFNH Z+,RCY8HP-NXD$X(QD$8 4D@'
MJ_B[7QX4\)ZWK9@^TC3;*>], ;;YGEQL^W.#C.,9P<9S@]*J_#[Q9_PG?@K1
M_$'V3[%_:%NL_P!G\SS/+SGC=@9Z=<#Z5XO\6)?B1\._A_XC.M:S:>-_#U[I
M\]C/<+8+975HTL;1I)M0E60,R@]3@@C'->D?L^?\D5\'_P#8/3^M 'H-%%%
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MQAUZ"5\>R!,D^PKFH_$FD>%_VP/$EWK.J66D6S^'(XEGOKA(4+EX"%#,0"2
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M^)-[JME;WGPDDL+2:=(YKHZ_ _DH6 9]H0;MH). 03C%1>!?VBM,\7_%/7_
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MQC'#_$#XE7'Q2_9%\3ZI?VJ6>J6UQ#97L,8(031W<!)4$D@$,IP2<$D9.,D
M^E-+OO[2TRSO-GE_:(4EV9SMW*#C.!G&<9P*LUX5X/A^*7Q$\-V&JZ?XBLO
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M=*L23-]G>*1Y(AN4C(*8R #D<$9JYHOB#X@V7F^.O&>HZ?H'@^"UDNG\.V\
M>Y6/8?+#R, ?,SM. P!)Q@<@ 'L]<1XV^)@\'>-O!?A[^SOM9\233Q"X\_9]
MG\H(<[=IW9WXQD8QU-<'X8E^+/Q5TU/$D'B.R\":1>+YVG::NFI>RO">4:5Y
M,8W#!RO4$$  @5Q/B/7O%%Q\?/A=H'B^VM?[5TNZN)$U"Q!6"]AE1 CA3RK
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M8000#P"<$X'J^M:3!KVCW^F708VUY!);RA3@[74J<'L<$U<HH ^=OAS\2A\
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M[3N9[A;>"Q$XA,A()8[MK$  $D@'D@<9!K9^&/C6+XA^ =$\018!O+<-*JC
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M(ZC/0@X(/4$ CD"O"/@0VIZ]\'_'/@)[ECJFB37VB6\SD#:K*RQY/7ARXY'
M  Z8 !T#_M#7_B*^N(O ?@75/&-E;R-"VIB9;.U:0=0CL"& XY.#STQ@F]X6
M_: @O?%5KX:\5^'-1\%:W>$"SCOB'AN23@*D@ !)/ XP3@9R0#P_P4^.'ASX
M:^#=/\%>,DNO">MZ4'B=+VU<12YD9MRLH/7=DDX!Z@D&O1?&WAOPI^T'X=M+
M2R\0VLYL[F.]AO-+FCFEA8 C'!)4'/(..0.X& #TRN;^(WCJR^&?@W4/$FH0
M7%S9V7E^9':A3(=\BQC 8@<%P3DC@'Z5TE>!?M?Z+K]Q\--9U.V\2?9?#\$-
MM'=:']AC?[3(;I )//)W)@LAP!@^7CN: /=M/O$U&QMKN,,(YXUE56 !PP!
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M#@ G!Q74Z7HWQG\7:6FM3>+=,\)3W""6#0X]*6X5%(R%ED?+*V,9QG!)Z=
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M^,/$_P 1_@;-I&L^(/$MGXS\,7%W':WR_P!FI:36V\GYDV'!  ."3R< @9R
M#TWQE\0I?"?C+P?H2:1)?IK\TT3WBRE5M1&$()&P[MV[ !*]#R:[.O+/BAXV
MUGP[\4OAAH^G7GV?3M:N;N.^B\I&\U8UB*#)!*X+GE2"<\T>#_&VLZM\?/'_
M (;N;SS-&TJVLY+2V\I!Y;21(SG> &.2Q."2!VQ0!ZG17EG[2OC;6?A]\+;K
M6-!O/L.HQW,,:RF))/E9L$88$<COC/IBN=^)GQ*\9Z/\=M)\(>&C!<)J6BB2
M&VNHU\F.X,LH:>1@-^U4C)V@X) &,F@#W6BOGSQ[XG^)/P-M[#Q+K?B:S\8^
M'WN8X+ZQ738[22$,#S&RDE@"" 6/4C(()(W+?2?B_P",=)37;?Q;IGA:2ZC6
M>UT)=+6=$5@"JRS/E@V"-VU2 <X&.* /6M:CU&33)TTB>UMM1('E27L+30@Y
M&=R*ZDY&0,,,$@\XP?&3\3_'MO\ "?4?%['P]=7 N?L5G91V,\8\P:@+0L[&
M<Y! 8@  @D9) (/8? OXD7?Q/\#?VCJ-K'::M9W4FGWL<6=GG1X)*@DD AE.
M"3@DC)%6_P#A55E_PK__ (1/[;<?9/MWV[[1A=^[[;]KVXQC&[Y<^G/6@#EK
MKXYW&I>)O -IHEI;R:=K8B;4I+@,SVIF21HXE(( <&"8$,#PHP.:]AKSVQ^"
M>C:7J"75I+-"XU\Z^5 !&\QR((0,<1@RNP Z$GU->A4 >5_$[XS:IX(\<:'X
M5T7PFWB?4]6MY+B)%U!;4_)N)'S(0<*A.21TQR:H-\6?B;$I>7X-7 C4$L8]
M?@=L>RA,D^PKG?BOK>G^'?VI/AOJ.J7L&G6$.G7?F7-U($C3,<RC+$@#)( S
MU) KTZ;XX?#Z&-W;QIH9"C)"7T;'\ "2?H!0!!\+?C%IGQ._M&T2SNM&UW36
M"7VDWZ[9H221D>HR""< @XR!D9[ZO"/A*O\ PG/QR\7_ !!TR*9/#4]C'IEK
M=2QF,7KJ8RTB@@$J/+P"<<$=\@6)/&OC?XN>,-8T[P+J-KX:\-:+.;*XU^>U
M6Z>YN!]]8D/RE5R.IY!!SR  #V^BO&M(\;>,/AUX\TCPQXZO;/7=-UQVBTS7
M[6W%N_G#&(I8UR 3D8(XRW4@'::_XR\9^.OB7JOA#P5>V>@V&AQQ'4];N;<7
M+^9(,B.-#\I(&<YQRIY& " >RT5X5JWB;X@?!GQ%X<D\4>(K/QAX8U>_CTN6
MX^PI97%M+("48+'D$##$]<A2."0:W?B7\2/$#>,['P%X&BMG\27$!O+S4+P%
MH-/MP<!BHSEB2, \#*\'<" #UBN!^%/Q9MOB1\/?^$LNK1-"M%>82++<AUC6
M,D%BY50!@9/''J:Y75%^*GPSL7U^\\1V7CO2K5/-O]/;34LIUC'+M"T9(8J
M2 W4 \9Q7@OA:ZN-:^"?PZ\"0W#6UOXH\0SQ7<D9(8V\<B%P/49=3CU4=.:
M/>E_:(O?$UQ*/ G@/5_%]A&S1G4VD6RMG8'!".X.1TZ@$9Z5;T/]H>WC\16F
MA>,_#>H^!]1O&V6LE^1):S'I@3  9S@=,9(R1D5ZGI6EVFAZ;;:?86\=I96T
M8BA@C&%10,  5SOQ2^'-A\5/!MWX?OW,"2LKQ7*J&:"13D.H)'.,CJ,AB.]
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M2RU;[%&9);21,!)=HY*X51GIRV<$KGW:B@#PKQ9^T9;>+M)?1OA>E]KWB>^
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MXSDC& " #6KKG[3MEK]G)IWP\TC5/%'B"=2D!2R:."!CD;I&<# 4\D8P<8)
MYKW.B@#Q'3?AG+\,?V;?&.G7<_VS6;S2M0OM0G4YWW$ENP(!QD@  9/4@GC.
M!UO[/G_)%?!__8/3^M>@T4 >(:.#_P -B:X<<?\ "**"?^V\->1Z2"O[".N
MC!%XN0?^OV&OLNO+_P!IK1;_ ,0?!#Q)8:797&HWTHMO+MK6)I97Q<Q,<*H)
M. "3@= 30!R_@O\ : TSP+X5TW1?'\%]H.K65K'%'<&SEE@OXU4*DL3H&R6
M!(. #D<8P)/ $.H_%SXP#XBSZ=<Z3X;TFR:PT=+Q#'-=,V[?,4.2%P[ '@'Y
M0,D-CV/PW$\'AW2XY$:.1+6)61@000@!!!Y!!XP:T: "BBB@ HHHH **** "
MBBB@"EK7_('O_P#KWD_]!-=WX'_Y$_1_^O:/^0KA-:_Y ]__ ->\G_H)KN_
M_P#R)^C_ /7M'_(4F4C=HHHJ1A1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 <5\7/^11/_7Q'_.LFM;XN?\ (HG_ *^(_P"=9-4B6%%%%,04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !6#XU_Y%^;_ 'U_F*WJP?&O_(OS?[Z_S% &U;_\>\7^XO\
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MGPQ\6S>'?$^C^)?'[^(X-8T^6QB9M)BM_LID1E,@VN2W#="0..M=1\-_!O\
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M&W.#G WOB)\&8?&7B"R\2:1K-WX4\46D9A75+%0WFQ==DB$@, >F2.#@Y
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M'?10EN2(C(1L&>AY/J2>:+#]FVST_P 6>&_$O]O7E[K6G73W5_?7Z>=-J!9
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M=KQL.5=&ZA@>0>G4$$$@^<6_P2\8P62:5_PMG6#H2X40+91"[V#C;]J)+=.
M<<>G:@#"^#^IV6K?M+?%>XL-IM]EO$2A!!= $D((]75CGWKZ!KS/X:_ W3/A
M;XNUG5=(N2+"_M8+9+!HB6B,8&YS(6)8L<L<@8)/6O3* "BBB@ HHHH ****
M "BBB@ HHHH *YW_ )GC_MU_K715SO\ S/'_ &Z_UH Z*BBB@ HHHH ****
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M3H%%SD/P.. ![=J]&\!^ M'^&_AR#1-$@:"TC)=FD;<\LAQND<]V.!D@ #
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MC/ 4W60QP.,X'T[5Z1X(\$Z1\/?#=IH>B6_V>RMP>6.YY&/+.Y[L3R3TZ
M   W:*** "BBB@ HHHH **** "BBB@ HHHH P?$?_(1T7_KY_P *WJP?$?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '._\SQ_VZ_UKHJYW_F>/^W7
M^M=%0 4444 <]9^![#3_ !MJ'BBVFN8+W4+:.WN[=9!Y$YCX21E()WJI*@@@
M8XP3S70T44 %%%% !1110 4444 <]XD\#V'BS6- O]0GNG31KDWD%FC@0/,
M0DD@QDE,DK@@ DY!Z5T-%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5C>+_#/_"7:'+IG]JZGHWF,K?;-(N?L]PN"#@/@X!Q@C!R#BMFB@#E/AW\-
M=&^&.DSV6D">5[F8W%U>7DGFW%Q(>K.^!D^@  &2<9))ZNBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L[Q%_R [W_K
MDW\JT:SO$7_(#O?^N3?RH /#O_(#LO\ KDO\JT:SO#O_ " [+_KDO\JT: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M YWQ=_S"_P#KZ6NBKG?%W_,+_P"OI:Z*@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N=_YGC_ +=?ZUT5<[_S/'_;
MK_6@#HJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KG?^9X_[=?ZUT5<[_S/'_;K_6@#HJ*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH SO$7_(#O?\ KDW\JDT7_D#V'_7O'_Z"*C\1?\@.]_ZY-_*I
M-%_Y ]A_U[Q_^@B@"[1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M10 4444 %%%% !1110 4444 %%%% &#XC_Y".B_]?/\ A6]6#XC_ .0CHO\
MU\_X5O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M47"QY7_8WB__ *!%K_X$+_C1_8WB_P#Z!%K_ .!"_P"->J447"QY7_8WB_\
MZ!%K_P"!"_XT?V-XO_Z!%K_X$+_C7JE%%PL>5_V-XO\ ^@1:_P#@0O\ C1_8
MWB__ *!%K_X$+_C7JE%%PL>5_P!C>+_^@1:_^!"_XT?V-XO_ .@1:_\ @0O^
M->J447"QY7_8WB__ *!%K_X$+_C1_8WB_P#Z!%K_ .!"_P"->J447"QY7_8W
MB_\ Z!%K_P"!"_XT?V-XO_Z!%K_X$+_C7JE%%PL>5_V-XO\ ^@1:_P#@0O\
MC1_8WB__ *!%K_X$+_C7JE%%PL>5_P!C>+_^@1:_^!"_XT?V-XO_ .@1:_\
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M>J447"QY7_8WB_\ Z!%K_P"!"_XT?V-XO_Z!%K_X$+_C7JE%%PL>5_V-XO\
M^@1:_P#@0O\ C1_8WB__ *!%K_X$+_C7JE%%PL>'?V;K_P#PF'E?8(/[3^R[
MO(\X;=F<9SG&<]LUN_V-XO\ ^@1:_P#@0O\ C6Y_S6#_ +A?_L]=Q3N%CRO^
MQO%__0(M?_ A?\:/[&\7_P#0(M?_  (7_&O5**5PL>5_V-XO_P"@1:_^!"_X
MT?V-XO\ ^@1:_P#@0O\ C7JE%%PL>5_V-XO_ .@1:_\ @0O^-']C>+_^@1:_
M^!"_XUZI11<+'E?]C>+_ /H$6O\ X$+_ (T?V-XO_P"@1:_^!"_XUZI11<+'
ME?\ 8WB__H$6O_@0O^-']C>+_P#H$6O_ ($+_C7JE%%PL>5_V-XO_P"@1:_^
M!"_XT?V-XO\ ^@1:_P#@0O\ C7JE%%PL>5_V-XO_ .@1:_\ @0O^-']C>+_^
M@1:_^!"_XUZI11<+'E?]C>+_ /H$6O\ X$+_ (T?V-XO_P"@1:_^!"_XUZI1
M1<+'E?\ 8WB__H$6O_@0O^-']C>+_P#H$6O_ ($+_C7JE%%PL>5_V-XO_P"@
M1:_^!"_XT?V-XO\ ^@1:_P#@0O\ C7JE%%PL>5_V-XO_ .@1:_\ @0O^-']C
M>+_^@1:_^!"_XUZI11<+'E?]C>+_ /H$6O\ X$+_ (T?V-XO_P"@1:_^!"_X
MUZI11<+'E?\ 8WB__H$6O_@0O^-']C>+_P#H$6O_ ($+_C7JE%%PL>5_V-XO
M_P"@1:_^!"_XT?V-XO\ ^@1:_P#@0O\ C7JE%%PL>5_V-XO_ .@1:_\ @0O^
M-']C>+_^@1:_^!"_XUZI11<+'E?]C>+_ /H$6O\ X$+_ (T?V-XO_P"@1:_^
M!"_XUZI11<+'E?\ 8WB__H$6O_@0O^-']C>+_P#H$6O_ ($+_C7JE%%PL>5_
MV-XO_P"@1:_^!"_XT?V-XO\ ^@1:_P#@0O\ C7JE%%PL>5_V-XO_ .@1:_\
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MV-XO_P"@1:_^!"_XT?V-XO\ ^@1:_P#@0O\ C7JE%%PL>5_V-XO_ .@1:_\
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M\"%_QH_L;Q?_ - BU_\  A?\:]4HHN%CRO\ L;Q?_P! BU_\"%_QH_L;Q?\
M] BU_P# A?\ &O5**+A8\K_L;Q?_ - BU_\  A?\:/[&\7_] BU_\"%_QKU2
MBBX6/*_[&\7_ /0(M?\ P(7_ !H_L;Q?_P! BU_\"%_QKU2BBX6/*_[&\7_]
M BU_\"%_QH_L;Q?_ - BU_\  A?\:]4HHN%CRO\ L;Q?_P! BU_\"%_QH_L;
MQ?\ ] BU_P# A?\ &O5**+A8\K_L;Q?_ - BU_\  A?\:/[&\7_] BU_\"%_
MQKU2BBX6/*_[&\7_ /0(M?\ P(7_ !H_L;Q?_P! BU_\"%_QKU2BBX6/*_[&
M\7_] BU_\"%_QH_L;Q?_ - BU_\  A?\:]4HHN%CRO\ L;Q?_P! BU_\"%_Q
MH_L;Q?\ ] BU_P# A?\ &O5**+A8\K_L;Q?_ - BU_\  A?\:/[&\7_] BU_
M\"%_QKU2BBX6/*_[&\7_ /0(M?\ P(7_ !H_L;Q?_P! BU_\"%_QKU2BBX6/
M*_[&\7_] BU_\"%_QH_L;Q?_ - BU_\  A?\:]4HHN%CRO\ L;Q?_P! BU_\
M"%_QH_L;Q?\ ] BU_P# A?\ &O5**+A8\K_L;Q?_ - BU_\  A?\:/[&\7_]
M BU_\"%_QKU2BBX6/*_[&\7_ /0(M?\ P(7_ !H_L;Q?_P! BU_\"%_QKU2B
MBX6/*_[&\7_] BU_\"%_QH_L;Q?_ - BU_\  A?\:]4HHN%CRO\ L;Q?_P!
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MO^QO%_\ T"+7_P "%_QH_L;Q?_T"+7_P(7_&O5**+A8\K_L;Q?\ ] BU_P#
MA?\ &C^QO%__ $"+7_P(7_&O5**+A8\K_L;Q?_T"+7_P(7_&C^QO%_\ T"+7
M_P "%_QKU2BBX6/*_P"QO%__ $"+7_P(7_&C^QO%_P#T"+7_ ,"%_P :]4HH
MN%CRO^QO%_\ T"+7_P "%_QH_L;Q?_T"+7_P(7_&O5**+A8\K_L;Q?\ ] BU
M_P# A?\ &C^QO%__ $"+7_P(7_&O5**+A8\K_L;Q?_T"+7_P(7_&C^QO%_\
MT"+7_P "%_QKU2BBX6/*_P"QO%__ $"+7_P(7_&C^QO%_P#T"+7_ ,"%_P :
M]4HHN%CRO^QO%_\ T"+7_P "%_QH_L;Q?_T"+7_P(7_&O5**+A8\K_L;Q?\
M] BU_P# A?\ &C^QO%__ $"+7_P(7_&O5**+A8\K_L;Q?_T"+7_P(7_&C^QO
M%_\ T"+7_P "%_QKU2BBX6/*_P"QO%__ $"+7_P(7_&C^QO%_P#T"+7_ ,"%
M_P :]4HHN%CRO^QO%_\ T"+7_P "%_QH_L;Q?_T"+7_P(7_&O5**+A8\K_L;
MQ?\ ] BU_P# A?\ &C^QO%__ $"+7_P(7_&O5**+A8\K_L;Q?_T"+7_P(7_&
MC^QO%_\ T"+7_P "%_QKU2BBX6/*_P"QO%__ $"+7_P(7_&C^QO%_P#T"+7_
M ,"%_P :]4HHN%CRO^QO%_\ T"+7_P "%_QH_L;Q?_T"+7_P(7_&O5**+A8\
MK_L;Q?\ ] BU_P# A?\ &C^QO%__ $"+7_P(7_&O5**+A8\K_L;Q?_T"+7_P
M(7_&C^QO%_\ T"+7_P "%_QKU2BBX6/*_P"QO%__ $"+7_P(7_&C^QO%_P#T
M"+7_ ,"%_P :]4HHN%CRO^QO%_\ T"+7_P "%_QH_L;Q?_T"+7_P(7_&O5**
M+A8\K_L;Q?\ ] BU_P# A?\ &L+^S=?_ .$P\K[!!_:7V7=Y/G#;LSC.<XSG
MMFO<:X?_ )K!_P!PO_V>G<+&'_8WB_\ Z!%K_P"!"_XT?V-XO_Z!%K_X$+_C
M7JE%*X6/*_[&\7_] BU_\"%_QH_L;Q?_ - BU_\  A?\:]4HHN%CRO\ L;Q?
M_P! BU_\"%_QH_L;Q?\ ] BU_P# A?\ &O5**+A8\K_L;Q?_ - BU_\  A?\
M:/[&\7_] BU_\"%_QKU2BBX6/*_[&\7_ /0(M?\ P(7_ !H_L;Q?_P! BU_\
M"%_QKU2BBX6/*_[&\7_] BU_\"%_QH_L;Q?_ - BU_\  A?\:]4HHN%CRO\
ML;Q?_P! BU_\"%_QH_L;Q?\ ] BU_P# A?\ &O5**+A8\K_L;Q?_ - BU_\
M A?\:/[&\7_] BU_\"%_QKU2BBX6/*_[&\7_ /0(M?\ P(7_ !H_L;Q?_P!
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M[&\7_P#0(M?_  (7_&O5**+A8\K_ +&\7_\ 0(M?_ A?\:/[&\7_ /0(M?\
MP(7_ !KU2BBX6/*_[&\7_P#0(M?_  (7_&C^QO%__0(M?_ A?\:]4HHN%CRO
M^QO%_P#T"+7_ ,"%_P :/[&\7_\ 0(M?_ A?\:]4HHN%CRO^QO%__0(M?_ A
M?\:/[&\7_P#0(M?_  (7_&O5**+A8\K_ +&\7_\ 0(M?_ A?\:/[&\7_ /0(
MM?\ P(7_ !KU2BBX6/*_[&\7_P#0(M?_  (7_&C^QO%__0(M?_ A?\:]4HHN
M%CRO^QO%_P#T"+7_ ,"%_P :/[&\7_\ 0(M?_ A?\:]4HHN%CRO^QO%__0(M
M?_ A?\:/[&\7_P#0(M?_  (7_&O5**+A8\K_ +&\7_\ 0(M?_ A?\:/[&\7_
M /0(M?\ P(7_ !KU2BBX6/*_[&\7_P#0(M?_  (7_&C^QO%__0(M?_ A?\:]
M4HHN%CRO^QO%_P#T"+7_ ,"%_P :/[&\7_\ 0(M?_ A?\:]4HHN%CRO^QO%_
M_0(M?_ A?\:/[&\7_P#0(M?_  (7_&O5**+A8\K_ +&\7_\ 0(M?_ A?\:/[
M&\7_ /0(M?\ P(7_ !KU2BBX6/*_[&\7_P#0(M?_  (7_&C^QO%__0(M?_ A
M?\:]4HHN%CRO^QO%_P#T"+7_ ,"%_P :/[&\7_\ 0(M?_ A?\:]4HHN%CRO^
MQO%__0(M?_ A?\:/[&\7_P#0(M?_  (7_&O5**+A8\K_ +&\7_\ 0(M?_ A?
M\:/[&\7_ /0(M?\ P(7_ !KU2BBX6/*_[&\7_P#0(M?_  (7_&J^I:3XJ73[
MHSZ7;) (FWLMP#A<') SV&:]<K.\1?\ (O:I_P!>LO\ Z :+A8\I\,Z7XDFT
M.T:QTZ"XM""8Y'G"DC<<Y!((YSVK3_L;Q?\ ] BU_P# A?\ &NM^&O\ R(VE
M?[C?^AM73T7"QY7_ &-XO_Z!%K_X$+_C1_8WB_\ Z!%K_P"!"_XUZI11<+'E
M?]C>+_\ H$6O_@0O^-']C>+_ /H$6O\ X$+_ (UZI11<+'E?]C>+_P#H$6O_
M ($+_C1_8WB__H$6O_@0O^->J447"QY7_8WB_P#Z!%K_ .!"_P"-']C>+_\
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M .!"_P"-']C>+_\ H$6O_@0O^->J447"QY7_ &-XO_Z!%K_X$+_C1_8WB_\
MZ!%K_P"!"_XUZI11<+'E?]C>+_\ H$6O_@0O^-']C>+_ /H$6O\ X$+_ (UZ
MI11<+'E?]C>+_P#H$6O_ ($+_C1_8WB__H$6O_@0O^->J447"QY7_8WB_P#Z
M!%K_ .!"_P"-']C>+_\ H$6O_@0O^->J447"QXEKVF>(([[21>6$$,K7 %NJ
MS AWXX)!.![G%;/]C>+_ /H$6O\ X$+_ (UT7CS_ )#7A/\ ["(_I7947"QY
M7_8WB_\ Z!%K_P"!"_XT?V-XO_Z!%K_X$+_C7JE%%PL>5_V-XO\ ^@1:_P#@
M0O\ C1_8WB__ *!%K_X$+_C7JE%%PL>5_P!C>+_^@1:_^!"_XT?V-XO_ .@1
M:_\ @0O^->J447"QY7_8WB__ *!%K_X$+_C1_8WB_P#Z!%K_ .!"_P"->J44
M7"QY7_8WB_\ Z!%K_P"!"_XT?V-XO_Z!%K_X$+_C7JE%%PL>5_V-XO\ ^@1:
M_P#@0O\ C1_8WB__ *!%K_X$+_C7JE%%PL>5_P!C>+_^@1:_^!"_XT?V-XO_
M .@1:_\ @0O^->J447"QY7_8WB__ *!%K_X$+_C1_8WB_P#Z!%K_ .!"_P"-
M>J447"QY7_8WB_\ Z!%K_P"!"_XT?V-XO_Z!%K_X$+_C7JE%%PL>5_V-XO\
M^@1:_P#@0O\ C1_8WB__ *!%K_X$+_C7JE%%PL>5_P!C>+_^@1:_^!"_XT?V
M-XO_ .@1:_\ @0O^->J447"QY7_8WB__ *!%K_X$+_C1_8WB_P#Z!%K_ .!"
M_P"->J447"QY7_8WB_\ Z!%K_P"!"_XT?V-XO_Z!%K_X$+_C7JE%%PL>5_V-
MXO\ ^@1:_P#@0O\ C1_8WB__ *!%K_X$+_C7JE%%PL>5_P!C>+_^@1:_^!"_
MXT?V-XO_ .@1:_\ @0O^->J447"QY7_8WB__ *!%K_X$+_C1_8WB_P#Z!%K_
M .!"_P"->J447"QY7_8WB_\ Z!%K_P"!"_XT?V-XO_Z!%K_X$+_C7JE%%PL>
M5_V-XO\ ^@1:_P#@0O\ C1_8WB__ *!%K_X$+_C7JE%%PL>5_P!C>+_^@1:_
M^!"_XT?V-XO_ .@1:_\ @0O^->J447"QY7_8WB__ *!%K_X$+_C1_8WB_P#Z
M!%K_ .!"_P"->J447"QY7_8WB_\ Z!%K_P"!"_XT?V-XO_Z!%K_X$+_C7JE%
M%PL>/ZOI7BF/2;U[G2[>.W6%S(XG!*KM.2 "<X&3BO1/!/\ R*.CXZ?94_D*
ME\7?\BKK7_7E-_Z+:H? _P#R)^C_ /7M'_(4;H9NT444@"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** .'^)_\ S+O_ &%(OZUW%</\3_\
MF7?^PI%_6NXI@%%%%( HKQ'7/VJM'TGQEKOAJR\%^-/$=_HLJPWDFAZ4EU$C
M,,KDB4$9P<9 SM..E1?\-51_]$G^*'_A.#_X[0![G15+2-1_M?2;*_%O<6@N
MH4G%O=1[)H]RAMKKGY6&<$=B"*NT %%%% !17.^,?'NA^ 8=,FUV]-E'J5_%
MIEJPA>3S+B0,43Y0<9"GDX QR1714 %%%% !1110 45SO@3QYH?Q*\-V^O\
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M%?.G_#<W@2/;-<:)XKM-+8C;JLVE@6S9Z8(D+=<_P]C7N'A/QAHWCK0+76M
MU&'4]+NAF*XA)P<'!!!&00>"" 1W% &W1110 4444 %%%% !17D/Q(_:C\"?
M#/73H5W<WFLZ\OW]+T6W-S,AQD*W(4,?[I;(R"0 <UF^"_VOO /B[Q%;Z%='
M5/"VK7!"PVWB"T%L9&/"C<&903VR1GH.2 0#W"BBB@ HHHH ***Y+X<_$[P_
M\5M*O-3\.74EW:6=X]C*TD+1D3*JLP 8#(PZ\].: .MHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N'_P":P?\ <+_]GKN*
MX?\ YK!_W"__ &>F!W%%%%( HKC_ (D?$0?#?2;:_;PYX@\2B><0?9_#MC]K
MFC^4MN==RX7C&?4@=Z\KUC]LK1O#L-O+JWPZ^(FF17$RV\+WFAI"LDK E8U+
M3#+$ X Y.#0!]"45XA:_M1)=74,(^%?Q,B,CJ@>3PZ JY(&2?-X SG->WT %
M%%% !1110 4444 %%%<[X$\>:'\2O#=OK_AV].H:3.SI'.8GB+%6*L-K@,,$
M'J* .BHHHH **** "BN/^%?Q.TKXO>#;7Q-HT%W;Z?<R21HE\BI)\CE"2%9A
M@D$CG..H'2NPH **\#M_VOM&U*ZU&+2/ /C_ %V*QNY+*:ZTO1DN(?-0_, R
MR]>0<'!P1D#-:NC_ +5W@J[U>UTS6[?6_!5[=$+"GBC3FLU9O3>25&.F20,]
MZ /9Z*R/%'B*T\)^%]6U^\$DECIEG-?3" !G:.-"[;02 20IQDCG'-<[\(_B
M_P"'OC5X5&O>'99O(65H)K:Z54G@<<[74$@9!!!!((/J"  =S15/5+^/2M-N
M[V8,T-O$TSA!EMJ@DX!/7 -8'PQ^(FF?%?P-IOBK1XKJ#3M0\PQ1WJ*LHV2-
M&P8*S ?,AZ$\8H ZNBN'^+GQ;T/X+>$3XAU]+J:V,Z6T<%DBO-+(V<!0S*#@
M!B<D<*>^ =_PCXIL/&_A?2]?TJ0RZ?J5NES"S !@K#.& /##H1G@@B@#9HHH
MH **** "BBB@ HHHH PO''_(GZQ_U[2?R-3>$?\ D5=%_P"O*'_T6M0^./\
MD3]8_P"O:3^1J;PC_P BKHO_ %Y0_P#HM: ->BBB@ HKQ?6/VF(]'U:]L/\
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M*YW7?'NA^&_$N@:!J-Z;?5=>:9-.@\IV\XQ*K2#< 57 8'YB,YXS0!T5%%%
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M#JWAS3=9NI+>[\07@L=/5(6?S)BRJ 2 0HRZ\GCFNMH **** "BBB@ HHHH
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MBB@ HHHH **** "BBB@ HHHH **** ,CQ=_R*NM?]>4W_HMJA\#_ /(GZ/\
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M, !0/WW3&,>U(9Z7\$?CAHGQP\%_V[IH-E-;MY5]8S,"UK(!D@GNI'(;C([
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MTE\M:-+&4C,T9ED(!9@#NV$9X!(P=K_@G3_R1/6_^QAG_P#2:VKW+XT_8?\
MA4/C7^TO+^P_V/=^9YF,?ZIL8]\XQWSC%>&_\$Z?^2)ZW_V,,_\ Z36U'0#Z
MGHHHI %<;\7/^1'O/]^/_P!#%=E7&_%S_D1[S_?C_P#0Q0!UEI_QYP?[B_RJ
M:H;3_CS@_P!Q?Y5-0 5\Y_#M?^%4_M4>,?";?NM'\96R^(--7/RBX4L+A !Q
MECYC$=E1?6OHRO /VM]-N=#T7PO\2=,B,NH^"]4CNY%4?-):2,J31Y'8_+GT
M&XT >@_'3X@#X8_"7Q-XC5PES:VI2US_ ,]W(CB^OSLI/L#7E?A/5KC]FWX/
M^ /".G:')K_CWQ&S-%IAE$6^X8"6>29R.%B#JI.,X4=!DB;XQWUO\8OBM\+_
M  +82+>:*Q'BS4V4Y1[6,?N 0.JNQ((/]Y3Z$=+\6O'UQI?Q)\->&?"GA73/
M$'C^YM)KJWOM4(CBTRU)*O(9 I?#%2"JD9QWX! ,CQ%X\^-WP[T6[\2^(?#G
M@_6="L4^T7EGH5U<I>0P* 7<&4;&*C)( Z X]:[SQ?\ &C1/"?PA/Q$99KO2
M)+.&[MH8P!)-YVT1)C/!)< ]<<GG%>:_%KPW\6+SX3^,;GQ'XU\/Z=91Z/=R
M7&GZ)I+$3J(6)B$TTI*AONDA2<'C!-7/#'ASPMXS_9-\&>'/%VHPZ9INK:79
MVL4\EPD+?:"H:(1EN"^Y<A<'.",$<4 6;KQ?\>[/2SKQ\&^$IK)8_/;P_%?7
M!U+;C)02;?++@=@#D]!GBL[XI_$+Q'\5/V<;KQ1X#&BQ^']0T/46UF/6_.^T
MQQ+$RR)!Y?R^8I689?Y20IZ$U=B\.?'CX>68BTKQ!X?^(NGVZ@)#K4#V=^Z@
M<*)$)0MVW2'G&2<FD7XA:5\2?V6/'^I:7HO_  CKV^D:K97ND[%7[+<I;OYB
M?* #U!S@9!Y .10!+^RC_P )[_PKOPW_ &[_ ,(Y_P (G_8T']F?V=]H^W]%
MV^?O^3[N<[>^,<5[O7G'[.?_ "0?P%_V![;_ - %>CT >.^,?B[XGOOB)>>!
M/AYH5CJNLZ;;QW&J:GK%PT5E8>8,QHP0%W9ASA>@]<'&6GQ:^(7PZ\4>'--^
M)FB:"VE:_>)IMOK7AJ>7RX+I_P#5QR1S#=AL'D'@ GG&*K0^//$_B[XC>,=+
M^%OAKPWIZZ;=K::UXFUI6'VJY5<%!'$ TC(,@,S8^@(SPO[0WA[QSIZ?#F]\
M6^,+'5X6\8:>D6E:=I@M8T<^83(79V=R "H& ,,2<G%4!Z)\3/V@M4\ ?&RR
M\%VVBIK<=_H2WMC9VX9;JZO6N'C6(2$[$C"(SLS+P%8Y. "W6O&GQR\(V,VO
M:EX2\*:QH]NGG3Z7H][<?VA'&,EL,Z['(7G"C)(( .:R?$3V:_MW^%Q<E1.W
M@YQ:AL?ZSS[DG'OL$GX9KZ-J0//KSXL66I?!'5/B#X:=+VWBT:YU.U6X4X+Q
M1.WER '((92K 'L0#WKSGP3\9_B9\8O">F:AX(\/:! /LL?VW6->EGCM)+HH
M#+%;PQYD*HQ*EF;!((!.,GD/A'M_X9+^,?V;']C^=X@_LS;]W[-]G.W'MNW]
M.*]A_99>SD_9[\#&Q*F#^SP&VXQY@9A+^.\/GWS0!4\!_&+7?^$\'@3X@Z':
MZ#XEN(&NM.NM-G,MCJ4:YWB,L RLH!.UN< DXX!P?A;_ ,G;?&W_ *]M'_\
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MKYJ^,OPZN?V,[G1/&_P^\0:@FD7.H):7GA^^FWQ2Y1G/0 %2L;#)!9200>P
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M'^.OQ?\ BAX=M]9^'G@;29-+6%%>_P!<F:);V<*/.%O'YBD('RH9F(.#D@Y
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M#?6_%5[:W.C2: )TUG2I\-<64T*EI(R.-Q('RG SD< Y YW_ (R1_P"J6?\
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MH6Y% %CQ!XX^.6B:/=^)CX1\)_V/:Q-=2Z'_ &A.^IB)068>8%$1<*#P <]
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MCO/-ITDV]=\,T;E9$;RO,93NP2N!G!KH/V:\'XC_ !O-UC^U_P#A*&$GK]F
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MX=\.ZGX:CPUY=^%9YS/81D\RO%,,R*HY;800,G& 16?X'Q_PV1\2OMN/M?\
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M<"#]0:8'>^)K^VU3X?ZK>VDR75I<Z7+-#/&P9)$:(E6!'4$$$'T->:?L5_\
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M)OMGAW4IEU>"]2=9"Q5G,>"I7 ;)!!$0&>.6!]H4444@"BBB@ HHHH ****
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MGQ0^"6@ZBK-8ZE?WMK-Y;;6VN;520>Q&<@^H%?5]?,_[4'_)>/V?/^PS<_\
MH=I30%?]F#Q?JGPU\6ZK\$?&$^Z_TO=/H-VXP+RU.6*J2><#Y@.2!O4GY,58
M_:@_Y+Q^SY_V&;G_ -#M*W_VJO@_?^-O#MEXM\+&2W\<>%G^V6$EN!OGC4AF
MB]R"-R@YY!&/F->.>)OB]9_&KQI^S;K\ 2&_&L7,&H6BG)M[A7M-PQDD*>&7
M/.UAGO0@/H3XU?'!OAI=:/H&AZ-+XH\:ZTQ73]'A;:-HSF61OX5&#]<,<@ D
M>=ZU\=OC%\*5@UGXB> ])E\)M(JW5WX>G9IK)6. 7#2,"02!P I/&X9%<K\0
M+3QY>?MJ:BG@V]T2QUD>'(VM)->60Q&#*APFU6._<7/  VA^<Y!Z;Q;X+_:+
MU_PKJ^G:UXD^'@TBZM)8;MI%G15A92')8PX7 R<GIC/:@#I_CI\=/$?PNL/"
MGC'1;+3=>^'E\T(U&80R&ZBCD(*21N) NUE.!N4X8 $_,,:GQU_:$L_AK\/=
M*U;PZ(-?UKQ"T<>@VH#2)=%]I\PA2&*@,O ()+*.,YJGX)\/:5X'_97BT?Q[
MJFEZQHEGIMQ%?7NG3F:VE@,C[!$Y )8*448&=P ':OEO]E&6QL?C)X3?QFFJ
M1Z?)9S+X+?5,>0N9GQ[;B2X!'&XC Y0A =?^V-J'Q9G^%]C'XNT_PU%H+7-I
M))/I@E6=;LQN3& TK#8I+KG&25!& <5ZS\0XOB]XF_9U^(-KXETW2+/Q"T"B
MSB\.F1O-MPR&=3N=B6,8D&!USC!JI_P4%_Y(/#_V&+?_ - EKV#XN?%C2O@O
MX/;Q)K-G?WE@D\<#+I\:/(I?(!(=U&,@#.>XH \9_9-^-WPST_X4Z!X<36-/
M\.ZU:Q;+RUU!A;--<$G=(';"R%CR,$D# P, 5W7C;X'VWC7XK>"OB1X>U6UT
MN^TJ7-[-!#YG]HV^0-FY6 SL,B[CGAP#D*!6MXL^ /PR^*B#4M3\+Z=>O>*)
MO[0M ;>64,,AS)$5+9!!R2<CKFOFKXR_#JY_8SN=$\;_  ^\0:@FD7.H):7G
MA^^FWQ2Y1G/0 %2L;#)!9200>P8'T7\:OC@WPTNM'T#0]&E\4>-=:8KI^CPM
MM&T9S+(W\*C!^N&.0 2/.]:^.WQB^%*P:S\1/ >DR^$VD5;J[\/3LTUDK' +
MAI&!() X 4GC<,BN2\<0^.]4_;,O3X,N]'T[6&\-126C>(5DV?9R4WJ@5&(?
M<7Z#& _/4'J?%O@O]HO7_"NKZ=K7B3X>#2+JTEANVD6=%6%E(<EC#A<#)R>F
M,]J /1_B_P#M!Z-\,/!.DZS9POXAO]>VIHFGVA.;UG"E2" <+ATY )^8 #FN
M'7XG_M!:'8?VYK/PUT2]TA5$LNF:9=L-0BCP2>KL&8#G"J3VQG./+M \,W?@
MOXO_ +.FC>(M4T_5K.SL;V&"^TV<S6DDWF3F(1N0,D9MEZ#D8':ON*D!X5^S
M/^T!J'QYN_&T\UI:VVE:9?+'IODQ,DSV[F0J9LNP+[57.W R3QTKW6OEO]C/
M[%_PG'QN_L[R_P"SO^$C;[-Y?W?*\VXV8]MN,>U?3=_>0:?8W%U<R>5;01M+
M+)S\JJ"2>/0 F@#XG^&/QK^&WA/Q5\4O$OC6:WGO=:\1R1V=I]E-U+]FA+!'
M P=JD28R2-Q4@9Q@?2?PB^)/PU^)PEN_!<FG/>VZ_OH4M!;W,*GC)4J&VGID
M97/&:D^"O@CX;>'_  ^=4^'5E8_V=?R.QU"WD:=Y2I*L#+(6? *GY2< Y('-
M>.?%KP_IOPZ_:P^$VL^&[6*PO]>EN+34[6S41K+'\J^8Z@8)(D<DXY,0.<C-
M %/XQ>//"FC_ +76E7?C"ZM[?0_#/AQY2L\9E\RYF9E"", EF*R*0 .-I8G
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MWI@ETZ\&;H:=XT>+XT?M7>#-"MW%WX?\'V']OW3*04:>3:T /K_RP89SD%L
M<FD!L^-?CMXWLO%VE?#WPAX:L/$'CX:9'?ZO+-*8;&SR%#8&_<1N8'!?(#*
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M)7AJPT;7;NU:[L+S2I6,%PJAF( 9F."J2'.[(*$$>GT'7S/\2/\ D^KX3_\
M8&O/_1-W7TQ0 45X-XCT7]HJ;Q%JCZ'K_@>#16NI6L8KQ)S,MN7)B#XA(W!<
M X)&<\GK6?\ V#^T]_T,GP__ ._=Q_\ &* /HFBN?\#6_B.V\)Z?'XLN+&[\
M1*K?:YM.#"W9MQQL! . NWJ!R#704 %%%% !1110!QOCS_D->$_^PB/Z5V5<
M;X\_Y#7A/_L(C^E=E0 445D^*-=C\+^&]6UF:"6YBT^TFNWAMP/,D$:%RJY(
M&X@8&2.30!\U?LK?$#P[X#M_%/ACQGJ=IH/Q ;6[B?4CJD@@:\+$%761R X(
M)( )X)(&&R?9?C-\+M,^.?PZN=&\^W6:3;/I^J*HD^S2@@B1"#GD @X(R"14
M6DZ?X&_:-\!Z/XDU#PW9ZI8W\)>#^T;=&GA 9E*AP25(((.UNU>=>-?V6=*\
M"Z'J?B'X9Z[JW@/6;&"2[2*WO9);.8HI8K+'(3D'&.20,Y*GI0!1_; TF:/X
M2_#73-7G75;A?$^F6UY,ZX6Y803+(Q!/1CDX)/7%3_"^^N/V<_BHWPOU::1O
M!NO2O=>%+Z9B1#(S9>S)/?)XYY)!ZR8''_%[Q_=_%']G'X.^)[^%8+V^\5V/
MGJBD*9$%S&S 'H&*%@.< CZU]#?&[X2V7QD\!W>AW#_9+]&%QIU^N0UI<KG9
M(".<=B/0G&#@@ \W_;R_Y-[O_P#L(6O_ *'1^WE_R;W?_P#80M?_ $.O(/C/
M\6+WQY^R_KOA_P 3Q_8O'7AO5+6RU>U? ,A#D).N.JN!DD<9R1P5SZ_^WE_R
M;W?_ /80M?\ T.@#Z)KYP_:-%O\ \+R^"!TP1_\ "4?VP=WE_P"M^P97SMV.
M=NW?C/'W\?Q5N?\ #*L?_16/BA_X48_^-5TWPW_9_P#"WPTUJ;6[9M1USQ%,
MGE/K6N79NKK9W 8@!<]R ">F<4 >FUY3\3_BYJWA_P 8:5X)\':'%XA\8:C;
M/?%+J?R;6RME8KYTS $D%@0 .21US@'U:O#/%WC[6+[XRW_A?X=^%M#NO%EE
MI\3:MXCUH%([6%R&C@)C'F29!#!0P S]2 "AXB^+'Q3^#]K!KGQ"T+PQJ/A0
M3QPWMYX7GN!-9*[A5D9)A\X!*C P22.E:_QV^/5Y\'_%WP_LK?3X]4T[Q!)>
M)/'%&TES(T:Q>3'!A@NYWE"Y8$<CIUKS/]JCPW\1X_@/XDOO%7C/29;&,VY?
M1](TKR4G8W,04&:21FPI.[  )*C)QFNF^+5O'=?&[]G%)4#H'U"0*W]Y;>W9
M3^! /X4 :WB+QW\<O"^D7GB:\\(>$Y]$M(S<S:+:ZA.VI1Q*"SYEV^4S!1GY
M0>G /2N]C^-'AO\ X5!'\1YYY+?P^UD+P[@#*"3M\H#."^_Y,9P6[XYKK?$"
MA]!U($ @VTF0>GW37Q)&V[]A_P"%9NSG1_\ A)HQJ9<DK]E^VW0.?;.SKQ0!
M[MH_C3XY>,+&'7M*\)>%=%T>=1+!I>N7EP;^6,\J2T8V1DC!PPR,X.,5Q7@?
MQQ)X\_;)M9[O2;C0=7L/"$EAJ.FW+!FM[A;IF(5QPZ%9$96'!##H<@?5=?.C
M?8_^&[D^S;//_P"$-_TK;U\SSSC/OL\O\,4 ?1=>7^ ?B=JFM_%KQ]X*UN"T
MMY=$:WN=.DMD=3<6DJD[FRQ!925!(P"3T&*]0KP?XG1GP/\ M(?#?Q>B^79Z
M['-X6OY!P"S?O;8'U)<$>N%'H, $?QF_:,U#X:?%[PEX7L[&TN='N5AFUN\F
M5BUI#-.(8V5@X5"#DG<&R", =^^^.7Q(?X2_"W7_ !/#%%/=V<*K:PS@E))G
M=4C# $$C<P) (. >1UKQ(^#1\;-#^/VOJAGDU"X.DZ25&2?[/C#1E/9Y@#QS
MD&G>(/%9^/%M\!-!602IJ[IX@U@*<@+:1C>C?[+2EU'J5[4 9_BKQQK/A7]J
M3PA>WNBG5_%NH> X;5=)T_\ <I)>O<RLRAG)\N-=KDLQ.U5).3P>T\6?%7XO
M_"G2F\3>,/#'A?4O"T,B_:X_#]W/]LM(V(7>WF@*^"1D*/Q Y#M6MXYOVY]%
M>1 SP^"&DC8_PL;N521^#$?B:[O]HY0WP'\>[@"/['N#^(0D4P+OQ#^+^A_#
MOX?)XMN6EOK.Y6(6%O:KNEO9)1F*.,>K#GV )[5P_P#PE'Q^GM?[8B\'>$8K
M-E\P>'YM1F.HXX(4S "$-CCG !KSS6&#67[)IU YT8QVQEWYQ]J^QP?9L^^[
M=U]_>OK:D!PWPC^*VG?%SPN^JV=O/IUW;3M97^FW8Q-9W*8WQL.^,C!XR.H!
MR!X[^RCXPTOX?_LCVGB'69C!INGO>33.HRQ_?N JCNS$A0.Y(%;?P5Q_PTI\
M=/L&/[*\[3-^W[OVGR&\S'ONWYQWQGM7S[;_ &QOV'/ \5M]G\F;Q6D=U]LS
MY'EF>8CS<<[-XCSCG'3G%,6I]#Z5X\^.7B[2X_$6C^#?"^F:-,GG6^D:S>SC
M4IHS@H=R@1QEASA@,9YZ<^A?";XI6?Q6\.SWT=G/I.IV5R]CJ>DW1!FLKE.&
MC;@9'.0<#([ @@<3_P 9(_\ 5+/_ "I5C_![PKXVT7QM\6=2O]9\%3^+-4@M
M7_LS1;B>2"SNUAD$37$; 21K)E6."2P#$8P*0SZ'HKQ*QC_:)%];_;)/AF;3
MS%\X0C4-^S(W;<C&<9QGCI7MM !1110 4444 %%%% !1110 4444 9'B[_D5
M=:_Z\IO_ $6U0^!_^1/T?_KVC_D*F\7?\BKK7_7E-_Z+:H? _P#R)^C_ /7M
M'_(4^@&[1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MC?BM_P BJ/\ KZB_]"KLJXWXK?\ (JC_ *^HO_0J[*@ HHHH ^:M/_9K\3V?
M[6[?%)K[23X?,LL@M5FE^U8:S: ?+Y>W.X@GYNG/7BOI6BB@#BOBY\*](^,G
M@F\\-:T'6"9A+#<18\RWF7.V1<\9&2,=P2.^:\ T_P#9_P#V@?"^G)X:T+XL
M6">%HD\F&2>-A=QQ] J$Q,R    +* !P,  5]:44 >/_  ?_ &:_#_PK\ :S
MX=DFDUJYUZ)X]7U"90K7(960J!D[5 =\ D\LQ).>/'_#/[+?QE^$=]>6'PZ^
M).GV7ARYF,IBU"(LZY &?+:*1-^  64J3M'3H/L"BF!\:>*?V+_B%<>)M$\8
M:=\18=4\:P3K<76H:O&RI&R$&/R5"2 A<$;6 4X' !(KU7]I/]GG4?CQX%T&
MQCU>VM/$&E/YGVB=#Y,Q9 L@.T97+ $$ XQC'I[M10!Y5\(?!?Q L?"&KZ1\
M4]?L/%,EV/L\1LUPJVYC*,C'RHRQ.2<D$G/)KQ3PS^RG\6_A-J^H6OPY^(]C
MIGAN^E+R+?0[YE'0$1F)T+@8!92I.!TX ^P**0'RE\/OV1_$O@;]HC2/'4WB
M*VUS3+=)7O;J\FD^WW5Q):R1N^S85 \R3@;SA1U)'/56G[/OB*W_ &N+WXI-
M>:8= FB$:VPED^U9%FD'*^7MQN4G[W3!Z\5]!T4P*NHZ?;:MI]U87L"7-G=1
M-!/#(,K(C JRD=P02/QKY6M_V6_BC\)]0OT^$7Q%M]-T.\E,K:=K2;A$3Z9B
ME5FP -P520 #G KZSHI > _!?]F6[\&^-KGQ[XX\1/XP\;3(8X[@J1%; KM)
M3/);;E00% 4D <YK!^)7[*WB1?B==_$#X6^+(_"NO7NYKNWNE/DR.Q!<Y"L"
MK$!BK(PW#/H!].44 ?*NG_LK>._B'XLT?6?C'XXMO$5MI4ADATK380(7.02"
M?+C50=J[L(2P&,CK7U5110!XY^TE^SW;_'[PU8VZ:C_9.M:7*\MC=M'O3Y@
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M\'@UJT4 >!?LR?L_:[\(;C6=1\5:K::SK%Q!;Z=9RVCR.L%E"N$3YU7!) R
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M^'/PQU/PC\5OB;XHN[BUEL?$\UC)9Q0.QEC$,<BMY@*@ DN, $\#D]J]0HH
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M3 ()'##KSGI7LGPK^&.B_"'P;9^&]"CD%G 2[S3,&DGD;&Z1R  2<#H
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M#@'@\9]AHHH **** "BBB@ HHHH *PO''_(GZQ_U[2?R-;M87CC_ )$_6/\
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MWGK(6(V[0N%QG=G)Z=Z]0HH \P_:.^&.I_&#X4ZCX7TBXM;6^NIH'66]=UC
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MBFCW(K,-RL.@ZJ.E=_I/@6PT[X=VO@]D$NF1:6NELO\ ?C$0C.?J,_G72T4
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M:KY8"D$@H<@D<'@]J]0HH Y'XK^$[OQU\-?$WAZPDAAO=3L)K6&2Y8K&KLI
M+$ D#)YP"?:K7PY\.W'@_P"'OAC0+N2.:[TK2[6QFDA)V.\42HQ4D X)4D9
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MXFTCPCK\NO:9H/Q/\.H\,6H:9 \MC<0'(,4B288@K@DXX); Y!$&O_#/XO\
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M@J% )&1ACP><4GQG^&.J?$?4OA_<:=<6EO'X?\1VNL70NG<%X8B253:IRQ[
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MYK]F7PC#X3^/'QALK*\N-4M;0:;#-J%TVZ6XNFB9YV8]V,ID) Z9 ]*ZNU^
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M1K.\1?\ (O:I_P!>LO\ Z : ,GX:_P#(C:5_N-_Z&U=/7,?#7_D1M*_W&_\
M0VKIZ "O'OC)\(=9^(7Q+^%OB'3KFQ@LO"U_-=7L=U(ZRR*S0$"(*A!.(FR&
M*CD?A[#10 5\KZ[^Q[>6_P"T9HWCWPS=:;9^'X]0BU*]TZ=W22.4-F3R55"I
M#8!P2N"2.@%?5%% 'D7QL^!<GQ*U#1_$GA_6Y?"GC;1=RV.K1)O#1G.8I%R,
MJ<GUQN8$$$BN$UCX,_''XE:>_A[QIX_T.Q\,S?)=MH-JWVJ[C&,JVZ-0N<<@
M'')!! P?IBB@#Y]^*'[.^L>/V\&^#K*\L='^%&B"+[7917$OVV[,8PJD!-N
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MBNC:'87%K<0RR.+AVDCG4%%"%2 95R2P. >#QGV&BB@ HHHH **** "BBB@
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MJUE<Z?\ ;X;RWFL=AD^U)*K1;1G+;@<8&#DY[5\HW7[4%TO[7%EH4?CK2?\
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M6O&&A_$C2O _Q&T32[*^UJ&:72M6T*>1[2Y:)=TD960;U8+@Y).<@8YS6O\
M%;XPW7A'Q!I'A+POHA\3>-=61IX+%IA##;P*2&GF<_=7(( ')P1D' (!ZE7
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M!%&Y'.TD[2<$Y%==\*_C)I7Q)^&8\8/&=&@MUF&HV]P^?L;Q9,H9L#( &X'
MX() /% 'H=%> :#\5/BS\5+5]=\">%_#VE^%6=OL<_BJXG6YU",$CS$2(8C!
M(XW9SU!(YKM_A+\6I/B!-K.BZSI#^'/&&A2+%J6DR2B0 ,,I+&X WQL.0<?F
M""0#TBBO#%^+7C[XD>(O$-E\--$T%-)T*^?3+C6O$UQ,([BY3'F)%'""V%R/
MF)P<@\=*N^"/BYXKUK7O$7@7Q!H>GZ%\0K#3FU"P*S/+IM]&<JDH( <()"H8
M<MC..00 #T32_'NAZWXOUSPO97IFUS15A>_M?*=?)$J!XSN("ME3GY2<=\5T
M5?&WPY_X7#_PT=\3OLG_  @__"1;-,_MCSOMGV3R_(7R_L^/GW;,;M_&[..*
M^R: "BBB@ HHHH **** .'_YK!_W"_\ V>NXKA_^:P?]PO\ ]GKN*8!1112
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M!G%=3\*OC!>>+O$&L>$/%.C#PWXVTE%FFLHY?-@N;=B L\#]UR0"#R"0,DY
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M;6'2SM-(T<&)+JZ(!?:7+%(E)&68D@$$CG@ ]0HKPC4/&/QW\-6,FN:CX/\
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M$G!.< $ZFF_%SQWX)^('A[PS\3-&T-+;Q%(UOIVL^')YC"MP "(9$E&X%L@
M\#)& >=H![I17EOQ:^,%YX-US1_"?AC13XE\;:PC2VUBTOE0V\"DAIYG[(""
M !R<$ @XSRVI?%GXE?"?[-JGQ*\/:#<^%995AN-5\*SSLVG;VPKS1RC++D@$
MJ1C/<D*0#WNBHH9H[B%)8I%DB==RR*058'D$'N#4M !1110 4444 </\3_\
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M\=,D  '&,4 >B?#_ /:(\'_$377T&VFO-'\1*I?^Q];M6M+E@!DE5;AB "2
M2< G&.:].KRWXV?!N/XN6.A7FFW\6C>(M'OHK[3]96+>\84Y*9!!*MP<9QE0
M:ROCI\=+[X/^,O &G0::FI6.O27L=Q#'$SW3O&D?DQP88*&>255^8$<CIUH
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M,,O-<Y\"?@A)\$;CQ;;6VJK=Z!JNH?;=/TY8BAL0=P*%BQW97RAD ?ZO/.>
M#UJBOE^']J#QEJWQ(\:>!=!\)VNO^(+#4GM]-6,M!#%;1EA)/=2,Y'!V !0N
M22.N :MY^U-X\^$_BR+0_BKX-LT;4+=Y=,G\-,SBXD'"1;6=LEFPO4$%E)!!
MS3 ^JJ*^6O&7QZ^-WPUTA/%GB?X=Z'%X35T%Q:VMZS7MLK,%7>X<J"20,A"
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MQ.\K&ZH!C!\EFR!C+ \"LCX1_&3]G#P1\.=(>XTBV7Q';VL8NX[K1C<WDLX
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MYVYXX(()%=%\8O@[<^-?#/@?1O#K6.FVOAS7K'41#<,RH+:W5U,:;58[@&&
M<#CDB@"#]KB2[A_9S\:FP!$OV6-2%_YYF>,2?AL+_A7,>#X_C]#X1T./1O\
MA5W]CK8P+99_M'/D"-1'TX^[CI7O&N:+9^(M&OM+U&W6ZL+V![>XA;.)(V4J
MRGZ@D5XGH/PS^+WPML4T#P7XF\-ZWX7A)6S7Q5;SBZLHCG$:O"0) N>-P'3
M &  "I\.O"OC>']HR?Q#XSUCP3'JTOATVDNC^'+F?[1)")U9)WAF&2 P*[\@
M< 8ZU'X&\=>-?B4-6N_A;X?\*^%/!W]H3(NJ:I#(TNH3 XDG2&':,DCEG))Q
MSSD#O/A/\(;OP7K6M>*/$FMGQ+XSUH*EU?B$0PPPI]R"%,G:@XYZM@$X-<5H
M/P>^)OP?GU'3?AOKOANZ\*7=T]W!IWB:&??8%R"RQO"<LO' 8CKTSDD Y;QE
MH7BK2/VD/@K)XK\56_B*XGGU'R8+33ULX[4"!,D#>S.6)&22,;  .M==X'Q_
MPV1\2OMN/M?]B6']G[NOV7:GFX]O-QG'&<5G>)/V>O'M_P"(/#OCJ/Q5I>K?
M$33+HNQU*&6+3$MRA4011QDLH&YB6/S,6))& *[OXH?!V^\7:YHWBWPWK8\,
M^.=)B,,=^(1+!<PMRT$T9ZIDDCG())P3@@ ]&UK['_8]_P#VCL_L_P B3[3Y
MGW?*VG?GVQG-?+/P,_Y,%\1_]@;7/_09J]$O/AW\5?B1:MHWCKQ'X?TKPW+\
ME[;>$X)Q<7T>>8VEF/[M6&-VT$D9&<'-7_A3\$;KPE\!;[X>:W=6Q:\BO[:2
M>P9G1(K@R 8W!22%<=1U'4]: -O]G/\ Y(/X"_[ ]M_Z *X/]A6WCA_9UT=T
M0*\UW=O(P_B83,N3^"@?0"NF^!/@WXB_#S3+?PWXGOO#>H>&M,M!;:=<:8DZ
MWK%6 7S0V$ "Y&%YR!SUJ]^SC\,=3^#_ ,*=.\+ZO<6MU?6LT[M+9.[1D/(S
M#!95.<$9&.N>3UH X_XH_+^UM\%2."UKJZL1W M6(!_&O?Z\P\9?#'4_$7QP
M^'OC.WN+2/3/#L-^EU#*[":0SPF--@"E2 3DY8<#C->GT >,?%KQ]<:7\2?#
M7AGPIX5TSQ!X_N;2:ZM[[5"(XM,M22KR&0*7PQ4@JI&<=^ >:^+7AOXL7GPG
M\8W/B/QKX?TZRCT>[DN-/T326(G40L3$)II25#?=)"DX/&":[#XL?!_6_$GC
M+0_'/@S6[?0_&&DP-9C[="9;6[MF))BE Y !9B" >O8@$8FK?"?XE?%C3;K2
MOB+XCT.PT*2-@=,\*PSJ+E\'RS-+*=VU6PQ1<!B "<=6!!HO_)C4G_8BW'_I
M&]=O^SG_ ,D'\!?]@>V_] %97PY^%_B2P^"=]\/O&%[I<T9L9M(M;K1UDS]D
M:+RPT@?&9!D_=P.GN:3X$^#?B+\/-,M_#?B>^\-ZAX:TRT%MIUQIB3K>L58!
M?-#80 +D87G('/6D!Z[7@.H_\GRZ7_V(S?\ I9)7OU>+?%+X5>,KSXIZ/\0O
M 6HZ+#K=KIC:1/9^($E-M+"9&D!S%\P(+GTZ#GJ* ,7X\6\=U^T5\ DE0.@N
M]4<*?[RPPLI_ @'\*]R\0*'T'4@0"#;29!Z?=->;>,/AAXA\8?$+X3>)Y[G3
M8Y/"_P!K?58XVD42R30QJ?(!4Y4,A^\00".2<UZ?JENUYIMW;H0'EB9 6Z9(
M(_K0!\+W3WLG["/PSCMS T4OB)8[K[;N^S^5]MNL>;CG9O$>?;ISBOH3_C)'
M_JEG_E2JQ\/?V?XK']G"S^%_C!X+\>5.ES-I[L5#/</,C1LR@[E+*02O5>01
MUS]-\'_'?PM81:%IOBSPEK.EPQ^3#J^L6=P-01!PN50F-B!@98DDC)S3 9\
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M& %!)')->W_&+X4ZO\1O#/@6QT^>TM;C0]>L-5N/MCL T<*.KJA56RQWC .
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M)X;@G6[OK=1EXW>4[8E8 [B@S@D=#5/]CWPW!K/[+.DZ;J]J)K#4Q?1RP2#
MDADFD4@@8P",XQC@@CL: &^#X_C]#X1T./1O^%7?V.MC MEG^T<^0(U$?3C[
MN.E+\.O"OC>']HR?Q#XSUCP3'JTOATVDNC^'+F?[1)")U9)WAF&2 P*[\@<
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M6:2V8M&SJH!*D@$C(XR ?:@#RSX&Q+_PTA\>GVC>+C2@#CG!@E)_,@'\*?\
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MZI!J=N2T<S1RW2ONB$$>T'<S/)&0.!\I.>*]MI %%%% !1110 4444 %%%%
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ME74J?H1BOF^U_9P\5Q_LGZG\*I=0TE]7:XS:7:R2_9S$+M+CYSY>Y6.'& K
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MH#R%..*](TX71T^V^WB%;[RE\\6[%H_,P-P4D E<YP2 <=10!;HHHH ****
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M\2_A;XATZYL8++PM?S75['=2.LLBLT! B"H03B)LABHY'X, _:Z_Y-R\;?\
M7M%_Z/CK!O/B)HGPO_9%\(:SKVEQ:[:?V!I<,>ESJI2ZF,$913N!& 1N)(.
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M&U,B7R;C<VH-(H(4N=@7@NV2&YP#@<B@#,_8'_Y)?XL_[&J[_P#1%O1^P/\
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M_89MO_0[NNW^!7P 3X4W6K^(-9UB;Q1XSUH@W^K3C'RY!\N,$DA<@$Y/.U>
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MY)(.:Z.W_9O\<?$SQ5I6K_&'Q98ZSIVE2">V\/Z+&RVCN#P7+*N0<#.5).2
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M#P_:7#7\T)&& $A"1EAD94\9R.F" =!^R[X;F\(_!/0=)EUK2O$*6[7 BO\
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M1P>/2E\&_#'4_#OQP^(7C.XN+233/$4-@EK#$[&:,P0B-]X*A0"1D88\'G%
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M'PWX%\-^#VE?0?#VE:(TW^M;3K**W+].NQ1GH.OI7SM_P46_Y(GHG_8PP?\
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M^'5CX5&I_P!KK:RS2"Z,'DEO,D+XV[FQC..O..U>@44 %%%% !1110 4444
M%%%% !1110!GZCHMAJ\EE)>V<%W)8SBZMFFC#&&8*RAUR.& 9AD<\FM"BB@
MHHHH **** .'^)__ #+O_84B_K7<5P_Q/_YEW_L*1?UKN*8!1112 **** "B
MBB@ K"\<>&QXS\%^(/#YN#:#5M/N+#[0$WF+S8V3=MR,XW9QD9QUK=HH YKX
M<^#_ /A7_@30/#?VO[?_ &59QVGVKR_+\W8H&[;DXSCID_6NEHHH **** "B
MBB@ HHHH **** "BBB@#A?BI\(])^+&G6$=]<7FFZGID_P!ITW5M.E\JYLYL
M#YD;!&#@9!&#@=P"."U3]GWQIXOLWTCQ9\7]6U?PW*0L^GV>EV]C+/'QF-YD
MR64]QCD$@U[O10!G:'H=CX:T>RTK3+9+/3K.)8+>WC^ZB*  !GDX ZGD]>:T
M:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *X?\ YK!_W"__ &>NXKA_^:P?]PO_ -GI@=Q1112 **** "BBB@ HHHH
M**** "BLCQ5XAMO"/AG5]>O5E>STNSFO9UA4%S'$A=@H) )PIP"1SCI7&:E\
M>?#^E>!_!WBJ:TU)M/\ %5Y:65E$D2><DEPK,AD&_  "G)!/L#0!Z56+XN\*
MZ7XY\-ZAH&M6JWFF7\1BGA8D9!Z$'L0<$$<@@'M6U10!X7:_ 7QWH-E'H^@_
M&;6+#P]$GDQ6EWI=O=7,4? 5%N#AA@< XX&,8Q7H'PM^%>C_  E\./I.DFXN
M9+B9KJ\U"]D\RYO)V^])(W&3T]N/7)/:44 %%%% !1110 445SOC'Q[H?@&'
M3)M=O391ZE?Q:9:L(7D\RXD#%$^4'&0IY. ,<D4 =%1110 4444 %%%% &?J
M.BV&KR64E[9P7<EC.+JV::,,89@K*'7(X8!F&1SR:T*** "BL#QMXVT;X=>%
M[WQ#X@NS8:19[/.N!$\FS>ZHORH"QRS*.!QG)XYK9MYDNK>.:,[HY%#JV,9!
M'!_*@":BBB@ HHKC_B/\3-*^%]GHEQJL-W.FKZK!I%NMHBL1-*&*EMS+A1L.
M2"3TP#0!V%%%% !1110 4444 %%%% !1110 5P__ #6#_N%_^SUW%</_ ,U@
M_P"X7_[/3 [BBBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M17'>*OB=I7A'QGX1\,7L%W)J'B:2XCLWA13$AA17<R$L" 0P P#SZ=:[&@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,+QQ_R)^L?]>TG\C4WA
M'_D5=%_Z\H?_ $6M0^./^1/UC_KVD_D:F\(_\BKHO_7E#_Z+6@#7HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKC_ (5_$[2OB]X-M?$V
MC07=OI]S))&B7R*DGR.4)(5F&"02.<XZ@=*["@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K.\1?\B]JG_7K+_Z :T:SO$7_ "+VJ?\
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M"S22.WNGC!DA5]N\*2,@-L7..N!6A10 4444 %%%% !1110!QOCS_D->$_\
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MH&  !P  .GM4]%% !1110!D>+O\ D5=:_P"O*;_T6U0^!_\ D3]'_P"O:/\
MD*F\7?\ (JZU_P!>4W_HMJA\#_\ (GZ/_P!>T?\ (4^@&[1112 **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>C7<U[_PC/Q1T.WB8W,30O8ZA-" =V%&8CE0<C!))P >A]7^%OC'2/B!\/\
M0_$&A0?9-+OH-T-OL">3@E6C(' VLK#CCCB@#K**** /$M>^,7B_Q7XXU?PG
M\,-"TW4)=%80ZIKVO321V,$Y!_<*L8WR,,<X/!!!'0FWX1^+OB72_'EEX*^)
M&AV.CZOJ<;R:7JNDSM)87Y09>-=X#(X&#AN2#T&1GQ;]F;_A<S?#V]E\)?\
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M-@8<K@_-U R:JKX=^-&MV[-JWC+POX6C9<N-%TF2Y9!WP\\@ ('\14COCM2
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M"_\ V>NXKA_^:P?]PO\ ]GI@=Q1112 S]=UJS\-Z+J&K:A*(+&QMY+FXE/\
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M-3 W]?\ BEXH^$OPU&J^/+'2=5\4W6H+8:;IOA<S+%=RR8$48,P+!B0Y)P0
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M8'<4444@,CQ5XDLO!_AO5-=U%F2PTVVDNYV09;8BEB ,C)P, =SBO&M'\?\
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M86*?;_\ A,['RL_>\O#>9CVR(\^^*^B: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K.\1?\B]JG_7K+_Z :T:SO$7_ "+VJ?\ 7K+_ .@&@#)^&O\
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M ]9JCK']H?V1??V5]G_M3R)/LGVS=Y'G;3L\S;\VW=C..<9Q5ZB@#XV^'/\
MPN'_ (:.^)WV3_A!_P#A(MFF?VQYWVS[)Y?D+Y?V?'S[MF-V_C=G'%>I?%#]
MHJ\^&OQFM_"7]DKJUK=:"M]9VEK&QO;N^>Y:*.!&W;0I"EB2I( 8Y.,&#X6_
M\G;?&W_KVT?_ -)5JMKFGP7O[=6@2S1AWM?!330L1]US<SID>^UV'XTP.HM/
MBAXN\"_#_P 3^+OBEI&F:)9V"I+:6.D3&>8ACM$<CEBI<NR*"N!SDX[9-CXF
M^/GB"QBUBS\,^"](LIH_-CTC5+RZ>^VD @,Z 1JV#T(&#P0*ZK]H#QQH_@/X
M?M>:QH$/BDW5W!9V.CSQJZW5TS9B4[@0,%2V<$C;QSBL:UTWXX^(HQ)?:YX2
M\'I(,B&PT^;4)H@>@9I)%0L/4#&1WI =)\&?BHOQ8\+75[-IDFBZOIM[+IFJ
M:9*X<VUU%C>H88R.1@X'<=J\B^$W[0OQ*^.'@R*;PKX:T%=8ADD74-3U22:'
M38&W'RXD12TDCE-K,00%W#^\ -']CRVFL6^*UO=7[:I<Q>,+Q);YE53<.,!I
M"%X!8@M@<#.!TJS^PK;QP_LZZ.Z(%>:[NWD8?Q,)F7)_!0/H!0!N^ ?C#XF_
MX68_P^^(.B6&E>()K,WVGW^CSO)9WT:DAPH<;E88)P>H4Y XR>)/BUXNU_XB
M:UX*^'.B:7>7VAQ1/J>KZ_<21VD$DJEHXE6,%W)4$DC !!';-8WQ1^7]K;X*
MD<%K75U8CN!:L0#^-3ZY\+[G5OB'KWC/X6>/[71O$$KK9:[I[)'>V<\T0VA9
ME!S%(HX/!(YP!EB0#1\(?%WQ9I7Q(L/ GQ&T/3M.U358)9M)U;1)G>RO#$-T
MD860;D95YY/<# R";/Q!^,VKVOCI? ?@308O$?BM8%NKV:[G,-EIL38VM,P!
M)8@@A!@X((SG%<[:?$[QAX.^('A;0_BMX7T.4:M<_8](\2Z"S/$ERP $;)*"
M\9;Y1D$ GH" =I^S=C_A9WQO^V?\AK_A)?WF[K]DPWV;KSC;N]O2@"34OC%\
M0OA)?:;-\3M!T&7PS?7*VC:YX8GF*6+L2%,T<PW%3W8$ 8/4D ZOQV^/,GP9
M\8>!;2:"&71=9^WM?,8FDN!Y,2-&D # ;W>0* P()(''6O0/B-?>%]+\'ZA<
M^-!8-X:CV?:EU*$30<NH3<A!!^?;C@\XKQGX[6=GJ_Q\_9\1XEDM3=ZC-&A7
M !2*"1#@CC!52/I0!N+X_P#B9_PA?C?Q)XI\(Z-H>AV>AW5]I^EW$S7-R\B1
MLX2Y (7:5!!4 $9P<5D>)_V@K[P'\"?AEXQ^Q:59QZY>V%MJ$:V\@M[6WEBD
MDE:)%?(*A. 2P'.0:]0^.?\ R1/X@_\ 8O:A_P"DTE?,OQ2>SC_9/^!+ZB57
M3UUC2#<%L8\L6\V_.>.F>M 'L:^,/C7XIMEUGP]X4\,:/H\@\RWT_P 17<_]
MH31$$J3Y0V1,PP=K$E<X)XK>^&_Q;O/B=X:\0VUMIL>@>/-%+VEWHVIN7BM[
MHJ3$S,G+0L1G<H!(#8SP3ZC7@'A7'_#:7C;[#C[/_P (Q:_VCM_Y^O,3RLX[
M^5Z\XQCB@#S7X<_\+A_X:.^)WV3_ (0?_A(MFF?VQYWVS[)Y?D+Y?V?'S[MF
M-V_C=G'%>\_%7XQ3^"]<TCPIX=T5_$WC36$:6UTX3"&*&%<@SS2$':@(/;)V
MD#!Z\C\+?^3MOC;_ ->VC_\ I*M-\$;?^&ROB/\ ;_\ C\_L.Q_LS=G/V7">
M=C/;S<9QQGWS0!)KGQ,^+_POL7U[QIX6\.:UX8A^>]?PK<3_ &JRAXS(R3#$
M@7J=I' )) !(Z?XR?&)_!GP&U#X@^%_L>J;8+6XLFNE=H9$FFB0%@I5ONR$X
MR#D<UZ-K7V/^Q[_^T=G]G^1)]I\S[OE;3OS[8SFOBP?:_P#AVK<?:]V-R^3O
MZ^7_ &JN/PSG'MC'% 'MT7Q"^+OCG28O$'@KPQX=M] D426L?B"YF2\U&/&1
M)&B +$K=5\QCD$$X!XSO!_[1'BKXR:4MOX!\*6=OKEHN-9E\17+QV>GS;F40
MCRUWRL=A;@ *",X)P/</"]O'9^&])@A01PQ6D4:(O15"  ?E7B?['L:KHWQ,
M8* Q\<:D"0.P6' _4T ;7@/XN>*K?XF)\/OB)H^FZ?KEU9M?:;J.B3.]G>(I
M(= LGSHPP3SV!X'!:Q\0/C%KD?CQ? ?P_P!"M]?\41P+=:A<ZA,8K'38FQL,
MI4%F9@00JX."",\@<_\ %+C]K;X)X[VVK@_^ K5P/PT_X6I)\5OC'+X+_P"$
M.\X^(WCO/^$D-UY_EKN%OM\GC9L)QGOG'% 'IMI\7/&WP_\ $NC:5\4M#T>V
MT_69UL[3Q%X<GE:SCN6'RQ3)*-R;N<-G&0>" 2/<*^4_C9X6^-'C+X<ZAIOC
M#5?A9H6AM)#(^I?:;ZV:W=95*,LD@*J2P"\@_>(')KZDLQ+]D@$[*\P1?,9.
MA;')'MG- %BBBB@ HHHH **** .-\>?\AKPG_P!A$?TKLJXWQY_R&O"?_81'
M]*[*@ K.\0:U!X;T'4]6N<_9K"UDNI<==J*6/Z UHU@>/O#[>+? OB+0E(1M
M3TZYL@QZ R1,G_LU 'C?[*/A+^W- N/BIX@C2\\7^*IY;@7,HW&TM0Y2."(G
M.U<+GC'!4'I7O5]8V^IVDUI>6\5U;3(8Y89T#I(AX*LIR"".H/6O&_V/_$D6
MM? W1M-93#JF@O+I5_:N,/!+'(V P[$J5/U)':O;: /+O@G\);SX/-XGTR'4
M8[GPO=WYO-'L/F+V*MDR1DGJN=F,>A)Y))^1?@IX7U?P+\'_  _\9/",#3ZG
MHUW=6^N:=&2!J&G>8"V0,_,G7)!P #_  ?L#X;_%Q_B/X^\=:/9V$:Z+X;N8
MK*/5$E+?:IRI,J@8P-C*1P3G(/>O/OV$HTF_9WLT=0R-?72LK#((+ $>XH ]
MR\'^+=,\=^&--\0:-<"[TS4(1-!(!C@\$$=F!!!!Z$$'I7RW\#_A_'\4?V??
MC!X:8*9KWQ1J0MV; "W"QV[1$GL ZKGVS70^&6?]EGXP?\(O<,R?#/QA<F72
M)F^YIE\Q&;<DGA&X SV*G/#FM3]B?_D3?'O_ &.>H?\ HN"@#LOV8?'TGQ"^
M"V@7=T6.J6"'3+]9,[Q/#A"6S_$RA6/^]7'?')3\3OCI\.?ARH\W3K%SXGUA
M.JF.(E858>C,&4CTD!]#2?#QA\*?VGO&WA.5E@T;Q;;CQ'IVX[56=21<(.V2
M=[GT5!T[S_LRPGQUXG\?_%6X7<NOZB;#2G;J+&W^12OH&(&1ZQGZD ^@J\V^
M,'Q:F^'?]A:5H^CMXB\5^(+AK;2]+$HB5BH#222.0=J(""3CN.@R1Z37C'Q:
M\?7&E_$GPUX9\*>%=,\0>/[FTFNK>^U0B.+3+4DJ\AD"E\,5(*J1G'?@$ R/
M$7CSXW?#O1;OQ+XA\.>#]9T*Q3[1>6>A75REY# H!=P91L8J,D@#H#CUKI/B
MY\9Y?"?[/]Y\1O#,5O>EK6SN[-+]&*,D\L2C>JL#D+*> PP1BN-^+7AOXL7G
MPG\8W/B/QKX?TZRCT>[DN-/T326(G40L3$)II25#?=)"DX/&":Y;XD?\H[K3
M_L#:5_Z56] 'H-C\1/BY\1-+M=<\$^'/#>G^'YHQ);R>);B=;F_3!_>1QQ B
M-6/*[R21@G /'4?!/XO2?%+3=9AU+2CH'B30KUM/U733*)5CD'1D< 95L''I
MM/)&">W\+V\=GX;TF"%!'#%:11HB]%4( !^5>#?"S5;+0?C9^T;J&H$)IEE_
M9UU<?+D"-;:=I#COD GWH T='^+?Q*^+OVS4OAKH/AVT\+0W#V]MK'BB>?-_
ML;:SQ1PC*KD$ L><>N0.B^&?Q;U[5/'FI> O'&BVNC>*K2R74H)M-G,MI>VQ
M?89(RP#*0QQ@Y)P>F#7)_#KQ!\3OB!X5L+[P9HOA+X=>"YP6TZWNH)+BY\HN
M<.(HBD:!N3CU.<D<G$\*Z/KVB_MG6<?B3Q''XFU*3P>\AN(;-;1(5-T0(EC#
M-@#!;)))+GH,"@# \'^-M?\ AOX/^/'B;P]9VFH7.F>/+R>XMKQ'8/;>:!*5
MVLN& .[)R %.0:^LM#UBU\1:+8:K8R>=97T$=S!(!]Z-U#*?Q!%>"_LVZ7;:
MY/\ '33KV(36=YXSU2WFC/1XW.U@?J"16/\ ##XF3?!_X$^/]&U642:Q\.YY
M[&+S.LT;DFR8^S%PHXZ** .G;]I*33+/XI>)=1LH9/!_A6_CTG3?LJ-]IO;H
M8252Y8J5\QT (484DG..7W7B_P"/=GI9UX^#?"4UDL?GMX?BOK@ZEMQDH)-O
MEEP.P!R>@SQ4&A_"#PUI?[-&D>!O'%_%I?\ ;"Q_:KF>X6&4ZC,WG (S\-('
MX (.0F"",T^+PY\>/AY9B+2O$'A_XBZ?;J D.M0/9W[J!PHD0E"W;=(><9)R
M: )?B)\>+6^_9<O/B5H.G6>I1216[II^L0F6$.;J.%TD4$9*L6P00,J#TKK/
MB=\6D^&?@K1;^+2FU?6=8N+?3M,TFW81">YE&54L<[5&#S@XX'>O%OB_\0M*
M^)/[%?C#4=+T;_A'7M[JWLKW2=BK]DN4O;?S$^4 'J#G R#R <BO6/BAX'\.
M_$CP?X6\/ZKKX\/:XTD-[H5U#<+'=+=1("&B4D&3:&R0.Q!R#@@ YSQ)\1OC
M3\.='G\3^(O"WA75O#MHOG7MGH-W<"^MH0!N<F0;'VC)(4=!U R1[7X=UZS\
M4:#INL:?)YUCJ%O'=6\A&"T;J&4D=C@BO#]8D^.?P[T:[FO?^$9^*.AV\3&Y
MB:%['4)H0#NPHS$<J#D8)). #T/J_P +?&.D?$#X?Z'X@T*#[)I=]!NAM]@3
MR<$JT9 X&UE8<<<<4 =95/5M4M=#TR[U&^G2ULK2%IYYI#A8XU!9F/L ":N5
MX]^UT;L?LY^-OL61-]FCW=?]7Y\?F=/]C?[>O% &)HGQ2^+/Q2LQK_@;POX>
MTSPK(Q-G)XIN)UNKZ,$@2(D((C#$<;B>.<D'-1_#O]HG7?&GQR'@/4?#L?A^
M2STB2XU2VGW/-%>+* !'(&"M"T;1L#MR=W7CGV#P"+)? OAP::%&G?V;;?9@
MO3RO*79CVVXKQ:1;3_ANV+[/L,Q\&9N=O7S/M! S[[/+_#% '5?$#XQ:Y'X\
M7P'\/]"M]?\ %$<"W6H7.H3&*QTV)L;#*5!9F8$$*N#@@C/(&=:?%SQM\/\
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M1_U]1?\ H5=E7&_%;_D51_U]1?\ H5=E0 4444 %%%% !1110 4444 %%%%
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M'(>.O@W\3_C)X-U#2O&OB#P[;(MO(;33/#\,\=O/=;2(9+B:0L^U&(;:JX)
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MS)<3-=7FH7LGF7-Y.WWI)&XR>GMQZY)[2@ HHHH **** "BBB@ HHHH X?\
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M;/PG#/YU_&"#Y;R3']VI(&=H.<8YS7OM% 'EGQN^#LWQ&\ Z1HWA^[MM$O\
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MZT[X>_ ?Q%\*_BU=:[H^LV>JZ#K5M&NN/JYE;4)KA-Y,L97Y,L[9()  ) '
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MN !QM&/>O0* /GW2_P!GGQ)'\;_"'Q%U?Q#:ZSJ=FMY_:TA5H1MDMS%!#;1
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M"/7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K.\1?\B]JG_7K+_Z
M:T:SO$7_ "+VJ?\ 7K+_ .@&@#)^&O\ R(VE?[C?^AM73US'PU_Y$;2O]QO_
M $-JZ>@ KROXI?!V^\4>*-*\9^$];'AKQKID36R74D/G6]W;DY,$Z9!*Y)((
MY!)."0"/5** / M<^%OQ6^+%FFB>/O$?AW2?##R WMGX3AG\Z_C!!\MY)C^[
M4D#.T'.,<YKH/C!\)M:^)5GX=\):?>6>B?#^)T.L102.MU<0QX\NVC4)M$9P
M,DL#TP#C#>NT4 <+\1?A#H/Q$^&\W@VXM4L].6%4L6@0 V3QC$3QCMMX&!C(
MR.A-<O'\']9^(/P7@\(?$J_M[G6K5U,&M:/,YD#Q_P"IN,NBD2@$AAR#R<_-
M@>Q44 >&?\(O\?H+7^QXO&/A&6S5?+'B";3IAJ.. &,()A+8YYR":[KX1_"G
M3OA'X7?2K*XGU&[N9VO+_4KLYFO+E\;Y&/;.!@<X Y).2>YHH \P_9Q^&.I_
M!_X4Z=X7U>XM;J^M9IW:6R=VC(>1F&"RJ<X(R,=<\GK26OPQU.']HR]^(#7%
MH=(F\.#1UMPS_:/.\]9"Q&W:%PN,[LY/3O7J%% 'F'[1WPQU/XP?"G4?"^D7
M%K:WUU- ZRWKNL8"2*QR55CG .!CKCD=:G^,'PA7XFPZ1?V&JS>'?%6AS&YT
MK6($$AA9@ Z.A^^C  $>P[9!](HH \&U;P/\</&VF3Z!KWBKPGH>CW"F&XU#
MP_:7#7\T)&& $A"1EAD94\9R.F#Z%/X'C\)_"&\\*^%+I=#-KI$UII]Y-(5%
MO)Y3!)G<#.0QWLP'7)Q7;U3U33;36M-NK"_MX[NRNHF@N+>90R21L"&5@>H(
M)&/>@#SG]F?4-;U3X'^&+SQ%?RZIJTZSR27LSEFF0W$IB8$@$@Q[,9'3%>I5
M!;V\=I!%!#&D,$:A$CC4*J*!@  <  #I[5/0!X9X@^%7C_P_\9-;\<> M1\.
MF+Q!!;0ZG9>(8Y_D,*A \1BY)V@<$@9)SG@CH[KX8ZG-^T99?$!;BT&D0^'#
MH[6Y9_M'G>>T@8#;M*X;&=V<CIWKU"B@#@?C3\*;?XP^"VT22^ETJ\@N([VP
MU"%=S6UQ'G8^,C(P2",@X)P0<&N,A\,_'C5H$TK5?%GA+3-/*[)=8TBRG;47
M7D,55\1(Q'0@<'D#C%>XT4 >*_!/X+ZY\%_%OB2TL+S3;GP'J4IO8(Y3*VHQ
M7!5%PS'Y2N 23DDG!XR:V_V<?ACJ?P?^%.G>%]7N+6ZOK6:=VELG=HR'D9A@
MLJG.",C'7/)ZUZ?10!YAXR^&.I^(OCA\/?&=O<6D>F>'8;]+J&5V$TAGA,:;
M %*D G)RPX'&:P?$'P?\7^&?B#J_B_X9ZYIMA+K>UM5T3787>RN)E! F5H_G
M1B"<@=223GH/;:* /$M-^$/C3QIXRT#Q'\2]>TJY30)S=Z?H7AZVDCM1<8P)
M7DD)=RO&!C@C@CD&_P#$'X,ZO=>.E\=^!->B\.>*V@6UO8;N S66I1+C:LR@
M@A@  '&3@ #&,UZ]10!X-=?!_P"('Q4U/3!\4M<T+_A';"Y6[_X1_P ,P2B&
M\D4Y0S23'<5!YV@8.>Q -=3\1OACJ?B[XK?#+Q1:7%K%8^&)KZ2\BG=A+()H
MXU7RP%()!0Y!(X/![5ZA10!S?Q&\.W'C#X>^)] M)(X;O5=+NK&&28G8CRQ,
MBEB 3@%@3@$XKYN^/W@!_#_P$^#7@W6_)NFM_$FE:;>?9F8QR#R9D?:2 <')
MY(!^E?6M<!\7OA4/BM8^&[9M3.EG1M<M=:#"#SO-,(<>61N7&=_WLG&.AH X
MRW\%_&OPC9IHGAWQ7X9UC181Y5MJ'B.TG&H01 853Y1V2E1@!F )QDUUOP?^
M$:?#&QU2YO-3EU_Q/K5Q]KU;6)T"-<2#(5549VHH)VKDXR>@P!Z+10!X9X@^
M%7C_ ,/_ !DUOQQX"U'PZ8O$$%M#J=EXACG^0PJ$#Q&+DG:!P2!DG.>".C^*
MOP=G\::YI'BOP[K3^&?&FCHT5KJ(A$T4T+9S!-&2-R$D]\C<2,G&/4** / ]
M<^&?Q?\ BA8OH/C3Q3X<T7PQ-\EZGA6WG^U7L/&8V>8XC#8P=H/!((()!Z?X
MR?!U_&?P&U#X?>%_L>E[H+6WLENF=88TAFB<!BH9ONQD9P3D\UZK10!4TNW:
MSTVTMW(+Q1*A*],@ ?TKSKX$_#'4_A?IOBVWU2XM+A]8\1WFL0_8W=@D,HC"
M*VY5PPV'(&1R,$UZA10!YAXR^&.I^(OCA\/?&=O<6D>F>'8;]+J&5V$TAGA,
M:; %*D G)RPX'&:S/''P=UZ#Q_/X\^'FNVNA^(KR%8-2L-3@:6PU)4&$,@0A
MD90 -RY.  ,<[O8J* /")O@_X^^*&L:3+\4==T3^PM,N$O!X>\,P2B"[F0Y0
MS23'<5!_@ P?;&:]WHHH **** "BBB@ HHHH XWQY_R&O"?_ &$1_2NRKC?'
MG_(:\)_]A$?TKLJ "BBB@#QKQE\"-0C\87?C+X=^)'\&^);T#[?"]N)[#42.
MAEB/1^OSC)Y)QDDG+U#P7\>/%MNVF:KXU\+^&]/D^26]\.64[WKH1@@&4@(3
MD\J01P0>U>\T4 <G\,_AOHGPH\(VGA[0H6BM(27DED.Z6>4XW2R-@98\9[
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MJM+)=2@FTV<RVE[;%]ADC+ ,I#'&#DG!Z8->'ZA_PN3_ (:NL\_\(-_PE_\
MPBC>1_Q^?8/L?VI_O_\ +3S=V[I\N,=\T ?9=%>6_$KXM:I\.]-\+:5%H\7B
M+QYX@86UKI=G*8K=ID0-/)O8$K$F<Y(S@C..2.3\1>//C=\.]%N_$OB'PYX/
MUG0K%/M%Y9Z%=7*7D,"@%W!E&QBHR2 .@./6@#WZBLKPSX@L_%GAW2];TYVD
ML-1MH[N!F&&V2*&&1G@X(X[5JT <?H/Q-TKQ#\1/$_@VV@NUU/P\EM)=RRH@
MA;SHPZ!"&+$@$9RH_&NPKR;P/X]N-;^/GQ*\,OIFFV]OHD&GM'>P0%;JX,L
M<B5\D,%R H & .]<1X9_:&\<^.O%GCCPGX<\,Z9?:WHFMW-E'=7,DD%E:V<<
MACCDN&RS22.RN L8&0K'@#D ^D*YW7?'NA^&_$N@:!J-Z;?5=>:9-.@\IV\X
MQ*K2#< 57 8'YB,YXS7ENC_&+QQX-^(6@>%/B9HFBPKX@9HM.UOP[/*UL9U
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MZ$#G_"?Q/\1ZYX9^,MYH6BZ+#K7AK7+ZTL88[5PM[Y'.9@'!>5P",@J,D?B
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M%?/7BCXS?$CX.7&GZM\1=!\.R^#KRZ2VFO?#D\[SZ<6'#2K(!Y@SD94#IZD
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M)(7!P\;C/#*00?S'!!H ZBBBB@ HHHH **** "N'_P":P?\ <+_]GKN*X?\
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M8H^)G[0&L^ _CEIG@>PT&/75U+1!=V=K#E+F>\:>1%0R%MD<02-G9BIP%)]
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MGU&3JGQ&^,WP_P!,D\1>*O"7AO5?#MNOFWEKX<NIS?VD( +2$2#9)M&20IY
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MXQC(!]-4444 %</_ ,U@_P"X7_[/7<5P_P#S6#_N%_\ L],#N****0!1110
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ML5 'T-1110 4444 %%%% !1110!QOCS_ )#7A/\ ["(_I795QOCS_D->$_\
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M'_7U%_Z%794 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<;\7/\ D1[S_?C_ /0Q795QOQ<_
MY$>\_P!^/_T,4 =9:?\ 'G!_N+_*IJAM/^/.#_<7^534 %> ZC_R?+I?_8C-
M_P"EDE>_5XM\4OA5XRO/BGH_Q"\!:CHL.MVNF-I$]GX@24VTL)D:0',7S @N
M?3H.>HH Q?CQ;QW7[17P"25 Z"[U1PI_O+#"RG\" ?PKW+Q H?0=2! (-M)D
M'I]TUYMXP^&'B'QA\0OA-XGGN=-CD\+_ &M]5CC:11+)-#&I\@%3E0R'[Q!
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M5SG'V7R!NSCMNV=?YXKZ(^*_A.[\=?#7Q-X>L)(8;W4[":UADN6*QJ[*0"Q
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MH"&3>!^\SG.T 8QU.:]%I > _"W_ ).V^-O_ %[:/_Z2K47[*MO&OB3XU3A
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M^?'YG3_8W^WK7L%4]6TNUUS3+O3KZ!+JRNX6@GAD&5DC8%64^Q!(I 97P_\
ML7_"!^&_[,V_V=_9MM]EVXV^5Y2[,>VW'2O%/C9]C_X:F^!NS9_:&=1\['WO
M+\H>7GVSYN/QK0T'X7_%GX4VO]A>!_$_A[6/"L;$65OXJMYS<6$9)(C5X2/,
M )XW8P.   !56#]G+Q')\6/!OC[5_$D&NZY8W$SZK-*K01K"82D,%I"H8!59
MF)+,"Q8DG)Q0!/#X\\3^+OB-XQTOX6^&O#>GKIMVMIK7B;6E8?:KE5P4$<0#
M2,@R S-CZ C/"_M#>'O'.GI\.;WQ;XPL=7A;QAIZ1:5IVF"UC1SYA,A=G9W(
M *@8 PQ)R<5Z%??!_P >^!/'?B/Q%\,=;T1;3Q%.;R_T7Q)#*8%N><RQR1?,
M-Q))''/<\ 8WCS]GKQ[\2-.MM:U[Q7IEQXSTR[AN](M8()(=)L]CAG4C)=V<
M@9=@2 H  !)J@-+]L+_D!_#3_L>M,_\ 09J[/]H#QQH_@/X?M>:QH$/BDW5W
M!9V.CSQJZW5TS9B4[@0,%2V<$C;QSBL[XO?"KQ#\6/AKH5E+J.G:;XPTJ]M=
M7CGA21K+[7$&! !R^P[VQD$\#(JMXF^%'BGXP_"M]$\>ZAI&E^)X+];ZPU#P
MRDS0VTD8'E.1,0S-RX(R.&&,$9J0%M=-^./B*,27VN>$O!Z2#(AL-/FU":('
MH&:214+#U QD=ZY?]CRVFL6^*UO=7[:I<Q>,+Q);YE53<.,!I"%X!8@M@<#.
M!TK;A\,_'C5H$TK5?%GA+3-/*[)=8TBRG;477D,55\1(Q'0@<'D#C%3_  3^
M"^N?!?Q;XDM+"\TVY\!ZE*;V".4RMJ,5P51<,Q^4K@$DY))P>,F@"LT?[2.X
MXF^&!&>,C4,X_*LSXQ?:?^%__L]?;?)^V^9JGG_9\^7YGV>'=LSSMSG&><8S
M7T-7E_Q&^&.I^+OBM\,O%%I<6L5CX8FOI+R*=V$L@FCC5?+ 4@D%#D$C@\'M
M0!QFK6\<W[<^BO(@9X?!#21L?X6-W*I(_!B/Q-=W^T<H;X#^/=P!']CW!_$(
M2*KW7PQU.;]HRR^("W%H-(A\.'1VMRS_ &CSO/:0,!MVE<-C.[.1T[UT7Q7\
M)W?CKX:^)O#UA)##>ZG836L,ERQ6-792 6(!(&3S@$^U '@_QB8M_P $^[$D
MY)\/Z$2>^?,M*[?]IJ2\B_97\2M8[O..FVRMM_YYF2(2?AL+Y_&M;Q%\%IO%
M7[-]K\-+R^BM[V/1K.P:\A!:+S[=8B& ."5+Q#J <'IVJ_X \+^-+[PCJGA[
MXF?\(YJ=E-;K8PC1!.#- 4*2>=YF &((^Y@#GVH X'P?'\?H?".AQZ-_PJ[^
MQUL8%LL_VCGR!&HCZ<?=QTI?AUX5\;P_M&3^(?&>L>"8]6E\.FTET?PY<S_:
M)(1.K).\,PR0&!7?D#@#'6K>@_#/XO?"VQ30/!?B;PWK?A>$E;-?%5O.+JRB
M.<1J\) D"YXW =,  8 ZWX3_  AN_!>M:UXH\2:V?$OC/6@J75^(1###"GW(
M(4R=J#CGJV 3@T <7^RK;QKXD^-4X0"5_&]_&S]RJN2!^!9C^)J3]J;Y=>^#
M#+PW_"<:>NX=<%N1GT-=?\&/ACJGPXU+X@7&HW%I<1^(/$=UK%J+5W)2&4@A
M7W*,,.X&1[FCXS_#'5/B/J7P_N-.N+2WC\/^([76+H73N"\,1)*IM4Y8]@<#
MW% &+\1/AG#XT^) U_P5XYC\+_$71[-;2[2(1W2O;.=Z1W%N2" 2<AC['!(4
MCFO$GQ*^(/PJ;3)OBIX>\.>)/"37L<)U[1 X>RD8D)+)#*#SR>4P!G@Y(!Z_
MXB?!_7KKQ]!X]\!:[;:%XH^R_8;VWU" RV>H0@@J) OS*P( W#)P !C!SBZI
M\(?B+\69K"T^)FOZ!;^&[2ZCNY-%\+VTP%\R'*+++,=P7/)"CGZ@$ $?QR_Y
M..^ ?_7SJW_HB&G^*8?^%;_M4>&_$"#R]*\;6#Z+>M_"+R$!X';_ &F4",>P
M-=7\1OACJ?B[XK?#+Q1:7%K%8^&)KZ2\BG=A+()HXU7RP%()!0Y!(X/![5=^
M.7PWN_BAX#DTW2[F&QUZSNH-1TJ\N,A(+J)PR,2 2 1N4D X#'B@#C/ARK?$
M/]HGQYXP<>9IOAN-/"VFMU'FJ1)=D>C!R%SZ&O./AI_PM23XK?&.7P7_ ,(=
MYQ\1O'>?\)(;KS_+7<+?;Y/&S83C/?..*^@/@E\.I?A;\.=,T.\GCO-5S)=:
MC=Q$E9[J5R\C D D9. 2 2%' KFO''P=UZ#Q_/X\^'FNVNA^(KR%8-2L-3@:
M6PU)4&$,@0AD90 -RY.  ,<[@#S7XV>%OC1XR^'.H:;XPU7X6:%H;20R/J7V
MF^MFMW652C+)("JDL O(/WB!R:^I+,2_9(!.RO,$7S&3H6QR1[9S7B$WP?\
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M#_Y'6O>XT6&-40!548 '0#L*\S_:.^&.I_&#X4ZCX7TBXM;6^NIH'66]=UC
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M#QMID^@:]XJ\)Z'H]PIAN-0\/VEPU_-"1A@!(0D989&5/&<CI@^N^#O">F^
M_"VF>']'A,&G:? L$*,<M@=23W8G))[DDT@.*\ K\95\11_\)J_@=M"\M]_]
M@B\^T[\?+CS1MQGKG\*Y']BC!^#ER9<?VL=;OCJ9'7[3Y@SG/.=NSKSC%>_U
M\\V_@+6K'QEXG\3?!?Q?H,D=_?.FM>']75YK%+Y0/,<-$=\<A)!90.2>3@
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M8>"/"^N:?JUY)XHU/Q%))-KFHWB!3?,ZE678"=J!20%!. 3SS0!U7P_^Q?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7D?[4G[*-Q\:M0M-;\,WUGI&O;1:W_VMG2&[@!!4L45B74@ 9'(P"1M%?2=
M'R9JGQLO=>_8ZT_[.S-XPU<IX1%ONQ*;PMY+Y]&:(%_8N.E?2'P[\'6WP]\"
MZ%X;M ODZ9:1V^Y1@.P'SO\ 5FRQ]R:\2T?]EW4M-_:$E\6/J-FW@:/4)M;M
M='5W\U=0EC56<ILV@!@6!#9X48ZU](4 %%%% !1110 4444 %%%% '&^//\
MD->$_P#L(C^E=E7&^//^0UX3_P"PB/Z5V5 !1110!\\?L(Z?!9_L]:9-#&%D
MN[VZFF8#[S"0H"?^ HH_"N)^&G_"U)/BM\8Y?!?_  AWG'Q&\=Y_PDANO/\
M+7<+?;Y/&S83C/?..*]N_9Q^&.I_!_X4Z=X7U>XM;J^M9IW:6R=VC(>1F&"R
MJ<X(R,=<\GK69XX^#NO0>/Y_'GP\UVUT/Q%>0K!J5AJ<#2V&I*@PAD"$,C*
M!N7)P !CG< >:_&SPM\:/&7PYU#3?&&J_"S0M#:2&1]2^TWULUNZRJ499) 5
M4E@%Y!^\0.374:]YG_#8_@0:HZ2!?"MQ]B8=#=[W$Q7MS%Z#./:KLWP?\??%
M#6-)E^*.NZ)_86F7"7@\/>&8)1!=S(<H9I)CN*@_P 8/MC-;7QQ\#Z-X\U3P
MM:)XGC\*^/;6>2Z\/7JE6F9E4&5!&2/,0@ L!Z#.1D$ ]0U=;1M*O1?E!8F!
M_M'F?=\O:=V?;&:^(--4M_P3:U0 $G[0#@#L-3C)_2O<M4\%?%;Q;I-QIGQ
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MY..V #C?A/\ ;?\ A$/VE/[-W?VC_P )%KGV;;G/F^6VS&/]K%>F?LJ?8/\
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MM>1_"/X,3^$?"OCO0O$ILM2L_$NNW^H&&V9V7[-<*BB-R54AL*<XR!D8)ZT
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M?_D3]'_Z]H_Y"GT W:***0!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 <;\5O\ D51_U]1?^A5V5<;\5O\ D51_U]1?^A5V5 !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M44 %%%% !1110 4444 %%%% !1110 4444 </\3_ /F7?^PI%_6NXKA_B?\
M\R[_ -A2+^M=Q3 ****0!17.Z7X]T/6_%^N>%[*],VN:*L+W]KY3KY(E0/&=
MQ 5LJ<_*3COBNBH **** "BBB@ HHHH ***YV3Q]H</CJ+P<]Z1XBEL#J:6?
ME/S;ARF_?C;]X$8SGC.,4 =%1110 4444 %%<?H/Q-TKQ#\1/$_@VV@NUU/P
M\EM)=RRH@A;SHPZ!"&+$@$9RH_&NPH **** "BBB@ HHHH *\=\1_ "YC\6:
MIXF\">,M0\!ZOJQWZBD-O'>6EU(.DK02<!^N2#SD]"23[%10!Y'X-^ LNG^-
M+?QAXQ\5WWCKQ)9QM%8R7<$=M;6>X89HH$^56(X)S^&0"/7*** "BBB@ HHH
MH **** "BBB@ HHHH *0@,"".*6B@"AH^BV'A[2[;3=,M(;"PMD$<-M;QA(X
MU'8 <#_Z]7Z** "BBB@ HHHH *X?_FL'_<+_ /9Z[BN'_P":P?\ <+_]GI@=
MQ1112 JZA8V^J6-S97<*7%I<QM#-#(,JZ,"&4CN""1^->*6'[/'BCP7 =-\!
M_%35/#7AT.S1:5>Z=!J(MPV25BDDPRKDD@<XR2<DDGW6B@#SSX4_!O3OA=_:
MEY]OO-?\0ZO*)=2UO4F#3W! PJC'"HN3A1TSUP!CT.BB@ HHHH **** "BBB
M@#"\<>&QXS\%^(/#YN#:#5M/N+#[0$WF+S8V3=MR,XW9QD9QUJO\.?!__"O_
M  )H'AO[7]O_ +*LX[3[5Y?E^;L4#=MR<9QTR?K72T4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7G_CCX5CQE\1O 7BK^TS9MX5ENY!:^1O\ M(GC
M5"-VX;-NP'.&SG''6O0** "BBB@ HHHH **** "BBB@ HHHH **** /'?$?P
M N8_%FJ>)O GC+4/ >KZL=^HI#;QWEI=2#I*T$G ?KD@\Y/0DDS>#?@++I_C
M2W\8>,?%=]XZ\26<;16,EW!';6UGN&&:*!/E5B."<_AD CURB@ HHHH *X?_
M )K!_P!PO_V>NXKA_P#FL'_<+_\ 9Z8'<4444@"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH PO''_(GZQ_U[2?R-3>$?^15T7_KRA_]%K4/CC_D3]8_Z]I/Y&IO
M"/\ R*NB_P#7E#_Z+6@#7HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *SO$7_ "+VJ?\ 7K+_ .@&M&L[Q%_R+VJ?]>LO_H!H R?AK_R(VE?[C?\
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MB_RJ:@ KY_U+]H#Q3_PN[QE\.]#\.V>LZC8)9MI@9W@1%D@62>>ZERP$:%T
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M;CMGRL>^/PKZ H Y#PC\4O#WC/X>0^-K*\$6@O;/<RS7 VFW5,^8) "<%2K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5A>./^1/UC_KVD_D:W:PO''_ ")^L?\ 7M)_(T '@?\
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M(ZI\1OC-\/\ 3)/$7BKPEX;U7P[;KYMY:^'+J<W]I" "TA$@V2;1DD*>0#T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N
M'_YK!_W"_P#V>NXKA_\ FL'_ '"__9Z8'<4444@"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH PO''_(GZQ_U[2?R-3>$?\ D5=%_P"O*'_T6M0^./\ D3]8_P"O
M:3^1J;PC_P BKHO_ %Y0_P#HM: ->BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K.\1?\B]JG_7K+_P"@&M&L[Q%_R+VJ?]>LO_H!H R?AK_R(VE?
M[C?^AM73US'PU_Y$;2O]QO\ T-JZ>@ KRGXG_%S5O#_C#2O!/@[0XO$/C#4;
M9[XI=3^3:V5LK%?.F8 D@L" !R2.N< ^K5X9XN\?:Q??&6_\+_#OPMH=UXLL
MM/B;5O$>M I':PN0T<!,8\R3((8*& &?J0 4/$7Q8^*?P?M8-<^(6A>&-1\*
M">.&]O/"\]P)K)7<*LC),/G )48&"21TK7^.WQZO/@_XN^']E;Z?'JFG>()+
MQ)XXHVDN9&C6+R8X,,%W.\H7+ CD=.M>9_M4>&_B/'\!_$E]XJ\9Z3+8QFW+
MZ/I&E>2D[&YB"@S22,V%)W8 !)49.,UTWQ:MX[KXW?LXI*@= ^H2!6_O+;V[
M*?P(!_"@#6\1>._CEX7TB\\37GA#PG/HEI&;F;1;74)VU*.)06?,NWRF8*,_
M*#TX!Z5VUS\</#UI\%Q\3)#-_8;62W8BP/-+,0HAQG&[>0G7&>^.:[3Q H?0
M=2! (-M)D'I]TU\L?"SQUI'@;]B?P?>:SH,7BIKJ[ELK'1[A%=;JZ:^G,2_,
M& QL+9P2-O'- 'H=CXF^/GB"QBUBS\,^"](LIH_-CTC5+RZ>^VD @,Z 1JV#
MT(&#P0*;>?%1?BQ^S7\2KZ73)-%U?3=,U73-4TR9PYMKJ*W?>H88R.1@X'<=
MLUIVNF_''Q%&)+[7/"7@])!D0V&GS:A-$#T#-)(J%AZ@8R.]>0?"^UFL?@M^
MTO;W-\VJ7,6H:XDM\RJIN'%LP:0A> 6(+8' S@=*8'6?#?XGZKX!\,_ ;2[B
MWLSX4\2:9'I\MX4?SX+SR@81NW;=KD@8*YR&.>,5[_XL\26O@_POJVNWIQ9Z
M;:RW<O."512Q ]SC ^M?/]QX$F\??L4^&[:PW#6=/T:TU33I$^\EQ"@==ON0
M&4?[U-^*'Q 7XU?"/X;^'],DQ<_$.YMXKE8C@PV\)$EZ1_N,A4CN,BD!L6?[
M07BM? OP^23P[9ZE\0O&BRSV.EV[M;VD$"@N)978LP B*,0.22P&,<N\0?%S
MXG?"%;75_B)X?\.7GA*2X2"ZU'PS<3F33P[!5>1)1EUR0#M Y(YZ ]!\5OAC
MHGCK7/#-GI/BM?!WCS0(6N=&DM&C>:. @1MFW8@R1':%/0<$$X)!Y'Q=XL^+
M?PK\/W&H>-M&\,_$3P=;;7OIM-1H+U(PPS(T,@,;!3@X4<8R2!R #M;OQ].O
M[35AX/33M->TE\,'5/[2,)-X&^T/&(UDS@1X&<8ZD\UBK\6O'WQ(\1>(;+X:
M:)H*:3H5\^F7&M>)KB81W%RF/,2*.$%L+D?,3@Y!XZ5B6.K6>O?MC^&M3T]@
M^GWOP]2YMV"[08WNG9#CW!'%6-/^%NMV&K:SXJ^#'Q"TT:3K=Y)>76CWL:WN
MG27).)&26,EHSD8(4'I@G   !U?PO^+NN:UXVU3P+XWT.WT+Q=86JW\9L9S+
M:7UL6"F6(D!@ Q P<GKZ$#UNO#? _P 4-?M_BM9^#OB/X5TO2_%5[922Z7KF
MCL9;>\CCRTD:EP7CP S;2?J!D$^Y4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '&^//
M^0UX3_["(_I795QOCS_D->$_^PB/Z5V5 !2$A>3TI:SO$&JV6A:#J6I:B0NG
MV=M)<7+,NX")%+,<=^ >* /$]'^+?Q*^+OVS4OAKH/AVT\+0W#V]MK'BB>?-
M_L;:SQ1PC*KD$ L><>N0.B^&?Q;U[5/'FI> O'&BVNC>*K2R74H)M-G,MI>V
MQ?89(RP#*0QQ@Y)P>F#7)_#KQ!\3OB!X5L+[P9HOA+X=>"YP6TZWNH)+BY\H
MN<.(HBD:!N3CU.<D<G$\*Z/KVB_MG6<?B3Q''XFU*3P>\AN(;-;1(5-T0(EC
M#-@#!;)))+GH,"@#?U3]H3Q0GQP\8_#K1/#=KK6H6,=HVEKO:!0'@66>:ZE)
M($:%T "KN)90,DY#]5^,7Q(^$^J:+)\2M"\.3^&M4O$L3JWAJXG_ -!D<G89
M4F&6'!R5P, G.<*6?"^WC?\ :^^-,Y0>:EII**_<*UJA(_$JOY"I/VY./V==
M;<<,MU:,K=P?/3D'UH [;XP?%J;X=_V%I6CZ.WB+Q7X@N&MM+TL2B)6*@-))
M(Y!VH@()..XZ#)'%>(O'GQN^'>BW?B7Q#X<\'ZSH5BGVB\L]"NKE+R&!0"[@
MRC8Q49) '0''K6O\6O'UQI?Q)\->&?"GA73/$'C^YM)KJWOM4(CBTRU)*O(9
M I?#%2"JD9QWX!YKXM>&_BQ>?"?QC<^(_&OA_3K*/1[N2XT_1-)8B=1"Q,0F
MFE)4-]TD*3@\8)H A_::\06?BSP#\(=;TYVDL-1\8:1=P,PPVR2*5AD=C@CC
MMTKT#P5\4-5U+XS>-? FO6]G;R:=%#J&D2VJ.IN;-^&+[F(+(Q525P"<\#%>
M&^-/^3:OV=_^QAT/_P!%2UZ1^T*G_"O_ !_\/?BC'^[M].O/[%UAQT^Q7!*A
MF]HW)(]V% '8_'CXF:C\,_"-A)H-K;7WB35]3MM*TRUO%=HWFE;DL%(; 4-R
M".2,^APO$/Q9\8:]X_U?P5\.]%TJ^U'0X86U76-<GDBLX))5W)&J1@NY(!.0
M< @@],U1U9?^%D?M3Z98X\S2O .FM?3=Q]NN@%B4CU6-2P/8Y]Z;KGPON=6^
M(>O>,_A9X_M=&\02NMEKNGLD=[9SS1#:%F4',4BC@\$CG &6) -'PA\7?%FE
M?$BP\"?$;0].T[5-5@EFTG5M$F=[*\,0W21A9!N1E7GD]P,#()O7WCRXC_:<
ML/!PTS36MI/#!U,Z@T!^V!OM#QB,29P(\#.,=23FN8M/B=XP\'?$#PMH?Q6\
M+Z'*-6N?L>D>)=!9GB2Y8 "-DE!>,M\HR" 3T! .UVH_\GRZ7_V(S?\ I9)0
M!;7XM>/OB1XB\0V7PTT304TG0KY],N-:\37$PCN+E,>8D4<(+87(^8G!R#QT
MK8^%_P 7=<UKQMJG@7QOH=OH7BZPM5OXS8SF6TOK8L%,L1(# !B!@Y/7T('*
M:?\ "W6[#5M9\5?!CXA::-)UN\DO+K1[V-;W3I+DG$C)+&2T9R,$*#TP3@ #
M4\#_ !0U^W^*UGX.^(_A72]+\57ME)+I>N:.QEM[R./+21J7!>/ #-M)^H&0
M2 >Y4444 >6_%3XP7?A'Q!I/A'PMHW_"2^-M61IH+)Y?*@MH%.#/._)"Y!
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M-)@:S'VZ$RVMW;,23%*!R "S$$ ]>Q (Q-6^$_Q*^+&FW6E?$7Q'H=AH4D;
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M3H.>HJ_XP^&'B'QA\0OA-XGGN=-CD\+_ &M]5CC:11+)-#&I\@%3E0R'[Q!
M(Y)S7K5% 'D7C[X-ZO<>.O\ A._ FNQ>'?%<ENMK>PWL!FLM2B7&P3*"&5E
M #KS@ #')K U/X._$/XN3V=I\4/$&AP^%[>=;B70?"T$RI?,IR@FEF.[:#@E
M0,'V(!'OE% 'EWQS^%NH_$O2?!]II$]G:'1?$5GJ\HNF9%,,(D#*FU3\V'&
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M\(;OXF:+X<OGU5?#WCS0BMS9ZSIT9>*&<J!,FQSEH6(QM)S@#.>0>8U;P/\
M'#QMID^@:]XJ\)Z'H]PIAN-0\/VEPU_-"1A@!(0D989&5/&<CI@^\T4 >9>)
M?@'X;U[X46'@.$3:;8Z8L;:;>0,//M)X^5F!XRV22W3.YNA.1SMKX:^/4-NF
MD2>+O"#6:@1_V_\ V=.=0(Z%C#D0[NA],_K[?10!XI\%?@#<?!_XA>+]5CU
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *X?\ YK!_W"__ &>NXKA_^:P?]PO_ -GI
M@=Q1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#"\<?\B?K'_7M)_(U-X1_Y
M%71?^O*'_P!%K4/CC_D3]8_Z]I/Y&IO"/_(JZ+_UY0_^BUH UZ*** "BBB@
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M(5OX\^(&O6FKZ_9VSVFG6&DV[0V5BLF0[*6)=V8$C+8P"1SQCV"BB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]\>_3FN9_:TU"#Q1\0OAM\/-1O19>';ZXEU76F:;RU:V@!8AFR,*%28DDX!
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M[90!P?Q2^-GA#X.V,%QXFU06TMQG[/9PH9+B;'4J@YP/4X'09R0*\TM_VX/
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MRDL;@#?&PY!Q^8()XK]AG_DW'0O^OF[_ /1[T >^T5%+*D,;R2,$1 69F/
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M_P"-+7P)X$\._P#"6^-9X/M,T+R^7;V,)QAYGR,9R#C(X(YRR@@'M%%?-/\
MPT%\1OA?XATJ#XN>$M,T_P /ZE,MLFO:#*S06\C=/,#.Q ZYR5X!(W8(KJ/V
MC/CY=_ W4/!$RVUO<Z1JEW+'J!>)Y9A"@0_N0KJ-YW$#=D9QTY- 'MU%?+_B
MSXW_ !S\-^'Y?&,OPXT6T\)P)]HFL;B[9M1B@SD,Y#@*0",C82O)(&#B[8?'
M[XE_%JQ&J?"GP18R:)'&H?4/$DY033[09(8D5USM)V[\[20>E 'TG17C_P"S
MO\<KGXQ6&O6>LZ-_8/BCP]=_8]2LD<L@8[@",\CYDD4J2<;>ISQ[!0 4444
M%%%% !1110 4444 %%%% !7#_P#-8/\ N%_^SUW%</\ \U@_[A?_ +/3 [BB
MBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &%XX_Y$_6/^O:3^1J;PC_R*NB_
M]>4/_HM:A\<?\B?K'_7M)_(U-X1_Y%71?^O*'_T6M &O1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5G>(O\ D7M4_P"O67_T UHUG>(O^1>U3_KU
ME_\ 0#0!D_#7_D1M*_W&_P#0VKIZYCX:_P#(C:5_N-_Z&U=/0 4444 %%%%
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M)K=S91W5S))!96MG'(8XY+ALLTDCLK@+&!D*QX Y /I"BO"]'^,7CCP;\0M
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M^0I] -VBBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '&
M_%;_ )%4?]?47_H5=E7&_%;_ )%4?]?47_H5=E0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA_3K*/1[N2XT_1-)8B=1"Q,0FFE)4-]TD*3@\8)KA_&G_)M7[.__ &,.A_\
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M8V^5M&S&.VW%<5H?P)\+Z+\'O^%;FW>YT&2W:"=I"!+*['<TI.,!]_S XP"
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M5QY:@9'! 89Z$D$@^Y>$?A[IW@'X=VOA+0T\JSM+5K>(RGEV8$L[$#JS,6)
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M,R+=R,""F6&60 D#<.<L2 6(H\P.M^%-UX;N_ASX>D\([/\ A'#9QBR5/X4
MQAO1@00V>=P.>:ZVO"O@7\%/%7P1\8:_IUIJ=A?_  VOI6N+*TFGD^V6<A .
M OE["#RI^89"JW!R#[K2 \OT[QUX-^,OBCQ?X!U'1#>W/AZ1%N[76+6)X9MQ
M8"2$;FR!@<D*1O7'4XXKQA^P_P##3Q LD^D6=WX4U/.Z*ZTNY<JCCD'RW)4
M$=%V^Q'6M/XM?LWW'BKQK#X[\%>)9_!GC>.,1274<?F07:@  2)ZX &3D$*
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M._$#XK:EIT?Q0US0O^$9L;A;HZ!X9@F$5ZZG*":24[MH/51P?8X(!&7<>/\
M5-+C^%GAG1?"NF^(?B?<^'8;K[=JI\N/3(3"JRR-)M,F&96!52"<<]@7?%KP
MW\6+SX3^,;GQ'XU\/Z=91Z/=R7&GZ)I+$3J(6)B$TTI*AONDA2<'C!-=?\5_
M@_K7B+QCHGCCP9K=OH7C#28&LQ]NA,MK=VS$DQ2 <@ LQ! /7L0",75OA/\
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M$.""<USGA_X0_'OX<Z9!X>\,>/\ P[J/AZV'E6DFM6CBXMXAP%4*C9 '0,Q
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M@D$CD$9ZUT>H? 7XJ?%N>SL?BGXSTD^%[>99Y='\-PNHO"IR!([(A _/& 0
M<$=G\:/@UJWQ"\6?"[4-&FT^SLO"NL1W]U#<NZ%H5DA;;$%1@3B,@ E1R.:
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MO^AD^'__ '[N/_C%/M]!_:9^T1>?XB\!&#</,"1S[MN><9AZXKZ&HH ****
M"BBB@ HHHH **** "N'_ .:P?]PO_P!GKN*X?_FL'_<+_P#9Z8'<4444@"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH PO''_(GZQ_U[2?R-3>$?^15T7_KRA_\
M1:U#XX_Y$_6/^O:3^1J;PC_R*NB_]>4/_HM: ->BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K.\1?\B]JG_7K+_Z :T:SO$7_(O:I_UZR_\ H!H
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MXKUU?$/C#5H$M9)K>#R+:UMU((AA3).,@$DG)P#@$DD ^5M)Q_PQ/X"^T_\
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MG_'G!_N+_*IJAM/^/.#_ '%_E4U !1110 4444 %%%% !1110 4444 %%%%
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MVH>/=?LH&M["2\@$,5JK @D)O;+8+#.0/F)()P1[E10 4444 %%%% !1110
M4444 %%%% !1110 5A>./^1/UC_KVD_D:W:PO''_ ")^L?\ 7M)_(T '@?\
MY$_1_P#KVC_D*W:PO __ ")^C_\ 7M'_ "%;M !1110 4444 %%%% !1110
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M-$OD5)/D<H20K,,$@D<YQU Z5V% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %</\ \U@_[A?_ +/7<5P__-8/^X7_ .STP.XHHHI %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!A>./^1/UC_KVD_D:F\(_\BKHO_7E#_P"BUJ'Q
MQ_R)^L?]>TG\C4WA'_D5=%_Z\H?_ $6M &O1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS15A>_M?*=?)$J!XSN("ME3GY2<=\5T5 !1110 4444 %%%% !1110 4444
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M15UK_KRF_P#1;5#X'_Y$_1_^O:/^0I] -VBBBD 4444 %%%% !1110 4444
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M/&VM>$KSP\%?SH=(247#,5.S&Z)1@-C/(X!ZT >R5\Z?L^R+'^T)\?MS!?\
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MT!XY\>>*O&OA7PWX<TN[UG1-=NK%;V[DE@LK6SC8I%).06:261E<!8P.%).
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M<V_F>7\W4OC'.<4 >IGQE\>K73SK]QX)\+3:<J><WAZVOYSJH3J5$F#$7 [
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M **** "BBB@ HHHH **** "BBB@ HHHH *X?_FL'_<+_ /9Z[BN'_P":P?\
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ME:!\3O#DL,,UGJDLDNG.)"&64-'ARK1AB!C()7)(->5_LO?\+0_X3+Q[Y/\
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M &>NXKA_^:P?]PO_ -GI@=Q1112 **** "BBB@ HHHH **** "BBB@ HHHH
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M<9*!8PIC!4 YR4=0N"6+ #K@[WA3]I+X$^+M;CTJW;3K*YF?9"]_I0@BD8G
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M65(+B)R"H#$D94J>2<9(YQ6?XV^)GB1?B]I7@+PC;Z7->2:/=:K?W&II(R0
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MT^9]WRMIWY]L9S7P]\,/M)\(_LPC5\_V1_;NI%!)G_6B4_9>O^WOQGG&,<4
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M>T?\A4WB[_D5=:_Z\IO_ $6U0^!_^1/T?_KVC_D*?0#=HHHI %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!QOQ6_P"15'_7U%_Z%795QOQ6
M_P"15'_7U%_Z%794 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,$_C7TO7G_PK^%8^&=]XSN!J9U'_ (2/7+C6MI@\K[/YI!,>=QW8/\7&?04
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *SO$7_(O:I_UZR_^@&M&L[Q%_P B
M]JG_ %ZR_P#H!H R?AK_ ,B-I7^XW_H;5T]<Q\-?^1&TK_<;_P!#:NGH *\>
M^,GPAUGXA?$OX6^(=.N;&"R\+7\UU>QW4CK+(K- 0(@J$$XB;(8J.1^'L-%
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MG:^ /@OXF>!--30_&FK:#J>A:?8Q66F+I:R><JH H\PM&N0$ '&??/6O8:*
M/FNY_9E\7?#?Q)J.K?![QI%X>L]0D,\_A_5H?-LMY_ND!MH[#"[@!C<1P(M9
M^!OQC^+%H='^(7Q!TNP\.2,IN;'PS:G=<J"#AG=%(Y X.X=\'%?3-% 'F?BS
MX ^%O%/PCA^'GV=K+1K2-!920G,MM(N=LH)ZMDMG/W@S ]:\X@^&_P"T7I5D
M-%M/B1X>N]-4&-=6O+-OMZIT!V^6REL8Y9B>3R2 :^DZ* /(O _[-WAWPO\
M"G5_!.HRS:\FN-)/JVHW'RRW4[8/F#D[2I"E>3@C)R22?/O#OP4^.7PQLO\
MA'O"'Q!T.\\+QDK:-K=JYN;1#T" (P.,\ MMXX !Q7T]10!\5^#?AQ>?#7]M
M3PE;:IKMQXEUS4M"GU'4=2N!M\V=A<H0B_PJJQHH&>@X & /M2O,=8^#/]K?
M'S0_B7_;'E?V9I3:9_9?V7/F9,QW^;O&/]=TVG[O7GCTZ@#Q7XT?L_W?CGQ1
MI?C7PCK[>$O'.F1^5'?"/?%<1\X25?8%AG!!!(((QCCM6^!/Q@^+,-OH_P 2
M/'FDP>%ED5[JR\-P,LEX%((#L\:XY&>ZY .TX&/INB@#S#XJ? /P]\3OAQ9^
M$<-HT.FB,Z5=6JY:Q9%VH5&1D;>"">1SD$ CSC_A6/[1<VF'0)?B5H*:65\D
MZNELYU'R\ '_ )9@;L9^;=NSSNSS7TM10!YY\+?@GX?^%OP[?PC;(=0M+I9#
MJ$URHW7KR+MD9P.Q7Y0.P &2<D^1Z+\ ?BW\(3=Z7\,_'.DGPM-,\L&G^(86
M9[/<<G8RH^2/P!))(R23]/T4 >,? WX!W7PYUS6O%OBG7F\5>.-:41W6HF/8
MD48(/EQCT.U,G  "*  !SP&N? /XLZ-\>O%7Q"\#ZOX6M!K$0ME357G9Q$1$
M2"JPD [H0<@GCZ\?4U% 'S3JGPO_ &A/'5F^E:]\1/#V@:7/\EQ)X?MI&G=#
MU&61"/HK#.3DXXKUCX2?"#1?@GX+&A>'8C-(29I[JY;$EW,1C<[ ' X   PH
M['G/?44 >%_"/X%ZYI/Q,\0_$;X@7MCJOBR]8PZ?'I[R26]A;8QM0NBD-CY>
M!P 3DEVJ#Q!\!_$7A_X[6OQ$^'U[IME%?C9X@TG4)9(HKL$C+IY<;?,PRQ)
MPR@\[F%>]T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<;X\_P"0UX3_ .PB/Z5V5<;X\_Y#7A/_ +"(_I794 %4-<T>U\1:+J&E7T?F
MV5];R6L\?3=&ZE6'X@D5?HH ^>_"WPS^-'POT>+PQX6\3>%-5\-6Q*6=SKUK
M<"]MH220@$1V.03@%CT'0#@)8_L_^,/"_P 4M#\=Z9XEL-<UR:)K7Q%<:U'(
M@GC9U)-LD>1'M50JJ2 -H))R:^A:* /,/!OPQU/P[\</B%XSN+BTDTSQ%#8)
M:PQ.QFC,$(C?>"H4 D9&&/!YQ1^T=\,=3^,'PIU'POI%Q:VM]=30.LMZ[K&
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M!H>+/BK\7_A3I3>)O&'ACPOJ7A:&1?M<?A^[G^V6D;$+O;S0%?!(R%'X@<@
M^A:*\V^*'QEM/ /@W1]7TZQD\0W^OW-O9:+8P.(_M<TPS'EB/E7'.2.X]:XK
MQ)\1OC3\.='G\3^(O"WA75O#MHOG7MGH-W<"^MH0!N<F0;'VC)(4=!U R0 >
MO^-O&VC?#KPO>^(?$%V;#2+/9YUP(GDV;W5%^5 6.691P.,Y/'-;-O,EU;QS
M1G='(H=6QC((X/Y5\N_MB:]XH\4? :\UCP_)H4WPZU"PL;JXDN1.-29GNHFC
M,0'[L+S#D-R!O]J]'T?Q%\1?!_PC\5:_XMC\+RW.E:/)?:5'HHN-CB*W=\7
MD(.250?*1_%TXH ]AHKYQ\%_'CXB_%K1=%G\#^%M+N$6"W.L:UJ<KPV2W#(K
M2P6\8;>Q3)!;) (P<]3W_@WXG:GXB^.'Q"\&7%O:1Z9X=AL'M9HD;SI#/")'
MWDL5(!.!A1P.<T >GT5YA^T=\3M3^#_PIU'Q1I%O:W5]:S0(L5ZCM&0\BJ<A
M64YP3@YZXX/2JO[17QBNO@GX:\/:S!#;2V]YKUMIUZ;F-W\NV=)'D= K [P(
M^,Y'/(- 'K-%>#:]\0OC5:Z'/XLLO!?AV+0((6NVT.]O)O[7: #=DE1Y2.5!
M)3YB#QR1@IX?^-OC7XT:3'J/PMT'28-,556?4_%D\J1FX*JSPQ1P@LVS< 7)
M"DY SC) />J*\E^$OQ<UGQ-XLU_P3XQT>WT3QAHL<=PXL)C+:WEO)C$L1/S#
M!(!!SC(YSD#,U[XQ>+_%?CC5_"?PPT+3=0ET5A#JFO:]-)'8P3D']PJQC?(P
MQS@\$$$="0#VVBO'?"/Q=\2Z7X\LO!7Q(T.QT?5]3C>32]5TF=I+"_*#+QKO
M 9' P<-R0>@R,\]JG[0GBA/CAXQ^'6B>&[76M0L8[1M+7>T"@/ LL\UU*20(
MT+H %7<2R@9)R #Z#KG?&/CW0_ ,.F3:[>FRCU*_BTRU80O)YEQ(&*)\H.,A
M3R< 8Y(KR'5?C%\2/A/JFBR?$K0O#D_AK5+Q+$ZMX:N)_P#09')V&5)AEAP<
ME<# )SG"GC_VQ?\ A8']H^$/+_X1O_A%_P#A*]._LG?]H^V_;/+DQ]HQ\GE;
MO,^Y\V-OO0!]845R_P /O^$Q_L(_\)Q_8?\ ;7G-C_A'_.^S>5@;<^=\V[.[
M/;I[UU% !1110 5A>./^1/UC_KVD_D:W:PO''_(GZQ_U[2?R- !X'_Y$_1_^
MO:/^0K=K"\#_ /(GZ/\ ]>T?\A6[0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%S0?C?H/B'P;XR\2V]OJ$=AX5N;VUOHY8D$K-:QB20Q@.005(VY(SW KP?\
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MSG;&"" 2>BDY !( /8**^8]:^.WQB^%*P:S\1/ >DR^$VD5;J[\/3LTUDK'
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M/.#_ '%_E4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_(5NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX[[]]6/A=\(]2\+^*M9\9>*]=7Q#XPU:!+62:W@\BVM;=2"(84R3C(!))R<
MX!))YF#X->.OA7JFJ2_"O7M'30]1G:Y;PWXE@E:VM96Y9H9(CO52?X<8&/Q
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MO>J\^^#_ ,)XOA?I6HF?4YM>\0ZO=&]U;6+A CW4QZ84$[44<*H/&3ZUZ#2
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MV,5  !8DG')-=M\(?A*_PUCUR^U'6)/$/B;7[H7FJ:I)$(1(X!"(B D*B@D
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M<XP0#C/BM;QWG[-_[/-O,@DBEU;PZCHW1E-FX(_$'%?56OC=H6H@C(^S2?\
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M1T>XL_-20*FU&RP(?(; /RC.!7ONFZ?;Z3I]M8VL2P6EK$L$,:]%10 H'L
M* / /V>?^3A/C_\ ]?\ IW_H-Q7T37S?'\)_B]X)^*?CWQ+X+N_!<EAXHNH9
MFCUQ[LR1B)6"@"-  <R-GDYP.G-:UYX'^.GC: V&O>-_#GA73YLK<-X5LYGN
M'7H5628@H2/XE((/KTH I? W9XH_:*^-/BNTPVG"XL](BF0Y622&()+@]#@H
MO3^\*^AZY?X<_#O1/A7X3M/#V@6S06%OEBTC;I9G)RTDC8&YB>_T    '44
M%%%% !1110 4444 %%%% !1110 5P_\ S6#_ +A?_L]=Q7#_ /-8/^X7_P"S
MTP.XHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!A>./^1/UC_KVD_D:F\(_
M\BKHO_7E#_Z+6H?''_(GZQ_U[2?R-3>$?^15T7_KRA_]%K0!KT444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %9WB+_ )%[5/\ KUE_] -:-9WB+_D7
MM4_Z]9?_ $ T 9/PU_Y$;2O]QO\ T-JZ>N8^&O\ R(VE?[C?^AM73T %><7O
MQ,\+>(OBA?\ PJU32Y+G4#IXOF74+>*2RNHSM.Q06)9ADD@H!\C'/ SZ/7CW
MQO\ V>[;XL:AI>OZ9K-SX6\9:0,6.LV@R=N20CC()&2V"",;FZ@XH R?%W[%
M?PJ\5K(\6A2:#=L.+C2;AXMI[$1DF/@\\**XC]FOQ#XE\ _'/Q?\'=8UN?Q/
MI6EV@O;&^GRTD(Q"P4DDD*5F&1D@,N!U-= O@O\ :5\O["WC[PG]FQL_M+[$
MQNL8^]L\D)N_'%=G\#_@!9?"&XU;6+O5;GQ+XMUEMVH:S=C:SY.XJBY.U<\G
M))) Y    /.[&W_X4U^V=-$!Y6@_$2Q:53T07T>68>Y)#'ZW YJS^S3#_P +
M(^+'Q*^*LP,EM<WAT32)#C'V:+;N8>S!83D<9W<DDTW]O*QMU^%^BZO#.]MX
MBT_6(1I,D/\ K6D<'<BXYY"AN.Z"O8/@KX 3X7_"WPYX9"@365JOV@KT:=OG
ME/N"[-CVQ0!X;9_ ;Q9X;UC5M=^!OQ)TZWT;4KIIYM)NMMS:+,>6"NHD'< ?
M*&  !)ZU=\)_&3QSX1^+?AWPK\6O">D17^L[K?2O$6D@'>PXVDDDX)?! VD;
MQE2#DS_\,\_$7X7^)-9O?A+XOTVPT75KAKN70M>@9H8I6ZE'5&..PP <!02V
M,UK^#_@+XQUSXB:/XU^*7BJTUZ^T0.VEZ7I5N8[6WD8#+EB%+8(!&1DE5).!
MBF!C>#_^3^O''_8JQ_\ H5G7(_$"T\>7G[:FHIX-O=$L=9'AR-K237ED,1@R
MH<)M5COW%SP -H?G.0>^^(GP1^(D7QLN_B+\.=>T.QO;[3ET^[MM;23;M&W.
M"J/D'RXSV((/6NC^+GP(O?B-_P (]XBTS7V\,_$+1(0L&LVJ;D?(.^-EX)0D
MOCT#,"""10!PGBWP7^T7K_A75].UKQ)\/!I%U:2PW;2+.BK"RD.2QAPN!DY/
M3&>U<#\??#-]X-_8A\):+J&I:?K%S9ZG'']MTJ<S6TB;K@Q['(&0$*CIP00.
M!FO1M8^#/QQ^)6GOX>\:>/\ 0['PS-\EVV@VK?:KN,8RK;HU"YQR <<D$$#!
MZ7X^?L^W/C[X)Z5X"\'M8Z;'IMQ;F#^T)76,11(RX+*C$L=P.2.3DDYH ]M@
MACMX8H8D6.*-0J(HP% &  .PQ7S7_P $^4"_ FX(4 MK-P20.I\N(9_(#\J^
MFJ\>_9=^$.L?!/X:R>'M<N;&[O6OY;KS-/D=XMK*@ RZ*<_*<\=^II <1X/_
M .3^O''_ &*L?_H5G7TQ7C^@_"'6=+_:<\1_$66YL6T34M%73HK=)'-RL@-N
M264IM"_N6Y#$\CCDX]@H ^=O[!_:>_Z&3X?_ /?NX_\ C%']@_M/?]#)\/\
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M33K#2;=H;*Q63(=E+$N[,"1EL8!(YXP >P4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 9'B[_ )%76O\ KRF_
M]%M4/@?_ )$_1_\ KVC_ )"IO%W_ "*NM?\ 7E-_Z+:H? __ ")^C_\ 7M'_
M "%/H!NT444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X
MWXK?\BJ/^OJ+_P!"KLJXWXK?\BJ/^OJ+_P!"KLJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;I7B'XB>)_!MM!=KJ?AY+:2[EE1!"WG1AT"$,6) (SE1^-=A0 4444 %%%%
M!1110 4444 %%%% !117'_"OXG:5\7O!MKXFT:"[M]/N9)(T2^14D^1RA)"L
MPP2"1SG'4#I0!V%%%% !117'Z#\3=*\0_$3Q/X-MH+M=3\/);27<LJ((6\Z,
M.@0ABQ(!&<J/QH ["BN/^%?Q.TKXO>#;7Q-HT%W;Z?<R21HE\BI)\CE"2%9A
M@D$CG..H'2NPH ***X_P#\3=*^(UWXFM]-ANXG\/ZK-I%TUTBJ'FB.&*88DK
MGH2 ?:@#L**** "BBB@ HKCIOB;I4'Q4M_ +0W;:S/I1UA9E1?LXA$ACP6W;
MMVY2<;2,=Z[&@ HHHH *PO''_(GZQ_U[2?R-;M87CC_D3]8_Z]I/Y&@ \#_\
MB?H__7M'_(5NUA>!_P#D3]'_ .O:/^0K=H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#A_B?\ \R[_ -A2+^M=Q7#_
M !/_ .9=_P"PI%_6NXI@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ KS
M_P +_"M?#7Q:\:^-EU,W'_"2QV<9L3!M^SF"(1Y#[CNW  XVC'O7H%% !111
M0 4444 %%%% !1110 4444 %%%% 'G_P/^%8^#'PZL?"HU/^UUM99I!=&#R2
MWF2%\;=S8QG'7G':O0*** "BBB@ HHHH **** "BBB@ KD_B5\-M$^*WA6?0
M->BE>T=UECEMWV302KG;)&V#AAD]B.2"""17644 >%S_  )^(5Y9-I-Q\;=:
M?0G3RFB32[=+PIT(^U@[\D=6QG//M7J/@/P)HWPU\)V'AS0;7[+IMFFU%8[F
M=B<L[GNS$DD^_88 Z.B@ HHHH **** "N'_YK!_W"_\ V>NXKA_^:P?]PO\
M]GI@=Q1112 ***YWP)X\T/XE>&[?7_#MZ=0TF=G2.<Q/$6*L58;7 88(/44
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M "+VJ?\ 7K+_ .@&@#)^&O\ R(VE?[C?^AM73US'PU_Y$;2O]QO_ $-JZ>@
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M >E445Q7BSXK:1X0\:^%?"MQ!>7FL>(Y)$M8K-$81+& 7DE)8%4 ).0"3M;
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M&MVL+QQ_R)^L?]>TG\C0 >!_^1/T?_KVC_D*W:PO _\ R)^C_P#7M'_(5NT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!P_P 3_P#F7?\ L*1?UKN*X?XG_P#,N_\ 84B_K7<4P"BBBD 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXM_=^2SFVDB@C9C;,2"H9F(RP.5 !P>:P]1_Y/ETO_L1F_\ 2R2CXY?\G'?
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MM[J_;5+F+QA>)+?,JJ;AQ@-(0O +$%L#@9P.E7_V&?\ DW'0O^OF[_\ 1[T
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ME4'&0<,I_A8=0PY! (KQ+]B?_D3?'O\ V.>H?^BX*^A)I4AC>21UCC0;F=B
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M"20,GC))]ZR?VAEM&^!7C[[;L$/]BW17S.GF")C'^._;CWQ3/V<_^2#^ O\
ML#VW_H H ]'HHHH XWQY_P AKPG_ -A$?TKLJXWQY_R&O"?_ &$1_2NRH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R/%W_(JZU_
MUY3?^BVJ'P/_ ,B?H_\ U[1_R%3>+O\ D5=:_P"O*;_T6U0^!_\ D3]'_P"O
M:/\ D*?0#=HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!QOQ6_Y%4?]?47_ *%795QOQ6_Y%4?]?47_ *%794 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %<;\7/^1'O/\ ?C_]#%=E7&_%S_D1[S_?C_\ 0Q0!UEI_QYP?[B_RJ:H;
M3_CS@_W%_E4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF-I9C^[5AC=M!)&1G!S73?L]_#/4/A'\,;/PUJ4UI/=6]Q<2[[)V:+;)*SJ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_"GX0WG@_7-8\6>)]9_X23QKK"K#<WR1"&"W@4@K!"G9 0"2>6(!/.2?4:*
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MZ/#IT.G0W!4Y43&(DR 8'''3(P:]PAB2&-(XT6.-!M5%& H'  '84 2T444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %</\ \U@_[A?_ +/7<5P__-8/^X7_ .STP.XHHHI %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!A>./^1/UC_KVD_D:F\(_\BKHO_7E#_P"BUJ'Q
MQ_R)^L?]>TG\C4WA'_D5=%_Z\H?_ $6M &O1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 9'B[_ )%76O\ KRF_]%M4/@?_ )$_1_\ KVC_ )"IO%W_ "*N
MM?\ 7E-_Z+:H? __ ")^C_\ 7M'_ "%/H!NT444@"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO/=4^#GC'P3XPUOQ%\+=<TNRCUN4W.H>'_$$$CV+W)^].CQG>C-U( Y/L
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M:,K=P?/3D'UKW^O,/VCOACJ?Q@^%.H^%](N+6UOKJ:!UEO7=8P$D5CDJK'.
M<#'7'(ZUZ?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%XX_Y$_6/^O:3^1K
M=K"\<?\ (GZQ_P!>TG\C0 >!_P#D3]'_ .O:/^0K=K"\#_\ (GZ/_P!>T?\
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M &%;>.']G71W1 KS7=V\C#^)A,RY/X*!] *D^*/R_M;?!4C@M:ZNK$=P+5B
M?QKL/V<?ACJ?P?\ A3IWA?5[BUNKZUFG=I;)W:,AY&88+*IS@C(QUSR>M'C+
MX8ZGXB^.'P]\9V]Q:1Z9X=AOTNH97832&>$QIL 4J0"<G+#@<9H ]/HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "N'_ .:P?]PO_P!GKN*X?_FL'_<+_P#9Z8'<4444@"BBB@ HHHH
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MU:XUTRF]>[:&51.I0%0&DD!(Z!20%. :8'J?[.?_ "0?P%_V![;_ - %<O\
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MU7]/^%NMV&K:SXJ^#'Q"TT:3K=Y)>76CWL:WNG27).)&26,EHSD8(4'I@G
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MGC/E8Z<^O:O?VQM.<8[UY_\ %_X1VWQ4TW3FCU*XT'Q!I-R+O2M:M5#2VDO
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% &1XN_Y%76O^O*;_ -%M4/@?
M_D3]'_Z]H_Y"IO%W_(JZU_UY3?\ HMJA\#_\B?H__7M'_(4^@&[1112 ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C?BM_R*H_Z^HO_0J[
M*N-^*W_(JC_KZB_]"KLJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N-^+G_ "(]Y_OQ_P#H
M8KLJXWXN?\B/>?[\?_H8H ZRT_X\X/\ <7^535#:?\><'^XO\JFH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M X?_ )K!_P!PO_V>NXKA_P#FL'_<+_\ 9Z[BF 4444@"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"\
M<?\ (GZQ_P!>TG\C6[6%XX_Y$_6/^O:3^1H / __ ")^C_\ 7M'_ "%;M87@
M?_D3]'_Z]H_Y"MV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** .'^)__,N_]A2+^M=Q7#_$_P#YEW_L*1?UKN*8!111
M2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MN'_YK!_W"_\ V>NXKA_^:P?]PO\ ]GI@=Q1112 **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N'_ .:P?]PO_P!GKN*X?_FL
M'_<+_P#9Z8'<4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'_0K:[_X"&NRHH XW_A85Q_T*VN_^ AH_P"%A7'_ $*VN_\ @(:[*B@#C?\
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MT*VN_P#@(:/^%A7'_0K:[_X"&NRHH XW_A85Q_T*VN_^ AH_X6%<?]"MKO\
MX"&NRHH XW_A85Q_T*VN_P#@(:/^%A7'_0K:[_X"&NRHH XW_A85Q_T*VN_^
M AH_X6%<?]"MKO\ X"&NRHH XW_A85Q_T*VN_P#@(:/^%A7'_0K:[_X"&NRH
MH XW_A85Q_T*VN_^ AH_X6%<?]"MKO\ X"&NRHH XW_A85Q_T*VN_P#@(:/^
M%A7'_0K:[_X"&NRHH XW_A85Q_T*VN_^ AH_X6%<?]"MKO\ X"&NRHH XW_A
M85Q_T*VN_P#@(:/^%A7'_0K:[_X"&NRHH XW_A85Q_T*VN_^ AH_X6%<?]"M
MKO\ X"&NRHH XW_A85Q_T*VN_P#@(:/^%A7'_0K:[_X"&NRHH XW_A85Q_T*
MVN_^ AH_X6%<?]"MKO\ X"&NRHH XW_A85Q_T*VN_P#@(:/^%A7'_0K:[_X"
M&NRHH XW_A85Q_T*VN_^ AH_X6%<?]"MKO\ X"&NRHH XW_A85Q_T*VN_P#@
M(:/^%A7'_0K:[_X"&NRHH XW_A85Q_T*VN_^ AH_X6%<?]"MKO\ X"&NRHH
MXW_A85Q_T*VN_P#@(:/^%A7'_0K:[_X"&NRHH XW_A85Q_T*VN_^ AH_X6%<
M?]"MKO\ X"&NRHH XW_A85Q_T*VN_P#@(:/^%A7'_0K:[_X"&NRHH XW_A85
MQ_T*VN_^ AH_X6%<?]"MKO\ X"&NRHH XW_A85Q_T*VN_P#@(:/^%A7'_0K:
M[_X"&NRHH XW_A85Q_T*VN_^ AK.\0>,;K6-#O[*/PSK:27$+1JS6AP"1@$X
M[5Z'10!YYX?\8W6CZ'864GAG6WDMX5C9EM#@D#!(SVK1_P"%A7'_ $*VN_\
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MA7'_ $*VN_\ @(:[*B@#C?\ A85Q_P!"MKO_ ("&C_A85Q_T*VN_^ AKLJ*
M.-_X6%<?]"MKO_@(:/\ A85Q_P!"MKO_ ("&NRHH XW_ (6%<?\ 0K:[_P"
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MKC_H5M=_\!#7944 <;_PL*X_Z%;7?_ 0T?\ "PKC_H5M=_\  0UV5% '&_\
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MR-NSNSGTQ^->IT4 <;_PL*X_Z%;7?_ 0T?\ "PKC_H5M=_\  0UV5% '&_\
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M@#C?^%A7'_0K:[_X"&C_ (6%<?\ 0K:[_P" AKLJ* .-_P"%A7'_ $*VN_\
M@(:/^%A7'_0K:[_X"&NRHH XW_A85Q_T*VN_^ AH_P"%A7'_ $*VN_\ @(:[
M*B@#C?\ A85Q_P!"MKO_ ("&C_A85Q_T*VN_^ AKLJ* .-_X6%<?]"MKO_@(
M:/\ A85Q_P!"MKO_ ("&NRHH XW_ (6%<?\ 0K:[_P" AH_X6%<?]"MKO_@(
M:[*B@#C?^%A7'_0K:[_X"&C_ (6%<?\ 0K:[_P" AKLJ* .-_P"%A7'_ $*V
MN_\ @(:/^%A7'_0K:[_X"&NRHH XW_A85Q_T*VN_^ AH_P"%A7'_ $*VN_\
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M]"MKO_@(:[*B@#C?^%A7'_0K:[_X"&JFJ>.+F_TR[MD\+ZVKS0O&&:T. 2I
M)]N:[VB@#S;PIXIO/#WA^STZ;PUK4LD *L\5J=IRQ/&<>M:__"PKC_H5M=_\
M!#7944 <;_PL*X_Z%;7?_ 0T?\+"N/\ H5M=_P# 0UV5% '&_P#"PKC_ *%;
M7?\ P$-'_"PKC_H5M=_\!#7944 <;_PL*X_Z%;7?_ 0T?\+"N/\ H5M=_P#
M0UV5% '&_P#"PKC_ *%;7?\ P$-'_"PKC_H5M=_\!#7944 <;_PL*X_Z%;7?
M_ 0T?\+"N/\ H5M=_P# 0UV5% '&_P#"PKC_ *%;7?\ P$-'_"PKC_H5M=_\
M!#7944 <;_PL*X_Z%;7?_ 0T?\+"N/\ H5M=_P# 0UV5% '&_P#"PKC_ *%;
M7?\ P$-'_"PKC_H5M=_\!#7944 <;_PL*X_Z%;7?_ 0T?\+"N/\ H5M=_P#
M0UV5% '&_P#"PKC_ *%;7?\ P$-'_"PKC_H5M=_\!#7944 <;_PL*X_Z%;7?
M_ 0T?\+"N/\ H5M=_P# 0UV5% '&_P#"PKC_ *%;7?\ P$-'_"PKC_H5M=_\
M!#7944 <;_PL*X_Z%;7?_ 0T?\+"N/\ H5M=_P# 0UV5% '&_P#"PKC_ *%;
M7?\ P$-'_"PKC_H5M=_\!#7944 <;_PL*X_Z%;7?_ 0T?\+"N/\ H5M=_P#
M0UV5% '&_P#"PKC_ *%;7?\ P$-'_"PKC_H5M=_\!#7944 <;_PL*X_Z%;7?
M_ 0T?\+"N/\ H5M=_P# 0UV5% '&_P#"PKC_ *%;7?\ P$-'_"PKC_H5M=_\
M!#7944 <;_PL*X_Z%;7?_ 0T?\+"N/\ H5M=_P# 0UV5% '&_P#"PKC_ *%;
M7?\ P$-'_"PKC_H5M=_\!#7944 <;_PL*X_Z%;7?_ 0T?\+"N/\ H5M=_P#
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MKC_H5M=_\!#7944 <;_PL*X_Z%;7?_ 0T?\ "PKC_H5M=_\  0UV5% '&_\
M"PKC_H5M=_\  0T?\+"N/^A6UW_P$-=E10!QO_"PKC_H5M=_\!#1_P +"N/^
MA6UW_P !#7944 <;_P +"N/^A6UW_P !#1_PL*X_Z%;7?_ 0UV5% '&_\+"N
M/^A6UW_P$-'_  L*X_Z%;7?_  $-=E10!QO_  L*X_Z%;7?_  $-'_"PKC_H
M5M=_\!#7944 <;_PL*X_Z%;7?_ 0T?\ "PKC_H5M=_\  0UV5% 'G^M^-+K5
M-&O[./PSK:/<6\D2LUH< LI )QVYKIO!\,MMX6TJ*:-XIDMD5XY 0RD 9!!Z
M&MJBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<!R1@CD#Z4 ?0GQ#^)^B_##PJNNZ\\L<+LD4-K;)YL]Q,_W8HDXW,>?3@$G
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M!(XKPYXZM?V;OC!\1QX]MKVQTKQ1J@U'3O$:6KRVSQG<1 [("04W8 P<8).
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M,(' E,,7#. 3@L3C)(&<$>Q? S_DB?P^_P"Q>T__ -)HZ .(_;4_Y-E\9?\
M;G_Z6P5[/I__ !XVW_7-?Y"N.^-'PU'Q@^&>L^$6U$Z4-1\G_3!#YWEF.9)1
M\NY<YV8ZC&<]J[.VB,-O%&3N**%SC&<#'2@#P^Y_Y/>M?^Q!/_I>U+^V!;RV
M_P ,=+\01QM(OAKQ!8:S($&6")(4) ]O,_+)KN)/A?YGQNA^(?\ :6#'H/\
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ME(VXZ!"* .Z^+7A#PM\1_%N@: _B&[\.>.],@DU31[K3LK-#$2(Y",C8RDJ
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M<GQ"\-ZE:>.?'&I^*M:N(!%::A);1P6]@P96,D-JF$#,4 8DDE20",DD ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#,\0^'['Q5H5_H^J0&Y
MTZ_@>VN8 [)OC8$,NY2&&03R"#3]%T>S\.Z-8:5IT/V;3["WCM;>$,6$<:*%
M1<DDG  &22>.:T** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#D?B%\+/"_Q6TZUL/%6EC5;2VF\^*/SY8=KX(SF-E)X.,$XK<T
M'0=.\+:/::5I-G#I^FVD8C@MK==J(H[ ?F2>I))/6M*B@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
L@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ilmn-20241229_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ilmn-20241229_g4.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@#
M( 54 P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HKD_CS\8O"_[//P0\8?'OQO%
M<R:/X*\,7^N:I%9Q[YI(+6W>=TC7^)RJ$*O<D"OSE_9[\=_\'"_[?G[/VG_M
MU?";]H/X,?"?2?%=I)JWP]^#NJ>!9-3%UIQ)^RC4-2=O-BDE50VZ)<;9 VV,
MDQH ?J-17PQ^QW_P5\O?VE?^"2'Q#_;Y\=?#ZU\*^,?A/H_B6T\>>'(Y&DM+
M?7-'M&GDCA)8LT4@,+*A8LIE,>YRN]O"/V5?&/\ P="?M9?LW>"/VFO"/QT_
M97T72/'GANUUS2=-U[PWJR7D5K<1B2$RK%#(@+1LK?*S###F@#]7J*^+_P!O
MW]OS]H/_ ()O?L >!_$7COPSX:\>_M#^-]4T?P5X:T/0_-BTC5_%MZI4NBML
ME%HK)(X4[&;]W&60ON7P7X]?M0_\%H/^"3'AKPS^U_\ MW?&CX8?&+X/W/B&
MPT[XLZ-X0\%/I5]X+AO)4A6[L9E/^FPQS.J'SE#N61=J[S)& ?J5145C?6>I
MV4.I:==QSV]Q$LL$\+ADD1AE64C@@@@@BI: "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2O"_^">__)$]6_['O6?_ $I->Z4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'A?_!/?_DB>K?\ 8]ZS_P"E)KW2O"_^">__ "1/5O\ L>]9_P#2DU[I0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >%_\ !/?_ )(GJW_8]ZS_ .E)KW2O
M"_\ @GO_ ,D3U;_L>]9_]*37NE !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!X7_ ,$]_P#DB>K?]CWK/_I2:]TKPO\ X)[_ /)$]6_['O6?_2DU[I0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 >%_\$]_^2)ZM_V/>L_^E)KW2O"_^">_
M_)$]6_['O6?_ $I->Z4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A?_!/?_DB>K?\
M8]ZS_P"E)KW2O"_^">__ "1/5O\ L>]9_P#2DU[I0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1139YX;:%[FYF6..-2TDCL JJ!DDD]
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MY.6RM:]^K?9=SV\IRW^R\,Z7-S7=[VMT2[OL%%%%>2>H%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 >%_\$]_^2)ZM_P!CWK/_ *4FO=*\+_X)[_\ )$]6_P"Q[UG_ -*37NE
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 453U_Q#H7A31Y_$'B7
M6+:PL;9-]Q=W<PCCC'J6/%>/3_&#XM_M"SOHW[.>FG1/#V\QW7C_ %JU(\P9
MP?L<#8,A_P!ML#J/E.#75A\)5Q"<EI%;R>B7_!\E=OL<]?%4Z#47K)[):M_\
M#S=EYG:_%O\ : \ _" 0Z9JL\^HZY>\:9X<TF+S[V[8] (Q]T'^\V!P<9/%<
M3!\(?B[^T-.FL?M$ZDVA>'"P>V\ Z-=$&5>H^V3K@N?]A<#H?E((KMOA'^S]
MX!^$/G:IID,^I:[>Y;4_$>KR^?>W3'KES]U3_=7 X&<GFNXK?ZS1PFF%7O?S
MO?\ [=7V?767FMC#ZO5Q.N(>G\JV_P"WG]KTV\GN4O#WAW0?">CP>'O#&CVU
MA8VR;+>TM(1'&@]@/\FKM%%>>VY.[W.Y)15D%%%%(84444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R?QY^,7A?]GGX(
M>,/CWXWBN9-'\%>&+_7-4BLX]\TD%K;O.Z1K_$Y5"%7N2!7YR_L]^._^#A?]
MOS]G[3_VZOA-^T'\&/A/I/BNTDU;X>_!W5/ LFIBZTXD_91J&I.WFQ22JH;=
M$N-L@;;&28T_4:O@W_@IO_P58\7^ ?'Z_P#!.?\ X)O>%E^(_P"T]XLM#%!8
M615]/\!VLB@-JNJS<I"8U=72%_5&<;6C28 R_@'_ ,%U_#/BC_@CKXV_X*7_
M !V^%JZ'XC^%UY?>'O'/@O3[L^3)XEMY88([2WE;<5BGENK7!.\Q"9@3)Y>Y
MO+/&/QN_X.)O@C^R6?\ @IUX^\??!W7M'T_P^GBWQ7^SG:>#);673M!\O[1/
M'#J?F-,;N&V)=E?<JF-\&7:$?QO_ (*Y_P#!/?2?^"9W_!M8G[-%GXJF\0WO
M_"RM%UCXF^)FW#^U]1NKU6NKC#<B,.((DW?,4BC+98DG];OVRQH@_8Q^*PU$
M0C31\,-=\_IY?D?V=/N]MNW/X4 ?./[;7_!8CP_\&_\ @G%\._VQ/V8?!,?C
M'Q9\=;O1-&^"_A349-BW>L:JFZ&.Z",&"P@2"1589D01[TWAQXE\>OVH?^"T
M'_!)CPUX9_:__;N^-'PP^,7P?N?$-AIWQ9T;PAX*?2K[P7#>2I"MW8S*?]-A
MCF=4/G*'<LB[5WF2/XS^!::S_P ,5_\ !'S_ (2L/]A_X7[?%_.^[YO]N.;'
MKWV_=_2OTT_X.23I8_X(C_'O^U]GE?V%INS?T\W^V+'ROQ\S9CWQ0!]NV-]9
MZG90ZEIUW'/;W$2RP3PN&21&&592."""""*EKR_]B$:LO[%WPA77]_VX?"_0
M/MOF?>\[^SH-^??=FO4* "BLGQUXAU3PIX1O_$>B>%;O7+NT@,D&DV+*)KIL
MCY$+<9^OI7D/_#6'QL_Z,?\ '?\ X%6W_P 50 ?\$]_^2)ZM_P!CWK/_ *4F
MO=*\ _X)NZC=:I\!-3N[S2IK*1_&^K,T$Y!92TP8@X[@L5/NIKW^@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!X7_P $]_\ DB>K?]CWK/\ Z4FO=*\+_P"">_\
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MG7ZQAZ]'%4(5J,E*$DFFMFFKIKR:/C*E.I1J2IS5I)M-=FMT%%%%;$!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'A?_!/?_DB>K?]CWK/_I2:]TKPO_@GO_R1/5O^Q[UG_P!*
M37NE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM[2+3TM9KW5MLHV2>ASXK)<#BZ7LY)K6]T_>>^[=V]S\XO\ A@O]K#_HE/\
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M "BBB@ HHHH **** "CIUKC_ (L_'3X=?!JRCD\7:LSWUUQI^C6,?G7EXQ.
ML<0Y.3QDX7/&:X#_ (0?X[_M)_Z1\5;VX\#>#Y>4\*Z7/_Q,;^/TNIA_JU(Z
MQKS@D$ @-791P<IP]K4?)#N^O^%;O\N[1R5<7&$_9TUS3[+IZO9?GV3-?QO^
MT[!<:_+\./@'X:;QIXE3Y;@VLF-/T[MNN+C[HP?X5.201D&OF7XW_L=?M?\
MCWXH:GXNU7PS::]<7WD/-J=A?VEO"Y$$:[$CDE5PJ8\L%E!;9N[YK[;\$> O
M!OPWT"+POX%\.6NF6$/W8+:/&X_WF/5V/=F))[FM>N_"9PLLJ-X2FMK7EJW]
MS5MME\V]&<6*RK^T::6*F][VCHE]Z=_5_*VI^<7_  P7^UA_T2G_ ,KMA_\
M'Z]'_9(_9(_:$^&/[0GA_P <>./A_P#8=+L?M?VJZ_M6TEV;[2:-?ECE9CEG
M4< ]<]*^UJ*Z\1Q7F.(H3I2C"TDT[)]5;^8Y:'#. P]:-6,I7BTUJNCO_*%%
M%%?,GT04444 %%%% !17">,OVB/A[X7U'_A'-(FN/$.M,2(]'T"'[3+N]&*_
M*F.^3D>E8_\ 8O[17Q5^;Q!K,'@32)/^7'2G%QJ,B^C3?=B/NO(Z$5\MB>+<
MO]O+#9?&6*K+1QI6:B^TZC:IP\U*7-;:+/8I9+B?9JKB6J,'LYW3:_NQ2<I>
MJ5N[1UGC_P",7PY^&<87Q;XEABN7 \G3X<RW,I/0+&N6YZ9( ]ZY/_A+OV@/
MBI\G@;PK'X-TF3IJ_B&,27KKZQVPX0_[_![&NG\ ?!'X;_#>0WOA_0%DOWR9
MM6OG,]U(QZDR-R,]PN![5UE8?V7Q)G&N8XCV%-_\NJ#?,_*5=I2_\%1I-?SM
M&GUS*L#_ +K2]I+^>HM/E33:_P# W->2//\ PK^SCX%TC4U\3>,)KOQ5K74Z
MGX@E\[:?]B,_(@!Z#!([&O0  H"J  !P!117NY7DV59+1=/!48TT]79:R?>4
MG[TGYR;?F>=B\=C,?-3Q$W)K:^R79+9+R22"BBBO3.0**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHK\C_ /@IY_P<8CPC\5_"?[//_!-U)?$OD_%K1?#?Q/\
MBRNB?:="T=Y[HJ='MY94,4]Y,D<Q+C*HD3["[;FB /UPHKSO]KKXWP_LT?LJ
M?$K]HF?RB/ O@/5]>1)QE9'M+.6=4(XSN9 N.ISBOSE_95\8_P#!T)^UE^S=
MX(_::\(_'3]E?1=(\>>&[77-)TW7O#>K)>16MQ&)(3*L4,B M&RM\K,,,.:
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MJW8X'B7Q K6UD/\ :1?ORCZ8(]*DLOV=9/%-W'K7QS\;WOBFX1@\>F@FWT^
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MM>HZE63E)[MN[?JV%%%%;F84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%>3_M[>+_'
M7P]_88^-'C[X7S3Q^)M#^$WB/4/#LEMGS%OH=,N)+<ICG<)%3&.] &1\&O\
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MQ4TG&+<(MI.<ND8K=W=KVV5V]$>OD>38O/,QAAJ,79M7=M(KJWZ+[WH>5?\
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M^]-WD_-74>T4(JJBA$4  8  Z4M%%?5GC!1110 4444 %%%% !1110 4444
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MX!?L1_ S1OV<?V9_ $/AOPEH:O\ 8["*>29WD=MTDTLLC,\LCL2S,Q))/8
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MO[$ $&OE7Q?A<8^7**,\6_YH)*E\ZTW&FUWY'.7]T]E9)6H+FQLXT5VEK/\
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MI->Z5X7_ ,$]_P#DB>K?]CWK/_I2:]TH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKS;XC_ +4'
M@#P3K)\$^&;>[\5^*')6+P]X>C\^56_Z:N,K"!WW'('.W%;4:%;$3Y:<;O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWLU!)QQ\[+S@' /-:XN67Y/A7BLUK1HTU_,U%_\ DS2BO.7R3.>C+%8^M[#
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M9?S2_2.C?SLO4X\2_M/?'_\ U*O\,?"\O\;@2ZW=I]/NVN?^^U/]X5W/PK^
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MT)?MWVK[1]JW?/YN[=OSZ[N<^M?CGBIXO3X8Q6!PV7QDJO.IUH3A*G-4X_\
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MI?RE-R<?2'*O(=;.,?5H^PA)0I_R02A'YJ-K^KN_,****^B/,"BBB@ HHHH
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M"L#8_P"^FKY[_:6\&>+_  E\1#<>+_$+ZO-J%K'*FJ&S6 2[0$*[$)52NT#
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M3"]@^C6['\Z /1**\[_X5/\ %[_HXO4?_!';_P"-'_"I_B]_T<7J/_@CM_\
M&@#T2BO._P#A5GQH3B']HZ\ _P!OP[;,?SS1_P *O^-O_1Q]S_X3-M_C0!Z)
M17G?_"K_ (V_]''W/_A,VW^-'_"L_CK'_P >_P"TE*,]?,\)VK_S;B@#T2BO
M._\ A6_Q^_Z.4_\ +.M?_BJ/^%;_ !^_Z.4_\LZU_P#BJ /1**\[_P"%=?M
M1_,G[1B2'^[)X0M@/KPU'_" ?M"_]' 6W_A*0?\ Q5 'HE%>=_\ " ?M"_\
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M[>QL;.!8H;>%%"I&B* J(J@ *    !5F@ HHHH **** "BBB@ HHHH ****
M/"_^">__ "1/5O\ L>]9_P#2DU[I7A?_  3W_P"2)ZM_V/>L_P#I2:]TH **
M** "BBB@ HHHH **** "BBB@ HHHH ***J:[K^A^%]*FUWQ)K%M865NNZ>[O
M)UCCC'J68@"FDY.R$VDKLMUG>*?%WA?P/HLOB+QAK]IIMC /WEU>3B-!Z#)Z
MD]@.3VKRF[_:1\;_ !6NI-"_9<\!-JL0<QS>,==1[?2X#T)0$!YR/10,<'!%
M7?#'[*VC7FL1^.OCYXKN?'6NQ?/&=44)I]F>I$-J/D ]VR#C. :[_J4*&N*E
MR_W5K+[MH_\ ;VODSB>+G6=L-'F_O/2/W_:^6GFC/D^/OQ4^-,C:;^S+X%,>
MFL2K^-_$\+0V8'=K>$C?.?0D8!&&7'-:_@C]E7PGI^MIXZ^+&MW?CGQ*.1J6
MN@-!;GKB"WYCB4'D=2#R"*Z'Q'\=OA'X-8:;<>*[::X7"16&EJ;B3(X"!8P0
MI]CBLK_A:7Q=\7?+\._@Y/:0M]S4?%,XME'H?)7+D>X-*6.E"+AAX\D?+XGZ
MRW^2LO(<<&I24Z[YWY_"O2.WS=WYGHX  P!6-XJ^(G@7P1&9/%GBRQL2!D13
MW \QA[(/F;\!7'7'PO\ B9XCA:[^*7QLN+6VQF6Q\.1K9Q*.X,S?.R_45F6]
MU^R!\)I3<R:SH#WB',D\UQ]ON W<\;V4_0"O!QV:99E=/GQE>%*/><HQ7WR:
M/6P^#Q>,ERT*<IOM%-_D:Q_:!G\2'ROA3\,];\0;ON7KP_9+0_\ ;67^6!1_
MPCW[1GC+G7?&>D^%K5NMMHMJ;FXV^C22<*?=:@'[3NAZN-GP_P#AMXL\09_U
M<]EHS1P'ZR2$;1^%!\:_M.^(AG0OA%HF@QG[L_B'6_/X]2D !'T->#_KMD-7
M_='/$?\ 7FE4J1_\#C%TU\Y)'H_V!F,/XZC3_P <XQ?_ ("WS?<B_I?[-WPX
MANUU7Q4M_P")+X?\O?B"^:X/O\G"X]B#7;V&G:5HED+/3+&WL[:,<101+&BC
MZ# %>0ZK!\2)LGXA?M7Z)HB?QV6B6L$9_"25M_Z5SUYI7[*KSA?&OQ2\0^,+
MC.1%>ZC=7 8^PA55Q[9KR<5QS7INT<-&EYXC$4:7X0=:?R<4_([Z'#<:BO[2
M4_\ KU2J3_&2IQ_&WF>O^(OC;\(_"FX:]\1M(A=?O0K>K)(/^ (2WZ5S1_:G
M\$ZH3'X#\)^)_$I)PKZ1H<AC_%I-N![XK%\.Z]\)=$V_\*X_9DUBY=?]7=IX
M:1 ?^VTAW5T@\??'?5!MT7X&PV2?PS:KKT0_-$&X5Q?ZPYYC?AQ4(KM0PU>N
M_E4=H?-T['3_ &1@</\ %1DW_P!/*U.FO_ -9?=(J_\ "P_VCO$?'ACX&V6D
MQM]RZ\1:VI_.*(;A^='_  @G[2_B/GQ'\:-*T6-OOV_AW1!)GV$DYW+]:M_8
M/VG=7_X^=>\):0AZ?8[6:XD4>_F?*3]*/^%2_%#4SGQ+^T#JS@]4TK3H;3'L
M"N3^-'U''XW^,L=7]:E+#Q^ZE*C.WDT_.X>VPN'^"6&I^D9U7]\XU(_BO(J?
M\,N>%M7^?Q_X[\5>)"?OPZEK;K#] D>W:/;-7K+X>_LU?#C!_L+PM8/'TEU!
MXFD7_@4Q+?K3/^&:_!%[SXG\0^)-:S][^U-<D;=_WQMK3TKX!?!K1L?8_AUI
MK8Z?:HC/_P"C"U=.$X9E0J^UH95AH3_GJ3=2I\W[)M_^##&MFM*<.2KC:TE_
M+&*A'_TM+_R0JWW[1/P0T11:CQQ:/M^5(K&"2;\!Y:D56_X:)TB_.WPQ\.?%
MNK9^[)::(PC_ !9R,#\*[?3/#^@Z*NS1M$M+08QBVMEC_P#00*MU]&L%Q155
MIXNG!=H47?[YU)+_ ,D1Y;Q&20^&A.3_ +U16^Z,$_\ R8\]_P"%E?&K5>-!
M^ LL*'I/JNN0Q8^J %JJZSI7[3_B_2;G29-1\*:#%=0-$TMMY\UQ&&&"03\H
M.#P1T->F45-3AROBJ;ABL=6FFK-)PIJS[.G"$O\ R:_F..;TJ,E*CAJ<6NK4
MI/\ \GE)?@?"7QE_9]U;X.^(X=#U#6Q=Q7-L)H+Q+4HK\D,N"QY!]^A![UR'
M_"-_]/O_ )#_ /KU]_?$/X;>$_B?H1T'Q98&6-6W031MME@;^\C=C[<@]P:\
MC_X85T3[?YG_  L2Z^R[O]3_ &>OF8]-^_&??;7\U\5> 6+HYM*624%/#R=T
MG4LX=T^>2NET:;=M]3]<R/Q)P%3 )9E-QJQW?+=2\URK1]U9+L>'?!7]GS4/
MC)XGET*VUXV,%O;&:YO?L7FB/G"KMWKDD^_0$]J^G/"W[)?PDTG0K6R\3:&N
MK7\,6RYU$W%Q#YY'\7EB9@IQCH<?3I78_#SX;>$_AAH8T'PG8&*-FW3S2-NE
MG;^\[=S[< =@*WJ_6N _"#AOAC+U+&X:%7$R7ON5YQ6MU&,9WCI_-RJ3N];.
MQ\-Q+QUFF;8QK"594Z*^%)\K?=MQUU[7MMU.&B_9L^!\(PGP^MCQCYYY6_F]
M6HO@%\&8?N?#G3#_ +T.[^9KKZ*_18<,\-T_AP5)>E.'_P B?*RSK.)_%B:C
M_P"WY?YG,P_!CX1P?<^&FAGG/SZ9$W\Q5F'X7_#2WQ]G^'>A)CILTB$?R6MV
MBNF&3913^##TUZ0C_D8RS',)_%6D_P#MY_YF7%X(\&0<0>$=+3C'R6$8X_[Y
MJU%H6B0?ZG1K5/\ =MU']*M45U0PF%I_#3BO1(PE7KS^*;?S8U(XXAMCC51Z
M*,4ZBBMTDEH9;A1113 **** "BBB@ HHHH **** "BBB@ K!^(?PV\)_$_0C
MH/BRP,L:MN@FC;;+ W]Y&['VY![@UO45SXO"8;'8:6'Q$%.$E9Q:NFO-&M"O
M6PM:-6C)QE'5-:-'@O\ PPKHGV_S/^%B77V7=_J?[/7S,>F_?C/OMKTC2O@'
M\+-*\%MX$'AB*XLY&WS27/S3228QYF\8(;T*XQVQ7945\SEG ?"&3SG+"X."
M<TT[WGH]U[[E9/JE9,]K&\4<09A&,:^(DU%W5K1U6S]U*[7=GF/D?%'X'\VA
MNO%WA:/K"QW:C8)_LG_EL@';K] *[?P9XZ\*_$#2%UOPGK$5U">) IP\3?W7
M4\J?8UKUP_C/X,6FI:NWC7P!JS^'O$(Y-[:K^ZNN^V>/HX/KU[G. *T^HYID
M6N7WK4%_RZD_>BO^G4Y=.T)NW2,XI6(^LX'--,7^[J_\_$O=?^.*_P#2HJ_>
M,GJ=Q17GWA[XSWNBZM%X-^-&D)H6IN=MKJ"L387WO'(?N'_9;IQSDXKT$$$9
M!R#T->QEN;8'-:;E0EK'246FI0?:47K%^JUW5UJ>?C,#B<#-*JM'JFM8R7>+
M6C7IML]0HHHKTCC"BBB@ HHHH **** "BBB@ HHHH **** "J^HZ3I6KP_9]
M6TRWNH_[EQ"KC\B#5BB@#CM:_9]^"^O9-]\.M-0MU-I$;<_^0BM9?_#.&@Z;
M\W@_Q_XKT3'W(K'6F,0]BK@Y'XUZ+10!XW\36^+_ ,%?"%QXN'QQ74+>%E2&
MRU/0XC)*[' 42*<D]3SV4FOES^U]3_M;^WOMTGVS[3]H^T[OG\W=NWY]<\YK
MZ4_:I^'WQH^*6MV6C>#_  DT^CZ?'Y@E.H6\8FG;J=KR X5< 9'4MV->3?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJK.RJ>7_ ."B?_!1)?\ @MC^S5;_ /!,C_@G]\!/BD?%OQ1UK2K?XCZMXO\
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M^7!:WDD,DO0)YT$D 8GLH,@)]A7JG_#NO_JL/_EO_P#W11_P[K_ZK#_Y;_\
M]T5\SF^>^*>9891I\.>SJ0DIPG]<H/EDO*RNI)N$E=<T)2C=7/6P66\'86JW
M/-.:$DU*/L*BNGYW=FG:2=G:23Z'TQ169X,T75?#GA6PT#6]=_M.ZL[589;\
MP>49]HP&*[FP< 9Y.3D]\5IU^S8>I4JT(3J0<)-)N+:;BVM4VFTVMKIM=G8^
M$J1C"I*,9<R3=GKKYZZZ^>H4445L0%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5?5=)TO7=/ETG6=/A
MNK6==LT$\89''N#5BBIG"%2#A-73T:>S7F5&4H24HNS1YG+X!\?_  ?E;4?A
M%<-JNB[BT_A2_G.Z(=2;:4Y*_P"Z?_'CBNH^'_Q4\)_$6&2+2;B2WO[;B]TF
M]3R[FV8<$,A[9[C(_'BNDKE?B!\(O#7CR:/6/,FTS6;;FRUO3F\N>(CH"1]]
M?8]LX(S7S#RK'Y*^?*7S4^M"3M'_ +A2U]F_[CO3Z)0U9[2QV%S%<N/5I_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#PO_@GO_R1/5O^Q[UG_P!*37NE>%_\$]_^
M2)ZM_P!CWK/_ *4FO=* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!X7_P3W_Y(GJW_8]ZS_Z4FO=*\+_X)[_\D3U;
M_L>]9_\ 2DU[I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A
M?_!/?_DB>K?]CWK/_I2:]TKPO_@GO_R1/5O^Q[UG_P!*37NE !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<9XY^#6E>(M3_X2_P *:E+H'B*,9CU:
MP&/-_P!F9.DJGOGGW(XKLZ*X<PRW!9I0]CBH<RW71IK9Q:LXR722::Z,Z<+C
M,3@JOM*,K/;R:[-/1I]4TTSQ3QM^TMXV^%%A)X7\=^#+>3Q$$5K.[MI\V=U$
M21YQ&=Z\@C9W.>5KR[_AKGXW_;_MG]OVOE[L_9?[.B\OZ9QNQ_P*C]KK[?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"V/[-5O_ ,$R/^"?WP$^*1\6_%'6M*M_B/JWB_P'=:79?#_2K>\@N[F2^FE
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_^">_
M_)$]6_['O6?_ $I->Z5X7_P3W_Y(GJW_ &/>L_\ I2:]TH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** $95=2CJ"",$$<$5S'B/X*_"GQ7N;6_ >G.[?
M>FA@\F0_\#CVM^M=117)C,!@<PI^SQ5*-2/:45)?<TS?#XK$X2?/0FX/O%M/
M\#SS_A0+Z)\_P^^*7B/1<?<MC>?:;=?^V<G7\Z/LW[2_AK_4ZGX<\30KU^T0
MO9W#?3;F,5Z'17C?ZK9;1UPDJE#_ *]U)*/_ ( VZ?\ Y(>C_;F,J?[Q&-7_
M !Q3?_@2M/\ \F///^%X>)-"^7X@?!?Q#IP'W[C3E2^A7W+QD8'X&O//CY^U
M;%=Z=!X>^$FL2QM/&6O]0\AXI8><>4H< JW&2PZ<8/6OH:ODK]L'P]J&E?&*
M?6;B)O(U2TAEMI,<'8BQLOU!7./]H>M?GWB;B.*>'^%IU,/C'.$I1A)N"C4C
M%WUYX.,5=I1?[N_O:-'UG!='(\VSR,*N'4913DES-P;5M.67,WNW\739GFW]
MN:W]O_M7^V+K[5NW?:?M#>9GUW9SFOHW]E+X]:YXQNI/A[XUOFNKN* RZ??2
MG+RJOWHW/\3 '(/4@'/2OFBO0OV:?AS)\1/B(+>>>\@LK.UDEN[FQG,3KD%5
M4..A)/3N U?A'AYG>>9=Q5AXX%N;J2490NTII[\V^RUYK.UK]S]0XMRW+,7D
M=5XE*/)&ZE;6+6UMM]K7UN?8U%>>_P##-_A(<KXP\5 ]B-?DR/TH_P"&<] _
MZ*%XQ_\ "@?_ .)K^N?[0XD7_,#'_P '+_Y6?@7U3)_^@E_^"_\ [8]"HKSW
M_AG;25_U'Q/\;1>HC\1,,_FM'_#/-A_T5GQU_P"%&?\ XBC^T>(O^@!?^#H_
M_(A]3RC_ *"G_P""W_F>A45Y[_PSZ.WQM^(7_A2__:Z/^% 3)S#\;_'X/??X
MA#?^R4?VGQ!_T ?^58?Y#^I93_T%?^22/0J*\]_X4+?_ /1<O'7_ (.A_P#$
M4?\ "B]=7Y8_CMXS"CINU%2?SV\T?VIGW7+W_P"#:?\ F'U'*_\ H+7_ (!/
M_(]"HKSW_A1_B-/FB^/'B\-VWWB,/RVT?\*4\7?]%[\4_P#?V/\ ^)H_M;/.
MN72_\&4O_DA?4<L_Z"X_^ 3_ ,CT*BO/?^%,^.4^6+X^^(PO;>D3'\\4?\*<
M\?KRGQ_\09'3=!$1^6*/[7SK_H73_P#!E'_Y8'U#+O\ H,C_ . U/_D3T*BO
M/?\ A47Q,_Z.#UG_ ,%\-'_"I_BJG$/[0NJ =]^DP,:/[8S?_H6U?_ Z'_RT
M/[/R_P#Z#(?^ U?_ )6>A45Y[_PJKXMCD?M#ZC^.B6_^-'_"LOC7_P!'%W'_
M (3-M_C1_;6:K?+*W_@>'_\ EZ'_ &=@/^@VG_X#5_\ E9Z%17GO_"M?CDG^
MH_:-D&>OF>%;9O\ V:C_ (5S\>O^CC__ "S[7_XJC^V\S_Z%E?\ \"PW_P T
M!_9N"_Z#:7W5O_E1Z%17GO\ P@/[0 X'[0$!]SX4@R?_ !ZC_A!?V@H_F3X\
M6DA_NR>%X0/T:C^W,P_Z%M?[\/\ _+P_LS"?]!E+[JO_ ,J/0J*\]_X0O]H?
M_HM>G?\ A-Q_XT?\(E^T8GRK\7=(<#^)M 4$_D:/[>QO7+J__E'_ .7"_LO#
M?]!=+_RI_P#*QOQ\^/FG_!S3X;.SLTO-8O$+6UM(Q"1H#CS'QSC/  QG!Y&*
M\'_X:Y^-_P!O^V?V_:^7NS]E_LZ+R_IG&['_  *L[]HZS\9V'Q1N;7QUK$5_
M>+:P[+J"W\I'C*9&U>V#N'U!KA*_F+CGQ#XJQ/$=:E0K5,/3I2<5"+Y6N71\
MW*_>;>N[CT6FK_:N&>$LCHY13G5IPK2FDW)JZUU]VZT2]$^Y]B? /X^:?\8]
M/FLKVS2SUBS0-<VT;$I(A./,3/.,\$'.,CDYKT2OD/\ 9&^W_P#"[]/^Q[O+
M^RW/VK'3R_*;&?;?L_'%?7E?OGAAQ)F'$_"ZQ&-UJ0FX.5K<UE%J7:]I6=NJ
M;/RSC7)\)DN=NCAM(2BI)=KMJWX77DPHHHK]$/D0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MPO\ X)[_ /)$]6_['O6?_2DU[I7A?_!/?_DB>K?]CWK/_I2:]TH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/=)R;LO2QZV9<1YWFU%4L76<HKIHE\[)7^=PHHHKZ@\0**** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/"_^">__ "1/5O\ L>]9_P#2DU[I7A?_  3W_P"2)ZM_V/>L_P#I2:]TH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /"_\ @GO_ ,D3U;_L>]9_]*37NE>%
M_P#!/?\ Y(GJW_8]ZS_Z4FO=* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MPO\ X)[_ /)$]6_['O6?_2DU[I7A?_!/?_DB>K?]CWK/_I2:]TH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_LC_ /1>M!_[_/\ _$T?\-S_ +(__1>M!_[_ #__ !- 'J]%>4?\-S_LC_\
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M:#_W^?\ ^)H ]7HKRC_AN?\ 9'_Z+UH/_?Y__B:/^&Y_V1_^B]:#_P!_G_\
MB: /5Z*\DF_;O_9#@>.-_CQHI,C84H9& /N0F%'N<5)_PW/^R/\ ]%ZT'_O\
M_P#\30!ZO17E'_#<_P"R/_T7K0?^_P __P 31_PW/^R/_P!%ZT'_ +_/_P#$
MT >KT5Y1_P -S_LC_P#1>M!_[_/_ /$T?\-S_LC_ /1>M!_[_/\ _$T >KT5
MY1_PW/\ LC_]%ZT'_O\ /_\ $T?\-S_LC_\ 1>M!_P"_S_\ Q- 'J]%>4?\
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M7K0?^_S_ /Q- 'J]%>4?\-S_ +(__1>M!_[_ #__ !-'_#<_[(__ $7K0?\
MO\__ ,30!ZO17E'_  W/^R/_ -%ZT'_O\_\ \34:_MW_ +(;7#6H^/&B[E4$
MDF0+@^C;,$^P- 'K=%>4?\-S_LC_ /1>M!_[_/\ _$T?\-S_ +(__1>M!_[_
M #__ !- 'J]%>4?\-S_LC_\ 1>M!_P"_S_\ Q-'_  W/^R/_ -%ZT'_O\_\
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M7K0?^_S_ /Q- 'J]%>4?\-S_ +(__1>M!_[_ #__ !-'_#<_[(__ $7K0?\
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M_LC_ /1>M!_[_/\ _$T >KT5Y1_PW/\ LC_]%ZT'_O\ /_\ $T?\-S_LC_\
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M_P#HG>A?^"B'_P")K=HH PO^%7?#/_HG>A?^"B'_ .)H_P"%7?#/_HG>A?\
M@HA_^)K=HH PO^%7?#/_ *)WH7_@HA_^)H_X5=\,_P#HG>A?^"B'_P")K=HH
M ^=?VI? ?@:P^,OP6MK'P9I,,=UXWE2YCATZ)5E7[,QVL OS#/8U[;_PJ[X9
M_P#1.]"_\%$/_P 34'C?X4^$?B#XB\.>*/$<,[7?A;4FOM),,Y15F*%"6'\0
MP>E=)0!A?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87
M_"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3O0O_  40_P#Q-;M% &%_PJ[X9_\
M1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_
M ,31_P *N^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"K
MOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_]$[T+_P40_\ Q-'_  J[X9_]$[T+
M_P %$/\ \36[10!A?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\
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M)K=HH PO^%7?#/\ Z)WH7_@HA_\ B:/^%7?#/_HG>A?^"B'_ .)K=HH PO\
MA5WPS_Z)WH7_ (*(?_B:/^%7?#/_ *)WH7_@HA_^)K=HH PO^%7?#/\ Z)WH
M7_@HA_\ B:/^%7?#/_HG>A?^"B'_ .)K=HH PO\ A5WPS_Z)WH7_ (*(?_B:
M/^%7?#/_ *)WH7_@HA_^)K=HH PO^%7?#/\ Z)WH7_@HA_\ B:/^%7?#/_HG
M>A?^"B'_ .)K=HH PO\ A5WPS_Z)WH7_ (*(?_B:/^%7?#/_ *)WH7_@HA_^
M)K=HH PO^%7?#/\ Z)WH7_@HA_\ B:/^%7?#/_HG>A?^"B'_ .)K=HH PO\
MA5WPS_Z)WH7_ (*(?_B:/^%7?#/_ *)WH7_@HA_^)K=HH PO^%7?#/\ Z)WH
M7_@HA_\ B:/^%7?#/_HG>A?^"B'_ .)K=HH ^=?VI? ?@:P^,OP6MK'P9I,,
M=UXWE2YCATZ)5E7[,QVL OS#/8U[;_PJ[X9_]$[T+_P40_\ Q-0>-_A3X1^(
M/B+PYXH\1PSM=^%M2:^TDPSE%68H4)8?Q#!Z5TE &%_PJ[X9_P#1.]"_\%$/
M_P 31_PJ[X9_]$[T+_P40_\ Q-;M% &%_P *N^&?_1.]"_\ !1#_ /$T?\*N
M^&?_ $3O0O\ P40__$UNT4 87_"KOAG_ -$[T+_P40__ !-'_"KOAG_T3O0O
M_!1#_P#$UNT4 87_  J[X9_]$[T+_P %$/\ \31_PJ[X9_\ 1.]"_P#!1#_\
M36[10!A?\*N^&?\ T3O0O_!1#_\ $T?\*N^&?_1.]"_\%$/_ ,36[10!A?\
M"KOAG_T3O0O_  40_P#Q-'_"KOAG_P!$[T+_ ,%$/_Q-;M% &%_PJ[X9_P#1
M.]"_\%$/_P 31_PJ[X9_]$[T+_P40_\ Q-;M% &%_P *N^&?_1.]"_\ !1#_
M /$T?\*N^&?_ $3O0O\ P40__$UNT4 87_"KOAG_ -$[T+_P40__ !-'_"KO
MAG_T3O0O_!1#_P#$UNT4 87_  J[X9_]$[T+_P %$/\ \31_PJ[X9_\ 1.]"
M_P#!1#_\36[10!A?\*N^&?\ T3O0O_!1#_\ $T?\*N^&?_1.]"_\%$/_ ,36
M[10!A?\ "KOAG_T3O0O_  40_P#Q->)>!? ?@:7]O3QWI,O@S26M(O!&EO%:
MMIT1C1C(V6"[< GUKZ*KF],^%/A'2/BCJGQ@LX9QK6KZ;!8WKM.3&88B2@"=
MCD]>] $__"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3O0O_  40_P#Q-;M% &%_
MPJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.
M]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG_P!$[T+_ ,%$
M/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_]$[T+_P40_\ Q-'_  J[
MX9_]$[T+_P %$/\ \36[10!A?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0
MO_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3O0O_  40_P#Q
M-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10!A?\
M*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG_P!$
M[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_]$[T+_P40_\
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M36[10!A?\*N^&?\ T3O0O_!1#_\ $T?\*N^&?_1.]"_\%$/_ ,36[10!A?\
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M1TOQ&D";YH;>_M6V?:$0%C$RC P"VYD5OM2OQ=^,G[2_QN_::_X+-_LM2?\
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M;!7@O[?7_!,']E'_ ()R?M ?L,6_P(\.ZGJ'B;Q-^U_H,WC/XA>+M3;4=?\
M$4PGB;S+JZ<#(W$MY:*D>XEMNXDD _;"O)_VV_VTO@5_P3^_9QUW]I_]H?6[
MBU\/Z&L<:6NGP":\U*ZE;9#9VT1(\R:1S@ D* &9F5%9AZQ7YF_\%^L>-/VK
M/V"?@;KR^=X=U_\ :=LM2U:QDYBN9+$P>4CKT8$7$JX/9S0!U_@W_@NKXC\(
M_$;P1X?_ &[?^"<GQ3^ /A+XF:Q#I7@CX@>++NUN]/:]G&;>WU%82'TR20=%
MD!*D,6PJ.Z_?6M:UH_AS1[KQ#XAU:VL-/L;9[B^OKV=8H;>%%+/([L0J*J@D
ML2  "37PW_P<O>#]$\8?\$3?C<NL6R,^EZ?I6I6$S#YH+B'5[-E=#_"2-R9'
M9V'>N[\9_L<?#'_@JY^P'\%/#7[5WB+Q7+H=WHGA[Q7XFT70?$$EA'XCF;2\
MM:7[Q_O);8R7'FLBLC&2*-@PV\@$G_!.W_@KC\ O^"F?QM^-OPV_9QTN>]\.
M?!W4M(LH?&WVL-;>(VO%N]\MO'L!2*.2SD57+-YJLK@*",_5U?EQ_P $,/AG
M\/O@U_P5+_X*#?"KX4>#-.\/>&] \6^![+1=$TBU6"VLX$L-3"QHB@  ?J22
M<DFOU'H ^-/VNO\ @K_8?!3]I^7]AW]E3]DWQQ\??B_IVBQZOXF\,^#9[>SL
MO#MG(JM$U_?7)\N!Y%>-E3:<K(F2"ZAM?]@[_@K+X*_; ^-?BC]DCXK_  !\
M8_!?XU>#]-34]7^&_CE(GDNM/9E47ME<PDQW<(9XP6 7[X(##+#UCPW^SO\
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M'KX;Q>(;OX;>+K;Q1X*DFU&YA73=6MV#0W.R&5%E*E1\DH=#R"I!- 'QK?\
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MB>+KZUU#2?$C1#=):P7]J=BW84AO(=0?F4;MSHK?:E?B-_P<,_\ !4']E?\
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M?_X*0?L5>"_VS_"_@&\\+V/C+^T?(T*_O4N)K;[)J5U8MND155MS6Q<8 P'
M[9KXI^(LW_#[+]HWQA\3)O\ 3/V6?V:1J<?A6)OFM/B-X[@M9 ]__=FL-/W%
M8CRLDK%@71G1?2_^#7'_ )04? WZ^)O_ %)]5H ^_P"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH _/7_@Z,\ >._B;_ ,$;_'WA#X;^"M7\0ZM/K^@-!I>AZ;+=
MW,BKJENS%8XE9B H)) X )KZ7_;[_:F\4_L4_L-^,?VCO _PIU7QMXC\/:%$
MOAWPGI.GS7,VH:A,\=O;HT<(,GE+)*KRE1D1HY'(%>YT4 ?@#_P30_;W^!7[
M/WQ U+]N?]O7]C']K;XL?M/^+?,.M>-)?@IYUAX:MF+!=.T>.2Y3[/"L9V%P
MB,0610B$JWZO6?\ P5'\%Z[_ ,$^=;_X*$^&/V7OC#)IFC2M&/AYJ7A 6OB>
MZ9;R.U)CL_-8$9D\P'?RBL?:OJ"B@#\VO^"V7_!4']J'X)_\$^OAUXF_8J^!
MOC^#QW\==+@GM[RS\'SW]_X'TU[6">ZEFAA5E2^0744*(Y #^:P),6#\^?\
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M\7/!W@[PQ#J&M:2L</EV6JIA//>%!LWJA" 6Y#8,JD?>=% 'X[?MQ_M$Q_\
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M8.-X5BYC1_UQ\ ^"]$^&_@31?AWX9B:/3= TFVT[3T<Y*P01+%&#[[5%:U%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>N_B/^P3\?OBY^SCXN?,EC?_  _\:W,ME%+R09(9G\]T!_@2YC&,@8'%>5_
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ME-GTO0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?[+GP4_;J\8Z[H7[(GC"XU2V\>2Z9K5QIVGZAKXC;[';ZK<V[H\5L"8&!+J
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MD?C+XJZ?X-UJ33KKQ5J5U-$EIITUQ$0ZVRQ3PR[01N_>YPWE.@!^GE%?E?\
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M/B7_ ,$L_AK^TKXT^*OP8L_A%;^+HK?QOKO]J7G@?56NH8EL3<X 02)(S^2
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MH*ZWQW_P<D?\$POA[XW.B:QXJ\<W'A--9;2IOBOIOP^OI_"BW:N8V1;]5Q,
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M_A1_PE'[57_1+/#/_@\;_"O3**\W_5C&?]#3$_?1_P#E)U_VO0_Z!*7W3_\
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M/B'<_;-;\)3V%N91*D^2?)SL'RB.)E,_[H-$KGUCQQ_P;NZ!X#^+/B+XM?\
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M,LEOI5GGND<8F=#GF.9/2OJC_@HO_P H^/CM_P!D:\4?^FFYKT7X5?#/P?\
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MB_P7<>&[O5;%$-S!#+!Y)E0,"I<#D9&,T ?D5X\\GQL/^",/@/XL[;KP)?\
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M7T=G&*>JT>IGB<YSC&4G2Q&)J3B^DIR:^YNP4445] >:%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R?QA
M^ GP+_:&\-+X,^/WP7\)^.='27S4TGQAX<M=3ME?&-XBN8W4-COC-=910!R?
MP?\ @+\#/V>O#3>#/@%\%_"?@?1WE\U])\'^'+73+9GQC<8K9$0MCOC-0^'O
MV<_V>_"7Q6U;X\>%/@3X-TSQQKT0CUSQGI_A>TAU;44 4!9[M(Q-,,(HP[$?
M*/05V5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077299712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Feb. 07, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 29,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Illumina, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0804655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5200 Illumina Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">202-4500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01&#160;par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ILMN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s proxy statement for the 2025 annual meeting of stockholders are incorporated by reference into Items&#160;10 through 14 of Part&#160;III of this Report.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001110803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077582208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San&#160;Diego, California<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937082288128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,127<span></span>
</td>
<td class="nump">$ 1,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">547<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,746<span></span>
</td>
<td class="nump">2,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">419<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,113<span></span>
</td>
<td class="nump">2,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,303<span></span>
</td>
<td class="nump">10,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">827<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Term debt, current portion</a></td>
<td class="nump">499<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,547<span></span>
</td>
<td class="nump">1,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Term debt</a></td>
<td class="nump">1,490<span></span>
</td>
<td class="nump">1,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">339<span></span>
</td>
<td class="nump">620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01&#160;par value, 10 million&#160;shares authorized; no shares issued and outstanding at December&#160;29, 2024 and December&#160;31, 2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01&#160;par value, 320&#160;million&#160;shares authorized; 200&#160;million shares issued and 159&#160;million outstanding at December&#160;29, 2024; 199&#160;million&#160;shares issued and 159&#160;million outstanding at December&#160;31, 2023</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">7,525<span></span>
</td>
<td class="nump">9,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,242)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost; 41&#160;million shares and 40&#160;million shares at December&#160;29, 2024 and December&#160;31, 2023, respectively</a></td>
<td class="num">(3,934)<span></span>
</td>
<td class="num">(3,792)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">5,745<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 6,303<span></span>
</td>
<td class="nump">$ 10,111<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085182608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">320,000,000<span></span>
</td>
<td class="nump">320,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">199,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">159,000,000<span></span>
</td>
<td class="nump">159,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common shares (in shares)</a></td>
<td class="nump">41,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937087558176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 4,372<span></span>
</td>
<td class="nump">$ 4,504<span></span>
</td>
<td class="nump">$ 4,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenue</a></td>
<td class="nump">1,511<span></span>
</td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">1,612<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,861<span></span>
</td>
<td class="nump">2,744<span></span>
</td>
<td class="nump">2,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
<td class="nump">1,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">1,092<span></span>
</td>
<td class="nump">1,612<span></span>
</td>
<td class="nump">1,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible impairment</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">827<span></span>
</td>
<td class="nump">3,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Legal contingency and settlement</a></td>
<td class="num">(456)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expense</a></td>
<td class="nump">3,694<span></span>
</td>
<td class="nump">3,813<span></span>
</td>
<td class="nump">7,151<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(833)<span></span>
</td>
<td class="num">(1,069)<span></span>
</td>
<td class="num">(4,179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(292)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(346)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before income taxes</a></td>
<td class="num">(1,179)<span></span>
</td>
<td class="num">(1,117)<span></span>
</td>
<td class="num">(4,336)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,223)<span></span>
</td>
<td class="num">$ (1,161)<span></span>
</td>
<td class="num">$ (4,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (7.69)<span></span>
</td>
<td class="num">$ (7.34)<span></span>
</td>
<td class="num">$ (28.00)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (7.69)<span></span>
</td>
<td class="num">$ (7.34)<span></span>
</td>
<td class="num">$ (28.00)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Shares used in computing loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">159,000,000<span></span>
</td>
<td class="nump">158,000,000<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">159,000,000<span></span>
</td>
<td class="nump">158,000,000<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,656<span></span>
</td>
<td class="nump">$ 3,787<span></span>
</td>
<td class="nump">$ 3,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">1,017<span></span>
</td>
<td class="nump">1,177<span></span>
</td>
<td class="nump">1,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">716<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="nump">631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">$ 367<span></span>
</td>
<td class="nump">$ 392<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085148176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,223)<span></span>
</td>
<td class="num">$ (1,161)<span></span>
</td>
<td class="num">$ (4,404)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Unrealized gain (loss) on cash flow hedges, net of deferred tax</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (1,200)<span></span>
</td>
<td class="num">$ (1,165)<span></span>
</td>
<td class="num">$ (4,418)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077945872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
<th class="th">
<div>Retained Earnings (Accumulated Deficit) </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jan. 02, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jan. 02, 2022</a></td>
<td class="nump">$ 10,740<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 8,938<span></span>
</td>
<td class="num">$ (93)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 5,485<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="num">$ (3,702)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance (in shares) at Jan. 02, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(4,404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Unrealized loss on cash flow hedges, net of deferred tax</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares', window );">Issuance of common stock, net of repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue', window );">Issuance of common stock, net of repurchases</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jan. 01, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jan. 01, 2023</a></td>
<td class="nump">$ 6,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,755)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Jan. 01, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">ASU 2020-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Unrealized loss on cash flow hedges, net of deferred tax</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares', window );">Issuance of common stock, net of repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue', window );">Issuance of common stock, net of repurchases</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ReclassificationLiabilityAwards', window );">Reclassification of liability-classified awards</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 5,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,792)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="num">(40,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Unrealized loss on cash flow hedges, net of deferred tax</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares', window );">Issuance of common stock, net of repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue', window );">Issuance of common stock, net of repurchases</a></td>
<td class="num">(91)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (142)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation', window );">Spin-Off of GRAIL (see Note 2)</a></td>
<td class="num">$ (2,399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 29, 2024</a></td>
<td class="nump">159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 29, 2024</a></td>
<td class="nump">$ 2,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 7,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="num">$ (1,242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,934)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance (in shares) at Dec. 29, 2024</a></td>
<td class="num">(41,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment To Additional Paid In Capital, Decrease From Deconsolidation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ReclassificationLiabilityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification, Liability Awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ReclassificationLiabilityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Net Of Repurchases, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Net Of Repurchases, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 80: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085203904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Jan. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,223)<span></span>
</td>
<td class="num">$ (1,161)<span></span>
</td>
<td class="num">$ (4,404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">380<span></span>
</td>
<td class="nump">366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(112)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GainLossOnStrategicInvestmentsNoncash', window );">Net losses on strategic investments</a></td>
<td class="nump">312<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="num">(315)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ContingentValueRightUnrealizedGainLossNoncash', window );">(Gain) loss on Helix contingent value right</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible (IPR&amp;D) impairment</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">827<span></span>
</td>
<td class="nump">3,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment', window );">Property and equipment and right-of-use asset impairment</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">19<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(14)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_IncreaseDecreaseOfOperatingLeasesNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(440)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">28<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">837<span></span>
</td>
<td class="nump">478<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Net purchases of property and equipment</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="num">(286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_PurchasesSalesForStrategicInvestments', window );">Net purchases of strategic investments</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions and intangible assets, net of cash acquired</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(265)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfIntangibleAssets', window );">Cash received for Helix contingent value right</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(178)<span></span>
</td>
<td class="num">(231)<span></span>
</td>
<td class="num">(591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="nump">1,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Payments on debt obligations</a></td>
<td class="num">(750)<span></span>
</td>
<td class="num">(1,235)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities', window );">Payments on contingent consideration liabilities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_CashDeconsolidatedFinancingActivities', window );">GRAIL cash deconsolidated as a result of spin-off</a></td>
<td class="num">(968)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(570)<span></span>
</td>
<td class="num">(1,210)<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">79<span></span>
</td>
<td class="num">(963)<span></span>
</td>
<td class="nump">779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">1,127<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
<td class="nump">2,011<span></span>
</td>
<td class="nump">$ 1,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for operating lease liabilities</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment included in accounts payable and accrued liabilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents', window );">GRAIL net assets, excluding cash and cash equivalents, deconsolidated as a result of spin-off</a></td>
<td class="nump">$ 1,770<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_CashDeconsolidatedFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Deconsolidated Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_CashDeconsolidatedFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ContingentValueRightUnrealizedGainLossNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Value Right, Unrealized Gain (Loss), Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ContingentValueRightUnrealizedGainLossNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_GainLossOnStrategicInvestmentsNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Strategic Investments, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_GainLossOnStrategicInvestmentsNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_IncreaseDecreaseOfOperatingLeasesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Of Operating Leases, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_IncreaseDecreaseOfOperatingLeasesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash Or Par tNon cash Spin off Net Assets Excluding Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property and Equipment and Right-of-Use Asset Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_PurchasesSalesForStrategicInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>(Purchases) Sales For Strategic Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_PurchasesSalesForStrategicInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for financing costs associated with business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085007056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.  ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a provider of sequencing- and array-based solutions, serving customers in the research, clinical and applied markets.&#160;Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Our customers include leading genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;24, 2024, we completed the separation (the Spin-Off) of GRAIL into a new public company through the distribution of 26,547,021 shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The distribution reflected approximately 85.5% of the outstanding common stock of GRAIL as of 5:00 p.m. New York time on June 13, 2024, the record date for the distribution (the Record Date). We retained approximately 14.5% of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL&#8217;s assets, liabilities, results of operations and cash flows have not been reclassified.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_1657" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (GAAP) and include our accounts, our wholly-owned subsidiaries, and majority-owned or controlled companies. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entities (VIEs)</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our ownership, contractual and other interests in entities that are not wholly-owned to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously perform this assessment, as changes to existing relationships or future transactions may result in the consolidation or deconsolidation of a VIE. As of December&#160;29, 2024, there were no VIEs for which we were the primary beneficiary and for which we were required to consolidate. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements requires that management make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures of contingent assets and liabilities. Though macroeconomic factors such as inflation, exchange rate fluctuations and concerns about an economic downturn&#160;present additional uncertainty, we continue to use the best information available to inform our critical accounting estimates. Actual results could differ from those estimates. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year is the 52 or 53&#160;weeks ending the Sunday closest to December&#160;31, with quarters of 13 or 14&#160;weeks ending the Sunday closest to March&#160;31, June&#160;30, September&#160;30, and December&#160;31. References to 2024, 2023, and 2022 refer to fiscal years ended December&#160;29, 2024, December&#160;31, 2023, and January&#160;1, 2023, respectively, which were all 52 weeks.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Functional Currency</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. dollar is the functional currency of our international operations. We re-measure foreign subsidiaries&#8217; monetary assets and liabilities to the U.S. dollar and record the net gains or losses resulting from re-measurement in other expense, net in the consolidated statements of operations.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customers</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact our operating results. A portion of our customers consist of university and research institutions that management believes are, to some degree, directly or indirectly supported by the United States Government. A significant change in current research funding, particularly with respect to funding of the U.S. National Institutes of Health or targeted cancellations by the U.S. federal government of certain grants or contracts, could have an adverse impact on future revenues and results of operations.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48%, 48%, and 50% of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53% and 55% of our gross trade accounts receivable balance as of December&#160;29, 2024 and December&#160;31, 2023, respectively.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no customers that provided more than 10% of total consolidated revenue in 2024, 2023, and 2022. We perform regular reviews of customer activity and associated credit risks and do not require collateral or enter into netting arrangements. Historically, we have not experienced significant credit losses from accounts receivable. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to risks related to our financial instruments, including cash and cash equivalents, investments, and accounts receivable. Most of our cash and cash equivalents as of December&#160;29, 2024 were deposited with U.S. financial institutions, either domestically or with their foreign branches. Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase. There is no limit to the percentage of the portfolio that may be maintained in debt securities, U.S.&#160;government-sponsored entities, U.S.&#160;Treasury securities, and money market funds. Historically, we have not experienced significant credit losses from financial instruments. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Suppliers</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require customized products and components that currently are available from a limited number of sources. We source certain key products and components included in our products from single vendors. Historically, we have not experienced significant issues sourcing materials to build our products.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report segment information based on the management approach, which designates the internal reporting used by the Chief Operating Decision Maker (CODM) for making decisions and assessing performance as the source of our reportable segments. Our CODM allocates resources and assesses the performance of segments using information about their revenue and net income (loss). Our CODM does not evaluate our segments using asset information. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2024</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard requires a company to disclose incremental segment information on an annual and interim basis, including significant segment expenses and measures of profit or loss that are regularly provided to the CODM. The standard does not change how an entity identifies its operating segments. The standard was effective for us beginning in fiscal year 2024 and interim periods within fiscal year 2025. We adopted the standard on its effective date in fiscal year 2024 and applied the amendments retrospectively to all prior periods presented in the consolidated financial statements. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_136" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">12. Segment and Geographic Information</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2022</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options (Subtopic 470-20)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard reduces the number of accounting models for convertible debt instruments, amends the accounting for certain contracts in an entity&#8217;s own equity, and modifies how certain convertible instruments and contracts that may be settled in cash or shares impact the calculation of diluted earnings per share. Specifically, the guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments and requires the use of the if-converted method to calculate diluted earnings per share. We adopted the standard on its effective date in the first quarter of 2022 using a modified retrospective approach by recognizing a cumulative-effect adjustment to retained earnings on January 3, 2022. As a result of the adoption of ASU 2020-06, we increased retained earnings and decreased additional paid-in capital by $61&#160;million and $93&#160;million, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Pending Adoption</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses -</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard requires a company to provide disaggregated disclosures, in the notes to the financial statements, of specified categories of expenses that are included in line items on the face of the income statement. The standard is effective for us beginning in fiscal year 2027 and interim periods within fiscal year 2028, with early adoption permitted. The new standard is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2024-03 on the consolidated financial statements and related disclosures.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) - Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard requires a company to expand its existing income tax disclosures, specifically related to the rate reconciliation and income taxes paid. The standard is effective for us beginning in fiscal year 2025, with early adoption permitted, and is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2023-09 on the consolidated financial statements and related disclosures.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated from the sale of products and services. Product revenue consists of sales of instruments and consumables used in genetic analysis. Service and other revenue consists of revenue generated from genotyping and sequencing services, instrument service contracts, development and licensing agreements, and, prior to the Spin-Off of GRAIL on June&#160;24, 2024, cancer detection testing services related to the GRAIL business.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of our products and services is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. Revenue recognition for contracts with multiple deliverables is based on the separate satisfaction of each distinct performance obligation within the contract. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of a good or service to the customer, meaning the customer has the ability to use and obtain the benefit of the good or service. The contract price is allocated to each performance obligation in proportion to its standalone selling price. We determine our best estimate of standalone selling price using average selling prices over a rolling 12-month period coupled with an assessment of current market conditions. If the product or service has no history of sales or if the sales volume is not sufficient, we rely upon prices set by management, adjusted for applicable discounts.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized generally upon delivery to the end customer, which is when control of the product is deemed to be transferred. Invoicing typically occurs upon shipment and payment is typically due within 30 days from invoice. In instances where right of payment or transfer of title is contingent upon the customer&#8217;s acceptance of the product, revenue is deferred until all acceptance criteria have been met. Revenue from genotyping and sequencing services, including cancer detection testing services related to the GRAIL business, is recognized when earned, which is generally at the time the genotyping or sequencing analysis data is made available to the customer. Revenue from instrument service contracts is recognized as the services are rendered, typically evenly over the contract term. Revenue from development and licensing agreements generally includes upfront and periodic licensing fees, contract research and development services, or payments for development and regulatory milestones.  Revenue for these agreements is recognized when each distinct performance obligation is satisfied.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of discounts, distributor commissions, and sales taxes collected on behalf of governmental authorities. Employee sales commissions are recorded as selling, general and administrative expense when incurred as the amortization period for such costs, if capitalized, would have been one year or less.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain markets, products and services are sold to customers through distributors. In most sales through distributors, the product is delivered directly to customers by us. The terms of sales transactions through distributors are consistent with the terms of direct sales to customers. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss per Share</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic loss per share is computed based on the weighted average number of common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. In loss periods, basic and diluted loss per share are identical since the effect of potentially dilutive common shares is antidilutive and therefore excluded. Potentially dilutive common shares from equity awards are determined using the average share price for each period under the treasury stock method. In addition, proceeds from exercise of equity awards and the average amount of unrecognized compensation expense for equity awards are assumed to be used to repurchase shares. Potentially dilutive common shares issuable upon conversion of convertible senior notes are determined using the if-converted method. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average shares used to calculate basic and diluted loss per share were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:60.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in calculating basic loss per share</span></div></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in calculating diluted loss per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity awards</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded due to antidilutive effect</span></div></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of assets and liabilities are based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize use of observable inputs and minimize use of unobservable inputs. We use a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:</span></div><div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;1&#160;&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Quoted prices in active markets for identical assets or liabilities.  </span></div><div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;2&#160;&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Inputs, other than Level&#160;1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.  </span></div><div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;3&#160;&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate the related fair values due to the short-term maturities of these instruments.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents and Investments</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are comprised of short-term, highly-liquid investments with original maturities of 90 days or less.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have strategic investments in privately-held companies (non-marketable equity securities) and publicly traded companies (marketable equity securities). Our marketable equity securities are measured at fair value. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Equity investments are classified as current, short-term investments, or noncurrent, recorded in other assets, based on the nature of the securities and their availability for use in current operations. Realized and unrealized gains and losses on our equity investments are recorded in other expense, net in the consolidated statements of operations. Our equity investments are assessed for impairment quarterly. Impairment losses, equal to the difference between the carrying value and the fair value of the investment, are recorded in other expense, net. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the equity method to account for investments through which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded in other assets, and our share of net income or loss is recognized on a one quarter lag in other expense, net.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. Receivables are considered past due based on the contractual payment terms. We reserve a percentage of our trade receivable balance based on collection history and current economic trends that we expect will impact the level of credit losses over the life of our receivables. These reserves are re-evaluated on a regular basis and adjusted, as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost or net realizable value, on a first-in, first-out basis. Inventory includes raw materials and finished goods that may be used in the research and development process, and such items are expensed as consumed or capitalized as property and equipment and depreciated. Inventory write-downs for slow-moving, excess, and obsolete inventories are estimated based on product life cycles, quality issues, historical experience, and usage forecasts.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, using the straight-line method. Depreciation of leasehold improvements is recorded over the shorter of the lease term or the estimated useful life of the related assets. Maintenance and repairs are expensed as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred to develop internal-use software during the application development stage are recorded at cost as computer software. Costs incurred in the development of such internal-use software, including external direct costs of materials and services and applicable compensation costs of employees devoted to specific software application development, are capitalized. Costs incurred outside of the application development stage are expensed as incurred.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of the major classes of property and equipment are generally as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 9 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></div></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have various non-cancellable operating lease agreements for office, lab, manufacturing, and distribution facilities. These leases have remaining lease terms of 1 year to 14 years, which represent the non-cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised. We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from 2 years to 20 years. Our lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms, as well as payments for common-area-maintenance and administrative services. We often receive customary incentives from our landlords, such as reimbursements for tenant improvements and rent abatement periods, which effectively reduce the total lease payments owed for these leases. Leases are classified as operating or financing at commencement. As of December&#160;29, 2024, we do not have any financing leases.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and liabilities on our consolidated balance sheets represent the present value of our remaining lease payments over the remaining lease terms, less any impairments recorded for right-of-use assets. We do not allocate lease payments to non-lease components; therefore, fixed payments for common-area-maintenance and administrative services are included in our operating lease right-of-use assets and liabilities. We use our incremental borrowing rate to calculate the present value of our lease payments, as the implicit rates in our leases are not readily determinable. Operating lease costs consist primarily of the fixed lease payments included in our operating lease liabilities and are recorded on a straight-line basis over the lease terms. We sublease certain real estate to third parties and this sublease income is also recorded on a straight-line basis.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the acquisition method of accounting, we allocate the fair value of the total consideration transferred to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the date of acquisition. These valuations require us to make estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill. Costs that we incur to complete the business combination, such as legal and other professional fees, are expensed as they are incurred.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain acquisitions, contingent consideration can be earned by the sellers upon completion of certain future performance milestones. In these cases, a liability is recorded on the acquisition date, as a component of accrued liabilities and/or other long-term liabilities, for an estimate of the acquisition-date fair value of the contingent consideration. These estimates require management judgment, including probabilities of achieving certain future milestones. Changes in the fair value of the contingent consideration subsequent to the acquisition date are recognized in selling, general and administrative expense in our consolidated statements of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the initial accounting for a business combination is incomplete by the end of a reporting period that falls within the measurement period (not to exceed a year from the date of acquisition), we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. We record these adjustments to the provisional amounts with a corresponding offset to goodwill. Any adjustments identified after the measurement period are recorded in the consolidated statements of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill, Intangible Assets and Other Long-Lived Assets</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired, including intangible assets and capitalized in-process research and development (IPR&amp;D), and liabilities assumed are measured at fair value as of the acquisition date. Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of the net assets acquired. Intangible assets acquired in a business combination that are used for IPR&amp;D activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project (i.e., upon commercialization), the IPR&amp;D asset is amortized over its estimated useful life. If the relevant research and development project is abandoned, the IPR&amp;D asset is expensed in the period of abandonment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and IPR&amp;D are not amortized; however, they are reviewed for impairment at least annually during the second quarter, or more frequently if an event occurs indicating the potential for impairment. Goodwill and IPR&amp;D are considered to be impaired if the carrying value of the reporting unit or IPR&amp;D asset exceeds its respective fair value.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with our reporting structure and availability of discrete financial information. During the goodwill impairment review, we assess qualitative factors to determine whether it is more likely than not that the fair values of our reporting units are less than the carrying amounts, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and our overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair values of our reporting units are less than the carrying amounts, then no additional assessment is deemed necessary. Otherwise, we proceed to compare the estimated fair values of the reporting units with the carrying values, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, we record an impairment loss based on the difference. We may elect to bypass the qualitative assessment in a period and proceed to perform the quantitative goodwill impairment test.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D impairment test is performed by comparing the fair value of the asset to its carrying amount. When testing indefinite-lived intangibles for impairment, we may assess qualitative factors to determine whether it is more likely than not that the asset is impaired. Alternatively, we may bypass this qualitative assessment and perform a quantitative impairment test. If the IPR&amp;D asset is impaired, the carrying value of the IPR&amp;D is written down to the revised fair value with the related impairment charge recognized in the period in which the impairment occurs. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our identifiable intangible assets with a finite life are typically comprised of acquired developed technologies, licensed technologies, customer relationships, license agreements, and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#8217; respective estimated useful lives.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform regular reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss in an amount equal to the excess of the carrying value over the fair value. Factors that may indicate potential impairment include a significant decline in our stock price and market capitalization compared to the net book value, significant changes in the ability of a particular asset to generate positive cash flows for our strategic business objectives, and the pattern of utilization of a particular asset.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review our operating lease right-of-use assets for impairment whenever events or changes in circumstances indicate the carrying value of the right-of-use asset may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. We consider a triggering event to reassess a right-of-use asset&#8217;s asset group to have occurred if we exit a portion of or the full facility or enter into a sublease. Factors that may indicate potential impairment include a significant decrease in the market price of an underlying leased asset group. If we conclude the carrying value of affected assets will not be recovered, we estimate the fair value of the assets and record an impairment in an amount equal to the excess of the carrying value over the fair value.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign exchange rate risks in the normal course of business and use derivative financial instruments to partially offset this exposure. We do not use derivative financial instruments for speculative or trading purposes. Foreign exchange contracts are carried at fair value in other current assets, other assets, accrued liabilities, or other long-term liabilities, as appropriate, on the consolidated balance sheets. The cash flows associated with such foreign exchange contracts, or derivative financial instruments, are classified as cash flows from operating activities in the consolidated statements of cash flows, which is the same category as the hedged transaction.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these derivatives are recognized in other expense, net, along with the re-measurement gain or loss on the foreign currency denominated assets or liabilities. As of December&#160;29, 2024, we had foreign exchange forward contracts in place to hedge exposures in the euro, Japanese yen, Australian dollar, Canadian dollar, Singapore dollar, Chinese Yuan Renminbi, and British pound. As of December&#160;29, 2024 and December&#160;31, 2023, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases were $477 million and $926 million, respectively. In September 2024, as a result of the European Commission withdrawing its previously imposed fine, the related forward contracts we previously entered into for a total notional amount of &#8364;432&#160;million were terminated.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other comprehensive income (loss) and are reclassified to revenue in the same period the underlying hedged transactions are recorded. We regularly review the effectiveness of our cash flow hedges and consider them to be ineffective if it becomes probable that the forecasted transactions will not occur in the identified period. Changes in fair value of the ineffective portions of our cash flow hedges, if any, are recognized in other expense, net. As of December&#160;29, 2024, we had foreign currency forward contracts in place to hedge exposures associated with forecasted revenue transactions denominated in the euro, Japanese yen, Australian dollar, Canadian dollar, and Chinese Yuan Renminbi. As of December&#160;29, 2024 and December&#160;31, 2023, the total notional amounts of outstanding cash flow hedge contracts in place for these foreign currency purchases were $621 million and $628 million, respectively. We reclassified $15&#160;million, $18&#160;million, and $53&#160;million to revenue in 2024, 2023, and 2022, respectively. As of December&#160;29, 2024, the fair value of foreign currency forward contracts was $27&#160;million, recorded in total assets. As of December&#160;31, 2023, the fair value of foreign currency forward contracts recorded in total assets and total liabilities was $5 million and $9 million, respectively. Estimated gains reported in accumulated other comprehensive income (loss) expected to be reclassified into earnings within the next 12 months are $27 million as of December&#160;29, 2024. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranties</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally provide a one-year warranty on instruments. Additionally, we provide a warranty on consumables through the expiration date, which generally ranges from <span style="-sec-ix-hidden:f-489">six</span> to twelve months after the manufacture date. At the time revenue is recognized, an accrual is established for estimated warranty expenses based on historical experience as well as anticipated product performance. We periodically review the warranty reserve for adequacy and adjust the warranty accrual, if necessary, based on actual experience and estimated costs to be incurred. Warranty expense is recorded as a component of cost of product revenue.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is incurred related to restricted stock, employee stock purchase plan (ESPP), stock options, and, prior to the GRAIL Spin-Off on June&#160;24, 2024, cash-based equity incentive awards. Forfeitures are accounted for, as incurred, as a reversal of share-based compensation expense related to awards that will not vest.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock units (RSU) and performance stock units (PSU) are both considered restricted stock. The determination of the amount of share-based compensation expense for our PSU requires the use of certain estimates and assumptions that affect the amount of share-based compensation expense recognized in our consolidated statements of operations. The fair value of restricted stock and performance stock units that do not include a market condition is determined by the closing market price of our common stock on the date of grant. PSU that do not include a market condition represent a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any increase or decrease in share-based compensation expense resulting from an adjustment in the estimated shares to be released is treated as a cumulative catch-up in the period of adjustment. The fair value of performance stock units that include a market condition is determined on the date of grant using a Monte Carlo simulation, which includes assumptions for expected volatility, risk-free interest rate and dividend yield. These unobservable inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. Share-based compensation expense is recognized based on the fair value on a straight-line basis over the requisite service periods of the awards. Compensation expense for PSU that include a market condition is recognized over the requisite service period regardless of whether the market conditions are achieved.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchased under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. The expected volatility is generally determined by weighing the historical and implied volatility of our common stock. The historical volatility is generally commensurate with the estimated expected term. The implied volatility is calculated from the implied market volatility of exchange-traded call options on our common stock. The expected term is generally based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be 0% given that we have never declared or paid cash dividends on our common stock and do not anticipate paying such cash dividends. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash-based equity incentive awards were classified as liability awards, as such awards were to be settled in cash. In connection with the Spin-Off of GRAIL, these awards were assumed by GRAIL. For purposes of valuation and performance measurement of the awards, GRAIL&#8217;s stand-alone value calculation, as estimated by GRAIL based on its analysis and on input from independent valuation advisors and analyses, was used. The fair value of the awards was recorded over the respective vesting periods of the awards, with recognition of a corresponding liability recorded in accrued liabilities in the consolidated balance sheets. The awards were remeasured to fair value at each reporting date until the awards were settled, with changes in fair value recognized in share-based compensation expense.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Expenses</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling expenses are included in cost of product revenue.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include personnel expenses, contractor fees, facilities-related costs, material costs, and license fees. Expenditures relating to research and development are expensed in the period incurred.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are expensed as incurred and were $37 million, $36 million, and $53 million in 2024, 2023, and 2022, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and accrue liabilities associated with employee separation costs, which primarily consist of severance pay and other separation costs such as outplacement services and benefits, at fair value as of the date the plan is approved and when such costs are reasonably estimable. The fair value measurement of restructuring related liabilities requires certain assumptions and estimates to be made, such as the retention period of certain employees. It is our policy to use the best estimates based on facts and circumstances available at the time of measurement, review the assumptions and estimates periodically, and adjust the liabilities when necessary.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise, we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.  </span></div>The impact of a tax position is recognized in the consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected in income tax expense.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084968528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GRAIL SPIN-OFF<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">GRAIL SPIN-OFF</a></td>
<td class="text"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.  GRAIL SPIN-OFF</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 24, 2024, we completed the Spin-Off of GRAIL into a separate, independent publicly traded company through the distribution of 26,547,021 shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The GRAIL common stock distributed in the Spin-Off consisted of approximately 85.5% of the outstanding common stock of GRAIL as of the Record Date. The Spin-Off was structured as a tax-free spin-off and Illumina stockholders received one share of GRAIL common stock for every six shares of Illumina common stock held on the Record Date. We retained approximately 14.5% of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL&#8217;s assets, liabilities, results of operations and cash flows have not been reclassified. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Spin-Off, we contributed to GRAIL an amount, in cash, to cover 2.5 years of GRAIL&#8217;s operations (the Disposal Funding), which was determined to be $974&#160;million, less the cash and cash equivalents held by GRAIL.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of GRAIL&#8217;s assets and liabilities included as part of the disposal group were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long term-liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL net assets</span></div></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,738&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of GRAIL net assets recorded to short-term investments</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of GRAIL net assets recorded to additional paid-in capital</span></div></td><td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional adjustments recorded to additional paid-in capital as a result of the GRAIL Spin-Off:</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-contingent indemnification liability (see </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_118" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax adjustment for difference between the book and tax values of our retained investment in GRAIL</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recorded to additional paid-in capital as a result of the GRAIL Spin-Off</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Includes IPR&amp;D with a carrying value of $140&#160;million after impairment. Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">5. Goodwill, Intangible</a><a href="#i64df1cccf2dd452496bdff4e9d30a288_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"> Assets, and Acquisitions</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_136" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">12. Segment and Geographic Information</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for GRAIL&#8217;s results of operations, prior to the Spin-Off, included in our consolidated statements of operations for the periods presented within.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In planning for and executing the Spin-Off, we incurred $53&#160;million and $17&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in separation-related transaction costs in 2024 and 2023, respectively, recognized in selling, general, and administrative expense. The costs primarily related to financial advisory, legal, regulatory and other professional services fees directly related to the Spin-Off. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Spin-Off, Illumina and GRAIL entered into various agreements to effect the Spin-Off and provide a framework for GRAIL&#8217;s relationship with Illumina after the Spin-Off, including a separation and distribution agreement, an employee matters agreement, a tax matters agreement, an amended supply and commercialization agreement and a stockholder&#8217;s and registration rights agreement (the Agreements). The Agreements determine the treatment of the assets, employees, liabilities and obligations (including certain tax-related assets and liabilities) of Illumina attributable to periods prior to, at and after GRAIL&#8217;s separation and also govern certain relationships between Illumina and GRAIL after the Spin-Off.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084407120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.  REVENUE</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated from the sale of products and services. Product revenue consists of sales of instruments and consumables used in genetic analysis. Service and other revenue consists of revenue generated from genotyping and sequencing services, instrument service contracts, development and licensing agreements, and prior to the Spin-Off of GRAIL on June&#160;24, 2024, cancer detection testing services related to the GRAIL business. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue by Source</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sequencing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Microarray</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sequencing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Microarray</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sequencing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Microarray</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,858</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">297</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,155</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,790&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,083&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,225&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">484</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">314</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,787&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,628&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,953&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">651</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">716</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,993</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">379</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,372</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,112&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,504&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,584&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue by Geographic Area</span></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Based on region of destination (in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,441</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,185</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">308</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific, Middle East and Africa</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">438</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,372</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,504&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,584&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">We implemented a new global commercial structure in Q1 2023 to improve operating efficiencies and better align with local markets. We integrated Asia-Pacific and Japan with emerging markets across the Middle East, Africa, Turkey, and Commonwealth of Independent States (CIS). Beginning in Q1 2023, and going forward, we report regional results for the following regions: Americas, Europe, Greater China, and Asia-Pacific, Middle East and Africa (AMEA). Prior period amounts have been reclassified to conform to this new presentation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">Americas revenue included United States revenue of $2,288&#160;million, $2,359&#160;million, and $2,290&#160;million in 2024, 2023 and 2022, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">Region includes revenue from China, Taiwan, and Hong Kong.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">Region includes revenue from Russia and Turkey.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly enter into contracts with multiple performance obligations. These contracts are believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The timing of shipments depends on several factors, including agreed upon shipping schedules, which may span multiple quarters. Most performance obligations are generally satisfied within a short time frame, approximately <span style="-sec-ix-hidden:f-594">three</span> to six months, after the contract execution date. As of December&#160;29, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations was $657 million, of which approximately 78% is expected to be converted to revenue in 2025, approximately 10% in the following twelve months, and the remainder thereafter.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets, which consist of revenue recognized and performance obligations satisfied or partially satisfied in advance of customer billing, as of December&#160;29, 2024 and December&#160;31, 2023, were $16 million and $18 million, respectively, all of which were short-term and recorded in prepaid expenses and other current assets.</span></div>Contract liabilities, which consist of deferred revenue and customer deposits, as of December&#160;29, 2024 and December&#160;31, 2023, were $327 million and $329 million, respectively, of which the short-term portions of $260 million and $252 million, respectively, were recorded in accrued liabilities and the remaining long-term portions were recorded in other long-term liabilities. Revenue recorded in 2024 included $245 million of previously deferred revenue that was included in contract liabilities as of December&#160;31, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084984208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">INVESTMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.  INVESTMENTS AND FAIR VALUE MEASUREMENTS</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategic Investments</span></div><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Equity Securities</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of marketable equity securities. As of December&#160;29, 2024 and December&#160;31, 2023, the fair value of our marketable equity securities totaled $93 million and $6 million, respectively. The increase in our marketable equity securities relates to the investment we retained in GRAIL subsequent to the Spin-Off, which was initially recorded as $397 million, representing 14.5% of GRAIL&#8217;s net assets disposed of at Spin-Off. Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_1657" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details. We recorded an unrealized loss of $309 million in 2024, subsequent to the Spin-Off, based on the fair value of our investment in GRAIL as of December&#160;29, 2024.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and (losses) recognized in other expense, net on marketable equity securities were as follows:</span></div><div style="margin-top:13pt;padding-left:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:66.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) recognized during the period on marketable equity securities</span></div></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(310)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net (losses) recognized during the period on marketable equity securities sold during the period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (losses) recognized during the period on marketable equity securities still held at the reporting date</span></div></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(310)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Marketable Equity Securities</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024 and December&#160;31, 2023, non-marketable equity securities, without readily determinable fair values, included in other assets, were $26 million and $28 million, respectively. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Venture Funds</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $201 million and $168 million as of December&#160;29, 2024 and December&#160;31, 2023, respectively. We recorded a net gain of $5&#160;million in 2024, and net losses of $33&#160;million and $25&#160;million in 2023 and 2022, respectively, in other expense, net.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitments to the Funds are as follows:</span></div><div style="margin-top:13pt;padding-left:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.965%"><tr><td style="width:1.0%"></td><td style="width:36.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital commitments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Callable through date</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remaining callable as of December&#160;29, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fund I</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2026</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fund II</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fund III</span></div></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2034</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Fund I also had recallable distributions of approximately $10&#160;million.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from transactions with our strategic investees was $20 million, $69 million, and $113 million in 2024, 2023, and 2022, respectively. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy&#160;for assets and liabilities measured at fair value on a recurring basis:</span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"><tr><td style="width:1.0%"></td><td style="width:28.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (cash equivalents)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">931</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">931</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helix contingent value right</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,111</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable equity securities are measured at fair value based on quoted trade prices in active markets. Other investments, included in other assets, consist of convertible notes, for which we elected the fair value option. Fair value is derived using a probability-weighted scenario approach. Changes in fair value are recognized in other expense, net. Deferred compensation plan assets consist primarily of investments in life insurance contracts carried at cash surrender value, which reflects the net asset value of the underlying publicly traded mutual funds. We corroborate the fair value of our holdings, comparing valuations obtained from our investment service provider to valuations reported by our asset custodians, validating pricing sources and models, and reviewing key model inputs. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Helix Contingent Value Right</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the deconsolidation of Helix Holdings I, LLC (Helix) in April 2019, we received a contingent value right with a 7-year term that entitled us to consideration dependent upon the outcome of Helix&#8217;s future financing and/or liquidity events. We elected the fair value option to measure the contingent value right received from Helix. Changes in the estimated fair value are recognized in other expense, net. We estimated the fair value of the contingent value right using a Monte Carlo simulation. Estimates and assumptions used in the Monte Carlo simulation included probabilities related to the timing and outcome of future financing and/or liquidity events, assumptions regarding collectability and volatility, and an estimated equity value of Helix. These unobservable inputs represented a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. On July 31, 2024, we received cash of $83 million to settle the contingent value right early. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Helix contingent value right were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received to settle</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(83)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Liabilities</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reassess the fair value of contingent consideration related to acquisitions on a quarterly basis, with changes in the fair value, subsequent to the acquisition date, recognized in selling, general and administrative expense. The contingent value rights issued as part of the GRAIL acquisition entitle the holders to receive future cash payments on a quarterly basis (Covered Revenue Payments) representing a pro rata portion of certain GRAIL-related revenues (Covered Revenues) each year for a 12-year period (through August 2033). As defined in the </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1110803/000095015721000850/ex4-1.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Value Rights Agreement</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, this will reflect a 2.5% payment right to the first $1&#160;billion of revenue each year for 12 years. Revenue above $1&#160;billion each year will be subject to a 9% contingent payment right during this same period. Covered Revenues for the periods Q4 2023 through Q3 2024, Q4 2022 through Q3 2023, and Q4 2021 through Q3 2022 were $117&#160;million, $85&#160;million, and $42&#160;million, respectively, driven primarily by sales of GRAIL&#8217;s Galleri test. Covered Revenue Payments relating to such periods were $1.1 million, $803,000, and $396,000 in 2024, 2023, and 2022, respectively. A portion of the Covered Revenue Payments in 2022 were applied to reimburse us for certain expenses. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our contingent consideration liability related to GRAIL was $71&#160;million and $387&#160;million as of December&#160;29, 2024 and December&#160;31, 2023, respectively, of which $70&#160;million and $385&#160;million, respectively, was included in other long-term liabilities, with the remaining balances included in accrued liabilities. We use a Monte Carlo simulation to estimate the fair value of the GRAIL contingent consideration liability. Estimates and assumptions used in the Monte Carlo simulation include forecasted revenues for GRAIL, a revenue risk premium, a revenue volatility estimate, an operational leverage ratio and a counterparty credit spread. These unobservable inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. Subsequent to the Spin-Off, we no longer have access to GRAIL management&#8217;s forecasts. Therefore, we must rely on information made public by GRAIL&#8217;s management and, beginning in Q4 2024, information published in analyst reports to estimate forecasted revenues through August 2033. In August 2024, GRAIL publicly announced a corporate restructure, including a reduction in headcount and planned hires and a substantial decrease in certain R&amp;D projects and investments. To estimate the liability as of December&#160;29, 2024, we selected a revenue risk premium of 9%, which was derived from reconciling our forecasted revenues for GRAIL to GRAIL&#8217;s market capitalization based on a 60-day trailing average. The significant decrease in the contingent consideration liability from December&#160;31, 2023 was due to a decrease in the forecasted revenues, following revised revenue projections announced by GRAIL in May 2024 and the restructuring announcement in August 2024.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in estimating the fair value of the contingent consideration liability related to GRAIL are inherently subject to uncertainty and we note that small changes in these assumptions could have a significant impact on the concluded value. For example, an increase or decrease of 20%, in each year, to the forecasted revenues would have resulted in an increase of $17&#160;million and a decrease of $18&#160;million, respectively, in the liability as of December&#160;29, 2024. Additionally, an increase or decrease of 250 basis points to the selected revenue risk premium would have resulted in a decrease of $12&#160;million and an increase of $15&#160;million, respectively. We expect certain levels of volatility in the GRAIL contingent consideration liability are possible in future periods.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the estimated fair value of our contingent consideration liabilities were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">387</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(315)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937261580528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS</a></td>
<td class="text"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.  GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(712)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,545</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,466)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"> The balance as of January&#160;1, 2023 includes accumulated impairment of $3,914&#160;million related to our GRAIL reporting unit.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2024 Impairment of Goodwill</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is reviewed for impairment annually, during the second quarter of our fiscal year, or more frequently if an event occurs indicating the potential for impairment. In May 2024, we performed our annual goodwill impairment test for our two reporting units: Core Illumina and GRAIL. We performed a quantitative test for both reporting units. GRAIL&#8217;s carrying value exceeded its fair value, estimated as $580&#160;million, and we recorded a goodwill impairment of $1,466&#160;million in Q2 2024. There was no impairment for Core Illumina, as its fair value exceeded its carrying value.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the investment bankers&#8217; enterprise value estimates included estimated revenues for a two year period based on assumed growth rates and implied revenue multiples for comparable companies. These estimates and assumptions represent a Level 3 measurement as they are supported by little or no market activity and reflect our own assumptions in measuring fair value. An increase in estimated enterprise values for GRAIL of 100% would still have resulted in a full impairment of goodwill. In prior periods, we used a combination of both an income (discounted cash flow) and market approach to determine the fair value of GRAIL. The income approach utilized estimated cash flows for GRAIL based on a long-range plan, for a 15 year period, which contemplated FDA approval. Based on this approach, in Q3 2023, we estimated the fair value of GRAIL to be $3.6&#160;billion and using this same approach in Q4 2023 suggested no further decrement in fair value. Initial analyst coverage of GRAIL from December 2023 into the spring of 2024 suggested that GRAIL could be valued between $3&#160;billion and $4&#160;billion. By May 2024, prior to the consummation of the GRAIL Spin-Off, additional information about GRAIL had become available in GRAIL&#8217;s amended Form 10 filings and a publicly available management presentation, which included updated disclosure about GRAIL&#8217;s business and anticipated near term financial trends. Prior to the consummation of the GRAIL Spin-Off, the amount of GRAIL&#8217;s Disposal Funding, $974&#160;million, was also disclosed. Analyst and banker valuation estimates then began to estimate fair values between $400&#160;million and $770&#160;million, consistent with the impairment recorded in Q2 2024.     </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the fair value of Core Illumina, we used a combination of both an income and market approach consistent with prior periods. The income approach utilized estimated discounted cash flows for the reporting unit, while the market approach utilized comparable company information. Estimates and assumptions used in the income approach included projected cash flows and a discount rate and represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated GRAIL&#8217;s IPR&amp;D intangible asset for potential impairment, in May 2024, as part of our annual test. We also concluded that the when-issued trading activity for GRAIL&#8217;s common stock, in June 2024, represented a triggering event that required an additional impairment test be performed. The carrying value of the IPR&amp;D asset exceeded its estimated fair value and we recorded an impairment of $420&#160;million in Q2 2024. The fair value of GRAIL&#8217;s IPR&amp;D was determined by the income approach, using a discounted cash flow model. Estimates and assumptions used in the income approach, which represent a Level 3 measurement, included projected cash flows and a discount rate of 46.5%. The discount rate was derived from reconciling GRAIL&#8217;s long-range plan, which contemplated FDA approval and estimated cash flows for a 15 year period, to observed market values of GRAIL based on when-issued trading activity. An increase of 300 basis points to the discount rate used in our analysis would have resulted in additional impairment of $20&#160;million. There is substantial risk inherent in forecasting revenues and spend associated with research and development, including assumptions around the timing and level of resources and investment to be made, which were made more challenging in light of the Spin-Off and related Disposal Funding.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a recoverability test for GRAIL&#8217;s definite-lived intangible assets, which included developed technology and trade name, noting no impairment. No impairment was noted for Core Illumina definite-lived intangible assets.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Impairment of Goodwill</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q3 2023, we concluded that the sustained decrease in the Company&#8217;s stock price and overall market capitalization during the quarter was a triggering event indicating the fair values of our reporting units might be less than their carrying amounts and that an interim impairment test was required. Based on our analysis, we concluded GRAIL&#8217;s carrying value exceeded its fair value and recorded a goodwill impairment of $712&#160;million, primarily due to the decrease in the Company&#8217;s consolidated market capitalization and a higher discount rate selected for the fair value calculation of GRAIL. There was no impairment for Core Illumina, as its fair value exceeded its carrying value.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed our interim goodwill impairment test using a combination of both an income and a market approach to determine the fair value of each reporting unit. The income approach utilized the estimated discounted cash flows for each reporting unit, while the market approach utilized comparable company information. Estimates and assumptions used in the income approach included projected cash flows for both GRAIL and Core Illumina and a discount rate for each reporting unit. Discount rates were determined using a weighted average cost of capital for risk factors specific to each reporting unit and other market and industry data. For GRAIL, the selected discount rate was 24.0%. An increase of 50 to 100 basis points to the discount rate would have resulted in additional impairment of $200&#160;million to $350&#160;million. The estimates and assumptions used in our assessment represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. In order to further validate the reasonableness of the fair values concluded for our reporting units, a reconciliation to market capitalization was performed by estimating a reasonable implied control premium and other market factors.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with our interim goodwill impairment test, we also evaluated GRAIL&#8217;s IPR&amp;D intangible asset for potential impairment. We performed our impairment test by comparing the carrying value of the IPR&amp;D intangible asset to its estimated fair value, which was determined by the income approach, using a discounted cash flow model. Estimates and assumptions used in the income approach, which represent a Level 3 measurement, included projected cash flows and a selected discount rate of 19.0%. Based on our analysis, the carrying value of GRAIL&#8217;s IPR&amp;D intangible asset exceeded its estimated fair value and we recorded an impairment of $109&#160;million in Q3 2023, primarily due to a decrease in projected cash flows and a higher discount rate selected for the fair value calculation of the IPR&amp;D asset. We also performed a recoverability test for the definite-lived intangible assets assigned to GRAIL, which included developed technology and trade name, and to Core Illumina and noted no impairment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q4 2023, we concluded, among other events, that our formal announcement to divest GRAIL represented a triggering event that required an additional interim impairment test be performed. As a result of our analysis, no impairment was recorded for Core Illumina or GRAIL. The fair value of GRAIL exceeded its carrying value by approximately $950&#160;million and the selected discount rate used in the analysis was 23.0%. An increase of 100 basis points to the discount rate would still have resulted in no impairment for GRAIL. We also performed a recoverability test for the definite-lived intangible assets assigned to GRAIL and Core Illumina and noted no impairment. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Impairment of Goodwill</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 13, 2022, the EU General Court ruled that the European Commission had jurisdiction under the EU Merger Regulation to review our acquisition of GRAIL. Additionally, on September 6, 2022, the European Commission issued its decision prohibiting the acquisition. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_127" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These decisions, along with a continued and significant decrease in the Company&#8217;s stock price and market capitalization, required us to perform an interim impairment test in Q3 2022. Based on our analysis, we concluded GRAIL&#8217;s carrying value exceeded its fair value and recorded a goodwill impairment of $3,914&#160;million, primarily due to the negative impact of capital market conditions and a higher discount rate selected for the fair value calculation of GRAIL. There was no impairment for Core Illumina. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed our interim goodwill impairment test using a combination of both an income and a market approach to determine the fair value of each reporting unit. The income approach utilized the estimated discounted cash flows for each reporting unit, while the market approach utilized comparable company information. Estimates and assumptions used in the income approach included projected cash flows for both GRAIL and Core Illumina and a discount rate for each reporting unit. Discount rates were determined using a weighted average cost of capital for risk factors specific to each reporting unit and other market and industry data. For GRAIL, the discount rate selected was 22.0%. In order to further validate the reasonableness of the fair values concluded for our reporting units, a reconciliation to market capitalization was performed by estimating a reasonable implied control premium and other market factors.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with our interim goodwill impairment test, we also evaluated GRAIL&#8217;s IPR&amp;D intangible asset for potential impairment. We performed our impairment test by comparing the carrying value of the IPR&amp;D intangible asset to its estimated fair value, which was determined by the income approach, using a discounted cash flow model. Estimates and assumptions used in the income approach included projected cash flows and a discount rate. Based on our analysis, the carrying value of the IPR&amp;D intangible asset did not exceed its estimated fair value and no impairment was recorded. We also performed a recoverability test for the definite-lived intangible assets assigned to GRAIL, which included developed technology and trade name, and to Core Illumina and noted no impairment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.982%"><tr><td style="width:1.0%"></td><td style="width:17.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible Assets,<br/>Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible Assets,<br/>Net</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">465</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(305)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,222&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensed technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">234</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Database</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangible assets, net</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">748</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(453)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">295</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-848"><span style="-sec-ix-hidden:f-849">In-process research and development (IPR&amp;D)</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">748</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(453)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">295</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant decrease in developed technologies, trade name, and IPR&amp;D reflect the GRAIL intangible assets disposed of in connection with the Spin-Off. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_1657" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details. Also, in Q1 2024, we placed into service (reflected in developed technologies), with a useful life of 10 years, the $35&#160;million IPR&amp;D intangible asset we acquired in 2021, net of impairments recognized in 2024 and 2023 of $3&#160;million and $6&#160;million, respectively. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $42&#160;million, with a useful life of 7 years, and a customer relationship asset of $2&#160;million, with a useful life of 11 years. We are still finalizing the allocation of the purchase price as it relates to the completion of certain tax returns. We expect to finalize the valuation as soon as practicable, but no later than one year after the acquisition. As a result of an acquisition in Q4 2023, we recorded a developed technology asset of $19&#160;million, with a useful life of 10 years. We finalized the allocation of the purchase price in Q4 2024 with no material adjustments to provisional amounts. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future annual amortization of finite-lived intangible assets is shown in the following table. Actual amortization expense to be reported in future periods could differ from these estimates as a result of acquisitions, divestitures, and asset impairments, among other factors.</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Annual Amortization</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination And Goodwill And Intangible Assets Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937086300368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND OTHER COMMITMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT AND OTHER COMMITMENTS</a></td>
<td class="text"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.  DEBT AND OTHER COMMITMENTS</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Term Debt Obligations</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.328%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2025 Term Notes outstanding</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2026 Term Notes outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2027 Term Notes outstanding</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2031 Term Notes outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discounts and debt issuance costs</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of term debt</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,989</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">499</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term debt, non-current</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,490</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of term debt outstanding (Level 2)</span></div></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,940</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense recognized on our term notes and delayed draw term loan, which included amortization of debt discounts and issuance costs, was $99&#160;million, $74&#160;million, and $21&#160;million in 2024, 2023 and 2022, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.650% Term Notes due 2026 (2026 Term Notes)</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2024, we issued $500&#160;million aggregate principal amount of 2026 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $497&#160;million, which were used to repay a portion of the outstanding debt under the Delayed Draw Credit Agreement. The 2026 Term Notes, which mature on September 9, 2026, accrue interest at a rate of 4.650% per annum, payable semi-annually on March 9 and September 9 of each year, beginning on March 9, 2025. We may redeem for cash all or any portion of the 2026 Term Notes, at our option, at any time prior to maturity at make-whole premium redemption prices as defined in the form of the notes.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.800% Term Notes due 2025 (2025 Term Notes) and 5.750% Term Notes due 2027 (2027 Term Notes)</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we issued $500&#160;million aggregate principal amount of 2025 Term Notes and $500&#160;million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $991&#160;million. The 2025 Notes, which mature on December 12, 2025, and the 2027 Notes, which mature on December 13, 2027, accrue interest at a rate of 5.800% and 5.750% per annum, respectively, payable semi-annually. Interest for the 2025 Notes is payable on June 12 and December 12 of each year and interest for the 2027 Notes is payable on June 13 and December 13 of each year, beginning in June 2023.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may redeem for cash all or any portion of the 2025 or 2027 Term Notes, at our option, at any time prior to maturity. Prior to November 12, 2025 for the 2025 Notes and prior to November 13, 2027 for the 2027 Notes, the notes are redeemable at make-whole premium redemption prices as defined in the applicable forms of note. After November 12, 2025 and November 13, 2027, respectively, the notes are redeemable at a redemption price equal to 100% of the principal to be redeemed, plus accrued and unpaid interest up to, but excluding, the redemption date. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.550% Term Notes due 2023 (2023 Term Notes) and 2.550% Term Notes due 2031 (2031 Term Notes)</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we issued $500&#160;million aggregate principal amount of 2023 Term Notes and $500&#160;million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $992&#160;million. The 2023 Notes matured and were repaid in cash on March 23, 2023. The 2031 Notes, which mature on March 23, 2031, accrue interest at a rate of 2.550% per annum, payable semi-annually on March 23 and September 23 of each year. We may redeem for cash all or any portion of the 2031 Term Notes, at our option, at any time prior to maturity. Prior to December 23, 2030, the notes are redeemable at make-whole premium redemption prices as defined in the form of the notes. After December 23, 2030, the notes are redeemable at a redemption price equal to 100% of the principal to be redeemed, plus accrued and unpaid interest up to, but excluding, the redemption date.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delayed Draw Term Loan due 2025</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2024, we entered into a 364-day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $750&#160;million (the Delayed Draw Credit Facility). On June 20, 2024, we borrowed $750&#160;million on the credit facility in order to provide a portion of the Disposal Funding to GRAIL as part of the Spin-Off. The delayed draw term loan incurred interest at a rate of 6.7%. On September 9, 2024, we repaid the full principal outstanding on the Delayed Draw Credit Facility, as well as accrued interest, in an aggregate amount of $761&#160;million and terminated the Delayed Draw Credit Agreement. We recognized a loss on debt extinguishment of $5&#160;million in 2024, included in interest expense in the consolidated statements of operations, related to the write-off of unamortized debt issuance costs.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0% Convertible Senior Notes due 2023 (2023 Convertible Notes)</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we issued $750&#160;million aggregate principal amount of 2023 Convertible Notes. The notes were convertible into cash, shares of common stock or a combination of cash and shares of common stock, at our election, based on conversion rates as defined in the indenture. The 2023 Convertible Notes matured on August 15, 2023, at which time the principal was repaid in cash. We did not issue any shares of common stock. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability component to be estimated by estimating the fair value of a similar liability that does not have an associated conversion feature. Because at issuance we had no outstanding non-convertible public debt, we determined that market-traded senior, unsecured corporate bonds represented a similar liability without a conversion option. Based on market data available for publicly traded, senior, unsecured corporate bonds issued by companies in our industry, and with similar maturities to the 2023 Convertible Notes, we estimated an implied interest rate of&#160;3.7%, assuming no conversion option. The estimated implied interest rate was applied to the 2023 Convertible Notes, which resulted in a fair value of the liability component in aggregate of&#160;$624&#160;million&#160;upon issuance, calculated as the present value of implied future payments based on the&#160;$750&#160;million&#160;aggregate principal amount. The&#160;$126&#160;million&#160;difference ($93&#160;million, net of tax) between the aggregate principal amount of&#160;$750&#160;million&#160;and the estimated fair value of the liability component was recorded in additional paid-in capital as the 2023 Convertible Notes were not considered redeemable. As of January 3, 2022, we adopted ASU 2020-06, which removed the requirement to separate the embedded conversion feature from the notes and requires the notes to be accounted for as a single liability measured at amortized cost. Accordingly, we reclassified the unamortized debt discount from additional paid-in capital to convertible senior notes in the consolidated balance sheets on January 3, 2022. This resulted in an increase to retained earnings and a decrease to additional paid-in capital of $61&#160;million and $93&#160;million, respectively.</span></div><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense recognized on our 2023 Convertible Notes was immaterial in both 2023 and 2022.</span></div><div style="margin-top:13pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revolving Credit Agreement</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2023, we entered into a new credit agreement (the Revolving Credit Agreement), which provides us with a $750&#160;million senior unsecured five-year revolving credit facility, including a $40&#160;million sublimit for swingline borrowings and a $50&#160;million sublimit for letters of credit (the Revolving Credit Facility). Proceeds of the loans under the Revolving Credit Facility may be used to finance working capital needs and for general corporate purposes. The credit agreement dated as of March 8, 2021 and the commitments thereunder were terminated as of January 4, 2023.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility matures, and all amounts outstanding become due and payable in full, on January 4, 2028, subject to two one-year extensions at our option, the consent of the extending lenders and certain other conditions. We may prepay amounts borrowed and terminate commitments under the Revolving Credit Facility at any time without premium or penalty. As of December&#160;29, 2024, there were no borrowings or letters of credit outstanding under the credit facility, and we were in compliance with all financial and operating covenants.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans under the Revolving Credit Facility will have a variable interest rate based on either the term secured overnight financing rate (SOFR) or the alternate base rate, plus an applicable rate that varies with our debt rating and, in the case of loans bearing interest based on term SOFR, a credit spread adjustment equal to 0.10% per annum. The Revolving Credit Agreement includes an option for us to elect to increase commitments under the credit facility or enter into one or more tranches of term loans in the aggregate principal amount of up to $250&#160;million, subject to consent of the lenders providing the additional commitments or loans and certain other conditions.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Agreement contains financial and operating covenants. Pursuant to the Revolving Credit Agreement, we are required to maintain a ratio of total debt to adjusted annual earnings before interest, taxes, depreciation and amortization (EBITDA), calculated based on the four consecutive fiscal quarters ending with the most recent fiscal quarter, of not greater than 3.50 to 1.00 as of the end of each fiscal quarter. Upon the consummation of any Qualified Acquisition (as defined in the Revolving Credit Agreement) and us providing notice to the Administrative Agent, the ratio increases to 4.00 to 1.00 for the fiscal quarter in which the acquisition is consummated and the three consecutive fiscal quarters thereafter. The operating covenants include, among other things, limitations on (i) the incurrence of indebtedness by our subsidiaries, (ii) liens on our and our subsidiaries assets, and (iii) certain fundamental changes and the disposition of assets by us and our subsidiaries. The Credit Agreement contains other customary covenants, representations and warranties, and events of default.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, the maturities of our operating lease liabilities were as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total remaining lease payments</span></div></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 years</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of our lease costs were as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Variable lease costs include non-fixed maintenance charges and property taxes.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Obligations</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we enter into agreements to purchase goods or services that are not cancelable without penalty, primarily related to licensing and supply arrangements. For those agreements with variable terms, we do not estimate the total obligation beyond any minimum quantities or pricing as of the reporting date. Licensing agreements under which we commit to minimum royalty payments, some of which are subject to adjustment, may be terminated prior to the expiration of underlying intellectual property under certain circumstances. Annual minimum payments for noncancelable purchase obligations as of December&#160;29, 2024 totaled $212 million, approximately half of which are due within the next twelve months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084998096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.  STOCKHOLDERS' EQUITY</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2015 Stock and Incentive Compensation Plan (the 2015 Stock Plan) and the New Hire Stock and Incentive Plan allow for the issuance of stock options, performance stock options, restricted stock units and awards and performance stock units. In 2023, the Company&#8217;s stockholders approved an amended and restated version of the 2015 Stock Plan and increased the maximum number of shares authorized for issuance by 8.0&#160;million shares. In connection with the GRAIL Spin-Off, all unvested RSU and PSU were equitably adjusted pursuant to the plan to preserve their intrinsic value and the number of shares reserved for issuance under the 2015 Stock Plan was increased by 160,000 shares. As of December&#160;29, 2024, approximately 5.4 million&#160;shares remained available for future grants under the 2015 Stock Plan. There is no set number of shares reserved for issuance under the New Hire Stock and Incentive Plan.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue restricted stock units (RSU) and performance stock units (PSU), both of which are considered restricted stock. We grant restricted stock pursuant to the 2015 Stock Plan and satisfy such grants through the issuance of either new shares or shares from treasury stock. RSU are share awards that, upon vesting, will deliver to the holder shares of our common stock. RSU generally vest over a four-year period with equal vesting annually. We issue three different PSU awards. We issue PSU for which the number of shares issuable at the end of a three-year performance period is based on our performance relative to specified earnings per share targets (EPS PSU) and, during 2024, we began to issue PSU for which the number of shares issuable at the end of a three-year performance period is based on our performance relative to specified operating margin targets (OM PSU). During 2023, we began to issue PSU with a market condition that vest based on the Company&#8217;s relative total shareholder return as compared to a peer group of companies measured over a <span style="-sec-ix-hidden:f-986">three-fiscal</span> year performance period (rTSR PSU). Depending on the actual performance over the measurement period, an rTSR PSU award recipient could receive up to 175% of the granted award. Shares issuable under all PSU awards are subject to continued employment through the vesting period. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock activity was as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted <br/>Stock Units <br/>(RSU)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(PSU) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant-<br/>Date Fair Value per Share</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Units in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSU</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.66&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.42&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(707)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.56&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.55&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.23&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.74&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.08&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,198</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">236.32</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">729</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">133.73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164.38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested adjustment for GRAIL Spin-Off</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">249.70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(443)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">195.11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">167.68</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,879</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158.60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164.87</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">For EPS and OM PSU, the number of units reflect the estimated number of shares to be issued at the end of the performance period. For rTSR PSU, the number of units reflect the estimated number of shares to be issued based on performance as of the current reporting period. Awarded units are presented net of performance adjustments. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax intrinsic value and fair value of vested restricted stock was as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax intrinsic value of outstanding restricted stock:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of restricted stock vested:</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">116</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability-Classified RSU</span></div><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q1 2023, we granted RSU that were to be settled in cash if stockholder approval to increase our share reserve under the amended and restated 2015 Stock Plan was not obtained. In Q2 2023, the Company&#8217;s stockholders approved an amended and restated version of the 2015 Stock Plan and increased the maximum number of shares authorized for issuance. Upon such approval, all RSU previously accounted for as liability-classified awards, approximately 557,000 RSU, were reclassified to stockholders equity and accounted for prospectively as equity awards. There were no RSU liability-classified awards outstanding as of December&#160;29, 2024 or December&#160;31, 2023.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:13pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity was as follows:  </span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Units in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock Options</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise&#160;Price</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.42&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.54&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.09&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.69&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">330.25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">330.25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">In connection with the GRAIL acquisition, we issued replacement performance stock options to GRAIL employees in 2021. The number of units reflected awards that had been granted and for which it was assumed to be probable that the underlying performance goals would be achieved. In connection with the GRAIL Spin-Off, all outstanding performance stock options were assumed by GRAIL. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was immaterial in both 2023 and 2022. None exercised in 2024. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Liability-Classified Awards</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the GRAIL Spin-Off, we granted cash-based equity incentive awards to GRAIL employees, which were accounted for as liability-classified awards. In connection with the Spin-Off, these awards were assumed by GRAIL. For purposes of valuation and performance measurement of the awards, GRAIL&#8217;s stand-alone value calculation, as estimated by GRAIL based on its analysis and on input from independent valuation advisors and analyses, was used. The awards generally had terms of four years and vested in <span style="-sec-ix-hidden:f-1101">four</span> equal installments on each anniversary of the grant date, subject to continued employment through the vesting period. </span></div><div style="margin-bottom:13pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash-based equity incentive award activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and paid in cash</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and paid in cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">292</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and paid in cash</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derecognition for GRAIL Spin-Off</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">The estimated liability immediately prior to the Spin-Off, recorded in accrued liabilities, was $53&#160;million, which was disposed of as part of GRAIL&#8217;s net assets. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_40" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional details.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized share-based compensation expense on these cash-based equity incentive awards of $52&#160;million in 2024, prior to the Spin-Off, and $95&#160;million and $67&#160;million in 2023 and 2022, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of GRAIL, we assumed a performance-based award for which vesting was based on GRAIL&#8217;s future revenues and had an aggregate potential value of up to $78&#160;million. Prior to the Spin-Off of GRAIL, it was not probable that the performance conditions associated with the award would be achieved and, therefore, no share-based compensation expense was recognized in the consolidated statements of operations. In connection with the Spin-Off, this award was assumed by GRAIL. For a period of 2.5 years following the Spin-Off, we are obligated to indemnify GRAIL for cash payments that become earned and payable related to this award. The indemnification is accounted for in accordance with ASC 460. As of December&#160;29, 2024, we recognized a non-contingent liability of $1&#160;million for this indemnification, with a corresponding charge to additional paid-in capital.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2000 Employee Stock Purchase Plan, or ESPP, permits eligible employees to purchase common stock at a discount through payroll deductions during defined offering periods. The price at which stock is purchased under the ESPP is equal to 85% of the fair market value of the common stock on the first day of the offering period or purchase date, whichever is lower. The initial offering period commenced in July 2000. During 2024, 2023, and 2022, approximately 0.5 million, 0.4 million, and 0.3 million shares, respectively, were issued under the ESPP. As of December&#160;29, 2024, approximately 12.4 million&#160;shares remained available for issuance under the ESPP, which includes an increase of 0.5 million shares pursuant to the terms of the ESPP to account for the GRAIL Spin-Off.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for the specified reporting periods and the resulting estimates of weighted-average fair value per share for stock purchased under the ESPP were as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.35% - 5.54%</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;0.78% - 5.54% </span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06% - 2.98%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41% - 49%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;41% - 51% </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37% - 51%</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.5 - 1.1 year</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;0.5 - 1.1 year </span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 1.0 year</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value per share</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37.24</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.87&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.22&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2024, our Board of Directors authorized a new share repurchase program, which cancels and supersedes all prior and available repurchase authorizations, to repurchase up to $1.5&#160;billion of our outstanding common stock. The repurchases may be completed through open market purchases, pursuant to Rule 10b5-1 or Rule 10b-18, or through an accelerated share repurchase program. Authorizations to repurchase up to $1.4 billion of our outstanding common stock remained available as of December&#160;29, 2024. We did not repurchase&#160;any shares during 2023 or 2022.</span></div><div style="margin-bottom:13pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share repurchase activity during 2024 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:81.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions, except shares in thousands</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares repurchased</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of shares repurchased</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Total cost of shares repurchased includes the 1% excise tax imposed as part of the Inflation Reduction Act of 2022, which is calculated based on share repurchases, net of certain share issuances.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;29, 2024 and through February 11, 2025, we repurchased an additional 1.0 million shares of our common stock for $126 million.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense, which includes expense for both equity and liability-classified awards, reported in our consolidated statements of operations was as follows:  </span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">194</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, before taxes</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of taxes</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">288</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, unrecognized compensation cost, related to restricted stock and ESPP shares issued to date, of $565 million was expected to be recognized over a weighted-average period of approximately 2.5 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937086295584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">SUPPLEMENTAL BALANCE SHEET DETAILS</a></td>
<td class="text"><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.  SUPPLEMENTAL BALANCE SHEET DETAILS</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, gross</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">744</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">735</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">225</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">404</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">660</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserve</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(113)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">547</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">772</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">683</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">478</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,069</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal contingencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation expenses</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">252</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1239"><span style="-sec-ix-hidden:f-1240">Operating lease liabilities, current portion</span></span></span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified equity incentive awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, including warranties</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_127" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional details.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">See table below for changes in the reserve for product warranties.</span></div><div style="margin-bottom:6pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the reserve for product warranties were as follows:  </span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repairs and replacements</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to cost of product revenue</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repairs and replacements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repairs and replacements</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q2 2023, we implemented a cost reduction initiative that included workforce reductions, the consolidation of certain facilities and other actions to reduce expenses, all as part of a plan to realign operating expenses while maintaining focus on our innovation roadmap and sustainable long-term growth. In both 2024 and 2023, we recorded restructuring charges primarily consisting of asset impairments related to exit activities at certain of our leased facilities.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the pre-tax restructuring charges is as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:47.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.025%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative charges recorded since inception</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee separation costs</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other costs</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">For 2024, relates to impairment of right-of-use assets and leasehold improvements for Foster City campus and other property in San Diego. </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For 2023, primarily relates to impairment of right-of-use assets and leasehold improvements for our i3 and Foster City campuses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">For 2024, $59&#160;million was recorded in SG&amp;A expense, $2&#160;million in R&amp;D expense, and remainder in cost of revenue.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For 2023, $122&#160;million was recorded in SG&amp;A expense, $24&#160;million in R&amp;D expense, and remainder in cost of revenue.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total restructuring charges primarily relate to our Core Illumina segment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, we recorded right-of-use asset impairments of $12&#160;million and $19&#160;million related to our campus in Foster City, California and another property in San Diego, California, respectively. In 2023, we recorded right-of-use asset impairments of $38&#160;million and $21&#160;million related to our i3 campus in San Diego and our campus in Foster City, respectively. The impairments were determined by comparing the fair values of the impacted right-of-use assets to the carrying values of the assets as of the impairment measurement date. The fair values of the right-of-use assets were estimated using the discounted future cash flows method, which includes estimates and assumptions for future sublease rental rates that reflect current sublease market conditions, as well as discount rates. The estimates and assumptions used in our assessments represent Level 3 measurements because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. In 2024, we recorded $14&#160;million of leasehold improvement impairments related to our Foster City campus and, in 2023, we recorded $16&#160;million and $22&#160;million of leasehold improvement impairments related to our i3 and Foster City campuses, respectively. The right-of-use asset and leasehold improvement impairments were recognized in selling, general and administrative expense. We continue to evaluate our options for the rest of our Foster City campus, for which, as of December&#160;29, 2024, we had remaining assets, consisting primarily of right-of-use assets and leasehold improvements, of $100&#160;million.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the restructuring liability is as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Separation Costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded in accrued liabilities as of January&#160;1, 2023</span></div></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recorded</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded in accrued liabilities as of December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recorded</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to accrual</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded in accrued liabilities as of December&#160;29, 2024</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078560672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">LEGAL PROCEEDINGS</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.  LEGAL PROCEEDINGS</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various lawsuits and claims arising in the ordinary course of business, including actions with respect to intellectual property, employment, and contractual matters. In connection with these matters, we assess, on a regular basis, the probability and range of possible loss based on the developments in these matters. A liability is recorded in the consolidated financial statements if it is believed to be probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review outstanding legal matters to determine the adequacy of the liabilities accrued and related disclosures in consideration of many factors, which include, but are not limited to, past history, scientific and other evidence, and the specifics and status of each matter. We may change our estimates if our assessment of the various factors changes and the amount of ultimate loss may differ from our estimates, resulting in a material effect on our business, financial condition, results of operations, and/or cash flows.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of GRAIL</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 6, 2024, all previously disclosed regulatory proceedings in the United States and European Union related to our acquisition of GRAIL have been resolved (as further described below).</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 19, 2021, the European Commission sought and subsequently accepted a request for a referral of the GRAIL acquisition for European Union merger review, submitted by a Member State of the European Union (France), and joined by several other EEA Member States (Belgium, Greece, Iceland, the Netherlands and Norway), under Article 22(1) of Council Regulation (EC) No 139/2004 (the EU Merger Regulation). The European Commission had never solicited referrals to take jurisdiction over an acquisition of a U.S. company that had no revenue in Europe. On April 28, 2021, we filed an action in the General Court of the European Union (the EU General Court) asking for annulment of the European Commission&#8217;s assertion of jurisdiction to review the acquisition under Article 22 of the EU Merger Regulation, as the acquisition does not meet the jurisdictional criteria under the EU Merger Regulation or under the national merger control laws of any Member State of the European Union. On July 13, 2022, the EU General Court reached a decision in favor of the European Commission, holding that the European Commission has jurisdiction under the EU Merger Regulation to review the acquisition. On September 22, 2022, we filed an appeal in the Court of Justice of the European Union (the EU Court of Justice) asking for annulment of the EU General Court&#8217;s judgment. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 12, 2023, the European Commission adopted a decision requiring Illumina to unwind its acquisition of GRAIL (the EC Divestment Decision). On December 17, 2023, we announced that we would divest GRAIL. On June&#160;24, 2024, we completed the separation (the Spin-Off) of GRAIL into a separate, independent publicly traded company through the distribution of approximately 85.5% of the outstanding GRAIL common stock to Illumina stockholders on a pro rata basis.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2024, the EU Court of Justice ruled in our favor, confirming that the European Commission had unlawfully asserted jurisdiction over our acquisition of GRAIL, and hence annulling the EU General Court&#8217;s judgment and the European Commission&#8217;s decisions accepting the referral of the GRAIL acquisition for EU merger review (the EU Court of Justice Judgment). The EU Court of Justice Judgment concludes these proceedings and is not subject to further appeals. In view of this judgment, on September 6, 2024, the European Commission issued a decision (the Withdrawal Decision) withdrawing all of its prior decisions, including (1) its July 22, 2021 decision opening an investigation of Illumina&#8217;s proposed acquisition of GRAIL, (2) its September 6, 2022 decision prohibiting Illumina&#8217;s acquisition of GRAIL, (3) its October 29, 2021 and October 28, 2022 decisions concerning interim measures, (4) the EC Divestment Decision, and (5) its July 12, 2023 decision fining Illumina &#8364;432&#160;million and GRAIL for closing the acquisition before approval by the European Commission. The Withdrawal Decision resolves all ongoing regulatory proceedings in the European Union. The European Commission has also been ordered to pay Illumina&#8217;s costs incurred in connection with the GRAIL-related proceedings before the EU Court of Justice and the EU General Court.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the European Commission withdrawing its previously imposed fine, we recognized a net gain of $481&#160;million in Q3 2024. We recognized a gain of $489&#160;million in operating expense, resulting from reversal of the accrued fine and related accrued interest, offset by a loss of $8&#160;million, recognized in other expense, net, for the reversal of associated foreign currency fluctuations. The fine accrued interest at a rate of 5.5% per annum while it was outstanding. The guarantees we provided in October 2023 to satisfy the obligation in lieu of cash payment while we appealed the European Commission&#8217;s jurisdictional and fine decisions are no longer outstanding. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 15, 2024, the U.S. Federal Trade Commission dismissed the previously disclosed administrative complaint in light of the completion of the Spin-Off.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SEC Inquiry Letter</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, we were informed that the staff of the SEC was conducting an investigation relating to Illumina and was requesting documents and communications primarily related to Illumina&#8217;s acquisition of GRAIL and certain statements and disclosures concerning GRAIL, its products and its acquisition, and related to the conduct and compensation of certain members of Illumina and GRAIL management, among other things. Illumina is cooperating with the SEC in this investigation.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Shareholder Derivative Complaints</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 17, 2023, a stockholder derivative and class action complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Icahn Partners LP, et al. v. deSouza, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, purportedly brought on behalf of Illumina and public holders of Illumina&#8217;s common stock, was filed in the Delaware Court of Chancery against certain current and former directors (including our former Chief Executive Officer). We are named as a nominal defendant in the complaint. The lawsuit alleges the named directors breached their fiduciary duties by knowingly causing Illumina to unlawfully close the GRAIL acquisition, concealing material facts related to the GRAIL acquisition and making inadequate disclosures. Before the filing of the complaint, the purported stockholders did not make a demand that our Board of Directors pursue the claims asserted therein. The complaint seeks damages, costs and expenses, including attorney fees, the certification and consolidation of a putative class, the issuance of amended disclosures, the removal of conflicted directors and declaratory and other equitable relief. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the defendants filed a motion to dismiss the complaint, which has not yet been briefed. On the same day, Illumina-joined by the director defendants-moved to strike portions of the complaint that contain improperly included confidential and privileged information. On January 16, 2024, the Court granted the motion to strike. On December 5, 2023, the plaintiffs moved to expedite the proceedings with respect to their direct claims. The director defendants opposed that motion and Illumina joined their opposition. On January 19, 2024, the Court denied plaintiffs&#8217; motion to expedite. On January 23, 2024, the plaintiffs filed a motion for reargument of the Court&#8217;s January 16 opinion, which the Court denied on February 19, 2024. On February 29, 2024, the plaintiffs filed an application to the trial court to certify the orders granting the motion to strike and denying the motion for reargument for interlocutory appeal. The Court refused the application on March 20, 2024. On March 14, 2024, the plaintiffs filed an application for interlocutory appeal with the Supreme Court of Delaware, which the Court denied on April 11, 2024.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Omaha Police and Firefighters Retirement System v. deSouza, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors. On April 16, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Roseville General Employees Retirement System, et al. v. deSouza, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors and officers. On August 16, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thomas P. DiNapoli v. John Thompson et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors. We are named as a nominal defendant in the complaints. The lawsuits allege the named directors and officers breached their fiduciary duties by knowingly causing Illumina to unlawfully close the GRAIL acquisition. The stockholders previously made requests to inspect certain books and records under Delaware law, and they purport to base their complaint in part on documents obtained from Illumina in response to those requests. Before the filing of the complaint, the purported stockholders did not make a demand that our Board of Directors pursue the claim asserted therein. The complaints seek damages against the individual defendants, costs and expenses, including attorney fees and other equitable relief. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2024, the defendants filed a motion to dismiss the complaint in the lawsuit filed by City of Omaha Police and Firefighters Retirement System. The motion has not yet been briefed. On May 16, 2024, the defendants filed a motion to dismiss the complaint in the lawsuit filed by City of Roseville General Employees Retirement System, et al. The motion has not yet been briefed. On September 16, 2024, the defendants filed a motion to dismiss the complaint in the lawsuit filed by Thomas DiNapoli. The motion has not yet been briefed.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Pavers and Road Builders Benefit Funds v. deSouza, et al., </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors and officers. Like the complaints described above, the lawsuits allege the named directors and officers breached their fiduciary duties by knowingly causing Illumina to unlawfully close the GRAIL acquisition. The stockholder previously made requests to inspect certain books and records under Delaware law and litigated a books and records action against the Company (described below), and it purports to base its complaint in part on documents obtained from Illumina in response to those requests and that litigation. Before the filing of the complaint, the purported stockholder did not make a demand that our Board of Directors pursue the claim asserted therein. The complaint seeks damages against the individual defendants and other equitable relief.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the fact that these lawsuits are in an early stage, we cannot predict the ultimate outcome of the suits. We deny the allegations in the complaints and intend to vigorously defend the litigations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Elaine Wang, et al. v. deSouza, et al.,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> purportedly brought on behalf of the Company was filed in the United States District Court for the District of Delaware (District of Delaware) against certain current and former directors. The Company was named as a nominal defendant in the complaint. The lawsuit alleged that the named directors breached their fiduciary duties by knowingly causing the Company to unlawfully close the GRAIL acquisition. Before the filing of the complaint, the purported stockholder did not make a demand that our Board of Directors pursue the asserted claims therein. The complaint sought, among other things, restitution to the Company for the alleged damages caused by the named defendants. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2024, a stockholder derivative complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michael Warner, et al. v. deSouza, et al.,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> purportedly brought on behalf of Illumina was also filed in the United States District Court for the Southern District of California against certain current and former directors. We were named as a nominal defendant in the complaint. The lawsuit alleged that the named directors breached their fiduciary duties by knowingly causing us to unlawfully close the GRAIL acquisition. Before the filing of the complaint, the purported stockholder did not make a demand that our Board of Directors pursue the asserted claims therein. The complaint sought, among other things, restitution to Illumina for the alleged damages caused by the named defendants. On March 28, 2024, the parties submitted a Joint Motion to Transfer the lawsuit to the District of Delaware, which the Court granted on March 29, 2024, and the Court transferred the lawsuit to the District of Delaware on the same day.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Elaine Wang, et al. v. deSouza, et al. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michael Warner, et al. v. deSouza, et al. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were voluntarily dismissed on April 29, 2024, and May 1, 2024, respectively. On May 1, 2024, Michael Warner sent a litigation demand to our Board of Directors requesting that a civil action for monetary damages be brought by the Board of Directors on behalf of Illumina against officers and directors involved with the GRAIL acquisition. On July 30, 2024, the Board unanimously determined that it was in the best interest of the Company and its shareholders to defer a final decision on the demand given, among other things, the pending stockholder lawsuits described herein and the similarity of issues raised in the demand and those lawsuits. Our Board will monitor the stockholder lawsuits and revisit the demand as warranted as the lawsuits progress. On June 3, 2024, Elaine Wang made requests to inspect certain books and records under Delaware law and the Company sent a production of documents in response to that demand. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2024, an additional stockholder, Jane Davidson, sent a litigation demand to our Board of Directors requesting that a civil action for breaches of fiduciary duty, indemnification, contribution and other appropriate claims be brought by the Board of Directors on behalf of Illumina against officers and directors involved with the GRAIL acquisition. On October 29, 2024, the Board unanimously determined that it was in the best interest of the Company and its shareholders to defer a final decision on the demand given, among other things, the pending stockholder lawsuits described herein and the similarity of issues raised in the demand and those lawsuits. Our Board will monitor the stockholder lawsuits and revisit the demand as warranted as the lawsuits progress.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:113%">Securities Class Actions</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Securities Class Actions. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 11, 2023, the first of three securities class action complaints was filed against Illumina and certain of its current and former executive officers in the United States District Court for the Southern District of California. The first-filed case is captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kangas v. Illumina, Inc. et al</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., the second-filed case is captioned</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Roy v. Illumina, Inc. et al.,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the third-filed case is captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Louisiana Sheriffs&#8217; Pension &amp; Relief Fund v. Illumina, Inc. et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (collectively, the Actions). The complaints generally allege, among other things, that defendants made materially false and misleading statements and omitted material facts relating to Illumina&#8217;s acquisition of GRAIL. The complaints seek unspecified damages, interest, fees, and costs. On January 9, 2024, four movants filed motions to consolidate the Actions and to appoint a lead plaintiff (Lead Plaintiff Motions). On April 11, 2024, the Court issued an order consolidating the Actions into a single action (captioned in re Illumina, Inc. Securities Litigation No. 23-cv-2082-LL-MMP), and appointed Universal-Investment-Gesellschaft mbH, UI BVK Kapitalverwaltungsgesellschaft mbH, and ACATIS Investment Kapitalverwaltungsgesellschaft mbH as lead plaintiffs (the Lead Plaintiffs). On June 21, 2024, the Lead Plaintiffs filed their consolidated amended complaint. The complaint alleges that Illumina and GRAIL and certain of their current and former directors and officers violated Sections 10(b) and 20(a) of the Securities Exchange Act and SEC Rule 10b-5 in connection with Illumina&#8217;s acquisition of GRAIL. On September 13, 2024, the Lead Plaintiffs filed a second amended consolidated complaint. On November 12, 2024, the Company and other defendants filed a motion to dismiss the second amended consolidated complaint. On December 20, 2024, the Lead Plaintiffs filed their opposition to the motion to dismiss. The defendants&#8217; final reply brief was filed on February 3, 2025. No hearing date has been set.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Securities Class Actions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On February 2, 2024, the first of two additional securities class actions was filed against Illumina, certain of its officers and directors, and several other individuals and entities in the Superior Court of the State of California, County of San Mateo, captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loren Scott Mar v. Illumina, et al. and Scott Zerzanek v. Illumina, Inc. et al</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Both complaints generally allege, among other things, that defendants made materially false and misleading statements and omitted material facts in the November 2020 and February 2021 registration statements and prospectus relating to Illumina&#8217;s acquisition of GRAIL. The complaints seek unspecified damages, interest, fees, and costs. On March 29, 2024, the parties to the actions filed a Joint Stipulation to Consolidate the actions and to appoint co-lead counsel for plaintiffs, which the Court granted on April 5, 2024. On August 12, 2024, the Plaintiffs filed their consolidated complaint. On September 6, 2024, Illumina and the other named defendants filed a motion to stay the litigation. On October 4, 2024, the plaintiffs opposed the motion to stay. At a hearing held on December 6, 2024, the Court declined to stay the litigation. The defendants&#8217; demurrer is due February 28, 2025. Plaintiffs&#8217; oppositions to the demurrer are due April 30, 2025, and defendants&#8217; final reply briefs are due May 30, 2025. A hearing is set for June 20, 2025.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the fact that the lawsuits are in an early stage, we cannot predict the ultimate outcome of the suits. We deny the allegations in the complaints and intend to vigorously defend the litigation.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">DOJ Civil Investigative Demand</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 18, 2024, we received a civil investigative demand (CID) from the U.S. Department of Justice, requiring production of certain documents and information in the course of a False Claims Act investigation to determine whether there is or has been a violation of 31 U.S.C. &#167; 3729. The False Claims Act investigation concerns allegations that the Company caused the submission of false claims to Medicare and other federal government programs because it misrepresented its compliance with cybersecurity requirements to the Food and Drug Administration and other federal agencies that purchase its devices. The Company is cooperating with the government. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Books and Records Action</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2024, a stockholder filed a complaint in the Delaware Court of Chancery captioned Pavers and Road Builders Benefit Funds v. Illumina, Inc. seeking to inspect certain books and records related to the GRAIL transaction, including certain materials and minutes from meetings of our Board of Directors, which have been withheld because the Company contends they are non-responsive to the request or subject to the attorney-client privilege. Illumina previously provided documents to the stockholder in response to a demand made by letter under Delaware law, but the stockholder seeks additional and unredacted materials through this action. On March 11, 2024, Illumina filed an answer to the complaint, denying that the stockholder was entitled to inspection. We deny that the stockholder is entitled to review the documents and intend to vigorously defend the litigation. The trial took place on June 7, 2024. On July 16, 2024, the Court issued a decision requiring the Company to produce certain additional documents to plaintiff. On July 26, 2024, the stockholder filed a motion seeking in camera review of certain documents that the Company maintains are not subject to the Court&#8217;s July 16, 2024 order to produce documents. The Court granted the motion on August 19, 2024, and the Company filed the documents for in camera review on August 29, 2024. On October 7, 2024, the Court ruled that the Company need not produce the documents subject to the motion for in camera review because they are privileged under the attorney opinion work product doctrine. On December 11, 2024, the Court entered its final order and judgment. On December 23, 2024, the plaintiff in this action filed a derivative complaint, described above.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BGI Genomics Co. Ltd. and its Affiliates</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, we were engaged in litigation in various U.S. jurisdictions with BGI Genomics Co. Ltd (BGI) and certain of its affiliates, including Complete Genomics, Inc. (CGI) since June of 2019. On July 14, 2022, we entered into a Settlement and License Agreement with BGI and CGI (the Agreement). Pursuant to the terms of the Agreement, we agreed to pay CGI a one time payment of $325&#160;million. We allocated the $325&#160;million payment on a relative fair value basis, resulting in $180&#160;million capitalized as an intangible asset in 2022 for the value of the license, which is amortized over a period of 6.5 years on a straight-line basis, $150&#160;million allocated to the release of past damages claimed, and a $5&#160;million gain for damages awarded to us. The fair value of the license was estimated using a discounted cash flow model, which included assumptions for projected revenues covered by the license, an estimated royalty rate and a discount rate. The fair value of the past damages claimed was estimated based on applicable historical revenues and an estimated royalty rate. These inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085154544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.  INCOME TAXES</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes summarized by region was as follows:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,834)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,735)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,942)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">655</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss before income taxes</span></div></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,179)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,117)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,336)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax provision</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes reconciles to the amount computed by applying the federal statutory rate to loss before income taxes as follows:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(248)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and other credits</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of R&amp;D expense capitalization</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of net operating losses on GILTI, U.S. foreign tax credits, and Pillar Two global minimum top-up tax</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign operations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual of European Commission fine</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(99)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">308</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of acquisition related items</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax provision</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to account for the global intangible low-taxed income (GILTI) as a period cost in our consolidated financial statements. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of foreign operations primarily represents the difference between the actual provision for income taxes for our legal entities that operate in jurisdictions that have statutory tax rates that differ from the U.S. federal statutory tax rate of 21%. The most significant tax benefits from foreign operations were from our earnings in Singapore, which had a statutory tax rate of 17% in 2024. The impact of foreign operations also includes the impacts of GILTI, U.S. foreign tax credits, and the Pillar Two global minimum top-up tax of non-U.S. earnings before the tax impact of net operating losses, and uncertain tax positions related to foreign items.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of R&amp;D expense capitalization is primarily the income tax expense impact of capitalizing research and development expenses for tax purposes on GILTI and the utilization of the U.S. foreign tax credits. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of net operating losses on GILTI, U.S. foreign tax credits, and the Pillar Two global minimum top-up tax is primarily the income tax expense impact of GRAIL pre-acquisition net operating losses on GILTI, the utilization of the U.S. foreign tax credits, and the Pillar Two global minimum top-up tax.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The impact of acquisition related items includes the income tax expense impact of transaction costs, acquisition related compensation, and changes to the contingent value rights associated with the GRAIL acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of deferred tax assets and liabilities were as follows:  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">189</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">252</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized U.S. R&amp;D expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">181</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other amortization</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">953</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance on deferred tax assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(278)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">675</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased intangible amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(117)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(847)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">558</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence, including operating results and forecasted ranges of future taxable income. Based on the available evidence as of December&#160;29, 2024, we were not able to conclude it is more likely than not certain deferred tax assets will be realized. Therefore, a valuation allowance of $278 million was recorded against certain U.S. and foreign deferred tax assets. &#160;&#160;&#160;&#160;</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, we had net operating loss carryforwards for federal and state tax purposes of $74&#160;million and $1,872 million, respectively, which will begin to expire in 2036 and 2025, respectively, unless utilized prior. We also had federal and state tax credit carryforwards of $140 million and $239 million, which will begin to expire in 2031 and 2027, respectively, unless utilized prior.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section&#160;382 and 383 of the Internal Revenue Code, utilization of net operating losses and credits may be subject to annual limitations in the event of any significant future changes in its ownership structure. These annual limitations may result in the expiration of net operating losses and credits prior to utilization. The deferred tax assets as of December&#160;29, 2024 are net of any previous limitations due to Section&#160;382 and 383.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing operations in Singapore operate under various tax holidays and incentives, which will begin to expire in 2028. These tax holidays and incentives resulted in a $33 million, $75 million, and $56 million decrease to the provision for income taxes in 2024, 2023, and 2022, respectively. These tax holidays and incentives resulted in a decrease in diluted loss per share of $0.20, $0.47, and $0.35, in 2024, 2023, and 2022, respectively.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, we asserted that $1,806 million of foreign earnings would not be indefinitely reinvested, and accordingly, recorded a deferred tax liability of $24 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gross amount of our uncertain tax positions:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">210</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to lapse of statute of limitations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the balance of uncertain tax positions as of December&#160;29, 2024 and December&#160;31, 2023, was $202&#160;million and $156&#160;million, respectively, of net unrecognized tax benefits that, if recognized, would reduce the effective income tax rate in future periods.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any interest and penalties related to uncertain tax positions are reflected in the provision for income taxes. We recognized expense of $6&#160;million and $2&#160;million in 2024 and 2023, respectively, and income of $3&#160;million in 2022, related to potential interest and penalties on uncertain tax positions. We recorded a liability for potential interest and penalties of $13&#160;million and $6&#160;million as of December&#160;29, 2024 and December&#160;31, 2023, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tax years 1997 to 2023 remain subject to future examination by the major tax jurisdictions in which we are subject to tax. The Internal Revenue Service completed an examination of the U.S. Corporation Income Tax Returns for tax years 2017, 2018, and 2020. Given the uncertainty of potential adjustments from examination as well as the potential expiration of the statute of limitations, it is reasonably possible that the balance of unrecognized tax benefits could change significantly over the next 12 months. Due to the number of years remaining that are subject to examination, we are unable to estimate the full range of possible adjustments to the balance of gross unrecognized tax benefits.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084173072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.  EMPLOYEE BENEFIT PLANS</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Plan</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a 401(k) savings plan covering substantially all of our employees in the United States. Our contributions to the plan are discretionary. During 2024, 2023, and 2022, we made matching contributions of $34 million, $36 million, and $30 million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Compensation Plan</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Illumina, Inc. Deferred Compensation Plan (the Plan) allows senior level employees to contribute up to 60% of their base salary and 100% of their variable cash compensation, and members of the board of directors to contribute up to 100% of their director fees and equity awards. Under the Plan, we credit the participants&#8217; contributions with earnings that reflect the performance of certain independent investment funds. On a discretionary basis, we may also make employer contributions to participant accounts in any amount determined by us. The vesting schedules of employer contributions are at the sole discretion of the Compensation Committee. However, all employer contributions shall become 100% vested upon the occurrence of the participant&#8217;s disability, death or retirement or a change in control of Illumina. The benefits under this plan are unsecured. Participants are generally eligible to receive payment of their vested benefit at the end of their elected deferral period or after termination of their employment for any reason or at a later date to comply with the restrictions of Section&#160;409A. </span></div>We established a rabbi trust for the benefit of the participants under the Plan and have included the assets of the rabbi trust in other assets in the consolidated balance sheets. As of December&#160;29, 2024 and December&#160;31, 2023, the assets of the trust were $70 million and $61 million, respectively, and our liabilities, included in accrued liabilities, were $65 million and $59 million, respectively. Changes in the values of the assets held by the trust are recorded in other expense, net, and changes in the values of the deferred compensation liabilities are recorded in operating expense.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084153696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND GEOGRAPHIC INFORMATION</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.  SEGMENT AND GEOGRAPHIC INFORMATION</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reportable Segment Information</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, we have one reportable segment, Core Illumina. Prior to the Spin-Off of GRAIL, on June&#160;24, 2024, our reportable segments included both Core Illumina and GRAIL. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_40" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details. We continue to disclose certain historical information for GRAIL prior to the Spin-Off. Segment information is consistent with how our Chief Operating Decision Maker (CODM), who is our Chief Executive Officer, reviews financial information, makes operating decisions, allocates resources, and assesses performance. We also consider the way budgets and forecasts are prepared and reviewed and the basis on which executive compensation is determined.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Core Illumina: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core Illumina&#8217;s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina sells products and provides services to GRAIL, and vice versa, in accordance with contractual agreements between the entities.</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRAIL: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRAIL is a healthcare company focused on early detection of multiple cancers. Prior to the Spin-Off of GRAIL into a separate, independent public company, GRAIL was required to be held and operated separately and independently from Illumina pursuant to the transitional measures ordered by the European Commission. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CODM allocates resources and evaluates business performance based on revenues and net income (loss). Net income (loss) is used in the annual budgeting and monthly forecasting processes and to monitor and assess budgeted/forecasted versus actual results. Our CODM does not evaluate segments using asset information. The accounting policies for segments are the same as those described in the summary of significant accounting policies. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present selected financial information with respect to segments for the periods presented:</span></div><div style="margin-bottom:6pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina:</span></div></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,332</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,424</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">988</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">638</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">262</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible impairment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal contingency and settlement</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(456)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,473</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL:</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,712&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated other expense, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">346</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated provision for income taxes</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment eliminations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net loss</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,223)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,161)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,404)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Core Illumina revenue for 2024, 2023, and 2022 included intercompany revenue of $15 million, $26 million, and $24 million, respectively.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">GRAIL operating expenses are inclusive of cost of revenue, research and development, selling and marketing, general and administrative, and goodwill and intangible impairment for the comparative periods prior to the Spin-Off on June&#160;24, 2024.</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">280</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">354</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geographic Data</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, consisting of property and equipment and operating lease right-of-use assets, were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">750</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">279</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets, net</span></div></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,234</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,551&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_94" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">3. Revenue</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for revenue by geographic area.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937184603984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,223)<span></span>
</td>
<td class="num">$ (1,161)<span></span>
</td>
<td class="num">$ (4,404)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084666912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 29, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 29, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ilmn_FrancesArnoldMember', window );">Frances Arnold [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On November 6, 2024, Frances Arnold, a member of our Board of Directors, entered in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on February 27, 2026 and provides for the sale of up to 120 shares.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Frances Arnold<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Board of Directors<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">November 6, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">February 27, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">478 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ilmn_JakobWedelMember', window );">Jakob Wedel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On November 7, 2024, Jakob Wedel, our Chief Strategy and Corporate Development Officer, entered in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on May 29, 2026 and provides for the sale of up to 3,182 shares.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Jakob Wedel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chief Strategy and Corporate Development Officer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">November 7, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">May 29, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">568 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">3,182<span></span>
</td>
<td class="nump">3,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ilmn_ScottDaviesMember', window );">Scott Davies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On November 8, 2024, Scott Davies, our Interim General Counsel, entered in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on December 16, 2025 and provides for the sale of up to 3,301 shares.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Scott Davies<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Interim General Counsel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">November 8, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">December 16, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">403 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">3,301<span></span>
</td>
<td class="nump">3,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ilmn_PatriciaLeckmanMember', window );">Patricia Leckman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On November 13, 2024, Patricia Leckman, our Chief People Officer, entered in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on November 14, 2025 and provides for the sale of up to 1,615 shares.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Patricia Leckman<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chief People Officer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">November 13, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">November 14, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">366 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">1,615<span></span>
</td>
<td class="nump">1,615<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ilmn_FrancesArnoldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ilmn_FrancesArnoldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ilmn_JakobWedelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ilmn_JakobWedelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ilmn_ScottDaviesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ilmn_ScottDaviesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ilmn_PatriciaLeckmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ilmn_PatriciaLeckmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937087531264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937081817312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data. Our cybersecurity risk management strategy is integrated into our established enterprise risk management program, which includes defined risk, assessment, mitigation, and reporting processes. Our information security team has deployed multiple technical and operational processes to aid in our ability to continuously identify and respond to cybersecurity threats and incidents. Our cybersecurity incident management process includes impact assessment, containment, mitigation and recovery strategies.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our continuous monitoring of our information systems, we utilize third parties to provide external threat intelligence and evaluation of incident notifications in order to identify potential threats or incidents that could impact us. We also evaluate our cybersecurity program against the National Institute of Standards and Technology&#8217;s Cybersecurity Framework. For all suspected cybersecurity incidents, the information security team conducts a preliminary assessment to determine the potential severity and impact extent of the incident and, where appropriate, a materiality assessment is made. Upon a confirmed cybersecurity incident, the information security team initiates an incident response process with goals to contain, respond, recover, protect and minimize any impacts caused by the incident. The response process includes deployment of a variety of short term and long-term technical and procedural actions as appropriate. Further, we have established a third party risk management program to monitor suppliers who have access to our information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">Our cybersecurity risk management strategy is integrated into our established enterprise risk management program, which includes defined risk, assessment, mitigation, and reporting processes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit Committee, a committee of our Board of Directors, is responsible for governing management&#8217;s review and assessment of our cybersecurity and other information technology risks, controls, and procedures, including management&#8217;s incident resolution process and any specific cybersecurity issues that could affect the adequacy of our internal controls. Our Chief Information Officer provides regular updates to the Audit Committee and to the Board of Directors, including a review of any security risk events and improvements in our security controls.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our Audit Committee, a committee of our Board of Directors, is responsible for governing management&#8217;s review and assessment of our cybersecurity and other information technology risks, controls, and procedures, including management&#8217;s incident resolution process and any specific cybersecurity issues that could affect the adequacy of our internal controls.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our Chief Information Officer provides regular updates to the Audit Committee and to the Board of Directors, including a review of any security risk events and improvements in our security controls.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information security team, under the Chief Information Officer, is led by our Chief Information Security Officer (CISO) and is responsible for assessing and managing risks from cybersecurity threats. Our CISO has over 20 years of information security experience, including as a leader of information security programs at other large enterprises, and is supported by a team of professionals focused on information security. Our information security team regularly meets to review our cybersecurity posture, the broader cybersecurity landscape and any identified cybersecurity incidents. Our information security team has procedures in place for investigating suspected cybersecurity incidents, as well as monitoring cybersecurity risks and ongoing mitigation strategies, the status of prevention, detection, and mitigation controls and any planned future control enhancement</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that risks from prior cybersecurity threats to information systems owned and used by us, including as a result of any previous cybersecurity incidents, have not materially affected our business to date. We can provide no assurance that there will not be incidents in the future or that they will not materially affect us, including our business strategy, results of operations, or financial condition. We maintain a cybersecurity insurance policy which may mitigate certain financial impacts of a cybersecurity inciden</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to &#8220;Risks Relating to Information Technology Security and Continuity&#8221; within the </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_22" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the Business &amp; Market Information Section of this report.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">Our information security team, under the Chief Information Officer, is led by our Chief Information Security Officer (CISO) and is responsible for assessing and managing risks from cybersecurity threats.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Our CISO has over 20 years of information security experience, including as a leader of information security programs at other large enterprises, and is supported by a team of professionals focused on information security.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit Committee, a committee of our Board of Directors, is responsible for governing management&#8217;s review and assessment of our cybersecurity and other information technology risks, controls, and procedures, including management&#8217;s incident resolution process and any specific cybersecurity issues that could affect the adequacy of our internal controls. Our Chief Information Officer provides regular updates to the Audit Committee and to the Board of Directors, including a review of any security risk events and improvements in our security controls.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937082231280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div>The consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (GAAP) and include our accounts, our wholly-owned subsidiaries, and majority-owned or controlled companies. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities (VIEs)</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entities (VIEs)</span></div>We evaluate our ownership, contractual and other interests in entities that are not wholly-owned to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously perform this assessment, as changes to existing relationships or future transactions may result in the consolidation or deconsolidation of a VIE. As of December&#160;29, 2024, there were no VIEs for which we were the primary beneficiary and for which we were required to consolidate.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of the consolidated financial statements requires that management make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures of contingent assets and liabilities. Though macroeconomic factors such as inflation, exchange rate fluctuations and concerns about an economic downturn&#160;present additional uncertainty, we continue to use the best information available to inform our critical accounting estimates. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Year</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year is the 52 or 53&#160;weeks ending the Sunday closest to December&#160;31, with quarters of 13 or 14&#160;weeks ending the Sunday closest to March&#160;31, June&#160;30, September&#160;30, and December&#160;31. References to 2024, 2023, and 2022 refer to fiscal years ended December&#160;29, 2024, December&#160;31, 2023, and January&#160;1, 2023, respectively, which were all 52 weeks.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional Currency</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Functional Currency</span></div>The U.S. dollar is the functional currency of our international operations. We re-measure foreign subsidiaries&#8217; monetary assets and liabilities to the U.S. dollar and record the net gains or losses resulting from re-measurement in other expense, net in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Risk</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customers</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact our operating results. A portion of our customers consist of university and research institutions that management believes are, to some degree, directly or indirectly supported by the United States Government. A significant change in current research funding, particularly with respect to funding of the U.S. National Institutes of Health or targeted cancellations by the U.S. federal government of certain grants or contracts, could have an adverse impact on future revenues and results of operations.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48%, 48%, and 50% of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53% and 55% of our gross trade accounts receivable balance as of December&#160;29, 2024 and December&#160;31, 2023, respectively.  </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no customers that provided more than 10% of total consolidated revenue in 2024, 2023, and 2022. We perform regular reviews of customer activity and associated credit risks and do not require collateral or enter into netting arrangements. Historically, we have not experienced significant credit losses from accounts receivable. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to risks related to our financial instruments, including cash and cash equivalents, investments, and accounts receivable. Most of our cash and cash equivalents as of December&#160;29, 2024 were deposited with U.S. financial institutions, either domestically or with their foreign branches. Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase. There is no limit to the percentage of the portfolio that may be maintained in debt securities, U.S.&#160;government-sponsored entities, U.S.&#160;Treasury securities, and money market funds. Historically, we have not experienced significant credit losses from financial instruments. </span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Suppliers</span></div><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require customized products and components that currently are available from a limited number of sources. We source certain key products and components included in our products from single vendors. Historically, we have not experienced significant issues sourcing materials to build our products.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segments</span></div>We report segment information based on the management approach, which designates the internal reporting used by the Chief Operating Decision Maker (CODM) for making decisions and assessing performance as the source of our reportable segments. Our CODM allocates resources and assesses the performance of segments using information about their revenue and net income (loss). Our CODM does not evaluate our segments using asset information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Adopted and Accounting Pronouncements Pending Adoption</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2024</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard requires a company to disclose incremental segment information on an annual and interim basis, including significant segment expenses and measures of profit or loss that are regularly provided to the CODM. The standard does not change how an entity identifies its operating segments. The standard was effective for us beginning in fiscal year 2024 and interim periods within fiscal year 2025. We adopted the standard on its effective date in fiscal year 2024 and applied the amendments retrospectively to all prior periods presented in the consolidated financial statements. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_136" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">12. Segment and Geographic Information</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional details.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2022</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options (Subtopic 470-20)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard reduces the number of accounting models for convertible debt instruments, amends the accounting for certain contracts in an entity&#8217;s own equity, and modifies how certain convertible instruments and contracts that may be settled in cash or shares impact the calculation of diluted earnings per share. Specifically, the guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments and requires the use of the if-converted method to calculate diluted earnings per share. We adopted the standard on its effective date in the first quarter of 2022 using a modified retrospective approach by recognizing a cumulative-effect adjustment to retained earnings on January 3, 2022. As a result of the adoption of ASU 2020-06, we increased retained earnings and decreased additional paid-in capital by $61&#160;million and $93&#160;million, respectively.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Pending Adoption</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses -</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard requires a company to provide disaggregated disclosures, in the notes to the financial statements, of specified categories of expenses that are included in line items on the face of the income statement. The standard is effective for us beginning in fiscal year 2027 and interim periods within fiscal year 2028, with early adoption permitted. The new standard is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2024-03 on the consolidated financial statements and related disclosures.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) - Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard requires a company to expand its existing income tax disclosures, specifically related to the rate reconciliation and income taxes paid. The standard is effective for us beginning in fiscal year 2025, with early adoption permitted, and is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2023-09 on the consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Shipping and Handling Expenses</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated from the sale of products and services. Product revenue consists of sales of instruments and consumables used in genetic analysis. Service and other revenue consists of revenue generated from genotyping and sequencing services, instrument service contracts, development and licensing agreements, and, prior to the Spin-Off of GRAIL on June&#160;24, 2024, cancer detection testing services related to the GRAIL business.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of our products and services is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. Revenue recognition for contracts with multiple deliverables is based on the separate satisfaction of each distinct performance obligation within the contract. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of a good or service to the customer, meaning the customer has the ability to use and obtain the benefit of the good or service. The contract price is allocated to each performance obligation in proportion to its standalone selling price. We determine our best estimate of standalone selling price using average selling prices over a rolling 12-month period coupled with an assessment of current market conditions. If the product or service has no history of sales or if the sales volume is not sufficient, we rely upon prices set by management, adjusted for applicable discounts.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized generally upon delivery to the end customer, which is when control of the product is deemed to be transferred. Invoicing typically occurs upon shipment and payment is typically due within 30 days from invoice. In instances where right of payment or transfer of title is contingent upon the customer&#8217;s acceptance of the product, revenue is deferred until all acceptance criteria have been met. Revenue from genotyping and sequencing services, including cancer detection testing services related to the GRAIL business, is recognized when earned, which is generally at the time the genotyping or sequencing analysis data is made available to the customer. Revenue from instrument service contracts is recognized as the services are rendered, typically evenly over the contract term. Revenue from development and licensing agreements generally includes upfront and periodic licensing fees, contract research and development services, or payments for development and regulatory milestones.  Revenue for these agreements is recognized when each distinct performance obligation is satisfied.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded net of discounts, distributor commissions, and sales taxes collected on behalf of governmental authorities. Employee sales commissions are recorded as selling, general and administrative expense when incurred as the amortization period for such costs, if capitalized, would have been one year or less.</span></div>In certain markets, products and services are sold to customers through distributors. In most sales through distributors, the product is delivered directly to customers by us. The terms of sales transactions through distributors are consistent with the terms of direct sales to customers.<div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Expenses</span></div>Shipping and handling expenses are included in cost of product revenue.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">(Loss) Earnings per Share</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss per Share</span></div>Basic loss per share is computed based on the weighted average number of common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. In loss periods, basic and diluted loss per share are identical since the effect of potentially dilutive common shares is antidilutive and therefore excluded. Potentially dilutive common shares from equity awards are determined using the average share price for each period under the treasury stock method. In addition, proceeds from exercise of equity awards and the average amount of unrecognized compensation expense for equity awards are assumed to be used to repurchase shares. Potentially dilutive common shares issuable upon conversion of convertible senior notes are determined using the if-converted method.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of assets and liabilities are based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize use of observable inputs and minimize use of unobservable inputs. We use a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:</span></div><div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;1&#160;&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Quoted prices in active markets for identical assets or liabilities.  </span></div><div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;2&#160;&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Inputs, other than Level&#160;1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.  </span></div><div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level&#160;3&#160;&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.  </span></div>The carrying amounts of financial instruments such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate the related fair values due to the short-term maturities of these instruments.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents and Investments</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are comprised of short-term, highly-liquid investments with original maturities of 90 days or less.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Securities and Investments</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have strategic investments in privately-held companies (non-marketable equity securities) and publicly traded companies (marketable equity securities). Our marketable equity securities are measured at fair value. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Equity investments are classified as current, short-term investments, or noncurrent, recorded in other assets, based on the nature of the securities and their availability for use in current operations. Realized and unrealized gains and losses on our equity investments are recorded in other expense, net in the consolidated statements of operations. Our equity investments are assessed for impairment quarterly. Impairment losses, equal to the difference between the carrying value and the fair value of the investment, are recorded in other expense, net. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the equity method to account for investments through which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded in other assets, and our share of net income or loss is recognized on a one quarter lag in other expense, net.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. Receivables are considered past due based on the contractual payment terms. We reserve a percentage of our trade receivable balance based on collection history and current economic trends that we expect will impact the level of credit losses over the life of our receivables. These reserves are re-evaluated on a regular basis and adjusted, as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div>Inventory is stated at the lower of cost or net realizable value, on a first-in, first-out basis. Inventory includes raw materials and finished goods that may be used in the research and development process, and such items are expensed as consumed or capitalized as property and equipment and depreciated. Inventory write-downs for slow-moving, excess, and obsolete inventories are estimated based on product life cycles, quality issues, historical experience, and usage forecasts.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, using the straight-line method. Depreciation of leasehold improvements is recorded over the shorter of the lease term or the estimated useful life of the related assets. Maintenance and repairs are expensed as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred to develop internal-use software during the application development stage are recorded at cost as computer software. Costs incurred in the development of such internal-use software, including external direct costs of materials and services and applicable compensation costs of employees devoted to specific software application development, are capitalized. Costs incurred outside of the application development stage are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have various non-cancellable operating lease agreements for office, lab, manufacturing, and distribution facilities. These leases have remaining lease terms of 1 year to 14 years, which represent the non-cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised. We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from 2 years to 20 years. Our lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms, as well as payments for common-area-maintenance and administrative services. We often receive customary incentives from our landlords, such as reimbursements for tenant improvements and rent abatement periods, which effectively reduce the total lease payments owed for these leases. Leases are classified as operating or financing at commencement. As of December&#160;29, 2024, we do not have any financing leases.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and liabilities on our consolidated balance sheets represent the present value of our remaining lease payments over the remaining lease terms, less any impairments recorded for right-of-use assets. We do not allocate lease payments to non-lease components; therefore, fixed payments for common-area-maintenance and administrative services are included in our operating lease right-of-use assets and liabilities. We use our incremental borrowing rate to calculate the present value of our lease payments, as the implicit rates in our leases are not readily determinable. Operating lease costs consist primarily of the fixed lease payments included in our operating lease liabilities and are recorded on a straight-line basis over the lease terms. We sublease certain real estate to third parties and this sublease income is also recorded on a straight-line basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the acquisition method of accounting, we allocate the fair value of the total consideration transferred to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the date of acquisition. These valuations require us to make estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill. Costs that we incur to complete the business combination, such as legal and other professional fees, are expensed as they are incurred.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain acquisitions, contingent consideration can be earned by the sellers upon completion of certain future performance milestones. In these cases, a liability is recorded on the acquisition date, as a component of accrued liabilities and/or other long-term liabilities, for an estimate of the acquisition-date fair value of the contingent consideration. These estimates require management judgment, including probabilities of achieving certain future milestones. Changes in the fair value of the contingent consideration subsequent to the acquisition date are recognized in selling, general and administrative expense in our consolidated statements of operations.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the initial accounting for a business combination is incomplete by the end of a reporting period that falls within the measurement period (not to exceed a year from the date of acquisition), we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. We record these adjustments to the provisional amounts with a corresponding offset to goodwill. Any adjustments identified after the measurement period are recorded in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill, Intangible Assets and Other Long-Lived Assets</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill, Intangible Assets and Other Long-Lived Assets</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets acquired, including intangible assets and capitalized in-process research and development (IPR&amp;D), and liabilities assumed are measured at fair value as of the acquisition date. Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of the net assets acquired. Intangible assets acquired in a business combination that are used for IPR&amp;D activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project (i.e., upon commercialization), the IPR&amp;D asset is amortized over its estimated useful life. If the relevant research and development project is abandoned, the IPR&amp;D asset is expensed in the period of abandonment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and IPR&amp;D are not amortized; however, they are reviewed for impairment at least annually during the second quarter, or more frequently if an event occurs indicating the potential for impairment. Goodwill and IPR&amp;D are considered to be impaired if the carrying value of the reporting unit or IPR&amp;D asset exceeds its respective fair value.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with our reporting structure and availability of discrete financial information. During the goodwill impairment review, we assess qualitative factors to determine whether it is more likely than not that the fair values of our reporting units are less than the carrying amounts, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and our overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair values of our reporting units are less than the carrying amounts, then no additional assessment is deemed necessary. Otherwise, we proceed to compare the estimated fair values of the reporting units with the carrying values, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, we record an impairment loss based on the difference. We may elect to bypass the qualitative assessment in a period and proceed to perform the quantitative goodwill impairment test.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D impairment test is performed by comparing the fair value of the asset to its carrying amount. When testing indefinite-lived intangibles for impairment, we may assess qualitative factors to determine whether it is more likely than not that the asset is impaired. Alternatively, we may bypass this qualitative assessment and perform a quantitative impairment test. If the IPR&amp;D asset is impaired, the carrying value of the IPR&amp;D is written down to the revised fair value with the related impairment charge recognized in the period in which the impairment occurs. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our identifiable intangible assets with a finite life are typically comprised of acquired developed technologies, licensed technologies, customer relationships, license agreements, and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#8217; respective estimated useful lives.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform regular reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss in an amount equal to the excess of the carrying value over the fair value. Factors that may indicate potential impairment include a significant decline in our stock price and market capitalization compared to the net book value, significant changes in the ability of a particular asset to generate positive cash flows for our strategic business objectives, and the pattern of utilization of a particular asset.  </span></div>We review our operating lease right-of-use assets for impairment whenever events or changes in circumstances indicate the carrying value of the right-of-use asset may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. We consider a triggering event to reassess a right-of-use asset&#8217;s asset group to have occurred if we exit a portion of or the full facility or enter into a sublease. Factors that may indicate potential impairment include a significant decrease in the market price of an underlying leased asset group. If we conclude the carrying value of affected assets will not be recovered, we estimate the fair value of the assets and record an impairment in an amount equal to the excess of the carrying value over the fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign exchange rate risks in the normal course of business and use derivative financial instruments to partially offset this exposure. We do not use derivative financial instruments for speculative or trading purposes. Foreign exchange contracts are carried at fair value in other current assets, other assets, accrued liabilities, or other long-term liabilities, as appropriate, on the consolidated balance sheets. The cash flows associated with such foreign exchange contracts, or derivative financial instruments, are classified as cash flows from operating activities in the consolidated statements of cash flows, which is the same category as the hedged transaction.</span></div>We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these derivatives are recognized in other expense, net, along with the re-measurement gain or loss on the foreign currency denominated assets or liabilities. As of December&#160;29, 2024, we had foreign exchange forward contracts in place to hedge exposures in the euro, Japanese yen, Australian dollar, Canadian dollar, Singapore dollar, Chinese Yuan Renminbi, and British pound.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranties</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranties</span></div>We generally provide a one-year warranty on instruments. Additionally, we provide a warranty on consumables through the expiration date, which generally ranges from <span style="-sec-ix-hidden:f-489">six</span> to twelve months after the manufacture date. At the time revenue is recognized, an accrual is established for estimated warranty expenses based on historical experience as well as anticipated product performance. We periodically review the warranty reserve for adequacy and adjust the warranty accrual, if necessary, based on actual experience and estimated costs to be incurred. Warranty expense is recorded as a component of cost of product revenue.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is incurred related to restricted stock, employee stock purchase plan (ESPP), stock options, and, prior to the GRAIL Spin-Off on June&#160;24, 2024, cash-based equity incentive awards. Forfeitures are accounted for, as incurred, as a reversal of share-based compensation expense related to awards that will not vest.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock units (RSU) and performance stock units (PSU) are both considered restricted stock. The determination of the amount of share-based compensation expense for our PSU requires the use of certain estimates and assumptions that affect the amount of share-based compensation expense recognized in our consolidated statements of operations. The fair value of restricted stock and performance stock units that do not include a market condition is determined by the closing market price of our common stock on the date of grant. PSU that do not include a market condition represent a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any increase or decrease in share-based compensation expense resulting from an adjustment in the estimated shares to be released is treated as a cumulative catch-up in the period of adjustment. The fair value of performance stock units that include a market condition is determined on the date of grant using a Monte Carlo simulation, which includes assumptions for expected volatility, risk-free interest rate and dividend yield. These unobservable inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. Share-based compensation expense is recognized based on the fair value on a straight-line basis over the requisite service periods of the awards. Compensation expense for PSU that include a market condition is recognized over the requisite service period regardless of whether the market conditions are achieved.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchased under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. The expected volatility is generally determined by weighing the historical and implied volatility of our common stock. The historical volatility is generally commensurate with the estimated expected term. The implied volatility is calculated from the implied market volatility of exchange-traded call options on our common stock. The expected term is generally based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be 0% given that we have never declared or paid cash dividends on our common stock and do not anticipate paying such cash dividends. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash-based equity incentive awards were classified as liability awards, as such awards were to be settled in cash. In connection with the Spin-Off of GRAIL, these awards were assumed by GRAIL. For purposes of valuation and performance measurement of the awards, GRAIL&#8217;s stand-alone value calculation, as estimated by GRAIL based on its analysis and on input from independent valuation advisors and analyses, was used. The fair value of the awards was recorded over the respective vesting periods of the awards, with recognition of a corresponding liability recorded in accrued liabilities in the consolidated balance sheets. The awards were remeasured to fair value at each reporting date until the awards were settled, with changes in fair value recognized in share-based compensation expense.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div>Research and development expenses include personnel expenses, contractor fees, facilities-related costs, material costs, and license fees. Expenditures relating to research and development are expensed in the period incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></div>Advertising costs are expensed as incurred<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_RestructuringPolicyTextBlock', window );">Restructuring</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure and accrue liabilities associated with employee separation costs, which primarily consist of severance pay and other separation costs such as outplacement services and benefits, at fair value as of the date the plan is approved and when such costs are reasonably estimable. The fair value measurement of restructuring related liabilities requires certain assumptions and estimates to be made, such as the retention period of certain employees. It is our policy to use the best estimates based on facts and circumstances available at the time of measurement, review the assumptions and estimates periodically, and adjust the liabilities when necessary.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date.  </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise, we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.  </span></div>The impact of a tax position is recognized in the consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected in income tax expense.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_RestructuringPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_RestructuringPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Paragraph 2AA<br> -Subparagraph (a)<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-2AA<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084957312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings Per Share, Earnings Per Share</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average shares used to calculate basic and diluted loss per share were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:60.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in calculating basic loss per share</span></div></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in calculating diluted loss per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity awards</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded due to antidilutive effect</span></div></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Estimated Useful Lives of Major Classes of Property and Equipment</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of the major classes of property and equipment are generally as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 9 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></div></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">772</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">683</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">478</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,069</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078409088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GRAIL SPIN-OFF (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Assets and Liabilities Included as Part of the Disposal Group</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of GRAIL&#8217;s assets and liabilities included as part of the disposal group were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long term-liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL net assets</span></div></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,738&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of GRAIL net assets recorded to short-term investments</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of GRAIL net assets recorded to additional paid-in capital</span></div></td><td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional adjustments recorded to additional paid-in capital as a result of the GRAIL Spin-Off:</span></div></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-contingent indemnification liability (see </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_118" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Note 7</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax adjustment for difference between the book and tax values of our retained investment in GRAIL</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recorded to additional paid-in capital as a result of the GRAIL Spin-Off</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Includes IPR&amp;D with a carrying value of $140&#160;million after impairment. Refer to note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">5. Goodwill, Intangible</a><a href="#i64df1cccf2dd452496bdff4e9d30a288_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"> Assets, and Acquisitions</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085003264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue by Source</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sequencing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Microarray</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sequencing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Microarray</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sequencing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Microarray</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,858</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">297</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,155</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,790&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,083&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,225&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">484</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">314</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,787&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,628&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,953&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">651</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">716</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,993</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">379</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,372</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,112&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,504&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,171&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,584&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue by Geographic Area</span></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Based on region of destination (in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,441</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,185</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">308</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific, Middle East and Africa</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">438</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,372</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,504&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,584&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">We implemented a new global commercial structure in Q1 2023 to improve operating efficiencies and better align with local markets. We integrated Asia-Pacific and Japan with emerging markets across the Middle East, Africa, Turkey, and Commonwealth of Independent States (CIS). Beginning in Q1 2023, and going forward, we report regional results for the following regions: Americas, Europe, Greater China, and Asia-Pacific, Middle East and Africa (AMEA). Prior period amounts have been reclassified to conform to this new presentation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">Americas revenue included United States revenue of $2,288&#160;million, $2,359&#160;million, and $2,290&#160;million in 2024, 2023 and 2022, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">Region includes revenue from China, Taiwan, and Hong Kong.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt">Region includes revenue from Russia and Turkey.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085387232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text"><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and (losses) recognized in other expense, net on marketable equity securities were as follows:</span></div><div style="margin-top:13pt;padding-left:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:66.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) recognized during the period on marketable equity securities</span></div></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(310)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net (losses) recognized during the period on marketable equity securities sold during the period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (losses) recognized during the period on marketable equity securities still held at the reporting date</span></div></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(310)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsTableTextBlock', window );">Schedule of Other Commitments</a></td>
<td class="text"><div style="margin-top:13pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitments to the Funds are as follows:</span></div><div style="margin-top:13pt;padding-left:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.965%"><tr><td style="width:1.0%"></td><td style="width:36.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital commitments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Callable through date</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remaining callable as of December&#160;29, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fund I</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2026</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fund II</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fund III</span></div></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2034</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Fund I also had recallable distributions of approximately $10&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy&#160;for assets and liabilities measured at fair value on a recurring basis:</span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"><tr><td style="width:1.0%"></td><td style="width:28.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets:</span></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds (cash equivalents)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">931</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">931</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helix contingent value right</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,111</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes in Estimated Fair Value of Acquisition Related Contingent Consideration Liabilities</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Helix contingent value right were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received to settle</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(83)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the estimated fair value of our contingent consideration liabilities were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">387</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(315)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about obligations resulting from other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078890304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span><div style="margin-bottom:1pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(712)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,545</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,466)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"> The balance as of January&#160;1, 2023 includes accumulated impairment of $3,914&#160;million related to our GRAIL reporting unit.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.982%"><tr><td style="width:1.0%"></td><td style="width:17.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible Assets,<br/>Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible Assets,<br/>Net</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technologies</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">465</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(305)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,222&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensed technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">234</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Database</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangible assets, net</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">748</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(453)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">295</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-848"><span style="-sec-ix-hidden:f-849">In-process research and development (IPR&amp;D)</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">748</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(453)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">295</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Annual Amortization of Finite-lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future annual amortization of finite-lived intangible assets is shown in the following table. Actual amortization expense to be reported in future periods could differ from these estimates as a result of acquisitions, divestitures, and asset impairments, among other factors.</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Annual Amortization</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085132512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND OTHER COMMITMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt Obligations</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Term Debt Obligations</span><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.328%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2025 Term Notes outstanding</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2026 Term Notes outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2027 Term Notes outstanding</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of 2031 Term Notes outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discounts and debt issuance costs</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of term debt</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,989</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">499</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term debt, non-current</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,490</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of term debt outstanding (Level 2)</span></div></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,940</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Leases</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;29, 2024, the maturities of our operating lease liabilities were as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total remaining lease payments</span></div></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 years</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Components of Lease Costs</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of our lease costs were as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Variable lease costs include non-fixed maintenance charges and property taxes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077284768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity and Related Information, Restricted Stock</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock activity was as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted <br/>Stock Units <br/>(RSU)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(PSU) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant-<br/>Date Fair Value per Share</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Units in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSU</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.66&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.42&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(707)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.56&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.55&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.23&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.74&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.08&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,198</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">236.32</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">729</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">133.73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164.38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested adjustment for GRAIL Spin-Off</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">249.70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(443)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">195.11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">167.68</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,879</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158.60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164.87</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span>For EPS and OM PSU, the number of units reflect the estimated number of shares to be issued at the end of the performance period. For rTSR PSU, the number of units reflect the estimated number of shares to be issued based on performance as of the current reporting period. Awarded units are presented net of performance adjustments.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock', window );">Schedule of Restricted Stock Activity and Related Information, Performance Units</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock activity was as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.828%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted <br/>Stock Units <br/>(RSU)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(PSU) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant-<br/>Date Fair Value per Share</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Units in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSU</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.66&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.42&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(707)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.56&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.55&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.23&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.74&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.08&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,198</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">236.32</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">729</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">133.73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164.38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested adjustment for GRAIL Spin-Off</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">249.70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(443)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">195.11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">167.68</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,879</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158.60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">164.87</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span>For EPS and OM PSU, the number of units reflect the estimated number of shares to be issued at the end of the performance period. For rTSR PSU, the number of units reflect the estimated number of shares to be issued based on performance as of the current reporting period. Awarded units are presented net of performance adjustments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock', window );">Schedule of Pre-tax Intrinsic Values of Vested Restricted Stock</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax intrinsic value and fair value of vested restricted stock was as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax intrinsic value of outstanding restricted stock:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of restricted stock vested:</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">116</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Total Fair Value of Vested Restricted Stock</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax intrinsic value and fair value of vested restricted stock was as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax intrinsic value of outstanding restricted stock:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of restricted stock vested:</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">116</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity Under all Stock Option Plans</a></td>
<td class="text"><div style="margin-top:13pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity was as follows:  </span></div><div style="margin-bottom:1pt;margin-top:13pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Units in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Stock Options</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise&#160;Price</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.42&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.54&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.09&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.69&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">330.25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">330.25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span>In connection with the GRAIL acquisition, we issued replacement performance stock options to GRAIL employees in 2021. The number of units reflected awards that had been granted and for which it was assumed to be probable that the underlying performance goals would be achieved. In connection with the GRAIL Spin-Off, all outstanding performance stock options were assumed by GRAIL.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock', window );">Schedule of Cash-Based Equity Incentive Award Activity</a></td>
<td class="text"><div style="margin-bottom:13pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash-based equity incentive award activity was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 2, 2022</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and paid in cash</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and paid in cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">292</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and paid in cash</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derecognition for GRAIL Spin-Off</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 29, 2024</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">The estimated liability immediately prior to the Spin-Off, recorded in accrued liabilities, was $53&#160;million, which was disposed of as part of GRAIL&#8217;s net assets. See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_40" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">2. GRAIL Spin-Off</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional details.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions used to Estimate the Weighted-Average Fair Value Per Share for Stock Purchase under the Employee Stock Purchase Plan</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for the specified reporting periods and the resulting estimates of weighted-average fair value per share for stock purchased under the ESPP were as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.35% - 5.54%</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;0.78% - 5.54% </span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06% - 2.98%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41% - 49%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;41% - 51% </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37% - 51%</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.5 - 1.1 year</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;0.5 - 1.1 year </span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 1.0 year</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value per share</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37.24</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.87&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.22&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share repurchase activity</a></td>
<td class="text"><div style="margin-bottom:13pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share repurchase activity during 2024 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:81.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions, except shares in thousands</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares repurchased</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of shares repurchased</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Total cost of shares repurchased includes the 1% excise tax imposed as part of the Inflation Reduction Act of 2022, which is calculated based on share repurchases, net of certain share issuances.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expense for all Stock Awards</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense, which includes expense for both equity and liability-classified awards, reported in our consolidated statements of operations was as follows:  </span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">194</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, before taxes</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of taxes</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">288</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Liability-Classified Awards, Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078120432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, gross</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">744</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">735</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">225</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">404</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">660</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserve</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(113)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">547</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of the major classes of property and equipment are generally as follows:</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 to 20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 9 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></div></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">772</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">683</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">478</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,069</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,007&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal contingencies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation expenses</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">252</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1239"><span style="-sec-ix-hidden:f-1240">Operating lease liabilities, current portion</span></span></span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified equity incentive awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, including warranties</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">See note </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i64df1cccf2dd452496bdff4e9d30a288_127" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">9. Legal Proceedings</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional details.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">See table below for changes in the reserve for product warranties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Changes in Reserve for Product Warranties</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the reserve for product warranties were as follows:  </span></div><div style="margin-bottom:1pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 2, 2022</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repairs and replacements</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to cost of product revenue</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repairs and replacements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repairs and replacements</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 29, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring and Related Costs</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the pre-tax restructuring charges is as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:47.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.025%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative charges recorded since inception</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee separation costs</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other costs</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">For 2024, relates to impairment of right-of-use assets and leasehold improvements for Foster City campus and other property in San Diego. </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For 2023, primarily relates to impairment of right-of-use assets and leasehold improvements for our i3 and Foster City campuses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">For 2024, $59&#160;million was recorded in SG&amp;A expense, $2&#160;million in R&amp;D expense, and remainder in cost of revenue.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">For 2023, $122&#160;million was recorded in SG&amp;A expense, $24&#160;million in R&amp;D expense, and remainder in cost of revenue.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total restructuring charges primarily relate to our Core Illumina segment.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the restructuring liability is as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Separation Costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded in accrued liabilities as of January&#160;1, 2023</span></div></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recorded</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded in accrued liabilities as of December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recorded</span></div></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to accrual</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded in accrued liabilities as of December&#160;29, 2024</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077874352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of (Loss) Income before Income Taxes by Region</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes summarized by region was as follows:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,834)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,735)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,942)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">655</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss before income taxes</span></div></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,179)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,117)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,336)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax provision</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Provision for (Loss) Income Taxes to Amount Computed by Applying the Federal Statutory Rate</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes reconciles to the amount computed by applying the federal statutory rate to loss before income taxes as follows:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at federal statutory rate</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(248)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and other credits</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of R&amp;D expense capitalization</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of net operating losses on GILTI, U.S. foreign tax credits, and Pillar Two global minimum top-up tax</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign operations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual of European Commission fine</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(99)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">308</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of acquisition related items</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax provision</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Significant Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of deferred tax assets and liabilities were as follows:  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">189</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">252</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized U.S. R&amp;D expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">181</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other amortization</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">953</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance on deferred tax assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(278)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">675</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased intangible amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(117)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(847)</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">558</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gross amount of our uncertain tax positions:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">210</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to lapse of statute of limitations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084957312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Operating Performance and Assets by Segment</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CODM allocates resources and evaluates business performance based on revenues and net income (loss). Net income (loss) is used in the annual budgeting and monthly forecasting processes and to monitor and assess budgeted/forecasted versus actual results. Our CODM does not evaluate segments using asset information. The accounting policies for segments are the same as those described in the summary of significant accounting policies. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present selected financial information with respect to segments for the periods presented:</span></div><div style="margin-bottom:6pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina:</span></div></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,332</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,424</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">988</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">638</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">262</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible impairment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal contingency and settlement</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(456)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,473</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL:</span></div></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,712&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated other expense, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">346</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated provision for income taxes</span></div></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment eliminations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net loss</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,223)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,161)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,404)</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Core Illumina revenue for 2024, 2023, and 2022 included intercompany revenue of $15 million, $26 million, and $24 million, respectively.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">GRAIL operating expenses are inclusive of cost of revenue, research and development, selling and marketing, general and administrative, and goodwill and intangible impairment for the comparative periods prior to the Spin-Off on June&#160;24, 2024.</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">280</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">354</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Illumina</span></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GRAIL</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Net Long-lived Assets Consisting of Property and Equipment by Region</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, consisting of property and equipment and operating lease right-of-use assets, were as follows:</span></div><div style="margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 29,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">750</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040&#160;</span></td><td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">279</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets, net</span></div></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,234</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dddddd;padding:0 1pt"></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,551&#160;</span></td><td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078483152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Business Overview (Details) - Spinoff - GRAIL<br></strong></div></th>
<th class="th">
<div>Jun. 24, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction</a></td>
<td class="nump">26,547,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf', window );">Percent of interest disposed</a></td>
<td class="nump">85.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal', window );">Discontinued operation, equity method investment retained after disposal, ownership interest after disposal</a></td>
<td class="nump">14.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Number Of Shares Issued In Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Percent Of Interest Disposed Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DiscontinuedOperationPercentOfInterestDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent, after disposal, of ownership interest of a discontinued operation in which an equity method investment is retained.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077801632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Concentrations of Risk (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember', window );">Credit Concentration Risk | Investment Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ConcentrationRiskThreshold', window );">Maximum investment portfolio credit exposure</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember', window );">Credit Concentration Risk | Issue Size</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ConcentrationRiskThreshold', window );">Maximum investment portfolio credit exposure</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=ilmn_IndustryCreditConcentrationRiskMember', window );">Industry Credit Concentration Risk | Investment Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ConcentrationRiskThreshold', window );">Maximum investment portfolio credit exposure</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Customer Concentration Risk | Revenue Benchmark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percent</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Outside the United States | Geographic Concentration Risk | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percent</a></td>
<td class="nump">53.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ConcentrationRiskThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Concentration Risk, Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ConcentrationRiskThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ilmn_InvestmentPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ilmn_InvestmentPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=ilmn_IssueSizeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=ilmn_IssueSizeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ilmn_IndustryCreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ilmn_IndustryCreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937079024272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Recently Adopted Accounting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="num">$ (1,242)<span></span>
</td>
<td class="num">$ (19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="num">$ (7,525)<span></span>
</td>
<td class="num">$ (9,555)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">ASU 2020-06 | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (93)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-5<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 80: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 81: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 82: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 83: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 84: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 85: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 86: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-6<br><br>Reference 87: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 88: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 89: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 90: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 91: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 92: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 93: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 94: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 95: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 96: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 97: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 98: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-3<br><br>Reference 99: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 100: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077497264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Revenue Recognition (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_RevenueFromContractWithCustomerPaymentTerm', window );">Payment period from invoice</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_RevenueFromContractWithCustomerPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Payment Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_RevenueFromContractWithCustomerPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937076914448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings (Loss) Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in shares)</a></td>
<td class="nump">159,000,000<span></span>
</td>
<td class="nump">158,000,000<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares used in calculating diluted earnings (loss) per share (in shares)</a></td>
<td class="nump">159,000,000<span></span>
</td>
<td class="nump">158,000,000<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded due to antidilutive effect</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Equity awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded due to antidilutive effect</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded due to antidilutive effect</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937072465008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Lives of Major Classes of Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ilmn_BuildingandLeaseholdImprovementsMember', window );">Buildings and leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ilmn_BuildingandLeaseholdImprovementsMember', window );">Buildings and leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer hardware and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer hardware and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ilmn_BuildingandLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ilmn_BuildingandLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937087535664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Leases (Details)<br></strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Lessee, operating lease, remaining lease term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, operating lease, renewal term</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Lessee, operating lease, remaining lease term</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, operating lease, renewal term</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077198576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Derivative Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Sep. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative term</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss) hedge</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Gain to be reclassified into earnings within the next 12 months</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ilmn_GRAILInc.Member', window );">GRAIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets related to terminated acquisition</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities related to terminated acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of outstanding forward contracts</a></td>
<td class="nump">477<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of outstanding forward contracts</a></td>
<td class="nump">$ 621<span></span>
</td>
<td class="nump">$ 628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 30: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937081961712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Warranties (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ilmn_InstrumentsMember', window );">Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyLiabilityLineItems', window );"><strong>Product Warranty Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_StandardProductWarrantyDescriptionTerm', window );">Warranty period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ilmn_ConsumablesMember', window );">Consumables | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyLiabilityLineItems', window );"><strong>Product Warranty Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_StandardProductWarrantyDescriptionTerm', window );">Warranty period</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ilmn_ConsumablesMember', window );">Consumables | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyLiabilityLineItems', window );"><strong>Product Warranty Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_StandardProductWarrantyDescriptionTerm', window );">Warranty period</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_StandardProductWarrantyDescriptionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the approximate term of the product warranty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_StandardProductWarrantyDescriptionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ilmn_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ilmn_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ilmn_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ilmn_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078731968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Share-Based Compensation (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077776576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Advertising Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937082169040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GRAIL SPIN-OFF - Narrative (Details) - Spinoff - GRAIL - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2024</div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction</a></td>
<td class="nump">26,547,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf', window );">Percent of interest disposed</a></td>
<td class="nump">85.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff', window );">Number of parent shares converted into one share of spin-off (in shares)</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal', window );">Discontinued operation, equity method investment retained after disposal, ownership interest after disposal</a></td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal', window );">Period of continuing involvement after disposal</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal', window );">Amount of continuing cash flows after disposal</a></td>
<td class="nump">$ 974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DiscontinuedOperationTransactionCosts', window );">Separation-related transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Number Of Parent Shares Converted Into One Share Of Spin-Off</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Number Of Shares Issued In Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Percent Of Interest Disposed Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DiscontinuedOperationPercentOfInterestDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DiscontinuedOperationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DiscontinuedOperationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) the discontinued operation after the disposal transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent, after disposal, of ownership interest of a discontinued operation in which an equity method investment is retained.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of expected continuing involvement with a discontinued operation after the disposal date, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937082127264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GRAIL SPIN-OFF - Assets and Liabilities Included as Part of the Disposal Group (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 24, 2024</div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILIncMember', window );">GRAIL Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract', window );"><strong>Additional adjustments recorded to additional paid-in capital as a result of the GRAIL Spin-Off:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,914<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Spinoff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventory, net</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">2,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities', window );">Other long term-liabilities</a></td>
<td class="num">(469)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets', window );">GRAIL net assets</a></td>
<td class="nump">2,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract', window );"><strong>Additional adjustments recorded to additional paid-in capital as a result of the GRAIL Spin-Off:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining', window );">Non-contingent indemnification liability (see Note 7)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal', window );">Tax adjustment for difference between the book and tax values of our retained investment in GRAIL</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital', window );">Total recorded to additional paid-in capital as a result of the GRAIL Spin-Off</a></td>
<td class="nump">2,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Spinoff | In-process research and development (IPR&amp;D)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Spinoff | Short-Term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets', window );">GRAIL net assets</a></td>
<td class="nump">397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Spinoff | Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets', window );">GRAIL net assets</a></td>
<td class="nump">$ 2,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Adjustment To Additional Paid In Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Net Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts of material contingent liabilities, for example, but not limited to, product or environmental liabilities or litigation, that remain with the entity despite the disposal of the disposal group that is classified as a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.Z.5.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480781/205-20-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit on (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937080166016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Schedule of Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 4,372<span></span>
</td>
<td class="nump">$ 4,504<span></span>
</td>
<td class="nump">$ 4,584<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,441<span></span>
</td>
<td class="nump">2,521<span></span>
</td>
<td class="nump">2,479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,185<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">Greater China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">384<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ilmn_AsiaPacificMiddleEastAndAfricaMember', window );">Asia-Pacific, Middle East and Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">438<span></span>
</td>
<td class="nump">459<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,288<span></span>
</td>
<td class="nump">2,359<span></span>
</td>
<td class="nump">2,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">3,656<span></span>
</td>
<td class="nump">3,787<span></span>
</td>
<td class="nump">3,953<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ilmn_ConsumablesMember', window );">Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">3,155<span></span>
</td>
<td class="nump">3,083<span></span>
</td>
<td class="nump">3,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ilmn_InstrumentsMember', window );">Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">704<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service and other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">716<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="nump">631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_SequencingMember', window );">Sequencing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">3,993<span></span>
</td>
<td class="nump">4,112<span></span>
</td>
<td class="nump">4,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_SequencingMember', window );">Sequencing | Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">3,342<span></span>
</td>
<td class="nump">3,475<span></span>
</td>
<td class="nump">3,628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_SequencingMember', window );">Sequencing | Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,858<span></span>
</td>
<td class="nump">2,790<span></span>
</td>
<td class="nump">2,919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_SequencingMember', window );">Sequencing | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">685<span></span>
</td>
<td class="nump">709<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_SequencingMember', window );">Sequencing | Service and other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">651<span></span>
</td>
<td class="nump">637<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_MicroarrayMember', window );">Microarray</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">379<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_MicroarrayMember', window );">Microarray | Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_MicroarrayMember', window );">Microarray | Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_MicroarrayMember', window );">Microarray | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_MicroarrayMember', window );">Microarray | Service and other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ilmn_AsiaPacificMiddleEastAndAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ilmn_AsiaPacificMiddleEastAndAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ilmn_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ilmn_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ilmn_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ilmn_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_SequencingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ilmn_SequencingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_MicroarrayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ilmn_MicroarrayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937082154848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Narrative - Remaining Performance Obligation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 29, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation</a></td>
<td class="nump">$ 657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation</a></td>
<td class="nump">$ 657<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame', window );">Product or service delivery period</a></td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame', window );">Product or service delivery period</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Percent of remaining performance obligation</a></td>
<td class="nump">78.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Percent of remaining performance obligation</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition, Multiple-Deliverable Arrangements, Delivery Time Frame</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937081950912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Narrative - Contract Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, current portion</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized, previously deferred</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937079179648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 24, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th">
<div>Dec. 29, 2024 </div>
<div>USD ($) </div>
<div>day </div>
<div>fund</div>
</th>
<th class="th">
<div>Sep. 29, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag', window );">Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">unrealized loss<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Strategic equity investments, without readily determinable fair values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,372,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,504,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,584,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ilmn_GRAILInc.Member', window );">GRAIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_BusinessAcquisitionContingentValueRightsTerm', window );">Contingent value right, terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability', window );">Covered revenues of GRAIL, contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment for contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ilmn_GRAILInc.Member', window );">GRAIL | Payment Rights Of One Billion Each Twelve Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage', window );">Contingent payment rights, first percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold', window );">Business acquisition, contingent value rights, revenue threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ilmn_GRAILInc.Member', window );">GRAIL | Payment Rights Of Above One Billion Each Twelve Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold', window );">Business acquisition, contingent value rights, revenue threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage', window );">Contingent payment rights, second percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ilmn_HelixContingentConsiderationMember', window );">Helix Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Contingent consideration asset settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ilmn_HelixHoldingsILLCMember', window );">Helix Holdings I, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_BusinessAcquisitionContingentValueRightsTerm', window );">Contingent value right, terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember', window );">Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundMember', window );">Venture Capital Investment Fund (the Fund)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_NumberOfInvestmentFunds', window );">Number of venture capital investment funds | fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain (loss) on equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (25,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Revenue Risk Premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Revenue risk premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Measurement Input, Calculation Trailing Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Revenue risk premium | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember', window );">Spinoff | GRAIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets', window );">GRAIL net assets</a></td>
<td class="nump">$ 2,738,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal', window );">Discontinued operation, equity method investment retained after disposal, ownership interest after disposal</a></td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Loss on disposal of discontinued operation, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 309,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease', window );">Increase in 20% of revenue, increase in liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease', window );">Decrease in 20% of revenue, decrease in liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease', window );">Effect of change of additional 250 basis points, decrease in liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease', window );">Effect of change of additional 250 basis points, increase in liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-Term Investments | Spinoff | GRAIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets', window );">GRAIL net assets</a></td>
<td class="nump">$ 397,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Value Rights, Pro Rata One, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Value Rights, Pro Rata Two, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Value Rights, Revenue Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_BusinessAcquisitionContingentValueRightsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Value Rights, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_BusinessAcquisitionContingentValueRightsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Covered Revenues of GRAIL, Contingent Consideration Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensive Income Extensible Enumeration Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Net Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_NumberOfInvestmentFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Investment Funds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_NumberOfInvestmentFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Decrease</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent Decrease, Decrease</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent, Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent, after disposal, of ownership interest of a discontinued operation in which an equity method investment is retained.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ContingentPaymentRightsAxis=ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ContingentPaymentRightsAxis=ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ContingentPaymentRightsAxis=ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ContingentPaymentRightsAxis=ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ilmn_HelixContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ilmn_HelixContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ilmn_HelixHoldingsILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ilmn_HelixHoldingsILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=ilmn_MeasurementInputRevenueRiskPremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=ilmn_MeasurementInputRevenueRiskPremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=ilmn_MeasurementInputCalculationTrailingPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=ilmn_MeasurementInputCalculationTrailingPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937079297296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Marketable Equity Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLossAbstract', window );"><strong>Marketable Securities, Gain (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net (losses) recognized during the period on marketable equity securities</a></td>
<td class="num">$ (310)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Less: Net (losses) recognized during the period on marketable equity securities sold during the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Net unrealized (losses) recognized during the period on marketable equity securities still held at the reporting date</a></td>
<td class="num">$ (310)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (81)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077711088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Other Commitments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 29, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_RecallableDistributionsCommitment', window );">Recallable distributions</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundOneMember', window );">Fund I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Capital commitments</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_RemainingCapitalCommitment', window );">Remaining callable</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundTwoMember', window );">Fund II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Capital commitments</a></td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_RemainingCapitalCommitment', window );">Remaining callable</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundThreeMember', window );">Fund III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Capital commitments</a></td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_RemainingCapitalCommitment', window );">Remaining callable</a></td>
<td class="nump">$ 47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_RecallableDistributionsCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recallable Distributions Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_RecallableDistributionsCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_RemainingCapitalCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining Capital Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_RemainingCapitalCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ilmn_VentureCapitalInvestmentFundTheFundThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077592480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Hierarchy&#160;for Assets and Liabilities Measured at Fair Value Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan assets</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="nump">931<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_OtherInvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ContingentValueRightFairValueDisclosure', window );">Helix contingent value right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan assets</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">1,111<span></span>
</td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent', window );">Deferred compensation plan liability</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value, Measurements, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="nump">931<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_OtherInvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ContingentValueRightFairValueDisclosure', window );">Helix contingent value right</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent', window );">Deferred compensation plan liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value, Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_OtherInvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ContingentValueRightFairValueDisclosure', window );">Helix contingent value right</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan assets</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent', window );">Deferred compensation plan liability</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value, Measurements, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_OtherInvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ContingentValueRightFairValueDisclosure', window );">Helix contingent value right</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent', window );">Deferred compensation plan liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 387<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ContingentValueRightFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Value Right, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ContingentValueRightFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_OtherInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Investments Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_OtherInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077235520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Changes in Estimated Fair Value of Acquisition (Details) - Helix Contingent Consideration - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning Balance</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Change in estimated fair value</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Cash received to settle</a></td>
<td class="num">(83)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 102<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-102<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ilmn_HelixContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ilmn_HelixContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937087530112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS AND FAIR VALUE MEASUREMENTS- Contingent Consideration Liabilities (Details) - Business Combination, Contingent Consideration, Liability - GRAIL - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning Balance</a></td>
<td class="nump">$ 387<span></span>
</td>
<td class="nump">$ 412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Acquisition</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in estimated fair value</a></td>
<td class="num">(315)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Cash payments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending Balance</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 387<span></span>
</td>
<td class="nump">$ 615<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 101<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ilmn_BusinessCombinationContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ilmn_BusinessCombinationContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077713040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Changes in Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at beginning of period</a></td>
<td class="nump">$ 2,545<span></span>
</td>
<td class="nump">$ 3,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="num">(1,466)<span></span>
</td>
<td class="num">(712)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">$ 1,113<span></span>
</td>
<td class="nump">$ 2,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILIncMember', window );">GRAIL Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937080044912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2024 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Dec. 29, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill and intangible impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,466<span></span>
</td>
<td class="nump">$ 712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillImpairmentMeasurementInput', window );">Goodwill impairment measurement input</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,113<span></span>
</td>
<td class="nump">2,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints', window );">Sensitivity analysis of intangible assets impairment additional charges impact of 300 basis points</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights | Fluent Bio Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Fluent Bio Sciences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ilmn_GRAILIncMember', window );">GRAIL Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillPotentialImpairmentLoss', window );">Goodwill potential impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount', window );">Fair value in excess of carrying amount (more than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillImpairmentTestDiscountRate', window );">Business combination impairment test percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Goodwill fair value recorded impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate', window );">Fair value of discount rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development (IPR&amp;D) | Series of Individually Immaterial Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember', window );">Spinoff | GRAIL Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal', window );">Amount of continuing cash flows after disposal</a></td>
<td class="nump">$ 974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Spinoff | GRAIL Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets', window );">GRAIL net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Spinoff | GRAIL Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets', window );">GRAIL net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_IntangibleAssetsImpairmentMeasurementInput', window );">Intangible assets impairment measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member', window );">GRAIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillAmountThatExceedsCarryingValue', window );">Goodwill amount that exceeds carrying value</a></td>
<td class="nump">580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill and intangible impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate', window );">Fair value of discount rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member', window );">GRAIL | In-process research and development (IPR&amp;D)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Goodwill fair value recorded impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate', window );">Goodwill impairment increase in discounted cash flow model discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillPotentialImpairmentLoss', window );">Goodwill potential impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate', window );">Goodwill impairment increase in discounted cash flow model discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillPotentialImpairmentLoss', window );">Goodwill potential impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Measurement Input Cash Flow Period Member | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_GoodwillImpairmentMeasurementInput', window );">Goodwill impairment measurement input</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member', window );">GRAIL | Measurement Input, Discount Rate | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_IntangibleAssetsImpairmentMeasurementInput', window );">Intangible assets impairment measurement input</a></td>
<td class="nump">0.465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Net Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_GoodwillAmountThatExceedsCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill Amount That Exceeds Carrying Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_GoodwillAmountThatExceedsCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill Impairment, Discounted cash flow model, Discount rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill Impairment Increase In Discounted Cash Flow Model Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_GoodwillImpairmentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill Impairment Measurement Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_GoodwillImpairmentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_GoodwillImpairmentTestDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Impairment Test, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_GoodwillImpairmentTestDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_GoodwillPotentialImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill Potential Impairment Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_GoodwillPotentialImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_IntangibleAssetsImpairmentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets Impairment Measurement Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_IntangibleAssetsImpairmentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Intangible Assets Impairment Additional Charges Impact Of 300 Basis Points</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) the discontinued operation after the disposal transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ilmn_FluentBioSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ilmn_FluentBioSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ilmn_GRAILIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ilmn_GRAILIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=ilmn_MeasurementInputCashFlowPeriodMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=ilmn_MeasurementInputCashFlowPeriodMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937082200560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Identifiable Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">$ 3,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(453)<span></span>
</td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">748<span></span>
</td>
<td class="nump">3,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(453)<span></span>
</td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 2,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Goodwill and intangible impairment<span></span>
</td>
<td class="text">Goodwill and intangible impairment<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 465<span></span>
</td>
<td class="nump">$ 2,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(305)<span></span>
</td>
<td class="num">(585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">2,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(305)<span></span>
</td>
<td class="num">(585)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ilmn_LicensedTechnologyMember', window );">Licensed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">License agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite Lived Intangible Assets, Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite Lived Intangible Assets (Excluding Goodwill), Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived Intangible Assets (Excluding Goodwill), Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets (Excluding Goodwill), Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of indefinite-lived intangible asset excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ilmn_LicensedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ilmn_LicensedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937072342720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Estimated Annual Amortization of Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Estimated Annual Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive', window );">Thereafter</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 2,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, After Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937076988128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT AND OTHER COMMITMENTS - Schedule of Debt Obligations (Details) - Term Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Sep. 09, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized discounts and debt issuance costs</a></td>
<td class="num">$ (11,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying amount of term debt</a></td>
<td class="nump">1,989,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,489,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion</a></td>
<td class="nump">499,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term debt, non-current</a></td>
<td class="nump">1,490,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,489,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of term debt outstanding (Level 2)</a></td>
<td class="nump">1,940,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,440,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">2025 Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">2026 Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">2027 Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">2031 Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937080556528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND OTHER COMMITMENTS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 09, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 17, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 04, 2023 </div>
<div>USD ($) </div>
<div>one_year_extension </div>
<div>consecutive_fiscal_quarter</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 20, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 03, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Aug. 21, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,525,000,000<span></span>
</td>
<td class="nump">$ 9,555,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,242,000,000)<span></span>
</td>
<td class="num">(19,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | ASU 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,000,000<span></span>
</td>
<td class="nump">74,000,000<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from the issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 991,000,000<span></span>
</td>
<td class="nump">$ 992,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">Term Notes | 2026 Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated rate</a></td>
<td class="nump">4.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from the issuance</a></td>
<td class="nump">497,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">Term Notes | 2025 Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">Term Notes | 2027 Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">Term Notes | 2023 Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">Term Notes | 2031 Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember', window );">Term Notes | Delayed Draw Credit Facility Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="nump">$ 761,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Senior Notes | 2023 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate used to measure fair value of convertible senior note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 624,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_AdditionalPaidInCapitalBeforeTax', window );">Additional paid in capital, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Agreement | Swingline Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DebtInstrumentNumberOfOneYearExtensions', window );">Debt instrument, number of one year extensions | one_year_extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DebtInstrumentExtensionTerm', window );">Debt instrument, extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Credit Agreement | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings', window );">Debt instrument, face amount, optional increase in additional borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio', window );">Number of consecutive fiscal quarters, minimum debt to EBITDA ratio | consecutive_fiscal_quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio', window );">Debt instrument, covenant, minimum debt to EBITDA ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition', window );">Debt instrument, covenant, minimum debt to EBITDA ratio upon consummation of acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition', window );">Number of consecutive fiscal quarters, minimum debt to EBITDA ratio upon consummation of acquisition | consecutive_fiscal_quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_AdditionalPaidInCapitalBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Paid In Capital Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_AdditionalPaidInCapitalBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Minimum Debt to EBITDA Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DebtInstrumentExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DebtInstrumentExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Face Amount, Optional Increase In Additional Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt to EBITDA Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DebtInstrumentNumberOfOneYearExtensions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of One Year Extensions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DebtInstrumentNumberOfOneYearExtensions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 470<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ilmn_TermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TermNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_DelayedDrawCreditFacilityDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_DelayedDrawCreditFacilityDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_RevolvingCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_RevolvingCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ilmn_SwinglineBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ilmn_SwinglineBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ilmn_TheCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ilmn_TheCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937079835600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT AND OTHER COMMITMENTS - Schedule of Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total remaining lease payments</a></td>
<td class="nump">753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(120)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">$ (86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937079872208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND OTHER COMMITMENTS - Schedule of Lease Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 123<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085154864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative (Details) - 2015 Stock Plan - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment', window );">Number of shares available for grant</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance (in shares)</a></td>
<td class="nump">5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Period Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ilmn_A2015StockAndIncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ilmn_A2015StockAndIncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937194743120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative - Restricted Stock (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 29, 2024 </div>
<div>award</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards', window );">Number of PSU awards</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based compensation vesting performance period</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSU</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based compensation vesting performance period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ilmn_MarketBasedPerformanceStockUnitsMember', window );">Market Based Performance Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout', window );">Share-based compensation arrangement by share-based payment award, maximum award payout</a></td>
<td class="nump">175.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Award Payout</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Number Of Performance Stock Unit Awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ilmn_MarketBasedPerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ilmn_MarketBasedPerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077195232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Restricted Stock Activity and Related Information (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at period start (in shares)</a></td>
<td class="nump">2,198,000<span></span>
</td>
<td class="nump">1,611,000<span></span>
</td>
<td class="nump">1,130,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awarded (in shares)</a></td>
<td class="num">(2,788,000)<span></span>
</td>
<td class="num">(2,032,000)<span></span>
</td>
<td class="num">(1,370,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod', window );">Unvested adjustment (in shares)</a></td>
<td class="nump">107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(771,000)<span></span>
</td>
<td class="num">(987,000)<span></span>
</td>
<td class="num">(707,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(443,000)<span></span>
</td>
<td class="num">(458,000)<span></span>
</td>
<td class="num">(182,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at period end (in shares)</a></td>
<td class="nump">3,879,000<span></span>
</td>
<td class="nump">2,198,000<span></span>
</td>
<td class="nump">1,611,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant- Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at period start (in dollars per share)</a></td>
<td class="nump">$ 236.32<span></span>
</td>
<td class="nump">$ 311.23<span></span>
</td>
<td class="nump">$ 345.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Awarded (in dollars per share)</a></td>
<td class="nump">133.73<span></span>
</td>
<td class="nump">195.94<span></span>
</td>
<td class="nump">302.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue', window );">Unvested adjustment (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">249.70<span></span>
</td>
<td class="nump">268.08<span></span>
</td>
<td class="nump">341.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">195.11<span></span>
</td>
<td class="nump">253.52<span></span>
</td>
<td class="nump">341.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at period end (in dollars per share)</a></td>
<td class="nump">$ 158.60<span></span>
</td>
<td class="nump">$ 236.32<span></span>
</td>
<td class="nump">$ 311.23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at period start (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awarded (in shares)</a></td>
<td class="num">(729)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod', window );">Unvested adjustment (in shares)</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(99)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at period end (in shares)</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant- Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at period start (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 446.74<span></span>
</td>
<td class="nump">$ 466.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Awarded (in dollars per share)</a></td>
<td class="nump">164.38<span></span>
</td>
<td class="nump">239.98<span></span>
</td>
<td class="nump">479.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue', window );">Unvested adjustment (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">492.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">167.68<span></span>
</td>
<td class="nump">299.98<span></span>
</td>
<td class="nump">411.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at period end (in dollars per share)</a></td>
<td class="nump">$ 164.87<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 446.74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084385680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Pre-tax Intrinsic Values and Total Fair Value of Vested Restricted Stock (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Pre-tax intrinsic value of outstanding restricted stock:</a></td>
<td class="nump">$ 525<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted stock vested:</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Pre-tax intrinsic value of outstanding restricted stock:</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted stock vested:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937076971696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Stock Option Activity Under all Stock Option Plans (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options and Performance Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at period start (in shares)</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at period end (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise&#160;Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at period start (in dollars per share)</a></td>
<td class="nump">$ 330.25<span></span>
</td>
<td class="nump">$ 319.72<span></span>
</td>
<td class="nump">$ 66.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71.09<span></span>
</td>
<td class="nump">6.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">330.25<span></span>
</td>
<td class="nump">330.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at period end (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 330.25<span></span>
</td>
<td class="nump">$ 319.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember', window );">Performance Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options and Performance Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at period start (in shares)</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at period end (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise&#160;Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at period start (in dollars per share)</a></td>
<td class="nump">$ 87.74<span></span>
</td>
<td class="nump">$ 85.54<span></span>
</td>
<td class="nump">$ 85.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.69<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">87.74<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at period end (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 87.74<span></span>
</td>
<td class="nump">$ 85.54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077703504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative - Liability-Classified Awards (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2024</div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Jul. 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 371<span></span>
</td>
<td class="nump">$ 380<span></span>
</td>
<td class="nump">$ 366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember', window );">Spinoff | GRAIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal', window );">Period of continuing involvement after disposal</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining', window );">Non-contingent indemnification liability (see Note 7)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ilmn_LiabilityClassifiedRestrictedStockUnitsMember', window );">Liability Classified Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Liability-classified awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ilmn_LiabilityBasedAwardsMember', window );">Liability-Based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based compensation vesting performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested', window );">Aggregated potential value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Award, Aggregate Intrinsic Value, Nonvested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts of material contingent liabilities, for example, but not limited to, product or environmental liabilities or litigation, that remain with the entity despite the disposal of the disposal group that is classified as a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.Z.5.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480781/205-20-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of expected continuing involvement with a discontinued operation after the disposal date, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ilmn_LiabilityClassifiedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ilmn_LiabilityClassifiedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ilmn_LiabilityBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ilmn_LiabilityBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937087529984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Cash-Based Equity Incentive Award Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward', window );"><strong>Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_AccruedLiabilityClassifiedAwardsCurrent', window );">Liability-classified equity incentive awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ilmn_LiabilityBasedAwardsMember', window );">Liability-Based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward', window );"><strong>Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue', window );">Beginning balance</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue', window );">Granted</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue', window );">Vested and paid in cash</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue', window );">Cancelled</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue', window );">Change in fair value</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition', window );">Derecognition for GRAIL Spin-Off</a></td>
<td class="num">(283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_AccruedLiabilityClassifiedAwardsCurrent', window );">Liability-classified equity incentive awards</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_AccruedLiabilityClassifiedAwardsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Liability-Classified Awards, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_AccruedLiabilityClassifiedAwardsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Change In Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Derecognition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Forfeited, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Granted, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Outstanding, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Vested And Paid In Cash, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ilmn_LiabilityBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ilmn_LiabilityBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085138704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative - Employee Stock Purchase Plan (Details) - Employee Stock - ESPP - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Specified percentage of the fair market value of the common stock on the first or last day of the offering period whichever is lower at which stock is purchased</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued in period (in shares)</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance (in shares)</a></td>
<td class="nump">12,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease', window );">Number of shares available for grant, period increase</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Number Of Shares Available For Grant, Period Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ilmn_A2000EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ilmn_A2000EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077470112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Assumptions used to Estimate the Weighted-Average Fair Value Per Share for Stock Purchase under the Employee Stock Purchase Plan (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">4.35%<span></span>
</td>
<td class="nump">0.78%<span></span>
</td>
<td class="nump">0.06%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">5.54%<span></span>
</td>
<td class="nump">5.54%<span></span>
</td>
<td class="nump">2.98%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value per share (in dollars per share)</a></td>
<td class="nump">$ 37.24<span></span>
</td>
<td class="nump">$ 49.87<span></span>
</td>
<td class="nump">$ 50.22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084560288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative - Share Repurchases (Details) - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 11, 2025</div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total cost of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Dollar amount remaining in authorized stock repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common shares (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total cost of shares repurchased</a></td>
<td class="nump">$ 126,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937080554080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY - Schedule of Share Repurchase Activity (Details)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 29, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares repurchased (in shares) | shares</a></td>
<td class="nump">904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total cost of shares repurchased | $</a></td>
<td class="nump">$ 116<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077507056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Share-Based Compensation Expense for all Stock Awards (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense, before taxes</a></td>
<td class="nump">$ 371<span></span>
</td>
<td class="nump">$ 380<span></span>
</td>
<td class="nump">$ 366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Related income tax benefits</a></td>
<td class="num">(83)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense, net of taxes</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ilmn_CostOfGoodsSoldMember', window );">Cost of product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense, before taxes</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ilmn_CostOfServicesMember', window );">Cost of service and other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense, before taxes</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense, before taxes</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense, before taxes</a></td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 189<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ilmn_CostOfGoodsSoldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ilmn_CostOfGoodsSoldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ilmn_CostOfServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ilmn_CostOfServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077156464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative - Share-Based Compensation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 29, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period of unrecognized compensation cost</a></td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078244864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Trade accounts receivable, gross</a></td>
<td class="nump">$ 744<span></span>
</td>
<td class="nump">$ 741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 735<span></span>
</td>
<td class="nump">$ 734<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077150624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 225<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory, gross</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory reserve</a></td>
<td class="num">(113)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory, net</a></td>
<td class="nump">$ 547<span></span>
</td>
<td class="nump">$ 587<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937076974880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, gross</a></td>
<td class="nump">$ 2,069<span></span>
</td>
<td class="nump">$ 2,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(1,138)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, gross</a></td>
<td class="nump">772<span></span>
</td>
<td class="nump">803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, gross</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">684<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer hardware and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, gross</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, gross</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, gross</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, gross</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078040640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal contingencies</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, current portion</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation expenses</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Accrued taxes payable</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Long-term operating lease liabilities<span></span>
</td>
<td class="text">Long-term operating lease liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_AccruedLiabilityClassifiedAwardsCurrent', window );">Liability-classified equity incentive awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other, including warranties</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 827<span></span>
</td>
<td class="nump">$ 1,325<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_AccruedLiabilityClassifiedAwardsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Liability-Classified Awards, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_AccruedLiabilityClassifiedAwardsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937190874608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Changes in Reserve for Product Warranties (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward', window );"><strong>Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance as of beginning of period</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Additions charged to cost of product revenue</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Repairs and replacements</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance as of end of period</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937076973936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Restructuring Charge (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">21 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Total restructuring charges</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
<td class="nump">$ 214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Total restructuring charges</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Total restructuring charges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee separation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Total restructuring charges</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ilmn_AssetImpairmentChargesMember', window );">Asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Total restructuring charges</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Total restructuring charges</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ilmn_AssetImpairmentChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ilmn_AssetImpairmentChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937082317568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS - Narrative - Restructuring (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Right-of-use asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements', window );">Right-of-use assets and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">CALIFORNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ilmn_FosterCityCaliforniaMember', window );">Foster City, California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Right-of-use asset impairment</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ilmn_SanDiegoCaliforniaMember', window );">San Diego, California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Right-of-use asset impairment</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Right-of-use asset impairment</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements', window );">Right-of-use assets and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-of-Use Asset and Leasehold Improvements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ilmn_FosterCityCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ilmn_FosterCityCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ilmn_SanDiegoCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ilmn_SanDiegoCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077527696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Charges and Total Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Expense recorded</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag', window );">Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</a></td>
<td class="text">Expense recorded<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">$ (26)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Adjustments to accrual</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Separation Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Expense recorded</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Adjustments to accrual</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Expense recorded</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Adjustments to accrual</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084568512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2024</div></th>
<th class="th">
<div>Nov. 11, 2023 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Sep. 29, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 03, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 02, 2024 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Jan. 09, 2024 </div>
<div>movant</div>
</th>
<th class="th"><div>Oct. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Legal contingency and settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 456<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="num">$ (619)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Loss contingency, new claims filed, number | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions', window );">Commitments and contingencies, number of movants filed motions consolidate actions | movant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions', window );">Commitments and contingencies, number of additional securities class actions | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ilmn_AcquisitionOfGrailInc.Member', window );">Acquisition Of Grail, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Legal contingency and settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementGain', window );">Litigation settlement, gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementLoss', window );">Litigation settlement, loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_LitigationSettlementFinePercentageRate', window );">Long-term debt, fine percentage rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ilmn_CompleteGenomicsMember', window );">Complete Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed', window );">Payments for legal settlements, amount allocated to release of past damages claimed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod', window );">Former gain contingency, recognized in current period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ilmn_CompleteGenomicsMember', window );">Complete Genomics | License</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_LossContingencyLicenseGrantedIntangibleAssets', window );">License granted intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-lived intangible assets, remaining amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember', window );">Spinoff | GRAIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf', window );">Percent of interest disposed</a></td>
<td class="nump">85.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies, Number Of Additional Securities Class Actions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies, Number Of Movants Filed Motions Consolidate Actions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DiscontinuedOperationPercentOfInterestDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Percent Of Interest Disposed Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DiscontinuedOperationPercentOfInterestDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_LitigationSettlementFinePercentageRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Fine Percentage Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_LitigationSettlementFinePercentageRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_LossContingencyLicenseGrantedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, License Granted Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_LossContingencyLicenseGrantedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Legal Settlements, Amount Allocated to Release of Past Damages Claimed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FormerGainContingencyRecognizedInCurrentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain recognized in the period that had been disclosed in prior periods as a contingent gain.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483049/450-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FormerGainContingencyRecognizedInCurrentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain from litigation settlement for amount awarded from other party. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483049/450-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from litigation settlement for amount awarded to other party. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ilmn_AcquisitionOfGrailInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ilmn_AcquisitionOfGrailInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ilmn_CompleteGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ilmn_CompleteGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084958352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of (Loss) Income before Income Taxes by Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (1,834)<span></span>
</td>
<td class="num">$ (1,735)<span></span>
</td>
<td class="num">$ (4,942)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">655<span></span>
</td>
<td class="nump">618<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before income taxes</a></td>
<td class="num">$ (1,179)<span></span>
</td>
<td class="num">$ (1,117)<span></span>
</td>
<td class="num">$ (4,336)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085399632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current provision</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred benefit</a></td>
<td class="num">(117)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total tax provision</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078359744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Reconciliation of Provision for (Loss) Income Taxes to Amount Computed by Applying the Federal Statutory Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax at federal statutory rate</a></td>
<td class="num">$ (248)<span></span>
</td>
<td class="num">$ (235)<span></span>
</td>
<td class="num">$ (911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State, net of federal benefit</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and other credits</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment', window );">Impact of R&amp;D expense capitalization</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount', window );">Impact of net operating losses on GILTI, U.S. foreign tax credits, and Pillar Two global minimum top-up tax</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Impact of foreign operations</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine', window );">Accrual of European Commission fine</a></td>
<td class="num">(99)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses', window );">Goodwill impairment</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount', window );">Impact of acquisition related items</a></td>
<td class="num">(46)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total tax provision</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Accrual of Potential Fine</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Acquisitions Related Items, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying statutory federal (national) tax rate to pretax income (loss) from continuing operation attributable to other reconciling item. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077521088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 189<span></span>
</td>
<td class="nump">$ 392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Other accruals and reserves</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized U.S. R&amp;D expenses</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other amortization</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInvestments', window );">Investments</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">953<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance on deferred tax assets</a></td>
<td class="num">(278)<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Purchased intangible amortization</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(117)<span></span>
</td>
<td class="num">(847)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets, net</a></td>
<td class="nump">$ 558<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Lease Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937084310528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance on deferred tax assets</a></td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Uncertain tax positions that would reduce annual effective tax rate, if recognized</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Potential interest penalties (income) on uncertain tax positions</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Liability recorded for potential interest and penalties</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2017Member', window );">Tax Year 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign subsidiaries</a></td>
<td class="nump">1,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Deferred tax liability for undistributed foreign earnings</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | IRS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">1,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Singapore</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount', window );">Decrease to the provision for income taxes</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare', window );">Increase to net income per diluted share (in dollars per share)</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayAggregateDollarAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482620/740-10-25-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 740<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 740<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InlandRevenueSingaporeIRASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InlandRevenueSingaporeIRASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937078230960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of the Gross Amount of Uncertain Tax Positions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of year</a></td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year tax positions</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior year tax positions</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Decreases related to lapse of statute of limitations</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of year</a></td>
<td class="nump">$ 232<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937082406784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Matching contributions</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents', window );">Employer contribution vesting percent upon the occurrence of participant's disability, death or retirement or change in control of the Company</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation plan assets</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=ilmn_SeniorLevelEmployeeMember', window );">Senior Level Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent', window );">Percent of base salary available for contribution to the deferred compensation plan</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent', window );">Percent of all other forms of compensation available for contribution to the deferred compensation plan</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent', window );">Percent of all other forms of compensation available for contribution to the deferred compensation plan</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement With Individual, Vesting Percent, Specified Events</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Base Salary, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Other Compensation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ilmn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements. Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ilmn_SeniorLevelEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ilmn_SeniorLevelEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937079270048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 29, 2024 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937081536496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Operating Performance and Assets by Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 4,372<span></span>
</td>
<td class="nump">$ 4,504<span></span>
</td>
<td class="nump">$ 4,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">3,694<span></span>
</td>
<td class="nump">3,813<span></span>
</td>
<td class="nump">7,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">1,511<span></span>
</td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">1,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
<td class="nump">1,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible impairment</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">827<span></span>
</td>
<td class="nump">3,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Legal contingency and settlement</a></td>
<td class="num">(456)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Consolidated other expense, net</a></td>
<td class="nump">346<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(1,223)<span></span>
</td>
<td class="num">(1,161)<span></span>
</td>
<td class="num">(4,404)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Core Illumina</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">4,332<span></span>
</td>
<td class="nump">4,438<span></span>
</td>
<td class="nump">4,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">1,424<span></span>
</td>
<td class="nump">1,582<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">988<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">648<span></span>
</td>
<td class="nump">677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible impairment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Legal contingency and settlement</a></td>
<td class="num">(456)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">1,473<span></span>
</td>
<td class="nump">552<span></span>
</td>
<td class="nump">481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | GRAIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">2,360<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
<td class="nump">4,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Consolidated other expense, net</a></td>
<td class="nump">346<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Eliminations | Core Illumina</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_CoreIlluminaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ilmn_CoreIlluminaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937077716080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Consolidated depreciation and amortization</a></td>
<td class="nump">$ 354<span></span>
</td>
<td class="nump">$ 432<span></span>
</td>
<td class="nump">$ 394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Consolidated capital expenditures</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Consolidated capital expenditures</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Core Illumina</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Consolidated depreciation and amortization</a></td>
<td class="nump">280<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Consolidated capital expenditures</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | GRAIL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Consolidated depreciation and amortization</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Consolidated capital expenditures</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentExpenditureAdditionToLongLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_CoreIlluminaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ilmn_CoreIlluminaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ilmn_GRAILInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45937085133440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Net Long-lived Assets Consisting of Property and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets, net</a></td>
<td class="nump">$ 1,234<span></span>
</td>
<td class="nump">$ 1,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets, net</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">1,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_SG', window );">Singapore</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets, net</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets, net</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ilmn_OtherCountriesMember', window );">Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets, net</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_SG">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_SG</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ilmn_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ilmn_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>117
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MEEJ5VT&ZZS;A!G5E'/HA45WR#"TD#&&(<31A:2+Y*WP&>IAF]>F=%J QJ#5
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M\RO5+4-,S%&MN9W"&N#2&N!&UN!/%H$%)3R?!^':Y9<C2@_:3-8<U!K6*2P
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MU*Y*=T*;FG?#TC19D-;!K.^%T$?#;M"U[?0O4$L#!!0    ( +B"3%KD=&R
M5@8  %8;   8    >&PO=V]R:W-H965T<R]S:&5E=#,N>&ULK5EK<YLX%/TK
M&F^GT\[$,1)@3!Z>29WNMC-MDZG3W<\*R+&F@%Q)SF-__4K@ $8/I]U^20Q<
M79U[I:MS+IP],/Y=K F1X+$L*G$^6DNY.9E,1+8F)1;';$,J]63%>(FENN1W
M$['A!.?UH+*8H""83DI,J]'\K+YWS>=G;"L+6I%K#L2V+#%_>D<*]G ^@J/G
M&U_IW5KJ&Y/YV0;?D261WS;77%U-6B\Y+4DE**L )ZOST04\682A'E!;_$W)
M@^C]!CJ46\:^ZXN/^?DHT(A(03*I76#U[YXL2%%H3PK'CYW343NG'MC__>S]
MSSIX%<PM%F3!BG]H+M?GH]D(Y&2%MX7\RAX^D%U L?:7L4+4?\'#SC88@6PK
M)"MW@Q6"DE;-?_RX2T1O (P< ]!N 'KI@' WH,[<I$%6AW6))9Z?<?8 N+96
MWO2/.C?U:!4-K?0R+B573ZD:)^>+JR_+JT\?+R]NWE^"=Q>?+KXLWH/EA_?O
M;Y9@#+XM+\&;5V_!*T K\)D6A<J\.)M(-;$>/LEVD[QK)D&.22Y)=@Q0>@10
M@"++\,4+AH>P'A[N#Y^H<-N841LSJOV%KIBWG)-* BP$D>+$%D_C(+([T*5U
M(C8X(^<C53N"\'LRFK_^ TZ#4UMTO\G97JQA&VOH\SY?8+$&N,I!IG^0'UMZ
MCPL5O'45&U=)[4K7__T<0I2<3>[[T5B,@FC6&NVAC%J4D1?E<LVX'$O"2[71
M[HF0I0MBXR?NS9Z& X"FR=2.+F[1Q5YT%UG&M@J/.K8RHO)W6Y C4!%IPQ<;
MDR=A/ !HLXGL$*<MQ*D7XD>5M4HR_N0$-C4FC:/ATEIL9HD=6-("2[S KCG9
M8)H#\JB(1Q!1[T4FUX2KTZU?AC;,B8$'1=$ L\7&E<Q9BWGFQ7S#)"Y> &]F
M3IU$TP$^B]$T2.T TQ9@>B"IBL:Y?*J3J6MZH^O%N?2I 6$&AWO2M(%!X%A[
M&'3D$GB!7BF86-+J#GPBBFN/0"T3QFPU_B8(N-"9M;))8*")8#I ;#&*(\?*
MPQX=0B_BOQC+'Q3166%!,TD0#H\?BQ6*H]@!K.,LZ*4)5>$25W=4G3V['>E<
M[IVC/0#I<+VM1KVC=!]EQS;03S>79$54V>1 XL>#.$-S :?#(\EJY$#9L0WT
MT\U5??ZX"QN:%!+V*&Z'S&(4NRJFHQKHYYKF[/% ,\EC&@;&'C2M8*#VJ@-=
MQS)P^B+E5%!\2PLJ*;'+)^AEJY_53[_+VW[0'8-!/X6U]+_!3YK[K0%;: C!
MX:K8^,QU,'1D!?ULI>#QK:JXWII8$9I$-#.TG<4(AL@%L:,KZ.>K&RWL<G*K
M*.J953=*\*EFPHK4Y*(H-4Y_TRBPPT0=6R$_6^WS_H%\(I-^H*FHK%:)"VG'
M4LC/4AVO%II7#V(U*2F.AT+*8C1UJ3_4:[7\M-4NO16724(P2H,A,)O5S"&A
M4$=5R$]5#0D4K+IK&H]#.32)* R'N])B-$6NU>[H"OGI:L'*DC8M4=/*L4JO
M/:DR%U:O/_N!":R=Z_]WM!]SQX,H]C+-4K+L^YH5.>'B]1\S!)/36NG*)WN_
M[F75GV[8?Y.W_=@[ED7^9D[U3#L5)706CL"KX#B S00;S('JX+=*2\, E,TK
MF>:16&.N&ZRM5-TT_9?DIZ!B8'>7"J%)HNZ^ME(H+9GKXP-+<*F:VO*6\,;)
M\UN:VG+_D?T-S"[_9NMHE+'/9#]3'34C/S7KRF"5/TTA"II[AY*%@GU#2^I@
MG.Z;O"B7IP"FJ1O#+_OW+HA%:PP7Q&>ROR"=&$$'Q$B>4\WKBD=UVS^F%<CP
MABI>M8(TY482HV&K8K%*X]@A2E G2I!?E"C=M"VW!9:D?2'!2E7/:_V.^IX
M6JEK MX43(BW5O2F!$%&CDV;L4.%AYU."?TZI8\\)RN:42N[AJ;V&$,4#2%:
MS1SL&G8*)?0KE!NNA,F6/SW7IMJ\&1/R%$306F1Z]T?V^ON5,^H(J)$;4G\C
M*)ZLV3'ESCA,PZ$JLIHEJ:-0PDX7A0=T4:TUA9/EK) M/7N8#'L_BU6<N-J,
ML/<>V2^7&L ]D51G_R<#,-\=6YI7BY6M>9WT/GKH+TZ?,;^CE5"*>*7&!<>)
MR@!O/N(T%Y)MZN\@MTQ*5M8_UP0KY-I /5\Q)I\O]*>5]E/:_#]02P,$%
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MP;,^+!M(%J>MS(Q)U1BEEX'J78'K '5_SIA<#W1W5'3#[A]02P,$%     @
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M&E%A&?O^2?J,\ND21=E,JK"-E)<K*1;!/*A=M9(/NX&2"!"*.FHF@"B"X53
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M2C>"!YL5S[[]II&IBQ69J)9* 4!Y6ND$0,3M(-'H'FR4!G4JUPP^HHS!M3(
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M<34_,;LKMA$R$6(C9XO)$"#PG<9N^]6SA.0\AM>W6W?T%FF/6Z<][M'+B'_
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M&)T@6X+CR<_]Y->V/PX)<0VQKI^&L% ,O-6*SG8ZA.KUWT= LQU(Y\,--7,
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M=&BJU&*!'Q088N)SL*HS+NE_(WJ[-:]OTLDE\J'9#\OHG8A<?NF; 8,Y&54
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MKO%*:93[UBKJ*+_% 0W4$'BM>40?:ZA'4$:K-<S6E-XJ]*25\N2K+/6F#D=
M:7*(Q"#R66&J81.@?!.:S+'WS/^S;&3'""OMAI1TO!@LK'&.*_D(IZ@#*1+O
M6^Q["LWD"MZ8>J=D"4F(]PW.3LQ7!;6A!P_=".;5S</I4%PB)^J:]!R<#3(V
MAJB8QW;2%I'8*2#>&.N[-.((. PECO:P66M38O@BKK#%O>ES)^H2)/IC/@1-
M?RT)EK?7RU,Z*ZA/(@3:((25::G>MQ)Q62E%.9Z7TCF("HT/O9A&RM #<3A1
MR/D8K3VG_Y"SND_Q_ABK\[+%O"$^U)HBU8&V7P:DKY(H02UWE1/1=XK\[+_)
M=-J#[M71".'0NCFC: /56$0X-HK'QO)IR"5R'RJUL^*@-\P8 ;GW4N]DI^@G
M ]#_C9\A%\N+[/<MX)',%E(&F"K+<S<.%/%NA>1E:!QE*R+9EM*63X**QE+V
MFL,!%U*U0A9HU!5%I9=C#G*&XOT6B!^Q24OA*C7LXBBM8)M&E"2?QI1+J$D6
M$ZX,!= ?PLL=&"SG8H531%*Z==.KLHX$5?*SZMNZ:S%U:=\&9R ;?*5LZWS;
MI4$81M@\X75%F4L3QU8WX1@)1>.H=SK2C)Q?PWYC^=PG</N3O!!M0]O R_,"
M76N*MJ0)88=.O&6#'55WC]:75EI "OVW!KG^#'B,59A+2D3!@>HXN0EZ9)2$
M3JI*V$\!EA5J3#;P[:O&90(9!3AAWV$R73JGNA'J%RU7NM2>VE>_+GE];W8W
M)1T/22@QLZGU_ZF%TN#RC-T'2ZE>X:K^Q@$ROG@,?.L^C&)%U5)OHBX9,*ZK
M:@7Z?F1GI3TUC:.N9^T4@'J% W=?;ER!\5&)'M=91-E#\H.;S,Q OD9(*N8E
M/VT1#$7+:*0NA/J*C'!=MP]'?MY:R^,=XS;\WDP^.KHX45OGZZ$#MFA>X0[5
M4_L;Z#)<O [;P_7U5M*IX$2IUF =#V>3@;#A2A@^O&GX&K8R'GCRZQ:W:&5I
M ];7QOC]!RGH[^47OP-02P,$%     @ N(),6GG0>A,Z#@  S"L  !D   !X
M;"]W;W)K<VAE971S+W-H965T,3(N>&ULS5II;QM'$OTK#44.)("B."1%2KX
M6I83!9;C2([S8;%8-&>:9,=ST-TSDIE?OZ^J>RY>DK'^L(8ASM75=;XZ9EX^
M9.:+72B5BV])G-I7!XL\7SX_/;7A0B72=K.E2G%GEIE$YC@U\U.[-$I&O"B)
M3_N]WN@TD3H]>/V2KWTTKU]F11[K5'TTPA9)(LWJC8JSAU<'P4%YX5;/%SE=
M.'W]<BGGZD[E?RX_&IR=5E0BG:C4ZBP51LU>'4R"YV^&]#P_\%FK!]LX%B3)
M-,N^T,EU].J@1PRI6(4Y49#XN5>7*HZ)$-CXZFD>5%O2PN9Q2?T=RPY9IM*J
MRRS^2T?YXM7!^8&(U$P6<7Z;/?RJO#QG1"_,8LM_Q8-[=M@[$&%A\RSQB\%!
MHE/W*[]Y/306G.]:T/<+^LRWVXBY?"MS^?JER1Z$H:=!C0Y85%X-YG1*1KG+
M#>YJK,M?7W_X?'7WZ>;JPZ<[,?GP5KR;7-^*SY/W?UZ)FZO)W9^W5WSOY6F.
MS6C):>@)OW&$^SL(!WUQDZ7YPHJK-%)1F\ IN*Q8[9>LONGOI?A6A5W1O^B(
M?J\_W$-O4(D^8'J#'?3>26W$9QD72KS5-HPS6QAEQ;\F4YL;>,N_MPGM2 ZW
MDZ0(>FZ7,E2O#A B5IE[=?#ZYY^"4>_%'H:'%</#?=3_%UOM);R=[6%7/'%#
M 5HR5W,=BNOT7MD<09M;<2/-%Y7+::S$U=="YRMQI\+"Z%Q#R[\70(9%9O*3
M7)E$Z,:Z,$/(VUQD,SAZ14(Y$K8BT1432\_ +50R5:9R#2'3J+XZ"/CJH"/R
MA1(SLOD]VQQ+,S"Q;PN19[F,520.+P8(OCAF' 'UPU%YV@$RV:5B;(E77?$)
MF^@T!#Y:.GA\"Z-BZ(ZV8@9K18@'A9LY<!4,@-(OMY/K]P#/J041NN]7W"UU
M>O+[;-81#PL=+L2#M'@<Q&4<KT AS SB3^#JX>!BW.2;;9WF.IV+8-@]>T8J
MX5U^_NF\'XQ?6)$B*TAK%:P2:;O,+ CA(9E7NW;%K9I!S6 FS7(E^EW/:/F
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MSJ<B!!^I19?\4OK+$+X +\PM=P+HE3^W[A[A %^4CJ]P^FM<& 30_%N]_#T
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M"W!]84P9/M !]2]%7O\?4$L#!!0    ( +B"3%KQ'5'O"1   +PN   9
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M;Z7-39GE_'TRO*?,-GRY5A+8B0;@_3)#>6]OB$'SP?K;_P!02P,$%     @
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M'L0P*==;6YZ\72Z/.Q*!TBLLU#]I"-CG9FOP/Q"[;1?P:U!;('2"N9U_JBD
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M%!(IDND',K#,"6NK..B.",25"GDQEXX@(;N"9$G&9;9#\MM2A8S38E$D(7-
MFN+:4>UQ*(?>K1' M*&J!9"U!9Z OB6A6,9;M8C_& 8:?LO.FBH33'_T &2<
MT$H',MQ23*@"/@CUI%(5UK0T,>?K4%XV>9GVUGBW;CX>S0:XG63!JTVB'%=;
MP/MRQ5$W60OE1NT*RJQFYVE<X/SJI<E9HW\@.),J+4 ,_>F)&ZT8Z!QF2%A'
M<S&+@1:4KY&%4S;N%<E#,.]C4]@U5==PAU<E0<F=>FVHF$-!3B)'0'^WADNV
MM"43$"!CN48OEW%$C$-BI!(*-&,TOK#^LCM,<!4QDU[TU0'Z.:^RMJN>$R)K
M2YN)KE'<VVBDFKNTY'&ON"*C 2F1A2854/HZ+;<E4<3'(_$:%2W,0X4^OI[T
MS)/2;"F]T@MA#61L,<P&*C8<,UT:>9,(LM&E7AE?F 8J77G+!?2 WYQVKU@B
MNG,PT>>24-CU<VDU$07DOH;*"IQ%2*GMC2C195 BUTM08B[0P\'0__BB+]H[
M%Y+]3ATSO:5OP)FK3*]+]4[734FK?OUNHN"U=#%5-U,,=EVU_]#QJPG ?KVM
M"-A"V(M:"DP</->Z6.[Q3%(#%2'Z")A)P?V$M4Z20Q\>GT. MV3),09=KJE:
M!-/0Y-9APD%PX@=%N&P78(:%E^4ZYE$'Q1C<R^^7:VN6ZL7/)FN98S _A+?Z
M>!HV14I-YD6A%ZZ$Z"YHOP^)CQ:;CJ9,7!4?Z?=," *8E0!;/TQ'S2*D\/C1
M@AH+K;2TB9*W7'U&T/A05A0=P68JRN_GE#'38,\S#MPG8C>:$XE8<Z72KAM:
MQC[H)S9N] <!;E(J;TQJE+1A$%$"A,:\7?99XO=8@M+T,[;<YE*+H0(8X>Z-
MX KX,I+1LTK7.8WX//(- P&DRQ1^-RKD662%QGH U2FZ,^8#9M(;6*V;>%Q$
MT_A0V]^D:C!+:1!)C?';0Z1<5&G7D2?=]DTLRVW;QOM[LC9YD=()4E1^8D.I
M<L^C37QDWS#6)/>#/!.VTO3TA-V@P:BUX,=D3P"":ORV"R+JDF/:]\@OI5"0
M%B^BP@;3TFI3A=J-CVE#J<GF!6%.$M".< S!SD6-J6BKZ*VHOL/*P-S=)"KG
M25>_E;Q?EI(0<8(EB]Y120"2)]7@,#)4'E$%*J:1>0,7\O8@041)&G-)SJD(
M83T$0"2ZL61WN0^..I:BOM-E2R8VZV6"XE96C&HDKG>\$?KZ)9CSE+-"I@70
M4W%1I%>Y;4S87(R0>KCS*:8O#/+:+,H[PC,@50'%S!%/(:TW^@3/=AF4G[;[
M*W^ROW(PSQ+VCROQCCEA0UA1;ZQYKYB2,&*@8H1AX>SJ59O6XOI5C$XRH-R6
M[+A$ ??HQ(@OS:+N+8?IBM_.G]Q-&-<<BV#0WOLUM6PUT4SX2HQ^%_:WR5>Q
MAH2T<:@BWD[+W>"!P>+I(X/P F!*[)G1KH@]U':7;4"8*:'X[XVNP9+Y:;)J
M^6KVZ%.6?(B*!**TP+:;).2&('R76/RFU&Q4)MU6VR&L,@9-+FD#'=._W>BU
M5N]H]T18_1(6LB0T39)Y#Q1=,R)3USL' /DK@<OO!T+2S;M?QY'W< ;P<T6W
M<?."&R8H,=OCQV\$Z'Y'<,9A3:"7ZR5GOXQ+/ZRK#4A]-P5R^%YOH3>T].\J
MX%SZ:>NPOL]I_;\,;;H>W'0>;X["S92__RKL*=3U\%Z2,6\HM?;II9,^( F,
M@5_4Q.=\"D?M,\[O0T66XY_8#[$+4N0^&2TDV;J??F]US9+M,MEJ05-1)85*
M/5WFQG6\+1")D?A :PRT?@:@]V.8US'H#9@W:B*#TC('/LK;5+$^#15_#(+Z
M(-7#6)\.0(.RAUQ*7H-F_L*0(!SRD]Z):M_H(4+\':C_9>[[ODOHZOZ_VT*\
MAPWN]?ZT11S=X<=/=.U&O=-4#F6IOZ]TKIZU5DSK&9BY!)DO6^KYV(]VGX6S
M'P2[UP0?^WX]:?K1"Z05DU0&G[^?_\W=//_L>Q)9:_=?\O6MU-5=^EWHHV$+
MU<17"X,RN!@TB+N_0\A0T<%WC96_,HS\"Z)(OW+R\2AR9V"X&E2_J005B]8N
M56ZN:E/*8KBITS6877H6J-^A4;X!E4>)'8A5VX#NV"["0S&HHIQ,4BDR&E^M
MW@-2HA!(B4K.X&_LJJI]89^7)_879><&R<WL%WFR%_2%43_I<G4'0+^'RTJ5
M?<]I]7L4GW,7!K@G+BSL+\6ODU1/'8U]>_R)N/:' 6V_NIR:;'7\)C75E'F?
MX/+^C<8;S=870 ]9+VO*V!X%[W$VMFG3 DC@05")P.U@_MP8'JMZGO71]A/D
M]_@7&<,;FZVU*6 - )KUK[.'Z)1OPX[YIUL$YB2.E3W3N-2%Q0.EU9^>W?%V
MW6>G_:W[/ZOT44M^M<;/'_>J;X ,Q.^N#5JK[RHB[DW$VC_4NG1+WU09).P-
M<<SK[I?=0KVZJPK&JF=HS9 '&S]5[4N*]Y@M''()M?WI/4,5SWQO0Q:+N*F*
MMFQDZ[C;78_5Q/ZJ.#4+7_A".AQ*L>L2M_!KGPQ F9*/RW3G6H+Z58>4+]GZ
M]H=M,MI9"$B3M 9*9AHV,:\R"Q,]DE>;D8$/;)9ZAQ+1NVR AY?BV:Q^Z\Y>
MNRWW")R=I@HI)+2E+NTF@!I_",:;GV_V\ YH01TBL55D@"_"/KOK=JK]N1I2
M9\W'-HJDJRT<EV)FKR"L<MPXV7*,]'RF3B/BP@[$B^5W)V'LQA90($FLN8</
MPM/6=1[?3R]O5 G:!,NB\&^1CI-$;>/]P2@9DG/<$,M[0SMPL/8VZ;O.XSO;
MNEJ!EZ[KQ8VI;V)8OV&JE K,:[YOE/ ;EETZLY>WZ,:O*2W#)@B7VI[E. Z?
M6(LLFM F#OR)1E[@:/_F]S$Y'^5XJ[ 7XG;2DKPIXU[M1+KP0\]QEYUP@Q_<
M"R4./IS\^PUWT%7Y_[;[N=GNM0'&DZ.!E]Q2<^$/M(9NL4,/##;F>SOS2UL'
M.=6&&O'C$.-M.RY)\(+B]?IM@J_P_<@CL-3$7I>HL;\A, Y=AUC6B9"9<6'%
M)5C_+_!VFLMS7;'MJLRF @S45%@#7E1E?G"0]]7NT C3#@-!1>O#8[RNR 0U
M6'>-):5[W^_\C0-_U)OMU^H]%S&XJGAP3G6457R,F0&)+,$KP/%>>7XE15\Z
M)<"@\Y!=L3..]14.$*&)IZ"#IH63VC=@4V&T-\!>"UWE,>A8[\^@Z>_.-KWQ
M'8:V].=0.]@\21I@I8E&6F:<A\QAJS^ZN24% VJ"Z<K24D=FWY0<E4Y9JGP@
M@2MG:(TX@_5W.]_JZ#5]?A<_"_9VO>.3L_UFB' $P/=7IZT^OE80" @'8BB?
M,L%.CSK=XL Z5)7$1;SNXN+WU53-STZRFY/YZ>/YR>O7)V_>O/-52K] # CK
ME";@DZLR-,J?O#+.%(4#UETBL5K\>:)^O%+/_OH7V-C6-AJ!I[[51=-"GU9[
MC]+X%Y<7/UQ=JV[(>[Q)3K+/;B<G)?H\]\R6PT<]7@^>\U)O_(Y=<C8^M$T-
M<N(NW^M:['0SUJPY<(E^BOL6Y]6-K:1'[MIXL<].CQ;'_-#\]$@?QT;;3K O
M?O;GK2]\FRGU>[YOH22ST\7)^5@G_CTML+^S<_9QCFKO1!,^)LQ-F-H+4/.^
M67380;S3O3>1[C]WMR=T>E\UZ1J<0B:[1X3OI8KD!M\N,*<V6ZX?D6/O8FK:
M720,/I_2^=^UT7RJC_U0O&_!&= OYSD/HH-!J3A=7Q?\;ZL>JAY' 7?%_LDP
M\(^C4;'Y_K'JKI;O-X#!;9[;HX+K=FOX5%/O9' \Q=J%_@D?H!8H=ZTI'V],
M->F%6YB=NLZJIJ&B13^4)B4$>>*_3/T/9!0?#N,$@#\8S^<45CW+HBU!UJ>R
M.1T5@ Y,U6;E3PA4>SWO )R<];7_SB ]+"FE=2UO;D$G@P^0$M=U8[?)N>#+
M0?36X]$[JTXXGF30'X0:QII=;+FS^"6A_#SI.0N=0SU3NT^PZ?NDD7.#O?A"
MHXI>#2N#(VX1,MX-]I!Z2=^A]KVNZ=,,1INJ"T(]P2^M3<'LB)YTI,65VH@E
M;SQ T+B[1)9$\;(FZ)RW)E'EQ\%!=MP-+W7N.2I,'(<J%320B,[7JLXGOH7R
MH][:Q0&HX!=>ISMW C,L*;YD+ (^XC-W[D+^[]J#G*KG;[]3EUP?N>I.D=Q0
MFP*GM6G;;RQ0RV$Z8V]80:6Z8GMO^Z3XZ/+J^;'L<7-J2,>BGM/A[R9T\?J3
M@)/DS'N_R!0B4O_@4-*4W?$@W!NEU4MVOI=2E2$$U3^LU+O!YW9MO&/GHU".
MKF2(L5E[\.:).9OQ&BZGBF[C@EZ=?35_(BK_D2G]P2/7DU[4F8"/_&:!"'X1
MSHM1D8I'#[L6E7I#FD,*UB&JI2\@K.AP>,G\Y;*#YL*4W,AD&XI&, .Z58R=
M7^Q5L'S(@(%DMJ.#2P(?=N$2)>&]M\*7527%E.=UNU(7R6&U7HDLD*3#34V\
MX&V+L!#Z)')S _$/MG@/G7GJED91.Y0QW_LRIF"E'E#J.IK[VXC!M^YU*-W1
MG-,AD/LW#@T0!P52'XD_7I4=/5C#^S 2_]+6NGCFS ,)YX%'V5(-ANV/+BKA
M\P/5\D#AM#NM$:X2(L9S3 CZT]/5BKT,H_2=/R19GO@R,/D 3WBX&JBJT^/W
M[,A\0^ )(HJHJS]TD1Q_2YJ XC'1SA7X@5+1#DK1<8>0\=EBAY23#T*.=8'2
MU5K#X:1[)8'5-%9;PG/K+(5NQ(9P384-6#OMK9_MQ?^NJ[YTM^2 JKXOGR1'
M ?0^903C&647HB1>HWC:+ER,O&C[[R6WK@Q][/VC"%FO''YHH,@$/C+> .3(
M^56"J^3T_0BNV+\VH8L(J=K1274.$"9J?2*=GFI$"-3-W&\H'7,)'B %4Z4\
M&\BLUO%>N+&0M.?(Z0Y3>L;%N]H&NC\XN9)RQ1>-DH7&B=(3'B-GC:H.MX[L
MX_K.C !<$_+E*,=PH=V^37I )H#-K_9%*->>[/&B-$:V[,-R^I,/&),<>=DC
M*7%#XG&28UK=]4*QS]@? N++7 .JH(FAJ.7@.-98%<]P<B,A4O"C"(8XVKOK
M9Z09M8? XSG=L /E56VLF64R[-I$I'MU1?V]2!8S!]*FZG633^,VS,62FBBX
MUG[A1@^3=^>\3;G2<J2M=S=C=T\G [3T1+P_;C9&@CK"M\=CVP4ZDI3&J$M_
M65 <R ?%HTL:QMF2[W,I&<'-3V=/$G?Q*+GR*4I%*J?7<.>%B7?7O :8(,]_
ML:J-?!OIIY\QE=08X^_'R#NH/X1:9\(A+@##>(@P/BAW)=&G>%L&C:9A)WC%
M;DR\@X#N9SB;GX<;&N141E%4F0[FFO[<O287BQ:B$$N-Q/)&%TA0_"6CO:L/
MOY@]/HTC9%)KE4LJG)S-;W2YXEM'J>6%X0W?IQ+V7V3D*MQ7F<EM$?ZJ24<%
M#Z3I-)Y<(:>X>,-PX<OIN=HAH?$7)1'JHUSHA)+"0.H7L_..NF3I 1 @31>D
MSI=6QDX90K>DKERQ5E]T+.)[-XCTV$6*H)W+B&VXHJ)C6']9$BC#[:1*.I8T
MFP<5FF1+1VY\A//)33&X<I-XZMK-UA<JJ*A05^2Q3!ZNRR.X>L-:N=CU.4K)
M7YRZKG:Z($1->9XL,E#!WQU:R!B7!JN*U\KZ$WHD>;D,%!^*CD[9!#U $\]/
MN+S<MKR[X],$T/F:;JI59^'*'5;8/6_LVJUOV"*<9<DP"?65%<)A_8'*;;2O
M%2_(-<N"[^P$&*UNRQZ7^?H$FHDO4(D,F8[=?OPPN;&:;Y:B>[GYYMBRD<NK
MX[?QZN\+N?&Z>USN#0=46U',+LP2KYY.OSI_H&JYBUL^--66[[]>5(@Q&_YS
M;0 L:WH OR^KJ@D?:()X(?K3?P)02P,$%     @ N(),6B]YBSP^#   :2(
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M_0_T:+'-LZ:9>%.%IT1J/#U,PK"@ER!:-J#UI3&^F_ !V[?E[#=02P,$%
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MM96?HG<E7LFT3]%Q0-$P2MZ1%W=>QTY>_".OY0+ JNE15MK4JES0ORYFMC;
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MK#="#T.NL=1""UXB\78K IF&2/!NY_*&N-GSA9.]PXI]^LJ& \!-Z4W32#Z
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MAJ/S,P*JE;K6,++Q'_^=-%9*_+*R?P=4+L#N+Z4T.\,EZ/\WV5]02P,$%
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ML[W2<WB\YV'V<<6HQT1: +Y?<"YW!^D%]MOMI_\#4$L#!!0    ( +B"3%I
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M" 24+C!0/SS %0@1B+R,GP,G'DL&X.G\R/XA>O=>]M3"E1;?.'-UCM]@Q.!
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MRFCD6E0I'>,@R%(%)604\(E8BYM'R&)2;)@1)%(8=D&Z>'"E#ZP@SU4.^!5
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M!7@_MS;4-W1 \^'8V7\ 4$L#!!0    ( +B"3%JJ0TT-H"@  &Z(   9
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MY:"6*.H7:TIX&2!O#=PAP@<PY&#_"=4I[+C&RA: ]3);!]#IPFW3@F&;K1L
MGJX:T$VF -PJW^'&$.UEID#<VW"1%8#:=D"J#6"WZA#!?"=XHW2-?,T R DK
MLTJ/X4UI45[!UF5FLFM0>1;N%-YI@$E@9U?E95<PR3)K9_:CH'95 E5VO/ L
M*VOXK &4[NE(^3XOE2#A@N&R&KCBU0K1#3LX-)+)_O$ :6[=-:E:,#'%ACY!
MOC0D\CQ02K?\4ZX%6(319^M=C62/'";0^@YNU_@L? $?U;F#!Q ,"QBMMRXG
M*F6>V3. PJ (5>%V90V:%![#;^ &"D1LJ?A[!]=(NR&2W @R$>8M[ [\!F0
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MD<S9=/F- T8&T;G7*B"0;L!6UYAZH<@%ODIQ7]9A,471WM0<=(K^2K(G5>/
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M%$AI181A4@"$6-)VW5BW77:-3^B6=F[[&HIE.JK9I5;T"@DIO84:0:H\Q-X
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M$0  &0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6RM6/M/W#@0_E>L+:I
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M*6P*NK@4?"[B(BNO@!-UVIQLS*7-%WV/R6O3_)AKT9HGG<#:*?4.,Z5(#EM
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M9\H*X'XFI=E.K('F?X#Q?U!+ P04    " "X@DQ:K(M9,U $  #7"@  &0
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M[3=*^Z)%8[X+@H-I49G')6=0UI  YA<"FI?N!04,7XI/_@=02P,$%     @
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M;L#[E92FO;$*NE]PKOX'4$L#!!0    ( +B"3%IXZ E"208  $\.   9
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M65HAPGC<:'K=EC9Q>_RB?NF\DY=[IG$JRY\\,\7(._4@PYPUI;F1ZZ^X\>,
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MZPKJ^8HQ>2CH!JH#]NE_4$L#!!0    ( +B"3%H'9-YD8@,  + ,   9
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M<&9I?CP@;8"Y7PNACXXMT/W*HK]02P,$%     @ N(),6FK%-QJF @  N08
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M0GQP<?\HC7F'!L8M&L8N]J5A2:Q!PQG75GMLY+$65+L31.^@:I.T,-D<'(D
MIR^$7DI)[KY[3?*XRVK68F7N?U]8MM2:M'8*$^<)6E#<"G6?4]+I)BT6AT="
MJ53;Y7,\;O,Q]K@W'TMJ33YU(>&8*XER08-U+J)0^"*A*]PA#X<9G!CB"'<X
MS29M3E9K!UMJ34YU]> 8+3%D(462&P9)N:3R> BY/>EH[+3A6+7SMM2:<&I#
M[Y@=_46>?0S1,NFN5YUHL6K-;:DU@=0FWC&[^&HM3\F]7LA[H1QUH R=]KIE
M[F=O*B]AT)W:H3M&9ZFI"&VBHWI'J!?,M >,T_9]YK[V)O,2GMBI3;%C=L7M
M+/P4H5F7T+03.E:=L2VU)J#:&SMF<UQDF(@#(45%/'P*4-<@#R?3>9N058]L
M2ZU)J';)CMDF%QL'"36ZOQZG/',[3Y95LVQ+K;E/6KME//[?;?MAFP9Z:57-
MLZ76G([:CF.S'?_"DV&QFW*C"Q66!#1.6,C\?%.ERGOWZ$!2BKYP1='L32]C
MFR9\6:KM[C2T#)MGJ\,FN)T-?[-/_TKN=@(8A5R@@(4AA7K/I^B:JEM*DSQ
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M1;A!R>*$7MQHL;2GXJG0>':SEPM@"4@S 9_/A-"[&[- ]9XD^A=02P,$%
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M'?3(=)T7Z;(N+&NPC)+-__!7?2)V"MCVG@)V7<!^44 &UA=PZ@+.BP*.M:>
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MG0[6JF['JRY6?D3F49;+K2*;RJWA@_9&JIG>6=]03ZJFC7>NH8,/ WOX,E>
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M@[A5++?ES0[6@!G#9+XT"T.O$1G.=?V6)U1D9L$["=1-J,--QF-#AX.*TV,
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M-3/SYD)I \S\6@C]VK$+U*^XZ%]02P,$%     @ N(),6H^O@-2& P  QPH
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ML^T-AP<B6Z)&MG,@LC.-=XH<-B*'G2)G\?>""*)?,FTJAT?YN]Z!Q.,0^^Q
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MM+R/R_7"HG)6M,N*KI>@Z$SR9&_/8?QVYTW2:_U=Z!U0M(J$:BZJ>:CFHYI
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M5'-1S4,U']4$J@6H%J):1&EJ6ML^T'@$[?ZB_2!4LU'-0347U3Q4\U%-H%J
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MEE6:3XQO65EFB_4_[V4\DWE]@^KGMUE6/G]13_"8Y;^O'\[E_P-02P,$%
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M;*%5<R'T!+%T$H#(>P!U9E&88%V_%#J V%L"((K9O>2D:@5 =RA5,#3YG2,
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MF2X"@C54]"H5/:.*^<LY\0'E-+\HG>A<]#0':NGB1QG&E.?*T.4]<8) YHV
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MS,_7T=?=D9-UM-NVG 4:ZJOB"-IT@:(U=W_==G'-?1=9/_MOU4_(=L84E!:
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M@_9"#T,1IDEQGPLSF<MY1WO[0'M- 9R6+_?Y-6M/K_F#IA2OY>J-&)R_$MI
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MDANK4W*]JQQ-R:&:@6HFJEFH9H_W[P.J=YY90[MU4<U#-1_5 E0+*:U=XTT
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M5Z42Z"H/BKD;>%[HQI0ESFB0W[N7HX'(-&<)W$NBLCBF\O$:N-@/'=]YNO'
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M!FDVX/^9$'J], &JEA[^!E!+ P04    " "X@DQ:#XNC(2(#  "#"P  &0
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MFDRSG(DJC1E*RZ#HX[WV&UU[74'<*HA;M<3CR;2*IS;HA;EH%Y+:K_RFV__
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MGA0XRS8<9Z"<&B<(]5:PO8P=**TDA+!=VQ@;+NYK4P%]V_"MOC@%$)O(L-&
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ME(24Y0!Q_#%-^<M&?H+ZJX_Y?U!+ P04    " "X@DQ:81ZEDX8#  ".#0
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M6+>F2ML$7'W;8OD$KFF,J,X7F.PA3\!$)T^_>!TA"3$1;Q3$PR("KU^] :\
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M+K'F<8U@@K@V4.^7C,GG@5Z@^*LC_!M02P,$%     @ N(),6F9/05Z3 P
M#PL  !D   !X;"]W;W)K<VAE971S+W-H965T-S,N>&ULK59M;]LV$/XKA ;T
M!6@M67[K4EM 8F=HMKYX<=IB&/:!EDX6$9'42,JN_WV/E*S9L>(E@+^(+[KG
MX=USXNG&&ZGN=09@R ^>"SWQ,F.*"]_7<0:<ZHXL0.";5"I.#2[5RM>% IHX
M$,_], B&/J=,>-'8[<U5-):ER9F N2*ZY)RJ[17D<C/QNMYNXY:M,F,W_&A<
MT!4LP'PMY@I7?L.2, Y",RF(@G3B778O9B-K[PR^,=CHO3FQD2REO+>+FV3B
M!=8AR"$VEH'BL(8IY+DE0C?^K3F]YD@+W)_OV']SL6,L2ZIA*O/O+#'9Q'OG
MD0126N;F5FX^0!W/P/+%,M?N23:U;>"1N-1&\AJ,'G FJI'^J'78 W2'CP#"
M&A ^!/0? ?1J0.^I@'X-Z#MEJE"<#C-J:#16<D.4M48V.W%B.C2&SX1-^\(H
M?,L09Z+%W9?I'Q^^?)Q=WRY>DNL_O][<_47>DL]4*6HS@O-K7N1R"T 61L;W
M9%ZJ.$.ER3RG@KR:@:$LUZ^/#7%C,9_CH#.J0.\&)LA=)DM-1:+'OL$8K"=^
M7/M[5?D;/N)O-R2?I#"9)M<B@>20P,?@&P7"G0)7X4G&&<0=$O[ZAH1!V&]Q
M:/H$>*_KX+T6^.PT_'<J.B1HA1]$TVORV7-\O<?R:45^:V]"0J:28W70U%VP
M2TRH6 '>6$.66[)O-Z=;MWVYH2HA?W]$2G)C@.M_VO)3G=]O/]]6J0M=T!@F
M'I8A#6H-7O3BE^XP>-^F[3G)9F<B.]"]W^C>/\4>+0J(6<I0S0)4C&IBS20R
M)28#DE*F\,ZJ>ZSB:YJ7S8M8<HZIT>ZZX,09,Z4-D8KD%,>$;G?&,DU!,;&R
M!S"9D$W&\!^P!D68)EB]<4)-M5LSXGY17]:D+9-51-W A63_#^LHZ+P;C/WU
M?HI.QOW<%)V)["!%@R9%@],IJNN/UB6F"<M0+>0KG%:UZ76;2A7I8$^D01 \
MT.C8IO_09G9LT]NS.8AHV$0T?$I$=(T5F"YS_'BD<O%1$</_Q34\\J<;'GD]
M/>G <[-_)K(#K4:-5J.36GTN^1*O"%XFW:;:"JNC>;/[))B(L8?2T*;;Z G?
MPTE7GJO:F<@JU?R]5H&#6KF62V,E*H6I_IG-;M/57;IFYL'^%79[57/V'TW5
M*GZB:L4$UB1(D3+HC% K5;5?U<+(PC4D2VFPO7'3##M64-8 WZ=2FMW"'M#T
MP-%/4$L#!!0    ( +B"3%I [>01IP0   <7   9    >&PO=V]R:W-H965T
M<R]S:&5E=#<T+GAM;,58:V_;-A3]*Q?:L+5 8STLOS+;@&.Y:+8&]>(^, S[
MP%BT+40259*R8Z _OB2ER)9&*TX@(/F02-0]ASR'O.0-ASM"[]D&8PX/41BS
MD;'A/+DT3;;<X BQ%DEP++ZL"(T0%Z]T;;*$8N0K4!2:CF5US0@%L3$>JK8Y
M'0])RL,@QG,*+(TB1/=7."2[D6$;CPVWP7K#98,Y'B9HC1>8?TGF5+R9!8L?
M1#AF 8F!XM7(F-B7GMV7 !7Q-< [=O0,4LH=(??RY=H?&98<$0[QDDL*)/YL
M\12'H602X_B>DQI%GQ)X_/S(_EZ)%V+N$,-3$GX+?+X9&7T#?+Q":<AOR>X#
MS@5U)-^2A$S]AET>:QFP3!DG40X6(XB"./N+'G(CC@".<P+@Y #G7$ [![0K
M -L] 7!S@*N<R:0H'SS$T7A(R0ZHC!9L\D&9J=!"?A#+>5]P*KX& L?'B\^?
MIG]]^/31F]TN?H?9WU^N/_\#%[ 0Z\M/0PQD!1,F%D4B9XE!RK /G,",\4"8
MCH%O,'Q3YF+_8K+%5"P6>(\""E]1F&*88PJ+#:(8Q!J%!2?+>YBG=+D1<P5I
M[(O/DF(6)2'98UR-F(<HAC<>YB@(V5LQL%_!!";YV-#D0K]482YSK5>95N>$
M5MN!&Q+S#8.9Z-@O$YC"N,(]Y]&]*Z>6T</+%CB#=^!8CJL9T/0,>-M6\+8&
M[M7#_T1Q"RPMO*2F7:R%MN)KGUH+TM<+F44^3$DDMA:&5').*$7Q&HMTYW"W
MA^.X.=JKYLD.41_^_2@HX9KCB/VGFY^L?U??O]SB+EF"EGADB#V,8;K%QOBW
M7^RN]8?.VR;)O(;(2KZ[A>]N'?MX]I"(75"8Z0?;P,>QKUW;&8=M*1*YG6_'
MUM#<'CM2V\US'6F(K.1(IW"D4^](:3O0N5&+?^Y*:I+,:XBLY%NW\*W[RAG<
M;=+W)LF\ALA*OO<*WWNUZ_4V8/<7*RH6;!!S+/@Y4'$ZOI,G=A"ED<[)C'%P
MG,XMRVUW*CFM#;-Z_7*8IP^S.H/R3X$JR>P7,OLOE(D>3LGLZP;6Z;@5F>>%
M>=HP9]#7ZQH4N@;G;<!;$HI\"0.^KYVZ@68K;KEV1=)949XVJMW3"[*M0UEG
MO4#2Z6G*Z:JC'50TZ<,Z55%/AI55'16K=@,G94Y2>U2>$>/5QY0E. <)3JV$
MHEA&>;&\%CLSO_!E,;V2=?-6U<V)*(Q5G0MO@AA\$H:(LD/K6ZWNK.?^T7#;
MO993335-F#MH]7M5]?\/ZU@MQSEAP*'(M&MKJ<K9#C_@YG2BU5,]][AIE,UK
MBJULXZ%FM-U7/NKM)LO)::-L7E-L9?,/Y:G]1'WZN ^)4U"_<.OQ78C4/Z):
MHUX,]5X$+5MPJ#3MVH)*D\8UATNC56.C;%Y3;&4;#X6CW7OM-*XM79]M?I-L
M7E-L9?,/Y:Q=7\\^G<;U>!OV&%&PL[R"+OAHK\_I9GB\LWATUIA'-X01IFMU
MT\I@2=*89]==16MQFSM1=YB5]BMYRZMN'@\TV17Q#:+K(&80XI6@M%H]L1G1
M[-8U>^$D4?>0=X1S$JG'#48^IC) ?%\1PA]?9 ?%W??X)U!+ P04    " "X
M@DQ:F-8ZN5($  !Z&P  &0   'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6RU
MF6]OHS8<Q]^*Q::ME6[A3TC2=$FD-H"NM[M=U[2;IFD/7.($5, YVR2W:2_^
M;" D),37;+_U0<._[\?&'S!@CS:4O?"($($^ITG&QT8DQ.K:-'D8D13S#EV1
M3.Y94)9B(5?9TN0K1O"\"*6)Z5A6WTQQG!F34;'MGDU&-!=)G)%[AGB>IIC]
M=4L2NAD;MK'=\! O(Z$VF)/1"B_)C(BGU3V3:V9-F<<IR7A,,\3(8FS<V->!
M[:I <<2O,=GPO66D3N69TA>U<C<?&Y:J$4E(*!0"RY\UF9(D4219CT\5U*C+
M5,']Y2T]*$Y>GLPSYF1*D]_BN8C&QI6!YF2!\T0\T,U;4IU03_%"FO#B/]I4
MQUH&"G,N:%J%90W2."M_\>>J(?8"DM,><*J <QCHGPATJT#W,.">"+A5P'UM
MH%<%>J\]AWX5Z!=M7S96T=(>%G@R8G2#F#I:TM1"H:M(RP:.,W5ES023>V.9
M$Y/9X\?I3V\_OO?\A]GWR/_EZ>[Q=_0#^ADSAI5SN3R+,"/H@:QR%D92(D<7
M'A$X3OBEW/LT\]#%MY>(JZ,XBC/T&-&<XVS.1Z:0-53EF&%5F]NR-LZ)VMCH
M \U$Q)&?S<F\)3_]2M[1 $S9-'7[.-OVN76TQ( \=Y!MOT&.Y?3:*J2/>R3L
M(&=8Q-V6N/>*>+<LO=L2]_7Q=SCK(.MT/-#';_)E7;JK:<MN?:UU"U[W!&^:
M8,X17:"9H.$+^N.]W(_N!$GYGVV72@ESVV&JQ[WF*QR2L2&[5$[8FAB3[[ZQ
M^]:/;9H@81XDS(>$!4"PAEZWUNOJZ)-=#Z$<AS1-Y9.CZA8NXNWB99MJ+?A<
MU26L5\#4@W4]&5KR\EWO&X0LT(>$!4"PAL%>;;"G-?A(!4ZD.2Z4P4H=J[6V
M=<BW6N*YZDK88$^=+0\M_@X$0A;K0\("(%A#8+\6V-<*G)8W7=&_MLG2IL^5
M!0GS(&$^)"P @C5\#FJ? \@GY@!2+R3,@X3YD+  "-;0>U7KO=+>KJ7570>+
M5HPN&4X1SD5$6?PWF2.<TCP3;;:U['-M0\(\2)@/"0NNCA\P/<LZ>,(T7 YK
MET.M2X\F"6:5+NE4?=7'V5)]$.W9Y">,M_G5EG>NW^'QB;M')U[:@RS7AX0%
M0+"&7]O:?2E;_]?[K9Y\KDM0FE?1]M^7#ZX(_^N'!%!U:KK9&\6P7_WB@_Y!
ML_R9DT\YD7>BOR;MW:>>>+832)H'2O-!:0$4K6G:V9EV(%^)*AJ494B:!TKS
M06D!%*UI>3=29&M'*OY37]L]ZJSLHX?<5%_^V29!1X1 :0$4K6ER-RADZT>%
M_LV80H5LO*TXK>, 4WWI9WL$'1<"I050M-*CN3=ED!*V+"9WN/0DWU[+T?%Z
M:SV!=%-,FQQLG]K7?CD-M,.4LU(?,%O&&4<)64BDU1G(6Y*5$SWEBJ"K8F+B
MF0I!TV(Q(GA.F#I [E]0*K8KJH!ZNFWR!5!+ P04    " "X@DQ:[.+"W(D"
M  ",!0  &0   'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q]5&U/VS 0_BNG
M@!!(C+S0\II&:FD1:&.PIFR:IGUPDVMCX<3!=EJ0^/&SG33KIK9?8M_Y[KGG
M[G(7+KEXD1FB@K><%;+G9$J55ZXKDPQS(D]XB85^F7&1$Z5%,7=E*9"DUBEG
M;N!Y9VY.:.%$H=4]B2CDE6*TP"<!LLIS(MX'R/BRY_C.2C&F\TP9A1N%)9EC
MC.JY?!):<EN4E.982,H+$#CK.7W_:M U]M;@.\6E7+N#R63*^8L1[M.>XQE"
MR#!1!H'H8X$WR)@!TC1>&TRG#6D<U^\K]%N;N\YE2B3></:#IBKK.1<.I#@C
M%5-COKS#)A]+,.%,VB\L&UO/@:22BN>-LV:0TZ(^R5M3AS6'X'*+0] X!)9W
M'<BR'!)%HE#P)0ACK=',Q:9JO34Y6IBFQ$KH5ZK]5!1/'F\^WSU^&8[&\<'>
M1>"?7\/HV_/]Y"=\@EC_ FG%$/@,XHP(A#&6E4@R70;HFWI2]0Z'0U2$,GD$
MTMA(H 5,,EY)4J3R&/:-_$ 9TTV0H:LT:1/:31J"@YI@L(6@'\ #+U0F852D
MF/X+X.ILVY2#5<J#8"?B$),3""Z/(?""#CS'0SC<7W'? 7_:5O34PI]N@1^]
M5J8JO_I3J83^Z7YORKF&Z&R&,(-X)4N28,_1DR91+-")#O;\,^]Z!\%.2["S
M"SWZ6N53%*:G3;]$V]04#G6S:O41?&PL2IU ':)K0YC!7T277B=T%QMX=5M>
MW9V\)EP1!@F7:@NW#]C?1*5&/5^CXOMG_U%QUR8D1S&W>T#J8%6AZF%IM>VJ
MZ=<3]M>\WE,/1,QI(8'A3+MZ)^<ZOJAGOQ84+^V\3;G2TVNOF5Z7*(R!?I]Q
MKE:""= NX.@/4$L#!!0    ( +B"3%J-TI#>8@0  $P7   9    >&PO=V]R
M:W-H965T<R]S:&5E=#<W+GAM;,58:V_;-A3]*X16;"V01 ^_Y,PVD%@9FJU!
ML[C9, S[0$O7ME")=$DZ3O[]2$J1+9G6$HQ%OM@2?>_1/8<\]!5'6\J^\A6
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M3 7(WQ>4BN<;]8#J 'WR+U!+ P04    " "X@DQ:&*'BC7D"  ")!0  &0
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M#<#]I93F:6*;5_.OBO\"4$L#!!0    ( +B"3%H.W4^0_ (  %8(   9
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M-%PKY7 )%S^1Q@#>SX70KQ-SMS1_)9*_4$L#!!0    ( +B"3%K=AZ82-00
M ,(6   9    >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;+5878_:.!3]*U:V
M6K72=!(G0& 6(C% U9&8"I69W8=J'SR) :M)3&T'IO^^=@CY !.5:?("2;CW
MY-SK$W-RAWO*OO,-Q@*\1F',1\9&B.V=:7)_@R/$;^D6Q_*7%641$O*4K4V^
M91@%:5(4FK9E]<P(D=CPANFU!?.&-!$AB?&" 9Y$$6(_[W%(]R,#&L<+7\EZ
M(]0%TQMNT1HOL7C>+I@\,W.4@$0XYH3&@.'5R!C#NXGMJ(0TXE^"][QT#%0I
M+Y1^5R</P<BP%",<8E\H""2_=GB"PU A21X_,E COZ=*+!\?T3^EQ<MB7A#'
M$QK^1P*Q&1E] P1XA9)0?*7[SS@KJ*OP?!KR]!/LLUC+ '["!8VR9,D@(O'A
M&[UFC2@EP,Z%!#M+L'\WP<D2TLZ9!V9I65,DD#=D= ^8BI9HZB#M39HMJR&Q
M6L:E8/)7(O.$MWQ>+.:SQ]F7I_$<W(_GXR^3&5A^GLV>P'3V-'Z8+\%'L)3B
M"9(0 [H""R8EQ,1/@.( S'XD9"L758#W4RP0"?D'&?Z\G(+W[SZ =X#$X)&$
MH5PO/C2%I*MN:OH9M?L#-?L"M2GV;X$]N &V97<TZ9/?2'=@FNY4TTW9I+Q3
M=MXI.\5S+N ="[\!BQ#)BJOU?YO+</ @<,3_UY5ZP.[HL=6S>L>WR,<C0SZ,
M'+,=-KR__X(]ZQ]=X0V!5=K@Y&UPZM"])RI0"+9E%>!C%V[ FE&N7>H#J)N"
MJJUEY]E6;S T=^6Z-$&PT\V#*GP[.=].+=^Q[R=1$B*! _EXRX;X!*D-1$?R
M@-0MW?\CM+N=$Y:Z*.CT]32[.<WN'[0UQD+'MWO&I ^[)VS/8Z!EN7JRO9QL
MKY;L',N-<T/# )!(4MYAQ5*[[+4XU\J^(;!*R6Y>LMOBT^\VV8:&P"IMZ.=M
MZ+?Q]/?/1.BZ]HE0SV/ZEJ/7Z2!G.ZAE^XC\C;S$3HCJ&-8"7;M"#8%5:H96
M\8]NM2C5#+RA3C2%5FU%R=S -N2:H9:UV.L[)WK5!G7T@H6%R8"U?][>A$;;
M1& &-H@%>\1P2IK3E5 G6K*-6HNFT*KE%^8".FUJM]:Z7-V*AM"JK2A\"ZPW
M+F_5[KD]Z;C]4^UJ@GH7-EM86!A8[V$^)2PF(LDTNR*OZEA/LA;HZH5J"*U:
M=F&&8*]-S39JD9I"J[:B,$FPUGR\6;/NF1R[9]NM)N;"JP$LW RLMS/W"0D#
M$J_UK&ISKUZ9AM"JE19." [:%&FC]J@IM.IK?.&/[%K3\5:19JB5/?/TU; ^
MILJW,#%VO8F9T)@+EAS&7B16S->R+WJ2M5!7SQD:0JL67AJXM#IQ:7;DTH8O
ML@M?9+<R=;'/)RK.Z=!%$S/HG6C6+ T8U73W$;$UB3D(\4HF6;>N5#P[#$P/
M)X)NTYGC"Q6"1NGA!J, ,Q4@?U]1*HXG:HR9CZV]7U!+ P04    " "X@DQ:
M/%"_C;$#  !7"P  &0   'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6RMEEN/
MVCH0@/^*E5,=M1*[N7#? A*WJI78%I7=GH>J#R89P*H3I[99V/[ZCI.0Y6*B
M/5)?('9FQM]</)G>3LB?:@.@R3[FB>H[&ZW3.]=5X09BJFY%"@F^60D94XU+
MN795*H%&F5+,W<#S6FY,6>(,>MG>7 YZ8JLY2V NB=K&,97/(^!BUW=\Y[#Q
ME:TWVFRX@UY*U[  _9C.):[<TDK$8D@4$PF1L.H[0_]N[&<*F<0W!CMU]$R,
M*TLA?IK%IZCO>(8(.(3:F*#X]P1CX-Q80HY?A5&G/-,H'C\?K'_(G$=GEE3!
M6/#_6*0W?:?CD A6=,OU5['["(5#36,O%%QEOV17R'H.";=*B[A01H*8)?D_
MW1>!.%*H=ZXH!(5"\%J%>J%0SQS-R3*W)E3304^*'9%&&JV9ARPVF39ZPQ*3
MQH66^):AGAXL'N?SV?1^^OEA.".CX6SX>3PEBX_3Z0.93!^&GV8+<D,66#S1
ME@,1*S(,0[F%B,P873+.- -%WDY 4\;5.Y1]7$S(VS?OR!O"$G+/.,=DJ9ZK
MD=6<Z(8%URCG"JYP32"\)4&W1@(O:%C4QZ]0K_N9>OU4W<4(E6$*RC %F;WZ
M%7M?Y)HF[#<UI5<C8W1)<!;1O!*3B,PE*$ATOH%1^L 2FH2,<K+ 3<"ZUXI\
M'RZ5EEBX/VSQR $:=@!SF^]42D/H.ZDY2SZ!,_CW'[_EO;=%YR\9.XE5O8Q5
MO<KZ8 9K]#L4B6;)&C *8,U_;J2=&3'-YFD0M'KNT[$7ER*-3J.4.8%KE'"-
M2CA,798"PE_JMX8734I,$4F%-!FTX>9FFR>XWAFO1:89V'F;)6^SDO=PW4(1
M8^=6>8'!WCS;P]JL9,@Y+3+FEM@X6R5GZU6<FNZQ(:3TF2XYV/A:%V?[GG_&
M=RG3[MKQVB5>NQ+O2PJ2FGHD'+#I_^_LMR\J\8@HA[X4Z;3LT)T2NO-*Z)F!
MKI4]]QE;4,Y<>^DOIVUG+A3+:N7[=*_-5Q?3@?K*WGNJ.68B6=]HD#$1U\-H
MZT)_W>Q)&+ME&+O5YQRB=A-RJA1;,:Q3^+7%'?Q&A1@Z'"0(W5$966]4]R*Q
MY_?^4J+9M*?>]UZ^RUYU\O4&9,T \FUD0H-\DB970CTJK)W>J_,2M0DUKA2I
M?S1!^)6D#T)CP=&B 527Q*BP=7)-@O8YYZ607P_.0^H>33UFY+RG<LT2A36T
M0C7OMHU^RGR*RQ=:I-D@M!0:QZKL<8.3+T@C@.]70NC#PLQ6Y2P]^ -02P,$
M%     @ N(),6O]>\^99 P  >0D  !D   !X;"]W;W)K<VAE971S+W-H965T
M.#,N>&ULK591C]HX$/XKHUQUZDKM!D* =@\B >'4/2T5@MWKP^D>O,D 5AT[
M9SNP_?<W3K(Y8+.T)_4EL9WYOLPW,QY[=%#ZJ]DA6GC*A#1C;V=M?N/[)MEA
MQLRURE'2EXW2&;,TU5O?Y!I96H(RX0>=SL#/&)=>-"K7ECH:J<(*+G&IP119
MQO2W*0IU&'M=[WEAQ;<[ZQ;\:)2S+:[1/N1+33._84EYAM)P)4'C9NQ-NC?Q
MT-F7!G]R/)BC,3@ECTI]=9/;=.QUG$,H,+&.@=%KCS,4PA&1&__4G%[S2P<\
M'C^S_UYJ)RV/S.!,B2\\M;NQ]\&#%#>L$':E#I^PUM-W?(D2IGS"H;;M>) 4
MQJJL!I,'&9?5FSW5<3@"= >O ((:$)P#PE< O1K0^U% 6 /",C*5E#(.,;,L
M&FEU .VLB<T-RF"6:)+/I4O[VFKZR@EGH_7#<GDW7\P_WT_N8#JYFWR>S6']
M:3Z_AWA^/[F]6\-[6%.QI85 4!N8[9C<H@$N884&]1Z!B@^66J5%8N$+TYI)
MR\GB;8R6<6&NB.%A'</;-U?PQN$67 C*N1GYEA0X/_RD]G9:>1N\XFTW@(62
M=F=@+E-,3PE\DM[H#Y[U3X.+C#$FUQ!\? =!)PA;')K] +S7+>&]%GA\&?X'
MD]?0:86?J.DUV>R5?+U7^!9JC[0GK8ORVC*9,IT"O6#^9-%%[#Q/WV"2)+I@
MXAW<RH3ZAD&7MVIT!7^ME!! &^Q 1'^WY:OR)VSWQ_6L&Y.S!,<>-:6R6KSH
MUU^Z@\YO;;'^F63Q3R([R4/8Y"&\Q!Y-F6 R06#&;9E'W'(IN=RZ28Z:J[0M
ME!7EL*1TW7H?!=V1OS\.T$N3[H=3D[B%)6A,3L3T&S']BV(F:<I=CS:0[)C>
M4A%9!8DRMI13UY/&/<H"VW15[/TCC\+@3-?W3>*7)F['M.D:-+H&%W6M,&=<
MFW)_:,P%%8/;.ZUM:?#B[^_#_IF(%IO>QS,5+3;!L%W&L)$Q_!^U1KO\<I4-
MOUM"LY<FYX487V2I9/A'AU*&5#?N<*<:4H6T57]N5IO[PZ0\-L_6IW2OJ*X!
M_]%4EY(%E2.GNA2X(<K.]9 "JZN#OII8E9='WZ.R=)"6PQW=C5 [ _J^4<H^
M3]P/FMM6]"]02P,$%     @ N(),6E[,3N4]!   7Q@  !D   !X;"]W;W)K
M<VAE971S+W-H965T.#0N>&ULM9EA;Z)(&,>_RH3;7':3W<(@4NVIB8J7;6+W
M3+5W+R[W8@J/2A88;F;4[K>_&: H2+FU&=]4P.?Y,<^?^0^/T\&!LN]\"R#0
M2QPE?&ALA4CO3)/[6X@)OZ$I)/*;-64Q$?*4;4R>,B!!EA1'IFU9KAF3,#%&
M@^S:@HT&=">B,($%0WP7QX3]F$!$#T,#&Z\7'L/-5J@+YFB0D@TL03RE"R;/
MS)(2A#$D/*0)8K >&F-\Y^&^2L@B_@SAP$^.D2KEF=+OZN0^&!J6&A%$X N%
M(/)C#U.((D62X_BW@!KE/57BZ?$K_?>L>%G,,^$PI=%?82"V0Z-GH #69!>)
M1WKX"D5!7<7S:<2SO^A0Q%H&\G=<T+A(EB.(PR3_)"^%$"<)V'TCP2X2['J"
M\T9"ITCH_.P=G"+!R93)2\ET\(@@HP&C!\14M*2I@TS,+%N6'R;JN2\%D]^&
M,D^,ED^+Q7SV,/NV&L_19#P??YO.T/+K;+9"WFPUOI\OT1>T8/!E15[0(W#!
M=K[8L3#9H.F6L V@CQX($D;\DPQ\6GKHXX=/Z ,*$_001I%\M'Q@"CE0=3O3
M+P8UR0=EOS$H;*,'FH@M1[,D@* !X+4#;-P",*5$I4[VJTX3NY7H@7^#[/YG
M9%NVTS"@Z4^D=W"6WFFJY]UWKU33*9]Z)^-UWN#5'B3E I$D4,\7V![0WW,9
MC^X%Q/R?IJ>7PYUFN%JI[GA*?!@:<BG*B,;HUU^P:_W6))Q.F*<)5A'5*45U
MVNBC%14DDFOAJ;1^YI%&"^2PVPRF5N?]R+4'YOY4FO,0W*W%>.<Q-G;*F$HA
MW;*0;FLA2[D*R\%_1AM(@,F:U-P@@5Q]0ED;40MU4T&MT$MGA4Z8IPE6$=,M
MQ72O:357IZ@Z89XF6$74VU+46YU6RV'=$X]T^S6KG8=@NVZUUC&]L^)>67&O
MM6(U7PCSM]GD"6 O&[94ME^BJ=Q6TJ5S1B?,TP2K*-@O%>Q?TXA]G:+JA'F:
M8!51L77L'RV=5BQHIT:KO_6:0IR:%=L']=ZB3YIFW%KT+$XC^@, <4B)>B/*
M7S"^G%'-);>R+ITZ6FF>+EI51_NHHWU-3Q9T7<KJI'FZ:%5ECPT^;FUU+[9E
MI^']5_?E>8S3J_OR/,:UFKM1?.RK<7MC/>8<! KCE(1,O?-:"VE%73PE=-(\
M7;2JC,>N'G>O:C:M_;U6FJ>+5E7VV.+CUF;W8K.YYT9RZV8[C\&657=;0] )
MJ5K-L;?&[<WU'V(++)L?S:/7U 87=>JD>;IH5>6./3KN7=5A6AMWK31/%ZVJ
M[+%WQZU=[,4.ZY_MBCAU@_UOB-<0TJN9RSS9>8U!#D?M8'/9"^X2D6\NEE?+
M7?)QMC=<NS[!=]-\K_N(R;?>'V258<)1!&N)M&YNI=U9OIN=GPB:9ON[SU0(
M&F>'6R !,!4@OU]3*EY/U W*_RF,_@-02P,$%     @ N(),6IKG+;/[ P
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M$*X7J/LKQN3K0&^0M1@'/P%02P,$%     @ N(),6A^"-0J#!   "A0  !D
M  !X;"]W;W)K<VAE971S+W-H965T.#8N>&ULM5A;;^(X%/XK5G:TFI&6ACA0
M:!>0N(VF4B^HT)V'U3Z8Q)#L.#%KF]+^^[6=-"$7#-.A+Q [YWS^SO'Q^<"]
M'64_>("Q "\1B7G?"H387-LV]P(<(7Y!-SB6;U:414C((5O;?,,P\K531&S8
M;%[:$0IC:]#3<S,VZ-&M(&&,9PSP;10A]CK"A.[ZEF.]33R&ZT"H"7O0VZ U
MGF/QM)DQ.;(S%#^,<,Q#&@.&5WUKZ%R/H:L<M,5?(=[QO6>@0EE2^D,-;OR^
MU52,,,&>4!!(?CWC,29$(4D>_Z6@5K:F<MQ_?D/_JH.7P2P1QV-*OH>^"/I6
MUP(^7J$M$8]T]PVG ;45GD<)UY]@E]HV+>!MN:!1ZBP91&&<?*.7-!%[#D[G
M@ -,'6#9H77 P4T==.;LA)D.:X($&O08W0&FK"6:>M"YT=XRFC!6VS@73+X-
MI9\8S)]FL]OIW?1^,;P%H^'M\'X\!?-OT^D"3*:+X<WM'#3 C.'& KV <8#8
M&G. 8A\LJ$ $C"D7''R>8(%"PK](VZ?Y!'S^] 5\ F$,[D)"Y&;QGBTD5[6B
M[:6\1@DO>("7 \$=C47 P33VL5\$L&606:3P+=(1-").L'<!X-4? #9AJX;0
M^ 1WU]'NKH&.FR7>U7CN ;Q'S 7;>F++PG@-Y BS9PS^?J2$ %F@.\3\?^K2
MEJ"VZE'5H;_F&^3AOB5/M<:T!K__YEPV_ZP+^4Q@A02TL@2T3.B#$5Z'<:R"
M7R*"8@_719M =#2$ZDC/ Z?;LY_W8ZB:-#.+ K%V1JQM)#9]D3V28]FD/,HJ
MM9?P:E=Y799X)2;M/9,VK"=VF1&[-!(KELQ-[&T9P[X^@V ND,"RO0KPL%*O
M:(3! Y/O(KEU@6J[LKK2^>F+4!-+(A_C;809TAWUG@HP";E'*)>H7PE:UT5N
MIGA"[L9&A'<672=+8<?(;XQX #;H566JMBMU*AO;@.6=[51VMN&VZK>VF_'J
M&GD-_7]EK]>L@*!2W#RV1:2.8+>Z>*O$S[C4.Q-\E05R92Z V#]RI*\J 93Y
M5RWV#GV!E=/,9:YIYA5M"'W%&,SQ!J4%K\6K5IJ,6#_;9,^%5HQ\3^"=#Q&:
M%/9<23@36C$),$\"_'6Q23$*A=<IU6:-S0&Y<?)? HY19T\2G!2BP V6N55M
M6H<.3J[2CEFFCW;,U+_0D6#Y2-<9N<X!;KE0.V:E/KUK.E4U;KAECL;%WENB
MN;@[1Z3S:.=, ?:#J)1 U62OA(O,<LUTS*+Y( +,#-W2Z/W3C>),:,58<QUV
MNA_3+<\DNFD2/D+"G5S#';.(G]8M:V2Z7(U5DP/-$N9"#H\(^0G-,H4P_<8P
MFA2IY4H+C2)VO%6F_L5662968^,>8);+'S3+W^F-$E;UK5'>5O-B[ZQ.F,LE
M/"*71QME"M Q-,H:D[(<V7NW*O)/TEI?-G'@T6TLDFN';#:[T!KJ:YS2_,BY
M'B?74CE,<DMVAY@\:1P0O)*0S8N.S#M++IZ2@: ;?7>SI$+02#\&&/F8*0/Y
M?D6I>!NH!;+KO\'_4$L#!!0    ( +B"3%H][02%1 @  $M8   9    >&PO
M=V]R:W-H965T<R]S:&5E=#@W+GAM;*W<:V_BN!X&\*]B<59'NU*GD' IG6V1
MVN:>SDXUU9Y]<71>N,%0:Y.8C4V[LYH/?YR0$D*#"]+S9J9 _,L%/S@Q?W+U
M*HH_Y3-CBOR=I;F\[CTKM?K<[\ODF654GHL5R_4K"U%D5.F'Q;(O5P6C\ZI1
MEO;MP6#2SRC/>[.KZKF'8G8EUBKE.7LHB%QG&2V^W[)4O%[WK-[;$]_X\EF5
M3_1G5RNZ9(],_;YZ*/2C_E:9\XSEDHN<%&QQW;NQ/L?VI&Q0+?$?SE[ESM^D
MW)4G(?XL'X3SZ]Z@W"*6LD25!-7_O; [EJ:EI+?CKQKM;==9-MS]^TWWJIW7
M._-$);L3Z1]\KIZO>],>F;,%7:?JFW@-6+U#X])+1"JK?\EKO>R@1Y*U5"*K
M&^LMR'B^^9_^71^(G0;6Z$ #NVY@[S6P[0,-AG6#X;$-1G6#T;$-QG6#\;$-
M)G6#R;$-+NH&%\<VF-8-IL<VN*P;7.XWL Z]<8.W=VYP[%MG;=_L3:?;])*J
MBSE4T=E5(5Y)42ZOO?*/JI]6[77/XGD9J4=5Z%>Y;J=F]ZY_<T\>OGV]<UTG
M_,U_)#\[3%&>RE_(3X3GY M/4]WWY55?Z=65C?I)33L;VCY #\D7D:MG2=Q\
MSN8=[5US>\LV 'V]G]N=M=]V]M8VBM$Z/R?VZ(S8 WO4L4%WYN:_B9=S8EE5
M\R%)Z:M<<]5U7,S,(UOIK;C<; 7Y_=$A/__T2]?A,3,.2XYBO".8X=M.'6;\
M#PXMU8=V\#$3''%L!L,/=RHT,QY[THQ=,X??J>B8G7H[Q)EXH7F7$IN5KXEJ
M#HVA%P^WD1U6WO!09(64Y$XG@^=+EB><2?+?>[T,"17+Y/\Z-O!V XZZP7+4
M_BQ7-&'7/3TL2U:\L-[LW_^R)H-?NT*"Q!PDYB(Q#XGY2"Q 8B$2BY!8#,):
M&1MM,S8RZ;-[MJ0I2;8A^TYH/B>2*94R?4+9]2EP:Q1/#1D2<Y"8N\$N*JP\
M87^9C<:3J_[+;G;>+_/)'K27\3N6F5B7[84"Y):'2"Q"8C$(:W7U\;:KC\U=
MO1Q.=GKZ&<GUA5"24IY)LN IF^MGUMD3*\@/PU!Z:US+J=U_@XUW.L>PW3,<
MY.I<).8A,1^)!4@L1&(1$HM!6"M-DVV:)L8TW8DLXZH<(F0U9"2[YVG;((E%
M?399)TP_*B<8JAQ*D?(Y5:R:;2B?^W'XS//6N#&GA@Z).4C,16(>$O.16(#$
M0B063=Y]'H_:G\<Q:'6MT%UL0W>!"1V=SWD9*GUN)UFR+O0#??6DQSH]!#9Q
M,PQRQNTX-6](S$%B+A+SD)B/Q (D%EZ\BXC=CDB$7%T,PEIYFV[S-C7F[2;Y
M:\UEE23R=4'\@O+TC(1Y<MZ5&:-U:F:0F(/$7"3F(3$?B05(+$1B$1*+05@K
M7I?;>%VB)_@ND1E#8@X2<Y&8A\1\)!8@L1")14@L!F&MC%F#YHNOP4GS'OH$
M,"G6-.V*EYDZ-5]0S8%J+E3SH)H/U8)::TUD#O=.V4+H*B.H%J.T=GYVOCBV
MX%/D9O+D'"$UI]9:_6%JM?N#"UVE!]5\J!9 M1"J15 M1FGM'-E-CFQSCO1U
MU))6UU)->,[(DO*\,T)&[>0((36GUEK31-/+_0@A5^E!-1^J!5 MA&H15(M1
M6CM"34&$9?PN^%"$4GV&UQDA:#D$5'-J;7<4FNX'"%KF -5\J!9 M1"J15 M
M1FGM #75#M8'Y0XB7WY2K,C(G#WIY"S*V885*Q*=([IDI*"*=28)6O, U1RH
MYD(U#ZKY4"V :B%4BZ!:7&O6<.?#=G ^&(^W'[CM.#45%9:YI.).9*N4*49\
MEHN,)]VC$+1@ JHY4,V%:AY4\Z%: -5"J!9!M1BEM1/65%E8$_04N06ME8!J
M#E1SH9H'U7RH%D"U$*I%4"U&:>V\-046EKG"XH%^WY17+$1!TFKFK[G2ZA[>
MH*424,V!:J[U_IO_H3W>JXB%KM*':@%4"Z%:!-5BE-9.45,V89GK)LPI.B,T
M$^M<$9JF(M%77'.B!"E8RJAD9?72BDI%YC335V1R4Z#;^;.J6_-6G!P]:,D%
M5'-K;3=ZUGBP'SUH,054"Z!:"-4BJ!:CM';TFI(*R_AM\JS\_2TKJEGU=K%[
MP1*QS/D_.FWE2^NBT%DLYSZXZ X7M-0"JCE0S:VUW7"]&]6@-110+8!J(52+
MH%J,TMJ_J6T**6QS(<6[V0[R@]SSA.6R<\[0K)T:(*CF0#47JGE0S8=J 50+
MH5H$U6*4ULY:4W1A6^AY#QM:<P'5'*CF0C4/JOE0+8!J(52+H%J,TMIY:XHS
M[(^*,ZIQC"P+FJOJ%%'1?,F?4D:HU-=NG5,?9O/DQ$%+-*":6VN[WU9;T_WK
M+^@J?:@60+40JD50+49I[2 U)1JVN43#XSE7[%/*7[I25%Z&E?=_TJ-:.0E2
M*/[/IISC\'68>7TGAPQ:Q '5W ^.[(1\9[209$*RZFXYG6,9M,@#J@50+81J
M$52+45H[@DV1AVTN\GA<\5PL%OKJS/]V$]YWA@I:SP'5'*CF0C4/JOE0+8!J
M(52+H%J,TMKY:JH^[#'\V@Q: P+5'*CF0C4/JOE0+8!J(52+H%J,TMIY:VI
M;/.M-AXV]8GE-V/ZA)+I52@RYW(E9/?78C5WV:KVFH[WYK3OS&L].470R@ZH
MYD$U'ZH%4"V$:A%4BU':)D7]G5N!9JQ85G>K+7_GN,[5YD:9VV>W=\2]J>X#
MN_>\:WWV-[<8;9C-;7:_T&+)<TE2MM#DX/Q"?PP4FSO7;AXHL:IN./HDE!)9
M]><SHW-6E OHUQ="J+<'Y0JV]P^>_1]02P,$%     @ N(),6API6/GM @
M/P@  !D   !X;"]W;W)K<VAE971S+W-H965T.#@N>&ULK59=;]HP%/TK5E9-
MK;223T+;021*.JW3NE6EW29->S#)!:PZ-K,-M/]^MA,R0"[J0U^([9QS?,^U
M<R_]-1>/<@Z@T%-%F1QX<Z46%[XOBSE46';X IA^,^6BPDI/Q<R7"P&XM*2*
M^E$0I'Z%"?.ROEV[%5F?+Q4E#&X%DLNJPN+Y$BA?#[S0VRS<D=E<F04_ZR_P
M#,:@'A:W0L_\5J4D%3!).$,"I@-O&%[DJ<%;P \":[DU1L;)A/-',[DN!UY@
M @(*A3(*6#]6, )*C9 .XV^CZ;5;&N+V>*/^R7K77B98PHC3GZ14\X%WYJ$2
MIGA)U1U??X;&3]?H%9Q*^XO6#3;P4+&4BE<-64=0$58_\5.3ARU"F+Y B!I"
MM$](7B#$#2%^+2%I"(G-3&W%YB''"F=]P==(&+16,P.;3,O6]@DSQSY60K\E
MFJ>RZV^C[S=7Z'[XZVJ,3M%87ZMR20'Q*3K^RJ4\0=>LX!6@">@[!IO9/7X"
MB2;/Z YFYOB.<U"84 T_10_C'!T?G: C1!BZ(91J@.S[2D=K]O2+)K++.K+H
MA<C""-UPIN827;$2RET!7]MLO48;KY?10<4<B@Z*SC^@*(@21T"C5]#CT-)C
M!ST_3/^"60<%3OJ.F[@]N=CJQ2^=7'L2*">RH%PN]?G\'DZD$OIK^N/*>*V8
MN!5-A;F0"US P-,E1()8@9>]?Q>FP4=7MMY2+'\CL9U,)FTFDT/JV0,C"DHT
M5EB!\Z+6])ZEFSJZRD[#LUA?H=5V/ERH7MS=1>4.5'*>1"UJQT&W== ]Z$"7
M0%W@F"OVFMC=VB_M[L4T<F#"L[VX'9@@=4>=ME&G!Z.^YPI3I"^NW%074M]I
M9:J+RTSJ2''8.]^SXT2%O3U##E02Q_N6_*W26H&8V18E4<&73-65IUUMN^#0
M%O^]]4O='>MF]E^F;JTW6,P(DXC"5$L&G9Y.LJC;53U1?&$+^(0KW0[L<*X[
M/ @#T.^GG*O-Q&S0_F?(_@%02P,$%     @ N(),6H8W5KN, P  CPT  !D
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M>=W]UP/)UKH??F)2==?Z<J5.3, K@+J_8$SN!]4"[1EL^AM02P,$%     @
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M*[>J6JF-OS ?N6") DU1$X(@N?>AZL,&#V!UO>ON+I#^^[N[. 83QPJ2I;R
MUYYS/'/FV,S2W3'^6ZP!)'I,"!4]:RUE>FG;8K&&!(L+E@)55Y:,)UBJ)5_9
M(N6 (P-*B.TY3M-.<$RML&O.37G891M)8@I3CL0F23#_^Q4(V_4LUWHZ,8M7
M:ZE/V&$WQ2N8@[Q/IURM[)PEBA.@(F84<5CVK+Y[.7 ##3 1_\:P$T?'2)?R
MP-AOO1A'/<O1&0&!A=046'UM80"$:":5QY^,U,KOJ8''QT_LWTSQJI@'+&#
MR']Q)-<]JVVA")9X0^2,[;Y#5I!)<,&(,)]HE\4Z%EILA&1)!E89)#'=?^/'
M3(@C@-MX >!E .^U #\#^*;0?6:FK"&6..QRMD-<1RLV?6"T,6A534QU&^>2
MJZNQPLEP/KJZ&4WN4'\R1%>CVZM9?_I]/$#CR;?;V4W_;GP[05_07)DGVA!
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M,,S;P(L,4,X Y3B6#YG8#Y;'STG,Y9]IDD11'&,K.IEX'4RP=8MC^/&K8=Z
M@>6!3'^WUOANXQ5RN ZP/3U4(=A,\4K$9HJO-2#^=0-&DOAW&\L##&P7L-J!
M_/X\4%-^3A3!KF+>L"<81Y($0Z 6_34:Q\CJQ/#Q[P_VE$11DO@1P/P.H@A#
MX&G$$<P!>,"0*++OP;WW4;AY3X7M_RC'?P!02P,$%     @ N(),6I>*NQS
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MHMY)0.],O;. WIEZ9P&],_7. GIGZIT%],[4.POHG:EW%M [4^\LH'>FWEE
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M'+\\TZ'NQI?\;/FCWNU/4$L! A0#%     @ N(),6@=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "X
M@DQ:6Z?IU^X    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " "X@DQ:F5R<(Q &  "<)P  $P
M@ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +B"3%H9&2!W
MK0<  $0P   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " "X@DQ: 996IST"  #"!0  &
M@('P#P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ N(),
M6N1T;(!6!@  5AL  !@              ("!8Q(  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( +B"3%H'#]VK'@,  !D+   8
M      " @>\8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M" "X@DQ:16*' P@'  !0)P  &               @(%#'   >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ N(),6MWOVK,# P  4P@  !@
M             ("!@2,  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( +B"3%J!A/.JPPD  !YD   8              " @;HF  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "X@DQ:CQP1'GT*  ">
M/P  &               @(&S,   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ N(),6L;X,$^+*@  5(4  !@              ("!9CL
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( +B"3%KOLKNE
MR@<  )H2   9              " @2=F  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ N(),6F*#N58;!P  HP\  !D
M ("!*&X  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "X
M@DQ:>=!Z$SH.  #,*P  &0              @(%Z=0  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( +B"3%KTB#OJ_ \  $4Z   9
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M970Q-RYX;6Q02P$"% ,4    " "X@DQ:+WF+/#X,  !I(@  &0
M    @(&%V0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M +B"3%J.!C:ZH 0  &<*   9              " @?KE  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ N(),6F@F8D='"   ]1(  !D
M             ("!T>H  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    " "X@DQ:V)1.TEX"  ![!@  &0              @(%/\P  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( +B"3%HOJX7PG 8
M 'HO   9              " @>3U  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ N(),6D![AD$1 @  W00  !D              ("!
MM_P  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "X@DQ:
M*Z]X-I,)  !$)@  &0              @('__@  >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( +B"3%JJ0TT-H"@  &Z(   9
M      " @<D( 0!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ N(),6CSNZ]Y)!   7PH  !D              ("!H#$! 'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "X@DQ:6(2+0C@$  !E"0
M&0              @($@-@$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( +B"3%J Y!TC#P4  +L*   9              " @8\Z 0!X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ N(),6M@YH'.U
M!0  81$  !D              ("!U3\! 'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    " "X@DQ:S;4QU>H$   /#   &0
M@('!10$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( +B"
M3%JLBUDS4 0  -<*   9              " @>)* 0!X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ N(),6OE*&A3>"   -1X  !D
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M=#,V+GAM;%!+ 0(4 Q0    ( +B"3%HZ()&&( 0  &P7   9
M  " @;IP 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
MN(),6@=DWF1B P  L P  !D              ("!$74! 'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    " "X@DQ:_M/P,6D"  "/!0  &0
M            @(&J> $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    ( +B"3%HR]UU6)P0  #H2   9              " @4I[ 0!X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ N(),6I8;-HN( P
M>!$  !D              ("!J'\! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    " "X@DQ:IV+,2(\"  !#"   &0              @(%G
M@P$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( +B"3%H_
M@3+.&@4  "\?   9              " @2V& 0!X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ N(),6C)$3#O! @  40D  !D
M     ("!?HL! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +B"3%I>3<ZTX@<  #M&   9              "
M@2*? 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ N(),
M6D>4:/*M P  ,Q$  !D              ("!.Z<! 'AL+W=O<FMS:&5E=',O
M<VAE970U,"YX;6Q02P$"% ,4    " "X@DQ:,''$G=D"  #;!P  &0
M        @($?JP$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0
M   ( +B"3%IYJ>.!%0T  ):5   9              " @2^N 0!X;"]W;W)K
M<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ N(),6DUS2^TE P  . D
M !D              ("!>[L! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q0
M2P$"% ,4    " "X@DQ:U!3%>_8"   2"P  &0              @('7O@$
M>&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( +B"3%JW7L+A
M;P8  $ I   9              " @03" 0!X;"]W;W)K<VAE971S+W-H965T
M-34N>&UL4$L! A0#%     @ N(),6LY2RB9E P  T0D  !D
M ("!JL@! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "X
M@DQ:CZ^ U(8#  #'"@  &0              @(%&S $ >&PO=V]R:W-H965T
M<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( +B"3%KU,53]=P,  #L-   9
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M970V,BYX;6Q02P$"% ,4    " "X@DQ:9H@$@AD2   3&0$ &0
M    @('?] $ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    (
M +B"3%HY#5N[K ,  (D.   9              " @2\' @!X;"]W;W)K<VAE
M971S+W-H965T-C0N>&UL4$L! A0#%     @ N(),6BU7#&OV @  W @  !D
M             ("!$@L" 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"
M% ,4    " "X@DQ:NEJ=8N$"  #>!P  &0              @($_#@( >&PO
M=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( +B"3%H/BZ,A(@,
M (,+   9              " @5<1 @!X;"]W;W)K<VAE971S+W-H965T-C<N
M>&UL4$L! A0#%     @ N(),6OHX96T>!@   2(  !D              ("!
ML!0" 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "X@DQ:
M81ZEDX8#  ".#0  &0              @($%&P( >&PO=V]R:W-H965T<R]S
M:&5E=#8Y+GAM;%!+ 0(4 Q0    ( +B"3%I+ 9'82@4  /8?   9
M      " @<(> @!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%
M  @ N(),6C3LP!\D!0  YB   !D              ("!0R0" 'AL+W=O<FMS
M:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " "X@DQ:2J< =# $  #V$
M&0              @(&>*0( >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+
M 0(4 Q0    ( +B"3%IF3T%>DP,   \+   9              " @04N @!X
M;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ N(),6D#MY!&G
M!   !Q<  !D              ("!SS$" 'AL+W=O<FMS:&5E=',O<VAE970W
M-"YX;6Q02P$"% ,4    " "X@DQ:F-8ZN5($  !Z&P  &0
M@(&M-@( >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( +B"
M3%KLXL+<B0(  (P%   9              " @38[ @!X;"]W;W)K<VAE971S
M+W-H965T-S8N>&UL4$L! A0#%     @ N(),6HW2D-YB!   3!<  !D
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M=#@Q+GAM;%!+ 0(4 Q0    ( +B"3%H\4+^-L0,  %<+   9
M  " @<U/ @!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @
MN(),6O]>\^99 P  >0D  !D              ("!M5," 'AL+W=O<FMS:&5E
M=',O<VAE970X,RYX;6Q02P$"% ,4    " "X@DQ:7LQ.Y3T$  !?&   &0
M            @(%%5P( >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4
M Q0    ( +B"3%J:YRVS^P,  &X4   9              " @;E; @!X;"]W
M;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ N(),6A^"-0J#!
M"A0  !D              ("!ZU\" 'AL+W=O<FMS:&5E=',O<VAE970X-BYX
M;6Q02P$"% ,4    " "X@DQ:/>T$A40(  !+6   &0              @(&E
M9 ( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( +B"3%H<
M*5CY[0(  #\(   9              " @2!M @!X;"]W;W)K<VAE971S+W-H
M965T.#@N>&UL4$L! A0#%     @ N(),6H8W5KN, P  CPT  !D
M     ("!1' " 'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +B"3%KYW$W>000  .<3   9              "
M@4*' @!X;"]W;W)K<VAE971S+W-H965T.30N>&UL4$L! A0#%     @ N(),
M6NU. )X_ @  MP0  !D              ("!NHL" 'AL+W=O<FMS:&5E=',O
M<VAE970Y-2YX;6Q02P$"% ,4    " "X@DQ:;V'#\UL&  ".(@  &0
M        @($PC@( >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0
M   ( +B"3%H,Q]RW' 0  ,L3   9              " @<*4 @!X;"]W;W)K
M<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @ N(),6O!K3 *- P  7A
M !D              ("!%9D" 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q0
M2P$"% ,4    " "X@DQ:SK)II48#  "P%   #0              @ '9G (
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +B"3%J7BKL<P    !,"   +
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4!08     :@!J !T=  ";K0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>434</ContextCount>
  <ElementCount>562</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>140</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - GRAIL SPIN-OFF</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GRAILSPINOFF</Role>
      <ShortName>GRAIL SPIN-OFF</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>INVESTMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONS</Role>
      <ShortName>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - DEBT AND OTHER COMMITMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTS</Role>
      <ShortName>DEBT AND OTHER COMMITMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILS</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - LEGAL PROCEEDINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/LEGALPROCEEDINGS</Role>
      <ShortName>LEGAL PROCEEDINGS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/EMPLOYEEBENEFITPLANS</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATION</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - GRAIL SPIN-OFF (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GRAILSPINOFFTables</Role>
      <ShortName>GRAIL SPIN-OFF (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/GRAILSPINOFF</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/REVENUE</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>INVESTMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables</Role>
      <ShortName>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONS</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - DEBT AND OTHER COMMITMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSTables</Role>
      <ShortName>DEBT AND OTHER COMMITMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/INCOMETAXES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATION</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Business Overview (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Business Overview (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Concentrations of Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Concentrations of Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Recently Adopted Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Recently Adopted Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Lives of Major Classes of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Lives of Major Classes of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Warranties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Warranties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeShareBasedCompensationDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Advertising Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeAdvertisingCostsDetails</Role>
      <ShortName>ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Advertising Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - GRAIL SPIN-OFF - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails</Role>
      <ShortName>GRAIL SPIN-OFF - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - GRAIL SPIN-OFF - Assets and Liabilities Included as Part of the Disposal Group (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails</Role>
      <ShortName>GRAIL SPIN-OFF - Assets and Liabilities Included as Part of the Disposal Group (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - REVENUE - Schedule of Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails</Role>
      <ShortName>REVENUE - Schedule of Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - REVENUE - Narrative - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails</Role>
      <ShortName>REVENUE - Narrative - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - REVENUE - Narrative - Contract Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/REVENUENarrativeContractAssetsandLiabilitiesDetails</Role>
      <ShortName>REVENUE - Narrative - Contract Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Marketable Equity Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails</Role>
      <ShortName>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Marketable Equity Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Other Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails</Role>
      <ShortName>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Other Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Hierarchy??for Assets and Liabilities Measured at Fair Value Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails</Role>
      <ShortName>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Hierarchy??for Assets and Liabilities Measured at Fair Value Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Changes in Estimated Fair Value of Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails</Role>
      <ShortName>INVESTMENTS AND FAIR VALUE MEASUREMENTS - Changes in Estimated Fair Value of Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS- Contingent Consideration Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails</Role>
      <ShortName>INVESTMENTS AND FAIR VALUE MEASUREMENTS- Contingent Consideration Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Changes in Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails</Role>
      <ShortName>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Changes in Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails</Role>
      <ShortName>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Estimated Annual Amortization of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Estimated Annual Amortization of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Debt Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails</Role>
      <ShortName>DEBT AND OTHER COMMITMENTS - Schedule of Debt Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - DEBT AND OTHER COMMITMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails</Role>
      <ShortName>DEBT AND OTHER COMMITMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>DEBT AND OTHER COMMITMENTS - Schedule of Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails</Role>
      <ShortName>DEBT AND OTHER COMMITMENTS - Schedule of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative - Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Restricted Stock Activity and Related Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Restricted Stock Activity and Related Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Pre-tax Intrinsic Values and Total Fair Value of Vested Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Pre-tax Intrinsic Values and Total Fair Value of Vested Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stock Option Activity Under all Stock Option Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Stock Option Activity Under all Stock Option Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Liability-Classified Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative - Liability-Classified Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Cash-Based Equity Incentive Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Cash-Based Equity Incentive Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Employee Stock Purchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative - Employee Stock Purchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Assumptions used to Estimate the Weighted-Average Fair Value Per Share for Stock Purchase under the Employee Stock Purchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Assumptions used to Estimate the Weighted-Average Fair Value Per Share for Stock Purchase under the Employee Stock Purchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative - Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - STOCKHOLDERS??? EQUITY - Schedule of Share Repurchase Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivityDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY - Schedule of Share Repurchase Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share-Based Compensation Expense for all Stock Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Share-Based Compensation Expense for all Stock Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareBasedCompensationDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative - Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9955567 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9955568 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9955569 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Changes in Reserve for Product Warranties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Changes in Reserve for Product Warranties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9955570 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Restructuring Charge (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Restructuring Charge (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9955571 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Narrative - Restructuring (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS - Narrative - Restructuring (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9955572 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Charges and Total Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Charges and Total Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9955573 - Disclosure - LEGAL PROCEEDINGS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/LEGALPROCEEDINGSDetails</Role>
      <ShortName>LEGAL PROCEEDINGS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.illumina.com/role/LEGALPROCEEDINGS</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9955574 - Disclosure - INCOME TAXES - Schedule of (Loss) Income before Income Taxes by Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails</Role>
      <ShortName>INCOME TAXES - Schedule of (Loss) Income before Income Taxes by Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9955575 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9955576 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Provision for (Loss) Income Taxes to Amount Computed by Applying the Federal Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Reconciliation of Provision for (Loss) Income Taxes to Amount Computed by Applying the Federal Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9955577 - Disclosure - INCOME TAXES - Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9955578 - Disclosure - INCOME TAXES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9955579 - Disclosure - INCOME TAXES - Schedule of the Gross Amount of Uncertain Tax Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails</Role>
      <ShortName>INCOME TAXES - Schedule of the Gross Amount of Uncertain Tax Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9955580 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.illumina.com/role/EMPLOYEEBENEFITPLANS</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9955581 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9955582 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Operating Performance and Assets by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Operating Performance and Assets by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9955583 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="ilmn-20241229.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9955584 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Net Long-lived Assets Consisting of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Net Long-lived Assets Consisting of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="ilmn-20241229.htm">ilmn-20241229.htm</File>
    <File>ilmn-20241229.xsd</File>
    <File>ilmn-20241229_cal.xml</File>
    <File>ilmn-20241229_def.xml</File>
    <File>ilmn-20241229_lab.xml</File>
    <File>ilmn-20241229_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ilmn-20241229_g1.jpg</File>
    <File>ilmn-20241229_g2.gif</File>
    <File>ilmn-20241229_g3.jpg</File>
    <File>ilmn-20241229_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="1331">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="36">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>124
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ilmn-20241229.htm": {
   "nsprefix": "ilmn",
   "nsuri": "http://www.illumina.com/20241229",
   "dts": {
    "inline": {
     "local": [
      "ilmn-20241229.htm"
     ]
    },
    "schema": {
     "local": [
      "ilmn-20241229.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ilmn-20241229_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ilmn-20241229_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ilmn-20241229_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ilmn-20241229_pre.xml"
     ]
    }
   },
   "keyStandard": 472,
   "keyCustom": 90,
   "axisStandard": 46,
   "axisCustom": 1,
   "memberStandard": 78,
   "memberCustom": 56,
   "hidden": {
    "total": 18,
    "http://www.illumina.com/20241229": 2,
    "http://xbrl.sec.gov/ecd/2024": 4,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 8
   },
   "contextCount": 434,
   "entityCount": 1,
   "segmentCount": 140,
   "elementCount": 988,
   "unitCount": 13,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1331,
    "http://xbrl.sec.gov/dei/2024": 38,
    "http://xbrl.sec.gov/ecd/2024": 36,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://fasb.org/srt/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://www.illumina.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.illumina.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "9952151 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "longName": "9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSoldAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "longName": "9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "longName": "9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES",
     "longName": "9952157 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.illumina.com/role/GRAILSPINOFF",
     "longName": "9952158 - Disclosure - GRAIL SPIN-OFF",
     "shortName": "GRAIL SPIN-OFF",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.illumina.com/role/REVENUE",
     "longName": "9952159 - Disclosure - REVENUE",
     "shortName": "REVENUE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTS",
     "longName": "9952160 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS",
     "shortName": "INVESTMENTS AND FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONS",
     "longName": "9952161 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS",
     "shortName": "GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTS",
     "longName": "9952162 - Disclosure - DEBT AND OTHER COMMITMENTS",
     "shortName": "DEBT AND OTHER COMMITMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITY",
     "longName": "9952163 - Disclosure - STOCKHOLDERS' EQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILS",
     "longName": "9952164 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.illumina.com/role/LEGALPROCEEDINGS",
     "longName": "9952165 - Disclosure - LEGAL PROCEEDINGS",
     "shortName": "LEGAL PROCEEDINGS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.illumina.com/role/INCOMETAXES",
     "longName": "9952166 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.illumina.com/role/EMPLOYEEBENEFITPLANS",
     "longName": "9952167 - Disclosure - EMPLOYEE BENEFIT PLANS",
     "shortName": "EMPLOYEE BENEFIT PLANS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATION",
     "longName": "9952168 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R22": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-434",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-434",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "longName": "9955511 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESTables",
     "longName": "9955512 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.illumina.com/role/GRAILSPINOFFTables",
     "longName": "9955513 - Disclosure - GRAIL SPIN-OFF (Tables)",
     "shortName": "GRAIL SPIN-OFF (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.illumina.com/role/REVENUETables",
     "longName": "9955514 - Disclosure - REVENUE (Tables)",
     "shortName": "REVENUE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSTables",
     "longName": "9955515 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "INVESTMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables",
     "longName": "9955516 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS (Tables)",
     "shortName": "GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSTables",
     "longName": "9955517 - Disclosure - DEBT AND OTHER COMMITMENTS (Tables)",
     "shortName": "DEBT AND OTHER COMMITMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables",
     "longName": "9955518 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables",
     "longName": "9955519 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS (Tables)",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.illumina.com/role/INCOMETAXESTables",
     "longName": "9955520 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables",
     "longName": "9955521 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails",
     "longName": "9955522 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Business Overview (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Business Overview (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-55",
      "name": "ilmn:DiscontinuedOperationNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R37": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails",
     "longName": "9955523 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Concentrations of Risk (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Concentrations of Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-61",
      "name": "ilmn:ConcentrationRiskThreshold",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-61",
      "name": "ilmn:ConcentrationRiskThreshold",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails",
     "longName": "9955524 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Recently Adopted Accounting Policies (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Recently Adopted Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R39": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails",
     "longName": "9955525 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Revenue Recognition (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Revenue Recognition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ilmn:RevenueFromContractWithCustomerPaymentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "ilmn:RevenueFromContractWithCustomerPaymentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails",
     "longName": "9955526 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings (Loss) Per Share (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings (Loss) Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
     "longName": "9955527 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Lives of Major Classes of Property and Equipment (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Lives of Major Classes of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-71",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-71",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails",
     "longName": "9955528 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Leases (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails",
     "longName": "9955529 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Derivative Financial Instruments (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Derivative Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails",
     "longName": "9955530 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Warranties (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Warranties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-87",
      "name": "ilmn:StandardProductWarrantyDescriptionTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-87",
      "name": "ilmn:StandardProductWarrantyDescriptionTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeShareBasedCompensationDetails",
     "longName": "9955531 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Share-Based Compensation (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Share-Based Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R46": {
     "role": "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeAdvertisingCostsDetails",
     "longName": "9955532 - Disclosure - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Advertising Costs (Details)",
     "shortName": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES - Narrative - Advertising Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdvertisingExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdvertisingExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
     "longName": "9955533 - Disclosure - GRAIL SPIN-OFF - Narrative (Details)",
     "shortName": "GRAIL SPIN-OFF - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-55",
      "name": "ilmn:DiscontinuedOperationNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "ilmn:DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
     "longName": "9955534 - Disclosure - GRAIL SPIN-OFF - Assets and Liabilities Included as Part of the Disposal Group (Details)",
     "shortName": "GRAIL SPIN-OFF - Assets and Liabilities Included as Part of the Disposal Group (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-198",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails",
     "longName": "9955535 - Disclosure - REVENUE - Schedule of Disaggregation of Revenue (Details)",
     "shortName": "REVENUE - Schedule of Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-132",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails",
     "longName": "9955536 - Disclosure - REVENUE - Narrative - Remaining Performance Obligation (Details)",
     "shortName": "REVENUE - Narrative - Remaining Performance Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-148",
      "name": "ilmn:RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.illumina.com/role/REVENUENarrativeContractAssetsandLiabilitiesDetails",
     "longName": "9955537 - Disclosure - REVENUE - Narrative - Contract Assets and Liabilities (Details)",
     "shortName": "REVENUE - Narrative - Contract Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
     "longName": "9955538 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "shortName": "INVESTMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ilmn:DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails",
     "longName": "9955539 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Marketable Equity Securities (Details)",
     "shortName": "INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Marketable Equity Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails",
     "longName": "9955540 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Other Commitments (Details)",
     "shortName": "INVESTMENTS AND FAIR VALUE MEASUREMENTS - Other Commitments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "ilmn:RecallableDistributionsCommitment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OtherCommitmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "ilmn:RecallableDistributionsCommitment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OtherCommitmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails",
     "longName": "9955541 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Hierarchy\u00a0for Assets and Liabilities Measured at Fair Value Recurring Basis (Details)",
     "shortName": "INVESTMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Hierarchy\u00a0for Assets and Liabilities Measured at Fair Value Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredCompensationPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-165",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails",
     "longName": "9955542 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS - Changes in Estimated Fair Value of Acquisition (Details)",
     "shortName": "INVESTMENTS AND FAIR VALUE MEASUREMENTS - Changes in Estimated Fair Value of Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-176",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-172",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails",
     "longName": "9955543 - Disclosure - INVESTMENTS AND FAIR VALUE MEASUREMENTS- Contingent Consideration Liabilities (Details)",
     "shortName": "INVESTMENTS AND FAIR VALUE MEASUREMENTS- Contingent Consideration Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-195",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-193",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails",
     "longName": "9955544 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Changes in Goodwill (Details)",
     "shortName": "GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Changes in Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
     "longName": "9955545 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Narrative (Details)",
     "shortName": "GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-199",
      "name": "us-gaap:NumberOfReportingUnits",
      "unitRef": "reporting_unit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-199",
      "name": "us-gaap:NumberOfReportingUnits",
      "unitRef": "reporting_unit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails",
     "longName": "9955546 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Identifiable Intangible Assets (Details)",
     "shortName": "GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Identifiable Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails",
     "longName": "9955547 - Disclosure - GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Estimated Annual Amortization of Intangible Assets (Details)",
     "shortName": "GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS - Schedule of Estimated Annual Amortization of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails",
     "longName": "9955548 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Debt Obligations (Details)",
     "shortName": "DEBT AND OTHER COMMITMENTS - Schedule of Debt Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-251",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-251",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
     "longName": "9955549 - Disclosure - DEBT AND OTHER COMMITMENTS - Narrative (Details)",
     "shortName": "DEBT AND OTHER COMMITMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AdditionalPaidInCapital",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PurchaseObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails",
     "longName": "9955550 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Maturities of Operating Lease Liabilities (Details)",
     "shortName": "DEBT AND OTHER COMMITMENTS - Schedule of Maturities of Operating Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails",
     "longName": "9955551 - Disclosure - DEBT AND OTHER COMMITMENTS - Schedule of Lease Costs (Details)",
     "shortName": "DEBT AND OTHER COMMITMENTS - Schedule of Lease Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "longName": "9955552 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-279",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-279",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails",
     "longName": "9955553 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Restricted Stock (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative - Restricted Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "ilmn:ShareBasedCompensationNumberOfPerformanceStockUnitAwards",
      "unitRef": "award",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "ilmn:ShareBasedCompensationNumberOfPerformanceStockUnitAwards",
      "unitRef": "award",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails",
     "longName": "9955554 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Restricted Stock Activity and Related Information (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Restricted Stock Activity and Related Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-293",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-285",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails",
     "longName": "9955555 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Pre-tax Intrinsic Values and Total Fair Value of Vested Restricted Stock (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Pre-tax Intrinsic Values and Total Fair Value of Vested Restricted Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-295",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-295",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails",
     "longName": "9955556 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stock Option Activity Under all Stock Option Plans (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Stock Option Activity Under all Stock Option Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-308",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-300",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails",
     "longName": "9955557 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Liability-Classified Awards (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative - Liability-Classified Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-298",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails",
     "longName": "9955558 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Cash-Based Equity Incentive Award Activity (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Cash-Based Equity Incentive Award Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "ilmn:AccruedLiabilityClassifiedAwardsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-315",
      "name": "ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ilmn:ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails",
     "longName": "9955559 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Employee Stock Purchase Plan (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative - Employee Stock Purchase Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-321",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-321",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails",
     "longName": "9955560 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Assumptions used to Estimate the Weighted-Average Fair Value Per Share for Stock Purchase under the Employee Stock Purchase Plan (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Assumptions used to Estimate the Weighted-Average Fair Value Per Share for Stock Purchase under the Employee Stock Purchase Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-325",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails",
     "longName": "9955561 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Share Repurchases (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative - Share Repurchases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-334",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivityDetails",
     "longName": "9955562 - Disclosure - STOCKHOLDERS\u2019 EQUITY - Schedule of Share Repurchase Activity (Details)",
     "shortName": "STOCKHOLDERS\u2019 EQUITY - Schedule of Share Repurchase Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R77": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails",
     "longName": "9955563 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share-Based Compensation Expense for all Stock Awards (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Share-Based Compensation Expense for all Stock Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareBasedCompensationDetails",
     "longName": "9955564 - Disclosure - STOCKHOLDERS' EQUITY - Narrative - Share-Based Compensation (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative - Share-Based Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails",
     "longName": "9955565 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accounts Receivable (Details)",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accounts Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails",
     "longName": "9955566 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Inventory (Details)",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails",
     "longName": "9955567 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Property and Equipment (Details)",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails",
     "longName": "9955568 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accrued Liabilities (Details)",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LitigationReserveCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LitigationReserveCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails",
     "longName": "9955569 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Changes in Reserve for Product Warranties (Details)",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS - Schedule of Changes in Reserve for Product Warranties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ProductWarrantyAccrual",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:ProductWarrantyAccrual",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails",
     "longName": "9955570 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Restructuring Charge (Details)",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Restructuring Charge (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails",
     "longName": "9955571 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Narrative - Restructuring (Details)",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS - Narrative - Restructuring (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:OperatingLeaseImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:OperatingLeaseImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails",
     "longName": "9955572 - Disclosure - SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Charges and Total Costs (Details)",
     "shortName": "SUPPLEMENTAL BALANCE SHEET DETAILS - Pre-Tax Charges and Total Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-33",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
     "longName": "9955573 - Disclosure - LEGAL PROCEEDINGS (Details)",
     "shortName": "LEGAL PROCEEDINGS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-386",
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "unitRef": "lawsuit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails",
     "longName": "9955574 - Disclosure - INCOME TAXES - Schedule of (Loss) Income before Income Taxes by Region (Details)",
     "shortName": "INCOME TAXES - Schedule of (Loss) Income before Income Taxes by Region (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails",
     "longName": "9955575 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)",
     "shortName": "INCOME TAXES - Schedule of Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails",
     "longName": "9955576 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Provision for (Loss) Income Taxes to Amount Computed by Applying the Federal Statutory Rate (Details)",
     "shortName": "INCOME TAXES - Schedule of Reconciliation of Provision for (Loss) Income Taxes to Amount Computed by Applying the Federal Statutory Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9955577 - Disclosure - INCOME TAXES - Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "INCOME TAXES - Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.illumina.com/role/INCOMETAXESNarrativeDetails",
     "longName": "9955578 - Disclosure - INCOME TAXES - Narrative (Details)",
     "shortName": "INCOME TAXES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails",
     "longName": "9955579 - Disclosure - INCOME TAXES - Schedule of the Gross Amount of Uncertain Tax Positions (Details)",
     "shortName": "INCOME TAXES - Schedule of the Gross Amount of Uncertain Tax Positions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails",
     "longName": "9955580 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)",
     "shortName": "EMPLOYEE BENEFIT PLANS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails",
     "longName": "9955581 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails",
     "longName": "9955582 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Operating Performance and Assets by Segment (Details)",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Operating Performance and Assets by Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-402",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
     "longName": "9955583 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails",
     "longName": "9955584 - Disclosure - SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Net Long-lived Assets Consisting of Property and Equipment (Details)",
     "shortName": "SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Net Long-lived Assets Consisting of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ilmn-20241229.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ilmn_A2000EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "A2000EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ESPP",
        "label": "2000 Employee Stock Purchase Plan [Member]",
        "documentation": "2000 Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_A2015StockAndIncentiveCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "A2015StockAndIncentiveCompensationPlanMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015 Stock Plan",
        "label": "2015 Stock and Incentive Compensation Plan [Member]",
        "documentation": "2015 Stock and Incentive Compensation Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdate202006Member",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASU 2020-06",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725"
     ]
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdateExtensibleList",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Standards Update [Extensible List]",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "documentation": "Indicates amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r346",
      "r347",
      "r348",
      "r417",
      "r418",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r470",
      "r471",
      "r480",
      "r669",
      "r670",
      "r671",
      "r672",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r689",
      "r690",
      "r691",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r704",
      "r705",
      "r706",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r748",
      "r749",
      "r766",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r1321"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r1140"
     ]
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails": {
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade accounts receivable, gross",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r420",
      "r1086"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts receivable, net",
        "totalLabel": "Total accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1332"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ilmn_AccruedLiabilityClassifiedAwardsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "AccruedLiabilityClassifiedAwardsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability-classified equity incentive awards",
        "label": "Accrued Liability-Classified Awards, Current",
        "documentation": "Accrued Liability-Classified Awards, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r297",
      "r852"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated other comprehensive income (loss)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r148",
      "r309",
      "r847",
      "r893",
      "r897"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r16",
      "r27",
      "r709",
      "r712",
      "r789",
      "r888",
      "r889",
      "r1305",
      "r1306",
      "r1307",
      "r1318",
      "r1319",
      "r1320",
      "r1322"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful life (in years)",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r1080"
     ]
    },
    "ilmn_AcquisitionOfGrailInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "AcquisitionOfGrailInc.Member",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition Of Grail, Inc.",
        "label": "Acquisition Of Grail, Inc. [Member]",
        "documentation": "Acquisition Of Grail, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1216"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "negatedTerseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r1140",
      "r1505"
     ]
    },
    "ilmn_AdditionalPaidInCapitalBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "AdditionalPaidInCapitalBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid in capital, before tax",
        "label": "Additional Paid In Capital Before Tax",
        "documentation": "Additional Paid In Capital Before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r909",
      "r1318",
      "r1319",
      "r1320",
      "r1322",
      "r1432",
      "r1506"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "ilmn_AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Spin-Off of GRAIL (see Note 2)",
        "label": "Adjustment To Additional Paid In Capital, Decrease From Deconsolidation",
        "documentation": "Adjustment To Additional Paid In Capital, Decrease From Deconsolidation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]",
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r346",
      "r347",
      "r348",
      "r349",
      "r359",
      "r417",
      "r418",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r470",
      "r471",
      "r480",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r689",
      "r690",
      "r691",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r748",
      "r749",
      "r765",
      "r766",
      "r767",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r802",
      "r803",
      "r804",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r588"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising Costs",
        "label": "Advertising Cost [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeAdvertisingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising costs",
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r627",
      "r1127"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1274"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1187",
      "r1198",
      "r1208",
      "r1241"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1190",
      "r1201",
      "r1211",
      "r1244"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1275"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1236"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1191",
      "r1202",
      "r1212",
      "r1236",
      "r1245",
      "r1249",
      "r1257"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1255"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails": {
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "verboseLabel": "Share-based compensation expense, before taxes",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r619",
      "r625"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-based compensation expense, net of taxes",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails": {
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Allowance for credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r421",
      "r438"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "srt_AmericasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "AmericasMember",
     "presentation": [
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Americas",
        "label": "Americas [Member]",
        "documentation": "Continents of North and South America."
       }
      }
     },
     "auth_ref": [
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1508",
      "r1509",
      "r1510",
      "r1511"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r457",
      "r464",
      "r1105"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potentially dilutive shares excluded due to antidilutive effect",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ilmn_AsiaPacificMiddleEastAndAfricaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "AsiaPacificMiddleEastAndAfricaMember",
     "presentation": [
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asia-Pacific, Middle East and Africa",
        "label": "Asia-Pacific, Middle East and Africa [Member]",
        "documentation": "Asia-Pacific, Middle East and Africa"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r1429"
     ]
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Domain]",
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r1429"
     ]
    },
    "ilmn_AssetImpairmentChargesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "AssetImpairmentChargesMember",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset impairment charges",
        "label": "Asset Impairment Charges [Member]",
        "documentation": "Asset Impairment Charges"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r223",
      "r301",
      "r337",
      "r371",
      "r379",
      "r404",
      "r408",
      "r427",
      "r503",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r699",
      "r701",
      "r752",
      "r842",
      "r951",
      "r1097",
      "r1098",
      "r1140",
      "r1165",
      "r1380",
      "r1381",
      "r1460"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r313",
      "r337",
      "r427",
      "r503",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r699",
      "r701",
      "r752",
      "r1140",
      "r1380",
      "r1381",
      "r1460"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets measured at fair value",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r728",
      "r1130"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assets:",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.illumina.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r1170",
      "r1171",
      "r1194"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.illumina.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r1170",
      "r1171",
      "r1194"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.illumina.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r1170",
      "r1171",
      "r1194"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1252"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1253"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1248"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1248"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1248"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1248"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1248"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1248"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r591",
      "r592",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1251"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1250"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1249"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1249"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r1471",
      "r1472"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r92",
      "r479",
      "r1471",
      "r1472"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ilmn_BuildingandLeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "BuildingandLeaseholdImprovementsMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings and leasehold improvements",
        "label": "Building and Leasehold Improvements [Member]",
        "documentation": "Building and Leasehold Improvements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r688",
      "r1122",
      "r1123"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r688",
      "r1122",
      "r1123"
     ]
    },
    "ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "BusinessAcquisitionContingentValueRightsProRataOnePercentage",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent payment rights, first percentage",
        "label": "Business Acquisition, Contingent Value Rights, Pro Rata One, Percentage",
        "documentation": "Business Acquisition, Contingent Value Rights, Pro Rata One, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "BusinessAcquisitionContingentValueRightsProRataTwoPercentage",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent payment rights, second percentage",
        "label": "Business Acquisition, Contingent Value Rights, Pro Rata Two, Percentage",
        "documentation": "Business Acquisition, Contingent Value Rights, Pro Rata Two, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "BusinessAcquisitionContingentValueRightsRevenueThreshold",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, contingent value rights, revenue threshold",
        "label": "Business Acquisition, Contingent Value Rights, Revenue Threshold",
        "documentation": "Business Acquisition, Contingent Value Rights, Revenue Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_BusinessAcquisitionContingentValueRightsTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "BusinessAcquisitionContingentValueRightsTerm",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent value right, terms",
        "label": "Business Acquisition, Contingent Value Rights, Term",
        "documentation": "Business Acquisition, Contingent Value Rights, Term"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS",
        "label": "Business Combination And Goodwill And Intangible Assets Disclosure [Text Block]",
        "documentation": "Business Combination And Goodwill And Intangible Assets Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of contingent consideration liabilities",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r693",
      "r1312"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liabilities",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r204",
      "r692",
      "r729",
      "r730",
      "r731"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue risk premium",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "documentation": "Value of input used to measure contingent consideration liability from business combination."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r730",
      "r731"
     ]
    },
    "ilmn_BusinessCombinationContingentConsiderationLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "BusinessCombinationContingentConsiderationLiabilityMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination, Contingent Consideration, Liability",
        "label": "Business Combination, Contingent Consideration, Liability [Member]",
        "documentation": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration, noncurrent",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r204"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations",
        "label": "Business Combinations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r202"
     ]
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "CA",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CALIFORNIA",
        "label": "CALIFORNIA"
       }
      }
     },
     "auth_ref": []
    },
    "country_CN": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "CN",
     "presentation": [
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Greater China",
        "label": "CHINA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of property and equipment included in accounts payable and accrued liabilities",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r38"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds (cash equivalents)",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1433",
      "r1434"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r164",
      "r335"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r164"
     ]
    },
    "ilmn_CashDeconsolidatedFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "CashDeconsolidatedFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "GRAIL cash deconsolidated as a result of spin-off",
        "label": "Cash Deconsolidated Financing Activities",
        "documentation": "Cash Deconsolidated Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain to be reclassified into earnings within the next 12 months",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1227"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1224"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1222"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r305",
      "r306",
      "r307",
      "r337",
      "r362",
      "r363",
      "r365",
      "r367",
      "r373",
      "r374",
      "r427",
      "r503",
      "r506",
      "r507",
      "r508",
      "r512",
      "r513",
      "r545",
      "r546",
      "r548",
      "r549",
      "r551",
      "r752",
      "r903",
      "r904",
      "r905",
      "r906",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r939",
      "r960",
      "r978",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1279",
      "r1314",
      "r1323"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r373",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r903",
      "r904",
      "r905",
      "r906",
      "r1116",
      "r1279",
      "r1314"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1228"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1228"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r213",
      "r844",
      "r938"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies, number of additional securities class actions",
        "label": "Commitments and Contingencies, Number Of Additional Securities Class Actions",
        "documentation": "Commitments and Contingencies, Number Of Additional Securities Class Actions"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies, number of movants filed motions consolidate actions",
        "label": "Commitments and Contingencies, Number Of Movants Filed Motions Consolidate Actions",
        "documentation": "Commitments and Contingencies, Number Of Movants Filed Motions Consolidate Actions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "verboseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1156",
      "r1157",
      "r1158",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1318",
      "r1319",
      "r1322",
      "r1432",
      "r1502",
      "r1506"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r939"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r137",
      "r939",
      "r957",
      "r1506",
      "r1507"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, $0.01\u00a0par value, 320\u00a0million\u00a0shares authorized; 200\u00a0million shares issued and 159\u00a0million outstanding at December\u00a029, 2024; 199\u00a0million\u00a0shares issued and 159\u00a0million outstanding at December\u00a031, 2023",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r846",
      "r1140"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1232"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1231"
     ]
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EMPLOYEE BENEFIT PLANS",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r191",
      "r192",
      "r193"
     ]
    },
    "ilmn_CompleteGenomicsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "CompleteGenomicsMember",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Complete Genomics",
        "label": "Complete Genomics [Member]",
        "documentation": "Complete Genomics"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r319",
      "r321",
      "r326",
      "r838",
      "r857",
      "r858"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer hardware and software",
        "verboseLabel": "Computer hardware and software",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r416",
      "r1068"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r416",
      "r899",
      "r1068"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r416",
      "r1068",
      "r1286"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentrations of Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r233"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration percent",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r416"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r46",
      "r47",
      "r99",
      "r207",
      "r1068"
     ]
    },
    "ilmn_ConcentrationRiskThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ConcentrationRiskThreshold",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum investment portfolio credit exposure",
        "label": "Concentration Risk, Threshold",
        "documentation": "Concentration Risk, Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r416",
      "r1068"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r245",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r341",
      "r371",
      "r381",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r409",
      "r410",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r1097",
      "r1098",
      "r1292",
      "r1293",
      "r1380",
      "r1381"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]",
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r245",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r341",
      "r371",
      "r381",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r409",
      "r410",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r1097",
      "r1098",
      "r1292",
      "r1293",
      "r1380",
      "r1381"
     ]
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entities (VIEs)",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r85",
      "r86"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ConsumablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ConsumablesMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consumables",
        "label": "Consumables [Member]",
        "documentation": "Consumables [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ContingentPaymentRightsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ContingentPaymentRightsAxis",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Payment Rights [Axis]",
        "label": "Contingent Payment Rights [Axis]",
        "documentation": "Contingent Payment Rights"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ContingentPaymentRightsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ContingentPaymentRightsDomain",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Payment Rights [Domain]",
        "label": "Contingent Payment Rights [Domain]",
        "documentation": "Contingent Payment Rights"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ContingentValueRightFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ContingentValueRightFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Helix contingent value right",
        "label": "Contingent Value Right, Fair Value Disclosure",
        "documentation": "Contingent Value Right, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ContingentValueRightUnrealizedGainLossNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ContingentValueRightUnrealizedGainLossNoncash",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "(Gain) loss on Helix contingent value right",
        "label": "Contingent Value Right, Unrealized Gain (Loss), Noncash",
        "documentation": "Contingent Value Right, Unrealized Gain (Loss), Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeContractAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract asset",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r555",
      "r574"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeContractAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liability",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554",
      "r574"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeContractAssetsandLiabilitiesDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contract liabilities, current portion",
        "terseLabel": "Contract liabilities, current portion",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554",
      "r574"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeContractAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized, previously deferred",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt, fair value",
        "label": "Convertible Debt, Fair Value Disclosures",
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1444"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Senior Notes",
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r515",
      "r516",
      "r526",
      "r527",
      "r528",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115"
     ]
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtSecuritiesMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible senior notes",
        "label": "Convertible Debt Securities [Member]",
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r1386"
     ]
    },
    "ilmn_ConvertibleSeniorNotesDue2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Notes",
        "label": "Convertible Senior Notes Due 2023 [Member]",
        "documentation": "Convertible Senior Notes Due 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_CoreIlluminaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "CoreIlluminaMember",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Core Illumina",
        "label": "Core Illumina [Member]",
        "documentation": "Core Illumina [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152",
      "r800"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSoldAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSoldAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of revenue:",
        "label": "Cost of Goods and Services Sold [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization of acquired intangible assets",
        "label": "Cost, Amortization",
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service."
       }
      }
     },
     "auth_ref": [
      "r1308"
     ]
    },
    "ilmn_CostOfGoodsSoldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "CostOfGoodsSoldMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of product revenue",
        "label": "Cost Of Goods Sold [Member]",
        "documentation": "Cost Of Goods Sold [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total cost of revenue",
        "terseLabel": "Cost of revenue",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r337",
      "r427",
      "r503",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r752",
      "r1097",
      "r1380"
     ]
    },
    "ilmn_CostOfServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "CostOfServicesMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of service and other revenue",
        "label": "Cost Of Services [Member]",
        "documentation": "Cost Of Services"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "CoveredRevenuesOfGRAILContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Covered revenues of GRAIL, contingent consideration liability",
        "label": "Covered Revenues of GRAIL, Contingent Consideration Liability",
        "documentation": "Covered Revenues of GRAIL, Contingent Consideration Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditConcentrationRiskMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Concentration Risk",
        "label": "Credit Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r1378"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r1378",
      "r1379"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r286",
      "r345",
      "r352",
      "r359",
      "r431",
      "r437",
      "r471",
      "r668",
      "r669",
      "r682",
      "r684",
      "r707",
      "r709",
      "r710",
      "r712",
      "r713",
      "r714",
      "r718",
      "r721",
      "r723",
      "r724",
      "r787"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r286",
      "r345",
      "r352",
      "r359",
      "r431",
      "r437",
      "r471",
      "r668",
      "r669",
      "r682",
      "r684",
      "r707",
      "r709",
      "r710",
      "r712",
      "r713",
      "r714",
      "r718",
      "r721",
      "r723",
      "r724",
      "r787"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r286",
      "r345",
      "r352",
      "r359",
      "r431",
      "r437",
      "r471",
      "r668",
      "r669",
      "r682",
      "r684",
      "r707",
      "r709",
      "r710",
      "r712",
      "r713",
      "r714",
      "r718",
      "r721",
      "r723",
      "r724",
      "r787"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1287",
      "r1317",
      "r1423"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1287",
      "r1317"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current provision",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r667",
      "r1317"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1287",
      "r1317",
      "r1423"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r416"
     ]
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1357",
      "r1359",
      "r1362",
      "r1363"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1268"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1268"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1270"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1270"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1183",
      "r1272"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1270"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1263"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1264"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1175",
      "r1264"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r1173",
      "r1262"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1173",
      "r1262"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r1173",
      "r1262"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1265"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1178",
      "r1267"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1178",
      "r1267"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1268"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1182",
      "r1271"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1269"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1177",
      "r1266"
     ]
    },
    "us-gaap_DatabasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DatabasesMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Database",
        "label": "Database Rights [Member]",
        "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files)."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1357",
      "r1359",
      "r1362",
      "r1363"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "DEBT AND OTHER COMMITMENTS",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r336",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r501",
      "r502",
      "r514",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r530",
      "r537",
      "r538",
      "r540",
      "r763"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r127",
      "r128",
      "r209",
      "r212",
      "r341",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1138",
      "r1315",
      "r1366",
      "r1367",
      "r1368",
      "r1449",
      "r1450"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DebtInstrumentCovenantMinimumDebtToEBITDARatio",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, covenant, minimum debt to EBITDA ratio",
        "label": "Debt Instrument, Covenant, Minimum Debt to EBITDA Ratio",
        "documentation": "Debt Instrument, Covenant, Minimum Debt to EBITDA Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, covenant, minimum debt to EBITDA ratio upon consummation of acquisition",
        "label": "Debt Instrument, Covenant, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition",
        "documentation": "Debt Instrument, Covenant, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DebtInstrumentExtensionTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DebtInstrumentExtensionTerm",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, extension term",
        "label": "Debt Instrument, Extension Term",
        "documentation": "Debt Instrument, Extension Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount of notes outstanding",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r763",
      "r764",
      "r1112",
      "r1113",
      "r1138"
     ]
    },
    "ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, face amount, optional increase in additional borrowings",
        "label": "Debt Instrument, Face Amount, Optional Increase In Additional Borrowings",
        "documentation": "Debt Instrument, Face Amount, Optional Increase In Additional Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of term debt outstanding (Level 2)",
        "label": "Debt Instrument, Fair Value Disclosure",
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r751",
      "r1112",
      "r1113",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1444"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate used to measure fair value of convertible senior note",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r543",
      "r763",
      "r764",
      "r1138"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r516"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r539",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1138",
      "r1315",
      "r1449",
      "r1450"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r341",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1138",
      "r1315",
      "r1366",
      "r1367",
      "r1368",
      "r1449",
      "r1450"
     ]
    },
    "ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of consecutive fiscal quarters, minimum debt to EBITDA ratio",
        "label": "Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt to EBITDA Ratio",
        "documentation": "Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt to EBITDA Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of consecutive fiscal quarters, minimum debt to EBITDA ratio upon consummation of acquisition",
        "label": "Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition",
        "documentation": "Debt Instrument, Number Of Consecutive Fiscal Quarters, Minimum Debt To EBITDA Ratio Upon Consummation Of Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DebtInstrumentNumberOfOneYearExtensions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DebtInstrumentNumberOfOneYearExtensions",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, number of one year extensions",
        "label": "Debt Instrument, Number of One Year Extensions",
        "documentation": "Debt Instrument, Number of One Year Extensions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption price",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r64",
      "r67",
      "r102",
      "r185",
      "r186",
      "r341",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r539",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1138",
      "r1315",
      "r1449",
      "r1450"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unamortized discounts and debt issuance costs",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r541",
      "r762",
      "r763",
      "r764",
      "r1112",
      "r1113",
      "r1138"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]",
        "label": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer contribution vesting percent upon the occurrence of participant's disability, death or retirement or change in control of the Company",
        "label": "Deferred Compensation Arrangement With Individual, Vesting Percent, Specified Events",
        "documentation": "Deferred Compensation Arrangement With Individual, Vesting Percent, Specified Events"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation liability",
        "label": "Deferred Compensation Cash-Based Arrangements, Liability, Current and Noncurrent",
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements. Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation plan liability",
        "label": "Deferred Compensation Liability, Current and Noncurrent",
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation plan assets",
        "label": "Deferred Compensation Plan Assets",
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements."
       }
      }
     },
     "auth_ref": [
      "r1298"
     ]
    },
    "ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of base salary available for contribution to the deferred compensation plan",
        "label": "Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Base Salary, Percent",
        "documentation": "Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Base Salary, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of all other forms of compensation available for contribution to the deferred compensation plan",
        "label": "Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Other Compensation, Percent",
        "documentation": "Deferred Compensation Plan, Maximum Annual Contributions Per Employee, Other Compensation, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1317",
      "r1422",
      "r1423"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1317",
      "r1422"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets, net",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r636",
      "r637"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred benefit",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r241",
      "r1317"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred:",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r210",
      "r658"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1317",
      "r1422",
      "r1423"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total gross deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized U.S. R&amp;D expenses",
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxAssetsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Deferred Tax Assets, Investments",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments)."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets, net",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1418"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1418"
     ]
    },
    "ilmn_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Deferred Tax Assets, Operating Lease Liabilities",
        "documentation": "Deferred Tax Assets, Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating losses",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credits",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other amortization",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accruals and reserves",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails",
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Valuation allowance on deferred tax assets",
        "terseLabel": "Valuation allowance on deferred tax assets",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r660"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchased intangible amortization",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "ilmn_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Operating lease right-of-use assets",
        "label": "Deferred Tax Liabilities, Operating Lease Right-Of-Use Assets",
        "documentation": "Deferred Tax Liabilities, Operating Lease Right-of-use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofSignificantComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Deferred Tax Liabilities, Other",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liability for undistributed foreign earnings",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences."
       }
      }
     },
     "auth_ref": [
      "r1420"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Matching contributions",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DelayedDrawCreditFacilityDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DelayedDrawCreditFacilityDue2025Member",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Delayed Draw Credit Facility Due 2025",
        "label": "Delayed Draw Credit Facility Due 2025 [Member]",
        "documentation": "Delayed Draw Credit Facility Due 2025"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r56"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r371",
      "r384",
      "r408",
      "r1097",
      "r1098"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative assets related to terminated acquisition",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r315",
      "r727",
      "r728",
      "r741",
      "r751",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r945",
      "r946",
      "r1030",
      "r1033",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1088",
      "r1130",
      "r1134",
      "r1158",
      "r1435",
      "r1436",
      "r1437",
      "r1503"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r929",
      "r931",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r952",
      "r953",
      "r954",
      "r955",
      "r966",
      "r967",
      "r968",
      "r969",
      "r972",
      "r973",
      "r974",
      "r975",
      "r1030",
      "r1031",
      "r1036",
      "r1038",
      "r1156",
      "r1158",
      "r1438",
      "r1439",
      "r1440",
      "r1441",
      "r1442",
      "r1443",
      "r1445",
      "r1446"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r93",
      "r94",
      "r206",
      "r929",
      "r931",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r952",
      "r953",
      "r954",
      "r955",
      "r966",
      "r967",
      "r968",
      "r969",
      "r972",
      "r973",
      "r974",
      "r975",
      "r1030",
      "r1031",
      "r1036",
      "r1038",
      "r1088",
      "r1156",
      "r1158",
      "r1438",
      "r1439",
      "r1440",
      "r1441",
      "r1442",
      "r1443",
      "r1445",
      "r1446"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r91",
      "r93",
      "r94",
      "r96",
      "r97",
      "r703"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r703"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative liabilities related to terminated acquisition",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r315",
      "r727",
      "r728",
      "r741",
      "r751",
      "r921",
      "r922",
      "r923",
      "r924",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r952",
      "r954",
      "r955",
      "r1031",
      "r1032",
      "r1033",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1088",
      "r1435",
      "r1436",
      "r1437",
      "r1503"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional amount of outstanding forward contracts",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1430",
      "r1431"
     ]
    },
    "us-gaap_DerivativeTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeTermOfContract",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative term",
        "label": "Derivative, Term of Contract",
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Derivative Financial Instruments",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r87",
      "r88",
      "r89",
      "r95",
      "r340",
      "r358"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as Hedging Instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DevelopedTechnologyRightsMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Developed Technology Rights",
        "verboseLabel": "Developed technologies",
        "label": "Developed Technology Rights [Member]",
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1357",
      "r1359",
      "r1362",
      "r1363"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Director",
        "label": "Director [Member]",
        "documentation": "Person serving on board of directors."
       }
      }
     },
     "auth_ref": [
      "r1294",
      "r1331",
      "r1504"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/REVENUETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1384"
     ]
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Total Fair Value of Vested Restricted Stock",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r72"
     ]
    },
    "us-gaap_DiscontinuedOperationAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional adjustments recorded to additional paid-in capital as a result of the GRAIL Spin-Off:",
        "label": "Discontinued Operation, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of continuing cash flows after disposal",
        "label": "Discontinued Operation, Amount of Continuing Cash Flows after Disposal",
        "documentation": "Amount of cash inflow (outflow) from (to) the discontinued operation after the disposal transaction."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-contingent indemnification liability (see Note 7)",
        "label": "Discontinued Operation, Amounts of Material Contingent Liabilities Remaining",
        "documentation": "Amounts of material contingent liabilities, for example, but not limited to, product or environmental liabilities or litigation, that remain with the entity despite the disposal of the disposal group that is classified as a component of the entity."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r1371"
     ]
    },
    "us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued operation, equity method investment retained after disposal, ownership interest after disposal",
        "label": "Discontinued Operation, Equity Method Investment Retained after Disposal, Ownership Interest after Disposal",
        "documentation": "Percent, after disposal, of ownership interest of a discontinued operation in which an equity method investment is retained."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on disposal of discontinued operation, net of tax",
        "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax",
        "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r121"
     ]
    },
    "ilmn_DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag",
        "label": "Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag",
        "documentation": "DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensive Income Extensible Enumeration Not Disclosed Flag"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of parent shares converted into one share of spin-off (in shares)",
        "label": "Discontinued Operation, Number Of Parent Shares Converted Into One Share Of Spin-Off",
        "documentation": "Discontinued Operation, Number Of Parent Shares Converted Into One Share Of Spin-Off"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DiscontinuedOperationNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DiscontinuedOperationNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued in transaction",
        "label": "Discontinued Operation, Number Of Shares Issued In Transaction",
        "documentation": "Discontinued Operation, Number Of Shares Issued In Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DiscontinuedOperationPercentOfInterestDisposedOf": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DiscontinuedOperationPercentOfInterestDisposedOf",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of interest disposed",
        "label": "Discontinued Operation, Percent Of Interest Disposed Of",
        "documentation": "Discontinued Operation, Percent Of Interest Disposed Of"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period of continuing involvement after disposal",
        "label": "Discontinued Operation, Period of Continuing Involvement after Disposal",
        "documentation": "Period of expected continuing involvement with a discontinued operation after the disposal date, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax adjustment for difference between the book and tax values of our retained investment in GRAIL",
        "label": "Discontinued Operation, Tax (Expense) Benefit from Provision for (Gain) Loss on Disposal",
        "documentation": "Amount of tax (expense) benefit on (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r110",
      "r121",
      "r1424"
     ]
    },
    "ilmn_DiscontinuedOperationTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DiscontinuedOperationTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separation-related transaction costs",
        "label": "Discontinued Operation, Transaction Costs",
        "documentation": "Discontinued Operation, Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spinoff",
        "label": "Discontinued Operations, Disposed of by Means Other than Sale, Spinoff [Member]",
        "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, disposed of in spinoff."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupClassificationAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Axis]",
        "label": "Disposal Group Classification [Axis]",
        "documentation": "Information by disposal group classification."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupClassificationDomain",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Domain]",
        "label": "Disposal Group Classification [Domain]",
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r106",
      "r119",
      "r176"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts payable",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r106",
      "r119",
      "r176"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accrued liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities",
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r106",
      "r119",
      "r176"
     ]
    },
    "ilmn_DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total recorded to additional paid-in capital as a result of the GRAIL Spin-Off",
        "label": "Disposal Group, Including Discontinued Operation, Adjustment To Additional Paid In Capital",
        "documentation": "Disposal Group, Including Discontinued Operation, Adjustment To Additional Paid In Capital"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r106",
      "r119",
      "r176"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r106",
      "r119",
      "r176"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory, net",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r106",
      "r119",
      "r176"
     ]
    },
    "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DisposalGroupIncludingDiscontinuedOperationNetAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "GRAIL net assets",
        "terseLabel": "GRAIL net assets",
        "label": "Disposal Group, Including Discontinued Operation, Net Assets",
        "documentation": "Disposal Group, Including Discontinued Operation, Net Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Operating lease liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability",
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset",
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r106",
      "r119",
      "r176"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other long term-liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r3",
      "r106",
      "r119",
      "r176"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r106",
      "r119",
      "r174",
      "r176"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails": {
       "parentTag": "ilmn_DisposalGroupIncludingDiscontinuedOperationNetAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r106",
      "r119",
      "r176"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFF"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GRAIL SPIN-OFF",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r173"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Domain]",
        "label": "Disposal Group Name [Domain]",
        "documentation": "Name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r1122",
      "r1123"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r1170",
      "r1171",
      "r1194"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r1170",
      "r1171",
      "r1194",
      "r1237"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1215"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r1168"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1226"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r360",
      "r362",
      "r365",
      "r366",
      "r367",
      "r370",
      "r686",
      "r698",
      "r724",
      "r725",
      "r839",
      "r859",
      "r1090"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r362",
      "r365",
      "r366",
      "r367",
      "r370",
      "r686",
      "r698",
      "r724",
      "r725",
      "r839",
      "r859",
      "r1090"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "(Loss) Earnings per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r369"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "ilmn_EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrual of European Commission fine",
        "label": "Effective Income Tax Rate Reconciliation, Accrual of Potential Fine",
        "documentation": "Effective Income Tax Rate Reconciliation, Accrual of Potential Fine"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Impact of acquisition related items",
        "label": "Effective Income Tax Rate Reconciliation, Acquisitions Related Items, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Acquisitions Related Items, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationGiltiAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of net operating losses on GILTI, U.S. foreign tax credits, and Pillar Two global minimum top-up tax",
        "label": "Effective Income Tax Rate Reconciliation, GILTI, Amount",
        "documentation": "Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI)."
       }
      }
     },
     "auth_ref": [
      "r1129",
      "r1414",
      "r1416"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation expenses",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average period of unrecognized compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails": {
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Related income tax benefits",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "us-gaap_EmployeeSeveranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeSeveranceMember",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee separation costs",
        "verboseLabel": "Employee Separation Costs",
        "label": "Employee Severance [Member]",
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1277"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1278"
     ]
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from External Customer [Line Items]",
        "label": "Revenue from External Customer [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1220"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1273"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1273"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1273"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r286",
      "r323",
      "r324",
      "r325",
      "r342",
      "r343",
      "r344",
      "r347",
      "r354",
      "r356",
      "r358",
      "r372",
      "r431",
      "r437",
      "r471",
      "r552",
      "r668",
      "r669",
      "r682",
      "r683",
      "r684",
      "r687",
      "r697",
      "r698",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r714",
      "r723",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r766",
      "r768",
      "r789",
      "r856",
      "r888",
      "r889",
      "r890",
      "r909",
      "r978"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r678",
      "r1281",
      "r1282",
      "r1283",
      "r1425",
      "r1426",
      "r1427",
      "r1428"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r389",
      "r408",
      "r423",
      "r1297",
      "r1337"
     ]
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsPolicy",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Securities and Investments",
        "label": "Equity Method Investments [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r101",
      "r425"
     ]
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNi",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable equity securities",
        "label": "Equity Securities, FV-NI, Current",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r750",
      "r1087"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (losses) recognized during the period on marketable equity securities",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r862",
      "r1336"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails": {
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Net (losses) recognized during the period on marketable equity securities sold during the period",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r860",
      "r1336"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails": {
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized (losses) recognized during the period on marketable equity securities still held at the reporting date",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r861",
      "r1336"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Strategic equity investments, without readily determinable fair values",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "documentation": "Amount of investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1230"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1187",
      "r1198",
      "r1208",
      "r1241"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r1184",
      "r1195",
      "r1205",
      "r1238"
     ]
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe",
        "label": "Europe [Member]",
        "documentation": "Continent of Europe."
       }
      }
     },
     "auth_ref": [
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1508",
      "r1509",
      "r1510",
      "r1511"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1236"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r728",
      "r741",
      "r1130"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r728",
      "r741",
      "r1130"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Domain]",
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r742",
      "r1132"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r742",
      "r1132"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument asset measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r742",
      "r1132"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Axis]",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r742",
      "r1132"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r726",
      "r728",
      "r729",
      "r730",
      "r731",
      "r740",
      "r741",
      "r743",
      "r793",
      "r794",
      "r795",
      "r1112",
      "r1113",
      "r1119",
      "r1120",
      "r1121",
      "r1130",
      "r1134"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r742"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r728",
      "r729",
      "r731",
      "r1130",
      "r1436",
      "r1447"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENTS AND FAIR VALUE MEASUREMENTS",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r736",
      "r738",
      "r739",
      "r740",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r836",
      "r1130",
      "r1135"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r578",
      "r583",
      "r728",
      "r741",
      "r793",
      "r1119",
      "r1120",
      "r1121",
      "r1130"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r578",
      "r583",
      "r728",
      "r729",
      "r741",
      "r794",
      "r1112",
      "r1113",
      "r1119",
      "r1120",
      "r1121",
      "r1130"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r728",
      "r729",
      "r730",
      "r731",
      "r741",
      "r795",
      "r1112",
      "r1113",
      "r1119",
      "r1120",
      "r1121",
      "r1130",
      "r1134"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r742"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Estimated Fair Value of Acquisition Related Contingent Consideration Liabilities",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r737",
      "r742"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r728",
      "r729",
      "r731",
      "r1130",
      "r1436",
      "r1447"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in estimated fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r733",
      "r742",
      "r1132",
      "r1133"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration asset settlement",
        "negatedLabel": "Cash received to settle",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r742",
      "r1132"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r742",
      "r1132"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in estimated fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r733",
      "r742"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r742"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash payments",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r742"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r726",
      "r728",
      "r729",
      "r730",
      "r731",
      "r740",
      "r741",
      "r743",
      "r793",
      "r794",
      "r795",
      "r1112",
      "r1113",
      "r1119",
      "r1120",
      "r1121",
      "r1130",
      "r1134"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value, Measurements, Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r1130",
      "r1433",
      "r1434",
      "r1435",
      "r1436",
      "r1437",
      "r1447"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value Measurements",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ilmn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Five",
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r442",
      "r463",
      "r1105"
     ]
    },
    "ilmn_FiniteLivedIntangibleAssetsAccumulatedImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedImpairment",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails": {
       "parentTag": "ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Impairment",
        "label": "Finite Lived Intangible Assets, Accumulated Impairment",
        "documentation": "Finite Lived Intangible Assets, Accumulated Impairment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r1080",
      "r1105"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r1080",
      "r1105"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r1080",
      "r1105"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r1080",
      "r1105"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r1080",
      "r1105"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r463",
      "r467",
      "r468",
      "r801",
      "r805",
      "r1080"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Annual Amortization",
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Carrying Amount",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r463",
      "r805",
      "r1105"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r463",
      "r467",
      "r468",
      "r469",
      "r801",
      "r1080",
      "r1105"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r463",
      "r467",
      "r468",
      "r1080"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofEstimatedAnnualAmortizationofIntangibleAssetsDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, Net",
        "totalLabel": "Total",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r801",
      "r1359"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets, remaining amortization period",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets acquired",
        "label": "Finite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_FiscalPeriod": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiscalPeriod",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fiscal Year",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ilmn_FluentBioSciencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "FluentBioSciencesMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fluent Bio Sciences",
        "label": "Fluent Bio Sciences [Member]",
        "documentation": "Fluent Bio Sciences"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Foreign Tax Jurisdiction [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r641"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Functional Currency",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r753"
     ]
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignExchangeForwardMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Exchange Forward",
        "label": "Foreign Exchange Forward [Member]",
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate."
       }
      }
     },
     "auth_ref": [
      "r945",
      "r949",
      "r954",
      "r968",
      "r974",
      "r1034",
      "r1035",
      "r1036",
      "r1158"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1191",
      "r1202",
      "r1212",
      "r1245"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1191",
      "r1202",
      "r1212",
      "r1245"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1191",
      "r1202",
      "r1212",
      "r1245"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1191",
      "r1202",
      "r1212",
      "r1245"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1191",
      "r1202",
      "r1212",
      "r1245"
     ]
    },
    "us-gaap_FormerGainContingencyRecognizedInCurrentPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FormerGainContingencyRecognizedInCurrentPeriod",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Former gain contingency, recognized in current period",
        "label": "Former Gain Contingency, Recognized in Current Period",
        "documentation": "Amount of gain recognized in the period that had been disclosed in prior periods as a contingent gain."
       }
      }
     },
     "auth_ref": [
      "r1376"
     ]
    },
    "ilmn_FosterCityCaliforniaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "FosterCityCaliforniaMember",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foster City, California",
        "label": "Foster City, California [Member]",
        "documentation": "Foster City, California"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1225"
     ]
    },
    "ilmn_FrancesArnoldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "FrancesArnoldMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Frances Arnold [Member]",
        "documentation": "Frances Arnold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Furniture and fixtures",
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "GB",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United Kingdom",
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_GRAILInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "GRAILInc.Member",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GRAIL",
        "label": "GRAIL, Inc. [Member]",
        "documentation": "GRAIL, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_GRAILIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "GRAILIncMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GRAIL Inc",
        "label": "GRAIL Inc [Member]",
        "documentation": "GRAIL Inc"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_GainLossOnStrategicInvestmentsNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "GainLossOnStrategicInvestmentsNoncash",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net losses on strategic investments",
        "label": "Gain (Loss) On Strategic Investments, Noncash",
        "documentation": "Gain (Loss) On Strategic Investments, Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossRelatedToLitigationSettlement",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Legal contingency and settlement",
        "terseLabel": "Legal contingency and settlement",
        "label": "Gain (Loss) from Litigation Settlement",
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r1097",
      "r1371"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments of long-term debt",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r60",
      "r61"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r962"
     ]
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeographicConcentrationRiskMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Concentration Risk",
        "label": "Geographic Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r1068"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r443",
      "r837",
      "r1098",
      "r1104",
      "r1131",
      "r1140",
      "r1341",
      "r1348"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r1104"
     ]
    },
    "ilmn_GoodwillAmountThatExceedsCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "GoodwillAmountThatExceedsCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill amount that exceeds carrying value",
        "label": "Goodwill Amount That Exceeds Carrying Value",
        "documentation": "Goodwill Amount That Exceeds Carrying Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and intangible impairment",
        "verboseLabel": "Goodwill and intangible (IPR&amp;D) impairment",
        "label": "Goodwill and Intangible Asset Impairment",
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill, Intangible Assets and Other Long-Lived Assets",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1339",
      "r1351"
     ]
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated impairment loss",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "documentation": "Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r446",
      "r453",
      "r1104"
     ]
    },
    "ilmn_GoodwillImpairmentDiscountedCashFlowModelDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "GoodwillImpairmentDiscountedCashFlowModelDiscountRate",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of discount rate (as a percent)",
        "label": "Goodwill Impairment, Discounted cash flow model, Discount rate",
        "documentation": "Goodwill Impairment, Discounted cash flow model, Discount rate"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment increase in discounted cash flow model discount rate",
        "label": "Goodwill Impairment Increase In Discounted Cash Flow Model Discount Rate",
        "documentation": "Goodwill Impairment Increase In Discounted Cash Flow Model Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Impairment",
        "terseLabel": "Goodwill and intangible impairment",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r444",
      "r450",
      "r455",
      "r1104",
      "r1131"
     ]
    },
    "ilmn_GoodwillImpairmentMeasurementInput": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "GoodwillImpairmentMeasurementInput",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment measurement input",
        "label": "Goodwill Impairment Measurement Input",
        "documentation": "Goodwill Impairment Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_GoodwillImpairmentTestDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "GoodwillImpairmentTestDiscountRate",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination impairment test percentage",
        "label": "Goodwill, Impairment Test, Discount Rate",
        "documentation": "Goodwill, Impairment Test, Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Line Items]",
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r1104"
     ]
    },
    "ilmn_GoodwillPotentialImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "GoodwillPotentialImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill potential impairment loss",
        "label": "Goodwill Potential Impairment Loss",
        "documentation": "Goodwill Potential Impairment Loss"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r153",
      "r222",
      "r337",
      "r427",
      "r503",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r752",
      "r1091",
      "r1097",
      "r1325",
      "r1327",
      "r1328",
      "r1329",
      "r1330",
      "r1380"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r703"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ilmn_HelixContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "HelixContingentConsiderationMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSChangesinEstimatedFairValueofAcquisitionDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Helix Contingent Consideration",
        "label": "Helix Contingent Consideration [Member]",
        "documentation": "Helix Contingent Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_HelixHoldingsILLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "HelixHoldingsILLCMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Helix Holdings I, LLC",
        "label": "Helix Holdings I, LLC [Member]",
        "documentation": "Helix Holdings I, LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r1170",
      "r1171",
      "r1194"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of indefinite-lived intangible asset excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r1365"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill fair value recorded impairment",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r1313",
      "r1361",
      "r1364"
     ]
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InProcessResearchAndDevelopmentMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-process research and development (IPR&amp;D)",
        "label": "In Process Research and Development [Member]",
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process."
       }
      }
     },
     "auth_ref": [
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1359",
      "r1361",
      "r1362",
      "r1363"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r639"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total loss before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r217",
      "r222",
      "r840",
      "r854",
      "r1091",
      "r1097",
      "r1325",
      "r1327",
      "r1328",
      "r1329",
      "r1330"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofLossIncomebeforeIncomeTaxesbyRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r639"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSContingentConsiderationLiabilitiesDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Axis]",
        "label": "Disposal Group Name [Axis]",
        "documentation": "Information by name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r1122",
      "r1123"
     ]
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/GRAILSPINOFFNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r21",
      "r24",
      "r106",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r120",
      "r122",
      "r123",
      "r177"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r479",
      "r483",
      "r733",
      "r737",
      "r742",
      "r883",
      "r885",
      "r963",
      "r1080",
      "r1133",
      "r1473"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r483",
      "r733",
      "r737",
      "r742",
      "r883",
      "r885",
      "r963",
      "r1080",
      "r1133",
      "r1473"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r640",
      "r641",
      "r650",
      "r664",
      "r1129",
      "r1419"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r640",
      "r641",
      "r650",
      "r664",
      "r1129",
      "r1419"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Axis]",
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r650",
      "r1419"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Domain]",
        "label": "Income Tax Authority, Name [Domain]",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": [
      "r650",
      "r1419"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r631",
      "r640",
      "r646",
      "r647",
      "r648",
      "r656",
      "r662",
      "r673",
      "r675",
      "r676",
      "r677",
      "r908",
      "r1129"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails",
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total tax provision",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r242",
      "r357",
      "r358",
      "r371",
      "r387",
      "r408",
      "r638",
      "r640",
      "r674",
      "r863",
      "r1129"
     ]
    },
    "us-gaap_IncomeTaxHolidayAggregateDollarAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxHolidayAggregateDollarAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease to the provision for income taxes",
        "label": "Income Tax Holiday, Aggregate Dollar Amount",
        "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r675"
     ]
    },
    "us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxHolidayIncomeTaxBenefitsPerShare",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase to net income per diluted share (in dollars per share)",
        "label": "Income Tax Holiday, Income Tax Benefits Per Share",
        "documentation": "Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r675"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r634",
      "r635",
      "r656",
      "r657",
      "r661",
      "r666",
      "r902"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r1129",
      "r1414"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of foreign operations",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r644",
      "r1129",
      "r1414"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax at federal statutory rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r1129"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss."
       }
      }
     },
     "auth_ref": [
      "r1129",
      "r1414",
      "r1416"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of R&amp;D expense capitalization",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense."
       }
      }
     },
     "auth_ref": [
      "r1414",
      "r1416"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1129",
      "r1414",
      "r1416"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying statutory federal (national) tax rate to pretax income (loss) from continuing operation attributable to other reconciling item. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law."
       }
      }
     },
     "auth_ref": [
      "r1414",
      "r1415"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State, net of federal benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r643",
      "r1129",
      "r1414"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleofReconciliationofProvisionforLossIncomeTaxestoAmountComputedbyApplyingtheFederalStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research and other credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r1129",
      "r1414",
      "r1416"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r334",
      "r663",
      "r664"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred income taxes",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r1312"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_IncreaseDecreaseOfOperatingLeasesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "IncreaseDecreaseOfOperatingLeasesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Operating lease right-of-use assets and liabilities, net",
        "label": "Increase (Decrease) Of Operating Leases, Net",
        "documentation": "Increase (Decrease) Of Operating Leases, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r461",
      "r466",
      "r1105"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-process research and development (IPR&amp;D)",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r466",
      "r1105"
     ]
    },
    "ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails": {
       "parentTag": "ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Impairment",
        "label": "Indefinite Lived Intangible Assets (Excluding Goodwill), Accumulated Impairment",
        "documentation": "Indefinite Lived Intangible Assets (Excluding Goodwill), Accumulated Impairment"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillGross",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-process research and development (IPR&amp;D)",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill), Gross",
        "documentation": "Indefinite-Lived Intangible Assets (Excluding Goodwill), Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r461",
      "r466",
      "r1105"
     ]
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived intangible assets acquired",
        "label": "Indefinite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r1361"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1191",
      "r1202",
      "r1212",
      "r1236",
      "r1245",
      "r1249",
      "r1257"
     ]
    },
    "ilmn_IndustryCreditConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "IndustryCreditConcentrationRiskMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Industry Credit Concentration Risk",
        "label": "Industry Credit Concentration Risk [Member]",
        "documentation": "Industry Credit Concentration Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InlandRevenueSingaporeIRASMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InlandRevenueSingaporeIRASMember",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Singapore",
        "label": "Inland Revenue, Singapore (IRAS) [Member]",
        "documentation": "Designated tax department of the government of Singapore."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1255"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1172",
      "r1261"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1172",
      "r1261"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1172",
      "r1261"
     ]
    },
    "ilmn_InstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "InstrumentsMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Instruments",
        "terseLabel": "Instruments",
        "label": "Instruments [Member]",
        "documentation": "Instruments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_IntangibleAssetsExcludingGoodwillAccumulatedImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "IntangibleAssetsExcludingGoodwillAccumulatedImpairment",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Impairment",
        "label": "Intangible Assets (Excluding Goodwill), Accumulated Impairment",
        "documentation": "Intangible Assets (Excluding Goodwill), Accumulated Impairment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross Carrying Amount",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "ilmn_IntangibleAssetsImpairmentMeasurementInput": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "IntangibleAssetsImpairmentMeasurementInput",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets impairment measurement input",
        "label": "Intangible Assets Impairment Measurement Input",
        "documentation": "Intangible Assets Impairment Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets, net",
        "terseLabel": "Intangible Assets, Net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r1359",
      "r1361"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense recognized",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r534",
      "r544",
      "r1114",
      "r1115"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r1310"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r332",
      "r333"
     ]
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InternalRevenueServiceIRSMember",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IRS",
        "label": "Internal Revenue Service (IRS) [Member]",
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntersegmentEliminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntersegmentEliminationMember",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Eliminations",
        "label": "Intersegment Eliminations [Member]",
        "documentation": "Eliminating entries used in operating segment consolidation."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r371",
      "r381",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r409",
      "r1097"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Gross",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1299"
     ]
    },
    "us-gaap_InventoryGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryGross",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Inventory, gross",
        "label": "Inventory, Gross",
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r1302"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory, net",
        "totalLabel": "Total inventory, net",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r1085",
      "r1140"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r295",
      "r311",
      "r439",
      "r440",
      "r441",
      "r799",
      "r1089"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Gross",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1301"
     ]
    },
    "us-gaap_InventoryValuationReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryValuationReserves",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Inventory reserve",
        "label": "Inventory Valuation Reserves",
        "documentation": "Amount of valuation reserve for inventory."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r1302"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work in process",
        "label": "Inventory, Work in Process, Gross",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1300"
     ]
    },
    "us-gaap_InvesteeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvesteeMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investee",
        "label": "Investee [Member]",
        "documentation": "A corporation that issued voting stock held by an investor."
       }
      }
     },
     "auth_ref": [
      "r1456",
      "r1457"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r382",
      "r408",
      "r1097",
      "r1309"
     ]
    },
    "ilmn_InvestmentPortfolioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "InvestmentPortfolioMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Portfolio",
        "label": "Investment Portfolio [Member]",
        "documentation": "Investment Portfolio [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_IssueSizeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "IssueSizeMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue Size",
        "label": "Issue Size [Member]",
        "documentation": "Issue Size [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_JakobWedelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "JakobWedelMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jakob Wedel [Member]",
        "documentation": "Jakob Wedel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease costs",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r774",
      "r1139"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Lease Costs",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1454"
     ]
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements, Gross",
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r782"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LegalMattersAndContingenciesTextBlock",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "LEGAL PROCEEDINGS",
        "label": "Legal Matters and Contingencies [Text Block]",
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1455"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total remaining lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, operating lease, remaining lease term",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r783",
      "r1452"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, operating lease, renewal term",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1453"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r214",
      "r849",
      "r1140",
      "r1316",
      "r1338",
      "r1448"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r294",
      "r337",
      "r427",
      "r503",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r700",
      "r701",
      "r702",
      "r752",
      "r1140",
      "r1380",
      "r1460",
      "r1461"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities measured at fair value",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r728",
      "r1433"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities:",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_LiabilityBasedAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "LiabilityBasedAwardsMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability-Based Awards",
        "label": "Liability-Based Awards [Member]",
        "documentation": "Liability-Based Awards"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_LiabilityClassifiedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "LiabilityClassifiedRestrictedStockUnitsMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Classified Restricted Stock Units",
        "label": "Liability Classified Restricted Stock Units [Member]",
        "documentation": "Liability Classified Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LicenseMember",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License",
        "label": "License [Member]",
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r1385"
     ]
    },
    "ilmn_LicensedTechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "LicensedTechnologyMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Licensed technologies",
        "label": "Licensed Technology [Member]",
        "documentation": "Licensed Technology [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LicensingAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LicensingAgreementsMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreements",
        "label": "Licensing Agreements [Member]",
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory)."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r630",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1359",
      "r1361",
      "r1362",
      "r1363",
      "r1413"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r131"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Axis]",
        "label": "Litigation Case [Axis]",
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim."
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Domain]",
        "label": "Litigation Case [Domain]",
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationReserveCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal contingencies",
        "label": "Estimated Litigation Liability, Current",
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r1371"
     ]
    },
    "ilmn_LitigationSettlementFinePercentageRate": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "LitigationSettlementFinePercentageRate",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, fine percentage rate",
        "label": "Litigation Settlement, Fine Percentage Rate",
        "documentation": "Litigation Settlement, Fine Percentage Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationSettlementGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationSettlementGain",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation settlement, gain",
        "label": "Litigation Settlement, Gain",
        "documentation": "Amount of gain from litigation settlement for amount awarded from other party. Excludes claims within an insurance entity's normal claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r1376"
     ]
    },
    "us-gaap_LitigationSettlementLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationSettlementLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation settlement, loss",
        "label": "Litigation Settlement, Loss",
        "documentation": "Amount of loss from litigation settlement for amount awarded to other party. Excludes claims within an insurance entity's normal claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r1371"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Long-lived Assets Consisting of Property and Equipment by Region",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net carrying amount of term debt",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r212",
      "r527",
      "r542",
      "r1112",
      "r1113",
      "r1138",
      "r1469"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: current portion",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r303"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term debt, non-current",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "us-gaap_LongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term debt",
        "label": "Notes Payable, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r1366",
      "r1367",
      "r1368"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r59",
      "r1366",
      "r1367",
      "r1368"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r494",
      "r626",
      "r1110",
      "r1372",
      "r1373"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r494",
      "r626",
      "r1110",
      "r1372",
      "r1373"
     ]
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyAccrualAtCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss contingency accrual",
        "label": "Loss Contingency Accrual",
        "documentation": "Amount of loss contingency liability."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r1280"
     ]
    },
    "ilmn_LossContingencyLicenseGrantedIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "LossContingencyLicenseGrantedIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License granted intangible assets",
        "label": "Loss Contingency, License Granted Intangible Assets",
        "documentation": "Loss Contingency, License Granted Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyNewClaimsFiledNumber",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss contingency, new claims filed, number",
        "label": "Loss Contingency, New Claims Filed, Number",
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period."
       }
      }
     },
     "auth_ref": [
      "r1372",
      "r1373"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_MarketBasedPerformanceStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "MarketBasedPerformanceStockUnitsMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Based Performance Stock Units",
        "label": "Market Based Performance Stock Units [Member]",
        "documentation": "Market Based Performance Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesGainLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesGainLossAbstract",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofMarketableEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities, Gain (Loss) [Abstract]",
        "label": "Marketable Security, Gain (Loss) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Marketable Securities",
        "label": "Marketable Securities [Table Text Block]",
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r248",
      "r250",
      "r251",
      "r253",
      "r282",
      "r283",
      "r490",
      "r491",
      "r492",
      "r493",
      "r585",
      "r626",
      "r731",
      "r798",
      "r882",
      "r884",
      "r898",
      "r930",
      "r931",
      "r985",
      "r1004",
      "r1009",
      "r1010",
      "r1049",
      "r1078",
      "r1079",
      "r1103",
      "r1116",
      "r1124",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1150",
      "r1382",
      "r1462",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1228"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1228"
     ]
    },
    "ilmn_MeasurementInputCalculationTrailingPeriodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "MeasurementInputCalculationTrailingPeriodMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Calculation Trailing Period",
        "label": "Measurement Input, Calculation Trailing Period [Member]",
        "documentation": "Measurement Input, Calculation Trailing Period"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_MeasurementInputCashFlowPeriodMemberMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "MeasurementInputCashFlowPeriodMemberMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Cash Flow Period Member",
        "label": "Measurement Input Cash Flow Period Member [Member]",
        "documentation": "Measurement Input Cash Flow Period Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Discount Rate",
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r1435",
      "r1436",
      "r1437"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Expected Term",
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r1435",
      "r1436",
      "r1437"
     ]
    },
    "ilmn_MeasurementInputRevenueRiskPremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "MeasurementInputRevenueRiskPremiumMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Risk Premium",
        "label": "Measurement Input, Revenue Risk Premium [Member]",
        "documentation": "Measurement Input, Revenue Risk Premium"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r730",
      "r731",
      "r1134"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r730",
      "r731",
      "r1134"
     ]
    },
    "ilmn_MicroarrayMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "MicroarrayMember",
     "presentation": [
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Microarray",
        "label": "Microarray [Member]",
        "documentation": "Microarray [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r248",
      "r250",
      "r251",
      "r253",
      "r282",
      "r283",
      "r490",
      "r491",
      "r492",
      "r493",
      "r585",
      "r626",
      "r731",
      "r798",
      "r882",
      "r884",
      "r898",
      "r930",
      "r931",
      "r985",
      "r1004",
      "r1009",
      "r1010",
      "r1049",
      "r1078",
      "r1079",
      "r1103",
      "r1116",
      "r1124",
      "r1134",
      "r1135",
      "r1136",
      "r1150",
      "r1382",
      "r1462",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1248"
     ]
    },
    "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165",
      "r166"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      },
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r166",
      "r218",
      "r292",
      "r318",
      "r320",
      "r325",
      "r337",
      "r346",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r357",
      "r358",
      "r364",
      "r427",
      "r503",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r686",
      "r698",
      "r725",
      "r752",
      "r855",
      "r959",
      "r976",
      "r977",
      "r1164",
      "r1380"
     ]
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r359",
      "r370",
      "r417",
      "r418",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r470",
      "r471",
      "r480",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r689",
      "r690",
      "r691",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r748",
      "r749",
      "r765",
      "r766",
      "r767",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r802",
      "r803",
      "r804",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r900"
     ]
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "documentation": "Disclosure of information about change in accounting principle or amendment to accounting standards or both. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards and other change in accounting principle."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r359",
      "r370",
      "r417",
      "r418",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r470",
      "r471",
      "r480",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r689",
      "r690",
      "r691",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r748",
      "r749",
      "r765",
      "r766",
      "r767",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r802",
      "r803",
      "r804",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r900"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Pronouncements Adopted and Accounting Pronouncements Pending Adoption",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GRAIL net assets, excluding cash and cash equivalents, deconsolidated as a result of spin-off",
        "label": "Non cash Or Par tNon cash Spin off Net Assets Excluding Cash And Cash Equivalents",
        "documentation": "Non cash Or Par tNon cash Spin off Net Assets Excluding Cash And Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1228"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1191",
      "r1202",
      "r1212",
      "r1236",
      "r1245"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1219"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1218"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1236"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outside the United States",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r1508",
      "r1509",
      "r1510",
      "r1511"
     ]
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total long-lived assets, net",
        "label": "Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Not Designated as Hedging Instrument",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other expense, net",
        "negatedTerseLabel": "Consolidated other expense, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income (expense):",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term debt, current portion",
        "label": "Notes Payable, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128"
     ]
    },
    "ilmn_NumberOfInvestmentFunds": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "NumberOfInvestmentFunds",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of venture capital investment funds",
        "label": "Number Of Investment Funds",
        "documentation": "Number Of Investment Funds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segment",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r1092",
      "r1102",
      "r1326"
     ]
    },
    "us-gaap_NumberOfReportingUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportingUnits",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reporting units",
        "label": "Number of Reporting Units",
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expense",
        "terseLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating expense:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r1091",
      "r1325",
      "r1327",
      "r1328",
      "r1329",
      "r1330"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease costs",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r775",
      "r1139"
     ]
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use asset impairment",
        "label": "Operating Lease, Impairment Loss",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1451"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: current portion",
        "terseLabel": "Operating lease liabilities, current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liabilities",
        "terseLabel": "Long-term operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for operating lease liabilities",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r772",
      "r778"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "ilmn_OperatingLeaseRightOfUseAssetAndLeaseholdImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "OperatingLeaseRightOfUseAssetAndLeaseholdImprovements",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets and leasehold improvements",
        "label": "Operating Lease, Right-of-Use Asset and Leasehold Improvements",
        "documentation": "Operating Lease, Right-of-Use Asset and Leasehold Improvements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r780",
      "r1139"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r779",
      "r1139"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r409",
      "r1097",
      "r1098"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r167",
      "r168",
      "r205"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other, including warranties",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "us-gaap_OtherCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitment",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital commitments",
        "label": "Other Commitment",
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Commitments",
        "label": "Other Commitments [Table Text Block]",
        "documentation": "Tabular disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on cash flow hedges, net of deferred tax",
        "verboseLabel": "Unrealized loss on cash flow hedges, net of deferred tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r316"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDerivativeFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss) hedge",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r316",
      "r317"
     ]
    },
    "ilmn_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other countries",
        "label": "Other Countries [Member]",
        "documentation": "Other Countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_OtherInvestmentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "OtherInvestmentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSScheduleofHierarchyforAssetsandLiabilitiesMeasuredatFairValueRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other investments",
        "label": "Other Investments Fair Value Disclosure",
        "documentation": "Other Investments Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other long-term liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other expense, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1228"
     ]
    },
    "us-gaap_OtherRestructuringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherRestructuringMember",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Costs",
        "verboseLabel": "Other Costs",
        "label": "Other Restructuring [Member]",
        "documentation": "Restructuring and related activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1106",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1189",
      "r1200",
      "r1210",
      "r1243"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1192",
      "r1203",
      "r1213",
      "r1246"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1192",
      "r1203",
      "r1213",
      "r1246"
     ]
    },
    "ilmn_PatriciaLeckmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "PatriciaLeckmanMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patricia Leckman [Member]",
        "documentation": "Patricia Leckman"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1217"
     ]
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for contingent consideration",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "PaymentRightsOfAboveOneBillionEachTwelveYearsMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment Rights Of Above One Billion Each Twelve Years",
        "label": "Payment Rights Of Above One Billion Each Twelve Years [Member]",
        "documentation": "Payment Rights Of Above One Billion Each Twelve Years"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "PaymentRightsOfOneBillionEachTwelveYearsMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment Rights Of One Billion Each Twelve Years",
        "label": "Payment Rights Of One Billion, Each Twelve Years [Member]",
        "documentation": "Payment Rights Of One Billion, Each Twelve Years"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForLegalSettlements",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for legal settlements",
        "label": "Payments for Legal Settlements",
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ilmn_PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/LEGALPROCEEDINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for legal settlements, amount allocated to release of past damages claimed",
        "label": "Payments for Legal Settlements, Amount Allocated to Release of Past Damages Claimed",
        "documentation": "Payments for Legal Settlements, Amount Allocated to Release of Past Damages Claimed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common stock repurchases",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_PaymentsForRestructuring": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRestructuring",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash payments",
        "label": "Payments for Restructuring",
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r1311"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Proceeds from debt, net of issuance costs",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfMergerRelatedCostsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments on contingent consideration liabilities",
        "label": "Payments of Merger Related Costs, Financing Activities",
        "documentation": "The cash outflow for financing costs associated with business combinations."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash paid for acquisitions and intangible assets, net of cash acquired",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1227"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1227"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1219"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1236"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1218"
     ]
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "PSU",
        "terseLabel": "PSU",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1391",
      "r1392",
      "r1393",
      "r1394",
      "r1395",
      "r1396",
      "r1397",
      "r1398",
      "r1399",
      "r1400",
      "r1401",
      "r1402",
      "r1403",
      "r1404",
      "r1405",
      "r1406",
      "r1407",
      "r1408",
      "r1409",
      "r1410",
      "r1411",
      "r1412"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1387",
      "r1388",
      "r1389",
      "r1390",
      "r1391",
      "r1392",
      "r1393",
      "r1394",
      "r1395",
      "r1396",
      "r1397",
      "r1398",
      "r1399",
      "r1400",
      "r1401",
      "r1402",
      "r1403",
      "r1404",
      "r1405",
      "r1406",
      "r1407",
      "r1408",
      "r1409",
      "r1410",
      "r1411",
      "r1412"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1220"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1276"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1219"
     ]
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PostemploymentBenefitsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Postemployment Benefits [Abstract]",
        "label": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r545"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r939"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r545"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r939",
      "r957",
      "r1506",
      "r1507"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.01\u00a0par value, 10 million\u00a0shares authorized; no shares issued and outstanding at December\u00a029, 2024 and December\u00a031, 2023",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r845",
      "r1140"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1304"
     ]
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the issuance",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from debt, net of issuance costs",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r903"
     ]
    },
    "us-gaap_ProceedsFromSaleOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash received for Helix contingent value right",
        "label": "Proceeds from Sale of Intangible Assets",
        "documentation": "The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_ProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductMember",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product",
        "verboseLabel": "Total product revenue",
        "label": "Product [Member]",
        "documentation": "Article or substance produced by nature, labor or machinery."
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r280",
      "r412",
      "r800",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r1082",
      "r1117",
      "r1149",
      "r1150",
      "r1151",
      "r1154",
      "r1155",
      "r1295",
      "r1374",
      "r1375",
      "r1384",
      "r1470",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1493",
      "r1494",
      "r1495",
      "r1496",
      "r1497",
      "r1498",
      "r1499",
      "r1500",
      "r1501"
     ]
    },
    "us-gaap_ProductWarrantyAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductWarrantyAccrual",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance as of beginning of period",
        "periodEndLabel": "Balance as of end of period",
        "label": "Standard and Extended Product Warranty Accrual",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r495",
      "r497",
      "r500"
     ]
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductWarrantyAccrualPayments",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repairs and replacements",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofChangesinReserveforProductWarrantiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additions charged to cost of product revenue",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_ProductWarrantyLiabilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductWarrantyLiabilityLineItems",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Warranty Liability [Line Items]",
        "label": "Product Warranty Liability [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProductWarrantyLiabilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductWarrantyLiabilityTable",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Warranty Liability [Table]",
        "label": "Product Warranty Liability [Table]",
        "documentation": "Disclosure of information about product warranty liability, including, but not limited to, reductions in the liability for payments made under the warranty, changes in the liability for accruals related to product warranties issued, and changes in the liability for accruals related to preexisting warranties."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r280",
      "r412",
      "r800",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r1082",
      "r1117",
      "r1149",
      "r1150",
      "r1151",
      "r1154",
      "r1155",
      "r1295",
      "r1374",
      "r1375",
      "r1384",
      "r1470",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1493",
      "r1494",
      "r1495",
      "r1496",
      "r1497",
      "r1498",
      "r1499",
      "r1500",
      "r1501"
     ]
    },
    "ilmn_PropertyAndEquipmentAndRightOfUseAssetImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "PropertyAndEquipmentAndRightOfUseAssetImpairment",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment and right-of-use asset impairment",
        "label": "Property and Equipment and Right-of-Use Asset Impairment",
        "documentation": "Property and Equipment and Right-of-Use Asset Impairment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r782"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r296",
      "r853"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r782",
      "r841",
      "r853",
      "r1140"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r234",
      "r240",
      "r851"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESTables",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Estimated Useful Lives of Major Classes of Property and Equipment",
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r782"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful lives",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PurchaseObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase obligation",
        "label": "Purchase Obligation",
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_PurchasesSalesForStrategicInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "PurchasesSalesForStrategicInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net purchases of strategic investments",
        "label": "(Purchases) Sales For Strategic Investments",
        "documentation": "(Purchases) Sales For Strategic Investments"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1217"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1217"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r248",
      "r250",
      "r251",
      "r253",
      "r282",
      "r283",
      "r490",
      "r491",
      "r492",
      "r493",
      "r577",
      "r585",
      "r615",
      "r616",
      "r617",
      "r626",
      "r731",
      "r796",
      "r797",
      "r798",
      "r882",
      "r884",
      "r898",
      "r930",
      "r931",
      "r985",
      "r1004",
      "r1009",
      "r1010",
      "r1049",
      "r1078",
      "r1079",
      "r1103",
      "r1116",
      "r1124",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1150",
      "r1158",
      "r1369",
      "r1382",
      "r1436",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r248",
      "r250",
      "r251",
      "r253",
      "r282",
      "r283",
      "r490",
      "r491",
      "r492",
      "r493",
      "r577",
      "r585",
      "r615",
      "r616",
      "r617",
      "r626",
      "r731",
      "r796",
      "r797",
      "r798",
      "r882",
      "r884",
      "r898",
      "r930",
      "r931",
      "r985",
      "r1004",
      "r1009",
      "r1010",
      "r1049",
      "r1078",
      "r1079",
      "r1103",
      "r1116",
      "r1124",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1150",
      "r1158",
      "r1369",
      "r1382",
      "r1436",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467"
     ]
    },
    "ilmn_RecallableDistributionsCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "RecallableDistributionsCommitment",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recallable distributions",
        "label": "Recallable Distributions Commitment",
        "documentation": "Recallable Distributions Commitment"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ReclassificationLiabilityAwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ReclassificationLiabilityAwards",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of liability-classified awards",
        "label": "Reclassification, Liability Awards",
        "documentation": "Reclassification, Liability Awards"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits [Roll Forward]",
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1184",
      "r1195",
      "r1205",
      "r1238"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r584",
      "r790",
      "r791",
      "r843",
      "r850",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r956",
      "r958",
      "r981"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r584",
      "r790",
      "r791",
      "r843",
      "r850",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r956",
      "r958",
      "r981",
      "r1459"
     ]
    },
    "ilmn_RemainingCapitalCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "RemainingCapitalCommitment",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Remaining callable",
        "label": "Remaining Capital Commitment",
        "documentation": "Remaining Capital Commitment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfConvertibleDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments on debt obligations",
        "label": "Repayments of Convertible Debt",
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r906"
     ]
    },
    "us-gaap_ReportingUnitAmountOfFairValueInExcessOfCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReportingUnitAmountOfFairValueInExcessOfCarryingAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value in excess of carrying amount (more than)",
        "label": "Reporting Unit, Amount of Fair Value in Excess of Carrying Amount",
        "documentation": "Amount of fair value of reporting unit in excess of carrying amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development",
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r629",
      "r1080",
      "r1097",
      "r1468"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development",
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1185",
      "r1196",
      "r1206",
      "r1239"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1186",
      "r1197",
      "r1207",
      "r1240"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1193",
      "r1204",
      "r1214",
      "r1247"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "RSU",
        "terseLabel": "RSU",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expense recorded",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r485",
      "r486",
      "r1370"
     ]
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Type [Axis]",
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r486",
      "r487"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r487",
      "r488"
     ]
    },
    "ilmn_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag",
        "label": "Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag",
        "documentation": "Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_RestructuringPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "RestructuringPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring",
        "label": "Restructuring [Policy Text Block]",
        "documentation": "Restructuring"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Restructuring Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r487"
     ]
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserveAccrualAdjustment1",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to accrual",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r487"
     ]
    },
    "us-gaap_RestructuringReserveRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserveRollForward",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Reserve [Roll Forward]",
        "label": "Restructuring Reserve [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringSettlementAndImpairmentProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringSettlementAndImpairmentProvisions",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total restructuring charges",
        "label": "Restructuring, Settlement and Impairment Provisions",
        "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated deficit",
        "terseLabel": "Retained earnings (accumulated deficit)",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r187",
      "r848",
      "r892",
      "r897",
      "r907",
      "r940",
      "r1140"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings (Accumulated Deficit)",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r342",
      "r343",
      "r344",
      "r347",
      "r354",
      "r356",
      "r358",
      "r431",
      "r437",
      "r471",
      "r668",
      "r669",
      "r682",
      "r683",
      "r684",
      "r687",
      "r697",
      "r698",
      "r707",
      "r710",
      "r711",
      "r714",
      "r723",
      "r766",
      "r768",
      "r888",
      "r890",
      "r909",
      "r1506"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total revenue",
        "terseLabel": "Revenue",
        "netLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r221",
      "r371",
      "r380",
      "r381",
      "r402",
      "r408",
      "r412",
      "r414",
      "r416",
      "r572",
      "r573",
      "r800"
     ]
    },
    "ilmn_RevenueFromContractWithCustomerPaymentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "RevenueFromContractWithCustomerPaymentTerm",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment period from invoice",
        "label": "Revenue From Contract With Customer, Payment Term",
        "documentation": "Revenue From Contract With Customer, Payment Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue Recognition and Shipping and Handling Expenses",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r1081"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.illumina.com/role/REVENUE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUE",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r576"
     ]
    },
    "ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product or service delivery period",
        "label": "Revenue Recognition, Multiple-Deliverable Arrangements, Delivery Time Frame",
        "documentation": "Revenue Recognition, Multiple-Deliverable Arrangements, Delivery Time Frame"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligation",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r237"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "presentation": [
      "http://www.illumina.com/role/REVENUENarrativeRemainingPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of remaining performance obligation",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r1284"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue:",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_RevolvingCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "RevolvingCreditAgreementMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Agreement",
        "label": "Revolving Credit Agreement [Member]",
        "documentation": "Revolving Credit Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "country_SG": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "SG",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Singapore",
        "label": "SINGAPORE"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Benchmark",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r1285"
     ]
    },
    "ilmn_SanDiegoCaliforniaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "SanDiegoCaliforniaMember",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "San Diego, California",
        "label": "San Diego, California [Member]",
        "documentation": "San Diego, California"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Receivable",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r144"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Accrued Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeBusinessOverviewDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Provision for Income Taxes",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1421"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Debt Obligations",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Compensation Arrangement with Individual, Postretirement Benefit [Table]",
        "label": "Deferred Compensation Arrangement with Individual, Postretirement Benefit [Table]",
        "documentation": "Disclosure of information about pension and other postretirement benefit arrangement between employer and individual employee with promise by employer to pay certain amount at future date. Includes, but is not limited to, amount of compensation expense recognized and amount of liability."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Significant Components of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1418"
     ]
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Included as Part of the Disposal Group",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r21",
      "r24",
      "r106",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r120",
      "r122",
      "r123",
      "r177"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Provision for (Loss) Income Taxes to Amount Computed by Applying the Federal Statutory Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r642",
      "r1129",
      "r1414"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Expense for all Stock Awards",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRevenueRecognitionDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting, Revenue from External Customer, Product and Service [Table]",
        "label": "Segment Reporting, Revenue from External Customer, Product and Service [Table]",
        "documentation": "Disclosure of information about revenue from external customer by product and service when not provided as part of reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r678",
      "r1281",
      "r1282",
      "r1283",
      "r1425",
      "r1426",
      "r1427",
      "r1428"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1433",
      "r1434"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Asset, Finite-Lived [Table]",
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r463",
      "r467",
      "r468",
      "r469",
      "r801",
      "r1080",
      "r1105"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-lived Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r1105",
      "r1358"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Table]",
        "label": "Goodwill [Table]",
        "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r1104"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Goodwill",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r1104",
      "r1340",
      "r1341",
      "r1342",
      "r1343",
      "r1344",
      "r1345",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of (Loss) Income before Income Taxes by Region",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1317"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r145",
      "r146",
      "r147"
     ]
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInvestmentsLineItems",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments [Line Items]",
        "label": "Schedule of Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058"
     ]
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInvestmentsTable",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments [Table]",
        "label": "Schedule of Investments [Table]",
        "documentation": "Disclosure of information about investments owned by investment company."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1040",
      "r1041",
      "r1042",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058"
     ]
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Reserve for Product Warranties",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeLeasesDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofEstimatedUsefulLivesofMajorClassesofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r782"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost [Table]",
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r487",
      "r488"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring and Related Costs",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r178",
      "r179"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net long-lived assets consisting of property and equipment by region [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r149"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r53"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Performance and Assets by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r53"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Pre-tax Intrinsic Values of Vested Restricted Stock",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]",
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity Under all Stock Option Plans",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r194"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assumptions used to Estimate the Weighted-Average Fair Value Per Share for Stock Purchase under the Employee Stock Purchase Plan",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Restricted Stock Activity and Related Information, Restricted Stock",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock, Class of Stock [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r183",
      "r185",
      "r186",
      "r187",
      "r305",
      "r306",
      "r307",
      "r373",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r903",
      "r904",
      "r905",
      "r906",
      "r1116",
      "r1279",
      "r1314"
     ]
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share repurchase activity",
        "label": "Class of Treasury Stock [Table Text Block]",
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r71"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r651",
      "r1128"
     ]
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings Per Share, Earnings Per Share",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Estimated Annual Amortization of Finite-lived Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1105",
      "r1360"
     ]
    },
    "ilmn_ScottDaviesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ScottDaviesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scott Davies [Member]",
        "documentation": "Scott Davies"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1166"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1169"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r223",
      "r371",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r409",
      "r410",
      "r416",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r469",
      "r484",
      "r488",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r1094",
      "r1097",
      "r1098",
      "r1104",
      "r1153",
      "r1470",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1493",
      "r1494",
      "r1495",
      "r1496",
      "r1497",
      "r1498",
      "r1499",
      "r1500",
      "r1501"
     ]
    },
    "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentExpenditureAdditionToLongLivedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated capital expenditures",
        "label": "Segment, Expenditure, Addition to Long-Lived Assets",
        "documentation": "Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r390",
      "r408",
      "r1097",
      "r1098"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r249",
      "r252",
      "r254",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r414",
      "r415",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r923",
      "r926",
      "r928",
      "r991",
      "r1005",
      "r1026",
      "r1055",
      "r1067",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1083",
      "r1118",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1152",
      "r1158",
      "r1384",
      "r1470",
      "r1474",
      "r1475",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1493",
      "r1494",
      "r1495",
      "r1496",
      "r1497",
      "r1498",
      "r1499",
      "r1500",
      "r1501"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT AND GEOGRAPHIC INFORMATION",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r371",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r391",
      "r393",
      "r394",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r412",
      "r413",
      "r416",
      "r1092",
      "r1095",
      "r1096",
      "r1097",
      "r1099",
      "r1101",
      "r1102"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r411",
      "r414",
      "r1093",
      "r1094",
      "r1100"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and marketing",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_SeniorLevelEmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "SeniorLevelEmployeeMember",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Level Employee",
        "label": "Senior Level Employee [Member]",
        "documentation": "Senior Level Employee [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of change of additional 250 basis points, increase in liability",
        "label": "Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Decrease",
        "documentation": "Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Decrease"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of change of additional 250 basis points, decrease in liability",
        "label": "Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Increase",
        "documentation": "Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Effect of Change Of Additional 250 Basis Points, Increase"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in 20% of revenue, decrease in liability",
        "label": "Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent Decrease, Decrease",
        "documentation": "Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent Decrease, Decrease"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in 20% of revenue, increase in liability",
        "label": "Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent, Increase",
        "documentation": "Sensitivity Analysis Of Business Combination, Contingent Consideration, Liability Changes, Impact Of 20 Percent, Increase"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sensitivity analysis of intangible assets impairment additional charges impact of 300 basis points",
        "label": "Sensitivity Analysis Of Intangible Assets Impairment Additional Charges Impact Of 300 Basis Points",
        "documentation": "Sensitivity Analysis Of Intangible Assets Impairment Additional Charges Impact Of 300 Basis Points"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_SequencingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "SequencingMember",
     "presentation": [
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sequencing",
        "label": "Sequencing [Member]",
        "documentation": "Sequencing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series of Individually Immaterial Business Acquisitions",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_ServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ServiceMember",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service",
        "verboseLabel": "Service and other revenue",
        "label": "Service [Member]",
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service."
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation vesting performance period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Change In Fair Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Change In Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested adjustment (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested adjustment (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period, Weighted Average Grant Date Fair Value",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Adjustments in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Awarded (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Awarded (in dollars per share)",
        "terseLabel": "Weighted-average grant-date fair value per share (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at period start (in shares)",
        "periodEndLabel": "Outstanding at period end (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r603"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Units",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at period start (in dollars per share)",
        "periodEndLabel": "Outstanding at period end (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r603"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Grant- Date Fair Value per Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of restricted stock vested:",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeShareBasedCompensationDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "verboseLabel": "Expected dividends",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregated potential value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Award, Aggregate Intrinsic Value, Nonvested",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Award, Aggregate Intrinsic Value, Nonvested"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Derecognition for GRAIL Spin-Off",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Derecognition",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Derecognition"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cancelled",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Forfeited, Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Forfeited, Value"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Granted, Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Granted, Value"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Outstanding, Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Outstanding, Value"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsRollForward",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards [Roll Forward]",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards [Roll Forward]",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested and paid in cash",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Vested And Paid In Cash, Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Liability-Classified Awards, Vested And Paid In Cash, Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareBasedCompensationExpenseforallStockAwardsDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ]
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation arrangement by share-based payment award, maximum award payout",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Award Payout",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Award Payout"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability-classified awards (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r196"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available for grant",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Period Adjustment",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Period Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available for grant, period increase",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Number Of Shares Available For Grant, Period Increase",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Number Of Shares Available For Grant, Period Increase"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at period start (in shares)",
        "periodEndLabel": "Outstanding at period end (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r594",
      "r595"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options and Performance Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at period start (in dollars per share)",
        "periodEndLabel": "Outstanding at period end (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r594",
      "r595"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Exercise\u00a0Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofCashBasedEquityIncentiveAwardActivityDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityandRelatedInformationDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "verboseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r591",
      "r592",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "ilmn_ShareBasedCompensationNumberOfPerformanceStockUnitAwards": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedCompensationNumberOfPerformanceStockUnitAwards",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of PSU awards",
        "label": "Share-based Compensation, Number Of Performance Stock Unit Awards",
        "documentation": "Share-based Compensation, Number Of Performance Stock Unit Awards"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r593",
      "r612",
      "r613",
      "r614",
      "r615",
      "r618",
      "r621",
      "r622",
      "r623",
      "r624"
     ]
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Activity and Related Information, Performance Units",
        "label": "Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash-Based Equity Incentive Award Activity",
        "label": "Share-Based Payment Arrangement, Liability-Classified Awards, Activity [Table Text Block]",
        "documentation": "Share-Based Payment Arrangement, Liability-Classified Awards, Activity"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "ShareBasedPaymentArrangementPerformanceStockOptionMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Stock Options",
        "label": "Share-Based Payment Arrangement, Performance Stock Option [Member]",
        "documentation": "Share-Based Payment Arrangement, Performance Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofPretaxIntrinsicValuesandTotalFairValueofVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-tax intrinsic value of outstanding restricted stock:",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeLiabilityClassifiedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofAssumptionsusedtoEstimatetheWeightedAverageFairValuePerShareforStockPurchaseundertheEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Specified percentage of the fair market value of the common stock on the first or last day of the offering period whichever is lower at which stock is purchased",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "STOCKHOLDERS' EQUITY",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r193"
     ]
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Short-term investments",
        "terseLabel": "Short-term Investments",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r216",
      "r1303"
     ]
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestmentsMember",
     "presentation": [
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Investments",
        "label": "Short-Term Investments [Member]",
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r1059",
      "r1060",
      "r1061",
      "r1084"
     ]
    },
    "ilmn_StandardProductWarrantyDescriptionTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "StandardProductWarrantyDescriptionTerm",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeWarrantiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warranty period",
        "label": "Standard Product Warranty Description, Term",
        "documentation": "Describes the approximate term of the product warranty."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StandardProductWarrantyPolicy",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warranties",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability."
       }
      }
     },
     "auth_ref": [
      "r1377"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails",
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofChangesinGoodwillDetails",
      "http://www.illumina.com/role/GRAILSPINOFFAssetsandLiabilitiesIncludedasPartoftheDisposalGroupDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofOperatingPerformanceandAssetsbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r223",
      "r290",
      "r371",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r408",
      "r409",
      "r410",
      "r416",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r469",
      "r473",
      "r484",
      "r488",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r1094",
      "r1097",
      "r1098",
      "r1104",
      "r1153",
      "r1470",
      "r1474",
      "r1475",
      "r1476",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1493",
      "r1494",
      "r1495",
      "r1496",
      "r1497",
      "r1498",
      "r1499",
      "r1500",
      "r1501"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r305",
      "r306",
      "r307",
      "r337",
      "r362",
      "r363",
      "r365",
      "r367",
      "r373",
      "r374",
      "r427",
      "r503",
      "r506",
      "r507",
      "r508",
      "r512",
      "r513",
      "r545",
      "r546",
      "r548",
      "r549",
      "r551",
      "r752",
      "r903",
      "r904",
      "r905",
      "r906",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r939",
      "r960",
      "r978",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1279",
      "r1314",
      "r1323"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r137",
      "r141",
      "r142",
      "r286",
      "r323",
      "r324",
      "r325",
      "r342",
      "r343",
      "r344",
      "r347",
      "r354",
      "r356",
      "r358",
      "r372",
      "r431",
      "r437",
      "r471",
      "r552",
      "r668",
      "r669",
      "r682",
      "r683",
      "r684",
      "r687",
      "r697",
      "r698",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r714",
      "r723",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r766",
      "r768",
      "r789",
      "r856",
      "r888",
      "r889",
      "r890",
      "r909",
      "r978"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSNarrativeRestructuringDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r249",
      "r252",
      "r254",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r414",
      "r415",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r923",
      "r926",
      "r928",
      "r991",
      "r1005",
      "r1026",
      "r1055",
      "r1067",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1083",
      "r1118",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1152",
      "r1158",
      "r1384",
      "r1470",
      "r1474",
      "r1475",
      "r1477",
      "r1478",
      "r1479",
      "r1480",
      "r1481",
      "r1482",
      "r1483",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1493",
      "r1494",
      "r1495",
      "r1496",
      "r1497",
      "r1498",
      "r1499",
      "r1500",
      "r1501"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r372",
      "r768",
      "r800",
      "r901",
      "r920",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r939",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r958",
      "r961",
      "r962",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r978",
      "r1159"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r372",
      "r419",
      "r768",
      "r800",
      "r901",
      "r920",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r939",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r958",
      "r961",
      "r962",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r978",
      "r1159"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1188",
      "r1199",
      "r1209",
      "r1242"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity awards",
        "label": "Share-Based Payment Arrangement [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r1324"
     ]
    },
    "ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "StockIssuedDuringPeriodNetOfRepurchasesShares",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of repurchases (in shares)",
        "label": "Stock Issued During Period, Net Of Repurchases, Shares",
        "documentation": "Stock Issued During Period, Net Of Repurchases, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "StockIssuedDuringPeriodNetOfRepurchasesValue",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of repurchases",
        "label": "Stock Issued During Period, Net Of Repurchases, Value",
        "documentation": "Stock Issued During Period, Net Of Repurchases, Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofStockOptionActivityUnderallStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r136",
      "r137",
      "r187",
      "r599"
     ]
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program authorized amount",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1383"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dollar amount remaining in authorized stock repurchase program",
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r141",
      "r142",
      "r171",
      "r941",
      "r957",
      "r979",
      "r980",
      "r1140",
      "r1165",
      "r1316",
      "r1338",
      "r1448",
      "r1506"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r777",
      "r1139"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r792"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r792"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r792"
     ]
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUPPLEMENTAL BALANCE SHEET DETAILS",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r1296"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_SwinglineBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "SwinglineBorrowingsMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Swingline Borrowings",
        "label": "Swingline Borrowings [Member]",
        "documentation": "Swingline Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforwards",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardLineItems",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward [Line Items]",
        "label": "Tax Credit Carryforward [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardTable",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward [Table]",
        "label": "Tax Credit Carryforward [Table]",
        "documentation": "Disclosure of information about tax credit carryforward available to reduce future taxable income. Includes, but is not limited to, description, amount, expiration date, limitation on use, and related deferred tax asset and valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "us-gaap_TaxPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxPeriodAxis",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Period [Axis]",
        "label": "Tax Period [Axis]",
        "documentation": "Information by period subject to enacted tax law."
       }
      }
     },
     "auth_ref": [
      "r1417"
     ]
    },
    "us-gaap_TaxPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxPeriodDomain",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Period [Domain]",
        "label": "Tax Period [Domain]",
        "documentation": "Identified tax period."
       }
      }
     },
     "auth_ref": [
      "r1417"
     ]
    },
    "us-gaap_TaxYear2017Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxYear2017Member",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Year 2017",
        "label": "Tax Year 2017 [Member]",
        "documentation": "Identified as tax year 2017."
       }
      }
     },
     "auth_ref": [
      "r1417"
     ]
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSScheduleofAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued taxes payable",
        "label": "Taxes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128"
     ]
    },
    "ilmn_TermNotesDue2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "TermNotesDue2023Member",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Term Notes",
        "label": "Term Notes Due 2023 [Member]",
        "documentation": "Term Notes Due 2023"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_TermNotesDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "TermNotesDue2025Member",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025 Term Notes",
        "label": "Term Notes Due 2025 [Member]",
        "documentation": "Term Notes Due 2025"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_TermNotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "TermNotesDue2026Member",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026 Term Notes",
        "label": "Term Notes Due 2026 [Member]",
        "documentation": "Term Notes Due 2026"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_TermNotesDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "TermNotesDue2027Member",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027 Term Notes",
        "label": "Term Notes Due 2027 [Member]",
        "documentation": "Term Notes Due 2027"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_TermNotesDue2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "TermNotesDue2031Member",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2031 Term Notes",
        "label": "Term Notes Due 2031 [Member]",
        "documentation": "Term Notes Due 2031"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_TermNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "TermNotesMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofDebtObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Notes",
        "label": "Term Notes [Member]",
        "documentation": "Term Notes"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_TheCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "TheCreditAgreementMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Agreement",
        "label": "The Credit Agreement [Member]",
        "documentation": "The Credit Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Axis]",
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r1331",
      "r1458"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.illumina.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Domain]",
        "label": "Title and Position [Domain]",
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1227"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r1333",
      "r1334",
      "r1335"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSScheduleofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade name",
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1359",
      "r1361",
      "r1362",
      "r1363"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1255"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1257"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.illumina.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1258"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1259"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1259"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1257"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1257"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1260"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1258"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, common shares (in shares)",
        "negatedPeriodStartLabel": "Beginning balance (in shares)",
        "negatedPeriodEndLabel": "Ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost; 41\u00a0million shares and 40\u00a0million shares at December\u00a029, 2024 and December\u00a031, 2023, respectively",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r71",
      "r141"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase of common shares (in shares)",
        "verboseLabel": "Number of shares repurchased (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r137",
      "r187"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYNarrativeShareRepurchasesDetails",
      "http://www.illumina.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cost of shares repurchased",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r68",
      "r187"
     ]
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeRecentlyAdoptedAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Adoption [Domain]",
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r346",
      "r347",
      "r348",
      "r349",
      "r359",
      "r417",
      "r418",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r470",
      "r471",
      "r480",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r689",
      "r690",
      "r691",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r748",
      "r749",
      "r765",
      "r766",
      "r767",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r802",
      "r803",
      "r804",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxChargesandTotalCostsDetails",
      "http://www.illumina.com/role/SUPPLEMENTALBALANCESHEETDETAILSPreTaxRestructuringChargeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Restructuring [Domain]",
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r486",
      "r487"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeConcentrationsofRiskDetails",
      "http://www.illumina.com/role/REVENUEScheduleofDisaggregationofRevenueDetails",
      "http://www.illumina.com/role/SEGMENTANDGEOGRAPHICINFORMATIONScheduleofNetLonglivedAssetsConsistingofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undistributed earnings of foreign subsidiaries",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r227",
      "r632"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1254"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on equity method investments",
        "label": "Unrealized Gain (Loss) on Investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of year",
        "periodEndLabel": "Balance at end of year",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r633",
      "r651",
      "r1128"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decreases related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r1128"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability recorded for potential interest and penalties",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r1128"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential interest penalties (income) on uncertain tax positions",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r1128"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to current year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r1128"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r1128"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESScheduleoftheGrossAmountofUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decreases related to lapse of statute of limitations",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r654"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.illumina.com/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax positions that would reduce annual effective tax rate, if recognized",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r1128"
     ]
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r231",
      "r232",
      "r235",
      "r236"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Axis]",
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r730",
      "r1134",
      "r1437"
     ]
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Technique, Discounted Cash Flow",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "documentation": "Valuation technique calculating present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r1134",
      "r1435",
      "r1436",
      "r1437"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://www.illumina.com/role/GOODWILLINTANGIBLEASSETSANDACQUISITIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Domain]",
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r730",
      "r1134",
      "r1437"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/DEBTANDOTHERCOMMITMENTSScheduleofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease costs",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r776",
      "r1139"
     ]
    },
    "ilmn_VentureCapitalInvestmentFundTheFundMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "VentureCapitalInvestmentFundTheFundMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Venture Capital Investment Fund (the Fund)",
        "label": "Venture Capital Investment Fund (the Fund) [Member]",
        "documentation": "Venture Capital Investment Fund (the Fund)"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_VentureCapitalInvestmentFundTheFundOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "VentureCapitalInvestmentFundTheFundOneMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fund I",
        "label": "Venture Capital Investment Fund (the Fund), One [Member]",
        "documentation": "Venture Capital Investment Fund (the Fund) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_VentureCapitalInvestmentFundTheFundThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "VentureCapitalInvestmentFundTheFundThreeMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fund III",
        "label": "Venture Capital Investment Fund (the Fund), Three [Member]",
        "documentation": "Venture Capital Investment Fund (the Fund), Three"
       }
      }
     },
     "auth_ref": []
    },
    "ilmn_VentureCapitalInvestmentFundTheFundTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.illumina.com/20241229",
     "localname": "VentureCapitalInvestmentFundTheFundTwoMember",
     "presentation": [
      "http://www.illumina.com/role/INVESTMENTSANDFAIRVALUEMEASUREMENTSOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fund II",
        "label": "Venture Capital Investment Fund (the Fund), Two [Member]",
        "documentation": "Venture Capital Investment Fund (the Fund), Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1223"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares used in calculating diluted earnings (loss) per share (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r367"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.illumina.com/role/ORGANIZATIONANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r367"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.illumina.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares used in computing loss per share:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-11"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(ee)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21D"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "740",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "740",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-3"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Paragraph": "2AA",
   "Subparagraph": "(a)",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AA"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-12"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-20/tableOfContent"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.Z.5.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480781/205-20-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-9"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-10"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/710/tableOfContent"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483070/710-10-25-9"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483043/710-10-30-1"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r212": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r213": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r214": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r215": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r216": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r217": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r218": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r219": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r220": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r221": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r222": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r223": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r224": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r225": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r226": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r227": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "M",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-4"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482620/740-10-25-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "SubTopic": "320",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Subparagraph": "(ii)",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "1",
   "Publisher": "SEC"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "6",
   "Subsection": "04",
   "Paragraph": "12",
   "Subparagraph": "(b)(1)",
   "Publisher": "SEC"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-4"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1367": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1368": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1369": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1370": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3"
  },
  "r1371": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r1372": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1373": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1374": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1375": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1376": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483049/450-30-50-1"
  },
  "r1377": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r1378": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1379": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1380": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1381": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1382": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1383": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1384": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1385": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1386": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1387": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1388": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1389": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1390": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1391": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1392": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1393": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1394": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1395": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1396": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1397": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1398": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1399": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1400": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1401": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1402": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1403": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1404": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1405": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1406": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1407": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1408": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1409": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1410": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1411": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1412": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1413": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r1414": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1415": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1416": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1417": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1418": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1419": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1420": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1421": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1422": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1423": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1424": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r1425": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1426": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1427": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1428": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1429": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r1430": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r1431": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r1432": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1433": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1434": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1435": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1436": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1437": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1438": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1439": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1440": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1441": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1442": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1443": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1444": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1445": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1446": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1447": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479365/842-20-25-6"
  },
  "r1452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1453": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1454": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1455": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1456": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1457": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1458": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1459": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1460": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1461": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1462": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1463": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1464": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1465": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1466": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1467": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1468": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1469": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1470": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1471": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1472": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1473": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1474": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1475": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1476": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1477": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1478": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1479": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1480": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1481": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1482": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1483": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1484": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1485": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1486": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1487": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1488": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1489": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1490": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1491": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1492": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1493": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1494": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1495": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1496": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1497": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1498": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1499": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1500": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1501": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1502": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1503": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1504": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1505": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1506": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1507": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1508": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1509": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1510": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1511": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>125
<FILENAME>0001110803-25-000019-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001110803-25-000019-xbrl.zip
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ME,"UY';@XCE_6XW6,1;IRB&VD>.>(,:L'4]%'= N!>IG[F!R.:EABC;JV!B
M%27Z$BXGJ+]W5XS!ZLX4/!A%"^$&S-1(@S%CJ+P(/IEF#-9Q\K SI4=/F?K%
MN4%:0X*7AB\HIUQYGTM)OAL;B^3ZH7Q+J=X\$C--<)R,79O9>1#DT)536VA/
M<;+<FY2%FDZQ'.JS70GZH@,)/A8UK3&TITA<W0&[HD;*:V?"D=7XF^V<0\O6
M]PO9DM20T(AZXZ(ROD)K(#.)7A<9F5C?JCV";'V3C2NP\A.5?%U6H]&G6@Y%
MA.A+!%:K\+/0^4-G>%@B_C#<G%/1!.6\'5RW5844<J3B*VO'V][[7N10+?VV
M.Q(IRVU$I6I+.4'?OJ__<]&%PX+_IWTY/:'>!"JR ,H9G378#A:;8\<@K+6J
M"#&.PZB9,/P:U)9D:2#..((&HPI(R+APVSC (CG2M-8$US7X2@OT6O,"P'U/
MK!/#I7%A5ZG(/)\_%J'M<Q':O4IO)_+X5. API.#Q:,.*QA/;XE(OM7!)0#A
M$IMV?:@K3>5(I%:4+4&ZTH\3CSE1C4)C$Y:#3-V5B(88/<[HA"56KAZ2_;<_
MN!1U.^4SZ)G?@7WB/42?CJ Q8L[?0RE) 9ZE:ND@8=EAWR-='$1%%AD0<H=-
M$T ;ZOBGVF^*:/M.E[7=+2V-/)Q<;#QQ@KE%1%G E&-2M=_(+]CUAV_2P-T.
MR)>L&AP V1J$$SX=V^C8:$M8UNPR9\N!WA[)P+2@F/A\+/G- 6:T9:A$<;FC
M#6_[T><^56!?PO9LHS>NZTW%]S["\2%+2E. #?>+')5D4(%WZ"Q$.]L$8Y!&
M3\<X*S&FZ'H0N#-E/I,@QBF]5LAXG"F<_XJ$*;.8<"":^8R#DL'[ F* &*@T
M;:/%D7_PT;IWP=B,H-<(+ 17]QOFT3BDYT1V4&6>A*1S&:P&8&=C_C%\2JI&
M*E!_UM7@>#MFFU8EUFP$#9Z$H9H9)]-,.,JOQ2?=8DOV)!2U8H#/!@-K4>98
MF<T%"![N_F 8\W,#PX)<^6J:5"(-.)4#W_)=3<'8B#YA=BG$BVL 4"U'/"M$
M1- GB;8=( X2<2^[. >(_8S6O<-PW)T=TG4:F-S\6LYM-3Q?=8C)7:F"^BXH
M@=VW-)&=*]@&$J34D,8 N?WKV?AM/03E; .KO5>)CF[8%5CK)(4KMS>>*MR8
MYK[THLO:("-;"$;=?5NB)*Q^256^8\0$VT=RCXJ6+!7L+R5DI9O5QL>LHB]:
M1T-!*)V-O?7!LLKB)&"6H9PW.P<=;H5#$Z/""!P2PC\GWZ 1&'2MC@2',_"8
M,7Q'E2NM1V6H1(]L5O=A1D[L!%@4)?#B+*,\2)7[@4T@&]4&WRJ(B\KVJW[I
M.KM&:F8-3CV=ZKPH,QL=Q'!,/FA^V#:E=WNBH][BT P?T5K#I >C?#9H^ ^V
MK4(LS^2(TV:8MJ/0&S:>N;8C/QAF =[NM>0CA/U_FID:N0\;]0H'7I1YED*V
MA-/ =9PA*!SL"D5Y0X3$;H6]3BVW-Q:S<O)3& N%(#.:5:,X'%\[LJ2!;7^<
M/9',^;RZ*L]*0( >-*[U3@>OH'P(W$/G^8E&"J?2"83627BHG:U>]M2N"C.:
MRJ0*8#'*'PHY3"G#JB+TLT::ID@V2C9\[V;U8!RY)3/>2%QMET,,;C%YF2*U
M64YS5+*QH>Y+>M&[+P+1Z-K]W< P?IQ(<)LPPI4_;K&"'BE[2Y3]F.M_2X>5
M.G3.FRU7#!)NCP2_)8)_"H':+293FW>,J54TX!XI?UN4_UG.[9@QAQU$DQMM
M&3"C%ST2^Y:);<.TM81I-01Z>?C8([V_CMX?)HZI!R*[SLMI$1-D2U6KERIP
M#Q/T7(#GP:2;/$J6VR+^C]0ED]MZ>\?AKOS 19O"&-,CZ6^)]%>5"J6.$HFU
M4.US#1])_-6BW&/UB2S39<:%-X[5 X,F$V@^/E+^#FS%"BT1T;6,[ZG'C"-:
M[X]$OQ.B*^JZM8;Z(XUOB\:4>#>@"F_P;QZ+YO:@:.Z1C]>I1IO&QC8R.2AX
MJ W&3AZ%Q2T1^3* $WXDZAUH.9#"%F@9J[RXSS(I*>8OXL*B_6!!OB@DYM&J
MZQ^WXRZB@@O,IKJ.+07>.U+HD?7OP&4T#&$U$1GH62HP.KS<[95%Z7A'<U.V
M%9([3="^QP!L.\IQ )GM\G#<""2_R#Q6MNN;S$C7_#BD;D@SMJG'Y7QI<'50
M:U:#IQYB<1PV4:UXABOKL _S-^+CH@ZB>NY3S5"FB_NO$K)5*0SR3=WLF"9E
MLA[97#D/" N&@[E--XK*9,?2C>@4.9=:-($U@A%.$3@1,AUR8G<)K#)DD:X;
MD@+O\.4I,RQV].4TMN\7=Q)[[=67:O ?)JY]3-NRD1CEDKN0+"LM,5DO^L3=
M_ 0<CO4U%8Q\6!A/VU:(:TE%  ;VTB!$O/@2Z4'JYR!@7ANK#K@3NIV*E'KF
M.;LX0H%;CH$D!:P;:V/X$[&(Q?BBETSRA':'2&E/08<+/BVB]TRFOK/0N*@^
M/!Y?@\_E>X*"HB.>*5."M('OCWGNB*4P<4B'46VK8JD8 TR%+=FAN59X&>\8
M%:%C<5)68KU1\)EVA.31X8!>U7K<AEN+00$<JN%GB#T2C=2PJ!7^MD'7(..L
MYI<7KUS?FZT$Z<#>,<A\")MKF_&PG"* IEY&-Z:DC\Y 3%()E6T=0(!K/"YT
MZNR61=KVA] D4#P_O*.YC"7P6Q)AKU[*>,\5DF\3[%<A:N"P<.V@U<QA7_'"
M7V,/LET1EWQU!FTK73'FL<NSME&@->GOBL5RB;4_U9L;7<L'PZ$M>'0H),'0
M.#W'00!<[V>KF:@T",@0*0NTWICPV,0="_:2Z84/"09$;@5?MR=VV KHWH/9
M\(_6EC%N2,=:F4*M0IO-UEV2/M)K)-]*9&_XRI'SI&E:7D,X_U9[NJXBB_K8
M'(>#(UY:)+%TAG5W/]O2VFF^NZ%D)#[GP".%9!.(%!QJE.7"Y*3"L;:VM*W+
M0.7@8#'K(T,JL=U\7-6G$CRK[0&VC45*D-M4$.P&ZWG3+)1%MUW*=WIZ[]YW
MI[]CC,W^2>_T.2YZR9">.OE@)SQP[78R(V41-!]M 9Q*!LV!;]CI/FT8[9&=
MN" 2<&[DZMD6#X'X9_M(?$=XZKT)>WA5:)Z:P+;JNCW;5ID^A#T\WY<]'!)4
M?OOL!F?SN&)YN]L^-F&!GV7@!F'[#OF^J%!?G.#43V,'![5QBR\3L,X1ZLUB
MKJN.(KJ_,8"V-G%V20 OCY^E;ANPG291_^3X[_A.]X__\]@WC:&TR@TJ]1\]
M%ZU?S=ZI&^=BV[SM%,LQW+9BA$*'^=ZC',%;K"5PM"W5S]J)[#NB5GWT@1^@
MBWTY0'6V'DN+$L'>0[IX"+1^NG>TEHJ.& H9FIPY5!:(2TS\D,'*$^2HKHN&
MTU$PV+/DPHL\TCH\\HW0U(H'=#D\PRTUH5N!JJI,2?V)%/N BO&$6J4PTE 6
M!)ZO1[F8<'3-=1TY4?!5B^ HI"C<T-)O7AMZ1?%1)7>F^(T\T,$W2.HJX<&Q
M]($!UP0#SBH;IB6)*0*1&./4 K0-Z+FNN0KOI^ M>_3U4%^73>T*X<U.D["A
M=Q:U\['N/@);'5B-SKU*KS "Q#W?#/+:M?"P,;,78: *^ MBM'BF=CUTEI4I
MBHIGH>KK13PWV0J<WA(%(N,XT7C.C7X(FN'9WFD&%^CV22$VSMQT/DSZ%8B8
M9W#"H21XOX>P$<_W;B,P-(D@P22R*)H6C32./A048K=ST06#!MC&)[P/]4\\
MECP=0<XHB&N';+LV0&=4?_]=_^FS5]'I^4FO?S*X..Z#ONKTCSI71^Y 7FD>
MV>LP(BU,$CW(P6C\4J8RXOL]E!4G:K*"8#T%9@' F8#EV!Y>S=J(>>PAL,^+
MO6,?H#[*30\7B%W0IHK*8Q@6[(I4$)@=CS2"OZ3RF,</<0&%-<U(:=:V&>T,
MN.? =ZU_LN-M.^^Q.A>%A;"=R#8W/^R0SQP6CMLA9P&Z2=]ZSDXY#YVT<3P/
M)6+%."&35;4/&?: '-3(.P1A":;,,#&<[C*R0#S:TOBE.X@""[>)%0EHU]<F
MKP60"ID<Z4)1AID3FE7) N$(7]\T&G7?2/6^%OTAEF*'H,+2Z3;[35QQ3WOR
M*2A;F*LTY8H44!P>B@+9$NM/,EAW$#GJM(>.=)D#C>L1I"/GXW1#%IYHV& L
M'J J!4H[2]R21O1)K)QK.1;!H7+AG&X(2H:!M)7+IA#;Z9%'$186XFH:0'=[
M-(EZ(F35(X-8EVM'H?L.,$5^:7U-PE6LC/;C%4&\@SE *&M6Q"%)XA"J67VJ
M55CX4"OPRI):REK;01+'9KED#*484+% !RI\OV6H=VZ,QF5<,+33%-TRA0?!
MJH0*2[["&5>FB@2TGQ&"R?;5 F09R#0U-]8*4(@8<8A=@CXLYK.%)=A+^.5X
M N0>.S5$Y .A,=*( XK%-XSL62LS\]$.!%U'WU'24 <<C#46272=Z7G*,S]8
M9JUQ(GO1/UQ@N$89/MVPDZE&@\@TYN/!*:?'DA*>X%R1S ;1>+=C"5+  H;;
M^L 51:9AB2J"-^=+A:^T04Y,NPN"5]@2/P3"#VH 17L5(,]4VK[<%9%]JC(P
MFSB@C:*"R(IP; V.]5S.4%S?4!^*S_207!L^W7Y[Q:H'*!@_9%AN<$C CA]3
MFI;#,'+1 C1TA+"V5H@Q$'^V"#1>@96+=M"6PP>LL"&#T[Q%HG_U3O]^XY)_
M'.AD 7^,BTGZYO\!4$L#!!0    ( +B"3%I<@6L!^ (  -X+   :    97@R
M,S%C;VYS96YT9GDR-#$P+6MQ-"YH=&W55FUKVS 0_KY?H24L;2%.+3NI\^(&
M2KO"6!FE_5#V:<CV.1&5)2/)R;)?O[.<](6D>X&M-/E@(G0OSSUWNKMX;@LQ
MC>? LNF[^+WGD0N55@5(2U(-S$)&*L/EC-QE8.Z)YZVESE6YTGPVMR3P@P&Y
M4_J>+UAS;[D5,-W8B8^;<WSLG,2)RE;3..,+PK/3%L_[29:Q**+@#_M1F(^"
MX0GU@V34I^$HA. ;;:$JBC<ZQJX$G+8*+KTYU/['45#:R9)G=CZFOO^AY>2F
M<:ZD16<:E9N_C8TM2Q:^6X\)/I/C%-&";C6ZF_M4":7';=_])O6-E[."B]7X
MX$QS)@ZZADGC&= \;ZX-_P$(!5&YXW(-$[4%E["!3?M]Q'JNI*FY5CGY)#,H
M 3]XO($9-X@%V;^N$L%3<I:FJI*VSL0EU\7SH'X5\,/=OPZHOS.@.R#I.B:K
MB)T#X3)5NE2:6:XD259$0XZ1R;2^<A*Y$D(MZ]":N->BMQ;+KZX@TVD/AI._
M"GD3;,FR# U[ G([#FEO@$&XC'-']-BCP]+^IXQO$134U7E(CS9H7\OIY!D+
M@U[D8M[--3F\5+H@MUY(OJ@>"</0"X9T%- C5Z-"5/CT6!>K->UUR3[Q'NP'
M[\-'WB.?#J.=O#.9[1/UX=Y1[Y\$=+"#>NQ$H\EVV;^5[HMX5:6QPV*_M89D
M;GY?0J(KIE>=-CWQ)S3HNI'=)4MNYRAJ2D@?FG7=NY7@C6*.8<L402'X32O>
MIJ0N1J<+>8Z6^ (D&"?'ZW$J41VM6JT$40O03ZPV,.N^OVT4IX:H,@3A9@0W
MY$S*"G5NG,XZ9=3W/N]($@X4[1"M@&E2C]2,7$ *10*Z(2$8.1+ZO3>;R4Z[
M'TV,^Y*/6AI+.NUP."%?<0N8D:NKZS>+_)9)<L%AIKKD'/<JS(7D[*4G\SJ0
M=K^ %SMHP?0,]\M$6:L*YZ/U)[O&TWVT5(;776:L0;#Z36QMJ!NMM1?_484E
M^ 0KNZWRFZ5V_6WVZV.WU_\$4$L#!!0    ( +B"3%I:6G,.T@<  -V3   ?
M    9GDR-#$P+6ME>#(Q,7-U8G-I9&EA<FEE<W$T+FAT;>V=75/;.!?'[Y]/
MH2>=[;8[B<D+T#909I) "UO:,@UT9_=FY]@ZB;7(5E:22=-/OY(=EP"E,6S;
MZ4KF@B2699_SU^]8+[:LW5@G?&\W1J![_]O]?ZM%]D64)9AJ$DD$C91DBJ53
M\AM%=4Y:K>5>(S%;2#:-->FVNUOD-R'/V044Z9IICGOE<78WBM^[&_E)=D-!
M%WN[E%T01I\W&&P^>P9;G1X =C:[(<+3<+L+VUTZ"=L1=+?^[#1,5K-[D4?I
M!<?GC82EK1CM^?N;6S.],V=4Q_U.N_U3(]]O;W<B4FU.)DWFXFMQC!M'TOA!
MMX"S:=J/C+4H&T7>,CT27,C^@W;^MV-36A-(&%_T?QY(!OSGIH)4M11*-BF2
M%?N(QA1C5?YS7ICYQ.3F+,72[,[FIK%U?#8<'^T?#=X='8S)VQ?D]/" C-Z^
M/AF\^?VJW:N^@YP:]T.AM4CZG9XYT7*3%K/B]_=R:O.Z4UU; *<QDHG@7,PM
M.$P1()PI3<2$J"Q4C#*0#)7]?<1Y9LH2FN0HC0("^<9]C# )43Y\T-EN[W2?
M-2UCFTTB$J:U/>25H\QC%L5-$HG4;$-I@&4IT<8$F$XE3@W"33(7&:<D%3K?
MS?"8:9-.E!&(35@$5IGRF(NJPL^T455#R+'<(1326- RZG*8*>R77W8H4S,.
MBSY+<[7R3#M7#V<IOD"IC35\671Y*1;)EX '[0)R;<C6M#SS,CG(DS8TO9G6
M>QIL=9[=FMP..O=*ZP2=SM8]<]YN;.=)L-WI?75CV\%6[_:3WM=8JVRWFK$;
M>:D5)6?@4#-(GS=ZC3+##"@U?/>[LP^D<S6,.4YN\B%FC2N +O.W[,[];M"U
M3)7;\HMUN3$_,$NIN38L-WV="\33=1>]G-TWD*"-\_$M(5?*^ 6%VJ0(OPJ[
M.B[FKYEDBK)(,Y'^EV7\GIKM"UN+#&W#!I4B _49X=:$ZO)2G]>X,V.UX(R2
MTMQKFA'[V5N!99U\WZ6JSI48T M((U-G'K._,^/!L9BR**^+/TER.QJ5-*B
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MRQ5R/M3&1<YX/F9E;G5)*S6R0$<(,1(YR_"*;&()C_"69BH3EEGEY98$<HC
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M_E"1;(.C"MO;:*W)?GL\7JPV7_=?C4BUJ7[XY(MX=/NCPOYNED(;U'[LG\?
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M>?7>UQ#5W_*ER+%Y&?,W4$L#!!0    ( +B"3%JE- X2F@X# -H )  1
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MVM^?>^6'O-D:\ $'FML\7&!MHXMU')+? X.RR.4ZCL#&_G4O%&/8\O?4=Z,
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MZ:27-II5!%'RO^C/^B4?<O->O Q- Y9!(F 1SJR#V&#]('F0^N5'9M8R:V9
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M@]&D*D(!'FP<B"C+0AB'!>#I\21WY OWAP&;C(3-W,Q>?0XLS(,3&.X)<\7
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M)9?[#Y!XE/KP50O]M[\T.^U57[U.2C\?%;WR"UP;?VM$Q/,C^.;/6*"B /U
M8=J TB_"9Q1'"W'2_%>439#JDIRP &>;0"WCF'A5)?*[[\9>Q (*B =ADJ=9
M!V-U#GXS1G>424@>1IR"!#.2\J[Q7B[G"'8-E!''8JZ;"$I6@OI<70 /7B T
M.3G)["_:F$'9P9\QZ\9RX%?PL/#22<!M3OY6HRF?1SF*H?4.'@JVCQ7&X).$
M(Q_CS#KU)!JQ:'8J#RR<EWBZ6<WF/6R-GF.]:V:FW <S"B[J_QLFA#?1]7 G
MCD<]C,IKTDAHN"R,K*.Z?(+#IN&K-D^5N2G3PM ^CE@4I^S?V.V=N[VS"+6
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MO/^(7+"CT/HDE$S>K"8%#PO=W 'N;2@NE8S6K63DQ,FJ68T[T-/&,L-*.5Q
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M2.*XC%%7,'C%=)Q,!4'4=J(RKY3316HAHPZ8,Y;["CUY1_)U@YY(O1Q4D;$
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MDH0Q^)G4CHP3FKPU),0M.\+*; 7)).DH88;LJ!:+/CH,CQ/75R>FLBE:&9^
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MT*MVM9):^W3^8-'YB'?)P0C007?O,PF\Y$TM./J9>7%JLB3BC""'G"E=*T^
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MK1E8.\[^FP:6& [2^V.P^ ,$F&P7/L_%Q*9^ ?Y*UVU<%5^QCM4!+;RD+04
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MPSSY(%10Y+*-&B'=+9VTCZD R4FS[AM*$DA\2.T[A1(:&K6@!E=CYVRX(RU
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M) CXMZG_N2FFX'YT<GY<(MC*S0*K^'X5EYP+R.NS0O*IE,!=#8*X,G/.G]/
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MTP*"/ZCZ952XBYZ#R8"S7I."I @A?4:%,R^4:/FM)#B/A$$;A04OWA[=$4C
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M^*8\?5.>?KGI]FA[Y]L%O-G<]#7;D,U-7]N;GMY]>,]92S=TMK[CR!4E,KY
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M@>- R23-?O.XADBE(-)MCI[ ./GC2C+\2S,PLH6Q\G=;T!7!M1()@$&%RHN
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M*F)@F45PW&QO;!'LGX?L.K6ZBA L1NI7G6YS6$/PD"%XW&YV*@3!+1DC%10
MYW)(*XV*?"4MD-?W2T&\^]!5X?$/R)%;1U4[M$O:>B+AL[ZDY^$]/L-92R**
M)>]X%L[B=K-=><]$[1#=K7VZKX2$&B!E(8-[UE!61"<\%#:_!>=T!7&JQ 70
M:7;7MS[J-(#=VH+M38SY&AB[!4:K.7AT8#P/A9HM<<EF&Y8OGDD"QN >OKI:
MF=H9>=? J PPNLW6HP/C^:1=;(?=WA5[K*C;O807#YO'&TOWNH5#Y1A'>Y,
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M:_4H.TRML:1#V>-W+ZH5^%*N6\.B(K"HFZQ5"ARO>H\\!'G;%8#'E;0R,P5
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MM"4;EI$5]M-^&$BZ[96GEZ^AH\-/J;G5JM-WJ(?-W13JJJ6S])D]YGTHL*^
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M8SVWN') >=798-!AK1BOH1BKCM[6*T?PGUZO[#-^3S>13%,H&"%V8$[#[0:
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M7(Z8DYMKR6AHZ)09T'PH4YW*.&[2R]5!^"B!&P';'7[B(3]'=OT/@.\UJKK
M)^4<\:57$&%2Q<?$O@Y"5EUFE*RC(J^84)J&C=,#FS?+ 1C*0^ DU#I@20'+
M]O,.6):D/2G#9%S5?%P<\AX*Y7XDWXU*QO'LFRAQ%5_S;!>G;H5NQ#R-B#7
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M6GO K+5VZ_C%>Z"]#TJE8,9U2G/QB)?M::P:B@QR563*I"JIJ'^23OQ3TH1
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MUK>/OYU=7'[\]O&#]?7[KY_/3LT6KI_.OOU>R<:M[3X<Z))+2$Q/O9ZO^VN
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M52LH>W_S/.O%=ARM^983L))N)96*09-RJ%M'F-&FE>!C$;6OQ68+W1.];M9
MTPIOU5D6*STX=;;%J[(M)!6Y4PY,O,N?V"<)"!&S0 ;E& 4<':$30JNZQR)_
MBP&SG&S&&&%]E),)KQ7B:G'PA4T9M0D.S9\[2V=UE9"]2V=)QROJ4W9O_HQX
M(0?=73#V^D>8&:=UXF.1R:7@V$,X:BUXWVY?2H33_MU7^7?CO*)KSYVL2RT:
M]&OC3DYIJ/*"52N[QR)8BR)Q $CLG6+NL=));OG2==LVT[VA.K!1RUN@MT(N
M=K>TH&-M+%(A64[\>N+RH*R-.ZR-^_5.\WA]X]4!1-'N)*<F&"KJ;7(R@N%
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MS(,5_(=?L=[4L-W0=!]M3"HQ@X"%KYM+G4,&-?"]_]['"7K>3*\B:IX3,?,
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M=7]C7-Q<W]U\N_IR?G_YQ?@*6[F^N#K_9MS=PP]^O[R^ORNXJ3>6"'^X#@M
M CPQ>9<8/CHT?(P5PD_]%SM@=?C9E/G,G<!/;1<^;0<X@=OS0Y0=*.?;S<]7
MCK, @)IU^GOK,SU4_.Z"BYSH5^+'+VSU)XL@^@DZ6,1/O84O?THKP;=&KS.N
MW$F#/FV'05J0!8N'P+9LT[=9G@ KQJ_81$]\B5]DUXL9D'^2M<97XN3^H^G:
M_Z%Z_XMH5? 7N%B_ WVQ/0#^]6;Z5<K;NTC<?K&#B>,%"Y_!I^\ \?84+B<W
M/.>169#=W^%Y$]C7/2SA5X=&ZLJ[M\45 ]M=,.L\%#_#!3*XI^?(_/Z"U=:!
MLM4A5-*%%XMJNEX!G8XY#]@G^8?/EAW,'7/YR78)6_2ES^)A0K[CI;!RN1(C
M\U\+&38:-MJ#'HHQX4P4+Q82K@%8_27[<_C6J)G_JV:C]5]%')0IK2+1XV(Z
M?>AV6U7Z*?OT3Y5BB>1^JV$8-[>_G5]?_7_G]U<WU\;Y]1?C[NJWZZNO5Q?G
MU_?&^<7%S1_7]U?7OQG?06)=7%W>I72OE'YS.''ZZR* GX'LN0$:/MOLI8C
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M40NG3R$:8AX$*:YD(20R</GXDBC!-F NAKYX:L]:*N>DU^K*[:(!K*$.8.D
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M =1/R;2>034V'YFW"&3'2M'.+'Y5_%S>&YBX ]LIQ7V28*GA"W7:X\^8F\@
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M*K4ONN?=)?F_DMX#(36Y^X'[JH#^8OVJCC"\P,E]\; _ *.0UEQ/=$WG#+U
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M 70CUTVTOY7/IK_=PY,+L$&R)T^*#;;?$Z.]+0J'ZF1-'V+.NLCI\M%/&E#
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M[BTV'V767B1EX16)0C)1  E? 0A_0QS\9MHN_O V6@F?E? K-?*X-W^6M5?
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M:F;.^S]_XI<@HQ)]0_-L)1XJIA)TL8GV4F@.+7D^N)(5!Z$+#GQL98K>L,L
M_C*BP%A5NK^"$AU[0(>;_&GR2FB4(HX@C%B4,L(;^(H7<(N[N9G]X?'1 3+J
MZ#3&F>YR)3(JMBA\TW[D2;\B+!>3%A7LH]_J%=B() ,8(P!GG9;$G8U)9CRC
M])V^G@:H!-L>C*  1;8:G]+3NZ !-HUV.K?E;<B[ XHZ/QIBGQE'4-)L9XJ(
M&3XR?.]A^L8;%5^OX"9>FB_HG=P*X8]-!+Q[9<_P=PYK&=;W >O3WK#WBKM7
MB/"IOEQO@LN_(M(CP#>.$^OI \![R23!XHBO.'U)"SY& (KI'\9H#VC@148!
M--I5<?Y]Z_5S1_0K/=N5 )0 **'G7SNV"#'E"()18]SMIR=+GKP@B"5OBB7.
M\/?GNG&X]$U"$YY!;;/-L< \,(C<2TI C:K#<+\GFQ]6\,AU9 VO(1JOF;^=
M)\S C('FH%-5(EFQ>SL&65H;'G(1C@I;YR91CV3?T;PGQ_7/>'OZL/RG+,,1
M,(O=8F>)4[A6Z(T_48Y3\LQ'SW(R.F+NP'+27$5OC#NCJE(L"MZ,4DRJ9RIF
M6#]#(Q3.J !LB44$.VLRI\]82I[YZ!E+1E_;P^DR!NHRG6Y54;W]\YU@"P',
M>[SKQ8XE-B6?+W#,MU*]$Y4+QH9/%N6(P>A>+!H.*NV2,X3/<S(#2@!R^QO9
MDUK</[  NW;L,\X['OD<TBE;V-8,MDR,*FH+^LYC3,O)'BG3\:O0_O;:<VS7
M'11O.J:C(Q5++[1!O-?8X6YYEUR:8W,IEI*U.<W:-Q23>S>S;V+RPZ>0?F)^
MQ-M@$)5,PG8:XYVEZXGY% _-^.ZQ%VDT@!E;LD3-AQ.]AZGU9M!LF'J2>\',
MOK!-2>0JP.8.)*Y4^EIU_1O@LL2PA-]XK^8OKK/X'K0>_N*XO\,U?'4\[\9.
MM5^)D5VW,>[M;$T?:4SKP"K@O>-3L^YJ-+Z=W&]1Z\Z$4OZ6H@%5 N14&5!9
M^_HB%![W3F3P? ?4OK(_<<0N;7GWR/(>I4.-.WG\=KKOK7G;X1L5_A7_D]DT
M*J%U=/H!95O4FO#\3!]6I8CT6D:1KL89^?%&:U@P/[Z"K19JOYSTM.JM/KE9
MKH*6_E??;__'7"P_?N8#:\RHWTXX!+-4HR<<-%:3/'<#,R"[655=P5 F:N]-
M#7XM%]E"2[O%GO H^VRT_2HTGM].OVX=6VSU6MKOCC/%KL!-+;I,LJ6/ZR3:
MA2C%07OB8O+OE25:'E?L%RARJL8X9^)/37IWW3%6.0$5>O4K>Y\J0[P.)7"W
MM#OVR*=+ N[]SIQ'UUP^61,@*,X-8?V#>Z?H@LGX3G9BD_:,Q.$8EA/.\HY:
M+L:GPO)9Y+&VZ?%FZ8D.E.&(#S%F>8G#-.Q@XIIE9S?7?TUJN+*CF1UX BH(
M_\DFJW "2Z(593 (LJ3LS=&1)19ZU":9IFR6%K'RB8=K$K;L,,91_^#G& *M
M9?D8Q#E*4MB]M0#UZIH]:[?.PK1WI+7#DS<.[@[G#8;3<_T(T&(BH!AJ&4RS
M["2G63;79X&S^9P&YCPR&^YN'@RZ6UBV1;-L:!:0F!- 77'Y6Z(YB;$Y!-%H
M!3':_06;=C[BJGS.$PWPB3J3+%UGQCR/>S/",8DX[5>;6K!//[E\LD-O8:'[
MAD;I]-0HG:-3S=4HG4-L\KKR43KR(35\K$B=U)P)#F474^'0HY#4;<*>\J3-
MDK>8+H>D _#<'\#DG96GF8\N$^H??"I&(28&(?"1: Z.C=-,;>:"AO#LN']+
MM=(YUQV?K"7?4[0+,OYE:BEU'(Y/W*5A[_'I%N$6489%DWY!Z_!QK$#\:XI!
MR;[ YN(X70/TW=5R.>?""IO',Q?E6C#L+WR$2TLM-K\@ZH),L^D>A12%A\C;
M%WL=[_%]$0+V/9>OT0=K8Q!]8-E^,+\W'#L*ZGPX2K>9G):)<O8!""YH*1X!
M,C8N*-0DY%V;WR<&#P#$"-S$KP /(IV?&Q0TU9A 0O>8O/:UNP-=TM$>L6V[
M'>XGCAG1Y%()CJ;Q1&*$IX?K%1M8-.IN-Z[HEOU@P"XPJ(:L Y76/P&[/ZT
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MNL)6K!]CGXC1SI/9%5$IHCH*HLKHB'I(0=9'=;4]5#2G:.YMT%Q.9\1#T-P
ME<>1OG,W)$5SBN:.@N9R.AY5I#P.092U^XJH%%&]":+*Z3=Z"$$V0N71,-*^
MSAK2W.G.VKN**OI.;+;>[A$!;$YV -G3;3?&W6%Z@G;M??X5-=O>DJ:D"51O
M%U7WD6B21E5=VLA)8:K"U**8.CP,HAJ-<:^='B>@,/6M8&H56O)!\GJZG<:X
M/]Q9#5:(4R/$V4<J21IQNB",J^J*KO"F!GBC[R,Y(8TWO<9XT$[;&PIQCA=Q
M#A)A[_81<13'.27$V4<4.8TX R6I3@QO]A$)3>/-$!B.L?/X^%<;"I>,P,3?
MJQLMHU=+AS"?4;5,=H/;RC6<YYBO(VE4X(G3]Q&P+!=;Z5)LI=,UCL__40II
M7BE\JK!_ _;O([*80O!>&Q!</\*0B4+OHT;O?<0#R['VGHZLO=]+IZHHW%>X
MOU^=OP;8;R#V=P=[3QI1N%AS7#Q(%+&']9AZ6HM6R/:6D.WU6WCTNLCV!L/=
MQW0K3#QF3-3U?42D2^)BCQ30W;UR"A>/'!</$N3N88W9_I.$%;+5&MEJP/8&
MR/9&F=,XZX.)IYNKGCE'1F6NKS-GXR"9)+TA3JE4699O-Y1<!:H>)'>E-^(#
M516F*DS=$E,/HN_VVXWQ0#]"[[Y"U-IHR[IQD*RNO@XLM;.S3THA3HT0YR!I
M77VC,1[NW/U,X4U]\.8@UD:_@Z)1\9L3PAOC(,T]^MW&N-?=V7.C$*=&B'.0
M-+-^#P157=*/%=Y4$;0X"-KT43%.N\5.(&U]5$O',,]9SW &%_3$BQG0'3CI
MU%GA1.E@MT?6#:G:QN]5@.78'3^Z\?J9;WT>?Y+TMZV]9ZARA*IWUS3%2!0C
MR60D!TE;[&,SPT&ZWE)Q"L4I%*<X#D[Q^@K'J#'N-CN#HZ\A5&SD6-A(M7U<
MCY^-5.$G>_W,N0&VMVSJ59=1*+)69/UVR?H@N2@#K#4=*;I5=*OHMB*Z?7UI
M;* T[NW>_DU1M:)J1=5$U9W7GRDYZ)"2/=@YZ*C(6I&U(FM.U@=)%AAT@7+U
MBLO*%-TJNGV[=/OZTKA'2K9DILLQ4C4E$'WP37@A_'=J_1C_"O\3;'IANH^6
MS5\-.SM41,5 M!!7J3V\:+\SY]$UET_61+MPF1E".&>[<3!,&*"1"P>@HX:7
MPD$+!YF;2X^=!W_Y.+6\Y=Q\.;=LVA@]]%$L+VX*.WRN@97>Q[_^^&Q-_2?$
M\%:;8[G(TA)O%E^WX*L/Z<][H]:HWY%^U6[ITL^SEM+U5K<M_RIKJ>S/>_KP
MQ#>U^>4YZ7:O6&4]#&B*ECFW?'C%I #S_<T$+J@!UW79(S)?9P;\U?,MVR1>
M_,ZR-7CY'/[NO<^LQ"X$ 4Z!!X'!QDBMT3:Z)4XB3;$]M@-W#G+@C3@>8],R
MMGQ(:!@5!KE[+:/ :S\N'<]"@CIWV1PHZP?[B$+JS&@-TU+D 4@2%VB,W^GO
MD[*.KJ^BG-\R-W=(=? "]#38AK?72Y*]>MM+,F27M$N7D'H:,]7F =7>5JD@
MS:=3@XA 'R>*=[M'V,:C++[4VZ=Q+%2NQBV7IO(:N"0&2.4]H^( @:(Y17,U
MI;G7'\,Q&))DE63BUY#F3K=MW.7*=9:J1UR:0O910UV20D:-L=[4)=-/:Z][
MJJKN&O'ZUZ_/'+8)D[NJK<TIX=7KMWX?ZHA7[6%=IB>>N&?Q=Y>9/G.U3T^6
M;1Z->[&3X5XL1,&2"ZH)!5>AXQQDA/L0Q]*TTXUB:J_$R(FS[LW/:XBJ50B;
M@]1T#'&D366)*0IQ:H XW8-TWQMBGJ*D&OAU$.?0WHI#!S@]RSS[;DZLF35I
M:M^LZ73.M$O3\ZGW_<4,HY]'HYUT=]%.ZFM?5*"== ^283S$;,3.$6HGRA2N
MD9 Y2$OI81]0M5<76U<A3A6(<Y"6TL,!MGC=6:VMEY-$M5P\DNBLZG]T>OV/
MAD/5_^@X<CA.AHVH6K 3;+@P'*F&"]51]2Z#+T^2GHL"Y.@I^?53*$?M U9U
M[GM :*J>\T 73W6;?\7_9)9JBG.>(=V>Z\. F"U[RFS__ P_J09=^X4V':NT
MV4,EDNR='Y,0:+?Z(SSRGTRS%LLY6V!AU%0S-9L]:X]SYP$,LHFS &R?P'MA
M?^YJXJ]<^+6M_9^N88V7YCOXK.O\8)JS9*[IP_(:F\VLB<5L^#^/',P/S,<@
M."&.]@QDI,T=P"1M8;I_,]]K:;@%>/DC+  [B'NKZ?E_F @@>A!VB16QC\&S
MFCEQ'<_3_"<6]VLWA5.[J=VOX'<O35KG$YS&L9^9.8>5G)EV!5>_9'3_VIT/
M[_:T=Y^N[MZWM-\8O,3&]T2'Y6L\.O@I4/JSZ4Z;VC,#HW7IN+ZH9B0CUEO-
M86?P&]K6S)G/G6=\BO_$.]>"@J.FQI,)FUHB48"_J8C37GMW\>WR C;\W;7@
M=7 %E@-7N #V #MX,N%>'AC#4LO)W/0\6 K@"Y<&S!"9%?[5?[(\NO(E;!P@
M0568K:.A(J,F5!1<:>## ,1!$0'@_@/$$/Q'(%CP-:#??Y=S?+U^ O)(QP1D
M(W.$C2C;;98]V>LGCHX,/%DGTU4<G@Q)K^3I7C^9<-2A>QME)1.*TR&OPU+E
M)N?M>%0L76TB1UNR"4;HYB_'PQDZ->$,M[S,7?"#B /,X,8#?G]O6L^F0*__
M=4!4_+_P/\<#ZNXQ@/IV!0+0)!!SI6 -OH(VKE?$R6O3E.0[<XG:[0G3;AY
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MX!&L'IF-;X=;\.!3C]0^!#UP>!/>B?HJ[!\) V01L)TEG.TG2 \?.+R60!A
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M6,K!^"D$(J'^+;YD1T+8$(&IO0FB8CXUPMM-3L;J\7:PH=1'X:W"VVH<C7O
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M_&4SKO?:(GUGZ5@V-]7P1:$)(C5 LG#^R&[V<C9C>+/\GS>S"&H %DJ5_$Y
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M)?,4-F$M4FHR;BO0J&-N^;B060/>-AE(@O]4FZBS;>UX21'3DQ>6K[E& #,
M%0!SX>Y9*,!SD H= YCS3&Q9CDE<W7R".T?O?T(A",<O!SZ &+SA%!-,&!5.
MBB@X=:@$HLQ<T#>40J2K%"*50J12B%XYA<B0IA!UZI-"].=ZGG0@JS,3I0,?
M2;XKVBR;QL#,R7K6<8Z'.CDG/-M++5FYMF[J,/]:Y&_!PNED[G4O4,8A6]KG
M^,_$3/28)RRX38XDJ!^)T/W$\4@M$BH!O8#,UAGH(([KH64ZL6;6A.)LZ3=S
M197R!@+HDFTY!:W7!47%],T6AG6#+#->,R"4BK2;J+2_)J&?&3FI)Y]#Q GB
MG-_0V1=\? N[D'J[<'A#MY7V ?R2<K.4WG^G7/+,E7C7E5WJ+-WH+"!\>NF3
MX.V6WGOWT'O'4D5):+2 8VNO/BQ#SVA'D@#$]R XLJ.M,$(C.<]]#D H>82,
M_(%]'&'4;HP[$B1,N]0VY"4F7)6>!W:JB _7+LB'J8-4A(JW$B19P5=DDXG
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M_S8F*Y.0(R\Z$:'))3_A'\:>;;CD"0MB:' HO(:PDGWK-),,/WHRW>3"(S1
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MZ*]<F[^4_5R2INL$+V7T\ ]SON)OA+4]A_]W2="?H#G0U!Y6/JBT&K[2A4>
MD3DVH]-HYHQ_QN(,!32E) ^")];Y39=DXE[Y3:'&KM5B\ !=-UG1C]U0V#@L
M"@_T;+V/L"G H6DQO WOO,N/#_BT0'P"<:>9TW\!Z^(*%&#GTG5^ *HX-GZU
M !O9]]9%[290I6C];O+$IJLY<V8;0/5E!83"XI[S2R 7VV/W2 /WL/QO<,*_
M(_C ?3"X_R6\R'=7:&/51/ZC?<R N2!XI]J,S@44:*\X.,/SX45M[NRF6< 0
MGIQGHEB\TYD#U_Q,O JA G0^\5/+,@XWO,D').XE?,?58;&7)9S+F7IP;:OY
M%(SKV0Q8R,QU%O@.+]J\AXPHP48B'@)"#\"-O\0E Q%(C"*FCC=Q9[!;!Q:&
M5P U.H"]);0V.F;HL^'.%[B]N;GTV'GPEX_H'YB;+^>63;=!#WT4BPE'#F8-
MK_E>R%CF7W]\MJ;^$SJ\6FWN]!()R^+-XNL6?/4A_?FPW^JVY5^U6[KT\ZRE
M=#UWJ9Q\ZE<L'!\&Y$'+G%L^O&)2P,-X96N"-7N9%=V%#C@!G&/N08ZX,5WH
M,J3^"T[V<;:6..+ICB,%2=/;3QN&4PP;G'I@8(>4U;1&< WKWC^S^0_V#5[R
M)*N(''0:XZJS8%1WD'+DWS^Q]APUHX+_#RR!^V=9\?H Z[_28SV/NORKGB@^
M.+%AVW5$\2>7,1F2]P#)=RYYER.;XN-Q)!\J/KYO)/_BK%P9CO<!QW<>A*L8
M>3Z.CQ0CWSN.PV]E.([)!E4E[R@^GEF?_L1<1L$"Q<V+87I.Z]1+"N8D<[TO
M$+Z;<!W+,TYQ@,J@-:AQ6X9*4P W9@&^!5=5%6 Y49:Q]4B$P4A>W;F'%-92
M%[6G1%;\-P+4LGG@.Q$$$I?2Z7">LG1XP.F<)U7\8%&LYI=DS$^<MQT]8C[
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ME>4*>2OKP@8?SRWS@2N-<!NP&LI3[J\#Y@<TA0=Z> G^06HBJD")*E,P3"R
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MV\4J57UC61/7UK,= 4$&%D&<*SJD_Z_(?TMI&/B7T(<IUTG6TS-A 2)W[J(
M50L_63BHZ+N #4\\.R+,K0S=K=5G\PXRIDA+],@HJ'"SY,[$*W'J*SMR,(;6
M8NDX8K?7&!MY=F)"NU]3-@,5D_ML@DR%F+LX?CFHK1%H-RJDQV-611B+-XQ)
MBP4T1NW[RL5@K!_$M+.7Y7$3-YY3@K5V%KV+Y_E:#MV$@]8R\1URUB.3(-4=
M"P8CO_X#11EC>:^^^1.-P2GF76"&2. (3S0M?7?YV]7]YXOWB=AQ/!:<S8$(
M628KU&[_FEF(?7\!UW+],EQI@^7W*5K^"ZW^?WQQ[YMEHQ<%G[IW^/9O\3!E
M+<-^8SP#CIXV#6,'T_C!-'$P3Q/&%XD#A,["01'%4-E8^VU3=*+0X,+1F8WB
MQ"[/S[.RXR60^R30,!M :2 ,,,=#PB,0U?16NRV\(V1Z(LZ+^M/D45O:'TLG
MBE^MT'LO\N_0/H2+F_/PV<4$4)V;.=J[=#K=!O<Q+VJ,LR( +59R"CJ[F((M
M80$D>"[8Q2-1&,4<B8X">>)M)50KO 2$U*<8D&YF,:#(;FB(_0<E5:'A#06-
M5I)W@C 5F87(LV. M[SHE@(7P#'1>0X$RS&!46/L@Q7%RG$!<EF07<O5'8DH
M"/2<)O);K&,0>BORZJ9&GEF>2(Y\]IWU7N23\DDA$YZJ8R/39U.;>1XFJ:'Z
M"<+: _PGI;0)S\&#<XOQ5?![$DQKO\-T+>8+OR \ L\$\GD&*I6)MX'"'/C3
MHXBNXV:F5,UBA91,B^ ^5I[T-1P4V=)3Z (@O9P%NA=#4#6CW$ !$O+>F"ZH
M;KX5.#39CR )'[B&N9K[KZU+R&W K\1EDEO;Y&K44X$#N&W&;@*,HO6^!ID+
MWT0M/AGS][#*;W-G\G>(SCW ; :HND13V%VQ^EB#N2[ >%HE%EJ0&S2@JCF9
M D'^AA6DJH $F3GSN?/LG6\?%I<Z-GS>F"%PT5$7?0#0W%QZ[#SXRT>DD+GY
M<F[9=&!ZZ&/RA>@,7!]B@^_C7T<.+V#DY/02,W3$F\77+?CJ0_KS8;_5;<N_
M BM-^GG64KJ>NU3.B)^2DWRJ'/@0>M%HF7,,+EF3 A,@KFQ-&$'>^F"%#0<,
M9X*<Z&391*7R%K,BCVK R;9C20=E)V;4=;))3I[31F'T7>0.?UZQ:UCQ_IG-
M?[!OL/R3)_%&]*B[2;I0+W$E!QT:>E":ZA=@,86.%Z#>"<S$K0CY,$!\_RR9
MBCOJ&?O N:/AXX.M<&X#NU,XE\ Y-!QE6(=I^^UT6N<;X71#Q>GVB75?P#22
M(5VW,1ZF:X;>"*<;*4ZW5YRS?D@970]P+IU[_Q;XW'WH 53<;E^81\T>-Z$?
M]A<>U$F[B_F=Q/-G^&-TKQB]PWG<.(92V-!E&%*,?&A!O:=\3G$9 &4.DVZO
M39=4B+V.V#)<'F!FW=O4&1%LYUB8O/)C9>)OA*^^.Q3^_6$'=8IL>OES C\-
M"EK3R(BCI(UTR/']/C@KOQR#&&3=,)/ST UQB%W43L5 4PB<@;HR%!TUQOW.
M6^:7/%+L!ST(%;NL"ML^<<!*D*[?!B&='I.\1[8XJB'V.:#54B9E";Y8&2\\
MV>A2:6EPZJ&G#.J\=D2.C)1 L3"R5[47[#BDPI_T#S8],V$CYB-+F7Y(L[M(
MB1B&=I;8B6R%.1(R%*VI[-B8AY.JP4[B7P#="P[<VP"V]"76 >K20D L^(NP
MTVB,AZUVJ@ 0?^2]!4=M"D7#SBE8;U%5;%XJ(FJ&@T533[L;6[QM1-'/ K98
MS2$:O<EJ.OH=S"_-:C:V2R*(7F=!]4N:WCY0_E;6X).2.7QP'SA_*2-/#]O+
MU#-/[Y[7S?/.4F$FWER4XGA^E9EWQY)GUV^W.J/NH?+LBG_>&52V*:/7K]^F
MNFU#9206R$B4') GLA[DB%G9T$%HMKM-;N4Q'[CSU@YLO&K [9!:P\V:QX,D
MHCR4MK6]7T-WA_SF4^Z.BH[\NNJB_*QE_!IZ&;\&*HDR1T9/VA@P@/CA,'X[
M,Z#839<V$#+Y9"Y3B?/94Z+,@H[(DZ#,W3V.>DZKXV*DV6^,=3VK*;.B%$4I
MIT IG2HH98"4DC5+NCZ4<J(!@3OTSYLTU@I;_FWE7I6<M";N5;F>5BH\G*.H
M!?"[(O#)\!O39/+"P9LP6XY'>^/T:Z^3VI['B0P5Y KDZ0;YV#!"8UAAPVE@
M0X[\R\6&0;L>V'#*WIB@7YG,&5/!+GHMH\ V)*T^444Y,UK#=$@"&ROQUI'O
M]/5^?Z<1]=R[^R2X]$V*YT#'QF='ZSVI@>5WY%BX?U=!(30TL#ZE#I%UA10'
ML8H+(45'JAB\#E)49/G2>P>\\W7-C&">P2^+UA14P(3;(6J$O)[X=DQ.L%T#
M.17#Y,15E8UL ,?AI7T'M5=1JL6 5[)OWQ3-[^KX/BF:W[]BN)'H>UA7ES7O
M3=%@X=,I MP2($=/?3D:^$;JZU<2CJKP.K96V9.IRH=SNU&*\%_Q/_\_>V_>
MG#B2[HU^E0SFG7.K(C"-Q%[5003E<M7Q')?M8[N[[WO_F1"0&$T)B=%BE^?3
MW^?)3&U( @0"))P]YW17L8A<GGWY/9G5OW'\@[[/@XAI:[J?+O"58JALBS"=
M6D28[@ 5=>D+70&.Z#+@B+18IP\Q3(":+V;Z+SKE^/&4SUN;S#7;Q_-=VMBL
MY[YQ4/B4P4;14G<YZ(@/.NJN'),<="0''1W2_Y2#CM(&'9UDI%'ZMN\]&X0J
MB-^[,9P\QRHOY4"3:U.,1;<7;$J+9_/A1&//T1%-/ISJ*V;Z^FCM;#S"TM_F
MLV5-V6 76,:+/F'#UG'FGS\E'M6,P;@MF/['1_[5<9P.' #LAS#%P*>;&/ ,
MTQ&3DXCC+9?P/H-Y?^:_WB#?V# #RZ'1-;%I&\%D*.QCY3N86FP=U''UA3]&
MGD]+L8(+(F/Z9N'4$_.-+/A$ <3Q!U+C4.,V+I6-BPHG7=B4@2K :SADM$%N
MPG6'BQ+#1-F(A5=_3A&;X2)^Q;;>\"P"R*4ZF($+=@W\2WB,D=D[X?2GNC]!
M-3*D%!:))V.)(9!+W0Y&;' Q^>:/FS)PA!).A@ET/E^I#_D_T>V)M\ 9BA/$
M[!_Q,3+^HOW%LJD28!1$[C@@B_!P'7%HZ;CN_"YHSM'K&]K"?1X,63#-U <U
MH*:8^GYW31UG?=G6+T8V0(-SS9C%+P;GHR+9B<DD)JR/N S@F"PL1#C>:C@D
M+F>SSE*4?FVG40&/8.'1N67@D*:K?WNZ^S8RI^S%+SC!QT><2O8?XD"3E>EQ
M\!K^0)ZNQ.,V[PWZ#;77R=N[!]\:[ =L'W?T(M[<;#9NMY6\E1+K'.PN^Z?P
MD':O04 CWUW^SW_?W7R]>GC\?\C5__YQ_?1_LUM@C]MOJC:5#GET@4"97K@V
MT:+!L2N7U@(4BL,EW;T!:V)3JR.?QQ<_!A-+;NDK^6\=N#?M8>S[&O:L!A-S
M= =G=?%A*P[["A](!Z(:)"=KY\=W5]Y"<#)@3I3*_!V49F**^*MFBYG6R0>P
MCS5@16S -!]Z@3L$S<2,I-YGAW]2<#2742]L1 _!(2U3,:T'%\"4 I"6(Y1
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M4/J8QE;I[L2@U\=0XHK_AJ^V@^!%NII0?"6A&POS4S+@$"J'P 8*32!N 8U
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M^(%P>%S3,(A3:Z(S"RTD$';7"?Q2O$"&9 CJU;)I'7YHL[#'!464@\YD/RZ
M.17L=\$1<ZF NH/MP$+9([:#541D0K[<"%YK'%-1$S!W&Z$%!YU5B?-5=P+L
MJ3M_81PK\&XF *V "Z[-%\MX87L8(0;<5V;&X56GX DB:F#DYCMH@G02*((,
M6U!@,"&?Q?>-S JL98W!]F=G"$2!;LK"U&<^C"/R*FI8L"+?^.DR6AC#92S
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MNYOKKZ.GJZ_D&RS[]O)Z=$,>G^"%'U>W3X_DO_[65Q7U,_EPR844G:Z"_>X
M7^<MEP;#3M.,+YJ!.)&/<TK=K[HS,2S' ^V9@D@W4+B&9(L8N?Z+^/@\0'55
MP.Z';PTVX(UMBO;&#,2("3B;C=MMI<A4;)?]4WA4KM\@Y/&/^_L;1HA E%]&
M-T">5^3QOZ^NGLC7JZ?1]<UC$EC)MTMW!%0<328X6\4!6X Z-Q9L8&1.O^DF
M$"F<%Q@"5'_!'T@C4#6-0-44 CT>I_O;(>'*@R-;,=D#1HZ:(Y'-72AK9WM4
M%[VPUVHH_7PH?A(H4 (%'AE&SG=9"7BKS#%X=\B!P0FTE. $6DD%<)9MR4^V
M-L5Q14*:VX$TKQ/8D;-KIK,J$4\)L9<SH+D)A4 04F@5?$<JNO1L&Y@]+0(T
M:-6&O78%&[HJ4G9[9@PK$<%R,NPF,(7\#-M&AMV[:TG6$^]# 9@W>L7X!@.?
MG]ATJKO$@(O;L6FIO"5\!=03;X&<P\[RFV5_M;RQ._.,)%NLXXA.;9AL^93E
MGB61EKEH90OLF?UHI9N&RU7IFDYV#>43D7S$4:IG8]($[-)[*_60%9PG]XQN
MJ;M.4/1 4+0JCS@NB[^J(A%D\=?)7:\-$J&/$F'_ ;IEX,^,2J]XP<J.F;9K
M\P5.T++?Q%D^9:75!J>?1):1Z_=W</X3OF2.3.;(*I0ADCFR=Y@C>]!>"1:0
MXI-D0NRLXNL'=_L"50Y$],.GH13K3FUB;:^<,'5J=ZXJ?"KS8,4Z8]OSJ0)\
MVI-P.B>]^+\L^R<.3U[:UH0FBU0JGL8XGE+"<[PV[_DIIE*[6ANVFQ6LSI Y
MM<I)WLW$V$)B5,\++[6$TO4;8IO/Z90\6]9T+Q#4$M+S\82K?XS?\113Z;E=
M&[:J"VM: J.^XK1X/-FZF18[0(M%09&6Q' M-^)4<#<9E=9Y[(:JX:4>3PBS
M:L94@N_6AMUNDN)++WWS7GD%S-ZJD>_QY'8V^6)Y2#,)YU5"8CI?0SFX)@3M
MH/:.DX#*:Y\<OO8V.,$_-8.G_1_X2:83/4Y74?:!Q)2F:V5*;7.2!LY249/.
MU-%)XUW8KKRV5@\MV#P5M7&=<S;U<_MF3HL_EC(JCT/HCEN:5B^G*LW:L--.
M%MM7S,(O>07M&A?@O4F ?7.RYR8!CN<F94D !21 "A)_%?EQ"VS$=(B5=J>?
M@;!RDMK6>]M:PA[?.*SAOST]/@5=%KK*0E=9Z'KZ,D]9Z/H."UUOJ.;0N65,
MB;Y8VM8+@]*3%:]G54E7P'3OSH9A%;Z*OS<TTQV9TT#+9T:S%;4V[/62E1VE
M=]5D\6MYI-?9LFP10ZPWC([8@65Q5EZS8-SYDB2@*E,'^T.;S.%%FWM3-.%-
MR7I8G_XWS&'8@?[;M6$W9>Y"Z566K(PMD5C>$.+>@2P[2)9[-XG+&MD-UXPC
M'CQP6,E<LZ>OFDV9!':LF8M_>1=U /DH?4,H=P=*[]:&[5YU!]J5P"VH.%D6
M(8"[A9-E#\BR6Y1=+$W?S"8%SX:+]83@G>F_\,^R$VR5PGN]P@F\7QMVI-TK
M[=Y]Q&[Q5(F#Q)+=\]+L+?:6OWBZ@4N476%)FNX73=-J$TR)"O;>2@.W1))V
M4#A5*JE4*>W;H@,,IN/:'K]B#G7P;$NL@Q02[S8+)W&U-FPE$;U++WBEB5L>
MP=LM/$FNMFK#P=[ ,^4R<:O0YK",5BP&.;9]NG8+R;I745;OF>Z(#$C^9'J+
MBZG%YL+B\U(9IET;JO5FMX*2O")U)>=,[0>O7B^:VCM([4I[[R"(+,G8:S+/
M9.(M/$/#>?53NK3APE@U_KNPVPL=RQ,>Y-?(.<*?#8I_ (X9+2S8\7_8ZYG<
ME)^1NK6A4E<[21]7CO0IB10N=*3/R>BLAW2FM)(I[$J/ ZJH-2]G LF90*7Q
M=S+Z&=5^;=A7*H\17?*.YOWKZ,]&(LB90&7Q"9E$R&M@("9*O=G<NP&Z%.Q[
MR)%!8 /:'IW>Z-I8-W17IT[&T""UU2SKT""Q!Q+9A.RJEEW5LJNZ1#W%LJOZ
MU%W5(."XR#YN7_4S>)Y<4SU3<Q(1S04LHMOH;+&*STO+T5%)?K*I =KRA7Y&
M87_1:J3(Y['F4'Q ;?A!^1C7(GN'CTMHYAZZ!;Q,)NS!G=H;H++G*%Y?]DA+
MM87#5)(I[8KYLQLNO-R^:B48]- -WV5BT(/[F+D8%.>_[-].>'!^.=]\XB5\
M D^=&*%?5R<3?F5DB8F)=Y)<+%!'^8?ZE^[.+ST'=D)MWV]^6\<.+=17U06-
ME_G(TDOGG4D3BYTZ[W4XTI$=.C_6-K$62VHZ'&Z1_L(_KT;=9(/,=B+Y:K$T
MK#=*'RA+Q4>BF.N(OI-.]*67Q[)%IBKR>#>Z[.(P7]D$?BPY[&J_J$.6VANF
M'Z0QG$_R/N'AW?.S6T?36*[4K."X.FG[5D76;DN)_=JPERSJ?Q^6[A$O-OI3
M\)#)A?[K8JY/I]3\Q*YAL/DS[69M>+>DMH:9#V(@ONQV@8SX?Z0-O94D#TZ:
M ?ENXS6VE516*KU,E_9S563Z#C2IUH;]O?L<I>V\*2GM7\7%Q- <1Y_IE!=$
MNV]$-[%P0'^A1'O5[!UG0)?7D#F8(-:-A?EII9CL[3(XWA$[S(#TH^5\,_T7
MG5[\A]I6*DNT4$+V547]7#U9+>WOLLOJ?&2;0I[M]P>^=))"HCMW3NTZBF?#
MP\42N!E;,]TJ%12I&05%%3>D#F_<X]TG"Y77L64'(S;2NI?6_>&L^_Q$B=VU
M[3,S[ZO0^*B)6+F1TA\@1[;N5%96_+&<N0[+)REZM6%?E?-;Y?S6BE29GILX
M.+CUL$8<Y&QU;/>QU;&E%N6$EJC5\2@WRSH(_QG])[-W4&SN MGSD]+W>58W
MIW!QGR[PE6+HL=-0MUAVEANJ-OI;]K4<H DJ?:&Q@U,:W0Z>U".EQ+1<2C8L
M9S8K>#GLUH"E+)N5KWT")J V/YS?M=,N@,QME!]_T[OMZ4R93"8S=3IM=]3V
MH#N>SF9M.IBVFIK:[_]301"508/P#JM[VYI0*O"IM2(-A6TV5!NBU")XR[@?
M6,^4NIIN.(USYR6U1+S$VY;'U+!>V75,YIKY3!V$T 5?E=B\Y8&]M;2MJ3=Q
M(T&TE9M:';"]^O?(38K%M5K<"4P>9-#F_/=XR[A0,<WP*]H8M(GG9G\ET=]Y
M+/W/B+ROKAQ2Y-]S.Z3L9WHQMJGV\T*;P1(_:<:K]N:@=HOVH>NF__ N*-G,
M'<<;RM=VUDLYF28G04HR1 -BS0A6F/.YOJ&(W( 0T$KK*CXJNL'US<T?/ZYO
M1W5R?7N9+5!/N\C;NZ>K1_)T1R[O;A_O;JZ_CIZNOI)OL.S;R^O1#7E\@A=^
M7-T^/1*1S2,?\#9T$ZS@U; X^_<*P(5O[RH#!>$L)OYW1V[PLEK;&07CGLO#
MO[@X? LR05E8&.W!%E@8@H*ZJ1@3QY-:EWG4 'FE.%?(@;<-T"/.)T*V9)0*
M0VGTN[GQ+_: TI"H%2OQEO.M(_RB&9HY8?P$VN<?&L@R^XVH=:(V576?@/]Y
M1(W2-E;UN(^R>>I(5-.P.%!Z8*?3Q$Z*,\P6*6I#+6>Z:"0<6 =])_L9VRLL
MV*[C(OOZRM*F+Q0LCS,K#"N \C</FDZA_+\"T^/:<<">2^4$Q,K8NZ6H7$4V
M_-9;I62#![K4=-MA.+$V!<ML0A?<;3JKHO0" )9WH_E[[8V=9RJM@Q>3DOG;
M'A>Y7 *_A-2=;I0IS"AK[2/5]X"5*0OQYYKSLQ/MI])\JS94DEC@>^6ORH"T
MLD[ROU\;J&H*(9<^4 ]F [5KP[;T!BIK!E7-\L]G!NU$]FO-H$[J',*JCH<H
M(77'S: H2NGNAM#^^'I5K/S;#&R^K1V$V!D5A!FH"L9=R?7-.XX^[<^$FV>.
M[FIX]5(-K](S9;D48,E9[YU$O H87;<3GZVU]/K 7\GB51GP.K2EIPZ8I9=
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M0NG'&O+@#O.1<&^#*W_G]RK>H%41DNV-Y>Q L+TUQ= ^P2)QYMS#AO+38O>
ML[XVZ<!(7R02H3!*@=$B5E>=7()] K]NZAK;M&:NL5BCGT;KV5E2[+6DQAMK
M]$QI[2R64#:%?(H]XT%MV,I*_NQ,)^O&C\>7_X!G=S?[PZ&L6@_D]8UO4U]'
M3.K<^^HW4\&EUM(.F.LA^03DP!V<;-**$\C3G,8NGPV8F%+L%@:I,R5C[/2%
M]YE$Q1;3&7R4O&B&1QV_ZQ2_/W%3"8OY)JR'6K/M-WQ&_*N^;Q)[EO!C%G"P
MGLW.DTQAWWRQ*;^?]K-L'Z .X+QQ99[CKW^J.Q/+8[WA,P\T!2[-F9,9]L3"
M3[IS:UK'GNO)W&\-=X+G<"<*?L%;+'F3-WI.XC$.1D2 % C."41EQ%TS[#&W
MZ<R (R<3/D0P_"CHD)_ ?4", ENJCD?Q2GF;N+]4_BB^_>RE> ZW7/#J\1 <
MQV_$7N)0$7C,#:AP@[2B!^N0,9UH>&YP-F]$8_M8+BW;Y7=OZ&B9$-BE:?FK
M%9W<;\)6X%O#7[5>S=B*8#'\IUC3>G!OOE1:45\Y!?NFH>1%"IT^AIPW65-
MC*GN=597/)Y8>GBBCB>7%-LY#VC3@.Q"#TB% \JJ8-M=>W<R-,LQY7)KS9B'
M?:Y^3:PE34:GZ.S,@$Y2H",-/9M@8#()X8!\@7.KDV=JPAD:7)1,0>#K8#_S
M-E'A$#3(7S3 1&!8#LC":$0SAH](03&\R/4A'9(;J[//,=%:7T$[XL?I0QXQ
MLI]KOB."TH-+]7H4=2(TZW,'O.H[&,,;_+FUU)B?ZMIY$P<;EI?*#-_MG7@]
MHS!Y/8^D^%71^6'O=61A:^58Y,A".;*P0*J3(PLWCRSD"#]K)QJJ)8;\B<>\
M#'\T8E7 ?G:<"=AN-WJM5E$8-J#3"@+6Z3<+ ]8IZ:)Z^Z#]E!&F\S@P0(7O
M_/"">CMHF0!+Y3'$4KF,]=^DMX+F.)H-^#N['&U9@'EXO]+EVGXE>5)!AN=T
MX$3';@5?\,!?)".I(2@K_-%7\0Q),3HDB_M;JP,B4HO;)8+$NT.0Z.7I8WW@
M4ZCCL8&9_HM.+_Y#;2LU+-!%3%YFB)<>1$)BL4A.VH.3\E1:[<))/<E)DI/>
M R?EP0;;A9'ZU6&D4O21*NJ1&TFW _9FZ;X8,5R;+)7.D+P?7<UE^8R[&;QL
M+>B=?6DMEC:=4]/17RA_\>J7BW\=&_3*Q%]CCNJMY7[5G8EA.73ZS=">(Z0S
M ,^6I\ "(SQ1#+8MUE&51CT=&_+ODA?II;'OH%D$L%]!@Y:*=,C?+V7DJ01>
M1QE* 9@1DC!*0QBYFD;7T85:&^;N#"W/:+9L1 JEM:UJ/]X%7V+9W%*,#GL7
M8$NY)K%M5(/^U+5OEAVC[U3";M6&K61U:(XI;!(@IT24L4$-YJ*,-E"&)(RS
M((R-<[KST 5.Z$[:2$<GC+/&Z\V3I(F7.B;F>._L0[ZS:=ZM7AX?(@@:I3 (
MHF[VJC[(\(0AW8(<FO=&O_T\\'CKZ!<;YB3Y2O(]*OGF:;A?1[S]<Y@B6X8T
MP)XU+>5( R0C[3M;1>5U$ K0';EF4JV+DPU2FZU+SW[262T1+>:I@LBFQ5:S
MF1;+EZ0H2?$0:*WK"%%)[6%]+Y184*#FC-,5Y<W I?-0SJ!T<<''5E--11_:
M/O@H<[-EHHP-FCX79;32(-,D8521,#;HW5QD@4AZ2=U[=+HX]YS]:/HOSW$Y
M,(1K\6S%2E?-N5J4^VI#!]8-?]HFXC7BQQH>MI)*\QV9N3T?>DGHR.+II9L6
M\)?T4D5Z2:C.XJDE=1*;3/^7(_WO(QWE[-*,IQ_.8$9$.BMMWR]3Y(&44:CD
MRRSG"81E)^=:S7Z:CU;Z.%B!M' BEU+RO>3[7?@^3U9P'=\/)-]+OI=\7Q&^
MWP" NRW7*]7,OYZ8ZS?X-3XZ&APIS1825?G4^]NL/W,L"ZQT+7QI' 4/16X4
M9"\HK1K^/K9_2P&-1,;<#$*IJ.#@A\"&FYNH0R389\WXH;DNM9V1.>60B<_4
MG("O^@3?^V)8DY\1\:#4 OS?Z<CU7\3G4A F2W@RB!GJ>]_'!0\<]!MJKY,7
M.Q"^-6BFO[4MC%U,ZD1$RVPV;K>5(M'LNNR?PA7-H$'(S=7WT0VY?[B[O+KZ
M>GW[_3&)KG7\V7M_409"KYLOEO'"@RHOFJU;GD,,[=7Q= 'L/#$T?0%_M'6&
M[ \?0S!,N!?=1'#,B>79#D-H'2/T/W6<NH#S9VC2$XY;_:J[<Q]KFPU1 \XQ
M$,[>TXQ@UD:=4 9QAZ$V/A\'^0$5)7YJP3F)8=K#ZR;EBIL]&5;$,/[9)QBH
M-<?EKQ-$0X<??O8,S29CS='A-5P__.;8!_!DZ/H:L";N8FDY#+R &/ '_ 8<
MC<7W/$54?VO)DSK\',)?;9!1'!,T&JUB<QG@')!V&33Y# X/! %LR_%!%>"1
M,Z*[^-4Q-73ZPA',Q_Y:#<I''&A\97,-/T=QMA!':&#;8),>>+1,H):R#T^
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MM%]?@VE,3_#Q+\#?/R.LT$MI[U9[^#BPT;4E)AQLC_) _/!WC@X7Y/705[C
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M:&R0:2"9!I*;E9L]CR*N1]>:_&0@.M1T=D_EE=<C+5,J[W&NV?2+YM#I9>3
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MA-@%_ -[EYIM[*+D)]-E8QE=\N+<P':BR:)K\.PV8]*J,K9M@N!\7%7A)BS
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MB=C![9U@:OGB1BUHU<4#LM0K*O)(+D5XLT91.0"ALC32FI*6-%))-B=04PY
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M:"#1H!B03<"6HR:\VM9'/KV._O@2%0ZQ'/8H=M.76;I/2"A@1,]__O)FF<$
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M-.8Z% A#&[::?@A;_LORHUY?C%WPAY&.&K\UXHDQL/:XL\; HGU"WZD1(FW
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MY\L6%4@%A-CD2_*G#I=T@9(64FU(0U54E659\X.H^6.H6-UD46-@* H<BLQ
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M('"3 _,D:A\UCN#<)YMGU%9E<-_.80-UQ.TC!*^=$VZKLNQKCG!;=(7KPIL
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M-+$Y[X2X/?8.3H.K7XND,_M>\F;9-KQW]JUNZ,W=B+D^[,U]"Z;[.GGW[/N
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M1Z65E>I-PCHF'NP#$R4L]LCDL0\2^;.XG0UI1&5\%RO1L7[CJY2<:=ZDIV!
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MJ:R@>*.4:LLK*%[U7',,_QD$0_OF_P-02P,$%     @ N(),6OGNFB3;'@
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M./BS#MNC<;_YOY_[W98^'.G_>.R,?SM4B7L@2K5XJZ[%)/B__/C^YOK=WU"
MYJS-=E,;?6YW^U\/'XD;0%+=O2TP @$J$F!/2%?]X;W6Z_R?6#6T7FO4N>]U
MVIVFUAMKS6;_L3?N].X'(+!F1U=66R&84@V^XVX^98;E,-\E\"4)'@%\E$"
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M D>Z/^7!4!!CZ$_\:6I^%A3^",.;_\.'^PH4GF<9E<"NK>3N?$9MPB!"7$Q
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MI8N<K;#*X-<VR124H]RLZF/\Q.=+_OR1S6\L!:$ISVM@"SB+RCOP&393:(>
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M ^EV=:!^9#@>Q#$KJ17M:5@'^@>8'V&EN$N,;PO9[F5&XV?EXY=+8(,9<[+
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M=H#;BS8$O2?E3D)^MK#FZ@[(RDC-M/#@?::-$E&#DR*#%/2:%;*65?.\CB;
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M]":R[ ,69,Z&ULO?$7*O)J]M3:7[.6'[DV/#C/V;H%^%A*1R">L@1\TB^2V
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M+A4O>?/)?>O@VC!CZWMA17.1-"/+&2YF!Q*PW\+TGU@M^"LE%6)V*:0,/-D
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M_IJ1^<N?UR\QS/!O?_K_4$L#!!0    ( +B"3%HT!EA1&+H   Q]"  5
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M=Z9],,G:Z"WZ0"80:44B(5(@/ML$.@C*9,49WI76;]B'.U'Z.G*MJ.SE*K8
M]GYF)?9\3!0LH-^KA")2&48\X*N@F'?>Y\A#(R6OL:7? %!3R?>9U?=J>%NE
MC&I)]*YZZ=8FVWQ<"S AQ,R"8$0)#D0F$8E-DA'!T9AQGGNK=6V+[3J ?5#O
MYA)M8?9^@F\P/(?)09A,QSY.<7?PVG/GB*<VXLBR(E[R1)*-:*TFRKPTE35\
M&T-W2F[)/M]*J"W,X06>MSCN0S3G"Z2_^M/3P_/)='0&XS<_XN"\G(T>3":
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M#&%>XG[F@R-6@R"1NY+Y;9EM=N;]2,G5)EB>\5%"*^*NN!<TP;>8!DT05JS
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M\!9LD:L=]:/OIZ/AH?_:G_K! EQ0'"B+B2B:6+GG+<5"E2)"&JHYHI.A41>
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M99!.Z&9UL78\D!?^[X(1]TR'[:Y1=C3XR[6 J^ ="YJ EIE(906Q4>*"P$
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M _P G)^-()MHH07+>.X\7 )<='5!:1R$R:Q.<<_DC$-+@61M!+J'EI;:09%
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M@95YK8&PS$)D]TV430/Q>G[YB+#27O+#1O3?I<59,IDX$SA8KR6".%JTHIP
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M;L?L?RXU<LVGSMD$+A,0BU:TL":7^G$!,HL<G+%>&7XP#\Y=WEZ.TEX>G!T
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M2Z(5!"J$R"[[P 9?[#X:W/;JU!D=;/NHMB)<E]7ZCS@'C\VINBK1Y]8:16.
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M3F*?UI!9Y6?S3_?W+4)H1 1:)B!GHT$8'L$G8D'B;QT-T1C9*=3QG/)N?_0
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MD EG$FW*EI2=,Q9]=BHE6(=@=5Q2)23WZ)<=><*Y!)F"*-4\T0E\M(,"F[.
MC/^C/%[T057?47J@"><^:-DEX=Q')6-).'?IPS-.!.-]V?S'/0AC,GB:,S!\
M&JR6Q+OJ4#N(GNG*B-BB;;J/9O;4\]J%Q)>VZ1U5NT7SZS9ZV1.$./71!AJ
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M9R5X@N"5R7K+95*T^MZ0S=0<(2XJB7[CW*OA!P-<M6.XB_AYNG#GRU!7Z\D
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M+V_*<C<CO]XGP]U$\[6[JH_.#XY/$.H?5C,EI-<BE'G6E@4BF93H[S!.0G8
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MLDP2%TPFDB8@+LM P((77((VHG:SQCT _5\Y=:JNAX5>KY9U;7?VR1NUK^@
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M]!/W9EM?LCZ3>CB'(L-"37PUF<Z'_UG=%P\GB0V*>VX"&F](I=XY^N+$:TG
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M#)BE#)D$[<M\-YUR8,XG%5X*#IY_1;\S[#K5RJ2Z2"O/$/Z$!V?$_[SJIX,
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M@G/B\9]$*@8D.(6!>90FN,@9JUZ^V 97O4* 9][V8:6%14[/61^=S$!H+*(
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MO]OF@$T4]7QSP"NDW'ES@(H*G)*!,-"X'?*2BI1&$XRW/:<4C1]JYV[>?'-
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M[H\9E#?K1T851[]9=?HPLO.4?JBR_=58L^'=DF^V00W\O%NUQ,8C=)1'AT1
MTXT>72!N@$"3I9_!MDFQ8,WQ&2\_].;*N(D=?![%ULK5(R\<.7/-&1=5I'&;
M$H6,+ G$RY'TR8[^]8W8L?6@BI^'3EBIS.QE2RU^X+GPB.7F(6-D;U2MO86W
MEQO-%-/Q*!1*?>Y!BEX7FQN#_)?&'P%O#VW1C:"[1B8PBRQ_S 0(?3OF*2AU
M)I!!,X%D-!,TP[]WWQ6:S:*GCTLS4+A-S9WQD:ZP([1<! F=1%6%M/9&(@7C
MV $/Y-\]1.UA7*^'(ODS0ASUAT378/Z;"0/VQ"G;_O&MZ7$>T*(G!;[Z!1JV
M]KKK%4<SPG3N)R$9,5@&5X 57$]YQX=P='7'I_1A>BX\N .&,NC]WCG9F&]W
MZBIO(A.X+%T9;;X&$8K"?(LT>8<)%-6XX-$3B$V;:Z$TGB/@O>PF_C^56M*V
M5TGQ15%A%SP L2L#'F8"#0B&4@+^",4>LF/=/$T6_\U0/Q!!Z$'"IA'=E@F$
M$*C.(BA;8B%HE76'L*;Q=[)2*C3(4/M38$?&=TCFZ]60(4<KB*N.(:B&L0)C
MMF0#8A!:EO),J_1JZ)*'W_"K2SXLSF\C1/73+\2D&G##$.$C79C7#?1N)D">
MAQ8DLG/Y,*?R%G17U/_(FC)6]73.U;?1-<39_C1;K95X]?V7+=(1-NB;+BW8
M>H>[E/=083=^27XF<G=!''X31GP5_W5Z-*M%:SPQ>8<1$:1/#:X-,TZ].?M*
M+8NCFD?0ZY0NKKI\,704P7!)PWR#T([O[-@</BFRNTX[ZW_<CPE(Z%N+U%H+
M.W2*M UU:W=RGVH8?*^!UJ0*(6#@L#XJ;!BSFD8 [UGYG25C1A,=ME!"<Y+P
M],D 9<,;X*:"%V9C9 M7%+C8,XH$C? 0:5<-$ZB\=3N2AT^B'4=^A'Y$["IX
M0:'[6@4+)EG1^W']TU"2;M4$)>D7/> ,@<>C&>;S6'H&$]C/!$;U$(P]!!WE
M;<R?0XJGT<]0VL1X+QA1]5Y^:W)"]]AYAZ('_1F-9JOT<ZZ@_O6J[&0E*W6Z
M37[S7/K>E5B#/MEQ<-S:7SS\K7*I0XM<2;<IVG-DY1/:<4C6C>H!):.6B#N8
M-1[H?%_L:VQ<--S'!#J5B$C&K2"HUC ^K]8VG2J*Y40IJ66??#^D^O23[Y6O
M:6L<JE-D5;/PE<+4[T6%O:HA!34-#V_<<^"4D\BS%%,J^6EI4'YK&.ZGEN@N
MQ/Z.=#F^&$<5#RS8;:U$<$5/S!VYASX<\&+>8Q!)R,#^TBK-X#TSPW[_Q%_R
M@-ZE&:3F>+0+V85R=RZI\%GMVUH_><_/A\N/IS5FW!';8ZJ/V7=_Z/SAI4$"
M<9# "U^&EMW)@P,U$=K@$%Q _PA)PJNWCI\/D6;L%UQT>\56UC7);K80D>NB
M7[.]4VF!\4&('S<,J2DH6'_C!LFX/_<6+@6[)Q)QI^' )?>7Z[FS!+<#&GZ(
MQ5$G@2C%U;?7MO,U#;!D:/_3<=!)O;N"<2M?/;"K3=X?NMTCOA?T+&!<P564
M'H>J)0=%Y<]P/]SNOF"H."#!MT5QCKACC!>$!4NH&L:U,H%>=SPF";[@@J ?
MVXG _J(:EI 0"17[VQO%X5N;A5LSZ+J=&1KA+NH6<0DTK^0'\?-@Y Z5,;YK
MR,8$KI81/E#EEM_6,%:PQ2LQ'.O>4&H!=_OM9M-4W<!YM3\JOM#_9@(UPE"B
ME.IQX4C[Y?,4^!RQBY]NO:"?;H3M'8FZH-UN^Z_$HZL(N<2.KG!9-$!7.)^0
M6\)-^%M2D(4-WN5M_(S=Y])=^& *RYPR@ION0^PNC&U6B5^'G3INEQ<4*N!C
M>YKG]M71 [30^:B6+9+:++Z\\*_D2+X7<QWU.L_V.L'RM/DZ'_7JXKI3RMTJ
M0E[6OTNPOO'4L_")N%-YX='F\PXZ,G>:)4M.HTO[$,*H4Y B&\UZ'E:!7Q@H
M),G;R=Q7?O+V^&2P&.Q&\$5ZE(S09/;4"#Q$Q7BNVV([G<?H<H3MY_"8ZP,E
M8DL+G#FTG_2CKE%ZZ1/F[0+^H-! DPKOTGIC_&JD?H 9>R-2(A&1;5,4WO-D
MBA/W%"^,Z70@1C$2?D= K&.H"MV4Q(>RG/N\NTC0LC[X:Z1F2?RA4YK<!;[\
MQ03AB^PF]Y\6_UFN"%(1"&'TA/2F\TD<C?431)Y+N+K5N?0)7]#J5284\ZZ$
M;=3V@[$A\./TUBFHZDD')UV&,C>Q:\I,0(/ >,L$UF.I;QZQB1 WUI]!W'J=
MG\;> B6@G8APEQ9"/9*>.0I?V\\/)BJ<Y/V)\<;L>&DR@=@>*#<8&=+<;%A3
M \O;"!MN?YMY]=L,?-T7,D/X[1%:TU0%Y8UDBC098NV'TQ5,8$0BE+'O<>^S
M%<+K'OH=%(()>%9BML4#5_1VKY(AIWD0F@)Y=1T.O*,29VZ9)OUXYQ_4X0+5
ML?^@#L+)\NV&637Z0]P>S*@HM(XS"EKR]I0ER LQ$'SRWBPF8(3KYF9(_^<Q
M >ER87M32Z.__WJ OBR>H)_\70,[0_K)^GM#XW&/X$%3[AX;R=>?F#[O>#-0
MZ&P\K;H4=>6B@842?$867_-'KHW0 \?S8$W!)I:DN%HUE0<W73W?*+:>E<S6
M"F$"6N0+VQ).R._",LL.C'LHM>(5]U])=>5/10/7-67N#^4@N[907]<XKAP"
M>@I"W6G<!%TT'_WB()H_.MF#9B$*=JW E58Z)_,?P#(OCLX^?M3)L:%=&6=>
MC![S@C6E/D^*#.2PSZUQ+[\TGZ^X1*A2A$VMSL$GE#_9KR+V59Y\JK#/M&BL
MS *@U5A8O^X)K_E,O^J)36<"P=8QM9W!3=(O+WR*D7W#>._(R2:_?2G-[8Y4
M48@,JRY'!D([\)OD<&5MW*G6[-</VJMLPGJ_AGVYG--FUU245Y!MVV0KK\G)
M7T#P3J<P 5(Z(Z(6C!@9SMQ$K*ECYKSG6::[ZB :>HFK//H/PCHW]!EE3-0A
M?4^1RANY\N789U62%'@S-5*J;A#K+E'GG51@*V3E%%#>YI%M7ZFG*6(5\C4@
M79;XZR^V7LW/DF<";4[49U[>_(K7]FWXAO.4?BE\HDWY$>S);,2RCK=O%[:<
MWIUZ7AVO916Y^&5DIW<!/(J"I\^%WM[0-U"9'S6/Z*O.E?MFULZ7>BFR3>\7
M3H9(6 OUG<4(+5.[HO/F9K=7.T):5:Z4'6Q;F4%BQ">H(WV/78K"V7VB)UJ.
MSL.Y5AHENH?+,2'#WR][?M+FO<2[Y7'-3F.1"5"\/\#!A DLG14!JN+S7R0#
MRIV@"KK;\ "E-/QP_G<;:<_+W)$\SFR6]SF>YDK#4F]+W-2XR1[[29B3TF['
M2**[2"ZD>%<M_]+*GY5_IV&\9F#%=I&?SCEB- L?O=74\9*DG73K]#F:IY)J
M4]@9W,8$<A[A8G]NUK='WY2(,!U$BWZC2)B=Z3U)>R01\[K]^^O+F=)7+RV.
MKL'DJ;$N3RD(LF8]D7!O.\T;Y:S2XO_KP52239(=Z)$X@3T^K]-^;F<[3?BF
M<INA!OB52+](,JVJ.?SA\).+-1ZV"L%GWHUO&J[]E(R:%UOWZC&%Z=?,8/[J
MP/- WA/C_GEE>MSK7-1$4A-![4N;H6_.+O9E;*ZP'8O7$5(*V3]Q;B1%R.-1
MZS[_U/K2X(7*D@>HBG;=;WH_M]>]QDR!F-!F_EO5J/V>EWV&I<^#_<<?X:>[
MQA8WF(#?$L105CM*BOFL37)SQ6LU')"<'?@6G6 KV%EL\-$,B_0X(2,AH!H5
M*AF>E[LZM9S/?X(B1SRG=D>+VG0B8*,LS6@^HB=$=I.\1XS6KCM%=2FV-P50
MD"[R:@0R 9/X:8H: M1%F%,<C:7V$_'IA5SXWL;('*W;/N^M=_U*WZ;F($,K
M _I.BZ&UB1TD;'QD'%<57]GTQ(=W.8?GGB>H[S'#Z.U.@V)71L!$+@+1BT"/
MP!>]N,FM"/7=T/\TKMYTM("?AX(P[XMOF[VVJA/,]NEZUF:?8[BX3O?D3GEV
M C:XW*T'>2-89*JHR\'UR.GEE=@$QV:1*\ELJ,_SZ:/%9P=5#[\CUK^FGC=2
M]HY-\&NXSB-S*A-=T/,A+(4F1!D)Z\;EW^VQ/[D >KGLX.K\BL.JMP@W,;Z>
ML):1/B]*HOVC5O6VKA]^L@(3"WM-TC[EP.ZOZ"P<6$>KTSG>4-[[OO!(.[U<
M7K2;PIDPJ;<6=L?/\R] 2\W6:D?O*.^F]&UL#86B6;:B';;:'Y Q;5RMSQ<D
MRY+YIC)WJ3ID:G6DY!_(X<RQ?P-02P,$%     @ N(),6O<G@;6&,0  ,30
M !0   !I;&UN+3(P,C0Q,C(Y7V<R+F=I9EUZ=U@4U_?^G9D[90LPN_0^2Q<!
M%P1%1)RE+B*R-,4"#(J*J+B(!?LL+(A]5%3LB[UG-1IK="@BEIBU8TL6-888
MDZS&))J8\.7S^_-W_SC/_6>>9V;N>\[[ON>>M/34V"$E 8@*>0W M&G3NKJZ
MWKY]6U!04%)2\N'#A_S\_+MW[ZY=N_;^_?M7KU[M[.Q<NG3I^_?O;]VZU='1
M\?3IT]>O7W=W=]^X<6/]^O4]/3TO7[ZT6"QOWKQY^/#ALV?/7KUZM7+ERHJ*
MBNSL;(U&LWKU:J/16%-34UU=W=#0L&C1HO3T=)[G4U)2ZNOK(R(B%BY<&!45
M5514-'?NW-FS9\^8,:.TM%2OU\^9,V?X\.&C1HV:.G5J;&QL__[]QX\?/W+D
M2"\OK_CX^.#@X/_^^^_*E2N[=^_^]]]_MV[=NF/'CIT[=V[9LF7?OGW;MFW;
MOGV[R63:LV=/<W/SM]]^NVO7KB-'CFS<N+&QL?&++[XX?OSX]]]_?^# @=]^
M^ZVIJ>GSY\_[]^_?L&'#IDV;#A\^O'?OWLV;-YO-YHL7+YXX<>+@P8-'CQX]
M=.C0N7/G_O[[[\N7+W_YY9>7+EWZZJNO_OGGG[-GSYX^??K4J5-GSIPY=NS8
MR9,G__SSS_/GSW_]]=<7+EQH:6EI:VMK;6T51?'V[=N?/GWZ^/&CS6;[ZZ^_
MWKU[U]O;J_H$P?]6V/_"_\X$D+W\LII:8UW]\H85*U>M7K-VG;!^P\;&39NW
M--7*Y53NLN'#:]@:T]8#!P\=/G+TV/'UT<ORP[/EH?G+S,O"8TY\??F*V-*Z
M\7Q^S';O<\MRO<-WM5GNW+UW?]WY<_+AWL/-U,ALZL&+EZ]^.';^UN,.<_3V
M1Z]M[][_;@P=GAV3^WC9I*$CY35QZN8TLTE39DH,O_C'<GM8G[_+>X?VY)ZK
MJ]P&EC_K/+GWVCHF::57^JE]US>&Y!Z9</W4_IM;/&MCZ:K@5N>FV*J@4/_]
M$ U,Y9,MZ8UEJ%M@B+$[L09KVZ,;[W<]TN^F"]-O0GS#C9A)6X$,_<CEI1(.
MWI&)QNH[?L9M)_2]P1W-2886>?]9SOF5W=W8NBO+AK:OR&C:Y1N<P^O=--8Z
MGQ2W&6[Z]2^,<@"T'_K=>CQ!B&,:9QBB4'Q-S"1%?H%B;\HJ-TA4T^_.??E+
M^<+-1EX9E&SG@TW4:O,,+932Z<T\8'WU^I<?[_Q95IF-=I ><&*U[<4S@7?T
MCPUK1G]HE^&6>PZY22W1ZSRF#[O$J3\(0"$/T4GVQO-_]XJ?N1ID@)Y.D@>H
M;35>#12' 2?.@*/] 4!XMPLY0#)D3C7JDB*H$ZGM[DH2Q)O4K SKX5OKW#N:
M5CK,<Q-&*T8%9#\",J\]J520!72-_>-Z66G0&$Z5U"OQTBOJZ4$V6ZM*$X^
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MH/YQR?2S@*/1*(#)P=2$(<5S;7BIGIA%$QEJ&#QOLKP?Y:I#;RJPKD *9Y%
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M+ :RUNPB*U$93T[AB#*6J #DUUM@(MT^@R&K=*34#!RMP%$=.U]-EHK78G;
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MXN</>.]_F$?A[0+;K4017_T9GV*K/GL)..ARG)81LN;WCSP/>CJH%G'?C+;
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M&<D9 :G8TH[,]5];AQL6H&$D9F&X0((MU8'BA:=2M6$@$$<L$AW\A*B0B:B
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M4?VEM[UV5U_+=E8=%DV6Z8H&5$+]H&2)\("/\[7T.S2; ]M,^Y!Z9^<#L),
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M@5Y[)#'U)!7ZR=Y/\:KEA[8@G2JTT)%A]F\X,JNC&C@OX:PA?.?;PM7X[J/
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M-&?@:W?G[T%R/CWGB9$1D/QT:F(;Z)@SMQP8K]XI$)B\#Y3W83@O!'PXZM&
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M.Q3Y0]Q-,*!N! .@.8YDR$$E5=)HEO2>\A9J,,!\%0D?!Y'0\M(0:5SZJ_%
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MML+ @'CORE8(?B-\';,]_79ARV1?@@0)JG3F?^[57=,B7.QYF#)3FDE[^W3
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M2-2G@OU(A/]XEBFK6YL',%L0MQ?R^W)!NB-&?6148:B[Y>A9S3MBL4/L:@Y
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MT"&0<=PQ<KPMPJ)P/@P:OHXTG3\?['[GFIEK[K)[(!AQ!5]_.(6 9.'@-S!
ME">0K$9X$87NXDDLL@ATL;$<D!62.3JM1<'GHGK7L<AAONW#=>!4'Q8ZB"-9
MB_QJ9_[5W<QS'VT$>@A>P2U"#QDZ+R!@X]T8EKS3\.\!\,M5JC(X$@QLJW=@
M6Y_WGT.1_(5YK;L)&J#.?86!,7<?"RB4&T?Q2D$F?@ZTARD</P5AJ?3;S6))
MZ!UV\>\1&/->%K=R[,K<NJ>/#)"P/<#2MHH+H 2T W%L<W\B>'7[=LR/KLC?
MXO%C;CY6B'1P]#">:B1+E<&S@IW4O]4_1XN$.F<,4O=4SFA8KYN0K-3WJK)L
M89;Y$%LS\#RU2D,LW]6?#YP!IQ5^W,_&&92P/UC0P)W#C1\,EQVN05#ES>VS
M\9G(=+]PW8>[[^/QUHLGVS^<O]4%^"Z]%_5<L@XO>KBGTN];:>E@+,8 P%_#
M2Y+-GRFWG*^,=+&)/LOPD)(S=\$UPANLQ21=Q%9+U;69[UUD]_><(4,1H>72
M"SPN>:8:%UT'3O3D9YD+OC:M2-=&=;D.[$*:\H(5*2XR/ P1"WE2W=H[UH2-
M&7,^'9E%F5GW)+U@Z_WAZL E5?D1LWUOIE1VF'>\I,(:&27=WXS6K?'GB=@?
M^D/_!U2,A"2'$?5]F/I4_*>7L[NV(C=P2!%.]9_)@8%33L#J4J3]#Q@($2"C
M-)%2>2^4M#K55-I/F\!J^ 3BN\[-: AQM,0J6,F2)PF?ZV1',50D+%*"'H%2
MJ^@'$M#!9/3Z>_S:/IO'R[RERU08Z*<2O@2K<<?6FNH?7)+9"*3EH:V%SAX7
MN'R;?#K#G^VHS:5FO:$;S.*#^JRVUISNFJUZGY76\X_4GG?E:Y3A[E,S7MQ
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MS0\W5WHOO4M6"7?@#?.!!]PF9P[@(]<?&.F0UQ6L].VKP?6$[PEF1XW;6X6
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M4$#W8FS80EY?RD+FPJ_WZ/E^]00)UW DO;+.+1@(@R@\MSM>O\T9FE;_%NA
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MO&!VL?G-X&'MV!]FN9<#O7<8<Z!RC0Y[NTC*F>S2;KWP]$#=%CTHY57]^47
MEEA2Z;N87='^H<9.10O^(8]]8NR/<LV,!#75*T8<O,*DS/03K6BL8O[*2.ST
M<VS]T.@.N0QWS<63E)[I I=@4STK])CA$PKZU%%'(&#0N!$U\4/FB3U!J"^
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MF@T&CC[P("&GG587"5EL@N\.77^4]!7$BOVXZ,D_<<50[U;/8; 5KU\O7$0
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MHYH4XY>0'&9Y5QJMOZ#^T$4]:?5)D J1&:DJ?RS1J# P=Z&*ZE)<>=EU%8+
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M=NW@ZF&8+U!X%) DL@\?[,(?Y=.!B7.5NS!-P3<_-JB0T'_FNC8.9Y)F)"+
M27:8&Y .VS(3OGUI/[PP_!8DD3$,X<=_".-)9)#W'[H&=F$:YTY:OX7O^OSS
M;B46SL0'_BW/AIEI4[@0'>#B)YO2]F:A(-;W!HSRT'#A.R8R.2TN[;\TYB'G
MG7+]-SO%VNBOAH3I,"NM9BQN=/2MFVCSN3UO'CFE,.^/8HO254?<Z*W%)8.3
M4]]DX6&A: ![K$?/X8\3^3FR,4HS;\/465[6940-;)_91K4=*!_$I[9R/?JF
M)U]T R$*!OL0TZV\Y-?N#WI1-[\L2,@+99D9XSY8BS.ML-1(UR*DJ\*-O>C
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M[6L$4.9@<Y:-R]E-^,8%?V.KL*,1J,RAQUNKT$7_X1I\T:;$<N$&P32L<U!
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MR8Q0Q]*CANB7YN4K:378YJ >3C@6T^_P1E!H,)0.? Q8HESEND73[BJ/ *O
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MNQ?CU5T0Y>RL)%K*%=EF+75.4='XQ+4!BR]/>%V?6?UXK;RHZW,Q1K.N?XE
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M3;!)1"(HJAC3MVYZVO?;!E%QAE!:XQD;]%:P\NR"#-UYA=A CB! 0S *D!]
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M[YBG\0?R?BJ@_Y?Q?_UT_^(X'8@?AX%# &*ZCVYA\__XB?7_'1?'QOBR(15
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M7Q:_RLO9GZXM#^-:49/K'J;H"VP6]W4.R)Q1ZORXB7E_JC&90NXYEY.;K[-
M+_%-/@1XOT])GGD-9;-[66+"Q"1O)=^>._H#0*\XDZ4^9;1[_]F5OB*17%XB
M3]_5X9'NJPE%?LK.A5X?QF3.)5*!>V%"]8]C<U_OIZ^4F3!R(8[#4TL/T4-N
M[P@2<6/5EOR4.S<M3XKG0Z]3;R$W5F%\$6!,%G;9?M ^[:=U('MJ+1(G.XBO
M^0SC23O;@$O]RRL1QK+9Z^HO#D3=&SFJSLAP?$Z9;+<4P$C^$@U1,,3;)B?O
MA5[;GMYY_%*#W)+[@Q0BL?28O+^D9(TEQ-W9WY$E32G:;H0O'@'RL;'(&1>
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MU)\!G1'@06["YIN\&PA8F420#NA#6_ZNSX-F?!)>(*<O("G]*]9'D!< CYV
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MY(EDVTSTD"$(W3X?7;N=/7A/0>B<R8F3:A?]4&]2*!1S*<*>?:O>KR[,OIM
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M-NOK$X'Y!+Y!SXD!&"^B!)X]WY.=CB7(P-.G.-^&=NYE[?4:M$%C4EW:7I;
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M P^O^Z[-'/TQF/13M_1I\)$3=891Z9[*O:6HX>%#NS:,JWIKN'>G-F><C5_
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MS,0]) [3@<$-<'Y/;4^-'",0<;1WPQR$1D'!]LRS,),%6ZW!G?QAJM".4U,
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M86?SSO]?AQ+^7X<B;J #CL6DXQX2,'N"$<PA_Q<^*$8*MU-%,.^XRP3KB22
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M3X3J\I9\L^3*FAJWM7RE9:#X:/5;X\?I;_8MM_ %BD6&-VX_%CYF$,EU>D*
M#L1Y7R2^N>W*KL57R,U$_7K%6>3-85:6[3TU3E.L]>W(%H%S?3*)5.-<^_7;
MGUV_E.\5BGRVNUF'.;8T]LV^TTFRS$6,:"V#T#.W()#FB)P4+X/!8HH-(X!W
M33EBR%4;9K2FN+%[KF]E3ZV/A'3A:6RV77UH_ \>D'9X>(=&T8?.H:5667/
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M"CX=[&Y9=1$6Y'/$6MCWT#4/FIBW!AUX\P)#:2@#W/L\<@S5EF4SWC$BP >
M0L;.G'QC]^@ 2.;9U5!RO;34X#BO3GE"(<?NE]UZ'X(_)3N(]L&W-!3#=GT'
M.96],G,,>+DN5)OG^C!#:B@&9USGG#U.V^T7&HR<WH_=ZF)DCH]*^B^^4!9F
MCIC 9K)Q?@HA-/)\#<*)=_Q\Q,.#1S2_<@-VJJE:A3+YS)T9-;3?9)-+XV&X
M;&+()(5S%^[FLZ/R2KBWX'*<M<2K<=Z:P#=.VY?D[AQ S9:MB*I[2DTK#A5K
M*0\X#Z2S^N5M5Q8+_7_<O7=<$TV[/[R(@@VX5;#08D%I*BH@HL""" @(H0D*
M0E14FH"("")DL:*T*(@H"$&07B+2$8@4":CT$J7W%EH@@9"R>3?>]_W\SG/*
M<W[GG_=]/^>/Y+,[NS.SLS-S7=_OM==<,[!N-ON9/TH-]>.\XK/K47-H5VBV
M)"?Y)/3CL'EQ;-!$[,0\?4LCIK1M?C\KTA;/\C._0$[8U9G:'+.LC+<K%.O9
M6/!Z\<R):+ @>(5HBY[=3^>X\@_&>[<A*(Q_&]M%Y %]P%B)O1E-S<6[&ZR2
M^PT49]"<#\1^CDN-.1K3E<4%JD4(_A>YP.!5*!RU\(C2_QIB[,2/&!2^9U/F
MA2V^36^@,-N;DBH+S?Q0#O L'A:09;3C'M#AZO;?53@O%T#Q@KQ2$RL+\-T;
M.-/9 4($+G#[KR< AP01B/09T7$/GL,J%3FH"9UOK.U-'Q(*@LUU!^B9 TB=
M WT(%ON"_,31#!WZ$'L[GK$=/X+N;H7O2!+RG%AZ@E!7%,LP$++-#1!!L.MM
MI.HU[6QG!,6B[.&Q-'A=&J-U%CD]*6SS\Y/J'L[T#HM=%&8GAG':9V#.%FF<
M+10NM^!0=L3H]PDO=%@7;BEQ[.0FH;->]NL2$H\HOOJTT)^S7J+KY_W0%-5\
MM]1^@_"Z 1@!?./Q1O8RH>8G/P=J2UJ_4DON*CT;>0'+?H&[9"2DZST\JV3(
M\X[47W^T(Q*]*%"Z7T[S;4#Z?%*Y=.&D-!#3V#8GPE$#F1O)S8I4[VISSOP?
MMA.LS$_;5M?FS@^ED90V-Z3;35JO;'/HQ5S*_"ISY(39CS5!OGRD7?7-MH.U
MM[])4SXK',TOG;MCKG?O^G\((O*O?E<9/?"9OOMP^6&09F?=^?NT$8*K5E#,
M0^G\XY.CR!QL2E5N[I8!&=3<^Z1C'L4!_G=RGGU TL=3$>&K= R:U/\8X($(
MZ(D*ZT0O?V4HA7^^JR*T.GNMG/IL?:-?4P1I=O?FV]JCPQ50]>+5/\#/]9H*
M^A%1%N]TG8BI;6!#4O_(CPBUYO,"^1KF=P[1U/$G=EFHSYU-:9W3Z#N.J/**
MG:JMWUD)GLI(KY84ORWZ="/5)ILQFO':=D+=Y[! =LXAXO '*HK5A6?N)1Q,
MH+]-46-;)>SA OYDGO%(^?Z/-,],UI2OQ<=MKW.W#9^+N]$6S%$!?]BXE=CP
M4T^:Y"-X!YGQ1^U_@B-[IW)=9/SE AN9$ZH8,\_>A!+2[K:G/0?\(XYI-MIT
MQ*W(\B?XJ=8<JM=8<;AIC]6D5"S8(1@_40K,N==?\J57Y!(<W<\XQ 5:K.Z;
M/;]1Q^E7:#?@:-A!4U:J<^<'6XL"[%,1 OC]:S$<K>NP]*\#E&H.1[&^>R9#
M1M4YS6)03A%3C99]U# <Z3C]Y XYBIZHZU'Q-P-='RCGKIS>GJQ54)>QGBW_
M^&ZJX2[X7;OA<,(7IJ6$"I^$%SMS%W;6=' X,6:N12"0U)>MJ3L'BY5ZKYA<
MF0;O!JF[&S/)XTXD:= 5M1,BMTS1Q)C7,YWHA!\#$6F>L[K#(^V<W:@6L^-7
M_*HB] /+R/+V!F'"%[P3%&,2=;I#Y,81T3T>Q4CG<]&4!QM26 4 )*:D\GC)
M4'OCO61BSGY1X$.+$/)?;K%D\J>8EY#M]7Q/^%0IB6(48[=+"2Z;)")J71XC
M3NQ#TO,JI8K9=@.;(B:,"DB<58=7?.WWWGE'Q LBY$NCO5BX(C#8]A%V3E#%
M8^1!0@5Q(X SR[<_/?#MQ<==O>>N\7^+)NVF+FUCB!@U28L5>1*];DUG%:GZ
MKMW=H'%9^+9A0\/4SXV=QYQ.J*^%,'"A0E'OHSH#M.<2>Y+_L))0SU>OS5D:
M7R-U]EA?OSPALWBV^?:)?4&"9.>\"?([?RN'RY?"F)NEB>BV**_Z$Q,O&P$?
ME'"EYS-I*:FF]X)],M#.T2V-V"<-M]9&*+>\[*K<P<&SU=6>:>US(:=?=%?)
M6$?[E*LM86IN.%\:M%-R,*IEJU:MO;$FPJF!J75?Z!P7R@DZQRT>&5+^>5)S
M]UL$%NM%N$#N!^OL= \UWZQ6P[*@0Q;M5NV_G:7XF\IU]L#];T169P07"5^:
M0PS@PY[A+*?:'234<AOQ?H . C-$&0BE& D+5%P A]^3:@?$<<PW2@@LAN0$
M6RA:0NS+"UR@1@JT>F3'"$SU:S-NB+R02KPN (@^3+[C7J7Q;DMSCK\"W*6U
MQH'(5ZZ"_62 4"O%<:V3Y@AC#+]CL,5B8_V2ZUB)?[O/@?B!."Z@/*W$</,$
M(M S"/]UI$>"L+(IJI!<,\<%\@<>-TN-HF%ES.$Y!-:>KN$"9#1%;#,7^+20
ME<P:6,5;BG2O#$U8LDXQSE(3KF%@7M![H< %JBDX%%^.,%!H&\\7X;O$L\&[
M*7VK/BGTD"?0C2N?081WOZ6#;%6D*75<(.[.PH,)V%^)"^Q*AB7XAWX-8IL2
M_I!M_X$4B#GHL:*UFCJ?W/,#^O7&<PRZSWMD/..F2#!"@Z+N+ 1SV,AM!NSC
M@C7O\0P2N)Z)[^>51(A><22,G#7UC]4LKV&I"?WBS+.;,Z$A0J440J9V3@R)
ML!A$]HTR:!W<@EU+#?TQLNRW\"3EE:[0K1\YI9_EI,T:YDQO"9827I6+#:E1
M3=\''Y)Z++-K3 J=).)-^>D]Y3#EFF=G]W7S^CQ=\<<1JCLW"@(;-<N_<N*>
MPC8KQ"7-<26<]-8(E3,,@Z%1/;[SYX, 88#?"?"W"J52JHDTPW*0"P1R@66Q
M(3?5LY^0K"1.7/ ,O ([E4+5C(5BSE9W?IC%!6;DP2%_AAW\7/_17QF&C?=(
M35$.2?<G0C>&D)>9@&C.3=^K26G5%9L#40CZ3E6K&]BLAG["E&.>X +#BJ3M
MVH$9OI;,6E;HWV\"XQG6+^&!%RJ(Y@(^,5S@6:9_VE?W-5S Y'-1Z!=_GP_Y
M9UJS)REO&M8*H':K[VHV;RLO0!G=\J:GT4->%T\^_O3CF,L'VA(TKI/CE3BM
MJPY>B\.S;G2.]J^[Z<<;!00]^/QT&?)@M3C+ORUOKQ@H1%DIP14[5FWDIU%E
M^/P!]@M,,&KYL,L TT3*7^C>RLP2CF%&%%HXR@5$Q^.YP(=6<F++D7_QF>X?
MOVS//XYW%7D,YL'G\R]@94X<Y_D%:TN*,P1:K^WWD9@D_S@V\_SAYI>/WJ'>
M)'Q(2 [C:[3';*I2"QYLRQU3?O93K5M,^ZKNUK1W([OJCOGM;%*T\:W@2^=7
M/+U041P\\?K"@4B;ET;QTUD-N_.^\&?P\R>%/>CH:IK&^:Q+7V/2X9&^TEH9
M)-.G/WUCWM^D@^_ M)K5_?2^>>VM'LD^RCX'YOV!*(0@:_Y*]JT ; L]:>G@
M &9<,3M7JY/8ALC2W%#VU[O_M45H$"SH$:ML#=1X>TMSY5"  <M 76M'JPCG
MG+4L%]"WZ8$*$*EP#M&)E# B<RNY%BJX"PV)M>(XYXZCFHP -A=P9#6  ]"X
M<S+C R]@VMO?T#W1)U&P_<GQ:&<^%]JWVRUKVC,*QJ:T-YFFML<<"A) :Z\#
MC#TW]9[+JSM&6N3O(-NDZFZ/VW VPE@R7QHI);C0\6?=(4?Z758C1V'Q4D !
MWZ?BX*YL7;^ K\R(Z,?%TG0--=3)I5ZS=<TB???\33XVFPPP):S+?1^SR/(?
M+HFUOY>.(](.Y.R<JZ!J2ZWI._]F7B3'^_N=0-=:7[R:K"A?R_ZA^=7.-P0A
M;VK?_<YG<^J4$&!RZUQ*)&5%J=F#'BS50&\\NX(I\[0%%J#00Y^M!>&W>1P3
M;#A,2L0]*,-P GH=<4QGMZ70X?=]&?J!5QV9L1P4!\=@2*1 Y*\D.%Q%2+I=
M3TQFR[WPYCXIJ/IAZ/9;M!<(:C6@9]W//-3AD;6;9X@^]-NL85Z6Q/M4\'?"
M9KRP&ON<AG$SNQ:1V%_\W#Q]+OMY$=O9"'*\@HB^#PM=7?,Y,FL_I_>9(V/@
MR-_N)&O^]D;9W^?0M[![PJ2C,@^9Y ,35,+F/H>QA1VPCC].<X0+_,J\()VA
M)VKQ[ZPE1(;"KWW+\>WJ.Q&@[- N";4W]F'+;$;1;#$_WK:(4]"RHBTT9=)W
M2>V '4H\WVI_*0GC[[V%$1NV]-+VA<ND._QVIX;D>'& 0%4EZ.?\D@L< C/)
M8%*#I-I9![TPIW5O!K&J;C5EG.)@^/"4;<>42MGUN''#V6&EER]N"ZZEJ9!/
M^X"!LSV^P3,@CTCO.;]AN-(3&7N#R2C^0B$E]"?QKD(I\MS@XEBKK&7YD+[I
M>B!2P#O$Q!/>N&=A7TU92G]<.B/9[.%RE_Y3!-[G3;CGEF]YL5[S9(3<V-W;
MD^B"D,@G=*T7'_HP"*&L^49T*D>PQA!6I#*<YQ_;3AQ",&Y^%P)E-X0O*P=!
M>;D@(U9%T7*JL:.Z<TF-K1''6Z?^OFDE5YGS9PYH:!2?WS6_*CE_TK<U%V+$
M^@NDM5]4N5&)\)?@%]AF>Y'PPU44W,Q]''P@=F#!0N07A1B>&\RI0NX-X;><
MRHZU[Z43WL; &W58FNZR\+;0=[Y-.!^D:$OBT,A ?HVCM/H[5* TA>=-K*KU
M1C!!0;MS20-:,"?\&@I"V,8BAL2SO@_+<X$%*I+FSUC6F>5$W8&6C6P%TMJF
MO4/>(@B"C%&698NZ+?M.P(HK*'O>[HK/,FS@C6JL4U"K#A@1PZO10HYY2?5L
M#D9%B2WJM.R#W+-ILTCN[TM6#5Q@W4Y./)K=@5#OJNL(F-ZBC3)6O&\UU5;I
MV0X-O@?S*]][BVYA&Q<\&;V<N6+MNV6W+.N')7 _0=-M,O XW&.55U3QJ?3I
M\K=QU=A-<??XOQZ\>2P[;,/:/VZO/Z$*V#LD)-")(LPW7(#G@&.S*-E%)_YU
MEJ1W)O)_A0/.5\@5M[JU ,_:( L'=<Z>'R86GIZH.FD^L<_<=!3BOSNOC5)F
M>,*Z[8%NO]BRW>5.-?A%R3B*0^,06$8T B@#<QN3;YW(FEU1>#62 YA=IYC/
MDHSB,X]C:KJ"]I(0X!A7E*+5T5? YTJ"-:_S3"#G-\W3!X+@PF1D.$HO0N5@
MM),KBD(<!$<<ZB2&]%M_?NB#Q)\:Q1H1]ONO3Y+7FOH=IM"3_9!GR0KA @IM
M+]AIO/6*+M#B!MX*1D5VEM['F8-OTR]U1*XPS_MZQJ582!6HJ C[^(&H4;<L
M#!W_(-<807.+.X*IL'Y9)X(RFDJ\[)35%;<IWA53Z/3Q=(VVK0RH_11NN0\K
M=MXV-3Q?6[PKW#K7;D5VRNIF=W:OVIS=E+:T^8@^0BN?:E*^E3M#;;NY@)]-
MNE]#?CHYQJ\5UXVH-?\@3=:R,6H*E@-G>G"M69/3JZ1E(YWE9E&B.N?+M%>8
MFB<%8_ OEXX*1K+=_L]*Q>:KK*0*D1$;-O8G,F&4V8WW1@/EQ _I6H,;'P[D
M7$BT/T.R/=Z>GBCP\;W>SM6,#J"OX');6PN_UY(YSPM&92,P'O][SR"*<=&3
M>;K*-.#1;5]P]7601)@XN-%'%&A33W8_&0*<EC^ZV)ZQ#CAPU-1\5D^!ENC\
M>LN2B%%O*S2Z1Y!5_7'(\XWU>"@70"U Y7+"::">Z+!?XOO"WT8M7A##$3')
M@<7O'"H[?(WC9%+\5WX)/='YH41=YQ1^E<_.? 7FIJ3OVG6MICT&5#-^%UJ<
M2_^KK=]?CSQP>#\HLKI&C7,'K+=YTV.3QM@$:Z?!9:A1N2UMK?\Y./C'SR:*
MC>4"+[#1,(W8X-:EV% )0O6@$=(+F-'"6XP7K8N>83LF(-OJ!41A&4N_S0W^
M.C(.Y5R>!*G+6DF%+][.EO%<6=$I+C<^T4 &U:C-H7"MJY'$PGA"A:NX?ZSJ
MFDOC[PIW>LA_:>&?_-!GK)TMFMAFKAW<:B(0Y,S786[2I)#-GYX:U;A_.Y_A
M^$,7N:0OHN$&*MVJ?*@Y?,H]WUIA BE7L0/#B^L?X\<(:*91]!/O:83"+[#E
MY)0 D9V,F*$PJ)EM7T%INH8>P.?X@U7"6@?\'&'B".P#76M%85OUQ+[]7Z'!
M?Z!"C 14'T> R$](<*AK=[:2Y)K^3>0O^PW;YP2&>E;<&X& KWS(&%Y.USQ\
M#<6@(O>+T+P'I OS7 >H9M/)< ("=%K"KS%^8@<Y\C3^)VTV:OS3X$EZ\Z:)
M[U(G$;%+MXF< JFT(Z>H#H5#=SG?:">D^#ZH7*163U23Y39,)U-[0:5JW.8)
MEB"ZH6%1'[+%[#@\+]*DC'_KM1KB&TSVP%T#IUZ(]7"!(T1E-]9KU<A42[-#
M1H75/QI>Q?YH0_\;RTAL:W:?(JRO] ?'':09IAH?G^KX=DMES?82PK/7!Q9-
M3D2DC\))GVV_=QV$?\E<<G(1I(NU!L<<.M.4?;+BC*O']W>;+T?0,9;?SQB>
M^#*Q.)S]FC-$DAR1;<N:OK:ZUNG=74T*WO+=4J WK 5)#C)7<EE5QG%;>B*B
MOU#P5'K":BZB5"1_/IJ1WWL1B[PSL:>\I7O;$9%V((D00. +'J>&!UG8</;^
MI$:0S2+5I9A8S:R!C&?_2MJ.L\\O-KK#%,BHML\6/N)>O'U@CN?IGS-8_/+2
M4-&[0=I(@O.N,?Q.HIO2TP%^U0?)C&"SS^7DX]F1+F4F1/S!C36[ZV^OB50'
M(F\9K"FG056&\!]0,RX$$M*$&)D,K+MFN1?!#U^[8R7\>(Y/=O\&V3>"F]=^
M$"Z/.*(\"617Z-:LE&$O]!AH.,93Y< W=:ZK=THUNO'WBMFBR8/,$0[_5R!!
MD&U,)G#H"*D1.<#0'E@<&L;554&,,O9D10GZ9.\]Y_51+ZSX6UA6EDWOV B<
M&MC'EK_]I+FUB L\C&3O)K'O^25S 6 '%PA-56.+Q@R)L%?]DJD?,?!AHFJN
M+'I.EK,(5N=['$#/$3B+\A<.8^.AF@:M+5!SS',N(+$. 0Y3Q(5%I<>8I;%A
MS[JOO*H+2UYX5\.G\\=?!@J.RGUL[GR*5/8R8 ^XB-S"YD.*CH4&/Z#6X]BE
M?@C)!Q"&%TIH*+4/%!RSNG'YOLBW4#YF-X)&+$0>ZZ(F'0Z,#D*)&0CFG%8'
M!Y.A#1(I^.?0P@9>3:$OG_JE-R1]P1:9(/!B&\-T=4US+3X< 7Y4G[>^2-(Z
MQD6%=Q?]<-1/O ;).;SWH 5QSE1RRK5V-<:_=MC#=D=:'D((P<H&G&DOMZ=^
MQE#UXBMHMO8S0TE+0WQ? &%M&9&F\J.XU<8C42W;5F.!%2&W"P6=+8;N1UX(
M;QQ9AWXO^/)"3U;80GAMO/'K]3!&5M9E%[]6K5?"V]Q:<>!VVS\^>TPQV_Q]
M5Q+7)45U19W@^?8(O [:'N+A]QX13_B1LQU8K0Z@-"E*PYQ,T=X@R\RGJ4YW
M.\V:)S- O;8"MW"%>]<_M<^^=]E^A^_9$W5@4?';)78XC1?*J0KS*QA-Q54K
M";H=Z\EJN)=B]^V' 7109$H;=1BJ<7*^_NK DSMPBH?C""4*C2H22&A\.<0%
MHC2VI<O=O!_TF)\1R[*!=RXA0PB/0+-*%W HX@Y^=0G-&@_24O;LINB?/]BM
M\=XKLGI:2T#Y9ZLC"S.Y(QPWT[!/,*RBS>87<8$4>V'*.1GFMT9T_C7[8WT/
MMG\#-P*K-@:(*$]R'07<$YO9M'+,I&(K;U<.E$/LT0,Y5R1OZ@=\CKY!4I=\
M(7A3&ONT,K2-"]SHV;2U),AKUC[AY<+3'K3BLR!2(> 4H-!!,U$Z&]%N6EH8
MLGE.QC1[#NU[<PQ'?A 5=$S/_YKMU_<DYC5P90$*5S-<^/E16\S+;LM/O!&0
M(9WC#(W-H:IU8-6[4D:_\D+?$ 7%5.X:M.7HNAJX J^;F =8^778,$77KFLW
MW7U 7:M#L_4Y9[>)\MU0;G]IT;ZM4.NWB5&CN1:U>!3-!>Q)-,*7@9!/ HR4
M$;^JU3JBOQ%KE[#()*3 6:(*LL.B\,R;8 IV7< %,Z)HN?-(EEMQ*6AH*L<O
M<.CX\,V;BYSBL\FK+ZW)-39M=UB@:>KX480N6&N-4(Q+F!R3HVZM<6Y#A_3*
M F/:8:UA9&YEZ@S.FN3A\OV]?5&(5+NP1G?:H,AY&[A2SW9NP=]//HEBG%;5
MY0):E8\XAT%8(4%C0Q;U:S&\CL1S_3@UT?"KIR?*Z' *:K&5"RCK/RQ@*B?Q
MEJ[8C(3>9 ;F@KQ 06+PQ_MV][E B@$O#[C\*YA="/UH79[B A-9B,30SSKM
M;EF*<*CJBB[_F2)-+C RC63,GB)N\FFTH.[6*P;>-<AV;WFH=%M;G2D\$3*>
M,Z?DD79V3Z3!RR8Q7Q2YI[]"K89%.W5T:U.SXA]M#5&OM?IK$E$X?\U66X)W
M25L ZGAXVE<7EZTR6R*4=W_?UOF\62:VQ41XI16<YVTU-+:W2Q9<[.0":UQ_
M^!=,9.>LMLZ%=-Z/-YHD)R!"*# D^DYHWB]H_CVL^B,U3>F>W5)&C-G+LOJ!
M>'$QUXK6UMP8[\E'\%J$X/PJWCDJRZ$I\GE*$<.))Z,]XEBCL$J!N.6<.Q=P
M:CHYRPN_HO#KVRD"<M-^#\,Y@Q&+@Q-D>LI[ZQAKE\ $\S[HJ.G1Z-&7(<U+
M%5/]GJ6)_B\8#Q=/!8I8'ML.V)I$[O.<0[DNB?"/^JG]96>:LAW9H")E8A?M
M=E%G%S(_R'%^LCB!*3Q]&HS>B^O#_*+ 9V5K(-8.E=^1S 3*6<O^7"!RP_\X
MDME:MJ+@5R$$I?-L2W:E)/^Q<L],6Q<N<)5ETF'-"GVR=.&PWZXZEP_SUV3W
MB]U35O-*]K7]A@R&. 2%)<:G<3BVX-"!-N*D/)('TK.1^;PK\"INB5 A_LJ)
M/?R).+3_']>4V#*Q-IRUL^#\9'*D_:.>5MAG)=DBY#M26(P1N+2M@ L0DZ+@
MK>Z*\,/7^!6&></AJME)+G"2U9H397C1L;;[S]P+'Z1YA<K^+E0R<@9U(9E-
MF=?/$8M&^/-AY$_G%)K%!NMP#,," G-#-S0P9"#S680B"L4'3G8VKWX];'(=
MJC;AH2#3=AA1@=0/OQ_AK_:(WC;^6%&!FL#XJ[KT9,G"6^UEX8=W\2LT"R13
M"M1BQ,NS47W_3\W?-ZD=1#/=2[A *L_<U>?66#"PQ>7VM+57;K+KW))"9G9B
MI"$ :)KX&YS(<,EI_>"J[];G*Z4G:B'WGX&'!:5N[_'R5I 2EH9TB2TC:CF2
M%VU5'YD]0WL_PK=M$$Q5\&FNO-6;"VA<A]TP6[%M#<559>K(K!,3"T:%O>);
MG<?W&\(L2-GX'$B1^6T82_OM!\J?X;(CY1!P,MJ_;:,<'RW+4 _0RNDFQ"PE
M5%1DEKOUPF+'Z(F;KKJ^/-#<E>&A\KX^46A=3']*B&,%-BG_<;3,;9B*30HZ
MZ-(^FQ]VOQA^[#I\B=FE^>I-$3H+FM3/SB[@RRV6Y@+Q1C%KK4\WDFS?WE#A
M*XA!/;D0,=DE?BF@\"1Z7EN"VO=HUE*5/(=K[.GZF%R2$3NRXI30P3<V("KL
M^1ZD?27F8%]BZS&+NG<(3 ;/CSP'$P=MNU=6#-*^($23<X#STH!]8586_MP+
M378E.B_[6,P^L.YPOR2L<*+].P9+FXGEPZ4TI%YK,]M#L_0VU!9)5NF-5=86
M:=R5>B.L14 M>"?G<RVTO UYHU./54NC+FA)(E2,"R TX>=9+C#YS,TU"*6G
M?" F%O 1[39UYJ.5IMX( ; F]PE?P-6UT[*<="ZP[+H0$+L"!6$6-W08L,RY
MP$P'WW3'O_>'7^5%WKH,4J/*,)R0+CS3TA>32_^=B$$4:0*BN/YV#BKQ.%>D
M=?3*.0<NT"RZ/%;A\OXN%S#J>(#7L4B62H1LGZW0&C6QLX"[G^^AC(L0N:^$
MP@5,(DMQ$9A%RW*D_BOR1)JRO<T3:/30E02\>Y$&PB2OY=J,O$;7-F]C<@$7
M4XBZ9$_@M!+GE>JIR"!ZH@H+KB8W_US^T,> 17N'(R:65,<3QI/S213#LA=4
M]I36JW5/3J0YH7*.A0B<C/*1*.&%V34[I.N[*NH!!UABZ8?X4>4TGA>UQTY)
MK%6_%T?>>?M[4Z$>*8[\JS%6S;2<D/'R\2/]NMXR,>8];V(4(M2]<82B$PT-
M4I\,9M#LK>!7\8C/K"/3)P-G:WIM)[MI746G3Z.CMY$D4_C FM*?#WJ\"'4(
M!+Q@D/S'B17"3S1C7_<;1-RBQ";@I[X3<-]P9MF-NRX5Z,_$AAP61$?>:PD8
M[=W9:L<%,OYV0I+[7^&$A%E&QMQ+"02L?GP%,3?9%-B$PIVHQ;U3Q.6MR-#5
M<0568VJ(B])Q%(?F(;!,L4X#Y )[IK"%L]+;)@OXR,6]F5&^64YS&S-D_6]N
M=#?O:#R7EK[E(T+T.IRF9MM2]L;6$!A6#VXTPYJCO(URK>\FP^6^JU!&CB(8
MNTLK$8Z.SQ3*ERV#$\F$IPSS['-30MJS=0H710AC9JK^Z_MKC_T9;^I&+#1L
M>0V:XKDBM;X(_VW F9J ]]]-2+ 86<S97O/QDY6017WGIO-BCKK( ^]\!*]C
MA_M$?_/SVD39@I_+.LK.X[AE>:11+IW(>?O$A*34]<'2;")%TXXXXL#79%IX
MT+W1VCK#T8/GA%2:I6;">D3+M,ZIYQU%T1)%9*GWG2Q4QZ6/(3.Z'NP7F\(J
MWIS6+_]>=PA^*\CJ?\5'4YIY =X;CH)[^6FNS,.5OIR7)':X 1RK#5*["$G_
MDG?S-\"J$&G\[[53+P.[:>AP%'7URE\)'SG=YYP+A=!F=IVXH50IW:[P@L"!
MG$-\5PHL6"T=(N;*1@:B]ULZ!)(L>#YY#/.RH XC^0Z\_X,+>M/8U) =Q([V
M=.DD:7\+BP1_,P-1@:0EDQ3)V.U!'6"SZ)NO2E@Y5WYSN11-.2DYL<=IAV2Q
M\M^UZ?L?/44U%:M@5M?;33PH<0JI*695(Z<(@'[$F5[7\87G\?0P*2X;,\\%
M="TZO'U">>8;P!#1!FO$@:^'_MG88CGUB@F4>G8$*K;SXOKOMOS+*>DX)ZN=
M+8@D6'.!W.#5C<#4?VMQ_"<[#45U= !%'*GYZ]2<\:)KXEOE04Q\R?R%D^((
M@@SS)^L.IZSB*1=.*G"!#[@<UQ6!^]((1I.6I^5(=<8EX6FJI,2OS@((+__P
M(\9'3E4\]I8*GT+QL/QTI]#A.><UESM*OQJ4Q?@ 9\7CS7ENGX9ZQ\)_)5JC
M] Y,JYEM1PB3R1ZM@G7!-\([NN4V;8HU&6AZ47A@.L<@'>P#C990TH$3)"WZ
M5/@*NJV<3+J43Y_T;WFN4:3'H3+)20';$&05,P0A<A2W2EY#88W@;.?A35R@
MP7B!R(&^]O039E[C*IV30L;^4Z7^7[ZE?X[_5)0E48=?E'4CTH= .!29TQX=
M"+(VS,(Q_:-X\:#B1JYSJIC6X7BM YV\#6<PG/6=*'$"4YTVCTZ4E([!%XB<
M6R)-..0/>3UKWUEU8H(L.5R>;&R^'-TLN4RP7FC8JZ49OB?9H/97E.X;K[!T
M(-# Z,:+XU.O'\%O12B6E-!QEV->5553<Z X#KUZTYU(>8-ZN?=S#(OP0[UL
M1T='J)E\AA5YPYEO;FI&(-6<$4QQ0Q[;3<=-[1PBG4)KP7E;:#+V[&L/?M/T
M\YG:+L^B? Q=,V3&[%C)J'B=$HB>N;UD,3>IJLH1UV']JOWVJ5NYG6+?W;Y_
M;/;NZ<^<?KS3<$3CEK!"T]V&=TLO!%'Q-IW*H^_>^633U2].B+>"+NQ[!.T%
M1$7KHG0N"1> ;2?H,XK$!5-LG5;\4<--%GT(UP]IJX$_]_#\7.8[!X_C%T]=
M%&&Z(Q@]Q8Q,M)3Y5WTQJN&U.V*8#/9ZCBL^ZB 4*;[PY\?5DQVIVTUBMK\;
M&?6<<'#*MA>S4":#]2V"XZ@G<T4&V0^1?MMVOV;UFYL]H8@&YMRV-6E]Z'Y=
MA\0V.=R,83J[MD\+193F=-4W9QPO]72!]B<FB'F/#W[<Z5EV/V2<CMXL;))2
MI[DOANU,E7V^N]6QH+3TX&Z6MOYUB:)1R:V:BM+HY^+*=SY[SX^I,:Q<.FXX
MI+CX7D7';^/#EPL8C"MN=WNWDAOAB7(1>F=_%*.[#7IRM=\M=EW/CJN&S?T7
M?D&OY<4RPE5)Q!&KU-CL@8;4ABA/O\%EF["7JUT:D5*U<HYS?"GII$:U"JN7
M*^(2]^#M[(P4%"MGU3Q]LR-[*JSCK-31Z-U.&6*;5,_RJ^HWZD!&SV.#ML2^
ML7WJ>D5EF3]E <]\"U+*>'ZDK]Q?7L(\1L_QUM]2V.%WC\9JFWSN#KKW(2EH
MQ[PY.T,N<9VM$?+7)->'P$ZEE/VB9GRP'L_Y2ZDM,GQ@1!N93=,?D'Y R*3U
M@"ZF$/QD&KN?\Q:[JU+Y\^DB=1)K#5',CG.1[;8BLJSY"#[J/80UE)G<GB8K
MU2+I-=46I"G(V@^5,LTYD<1>CN+[13WILXG"]_]CVF:1F11X5L/E$8N8XG%O
M7_NJQ>H^5@%?B,K0%-.2C%[F*&(:I%_=T^K@>WTPD&@4?9/:0\L14>I^MX_D
M"F1(5?9W7M\FNO!J4(Y/U#+]3T<BC78$MKT,P2(D4!)[GB%&]8:-<&$(N#L5
MR 62P[$LMX'%([T0^3J%83,(?ETJ'HX)(T&S/3,(21[1EDR87T@^D>I!9T_Y
M>DW*\758^GHW'I@& E'?XC[WA_?3@&E,^2T!4[\OXTE]R$O*T3R^9=/S:RS&
MJM7R"K,%$8G!,S$F8?4C:L<V'X4G::BNXJOE*[D>IXA0=3;)[\1XT$EG@N;T
MJ&]PA%M,Q%)_KH&_IC-_>LA2FJKKJ42O9LJE<M]*^NU30Y35%D%C*5+%Q8CI
MTGI"L&1G_3P? MBSO!+HQTSF+^3U"==E&_@@*9N\*)8'D_.RW\P%\_8ANAB<
M Z"S#;G 5GM=N&(4Q9@B:"Z@V<_+G#C^8=CS/:[Y4&T"VPFVYUW*E:T"%P_\
M26,![#2V&5S4T9) H'=Q&L1;BW1^8B"_N7%AVU I N*\37]OYMGR+]<T_^.7
M:TG:?K?8^/IRG//ATZ][)LX0PAZ\NR;IQ+2QN=0<KC6+[R2^2!0V8*$0:95H
MCX/7&,"BD.,41-N4QP6^7. "U:G)OB>:5;Y>T^'@4A!N>)BW'8\C;^.<F4 E
M^,%KD+$)Q3B/](C'2N+!9V >C<A<]Y,+#!Z$A@PY+_\I!_Y6\BU$1%\-^K0'
M)B$X?W*'XU^[D:-^B6,X:V:@A>W@0D:QB*V:/Z2PIOX1"V7\UU.18%'B3^:_
MN6>C2?5_+$9I62N&"VA_1K'7X=@*[M7A-5W_N&G7WSN?H_YM.56T9/7$@\%3
M_M;QV]-N4*>*O$JBSUXKUM:I'_WCF$A;Q>'R>1-'3@K"J>UC5D-H1KK_5?@:
M#=GEER;DLJ,(X[40Z70;AKJ][C)D$;F<AT-/T2,K>SG)^IXJGLPQV25;1MIR
MDGVE8-L&A*YLD,:S1Q-%FJ+@3^B5GM78V[14/#T2JASXT<ZS:/(DA,\QO/;&
M@H)08VUAAU=CJ03;R""9S?(NH6TA0)S*Y\S]:1Z)&Z*?RM=C?9BX";,LJV>_
M#[0W%X&E*&O>-PV3DDZWJP$OX26$D*;V:6^3B59H.!^=T<'G=2/#&N.?F*V3
ML=T(:+WX$6+2C\:-@6C;'Q<5/$^-L>7X0QBOH$!$H3E,,,E3F)D0@(%*3L!7
MEK#9=81&\#F*<A#IT%[\!"81GX^N)8KXH0?A\"L9O8UB#?=&>Z0^GZB*SJO?
M.>.7&L0\M3>\LPH93W,+$)L+]$*#,O@AL]Z ^PMZN1I]IL,:[S;_:H#%M/VE
M#7)VB8T3%UJEUR"=7\X%&(*R# 0=UNCZB< /EZ!!4?R0MG34Y_Z'-1WD6%XZ
M@Y>.##GDPMF! K4'1<.'3"]>EUD7GM-_Q/#$KMM'DCL2 %&^J7NH<*3D@84*
MM@8TEH.PII)WF"$#MI*G"-1L![)W?85%@VCQ_;2W8N-<8*&B_!07T+R)'#GM
M8)CS-G.J&5CJ:N8" E[0$^"NM)0G;6 +0@Q^G,.Q'PC='+5YKC2[96A>9#JV
MP-U=<Z&L;(?B_G?IU*"KX7?G1F1$U?>%Q,'B435XVH8.2!#'=N&;8043NL*&
MRR]A._HE/5<?3X,K'= (SZ_.<.@'%ZA71"JM'.$"XI?]X63W98IZ3IOEEI=W
MGP,-#CI3#$=JMC&XV>%B3V"LYFWGV8ZCX8[VV9NTAKT3'KT09)U97E.BB.KV
MK5Y1>_G5RRGP.O]6\:'EDG-K=!1*967Y']1YMQ5R@:'W/$2K@XSNA8WHA91$
M*4OGDPF_CC,>CG@WO/CQ=N-;06<@0G]]0Y/.[H@W P?52?R:RMWE/;"XQ!<,
M30SAOE_DP>I7V)8$?DU5I! )=; Z'*"%UXC-XQ$&SWY %S[1AP)7.@/N(XWB
M'S1EEB?Z.KH< .@:-AV\G>Q""R!Q/XQE>:NGWLP&A3.S>2^R -+:/S3](XA/
M-HO<3@J1_^?/GJ-J;+%'L.E]Y!WEV;9S 2,/"GV<N <<S ZS64YH*T4M_G:(
M&4#&:^:IJ$.X<+5!9KLOI$67'F&LI#2OKN0\VT'6=%'&N>H[-JKD-8 IP!V'
M+:<*XQ"6C'X]P07VYMS&2TK\8$0-6YR4.HV(%9SX=+G(DM\C4Q1M51 .MQW5
M4MV*W>,7#-+^B..ASVYD)'.!V?D6*C3N3/S"!51N61%'+;"B-K'WAUM-8 7K
MQ+6RL>;]<<:P'B W99APG]D*FTA-\LD;+'Y($W;F0VA,VI0AVPIZ9\8WC\:]
M1J?#=Y#.?YYF .=ADX(.]TR;.$G1C"4-9OF_'SOYL)Y_S=V$VI&US*VGR)1F
M-O+<L$EQ;3C9]_D'5'3Y^=5U8NGX68M=8ILO?\HZLB["GV\@+&&@C8@A#KX@
M*LU\S\7/^\4ZKNK\D296&F7=B?)1\I\<X@*6*%;RJLU1B8F<.PM_FPFN_6\Q
M$]C]-A/L^-M,0"X@AV([37!K_C(3:/L#JW$\#XDCAG2"RP*^SY9J+PCK;] J
MG'78QLK2EO)B/<QLZ,]!E2ADQT]]5%#SOWYVP/]-!YTOQV06G6J>ONU"\;P4
M6'Z"&0'5)78.'?*0D7)4!W6[PEY='DE71]FVG'+"^4D>J9+F5.7V:LRF.9ZM
M,#72SYSI?)_Q,^Y _;C 9'\"B>G?Y1A+3^J(;NW*[FR5#![S?)_=J#)AF-_,
M7L2,V6Y%O>*(+&;W_9L0+-^OX"+?'TB)3&VCE?JXA3]?K$U;B;QK/JG9?,5T
M6M'LEWUL_[9\1<F5:[=^AFL]BH0T1*J+,6'8.Y-#$?VB(4<_R74 FL'T]%!/
M=0)*S&*:)-/W,Q'1DR?=Y53'WF[U$)-Q-[LVC)?PUA9?SFG+=E!CJC//*UH/
M!KK>K^,"!I[O$T7DJ;I0;0LYEH$,^S0=>(&@3]WG9.69<X\4BF,&@/,A %-Y
M&4&NYX<186"2. &OZ:1I!BRQ]D$D8@BB-LI13'Z;EHY_Y>G -X82!T<6:_[T
M"'%D%4YBD/.YO\Z3605O6CW$$]X79TFVKST>XJOR2G2_Z-S#..W"C?+.B5?-
MC?6 _:+#\@7 \X%I%V<$CUH:Z\@9R24]?/@Z9E=R8J)M. *1A$Z'W.T6D9+;
MV7V[S2)G[2=G+;J[RS&9'>8-^]:&'_OQPP_8'(E]F'>9U9E(I%(0;G,)C\A,
ME?5+!,8EZ0U<X#T>C<CI9IZ*JAY<,.!L7D:M_$+0#H,+?$_^+LJW+,@^++(6
MT</-:0BT=6(KJ%<>\9-[0QVVXU]Z>&LB5:0P(/BC/[;@WIU_=VL-@L3^?8E.
MQ12#UW+\,WS41U4@37F*"_R^@D8>93WR* DU, L<PNQVY\6*]EQM! (?((H+
MXMWJ\M>M@G4B:U>H6D@; O$+!!R[3",/-OGSOG\J$ARZY2<+/PT$?Y>(6KUS
M4[ [2 OIZB?$01QS5P$78"%0_0G_B.##^XR_7H$-"<:L-DI?H'&<__&(/R%>
MFPL&I+6D>AH^879.'05-/ID4P&=L&LSK-*I@U0G4ED,OZ>;1@A'##WYR9!<\
M(PI$I#0H0XT64G=Z@F[8:^P*NQS)=T)PUV[X_&R"H W.0%'F]IEAW>C(8VF)
M,]H$'#08F_=LEFT$\*\<G>!'U76NJ*[Y;X-.+WKB!JA#*5"%TJ(M/18Y(W$$
M_[;$]+IYCQ%%-^<QNPY$$*>,Z23;?NJQL?"K4XKP*\UCBC8ERIT%WO!3XA.,
MT,5N-/M>CD.?A<ESG10A\PD5_JGS5PV++1]9263XMEZ6[3/^W/^^U\77ZH'6
MO)$]HBKHTT(=L[WG+Z@>$-*?#@X\/'UP+2M?6RM:8-J^GW;!YH!@V^^%N?=;
M+Y<>U2J(RS/W3+XK]_%2E,\>K8+&@2<'IJ]*#MSA*#8%N#5X3CD\;ES$I]R;
M#_ODZ_5513"NGE@!VLYC-V\..,<SP9#8E&<O03^W$H8:%]BO7(W4S@5V+&6Q
M#GX(I.B)VNSZ'VPV$!><GK@NVU,<JH_/Y0+DQUR >2@+<XN.BK_*X!ED) B7
M@P8NXZ/:.79F@M^+P$5E-Y"^H@0_=B6$[S@^2\N*O=PW'.X$5X[Q$*D-]1-"
M HO;\-HGI.2AMN .FPP_7X7DJ(<G[Q .(5)H9)*/XO!^J)GN*'F93@KP9EJ(
MJQ%V-!8>'05T)+'0A*IM(]1"[3^^&^?8O%2?A5_\,2JYY=U$=T96X.N1>VNK
M1]S2I7"RTB,/%5MJ;+VB=W1,9'+B+"<O6%ID69F@7OULT@&RA!]+/[:,S@HQ
M][I[/RXUMDS6]@=2\^A5JF 7+[)-;(M O@HBZD*":U%V:,Y6UXT=O0(Q7NG%
MEBMF1UE9<GV!6;4;/'<U1QX;,&_@G!73RL@X$'-U1>A[X$\RJ_%GH*#EC.8T
M_A&-_+#?CA*VNB*[S]>^M,EKVK"Y7:S'5*LI+IT99QGP\O;TG4V?O69;(H[R
M=N_S67=@N^R[.X*I:-NW^9_;U]Y*>^=_WMZPJ%I_PZ!3A!=^C$D63A5/@+*/
MN.$#EAP>#>(92RB=59OXZ0$J0^"(=Y1#Z.\D4V>=#$T\.V(90^__,P8W1,#G
M>"-THR*AC6\I)_\E GC,1K&841H!ZM5TB3P9XC$T#9ZT1PC3]O]"DXJ C#<]
M'MG!'&7/"0?+;).WX#:'%*IA41\O3-AQV&?4_T-<:J(S.R]BY%N'*L*TS$]%
M(8I7:*N#3W;/=YS21;(H:O7Y)82*U9P?+5_)L:[_X?F<AL#[LRKYKH>UFG=[
M[3VK/[B^V;Q7,G8$_V6%0KX8S L*0#Z_OY6>^:D7;QMS0U %WDI$BJCM1E5O
M@U77)NRJY)VU*57O@U5;#+W(L1D'85JV=>H^9]]O1U1W<H'Y7^EQAA6HI3]P
M,">V,]+3_\'82K+YVS1T!685"F/=NY$82S;#O2H+;TZT4-1+29=&UW8\>.ZC
M^DOBL,BNJ6))CFNRJF=]U0-!P9]= <NW&B+Y=.%F(^#[C515V]BZ,ZS'9\%]
M5@-RV"M/:7N#_HAU4]VCTN:E+67P&!SIAYAS^'KR%10M5ZUJE:6!3+\^Z&5N
ME1!@HJWRRHS_^7!X1_R4'-_ :*M)<C$]4= IQ-8=-9$"R-.2YRV=$P4#NS>D
MMFH+-XO>04B NR@P)]>L\NH58+@B,>FVHKRLR06B[!AV7. J)PT.4ESXAJ8[
M(1?4EC5!:BBT"9K!($*Z]6J09LA_@Y%$U,C$T<MQ83 ;,F*O8]2G8.7]*DJZ
MN^<2!40T3'7JV6XK\YB12^^X0+L71W&5S:B#AF?\.N::?+[W0[,9B<)HWPJ)
MBNE#-)[S/,1,[RMF=MA--OL#,;S/8HBF[[#+;]32\%'AN[&NJC_03\S]!LCQ
M3QZW?/R*+RD&Q/OG29$U[\U?/(VN^W#Q+&E)A:]0BEQQ,8+2_]&Q9!]QQ)+D
M,Z\MM=DWP.>K7<12?VG)7 47L"V4ZCK5(F@B-%%A&[$44?B#Y#MO/5(^U0C<
MH?;?&<_5O3?/)"N)351<"EGJ#SKI//=@WCJY9"770['R'5QX5Z(YH$6@D%9Y
M(\[O$5 @+& JJ. 6NV# ?M[MQ+DO,F8K_J2)HT#SK]K-VZ_)Z>_E+#:K9H)S
M^!E$C,IL&R)R0F-]>>&&'SD$LC2AAG4,3Z0O_K&6Y?]*L%XB1)AN_SZ-L#V;
M\Y?P.(FQ/%(6;X6S9*5S?7HQRV(UX<\5)EI7X/DQ@S?]K_B._SZ;8,MK-"_K
M >@2\Q(K 5U]+G!EU6PMZXG$$QWBU*HYL6?J*X#FQ7B8O[)J/G[?;&U/>GUZ
M='.*7%1/"%"1@F?$\F;M=?AJA4(YR3@*/O#:(>$V=-0A_K]<CRJ]AZ4'D<81
MQ'SI ^R&$<-V4(J_^)OSZ ):@W.-@-!)9XC!;@,IK_"-;L/X;@)L.!?#!1RW
MQY-&]FL%86^CB+*L67:C',4$E@<'/,==7  F3Q7[\):E=#"OGZV0X[,)"?S3
MVM'M \BE6<K3@*RN!/P]++$K.6/;O!*9V;+6>F)EW_0 <TN&KY49%\CZT\1A
MJ"TL9''C?9JBV=JX3&UOL[DT^<0-+D--O59V&>?3^5\S<"L(6J'\1,8-$S<T
M_S3 *=,9*XS7NS19:;>A1W'LX6&98_>"V+5BNP\KUVN*J"X.U'I6($C;@<0D
MMV"E&);41W5:N]H(;+',Z>/^LI&MSV;3[J"/G&5%\-69Z@&!.]0>ARSN/C'[
M"JG$1F)X7BCZPJ?'5TI'* X([MK,8B$=U )= )?ILHR.V]@F+E!PIF:KV\E\
MG'Z)-[L1\,'_U-327;4(WZ2Q=F+JDC'\8Z!@$S+?W*9K.#UO!>FI4,U1N 5%
MV]F)4'4%-#51F,):NX*NMQ!:3Y.GG\B5@'?AEH.X0&(=@0L\L. M!?\!%0AR
M!%0A]L8HMC-_*5RU)ZAG-00]LXW3=/).+NJ_RU FO@%5@Z_&S?!7R3-M-B&-
M(+&TH19'7KC?#+ NYN_\37E_Y@=\'76:M-!M6=,.J%)WK=&+>T/S=RV&WNF+
M4.Y9&CG1+%;W5Q-V=8&\%B3_AP+N].]8@+.6!>%.0XWY(ZM7+5*6!P.'3U#>
M^9*&;)%F(R.O'6PKV<,ZAFT!:>)_%I/"!9Y>XR1"D\K9T. E_(BVU"(#NL4%
M;-J[D7FX?ESXN.,"00O,5YH5 ,>5L]4X%0VP*CG@),.8FE9UB^*6,VE;'-*]
M*-?6B3<#>CY57@@?I$MZ1;P;-1.HQ>[4#,AOSU68)3P^$RR-T:I1S1B:51P6
MB#N%2-ZJ"CMSV9TW.B]?<NS-2*\\YJ<['%Q+V#@E#CT)X,_TVV16^-EEHB+4
MTD:YSM(Y[$TG6E VTJ 0<'=VX-=5V"9@ZC=<.<6)H96PY8?41R//Z_I;?GMB
M!RK,G:(F/*X4E'PBLW6][%+H$'YFBII*-G]&46-&_P >6@P/C6+J(Q7G,8\J
M=Y#O2/@1"QST X1^U$;A;SOS3UWO_&,E8X>9_ORE:\H-=6B*S=ZW',@6F'XR
MJ#FM<UO$?^+JRPK740N4+=!]T=>2HK5CA>-*<PH! GES'*N#M.JB'7SLOC&*
MKG@1SW[[F4#^QH:XP,/\8O9UX=?@]/D__3)X(="I(<4_P*<I@B#'ZWRQ97E3
M/$?QJL]^SW)7-<\XV@>7(S]!(\?C<_&!SD*F^"_&GVMMG>D5Q:A5,;<H1JLP
M=H]?Z#HOSGLU"T%J+ 4KE1'UU?8$O\Q SP/&M\)ZML<J=I_?"Q^P6QG7T.@+
MKLC"2BT+Q'$W+N !S9(VC&YC&R,C69:3POZJM]I:5%XST!$S,P,]AX["*L3K
M,DZWH0%=MNL^9ML6;5?TL@',A 8<V2Y:=9RWH"!J!!$:":^$3[8<NU$<P$'0
M:"6)T8[],="/9DV*4,S-M;=QHG'4-#(RB,3-G;E /PYFH4;.3R9N$KHQ$4Y%
M>!E2%A8!A@,XF(E<H$89#&D7RK+V(80*G,^#51@S=K[,>I)Z$Q56M7G4C4?U
M[Z(GJLJZ8=ZPI\@:'T?H/*<-F9!53+YP[C$1ME4Q$*WU\@S8I.E&'=4/NW9X
M:.?FS)%3$?Y.A=@JJ&I_)?K7?4M-Y6&[Y%4],2O?O0:]6XIS?%[\9:;)"KUX
MRO?KW1>H7A(\"9\_)LDSVCS\_]9H(Y]=I6_X)5'04N:% 9F08EG287"6"VPG
M+68^'4PP5$\4XK]EAZBOZ?<3YA/G7==Q@9.XD^GW.NYU_/_^N-QQ.37*]^$=
M'K@51;"5IT/>A$T$W![IN8!]!4[O1EC[G@KQ!TMUP5Q@WUJ\[3)A(^<K87LK
M-'HYLB*KFCC=/F4A:(L=S/SDFV4PMS%G/V#E67'N"AKY<\W1-M)/^>!JK^U4
M/(4N+CD^VRZ'742&*JW;S0M6.3 \%SR.N6;\K&&G7WW59O"TXM:EFO>?NN:1
M =RN-HH53.>X#M>W%HW*H#PIUMO9:EMEV1N@ZL]3PUL']%U3NTB*7DD#=00X
M @-PJD4\<ZX[^VO.CH=?IO8<KWMP]L;NS5O(!"/:]I*@Y"'J8D+RSR[P<5HH
MO$43I82GG65N7L[]^OQ3;WOWIR>$Q\9_D&]3^T^4P;)L1:R$7\ZA:OU04>-6
M*R\$4( Y(GZ"O>?PB$[>F".3(WL0FQ#=:+DM,"SE^,IVE_*:H"/XB=B0$,7F
M5^_B?[T>GDOVV2^FQD<;NVEEE84V4STDL3>MPI/FRSQO?'S*$J/&/,51T%[$
M_U'DX\@@)S!*)LR"H +%2G+<R2S?\7*$=0;#!\R@<CG^2<*OXR9%L#R*UH_B
MK,N:1)VL].%$7U,4"0$I!2!SDTW%:J?M Z@IN2E3VD?:1_Q_?)@]7KJI,\^\
M<&%V-5:5WX:78M !=LM2OZ3'(0)%IN,!*>"R^\K=2S1<VK#;8]Q<R'2EC,F$
M_1GHISDS=LQQS.5H4E_%!1(7R$TLGK4^\?7H>AYVHJ0DBVYVGM>V]1$%XIR[
MY9T3=0S#VEJU!8U,DEZ' %=]>=NL\<+RM/ 9%B$)1D=C;>7XCK=8(\?H1>=]
M(;9R0 _#(F>_NK_9VH^<Z8HOA24R0V>.;34<D3!U#=-T79G3(GDOIW?;>>Y%
M'U==&V.?MINO0>;:93/!"<+RDS0V!V&' PBH$ <+W,&)N0$8)C#(A<7L8UTC
MN,?,KEY$WFW=-(>/EV5?)7.V\KX$K=TQ,*)-T[!AG6Z'L;,(P4+ :SBJ>SM^
M:460P\%0"1X8QO4(A&G2">P_!J#PL\2%;P,T0U5BC4XE4@^_;@U4<.COJEHY
M[Q%\!-[E BMTJ*ZB&?4IC;/5Q/O/6@S85_]QQ@5&M)W]G);#_\TC8V8WH5=9
MCV NH,0@ET)U"E"K#!E<T($0+4 -P2-U-K/_P$#A?.^'H-_/A\!S*(;M#+<@
MO C_&6(QB2,.$[A?EO#S Z6(EMLT3TWI82D@\UJF"\$;NH&PBD#P$P36VD+-
M?41>VQ)=_T\S?;; WTBPRX%B)*?$/*P0?1G1&^PV$Z22M38#[/-(K6#W\;]J
MM6&[_-L77!$8LVSCN?JAFPRO)Q 9F=1FW,!F^ ^W?M&N_0SW(4W(E"I56S3>
MU6^_?5KNLM[UI5NU6XWE/$I'X=U"FTOH$B8CG,-_EL0_DI6^O^-35.V(U/DJ
MN+ +VX079 NE=D^/#*<%JWX/Q174[']>V.9Q0."(R)OP(&#M2%$@96I_&W0]
MOWU(*_L40CRVTZ"9#A&+%?8V[)511M1:1)6\D^0"$C8]E3X!Q0LK([)57.!)
MT;%?#..J[O$GGD>%]G9/[@!*I8Z=E1F1)7K;AV"[I+=XQ/H^)TIM]>+(R:R
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M7N(K6-.YM^!3^1=[OW*$%&)B ,%/1)<R7M[.AH<P50^:)(%NQFQM$>+5MTM
MXD>JA3SW\E6R9N[6@?+SB./@Q "*'\0OU(.DLTXT1<B%<1:2NM$D"N$I':C8
MZ6!L'XC(3!?V\*99OG81P5O_TJ:H8*>T*302].NS=="!YFS(E[+DD3J-H;'<
MC<[_2 <H=E@#"JTF/C.WS^7H:LE*%EAW@B:_V:<JK%Y5BJ'805Z$,Y/T35L%
M$](R:!@#"6H\G_6:QI?-DD3Q3'T%.X\XP4/;HT=,I /?D'5#$*K(A7HE8@E7
M$)&0OSI,<!HD&S$.R,PY@8\"55XJ94.=Y!''892#X5,7K6G' CC6Z,!+!JLD
M+$%W[ 4,3E0@0%.Z@D$':WSDRGM4E$IW:\A;3 Q#^+>D7BADH=C0Y C('S9_
M[ ,)NLC(<):%@'U".,K5!PCR%:S1P$52'Q&J'IB)D]IZNW4#"E<L+TA%BA1=
M[TFGW<-F)4P2];?UCFO^?'(@$G-'>P*5#@+J^^;@)<OU_CRU"1*-@Y^& [:.
M?4ET\'WW3, M^E7TX4.UU_4!9O'II%Y/K.+)FX\1L>?-[]XNWE;T.%L"IEZF
MC=,N5#R=[G _L@JF-@W^1O\R;:UX)_=-?"HEVYZG,\=C.'#B/D(+LN76+NQE
MB5/_Y==@_6_]W#(-/BX>"+,8.)(RJ6C18M\V>U\,77N=+6^$8F2_FEC^0,C^
M(/ZF[YOI"425BI'YB$*DZ3MG2?&8F&NKU+DA#B[$*!HQ6D*A SZJT"=90?6O
M;[A5ZBSTQWP1MYF*V\RE SL- _]OK"^0H:;DI=<0'%);!'1$/IOR9G5V&88A
MRQ5GU<$OVH@X=_:F$R=?G3O1VB 2,A0!D%9UJ*/5^#)?XU#.NUI"TG@<OU?"
M<CWM=)\E^SE'$?/*&U;WC/<*!C+QS0+<<^"^FF/'RE2/H-/:G<0BWYA>E*+4
M*@*^1\EE1OKKAQ.J;U#"E.4768T=S)@I![E(' !C1VW_[3*I+^*,,U,R;S[O
M09)G(#C>(QQ[??XE9P\XAJ#ZV-MU^>@Q#MU:G^UC=QO\Z)!G7D!HW[DP?W8P
MC^<CY&P#Z,#V6CP/[C".F+M!Y$ZF[8%\/F,_^ >G0Z9TP -* 1]AM]<">YVJ
MQGYCINTEZZ&K3VYIX6"+SQ+]I9RX3980$BT7F%8^O]3.>S@;(%K2ZZ:FWN.L
M])Z%76 1+2;B&I)T64UCKNJ6;JX6,2/A2SYV&0*2_,^JW=,+""/@6 A-89TY
MX&62]'LGN*W>\ *- B=F_9CD9&RX0NTDG?Q!/3<LVOTN=;=0J%!<A#KT$GFT
MUS[3@5I7FN)9*Y4(EX1?X(25#2T.)'&"4%0U&4:DXVG,&&(RYV1_E;_=-0@<
M=N-Z*BH")&V*Z #KW#9T83"SG2A_M;KQAKEE]$\VFUHX6F'WK_7FSMR LCJO
M+/S-<OA21!\1%256.)!O=5O=]JJ8>-Q>3O_S@TF(%S*4:UF?J1'2$D\/5MS#
MBYT33]P+;!=LW.42*G\F?C18@0@TNA_5=]Z*V(0C1BN1+#]^S-5P]TR5A9T[
ML#05&\MV9C$YVE]7,CL/BQC-9DK!D[OQY $0LZR-6;[ZKZT-Z-J9A N(G3F:
MS*A^E1^\+\9TR;U,]U37PRRU"0_Q!&#(06.#=U/Q$*K<D\*4Z_EY?+7).'JS
MBV9XDN-3S:[DF.O"92''4I8-T_L81S1K..I^].WWZ-]-DQVHA/(_#H.8ZRW*
MR7G7KIE]LW^TYW/$F.-I"SG)@CNG5=9QJ@2YF-7!9NPP/U>PI;C*I5'!BD'N
M"_#2'R-I8J?XVU[DIA$$79,J"^Y4#;X1+M@>;$%\4JRW$U98O3Y]P&GKN8DF
MU88[JOTRM?Q._\.5<8+$N!KR[4<M1#3_+&(B-Q^<U7I)=7>C U.&*]9!4^Q^
MNQ<BUO*J0;-=+:5TH,'4@K%=11)+N0;Y_Q<W,<-?H3GQ[84DC8-1-HYXI+#T
MFA5M2P?"BBH8\/0J'1BZC2#UPPD#QO U,5TTF3T3FF\%W#_T2C(7-$PV,"1[
M ?3V 2A7J*N"@B<D@@QB5@M*?=B@K+AYH<G#6>OK']8F%B#$&;6]0X"Q<:)P
MAP,2)+W[0W*OS0^(8,$?@FDMU+!#D$A0!L/Q #*;"PI)4'ZBA*0I6DH7OV#(
MB!JN'W?$!:7-(_D9G%$D>W9&O[\$(:)DT#*!14L(PH 2 A*<#H0P!L4 "Y69
M:?=M$01'*#!6&S\00%#=_FA<7"FDRB'92V;H*TM1C&VA[BX&QT>@DE=!'$.+
M,A!28H.@@(G*A_JB2?;2073@C *&]$>L$H50#B:K83HPD>MXWHL?V6(,7=:@
MYEHSU$11!%J@ <EI\KA1#(FEO5%8L31NBQ!B,--V)]_6L[);Q0:ERV6U_<AI
M1M(B"OB_1V3G9U)T91 C"JSHNUUTP%&/P^RWM Z%.TOB9_'N@;-8M.-N98E/
MQ&"@6;G3U[AOF+.(NRGTQ=:/_95E41-6'JI[Q/8QB0@'!8HSCP&#OPJ"K=@G
MEQ"T*O0"*GE;]NFKTMM\S%..[VW2K"N"Y:A2[,+OJ>65SW"W%FZVY))I977:
M'YUFQ_),T3?52P_[[%-IP2X8B_5K%X!FJT/N%UL0>9;/#>=6K\/<JI+7J7:7
M^X*6+2Q\,K$+1E9]C/UQ>XH&3Q$415&ONI]M*+9K9_GV9SGY7]NE\K3@2:(P
MAQZ>/'BNW#K?>WZW8@K'V%M>97Q*#C/R?SXP_:T^9DEX:C69 [[3LGAXBR<'
M73OSEIJ6M,94\,?!*&TDTY87KM&&;D SW?]F'P=VIVTA]I/:X&H&'7! &T*$
M('^+Q9/[/-DYIH\=GXKR>A<<+?4 <=TK5SY?%L*-F.:7"[6>MTAT (HJ>Q/B
M&KCVV#6^>W'PA_ATJ?)3FLUE+SK0A H[8LE>^:E/(6M4366BND1 &3RAL0<X
MJ'LT4#+ZL2:>A0F:YB^SY@W\[6-)L5D7<[W.TG8MK*B>D5N[H7 G<:-6,EUA
MG?\+C@-M7%U>R_E9OG58'IWG@AI&'31&0BG2'ECX*'GQIDB\[=5#2P&.5J\S
M5LE%1V[$*(^$P02-]1:UQ4(2;J?VE%:,Y-_[5#9U(PM&Z^VIJ=M8=^4M4K<>
MHE2K:I:@%7178<UG"5KV:N[H9_:92_ZN#4O@QL%@PYXA[0V<PH%C(ULKD:8W
MW[8Z:K9P]YTIR)RZ<1IYY7[B$KH1O1^7:_?&I=WN8.\-O<NB/W?=F#@HH^\S
MG>0;%&FX3$*NHTNV1OTKA'5?!DS?<7@D[-J[90P#V=+MIUX\&"^I.KM">J[U
MZKY)?*I6-_?;H.:S!5IB0<TZN?*>!>HA(6FH/<:7!WAVL9V:2>\Z'6F5(_4U
M*LWES'$+,^%*2/7.$KQW@!]\X0EJ'N;^\SR$@PL5T2)Z&\]=5 N4J#J+/Y !
ML?5F/^WW3/IGU$__$ +U;\Z<99\NRUP6[Y0K,P>2 @F/[7>M3%D*'UJUZI55
M_PYE!$N]NXU@(WCV+FZYR-]2NLS9S"+WGH?B4%"H7S E:T9VL/DM2S_5OOTY
M4)V4A9VX:X^P7MVW00?FGU3LCUHJW9RSN"1O9]U8KU1882+0Z)P=]_6H7\R]
M/2\3_2$O(./#W.S:Y*KG75 0!F6/#RRWL(0HZ2<K<$_,QB(O,?+W]U6K?.6Y
MRVUJH=7>>2=IQA@F4:.G0<#BYT+OA1L%C:<>I(SA?]"!CZ9>@5:LA<H=CP>C
M[:R;F [63RPQSC.JO"C:^,/OU8-8O[5AU"]8BJI[KH#O%T_:@1M'>V5#VVU\
M7.,C.2JN.+:^<H[\O2=8^[JRV&$++@LG87N]HQ=5X0N6B'5FDK%Z&3_EPH"9
MR*07Y[TH#;^@D,K"\X-LQ?/H26^6-SRB0_8JA:;[',J_FM^Y=\?Y1>YW8$TR
M*,:D^+9]L:T4VSLO./G\11'O?5SQO3226Z>!8.%\\OW)YT$+( %CK_ZP%V(C
M?M5;C*2%!--/^UT8&%:KM_?;<O[D%^CM&C1:O9[O;O+[YW/VS*;1:K!?CN4D
MJ@(OQ!O(TY<D;^#P6[&->U^5^_@W2_@M>'0#:_R[D%X2[!1UE/1AW$<KFRAM
M4?1B6C=O(W-XSP@P=_C!TX6%2,S5@8?/IYR>)D!1PHVJ-6;8?6KZ2V_>,4V9
M!//[W^HR[S&O9,B7&0@+1.M,5I,-8FY7E5=<ZG'2\$4=VG_UI'?S#^=(*UF*
M&)]C_SSM4)D]<L^LT4K8P89,<ZWY!I;3SS19/$2"=R_:C 1B":\@@U]JH@-E
MI3>L-]YE'.!0BTS2O&K6;.ZA)+TJ9C4C"*CTZ17X:9&E;N7;B$XM;GR]SV_N
ML!HR\ZMV9-,TP  UH1KM8X03:K:]DIEN%*B=0<(T=FN[4M-]K5R67*4U-^R1
MIZP",2/-W\5+/E)GQ@]Z 88C_.W7B8-/3Y8^G39\,W^5;Y<S/Z!7Q(<'#L*@
MX2S)N!L2L1S O!C>%+?9DG;D%-])MC,KQW["+<36YM5C]=MV]2<56!'.UQW1
MY?7G<YPV!-K<3T8?J9W7/._B0P#6 &/3#R1/+<+\J_0Y#Y\ K3V?@JZ_FM6!
M7%\66*^A9H0FZ< ^#JK]F#?MWJ*M>=/6.U_XP7_30*H/:JF.L4,.\>*4QJS?
M7ZZZE@8%6$\*36%Y*8CZBS+;QS&VXW:+V HSD^'7^I:7-'\&E-9^_X/R1.QT
M1EJW(WQ&4]V<MR8#%?\_#!BIT6N7E!&!"QK\2> 78?#+G6MYO*LODCW:9DHR
MB$=O!CQRQ53;.<+N;J!]D*6A\T/;">,/B7<M5K";@U"TS,)-W8)# *4&3;KA
M/+16XI'3WV)AI!0I>Z!:,A^@4,.FZ,#E,N]%.K!_+_[USM-.1H_&#B6P<0J?
MUFQ5OTL']LH<L99-SI%\YNXR?UWQ9]H1P0,5*VH!9? H@4U)X5B)%K3"*;4D
MG;4?>MI.-0/R[?;8Q.FG5X*]Y[7LI\:>8P[3I.?45?H62Y$\[=X?]!XO9;9X
M.K$LBDI*I7_3?!M<S)ST) EY,[CERW<Y\Z#U#A^E\!_3^FI1WDLHYC9BZI1,
M$A//FS/J&M>''YE:O0KJ39'@42^6]>N'9K,])K+*SW>RSVWPA=:D_JLC5]"G
MVN::[[V$.V0.!,%3YX[.?183VKX5YQ(-$\MN41W$&R#*QEI,'<5"R!>OKNY[
M=LA*^ZE[DHG^N:F3$2#S4(_DT@.RIH7I%G%L3L+OE2PE^*B:0V/EW,]I*L<I
M;=<U*X]%YZ1QYA^C<=_4M)&.TJL=H!UBF&=I]#JV9\,_6;N<+"HXU2GE"[H%
MK>,+%,UI_#D;8639=QM4:75D/&(2"4.5O%63ZSO4FW[DKNMR.VXI:_W^FZ$F
MB>A=')^_\CA+!WH+[A]:CF0>?8MM?!L)7]S8U_AY"2'")\*4Y/)XCZ2(SV#]
M#5H?JE1L;#=M)'WKX5WAL<5XUQ WT07T[Y?JU7C5?D5J#L+&H^00%7NE+?0^
MG"@5SG=V63)#)4-;Z-Q<DU&*ZQI"-WIS\5?9X2CE[S]^A9:S6GX_5Z>FJ3ZZ
M[J?C 8!,J/<YY)L!7>WNO_RQ>BN4*8C#4U>TFMC:FI^_OL^JX>!&/O5#0,<,
M:&,KOG4,N<5RL>_2HJ_;5^8U6%&3].EN>&K$=UY)K"7F2JRX0VHTIU<+/"_
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ML0Y;@9>3P1MRP[;%(&>>JV+:&9VOI]D/L[P\[X+D1F=<Y;E>_O#H@?LW3:,
M(%A7+5 P9O8$-O1WI(_,F]T/I*T=][X*1GA4'U@PP:6DJ;S'_./OK9M=:9TC
MX'*@DP2AIS7("_R(,'C+G+(O,X6[$9H&#UN,HINOIGR%5S\A@-NT];/,Q1\^
MFLSO'VNJD6\E?_4),9K[3U]2];_WHQ@O&JT#<+IJ<'[D?U/DE-[R%H5'>"B2
M6PBTLI \TO YSXMW+J&[OFD9^,/  F2>B[QEFVJ8KN#GHK:'JKV%+T;T&@_9
M7;TH],KZ:1^$)VX9J'=)G]\)0Q\YKL%+]_Z]F*RH$- E1=;(7?ZSY-C73=9(
M7=I54OV7Q3/?TE[:A2[=V_EG(>#_Y,[9ZD6"RNO,D<2.BWCRH&3VM:,/6ZXF
MO-D]=XQXR3G*@[$"G .%DK2]4WZ!Q[1\W)8MP2S%=FN^F4IRZS*G\V<%;BL<
MQ3.U[6RZRPK'BL**3J/+8XN7 4_V:]O-UQR8RV$K>#0TJ\Q]RZ#74=;X4--,
MX.GT(!;_W77P(&ZV.,\\DH?SJ=C&[J79W".:= "=+4E4"&[IBOEQJ0=.R  ?
MBKE&$&W5I;RZE'@.T(%Q(2P=X,]J:7(2E-2+;Z%6FD/Y],==+:7O3_D?#]=#
M7B%B2>:6D-UAXAFG&8[]N7/-;MV"6%V%TYAV6LL<47LZI[&1]4,73JLBKA*M
M6B1IEE90DBD-TA2O0>@\<PJ]M8VF \ 2A/7[F;(77J1Q70E="YJSO!X@1?H)
MQ8UO 1CBG!-C!QIBPIHT1@NX!:6PIZ#6(SSLPLG;YVC+<]?5HQ"?MXT3P/IO
MQ.P%9SAMUP[SBT3)9FN:>>9?Q5TM']I2"]*-8R[?&JZF4"X3GT$(?0Y*FM\P
M]K*]@T1G;X:OCB (!W=4>5STLRVE('/.<+I+.]T92\!X?<'^*@;'3\(I=O%^
M[I.]=. 4E(4PW6'<8K<XZ5Z0C$;V?'!@\0F(_8H1\"J$1(=@=*T-@C2B0,(U
M@:O]((&?BZ:H/_'0K2-9=E-+/5; YC@5UU/9,,5U&+-EA]BIUO&[/8G9FM\I
M*%WN,GW/L[$7= LP .]D;MHG0J&V!,J0^L!Q!3CC=KR>*I(.J,%HS'70 ,U6
ML<NGW69%5"!.E%M]"*U 1]%B6\%ZTTF004\8HG>K81)W* S640<3.T( B54*
M[/+R+?PZ*K0TYR&KE7R>ANWS_L6W2FR4F1\W(^_(]V$T.WPD&N:KTAM+?JI&
MK03R,A?"ZS2RU[Z<\#T[QL)^.#SG(V4,@QIX:;*)Y"!EF7KY7OD42U0]^UA;
MQ"J:5RLE:!,F0I6V@Q_1%H%[+EA*6G/,+E15<:C):,G'7#WI\XV_1W<03N#_
MLA%DZ9]9^I7-=1A*^1!CZRD'.V3_P=+^C;^0N7V;]2DYT9!/AJVW0]M=SL8G
MBE/?7MV4#GBV6%8;%+U)JU3E:L[N<*=))N1)U+7BRWVR%48SAU\>N?^YQ2=;
MXI=!M.O:Q^C.:ZQV%M$+HR7K[,LR9S0WLM+B!SQ2CGJU'MZ'5WQO6]V,KVQ1
M7%5:$O*7&$UE(0[?'@G^JF=>VQ/(HE,]+NCR)("YS[@KH2RQF*>68O]5U6E<
MFFH#^3TFW$@R5Y(;@M?,YI;"H(?9:^<LB7>+D:>!-LESM<)EW>84#T)3SR&@
M3]* STKHTSA,7T?!Z_F&UT"9Q*M#MRJ?67 _,#1B.1"\6V1ZO[/)$41)YC.W
M4S(S]0W7PZ3RST4;]7ZP+3S]6# RT+E3+H$UNUN;V-#@:GW?+":H+R\?5+<5
MF(H+B\GU>:J^D0::36=0$ZOU3AX_-!^5M5NRK2SJ3*,UR\LS/DGK<(J\8P$Z
MR3MQNXPI>PBL7R.TW$X(IS&#ZXQEVZ4)]+6+T/0&M]>;X=\_&\!;)!<@^+EO
MXB/H@QP(>I])D77:Y]:< MD/ENJ#F/#U0O5>A^:[$^V+,TCHV,[<3&.DWV&/
M^Q%?)!<TA';:^]C!21QT8##]GQDT@0U*\YBQF/54&E^# 6T-\S:9$T?C*0]#
M?,X"QV7I@&4<HR2_PP"UPZ"3'V) Z9"DR =D4[= ,V )A$2P(E>%TW;1@?6Y
MOY<@=1CO\?Q+#NV=]G,(^1V!4/NV_Q(HE<93$*:FR,4XG'5AD.?O>J))#ZFW
MR"L!I4S#8/TZ ;OI_J=)]\[AM/ 1QE:H;BRD 1U@J##Z+RKD 1X8PI?JT[X0
M!W:(0QI"R$]FK.$O?2IP.X1[ DK_IGHR9R]#!N3E/@0[I"*"QA,>?C;FEYU)
MLR[Y> L^81(Q\6[](L4%G:)0&-"I0JV>-%$4>').)$<K/PV:*G<N QXAT.^>
MH/12.^NUYIN[=H]AE3ANUI9F',>"F1O!-"/E_!1+^J?Q/9WRP<Z8.9,JL!;+
M_=T__>;&'I&*F^A]PVXR\6JU8L'G#X08K&&_>QH7OT\ZO]6EW"[N_%$F(-"W
MBRTN:+TUC6CX!//PB\G ]:;A_D# )]%X<%28"'MG:_=Q:V4B2G[=<"\8ZS<V
M@0U6R7AW0AXI-DX'#A2X$I)"7#-^?%#79<Y.YC+I61<3M]/-,X0"I7+^K2MC
M_%**N27\P,^(U=&\)O]EBT57_G+!YD"5<Q"HN!VV4IGU4-&'#ST0J*)3H+9J
MG%+%Z.8H$&*<G$CL8"E)"UOP&/7/N=")7XXDUN4_Y.O45ELU,S*&G_=7Z;V@
M](\A.LLL 6%SV#_9R','E&G8V5"3;VP$F8[N@#.F[-2-(.UA5NL=3+[&EH$>
M9H7;<+__@\WY_SM=T]L*GJAR?O'^Z#+Z9OK3LN;UGP%DEK.\SKCTF[%OM7@/
MS/K/F[3?G&=U1?=\U,V.G:/,Y^:.F>6(E@2X!98=R]7V,S15C&;L*,HY*9L(
M7LF6^(Q/$1Y*]N&Y/[A;#30+ON85N6IPOPR\DK_A-&O#ESPJ*O;%,*;I)*9E
MNU^R]^<Z6TY;&FS^[>%]LM6/CL+P5/NHP9JCS_(<[YP9OR:@W38E[HQIY'SL
M/ CC[NV8>.?M6@.,,1[<2U4*+&VKH0:74Z ,^ 7P>'FR0U3W=L>V^:XA=I>]
MG#Z[*)G3C8;M_A?8F\8<7)U<WC;//C3F6VL5MWZU-:@!F<2:DK**F77?>:X%
M@_P:=I+^>LA/DL_ Q#;;ZR./?.ZOHAUC_4::*M^+UWF=T<KL3KL.BMI^?NZR
M]]4\+WS!&#&A13HG PM;NN%_F!O^4E' ;S?!W)TP4K0-!6A^O_HB<]\I@5I>
M,8'PBX-?Y+\Y;<W*UY&GRO77[]8 ) GLC,DGR@^*+8: 2X*I^<E"B,%?B=0S
MPW.<*]YYL^4JF"N$4$&JKJ_R%*!.NU/FC:A)JI!=7BC#4B$@/L5P;4OCR&UN
M*"%?9NS-4PYYC>ZD QG/(JVH=^:VNC?0VX_>N](*W2D09"!T!C!#B;O9&&T;
M9+RS*\R5P$/=^XD.;#*V% K6?97'":D.$2/!/,ND]S9DG05\2R*>:K=.F4>2
MK.$ '>C*=F <7D/J 1N423!:J!Y(9NP=C+KSBV\C"+U.W.!=-:;8!G0A\-7^
M=.#7Q\V%40PDX=0X?)O[%'9'0(@2@@GLRG;:(=3]33!UI[G7.,1TY/Q&.EF'
M#B01-R&,DS-6$, X]<\:Q01QSONK T1N>1P%*8S]F[XV5?#54?6QE7Y?M^7A
M.!SDG$]]6(<F(78*B?J^7-O>6[\Q16.!!@N)"A3>:YG$5PXG'&-T#6V?T<9+
MVMZC ]@<FD*T7I'G^0]<R_( XHS=,&4/P<6-\*N"#@1!/T=!+995>I>JK%7B
M=,"R:B\>?KS3PBM&KTTS>[B5)/GHX!ZT<%L%NM&H)83B?"1B\)ZR?GL0S]<A
MF-0#Y69=X!D C!-<8'P_4*'J\$A (1UP$QA"XXTF2*ZI#;0"_1MK#R%Q]*_E
M[(HP>W<6L9]E7DYRP:R+5/(-BFAYKH6D"SWP2H?RV>9\[91<T$,UX%ARB;^J
M%CXEV[CQI.\ _USN%S8$_]N3J)^TP[M_HBU/C>9JYQ_T@=(=H9AM_A*A'&(3
MX-B2>Z09N6 TV8\6Q"?41HRL]BHZ\IH%V3BU9!_)<1X[0@=VV>]2E(XH$Q!T
M;]JEE%ISO-51;=NPU8DE!^/'7_NT9%QJJF\MIQOQ.AY6H_M1P\[_'QR)W'_7
M)7%C_-T\E=3.P=_8,G*.@L<?+HM;J87KJTFQQP^'KN8_]MT>5/+/UL4I=H^:
M_[Z'8%[/->]0*'<<<;Y^HWW4+GK?BCW;IDD<)I[FWG][-K*1:#(8(.B!@Z>S
M"KIO%,EP=8(J>$6.>Y8!KEN#KMX3RN*=L#D3I5'6)(W'B"O RO)!4M!$:/-4
MM)J]YWA'67E$:<^FQ\OY/4[9O"/B&M/BK_+/<(D<#(>E**]EJ6H3"FY6CUZW
M[HU8=3 ?QSP;CV_/Q+E;.7?^>&XLM?";=[_VN,TA=1I1:7%L7.A6@]QHRT3[
M.4=#[M@/^^)%<CB9F$/X!:U(E_U2)V4# PZ555>4T;Z)'M-Z\O%;PR^Y^*<P
M9;@DWU+0K'0X <IM$+;@KC2"*6EXV:+8JSJ];'"2;"?"<B?[4:$8;ZL:IS)W
MVWR2 C7UM[BLQ,P[:6(<[1M:U7-:N/3[6>MR4[]#A(ZFU@K[/?M&;1*5DFJ=
MR)J5G?+H];1$MSJQE"8+R!SJG]MO/"BNT*E.8>O__-(OF$MD7\A@^Y2:*\YL
MBS8V"2Z)9>X3G5V9JDXPN$0'CAJ]FP*79*K9K\'0VT]::/"O+^%0!E:/)FP.
MA^*^2Z[ZT8%2ZR79%S2;N'.=<M7,4?%3Z1J,.RZAM/8-L&C$V]+X58CG,8\M
M-N'*3H^#\H.JZS/5 ,6-F@&#/^P""3?^.C!_(ZZ%XC,+1RT^Q=8'EZD_1075
M"$=-6[#K-GZX<1IAZ^?(LVM<T)IW5>/<'#HND_LV:(UE9Y?X=,33\OJS.^P;
ME?)%=VR 3M=7 H6XFSIJ&HJKFQ19S+ 5S1_*-PY?IAU.G1I<DA\>U,!1@T7I
MP%Y6J]D"THT 0?N"4@$]M%*'?+0,2B"R77GJ7//:K:AX%C=Q P0!5W.$C'BU
MH8>1_GIZ:LG%VO;9!U6\\O 2SB)QG7MUC"*+&WY096;#/)>VPP"_= ;\U:LA
M3 >^'P!#F?[B0-;&;.A2<*>_ZE;Z.:Y&6S4[OR"FM%S=I7+P1.)82?@3F9,=
MI0EN*Q?NK9P>O'G0>''%W$IY_EYLLT^TYCQ3 3,<(F>+V5KO0C"&RN Y<6HC
MX4'+=P6F,<3W ]9S/4'"$]E^'(3AJ[W4($J#M#XR8>CG@ZB;SG,UO)UJ/$(=
MY^L0C!\CO\S<US4]IR5(6/S5NU_#QK D+W'!;8P9P1P=,59:D[HYIA,RK';L
M*!TH3NB!IF&CTS#R6DWPS/DOX@H.G^UM;\0ZR@4#@IY3@EVP68NQ$EQ@]?'Q
MMXX.%$5KM7&DW/VW_$8C;:T_D<KB:[_M)['/$^(V9!O/+:9*\\38[K'I9;8_
M:Q$,NQ@NN']WOK9%-34EX*B%_J@H*2A?+7&%QT&]WJCL$W/QTZG:815 <S*]
M*V#/PJM680.7Z>D23\EH\)!&]XA-U53'P=.N70^K.A F<>A$FCOC<,;RC:<L
MP9^E95EQPF<05_:>'%HX0US%=)8OECWSVD+C#18ITJ)3TMM&_9CP[W(M<QK\
M9U72P@4'=3/F99QC3 9\E"V<S0?.JEN>HT@=Z)[;?/15OK?&WD/@?7>VFK/%
MTFMM@A!R:]G,_K0A\/C\7IL8O7]8&)D/93@Y@P))Z@0^*XMQTZ? ^YB!4B8J
MG2E;?\5UU=5D\):P=\[F/J1^['MG8=?MF>34,Y-6'=>3;G78M'.Z-JM]3/N$
M[PF*5_E0VE6XSOVKYACA44)0 )?B8H_I&R&H-N%>.:L4WTK<4W4./7_LM*-_
M#JX,_3U[V>07G%!0B=%Z495,N:PQ"G\*I>QRZ'3 #P;%QE3Q,]ZO]-S9D^0%
MIK8B3!$/WFVIS/N@J1N(^AJ2$R>4;ZNV_()0P^Y%^.JW (.]+;5<9/'2O!K3
M90EP^?SJ]MX2KL5\XCZ6EW2@6K?@"W9"*(3FC?Z*)FG?@>*RU4KR23\XQ*9!
MEK+J!%U]R ?BWQF/P@E1?RAK4\0*09S<UG5Y"$&3'AZ':@,,P(;3[5#M< TT
MLYYX<&W-($X@_J(;J,X%P9![<33O<JBO_#[L:D?.,M??F*72#@PA\/&4+.;_
M"K4(@'2>QA>&VIH9B]4:*_Y1/OJ$9KB921%[">)4N,+O_I'?2'TWHK@3\2N(
MDHV8> /.!5%RED&2UL3?&%: #(;L<!:PX20=Z&7>@OS3/LB&KG+]0OE"KD^)
MB[(*CX437C3L**QA0A*C\5G3XOG_4"N X.^$0/B?,?N+*C1F!_XBP@$GM"/6
M:@='(3#V%P5HR![3 <:8'5&'\&N8*83>V-"D!YCM.^ )\MC?)(*4=80SE-W5
M4O>'" T:"FF&B/^!7'M1W\\J5]5""$;T'7PQ 8(YQA)]_C6F7"3CL7^?/1OR
M^\-)]3BE&NC'A[+%Z]CBI[Y!XL\5"FI_+NK6%M2 _XYF=S_0.L&[8@>$I;NK
M$817BU?\GE@)Y<R6=8FBMAXB3KQ7,+!\BCC!Y@UY(8J"VT@F;Y/GX^.&W"YJ
M"K*7J2?JAY+J Z6UDTY,BT\;/']HUVA44\IDUX;C[IY;L>(.=>#LD7[8?V4R
MV+3'M'U5!*>,^V6&LN$.O3?4[K-OE[]O/PXQFJOU3^CB%&/-Y5&<N96DVL=P
MS+).K^/-/?-R&G8&U7U[8[;PBN_.9GGC#Y.;SC]=-NTQCZ$#\UF\)?9<"X;B
M YB!=Z?>K3491M>AK4@1L.1B^X(%P[3!-*&.L]<4MR=S=-,JES2U%:>6GQZR
MJ3*G!'O]W-7]R2?DI2;+?LWI_9I"Z&,U!L3,)0G;U&NBJ#DNET#,Z*4).-]O
MX 2R8J_:Y\%!E<$0JX&4E?Q#TCW5@XWPXN4PBH;)SV%IO/(^J2/X=KF K@3A
M+SD6II+A9>+1)Q^,ZCQ5!B(!U]$<KYPI6'CI.U/1+X3U];Z#V5J7;&I%UN<O
M^^^17%0>][B'U[_=N/+U&]>L;?B&$.&<,JT31^[LH'3L*EKYA":6UPGSK$Y]
M(M"RQ#T:7YR<7ZH[Q]<"W">HQ,3$F"$(/:.'Z4#RD50(7Q>0C'O;R#RD*S('
MFPQ\]]XB"Y!0-'\8=57#9 ND\9O78]9V]8$[]PH1$^G5Q^F QBEM&AE%*,C$
M+;HR7L,G$T+;8F06RH1RRC87>2:P:)6+HE >BIAEA:;PF#WM,-B@YW6+%FB&
M[O6!YH2_&F09KA-.6VOPS0XXH44= J(8"&+X=1UA;)4->T/(I )ELN0EL!Y-
MLG7:"W:Q,UYV,TB1GELF66'805PR5+3YSSAR"[4L24SH3MRGU?=I:2D_@(3?
M?D[CQ=>/K<XBEA,0$U%^I^B .B1X\LD =\J%/@4<O]?'VS=[E$\Z#(L_O3#^
M9DNS37R?*Z:G$K=HCM@B.9&G(<D#WM&!!D&2^<[X:%/D<*%8?!<XIL"*_H;Y
MAV;PH4_@*F%LLPUB2SW[#W*^#FA1YT&L,$38U3*CO7$*0Z$H45?&)O[^%:S'
MZFM#PPI"@Q,K'=!<<]B1OT-G\S KND,:W*M:_F9@8%."H^]! ^ <J%,WI3R^
MHF;O KF?^]L<R971,\>O[UNZ= >\$4'="PZ%UQTZ+9LI,]'].A:1<GB"S$$2
M7"\4]U&(U)Z^QF0U[L0ZY^%I;#3G*E\?Q7Q T/<=K+"-67&;F7QVP4PIQ*W.
M*GE.]^&F"/N[N=.;2KS3,+]]4JJAUWE47R(5?76H47Y'4UOY1]OV1P7<L'PU
M,?9D0UCH^X9-47D&*W/?\E$B\[C@1LZ-A4[GMMSXM7(+9R.KWML^$6R/M/.5
M6SJ@E.1[48>5]IVIHCFCR1)07TKRHN.8@7KE9IXO^W+\_?4I.)Z0?T_JRNH6
MT9S?YWWM!DR<W'M!Y9]66H_\+ZQZ_.NN<!O>A>U^@1<V%WO7,Q2:7D>NLQ@K
M9XE'R[447#4HO/Q%KXGW5AA^P>)-.I%?C?M!@ODSATW1YJO.C>.A)QN.=D=I
MNF[JM#:[1KC_BNRQYJ/DQ!)A3_3+F2)NU_EG<Z=XZI+R$,]E)$.T^@>\\SX8
MQ_\TO51Q[$(U*[!?4[\ZF.N<&"]-AA0^=?OPED=5:-2*QD'%B$)XF#U.%FO-
MKBLK_KFL3_&4^D1?JNX#=_&3!N,OK[Q\K ,3.L-ZOX,L_\98FPA_*J%U,[?8
M+J90)'*_II]@L/:4ALFXWV6R(T7/OM#MA;GVI^> @K'92:=6P9>:.,ER#=B$
M*8+P ^2E [.("2QE?P%I$'+7^YZG%K"+D[8A XE6P&S-J3%9A4#3]P>IA0Y
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MNT!C27O_"(_3"YDS+&?\9!MPKBX:GXUI)1-[#=;'.9V"LEKO-?0T9AF$5D?
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ML_P61Y:<Y:+!-EZX:;Z&KA':+LWN+2"-\J?EHIL\3P;B92&U!NT)KKFNC6<
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M@>+JDMIBBBPG"8!GH*!&PVY09.[,&I( 7WQ#]Y+TQ3_;^S,QVE0Y*"+\5@>
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M+_Q%((J$7"DA&+576EWWHEPC1F+TSJ6S7W'WYQ_5,<8-7+=_\.)(5P;D'28
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M8L)>'2\_M1*N-T!97!]H=1:-7D7-V=$$B Y@TG+7OM^.$)]G5AK#JT 358-
MS_U-CQ[<L*-C_%)N[G Z-=N2]W;]X](TXZ]5[X\TCKRT[/*K&O;;<]"'W=VE
M^=H6[SMZ&&K,<W[^Q/\Z5(+@*/"B<X07(SN2/6B=U\#+4UU#%3T\Q[=?/.DK
M9P?D7NSAE'LCMY37. 2R<:*<S7>UKR4!0E+$]_-I-$0IHVH,[][OW$UV:UZW
M3,7?ADY)M]%-D@"&.#^GM)$*]Y"]\2=?KC%GS0<W\:YV[-6_GI!S216+P9['
M)'N&<6,NO$GT27&DB:&D'HT.4("Q(5CYK0T>6YAZ30W_2$,SE-?N%.OUS+)?
MX"R$!(;;J?OVFTYB*PZ4WE:,U<L6$KOF;C7NID1/<;X5#LVEALH"YKX_ZC(I
M!@OJ5^DA<XJBX-8DP+',P$6@+^*4.[&Q;Q?^00$$WZ4TWJ5\[[[I8"&TY201
MX_?\)W6"3L]U@11IS=1X&?;G41!&OSLUD+>(<H_/M:?MU5K )W$_MU&W'FO6
M2@<GTY^9DE[CODPIV1,G*<>\(;$]K8V<S9/WZY_9$,\*Z7%A%$QG8IB:E,_[
MBO@+Y]61O2'D9. ??U^ZIY8/-/F++YWM7L*+,$U/-6?9"5T)D8E#R6)9N)^4
M4C'9/</['C(7JOY][?["/];NLP0?\2_39S+M/.@F5S9J7ZSL!U%!R,0CV]Z1
M6N2LC=,6YGP&HM(SPG0!];+0W;;R* 9]'WYP]G 57JD0HXY_B/NB^36H,N\Z
MO [[<H!S.A1684YX$+]HBU8M\HKC%FNW0[$M*FBH#OQV7!=\T=QD$?XU'PXY
M^[IHRG5:"]/YYG":KDJ=OEEZBJ,^0=^5@I&F^];:.<;EI^S6*5VC)C"I".&&
MX]M: E@?]LO)98\K&ZEIG>PN11AN1Z:0 -;>/)'8@-W!4'D6X0^(;?^4AP.$
MBT*.L-F[4ZV85O>:WN%UCQTW-,\Z WSIK< D\1*!:AAAP^:OV<FI@'RE-,NN
M=0YDZ['W3*_[DK& 0G@8@.GM)_$4I8>X!LQE2 C\JF0J_<_P2Q8]03=E?C[Z
M)FCOTN'Q-M45FD>G*T,8-ZX%GK.&HCU<4#F: MTWW[61 /1NJQ584^!SV'Q8
MZP+QPQG\U.@-$F ^N,]O# ^$=W=X/3S=+/J=.3&G"!:SQ<OO RB)O,X'H(,=
M%X@DL7-9!,VT>%;[PM^^4UV*.+YJ=)"Z[+$&)HJ9R^\'KGJ _O)$6V[CY]/&
M+](=#H+OHTX#Z< GO_M!#C^'[PEGKA-MNS"\A/"\$V*@_Z[M K8 D]?>^FB$
M.V)8)DU\UK*72LWZ',V"_RIWF C+<K2HY20*_ %X1NG:3&,"*O+Z)FM_C>.]
ME.%.]FM=YVY9:8NV*GD/^&3A+^+V57<1$9(-7'HI<_T6-G,WH2ZRU E<-DK&
MUB/.KLX^GSDP%KSM3A.1[4I\&&)5X<O$U=C;<5G>0JNS#]2MH\6YK@OLI9\]
MPTT1U<2XN%02B7^@+RII(6=GYX@07]^;.0<OM0YN>6*06[F=D@L22,G"\V_.
MT[I;HS0A@9; VN%GI9I.%7,0^N&9^'V7;@\9-JJ-"\8+EX[QB\P#Z"%77[@3
M%'1ROL^?$B]&D!Q4HIJQ;V2+:1OWJ0H[9!Y?Q0Y/X@+XNO4![ILWN2NI9D<H
M)%=8Z5K]51?GT:WI W WJ(+/REQ6KMGIUR^?0]2VU>AB 7?7F[GFZODE^7)Q
M[512F92V0G.!P\_N&'GYG<M5N=.1MJI3$3L7^C#VM#$ALD-+T/;M]Y9[)P-*
M\$^$O/)_M;W&!50U<@'7E_G)%53\]_--IN#-\L;_^(=YDP1PDMP8)SMP%S_$
M08;7%QO$^"1(%KXNN%M@+Z".L!?XM1,Q?1WS.516EDR'3D'6G970>=#"][V?
ME8T4P6[+XI;R)$#]N9OP!V/[P/:\8*%&45S_2\BKJ$UD883\5>=E8%,(7@H[
MWSI?Z=GL>RY0]UUK>Z)/\"7;).BGZJ?KHVVG7UXOA,7>JFR7_ICSKF,4P6V0
M&CN^RN)C_%,VP$(K4U=[LW_ >H$OPVM%-3PH2HV_9_2*Z\6C/O]IO+MB;RH%
MX>Y14(E%98&C3?CE!]U8NYXS UR235X/L;(QBQWY*7RXT*)?&"\WM5MH5%G4
M1'^7YSGYL;N7Y6AB!B][[9"UN$^#UFPA-:!(:.*+HZ2OMY[S&M1,6T75NBN_
MI'I#9J:5>DM2QZ?.LS*@!F86U%,:YC0>+Q!M:(0>Q2E5^5$O40\ < AUS/44
MQL*#S8]?&;LO+3CK+T0PTU]6U++"%DXO(()> ZD):D-%!)T?TQNUE_<99YB>
M"'9E;QC!QBGEU6G#X%1G&Z<9G:SD.Y-4L]SVDQGG>+YF=FU7H%?]37)_+Q_A
M[]M5MG8,*H7FM:68.[V.*%6.B:;W:M;]%K98++L^7GP(GLAJX9087AE5XO":
M=<2^,91=B=B@G_NX!,CB_!YN[_?L]-.6$I^EB5?2XH_OW]>Q3$_XH(\X#?(6
M,-PVMZVB9;B<#/I]QJNV\+L\.UC[^O%ZLR70-3N/<:?G#KU2PXC8H_?;-N[F
MQ9,?G]#-V1.F-QF<#V1W)5=8X -5A0V5H&<G%7Z6O),VQB]_2A'Y1[3Q*5IX
M-IPEF)8X-!404Z"*M3#2+*T->_@)[E<8U,1) MQQZ]09T%@&O3)Y$8,-PMR+
MD;_J8*@0N8B7>+0TS4V4S5+'; B!L,DUN%!K"JDO1Q,O'UF9:NJ^N^5! GA]
MF^W&S_HB!T%L1, $;'C8CBB]>[GNAV+;T$5A5D\7AF;8^FV#!(O[S;J-"1VR
MV!>&Q@HM*>+7"UB:1;B/2O:'6COO_K1?N$N7J+\A#=U8*K5M/;&=;AR<)XN]
MW7YE\FF\![J&I5_>%A@A, %Z/E\!;]7TTD.G>$ZYN=>A6>9) $XW:]FU'Z+H
MD!/>A9T6!P&LYJ#[ )/7M$5IS).4JV=OY]Q^0)?4$W97=[N7J6HWTF<7,;G?
M7N:UA&T<)CQT?L<BR=:S&2G(R47K(,6DN'L7=&FCX(LJQT.&[,Z9,&##[/3@
MXO=8A=)&ZNG1T^4LMM;2QM5Y]*F_!.)ZN9F*JU6@BCJC[P6[51KXE=!C0_"6
M$-3!!=/36^U?VOS#7-U1YCA#,#02OYB:E35>!)M_S+8D%?\^%1?U]\KDDQ_;
MW]8E@DZD@^G%)0Q+8ZN#7>(_OC4!'$VI<R[H?/@N=\R:"?:\+NC(SPR[[9Z+
M<-<"ZA%\?B\.?]5$_2@!A?L9Y:_/<;?=6AV?NF/*U_11ZKP !0WCE)=UMR(=
MA<AB0 5>SH\7\XKSYA#!*5]R2Z?^OK"#(ZN4(?.-MX[BF\AL1@0F'0L;(0?;
M3K#>>X'#$RS-]"3?Z-:JRE4-?4!&[/FHT2N9:K\H 6NR$%KXBUG*A?#&[ZCY
MD-JXT.RIZ19=-OH4]\:EF&CN)Q9=S ;4HRE9S,<38-I#28U,GV1L%6_*^+3U
MIOU?ER+F\,FC,('=K+:=:6AK8G^4G^-!:$!XX]"*@EE6Q"R61N[]49SH2/*N
MCU$6<221M[E/K_,Z'8:NK;8P*N]'2AHUE"_C9>\%];OS@L)B9LX*:ROLGB#.
M3>#5M$#4IE=G:ZU%8:2#0_;ML?"/]0(,ZNS/S^OFWJ6BWK>N 9F>S*-L6]&4
MV([=B!@4_.(&%NMS^!GVN,1"M"6/_4LF=72FF0O-A<M@G7?R+M60W/%6@YP[
M#Q)#0J&O"0<RK@1;I/-$K40Z:ZSY3#XV>L]HKW&-:F$"83- @4O71![LL&\&
MX,$)MJ&]E<G?N<K.O!*[V'6#\[YD*W$"<JW^#D:S@Y4G<]'AT89.\S.';6Z\
M0HG#K0<_[VYD['9&M?N 6X$38S#@)GPWFJ ^5BY;KBCY^$>_E-C]F[]H?CS2
M*;?=7EA>PAQO+F6%*B@NT05YQBM=&Q8\@-,UY3E!.;[FF@4_6$XP,5 55._P
M!@C["Q11@.G,.- O^]UE]8Z^%A1I1<J+YH6VOFCLO*K-4+/<,)HJ]=73%@FL
M6KJ+ WT'P+ 5%T%'*#>()*QS?L\EY0H)X$/6(W6>H@RR*G4:XAY^6WQ+ @3/
M*-*=RI/K:GC),35>&7<OYFWMW[Z6+_8/K^+P%83K=M[I!R9,P.;A>R;E"/R9
M?VS"@_'#NP,F2( ))A6R]L6-+4'^KH8+:T3NO]L9+"@D#+';/,[%!9JHE68A
M 7[$C9'39[:4!,"(]![<0B+%(;N@KF7$PE>X+XKN;\^%0\3]GC^;9_)S5N\F
MSC1R^/,Z"ZQ'XGBAYYV"9&_X57+ T:N-+W#M9-_LV0G$LC>2 ,.!19Z4O_>&
M@=,(4?LF[R$;J[3>/?NVDY!+\.76(A)@BRJ?/!Q/R29XLR)K#Y$>R!+,1.2Y
M,#[=[>@5Z7;\?E_4%W-8>+2H=P9/.1_>"II('/@]UGC)/<36#L:3R(!L\[6P
M\5I.TJ@.FYKO9.[QUGI?HR++;V V<U8>&:Y*IZ#%[B_GNP_3*OL%?;;^%"-K
M85\T^T3]V(+;FN"T3P(LNN"6T++[\$K'D\/I-:GY5D?0):S3Q#ES>,O4>,@V
M'H252+']L:/$47.$']N T\-MY\\0AQ);O1"MG%+E(XZ.M_9%6,]I!LV<*9?G
M.7C^] (;;S+-&V4'6-\)^ V1&5>ZTS3'.HILY[P9UWU(JV<:RFGZ(5HB@O&2
M&G!3O>G9??:4>Q:BWIG\DV:M*B)?N1,KQTM2*+B+ OOCA-TL^[K+MQLVMZ+G
M1X^AV"82("8, Q]'DI/@9A%KT8O38OCRD@*$>%A$C'YH*0FQC24!JH=( !HX
MUW[O)E'%.!+3LV^ES&"4X=7\3WX%P?^:!LD#E:T1HH 4Y+G",TT"*!? ]/Z]
M9TS.M\\W96Z> '.<Z?!CD%UB]@$_7QI"!.3XSSXC7,GWM!JQ_&$6CCQ$$#]
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MC[165XU2-JN(JAJ'NKGMUQU5Y[=/E-$;1ZM;Q\3,C+Q,JRR5/4X:2D'BA7'
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M->08Y$X"=+XD 4R+(3TBK8364^5>^-JRTA%1M2DU'!CN?_27RY3#6X4)8B3
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MAO/8E(:SD^V"@,M+GI4')Q;8O4",F?:T1P>"_^3B'>,"?)U4A/>IZEHN4%X
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M]$LUI(0W$QD$NRQZ?NM,")MLFJW:DGRWM;FIUH3ZSK>KMT*S2[F>NFYU[PJ
M?^RY#RYSHC_G"UM;3DF4L)"0^?MP0$,'E9Y2*VQ_3ZYP6, 5+1Q].C-77>2[
M=Y(L5)( XG5+$@^A%E\R^IA3-[>+!PH0ANC=95G,XE?')M_"_@\L&\T>A@9/
M*WC%$OI3* %B@,'%?<@ !9O_U1](UBEN^CR;LN7AZJ>@,C]';P_O/9X(_6;V
MJ$RQY&%^B/P&N 1K6;!M&,A\_L3='<,TU]^8K# 2K13]T&%%=[2;1X(O,M[J
M(P<HQ'7/(MYZ_8#RN:G_**XH\BBCC$*?^)>>Y3W,/5VE?98P_D;U4<37,UF"
MBIQ$/"2HR-:(BY0*%UAM3J\";*UO1V.-;)]OO'[D2O*9%.M]+?E)$E!F)351
M'@LQ1Q.Q&REDX90YNEZ4@8PZML+AM#F&Z/O@MNS)9G!6P3JF@KVL6<AIH[DE
M6\X/WF.78DA>"M'7Z 8OS0TJ"J!5BKJ1"]$]M'!3DPH)G+[?4Z>%.XM,)I_%
MU)(T; 6'ES2(CU?95G#YS@VPJ!7.>IJPD[ED4P>M;PV30\//;,7:7[E0?PGJ
ME@<G+P<IOIWJY(%;&C-?ZR,$@!^-L869BRLJ_&^BQ#YCK>M!(_R =]D"\VN)
M> :3CN784I/G)R/\;WY^68(.<P":*7^14A<=%^5]P<V<J)S:JK!S.30>>##3
M#A4YRG+4K$]:1TKKX $'%7T;(^($BFNHPR!J%V7BF94OEA<:(A5XX,E(UY%*
M!^#/:,*V&>-!0RE665/IT*HE%F[0V19'KPPEDJ9+3%#U5W%8\EFQ2QV>WW12
MM$S+:JL9=%V4&9,=0(1^.+^"5HMHURY_#F,Y=RAT-&T_W&=J7(@)#N4X$"L-
MYN%YVTT,@%AX@T#'X:_7G+C[Q]M;5<NL2_O?+9U(DXG%;++>4&?M&?1=G8)$
M>TC-V4R0U!%2UPO5MAQ=Y@>X/-7Q^5N;+NSJLKQYD+RJ* ESK5X+9EPA0D"1
M99M93;6U.7QYRSQS\'X2(WP.3OF1H5+:)D2,K'MP*.Z<CS\>]J+#LF_MQ$EQ
M ?=$J\5IT?$=TT=^#PCD4H@3DC=;F948O.,$6X.$'3NIG2E^(JS_MPLO7,KR
M*7^J8@;X<C8-2\4V=NHD%PM!Q8==4$^VWT795TI\>E?%V_ V8(+W=YK1DVO&
M2>7D-*U*/3](-S_@\@-N/#^!U1V$T+.G79F6U[9U%O[VV:DABI1N0T]IW?WV
M!H$A6878@W\8=UZ%&_JK.TQ@,]22]83K32O.51]O$KBC+))E "[=X\SLV%JU
MIX&!:';,>E*,BLP*3EV*'9B.)U9YF6\@\.KM8R*E;A;BX)X*&M*+P4Y*2_""
M<L6 CTB7/ 7TUXC+\+BZJF8^N G(1'0GQVS8@9%XP%:!ZV<?'JCWCCD:O?.M
MROG%T5F;STOC)%M!3Z)]Z*%[S$^D_$\E;IM9NRAY90<4C'K;=W3G17UUD]]K
M62"A5(?$+].*>B-XN7[G.QY8M!OJ^M))4HT>*'_7-ON,1JQD<Q>3X*)VIEO'
ME6>L!XG <J];QDG V.RY1.<:1@W7^TS#BR3T%[6]>1??LB/&:Y+KB2\3Y0(@
M/9);EHBOEF;&\UH^[JZ,'06WTFR;W_;F\Q"G"*D# !DT$Q"WO(6PPHI)Y,P;
MJ=;'<3Q7Y%(_^/[;9;$ N0 99R7;K'_:2@/"HN$_3]3FOJ7HBN$!G?&J^K.*
M?CL/KUU:M/M'!FB"F/M<"7#BB5D)SU&YW8N-T+BME-#O/'O"2[(J9O3Y:Q./
M>\SW;(0S:J!C:G>LJS"ZXPXT^^/2\E#G=^FQH5CW5,.>'CWEGAZ9JE@\\&PE
M^!;"!GTTUPGMZM"E<4BE<K:U=N11^GF3AI=>>1"DG" &9P6Y/KR8Y.)LGPB0
M1,#0O\+Y4BB:/>2$Q77?YFP^W-2FO_4DAI:4+_RF*GP \$]T6(MEUIOEGW1J
M\&./-?RJ-6K-^%$"4WQ%PX:X&D@@XP'4.;7MMF'T\GSOER4+\4"4A)E@X=/8
M2X-Y#"]9.&@?5?.$#MY*Q\S@4O+1W*\\W5=Q7HZZ]"O&&>Q91OJ9!5H4ZO&"
M0*D7/6^WK SQ1G*(# WUN026$45#XY\\&'"M>K9=Z>.*?4OU]+4DF7?)\4)W
M "A1"R79L+SUU2#%VIS^!87&*,_7GF8L]6% QJ]F9>!28X@-_TMIVMO'ZQ4P
ME;EZ)+UQ]%=^O?H9H4^,S$P/"R8V/$%O$A.7[**P*R<.M348[\@+*)9?MZTY
MI^<T[-7@C,B@,4C N)#'FA),Y$*BS@H&J+M.KF,NC27ZK*V MJ^\;ZO._ H5
MNE432E#X,KR4O.LL(PHT>C0%HNVVN0[I_6PJWUL^+#QONG1/2OSK8/*P,<HK
M[TJ<.H\51V*P:LNZ,+AW]W7Y3OK+A,_@&ROF0V0\22!0Y/ PKV+NW*<N\C5N
M%CSP_( 62PB ?H4_8D9?:F85%!\^.:4'JXM_]?7U^9#('W:4$[7,'[^NFE6Z
MO"RQ:5T0QVCF;E-M2/DHI% S"> @(NV&+"_ (B6ZZ,PR8@4?U$_O]?2DC'FF
MN6^]A1J<_HY?S>GK(C$[OZ]X!>N*H6+76;AWP9E$(M:NXJ(LLKU!TD>DMQI$
MIG"1^2]E+TIN.CPPK*:"!ZIRT!7;/1CN\U<>EJ>_\0#Y\K_\ PTOKCC@JC;Z
M *6]FV*DZU"V+=)HF'3WVCRO<-)^ 4<(K13I!GU[:-2AZ+SWFMKK(^3K5 LZ
M3%Q9\<JGDGDU=WM)]J+,P0OC-"41#5"^FSKG-*5KHN7Z# 8[<*:*M>Y.V9_<
M6O"(9AR.3VRIX>M9/ZLIYCBZX:^M?6;NX(X%KTF'M@<6JM;<9GS=2TDCQD09
M=-)W13#^GKP>9):ML>9)[M;ARK9WXZEGC,Q/D9??C//O)[P7Z@<E*;'*)T$>
MFC1ERZ-GPE.=2I8(KM<T51DL]2MIN;_Z(ZCGR[>@%UPRU]J'3I)F*Q :9[=V
M3"N2?Z=X5QLOW5NR<WS<J^JB/@PA)G)QM]!&<Y^\K,56K#J*TF'[]*:AP6\K
M/#[)^=QS9*"K,9_G24RE5@*H"S:] 6YCT6@)#<G-\2GCJ44SY9;ZF=:8I>(%
M]FOR^V '"-2#YTBB%18EX4RG[<F47/9EVVV!D9EN?JE@E.S%JHR^YB:$==#%
MGPIAB[G;YYL3"W/<L^M;,-](1Z3G-C4UM\0?\'5]67.(W/!4X65E'9.;*X:W
MG5CKDIXK3!]5D<"#/=0EK_,X6?PT;;M1Q7!'NY15[]*E@A$($ 2Y'P+:TT?H
MH5](PYXE#[0R>!.OWEMX<Z7N2#1[IK ,7J0Z[O&E@4K7J'JJ_G=4Y'YEI;Y
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M=6$X+#0.![M2YEH=.N[YT9#^,#6L<2^=MU_PSR[Q8-'U=W9DTQ5XRAK:#,J
M$KGIJ!,?WO"W5IZ25R$LF)$.@0G5Y5P[O)0F/B5CI>ISE$L3WWZW\OS67+M6
MH3TW92>W";Q*KS6A/.GQD"OE#5(67B$64)+).P 84]]P1#R=6I\,?.X<QO1
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M93[1OBET9*&>PRYMP;_&'.\:CWL@Z4QQ&093%9)R+S9'VH.?W3\:8Z'+]A<
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M'>IXQKK9(+">]7Y-GKZWD^!K,I3R,,<XI.QO+1<6=ACW=?"Y0ON$!R>[2NH
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M]=PERSTN[^R),(C7>//C]9?N*PV ;]@_Z^G]Q_IEDR/%$/<A_P[W\1[_H00
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M)++_@[WW#(NB[=)%BR!!@29(#HT$44F"Y-2@DD3 0)+4*BA)LD"##4V0G$%
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M+[E/!<T;<=X?,8;A:?+NLYN)A*!4IV$%13()MJ=D+ZB#:08T@@U,_FQ[OLX
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MT\J^_S+W.0(\1R4'']"!5PCL52M$;MS/T:YXEL56_+<*'Y2^ >+(MTXHV<5
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M$)1QOYX0HHMAST_ZK;EQ%][*S>"/K?GVOZ(OYA7:$C=OAP0%)7EHD:GRA9Q
MX3)351=2\S\M$J /1^B+.QR$RR1/OFMH$#Z702Z1;CHJ_>ES!</8>_M'AHS&
M756&KW+\Z/\C)W9)<'_ \\(U78Z3)06%@_C+,.@=G$FZ<'%'L=FF-[<N;"__
M"2.=1\"S@4D;CF$='I=,)^1*8,>ENAW/.YI\?#'ZY9^#D=^36JZAY;X"4L8
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M*W]1V_F9RT"NV)W/D>0'7P451JB<0K$7!B)G\,-6RGU?>MY\<@BXG#0F>TV
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MF/4P^RY>$@_^37/0]RVIE% W"0]*3W>E\?E174K%I(?5*O.*II<UYC0(C/P
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M8=I]' T.W[2!9VI444S8((1%EA@,L<_5)/(K;%Z>;M2M9$OKQV9.BDB8*ER
ML/!GE_6% M9C,(J_$T/UIMJGAVI>7 WUZP+.&F_=,J?X-?ZFOJ*B O[/M[H=
M4H$_RJCM 7_J2^GO( +^ HYO$V61J%J1->_"/+C=FAW"G1"2'A1; O2Q%[OF
M.EK-JR&/;WA&@=IFWLX_U;X,#SFUR?OPVA[4F7S2\.N%!UL6"?=VMD_I?ZWM
MF"-#X=W2R-[8%C7R?;I5C2IO3JM\ X''+Y_FN)I5Y,7\R0XA29_7]WC:^CS
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M)1)D)$3L+H5-Z&-4=)(JK[=E^./2WFG9"^T3,1E#[ZE:<9Z'J*CAC?1L5;/
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M7S=C\PD^@A^?L:#2@9X@(QZ7V-6NTI'9!A5#(,(B#1&QJH8,385H"*4=*)7
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M\POXQVB_H8A%])+V,SI&W:+$U$C;X?UNLF=.=T"N_#A*'Z^U],=6SO=6ZMU
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M1-X5>9\T??7A%B#X.]].<<S>"2",C%> TJ 4\1H*=;++7,T6%J="])1J#F_
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ML/0AAY*Z5!A2#MY[ HBAI#\,$MFM.W7Y)OQ>.^]LJ>2([Z,WF0J%%**=G -
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M(LN_O[==<11N,#6-,HZE?Y%=IC'O&][^]1.X%@A1-$ N=[%"H4@1XH7W!+-
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MK=$7H8[SH5N!S[83 RLY_J_HON2W6DCX(=I]'<9^6EOME(&=YLM3"[@^VQ,
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MW7^&>A2^XR)1PMB,KHEN8PG)/<1/80I^5!U7CGV7ESL ]>]$TB6C0OFV_K$
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M+(_K)QN'!2-?MHN9_</\4T^YKWU.\QG/ZK;+P^E*MIK"HWWSUT7AH8FA+]/
M),<'A_H>/!X+G]JBMK=,@N,V:^I2&U\YY?-04^ DA-,(.!&I1NHMA226TT0H
M(EUR^&TN1.11CH\H,9A=#U,F6KC5)KFHH1UF+ 7:V,/GU=7EMI$+%?Q__C0H
M188>#]_^G W)TD#M)G(&8:2DU\ _7&BF%.M875YJO1[U/=_^NQ(JV#*"U3/8
M*.W%^63X#OU&8[22L1XS71A(6K)L$0@1,$!MD[9%UA#"K5*K>1 :N'+6QK7N
MG!R\._?LF/RMIRF?V/F:[[QC4 E;S-!A6N.+"@'S/A0<4VSXF)1?S:^;G?8<
M_D6%KHOF0*UR(>?IUS2F]8:X6/UXEM9W:TR.B<?17LV 85>\(C(1PRPA#CWF
MAN#XC8]GM2_A7[_KW=XH_B&M%H)94($JZ!@&N?"I;9[%([C7!8[!E,PH66O;
M"91DB<[H*.XV%$=,N>A=1&E@$/R;IF3([@&;X>FH"^3"(9O,*."P[;>_7&N_
M*QF8S74V,O;C\2E*&OD<U?CEWC*O^(0RMZD@R[YHFF5!_]D)%=->-G)ZMM(5
M4)"HJ"IX45_WC:-&"56A,X]75MN2>'+*'0J/N3U=;FJZK]NJ%@Q6_9"YP6SX
MY[Z2A$:79[^V\.11=C,:UNWU4I._$+6%ZZEQ@?^X4;1]>$O:^=4P1164]^]A
M$E=LM@LUN6*0 B:!$RODGU72=/!)YVL&Y63-B9/$/YR#*LF"ZK*)JOP2.<68
M?Q9.!1P[ZCK%H]W6*%$A] JR0,?E7JU=D0/'FOI3.8<PW=OA=Y<NAEJ="9?B
M]'8%K?XWCI6=MFAE$CQN@:,2!2.U(!#DWJ8B][%K5]LX9EF9_=6=&:3:HR2=
MHS7LV?ZYVW<3#WO0%O."ZI./K#_F]N)*- D4V.?\ ?O7,7L\,+5^&\WO>_!E
M/Q]2=CJNW8%FRT,3:EFW[S2R^BXYL.N[^+Z9_$2- .?\VMV^X\]W%1D^TNL!
M;)Q!],QEWFOBTE0PA:=+6+6*Z'$"""*AW0>PZ<DIVP[KUO%MXV_&8V':/>GY
MPQ(1WHH[0 C( -5P%2Z&[-HOH*;C6Z2[#QI58T2%4;_G9-[8?CWK*>2ZZ8PJ
M\I(9',3C941Y$JVH_\QK'KVE&1#>T-2(<XC>1G3LUHS)\3?*X_XOB@[],)]S
M-^E3FI(O P3C88D2\,0_UN'40CPZT=./]2A@G+B0($7Q;&F:[=7^F6Z69GEG
MYDR^V3L3 ##I#?X-T2#"<"*.$VB7X9A0B?&M"C\QNY[&1&&=R2J5!_GC R\D
ML[S+ Q)5;H1UAS$/]'\'0F &J#__-SNG=;"=0>^7:@DYET^ VY_237_(>SJ_
M6NJ%MWA=LG!47J_]K+S 2U?UKU04(0W_84?"CSLE_UH_MO=*ABU>)< .F9)7
M_Y<]R%OR(%ZUC(2=9NSJ%,Y6<Q2DB-5N3-5YENB1FP68M5Y/_Q/686,B!.!5
M]=0[-OWR,/,P<FVVJK@JU8QH^OT.IV3:*5.@G-]K&1!]$<8H0H?'IV."_,0/
M3Q\]0&*']2%JCB8SWSE2==?;CX'Z9LR!1<-DCL'FRC7CJ+,,&T/F)OTKOKWC
M$R@X&1ZO+4VY-DQ$A]?\F)*W'3[4LA])+)!NKF=0,N$1U^YI%]2Y%@:^T-)[
MJBH7>A$\VEZ4P*Z#7&YR3-<"-]5]^^YUM\ *ZJM9&_W'K&S&E)2>HJ?<C+.B
MV8G$4NH@82%6EYMZV*ZK1-Y*""0YR.B/G "?%)XZ.7E9&A+EG=E"GSSL\Q;%
M<XVDZ?Y3$*8;1"E.0GE2^CJ#AJ-1<GC/X,Y74Y/IUP/+D!_F/ 4-[T7R7MD^
MGP5O:DCA592N]5;#(>*T3<E0@CA&6X0HP@[O<KP\AF^M;_SD-&^OV"].  :N
M1+1[20"^/Q\=Q1@ ?$38Y[X8?R^.E39.'LMQ^=W>)LJK=X'/ZKU5#/\';>\9
MU52X=HNN$"2B0.B]"4%40 2DEX H1:0H"M(54$JH(CU" .D=!!2I4A41E2H=
M$YI*;]))0'I)$$*$D!S<W_WQ[7WN/=\^WSDW8[P9(V.-L;+&6L_[/'.N]WGG
MO&]A?U8D"GQ)3TDT(B+"=O8_A%XX?G^HP,+YR%!2&<Z8DZ2J)2B+KXJ=]:A5
MYZ4?EVBR2LWY+KC-+?,8QI!F= 6@:XT[8;OG%XD)!/D]*%T\'M$UXCKS[OQ;
MUTR_Z28V&7N9=>^MO/VJ(SA2>D*-32BV61?7*S7?.2?1PC4Q.)F#=GMW.HE#
MG;B#S$GM 7(<#X\?;TQD387$A_J4K"V:C=I'+M5_<L'0X#3I[Y._GK;.D]4Y
M!2!?$:H[LIN%^$OQ&B^>!_CC7F3ZJX3I"']UMZX=TE3A3)!@ZS)PJ VF EU5
MD(!X3#[4L"R\5OFJ8:A1-M]W$,,6K0]W\F'T)9W;+U(C=I<N!W#TD17Q_O%D
M?<+-(YQTTEY%*'1&^\'5%B'MJ"V/[''9Z5^I2\8OF@1! K$0;A[B.P _;3?%
M=U*I'0P,DB/RK@J*3M=6XNH3?@;F[^_9@7SF7=HW7:O0R>&-.]%PIU >TN-C
M*7>R%LYY7S7"P:U]>K+7A^5ZI)%WK5<+$TB<-LFX];:FD")2HNX+*1%O9O>\
M50SO'XN4\W4IC.?9E])I%WNM@KU=F.Z_PRU0E0#:S7.=CZ!<(LUC/<(<L)X\
M2&6"0MM;EZ'*'-[NR*W,PRGB5;X[NF(ONO0  31L*44N;$^>';0D1+]'!?A)
M\5U3$TEJ=@(3T6X>E6G=^OAJ6Q[.T]H>+LOW5-7&A1\L/@G76N3(_]]8/3@+
M95JO.+)?MYP<\>A*F&.TNC'*2\>Y[%DK&FA_RUVJABUA!:Q41.S";U?@JE!3
M_:^+7+*"Z@JE.M\:6%W@=;%BNPB[%.X%@2T"-(;!S]C_H=_Z_S% J;B=/QR^
M58>[KZG C5KM_V2A_+IS?O?2AMW^+T5*O&MT.Q78%5^E OM;0KOLAZ"F&^QW
M_EN+1O]+Y412)140*:<"5>5M>Y<V*_[E=_G_T1]\4,2MD&,.\G>ZJ4!AW-^3
M?SDYN?K*$8$*K-JC5+X;DWY'''=2[LEKNU !0:_0AK9OI04TK?ZD1W]W !#2
M*1V'3I1TM-UU<ZY"LL3P4VCL"0-M:9Y(KD#@.QA'[ZB\9+\>%W?[6A1MY%_S
MN (F/F(2R>$=PJS1*5F-G\%6'?])D?,U>WHPT)LVB>IXH&4/>6*AH\AFZX07
MQYGE$A#$CZ-JAJ41_/ZV9V[+-_'7L$EA:/0&&AX$;E\)GIB07[9E.LYOEEB
MQZFL).T]:JH=DX\1Y(N'RX1\:YH5F&0_O_!C*#S$7EF)!J64_W-Y[:H0W08%
MW.PI?8($/OF<FKD<XJ_[9*AONS(-M%.OWFEPY.0J,X<4I0+/-2:X!(4)AL>5
M4:^=RZ1%)0D]?4G?: !CK0:G2C\JP*P!)CG@F&HYO\B,7I5FO1Y^=>*J1%U-
MTT^5BP]3T"->L >@;@X(JLUIGB$ BA'"I_#4&K.24L1?- [$5%GN_F)?>0X#
MOO3R /RL<N%/0+V4X:E;>:Q#9"["F1]7)VQ/CSY,^S6*W+W_O8XO$O 7?DOD
M2U3MN*-+4"6^((C'+KZP<<YC&<$-/5UC7U;\\C*PGO7B_CT1N<T;P=(Q-7QP
M=F>5S.3R&\L_USEW+0>$GB25W ?_7,@+-E?%9V$UXO%.7R]B9^D_E-;^7OJ2
MAOLSMIRI*RK9>4]+^-1ME-+MG#P]2&H $C%? \54Q7!F463&D?+8'89U)X/Z
MH:=GPURN-OF#KXZ FBLRE("P+J6. :ZCZT@EO#$ZUP%;S/LTRU_P4A/A1D*4
MN_;MO&V_6O-SO:S*IYNF-#1Y1 42@Z,3VYR,&4GH3K: S.G;$T@Q',\BR\RZ
M+<\H8W']&3HZRFD8*&$1Y@!;L,\8V/RT4#' 8+=FSNIZP%5?W>FC&'-9>LK&
M^$=,.A_]2W[WWG8P?WK"[UNGZD@=Y2ZA-7YE"T+,?*I2(K^-XGYKODHISI*.
M9-6Y_XEA^OES /1U,8]2\6[U,*3E,3$[([&NR'EQN;XI]I'.804-H_?<!9(X
MUE,@0/<6G@K$;CTFT 8]=4UQY1JIMHT"P.(Y#>Y]J/L)-)H]"^:LH8XM](L(
MBV;$8N]>%\CHU?E6*O!8F,'!V7J1W[<8\NH$2/M])U@MAD:$"&G,G[$)>*(W
M=];%P,K*]4GW)S.Y'M.(\YIJ'*)O4&+'N2&,D\CK)(,WK@KY;!01%].O4<,[
M!B.^.R)\RD5BEO+)W\4@()2XTH/@B>$\$,D'.Q"E<L:9PCU<.")Y=_M1LN2N
MHF'_BN16EZRQ)D0K;E'M]I$""6%#$%AN*UD/H@+A^\'+T$ ?[#/]]ZVC6OV.
M)F?2]&$I(%C:$\,K2GS0J!!.?-86>*%2=J-+ TZ(CJO$?AF5<ACSU:N2>B^R
M^ZWZ%@]8.#V2+RB#9Y%G_#AQF^L&7N'+0GS=[OX\PX:BV8173VC >K_->8UW
MD\*"1R$9)PF1D<(8@, ^S9JPO,6EJ/*A0*MYK%8BZDM30[?FKDR_$C\ :A?/
M0\!QD'8X UESHFCBY(FBY\3TR/E;;= Y^9(1<<WW[<P_ > ^*P NZ!16.R)N
M$NY%Q>/9[@PM9X3,OQ_P9*Q1YHM)<O[E!SXJ.$^_>3]HHG45O@L>:=N8@A_3
MFG^G C5E'>I@[%_=@<5GMA?WU?WMLE65["PFJGBW=[X?N4$>^+7?&X!=X-D9
M-!_EA9)1>SLG*9X*:+&#5MIJ()VQ(9PD#?GA D6*U/ACWI#H!W$\)5_<@.G@
M=TML/],*%GT#]]H^NWDAF>/U:YJI0'SLJ9X)!P+(<R[7. K>O/$Q/TM\4(8V
M;O]U\O,@C4*"V7SWQ 37Q%1M;F'-I]J&5,/*%#4Y3!B(J?VCY'U\]Z##EP*H
M[ E'<$9:XF_.V**)4-:U-#Y&A/'#VH(O1MQ;:I%NK.K*/&*&?B$*5"!5T?:D
M IQ-/N8<ZU]K@^RY<^$R2Q9;5)8/T::C6Y$MQR^8PH<WN#%)D?2_Z2 _N/WW
MW8B\)<^#2E_[/Y)Y%(4['_E-Z#6"ADD6JG0>I>%]G-K*3A+'Y%=/1,I+V75,
M,564&Q*K%+:/#,)=BCMGOBFJGA,_ _"L @(5<TA5_-'7.>:,7X/-\L7.:6U,
MA[[/3>2>W;S0=X_D@-^Y1;J]X"[WM5&MWG1M*O2E2-K^6(GJD@OWIWLF(4[J
MP"+'V" $17Y"!=*32! J8*=23XF)*B+YR)X4F#I(YW>+GW]=UERRS'H"?HLF
MT2;V[*.9E:IN$\S1 A*=<W+XY-@JIZ9D$_R/+%:+XLMOQ.5$BF)!=_1 6MS"
M*Q,EC\@W27S8MCC>Q*0*Y&%4>M7]PJ1IRR&/J?%M&"RML%TX(4U3>%&<N[<'
MDDF9#Q&O'@Z!Y)ZWX-IJK-V[R*#\)ZZK8_;3ZI6"?#-PB_\\QV4R_:(T]VH;
M ]FEL+7@L*4FJXZ+K?P^LF>7AU43.VY2D/^"Z33/"L?K=R&]%.8)-<7RM: /
MA3A&>^*Q?9R[C^FHX1@5R.*/%TYT3+6X;2#<<^\DVAP:2>GX"G0^Y]4 -S5M
MQY%X%^215;FCC+65'CQ)&7(IR/&I$@^$!J5FC#/_VF*^(!3N*\U%XL(QM91U
M%@DWJ A^\2?V:3@R@&+OM5^P4J)EU6_G[M<=#&&<@!'@SY^JVUOYN%PN=#@U
M/5U_/R&U@@-^:Q%?)5=[G(F4D?K5W'IN0LUTT2K8GU7; 6=H;U#A^'#PSX,+
M2GMN$3.\Q!LF<0  7)'1%(0O[B3P)J-WDFRA@[[:3DX++2']>N.4I^?&_Q@P
M1QE.7TMQ %C&&@^#QGZ]X(ULFI[5$OC!=&7H5EA&="$DXOZ< EXP@L"GE76#
M()C%5%FFUY%@2G/F2C_/?>9OZ+R[$>&Z/K860IL9!9;"]9\(^4DULXI\H=7N
MO@=6SUJBAHL7@AZCE(ZEKPTA.8Z<7!K]46_BNL8/=!NR,(TA>=[N]'P)MTR0
MY9WD5KHKW,QTBZ^*"4^%JK,Z[>(4)JP<AFHKY<E6I:)>E4\+B@E0,_\I[Y\@
MTI$NVBYBCIVD[Z#>%E536Y/VJWYF5F]+"K.2GI4:*YZF)T!G!/0%"FU)81/Y
M<&6=GI$A#&GR7T:'B38Z1RZ]T<::O#>\?^KUO*/?+DMR!M>0V H,\=T+AB7;
M19[>@>^-/15:WNJR1J@=L$;("=.BK!G+E<&7E'>LNZ,IC.2KI,FB::06_D5V
M=\2.O-=PRT[T3E]&>[HW ^R&9!@:G,.D#TO//N1L1I@<9Y*O3'42"PLV0L3Q
MM]M>]/FZ8W,M*H5?#=PQ_6O8"6S% ;TD11R<G>2Y*![;RH-H%0[EMG Y=+,L
M*:WTYK9Z"9:M2E46"DS::L_3XUG59#B.NA^*5G:VG5!TH *BM4'FZ/SGK;PD
M*X2_8*2+B+5M0]KNX;I3WO):E]>P'B8](4^%(0UR_@0)@BD#0>+H?"[]2F?>
M^9CW[XO37)*CN]X89;5J:GF*>^CS]'SW#EO3%*0_4B1S)F/RA":>(O)C6E7P
MRTT%KA,*YE-F\97/,CG.]5I<#Z9')Y G.RYYVQ@G:4!)YE\%K^ Y<S\$'.",
MX_95CSUXKLY>6K&(VY9/$VV8T4L3QCC+?7FQ#8H1(&QH_%]6XK_%)/[/YI+.
MQ^]"EU3Q#I3N2E4J<$U^;8H++26!;F-1,UZ4<-F>-B6P^PW-=HJ^C;PN$S-8
M<(:;%>B_GUPBJ$%Z5(*\T83OZRJ1GS'&'IL)V(ZYV]Q5&^(O1[X5\QFE@;8(
MJP@$4S2#DH^#]:E 0?8?JX70V&91IR,YI!2^/O%JU&A-/OOLW-H:[%.1U8TK
MS2\+4N-I(F/_W S7HB4D3(PK9GX/=%)O2F.]ZSSMLD++[/UG(G<MM)H*1&R&
ML$R1%9MJ7EO@?]7MYGNF\*!KJB[C5[D0='X=)E>4MI^ O@;$$SWMHAN9BMZ1
M-0@K,4C.0R2KC>XC]3]?1H ;4M%QM[ !'?9&=$90[9.238,,?$90Q4I'-1N\
MG9;Z4!CJ8>F\2'OQD=^U=A_4M#\H/1&=O>1P_$)-T2O6Y1WI=5<0):YA^LUZ
MT&;RH[ AOPMW-/?$:X,Y7Y=9KAX^JTU,;/;+-!MZ?Z7C3*3>D X-2@4 "LX^
M_2^T@?Y%],>?X]^PRZY!8>$G9.2/XCP-%?@I#W]5Q4=P\SR2)(U8A8&2L:&)
M;W)$RC5LT\MK#%&JE^ /VX$@W8'AN5/X1UGH><B:!M_(HSPK 060)T/6+5ZS
MVWGW42"XYB6X$ FB2WJ%%=!&!VW2/5/YH]#Z%5Q$<Z:1E8E'CY9?,"=<]@)X
M\1ANW.CYTQP[]\43/-.);7F*4%18#4SCWOEPKTLU;)GF&2!>^ZSBS8:9K<BP
M9*VARJ_+F](B%@L-";]LN&E.:RQ,P/$;V+Q4_ #V.#GBZ8[*D6Z-?A'XMH1$
MSV>];2R^4$_LIX,S=_N',YZ3NE_QO5>#%%IP V==3+\$/GW&9IEV5E%<^8<C
M*ZC?Z[30-Y0,6='[KTQ\8NC]X1GCT@ GM,N;.>ON;WSU#;*!#P[.&40D19Z6
MCZ<"]&[PZGQ,<KQ?EJK#L*^Z$JGM9FR#>4-'4D#TD>'E'Z DF?VJ0+P0>AY*
MEL/O64I'[?W<FZ85^U8HN2NSOKV4Z:?$GV8$" #@/-(GO#@:SN.I!O?&@7S;
M=!I^XS@_7XI]D2'%_LKTA7U\RI6 A3C@=^)E=U.B[W'*MB\F?LM6_$B:F#MR
MJRFVN3'C2;_JGQ#[<-48*L [@4]NOXW;@:YE=\<W!^/R.6SLIKM]1;0J]%T<
MLC3GF^)8"Z35^)?P 6NV(^]=."TI6?ZEZPI#<_=M,(,#GK+;^BQ19U)7M:KX
MZH[3U.2<A'Y6(HT75>V@CE2@4YVI2>3GEKB80EB30"O1>UYM$/*:S!QM-!0B
MA0R(QC:;&'+DY;H+9O&I#K#-PF1ISE9GGDPHQ^W>WI7"*K?C/(ID51<TJC&D
MVENJ<<-[.\*T!L5QI+:.839)N\L,9LC;.U9<$(]"PA>GH1S.::XJ#,2Z6,<I
MCUR?7Q;6F+A[M)\<EJ>8=(4=:9X\,0I-"'UL=RJ@"2.W@3]?A*WT6TA7*,)N
M3%1GW@G*!%_25TNOA^V?1[$1$_#P,/GYJ!#A434[AX=<DYN_ GPO<MS!7;R6
M&ZZL0;!O!UZ=:Z#EQ[4^)8CE558B+QSG-FOA9AW,AMP+OV1^.[C_Z<N56:MN
M[]VI@65F/\JVO%B/FLQ&SD3+3TIO*R-EN+:5<(H*Q#1[RU= (I&&[]2G))A^
M77D7\IQER_8M#GIF3? 2_K@_NL(%;[?&)?/GSM3-MG.W$P#(M=.T+.&G:1^$
M:0KJS%?S(^A?D.U(;T3.-K2186@/F9R5;UVJR\W:UGA*& +/=-2IP?@:T[B=
M41*P+N5Q^-LN\V+)*#+]EX&:&\HS-C[B"\K^7FR7Q(SN9@8V'32R1%!,6,$O
MTT"9>JOTB8P1)!J ST.I:WV_4N[KH4XR]F?-676%*49.)<;//V.ZTW^EAD?J
M+3$;^>0LK2A?!7GJC[GM_]U_];$A:;MK72S[A"*877]P^L&STR*M3T:0]Q[B
M0J?K<.H:]W)<;#F>J;@P_[KU72D5)?K6[NI%@;B40([QJLTB;#R/6+P. 1K?
MK%Q\<W/7.5NG'J9P2[_WSVD8C4_[P_$OAM"OO/ PN)O-V1N#;J(C-=.A-!^3
M3N\&*GY.PZ09R,!.OO5[3W!U5M7K$/ J40-Z7*(AMU;OG(K@3<3PEA1= ?H0
MY])T+ZZ#>PH_C8;E:74/WVM'WCIAG_EQZ?=MUC_96*P3>8[.5Y5:\R%Z0)N?
MI6_W*@FC]$5YKH)>'1FZ6AJ]Q@MUE5D$8-C6JJVFBU_^V;;10UW8_FKXW*%T
MAE@E^*FVC62S6(6R%2&PJ==PV0K:,;C*&7E)+<M (JWS?O6/I)-A>1GK<X+'
MK\ARI0@SR];J=Z3XK@/B9;'/Z9V617.5%1$I/2_/I@321H2#^%&(0:3=PBQ?
M]YQ0T^#^L8:4L4$C=QJ]5C=$.)SI7M@2LQ:D!'!VG:K,BRZU65<\8)FZ/X49
M,?2^^+4KCE[2N "8Z&0-L+L[#G\LQ$K6K*MY83L;T&7,.VWU\=S4J9<7--HO
MIOY>ZUGDV(X@WL+7=J>[OPN(Z)S:CJ6WD]8:K?T"^Z19)GRZG39L]?X>Q^;'
M->(X46;RACN#GSYWI/L0D.@ !M$L@C07!2[05$6K:3W$M9Q!6PQO<^X8MT9Z
M"+\ZC99@2"Y<H?43CK#3T"[N)+PFQI'2?9R$LVX.DR\AQ8FUOQA__.A?$'Q>
MNG)'5:A*_5'W9@G6,1O[U-V_,X1C>!LF:UBT&O1]>K+'Z F#(S\X#X52 H/C
M]O)I2-!K)'?L]+.SZ$9DD$<NO=2O4HO<9',_6*9#4O'*2=&[ .ZC HZ>+(SF
M"W49Q=:4#4O\[^_%K@I)(0&P.)TSI]5E7T-+GT!N]AP7EL5WY;.ULI%8!^/C
M1R=$":>6G)\\K*LS4\T?5%@!CR;X\VR078Y429Z=K2*O,0I94_//:X^>L\RL
MA_".\O8C(L'@'^V7,$Q+3F%I7A*FV*J.4$;DY;S#WP9)VP?WV[JG]A/-L!\\
MQ<'<C*)/^<%A*#W:/7;0<C:4G.\?"]^\97Q\H;ZJ\'S&N<2EU'&E00\G>\!$
M&99_<]=.,*0O")Y$#E1,X.H\20ESU5)O)M7RA$;OC%Z]^02D8>'&"A+UDRU8
MC/M&!:)T\7/%M"'"!+O$9@N7!C:G2D25I"1$\]JEG!#E@P*&Y"C%(:3E<2G9
M=+%/OG4,FPLQL&/Z.2\M8_W#\3?,>8!P2JQ+EU8V-04A3HP/MYN2Z.*<IU=3
MJ.L^DHHJJ=Q(ZUX^GW/M8Q('?-X^$%CA]W-[QE9,<C#"KT0O#CTU<-XSX+:7
MT1)(<,XS\OE]03A\4KD7(IZ>AX!@/;\^8\->CO=U*)8?FYG(D@X,+%]GI??X
ML.R0MJL$L*IX ?QYQ6D@-.5'B)IB'E]6NTI7/E,D;N?TI9^V:T.H"IBKC #F
M@:\Y-RQI19W'9VOL*V+^A';[XQ1B%Y\WM XW:Y44/N\KZXFI3\G[.$.G,]><
MXT#K)!P.$I@% G8V-P@1MTD9)1O93K%]N64)->HZ"-4MC4D&J]MZ],(Z]G[I
MJ2G>J=L2-:3$A38(J1Y=']&EXI?K4ZK+=K5>\5O%T@7^AA<+7;H'8;1F$(ST
MY$I'/JM\^7[%D6JN(H8%5?'>A4L:X=O>_OWB"5D^%28,@#I][/ ]<^Q_-],P
MM>%VN*8PV+0!F_&E;):(%(5R6TAID F=T&9Z:>\B='+>=,C7+^\ 7<^5->67
M<Z L=3Y/\W:O )A'<U,FK!T(G FY."8=<FH:R1T<9<Q)!;Y>5^.38^*WD B,
M\E(^GD^A66GH5S7_.?4XR^7-&I'(R3ED86%5D,07_)2>WY6.IAP,G/FSTI['
M/=3L?F1+&NG*=C,0JXK>Q(YD+\N]R#)Y.BUZ<>U%3* ;Q"=OKWVG]8)KWFG\
M^"LL'!Q0=!TQ $6,7$Y%M%Y%6/G?N,W:TQEVS8LF@S:\^ 0?\^&D)UM"!%=5
MDBKP1]UYY_!6:WA]7X$7!\LKMT#L=8(7Y2(73\4J\2BI0S\';+1;<F&J&&=6
M;45'%D>?]N)O&:=\0Q=5T)SYN)*BM93T/.ZW'A5X!&6<$;%T;3U/R&M[\T%A
MM3&O273RP5.;./84=?HM/2B<U++X?2>V[:/[3FRMQ*.:4>FM+5[G1>X[W\NO
M1Z*4V]V;4+U=FV8[6[XEW\N18#RE(,U&UZG8-<BO,% LWOX1ZJ*.HY*2<$\Q
MOY=.L'DM*1Y+C,"=H$?2M=_&B4BX^L>:(YA0X_U%:S?ZY*8:E([* S,A=%M$
MHS_ZF,MT:-IJHMFXU$[DJQM9/Y#8@WU^T>Z2_"6:0L;P*T^ @9L =F]^LG7B
M_LA6U6:K#-FXJ?I+XJ,HY^9;/(XZ/ RGXU.T.+ZZ:/#CZ]*Q0E.\AF!+@GFL
MY]:>02+\SCA2VY]CU)RUVT6&GCT.+),@4-E4]@W"L3J/[Z7PULI:K6F($9+"
MWN@WU$66;*3=L/?G3_T8KJFVY[K]GL(:X*1/\GRV8',)?22./LCTF=07J+ W
M_%RHZ[Z59AT>\GA *V>0SFESA0K A-KMB) Z*C!XREL('+JTV*H1.M&?3@7>
MG*]ZB+=[OJ5&CU4718^S]DEEOG++_-C[1/MF3P%P@LJ5]F@^DR7PW3?QR0ED
M&QSBXO;2J)JA6'-6K-S;6(8+/>%7V)E/VQOI*^^=,-)'1W>I0(__0O=QLJ4_
MY3G"KIM3"*IQ%:G30@K&)9YQD=\2'%:_-KRKO21WG?3=ZEL2?Z0;'2TH=7!1
M?IITA,W,('#NH!5Y7TQXPZ/W[_L&WZOU-?E]_4GA;G'&@,EIC7U=G'F''2/R
M[FOCIC&'INJQO5W#O*J2&?G:&6#_K AQ":\%I"<\1JDYX#S"3H(TPF"D^1XV
MGW\C:#RI'F]I'>" ,1?9<M+GXY.:0?6T,YP$#BP-!%FWW+5C"ND+X1G:WU!'
MF(TV:RT:&G62ORN3;[]M69E\R1]U7?B",$I+> &E*\R[_^X?K? 29[N%=L4W
MA/:WQ'?EF^[_DWUS ?@_+U%QG!R%_#VJ>W+4F0JD5$X!$BONP13C)G0H\3R<
M\L+:?$B^<Q8I.>P9(F&!U RLHJMU*16X>,Z":W-99/,H;FNVZ3+ZW*>D45 D
M@0I@Z4E5"Z2N7$5B:%Q-;,C\&]=+?C5<9\.Y_!^Y <$T[ M;G<B#!2H0STAP
M(F:0%+W+K7+AF$:;#V_+-E2"+YJ%_Y):9NQ8Y>,!?^I9BK!SG?AW?0X!?!6(
M?#$9D\_7*KEJ/J=,B'Z^[SO.=R]J GU8_W-X?3PTUU'BXXY$2G$2*FQ"OH10
ML9 5I<:U,#LG0?J[IY33,G)4P62UXD.WUT&U7'C,)WUN,^'$F3R%)9\PVWF"
MZ$)^5(BXK84K;YRMR^&O& F72A=%*40@H+R@UZ(K#@H#BW/W]AL_#W6",P8X
M8<SRA-M&Y>>Y$76:\094@&U=*E"L+NAE!TAKK5]6)D6K0,=\BV/Q.7X@W!W)
M5G*_NRJ@JI/E)-.X3%DO:-S+0@Q<6/L$@J5WZ1; O(2J^W).F#$\L81D@7M4
M)X/ V*W."4>IQP9?N6<A]3,?=T?#Q"B0"KC?"(Y*Q4?K#%/.N^:I9>*.[A).
M[4FX\V<-B^H^.DT%,KTN%?PL^P++,X;+/;:+RS_S%!X_)Y!\<[QUQ'/)*,NL
M?ESV]';E(],4@C+$I4NK1_V9IC#/\CS_"1&+2B1!\O_\&6O;NR[_Y=]\"?A4
MB$7CS.H\V]XSUA&S47EG7T8!3%W06&1/^*&R0J034T6-W .V2+ P\RF+!I(V
M]AB!W6^+(.L2V[C6!B->Y_KYJ,\D-J0L/P![\,4P-+0OE@!^BIDFKIP[GKZT
M_E>4T#=DZ<P$GPLR(KM+5BVEP]O<MA2-\.RW[T_-K1ZPDK*,1_JE"D6]8^.@
M&=QM6>U=8!I@QN>G[I&8,V>,U";2:;%2T;!K?G/:YMGXO.?#FK=*@J\^')T@
MI)TS2-BGO'FTI>64_I/I;8]BOTR<3^_W'DQZ+XPI0AQXC-)X?/R:<E879PS=
M:)0?P-@)!/C8#,HC7DML2=P8;_U^)F7I_1OUY]BN$+>%#*4/9=U"$+($%LH=
M<-9H0BV8(-X9E$NI9\CVR/!YW^G/V\LRXP'39[:_RC/SS1_ ,)'V\P5#!B@\
MA+FV$U9.,^,ZQT,XE]S[S E=W^?D*P( 3)KG&@#'<"^@'^"01H6 20@LI>5R
M&W]V9@M.WV'7RO+O6L:JN*^9TAFH\A1H14"I%'(63X=5DR:D+T*?U]+MUAI4
M.FZ,O]'^;6UE)/="_:M P2%GMX.-_Y8RK@)*3SY+2,@:?L>WI?),8TXVQ.51
MMD+BM:0E#TGO2?TM2RKP_X=;I:;_27SGDU-"0:$_!:>I@"9'*&Z^\ZS0<PJK
MN^7RE,VUW<#A >.1!_#FYD9D#,Z622Y<OZ.==B'O4O2_U _ISIUP2_,NXTVY
M\@W>N42%9*\)A>K5K(NT\>< NID>#$O2Z0Z>$Z8OA+4+"ZI*DJ\PYB);-QMZ
MWDM\/J[!\YP*8*H-!H3=^\^G>&>Z)2PAV\&V+;AC*(4UF7[#4L8]XO:GO!'_
MLE=\YT,9)M)"T9>ZJ< -!UPTA=V!"B2:%R#E26YMC#5'WV\0I&.:#8FOKK?Z
MQU11)F#WN:<2:[W*/J@[@V..4YNOR]N%3YFE^AQ5(M #EU/+IY3_+*1=Y+X@
MO/?-3>-5CX"$*#$J3YH7:40R7C"X=EG:U#H9PY5:V!LU-7E_.U1S.@=Z1V;&
MJ8I0MKF#;>,DQ7DR3]DA0E@GMIEU?=Z2$"8(Y0_L#% YH()9-36/3K^]TCBJ
M[119'M\8O-%W6;5IUIX*""'&Y:VBOC3G,#RXFCCHQ40'$F8;-('DD7E?!H@3
M4:1*+-_*KN/8=A&!,YM_<8OE6_$M$_^I::UN<=H]CF'*:*MD/;[^I)*P8;8:
M#\QKGXE\FPQ,"RRC4R]72>-XN>!G:B.$28Z@\)'*!-(1"K_1Y?<5CJ1,C7,K
MM[?N[U\4V94+Z^CI@?  $W"L\20:;2M D"^+\14PL"4D53\VL)@->'T;,>*J
MO\&;PL[214^;0',EL !ZI1G_AR1*@"]XE)4W1-Q2X2*+^!](>J4:B<X*+HXP
M7A1-1['GC>W-5;Z;7 UZ-%<4ZBU0DOC>\.H$:XZD<T$:YA!@="*U=30J)C?#
M_0LW#I&6>5E/96"L$4E,6K3\%> >X7#HS=V.H_,!EHN]=6-J6K@M_^O/J[(*
MUBUGTNX7F*;0/J#1W),,.@-$$+4_Y2VVMYXCW,- 002G&$_?ADRMJ%U'+S;1
MF0J6]=/JC/YMO&3]*A(<ZQE3V\9@A?:M="'BEB]\$)4]=^^1["\M6MR5I0?[
MX#6;Q,IB!<Z/TU;7,HGX@B0E>\WR. !TEPDX^2S&Y:#:PY4*F$RQT<F2(><#
MV'0)')$81?I C^0+SY=N* PMZ^CHG[(2CACA6)RO,X\@<WCBJTP)'/N5>:]P
MK\T2]RIUIIEG6WI\I]Y]CPJ1U5-N/Q5UNF?--WD2WF%N63M>5CB#R*-O;K0?
M@4?N<U:;V_ODOKRD@0)MF2'ECJ0#I+4(''4MY1J5N-G'/[?KFPEB1W,UU_G#
M05^7^)GU8,RGEU$R%-D 8VM"_>9LZ?R,J.ZB#6O_@&UB'7GM&2T"AF)@TOL-
M@/E3]]ZKPSO'J4"->)=TM*Q%RB%G1%$RNZU.,8=5+RJ)^_50D>K/9XS/&-^[
M9EI>3@\,+1\0J(RL,93"C/"+Z!1DP@Y!V7C/G_7M=2&"I."*@+3QOO=%!(T2
MJ5_OI0^*/IL]JM?>"&N(6/V*4B1[/\3_7M3%(.:C6R\,EJ;;#FV)CDI)PS2T
MKQHGU#:78WO,VA]H\@@PR5E#,;-@C%TU75990 5:0WE\OU+ <Z&F =\=\^'&
M5'^:@H+5%U JB@?P0>G#:*#5Y)LD"6Q57+K+0=![?[^@UCS]$Y#7%%77A!(L
M=+2=R3LMS.J=,"X4#7_<QK!ZN)]76^%J*TPH+;.G/,JA7!B=^[WY@TE;A)F=
M65,XQ4M3-(41\ G]U^KZG1R$SPG*VE)>T*^59MD(X1CQS15Q/S]O.K@3TGO)
MNCA1.*$W H6[8>V0CE+A)5;%A4+VC./-&EW7LWBC<I^5&GE(^JJ++$W/6BD#
MK,GA=%YR*8'@X;2CA;FP*J1*/=XS9NJH,PBI%M_GNM07-) I8JP$='3A0-R+
M23G,4/@$W"E8FLGYH+&TB)",BRR)S)%2^]V+<[LD$JXO_FWS5*!=;$T+U. X
MCW(FF;'S/?J-=<#RM^5)WT6N*6+33&[?+U2#O?]EE;>TNX;!L-#/R5$>V1=J
MVUA(;9TJMV0E4U>GYNIAXXAZ/IUV]I0K5^C594:$#P0U2*9OD-HC:O"R>;YX
M"1NH:?V8E.C(-QW:E*C3S]E%'W.' Y"P\ O@THFV)4@Y%9BHR3^DKQ(ZCJ,"
M2Y-(/BK@F7]HI1Y\X]?G.8L!CZ7G&;P*4X$=M/PAOGUD&9)_*?("7N$5UD;0
MZNW>%OP'BW[0^G#N[M6$^^_*X7)Y*.\X8+=/E6*<=<(./O&$[GU6B=;'"Z'A
M4Z9;<Y<_C>S;,09DCN\::NSN=BW]7&?NXP%B:3V^Z?/IP=A0= $B+49"499W
MA3@NJR&K;>JJ-5Y<]8O,#>D_QTJO>&JZR>\76#6FV_47V>)(D83 Y%UH)G#F
MEV_,02>D=:2ED3+EM:^M4V?;3^D?@&$Y.7G.X!1\R4%<""LY<) B9$.J.^AJ
M%9RH.8HOMS(7,3A6?\.@%:A[.;'>&?9$OYU;K#6F"DX*QANCX8R^9ROO=$C+
M2_EMJ34E(LP;@RMZS86W+G>'I3"Q,RPX*7'OG?D',\!2Q*G CR8J\%"OK=*?
M TTVI@*O_"E?4T,MMR^B;M]@1^&%)NTHVFV\\,V@T="]<^8GP-+XCX(=3^AT
M/B6SPX8*H$)X7.R8/I -O4O[_"5($?=>FS=:E9G17RV39#MSVGJ/-GWG#MGH
M[WTWQRN486WLK<JO;FE_9^UU7/^<F"89=_?S1R%9I@)"-C#SGZ7 &(_3E@6Y
M/Q'RT=/=NR=W?2/KE+!/5+"^7D )0 7.LG8G*0O6[IC]SU;'IPAG%_RC*"(;
MG%-CZ'5>Q1AWTV_QEH/;4\.;XC8E$U'\>P^\^U6R 6R;F\&O<0W!M3EPK:><
M)<'O+<+!TR.G+?/S^^1S AE^E_47/(1NGTK.PJ\06YOBUEH'2DG=6I&2Q3Z1
MP17V;W^!!^LSZ5?R7X+&F_*CJ0#0+(^G K;/GGG(V[$$Q+[9#:U#:@=-9.E%
MEYL)G^KWT@,64G-8)0I)D?@1]#Q[C?QPL^X#:6%=-FV13TG., %8XFCX>_5D
M]5VE @CR)J$V"]U&LQ%RKNV5<%37V)+-"M]2Q^F(T6IFR)</<L1[^,3N\! 0
MR<"X.;:P.6VV2BRQB^?6\-4"EI^1OK2"3Y27*USF/\]'+HZ]W_&=16#FY*PN
MTM;5V8J-96]/T8&!F!Y@<>@S%#GQV02221D5VO5L5:$"'Q%40.:$%M)1&$F0
MNR3M!<3T/#C 8WMW\=JG;$1\HLB<OIA?_;4?/TS%8F%I1OKR:[8J^$=9&&G(
M^AS?:$F>A,!-L.?5S/><]TR3[J9HPDU<!R*1ZNY8(88U7L9T/6*038Z"R54,
MEPPFC/T30.-5! /U!YF U507!J"D:^+)UP9K9CD5?Z4;U23-*(X*\U3Q_9.F
M5U7(!Q7/D\E%!3BDR,@1FP_5="^>^D;:A/0_E.51Y#B97<NBJJAN5V"7"DR&
M.-82RKI:+IN=#19*N%S%>YERM_CE].JU_&^?0UT'V":K, /A&H(6]ZKF.S/-
M=WCW]<8=$_7W&"Q0^U//)(:0@4=J)$2WX'D-6-R!);XM9DZ&O;$J6IZN.L_Q
M[WJR5CO@Q-,.Y(#BXH]D2%J/AC[<FJKM>EOF2CP<6<\R+\5M$P-\?KW?[>'^
MS)"?X1?6RPU; @N9X@?0?]]7VL(^C5X-_@[E)-U9LC! IKTV:"]FX__4[.'?
MI>.7Q>^(E[/>+O'$A4ZNX'11FU)JB'>D)K3M^=&HK,OI./H;?6.MWD>KI>WV
M%7DZ !A8$4Z^10K#0]%VS$AM:(RMNRF: DN"PQ"6IS8L9F7]S!Z<?J#R'PR!
M?1Y,.2$3>.,8-@RKM>O<>0*_LT.\.8'C:&[F>C'S-;9(ZW =S7YZGHX"J.'?
MSM)O;<X#,:W")%,\19IUU>RC3;=+N:8\1T-L\?1C3,5G%)J!N[NWAT=9H/N-
M<^-8=.S5>$-CPZ:31&S4E&# B)'Z C,=C#B^U/DKM[4$H5XYPS(S;12E_/ 5
MN#A.Y\SGU/#3/<)$^476D!X*2W5CIB<30O BWOI)VTLB16#<L3XFCPI(T'4%
M>2<PT5T 1QY_($MC=QA"OU[$01DL+=?LV(0LZI-OJ7BQ&/MGGHMXEYP;1(,1
M+/2)$B;.U\H_/^1,Q>;'<C+7U%/.C@YOWTM #EM\N^Y_6J/@K?A'VHD;"T*3
MWSORH61-7Y)PRWBS=F)%!2++W=^KB!99TF!Z<A\@M D+N/I6V8ULZ>@0#E+I
M;XPJGQXO<JB/(3%9]0D'2\3Q,NS"@0A*;:/#WX1L=EQ<.\!F]:T^"/K\Z<^:
M%A5'Y22#UY&L?2+Y)L_/$46*1\ER^ EB'"$K5M*747 7W=G*_H7SSCRL=!A_
MD;9;TI,OEY":6]+-H\8P7K]9AM\C*Y*$L$<7<3*N7*N^JNUHQN5;8.#9&*US
MZ&RE<8P00)8G0#!72)'+8VIPG-[BKDYM@6UM[HCXH\= %+A43QQ@6 !I"CJ]
MM2+E$P-)J0NJ9XUYUULOXR=B:\^5?"\FA=_V\?7,"3F\^)'[W4HJ"FA7[A%U
MN"-*X4N_>8"7"UUSK)T,$"*&X@?"D9IYPFF+9@3%F$5M?LNVF*HY(DY,.)PY
MY](2JRR=EUX_HSY!;L$HEJ!J.>+[ME;=$SVUG<^F15>!/5I$>(DXI$5^G.01
MKR?P @0[%K)&LLUQE9IQF:NM%$'ZN>/$T]=6L[*>T'6XO>(U&(L^BWM9X"F>
MNB04VYH5G%V#SMGV%)ZI]CTI"]?=2;^G)S7K(66'N4D%7!@4_IP3O/+>.K=0
MOZ,?RE-E2\CJR&=$:N'G,HH1^%E75A?7?(<Q2VPFA<L$\O(\M_N*LV00*T@X
M1>:'"_SS"<QRWT=(' =;$A238!_3^VNB.WDK;+7!20FB7]^*'A>$:FD*^E>M
M*60+8>PFGW1]E5B5+*AKNW]N3.'X+=OF1^;/6W_\49I*"\S>MAU'.J&]$,+.
M<=AVZ![8<NX2R:$DH*DKA(4@OWG@O2[(DX8SN!HY>GW9\:ZW\"7]O\)[_(=[
ME<:\ 48CW2%L8V3U4,DA"U>_ <353(SDNX338OJTX&039S#;@A,Y%1X]3Y1V
MH0*'A@*!=E]S;SFW"80Z5UZ?[O.KB[[5H$#\QFNA,&TT;<(JV\T-I-"+9A_8
MG2$%37_5X!F^RG<^=7.O2<FMP"7FLD,LS45[@!:KHP?.V7MO=X8L,]PLN@CG
M"LC^%OQ%'LJF[RF&N[5NKWU&5CCA%"T-=WJ:T3,5$T@&*71A'FV<F*U>CQ&B
MUW\?H/';G%%BCA1"GK2F5V3^>OU.#_\5Y?:E-'WE"CLZLBXNGY'L2%!$2_EC
MH(MGI>"&\7=KQCZ(GO4!'M_;%1?=D9EM8.L%JY\&6_T[;4R;(?QD,?S$UVFK
MACT)?5;</B8K:\)4[4#12"XJ30>6XT@8=$Q1O@J:^G_KTS>'4@'Y" HV]$C]
M!-I0@;X'5*#!CC)PBPGW#VU50A4FFPI$4#A)\5;XSF9%R_%\C\OV<3@Y$0XS
MT\MWF8U$F72@)AH9_O\UV1I+X6;6Y5CD[=[,7ZBHM-PP'=R6'Z"=LY%QR?]Z
M&&]1\4FY_P>'D"9 +&!"$+_A0\,K*1SK(2*MM=4C:J:N0ZT9Y=/V?/5?F)KN
M67@-=.E#E("/'3P,I G/]VNA#!K\2,.F<!V";L14_]&=1'.FP>^\8DL!B_PY
M>2\!PMI/DA/1%F\;@9-P#S9Y9M79V/=IUC,09W#0XARC3 N.[%$23M$39NGS
M#>7Q[>-"MYTAFP;B!!*+&36<EZ-TNG._G(GIH/QF90].U13T76@J#Y$(&;9<
MB:W\9=4"^:KB9FF;*\O?+=;W-?9QJG'Y->8C%DM;I8^D0$(13G[G!,DXF^I7
M.1-3USFSTH3.98MW6<[=]5J2>'!%F"$IFJ="Z',^>@0_OQ :O5D6TUEN5SBZ
M V90?'6% 71PEZ60"O@U"L7:G4+*$^ZX:^S<2]H>,!_I50AJS?(:G_ "CTK&
M3Z=WT-(8R60#A.381DA,VV-&:2.">132IW+#4F6^P\4;F\QB'5^;"W-SJW\"
M%@5D@14@38]6\/4_9;)AD@\1@>]/KK+8L*PKP4%Y7?VDERT&<(F&.QH_VI=D
MSX&T:&GH(;0TRL!X,F8@3$4<LX4P'"\=W6^#(AJ1AK2\5=$[B97ML4DW.=&.
MCGGS&&=P3ZMZ@)&Z 3$'#YO*BMEO.[/6V)^JD.[Y=M6_S3'C\AV=%!W'CG9O
MD0\RO>T"C+XJ*YL[C[!]@@=W1T-DR"8U'ZLCR_("U0PCKYOHP_[8H*J,"/"O
M5 !*FN_P"K##^'U&-#Z]W15N-7G6FNO&E-AO'6[]T4Q:MO3U&UXRE&\:/(W.
M;\9/9AL58%^[TO-9MP@1-)-N\6'&G0^XH]G>#MOKOA7>3FAC<PD2S#I2)W,(
M\L5;1%]O(/1E]'W>Z)*NW?+_HOKZ.\@+LVWM>X=^*?OHK"T52!$L.H&PPZ&K
MY[_D"R$O#FF<6\L3&ME)[,SX$/UV>CTS=>V7*(V>-NVU,RS5#%H N+V#8\+6
M2NI7#G%;3_]VD7M9#K-6]XH>E.M?N-A#Z_6(&\>?R;KEKP,_=):AEQN.U#]'
M96K6Z_T_:2N'55=^$\X0(K"6?T:-L33 7#=S_9FJ\6_:.[:--67(1%'.2^^@
M/U8*^.T+H[&9&9!.@V0AR0GW]P,EC *%3G;5,=?##3O\MF>_:/;C9*90:E7H
MORB6%^DVM'6"7FX:.G0<9#>XV!Z@#Y:_+>@W1+&*9&IBP_HAL#3]/LO_G49)
MWJGHS7ILU+AT+2/$B@ /3R27(BH\&=;[7&C[@])>"CL->4'<S!WP*UCIJ%;.
MJ=GN0DN]+*X/L.;6QE<K7QJ]<ZZFR< 6Q9,B8&&]!4S#<1<*:/X[HR'TSWNA
M@[,G.'>CX3_)R3WP9[]]0_A_9>;^[XXKS=Y_7=X__2,<1$T#="DW;+@HS2<3
M=@AA0EJD7#]VH+044W1*\<GDN$;IXT!M*O!F'"6_^N8_Q)?^;PP)58S=KK1K
M_OZ&- 6%T*ENOG%R2<2W)Y=T4KU7Z5"R(;Q4H">Q)+1A_I#/W-BZ&VWWAZ6F
MZN DZK1=UU:!JMS:G3\:.XQ4X.?+D_)YV]ON^@27+[Y:OX54^8@ 6F[F'2M]
M^;0XTM&N^F5\];9$O=]F$T-4EZH)'5<W%7@NCFN+6.1].C])N30L=A026_YV
M:M#Z\FF;V8R/H,W3IA'U'+_G(RB2BIWY4^8+LUV%'D^I .N:7V-I_ONUS1++
MLR_J7RI""MP<F;I%TQB?5=@Z*6X>8RTTY"R11I$>6VHW:&1KO/3>3/DY9XN*
MOKUCX/9$EIL)))RS!/[:#,&7PEF1'J3J0KN E2Y!MK&)^^YF?';0]7D'@PH+
MBF_*!W3SAVMI*C00Z_&LKJIP6VZ\781_0!4.WBG-;.'*93*I_>9#DP!Z[D?_
M&9%.V,/[X8I/ J93^T\%AV*2PT-X2+F!C\I=+P:6;60*5Y;6%L_45BX!*V$B
M^_PY=+0,.0[BRAHLQSED>6P^BV7 7W'C">3##Y,T4M)DX_+:I<S)=0?:4Y R
MI9XN+;HP'KL:\R0VM 9]+=XHPT&P!=?&KGN<4>;B@_IC9E.E5E2*H4TSYA%$
MI;:'#"CX4'Y0%+*P3K&9/SNK6$*+ L*YB6*;'?<<Z^U#8_7^:"FO'-=R;//J
M?A7@,R"]>A>P:Q6_98KA&JRL>6*GERCP0I1BT?XNPCYO*2U0C=SW*N02\N(@
M13K 3UW"\LBP+57%QG+^?H]H8VV&D39F2:",!R*\OP^@G%XCGXA2>!47!$-7
M5LQ.0IAY0HLP@1NOP"=;XL6VO]_%9Q:^?2W@L8M3<'#CEWZ!#0-I8IZG0;5&
M6E<PQN&-BIACH>LU8[6,E@+:NMY2>;4/GPBW)AD66J#?;3'\I,5J]M""+(EP
MIKU./&^ P?W,G<X@IQ</L^V8#8AOM[7L)U-[>(13PV42&!XD#$)T*ND*77EN
M^7..")\+8TAZ[BAT[33%]X2R=B8S.FN</2[6X+0.$!F?-R \+BJ_:EF9^9)&
M<IP6+)G6500^VQRNV3^L+Z8E\#[T,SSJZ;C,JNT%0EF4I*PQ,23Y0R\[_S[W
M@VZA1%\JP!@")L&Q-K_&*(D/85.=@YC#ND)5ZUD]J(E-,K#@>(&GO=_K GC%
M>+)MH28$AJ<T%5F3;Q FHN5GP69?/K<.U]@@-C^^9;KY3?2G$;_3<C^]:=PZ
MTAL?^K65F1"-JMGRZ6YC19J_G=_PZBU=,U?Y8>[]/E6@"W<]E4Y4*_='F1>#
MYDZR!6%E\Z]AH< &%<"G2'558O-9N<E9XTA5Y+C_'6$ 6*+A0]']!U.Y0X(L
MP*-:A3:&-PB];Q%SL$RX6&UE$.'#=KC_/0=4P>_< D'OD;@'7FV !]M)LN/1
MN$(R,/&4N-LX;M3B"H/+=]8L*FO/G)N"%KKYR4^$C.1=^HC/;V_C[GUVJ;!U
MI&QD:U%\.=.BR'GTPK8.KEO@1=Y8%4%BH2TJY**A0^ [M(_+^_M.FT%=?X%'
MYI^!LR+[/+"%)1I]</9OSQBA:BH031;'=W>K_%HN^T"JMZK%;Q=+U4+97*6#
MQ>K<'6F[3I\I3I+ETHA.?P$)/5*F KT0/-=QV%;;'N@.THN4ZX./[D@-2).2
M.+K3+[%ZKO48:U<]W3-MZ0'JYR[O?C;[#CXY0-&#H]HVH>Y4H.#,]KZZPHC%
MR+:;=.6;YL\-B6^RYQP9TLYQ7]):B,@Q 6]Z%HQN5NY(B2<MC^/D,R^^>="S
MWL[<GE00SH18,69:3]\0JIGHE&8+L)WT-7 70L>6?ON4QOK[]AV8'CHA7%.;
MIQWFO97W"NZXP_#S3]V4<0SY8:%S6IJ5]HAOK^AGX9S4C^'M@D_ _AH_]TX*
M:8#0-5)P@=:; '_#Z)LCYY3O/X1D*GV78S60Z8:E&9T"[)'<I$($(0*[_1IG
MX)@T%]B1M-X'FW,OO:/=900:N"9+IP5I":S: GL+Q6C((?GQVYEF[B$3EKS-
M. W+N6]7&$H^'6BC-/<EDAU&2/%$9WQ=)4ZUTE^_;:*9Y]U<Z]'WY+/KAH\O
M6RF+39S27UI"R:49JTWHXE<6=J)"N'L#?8JGC;TKYAVVLEN+5*WGK!>YYR58
MO=L7'G@QR?4!@0,=;Z/#0YVA<7,LK:'G#6W7X2PNA?T:0_SOKG="GE76\#_Q
M,M:RD=XRP'T//8N$$M2,IJM\@\V')2NS7HEG>SE,1;P]9Y$$>20_1-8[F5)M
M<=Z3"M6>:BJ1$9Z?QZ[^F9K;'DN^DR8MJL3/GX#R3F'TH; ?YZC)8^?9+ .B
M;X_6[G!O*#C6YI[0;LX6A>*\3V]!6OP/4O3:12'9P&[H5#I:>J'MYXC.8 EW
MOI&API0U_Z]18$5CD[[JO40<J19?I4_J79@DRU=:VT[?_R[IPR,IP&K2\^2*
M!;?#A$@#QW&&>SQ(L1,:FR43RBX7$/_+TR&F@YP(.%(F>)=") ?WJB)5U+ZN
M8%HOM-8G;CU41@3?3='[K0>9-3$1#$+]7$4$$^,(-;8<>,/ZL!IW%0$$AB*>
ML*;R.%68H>G,5J C!!73O$1(D6NW5YF/:J-5$\+G?C@_>+6O,6."BS=C)E%]
MM*5'5@9&HPECH-'QSG,U%,4R)9:0;XVI!4IU$M_BSJZ:32E+%^LD?6.A I(+
M][0^&3_15\L+>=P#B:;\FP5A_YZW'8<&^VHH5[.J8$;EL]+YGMS+E9[O'5EF
M+;^5G<,]81I)B$@).D3I6CBX$?W,QG>\I:8[>;LFV+9^BPD_J'8'/-2- !XU
MT#!*[77W/+>\4/0\?[-0P7I4_T!'T'%.:B5Y5;MR-_,<P^NZ2.$N0+3"=V^_
MXOL%^;/^]8WAJB_Y'[YY!9: 7H/2?6IV7U"'X!0B+L?CU"\+6!FE1G"7TK(_
MS)']>"XC6NTMA#9IN?DS?%)"LT;+TV$1+N#2Z*% !1Y/;6S7'04SENBW[_4!
MWH>VD6]($L3^D:<[H!L<B97;R=[2L4^/U7!3K(K<+PO^W([_@V0X(5",W7+Z
MN%6XDW1<&[O[A[KN(H0E@E1_2P=KN::ECQ-\OU.S^!%,("9'M4&:+^+3NH)#
M&5T0+F+?/;\TIDY9Q0Z(2XNR&L-25!AR0-F[\"DK-*]BIW'<_!DR#PSA\[9D
MLS&1.)+.E(>Z&K?X,37U+MNL,?\@W0[Z7O*"W>9PXT[,^\O[!J^$W3TMHN;D
M W^E82/T,^S9,\Q!G[UC!BS#NT\8E72,FQ39<$'*RAJO.29BT%.&[R\>U!9^
MP,W&(]G0P7.O?9%C.\OLDYV5H:<WJS%MCT/:17;9QA2M.U!:9N^(#5O9ML^A
M437$3"DV3*L,OC]#HB:Y:/5P*66*51_F)IS"9 P,@MN<['A)Z??&D+Y8(=;U
M5%+<RM>@YW[>B%2,J*+S.D8BK/OE:Z^?JT;T,,=E"EH2CLVID4:\/D&NJ5,M
M#NUP)C(</Z#%"X_:6QIY7__*CL'F5PK>9C;VL4-8KS@*HGGJB0;D.&_/.%KC
M<KKEH'P;BX6%/FQ$")IX/5<:B0J?,YI)DTO-7 2?Q X;T9,D)12K!O^P.@%G
M.;F>/G_-L0]N53657)9'DI>TTS['$-FB>?Y4A]_%->;S(X7P5<_5'BY(J5H3
M=C#Y'.O^AS.R+HWW^JLY9A P7>^&5)A6S*"3S\49,+/JXC@R\ A.<NH.H@)D
MV%GOB@ G3!1<;#^?:5X^=S0& )2!J 50&GT[6 FXVPHB0;%5T8=[C>0GKI8'
ML6+)O>X(VV9$4T'NV/V%"VHKSI"<I[B7_,9?Y_^H>B:V[6^=\+JU2T/_TO$V
M4B,=96D>'2(2D-]E-C);5X:[L%74%*=K>B;&@:50D_T*#)3S2>BFVC/\]YND
M>'_LZ\2;B(9\].%[E99W4XWE@6^43?[<N;E23BL4I/E4Y8",VA<Z)*93 2WY
MW7^T @3H#! ?DZRPGKPNC&]=-"XVM8P,ZSOHU,4]#)31$N4\=99M-X,VG'Z1
MI^J]IU3F;G^P/PQ6/E0WTG]:>/%WE>HP%7"B I"?9-%:DJ>_BT(U]KO[+XUY
M8;EH%UL;[.#E<8:M\(('WC-+X.<$KLVY-NA3 =U[I&>+ \PDJ3T2K#'I6_!O
MGU(@S@K*_NHK(1R3PY C&#U$H27M'N'\O]HQ!F29UEG97*/,U QUG;[S;3,2
MM0*JVP:+\T7+]W0?70CPP+*.W",H)NP?<WC7WQC=GQ3\#GZS:5(<MFKL2I12
M-*H=VCM"\/$%;$E6%MU_&,YQ)O5-PBG@*0#2Y/Q+@Q:1@53@7!7]"?VX'GIS
MLR*1L$*.:A:G @]9CB4^__=XWW\Q&)*Y0GLJ*D,G7LP?2KT3 I\\[?RBOPND
MH3UWYRZ?S AS2RI0=;%MS^JNQC]U^94-,DY=>)/R/QD-_!\.?L].SS\<NL?_
M@[WO#FNJ6_/=(4#HO7<EB$I'J@0"-H@H111$F@I*DRHE2" 4Z1T$%)$B390B
M':6$&D"E"8(4(20HTB0!P0@AW'CFW)GO.\_,-V?FGEMF[O<\[#]XDJS?WFNO
M]_?^WK7>]:X06N16^*L:S^_^_5]KW@<C"%\T;#T 0N'[;']I>_@G]P9\/H46
M_?&!)JZA^W(EOREMEC\7_><"%7\I*_-'UW7R<&>.9H\2VQP9W2. GA8Y^V54
M]U4:8;[AP^274T(W,DWI_2H3D)<FYK0<11V33AU?T@*\X<=S_CB.3;XZX3*G
M*9K6:2E1D,AM:]J-B0AE)INKC\_Q$RDBEW\8-UKWI!M+*]YM0B6^$Y02 R=#
MQ*S\__A._V"+W-/X8W]4N02PTE4*^Z[=ZB68,-<CR=WKN)^3W>Z^:).M:'$[
M(/]A1JYS[NW7(G]?X1$P=HYIE$8? 4NG2.RIXVHO(BH5,#FDQ1>,%J^8;D2
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MIS4\I?=^@^Q?$M92KSP 6"WP*?O<C]#$(IKGP1\%?_SZ_*3XYR^%3S_.K@A
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M)"]=,7MEBZR6:-" T!(?:(QB0GYUM[A[85"Z<X*X*B%#TF(OC4-P]7&,8(.
MSFF^10XM^OS7!D/YW1AA%-QQOUPPT:^:]Q.V%.&'^-[0%$<\4:M].1JZ(P\,
MG>CUI@K7-A$QV.K[$1<-ML45T2RBXCIFS6$=,M[0&_=OGD]/C.?+30P?#W>X
MV%+A8M=_Q@QQ&P:<3'<!+^5'SXN@3A,<HC'\*$.%;IOADH17?OU.\;"IJ/#B
M,UIF8N7@+/K<NY/\*_,0E $:7QU%%?VPC:"./;.WKJ@;K+&X*[:XH _^"O#C
M\EFJ%1JJHPX 2<_OBP? Z99\BZRIRSXU!:D%DN'\ZY)UK0.:G7!(K;*W_!6$
M1$&J(<Y ,@HP&T-Y5 SO(=S:^=*W J(X8R9V=1R.,4XEUI1[='C"5(2@R?<L
MQ?+429C>82%WD<!P?U$'=J3[V=PI6_>MZ<JQV5G.]II#/\]7&5KT2RVE,IBR
MNYFY238:QKUG%C"M);M>3RVG9^29J1$+% V3KF%LSI\:ZY+0^M J^JSW*<I0
M0D3CWI,>P7LW1G"O_1YR9RDN:KY3Z102DO)3 RW?,TQJO4%<[<LQC(;Y!SM7
M+;\FU%^[C7'W5)@?$NJYA'T%Y"9R8VW*@?7.\79IBL$'FH%B.N;$FALV;T1,
M&P=M%%APY M':*:?;@@T>C=$]X)'=38,]+P=3N1HX:C$?6UU)7G/U;E;;KIF
MU9#=U-*-,^&*(H*S11#Z_ <\S(LLL^30(JI($;[HNI.U*TY#NS-"/F4D]#+H
M-%9"EIQ"U/"0MB9!XNY0G!<2$IK7O;+WU!6.-,Z9OGO,P02(\01IT;,M^L-Y
MVV567Y*[38A*$0J5GC#3(.;7S:VMT,ZRF<6D;Q"9N$7P>N>LG.A./XWX)$,.
M (>L V!7_$0WAUK^] S6W#Y%T<[*L#';U%5K7@3JMI*'4571HBY_5P-))CB1
MFX@OSF7TO"?G=6-W_7/BO+Z_4JNOOY62]$4S,3U@T]<GC+D3*V?<F\_OSTRY
M10S>8_G1/T(Q\Y1Y'?4T*;$F%N]TR4C&2-%@VF#(8-F^")_"8XT\W3V=W%1N
MY%A3$UZ6^8#NHWDN8#0@"[!M&HFO]N@=1D9P"J!,R,P5TV=A I/OYVS/9!_E
MWU'SSH32Z?=+)9O2FX'*48;DR.>H(!(ZO%7;QWVQFZ$^:VM>OU1<[P2]%S3&
M[5O:HUP&2^BM5P#8E!031Y6FL#\VFD 9X&W@PN2;^&\Z-I^I@\:(RJ:,K2/=
M$0"$/L\$!-86I$H^.P"BGY&??106N(9D3_:^GB#]73)3:3WM (#J[5$Q"@?
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MQ]2FA,+YYW E5W'B18>:.Z7!4GG2C[O1(H11= .>U)[A\YR)0BA4S!!J=(Q
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M5,QL.S$S8!7QF+AQ!K!T\VVWUZ2\V:[FF!_D8KJVS_9&#Q)]FV,1$M,"%DX
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M^;@H@-^MX:G#0&)DJ0\]'Q(OHSM(9W1\9S#.;J? 4/I5)"S3Y$;1(A\^DV4
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MTN]*?,@^_T[\BV:86VIAH/J![>]P?,O J@@FS'U-A2"?/?"G=_9"LR>CA_5
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M>6%=_JZ;GBF='I)ZRFI CVN]>/H,H1U^%-+DPT9ZZS13XKM5\3"_/G?1A5?
M("9=DQ]PV\EZ-5EQPCQEB_%2O3GI6[*I>2V52M="03NQ[CHQ*/)OB6Z??Q1/
MGSVTO/69K__'_LG(9U47J-J$7U:A"[3&8]GNBIL/5U<G',PND:Y69O$F&0
M-4H#1=+ ]81%2R(F-#*B'GDEQ'2&/L&.38I"NZ3N"PW5?$PN14R!4PWJ =?H
M@(S:L(R$'EIG0D;BY1-X]7?5"&GB]<$(DSG9I[+9(H^3Y4STPC/-!9FH]0_"
M)$ ?=!^J'6R2Q.L$?GV&1=SZ_#Y39/?"E?W^ !1\1&W3PV6I739&AU$'(+F5
MNN]?EN6@4EY6P*;N<^Q[:\.9!EU_QHGH&]J21,I"\M W0F*LYY1K[HBVVE4I
MA7>L_D'<E  X8^N$%%,Q*']ZF-5+2JQVP$U&*SB1T$Y<I%N#+1%,"]X68ANY
MGZH)#BYE6M?TI $TO _M5YB]K61!EQN"Q*0-GXA9"D.)"<E[G6YO/'8<AQ[$
MR=34+$8R2E_*ZHCTI]^@UH>PCT<L+%WC7XA^+*4&%X:TSF%;9K@5$QYD<OG*
M!;2 7=-C96O"AT+7\@BZ1N^)G1&7NBC]1-Z(VD!-:]_[M<OV.0]6?.E<6HD;
MP.$7E:X' ;TCU"5X=8IA7\A>:03L/(ZFEDO/\?C> >I!;9#L;;C6@CHA /N,
M!,<\T])2%MF]P3E]]3*3L%FP(-[[Z]:,^N8G*Q]*Q!2&D!XH[R4[<A.S9A$9
M.VK>%[@=C?8TQ].R-7\QMZX6>JD/W[#19>]F=20UH&V=4I18.:]C?=BLEYHR
M6^V4VN&BTM;4J7HCET]0^B,8]OR#)0G09.<50BU^< U&H&T)K>7I)+1E?75Q
MIULN^B?-YATO_;Y%(6 \'DDKU3HGC6QL'!O3)CLMB8:TX#6#+_&AC?P*\1>J
M*>O'I?2$9FJWF_DS0F>^TNO>Q.)(/Q&Z#[/AM\HTB9%I>MH&;$13C4"RK(<Q
MR#38#++^%:GEK4ZLU=@^CWF2=V=WW/4)T\)T!6-LNM3G;R4L0MU,(3>Z^8M!
M2#>\P><6=Y^UW\\G"WKXUCL*\7QX7ER;@$]TA&K#S,S5!-R/ZGP-((5W!J>J
M;P108YJ)D7+T6W^L&F[H"3M5GX"F+Y)4PPF_C-JSKS:VNV;5O3+7N77A XK'
M+V?%K%<-0I7*!$ANII,9%T/6X9]Z9R\WO@C_YPZWQES&F)*K!)B]Z#:&@V%$
MFQX<\^TIA;\[GM 165.@Z6-H)(>R+)O[0_WLZTWUR4,/@&AP:FPN'U"8NN'*
MYNNY*+TK.K,+:6Y.<VZ)5TY7^^0L604 V@ 0P27S'P\K+?\EH]0R[5]R30'A
M?\DH57[Q+[FF>C2A1QF$@A'2ZRK2IO7<LG5/2/=XA=TSK?*94G4:JZ]>'_4A
MS3Q[\L/CPR53>O3?WHL:4TU%T5C[ZF_3U_&TG!::%6#7!4@!YD0!6U+ X#^C
M/I5-SY$[6XS45U7S52\!3&PLU#\S W8I"R;)0Y<F OHM[$YN@0LQVD2Z&F,:
M<N$,B VCYE"R>-.FP.$+\,&*U)6[L,644/;X1=C$SSNDLHLME8/'%3/+AM'L
M"IBTC@%49Z8_;4B=.25 "0ST-$RF=G*WQPH+DBK^7,GYLI%7Y]W.>9-,)#"L
M3*-"[@@Z^Q4RY<^? 7%61&-RBE(/R<SN#" &[E  _QF)%;.Z'G_RI"IDP($H
M$%)LTU:?C%9W'/4:E"PUS 2QYTJR B[2ZJ/*6[.4\4?B)F/Q@R+GM>3QGC(6
M6V'QF35,Q!0_B<[(S5^N/P1,F/!J/ITL:ERRD60>5A!I!MT-X7_>I0-K3<8L
M_Q;0F6Q "K0(??[)JL8[;)C_X]M_NTK6.8/CZ1U71+<?.$)G#BDTZ1RI K:/
MKGDUVE1N#X!3,GD!^3YP.@,$T+Y,X5*>=5%D];F:Z[F51*1EL;GSG;*F&7Q+
MSE."?I9]=E;6A+&V5#-AO3_M?%\1J(O0G"!@L^QP11+N)_I3+!1F4&&LY:TV
M#/I+2QU><%)AR-PD$'X=_$UE226%Z&TJI+ <G./=+1(7_>/>[MA5^)B\5O;"
M=.U:Q"092KQ74Y<:(?YPZ4?F(L>BC:WQO6S 'Y0C33_! '9+IU>#+E$6VJU!
M)\8395P&N#)V[_'(&5!_(<TEFC[I%I6%@8)P::1X=N%&3*:)%G-E;P^_NU_*
M]?.XK_4>E1+[^.@_:,V6?T!4A@U,S@ 5X,P"U'E0AK>G5Y>J6DL<=POWQ,5Z
M5LL.]^05=%99923.!)+XB8,'DH4RHX*XB.N44DCA .(:"?[JY*H=XW-O[\8T
M'S,7L?2ZRNY1C'AS^&L(!PNK('MVD1D>(]R">UWC3.P9%#(<TA#KJ"[^?..S
M\7W!H5#J6WQBZ+!-\!'DI^/8%<"WAS.">X@H<.53X[<Z*^,4^.SN(>]@$'8V
M,>>I$:="'%@7[,8KR/^CZF6DFFX\\IPSZ4D)*>9J:Z?#@W7KV5IE!DM3WV3N
M.W?DN:3[(AFBX7RC&"N9^X3S#H04<R],<6)^0OR!NGWK] ]IEV[K@%'VSE@N
M/E@J]1,*>+^G"#?= =W8/\$#@;.7+7]\MUT(%.=P>OAKM]UCY!O=_1O9D8H_
MS&AY,)L#\H3L/KF0D(>Z2R\OE3^UY]4J_*&.7AV?J0B8+*E=2P9PTF2^%*=4
MJS6*3%SS?ISU*H45*N!W0>>O3-0-X%W2V/QW"(V@<5HW7P8O:;DO0I0\=2Q*
M6)GY('.21A%:/PV8O%=4\ \"8@H/N%+^K\1.U4&?F(5N:6)N'FX<-'0^Q&Z0
M6Z7&]3+W^&64B2DW4,:FP-@#R_17 S_H4DD&?NZQ(Z1:B:I)6E0U:YYQ>UJ7
M74.?+5$=;69!+1_14FL]%0?8?SI3)1_P2PD,D?DHX--AF'>-/#=[X".?T_VY
MW/ZT".NKWXL0!*6RQV3ZZ0GS8"=!6W\V=_UPVK8COW/YI=E75B!4+_ECZV-[
M-P4H*R4LGJZ4KZ[,\RDIF+!@1'(IG[Q?SO E_'G:T-R7C2*OH<&$MYH8US\
MP"=. ;?:_WDVH[[^/SWC-Q$.9X!<SY\_MM^J@"K9LB)/J<1=-SO/W+3<2T7:
MWP78].ZU"42JJ8U,R&?-5U(FG'ELS[D2DM,KI[)M#L^P^4K_A;#T&JUPX:\&
M<)'+9@"8F#WJ4N2KVNF'6=4=)G/-/F:^J7V4E\4I33<N$&CE% AA_R'GKR 5
ME P03EV.@N:;,NA)FE>1@N\?ZO!TJ'+;EDX/--/.\#]5R+S*!7"80 !C<$$/
MX0U9X@R8>I!W!C",(<F7N]*3@7TXF9748D_A<@>L'(A_GH0)6:XZ)QM-X6)V
MJGGE'T&_O =X86%?&QX71_>P'VA+CEVO)_7!N"U]Q3K9D?W:5 S\$G?LGS.H
M 4PH<\'\(PJ#&*G^3_?(*'2OYUPIR11;D*:YN_MV?745'AQ:I77A8KY1+Q_?
M/0!@X@B%$0NM@J\ 7%\U=/OT2T@%PV%QN>^G/(HDHV+S/9K!^IJ7:"V.?X\&
M:P9E=-*&<&W-6M")$8I[H5CDP*G4 /49<&R^H^/SYT;*A_5NJ^P?WH]<(C0*
M\=I$!Z__GN^6MBW2\&PF\.VX>2]9>O:$Z5?&5WN;SU'*92HZA,1,JHU"UZA"
M@([+\>=1\-R)@](-TCKN<@W.09Y7T^.37<U3A:R9D)O^.I$B!JS*NQ0>\.+$
MDJ3N213 S@JSO^^\3CVQ9F++G;X^<=NZC\K QU'.KY"8?AA%"0UUN(Q3;@\D
MH?"OY<WWQ6\EK!>F>MR.6HE"N6UX<^Z'CBJ=[_(F&EK:KT3/BW_O&+WIKP^D
MLJGQ@5V$Z 8G8\)4!T>EZ]R*]DP6'O\LT'8QRQYK34#I31JTJ??UT:E!Q;5W
M.:EP9P#A%1FBW=:(3 U[W:"&55J<?_3X#+ 5"<:3%MP(P]C+282WYFTIUW[^
MJ//AA8=7.<*[P^/Y^EQZ 4K\_D$AYMHUG(!5'JD!$S*K92.;W"F#$YBD#4G&
M&JR:>W*,TWP28LJLI\H %6+P, YXG04%Z#LH0M/U/=%56(+HD^1]XE&[]-I.
M_;*SM<PNP_94?WF5R_="EM81L)<C0I''B;<:$7Q:]F[90]Q41=@H^('Q$_*#
M'SID^<:#"<\6RKK:2]0Y_]_,GX83R M'(KN,03&[PD[/OVP*[HY,FCT7L1WM
M))F6?2]F/)@$>VHV,4I)287?:=/_8B(LT2_]>G1IA8/6I ^RP<%*(<DA?201
M/%QI?<<C0F9[LI1K_R1N!F=7)UMZ*P"U"4W-(KDDKQ%%>G>A%B35 ,)/H[QC
MCOX[J3*C&1->8Y)7;=!6 ?)F9D:*:(#Z[R9FS:M%BG[;R@T*/YELZ,_R0:MZ
M62BF%KKQH:_[ZS*0^3+B_C@V/: P=MU=&=LG%CU97T(CG/4;! K4/B] U;])
M45Y/+8,-H<C_:TB6,61D6\?X2%"5G5$6&OSB*WKTQ7'\BO>$2B&^JN);,2-^
M.D(\I&'HO5/-2MAI5R=K95<K(V^ZLF&>M"$M8R$7[X1Z[5<*HRC0C0Q;C_66
MA1)4!P7V&-T7.)3*KN:B-;]AI?W_>6"@DGJ *;YIKCR'4"49NV$$=@VM6F?W
M$(8X;?@=[T,O_:C@.]^JZ,Z54*'-]2< 4"=E,"OA))DW)"<<=V4="8D.\,@W
MJZEB-KPQY3J#?^YV+U@C"4X#XEB)RF2]%>F)'#@#F- Q1-,A'07^C.+3-N9.
MH[&1Y8W?-]ZX1> [- /2ROBV_XZJU/8EKXO%_GG=3HM+%\__+@?OCVBVG/_D
MHB[>%,*S$XQI52IF^AX!-5<P:3)%M[Q#!?[N'F94* 4?T*2XLBB4U?E8D-((
MM3.X>WU<Y+;:K7GW-,'F,(>]+.8/]>"D6QY,:KU;?3I-,^ZV0GGQC9[:4M=:
M[$P%U')Y[^KW5_$*;Q25%\%AA2AWZM/_RIN#UBKYL ^;P?B=OR]Q0NGX4NU'
MEVB<DDSJSP7>K;5. 6Q=W[)L6M'Y=\3BC$ '4Z?N.:W1FZ/>^0)V[@/OK*<X
MH^6CS>@%\7S@XM) Y<9L\];DXP_'G/7/OMJ,T-^)GV;0<MX4_EW'UD0ZCY=-
M(#]$J!(W%QM?"X[D&S4 1?3[ ?LZ#$#A@86YO[D2519N#[3=TU!SE(/3!3MN
MMV<D;'28/C$?:!A9D'1Y1*;\]28 58-QL)B,O$4V/<CVPC&'8QUSGO#E?SAV
M,O7 ,UD]]IYZRQ1-/P)S93,*><NSSJ\#.9%V%R.E8*7@!Q<#DPY[6#_8N,"B
MVO#WS%B,'4JRH[*'+$ZK9"\':IMBQ>:C9*I;@OE7;F[]M/>64ZQ/1$^VO(C-
M$1?$JWV-U,@@N2+C\#F?+AJH,[7'H?4/1;0#(L[/^$0PGCR9UN*I>-BRE!&G
M?,Q7"WW?D_GAT4::0Y+1#FM>>HSH.WT(_Q9SS_# \-()H.G*^/$,^*:,)IW[
M:4,H1G\/C;BT-"J>=/B,N2CMK;YD4W*5NAPZ2M\(AH>A3)FB6E%4]3AL.#$%
MG_X:(Y5V[]B8@$ZX*S2^VETLFR-V@ ([\Q%?1&H01SX4Q49?WD:^STB0KEY#
M,CS4H$BOQ87 K@/5:3D%EG@].$PX >SW_=/.B1Y)GBY-ZZ;6+6P=QTJ(RU#0
MU&F^Z9C,^_+(QS:WH#!G%G,]*CH0K[\#(IA@[P-[1T(.YZ;\E(M1:;'F&P&=
M:X.^8PKH%4JD<R#PH#7V4D] @F2Q!M2,W?M6%/I+>6IEX2VP"2T Q -9?9"L
M2%]M[E:?V!YN"B:G\&NOCG>]0C^O6OSHM=>X7'J\'*J.*62*B::""$;3@]D=
M6%,#T82>V,#Q^S=<O330X;UIA2*751X)!L2D^NGQ1BB1QC$]"2T&"TY$FJ:T
MSP)I[6^O2_".B$&9>MG\%6B-K\UGQ.A 0SQQ7-5YPD+S,DTF.+4L%S$';54H
MT"L\&,GZ\.?DY^R^H-QN<"-%4WF&XYX@N@[77JDQ7V(:C[/4BDKEH%6 3^K1
MP0,)$=,BR4MNZ4KAC5,_H/$FR@)J7GW7]:W9&-G&XL$Q* $Q*VUUX.<IW>"2
M4^S?@^84VZ(&),N+N\RYQ>WA"4ME<L:1FB@S7P!6%+GPDF2.'X[L]'MS\459
M"&KIZ^DH^_*H8&9#UF=P<D?&NU%H4<Z7-1&"]PM<\=+><(OMB\[@=Q[-S?Y#
M/AKQ&1.>[CGVK\$<)=V*GYJ-(>ROCYT]@N:+61Z=&(,9N.O+MKGW;5?1I??U
M6].B$B"N,>G/@4]T[TG%0_FZT0?/E;4#+&*NU1MPCOLNTJ3[E@3",!@ WH=/
M_JH%)<[T1FC,HE^\I/1I^W=#\]H_*&Y$(#WLSDHXQA4O7C(>LC"8(1QB9+YD
MY(E,Y'G+$H5]RTL><(-Q3'*V^+\Q<9B[$R7J)!BI\'8!?!X?C):-+6;38@T6
MBN]@(PJE1D1D!PJ_"!"LO\ZWDISQA8FVSYZ#DX.A#XAD+3VY@]<6Z+,\NO5=
MM?A>\M$/38&@_=5?'S%/[2741FZ-]O)N)&\<BBQ)8=$YU<UY ;@.I4XK^>:Y
M++PE'9B/ZRJ3,(M=^N'&NG#@:[(H D1RJ]*JX?KZ^NW65_AM&BDI?;D@WJWX
M4=[==+JK1Y-L)%:]!I+3FY @(<EYF0N:##=D!@W=+RB #K[T 3^^9Q5NY@-:
M=XG9?1'4QZI'FXE>7L)?Y:5OH/F#72%L?2Y,084$D[Y-,&:^+@81BCT#$OD]
MUTG!=V)N-QLM[K*+9AX.7*)ZFC4RPB>8O)]!B9?]\Y9(AL>G3U[:'#I<__+S
M<CG5*_9AJ$%6O%8<M9P>'>AB >:85TOWV)94.V:>)".]UZDMM#-/J/I'H3I+
MPJL,!%/D"$,-'EZD0$Y,F&-4Q?<>-J<K"R+617C'(B\#U1;W[E%?FQ0#!I O
M'10*3<Z^>5H>P;^ED;VX$O)^89=^2& TW2:3S=?_6US8KPFI\6[!;_D)28]]
M,I8L<^1B;G0N!-)#_'U5Y7VIM!L*W9H#EO*PZT-U# AU@F,Q9E* Y/BS_WP?
M=5^0[&.\3,TR58SH?;J@?098-!7,-2H?.$)R("P)Q;$GLFXX;5.;."7-46X)
MV9JI'QQ&SH-47^*UV=O05&!!8:F1GOLBJ?D/FK .F@/\=8F7 UFYQY4'4Y@7
MBZSDHZTC#J/L:<"1=LWR15*?NFE(3H:$R7B?'BS?@LO\B?83I,R7E\/1S5'U
MS_1'U7@%V>C58:[Y7WI<D+]%CW0/?_N= :6?Z,+]*&.6&Z0Q_@7=X^/C4^[8
M7!SR4ZIB+$Y-ODJ2*=;YM%>_3SO-FB!"X1XGU^SF"?-OVI\U2(@O,V4]76.X
MEF!AIJ>5ND^_+37038?0F#ZQ(5KAO.MJEHU?]U60DO<U-35S6,^9PJI=GY:.
MR#194.NC&00QZ7GV32E8GUU1[.G-);'FJ4X']\=O$_$6[-XNP[EZO""(45F=
M90FK(S$X50E)[7[KN\;N]J+'IQRKYSF%7Q(MJ*NDX3!?*K71;PS\4R87DV 6
MO7),H$NWHA5'(&Q/$L'!==RDB;+A8DXM$$;L],O+B:4?K_D$0^5=C<K3?<>[
M3#"NK_^$_T>GK_]=^\_<O_@<I1;HXK5DJSUIH6HS.Q4=\NF,B9^:%2?M72K#
M"#[Q/72/NE5"S ;0$=IS@3(1Q[=_BIF*M;M[>96Q]+G\<Y,>S: &"4AUY8B(
MFYV?OJZ#D]J3VKF)=GGN!A&U%#"!$6,*P[]V&BQ@S%.[17Z_)JP/%]^;+@^X
MX,'_D3H$.CHY0H)1!TSI:X]J?:(U3NED?4.>:%FR2CQA#W^SK2."VI4YU&69
MA-J_3FLX'B&)F0"IF$P3=>B%&O)<_O661.6]N+ [!P\\I7:?R%2FRCM,=1A5
M*]!#(5F9^GRX:B>$.RF&4%^2AY.-K1'_]'Q>?/Y$]]+]5!3M9EJ2FKI04+09
MK3F7X5%)9]OLH6QLGBVX^?WJBJ>?:>6X7VOO!!HJH+,6Q'&[," 5GP]LZV*S
MR#SI5GK/Z3<4MGGXZ&81A^,D\^M=)%GB+Q."X_,WZP]U.!=V'K2F?R ;7FI
M*0>)";S3<=1@BN\#1WJ6JYP!(JPBG@1@-U-6\0PH61# 2(V[]2,%:KZ0*CUA
M1>+SSBIA*C7@-_.2)1L#_#0TO-FI*+BT BW.A'8X)6X/+9NN41E9JYRR*S+
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MX8K<MZ08<YDX)S)T-8<X"98Q< 2^>0AC/.FSO5NN-FT3CQ_D>W:KYL&-!Q#
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MIV=B#>AAD=*%34<5+2P^R'U'S^G>0CW&DNG5'0;CQY /@#/Q%<SMU:K=N#Z
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M)M[=%,G3YLM)=T9088G0!0L[D8^NN_%B>.9'F3Z;[&T]#!GV!XN6(M\-T\@
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M&"$MAG6680C24SW;%LLOC <P3<#/U@M06PU4?0>"N^/U&HO<30:GJ2J('\L
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M<!<7?7@$F9K-=]0JL@Z.U+V_8],RL=.BLQC4WVWD,OUR^W$DQA[<W@#80U
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M6%H\<#&4H!'8C.*!"]I/DZ8%7K^Y]V_XTOZS@XP9[8U3)P![6\+KRPU4>"3
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MPFP/+L7=_EL!-+#-@WWJ1$QQ!5VH=XHT^)G!B-/+[YC7BX2?%-Z64/J\GF;
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M&22 ?G=IF[_NZ4%^H_5>VZ4 H@NTG&I6<,U-6%^3DT)QCYQ3#(<$N1YF$A!
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M6]9UU3M%@462#]:%^ 0IGOH)1M?P25"?K/"T94\,1-UD+<_FK1//8HN2?0R
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MCJ0WT6Y\(IHD>@' P4 ^9?P\)[4XW:'7N:C[.(R725O!!YV>AW9^2ZB<-*K
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M1$\FZA3J @57V_32?XIZIO0Q2_K!DK*6WYH0>.&#DU10&YPUF@3TEUSJ-L>
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M+'@1PR?)8H SN]\\C] @CMN6EO8UGZWNR[T(9VSF74'2.FJ[L>GSM"@BJ8;
MV*YN=^RA(7:_M.G-@M0+[_B2M;]L1&UD2G?LW[-5/ )DDZ7B^&3$ZSO.]"%+
M:^,=[OXX"_UIC^GCZ\\>[#BR1U8)AS#5@@3;7<9R*'CY)-XLWX<EG>!Z]F-P
MKT,2Q\S,I;C.DGSO2<9*6?_D/$1^N%)HBU?+K'C:'5Q=,U$1<!UX@*/+UM/T
M*M)=38,_ALJ<PWTY',PJR#!\Z_19FH&'L/-MMJ!R+,6$/LCP%8X.@]GN:;(G
M 9Q0Q4#J@Y.3F:6EG0M?T]W:LV6L+_3F514'+7P^'HH:1JA[V:9*2.Q-P[:D
M$<J2)&"@"69!J)VD:[4A&.&K<>)C5P(I\+"!5F'AAR]\#SDMM$;?7-09Y;S-
M-)R5V-PQRJNQT4;D@CIWXR)2K\#I(=5&P@*XUKP,M;G;7S;Z0@,&:4KI#CI$
M62.IX_-"Z+S79)KR>XE"_FHU,TNWVJ[^"(8K?G9H'VF5&R$$P_%^\.0>EQ$D
M"6A4) '-5X_/%.9_-NUO;/)A-,LOD("F6U7^K[Y#@WL^/I>OW8=ZUTRH30?5
M\)=\'3P%&, W&LL)]_!-N#O?CE<I(4X#2*<DFZ6]4/Q;=%C'K 0U7)E=++5/
M(FMQPM)DHSO%LN"G8CSY)ML?OF_"^A]"ZMK .V-?72P&'D+//#Y:]^$(L2G]
M6H)1Z@39P[VPQGB_IO-79:)&+_6*8Y8?O::+P5:C_^!F?(ON=U2I)T-M4+_O
M?5/KJ&*7?<=4.]5.]<B/UF!$&$.-<Q0F,X 9^N"%3*J>" 0V<%^8V[LR>QPS
M^)OC_.6?V^F%]QZ[*-F8_$D;!MF.8YU2"#;54.@L]#:.T0$K5#)"$/]IM^+=
M*;3\1:S%)I$QS:78TR7GLYLD$Z#K8\%(D,2-#'Q7=L,;8CY*W,/&?&GYEIV!
MIC<?:KZQWLAFWV_&*9D']!Z82N;%;9/5<. 0F0M%N+=:M:Z^0*VFK0@5\2JH
MG;O82#7^^>3^1,=9V4A_G>*3=HB)II[5F2*LGVS2'W\905@0Q,&+9=CG#K!^
MPXV8=^._VD#:>\_^A(<M;83.7-D%T\?*K. 31XK(_*EC@_)U8H;\'$9J=ZQ_
M<"\0.'.Y5ELCK>[,_LJ7(S.^.(%69J^.+$)7,\EV3=<'?,I:#HK]'X^'$2'Z
MTIWWDS\==?#/79//A(8X;YM0]J@A*#91_F4#A^G*A")HT?%$RG'R""6?Q+7,
MR#VFK+)[M_.+K;?]H>9GV@1M$<X>EU4N",1(LJN4N&&GDWU]T)MC)''I<H7I
MD8N6X%W]F.>U/JU(EMSH&L=/8A\^Q!]XYG9*>E4]*RNG[=%J_JYPZ$@>;E!:
M467T%1 ?!&_!WH:U,PZ]\!+N/-1[?*%:^J/Z4!E_0ZQH["@"A"66B.8/(2YV
M90RP#^7V/+KY3H*-./U'\XCCI!Y^$H_]6)8 -3V[ZL5-Q1T5F"I?YXJA3BI8
M"-!;3["HD9R,.X+#G3@4H7086))M6'UAE=-(PVZ:JUIG4I>9?.?SAW>P.0.N
MJ-%1:C<6C0:I\WJ%5]B)?0KLR"!"MKG@=R^W=ZL5VW-7LWB)@LL?&?J2&K\]
M=@."TW?!OA9_9$4 $K#GDT&&]B7K-RN$F]BV5,1%)X(L.7P5PJBJ,S8<KJU<
MNES_2OO6$$V:!Y]D0APT,[3W$VU*<NQ%/ AM!<^MA&08S[WLL)#?ZSY2^#Q
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MJYN+\FM8U2?XTBS\4SEUT=(#X48+0T_?W'\)\?!I"=DSF)0,V&D8H:@929P
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M7\W2B4 F&\@Y4V3)=H*=A(KJ[7U*"J(>!C=_V-[VY(SV*U[X8A3+N R[D39
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M6^3S?6O-B-<+*HR2AH-1TV[DXM)?JF2WPQ\^8O>(O7O\]4_ YPITXO'E[:>
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M,L3C,R9IUM$/^VQ#O8/!QQ;@8ZLPH<T\81 _RL" D8#/IWL<%'UIC F7\[?
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M--T\X>-JH4=7?19V2KXN3S ]AZUVAT,QXW.%?2B)R?O*G@6(^!#FUW=TGIP
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M[$M_2M>%924I"F&Y^M#/SNY8DMT)Q6#R7<\2>YH0XNX9.8A(M^ZWA6>13UF
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MK'5C-V!!R O=RC8]QC]CR%+GHOIS.T;=+EMVO,1\KXT(&WT+"^U]M;XU>:1
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M 9TNTG5BQ+I) N("V%6[ "A*\(*=="$]8F<19^EG2:4A3R\ UX#5D 5\Q 7
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MMHWBM+'0I*/Y"O>-3QG;NI.I:)@T=(1$N#T  H&0VE//=9B.K=6HX%]V*%T
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M..GO+Q3YE5^ZL#6_UZB?X7>[(_N:&3G<^,614O(@8CKTN2&D?=*2.H1=48:
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MGWV2+MWWC.%NS3#N6A?__L0]O8:2\,5QQ/?AH%=@F9N(SJNYP]Y@/I 66&(
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MQG:%S)L'*PLP:\V"&MH2ML#J^>7"M#N/S_)5EP+2H1V <Z[A842]U<0>0+F
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M_ADV#-&DKB.\Q.=@OBSEO^/.I<FII^J93RT9\'H>8R_>K)&.R\X?<F42>"1
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M#_7+9%Y">3F^=MY1V!'27-LA>K*'GGX@M:_])F'<&\*M5LF^TK@.1U"9B9!
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M/ Q&W2WYK2G-RV[WV0,VPLGMY-C(GN Z6_9'!RG/JQ5%BF,ON?IN3IN ]E4
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MVIIH\_7^C-4%@RGG20,$78OX+@-._&1"F"+K+)4X".5TOJ'_HU]*5Z)+_$[
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M(?9[(^B,8=OV\U-JI'%T@+]Y#K\K;2)H?C,XG7H^%;'9=XS7E\M%%M>&XX\
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M*SA))?#WE;I:6HJ&\P2,J#"G)HNI9T4X&33CJ6IK+);TPA]-3U0N+W2PY[V
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MNQ/FN""@I:MH[P&]*U_Q^=',<YEF@.]LLJ^-:BE1$>S M1JT-. TDIML.<"
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M3F#J)$V\HL$S<>ZGZ>YKJX%UNOZ<7]EW/ROUN%#;D#VDL_.2C9RN.?V'S5:
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ML2#^09U2LBN81OWCE1R8R0<5/_GOL":?6!"ZOMS#?)+F%<[T)%'3"DS A^B
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MURD?J+FOSI7_VW"X,H!E6#A5WE:,4C#=Y N+DIK Q^_M_YO%M^6+"#5.]!E
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ML^1B)9G$T(BN]OTSCN3:M9'8SQA^0M8=9'-.YGQR!A@>LLB.(ES&K]JS=O"
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MXL67 GQ%!CM=3),ND][L;&(>I<CH!7YQL H?AC9ZL22,CXM5E:J$67%S[OJ
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MUC9CJA?1;R0N9PU%Z4SM/R%.9C.<7RUBUEGU:\AJR&/-L WLZ4S.->\MC'5
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MDJY",?+F2BFO7=I:9]_]WR*[*3$(0KT,N9*8##EV"'2)KX)X6@,1A'31:O"
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MSP#VH!%(WT)%%,SG^>*&O=2;!AO<2,HW&^.M^YTF=4RD $=43/;L>-0GCS.
M.JB%UL8*:]F9GF#M/A'4,B@M51\V-W-DFK568#@HX5SO)G!>5%/&%""]_5]Q
M;(;D'W[7IWQM9]62L<,9]'"9/8))EL"[C-%>5ESN$D4.EZG=65;'U']>66,
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MF0?GX8M$]SY9J)T6FZ+*\&,C7/[X))R(]Q 7(H E& @7BSJUT-1^H&9?Y_.
M"9)89#SH=J,OU/53[(7"06ZCK10:RX;/1-@)3FHE]WL)LYK1N(EIZ3UV?8:&
M0.\USN[;?)6W_B+&^6CT=4C?HG8W8 KTR1G]W%THZ6Q3GB+"OKSUGNLAUW)^
M3AB[UQ=2=_L.-"(\LMRGO[H^SLW$E_#?C&1A,A"<;88>K5I#D_M(^[2XL7S/
M5VO9GNK5+\1&EWZVNZHF,?Y^ 8<F3XM1[>@SS3W1^&[=GQA8"$&!TFI;PX2S
M1=^_K8.(5GE.W#MR<7<2E*?K0=3HZP&>>&.<0L1%]S:>#_730IB59+R&A9>\
M99/.Q>@KQ6IJS/&I;T@XM]528H8?+)/CD&@ON7!2>ZSEHWU-/J2),E=\_(X4
M%\'=L!L0O"@@(2=7D;(6V'F4)TK:3Q#%TW(=;6-#,9-=U[TJHB[4LZ7"M@7X
M[F _]<[?*6CL$XS]FJ_XO=FNQ6JSD;@G0U_<$7KH#(#+;(B[10MRI>O4N,N!
M54L$6G08IKJM<5,Q>T&76MXPF<8T_=NYXG/&*8 9<"K^>#*"'G8%9Q 0!L&T
MV(V787JG=OSX8E!/7<4<A_U1G/?4D[+\6>/(/P@B8,1QTY'$D(_6>Z7?'[K7
MG[?-=08DZ=6]>]OT)K+;I>**J=U]"R+<+VAQ7,TD1I1_CWGB/[9_Y\C?>O^'
MA ''D/]5X/O_T_3_$YI^F[X5<KRE$U8-C2+O_NAC.GE0>&5&_;K9]1EDR+O6
M.X! 3OHW"Q)M])O5E(*3ZRPD>Q5I6N=P9P#:+#:(&PR"(HR25J^8YI>[,YCD
M,-IB$\O=A(UDY  !ZO<9E!W5S[28<(L]?,(XW5K(41[]8JO@T<J">$7]$$^E
MA >//L,G(T<&MJ4[S@5^O6%/6$ANWVF"C"C]^$)!+V$2V62287!02_$9[JJ>
MC)BOO8(+JOK^V6HK[WKWBLV#9N]-IN7U':8A[I>.99%6US*T-0KXXMJBB=:K
M!J+!0Z>+KXN;8]T>U8]HU P&I5[Z%#QE%TIC[L HP#@>U;E&)WNWC?.T &^T
M&BZ-<HL-]-(U@I-#B_JVK4ZKRR$;WF615S7Z.F\5&O/=+6 @,ZQ]L5%,9X T
M>/0#3XV9[=;B:\_BK T<HO!RS9I/UA]]37+9\'Q*FAS)82WI:4$$=W5Z?WJ"
M<H9M?CL=U/I'N+)>/*BE,0?9TT014V=R7JNE<B7B$C'*;A/YO-J(Z4]&=,XF
M*_WR83=+VA_DFZ )<^87&SPOHWHA[-L+G#EFS!1GMHI3D-3RJ.4>"<NOW"IY
M5E/#\_5KP'=3\C= 0,HX.1@;AKRPFZJ82MVKQ3D3'Z_A\3S7QGCS(E.WAI0,
MQJ1PZE"@W)3,U$"\%B^/:\<:7\OO7I;'*L<%FM'9(J7)8W?<()4O.\_WV3LE
M=#ME%6,,^:-UCCZ)D@YZ$FB7-L&\^P[L'C^M.I$?E;N&D+CMH_:BE'?R%TF]
M)YX;<DH6J7&M[Q#H8=HXFQJ(/$QF-E  >6JQ66MS!:O S%$M O.1-:+\4I^A
M=3L2(,T>"9MF(4$3J'!Z*+&VBS:X/1391X_*K</@,8^*NQY*.[1/D@8SMLL2
M0US/IS3*4/)@TQW_!Y;H/Z.F> G)TZQ-J+?3O=:6/O*VK2EK!GKLG3I52=_#
M=/F4:/(KL6V<>'><0TDO,IT:FM^55QM7G6BL7OAP9M5^\8K112!AVY^R0^(A
M7:0O4_\A'!L?2Q!SCU"?U#"^5P/)OCK3=NG]3$GF>>R[5\+S @/I#UZ:W]+F
MUA%<FQVOOT'^%*J,3*M KJ2!&%K=_/P\A)^A1#V99C@*4SX_O<C8AKDC>CXE
M179U+PGLOANGANBCCU5+C]U/3K:QV7I5')1S\,6)1-!"]7)50*2O["Q/6L/F
M_@WR3/Q='+@:E]UG#4J#<58O;D3(3#A"9 \W3!J;@H>-9*^1\Y\;U@$.MK4%
MF"UP9EAQ5%]^4!E,#\L7?^^Y$3=I.=2"<\JVC3['->=VRX-&CA>KL@!S6MNN
M'@!;B""![MW"6:XZ4'W/2X\O0G<577K;%AUV6ZVJ46EC*$Z(4IYI/?+<*DW!
M&L(!-XC\HMX+I\);EGV?*&M#*!7*&_FB+_&^MG/N/Y%XWKZJ.#_[!&:%TZW!
MF[><T!2IM7S&\_I1Z<&?6\WIM:W36"5\$'E(QG'!5Y_\0S&=SZ$R9H2 P!1J
M&%5?.U);3_RFEG+$''Z8()H&F/G5D=(??5]/T*+'M7>#&8+@['CY685%RJ"/
MU:\W\K:E#BV91?E-JD&C*3JJI*\$"_;Y^LLW#X]-$9![;DR+"]8];[JIZ)\P
M:IO?W 9(,95W_DM'P>I-#C1!JNWN0]()U'[N"@DPE<#@)HDSP'VO]3!#ACOX
M2;>3^KO,R8\/?Q]?-)X!Y&W\,,E9Q6=M')!F1@RA,G"V^CDTCS+%(KM-^6GI
MHQ\+AB"Q#H!D\%MC*RLFN><V[$H3=KV']N&DY>SV3M&DZ9L)KP5N<=;LB_/&
M3#^&*3D]'9E4T7R=1&25&^^,-0$WY"9Y>0=]:\.4YIT/"3Z^$R O]+AJO$_Y
M%8>%$VLW#7-&#S;O<&'LW6=/A<6MDT4;%<D?NVM64NMI,GS!YA1E SP9KX$Q
M;?$KD1JW_[+. &,/WAT#[_%AA(EAS==[$(S0B#&]286AY)?U8]2]<M4[GTJX
MX6I&B>I7\RGT.%Q)-2\\'.LY Z)GP(R*7M+V#=-$[X0:$;MF!;&&T,O>*'BZ
M=DMI(%[DJU9% 1.]4,B)*BZF;]):!\N,LB]!\U(MNSS=P&R.;XXOL:K>E$W(
MYN?@\9L4((M4: /A52?Q82?24)NNHHM- 6[AQ0M5KRL\,Q&2=IQ&Y#05$)J8
M:!F=-0O[OWR;XQ\G&*>0IG 7K=-P4_]<5 <0S"H)0'\D8QCQZIB*?BZJ!SM5
MN-K>G%RG&[/2LXY%W^Y:*PI9JCO=6A(=)5'92MKY*QIQ6R^+Z:4;<$ZOND_T
M[?':D&3=TNO(SI+J]VXG!H7K5;$)B_52[)Q?"HH*MQ#36G30_DXMF1F\'J;)
M=F*[9.:KLEI\/%[G?/K](Y%=TW3.Y90OAJ39VP ?DF@4C5$8>&^1,/9;)FHE
M\>&/PI=C+W*RC<?W5?C4N4.?.@Z/7)06()GD=XS4V;&?_"=!;N;?9:7,_[L7
MFBS')"W_"_FGI*FX:B*V>7D&U+YLW[],].M_[K_\[R6U*J/6\0E'B-W^,^!Y
MTN_!/Q 'UUP_P9X!&_<CU8;,<'LQI[T$<T5=CS. SQ?^OOU3^6\:P;[_&O5$
MI&9>$C:= F:'=7V"O=3=@6"LUU0WG5:\*Y1O-%UO5+A=2Z,;F!F;X:UOOIZ]
M1$,3[8G7P8U4+N V8>2KU\FD&7'5CC:5\S7KOXOEE93JATF$$O@?<:CPIZRS
MD&Q-649]=^!HNP@3;)MTQ146;\CA7(^_>G';8GKV6.J"!<7R5.-0%2WG@,[O
MAN3O<)W8!S[Q\#EKB_22IH162Q1U7./$?IUHXMV7M()9JN0/^/FST]#%@P!?
MMBV\!YZ89]EUHLF$-H_[$3A]<%<A.:A>[[[P8]E;B\]\2^X-GB]Z2M;:WV.O
M@?N"V=5KP4HGP%173]VNU)G5VUMM6%J*A=)0D820W:Q+2LD"-N@T(=+_/*,(
M.+Z6M->>XL#V F=3X5&WZ)$-(0C.>&OUEV[,;#/6N*QFW8UI8&&PJNLS^'_8
M>\^HIMYW6W1A4'J5*EVBJ#1!D4XHTD1$4;H4!:1W@0"!4*1W$%"Z(B+2>P\E
M5)&.($4@"8+T!! 6$,+AM\<=9_SW'N><\;]G['$_W0_YLM:'O&N-O/.9\\U\
MYC/I<:6HVRUND6%_0$$=6T$%=S/ ;S4?-:2CN)NS%V=5 5$!9KH4%T[HS67(
M*.TH1=N822X/X6)D3*THS'A\FVU'#Q4NQO_>7_)V_S&O'T62AO"C_[XPH_^U
M&-J^&?R/+-E-#$769KPA*2@5T0<W3/EFPHU2IO439)9M7"%?C*R,%"[G4G%R
MQQVW!=DA!/'E=4MNX<V6O154D5F/1[U-MNJ<1')J9E@3H2$_7:U^#I/1]78Y
M[>MT*DF.DP3@>@\)]/&PV;M;JDPBNO,^M] U-R]J;:JP=+\@\H)M!41G?"H\
M5JT>55MMEE$GL4X9??TWM7:7/"T"W5[FZ[U[N,GUQ<R!KP;U 1D@9V8RN^[[
M5.]N),T5D2<U$HK!0/8Q=5#JB0K" .R4^KW3-0)9"T.S[=8^64==2\[8NF_#
M$Y70N#5:R=')GTU^9VU=&*W$2!H]CHQ1\/)>XN.!OP8U>Z<([S^&6 :V+5LQ
M/W1)[0=R:2ZP1BDPBMBW7Y'ZB72(M\24MSD5=7X>M!+?-RN!+YL4<= :#'A2
M 0\D@3/@&7PE6+$\9A<V^Q3']@%OU^'3'!'MX/(%'O:D/:*K:WR-<VRFVNQ6
M:6F0 ;]5@HG7'TM"),Z@KW.1TE[4HS >V7/\/?GGK$,ZM(][6ET#2S6O>HF?
M;.#HK5TQP%OS1/>N#[ZUNK^J.[;IT\L+7[A3]*R$5]P8B<:G'Q ,'W[!,Y[C
MV2.$1K<$I=D-ZZ7U#KZ\Y*X27:G.R>=.>YK0V"$U230BB.[TBL_ 3*9:^5B[
MYM>/38=X&L\ LTJM=OO8A**7WUJ]MZ:"A9U@]7GH$U%];)]F_72KY;46EQ0]
MAC42PII'ZY4WN5U<7%@N%??T"WS1011>KU?^_>:^J*IQG9-'L[DD29"NZTL'
M]";T-OG2EA /(=G"\N0ZT16T*R+>'%60R>S-P_QRG!+-2&\.HWF5N93:K+P5
MGE2U;)5RZ=(EH'RC=Q&RU>I$,.NT9%90_#J[YCO[K*DMDQ(QLL6%"*GQK.3\
M:6/>IR!#(:"<SV#SL7459]2KPQ>6RU/7G#+L8FTR:<>6:9'L1*K?]AK3(.O@
MY)112+JM?:&UQ/@<6_8Z_9W@J1:@VX<13+]FCK=MD7F-I9FJ[,N^[[90VA2#
M1W))E[2 8]<8C  XA/$+NLP0]7EK&HVT.7FJ920I+O_05@6F= :D<I[,V[7!
M#R.#[B"\P7@K!76,7F0S3T/$]6M;@E.N[UW+"U:=;M+GVUB3E\LN)0\!@;+J
MB$'\X<%G GL\2L&!E[P-_]V"F^]EUHGI^%_S[?P6]>0J[I"N=S&4[YC?RR=0
M<4CM_P >3TF5,# X^,JE%_G1A8=7<UYO:DR">GS9UEY"_MWH[MMJPT>M=PV2
MF&GBL^I/:S8O^\G^'?[U\["O_9'3^],R*4J%)P0:3 -Z2&/?!.YSC#4W,GV5
M-6A8'\PFD"5(S7H=FAJLK/AUZ'!+"@\Q'+?LO#/?>090$J-<5,\ 6ZWZ*,I;
MU,3W^G?0P&V__@UE/@V'S+3/-45SEC_GU?ULO:X,TG6+<4+U)3F8.LFYIY/
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M\=;]1/"#;1ZX":RB4+><)E'0XA9^?I"M^,6J7]5%6U'N,=2E)\%0?[+)4#K
M/Y!UB9?W'.YTL-M90E%*?' DVI"7S>%3PC"N^_#RZ<>C)S$9S]Z\O&VB=13=
MRV"ZB:(CFC:#X=)1=\U]-91X"+Z1=EI2H@HZ*WTG/:+<5:A+!L%0^GE/3SK
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M>\CBEPIF\,>)JCAZ)R*(AE >EWXH9]A2/-,CO*#Q77_8_E/:_*W*[I#'[MK
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M5NC^^R$>Y0+@1=R0#L8R!"'\U5&)-R"1&A[S[9AJZ^%Z]<^Y C&.M]#O.KD
M3;"D5XKR#<1_1USS!NHV0L RNG*-_>!*Z0(/P3!2HFF\+HI1Z\4K0$Z.#Q4'
MD ?0SU D_&AE(*![9VV.+[5A*ZC^^"MVO7.58F"8?2Y%'$V. +14-8QM;/4X
M^]="R4:#!E%<YUR<?)_GNKG3 P*U65U'S/DV;Y:^5QKA:U4L )'7O@5?BO.I
M,"F%4<#U=/%\X;4C#'_P[^YN*5T,9;%.[UC7WNY>3IU/<?+\_\@_>11V0%D7
M<7XAL*VN*5JH/L^@.<'XTV.#'P51K/Q_R9EO!SKQ8<J&1C9+"%W(R,RWU7P
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MMCNZ<&#5U-[T.:]NBI+*(#-+(Y0V/C\;>"1)27'SY$%%C!3?K!I&B"AX9^U
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MJ$\5,40N/'8/4[%5C!%V>6K>2!!K*K9_NBZ74.A^[ZBFLDF5"1EN8*T.4:0
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MEZB7K,GWZI%DK2:8-FO#Z:!+1.V)LGV7!VM%6=K-<U[V-;S&PE^2? '$AV"
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M7K?GL6WS->[09DUX4,*]Q$WKW2=8YA\((-3=KBW#JBNVR YX%NP)X;LY36?
M,YLZYM=;E:C &HN2)9 $4\/PT"MRD5A]#^1^=M2;D,9&D@2?\#U2VI8S,L$G
M+G63F/ 5"?OBS%FB#T:ZF[=(^2_J[6Q/I+H^1LVGZ7-1>\6%)(?Z3\/RB7?
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MU;I)I8M[TAZ[_:Z%AH*\W]&$LD#8TDB<@C?V%Y<%6%2QEOGFBDC7-AH]2\[
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M* =L7S>@DO)Y#R!12R?UQ6?&-SR==.Q-Z3-DA^52<NC9!CB >_ZF+.$K(D<
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M?B%AF4< [<@NT6\I4F?8B6Q$/D,FRVX= ?-Y%_.=R2Z[$B/SP:'92*_FRIR
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MA+8UZ/$,V8TXTFMQXV8JUBVVHCV^ZNI!-0["924SXW@5I9B@F7!@C4S5U-J
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M8^)3$/UHP(4FJX)O.82;&' 02DHFHKMV,+A2CI7+=E&8XZ=5GO56I_'MZ.N
M2H-/CHDT_TWVLP]U [+WYLY2_42*H*2P2"&XY:<K1)'&$O#[#QUQ'K^CLB1'
MH=2("A[33_[&5 .TB[']/_"$$(SCI9$CT'5B:8)W8R54QA%I]:[ JQ8LFA67
ME-V/]_UAUC\@]-NDIS9A6JK7Y\Q(&6STKX.,=3G_F?:!LKR 9M,9$+-R.,<
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M$_L8^!M<<!X6S$\R0?/6.0Z\A!>:)VW,G[W!R7?-\7-<G2A[)S/-2)7=!FR
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M?55:76@Z@;TUV<X]))CL3>R+A>&0;'#[[K#(Y%#V]XWC0;"I:0K<ECK1GTJ
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MW K<O+U9JQK.6.8G')NU*)MU FCC!T&"ENR_"50;-VW2*)\7!-4@:4X"$R<
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M':MCG2$#@1. \.W:"3 J17IVFBP73P!\4^V;R#$!C<1(WEGXLBUA,D45QJ#
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MN,PC2:V2!TX/YEZ$,!4H;'H2&TM.0P7R^)R=X]^6"OM_V'O/J*:Z=FUT84!
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MVG&EV-$&9<[SF:]J+6UW6$$S-L^__5M9RAHF<NUP2]8.+]5=H/WS>Q5J@DG
M3A<2K;Q6?_Y>PY(;1=+_@TY TB\ANHH)_94[_>KK7BS^,UT>_+EKB(!*D>2@
M?+',4?5<[SZGCWV?*J82TVA^DAES;8%W FI!1O6B.&R-"CW;%,C9U<58<!87
MIOS&S&%#'K_&J\<UI&ZY)LJD/!UE*@!HBD0'?F(\+L\*]ZOW_GJ0C_5D_[UB
MA..BC6!F^1V!%VD&HJK'TF>R&A:V#[1^:]EE *PN1)O0LEUBP94GCA0N3" \
MR.<VX8#^6&_)$?[:(WZON44@M5_5(G\.[+"':>P5^,2^O:+S3?/8BB]TW-5T
MJ T+7K9I][F#ZLJKW7R[A]EK=-[+R6_WG/-/"<AK_A4PWM*^8TD-)W% 8W[9
M)"&9,).3,+R9GEU<1D7'YN3LH\4@,\.SDIH<L;)WA9DR>B'8YT@)"BJYQ;N(
M6D1,JR_^QFJ$@EI\#!1V,1>NU+4</#JWVFH@'<W$^E+YI?#48@'+QMJG9^9J
M3G,3G19J"B:S 0$Z+F%KP>!4JUTCGWT@MI6LN<9 "2STF8+!V;QVK\D"MZ$[
MZ[,I6\MSS1Q_J5:J;SM%.S-"5Z1"PD%7[U6,]=4+3F0/UGG?&)65/3>9DK'.
M+K%ERO6N#4651U,]K=(*;O7NV.25P*=_1(PN:#Y&AT]OI5&'O)I_L\9ZORJB
MWA(IZ/NNU=<V>Q..CY:(IFDQI4@],G?.O\M>N4)@H'-= C@6?Z&JH>!2<V,>
M1OF[?/5CC!),;,%Y6DM8?)[+3%L&]*'=%?Z3B^;^&ZQ=8H"U6+]]@!.U,,N
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MUKCP_=FA]JK222@AG\:_EU??MRLT5$\/@\,U(72W7XM0KU64!_+8[G%HW3Y
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MZ[H_A/0 C?@E;=8V:B+9A"@#$U.B'Z-I3]3HBDVO:0?N-OOXR$S7^'PX5+0
M5E*=C.:V^TI70K*U4E,9Y=Z/A)K!\!95"L?Y^PJB@Z]]3?IT2:[S#V3:]$&G
MI:*- +]\13)L30A#M;$9K<7P(?5$C3Z]>#-;DZQSJNO=N<P><:6#EE87W6O]
MH&"D:O@\?C*^RTZI\)7GK^[!_%)QE,](J:J]Z9-*SC#QJ'2>E\N=S%P'O8=K
MT3%0\0A9SPW"AB@#8IY[2WZ/EYWVT*C8*6OH4:EH4N=X>I>!VWD,.I<C(!%#
M]1 (5:X8P=&YYES26S)C_PA:(QN48L2G,E]5Q-?KIRV=E6GI 9J^%:>+N!TG
M8TM,/?O\1(?U00#TIALYL0\P_S1H/^#+9LWAK<F<KE.@=/0W^FK+Q4CNY43P
MK("9Z:+]A+6[BSWKWS%?FK;4?DH0I]Y%<C:=''H7T!M1DBYN$K,/+-!_BP3?
M+D?]$L@+/^,(?48[.A[8/A6 0_&Z-K[UX;\\;&.9-"L3<+<*Y&OF>K)&>=T^
M';>IM4":/ %:@J^"I\+H<5;Q^\"/=1(#I5[:B]FU0GWL)^\#]+T9%"7IU_$D
M8&B8CZXOV:EN=BSGBCVB>RQ[_J?/Z4LME08_S=U%0"DV@[ :H>@:>$)!K7(7
MBAL1/;1[SJ3ES9C>+DJ=A*\Z*1'A<C1.Y C9Y*)XM!$#4EPA<<?J8!(@4 1'
M[^F;GWN+/00GTF<ZI=OSUQ0L$]^PG#*&R62+<ZD:"./)W:B#J*^6^\"[XJ5]
M0++2:N<#>;V  /X<MBMVH7Y7Z;%S@#L<?G G/*/LUN'WYN),8YGA*\M-F^@I
M>X)E&>4)P6<BKL;^B:[]3Z7"/)?V8-,WJ9GL5YTS]5^"/JUT0GU\#%$$8\>O
MEU[F7*:P[.7GN0)0M<R?RU) D)ZQR1BZL*H.7X,L=<E!<<Z?&S?-W)L,9P+
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MX 1-$95DMUXA6SP4W^+D[.E2-ZQ[CW 9W_] ZQ3 ^I2G%Z-5Z?S7E74!88C
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MV&,E^CXD@A/RY<@^-4+>KZCW%%\T9U\UY+@W'&]P_\QM VGM2]0)IW\RFVW
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M<==S%ZY,^H__O_*ZCA,*--7G7CH]19J?M_<@<^;-CX,%/_.==+\#F'4PSQ]
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M@,S).5OA77?TC%8K;U!PN.BHZ*GH=2AQ%A?!7!IP&]L':)"@J4.,8$]B)NR
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M7=GA_R082MSJ/0$X"YOC[7!)1GH]F>U"&4FGK5I0>&#!9A&K9@."VNOX99(
M75<^&3#%D<1A!MB6I98B8S6>K%X5O8<Z[+KG$K5=+Z<+)QD]#%:$)'Y?;V.
MVP-CX/Q(;N;1"*120=^;S@G)%Z\=$1!E+QE75TF><48]D>=X6=:KE:BMD#(L
M[5?QO7D1S'Y2M9?YL(P(Z:N.\F4BKR[QPDIU!=*---*L\I+&KW)W61O4W?G4
M(K]#XXA"@]4!7A<5)XP3>K'*;-.1-(B3$=.J:ZAN%KG5')'4U"13?4YQBD5S
MD%V#2HG1SHS0@I-"2;XHLH)ICT/DW5&65_$JO/) YD7#UHXU1>VTIU0>:P)I
M5%2M;CR3&.,?3?5G[]G"6'A \/I>V4/V"R> 1BEB=MZ[@+BRJ\ ?C;>>4<S
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M;:OYOFLIAD21YM6!C1#1.5"Q/SE?;)P P*!V:SQ= SFFT@"\6Z5(Y 4:[G-
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MZ*9R:XV=FSRU9N<GH^=S(2'IX!093ZL]+8"?5#C<KD5,%TL7 U&OLK: IIP
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M KJ1&%M(:B5#H+&RMY5_?/NO'?[W:EH_)0#0&\3H@_R]GUK1L8 M"77,"/"
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MY?GA8>QFU !'S/E%!2$J2CIJ# #SDE"/"_W6T;R.0*DSV9=TMUZ982MNJ'&
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MO?/O5E6O_3T/;<#LG]EO7K['!N]O>0.?+6\[HJC@&\%Q$^/F2W[X#YX "O@
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MJY02L' JM$K9NI'%;(S??O;N'=*/(U*W<ULWC>W>^=^""SQG@E776^$_LLD
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M\U+9)Q"WAOWGDVY\&$3HOIF,:Y*RJKD^A#-NT>10D0)H[L;C_3J]=PH?4]7
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M#WSQN [^;4IGP;];@D@[U//+?U+&_?<0D5*H[K?0Y279O>,-Y_[<^H]52TL
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M5K/611TA6(O-Z>4;H"FQ.=KJC0Q/.=&IX>N5YJG8;V8C4YK;- %L(7P6Z?M
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M!#F\)AR<*;X'TH@OV[:7[;N3$\>U<V<Y&""BI593XXBK>VFKFS+3.+E%W),
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MG(W_QJMW9<WL$DIF>($'S_HY3DDJ8Z4(O[OVEY[]VSH6]A_JV3]W[/_IUP3
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M5$D4#APQBIX1)_2%[9$K%KIP]H'WPS2, NV];/)2UT:9MQ79W_#)H&L;*CK
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M,R@^X.VK$%UEFT.CJ6+,ZQ$Z0.(='5G*Y#>%_HQ:TOG?=F'*NAU<A=GT)-^
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M%9O7,NZK'@L?\/.?1D030ECG^Q*UCZ\1:4S4_,>X2-D<'C='S;*X4X)YY3\
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ME* G\]I5#]\+R YAY$Q^_)@&>9KE"NN/6OW>J.W\E_7M0!D4TE7,X!9!<E:
MD:?\%+@"4B%IA\TO,U6MES5<HY\6!5)Q\6&&:_[<]N]KWL441J;,'4P_2=L8
MZ14:;1UHTQ^T?TQT.X"\6\KFP#S:5&U/(Y#<"#(WT"T(I>=>\C&(>9=9JG(5
M>NM[%'/HB0"MZ]..Z'N8=FAX%D#J^3.!LU/DVNNVR8W2/SU_2]@^_O#7:L"A
M*%>XHP=K&S@.6L'5E0.'P;+Y29<O&T%.VUVWVVKV#JTIBT]E>KX4GSSKI6$
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M23HNW?[:V&<<=.[4/!AZ>P=$@G$G9.\YT308RJG0DW:A<2 6P'.3I+<^^!;
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M@4TFQB$.HAU.#$X0;$L5=6\2'D;WU%7?'PKU6I+Y4/K@RC$OA\6G=$"0=B1
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M89>;>_EA""T"EU78#;WB@N,'@A#JV >04L9<$->.7B QCWPC8'W^V#O5%W3
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MJ*9JC/3,Q7]:N:71VB%]*L4L_EGT)WI.]G#'G<U824H:Z7"]/F\;137I587
ME!4UI"LS-CZ_XUH8:O2\><;B7ARZP/+"YQQ8D]?!4#F<FY3WXZ53[L[)E;%9
MRQ397/@/TXK5<C1R<HWC[>FEPL,*\Z,1*RW3I[FJ!IFG_"/,2&'+:;]'%8@!
M)\&4:4_3B&\_"]=; VR7TJ]Q5:T]8^"2W^.[HZ1'!&0=I4^R,]$;AB3_1HJ&
M=-0&"UAU&_6;7A>N#\WQ)S2HCB\67\)X,.9BL;YMC,0Y#-6/\HD*R\?'@IK]
M_)#" WN*:00]DV?LI%Z+E[1%*QKFP'5B2AU,C5HW'S_3X(.WC4Q08K9SE)A'
M?GV:>;C#:0)ZUFOC7 \/;"/&,^KX KF?4,=^UO-0XZ='Z)+$X/UXX_XUSO7+
M:[QG17]G>Q:J73T;UUH^]3UDB;^ZXM/YV(%KNJ?W%VIHGG'>WO9>4JY0ALH/
M+_B7A;SS>->?[QC&B"#*KF3Z+8JQ@#88R(XV]-QO:?2\/2V":2MF1->X 6[<
M)SD$$:7?(1FV&'*W$'#[_$.XM3MLE9KQ\B[_6'%.RSY@E3C# DY@';DZ82>[
MR%84Y'!_X^1%5/(&\*F_ NE5.G?NY_GYG:AK1R0/;FB X1&MBU83Z$UO%$&/
M!=R%R>\H:R0B1,OK%E"RIDP!%B"Y ;<?DL+(4:UH.A;4^&8HJ1 BO0":A@HU
M ZKZ1.8<K>H37'8BT0"RYC7 _>="G>KWY>FEZ;Q.(ZL-^(\@A;FX'PJ+=N>Z
M.%%= 0H_D/?8 =X\\.^3U'?9:&BYX0LFWX36=#NDOY :MQX+;5*51_K,K.@(
M&3&+@M:>>[S;URIC*?]L&"VAX.O(3O\GYK^LQ"T%3%6\7'-]>H<8JZ=[/F9_
M_LMWNAH<;&H9B7+6#VH;;69R,)(0U\&1ZY]15VC-PT]RW^:!3<[.^9[QS;/-
MJ#R<WX,0HE:0F=Y#*.<SCQ95CSRB3 (]Q9':0K]H3Y:\+FZ;*G<?EOF%@9%V
M(N1!_^QNJ/"WNZ%+2%\?CXB3Q@LB'5Z6="246F0<7-^XC8+/.LQU&SPWDYFN
M/8=?A6I1D(&[XMW,,\S?R=H)A(/4MV2O9EY_7$OMM27+9%#9B&B-2P;M+1 H
MXJ@>6RU6IQV7!H\BQZ\>(:4TF$-'JB:EXS;HE0/]WCE*)F4HO^<!HZA)L5IK
MHD;#(V>&_;5F[51? V,CV[<&G;VRW[=*Z:45SD&7)"0E:TI=]JH*=LLJLOWN
M]+2+AYD*_4W#10$1]$N@4:XVO.0+B*#F=*<2[4=>=*Z8=6"T$]/!;><UWU>:
MLB&A2A FC+P AUQ0Z73N[:2HG4 MO[_M*%HMA/G$ BQ*/C*NI?+?+=A=L@V3
MK8>/ZOJZYYRGK02!1^2OCA(]>")V[&GMC%Y$09^)X:]^LN&J!"FKR1S[9RAP
M)GDRVX#W'HE^:,T1@I;L )4\@LLR3V)&#0F<G=.P \[,$R7(I,ES*;@?,DO?
M) ]/XFSFPVIYIT$'+5".5)TF,TOOA[L?^B;N8VM.7&L;GQG* ?\9U_H$_TBL
M2T4E'*^&&!16YT,?!DG.@&T[2-BU[TA'^B!,:8+#":/KE>[@1KN^J+JU^(7^
MB-Q:1E@.<VGDZ@SE2%;*;^#9A_PD/EK#.- $$2'EO.A7O_[98I%"S%;T719F
MW+E_+7AIFW]I-E7EW9--GZOO^9[NI-3FZ]%-SX_/L@ WW53_VOZK;5K:%=J$
MRJ@^F3[I7MAY=OH.TOFO;WP )3O^E$.84<T);F']RTF!=OY)33L_3);,N%^O
M<C2#CB1?'QE&SN[L_W%4Z@#9?HJ3?C*)>?0OFU4CWV9"&?'8IW]7^56 (^S3
MYI*9-,UX-O*=L(M\]_O-9,>&3HS(8ULS3^5(D:,=C+?0J1)H63:49 .-1)]!
MN:"XJ/$4E^]D6,-E\28!)IC:D-MNU_O,=WCR293CR&PVQ[5V]4GC2M"M&.:D
M^1':#>9O<%G>JM54$M6+=A?!0VJ+\S:?*&UJ'I57@G/QA)"%^,IE%Q9,PP\=
MSCB.;DA7(CDVNQT;]>^?7H\NKPO2'A#;O*3@(LQ4*X"_9VYY-O^.TV@0JY"9
MPE(5:2WXH[5N[#GUE W7'T. RJ@^TQ3J2\*I5<3%/+9-8@1BD@H+C>&5SI%V
M2BY/7:I_*F/J_BTA_:_KJ_;=+0I=KM,$?N69FXAYUF>[?'W*@AIT)W(<9BU'
MR[B-]=.(=N$L*;IH5&"+>$\8V[A>8)9VRNN!KZVCEVTPF4TAJ6XDG!&,Z\B:
M#X[GM^^8/_S&J_&)&M]C!<U(K!RGR MX(K.1D5L/I4]>'$!/8\+8@?G1]=/5
MA(<_XOMT2RKQXJ6Q36\TEVU#2=BIO"9H:++70W_.1M*H>A9#>G=3HJM]Z=Z[
M2HOJ>:&?.,#<\5OC8VSL%6?4)5NTBLM&+,.H<[7D8?S4WT64\A^P4NL[8[WI
MP2S@L.#J:?+F#IL,TN],'B"-UZE?GQY[L[-S.,C:QOM>7'[H09$3((5%Z'$(
M+UV-JIO%S36]'G;9^\\=47CSIP]V:NWB#JFT$H5>(PNS5K,BT-.B4RCI7L1>
MU=S8T_?N[[_JI='ZUK915SK;+?ZV-(SX9R\;!%L^<RNQ "$Y%G .1,V#SO#O
MU!O6L0"P*'I9C05XOH!$_B?'IEPJ:3JM+Q\5F?'AJ3(0F& ->HURAH4G0S*\
MP<>M;?R33!=^N$5<CNV?GTB:$=F>%^^K_8U3[?!\=C=7M=8Y+W/.6072:]6^
MJZ4TXS-]]=0X8MQ]:SQYLE-K;K(]H YTXW_]\&,^'#;J1M YT93K#S) $=Y$
MK][ ]$?VBP\?D]Z)8 %/41&*PB'+3%F:6U2%YA +:/:[0!3M%-H%MDXI;V-
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ML?;#EV^MWM_GG(VG:UF10,RW>;2'J.G*"A8P,PHE2.-?H+9BH:/LN7!78%C
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MVCWY  ,#PQL>7?:112(:1P:=*_@F,E-<.RBZS_!/*MQNVRBK5H@?[*O1,W?
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MB/#E%6U[Z' (N I'I\/O4=E)6@L(E."?1SDS\M>@@\[I!]G4HGC3!LL,U:'
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M[_5#IY/I/$&XU_1;!'TX-(AF8OVV"H4_#3>\2^4@P;7;_C#/.!?%H9]%XEA
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MV\\@C*C@KL\_R'YA6<M<9T9C0U"EJ-G2?6.8GJ.K="$BYBC]1I^@%2F]A']
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M+G;>?T7Y5^SY/LQ,:KW(@H[F0C3YE.E5:_+7(;N+9RIQ"=@>GJ>;-A99J$/
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M3;5X"Q6<N7II,EUZ;8G#AB@IZ>P_9=]\#3EAEYHC(W9V\7@V7H.FY)^WB-B
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MAH\DU07O+@0ZR+8CK?4I%TZ.(<>O5,9(Z,A<MUGXZEO(N\I'55_$DW-Q8FS
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M%TAM-.!/&^_J:"SSDB^Q0 =YH2HDC9##EUV^M"4?K@H98CS%3^3A>!B%!NI
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M[H: EPY71V?$W?##$_T%4H<4;AB_*-I*3*R_$Z_IT?OI]ZM<5J>;V5S='BN
MK&YE:O3A;Z$!.=%F:&P:-^"2!\M"#I%4GA4L*MT/'@6->>Y^>Z@)]X$2=<>D
M)/[*1Z>'OC0.:B/E0SF90#4!LBG@1DWPWJQW=.TA=0F#:UUB<D\:7!QO!AD>
M4U\9^IN=X2.#1$8$^O[R8W3Y\L+DN^!^2'%+M:<_<<Q?&EY,J#M2T[=T^W:"
M[8TF[I6IZ'IKT NDTUUK:P-=VO:5)K=9H+O8[ZO4S\ 9FD"U2@13FFY#&4]*
M-R<R%"Z?0^^]/M[UHB =Z5M&2#EW?,?(2L$4YU4O%-=_QOV*3.#+A^A"7%2V
M&3[Q"OX&*6S&U\7NG0L(#:^QH,%G3B&[2:*1I1K]/BR0P 6Y\)J.W&P.*4^E
M7QGO \/=JL.E.:@--1CJ**,$QR;54+RSA!\5PTA?KXZ$@V<0AUP0V76R-?T%
M66XOAD?/F:[*QG6!I(_M2$ZVO!Z:9S/%=J#SDFJ,7.A-S..JE<WQ[6[)+J-*
MYM:?$UX7W/E\PM]TON>QJ& !V%EMQQ#PCYQ;)M@.EF8"WB95%'"8#P+!;] R
MO*2"Q3K_Y7K0XK:E)GGYC]*?#X.XU<F$O_G4<C5>C-D*X4-/Y&(*(?4P_N"!
M\:.4&U42X^'$91$@U>@;ZHS,LV"IY)*:TBQ:*ZW=+2I)$G&TZ&3\L>\G1MMV
M8<@7"8!";)T*<!S30HC&\[-G3SF0L!<ET5\2>0SE1BT<')="-%<3E&H"=YAF
MQG<9V2B.NQ95\.SI'AC8]&03]Q. ,YDVP?9\*DP>?G(NT>2IVC(8Z7&:XO%X
MH<1>R+3TFE+>A#G_!<5[$2!0\/MX+S-L?P (Z*-6L5<;_QTES,C^Q0A%.\&&
M-5LAD&"5V1'% 'QXS:F)X<6%A1I=YZ.YYX8VAN0Z'O^TB4[4>),7'L_[T0W]
M79?)TS&!'>68A$= [\1&L$ @E",9/FGS=*V_?QT=PM0V33//UT^^XC!\H^&"
MWX,09/U-T>4G''R%Z['\S"XV%=)<B)OLCL"7:;PE+JHTB+?&WB[K9\HC^ZX.
MR>W[T7Q+..-XEN:I V[QQWXF&%R+-FU96+R!$J5QS.,.L\>=Q[8,9Y]N0"&T
M$<OC,,-F[ 8'Z-H88G<C5,!UOX>'9HQR9W_OC?&6&(Z@5QIIQ#/WO7]&<0E)
MWY1LIL"8O/;8.4P)-!KM#/\N1]T%A-+.CM%/X#4@ G0CXMN+W1=Z2U)_C4U=
M:_9\B.XMN)2;>^Z=Q)>SK^I;J]E?:X!F)\V[V%$*S:6"DZ<?Z5,?V\L"-6XQ
M6IY.PG8CRV$TV7QBIRV??YG?I9";!]QWG9#>9ZKE]-#!8S(XH8"M0(NY>RX%
M0Q="L-,V2).^7S-.HV+ IWLWTJ9)(T#8R[[[?J=!KJ?^X)7X0;*QY0Y?Y?=[
M^5'%+-#N061L8_ I^(@Y"=:$%39WI&RTH ^XJ^.CH7P%#[77!LEW>M4:!CN/
M8I14(00,%'KR(.QX;1WTTKW_2_7 YBDFSP [9#S=ONLG'L)Y"WA,<;A"X8I4
M][>"<M-U^TJE0R\-A)"E4V7LVLNC_?8GORR8V.?TFF?+A*39C ;1#P-7\^BN
M0!;)/ C<Z"#Q;6I@?<R:$IOD[,)G?/W._9T7!ZP>[)![M^N% F6(N5>/O6XW
MF%_@Q5BZ4/'DQF)VUDQ5>3A[R6FM54Z+&]$HIT_JC/$DA'=^X^&^^QR@5[YQ
M"GLL+?TV73]V?0%!"N!B!COH,HR/N)VN:%"P+M(4,2Y ,4@4*:C.+%V@DN;V
M65+%#C^,,_YY>:6PZ^2WN-,0[E'V=-?!]]>8DWLGJ9\ MC_=%0S,8NE<92%V
MC11YW<@][DMJ,^VK*A.]R?3AFSQYQ(WGWWD%WQT*&J*I!O>BN?#WP8]P!QA9
MP3N0^>K8/4"UA6B*_E:+9<32'>1/XREMJ3A)3<,O5:IIB:M)=.%4*AG@8'_'
M.T;<0_13Z%X]^:KNZ/6@G2K<*#Y /S-S'.[:EZ?@XK(O5$7*SHA6N*)A#MJW
M/V[@(I:^;X-ZF,("T86ZF=Q)[.#C#!3[QI*J%1"UL*97Y*_2,5^6J'-V'TJM
M=X6LG,L54HW/FUEX'R*\8Q9=CE^<)$.8W)TT/0=F#QZRM"[:-XD+O=A38B_X
M[8:KSGB6P?+1EMZC7Z23J97U3CLL7[\0'NHT$&2OQD]D=AU!2$]@@@4:W6!R
M=U ,J<%D%JBIUDL"4F^@35%?3TO_4$O_4>\6[-86I'-=>\<=*^,#90,F/C3(
MI,K"&%F*&E)!;B:T+#]/,0E_3X:'N]6<(=H,N-4T?G#U71 _^!%??31NZ(/J
MWC-'\3+HB6I"26PK(=I!GZRY,$"[%_S%=J..!1KVN @0$9IA3(,;]B8%&OG\
M+U>R"MH4BT:NV&@K2F.4.7)&5U2UN!9:2O/O,0_U+-48DB1L1QIAG\L"(^?G
MAP>/N1&-%%=T/_-$?.)6- 7MM$"5LM=@<3NGI.]D?R;3W8!1\BC5LW>ZECQ=
M/V9N6A3:0D#PNY$T:NQJ5T9;"X4CM!5_7O7JG,I5>/0N:@->#EZ08T\ICR4Y
MM9' 8Z #)#1Y T?[FGQ'UJFQ1 ^!VL3R<"E3&=-%%>G0J92>J [E_CLRI/"G
MT37TZW^71WX'[@_XQSRR1]%\&UV3ILML(Q29Q!K(,[^/^(66X/<@)/4C1B\#
M.9,6-C?>&'J+/+,*^_#RQ]=;9>Q8<F'SMKK4P>+2!]OY3Z$?722I'E[&U8(7
M#FZ'B#!!0.L$O@7+-9N3,\<"\=.]XO22; -5/]8653Y[O43DHSRI4R'LVBUV
MJX%^F3WN(<16]B)X$CX\1.5F/#8XPOQ6CN93Z0QM0@L@G2\7]ZGERV[Z^;\Z
M><,>LI;[4GZNYQB7UXNL0L])_#^T$6"RCFUAR-FSG_.D\P^H0P%9-I.)AX8%
M+$>BW-A)3AH?&1MV?^W8S^JTX90@:U)@7HY,_D14QLX%>]-#XJ!9*#O1(%_"
M/H&2+?%/DP@BP?MF4Y9"T41&\.092O93/;ML1H(U>2I_M]ZH[D?#$WR:.P\(
M[I$^I%JE4CWT:X-^\#H)R@]THEU4PJ&"-99*;'B+T6]5##+5Z*J5WZ;[[.H3
M3/MX[=0B4"5MZ& 4G=[DIO=A@W'F]\L7<1?8[U&*KK^YS?F _\7>FX=#%?Y_
MXR-;*%/9B4D464ND(E-)2!I:K#%M2&(20L:<R+Y&H2B3+=G+6I89NTHE>T;,
M&*5L.4.-P\P<S]'S^_/[_>?S/-?O^\]SN8[+'^[[G/->7Z_[?I_WK1K=XD#:
M0;1/,S[&_.1Z/KD5$/\S;ZD\8'"Y463W>[M%[TF7CA=NFF\$Y-PW4*HJ.K#0
MP:5_)Z^1/B,TM">97IN=D3LSKH8H?T%I.J-NW("5_G)X^:Y+V>>Z3?>M7VW:
MX$@[4:IL9D;_49QGI(Z88@?Q)$+9$/HM6D-.Q$LV6A)R(*^V^NTT2D/Q^+[%
MN7GEF&ZMQ'N6M.(S*-4_J%1!4NA_'F%'6 \9F%8\+9ZQNQ 4GJR+B&J:P$A,
MVSK-UANY]OCHY AB+J<*6TKZF&$U-TTJBD@M)?_G$=9"N)=:I3:O!H:PFR&Q
MB62:/4,FKM\)3(ZO[@W.HY>ZR99/F2>=\+F:>FCKI+]Q2=Z>Z8O1\RS.7:[@
M.B:&>^JPU=AYOH BRRL!LOJ?T*9?2CL^%Y3?./=[\:;W3JU<RZ<J=5K%4G*Q
M*/LLH 4-7$%C$,$@&8_Q!$#8D3L0;W@=UJRL;1C@6A(VM5K,E2_X%-1[7;AD
M05 ]]7K_'HW/21\L+KL.<HZ2W@%5%?-699!".UZ)HM#!5*!&C>O4LLS#\[-L
MWT;ZCSF-W3?UJY2S==,X3TR--GVG<4R?CU6&I Z9O"[RAAJL.$2&U[N="%"A
M*E!W@AH7X*#/0<<Z#?*R"SP*K0Q7\XI,?4[4BH9$;6H./_!T>\@P5](>%DT!
MS6$1^@1](VT]K<HD-P:R,.<. VV$J''!:N>R<^V&_.Y3"=NDE,^I7LX_A&VT
M*?X9MV+ZG^]?W48XFJTE5QD9-X2(N(7T#E\+S&^LO\_=!M);2WJB%H.&O S?
MQ+?54Q_>?C#V[>:FJ_O-#N_Q*5!Y$D6L5.>?[OD_V,"Z8<\TY&[?CV"?8[RT
M-=3U(VIL(DB>N\ Z9P7%,G'\I"^N"JP[!<P%06OV*$:\,]O_ 'MQW.QQ:DAL
M@9V#:49'5KIMC1=[ZIZ)/J^<RJA@8P2QGBO 9?K(.;8UJZN+'K]Z)UZI@DG8
M!!T("3'2%1]Y5]QKP/O[?I$1+#7I9EVHN?-:^(P"GHT@Q_!*2!,QRF%F\H@*
MD]J,D>7*0(,,GH'!$?P$->FL6NHLSOV"3*W]WH>*WY2S]SH(<ACWVK2.7&T#
MJJASB1S5H"5FQ7QB85"(%1CU>O)K60TV+EM_,.!]N^$^!S/U.$_KCYT*U^(.
MJ?:DJYS=UV!DCQ&$6^078K",$BSH^"D0%IT %UHSZK'-/5$8<0_(#^QOOQN9
M-?II,KXJ0#_#\'7>/;I;8N$;&^?M,2?Y8U/WHK]4T.CLE] 1C@3\.5N3]]+$
M."C"<UP63$I?#BQ_H_?-Y'B'MVBJX2>MA)2=W]W&CNVXEH285@7G%@3 HL<X
M4D&Z[!Z0>H]@K'MU4G<>HW*<VF056T9Y7^3B4#N]]8*SG[.,+#]?\WPF5,C4
MHH,<79IA)T9B]QKJ-"\=<$\IZIIPR)JJAA(GWVA?0P.\D5)]7L<5X]+4UY=<
MY'I#=>'-""MZ)$G<O IEK:'.AMK=,UG[O_)M\Q*"81- X208>906!6[H!#H*
MP<]<TQ)<Q:_-0ADYTY5CW]Z5%#M7227M<M^AKOK@("IS%<_F\(H:SW$DX3;2
M/EY>(QHLO,"JB^$>R3E!402S'Q9^\CN0\_(T:W0TSWRC7K"5:O%BFMS6O)1W
M4K_];809:*Z$*7L9DN)@B4<'J#[ Z#!['Z^,HD7JA[67Q&LF+4FBP4-*\K57
M6OSGE0[IG)L#2STNWXIIES;;&%%"JECOQ&/+E5EG'28!5$@=%X5U6TC0\\S4
M+Y.%@HN"CCI!V=/IBT9GKU8M.6Q]8MP<N!C71:,\S[V'/4!EU.+!\QA:- /A
M*K,3P['4*Q5A%.S]+D#1_XU:76,52%Q>AH7[78=$?A=DREY(TWW@8B:J\H!_
MI51DWR7N"N+83,2ZTX$6(RPCDRQ2"-JW I :?CZM+*@0_]B5>Q1*9J+#2PY4
M,9\=3>WQ]=OOFC[:]#3_:)KU1Y*'1R#O9>X]$UEDAD?KV\O;342G 6&*WAC\
M3HUI/]<U:;7GW.2+,+6P:X-$T^=MOC=3OWX[0L[L?;SM)&]5'U?=:G]+)VVQ
M)W879(YX>1BT &+9_U "Z=UJ=-@:R@,319:\":MPG5C]1(,U5 3>8J"\]$)'
M>8:GF)G$Q6[E5+.'WP5-\Q:W9/(2<^\98YDR\U5700Y[&D3/&:DU$Q1GSD%+
M;1F9U21L?_6#5:'4'4DSN*JQ;SX?;U-'+"ZTO,_$.OTE8SJTN\(,WNR(?4:W
M>'O^Q,7TW;N;^=^6W57G9^A"!U2:20?_I<Q+D MC(69\TV CMH0VXZIL>-BN
MKM#*TV]+J,_?@>JSQ94_'/:^^[[%7*B1S+3G2OI-F+=6T-!,X58<I&/.E5A#
MG1DT/C8!R%ZD-M.W!P&,BS28S-05I\A_TG[QP$4_\'F4GLZ?HWV"1G(*V.)J
M&^&?==RM9(9]%R$&6^W1U0-I+,RK@('GH>!05IM-WY^>:!.^X?EV^:3X"6\]
M^KO:D)?FW)#N@PY/<@]J7-;N.XK[9?U?5\\(8=MU!:Z3)8SYRXD'6?HW5PDQ
M^B'/#&U.'-068.F?Y5NH^42R0 R"RLA3@3<6<?9V(R_?@Z@EG(B"\K/W0<ZE
M-]+): /<1DA\]GPE%/8"%WQDK#1=HGW3E>/NU]D6'[8(;&IICR&_^F,CW(H!
MCV%'O";K6I )L!+4&[JTK.:'D#T3,R_#\KK @LLFC!KC$T4__UCR=--[(/HN
MI^!VOM QO3R-^LHD BSV#.1T40[P"H#+WE8MV1L'_X:$HMDEO82 DD1=Z_0)
M?8Y;NF+_Y]ZBK2?WWIZ/E)W%YR(>F4GZBJ].JYN+YA@&Y;$3&R$7)B!O/A%_
M?3=A4Y!>L\N-0-BMW<8[?.?)18K/4H]H0HA])Q5TP$50MU.]Z%\G$8^6Q+#/
M0?O+9DRPT)%)0)QXH8^B0&_Y,5-'"XX[]/M/WI;W'!N[>'^O=),3,6'/'F%Z
MG=3Y69.PJ!IBR-OPD';RW" !$=L[Y*T!H@"43W1FF3OUE<$J,^.ZH.)0AAM"
MX4[5-8;_GK*:+N#;%)9S8D1AKV^CILR^/-X>#HGHQZM>=TA)BC#7!MH'+KFR
M>N::)CZ)< U9?BWCXF#[X:B:_-);*W><BB\;+T<*?9J)V"']_<"F8O-Q1 "3
M=?-=G!/K#=101"M(D:,&MV(%&X.QX8V*K,#3K)[VB@22.A@PE/SBUYW:/?K
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MCCGYH+G^VN5G]T[<=A/^<+; <;"3AN+DQJU,PB)K*"1-'.4]7$,Q\E<QL;J
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M7;/,3K]^]$.Z*4$&%D0F%3_HV&G)<<1RA==0*:+<]29C.TDM6%& @> IT+N
M/E?$<C4(,P 4@L(GVU9IK4K>$A?BOF<Y_ZK?GO=4+]RP<_&DA;@7NY@2NMZ?
M#&@Y0N1#_+N-ES9'=<-&91L/&5L6C'C9UZ?>N#OGNZOMR,?LJWNV:I3S,7PS
MF4;H#DP<N0[HH">8[.0E_ZO4K6WM]N <AWLPM141?[!R90.16?C^$[_2G1I]
MFN4B4B+0:D9+V]N3J]4Q+D!+&VD_-,AQ@;]2JY:YV_+8%Z'+ER=YKCUG,5(F
MRI#IV:'4UL^<,Z]24OOZ9KZ'[XP[J],6OC^C;H?;H^02P)L.[?28:^-XPS2J
M"$# ;9E=[8HR#@0K7/IK^'V?=PAG,&7G"%<::L)!BXAGR0K/_979I\ZG2AU8
MQF\ &%EDM(D83"=+4QFY]<GMUH1VBB%46.#HJ2E>)*E)>.Z9WKI7:WZ#NG?R
M=V=I+4MM\=^E WPK"#P5?(&H*GP$FIWP"*,B$"H. '%4%"2^S'9C19@<Z&]T
MG"#$[9NILW4JZ=3QSORZ,Z/N=OJBU?U6YZ?A^<._=.<W(W,<0J8@07GLFY!"
M(,<\:/=D.UD<ZR5R4]];2K<ZQ.O3[G'G=Q,IRH/RGE*71/LN/2A]!QYJ?;QH
M4@DE_RLPE28IS=)%N:'YYB^ON^[J+:\NN]&*;_#S])4PU?<82?E*,F MMRY
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M]ONQF_X.+4&T2K20ET6.6,F:9T>.$.A[ =5>=*9JYVB'+ O=76 E\^C9=$G
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M#\RM"FN=R"^&C]0V&Q8=V"UD_);5K>@\TGLC\:?98>5+NWLW94R5)!X1?W7
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M@#+_Y25 /CV.TV/TU;&H*=JHSM&W,9???MGZMF3%<5H[S\;']Z6;X$ZD*,(
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M1LW7^+DI1% E P$=_C\UN]?3.-')YUY27^+:2SR[K2\,9(U ZY#UG^?X$A,
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M/O]=\/CSGJI>EAW(I&0GOG?+3_S,YBK.>ZGAEA63Y?SY^WL;]?S[T^[VVZS
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MHXE.,0.B84%G.+ E$X T7( ?G^>E /43F5D.^78$WW1/'QI2VRU^R0_0#%V
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M4.84021H#FG(!%1.7T)DP@07N8E]-R,WL"UO&0 M!Z!AX0*T3( -+LQ,CB&
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M*+]*\@#B-, P3F1.9(;C@$9G=%BPY6><0PK%C*C "RDX*%L&=?Z(;L#0I):
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M,_4C:W*\JMORZDDW'[B>;7ZB4)'QRU0T=GZ"@P2S&,<Z&Y:J.!91I?$4PS#
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MJ9:#PB;.L-0Q?#^Q4NLI:YJ=#8O@,(G@)2&5^'=/AUF<9:G'?0X#'&"(A#^
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M[D=0=>2$XO-XDUM.T9ZA+0W14I@*6EM[C8$O0&<O: UN\DZ!-!E(FYL\G0_
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M7V/R]/ 7F[^R/QBN.C9IST=>0F("PP@E$+&,0XR# /*$QAR1R,]\7SM<::'
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MZ6:=0NI?JB<47'"X$F=O++4"Q5HM@Z"W,=[#GF9T%,T<SA: UUL WG< "GV
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MJV1]C/S4\E,O=K)C!MA:P1YF.W/A&36W1@M=JZWU$K5<H+WF"U>[W1<\-EP
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M.R?E,&7C/R%Y*3L"#JO,9;+!].58)HJOO<EI.1P33W:&FC#CY)@(NZDF1Y^
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MR3O>;VXB<R))GH>X("8$G(89SKE>@P5-BT %8<98#KCJ?YK2R"OH#FE0QMH
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M]C"M28^GK<3>/W&V>\DUM:]:WZK6Z,Q$K@1G88"5(N:^9*#=QX"&IJ8OC\-
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MI!W9D2UF2]RM./P9P.R4VS\,,#W?E'QO&1@L_>Z_L+N=V)YKN)\A^B;EVNV
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M4TD@I*(@73VD,;*67G.^,C?>ZLYZZ*DA#536(\!8JNEEX@(5M):PI39"3O*
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M#SUZ83:-:;(T7YJ$DFV+0^W/,AG0 @NE=[<D9Q07H0IPFD<1"_(@R@M8AO(
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MU-PT38G>PBJ):49"G*0T#$.JHM!N"[L_\,B:V9 "EB,]$'Y8Y2X1":9CMM*
M;G$?8]WI]O;.0)/=VC[&?O^V]M'/W1:QS^5"KXSO5U*4ZT^,U\'LW]F/\O'Y
M\=URM5K^K?V^]^Q)?[)^G?$TCV62<TPHURL;)PH7>1)B%:A0!$FJ@IA!5C8(
M\9&5JB6+BHXNXBUAV H'PM-NV1L+)9B>&BZ,L]OP@3I&3.?"!KD-+^C].>3
M2Z0+!)[631#I21=3%U#V5UBG,5S=92W58KVJ3]"^EM6_[N3*_($]F!H0J>0J
MSB)<D$);EKA(<!$S_:M@C(5"I#D%74L;(C9^+LZ6M+D*S<&1Y$&H;'UE/P!
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M[-,3(:S#"TB":S_)LMU+>[LM;5O=$RO\4(&KQ>D22U.L<MOSZP] LJI8-Q8
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M>3(2T5?.4S^Q:7.>C 0_RGDR>\M-W76\^9*PU=^+U?.FJ,NVR_PL"U"296D
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MQ;(L2'MKD 4\9&& 89AF&"*>$)@S&D"UC<\21HG(J5%%O MT1K9?#6&@*=^
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M< %:-CJW7J"&Z)?5LZA_^ML-4.RX1!M8 6<1:S 6@&Z1!MZ!M(LX< &C-][
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M+ M(:I6)U4]N_(6J#2>K%Z ;4-7T =DR 'XIRO:WY\/)7' T6T#\H6-GXG?
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M:1O].8)SU/S/=1P'7\V?I.2_Z,$_*)6XJ_9G[*4Y_?K(NF1?FE+7ME.+H>8
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M-TD)3M2JAB1@2*_W%&(18LAX@HDD@4Q2J[3W'EHCK_6:%(CLUG4?-&9KVI/
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MH<Q03B +=?(@(A)2QA(8!S3#NCIJQ*SNB ?P,K:;^_CZ:"DLX]F'(&VL:*;
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MI#3&/&%6I91,"8]L^WR]_J_K+[^=[R$Q##0S-3$&%':*HN6@J36[Y0'\J9@
M6RY&2EVWE=V3MC F.ZF^L 7CI<:P?M^^4OR'UC?P42DBLM!W91_5;ZHY36B:
M4A1#E"44(A0+F$<QAS2*8T:#1*(H-*T4?X;&V!? +570D&WN 6O"YG7BSZ'3
MKP<\R6QY K$7UZI*_ 6!G*K$GQMSLBKQ%X3J5HF_]*B#0_G70C%*RI)L[\MH
MGD0IRSCD@<C4RD,(TBR+( T)X4$:YP@;71Z>''WDY;8G9^$G/4*@?V$-ELMN
M2>TI7;X<-)#-PO$[1$8W;Z^-K'8>WG.R]+IUCUZ:SI=[CM\#!^[9A]RL]N^E
M(.H0\%S766T:W>F8NU('WE;K7\7Z7J=(\"#,94HAI0&#2.0<XCQ6AWTFI4RR
M)$>!5;UH$Z(C*XW&=:=;0NBKQB:O 93B43U^KV.*[<QX(Q3-3'C?V-@IGBWU
MI@KVK#GES\"6A1G03("&"W^FNXW,GLQV(Y*3FNPV(+PTUZW>=5,43:^:WPLN
M/BWEJGRHE7SGF*!#2<HE66R/")^+I?BT%@_5' O"$\Q#F'$B(2)4G?=3)M3Q
MGXI0A$F*<6:C/9PY&?L"H'OTW3+1.?5J/D#-B&7LO#OT9BIG$D '7",X8FFM
MA@;CX$DWN?,QJ<(:#-=++39\0->R&-V8N"_D07Q8/9!B.<=)B((8)3#-0AU2
MP2.8!U$.99*0$".,96)5=.D<H;'O(U[&4VK*X(^&MJ4N.HN5F:KQ@8#E[82;
M\ [U)?HE\U8YX@R9B6M"] M[7.WAPO-N"[<.R[MBK-P(WO%QO-^4I2(S1YR(
M$,L<LC!+(4JB$-)44AA+G$8$L4PR9K-\^\F-O(AKXC-0[(K$_JD/@4O-@-T*
MO@":V3KV!X7=:FXB-EO"X, KV=+VMZ+-9/2TKB\0FW1UFPG^<HT;ON78I:7.
MJ#GAO)SKWG181@SFL0P@TN%4.,;JIX3@/.8LJO-?+C<&OTC):GW;]_UN+B1(
MDRGV4!_GU!=.UD!J;_N3YL6R9<A9R,R6N!<@[%9W0_),@('';B"7)//5 .0L
MG6E[?EP2]ZC-Q\47W!9Q4Y)5%XS9^A6+Y49M9?OBU>_J!CF[TJVB:N,VYR()
M$HD#!$64,H@HB2#) PI33 /!)(I#&MELY>ZLC+S-.X5 #P#63!=, Y>=LF@+
M/O^DN?IY'V_0,-:IFK_MNK0O$"V:FB:].%LKE>$0>=(Z QB95"T-!^REWO(P
MHF,^QODDX*N'5;DN_M'MCU1[<-6S<QXF&&.:0ZZ;H"'&$DA2PB$EH<PD17$>
M(:N,#2<V1E9HZOO$E@D=;FB::;+Q,;+38KTE YI.:'6V69>Y61MBH=[QF#(R
M"!A?225N3$R;=C((J*/$E&&CN8==-<6/KI?\ UF+.0GB*$]% EE.E'T5I"G,
MLRB#<1[D"4$D4J<IVZ"K PI3A5PU1(&B"C19^X"K0USZE8H7:2VO,VT%=0JU
M.BG,H$"KPQ$G#[,Z*="I(*O3#SKF3M0]P%OK8WE7-P/?WHP\MT7+J@\;,<_R
M*(YS'$%)>0:1U-4GXQ3!-$Y$*D1,)0EM[C!,"4]RI5$*?=.K;?*%Y@,\MO0M
MLRE,L30S \9 R&XA-QS,P(X'4#,QVUUJ/L]TNAP5=5JZQY0*2\E])568DITV
MK<(2C*/$"MOW'6(UOXEEL2H_BR>Q:*MCBS:L+U9;<R)Q I.<*+41JYT[SV,*
M!0IIGN<,B<RHVV _F9%W[H8NJ EO"\,;;ML7X.G7!/Z$MEOW)^5UB?(\+[A%
MN*<7 -SB/AV!L L!O2A?;RSH^;>G"PJ]*,%!=.CEI]]:0>XOJ[J%J^!-2U=U
M$B$X2W,,(YK$2JG1&.91(-1Q),DCFH=Y&O'Y8VVE?5N3<FUF$4W&O\VZ>2F%
MN1=TLZ[46;%V Q/=9[ ^"E1ZH+=8IOOE%,?Z$C_B$8QQEK5=<F."82@#$:-(
MXB@3[10K0_R??H*W,@R<7K%\DS787TZNF?W])J?+<B.?K/[Z3B3U8RW4/T/U
M]3/S\.9KK[_D^_^3RNMGIF.ZNNOG&'#TN&R=T^^>Z\O2]PM254W==2DYP:&
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M4U3QZ1$GBRKN%:@;5=S_X+FUU$7]L_KI/_[']C?J/Y14XC_^Q_\#4$L#!!0
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M^'S^=7XPG4ZF^Q,D(MYP8[S*0BE'A.-FD94C00M)C'01C:-5/-4IU7Z:ALW
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MC_["M95:9PUEW =&%D?3O.9@<3$E-&2F3>00 G)0LMY.NX+@DF<*6;!.A'9
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MDXQOIV4V_[;4PC4J7I/(Y[2;+RB@")F<FGR>SNK+D6.<_Y@D7#^-#,9&'80
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M&IV]NWK(Y9ASWI+_H^H-CDD(/M5Y+2*8S+GE2K<>EKHUL>/6__83"Q]6ZQW
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MQY/+ 3!U[HM.=6Q4$,L!,)DB4B7!H&4B4!PI<AQTN@U=L3_,;*/>V;YEW1N
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M[ F!D=SDZ&K>S L),64%=&8$+9CSWNBF%O8^*H;!\SFE=PZKF.>"P+5O\YF
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M9'4"R%90&-!O<A>]= JUQ>6.75]/"F%+5'2,<"N()^L3A&PY2.9DD9IA".D
M6+M-5R=@:P6& 6#;23.C!NCW;-'++R_=^W?X T^7NS2(Q"D:32"XC: R2G!!
M.RB\F!!R,3SOS;H]2MFX5T#=G;BM=-BK);S+WWIG2W*FK4,/)NC:<8,CQ(P1
M> HLE.RRU^40)O$A CNQC0T1,L0\-E%73UA<=:]>2HRO3;Z*D:<Z@:+46N;Z
MVA@B%@Y<>>)1>9+<WDSC77(ZP5E[$#P$MQTUTM<A?(T9<9&*1M1&AP3:*P0E
MI0.7D@6N?7'D;F"2K=\T/$).)\?M*/#:1B.=VBYY48?%;&VNKT$'K"+R#H)E
M#'3. CDJH7/K^3*/D#-NCF9<<&VCD9[ M8,#?)4'"PG1:B/ <J2=A2E#I)@)
MC/1)^&S0F=8=<9LRT F ^PA&#HZ(#K;#BN=[,@)7S^Q*(<N0(Q1C)2CK6&T6
MG "S"LC09-8\ ?4D49WXC(<'S&R?VNO"LWP9%E])8/6O6EKY(YS>.-6N6#S)
MSEFA>(&LF 6E=8 0A(=LM/,Z$76V-3 '$S<N0!O#8G8(#75@"^][%'Q2A-7<
MB C!D%-#S"1PC,25F4^LE" S[GM =*5CW#!FOX#:6>YCUQ0NZR&OU4G=MQ>D
MET$JGT$F*T!Y;R DK^IK=4.\HM#IUC"X!PK'!BPVKE>W'[#L1=!C ^>^N3;W
M\L0R!6E, ?,VUY2CAQ@L!VM]#,PEY&Y8-\F!"PX"T-XZU>T10/L0> <GUZOU
MLB]GW[[C=+'4U,?3,%U)\D3S'),7"#QDVA)25W%% <6BT[&XV+[+R.,4#<+7
MW@97[?<T:ZB+#I#UH*Q.G$M<:.? >TXA=R#G+AKOP4L=,K<FD?-WJ+AP$)[V
M-I)JOWAJHX$..G!="Y(?D]6R<X^F\]LR70L22H3(E*3(01FFE(_:MZZ3&T99
M)YF$T2\=]J#'+FX>MAE9E(-RF==W"D4$<C9K>8YQ9,UE-E;Q2/%OZ[JFO8V9
MVA=R]X&7!M.F-E%=!P?Q?6[%5>_DU3"BU9Z_F$S$T"II:K<R58=92$F!D"31
MHI VYEB",*W'CV],Y+@V]0#(W*_:.L#EXS(\D9'[HD*] @R,?)3BP'$6H8YI
MM3PPSFZ/T-GS:3[NW<@!$-=0(<V<QL,_KUMWDY],7R_.)M_"&>9+8<S*M<G"
M^WT[MRD5AWH8MY-T#O'JC2DCG:8P*:E8_5/+(199:Q<*A4HZ6%'V5J*V_U=O
M][CK2__\C^DL+G#^HZ:TEY46]&LZ&&@W+V&P[OC D]=96$C:U.&MG/P67BL@
M%4ICO/+F]CB,UB4'NY#?2>9V5\P]44-P, 5WX !<J]1=,O_R-"P6R^)<5YB,
M5E%4J;*EHT8DJ!/4@+F4K=+TM=U;K=9M8CK!W:'A\7#=_0ZZZ@ET.PGTNA36
M57),<UG(RP:?L+8R218"B1=\X9BS927CWEYI-N:E$\CO!K6]V-D=]3YVUO"_
M\73RUP/W&Q<=YEP2W*<,W'(*($KFX#*2C%F=L8W%!>F?\F\'KM4)S$8%Q&Q_
MVOEEC.W5Y3,=7,GD0CX6UYK^$ JBX!3L1FF\BR@\#FK3?' ;^ZZ/=G#=>1,C
MX**G;?%X(F:(#%Z&TW1^NOSRT^ST],UL_F>8YY/LI-;&(FC#22!9>'#645A"
M!Z5E(A@>]M;B9%],_0K'Q9:0?6C[=(&?GC;4M?<L_YB<?;W#_.(F]S=%M=3L
M\F-.E/(Z:L- N+1L+%[HG,V.4,]3T#Q*JUMG0%KST,EVZ0.B Q[P'@PO6^^7
M[SB?S/+Q69B?];9K+N8>O9VFT_.,^>WT=9C7OHX+?I*%X]9X<H"EES5JT^!\
M]K4)BG1*>FW<(;K%M.>L$U_N5]]AK;#U:YU3QWAV=KIZN'FB=>)!DZ)2K.W7
MD%-4* (#SD)F-HN80L>GU35..GE4^*OOJ&VQL_D.\JL=-,4O-578VQY:G=TV
MZN(Y68Y@(DD@J/IRA,YNXXKU&J-,>6_#E@_IZ^VMZO[?9M]LCI<=?;W7TSQN
M+<3CI7!['QP_?/V#U3]L)Y%#5#ZD9)10*0)%' D4RPP\BP13J[-!;@P9^'_3
MRH<H@E0H"@A57W8)[L [88"KY+W5L03=9VZN]\J'33"WS\J'313<4QSPXN=5
M2>=EFC-IH76.#K0+""H9 =%EXLUP+IB5HKB].23W$=0)_@X-DX<K(';464\
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MVEL1\P.)Y(=6>%Y=H;9!3#L!=V"25GS4NHDO<UQ69%\ GBNF2\A+E]. RE$
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M0F7I:91<U42V &UT8=(:'V+<"C5;?-FX4S#;0Z:U?,?&RT?\,3_[,9U]N3@
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M#'/^]O;X85_L!L@^B<Q"GQKNP._^<+Y(7\FJ?A_/IE_"!0?&2<-8A,*+N>#
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M%]*?\UG:\)4L%NXRW:S<I^J"9XBN9.#)&A&$=K*TCI,\250'O:[' =>>>NC
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MQQ0G41AN%5V=.3BZ1!TY+$Y) \QZZ4-!)6/K"JV;%'19ZG$(2 X0\*$>81.
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M"J@C=Z717@77>J]!K[.8(N.Z%.7!6+J,5$P:8F()F')9<R>83/^:Q73OVW(
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M#@G 4SB@C4Q]K81.7'#0"D,M'B\0E<T0O.-D[ALLI>."BX./XRD$2KLXCB/
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MH'ADO76 T,]U7M3YXN>:X\ULJ?2_YU.B9!*LLS)C!AUJ9Z+3&8*GGXHU1HN
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M#;-/X0P_?9_.YJ5LTJP^>H<L$\,L)F(X(@1M(F2,3$G&>62M3?2#B>X6H/N
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M%?BH"!U6N778@;")Q+M?BH#"/KA$DF*M-%/,IDY>'"YMN2[L/GQ:MY='0J\
MSV UT\\N *6FKZ8ZP4I4%KG@V5@?=AVL-5#6\^"5"T]<A9W29!PR;A,I<XW6
M(S%C,R&3P%0.ZQ;5FTX:^RW\PH9)<2FQ4$X"[RR)'@\!4DL(('9">^4\PJEW
MA%Z"Y3T-Y65@0LC*X>'J5/=Z.A1!J1;]442%5V67;/"^B>+*BHH+2U*?;=X0
M*>_Y)+/U2P%3.:S;HL6)D%5%*A-;V.$*4"HID-P9X+@72(?#'TI>#7VW1'GS
M1/)R+@5(R4Z]!U2C7'UVB!8M4IXA4P%&"5[UNQ!6!4<:*55Q&NQ]ZMSP \0M
M]ZKRD /)L? KP#H^3'7EZVY;@%([K#'VP%JI@]LKXTN!ED )0KWVG@3]CL3*
MW9)EKE1Y+*)L(6A"U KBX@NO=]O<"))<:5D!S1?%^V)7;1^V!(1XY6W8>*1,
M'82[CWQY#6-N7B9'L"!VKOSB;;-2OM(T+#I .(Z-R8*+K!U"P'GB)%0LS"MU
M,GL_R?*>97(S,B%J!7%QVW2@CDG60H!*1<,ON0=2> ]899AC&B**4[<U?T.D
MO*>:W.Q+@5,!YYIMTZ"$A;5C?##=L0>HA1 (%R/I??#!C8_/]*FK+!1IY,8Z
MCZ30^[MZ#(Z!GHVII_5B^)>/IT^1@8L'U'F[#%:.95?OYL[J^Y/;VVFLF#/_
MX5;^<71'[@*U[V-Z>.H7Y6/(.MZS]-$U?8P S=AAR&,$#)8^+ ;"@=38@$H[
MRH@UAE2I7;#1 S3#T"^AVF(33N;K2#S]?JR-8#7TK++A#(B"W:!.,B 55P!Q
MZ"SBBMCU#+-TNDDQ@7)?P/=AW58#?W2,"W!FMTQ^\QG2S2:(86NYB9IEP2'S
MA@.E:/BK0-!Q%G[*4C^2[REBN;>B(Y T"4[ETC#\X&,0IHXY>C,7)/PQ"<=#
MJ @CP$(NE^FB"C,-&*'("J.D@_XX!'PM7+D.\ C4.Q";_4DGEZ1KW/4B+6YL
M[GW\H9IK][5Y.$:&?[!,%XW%()>@3J?MG[$5UZ22GC/L': 5#>HU0;,"A]7&
M!-<5M<9Z-EI WV"I\]X*')FM8Z%9KNT\:Z.G?V?F,=%YY<,\K-2P8WQR/]VT
MO5T4G*10&<*5!MY7BX1!!U3%+"!&>Q9S^ZA(?9U_L-!Y"_(=F;TC85D >4^]
M=V%:/]T++_KE[+_4TWF]//Y.8.SGXPP&GE8L;#$\%HH@"###(:NX"+YWZHCA
M/47,6_EO+&*.B5,!--RR[M8?+A87*W50182B5M.)=1@:&DY[G,>P&THLD-10
M0(CRCA FJ$S=(WV@J'G+!1[97B;%K5QZ;MH6+G\$0#ZHF;/QJC#\9.G^M+/Y
MQ$NFM:P$T,K&TDU.  6Q!\A*8I41 E6CO10<(GC>4H,%;/6),,U=GJ;/'K(J
MO7_N+]KY<JW&&K/A9 F5< (#194!5$(#9,5D+#(+O4<HR-JOU^YP&?)6%DS-
MPF,"\KX,Z->;6U5W#Z6PW6Q",1;(: [THIQ*I0@0L?\1"GZVD=946*5^SS]
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M_\V\L6CC46I,U9=HS8*M#G.;WU],53,/EOKT7W?UTDY+K"'#*M9%A#*L%2V
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M!^PZ909K.?<+_L?8.W-U2;,RI:;R%#DK #'QH4(&^ZQB.TUL%1(L%@VW;]Y
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M)8(9FZIF)?#7F]M8L#),0-?3>GZ?QG<;]L5\L0&)2+&?9LLY@:5T\78,FR^
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M9M\&@O)" 9E1^7XW=0AJAN+AUK:W<V<_3]7U0?!L&S-;K9/]<'I#)?E?=<?
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M,"UK<30N:'1M4$L! A0#%     @ N(),6EI:<P[2!P  W9,  !\
M     ( !4R@  &9Y,C0Q,"UK97@R,3%S=6)S:61I87)I97-Q-"YH=&U02P$"
M% ,4    " "X@DQ:3MAHZ#4(  #C.P  #P              @ %B,   9GDR
M-'$T97@S,3$N:'1M4$L! A0#%     @ N(),6GH$X&0:"   "3@   \
M         ( !Q#@  &9Y,C1Q-&5X,S$R+FAT;5!+ 0(4 Q0    ( +B"3%KB
M&TF39P4  )09   /              "  0M!  !F>3(T<31E>#,R,2YH=&U0
M2P$"% ,4    " "X@DQ:@/V'KV %  "3&0  #P              @ &?1@
M9GDR-'$T97@S,C(N:'1M4$L! A0#%     @ N(),6J4T#A*:#@, V@ D !$
M             ( !+$P  &EL;6XM,C R-#$R,CDN:'1M4$L! A0#%     @
MN(),6OGNFB3;'@  ,V8! !$              ( !]5H# &EL;6XM,C R-#$R
M,CDN>'-D4$L! A0#%     @ N(),6KT6[SYG-   R \" !4
M ( !_WD# &EL;6XM,C R-#$R,CE?8V%L+GAM;%!+ 0(4 Q0    ( +B"3%HT
M!EA1&+H   Q]"  5              "  9FN P!I;&UN+3(P,C0Q,C(Y7V1E
M9BYX;6Q02P$"% ,4    " "X@DQ:C121JW@8  "K&@  %
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M2P$"% ,4    " "X@DQ:QJ-4J3*] 0#%/A$ %0              @ $X%PX
M:6QM;BTR,#(T,3(R.5]L86(N>&UL4$L! A0#%     @ N(),6BI\<"$"& $
M]@4- !4              ( !G=0/ &EL;6XM,C R-#$R,CE?<')E+GAM;%!+
4!08     $0 1 &8$  #2[!     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>ilmn-20241229_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:ilmn="http://www.illumina.com/20241229"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ilmn-20241229.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <instant>2025-02-07</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2022-01-02</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-24</startDate>
            <endDate>2024-06-24</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ilmn:InvestmentPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ilmn:IssueSizeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">ilmn:InvestmentPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ilmn:IndustryCreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-03</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ilmn:BuildingandLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ilmn:BuildingandLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-29</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-24</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-24</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-24</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-24</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ilmn:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:SequencingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:MicroarrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:AsiaPacificMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:AsiaPacificMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:AsiaPacificMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ilmn:VentureCapitalInvestmentFundTheFundThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ilmn:HelixHoldingsILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ilmn:HelixContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ilmn:ContingentPaymentRightsAxis">ilmn:PaymentRightsOfOneBillionEachTwelveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ilmn:ContingentPaymentRightsAxis">ilmn:PaymentRightsOfOneBillionEachTwelveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ilmn:ContingentPaymentRightsAxis">ilmn:PaymentRightsOfAboveOneBillionEachTwelveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ilmn:ContingentPaymentRightsAxis">ilmn:PaymentRightsOfAboveOneBillionEachTwelveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-02</startDate>
            <endDate>2024-09-29</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-03</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-04</startDate>
            <endDate>2022-10-02</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ilmn:MeasurementInputRevenueRiskPremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ilmn:MeasurementInputCalculationTrailingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2022-01-02</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ilmn:BusinessCombinationContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ilmn:MeasurementInputCashFlowPeriodMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-01</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ilmn:GRAILIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-03</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-01</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-01</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-03</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-03</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-03</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ilmn:GRAILIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-04</startDate>
            <endDate>2022-10-02</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ilmn:LicensedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ilmn:LicensedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ilmn:FluentBioSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-29</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ilmn:FluentBioSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-29</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ilmn:FluentBioSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-09</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-09</startDate>
            <endDate>2024-09-09</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TermNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-17</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-20</instant>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-09</startDate>
            <endDate>2024-09-09</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:DelayedDrawCreditFacilityDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ilmn:TermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-21</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ilmn:SwinglineBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ilmn:SwinglineBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:TheCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ilmn:RevolvingCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2015StockAndIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2015StockAndIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2015StockAndIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:MarketBasedPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityClassifiedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-02</instant>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityClassifiedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityClassifiedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:ShareBasedPaymentArrangementPerformanceStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-02</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ilmn:LiabilityBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2000EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2000EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2000EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ilmn:A2000EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-30</startDate>
            <endDate>2025-02-11</endDate>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfGoodsSoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfGoodsSoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfGoodsSoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ilmn:CostOfServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ilmn:AssetImpairmentChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ilmn:AssetImpairmentChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ilmn:AssetImpairmentChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:FosterCityCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:SanDiegoCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:AcquisitionOfGrailInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-03</instant>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:AcquisitionOfGrailInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-29</endDate>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:AcquisitionOfGrailInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-01</instant>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2023-11-11</startDate>
            <endDate>2023-11-11</endDate>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <instant>2024-01-09</instant>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <instant>2024-02-02</instant>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:CompleteGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:CompleteGenomicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:CompleteGenomicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ilmn:CompleteGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InlandRevenueSingaporeIRASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InlandRevenueSingaporeIRASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InlandRevenueSingaporeIRASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ilmn:SeniorLevelEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:GRAILInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ilmn:CoreIlluminaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-03</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ilmn:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:FrancesArnoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:FrancesArnoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:FrancesArnoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:JakobWedelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:JakobWedelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:JakobWedelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:ScottDaviesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:ScottDaviesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:ScottDaviesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:PatriciaLeckmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:PatriciaLeckmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ilmn:PatriciaLeckmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-29</instant>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001110803</identifier>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="fund">
        <measure>ilmn:fund</measure>
    </unit>
    <unit id="day">
        <measure>ilmn:day</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>ilmn:reporting_unit</measure>
    </unit>
    <unit id="one_year_extension">
        <measure>ilmn:one_year_extension</measure>
    </unit>
    <unit id="consecutive_fiscal_quarter">
        <measure>ilmn:consecutive_fiscal_quarter</measure>
    </unit>
    <unit id="award">
        <measure>ilmn:award</measure>
    </unit>
    <unit id="lawsuit">
        <measure>ilmn:lawsuit</measure>
    </unit>
    <unit id="movant">
        <measure>ilmn:movant</measure>
    </unit>
    <unit id="segment">
        <measure>ilmn:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-32">0001110803</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-33">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-34">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-35">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList contextRef="c-13" id="f-232">http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <ilmn:StandardProductWarrantyDescriptionTerm contextRef="c-88" id="f-489">P6M</ilmn:StandardProductWarrantyDescriptionTerm>
    <ilmn:RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame contextRef="c-147" id="f-594">P3M</ilmn:RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-149" id="f-607">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-1" id="f-848">http://fasb.org/us-gaap/2024#GoodwillAndIntangibleAssetImpairment</us-gaap:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-12" id="f-849">http://fasb.org/us-gaap/2024#GoodwillAndIntangibleAssetImpairment</us-gaap:ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-283" id="f-986">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-314" id="f-1101">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-5" id="f-1239">http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-1240">http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <ecd:TrdArrDuration contextRef="c-423" id="f-1605">P478D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-426" id="f-1606">P568D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-429" id="f-1607">P403D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-432" id="f-1608">P366D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-12-29</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-29</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-35406</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">Illumina, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">33-0804655</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">5200 Illumina Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">92122</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">202-4500</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, $0.01&#160;par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">ILMN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-24">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-26">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-27">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-28">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-29" unitRef="shares">158400000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityPublicFloat contextRef="c-3" decimals="-8" id="f-30" unitRef="usd">14700000000</dei:EntityPublicFloat>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-31">&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Portions of the registrant&#x2019;s proxy statement for the 2025 annual meeting of stockholders are incorporated by reference into Items&#160;10 through 14 of Part&#160;III of this Report.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-36">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data. Our cybersecurity risk management strategy is integrated into our established enterprise risk management program, which includes defined risk, assessment, mitigation, and reporting processes. Our information security team has deployed multiple technical and operational processes to aid in our ability to continuously identify and respond to cybersecurity threats and incidents. Our cybersecurity incident management process includes impact assessment, containment, mitigation and recovery strategies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to our continuous monitoring of our information systems, we utilize third parties to provide external threat intelligence and evaluation of incident notifications in order to identify potential threats or incidents that could impact us. We also evaluate our cybersecurity program against the National Institute of Standards and Technology&#x2019;s Cybersecurity Framework. For all suspected cybersecurity incidents, the information security team conducts a preliminary assessment to determine the potential severity and impact extent of the incident and, where appropriate, a materiality assessment is made. Upon a confirmed cybersecurity incident, the information security team initiates an incident response process with goals to contain, respond, recover, protect and minimize any impacts caused by the incident. The response process includes deployment of a variety of short term and long-term technical and procedural actions as appropriate. Further, we have established a third party risk management program to monitor suppliers who have access to our information.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-37">Our cybersecurity risk management strategy is integrated into our established enterprise risk management program, which includes defined risk, assessment, mitigation, and reporting processes.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-38">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-39">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-40">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-43">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Audit Committee, a committee of our Board of Directors, is responsible for governing management&#x2019;s review and assessment of our cybersecurity and other information technology risks, controls, and procedures, including management&#x2019;s incident resolution process and any specific cybersecurity issues that could affect the adequacy of our internal controls. Our Chief Information Officer provides regular updates to the Audit Committee and to the Board of Directors, including a review of any security risk events and improvements in our security controls.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-42">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Audit Committee, a committee of our Board of Directors, is responsible for governing management&#x2019;s review and assessment of our cybersecurity and other information technology risks, controls, and procedures, including management&#x2019;s incident resolution process and any specific cybersecurity issues that could affect the adequacy of our internal controls. Our Chief Information Officer provides regular updates to the Audit Committee and to the Board of Directors, including a review of any security risk events and improvements in our security controls.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-41">Our Audit Committee, a committee of our Board of Directors, is responsible for governing management&#x2019;s review and assessment of our cybersecurity and other information technology risks, controls, and procedures, including management&#x2019;s incident resolution process and any specific cybersecurity issues that could affect the adequacy of our internal controls.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-44">Our Chief Information Officer provides regular updates to the Audit Committee and to the Board of Directors, including a review of any security risk events and improvements in our security controls.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-45">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-47">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our information security team, under the Chief Information Officer, is led by our Chief Information Security Officer (CISO) and is responsible for assessing and managing risks from cybersecurity threats. Our CISO has over 20 years of information security experience, including as a leader of information security programs at other large enterprises, and is supported by a team of professionals focused on information security. Our information security team regularly meets to review our cybersecurity posture, the broader cybersecurity landscape and any identified cybersecurity incidents. Our information security team has procedures in place for investigating suspected cybersecurity incidents, as well as monitoring cybersecurity risks and ongoing mitigation strategies, the status of prevention, detection, and mitigation controls and any planned future control enhancement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;s.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that risks from prior cybersecurity threats to information systems owned and used by us, including as a result of any previous cybersecurity incidents, have not materially affected our business to date. We can provide no assurance that there will not be incidents in the future or that they will not materially affect us, including our business strategy, results of operations, or financial condition. We maintain a cybersecurity insurance policy which may mitigate certain financial impacts of a cybersecurity inciden&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;t. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please refer to &#x201c;Risks Relating to Information Technology Security and Continuity&#x201d; within the &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_22" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Risk Factors&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within the Business &amp;amp; Market Information Section of this report.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-46">Our information security team, under the Chief Information Officer, is led by our Chief Information Security Officer (CISO) and is responsible for assessing and managing risks from cybersecurity threats.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-48">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-49">Our CISO has over 20 years of information security experience, including as a leader of information security programs at other large enterprises, and is supported by a team of professionals focused on information security.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-50">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-51">42</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-52">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-53">San Diego, California</dei:AuditorLocation>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-6" id="f-54" unitRef="usd">1127000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-6" id="f-55" unitRef="usd">1048000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ShortTermInvestments contextRef="c-4" decimals="-6" id="f-56" unitRef="usd">93000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-5" decimals="-6" id="f-57" unitRef="usd">6000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-6" id="f-58" unitRef="usd">735000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="-6" id="f-59" unitRef="usd">734000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-6" id="f-60" unitRef="usd">547000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-5" decimals="-6" id="f-61" unitRef="usd">587000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-6" id="f-62" unitRef="usd">244000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-6" id="f-63" unitRef="usd">234000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-6" id="f-64" unitRef="usd">2746000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-6" id="f-65" unitRef="usd">2609000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-6" id="f-66" unitRef="usd">815000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-6" id="f-67" unitRef="usd">1007000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-6" id="f-68" unitRef="usd">419000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-6" id="f-69" unitRef="usd">544000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-4" decimals="-6" id="f-70" unitRef="usd">1113000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-6" id="f-71" unitRef="usd">2545000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-6" id="f-72" unitRef="usd">295000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-6" id="f-73" unitRef="usd">2993000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-6" id="f-74" unitRef="usd">567000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-5" decimals="-6" id="f-75" unitRef="usd">56000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-6" id="f-76" unitRef="usd">348000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-6" id="f-77" unitRef="usd">357000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-6" id="f-78" unitRef="usd">6303000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-6" id="f-79" unitRef="usd">10111000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-6" id="f-80" unitRef="usd">221000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-6" id="f-81" unitRef="usd">245000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-6" id="f-82" unitRef="usd">827000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-6" id="f-83" unitRef="usd">1325000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c-4" decimals="-6" id="f-84" unitRef="usd">499000000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c-5" decimals="-6" id="f-85" unitRef="usd">0</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-6" id="f-86" unitRef="usd">1547000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-6" id="f-87" unitRef="usd">1570000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-6" id="f-88" unitRef="usd">554000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-6" id="f-89" unitRef="usd">687000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable contextRef="c-4" decimals="-6" id="f-90" unitRef="usd">1490000000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable contextRef="c-5" decimals="-6" id="f-91" unitRef="usd">1489000000</us-gaap:LongTermNotesPayable>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-6" id="f-92" unitRef="usd">339000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-6" id="f-93" unitRef="usd">620000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-94" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-95" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-96"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-97"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-98" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-99" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-100" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-101" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-102" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-103" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-6" id="f-104" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-5" decimals="-6" id="f-105" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-106"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-107"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-108" unitRef="shares">320000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-109" unitRef="shares">320000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-6" id="f-110" unitRef="shares">200000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-6" id="f-111" unitRef="shares">159000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="-6" id="f-112" unitRef="shares">199000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="-6" id="f-113" unitRef="shares">159000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-6" id="f-114" unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-6" id="f-115" unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-6" id="f-116" unitRef="usd">7525000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-6" id="f-117" unitRef="usd">9555000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-6" id="f-118" unitRef="usd">22000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-6" id="f-119" unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-6" id="f-120" unitRef="usd">-1242000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-6" id="f-121" unitRef="usd">-19000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="-6" id="f-122" unitRef="shares">41000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-5" decimals="-6" id="f-123" unitRef="shares">40000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-6" id="f-124" unitRef="usd">3934000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-5" decimals="-6" id="f-125" unitRef="usd">3792000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-6" id="f-126" unitRef="usd">2373000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-6" id="f-127" unitRef="usd">5745000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-6" id="f-128" unitRef="usd">6303000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-6" id="f-129" unitRef="usd">10111000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-6" id="f-130" unitRef="usd">3656000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-6" id="f-131" unitRef="usd">3787000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-6" id="f-132" unitRef="usd">3953000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-6" id="f-133" unitRef="usd">716000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-6" id="f-134" unitRef="usd">717000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-6" id="f-135" unitRef="usd">631000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-6" id="f-136" unitRef="usd">4372000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-6" id="f-137" unitRef="usd">4504000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-6" id="f-138" unitRef="usd">4584000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-6" id="f-139" unitRef="usd">1017000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-7" decimals="-6" id="f-140" unitRef="usd">1177000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-8" decimals="-6" id="f-141" unitRef="usd">1144000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-9" decimals="-6" id="f-142" unitRef="usd">367000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-10" decimals="-6" id="f-143" unitRef="usd">392000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-11" decimals="-6" id="f-144" unitRef="usd">295000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization contextRef="c-1" decimals="-6" id="f-145" unitRef="usd">127000000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization contextRef="c-12" decimals="-6" id="f-146" unitRef="usd">191000000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization contextRef="c-13" decimals="-6" id="f-147" unitRef="usd">173000000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfRevenue contextRef="c-1" decimals="-6" id="f-148" unitRef="usd">1511000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-12" decimals="-6" id="f-149" unitRef="usd">1760000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-13" decimals="-6" id="f-150" unitRef="usd">1612000000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-6" id="f-151" unitRef="usd">2861000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-12" decimals="-6" id="f-152" unitRef="usd">2744000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-13" decimals="-6" id="f-153" unitRef="usd">2972000000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-6" id="f-154" unitRef="usd">1169000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-12" decimals="-6" id="f-155" unitRef="usd">1354000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-13" decimals="-6" id="f-156" unitRef="usd">1321000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-6" id="f-157" unitRef="usd">1092000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-12" decimals="-6" id="f-158" unitRef="usd">1612000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-13" decimals="-6" id="f-159" unitRef="usd">1297000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-1" decimals="-6" id="f-160" unitRef="usd">1889000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-12" decimals="-6" id="f-161" unitRef="usd">827000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-13" decimals="-6" id="f-162" unitRef="usd">3914000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-1" decimals="-6" id="f-163" unitRef="usd">456000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-12" decimals="-6" id="f-164" unitRef="usd">-20000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-13" decimals="-6" id="f-165" unitRef="usd">-619000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-6" id="f-166" unitRef="usd">3694000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-12" decimals="-6" id="f-167" unitRef="usd">3813000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-13" decimals="-6" id="f-168" unitRef="usd">7151000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-6" id="f-169" unitRef="usd">-833000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-12" decimals="-6" id="f-170" unitRef="usd">-1069000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-13" decimals="-6" id="f-171" unitRef="usd">-4179000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-6" id="f-172" unitRef="usd">46000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-12" decimals="-6" id="f-173" unitRef="usd">58000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-13" decimals="-6" id="f-174" unitRef="usd">11000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-6" id="f-175" unitRef="usd">100000000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-12" decimals="-6" id="f-176" unitRef="usd">77000000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-13" decimals="-6" id="f-177" unitRef="usd">26000000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-6" id="f-178" unitRef="usd">-292000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-12" decimals="-6" id="f-179" unitRef="usd">-29000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-13" decimals="-6" id="f-180" unitRef="usd">-142000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-6" id="f-181" unitRef="usd">-346000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-12" decimals="-6" id="f-182" unitRef="usd">-48000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-13" decimals="-6" id="f-183" unitRef="usd">-157000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-184" unitRef="usd">-1179000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-12" decimals="-6" id="f-185" unitRef="usd">-1117000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-13" decimals="-6" id="f-186" unitRef="usd">-4336000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-187" unitRef="usd">44000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-188" unitRef="usd">44000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-189" unitRef="usd">68000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-190" unitRef="usd">-1223000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-6" id="f-191" unitRef="usd">-1161000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-6" id="f-192" unitRef="usd">-4404000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-193"
      unitRef="usdPerShare">-7.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-12"
      decimals="2"
      id="f-194"
      unitRef="usdPerShare">-7.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-13"
      decimals="2"
      id="f-195"
      unitRef="usdPerShare">-28.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-196"
      unitRef="usdPerShare">-7.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-12"
      decimals="2"
      id="f-197"
      unitRef="usdPerShare">-7.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-13"
      decimals="2"
      id="f-198"
      unitRef="usdPerShare">-28.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-199" unitRef="shares">159000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-12" decimals="-6" id="f-200" unitRef="shares">158000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-13" decimals="-6" id="f-201" unitRef="shares">157000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="2" id="f-202" unitRef="shares">159000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-12" decimals="2" id="f-203" unitRef="shares">158000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-13" decimals="2" id="f-204" unitRef="shares">157000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-205" unitRef="usd">-1223000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-6" id="f-206" unitRef="usd">-1161000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-6" id="f-207" unitRef="usd">-4404000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-1" decimals="-6" id="f-208" unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-12" decimals="-6" id="f-209" unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-13" decimals="-6" id="f-210" unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-6" id="f-211" unitRef="usd">-1200000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-12" decimals="-6" id="f-212" unitRef="usd">-1165000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-13" decimals="-6" id="f-213" unitRef="usd">-4418000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-14" decimals="-6" id="f-214" unitRef="shares">197000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-14" decimals="-6" id="f-215" unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-6" id="f-216" unitRef="usd">8938000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-6" id="f-217" unitRef="usd">17000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-6" id="f-218" unitRef="usd">5485000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-18" decimals="-6" id="f-219" unitRef="shares">40000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-6" id="f-220" unitRef="usd">-3702000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-6" id="f-221" unitRef="usd">10740000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-6" id="f-222" unitRef="usd">-4404000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-6" id="f-223" unitRef="usd">-4404000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-21" decimals="-6" id="f-224" unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-13" decimals="-6" id="f-225" unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares contextRef="c-22" decimals="-6" id="f-226" unitRef="shares">1000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue contextRef="c-23" decimals="-6" id="f-227" unitRef="usd">63000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue contextRef="c-24" decimals="-6" id="f-228" unitRef="usd">-53000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue contextRef="c-13" decimals="-6" id="f-229" unitRef="usd">10000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-23" decimals="-6" id="f-230" unitRef="usd">299000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-6" id="f-231" unitRef="usd">299000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-6" id="f-233" unitRef="usd">-93000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-6" id="f-234" unitRef="usd">61000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-6" id="f-235" unitRef="usd">-32000000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-28" decimals="-6" id="f-236" unitRef="shares">198000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-6" id="f-237" unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-6" id="f-238" unitRef="usd">9207000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-6" id="f-239" unitRef="usd">3000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-6" id="f-240" unitRef="usd">1142000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-32" decimals="-6" id="f-241" unitRef="shares">40000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-6" id="f-242" unitRef="usd">-3755000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-6" id="f-243" unitRef="usd">6599000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-34" decimals="-6" id="f-244" unitRef="usd">-1161000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-6" id="f-245" unitRef="usd">-1161000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-35" decimals="-6" id="f-246" unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-12" decimals="-6" id="f-247" unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares contextRef="c-36" decimals="-6" id="f-248" unitRef="shares">1000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue contextRef="c-37" decimals="-6" id="f-249" unitRef="usd">64000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue contextRef="c-38" decimals="-6" id="f-250" unitRef="usd">-37000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue contextRef="c-12" decimals="-6" id="f-251" unitRef="usd">27000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-37" decimals="-6" id="f-252" unitRef="usd">275000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-12" decimals="-6" id="f-253" unitRef="usd">275000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <ilmn:ReclassificationLiabilityAwards contextRef="c-37" decimals="-6" id="f-254" unitRef="usd">9000000</ilmn:ReclassificationLiabilityAwards>
    <ilmn:ReclassificationLiabilityAwards contextRef="c-12" decimals="-6" id="f-255" unitRef="usd">9000000</ilmn:ReclassificationLiabilityAwards>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-39" decimals="-6" id="f-256" unitRef="shares">199000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-6" id="f-257" unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-6" id="f-258" unitRef="usd">9555000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-6" id="f-259" unitRef="usd">-1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-6" id="f-260" unitRef="usd">-19000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-43" decimals="-6" id="f-261" unitRef="shares">40000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-6" id="f-262" unitRef="usd">-3792000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-6" id="f-263" unitRef="usd">5745000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-44" decimals="-6" id="f-264" unitRef="usd">-1223000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-265" unitRef="usd">-1223000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-45" decimals="-6" id="f-266" unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-1" decimals="-6" id="f-267" unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares contextRef="c-46" decimals="-6" id="f-268" unitRef="shares">1000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue contextRef="c-47" decimals="-6" id="f-269" unitRef="usd">51000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares contextRef="c-48" decimals="-3" id="f-270" unitRef="shares">-1000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesShares>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue contextRef="c-48" decimals="-6" id="f-271" unitRef="usd">-142000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue>
    <ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue contextRef="c-1" decimals="-6" id="f-272" unitRef="usd">-91000000</ilmn:StockIssuedDuringPeriodNetOfRepurchasesValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-47" decimals="-6" id="f-273" unitRef="usd">318000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-6" id="f-274" unitRef="usd">318000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <ilmn:AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation contextRef="c-47" decimals="-6" id="f-275" unitRef="usd">2399000000</ilmn:AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation>
    <ilmn:AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation contextRef="c-1" decimals="-6" id="f-276" unitRef="usd">2399000000</ilmn:AdjustmentToAdditionalPaidInCapitalDecreaseFromDeconsolidation>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-49" decimals="-6" id="f-277" unitRef="shares">200000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-49" decimals="-6" id="f-278" unitRef="usd">2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-50" decimals="-6" id="f-279" unitRef="usd">7525000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-51" decimals="-6" id="f-280" unitRef="usd">22000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-6" id="f-281" unitRef="usd">-1242000000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-53" decimals="-6" id="f-282" unitRef="shares">41000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-6" id="f-283" unitRef="usd">-3934000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-6" id="f-284" unitRef="usd">2373000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-285" unitRef="usd">-1223000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-6" id="f-286" unitRef="usd">-1161000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-6" id="f-287" unitRef="usd">-4404000000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c-1" decimals="-6" id="f-288" unitRef="usd">224000000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-12" decimals="-6" id="f-289" unitRef="usd">235000000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-13" decimals="-6" id="f-290" unitRef="usd">215000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-6" id="f-291" unitRef="usd">130000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-12" decimals="-6" id="f-292" unitRef="usd">197000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-13" decimals="-6" id="f-293" unitRef="usd">179000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-6" id="f-294" unitRef="usd">370000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-12" decimals="-6" id="f-295" unitRef="usd">380000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-13" decimals="-6" id="f-296" unitRef="usd">366000000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-1" decimals="-6" id="f-297" unitRef="usd">112000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-12" decimals="-6" id="f-298" unitRef="usd">33000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-13" decimals="-6" id="f-299" unitRef="usd">23000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <ilmn:GainLossOnStrategicInvestmentsNoncash contextRef="c-1" decimals="-6" id="f-300" unitRef="usd">-312000000</ilmn:GainLossOnStrategicInvestmentsNoncash>
    <ilmn:GainLossOnStrategicInvestmentsNoncash contextRef="c-12" decimals="-6" id="f-301" unitRef="usd">-40000000</ilmn:GainLossOnStrategicInvestmentsNoncash>
    <ilmn:GainLossOnStrategicInvestmentsNoncash contextRef="c-13" decimals="-6" id="f-302" unitRef="usd">-122000000</ilmn:GainLossOnStrategicInvestmentsNoncash>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-6" id="f-303" unitRef="usd">-315000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-12" decimals="-6" id="f-304" unitRef="usd">-24000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-13" decimals="-6" id="f-305" unitRef="usd">-205000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <ilmn:ContingentValueRightUnrealizedGainLossNoncash contextRef="c-1" decimals="-6" id="f-306" unitRef="usd">15000000</ilmn:ContingentValueRightUnrealizedGainLossNoncash>
    <ilmn:ContingentValueRightUnrealizedGainLossNoncash contextRef="c-12" decimals="-6" id="f-307" unitRef="usd">10000000</ilmn:ContingentValueRightUnrealizedGainLossNoncash>
    <ilmn:ContingentValueRightUnrealizedGainLossNoncash contextRef="c-13" decimals="-6" id="f-308" unitRef="usd">-7000000</ilmn:ContingentValueRightUnrealizedGainLossNoncash>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-1" decimals="-6" id="f-309" unitRef="usd">1889000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-12" decimals="-6" id="f-310" unitRef="usd">827000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-13" decimals="-6" id="f-311" unitRef="usd">3914000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <ilmn:PropertyAndEquipmentAndRightOfUseAssetImpairment contextRef="c-1" decimals="-6" id="f-312" unitRef="usd">46000000</ilmn:PropertyAndEquipmentAndRightOfUseAssetImpairment>
    <ilmn:PropertyAndEquipmentAndRightOfUseAssetImpairment contextRef="c-12" decimals="-6" id="f-313" unitRef="usd">100000000</ilmn:PropertyAndEquipmentAndRightOfUseAssetImpairment>
    <ilmn:PropertyAndEquipmentAndRightOfUseAssetImpairment contextRef="c-13" decimals="-6" id="f-314" unitRef="usd">9000000</ilmn:PropertyAndEquipmentAndRightOfUseAssetImpairment>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-6" id="f-315" unitRef="usd">-14000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-12" decimals="-6" id="f-316" unitRef="usd">-17000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-13" decimals="-6" id="f-317" unitRef="usd">-8000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-6" id="f-318" unitRef="usd">25000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-12" decimals="-6" id="f-319" unitRef="usd">40000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-13" decimals="-6" id="f-320" unitRef="usd">12000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-6" id="f-321" unitRef="usd">-19000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-12" decimals="-6" id="f-322" unitRef="usd">20000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-13" decimals="-6" id="f-323" unitRef="usd">135000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-6" id="f-324" unitRef="usd">14000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-12" decimals="-6" id="f-325" unitRef="usd">-11000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-13" decimals="-6" id="f-326" unitRef="usd">-16000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <ilmn:IncreaseDecreaseOfOperatingLeasesNet contextRef="c-1" decimals="-6" id="f-327" unitRef="usd">32000000</ilmn:IncreaseDecreaseOfOperatingLeasesNet>
    <ilmn:IncreaseDecreaseOfOperatingLeasesNet contextRef="c-12" decimals="-6" id="f-328" unitRef="usd">16000000</ilmn:IncreaseDecreaseOfOperatingLeasesNet>
    <ilmn:IncreaseDecreaseOfOperatingLeasesNet contextRef="c-13" decimals="-6" id="f-329" unitRef="usd">8000000</ilmn:IncreaseDecreaseOfOperatingLeasesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-1" decimals="-6" id="f-330" unitRef="usd">15000000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-12" decimals="-6" id="f-331" unitRef="usd">-5000000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-13" decimals="-6" id="f-332" unitRef="usd">-19000000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-6" id="f-333" unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-12" decimals="-6" id="f-334" unitRef="usd">-44000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-13" decimals="-6" id="f-335" unitRef="usd">-38000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-6" id="f-336" unitRef="usd">-440000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-12" decimals="-6" id="f-337" unitRef="usd">15000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-13" decimals="-6" id="f-338" unitRef="usd">381000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-1" decimals="-6" id="f-339" unitRef="usd">28000000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-12" decimals="-6" id="f-340" unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-13" decimals="-6" id="f-341" unitRef="usd">-19000000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-6" id="f-342" unitRef="usd">837000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-12" decimals="-6" id="f-343" unitRef="usd">478000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-13" decimals="-6" id="f-344" unitRef="usd">392000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-6" id="f-345" unitRef="usd">128000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-12" decimals="-6" id="f-346" unitRef="usd">195000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-13" decimals="-6" id="f-347" unitRef="usd">286000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <ilmn:PurchasesSalesForStrategicInvestments contextRef="c-1" decimals="-6" id="f-348" unitRef="usd">52000000</ilmn:PurchasesSalesForStrategicInvestments>
    <ilmn:PurchasesSalesForStrategicInvestments contextRef="c-12" decimals="-6" id="f-349" unitRef="usd">6000000</ilmn:PurchasesSalesForStrategicInvestments>
    <ilmn:PurchasesSalesForStrategicInvestments contextRef="c-13" decimals="-6" id="f-350" unitRef="usd">40000000</ilmn:PurchasesSalesForStrategicInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-6" id="f-351" unitRef="usd">81000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-12" decimals="-6" id="f-352" unitRef="usd">30000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-13" decimals="-6" id="f-353" unitRef="usd">265000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets contextRef="c-1" decimals="-6" id="f-354" unitRef="usd">83000000</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets contextRef="c-12" decimals="-6" id="f-355" unitRef="usd">0</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets contextRef="c-13" decimals="-6" id="f-356" unitRef="usd">0</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-6" id="f-357" unitRef="usd">-178000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-12" decimals="-6" id="f-358" unitRef="usd">-231000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-13" decimals="-6" id="f-359" unitRef="usd">-591000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-1" decimals="-6" id="f-360" unitRef="usd">1241000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-12" decimals="-6" id="f-361" unitRef="usd">1000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-13" decimals="-6" id="f-362" unitRef="usd">991000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="c-1" decimals="-6" id="f-363" unitRef="usd">750000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="c-12" decimals="-6" id="f-364" unitRef="usd">1235000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="c-13" decimals="-6" id="f-365" unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities contextRef="c-1" decimals="-6" id="f-366" unitRef="usd">1000000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities contextRef="c-12" decimals="-6" id="f-367" unitRef="usd">1000000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities contextRef="c-13" decimals="-6" id="f-368" unitRef="usd">0</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-6" id="f-369" unitRef="usd">56000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-12" decimals="-6" id="f-370" unitRef="usd">67000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-13" decimals="-6" id="f-371" unitRef="usd">63000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-6" id="f-372" unitRef="usd">32000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-12" decimals="-6" id="f-373" unitRef="usd">40000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-13" decimals="-6" id="f-374" unitRef="usd">54000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-6" id="f-375" unitRef="usd">116000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-13" decimals="-6" id="f-376" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-54" decimals="-6" id="f-377" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <ilmn:CashDeconsolidatedFinancingActivities contextRef="c-1" decimals="-6" id="f-378" unitRef="usd">968000000</ilmn:CashDeconsolidatedFinancingActivities>
    <ilmn:CashDeconsolidatedFinancingActivities contextRef="c-12" decimals="-6" id="f-379" unitRef="usd">0</ilmn:CashDeconsolidatedFinancingActivities>
    <ilmn:CashDeconsolidatedFinancingActivities contextRef="c-13" decimals="-6" id="f-380" unitRef="usd">0</ilmn:CashDeconsolidatedFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-6" id="f-381" unitRef="usd">-570000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-12" decimals="-6" id="f-382" unitRef="usd">-1210000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-13" decimals="-6" id="f-383" unitRef="usd">1000000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-6" id="f-384" unitRef="usd">-10000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-12" decimals="-6" id="f-385" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-13" decimals="-6" id="f-386" unitRef="usd">-22000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-6" id="f-387" unitRef="usd">79000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-12" decimals="-6" id="f-388" unitRef="usd">-963000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-13" decimals="-6" id="f-389" unitRef="usd">779000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-6" id="f-390" unitRef="usd">1048000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-33" decimals="-6" id="f-391" unitRef="usd">2011000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-19" decimals="-6" id="f-392" unitRef="usd">1232000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-6" id="f-393" unitRef="usd">1127000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-6" id="f-394" unitRef="usd">1048000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-33" decimals="-6" id="f-395" unitRef="usd">2011000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-6" id="f-396" unitRef="usd">83000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-12" decimals="-6" id="f-397" unitRef="usd">73000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-13" decimals="-6" id="f-398" unitRef="usd">17000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-6" id="f-399" unitRef="usd">105000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-12" decimals="-6" id="f-400" unitRef="usd">65000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-13" decimals="-6" id="f-401" unitRef="usd">122000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-6" id="f-402" unitRef="usd">132000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-12" decimals="-6" id="f-403" unitRef="usd">123000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-13" decimals="-6" id="f-404" unitRef="usd">112000000</us-gaap:OperatingLeasePayments>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-6" id="f-405" unitRef="usd">4000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-12" decimals="-6" id="f-406" unitRef="usd">12000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-13" decimals="-6" id="f-407" unitRef="usd">16000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <ilmn:NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents contextRef="c-1" decimals="-6" id="f-408" unitRef="usd">1770000000</ilmn:NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents>
    <ilmn:NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents contextRef="c-12" decimals="-6" id="f-409" unitRef="usd">0</ilmn:NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents>
    <ilmn:NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents contextRef="c-13" decimals="-6" id="f-410" unitRef="usd">0</ilmn:NonCashOrParTNonCashSpinOffNetAssetsExcludingCashAndCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-411">&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.  ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a provider of sequencing- and array-based solutions, serving customers in the research, clinical and applied markets.&#160;Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Our customers include leading genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;24, 2024, we completed the separation (the Spin-Off) of GRAIL into a new public company through the distribution of 26,547,021 shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The distribution reflected approximately 85.5% of the outstanding common stock of GRAIL as of 5:00 p.m. New York time on June 13, 2024, the record date for the distribution (the Record Date). We retained approximately 14.5% of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL&#x2019;s assets, liabilities, results of operations and cash flows have not been reclassified.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_1657" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2. GRAIL Spin-Off&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional details. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (GAAP) and include our accounts, our wholly-owned subsidiaries, and majority-owned or controlled companies. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Variable Interest Entities (VIEs)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate our ownership, contractual and other interests in entities that are not wholly-owned to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously perform this assessment, as changes to existing relationships or future transactions may result in the consolidation or deconsolidation of a VIE. As of December&#160;29, 2024, there were no VIEs for which we were the primary beneficiary and for which we were required to consolidate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements requires that management make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures of contingent assets and liabilities. Though macroeconomic factors such as inflation, exchange rate fluctuations and concerns about an economic downturn&#160;present additional uncertainty, we continue to use the best information available to inform our critical accounting estimates. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fiscal year is the 52 or 53&#160;weeks ending the Sunday closest to December&#160;31, with quarters of 13 or 14&#160;weeks ending the Sunday closest to March&#160;31, June&#160;30, September&#160;30, and December&#160;31. References to 2024, 2023, and 2022 refer to fiscal years ended December&#160;29, 2024, December&#160;31, 2023, and January&#160;1, 2023, respectively, which were all 52 weeks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Functional Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. dollar is the functional currency of our international operations. We re-measure foreign subsidiaries&#x2019; monetary assets and liabilities to the U.S. dollar and record the net gains or losses resulting from re-measurement in other expense, net in the consolidated statements of operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact our operating results. A portion of our customers consist of university and research institutions that management believes are, to some degree, directly or indirectly supported by the United States Government. A significant change in current research funding, particularly with respect to funding of the U.S. National Institutes of Health or targeted cancellations by the U.S. federal government of certain grants or contracts, could have an adverse impact on future revenues and results of operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48%, 48%, and 50% of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53% and 55% of our gross trade accounts receivable balance as of December&#160;29, 2024 and December&#160;31, 2023, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no customers that provided more than 10% of total consolidated revenue in 2024, 2023, and 2022. We perform regular reviews of customer activity and associated credit risks and do not require collateral or enter into netting arrangements. Historically, we have not experienced significant credit losses from accounts receivable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are also subject to risks related to our financial instruments, including cash and cash equivalents, investments, and accounts receivable. Most of our cash and cash equivalents as of December&#160;29, 2024 were deposited with U.S. financial institutions, either domestically or with their foreign branches. Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase. There is no limit to the percentage of the portfolio that may be maintained in debt securities, U.S.&#160;government-sponsored entities, U.S.&#160;Treasury securities, and money market funds. Historically, we have not experienced significant credit losses from financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Suppliers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We require customized products and components that currently are available from a limited number of sources. We source certain key products and components included in our products from single vendors. Historically, we have not experienced significant issues sourcing materials to build our products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report segment information based on the management approach, which designates the internal reporting used by the Chief Operating Decision Maker (CODM) for making decisions and assessing performance as the source of our reportable segments. Our CODM allocates resources and assesses the performance of segments using information about their revenue and net income (loss). Our CODM does not evaluate our segments using asset information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Adopted in 2024&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard requires a company to disclose incremental segment information on an annual and interim basis, including significant segment expenses and measures of profit or loss that are regularly provided to the CODM. The standard does not change how an entity identifies its operating segments. The standard was effective for us beginning in fiscal year 2024 and interim periods within fiscal year 2025. We adopted the standard on its effective date in fiscal year 2024 and applied the amendments retrospectively to all prior periods presented in the consolidated financial statements. See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_136" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;12. Segment and Geographic Information&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Adopted in 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard reduces the number of accounting models for convertible debt instruments, amends the accounting for certain contracts in an entity&#x2019;s own equity, and modifies how certain convertible instruments and contracts that may be settled in cash or shares impact the calculation of diluted earnings per share. Specifically, the guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments and requires the use of the if-converted method to calculate diluted earnings per share. We adopted the standard on its effective date in the first quarter of 2022 using a modified retrospective approach by recognizing a cumulative-effect adjustment to retained earnings on January 3, 2022. As a result of the adoption of ASU 2020-06, we increased retained earnings and decreased additional paid-in capital by $61&#160;million and $93&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Pending Adoption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard requires a company to provide disaggregated disclosures, in the notes to the financial statements, of specified categories of expenses that are included in line items on the face of the income statement. The standard is effective for us beginning in fiscal year 2027 and interim periods within fiscal year 2028, with early adoption permitted. The new standard is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2024-03 on the consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740) - Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard requires a company to expand its existing income tax disclosures, specifically related to the rate reconciliation and income taxes paid. The standard is effective for us beginning in fiscal year 2025, with early adoption permitted, and is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2023-09 on the consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated from the sale of products and services. Product revenue consists of sales of instruments and consumables used in genetic analysis. Service and other revenue consists of revenue generated from genotyping and sequencing services, instrument service contracts, development and licensing agreements, and, prior to the Spin-Off of GRAIL on June&#160;24, 2024, cancer detection testing services related to the GRAIL business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of our products and services is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. Revenue recognition for contracts with multiple deliverables is based on the separate satisfaction of each distinct performance obligation within the contract. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of a good or service to the customer, meaning the customer has the ability to use and obtain the benefit of the good or service. The contract price is allocated to each performance obligation in proportion to its standalone selling price. We determine our best estimate of standalone selling price using average selling prices over a rolling 12-month period coupled with an assessment of current market conditions. If the product or service has no history of sales or if the sales volume is not sufficient, we rely upon prices set by management, adjusted for applicable discounts.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from product sales is recognized generally upon delivery to the end customer, which is when control of the product is deemed to be transferred. Invoicing typically occurs upon shipment and payment is typically due within 30 days from invoice. In instances where right of payment or transfer of title is contingent upon the customer&#x2019;s acceptance of the product, revenue is deferred until all acceptance criteria have been met. Revenue from genotyping and sequencing services, including cancer detection testing services related to the GRAIL business, is recognized when earned, which is generally at the time the genotyping or sequencing analysis data is made available to the customer. Revenue from instrument service contracts is recognized as the services are rendered, typically evenly over the contract term. Revenue from development and licensing agreements generally includes upfront and periodic licensing fees, contract research and development services, or payments for development and regulatory milestones.  Revenue for these agreements is recognized when each distinct performance obligation is satisfied.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recorded net of discounts, distributor commissions, and sales taxes collected on behalf of governmental authorities. Employee sales commissions are recorded as selling, general and administrative expense when incurred as the amortization period for such costs, if capitalized, would have been one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain markets, products and services are sold to customers through distributors. In most sales through distributors, the product is delivered directly to customers by us. The terms of sales transactions through distributors are consistent with the terms of direct sales to customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic loss per share is computed based on the weighted average number of common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. In loss periods, basic and diluted loss per share are identical since the effect of potentially dilutive common shares is antidilutive and therefore excluded. Potentially dilutive common shares from equity awards are determined using the average share price for each period under the treasury stock method. In addition, proceeds from exercise of equity awards and the average amount of unrecognized compensation expense for equity awards are assumed to be used to repurchase shares. Potentially dilutive common shares issuable upon conversion of convertible senior notes are determined using the if-converted method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average shares used to calculate basic and diluted loss per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.276%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares used in calculating basic loss per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares used in calculating diluted loss per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Antidilutive shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded due to antidilutive effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of assets and liabilities are based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize use of observable inputs and minimize use of unobservable inputs. We use a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;1&#160;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Quoted prices in active markets for identical assets or liabilities.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;2&#160;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Inputs, other than Level&#160;1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;3&#160;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of financial instruments such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate the related fair values due to the short-term maturities of these instruments.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Equivalents and Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are comprised of short-term, highly-liquid investments with original maturities of 90 days or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have strategic investments in privately-held companies (non-marketable equity securities) and publicly traded companies (marketable equity securities). Our marketable equity securities are measured at fair value. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Equity investments are classified as current, short-term investments, or noncurrent, recorded in other assets, based on the nature of the securities and their availability for use in current operations. Realized and unrealized gains and losses on our equity investments are recorded in other expense, net in the consolidated statements of operations. Our equity investments are assessed for impairment quarterly. Impairment losses, equal to the difference between the carrying value and the fair value of the investment, are recorded in other expense, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the equity method to account for investments through which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded in other assets, and our share of net income or loss is recognized on a one quarter lag in other expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. Receivables are considered past due based on the contractual payment terms. We reserve a percentage of our trade receivable balance based on collection history and current economic trends that we expect will impact the level of credit losses over the life of our receivables. These reserves are re-evaluated on a regular basis and adjusted, as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is stated at the lower of cost or net realizable value, on a first-in, first-out basis. Inventory includes raw materials and finished goods that may be used in the research and development process, and such items are expensed as consumed or capitalized as property and equipment and depreciated. Inventory write-downs for slow-moving, excess, and obsolete inventories are estimated based on product life cycles, quality issues, historical experience, and usage forecasts.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, using the straight-line method. Depreciation of leasehold improvements is recorded over the shorter of the lease term or the estimated useful life of the related assets. Maintenance and repairs are expensed as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred to develop internal-use software during the application development stage are recorded at cost as computer software. Costs incurred in the development of such internal-use software, including external direct costs of materials and services and applicable compensation costs of employees devoted to specific software application development, are capitalized. Costs incurred outside of the application development stage are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated useful lives of the major classes of property and equipment are generally as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 9 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have various non-cancellable operating lease agreements for office, lab, manufacturing, and distribution facilities. These leases have remaining lease terms of 1 year to 14 years, which represent the non-cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised. We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from 2 years to 20 years. Our lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms, as well as payments for common-area-maintenance and administrative services. We often receive customary incentives from our landlords, such as reimbursements for tenant improvements and rent abatement periods, which effectively reduce the total lease payments owed for these leases. Leases are classified as operating or financing at commencement. As of December&#160;29, 2024, we do not have any financing leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets and liabilities on our consolidated balance sheets represent the present value of our remaining lease payments over the remaining lease terms, less any impairments recorded for right-of-use assets. We do not allocate lease payments to non-lease components; therefore, fixed payments for common-area-maintenance and administrative services are included in our operating lease right-of-use assets and liabilities. We use our incremental borrowing rate to calculate the present value of our lease payments, as the implicit rates in our leases are not readily determinable. Operating lease costs consist primarily of the fixed lease payments included in our operating lease liabilities and are recorded on a straight-line basis over the lease terms. We sublease certain real estate to third parties and this sublease income is also recorded on a straight-line basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the acquisition method of accounting, we allocate the fair value of the total consideration transferred to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the date of acquisition. These valuations require us to make estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill. Costs that we incur to complete the business combination, such as legal and other professional fees, are expensed as they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with certain acquisitions, contingent consideration can be earned by the sellers upon completion of certain future performance milestones. In these cases, a liability is recorded on the acquisition date, as a component of accrued liabilities and/or other long-term liabilities, for an estimate of the acquisition-date fair value of the contingent consideration. These estimates require management judgment, including probabilities of achieving certain future milestones. Changes in the fair value of the contingent consideration subsequent to the acquisition date are recognized in selling, general and administrative expense in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the initial accounting for a business combination is incomplete by the end of a reporting period that falls within the measurement period (not to exceed a year from the date of acquisition), we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. We record these adjustments to the provisional amounts with a corresponding offset to goodwill. Any adjustments identified after the measurement period are recorded in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired, including intangible assets and capitalized in-process research and development (IPR&amp;amp;D), and liabilities assumed are measured at fair value as of the acquisition date. Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of the net assets acquired. Intangible assets acquired in a business combination that are used for IPR&amp;amp;D activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project (i.e., upon commercialization), the IPR&amp;amp;D asset is amortized over its estimated useful life. If the relevant research and development project is abandoned, the IPR&amp;amp;D asset is expensed in the period of abandonment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and IPR&amp;amp;D are not amortized; however, they are reviewed for impairment at least annually during the second quarter, or more frequently if an event occurs indicating the potential for impairment. Goodwill and IPR&amp;amp;D are considered to be impaired if the carrying value of the reporting unit or IPR&amp;amp;D asset exceeds its respective fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform our goodwill impairment analysis at the reporting unit level, which aligns with our reporting structure and availability of discrete financial information. During the goodwill impairment review, we assess qualitative factors to determine whether it is more likely than not that the fair values of our reporting units are less than the carrying amounts, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and our overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair values of our reporting units are less than the carrying amounts, then no additional assessment is deemed necessary. Otherwise, we proceed to compare the estimated fair values of the reporting units with the carrying values, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, we record an impairment loss based on the difference. We may elect to bypass the qualitative assessment in a period and proceed to perform the quantitative goodwill impairment test.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The IPR&amp;amp;D impairment test is performed by comparing the fair value of the asset to its carrying amount. When testing indefinite-lived intangibles for impairment, we may assess qualitative factors to determine whether it is more likely than not that the asset is impaired. Alternatively, we may bypass this qualitative assessment and perform a quantitative impairment test. If the IPR&amp;amp;D asset is impaired, the carrying value of the IPR&amp;amp;D is written down to the revised fair value with the related impairment charge recognized in the period in which the impairment occurs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our identifiable intangible assets with a finite life are typically comprised of acquired developed technologies, licensed technologies, customer relationships, license agreements, and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#x2019; respective estimated useful lives.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform regular reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss in an amount equal to the excess of the carrying value over the fair value. Factors that may indicate potential impairment include a significant decline in our stock price and market capitalization compared to the net book value, significant changes in the ability of a particular asset to generate positive cash flows for our strategic business objectives, and the pattern of utilization of a particular asset.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review our operating lease right-of-use assets for impairment whenever events or changes in circumstances indicate the carrying value of the right-of-use asset may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. We consider a triggering event to reassess a right-of-use asset&#x2019;s asset group to have occurred if we exit a portion of or the full facility or enter into a sublease. Factors that may indicate potential impairment include a significant decrease in the market price of an underlying leased asset group. If we conclude the carrying value of affected assets will not be recovered, we estimate the fair value of the assets and record an impairment in an amount equal to the excess of the carrying value over the fair value.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to foreign exchange rate risks in the normal course of business and use derivative financial instruments to partially offset this exposure. We do not use derivative financial instruments for speculative or trading purposes. Foreign exchange contracts are carried at fair value in other current assets, other assets, accrued liabilities, or other long-term liabilities, as appropriate, on the consolidated balance sheets. The cash flows associated with such foreign exchange contracts, or derivative financial instruments, are classified as cash flows from operating activities in the consolidated statements of cash flows, which is the same category as the hedged transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these derivatives are recognized in other expense, net, along with the re-measurement gain or loss on the foreign currency denominated assets or liabilities. As of December&#160;29, 2024, we had foreign exchange forward contracts in place to hedge exposures in the euro, Japanese yen, Australian dollar, Canadian dollar, Singapore dollar, Chinese Yuan Renminbi, and British pound. As of December&#160;29, 2024 and December&#160;31, 2023, the total notional amounts of outstanding forward contracts in place for these foreign currency purchases were $477 million and $926 million, respectively. In September 2024, as a result of the European Commission withdrawing its previously imposed fine, the related forward contracts we previously entered into for a total notional amount of &#x20ac;432&#160;million were terminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use foreign currency forward contracts to hedge portions of our foreign currency exposure associated with forecasted revenue transactions. These derivative financial instruments have terms up to 24 months and are designated as cash flow hedges. Changes in fair value are recorded as a component of accumulated other comprehensive income (loss) and are reclassified to revenue in the same period the underlying hedged transactions are recorded. We regularly review the effectiveness of our cash flow hedges and consider them to be ineffective if it becomes probable that the forecasted transactions will not occur in the identified period. Changes in fair value of the ineffective portions of our cash flow hedges, if any, are recognized in other expense, net. As of December&#160;29, 2024, we had foreign currency forward contracts in place to hedge exposures associated with forecasted revenue transactions denominated in the euro, Japanese yen, Australian dollar, Canadian dollar, and Chinese Yuan Renminbi. As of December&#160;29, 2024 and December&#160;31, 2023, the total notional amounts of outstanding cash flow hedge contracts in place for these foreign currency purchases were $621 million and $628 million, respectively. We reclassified $15&#160;million, $18&#160;million, and $53&#160;million to revenue in 2024, 2023, and 2022, respectively. As of December&#160;29, 2024, the fair value of foreign currency forward contracts was $27&#160;million, recorded in total assets. As of December&#160;31, 2023, the fair value of foreign currency forward contracts recorded in total assets and total liabilities was $5 million and $9 million, respectively. Estimated gains reported in accumulated other comprehensive income (loss) expected to be reclassified into earnings within the next 12 months are $27 million as of December&#160;29, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally provide a one-year warranty on instruments. Additionally, we provide a warranty on consumables through the expiration date, which generally ranges from &lt;span style="-sec-ix-hidden:f-489"&gt;six&lt;/span&gt; to twelve months after the manufacture date. At the time revenue is recognized, an accrual is established for estimated warranty expenses based on historical experience as well as anticipated product performance. We periodically review the warranty reserve for adequacy and adjust the warranty accrual, if necessary, based on actual experience and estimated costs to be incurred. Warranty expense is recorded as a component of cost of product revenue.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense is incurred related to restricted stock, employee stock purchase plan (ESPP), stock options, and, prior to the GRAIL Spin-Off on June&#160;24, 2024, cash-based equity incentive awards. Forfeitures are accounted for, as incurred, as a reversal of share-based compensation expense related to awards that will not vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock units (RSU) and performance stock units (PSU) are both considered restricted stock. The determination of the amount of share-based compensation expense for our PSU requires the use of certain estimates and assumptions that affect the amount of share-based compensation expense recognized in our consolidated statements of operations. The fair value of restricted stock and performance stock units that do not include a market condition is determined by the closing market price of our common stock on the date of grant. PSU that do not include a market condition represent a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any increase or decrease in share-based compensation expense resulting from an adjustment in the estimated shares to be released is treated as a cumulative catch-up in the period of adjustment. The fair value of performance stock units that include a market condition is determined on the date of grant using a Monte Carlo simulation, which includes assumptions for expected volatility, risk-free interest rate and dividend yield. These unobservable inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. Share-based compensation expense is recognized based on the fair value on a straight-line basis over the requisite service periods of the awards. Compensation expense for PSU that include a market condition is recognized over the requisite service period regardless of whether the market conditions are achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchased under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. The expected volatility is generally determined by weighing the historical and implied volatility of our common stock. The historical volatility is generally commensurate with the estimated expected term. The implied volatility is calculated from the implied market volatility of exchange-traded call options on our common stock. The expected term is generally based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be 0% given that we have never declared or paid cash dividends on our common stock and do not anticipate paying such cash dividends. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash-based equity incentive awards were classified as liability awards, as such awards were to be settled in cash. In connection with the Spin-Off of GRAIL, these awards were assumed by GRAIL. For purposes of valuation and performance measurement of the awards, GRAIL&#x2019;s stand-alone value calculation, as estimated by GRAIL based on its analysis and on input from independent valuation advisors and analyses, was used. The fair value of the awards was recorded over the respective vesting periods of the awards, with recognition of a corresponding liability recorded in accrued liabilities in the consolidated balance sheets. The awards were remeasured to fair value at each reporting date until the awards were settled, with changes in fair value recognized in share-based compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling expenses are included in cost of product revenue.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expenses include personnel expenses, contractor fees, facilities-related costs, material costs, and license fees. Expenditures relating to research and development are expensed in the period incurred.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are expensed as incurred and were $37 million, $36 million, and $53 million in 2024, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure and accrue liabilities associated with employee separation costs, which primarily consist of severance pay and other separation costs such as outplacement services and benefits, at fair value as of the date the plan is approved and when such costs are reasonably estimable. The fair value measurement of restructuring related liabilities requires certain assumptions and estimates to be made, such as the retention period of certain employees. It is our policy to use the best estimates based on facts and circumstances available at the time of measurement, review the assumptions and estimates periodically, and adjust the liabilities when necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise, we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.  &lt;/span&gt;&lt;/div&gt;The impact of a tax position is recognized in the consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected in income tax expense.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <ilmn:DiscontinuedOperationNumberOfSharesIssuedInTransaction
      contextRef="c-55"
      decimals="INF"
      id="f-412"
      unitRef="shares">26547021</ilmn:DiscontinuedOperationNumberOfSharesIssuedInTransaction>
    <ilmn:DiscontinuedOperationPercentOfInterestDisposedOf contextRef="c-55" decimals="3" id="f-413" unitRef="number">0.855</ilmn:DiscontinuedOperationPercentOfInterestDisposedOf>
    <us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal contextRef="c-55" decimals="3" id="f-414" unitRef="number">0.145</us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-415">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;The consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (GAAP) and include our accounts, our wholly-owned subsidiaries, and majority-owned or controlled companies. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="c-1" id="f-416">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Variable Interest Entities (VIEs)&lt;/span&gt;&lt;/div&gt;We evaluate our ownership, contractual and other interests in entities that are not wholly-owned to determine if these entities are VIEs, and, if so, whether we are the primary beneficiary of the VIE. In determining whether we are the primary beneficiary of a VIE and therefore required to consolidate the VIE, we apply a qualitative approach that determines whether we have both (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the rights to receive benefits from, the VIE that could potentially be significant to that VIE. We continuously perform this assessment, as changes to existing relationships or future transactions may result in the consolidation or deconsolidation of a VIE. As of December&#160;29, 2024, there were no VIEs for which we were the primary beneficiary and for which we were required to consolidate.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-417">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;The preparation of the consolidated financial statements requires that management make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures of contingent assets and liabilities. Though macroeconomic factors such as inflation, exchange rate fluctuations and concerns about an economic downturn&#160;present additional uncertainty, we continue to use the best information available to inform our critical accounting estimates. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:FiscalPeriod contextRef="c-1" id="f-418">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fiscal year is the 52 or 53&#160;weeks ending the Sunday closest to December&#160;31, with quarters of 13 or 14&#160;weeks ending the Sunday closest to March&#160;31, June&#160;30, September&#160;30, and December&#160;31. References to 2024, 2023, and 2022 refer to fiscal years ended December&#160;29, 2024, December&#160;31, 2023, and January&#160;1, 2023, respectively, which were all 52 weeks.&lt;/span&gt;&lt;/div&gt;</us-gaap:FiscalPeriod>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-419">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Functional Currency&lt;/span&gt;&lt;/div&gt;The U.S. dollar is the functional currency of our international operations. We re-measure foreign subsidiaries&#x2019; monetary assets and liabilities to the U.S. dollar and record the net gains or losses resulting from re-measurement in other expense, net in the consolidated statements of operations.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-420">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact our operating results. A portion of our customers consist of university and research institutions that management believes are, to some degree, directly or indirectly supported by the United States Government. A significant change in current research funding, particularly with respect to funding of the U.S. National Institutes of Health or targeted cancellations by the U.S. federal government of certain grants or contracts, could have an adverse impact on future revenues and results of operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48%, 48%, and 50% of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53% and 55% of our gross trade accounts receivable balance as of December&#160;29, 2024 and December&#160;31, 2023, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no customers that provided more than 10% of total consolidated revenue in 2024, 2023, and 2022. We perform regular reviews of customer activity and associated credit risks and do not require collateral or enter into netting arrangements. Historically, we have not experienced significant credit losses from accounts receivable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are also subject to risks related to our financial instruments, including cash and cash equivalents, investments, and accounts receivable. Most of our cash and cash equivalents as of December&#160;29, 2024 were deposited with U.S. financial institutions, either domestically or with their foreign branches. Our investment policy restricts the amount of credit exposure to any one issuer to 5% of the portfolio or 5% of the total issue size outstanding at the time of purchase and to any one industry sector, as defined by Clearwater Analytics (Industry Sector Report), to 30% of the portfolio at the time of purchase. There is no limit to the percentage of the portfolio that may be maintained in debt securities, U.S.&#160;government-sponsored entities, U.S.&#160;Treasury securities, and money market funds. Historically, we have not experienced significant credit losses from financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Suppliers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We require customized products and components that currently are available from a limited number of sources. We source certain key products and components included in our products from single vendors. Historically, we have not experienced significant issues sourcing materials to build our products.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-56" decimals="2" id="f-421" unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-57" decimals="2" id="f-422" unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-58" decimals="2" id="f-423" unitRef="number">0.50</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-59" decimals="2" id="f-424" unitRef="number">0.53</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-60" decimals="2" id="f-425" unitRef="number">0.55</us-gaap:ConcentrationRiskPercentage1>
    <ilmn:ConcentrationRiskThreshold
      contextRef="c-61"
      decimals="INF"
      id="f-426"
      unitRef="number">0.05</ilmn:ConcentrationRiskThreshold>
    <ilmn:ConcentrationRiskThreshold
      contextRef="c-62"
      decimals="INF"
      id="f-427"
      unitRef="number">0.05</ilmn:ConcentrationRiskThreshold>
    <ilmn:ConcentrationRiskThreshold
      contextRef="c-63"
      decimals="INF"
      id="f-428"
      unitRef="number">0.30</ilmn:ConcentrationRiskThreshold>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-429">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;We report segment information based on the management approach, which designates the internal reporting used by the Chief Operating Decision Maker (CODM) for making decisions and assessing performance as the source of our reportable segments. Our CODM allocates resources and assesses the performance of segments using information about their revenue and net income (loss). Our CODM does not evaluate our segments using asset information.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-430">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Adopted in 2024&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard requires a company to disclose incremental segment information on an annual and interim basis, including significant segment expenses and measures of profit or loss that are regularly provided to the CODM. The standard does not change how an entity identifies its operating segments. The standard was effective for us beginning in fiscal year 2024 and interim periods within fiscal year 2025. We adopted the standard on its effective date in fiscal year 2024 and applied the amendments retrospectively to all prior periods presented in the consolidated financial statements. See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_136" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;12. Segment and Geographic Information&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Adopted in 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard reduces the number of accounting models for convertible debt instruments, amends the accounting for certain contracts in an entity&#x2019;s own equity, and modifies how certain convertible instruments and contracts that may be settled in cash or shares impact the calculation of diluted earnings per share. Specifically, the guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments and requires the use of the if-converted method to calculate diluted earnings per share. We adopted the standard on its effective date in the first quarter of 2022 using a modified retrospective approach by recognizing a cumulative-effect adjustment to retained earnings on January 3, 2022. As a result of the adoption of ASU 2020-06, we increased retained earnings and decreased additional paid-in capital by $61&#160;million and $93&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Pending Adoption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard requires a company to provide disaggregated disclosures, in the notes to the financial statements, of specified categories of expenses that are included in line items on the face of the income statement. The standard is effective for us beginning in fiscal year 2027 and interim periods within fiscal year 2028, with early adoption permitted. The new standard is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2024-03 on the consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740) - Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard requires a company to expand its existing income tax disclosures, specifically related to the rate reconciliation and income taxes paid. The standard is effective for us beginning in fiscal year 2025, with early adoption permitted, and is expected to be applied prospectively, but retrospective application is permitted. We are currently evaluating the impact of ASU 2023-09 on the consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-64" decimals="-6" id="f-431" unitRef="usd">61000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="c-64" decimals="-6" id="f-432" unitRef="usd">93000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-433">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated from the sale of products and services. Product revenue consists of sales of instruments and consumables used in genetic analysis. Service and other revenue consists of revenue generated from genotyping and sequencing services, instrument service contracts, development and licensing agreements, and, prior to the Spin-Off of GRAIL on June&#160;24, 2024, cancer detection testing services related to the GRAIL business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of our products and services is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products and services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. Revenue recognition for contracts with multiple deliverables is based on the separate satisfaction of each distinct performance obligation within the contract. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of a good or service to the customer, meaning the customer has the ability to use and obtain the benefit of the good or service. The contract price is allocated to each performance obligation in proportion to its standalone selling price. We determine our best estimate of standalone selling price using average selling prices over a rolling 12-month period coupled with an assessment of current market conditions. If the product or service has no history of sales or if the sales volume is not sufficient, we rely upon prices set by management, adjusted for applicable discounts.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from product sales is recognized generally upon delivery to the end customer, which is when control of the product is deemed to be transferred. Invoicing typically occurs upon shipment and payment is typically due within 30 days from invoice. In instances where right of payment or transfer of title is contingent upon the customer&#x2019;s acceptance of the product, revenue is deferred until all acceptance criteria have been met. Revenue from genotyping and sequencing services, including cancer detection testing services related to the GRAIL business, is recognized when earned, which is generally at the time the genotyping or sequencing analysis data is made available to the customer. Revenue from instrument service contracts is recognized as the services are rendered, typically evenly over the contract term. Revenue from development and licensing agreements generally includes upfront and periodic licensing fees, contract research and development services, or payments for development and regulatory milestones.  Revenue for these agreements is recognized when each distinct performance obligation is satisfied.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recorded net of discounts, distributor commissions, and sales taxes collected on behalf of governmental authorities. Employee sales commissions are recorded as selling, general and administrative expense when incurred as the amortization period for such costs, if capitalized, would have been one year or less.&lt;/span&gt;&lt;/div&gt;In certain markets, products and services are sold to customers through distributors. In most sales through distributors, the product is delivered directly to customers by us. The terms of sales transactions through distributors are consistent with the terms of direct sales to customers.&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling Expenses&lt;/span&gt;&lt;/div&gt;Shipping and handling expenses are included in cost of product revenue.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <ilmn:RevenueFromContractWithCustomerPaymentTerm contextRef="c-6" id="f-434">P30D</ilmn:RevenueFromContractWithCustomerPaymentTerm>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-435">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Loss per Share&lt;/span&gt;&lt;/div&gt;Basic loss per share is computed based on the weighted average number of common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. In loss periods, basic and diluted loss per share are identical since the effect of potentially dilutive common shares is antidilutive and therefore excluded. Potentially dilutive common shares from equity awards are determined using the average share price for each period under the treasury stock method. In addition, proceeds from exercise of equity awards and the average amount of unrecognized compensation expense for equity awards are assumed to be used to repurchase shares. Potentially dilutive common shares issuable upon conversion of convertible senior notes are determined using the if-converted method.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c-1" id="f-436">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average shares used to calculate basic and diluted loss per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.276%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares used in calculating basic loss per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares used in calculating diluted loss per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Antidilutive shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded due to antidilutive effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-437" unitRef="shares">159000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-12" decimals="-6" id="f-438" unitRef="shares">158000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-13" decimals="-6" id="f-439" unitRef="shares">157000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-6" id="f-440" unitRef="shares">159000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-12" decimals="-6" id="f-441" unitRef="shares">158000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-13" decimals="-6" id="f-442" unitRef="shares">157000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-65" decimals="-6" id="f-443" unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-66" decimals="-6" id="f-444" unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-67" decimals="-6" id="f-445" unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-68" decimals="-6" id="f-446" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-69" decimals="-6" id="f-447" unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-70" decimals="-6" id="f-448" unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-6" id="f-449" unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-12" decimals="-6" id="f-450" unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-13" decimals="-6" id="f-451" unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-452">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of assets and liabilities are based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize use of observable inputs and minimize use of unobservable inputs. We use a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;1&#160;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Quoted prices in active markets for identical assets or liabilities.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;2&#160;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Inputs, other than Level&#160;1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level&#160;3&#160;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.  &lt;/span&gt;&lt;/div&gt;The carrying amounts of financial instruments such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate the related fair values due to the short-term maturities of these instruments.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-453">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Equivalents and Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are comprised of short-term, highly-liquid investments with original maturities of 90 days or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="c-1" id="f-454">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have strategic investments in privately-held companies (non-marketable equity securities) and publicly traded companies (marketable equity securities). Our marketable equity securities are measured at fair value. Our non-marketable equity securities without readily determinable market values are initially measured at cost and adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment. Equity investments are classified as current, short-term investments, or noncurrent, recorded in other assets, based on the nature of the securities and their availability for use in current operations. Realized and unrealized gains and losses on our equity investments are recorded in other expense, net in the consolidated statements of operations. Our equity investments are assessed for impairment quarterly. Impairment losses, equal to the difference between the carrying value and the fair value of the investment, are recorded in other expense, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the equity method to account for investments through which we have the ability to exercise significant influence, but not control, over the investee. Such investments are recorded in other assets, and our share of net income or loss is recognized on a one quarter lag in other expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c-1" id="f-455">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at the net invoice value and are not interest-bearing. Receivables are considered past due based on the contractual payment terms. We reserve a percentage of our trade receivable balance based on collection history and current economic trends that we expect will impact the level of credit losses over the life of our receivables. These reserves are re-evaluated on a regular basis and adjusted, as needed. Once a receivable is deemed to be uncollectible, such balance is charged against the reserve.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-456">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;Inventory is stated at the lower of cost or net realizable value, on a first-in, first-out basis. Inventory includes raw materials and finished goods that may be used in the research and development process, and such items are expensed as consumed or capitalized as property and equipment and depreciated. Inventory write-downs for slow-moving, excess, and obsolete inventories are estimated based on product life cycles, quality issues, historical experience, and usage forecasts.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-457">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, subject to review for impairment, and depreciated over the estimated useful lives of the assets, using the straight-line method. Depreciation of leasehold improvements is recorded over the shorter of the lease term or the estimated useful life of the related assets. Maintenance and repairs are expensed as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred to develop internal-use software during the application development stage are recorded at cost as computer software. Costs incurred in the development of such internal-use software, including external direct costs of materials and services and applicable compensation costs of employees devoted to specific software application development, are capitalized. Costs incurred outside of the application development stage are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-458">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated useful lives of the major classes of property and equipment are generally as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 to 20 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 9 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;772&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,069&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-71" id="f-459">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-72" id="f-460">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-73" id="f-461">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-74" id="f-462">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-75" id="f-463">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-76" id="f-464">P9Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-77" id="f-465">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-466">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have various non-cancellable operating lease agreements for office, lab, manufacturing, and distribution facilities. These leases have remaining lease terms of 1 year to 14 years, which represent the non-cancellable periods of the leases and include extension options that we determined are reasonably certain to be exercised. We exclude extension options that are not reasonably certain to be exercised from our lease terms, ranging from 2 years to 20 years. Our lease payments consist primarily of fixed rental payments for the right to use the underlying leased assets over the lease terms, as well as payments for common-area-maintenance and administrative services. We often receive customary incentives from our landlords, such as reimbursements for tenant improvements and rent abatement periods, which effectively reduce the total lease payments owed for these leases. Leases are classified as operating or financing at commencement. As of December&#160;29, 2024, we do not have any financing leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets and liabilities on our consolidated balance sheets represent the present value of our remaining lease payments over the remaining lease terms, less any impairments recorded for right-of-use assets. We do not allocate lease payments to non-lease components; therefore, fixed payments for common-area-maintenance and administrative services are included in our operating lease right-of-use assets and liabilities. We use our incremental borrowing rate to calculate the present value of our lease payments, as the implicit rates in our leases are not readily determinable. Operating lease costs consist primarily of the fixed lease payments included in our operating lease liabilities and are recorded on a straight-line basis over the lease terms. We sublease certain real estate to third parties and this sublease income is also recorded on a straight-line basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-78" id="f-467">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-79" id="f-468">P14Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-78" id="f-469">P2Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-79" id="f-470">P20Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:BusinessCombinationsPolicy contextRef="c-1" id="f-471">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the acquisition method of accounting, we allocate the fair value of the total consideration transferred to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values on the date of acquisition. These valuations require us to make estimates and assumptions, especially with respect to intangible assets. We record the excess consideration over the aggregate fair value of tangible and intangible assets, net of liabilities assumed, as goodwill. Costs that we incur to complete the business combination, such as legal and other professional fees, are expensed as they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with certain acquisitions, contingent consideration can be earned by the sellers upon completion of certain future performance milestones. In these cases, a liability is recorded on the acquisition date, as a component of accrued liabilities and/or other long-term liabilities, for an estimate of the acquisition-date fair value of the contingent consideration. These estimates require management judgment, including probabilities of achieving certain future milestones. Changes in the fair value of the contingent consideration subsequent to the acquisition date are recognized in selling, general and administrative expense in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the initial accounting for a business combination is incomplete by the end of a reporting period that falls within the measurement period (not to exceed a year from the date of acquisition), we report provisional amounts in our financial statements. During the measurement period, we adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. We record these adjustments to the provisional amounts with a corresponding offset to goodwill. Any adjustments identified after the measurement period are recorded in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c-1" id="f-472">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets acquired, including intangible assets and capitalized in-process research and development (IPR&amp;amp;D), and liabilities assumed are measured at fair value as of the acquisition date. Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of the net assets acquired. Intangible assets acquired in a business combination that are used for IPR&amp;amp;D activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project (i.e., upon commercialization), the IPR&amp;amp;D asset is amortized over its estimated useful life. If the relevant research and development project is abandoned, the IPR&amp;amp;D asset is expensed in the period of abandonment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and IPR&amp;amp;D are not amortized; however, they are reviewed for impairment at least annually during the second quarter, or more frequently if an event occurs indicating the potential for impairment. Goodwill and IPR&amp;amp;D are considered to be impaired if the carrying value of the reporting unit or IPR&amp;amp;D asset exceeds its respective fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform our goodwill impairment analysis at the reporting unit level, which aligns with our reporting structure and availability of discrete financial information. During the goodwill impairment review, we assess qualitative factors to determine whether it is more likely than not that the fair values of our reporting units are less than the carrying amounts, including goodwill. The qualitative factors include, but are not limited to, macroeconomic conditions, industry and market considerations, and our overall financial performance. If, after assessing the totality of these qualitative factors, we determine that it is not more likely than not that the fair values of our reporting units are less than the carrying amounts, then no additional assessment is deemed necessary. Otherwise, we proceed to compare the estimated fair values of the reporting units with the carrying values, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, we record an impairment loss based on the difference. We may elect to bypass the qualitative assessment in a period and proceed to perform the quantitative goodwill impairment test.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The IPR&amp;amp;D impairment test is performed by comparing the fair value of the asset to its carrying amount. When testing indefinite-lived intangibles for impairment, we may assess qualitative factors to determine whether it is more likely than not that the asset is impaired. Alternatively, we may bypass this qualitative assessment and perform a quantitative impairment test. If the IPR&amp;amp;D asset is impaired, the carrying value of the IPR&amp;amp;D is written down to the revised fair value with the related impairment charge recognized in the period in which the impairment occurs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our identifiable intangible assets with a finite life are typically comprised of acquired developed technologies, licensed technologies, customer relationships, license agreements, and trade names. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#x2019; respective estimated useful lives.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform regular reviews to determine if any event has occurred that may indicate that intangible assets with finite useful lives and other long-lived assets are potentially impaired. If indicators of impairment exist, an impairment test is performed to assess the recoverability of the affected assets by determining whether the carrying amount of such assets exceeds the undiscounted expected future cash flows. If the affected assets are not recoverable, we estimate the fair value of the assets and record an impairment loss in an amount equal to the excess of the carrying value over the fair value. Factors that may indicate potential impairment include a significant decline in our stock price and market capitalization compared to the net book value, significant changes in the ability of a particular asset to generate positive cash flows for our strategic business objectives, and the pattern of utilization of a particular asset.  &lt;/span&gt;&lt;/div&gt;We review our operating lease right-of-use assets for impairment whenever events or changes in circumstances indicate the carrying value of the right-of-use asset may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. We consider a triggering event to reassess a right-of-use asset&#x2019;s asset group to have occurred if we exit a portion of or the full facility or enter into a sublease. Factors that may indicate potential impairment include a significant decrease in the market price of an underlying leased asset group. If we conclude the carrying value of affected assets will not be recovered, we estimate the fair value of the assets and record an impairment in an amount equal to the excess of the carrying value over the fair value.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-473">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to foreign exchange rate risks in the normal course of business and use derivative financial instruments to partially offset this exposure. We do not use derivative financial instruments for speculative or trading purposes. Foreign exchange contracts are carried at fair value in other current assets, other assets, accrued liabilities, or other long-term liabilities, as appropriate, on the consolidated balance sheets. The cash flows associated with such foreign exchange contracts, or derivative financial instruments, are classified as cash flows from operating activities in the consolidated statements of cash flows, which is the same category as the hedged transaction.&lt;/span&gt;&lt;/div&gt;We use foreign exchange forward contracts to manage foreign currency risks related to monetary assets and liabilities denominated in currencies other than the U.S. dollar. These derivative financial instruments have terms of one month or less and are not designated as hedging instruments. Changes in fair value of these derivatives are recognized in other expense, net, along with the re-measurement gain or loss on the foreign currency denominated assets or liabilities. As of December&#160;29, 2024, we had foreign exchange forward contracts in place to hedge exposures in the euro, Japanese yen, Australian dollar, Canadian dollar, Singapore dollar, Chinese Yuan Renminbi, and British pound.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-80" decimals="-6" id="f-474" unitRef="usd">477000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-81" decimals="-6" id="f-475" unitRef="usd">926000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-82" decimals="-6" id="f-476" unitRef="usd">432000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:DerivativeTermOfContract contextRef="c-1" id="f-477">P24M</us-gaap:DerivativeTermOfContract>
    <us-gaap:DerivativeNotionalAmount contextRef="c-83" decimals="-6" id="f-478" unitRef="usd">621000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-84" decimals="-6" id="f-479" unitRef="usd">628000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-1" decimals="-6" id="f-480" unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-12" decimals="-6" id="f-481" unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-13" decimals="-6" id="f-482" unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeAssets contextRef="c-85" decimals="-6" id="f-483" unitRef="usd">27000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-86" decimals="-6" id="f-484" unitRef="usd">5000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-86" decimals="-6" id="f-485" unitRef="usd">9000000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths contextRef="c-1" decimals="-6" id="f-486" unitRef="usd">27000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:StandardProductWarrantyPolicy contextRef="c-1" id="f-487">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;We generally provide a one-year warranty on instruments. Additionally, we provide a warranty on consumables through the expiration date, which generally ranges from &lt;span style="-sec-ix-hidden:f-489"&gt;six&lt;/span&gt; to twelve months after the manufacture date. At the time revenue is recognized, an accrual is established for estimated warranty expenses based on historical experience as well as anticipated product performance. We periodically review the warranty reserve for adequacy and adjust the warranty accrual, if necessary, based on actual experience and estimated costs to be incurred. Warranty expense is recorded as a component of cost of product revenue.</us-gaap:StandardProductWarrantyPolicy>
    <ilmn:StandardProductWarrantyDescriptionTerm contextRef="c-87" id="f-488">P1Y</ilmn:StandardProductWarrantyDescriptionTerm>
    <ilmn:StandardProductWarrantyDescriptionTerm contextRef="c-89" id="f-490">P12M</ilmn:StandardProductWarrantyDescriptionTerm>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-491">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense is incurred related to restricted stock, employee stock purchase plan (ESPP), stock options, and, prior to the GRAIL Spin-Off on June&#160;24, 2024, cash-based equity incentive awards. Forfeitures are accounted for, as incurred, as a reversal of share-based compensation expense related to awards that will not vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock units (RSU) and performance stock units (PSU) are both considered restricted stock. The determination of the amount of share-based compensation expense for our PSU requires the use of certain estimates and assumptions that affect the amount of share-based compensation expense recognized in our consolidated statements of operations. The fair value of restricted stock and performance stock units that do not include a market condition is determined by the closing market price of our common stock on the date of grant. PSU that do not include a market condition represent a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. At each reporting period, we reassess the probability of the achievement of such corporate performance goals and any increase or decrease in share-based compensation expense resulting from an adjustment in the estimated shares to be released is treated as a cumulative catch-up in the period of adjustment. The fair value of performance stock units that include a market condition is determined on the date of grant using a Monte Carlo simulation, which includes assumptions for expected volatility, risk-free interest rate and dividend yield. These unobservable inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. Share-based compensation expense is recognized based on the fair value on a straight-line basis over the requisite service periods of the awards. Compensation expense for PSU that include a market condition is recognized over the requisite service period regardless of whether the market conditions are achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes-Merton option-pricing model is used to estimate the fair value of stock purchased under our ESPP and stock options granted. The model assumptions include expected volatility, term, dividends, and the risk-free interest rate. The expected volatility is generally determined by weighing the historical and implied volatility of our common stock. The historical volatility is generally commensurate with the estimated expected term. The implied volatility is calculated from the implied market volatility of exchange-traded call options on our common stock. The expected term is generally based on historical forfeiture experience, exercise activity, and on the terms and conditions of the stock awards. The expected dividend yield is determined to be 0% given that we have never declared or paid cash dividends on our common stock and do not anticipate paying such cash dividends. The risk-free interest rate is based upon U.S. Treasury securities with remaining terms similar to the expected term of the share-based awards.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash-based equity incentive awards were classified as liability awards, as such awards were to be settled in cash. In connection with the Spin-Off of GRAIL, these awards were assumed by GRAIL. For purposes of valuation and performance measurement of the awards, GRAIL&#x2019;s stand-alone value calculation, as estimated by GRAIL based on its analysis and on input from independent valuation advisors and analyses, was used. The fair value of the awards was recorded over the respective vesting periods of the awards, with recognition of a corresponding liability recorded in accrued liabilities in the consolidated balance sheets. The awards were remeasured to fair value at each reporting date until the awards were settled, with changes in fair value recognized in share-based compensation expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-1" decimals="INF" id="f-492" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-493">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;Research and development expenses include personnel expenses, contractor fees, facilities-related costs, material costs, and license fees. Expenditures relating to research and development are expensed in the period incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="c-1" id="f-494">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;Advertising costs are expensed as incurred</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense contextRef="c-1" decimals="-6" id="f-495" unitRef="usd">37000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-12" decimals="-6" id="f-496" unitRef="usd">36000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-13" decimals="-6" id="f-497" unitRef="usd">53000000</us-gaap:AdvertisingExpense>
    <ilmn:RestructuringPolicyTextBlock contextRef="c-1" id="f-498">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure and accrue liabilities associated with employee separation costs, which primarily consist of severance pay and other separation costs such as outplacement services and benefits, at fair value as of the date the plan is approved and when such costs are reasonably estimable. The fair value measurement of restructuring related liabilities requires certain assumptions and estimates to be made, such as the retention period of certain employees. It is our policy to use the best estimates based on facts and circumstances available at the time of measurement, review the assumptions and estimates periodically, and adjust the liabilities when necessary.&lt;/span&gt;&lt;/div&gt;</ilmn:RestructuringPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-499">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and credit carryforwards. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the provision for income taxes in the period that includes the enactment date.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets are regularly assessed to determine the likelihood they will be recovered from future taxable income. A valuation allowance is established when we believe it is more likely than not the future realization of all or some of a deferred tax asset will not be achieved. In evaluating the ability to recover deferred tax assets within the jurisdiction which they arise, we consider all available positive and negative evidence. Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.  &lt;/span&gt;&lt;/div&gt;The impact of a tax position is recognized in the consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected in income tax expense.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="c-1" id="f-500">&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.  GRAIL SPIN-OFF&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 24, 2024, we completed the Spin-Off of GRAIL into a separate, independent publicly traded company through the distribution of 26,547,021 shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The GRAIL common stock distributed in the Spin-Off consisted of approximately 85.5% of the outstanding common stock of GRAIL as of the Record Date. The Spin-Off was structured as a tax-free spin-off and Illumina stockholders received one share of GRAIL common stock for every six shares of Illumina common stock held on the Record Date. We retained approximately 14.5% of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL&#x2019;s assets, liabilities, results of operations and cash flows have not been reclassified. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the Spin-Off, we contributed to GRAIL an amount, in cash, to cover 2.5 years of GRAIL&#x2019;s operations (the Disposal Funding), which was determined to be $974&#160;million, less the cash and cash equivalents held by GRAIL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of GRAIL&#x2019;s assets and liabilities included as part of the disposal group were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long term-liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GRAIL net assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of GRAIL net assets recorded to short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of GRAIL net assets recorded to additional paid-in capital&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional adjustments recorded to additional paid-in capital as a result of the GRAIL Spin-Off:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-contingent indemnification liability (see &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_118" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax adjustment for difference between the book and tax values of our retained investment in GRAIL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recorded to additional paid-in capital as a result of the GRAIL Spin-Off&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;Includes IPR&amp;amp;D with a carrying value of $140&#160;million after impairment. Refer to note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;5. Goodwill, Intangible&lt;/a&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt; Assets, and Acquisitions&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_136" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;12. Segment and Geographic Information&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for GRAIL&#x2019;s results of operations, prior to the Spin-Off, included in our consolidated statements of operations for the periods presented within.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In planning for and executing the Spin-Off, we incurred $53&#160;million and $17&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in separation-related transaction costs in 2024 and 2023, respectively, recognized in selling, general, and administrative expense. The costs primarily related to financial advisory, legal, regulatory and other professional services fees directly related to the Spin-Off. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Spin-Off, Illumina and GRAIL entered into various agreements to effect the Spin-Off and provide a framework for GRAIL&#x2019;s relationship with Illumina after the Spin-Off, including a separation and distribution agreement, an employee matters agreement, a tax matters agreement, an amended supply and commercialization agreement and a stockholder&#x2019;s and registration rights agreement (the Agreements). The Agreements determine the treatment of the assets, employees, liabilities and obligations (including certain tax-related assets and liabilities) of Illumina attributable to periods prior to, at and after GRAIL&#x2019;s separation and also govern certain relationships between Illumina and GRAIL after the Spin-Off.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <ilmn:DiscontinuedOperationNumberOfSharesIssuedInTransaction
      contextRef="c-55"
      decimals="INF"
      id="f-501"
      unitRef="shares">26547021</ilmn:DiscontinuedOperationNumberOfSharesIssuedInTransaction>
    <ilmn:DiscontinuedOperationPercentOfInterestDisposedOf contextRef="c-55" decimals="3" id="f-502" unitRef="number">0.855</ilmn:DiscontinuedOperationPercentOfInterestDisposedOf>
    <ilmn:DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff
      contextRef="c-90"
      decimals="INF"
      id="f-503"
      unitRef="shares">6</ilmn:DiscontinuedOperationNumberOfParentSharesConvertedIntoOneShareOfSpinOff>
    <us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal contextRef="c-55" decimals="3" id="f-504" unitRef="number">0.145</us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal>
    <us-gaap:DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal contextRef="c-55" id="f-505">P2Y6M</us-gaap:DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal>
    <us-gaap:DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal contextRef="c-55" decimals="-6" id="f-506" unitRef="usd">974000000</us-gaap:DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="c-1" id="f-507">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of GRAIL&#x2019;s assets and liabilities included as part of the disposal group were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long term-liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GRAIL net assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of GRAIL net assets recorded to short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of GRAIL net assets recorded to additional paid-in capital&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional adjustments recorded to additional paid-in capital as a result of the GRAIL Spin-Off:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-contingent indemnification liability (see &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_118" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Note 7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax adjustment for difference between the book and tax values of our retained investment in GRAIL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recorded to additional paid-in capital as a result of the GRAIL Spin-Off&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;Includes IPR&amp;amp;D with a carrying value of $140&#160;million after impairment. Refer to note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;5. Goodwill, Intangible&lt;/a&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_106" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt; Assets, and Acquisitions&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="c-90" decimals="-6" id="f-508" unitRef="usd">968000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet contextRef="c-90" decimals="-6" id="f-509" unitRef="usd">13000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1 contextRef="c-90" decimals="-6" id="f-510" unitRef="usd">22000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent contextRef="c-90" decimals="-6" id="f-511" unitRef="usd">27000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment contextRef="c-90" decimals="-6" id="f-512" unitRef="usd">80000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <ilmn:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset contextRef="c-90" decimals="-6" id="f-513" unitRef="usd">74000000</ilmn:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets contextRef="c-90" decimals="-6" id="f-514" unitRef="usd">2201000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets contextRef="c-90" decimals="-6" id="f-515" unitRef="usd">14000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable contextRef="c-90" decimals="-6" id="f-516" unitRef="usd">12000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities contextRef="c-90" decimals="-6" id="f-517" unitRef="usd">118000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities>
    <ilmn:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability contextRef="c-90" decimals="-6" id="f-518" unitRef="usd">62000000</ilmn:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities contextRef="c-90" decimals="-6" id="f-519" unitRef="usd">469000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities>
    <ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets contextRef="c-90" decimals="-6" id="f-520" unitRef="usd">2738000000</ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets>
    <ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets contextRef="c-91" decimals="-6" id="f-521" unitRef="usd">397000000</ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets>
    <ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets contextRef="c-92" decimals="-6" id="f-522" unitRef="usd">2341000000</ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets>
    <us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining contextRef="c-93" decimals="-6" id="f-523" unitRef="usd">1000000</us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining>
    <us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal contextRef="c-55" decimals="-6" id="f-524" unitRef="usd">57000000</us-gaap:DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal>
    <ilmn:DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital contextRef="c-55" decimals="-6" id="f-525" unitRef="usd">2399000000</ilmn:DisposalGroupIncludingDiscontinuedOperationAdjustmentToAdditionalPaidInCapital>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets contextRef="c-94" decimals="-6" id="f-526" unitRef="usd">140000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <ilmn:DiscontinuedOperationTransactionCosts contextRef="c-95" decimals="-6" id="f-527" unitRef="usd">53000000</ilmn:DiscontinuedOperationTransactionCosts>
    <ilmn:DiscontinuedOperationTransactionCosts contextRef="c-96" decimals="-6" id="f-528" unitRef="usd">17000000</ilmn:DiscontinuedOperationTransactionCosts>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-529">&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.  REVENUE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated from the sale of products and services. Product revenue consists of sales of instruments and consumables used in genetic analysis. Service and other revenue consists of revenue generated from genotyping and sequencing services, instrument service contracts, development and licensing agreements, and prior to the Spin-Off of GRAIL on June&#160;24, 2024, cancer detection testing services related to the GRAIL business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue by Source&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.986%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.813%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.813%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sequencing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Microarray&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sequencing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Microarray&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sequencing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Microarray&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,858&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;297&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,155&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;484&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;314&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service and other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;651&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,993&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;379&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,372&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue by Geographic Area&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Based on region of destination (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,441&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific, Middle East and Africa&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,372&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt"&gt;We implemented a new global commercial structure in Q1 2023 to improve operating efficiencies and better align with local markets. We integrated Asia-Pacific and Japan with emerging markets across the Middle East, Africa, Turkey, and Commonwealth of Independent States (CIS). Beginning in Q1 2023, and going forward, we report regional results for the following regions: Americas, Europe, Greater China, and Asia-Pacific, Middle East and Africa (AMEA). Prior period amounts have been reclassified to conform to this new presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt"&gt;Americas revenue included United States revenue of $2,288&#160;million, $2,359&#160;million, and $2,290&#160;million in 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt"&gt;Region includes revenue from China, Taiwan, and Hong Kong.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt"&gt;Region includes revenue from Russia and Turkey.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We regularly enter into contracts with multiple performance obligations. These contracts are believed to be firm as of the balance sheet date. However, we may allow customers to make product substitutions as we launch new products. The timing of shipments depends on several factors, including agreed upon shipping schedules, which may span multiple quarters. Most performance obligations are generally satisfied within a short time frame, approximately &lt;span style="-sec-ix-hidden:f-594"&gt;three&lt;/span&gt; to six months, after the contract execution date. As of December&#160;29, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations was $657 million, of which approximately 78% is expected to be converted to revenue in 2025, approximately 10% in the following twelve months, and the remainder thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets, which consist of revenue recognized and performance obligations satisfied or partially satisfied in advance of customer billing, as of December&#160;29, 2024 and December&#160;31, 2023, were $16 million and $18 million, respectively, all of which were short-term and recorded in prepaid expenses and other current assets.&lt;/span&gt;&lt;/div&gt;Contract liabilities, which consist of deferred revenue and customer deposits, as of December&#160;29, 2024 and December&#160;31, 2023, were $327 million and $329 million, respectively, of which the short-term portions of $260 million and $252 million, respectively, were recorded in accrued liabilities and the remaining long-term portions were recorded in other long-term liabilities. Revenue recorded in 2024 included $245 million of previously deferred revenue that was included in contract liabilities as of December&#160;31, 2023.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-530">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue by Source&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.986%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.813%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.813%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sequencing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Microarray&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sequencing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Microarray&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sequencing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Microarray&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,858&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;297&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,155&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;484&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;501&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;314&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service and other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;651&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,993&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;379&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,372&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue by Geographic Area&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Based on region of destination (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,441&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater China&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific, Middle East and Africa&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,372&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt"&gt;We implemented a new global commercial structure in Q1 2023 to improve operating efficiencies and better align with local markets. We integrated Asia-Pacific and Japan with emerging markets across the Middle East, Africa, Turkey, and Commonwealth of Independent States (CIS). Beginning in Q1 2023, and going forward, we report regional results for the following regions: Americas, Europe, Greater China, and Asia-Pacific, Middle East and Africa (AMEA). Prior period amounts have been reclassified to conform to this new presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt"&gt;Americas revenue included United States revenue of $2,288&#160;million, $2,359&#160;million, and $2,290&#160;million in 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt"&gt;Region includes revenue from China, Taiwan, and Hong Kong.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.69pt"&gt;Region includes revenue from Russia and Turkey.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-97" decimals="-6" id="f-531" unitRef="usd">2858000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-98" decimals="-6" id="f-532" unitRef="usd">297000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-99" decimals="-6" id="f-533" unitRef="usd">3155000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-100" decimals="-6" id="f-534" unitRef="usd">2790000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-101" decimals="-6" id="f-535" unitRef="usd">293000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-102" decimals="-6" id="f-536" unitRef="usd">3083000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-103" decimals="-6" id="f-537" unitRef="usd">2919000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-104" decimals="-6" id="f-538" unitRef="usd">306000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-105" decimals="-6" id="f-539" unitRef="usd">3225000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-106" decimals="-6" id="f-540" unitRef="usd">484000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-107" decimals="-6" id="f-541" unitRef="usd">17000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-87" decimals="-6" id="f-542" unitRef="usd">501000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-108" decimals="-6" id="f-543" unitRef="usd">685000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-109" decimals="-6" id="f-544" unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-110" decimals="-6" id="f-545" unitRef="usd">704000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-111" decimals="-6" id="f-546" unitRef="usd">709000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-112" decimals="-6" id="f-547" unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-113" decimals="-6" id="f-548" unitRef="usd">728000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-114" decimals="-6" id="f-549" unitRef="usd">3342000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-6" id="f-550" unitRef="usd">314000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-6" id="f-551" unitRef="usd">3656000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-116" decimals="-6" id="f-552" unitRef="usd">3475000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-117" decimals="-6" id="f-553" unitRef="usd">312000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-6" id="f-554" unitRef="usd">3787000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-118" decimals="-6" id="f-555" unitRef="usd">3628000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-119" decimals="-6" id="f-556" unitRef="usd">325000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-6" id="f-557" unitRef="usd">3953000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-120" decimals="-6" id="f-558" unitRef="usd">651000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-121" decimals="-6" id="f-559" unitRef="usd">65000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-6" id="f-560" unitRef="usd">716000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-122" decimals="-6" id="f-561" unitRef="usd">637000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-123" decimals="-6" id="f-562" unitRef="usd">80000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-6" id="f-563" unitRef="usd">717000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-124" decimals="-6" id="f-564" unitRef="usd">543000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-125" decimals="-6" id="f-565" unitRef="usd">88000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-6" id="f-566" unitRef="usd">631000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-126" decimals="-6" id="f-567" unitRef="usd">3993000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-127" decimals="-6" id="f-568" unitRef="usd">379000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-6" id="f-569" unitRef="usd">4372000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-128" decimals="-6" id="f-570" unitRef="usd">4112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-129" decimals="-6" id="f-571" unitRef="usd">392000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-6" id="f-572" unitRef="usd">4504000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-130" decimals="-6" id="f-573" unitRef="usd">4171000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-131" decimals="-6" id="f-574" unitRef="usd">413000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-6" id="f-575" unitRef="usd">4584000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-132" decimals="-6" id="f-576" unitRef="usd">2441000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-133" decimals="-6" id="f-577" unitRef="usd">2521000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-134" decimals="-6" id="f-578" unitRef="usd">2479000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-135" decimals="-6" id="f-579" unitRef="usd">1185000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-136" decimals="-6" id="f-580" unitRef="usd">1140000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-137" decimals="-6" id="f-581" unitRef="usd">1089000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-138" decimals="-6" id="f-582" unitRef="usd">308000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-139" decimals="-6" id="f-583" unitRef="usd">384000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-140" decimals="-6" id="f-584" unitRef="usd">472000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-141" decimals="-6" id="f-585" unitRef="usd">438000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-142" decimals="-6" id="f-586" unitRef="usd">459000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-143" decimals="-6" id="f-587" unitRef="usd">544000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-6" id="f-588" unitRef="usd">4372000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-6" id="f-589" unitRef="usd">4504000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-6" id="f-590" unitRef="usd">4584000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-144" decimals="-6" id="f-591" unitRef="usd">2288000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-145" decimals="-6" id="f-592" unitRef="usd">2359000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-146" decimals="-6" id="f-593" unitRef="usd">2290000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ilmn:RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame contextRef="c-148" id="f-595">P6M</ilmn:RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-4" decimals="-6" id="f-596" unitRef="usd">657000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c-149" decimals="2" id="f-597" unitRef="number">0.78</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c-150" decimals="2" id="f-598" unitRef="number">0.10</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-150" id="f-599">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-4" decimals="-6" id="f-600" unitRef="usd">16000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-5" decimals="-6" id="f-601" unitRef="usd">18000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="-6" id="f-602" unitRef="usd">327000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-5" decimals="-6" id="f-603" unitRef="usd">329000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-6" id="f-604" unitRef="usd">260000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-6" id="f-605" unitRef="usd">252000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-12" decimals="-6" id="f-606" unitRef="usd">245000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-608">&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.  INVESTMENTS AND FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of marketable equity securities. As of December&#160;29, 2024 and December&#160;31, 2023, the fair value of our marketable equity securities totaled $93 million and $6 million, respectively. The increase in our marketable equity securities relates to the investment we retained in GRAIL subsequent to the Spin-Off, which was initially recorded as $397 million, representing 14.5% of GRAIL&#x2019;s net assets disposed of at Spin-Off. Refer to note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_1657" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2. GRAIL Spin-Off&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for details. We recorded an unrealized loss of $309 million in 2024, subsequent to the Spin-Off, based on the fair value of our investment in GRAIL as of December&#160;29, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and (losses) recognized in other expense, net on marketable equity securities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.096%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) recognized during the period on marketable equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net (losses) recognized during the period on marketable equity securities sold during the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized (losses) recognized during the period on marketable equity securities still held at the reporting date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-Marketable Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;29, 2024 and December&#160;31, 2023, non-marketable equity securities, without readily determinable fair values, included in other assets, were $26 million and $28 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Venture Funds&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We invest in three venture capital investment funds (the Funds), which are accounted for as equity-method investments. The aggregate carrying amount of the Funds, included in other assets, was $201 million and $168 million as of December&#160;29, 2024 and December&#160;31, 2023, respectively. We recorded a net gain of $5&#160;million in 2024, and net losses of $33&#160;million and $25&#160;million in 2023 and 2022, respectively, in other expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commitments to the Funds are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.965%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.667%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.013%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.991%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Capital commitments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Callable through date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Remaining callable as of December&#160;29, 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fund I&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fund II&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fund III&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;Fund I also had recallable distributions of approximately $10&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized from transactions with our strategic investees was $20 million, $69 million, and $113 million in 2024, 2023, and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy&#160;for assets and liabilities measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.779%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.015%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (cash equivalents)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;931&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;931&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Helix contingent value right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable equity securities are measured at fair value based on quoted trade prices in active markets. Other investments, included in other assets, consist of convertible notes, for which we elected the fair value option. Fair value is derived using a probability-weighted scenario approach. Changes in fair value are recognized in other expense, net. Deferred compensation plan assets consist primarily of investments in life insurance contracts carried at cash surrender value, which reflects the net asset value of the underlying publicly traded mutual funds. We corroborate the fair value of our holdings, comparing valuations obtained from our investment service provider to valuations reported by our asset custodians, validating pricing sources and models, and reviewing key model inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Helix Contingent Value Right&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the deconsolidation of Helix Holdings I, LLC (Helix) in April 2019, we received a contingent value right with a 7-year term that entitled us to consideration dependent upon the outcome of Helix&#x2019;s future financing and/or liquidity events. We elected the fair value option to measure the contingent value right received from Helix. Changes in the estimated fair value are recognized in other expense, net. We estimated the fair value of the contingent value right using a Monte Carlo simulation. Estimates and assumptions used in the Monte Carlo simulation included probabilities related to the timing and outcome of future financing and/or liquidity events, assumptions regarding collectability and volatility, and an estimated equity value of Helix. These unobservable inputs represented a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. On July 31, 2024, we received cash of $83 million to settle the contingent value right early. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Helix contingent value right were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:88.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.676%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received to settle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Consideration Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We reassess the fair value of contingent consideration related to acquisitions on a quarterly basis, with changes in the fair value, subsequent to the acquisition date, recognized in selling, general and administrative expense. The contingent value rights issued as part of the GRAIL acquisition entitle the holders to receive future cash payments on a quarterly basis (Covered Revenue Payments) representing a pro rata portion of certain GRAIL-related revenues (Covered Revenues) each year for a 12-year period (through August 2033). As defined in the &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/1110803/000095015721000850/ex4-1.htm" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Value Rights Agreement&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, this will reflect a 2.5% payment right to the first $1&#160;billion of revenue each year for 12 years. Revenue above $1&#160;billion each year will be subject to a 9% contingent payment right during this same period. Covered Revenues for the periods Q4 2023 through Q3 2024, Q4 2022 through Q3 2023, and Q4 2021 through Q3 2022 were $117&#160;million, $85&#160;million, and $42&#160;million, respectively, driven primarily by sales of GRAIL&#x2019;s Galleri test. Covered Revenue Payments relating to such periods were $1.1 million, $803,000, and $396,000 in 2024, 2023, and 2022, respectively. A portion of the Covered Revenue Payments in 2022 were applied to reimburse us for certain expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our contingent consideration liability related to GRAIL was $71&#160;million and $387&#160;million as of December&#160;29, 2024 and December&#160;31, 2023, respectively, of which $70&#160;million and $385&#160;million, respectively, was included in other long-term liabilities, with the remaining balances included in accrued liabilities. We use a Monte Carlo simulation to estimate the fair value of the GRAIL contingent consideration liability. Estimates and assumptions used in the Monte Carlo simulation include forecasted revenues for GRAIL, a revenue risk premium, a revenue volatility estimate, an operational leverage ratio and a counterparty credit spread. These unobservable inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. Subsequent to the Spin-Off, we no longer have access to GRAIL management&#x2019;s forecasts. Therefore, we must rely on information made public by GRAIL&#x2019;s management and, beginning in Q4 2024, information published in analyst reports to estimate forecasted revenues through August 2033. In August 2024, GRAIL publicly announced a corporate restructure, including a reduction in headcount and planned hires and a substantial decrease in certain R&amp;amp;D projects and investments. To estimate the liability as of December&#160;29, 2024, we selected a revenue risk premium of 9%, which was derived from reconciling our forecasted revenues for GRAIL to GRAIL&#x2019;s market capitalization based on a 60-day trailing average. The significant decrease in the contingent consideration liability from December&#160;31, 2023 was due to a decrease in the forecasted revenues, following revised revenue projections announced by GRAIL in May 2024 and the restructuring announcement in August 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used in estimating the fair value of the contingent consideration liability related to GRAIL are inherently subject to uncertainty and we note that small changes in these assumptions could have a significant impact on the concluded value. For example, an increase or decrease of 20%, in each year, to the forecasted revenues would have resulted in an increase of $17&#160;million and a decrease of $18&#160;million, respectively, in the liability as of December&#160;29, 2024. Additionally, an increase or decrease of 250 basis points to the selected revenue risk premium would have resulted in a decrease of $12&#160;million and an increase of $15&#160;million, respectively. We expect certain levels of volatility in the GRAIL contingent consideration liability are possible in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the estimated fair value of our contingent consideration liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ShortTermInvestments contextRef="c-4" decimals="-6" id="f-609" unitRef="usd">93000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-5" decimals="-6" id="f-610" unitRef="usd">6000000</us-gaap:ShortTermInvestments>
    <ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets contextRef="c-91" decimals="-6" id="f-611" unitRef="usd">397000000</ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets>
    <us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal contextRef="c-55" decimals="3" id="f-612" unitRef="number">0.145</us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal>
    <ilmn:DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag contextRef="c-1" id="f-613">unrealized loss</ilmn:DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax contextRef="c-95" decimals="-6" id="f-614" unitRef="usd">-309000000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="c-1" id="f-615">&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and (losses) recognized in other expense, net on marketable equity securities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.096%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) recognized during the period on marketable equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net (losses) recognized during the period on marketable equity securities sold during the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized (losses) recognized during the period on marketable equity securities still held at the reporting date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-1" decimals="-6" id="f-616" unitRef="usd">-310000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-12" decimals="-6" id="f-617" unitRef="usd">-2000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-13" decimals="-6" id="f-618" unitRef="usd">-81000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-1" decimals="-6" id="f-619" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-12" decimals="-6" id="f-620" unitRef="usd">-2000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-13" decimals="-6" id="f-621" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="c-1" decimals="-6" id="f-622" unitRef="usd">-310000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="c-12" decimals="-6" id="f-623" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="c-13" decimals="-6" id="f-624" unitRef="usd">-81000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="c-4" decimals="-6" id="f-625" unitRef="usd">26000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="c-5" decimals="-6" id="f-626" unitRef="usd">28000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <ilmn:NumberOfInvestmentFunds contextRef="c-151" decimals="INF" id="f-627" unitRef="fund">3</ilmn:NumberOfInvestmentFunds>
    <us-gaap:EquityMethodInvestments contextRef="c-152" decimals="-6" id="f-628" unitRef="usd">201000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-153" decimals="-6" id="f-629" unitRef="usd">168000000</us-gaap:EquityMethodInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-151" decimals="-6" id="f-630" unitRef="usd">5000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-154" decimals="-6" id="f-631" unitRef="usd">-33000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-155" decimals="-6" id="f-632" unitRef="usd">-25000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OtherCommitmentsTableTextBlock contextRef="c-1" id="f-633">&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commitments to the Funds are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.965%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.667%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.013%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.991%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Capital commitments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Callable through date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Remaining callable as of December&#160;29, 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fund I&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fund II&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fund III&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;Fund I also had recallable distributions of approximately $10&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherCommitmentsTableTextBlock>
    <us-gaap:OtherCommitment contextRef="c-156" decimals="-6" id="f-634" unitRef="usd">100000000</us-gaap:OtherCommitment>
    <ilmn:RemainingCapitalCommitment contextRef="c-156" decimals="-6" id="f-635" unitRef="usd">3000000</ilmn:RemainingCapitalCommitment>
    <us-gaap:OtherCommitment contextRef="c-157" decimals="-6" id="f-636" unitRef="usd">150000000</us-gaap:OtherCommitment>
    <ilmn:RemainingCapitalCommitment contextRef="c-157" decimals="-6" id="f-637" unitRef="usd">46000000</ilmn:RemainingCapitalCommitment>
    <us-gaap:OtherCommitment contextRef="c-158" decimals="-6" id="f-638" unitRef="usd">60000000</us-gaap:OtherCommitment>
    <ilmn:RemainingCapitalCommitment contextRef="c-158" decimals="-6" id="f-639" unitRef="usd">47000000</ilmn:RemainingCapitalCommitment>
    <ilmn:RecallableDistributionsCommitment contextRef="c-4" decimals="-6" id="f-640" unitRef="usd">10000000</ilmn:RecallableDistributionsCommitment>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-159" decimals="-6" id="f-641" unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-160" decimals="-6" id="f-642" unitRef="usd">69000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-161" decimals="-6" id="f-643" unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-644">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy&#160;for assets and liabilities measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.779%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.550%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.015%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds (cash equivalents)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;931&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;931&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Helix contingent value right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-162" decimals="-6" id="f-645" unitRef="usd">931000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-163" decimals="-6" id="f-646" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-164" decimals="-6" id="f-647" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-165" decimals="-6" id="f-648" unitRef="usd">931000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-166" decimals="-6" id="f-649" unitRef="usd">774000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-167" decimals="-6" id="f-650" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-168" decimals="-6" id="f-651" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-169" decimals="-6" id="f-652" unitRef="usd">774000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-162" decimals="-6" id="f-653" unitRef="usd">93000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-163" decimals="-6" id="f-654" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-164" decimals="-6" id="f-655" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-165" decimals="-6" id="f-656" unitRef="usd">93000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-166" decimals="-6" id="f-657" unitRef="usd">6000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-167" decimals="-6" id="f-658" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-168" decimals="-6" id="f-659" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-169" decimals="-6" id="f-660" unitRef="usd">6000000</us-gaap:EquitySecuritiesFvNi>
    <ilmn:OtherInvestmentsFairValueDisclosure contextRef="c-162" decimals="-6" id="f-661" unitRef="usd">0</ilmn:OtherInvestmentsFairValueDisclosure>
    <ilmn:OtherInvestmentsFairValueDisclosure contextRef="c-163" decimals="-6" id="f-662" unitRef="usd">0</ilmn:OtherInvestmentsFairValueDisclosure>
    <ilmn:OtherInvestmentsFairValueDisclosure contextRef="c-164" decimals="-6" id="f-663" unitRef="usd">17000000</ilmn:OtherInvestmentsFairValueDisclosure>
    <ilmn:OtherInvestmentsFairValueDisclosure contextRef="c-165" decimals="-6" id="f-664" unitRef="usd">17000000</ilmn:OtherInvestmentsFairValueDisclosure>
    <ilmn:OtherInvestmentsFairValueDisclosure contextRef="c-166" decimals="-6" id="f-665" unitRef="usd">0</ilmn:OtherInvestmentsFairValueDisclosure>
    <ilmn:OtherInvestmentsFairValueDisclosure contextRef="c-167" decimals="-6" id="f-666" unitRef="usd">0</ilmn:OtherInvestmentsFairValueDisclosure>
    <ilmn:OtherInvestmentsFairValueDisclosure contextRef="c-168" decimals="-6" id="f-667" unitRef="usd">0</ilmn:OtherInvestmentsFairValueDisclosure>
    <ilmn:OtherInvestmentsFairValueDisclosure contextRef="c-169" decimals="-6" id="f-668" unitRef="usd">0</ilmn:OtherInvestmentsFairValueDisclosure>
    <ilmn:ContingentValueRightFairValueDisclosure contextRef="c-162" decimals="-6" id="f-669" unitRef="usd">0</ilmn:ContingentValueRightFairValueDisclosure>
    <ilmn:ContingentValueRightFairValueDisclosure contextRef="c-163" decimals="-6" id="f-670" unitRef="usd">0</ilmn:ContingentValueRightFairValueDisclosure>
    <ilmn:ContingentValueRightFairValueDisclosure contextRef="c-164" decimals="-6" id="f-671" unitRef="usd">0</ilmn:ContingentValueRightFairValueDisclosure>
    <ilmn:ContingentValueRightFairValueDisclosure contextRef="c-166" decimals="-6" id="f-672" unitRef="usd">0</ilmn:ContingentValueRightFairValueDisclosure>
    <ilmn:ContingentValueRightFairValueDisclosure contextRef="c-167" decimals="-6" id="f-673" unitRef="usd">0</ilmn:ContingentValueRightFairValueDisclosure>
    <ilmn:ContingentValueRightFairValueDisclosure contextRef="c-168" decimals="-6" id="f-674" unitRef="usd">68000000</ilmn:ContingentValueRightFairValueDisclosure>
    <ilmn:ContingentValueRightFairValueDisclosure contextRef="c-169" decimals="-6" id="f-675" unitRef="usd">68000000</ilmn:ContingentValueRightFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-162" decimals="-6" id="f-676" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-163" decimals="-6" id="f-677" unitRef="usd">70000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-164" decimals="-6" id="f-678" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-165" decimals="-6" id="f-679" unitRef="usd">70000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-166" decimals="-6" id="f-680" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-167" decimals="-6" id="f-681" unitRef="usd">61000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-168" decimals="-6" id="f-682" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-169" decimals="-6" id="f-683" unitRef="usd">61000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-162" decimals="-6" id="f-684" unitRef="usd">1024000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-163" decimals="-6" id="f-685" unitRef="usd">70000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-164" decimals="-6" id="f-686" unitRef="usd">17000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-165" decimals="-6" id="f-687" unitRef="usd">1111000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-166" decimals="-6" id="f-688" unitRef="usd">780000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-167" decimals="-6" id="f-689" unitRef="usd">61000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-168" decimals="-6" id="f-690" unitRef="usd">68000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-169" decimals="-6" id="f-691" unitRef="usd">909000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-162" decimals="-6" id="f-692" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-163" decimals="-6" id="f-693" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-164" decimals="-6" id="f-694" unitRef="usd">73000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-165" decimals="-6" id="f-695" unitRef="usd">73000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-166" decimals="-6" id="f-696" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-167" decimals="-6" id="f-697" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-168" decimals="-6" id="f-698" unitRef="usd">387000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-169" decimals="-6" id="f-699" unitRef="usd">387000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-162" decimals="-6" id="f-700" unitRef="usd">0</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-163" decimals="-6" id="f-701" unitRef="usd">65000000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-164" decimals="-6" id="f-702" unitRef="usd">0</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-165" decimals="-6" id="f-703" unitRef="usd">65000000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-166" decimals="-6" id="f-704" unitRef="usd">0</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-167" decimals="-6" id="f-705" unitRef="usd">59000000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-168" decimals="-6" id="f-706" unitRef="usd">0</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-169" decimals="-6" id="f-707" unitRef="usd">59000000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-162" decimals="-6" id="f-708" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-163" decimals="-6" id="f-709" unitRef="usd">65000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-164" decimals="-6" id="f-710" unitRef="usd">73000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-165" decimals="-6" id="f-711" unitRef="usd">138000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-166" decimals="-6" id="f-712" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-167" decimals="-6" id="f-713" unitRef="usd">59000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-168" decimals="-6" id="f-714" unitRef="usd">387000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-169" decimals="-6" id="f-715" unitRef="usd">446000000</us-gaap:LiabilitiesFairValueDisclosure>
    <ilmn:BusinessAcquisitionContingentValueRightsTerm contextRef="c-170" id="f-716">P7Y</ilmn:BusinessAcquisitionContingentValueRightsTerm>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements contextRef="c-171" decimals="-6" id="f-717" unitRef="usd">83000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-718">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Helix contingent value right were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:88.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.676%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received to settle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the estimated fair value of our contingent consideration liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-172" decimals="-6" id="f-719" unitRef="usd">65000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-173" decimals="-6" id="f-720" unitRef="usd">-7000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-174" decimals="-6" id="f-721" unitRef="usd">58000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-175" decimals="-6" id="f-722" unitRef="usd">10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-176" decimals="-6" id="f-723" unitRef="usd">68000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="c-171" decimals="-6" id="f-724" unitRef="usd">15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements contextRef="c-171" decimals="-6" id="f-725" unitRef="usd">83000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-177" decimals="-6" id="f-726" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <ilmn:BusinessAcquisitionContingentValueRightsTerm contextRef="c-178" id="f-727">P12Y</ilmn:BusinessAcquisitionContingentValueRightsTerm>
    <ilmn:BusinessAcquisitionContingentValueRightsProRataOnePercentage contextRef="c-179" decimals="3" id="f-728" unitRef="number">0.025</ilmn:BusinessAcquisitionContingentValueRightsProRataOnePercentage>
    <ilmn:BusinessAcquisitionContingentValueRightsRevenueThreshold contextRef="c-180" decimals="-9" id="f-729" unitRef="usd">1000000000</ilmn:BusinessAcquisitionContingentValueRightsRevenueThreshold>
    <ilmn:BusinessAcquisitionContingentValueRightsTerm contextRef="c-178" id="f-730">P12Y</ilmn:BusinessAcquisitionContingentValueRightsTerm>
    <ilmn:BusinessAcquisitionContingentValueRightsRevenueThreshold contextRef="c-181" decimals="-9" id="f-731" unitRef="usd">1000000000</ilmn:BusinessAcquisitionContingentValueRightsRevenueThreshold>
    <ilmn:BusinessAcquisitionContingentValueRightsProRataTwoPercentage contextRef="c-182" decimals="2" id="f-732" unitRef="number">0.09</ilmn:BusinessAcquisitionContingentValueRightsProRataTwoPercentage>
    <ilmn:CoveredRevenuesOfGRAILContingentConsiderationLiability contextRef="c-183" decimals="-6" id="f-733" unitRef="usd">117000000</ilmn:CoveredRevenuesOfGRAILContingentConsiderationLiability>
    <ilmn:CoveredRevenuesOfGRAILContingentConsiderationLiability contextRef="c-184" decimals="-6" id="f-734" unitRef="usd">85000000</ilmn:CoveredRevenuesOfGRAILContingentConsiderationLiability>
    <ilmn:CoveredRevenuesOfGRAILContingentConsiderationLiability contextRef="c-185" decimals="-6" id="f-735" unitRef="usd">42000000</ilmn:CoveredRevenuesOfGRAILContingentConsiderationLiability>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities contextRef="c-178" decimals="-5" id="f-736" unitRef="usd">1100000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities contextRef="c-186" decimals="-3" id="f-737" unitRef="usd">803000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities contextRef="c-187" decimals="-3" id="f-738" unitRef="usd">396000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-93" decimals="-6" id="f-739" unitRef="usd">71000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-188" decimals="-6" id="f-740" unitRef="usd">387000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-93" decimals="-6" id="f-741" unitRef="usd">70000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-188" decimals="-6" id="f-742" unitRef="usd">385000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-189" decimals="2" id="f-743" unitRef="number">0.09</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-190" decimals="2" id="f-744" unitRef="day">60</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease contextRef="c-93" decimals="-6" id="f-745" unitRef="usd">17000000</ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentIncrease>
    <ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease contextRef="c-93" decimals="-6" id="f-746" unitRef="usd">-18000000</ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesImpactOf20PercentDecreaseDecrease>
    <ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease contextRef="c-93" decimals="-6" id="f-747" unitRef="usd">-12000000</ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsIncrease>
    <ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease contextRef="c-93" decimals="-6" id="f-748" unitRef="usd">15000000</ilmn:SensitivityAnalysisOfBusinessCombinationContingentConsiderationLiabilityChangesEffectOfChangeOfAdditional250BasisPointsDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-191" decimals="-6" id="f-749" unitRef="usd">615000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="c-192" decimals="-6" id="f-750" unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-192" decimals="-6" id="f-751" unitRef="usd">-205000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-193" decimals="-6" id="f-752" unitRef="usd">412000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-194" decimals="-6" id="f-753" unitRef="usd">-24000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="c-194" decimals="-6" id="f-754" unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-195" decimals="-6" id="f-755" unitRef="usd">387000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="c-196" decimals="-6" id="f-756" unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-196" decimals="-6" id="f-757" unitRef="usd">-315000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="c-196" decimals="-6" id="f-758" unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="c-197" decimals="-6" id="f-759" unitRef="usd">73000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-760">&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.  GOODWILL, INTANGIBLE ASSETS, AND ACQUISITIONS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(712)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,545&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt; The balance as of January&#160;1, 2023 includes accumulated impairment of $3,914&#160;million related to our GRAIL reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2024 Impairment of Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is reviewed for impairment annually, during the second quarter of our fiscal year, or more frequently if an event occurs indicating the potential for impairment. In May 2024, we performed our annual goodwill impairment test for our two reporting units: Core Illumina and GRAIL. We performed a quantitative test for both reporting units. GRAIL&#x2019;s carrying value exceeded its fair value, estimated as $580&#160;million, and we recorded a goodwill impairment of $1,466&#160;million in Q2 2024. There was no impairment for Core Illumina, as its fair value exceeded its carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the fair value of GRAIL as of May 2024, we utilized enterprise value estimates of GRAIL, as estimated by investment bankers for purposes of determining pricing for the Spin-Off. Estimates and assumptions used to derive the investment bankers&#x2019; enterprise value estimates included estimated revenues for a two year period based on assumed growth rates and implied revenue multiples for comparable companies. These estimates and assumptions represent a Level 3 measurement as they are supported by little or no market activity and reflect our own assumptions in measuring fair value. An increase in estimated enterprise values for GRAIL of 100% would still have resulted in a full impairment of goodwill. In prior periods, we used a combination of both an income (discounted cash flow) and market approach to determine the fair value of GRAIL. The income approach utilized estimated cash flows for GRAIL based on a long-range plan, for a 15 year period, which contemplated FDA approval. Based on this approach, in Q3 2023, we estimated the fair value of GRAIL to be $3.6&#160;billion and using this same approach in Q4 2023 suggested no further decrement in fair value. Initial analyst coverage of GRAIL from December 2023 into the spring of 2024 suggested that GRAIL could be valued between $3&#160;billion and $4&#160;billion. By May 2024, prior to the consummation of the GRAIL Spin-Off, additional information about GRAIL had become available in GRAIL&#x2019;s amended Form 10 filings and a publicly available management presentation, which included updated disclosure about GRAIL&#x2019;s business and anticipated near term financial trends. Prior to the consummation of the GRAIL Spin-Off, the amount of GRAIL&#x2019;s Disposal Funding, $974&#160;million, was also disclosed. Analyst and banker valuation estimates then began to estimate fair values between $400&#160;million and $770&#160;million, consistent with the impairment recorded in Q2 2024.     &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the fair value of Core Illumina, we used a combination of both an income and market approach consistent with prior periods. The income approach utilized estimated discounted cash flows for the reporting unit, while the market approach utilized comparable company information. Estimates and assumptions used in the income approach included projected cash flows and a discount rate and represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluated GRAIL&#x2019;s IPR&amp;amp;D intangible asset for potential impairment, in May 2024, as part of our annual test. We also concluded that the when-issued trading activity for GRAIL&#x2019;s common stock, in June 2024, represented a triggering event that required an additional impairment test be performed. The carrying value of the IPR&amp;amp;D asset exceeded its estimated fair value and we recorded an impairment of $420&#160;million in Q2 2024. The fair value of GRAIL&#x2019;s IPR&amp;amp;D was determined by the income approach, using a discounted cash flow model. Estimates and assumptions used in the income approach, which represent a Level 3 measurement, included projected cash flows and a discount rate of 46.5%. The discount rate was derived from reconciling GRAIL&#x2019;s long-range plan, which contemplated FDA approval and estimated cash flows for a 15 year period, to observed market values of GRAIL based on when-issued trading activity. An increase of 300 basis points to the discount rate used in our analysis would have resulted in additional impairment of $20&#160;million. There is substantial risk inherent in forecasting revenues and spend associated with research and development, including assumptions around the timing and level of resources and investment to be made, which were made more challenging in light of the Spin-Off and related Disposal Funding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We performed a recoverability test for GRAIL&#x2019;s definite-lived intangible assets, which included developed technology and trade name, noting no impairment. No impairment was noted for Core Illumina definite-lived intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2023 Impairment of Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In Q3 2023, we concluded that the sustained decrease in the Company&#x2019;s stock price and overall market capitalization during the quarter was a triggering event indicating the fair values of our reporting units might be less than their carrying amounts and that an interim impairment test was required. Based on our analysis, we concluded GRAIL&#x2019;s carrying value exceeded its fair value and recorded a goodwill impairment of $712&#160;million, primarily due to the decrease in the Company&#x2019;s consolidated market capitalization and a higher discount rate selected for the fair value calculation of GRAIL. There was no impairment for Core Illumina, as its fair value exceeded its carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We performed our interim goodwill impairment test using a combination of both an income and a market approach to determine the fair value of each reporting unit. The income approach utilized the estimated discounted cash flows for each reporting unit, while the market approach utilized comparable company information. Estimates and assumptions used in the income approach included projected cash flows for both GRAIL and Core Illumina and a discount rate for each reporting unit. Discount rates were determined using a weighted average cost of capital for risk factors specific to each reporting unit and other market and industry data. For GRAIL, the selected discount rate was 24.0%. An increase of 50 to 100 basis points to the discount rate would have resulted in additional impairment of $200&#160;million to $350&#160;million. The estimates and assumptions used in our assessment represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. In order to further validate the reasonableness of the fair values concluded for our reporting units, a reconciliation to market capitalization was performed by estimating a reasonable implied control premium and other market factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with our interim goodwill impairment test, we also evaluated GRAIL&#x2019;s IPR&amp;amp;D intangible asset for potential impairment. We performed our impairment test by comparing the carrying value of the IPR&amp;amp;D intangible asset to its estimated fair value, which was determined by the income approach, using a discounted cash flow model. Estimates and assumptions used in the income approach, which represent a Level 3 measurement, included projected cash flows and a selected discount rate of 19.0%. Based on our analysis, the carrying value of GRAIL&#x2019;s IPR&amp;amp;D intangible asset exceeded its estimated fair value and we recorded an impairment of $109&#160;million in Q3 2023, primarily due to a decrease in projected cash flows and a higher discount rate selected for the fair value calculation of the IPR&amp;amp;D asset. We also performed a recoverability test for the definite-lived intangible assets assigned to GRAIL, which included developed technology and trade name, and to Core Illumina and noted no impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In Q4 2023, we concluded, among other events, that our formal announcement to divest GRAIL represented a triggering event that required an additional interim impairment test be performed. As a result of our analysis, no impairment was recorded for Core Illumina or GRAIL. The fair value of GRAIL exceeded its carrying value by approximately $950&#160;million and the selected discount rate used in the analysis was 23.0%. An increase of 100 basis points to the discount rate would still have resulted in no impairment for GRAIL. We also performed a recoverability test for the definite-lived intangible assets assigned to GRAIL and Core Illumina and noted no impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2022 Impairment of Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 13, 2022, the EU General Court ruled that the European Commission had jurisdiction under the EU Merger Regulation to review our acquisition of GRAIL. Additionally, on September 6, 2022, the European Commission issued its decision prohibiting the acquisition. See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_127" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;9. Legal Proceedings&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. These decisions, along with a continued and significant decrease in the Company&#x2019;s stock price and market capitalization, required us to perform an interim impairment test in Q3 2022. Based on our analysis, we concluded GRAIL&#x2019;s carrying value exceeded its fair value and recorded a goodwill impairment of $3,914&#160;million, primarily due to the negative impact of capital market conditions and a higher discount rate selected for the fair value calculation of GRAIL. There was no impairment for Core Illumina. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We performed our interim goodwill impairment test using a combination of both an income and a market approach to determine the fair value of each reporting unit. The income approach utilized the estimated discounted cash flows for each reporting unit, while the market approach utilized comparable company information. Estimates and assumptions used in the income approach included projected cash flows for both GRAIL and Core Illumina and a discount rate for each reporting unit. Discount rates were determined using a weighted average cost of capital for risk factors specific to each reporting unit and other market and industry data. For GRAIL, the discount rate selected was 22.0%. In order to further validate the reasonableness of the fair values concluded for our reporting units, a reconciliation to market capitalization was performed by estimating a reasonable implied control premium and other market factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with our interim goodwill impairment test, we also evaluated GRAIL&#x2019;s IPR&amp;amp;D intangible asset for potential impairment. We performed our impairment test by comparing the carrying value of the IPR&amp;amp;D intangible asset to its estimated fair value, which was determined by the income approach, using a discounted cash flow model. Estimates and assumptions used in the income approach included projected cash flows and a discount rate. Based on our analysis, the carrying value of the IPR&amp;amp;D intangible asset did not exceed its estimated fair value and no impairment was recorded. We also performed a recoverability test for the definite-lived intangible assets assigned to GRAIL, which included developed technology and trade name, and to Core Illumina and noted no impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible Assets,&lt;br/&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible Assets,&lt;br/&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;465&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-848"&gt;&lt;span style="-sec-ix-hidden:f-849"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant decrease in developed technologies, trade name, and IPR&amp;amp;D reflect the GRAIL intangible assets disposed of in connection with the Spin-Off. See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_1657" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2. GRAIL Spin-Off&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for details. Also, in Q1 2024, we placed into service (reflected in developed technologies), with a useful life of 10 years, the $35&#160;million IPR&amp;amp;D intangible asset we acquired in 2021, net of impairments recognized in 2024 and 2023 of $3&#160;million and $6&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $42&#160;million, with a useful life of 7 years, and a customer relationship asset of $2&#160;million, with a useful life of 11 years. We are still finalizing the allocation of the purchase price as it relates to the completion of certain tax returns. We expect to finalize the valuation as soon as practicable, but no later than one year after the acquisition. As a result of an acquisition in Q4 2023, we recorded a developed technology asset of $19&#160;million, with a useful life of 10 years. We finalized the allocation of the purchase price in Q4 2024 with no material adjustments to provisional amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated future annual amortization of finite-lived intangible assets is shown in the following table. Actual amortization expense to be reported in future periods could differ from these estimates as a result of acquisitions, divestitures, and asset impairments, among other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ilmn:BusinessCombinationAndGoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-761">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(712)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,545&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt; The balance as of January&#160;1, 2023 includes accumulated impairment of $3,914&#160;million related to our GRAIL reporting unit.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-33" decimals="-6" id="f-762" unitRef="usd">3239000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-12" decimals="-6" id="f-763" unitRef="usd">712000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-12" decimals="-6" id="f-764" unitRef="usd">18000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill contextRef="c-5" decimals="-6" id="f-765" unitRef="usd">2545000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-6" id="f-766" unitRef="usd">1466000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-6" id="f-767" unitRef="usd">34000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill contextRef="c-4" decimals="-6" id="f-768" unitRef="usd">1113000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-198" decimals="-6" id="f-769" unitRef="usd">3914000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:NumberOfReportingUnits
      contextRef="c-199"
      decimals="INF"
      id="f-770"
      unitRef="reporting_unit">2</us-gaap:NumberOfReportingUnits>
    <ilmn:GoodwillAmountThatExceedsCarryingValue contextRef="c-200" decimals="-6" id="f-771" unitRef="usd">580000000</ilmn:GoodwillAmountThatExceedsCarryingValue>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-201" decimals="-6" id="f-772" unitRef="usd">1466000000</us-gaap:GoodwillImpairmentLoss>
    <ilmn:GoodwillImpairmentMeasurementInput
      contextRef="c-199"
      decimals="INF"
      id="f-773"
      unitRef="number">2</ilmn:GoodwillImpairmentMeasurementInput>
    <ilmn:GoodwillImpairmentMeasurementInput
      contextRef="c-202"
      decimals="INF"
      id="f-774"
      unitRef="number">15</ilmn:GoodwillImpairmentMeasurementInput>
    <us-gaap:Goodwill contextRef="c-203" decimals="-8" id="f-775" unitRef="usd">3600000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-204" decimals="-9" id="f-776" unitRef="usd">3000000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-205" decimals="-9" id="f-777" unitRef="usd">4000000000</us-gaap:Goodwill>
    <us-gaap:DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal contextRef="c-206" decimals="-6" id="f-778" unitRef="usd">974000000</us-gaap:DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal>
    <ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets contextRef="c-207" decimals="-6" id="f-779" unitRef="usd">400000000</ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets>
    <ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets contextRef="c-208" decimals="-6" id="f-780" unitRef="usd">770000000</ilmn:DisposalGroupIncludingDiscontinuedOperationNetAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-209" decimals="-6" id="f-781" unitRef="usd">420000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <ilmn:IntangibleAssetsImpairmentMeasurementInput contextRef="c-210" decimals="3" id="f-782" unitRef="number">0.465</ilmn:IntangibleAssetsImpairmentMeasurementInput>
    <ilmn:IntangibleAssetsImpairmentMeasurementInput
      contextRef="c-211"
      decimals="INF"
      id="f-783"
      unitRef="number">15</ilmn:IntangibleAssetsImpairmentMeasurementInput>
    <ilmn:SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints contextRef="c-1" decimals="-6" id="f-784" unitRef="usd">20000000</ilmn:SensitivityAnalysisOfIntangibleAssetsImpairmentAdditionalChargesImpactOf300BasisPoints>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-212" decimals="-6" id="f-785" unitRef="usd">712000000</us-gaap:GoodwillImpairmentLoss>
    <ilmn:GoodwillImpairmentDiscountedCashFlowModelDiscountRate contextRef="c-212" decimals="2" id="f-786" unitRef="number">0.240</ilmn:GoodwillImpairmentDiscountedCashFlowModelDiscountRate>
    <ilmn:GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate
      contextRef="c-213"
      decimals="INF"
      id="f-787"
      unitRef="number">0.0050</ilmn:GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate>
    <ilmn:GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate
      contextRef="c-214"
      decimals="INF"
      id="f-788"
      unitRef="number">0.0100</ilmn:GoodwillImpairmentIncreaseInDiscountedCashFlowModelDiscountRate>
    <ilmn:GoodwillPotentialImpairmentLoss contextRef="c-215" decimals="-6" id="f-789" unitRef="usd">200000000</ilmn:GoodwillPotentialImpairmentLoss>
    <ilmn:GoodwillPotentialImpairmentLoss contextRef="c-216" decimals="-6" id="f-790" unitRef="usd">350000000</ilmn:GoodwillPotentialImpairmentLoss>
    <ilmn:GoodwillImpairmentDiscountedCashFlowModelDiscountRate contextRef="c-217" decimals="2" id="f-791" unitRef="number">0.190</ilmn:GoodwillImpairmentDiscountedCashFlowModelDiscountRate>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-217" decimals="-6" id="f-792" unitRef="usd">109000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount contextRef="c-218" decimals="-6" id="f-793" unitRef="usd">950000000</us-gaap:ReportingUnitAmountOfFairValueInExcessOfCarryingAmount>
    <ilmn:GoodwillImpairmentTestDiscountRate
      contextRef="c-219"
      decimals="INF"
      id="f-794"
      unitRef="number">0.230</ilmn:GoodwillImpairmentTestDiscountRate>
    <ilmn:GoodwillPotentialImpairmentLoss contextRef="c-220" decimals="-6" id="f-795" unitRef="usd">0</ilmn:GoodwillPotentialImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-221" decimals="-6" id="f-796" unitRef="usd">3914000000</us-gaap:GoodwillImpairmentLoss>
    <ilmn:GoodwillImpairmentDiscountedCashFlowModelDiscountRate contextRef="c-221" decimals="3" id="f-797" unitRef="number">0.220</ilmn:GoodwillImpairmentDiscountedCashFlowModelDiscountRate>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-798">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible Assets,&lt;br/&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible Assets,&lt;br/&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;465&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensed technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finite-lived intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-848"&gt;&lt;span style="-sec-ix-hidden:f-849"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-222" decimals="-6" id="f-799" unitRef="usd">465000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-222" decimals="-6" id="f-800" unitRef="usd">305000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-222" decimals="-6" id="f-801" unitRef="usd">160000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-223" decimals="-6" id="f-802" unitRef="usd">2807000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-223" decimals="-6" id="f-803" unitRef="usd">585000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment contextRef="c-223" decimals="-6" id="f-804" unitRef="usd">0</ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-223" decimals="-6" id="f-805" unitRef="usd">2222000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-224" decimals="-6" id="f-806" unitRef="usd">234000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-224" decimals="-6" id="f-807" unitRef="usd">114000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-224" decimals="-6" id="f-808" unitRef="usd">120000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-225" decimals="-6" id="f-809" unitRef="usd">274000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-225" decimals="-6" id="f-810" unitRef="usd">133000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment contextRef="c-225" decimals="-6" id="f-811" unitRef="usd">0</ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-225" decimals="-6" id="f-812" unitRef="usd">141000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-226" decimals="-6" id="f-813" unitRef="usd">19000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-226" decimals="-6" id="f-814" unitRef="usd">13000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-226" decimals="-6" id="f-815" unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-227" decimals="-6" id="f-816" unitRef="usd">14000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-227" decimals="-6" id="f-817" unitRef="usd">13000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment contextRef="c-227" decimals="-6" id="f-818" unitRef="usd">0</ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-227" decimals="-6" id="f-819" unitRef="usd">1000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-228" decimals="-6" id="f-820" unitRef="usd">16000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-228" decimals="-6" id="f-821" unitRef="usd">14000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-228" decimals="-6" id="f-822" unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-229" decimals="-6" id="f-823" unitRef="usd">14000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-229" decimals="-6" id="f-824" unitRef="usd">13000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment contextRef="c-229" decimals="-6" id="f-825" unitRef="usd">0</ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-229" decimals="-6" id="f-826" unitRef="usd">1000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-230" decimals="-6" id="f-827" unitRef="usd">12000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-230" decimals="-6" id="f-828" unitRef="usd">5000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-230" decimals="-6" id="f-829" unitRef="usd">7000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-231" decimals="-6" id="f-830" unitRef="usd">12000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-231" decimals="-6" id="f-831" unitRef="usd">3000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment contextRef="c-231" decimals="-6" id="f-832" unitRef="usd">0</ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-231" decimals="-6" id="f-833" unitRef="usd">9000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-232" decimals="-6" id="f-834" unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-232" decimals="-6" id="f-835" unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-232" decimals="-6" id="f-836" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-233" decimals="-6" id="f-837" unitRef="usd">43000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-233" decimals="-6" id="f-838" unitRef="usd">14000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment contextRef="c-233" decimals="-6" id="f-839" unitRef="usd">0</ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-233" decimals="-6" id="f-840" unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-6" id="f-841" unitRef="usd">748000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-6" id="f-842" unitRef="usd">453000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-6" id="f-843" unitRef="usd">295000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-5" decimals="-6" id="f-844" unitRef="usd">3164000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-6" id="f-845" unitRef="usd">761000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment contextRef="c-5" decimals="-6" id="f-846" unitRef="usd">0</ilmn:FiniteLivedIntangibleAssetsAccumulatedImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-5" decimals="-6" id="f-847" unitRef="usd">2403000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <ilmn:IndefiniteLivedIntangibleAssetsExcludingGoodwillGross contextRef="c-234" decimals="-6" id="f-850" unitRef="usd">0</ilmn:IndefiniteLivedIntangibleAssetsExcludingGoodwillGross>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-234" decimals="-6" id="f-851" unitRef="usd">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <ilmn:IndefiniteLivedIntangibleAssetsExcludingGoodwillGross contextRef="c-235" decimals="-6" id="f-852" unitRef="usd">705000000</ilmn:IndefiniteLivedIntangibleAssetsExcludingGoodwillGross>
    <ilmn:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment contextRef="c-235" decimals="-6" id="f-853" unitRef="usd">115000000</ilmn:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-235" decimals="-6" id="f-854" unitRef="usd">590000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-4" decimals="-6" id="f-855" unitRef="usd">748000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-6" id="f-856" unitRef="usd">453000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-6" id="f-857" unitRef="usd">295000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-5" decimals="-6" id="f-858" unitRef="usd">3869000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-6" id="f-859" unitRef="usd">761000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <ilmn:IntangibleAssetsExcludingGoodwillAccumulatedImpairment contextRef="c-5" decimals="-6" id="f-860" unitRef="usd">115000000</ilmn:IntangibleAssetsExcludingGoodwillAccumulatedImpairment>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-6" id="f-861" unitRef="usd">2993000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-236" id="f-862">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-237" decimals="-6" id="f-863" unitRef="usd">35000000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-238" decimals="-6" id="f-864" unitRef="usd">3000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-239" decimals="-6" id="f-865" unitRef="usd">6000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-240" decimals="-6" id="f-866" unitRef="usd">42000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-240" id="f-867">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-241" decimals="-6" id="f-868" unitRef="usd">2000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-241" id="f-869">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-242" decimals="-6" id="f-870" unitRef="usd">19000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-242" id="f-871">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-872">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated future annual amortization of finite-lived intangible assets is shown in the following table. Actual amortization expense to be reported in future periods could differ from these estimates as a result of acquisitions, divestitures, and asset impairments, among other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-4" decimals="-6" id="f-873" unitRef="usd">69000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-4" decimals="-6" id="f-874" unitRef="usd">57000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-4" decimals="-6" id="f-875" unitRef="usd">55000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-4" decimals="-6" id="f-876" unitRef="usd">52000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-4" decimals="-6" id="f-877" unitRef="usd">23000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <ilmn:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive contextRef="c-4" decimals="-6" id="f-878" unitRef="usd">39000000</ilmn:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-6" id="f-879" unitRef="usd">295000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-880">&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.  DEBT AND OTHER COMMITMENTS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Summary of Term Debt Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.328%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.371%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.330%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2025 Term Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2026 Term Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2027 Term Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2031 Term Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discounts and debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying amount of term debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;499&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term debt, non-current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,490&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of term debt outstanding (Level 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,940&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense recognized on our term notes and delayed draw term loan, which included amortization of debt discounts and issuance costs, was $99&#160;million, $74&#160;million, and $21&#160;million in 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;4.650% Term Notes due 2026 (2026 Term Notes)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 9, 2024, we issued $500&#160;million aggregate principal amount of 2026 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $497&#160;million, which were used to repay a portion of the outstanding debt under the Delayed Draw Credit Agreement. The 2026 Term Notes, which mature on September 9, 2026, accrue interest at a rate of 4.650% per annum, payable semi-annually on March 9 and September 9 of each year, beginning on March 9, 2025. We may redeem for cash all or any portion of the 2026 Term Notes, at our option, at any time prior to maturity at make-whole premium redemption prices as defined in the form of the notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;5.800% Term Notes due 2025 (2025 Term Notes) and 5.750% Term Notes due 2027 (2027 Term Notes)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, we issued $500&#160;million aggregate principal amount of 2025 Term Notes and $500&#160;million aggregate principal amount of 2027 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $991&#160;million. The 2025 Notes, which mature on December 12, 2025, and the 2027 Notes, which mature on December 13, 2027, accrue interest at a rate of 5.800% and 5.750% per annum, respectively, payable semi-annually. Interest for the 2025 Notes is payable on June 12 and December 12 of each year and interest for the 2027 Notes is payable on June 13 and December 13 of each year, beginning in June 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may redeem for cash all or any portion of the 2025 or 2027 Term Notes, at our option, at any time prior to maturity. Prior to November 12, 2025 for the 2025 Notes and prior to November 13, 2027 for the 2027 Notes, the notes are redeemable at make-whole premium redemption prices as defined in the applicable forms of note. After November 12, 2025 and November 13, 2027, respectively, the notes are redeemable at a redemption price equal to 100% of the principal to be redeemed, plus accrued and unpaid interest up to, but excluding, the redemption date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.550% Term Notes due 2023 (2023 Term Notes) and 2.550% Term Notes due 2031 (2031 Term Notes)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, we issued $500&#160;million aggregate principal amount of 2023 Term Notes and $500&#160;million aggregate principal amount of 2031 Term Notes. After deducting discounts and issuance costs, we received net proceeds of $992&#160;million. The 2023 Notes matured and were repaid in cash on March 23, 2023. The 2031 Notes, which mature on March 23, 2031, accrue interest at a rate of 2.550% per annum, payable semi-annually on March 23 and September 23 of each year. We may redeem for cash all or any portion of the 2031 Term Notes, at our option, at any time prior to maturity. Prior to December 23, 2030, the notes are redeemable at make-whole premium redemption prices as defined in the form of the notes. After December 23, 2030, the notes are redeemable at a redemption price equal to 100% of the principal to be redeemed, plus accrued and unpaid interest up to, but excluding, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Delayed Draw Term Loan due 2025&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 17, 2024, we entered into a 364-day delayed draw credit agreement (the Delayed Draw Credit Agreement), which provided us with a senior unsecured term loan credit facility in an aggregate principal amount of up to $750&#160;million (the Delayed Draw Credit Facility). On June 20, 2024, we borrowed $750&#160;million on the credit facility in order to provide a portion of the Disposal Funding to GRAIL as part of the Spin-Off. The delayed draw term loan incurred interest at a rate of 6.7%. On September 9, 2024, we repaid the full principal outstanding on the Delayed Draw Credit Facility, as well as accrued interest, in an aggregate amount of $761&#160;million and terminated the Delayed Draw Credit Agreement. We recognized a loss on debt extinguishment of $5&#160;million in 2024, included in interest expense in the consolidated statements of operations, related to the write-off of unamortized debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0% Convertible Senior Notes due 2023 (2023 Convertible Notes)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, we issued $750&#160;million aggregate principal amount of 2023 Convertible Notes. The notes were convertible into cash, shares of common stock or a combination of cash and shares of common stock, at our election, based on conversion rates as defined in the indenture. The 2023 Convertible Notes matured on August 15, 2023, at which time the principal was repaid in cash. We did not issue any shares of common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2023 Convertible Notes were initially accounted for in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance required the carrying amount of the liability component to be estimated by estimating the fair value of a similar liability that does not have an associated conversion feature. Because at issuance we had no outstanding non-convertible public debt, we determined that market-traded senior, unsecured corporate bonds represented a similar liability without a conversion option. Based on market data available for publicly traded, senior, unsecured corporate bonds issued by companies in our industry, and with similar maturities to the 2023 Convertible Notes, we estimated an implied interest rate of&#160;3.7%, assuming no conversion option. The estimated implied interest rate was applied to the 2023 Convertible Notes, which resulted in a fair value of the liability component in aggregate of&#160;$624&#160;million&#160;upon issuance, calculated as the present value of implied future payments based on the&#160;$750&#160;million&#160;aggregate principal amount. The&#160;$126&#160;million&#160;difference ($93&#160;million, net of tax) between the aggregate principal amount of&#160;$750&#160;million&#160;and the estimated fair value of the liability component was recorded in additional paid-in capital as the 2023 Convertible Notes were not considered redeemable. As of January 3, 2022, we adopted ASU 2020-06, which removed the requirement to separate the embedded conversion feature from the notes and requires the notes to be accounted for as a single liability measured at amortized cost. Accordingly, we reclassified the unamortized debt discount from additional paid-in capital to convertible senior notes in the consolidated balance sheets on January 3, 2022. This resulted in an increase to retained earnings and a decrease to additional paid-in capital of $61&#160;million and $93&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense recognized on our 2023 Convertible Notes was immaterial in both 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revolving Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2023, we entered into a new credit agreement (the Revolving Credit Agreement), which provides us with a $750&#160;million senior unsecured five-year revolving credit facility, including a $40&#160;million sublimit for swingline borrowings and a $50&#160;million sublimit for letters of credit (the Revolving Credit Facility). Proceeds of the loans under the Revolving Credit Facility may be used to finance working capital needs and for general corporate purposes. The credit agreement dated as of March 8, 2021 and the commitments thereunder were terminated as of January 4, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility matures, and all amounts outstanding become due and payable in full, on January 4, 2028, subject to two one-year extensions at our option, the consent of the extending lenders and certain other conditions. We may prepay amounts borrowed and terminate commitments under the Revolving Credit Facility at any time without premium or penalty. As of December&#160;29, 2024, there were no borrowings or letters of credit outstanding under the credit facility, and we were in compliance with all financial and operating covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans under the Revolving Credit Facility will have a variable interest rate based on either the term secured overnight financing rate (SOFR) or the alternate base rate, plus an applicable rate that varies with our debt rating and, in the case of loans bearing interest based on term SOFR, a credit spread adjustment equal to 0.10% per annum. The Revolving Credit Agreement includes an option for us to elect to increase commitments under the credit facility or enter into one or more tranches of term loans in the aggregate principal amount of up to $250&#160;million, subject to consent of the lenders providing the additional commitments or loans and certain other conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Agreement contains financial and operating covenants. Pursuant to the Revolving Credit Agreement, we are required to maintain a ratio of total debt to adjusted annual earnings before interest, taxes, depreciation and amortization (EBITDA), calculated based on the four consecutive fiscal quarters ending with the most recent fiscal quarter, of not greater than 3.50 to 1.00 as of the end of each fiscal quarter. Upon the consummation of any Qualified Acquisition (as defined in the Revolving Credit Agreement) and us providing notice to the Administrative Agent, the ratio increases to 4.00 to 1.00 for the fiscal quarter in which the acquisition is consummated and the three consecutive fiscal quarters thereafter. The operating covenants include, among other things, limitations on (i) the incurrence of indebtedness by our subsidiaries, (ii) liens on our and our subsidiaries assets, and (iii) certain fundamental changes and the disposition of assets by us and our subsidiaries. The Credit Agreement contains other customary covenants, representations and warranties, and events of default.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;29, 2024, the maturities of our operating lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total remaining lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of our lease costs were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;Variable lease costs include non-fixed maintenance charges and property taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Purchase Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we enter into agreements to purchase goods or services that are not cancelable without penalty, primarily related to licensing and supply arrangements. For those agreements with variable terms, we do not estimate the total obligation beyond any minimum quantities or pricing as of the reporting date. Licensing agreements under which we commit to minimum royalty payments, some of which are subject to adjustment, may be terminated prior to the expiration of underlying intellectual property under certain circumstances. Annual minimum payments for noncancelable purchase obligations as of December&#160;29, 2024 totaled $212 million, approximately half of which are due within the next twelve months.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-881">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Summary of Term Debt Obligations&lt;/span&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.328%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.371%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.330%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2025 Term Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2026 Term Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2027 Term Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount of 2031 Term Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discounts and debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying amount of term debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;499&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term debt, non-current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,490&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of term debt outstanding (Level 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,940&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-243" decimals="-6" id="f-882" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-244" decimals="-6" id="f-883" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-245" decimals="-6" id="f-884" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-246" decimals="-6" id="f-885" unitRef="usd">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-247" decimals="-6" id="f-886" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-248" decimals="-6" id="f-887" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-249" decimals="-6" id="f-888" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-250" decimals="-6" id="f-889" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-251" decimals="-6" id="f-890" unitRef="usd">11000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-252" decimals="-6" id="f-891" unitRef="usd">11000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt contextRef="c-251" decimals="-6" id="f-892" unitRef="usd">1989000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-252" decimals="-6" id="f-893" unitRef="usd">1489000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="c-251" decimals="-6" id="f-894" unitRef="usd">499000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-252" decimals="-6" id="f-895" unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-251" decimals="-6" id="f-896" unitRef="usd">1490000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-252" decimals="-6" id="f-897" unitRef="usd">1489000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFairValue contextRef="c-253" decimals="-6" id="f-898" unitRef="usd">1940000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-254" decimals="-6" id="f-899" unitRef="usd">1440000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:InterestExpenseDebt contextRef="c-255" decimals="-6" id="f-900" unitRef="usd">99000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-256" decimals="-6" id="f-901" unitRef="usd">74000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-257" decimals="-6" id="f-902" unitRef="usd">21000000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-245"
      decimals="INF"
      id="f-903"
      unitRef="number">0.04650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-258" decimals="INF" id="f-904" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c-259" decimals="-6" id="f-905" unitRef="usd">497000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-258"
      decimals="INF"
      id="f-906"
      unitRef="number">0.04650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-260"
      decimals="INF"
      id="f-907"
      unitRef="number">0.05800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-261"
      decimals="INF"
      id="f-908"
      unitRef="number">0.05750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-260" decimals="INF" id="f-909" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-261" decimals="INF" id="f-910" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c-262" decimals="-6" id="f-911" unitRef="usd">991000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-260"
      decimals="INF"
      id="f-912"
      unitRef="number">0.05800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-261"
      decimals="INF"
      id="f-913"
      unitRef="number">0.05750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-255"
      decimals="INF"
      id="f-914"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-263"
      decimals="INF"
      id="f-915"
      unitRef="number">0.00550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-264"
      decimals="INF"
      id="f-916"
      unitRef="number">0.02550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-263" decimals="INF" id="f-917" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-264" decimals="INF" id="f-918" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c-265" decimals="-6" id="f-919" unitRef="usd">992000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-264"
      decimals="INF"
      id="f-920"
      unitRef="number">0.02550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-265"
      decimals="INF"
      id="f-921"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentTerm contextRef="c-266" id="f-922">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-267" decimals="INF" id="f-923" unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-268" decimals="INF" id="f-924" unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-267" decimals="3" id="f-925" unitRef="number">0.067</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-269" decimals="-6" id="f-926" unitRef="usd">761000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-270" decimals="INF" id="f-927" unitRef="usd">-5000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-271"
      decimals="INF"
      id="f-928"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-272" decimals="INF" id="f-929" unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-272" decimals="3" id="f-930" unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-272" decimals="-6" id="f-931" unitRef="usd">624000000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-272" decimals="INF" id="f-932" unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <ilmn:AdditionalPaidInCapitalBeforeTax contextRef="c-272" decimals="-6" id="f-933" unitRef="usd">126000000</ilmn:AdditionalPaidInCapitalBeforeTax>
    <us-gaap:AdditionalPaidInCapital contextRef="c-272" decimals="-6" id="f-934" unitRef="usd">93000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-272" decimals="INF" id="f-935" unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-64" decimals="-6" id="f-936" unitRef="usd">61000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="c-64" decimals="-6" id="f-937" unitRef="usd">93000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-273" decimals="INF" id="f-938" unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-274" id="f-939">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-275" decimals="INF" id="f-940" unitRef="usd">40000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-276" decimals="INF" id="f-941" unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <ilmn:DebtInstrumentNumberOfOneYearExtensions
      contextRef="c-274"
      decimals="INF"
      id="f-942"
      unitRef="one_year_extension">2</ilmn:DebtInstrumentNumberOfOneYearExtensions>
    <ilmn:DebtInstrumentExtensionTerm contextRef="c-274" id="f-943">P1Y</ilmn:DebtInstrumentExtensionTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-277"
      decimals="INF"
      id="f-944"
      unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ilmn:DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings contextRef="c-278" decimals="-6" id="f-945" unitRef="usd">250000000</ilmn:DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings>
    <ilmn:DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio
      contextRef="c-277"
      decimals="INF"
      id="f-946"
      unitRef="consecutive_fiscal_quarter">4</ilmn:DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatio>
    <ilmn:DebtInstrumentCovenantMinimumDebtToEBITDARatio
      contextRef="c-278"
      decimals="INF"
      id="f-947"
      unitRef="number">3.50</ilmn:DebtInstrumentCovenantMinimumDebtToEBITDARatio>
    <ilmn:DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition
      contextRef="c-278"
      decimals="INF"
      id="f-948"
      unitRef="number">4.00</ilmn:DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition>
    <ilmn:DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition
      contextRef="c-277"
      decimals="INF"
      id="f-949"
      unitRef="consecutive_fiscal_quarter">3</ilmn:DebtInstrumentNumberOfConsecutiveFiscalQuartersMinimumDebtToEBITDARatioUponConsummationOfAcquisition>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-950">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;29, 2024, the maturities of our operating lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total remaining lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-6" id="f-951" unitRef="usd">105000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-6" id="f-952" unitRef="usd">105000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-6" id="f-953" unitRef="usd">103000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-6" id="f-954" unitRef="usd">84000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-6" id="f-955" unitRef="usd">81000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="-6" id="f-956" unitRef="usd">275000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-6" id="f-957" unitRef="usd">753000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-6" id="f-958" unitRef="usd">120000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-6" id="f-959" unitRef="usd">633000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-6" id="f-960" unitRef="usd">79000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-6" id="f-961" unitRef="usd">554000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-962">P8Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="3" id="f-963" unitRef="number">0.044</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-964">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of our lease costs were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;Variable lease costs include non-fixed maintenance charges and property taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-6" id="f-965" unitRef="usd">93000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-12" decimals="-6" id="f-966" unitRef="usd">116000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-13" decimals="-6" id="f-967" unitRef="usd">112000000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome contextRef="c-1" decimals="-6" id="f-968" unitRef="usd">19000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-12" decimals="-6" id="f-969" unitRef="usd">20000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-13" decimals="-6" id="f-970" unitRef="usd">20000000</us-gaap:SubleaseIncome>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-6" id="f-971" unitRef="usd">25000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-12" decimals="-6" id="f-972" unitRef="usd">27000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-13" decimals="-6" id="f-973" unitRef="usd">20000000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-6" id="f-974" unitRef="usd">99000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-12" decimals="-6" id="f-975" unitRef="usd">123000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-13" decimals="-6" id="f-976" unitRef="usd">112000000</us-gaap:LeaseCost>
    <us-gaap:PurchaseObligation contextRef="c-4" decimals="-6" id="f-977" unitRef="usd">212000000</us-gaap:PurchaseObligation>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="c-1" id="f-978">&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.  STOCKHOLDERS' EQUITY&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2015 Stock and Incentive Compensation Plan (the 2015 Stock Plan) and the New Hire Stock and Incentive Plan allow for the issuance of stock options, performance stock options, restricted stock units and awards and performance stock units. In 2023, the Company&#x2019;s stockholders approved an amended and restated version of the 2015 Stock Plan and increased the maximum number of shares authorized for issuance by 8.0&#160;million shares. In connection with the GRAIL Spin-Off, all unvested RSU and PSU were equitably adjusted pursuant to the plan to preserve their intrinsic value and the number of shares reserved for issuance under the 2015 Stock Plan was increased by 160,000 shares. As of December&#160;29, 2024, approximately 5.4 million&#160;shares remained available for future grants under the 2015 Stock Plan. There is no set number of shares reserved for issuance under the New Hire Stock and Incentive Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We issue restricted stock units (RSU) and performance stock units (PSU), both of which are considered restricted stock. We grant restricted stock pursuant to the 2015 Stock Plan and satisfy such grants through the issuance of either new shares or shares from treasury stock. RSU are share awards that, upon vesting, will deliver to the holder shares of our common stock. RSU generally vest over a four-year period with equal vesting annually. We issue three different PSU awards. We issue PSU for which the number of shares issuable at the end of a three-year performance period is based on our performance relative to specified earnings per share targets (EPS PSU) and, during 2024, we began to issue PSU for which the number of shares issuable at the end of a three-year performance period is based on our performance relative to specified operating margin targets (OM PSU). During 2023, we began to issue PSU with a market condition that vest based on the Company&#x2019;s relative total shareholder return as compared to a peer group of companies measured over a &lt;span style="-sec-ix-hidden:f-986"&gt;three-fiscal&lt;/span&gt; year performance period (rTSR PSU). Depending on the actual performance over the measurement period, an rTSR PSU award recipient could receive up to 175% of the granted award. Shares issuable under all PSU awards are subject to continued employment through the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.825%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.828%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted &lt;br/&gt;Stock Units &lt;br/&gt;(RSU)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(PSU) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant-&lt;br/&gt;Date Fair Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Units in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,198&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;236.32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;729&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;133.73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164.38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested adjustment for GRAIL Spin-Off&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;249.70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;195.11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;167.68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;158.60&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164.87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;For EPS and OM PSU, the number of units reflect the estimated number of shares to be issued at the end of the performance period. For rTSR PSU, the number of units reflect the estimated number of shares to be issued based on performance as of the current reporting period. Awarded units are presented net of performance adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax intrinsic value and fair value of vested restricted stock was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax intrinsic value of outstanding restricted stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of restricted stock vested:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liability-Classified RSU&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In Q1 2023, we granted RSU that were to be settled in cash if stockholder approval to increase our share reserve under the amended and restated 2015 Stock Plan was not obtained. In Q2 2023, the Company&#x2019;s stockholders approved an amended and restated version of the 2015 Stock Plan and increased the maximum number of shares authorized for issuance. Upon such approval, all RSU previously accounted for as liability-classified awards, approximately 557,000 RSU, were reclassified to stockholders equity and accounted for prospectively as equity awards. There were no RSU liability-classified awards outstanding as of December&#160;29, 2024 or December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity was as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Units in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Stock Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;330.25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87.74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;330.25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87.74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;In connection with the GRAIL acquisition, we issued replacement performance stock options to GRAIL employees in 2021. The number of units reflected awards that had been granted and for which it was assumed to be probable that the underlying performance goals would be achieved. In connection with the GRAIL Spin-Off, all outstanding performance stock options were assumed by GRAIL. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of stock options exercised was immaterial in both 2023 and 2022. None exercised in 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Liability-Classified Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the GRAIL Spin-Off, we granted cash-based equity incentive awards to GRAIL employees, which were accounted for as liability-classified awards. In connection with the Spin-Off, these awards were assumed by GRAIL. For purposes of valuation and performance measurement of the awards, GRAIL&#x2019;s stand-alone value calculation, as estimated by GRAIL based on its analysis and on input from independent valuation advisors and analyses, was used. The awards generally had terms of four years and vested in &lt;span style="-sec-ix-hidden:f-1101"&gt;four&lt;/span&gt; equal installments on each anniversary of the grant date, subject to continued employment through the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:13pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash-based equity incentive award activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and paid in cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and paid in cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and paid in cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derecognition for GRAIL Spin-Off&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;The estimated liability immediately prior to the Spin-Off, recorded in accrued liabilities, was $53&#160;million, which was disposed of as part of GRAIL&#x2019;s net assets. See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_40" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2. GRAIL Spin-Off&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized share-based compensation expense on these cash-based equity incentive awards of $52&#160;million in 2024, prior to the Spin-Off, and $95&#160;million and $67&#160;million in 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition of GRAIL, we assumed a performance-based award for which vesting was based on GRAIL&#x2019;s future revenues and had an aggregate potential value of up to $78&#160;million. Prior to the Spin-Off of GRAIL, it was not probable that the performance conditions associated with the award would be achieved and, therefore, no share-based compensation expense was recognized in the consolidated statements of operations. In connection with the Spin-Off, this award was assumed by GRAIL. For a period of 2.5 years following the Spin-Off, we are obligated to indemnify GRAIL for cash payments that become earned and payable related to this award. The indemnification is accounted for in accordance with ASC 460. As of December&#160;29, 2024, we recognized a non-contingent liability of $1&#160;million for this indemnification, with a corresponding charge to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2000 Employee Stock Purchase Plan, or ESPP, permits eligible employees to purchase common stock at a discount through payroll deductions during defined offering periods. The price at which stock is purchased under the ESPP is equal to 85% of the fair market value of the common stock on the first day of the offering period or purchase date, whichever is lower. The initial offering period commenced in July 2000. During 2024, 2023, and 2022, approximately 0.5 million, 0.4 million, and 0.3 million shares, respectively, were issued under the ESPP. As of December&#160;29, 2024, approximately 12.4 million&#160;shares remained available for issuance under the ESPP, which includes an increase of 0.5 million shares pursuant to the terms of the ESPP to account for the GRAIL Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used for the specified reporting periods and the resulting estimates of weighted-average fair value per share for stock purchased under the ESPP were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.359%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.267%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.267%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.271%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.35% - 5.54%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;0.78% - 5.54% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06% - 2.98%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41% - 49%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;41% - 51% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37% - 51%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.5 - 1.1 year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;0.5 - 1.1 year &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5 - 1.0 year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37.24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2024, our Board of Directors authorized a new share repurchase program, which cancels and supersedes all prior and available repurchase authorizations, to repurchase up to $1.5&#160;billion of our outstanding common stock. The repurchases may be completed through open market purchases, pursuant to Rule 10b5-1 or Rule 10b-18, or through an accelerated share repurchase program. Authorizations to repurchase up to $1.4 billion of our outstanding common stock remained available as of December&#160;29, 2024. We did not repurchase&#160;any shares during 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:13pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share repurchase activity during 2024 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.794%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions, except shares in thousands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost of shares repurchased&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;Total cost of shares repurchased includes the 1% excise tax imposed as part of the Inflation Reduction Act of 2022, which is calculated based on share repurchases, net of certain share issuances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;29, 2024 and through February 11, 2025, we repurchased an additional 1.0 million shares of our common stock for $126 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense, which includes expense for both equity and liability-classified awards, reported in our consolidated statements of operations was as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of product revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of service and other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;288&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;29, 2024, unrecognized compensation cost, related to restricted stock and ESPP shares issued to date, of $565 million was expected to be recognized over a weighted-average period of approximately 2.5 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-279"
      decimals="-5"
      id="f-979"
      unitRef="shares">8000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment
      contextRef="c-280"
      decimals="-3"
      id="f-980"
      unitRef="shares">160000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodAdjustment>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-281"
      decimals="-5"
      id="f-981"
      unitRef="shares">5400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-282" id="f-982">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ilmn:ShareBasedCompensationNumberOfPerformanceStockUnitAwards contextRef="c-4" decimals="INF" id="f-983" unitRef="award">3</ilmn:ShareBasedCompensationNumberOfPerformanceStockUnitAwards>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-283" id="f-984">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-283" id="f-985">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout
      contextRef="c-284"
      decimals="INF"
      id="f-987"
      unitRef="number">1.75</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAwardPayout>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-989">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.825%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.828%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted &lt;br/&gt;Stock Units &lt;br/&gt;(RSU)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(PSU) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant-&lt;br/&gt;Date Fair Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Units in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,198&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;236.32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;729&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;133.73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164.38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested adjustment for GRAIL Spin-Off&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;249.70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;195.11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;167.68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;158.60&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164.87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;For EPS and OM PSU, the number of units reflect the estimated number of shares to be issued at the end of the performance period. For rTSR PSU, the number of units reflect the estimated number of shares to be issued based on performance as of the current reporting period. Awarded units are presented net of performance adjustments.</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock contextRef="c-1" id="f-988">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.670%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.825%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.828%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted &lt;br/&gt;Stock Units &lt;br/&gt;(RSU)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(PSU) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant-&lt;br/&gt;Date Fair Value per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Units in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;479.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,198&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;236.32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;729&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;133.73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164.38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested adjustment for GRAIL Spin-Off&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;249.70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;195.11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;167.68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;158.60&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;164.87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;For EPS and OM PSU, the number of units reflect the estimated number of shares to be issued at the end of the performance period. For rTSR PSU, the number of units reflect the estimated number of shares to be issued based on performance as of the current reporting period. Awarded units are presented net of performance adjustments.</us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-285"
      decimals="-3"
      id="f-990"
      unitRef="shares">1130000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-286"
      decimals="-3"
      id="f-991"
      unitRef="shares">328000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-285"
      decimals="2"
      id="f-992"
      unitRef="usdPerShare">345.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-286"
      decimals="2"
      id="f-993"
      unitRef="usdPerShare">466.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-287"
      decimals="-3"
      id="f-994"
      unitRef="shares">1370000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-288"
      decimals="-3"
      id="f-995"
      unitRef="shares">108000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-287"
      decimals="2"
      id="f-996"
      unitRef="usdPerShare">302.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-288"
      decimals="2"
      id="f-997"
      unitRef="usdPerShare">479.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-287"
      decimals="-3"
      id="f-998"
      unitRef="shares">707000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-288"
      decimals="-3"
      id="f-999"
      unitRef="shares">99000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-287"
      decimals="2"
      id="f-1000"
      unitRef="usdPerShare">341.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-288"
      decimals="2"
      id="f-1001"
      unitRef="usdPerShare">492.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-287"
      decimals="-3"
      id="f-1002"
      unitRef="shares">182000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-288"
      decimals="-3"
      id="f-1003"
      unitRef="shares">47000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-287"
      decimals="2"
      id="f-1004"
      unitRef="usdPerShare">341.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-288"
      decimals="2"
      id="f-1005"
      unitRef="usdPerShare">411.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-289"
      decimals="-3"
      id="f-1006"
      unitRef="shares">1611000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-290"
      decimals="-3"
      id="f-1007"
      unitRef="shares">74000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-289"
      decimals="2"
      id="f-1008"
      unitRef="usdPerShare">311.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-290"
      decimals="2"
      id="f-1009"
      unitRef="usdPerShare">446.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-291"
      decimals="-3"
      id="f-1010"
      unitRef="shares">2032000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-292"
      decimals="-3"
      id="f-1011"
      unitRef="shares">39000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-291"
      decimals="2"
      id="f-1012"
      unitRef="usdPerShare">195.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-292"
      decimals="2"
      id="f-1013"
      unitRef="usdPerShare">239.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-291"
      decimals="-3"
      id="f-1014"
      unitRef="shares">987000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-292"
      decimals="-3"
      id="f-1015"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-291"
      decimals="2"
      id="f-1016"
      unitRef="usdPerShare">268.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-292"
      decimals="2"
      id="f-1017"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-291"
      decimals="-3"
      id="f-1018"
      unitRef="shares">458000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-292"
      decimals="-3"
      id="f-1019"
      unitRef="shares">113000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-291"
      decimals="2"
      id="f-1020"
      unitRef="usdPerShare">253.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-292"
      decimals="2"
      id="f-1021"
      unitRef="usdPerShare">299.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-293"
      decimals="-3"
      id="f-1022"
      unitRef="shares">2198000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-294"
      decimals="-3"
      id="f-1023"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-293"
      decimals="2"
      id="f-1024"
      unitRef="usdPerShare">236.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-294"
      decimals="2"
      id="f-1025"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-282"
      decimals="-3"
      id="f-1026"
      unitRef="shares">2788000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-283"
      decimals="-3"
      id="f-1027"
      unitRef="shares">729000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-282"
      decimals="2"
      id="f-1028"
      unitRef="usdPerShare">133.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-283"
      decimals="2"
      id="f-1029"
      unitRef="usdPerShare">164.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod
      contextRef="c-282"
      decimals="-3"
      id="f-1030"
      unitRef="shares">107000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod
      contextRef="c-283"
      decimals="-3"
      id="f-1031"
      unitRef="shares">12000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriod>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-282"
      decimals="2"
      id="f-1032"
      unitRef="usdPerShare">0</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-283"
      decimals="2"
      id="f-1033"
      unitRef="usdPerShare">0</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-282"
      decimals="-3"
      id="f-1034"
      unitRef="shares">771000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-283"
      decimals="-3"
      id="f-1035"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-282"
      decimals="2"
      id="f-1036"
      unitRef="usdPerShare">249.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-283"
      decimals="2"
      id="f-1037"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-282"
      decimals="-3"
      id="f-1038"
      unitRef="shares">443000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-283"
      decimals="-3"
      id="f-1039"
      unitRef="shares">41000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-282"
      decimals="2"
      id="f-1040"
      unitRef="usdPerShare">195.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-283"
      decimals="2"
      id="f-1041"
      unitRef="usdPerShare">167.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-295"
      decimals="-3"
      id="f-1042"
      unitRef="shares">3879000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-296"
      decimals="-3"
      id="f-1043"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-295"
      decimals="2"
      id="f-1044"
      unitRef="usdPerShare">158.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-296"
      decimals="2"
      id="f-1045"
      unitRef="usdPerShare">164.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-1047">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax intrinsic value and fair value of vested restricted stock was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax intrinsic value of outstanding restricted stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of restricted stock vested:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock contextRef="c-1" id="f-1046">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax intrinsic value and fair value of vested restricted stock was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax intrinsic value of outstanding restricted stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of restricted stock vested:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-295" decimals="-6" id="f-1048" unitRef="usd">525000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-293" decimals="-6" id="f-1049" unitRef="usd">306000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-289" decimals="-6" id="f-1050" unitRef="usd">326000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-296" decimals="-6" id="f-1051" unitRef="usd">95000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-294" decimals="-6" id="f-1052" unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-290" decimals="-6" id="f-1053" unitRef="usd">15000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-282" decimals="-6" id="f-1054" unitRef="usd">116000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-291" decimals="-6" id="f-1055" unitRef="usd">122000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-287" decimals="-6" id="f-1056" unitRef="usd">162000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-283" decimals="-6" id="f-1057" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-292" decimals="-6" id="f-1058" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-288" decimals="-6" id="f-1059" unitRef="usd">49000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-297"
      decimals="-3"
      id="f-1060"
      unitRef="shares">557000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-298"
      decimals="INF"
      id="f-1061"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-299"
      decimals="INF"
      id="f-1062"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-1063">&lt;div style="margin-top:13pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity was as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Units in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Stock Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;330.25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87.74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;330.25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87.74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;In connection with the GRAIL acquisition, we issued replacement performance stock options to GRAIL employees in 2021. The number of units reflected awards that had been granted and for which it was assumed to be probable that the underlying performance goals would be achieved. In connection with the GRAIL Spin-Off, all outstanding performance stock options were assumed by GRAIL.</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-300"
      decimals="-3"
      id="f-1064"
      unitRef="shares">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-300"
      decimals="2"
      id="f-1065"
      unitRef="usdPerShare">66.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-301"
      decimals="-3"
      id="f-1066"
      unitRef="shares">17000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-301"
      decimals="2"
      id="f-1067"
      unitRef="usdPerShare">85.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-302"
      decimals="-3"
      id="f-1068"
      unitRef="shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-302"
      decimals="2"
      id="f-1069"
      unitRef="usdPerShare">330.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-303"
      decimals="-3"
      id="f-1070"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-303"
      decimals="2"
      id="f-1071"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-302"
      decimals="-3"
      id="f-1072"
      unitRef="shares">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-302"
      decimals="2"
      id="f-1073"
      unitRef="usdPerShare">6.55</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-303"
      decimals="-3"
      id="f-1074"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-303"
      decimals="2"
      id="f-1075"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-304"
      decimals="-3"
      id="f-1076"
      unitRef="shares">187000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-304"
      decimals="2"
      id="f-1077"
      unitRef="usdPerShare">319.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-305"
      decimals="-3"
      id="f-1078"
      unitRef="shares">17000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-305"
      decimals="2"
      id="f-1079"
      unitRef="usdPerShare">85.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-306"
      decimals="-3"
      id="f-1080"
      unitRef="shares">8000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-306"
      decimals="2"
      id="f-1081"
      unitRef="usdPerShare">71.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-307"
      decimals="-3"
      id="f-1082"
      unitRef="shares">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-307"
      decimals="2"
      id="f-1083"
      unitRef="usdPerShare">16.69</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-306"
      decimals="-3"
      id="f-1084"
      unitRef="shares">144000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-306"
      decimals="2"
      id="f-1085"
      unitRef="usdPerShare">330.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-307"
      decimals="-3"
      id="f-1086"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-307"
      decimals="2"
      id="f-1087"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-308"
      decimals="-3"
      id="f-1088"
      unitRef="shares">35000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-308"
      decimals="2"
      id="f-1089"
      unitRef="usdPerShare">330.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-309"
      decimals="-3"
      id="f-1090"
      unitRef="shares">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-309"
      decimals="2"
      id="f-1091"
      unitRef="usdPerShare">87.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-310"
      decimals="-3"
      id="f-1092"
      unitRef="shares">35000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-310"
      decimals="2"
      id="f-1093"
      unitRef="usdPerShare">330.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-311"
      decimals="-3"
      id="f-1094"
      unitRef="shares">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-311"
      decimals="2"
      id="f-1095"
      unitRef="usdPerShare">87.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-312"
      decimals="-3"
      id="f-1096"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-312"
      decimals="2"
      id="f-1097"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-313"
      decimals="-3"
      id="f-1098"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-313"
      decimals="2"
      id="f-1099"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-314" id="f-1100">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <ilmn:ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock contextRef="c-1" id="f-1102">&lt;div style="margin-bottom:13pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash-based equity incentive award activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and paid in cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and paid in cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and paid in cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derecognition for GRAIL Spin-Off&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;The estimated liability immediately prior to the Spin-Off, recorded in accrued liabilities, was $53&#160;million, which was disposed of as part of GRAIL&#x2019;s net assets. See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_40" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2. GRAIL Spin-Off&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; for additional details.&lt;/span&gt;&lt;/div&gt;</ilmn:ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue contextRef="c-315" decimals="-6" id="f-1103" unitRef="usd">184000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue contextRef="c-316" decimals="-6" id="f-1104" unitRef="usd">168000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue contextRef="c-316" decimals="-6" id="f-1105" unitRef="usd">41000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue contextRef="c-316" decimals="-6" id="f-1106" unitRef="usd">41000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue contextRef="c-316" decimals="-6" id="f-1107" unitRef="usd">23000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue contextRef="c-317" decimals="-6" id="f-1108" unitRef="usd">293000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue contextRef="c-318" decimals="-6" id="f-1109" unitRef="usd">116000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue contextRef="c-318" decimals="-6" id="f-1110" unitRef="usd">77000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue contextRef="c-318" decimals="-6" id="f-1111" unitRef="usd">32000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue contextRef="c-318" decimals="-6" id="f-1112" unitRef="usd">-8000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue contextRef="c-319" decimals="-6" id="f-1113" unitRef="usd">292000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue contextRef="c-314" decimals="-6" id="f-1114" unitRef="usd">67000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue contextRef="c-314" decimals="-6" id="f-1115" unitRef="usd">54000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsVestedAndPaidInCashValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue contextRef="c-314" decimals="-6" id="f-1116" unitRef="usd">13000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue contextRef="c-314" decimals="-6" id="f-1117" unitRef="usd">-9000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardChangeInFairValue>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition contextRef="c-314" decimals="-6" id="f-1118" unitRef="usd">283000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsDerecognition>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue contextRef="c-320" decimals="-6" id="f-1119" unitRef="usd">0</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue>
    <ilmn:AccruedLiabilityClassifiedAwardsCurrent contextRef="c-320" decimals="-6" id="f-1120" unitRef="usd">53000000</ilmn:AccruedLiabilityClassifiedAwardsCurrent>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-314" decimals="-6" id="f-1121" unitRef="usd">52000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-318" decimals="-6" id="f-1122" unitRef="usd">95000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-316" decimals="-6" id="f-1123" unitRef="usd">67000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested contextRef="c-320" decimals="-6" id="f-1124" unitRef="usd">78000000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested>
    <us-gaap:DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal contextRef="c-95" id="f-1125">P2Y6M</us-gaap:DiscontinuedOperationPeriodOfContinuingInvolvementAfterDisposal>
    <us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining contextRef="c-93" decimals="-6" id="f-1126" unitRef="usd">1000000</us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="c-321"
      decimals="INF"
      id="f-1127"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-321"
      decimals="-5"
      id="f-1128"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-322"
      decimals="-5"
      id="f-1129"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-323"
      decimals="-5"
      id="f-1130"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-324"
      decimals="-3"
      id="f-1131"
      unitRef="shares">12400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease
      contextRef="c-321"
      decimals="-5"
      id="f-1132"
      unitRef="shares">500000</ilmn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPeriodIncrease>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="c-1" id="f-1133">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used for the specified reporting periods and the resulting estimates of weighted-average fair value per share for stock purchased under the ESPP were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.359%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.267%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.267%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.271%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.35% - 5.54%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;0.78% - 5.54% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06% - 2.98%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41% - 49%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;41% - 51% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37% - 51%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.5 - 1.1 year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;0.5 - 1.1 year &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5 - 1.0 year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37.24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="c-325"
      decimals="4"
      id="f-1134"
      unitRef="number">0.0435</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="c-325"
      decimals="4"
      id="f-1135"
      unitRef="number">0.0554</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="c-326"
      decimals="4"
      id="f-1136"
      unitRef="number">0.0078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="c-326"
      decimals="4"
      id="f-1137"
      unitRef="number">0.0554</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="c-327"
      decimals="4"
      id="f-1138"
      unitRef="number">0.0006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="c-327"
      decimals="4"
      id="f-1139"
      unitRef="number">0.0298</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="c-325"
      decimals="2"
      id="f-1140"
      unitRef="number">0.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="c-325"
      decimals="2"
      id="f-1141"
      unitRef="number">0.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="c-326"
      decimals="2"
      id="f-1142"
      unitRef="number">0.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="c-326"
      decimals="2"
      id="f-1143"
      unitRef="number">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="c-327"
      decimals="2"
      id="f-1144"
      unitRef="number">0.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="c-327"
      decimals="2"
      id="f-1145"
      unitRef="number">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-328" id="f-1146">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-329" id="f-1147">P1Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-330" id="f-1148">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-331" id="f-1149">P1Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-332" id="f-1150">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-333" id="f-1151">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-325"
      decimals="INF"
      id="f-1152"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-326"
      decimals="INF"
      id="f-1153"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-327"
      decimals="INF"
      id="f-1154"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-325"
      decimals="2"
      id="f-1155"
      unitRef="usdPerShare">37.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-326"
      decimals="2"
      id="f-1156"
      unitRef="usdPerShare">49.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-327"
      decimals="2"
      id="f-1157"
      unitRef="usdPerShare">50.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-334" decimals="INF" id="f-1158" unitRef="usd">1500000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-335" decimals="-7" id="f-1159" unitRef="usd">1400000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-336"
      decimals="-5"
      id="f-1160"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-337"
      decimals="-5"
      id="f-1161"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock contextRef="c-1" id="f-1162">&lt;div style="margin-bottom:13pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share repurchase activity during 2024 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.794%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions, except shares in thousands&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost of shares repurchased&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;Total cost of shares repurchased includes the 1% excise tax imposed as part of the Inflation Reduction Act of 2022, which is calculated based on share repurchases, net of certain share issuances.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-1" decimals="-3" id="f-1163" unitRef="shares">904000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-6" id="f-1164" unitRef="usd">116000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-338"
      decimals="-5"
      id="f-1165"
      unitRef="shares">1000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-338" decimals="-6" id="f-1166" unitRef="usd">126000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-1167">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense, which includes expense for both equity and liability-classified awards, reported in our consolidated statements of operations was as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of product revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of service and other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;288&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-339" decimals="-6" id="f-1168" unitRef="usd">25000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-340" decimals="-6" id="f-1169" unitRef="usd">29000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-341" decimals="-6" id="f-1170" unitRef="usd">26000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-342" decimals="-6" id="f-1171" unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-343" decimals="-6" id="f-1172" unitRef="usd">7000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-344" decimals="-6" id="f-1173" unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-345" decimals="-6" id="f-1174" unitRef="usd">146000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-346" decimals="-6" id="f-1175" unitRef="usd">155000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-347" decimals="-6" id="f-1176" unitRef="usd">153000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-348" decimals="-6" id="f-1177" unitRef="usd">194000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-349" decimals="-6" id="f-1178" unitRef="usd">189000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-350" decimals="-6" id="f-1179" unitRef="usd">181000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-6" id="f-1180" unitRef="usd">371000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-12" decimals="-6" id="f-1181" unitRef="usd">380000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-13" decimals="-6" id="f-1182" unitRef="usd">366000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-1" decimals="-6" id="f-1183" unitRef="usd">83000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-12" decimals="-6" id="f-1184" unitRef="usd">87000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-13" decimals="-6" id="f-1185" unitRef="usd">83000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-1" decimals="-6" id="f-1186" unitRef="usd">288000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-12" decimals="-6" id="f-1187" unitRef="usd">293000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-13" decimals="-6" id="f-1188" unitRef="usd">283000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-4" decimals="-6" id="f-1189" unitRef="usd">565000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-1190">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-1191">&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.  SUPPLEMENTAL BALANCE SHEET DETAILS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;744&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;225&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;404&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;547&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;772&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,069&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1239"&gt;&lt;span style="-sec-ix-hidden:f-1240"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-classified equity incentive awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, including warranties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;827&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_127" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;9. Legal Proceedings&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;See table below for changes in the reserve for product warranties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the reserve for product warranties were as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to cost of product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repairs and replacements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to cost of product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repairs and replacements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to cost of product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repairs and replacements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In Q2 2023, we implemented a cost reduction initiative that included workforce reductions, the consolidation of certain facilities and other actions to reduce expenses, all as part of a plan to realign operating expenses while maintaining focus on our innovation roadmap and sustainable long-term growth. In both 2024 and 2023, we recorded restructuring charges primarily consisting of asset impairments related to exit activities at certain of our leased facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the pre-tax restructuring charges is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.820%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.015%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.025%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative charges recorded since inception&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee separation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;For 2024, relates to impairment of right-of-use assets and leasehold improvements for Foster City campus and other property in San Diego. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;For 2023, primarily relates to impairment of right-of-use assets and leasehold improvements for our i3 and Foster City campuses.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;For 2024, $59&#160;million was recorded in SG&amp;amp;A expense, $2&#160;million in R&amp;amp;D expense, and remainder in cost of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;For 2023, $122&#160;million was recorded in SG&amp;amp;A expense, $24&#160;million in R&amp;amp;D expense, and remainder in cost of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Total restructuring charges primarily relate to our Core Illumina segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2024, we recorded right-of-use asset impairments of $12&#160;million and $19&#160;million related to our campus in Foster City, California and another property in San Diego, California, respectively. In 2023, we recorded right-of-use asset impairments of $38&#160;million and $21&#160;million related to our i3 campus in San Diego and our campus in Foster City, respectively. The impairments were determined by comparing the fair values of the impacted right-of-use assets to the carrying values of the assets as of the impairment measurement date. The fair values of the right-of-use assets were estimated using the discounted future cash flows method, which includes estimates and assumptions for future sublease rental rates that reflect current sublease market conditions, as well as discount rates. The estimates and assumptions used in our assessments represent Level 3 measurements because they are supported by little or no market activity and reflect our own assumptions in measuring fair value. In 2024, we recorded $14&#160;million of leasehold improvement impairments related to our Foster City campus and, in 2023, we recorded $16&#160;million and $22&#160;million of leasehold improvement impairments related to our i3 and Foster City campuses, respectively. The right-of-use asset and leasehold improvement impairments were recognized in selling, general and administrative expense. We continue to evaluate our options for the rest of our Foster City campus, for which, as of December&#160;29, 2024, we had remaining assets, consisting primarily of right-of-use assets and leasehold improvements, of $100&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the restructuring liability is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.287%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Separation Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded in accrued liabilities as of January&#160;1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded in accrued liabilities as of December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded in accrued liabilities as of December&#160;29, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-1192">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;744&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="c-4" decimals="-6" id="f-1193" unitRef="usd">744000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="c-5" decimals="-6" id="f-1194" unitRef="usd">741000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-4" decimals="-6" id="f-1195" unitRef="usd">9000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-5" decimals="-6" id="f-1196" unitRef="usd">7000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-6" id="f-1197" unitRef="usd">735000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="-6" id="f-1198" unitRef="usd">734000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-1199">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;225&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;404&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;547&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials contextRef="c-4" decimals="-6" id="f-1200" unitRef="usd">225000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="c-5" decimals="-6" id="f-1201" unitRef="usd">276000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess contextRef="c-4" decimals="-6" id="f-1202" unitRef="usd">404000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="c-5" decimals="-6" id="f-1203" unitRef="usd">402000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods contextRef="c-4" decimals="-6" id="f-1204" unitRef="usd">31000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="c-5" decimals="-6" id="f-1205" unitRef="usd">30000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryGross contextRef="c-4" decimals="-6" id="f-1206" unitRef="usd">660000000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross contextRef="c-5" decimals="-6" id="f-1207" unitRef="usd">708000000</us-gaap:InventoryGross>
    <us-gaap:InventoryValuationReserves contextRef="c-4" decimals="-6" id="f-1208" unitRef="usd">113000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="c-5" decimals="-6" id="f-1209" unitRef="usd">121000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-6" id="f-1210" unitRef="usd">547000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-5" decimals="-6" id="f-1211" unitRef="usd">587000000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-351" decimals="-6" id="f-1212" unitRef="usd">772000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-352" decimals="-6" id="f-1213" unitRef="usd">803000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-353" decimals="-6" id="f-1214" unitRef="usd">683000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-354" decimals="-6" id="f-1215" unitRef="usd">684000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-355" decimals="-6" id="f-1216" unitRef="usd">478000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-356" decimals="-6" id="f-1217" unitRef="usd">463000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-77" decimals="-6" id="f-1218" unitRef="usd">53000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-357" decimals="-6" id="f-1219" unitRef="usd">55000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-358" decimals="-6" id="f-1220" unitRef="usd">44000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-359" decimals="-6" id="f-1221" unitRef="usd">44000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-360" decimals="-6" id="f-1222" unitRef="usd">39000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-361" decimals="-6" id="f-1223" unitRef="usd">96000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-6" id="f-1224" unitRef="usd">2069000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-5" decimals="-6" id="f-1225" unitRef="usd">2145000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-6" id="f-1226" unitRef="usd">1254000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-5" decimals="-6" id="f-1227" unitRef="usd">1138000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-6" id="f-1228" unitRef="usd">815000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-6" id="f-1229" unitRef="usd">1007000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-1230">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1239"&gt;&lt;span style="-sec-ix-hidden:f-1240"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-classified equity incentive awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, including warranties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;827&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_127" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;9. Legal Proceedings&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;See table below for changes in the reserve for product warranties.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:LitigationReserveCurrent contextRef="c-4" decimals="-6" id="f-1231" unitRef="usd">26000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent contextRef="c-5" decimals="-6" id="f-1232" unitRef="usd">484000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-6" id="f-1233" unitRef="usd">260000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-6" id="f-1234" unitRef="usd">252000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-6" id="f-1235" unitRef="usd">252000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-6" id="f-1236" unitRef="usd">223000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-4" decimals="-6" id="f-1237" unitRef="usd">101000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-5" decimals="-6" id="f-1238" unitRef="usd">79000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-6" id="f-1241" unitRef="usd">79000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-6" id="f-1242" unitRef="usd">86000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <ilmn:AccruedLiabilityClassifiedAwardsCurrent contextRef="c-4" decimals="-6" id="f-1243" unitRef="usd">0</ilmn:AccruedLiabilityClassifiedAwardsCurrent>
    <ilmn:AccruedLiabilityClassifiedAwardsCurrent contextRef="c-5" decimals="-6" id="f-1244" unitRef="usd">55000000</ilmn:AccruedLiabilityClassifiedAwardsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-6" id="f-1245" unitRef="usd">109000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-6" id="f-1246" unitRef="usd">146000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-6" id="f-1247" unitRef="usd">827000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-6" id="f-1248" unitRef="usd">1325000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="c-1" id="f-1249">&lt;div style="margin-bottom:6pt;margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the reserve for product warranties were as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 2, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to cost of product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repairs and replacements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to cost of product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repairs and replacements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to cost of product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repairs and replacements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 29, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual contextRef="c-19" decimals="-6" id="f-1250" unitRef="usd">22000000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued contextRef="c-13" decimals="-6" id="f-1251" unitRef="usd">23000000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c-13" decimals="-6" id="f-1252" unitRef="usd">27000000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual contextRef="c-33" decimals="-6" id="f-1253" unitRef="usd">18000000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued contextRef="c-12" decimals="-6" id="f-1254" unitRef="usd">42000000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c-12" decimals="-6" id="f-1255" unitRef="usd">39000000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual contextRef="c-5" decimals="-6" id="f-1256" unitRef="usd">21000000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued contextRef="c-1" decimals="-6" id="f-1257" unitRef="usd">42000000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c-1" decimals="-6" id="f-1258" unitRef="usd">45000000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual contextRef="c-4" decimals="-6" id="f-1259" unitRef="usd">18000000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="c-1" id="f-1260">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the pre-tax restructuring charges is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.820%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.015%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.025%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative charges recorded since inception&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee separation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;For 2024, relates to impairment of right-of-use assets and leasehold improvements for Foster City campus and other property in San Diego. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;For 2023, primarily relates to impairment of right-of-use assets and leasehold improvements for our i3 and Foster City campuses.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;For 2024, $59&#160;million was recorded in SG&amp;amp;A expense, $2&#160;million in R&amp;amp;D expense, and remainder in cost of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;For 2023, $122&#160;million was recorded in SG&amp;amp;A expense, $24&#160;million in R&amp;amp;D expense, and remainder in cost of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Total restructuring charges primarily relate to our Core Illumina segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the restructuring liability is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.805%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.287%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Separation Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded in accrued liabilities as of January&#160;1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded in accrued liabilities as of December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense recorded&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded in accrued liabilities as of December&#160;29, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-362" decimals="-6" id="f-1261" unitRef="usd">12000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-363" decimals="-6" id="f-1262" unitRef="usd">48000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-364" decimals="-6" id="f-1263" unitRef="usd">60000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-365" decimals="-6" id="f-1264" unitRef="usd">46000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-366" decimals="-6" id="f-1265" unitRef="usd">100000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-367" decimals="-6" id="f-1266" unitRef="usd">146000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-368" decimals="-6" id="f-1267" unitRef="usd">4000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-369" decimals="-6" id="f-1268" unitRef="usd">4000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-370" decimals="-6" id="f-1269" unitRef="usd">8000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-1" decimals="-6" id="f-1270" unitRef="usd">62000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-12" decimals="-6" id="f-1271" unitRef="usd">152000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-371" decimals="-6" id="f-1272" unitRef="usd">214000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-348" decimals="-6" id="f-1273" unitRef="usd">59000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-345" decimals="-6" id="f-1274" unitRef="usd">2000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-349" decimals="-6" id="f-1275" unitRef="usd">122000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c-346" decimals="-6" id="f-1276" unitRef="usd">24000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-372" decimals="-6" id="f-1277" unitRef="usd">12000000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-373" decimals="-6" id="f-1278" unitRef="usd">19000000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-12" decimals="-6" id="f-1279" unitRef="usd">38000000</us-gaap:OperatingLeaseImpairmentLoss>
    <ilmn:OperatingLeaseRightOfUseAssetAndLeaseholdImprovements contextRef="c-5" decimals="-6" id="f-1280" unitRef="usd">21000000</ilmn:OperatingLeaseRightOfUseAssetAndLeaseholdImprovements>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-374" decimals="-6" id="f-1281" unitRef="usd">14000000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-375" decimals="-6" id="f-1282" unitRef="usd">16000000</us-gaap:OperatingLeaseImpairmentLoss>
    <ilmn:OperatingLeaseRightOfUseAssetAndLeaseholdImprovements contextRef="c-352" decimals="-6" id="f-1283" unitRef="usd">22000000</ilmn:OperatingLeaseRightOfUseAssetAndLeaseholdImprovements>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-376" decimals="-6" id="f-1284" unitRef="usd">100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LeaseholdImprovementsGross contextRef="c-376" decimals="-6" id="f-1285" unitRef="usd">100000000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:RestructuringReserve contextRef="c-377" decimals="-6" id="f-1286" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-378" decimals="-6" id="f-1287" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-33" decimals="-6" id="f-1288" unitRef="usd">0</us-gaap:RestructuringReserve>
    <ilmn:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag contextRef="c-1" id="f-1289">Expense recorded</ilmn:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag>
    <us-gaap:RestructuringCharges contextRef="c-363" decimals="-6" id="f-1290" unitRef="usd">48000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-369" decimals="-6" id="f-1291" unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-12" decimals="-6" id="f-1292" unitRef="usd">52000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring contextRef="c-363" decimals="-6" id="f-1293" unitRef="usd">31000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-369" decimals="-6" id="f-1294" unitRef="usd">3000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-12" decimals="-6" id="f-1295" unitRef="usd">34000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-379" decimals="-6" id="f-1296" unitRef="usd">17000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-380" decimals="-6" id="f-1297" unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-5" decimals="-6" id="f-1298" unitRef="usd">18000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges contextRef="c-362" decimals="-6" id="f-1299" unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-368" decimals="-6" id="f-1300" unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-1" decimals="-6" id="f-1301" unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring contextRef="c-362" decimals="-6" id="f-1302" unitRef="usd">24000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-368" decimals="-6" id="f-1303" unitRef="usd">2000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring contextRef="c-1" decimals="-6" id="f-1304" unitRef="usd">26000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-362" decimals="-6" id="f-1305" unitRef="usd">-3000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-368" decimals="-6" id="f-1306" unitRef="usd">-1000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1 contextRef="c-1" decimals="-6" id="f-1307" unitRef="usd">-4000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserve contextRef="c-381" decimals="-6" id="f-1308" unitRef="usd">2000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-382" decimals="-6" id="f-1309" unitRef="usd">2000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-4" decimals="-6" id="f-1310" unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="c-1" id="f-1311">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.  LEGAL PROCEEDINGS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in various lawsuits and claims arising in the ordinary course of business, including actions with respect to intellectual property, employment, and contractual matters. In connection with these matters, we assess, on a regular basis, the probability and range of possible loss based on the developments in these matters. A liability is recorded in the consolidated financial statements if it is believed to be probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review outstanding legal matters to determine the adequacy of the liabilities accrued and related disclosures in consideration of many factors, which include, but are not limited to, past history, scientific and other evidence, and the specifics and status of each matter. We may change our estimates if our assessment of the various factors changes and the amount of ultimate loss may differ from our estimates, resulting in a material effect on our business, financial condition, results of operations, and/or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisition of GRAIL&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 6, 2024, all previously disclosed regulatory proceedings in the United States and European Union related to our acquisition of GRAIL have been resolved (as further described below).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 19, 2021, the European Commission sought and subsequently accepted a request for a referral of the GRAIL acquisition for European Union merger review, submitted by a Member State of the European Union (France), and joined by several other EEA Member States (Belgium, Greece, Iceland, the Netherlands and Norway), under Article 22(1) of Council Regulation (EC) No 139/2004 (the EU Merger Regulation). The European Commission had never solicited referrals to take jurisdiction over an acquisition of a U.S. company that had no revenue in Europe. On April 28, 2021, we filed an action in the General Court of the European Union (the EU General Court) asking for annulment of the European Commission&#x2019;s assertion of jurisdiction to review the acquisition under Article 22 of the EU Merger Regulation, as the acquisition does not meet the jurisdictional criteria under the EU Merger Regulation or under the national merger control laws of any Member State of the European Union. On July 13, 2022, the EU General Court reached a decision in favor of the European Commission, holding that the European Commission has jurisdiction under the EU Merger Regulation to review the acquisition. On September 22, 2022, we filed an appeal in the Court of Justice of the European Union (the EU Court of Justice) asking for annulment of the EU General Court&#x2019;s judgment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 12, 2023, the European Commission adopted a decision requiring Illumina to unwind its acquisition of GRAIL (the EC Divestment Decision). On December 17, 2023, we announced that we would divest GRAIL. On June&#160;24, 2024, we completed the separation (the Spin-Off) of GRAIL into a separate, independent publicly traded company through the distribution of approximately 85.5% of the outstanding GRAIL common stock to Illumina stockholders on a pro rata basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 3, 2024, the EU Court of Justice ruled in our favor, confirming that the European Commission had unlawfully asserted jurisdiction over our acquisition of GRAIL, and hence annulling the EU General Court&#x2019;s judgment and the European Commission&#x2019;s decisions accepting the referral of the GRAIL acquisition for EU merger review (the EU Court of Justice Judgment). The EU Court of Justice Judgment concludes these proceedings and is not subject to further appeals. In view of this judgment, on September 6, 2024, the European Commission issued a decision (the Withdrawal Decision) withdrawing all of its prior decisions, including (1) its July 22, 2021 decision opening an investigation of Illumina&#x2019;s proposed acquisition of GRAIL, (2) its September 6, 2022 decision prohibiting Illumina&#x2019;s acquisition of GRAIL, (3) its October 29, 2021 and October 28, 2022 decisions concerning interim measures, (4) the EC Divestment Decision, and (5) its July 12, 2023 decision fining Illumina &#x20ac;432&#160;million and GRAIL for closing the acquisition before approval by the European Commission. The Withdrawal Decision resolves all ongoing regulatory proceedings in the European Union. The European Commission has also been ordered to pay Illumina&#x2019;s costs incurred in connection with the GRAIL-related proceedings before the EU Court of Justice and the EU General Court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the European Commission withdrawing its previously imposed fine, we recognized a net gain of $481&#160;million in Q3 2024. We recognized a gain of $489&#160;million in operating expense, resulting from reversal of the accrued fine and related accrued interest, offset by a loss of $8&#160;million, recognized in other expense, net, for the reversal of associated foreign currency fluctuations. The fine accrued interest at a rate of 5.5% per annum while it was outstanding. The guarantees we provided in October 2023 to satisfy the obligation in lieu of cash payment while we appealed the European Commission&#x2019;s jurisdictional and fine decisions are no longer outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 15, 2024, the U.S. Federal Trade Commission dismissed the previously disclosed administrative complaint in light of the completion of the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;SEC Inquiry Letter&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2023, we were informed that the staff of the SEC was conducting an investigation relating to Illumina and was requesting documents and communications primarily related to Illumina&#x2019;s acquisition of GRAIL and certain statements and disclosures concerning GRAIL, its products and its acquisition, and related to the conduct and compensation of certain members of Illumina and GRAIL management, among other things. Illumina is cooperating with the SEC in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Shareholder Derivative Complaints&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 17, 2023, a stockholder derivative and class action complaint captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Icahn Partners LP, et al. v. deSouza, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, purportedly brought on behalf of Illumina and public holders of Illumina&#x2019;s common stock, was filed in the Delaware Court of Chancery against certain current and former directors (including our former Chief Executive Officer). We are named as a nominal defendant in the complaint. The lawsuit alleges the named directors breached their fiduciary duties by knowingly causing Illumina to unlawfully close the GRAIL acquisition, concealing material facts related to the GRAIL acquisition and making inadequate disclosures. Before the filing of the complaint, the purported stockholders did not make a demand that our Board of Directors pursue the claims asserted therein. The complaint seeks damages, costs and expenses, including attorney fees, the certification and consolidation of a putative class, the issuance of amended disclosures, the removal of conflicted directors and declaratory and other equitable relief. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2023, the defendants filed a motion to dismiss the complaint, which has not yet been briefed. On the same day, Illumina-joined by the director defendants-moved to strike portions of the complaint that contain improperly included confidential and privileged information. On January 16, 2024, the Court granted the motion to strike. On December 5, 2023, the plaintiffs moved to expedite the proceedings with respect to their direct claims. The director defendants opposed that motion and Illumina joined their opposition. On January 19, 2024, the Court denied plaintiffs&#x2019; motion to expedite. On January 23, 2024, the plaintiffs filed a motion for reargument of the Court&#x2019;s January 16 opinion, which the Court denied on February 19, 2024. On February 29, 2024, the plaintiffs filed an application to the trial court to certify the orders granting the motion to strike and denying the motion for reargument for interlocutory appeal. The Court refused the application on March 20, 2024. On March 14, 2024, the plaintiffs filed an application for interlocutory appeal with the Supreme Court of Delaware, which the Court denied on April 11, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 26, 2024, a stockholder derivative complaint captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Omaha Police and Firefighters Retirement System v. deSouza, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors. On April 16, 2024, a stockholder derivative complaint captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Roseville General Employees Retirement System, et al. v. deSouza, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors and officers. On August 16, 2024, a stockholder derivative complaint captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thomas P. DiNapoli v. John Thompson et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors. We are named as a nominal defendant in the complaints. The lawsuits allege the named directors and officers breached their fiduciary duties by knowingly causing Illumina to unlawfully close the GRAIL acquisition. The stockholders previously made requests to inspect certain books and records under Delaware law, and they purport to base their complaint in part on documents obtained from Illumina in response to those requests. Before the filing of the complaint, the purported stockholders did not make a demand that our Board of Directors pursue the claim asserted therein. The complaints seek damages against the individual defendants, costs and expenses, including attorney fees and other equitable relief. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 26, 2024, the defendants filed a motion to dismiss the complaint in the lawsuit filed by City of Omaha Police and Firefighters Retirement System. The motion has not yet been briefed. On May 16, 2024, the defendants filed a motion to dismiss the complaint in the lawsuit filed by City of Roseville General Employees Retirement System, et al. The motion has not yet been briefed. On September 16, 2024, the defendants filed a motion to dismiss the complaint in the lawsuit filed by Thomas DiNapoli. The motion has not yet been briefed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 23, 2024, a stockholder derivative complaint captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The Pavers and Road Builders Benefit Funds v. deSouza, et al., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;purportedly brought on behalf of Illumina, was filed in the Delaware Court of Chancery against certain current and former directors and officers. Like the complaints described above, the lawsuits allege the named directors and officers breached their fiduciary duties by knowingly causing Illumina to unlawfully close the GRAIL acquisition. The stockholder previously made requests to inspect certain books and records under Delaware law and litigated a books and records action against the Company (described below), and it purports to base its complaint in part on documents obtained from Illumina in response to those requests and that litigation. Before the filing of the complaint, the purported stockholder did not make a demand that our Board of Directors pursue the claim asserted therein. The complaint seeks damages against the individual defendants and other equitable relief.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In light of the fact that these lawsuits are in an early stage, we cannot predict the ultimate outcome of the suits. We deny the allegations in the complaints and intend to vigorously defend the litigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 21, 2024, a stockholder derivative complaint captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Elaine Wang, et al. v. deSouza, et al.,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; purportedly brought on behalf of the Company was filed in the United States District Court for the District of Delaware (District of Delaware) against certain current and former directors. The Company was named as a nominal defendant in the complaint. The lawsuit alleged that the named directors breached their fiduciary duties by knowingly causing the Company to unlawfully close the GRAIL acquisition. Before the filing of the complaint, the purported stockholder did not make a demand that our Board of Directors pursue the asserted claims therein. The complaint sought, among other things, restitution to the Company for the alleged damages caused by the named defendants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2024, a stockholder derivative complaint captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Michael Warner, et al. v. deSouza, et al.,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; purportedly brought on behalf of Illumina was also filed in the United States District Court for the Southern District of California against certain current and former directors. We were named as a nominal defendant in the complaint. The lawsuit alleged that the named directors breached their fiduciary duties by knowingly causing us to unlawfully close the GRAIL acquisition. Before the filing of the complaint, the purported stockholder did not make a demand that our Board of Directors pursue the asserted claims therein. The complaint sought, among other things, restitution to Illumina for the alleged damages caused by the named defendants. On March 28, 2024, the parties submitted a Joint Motion to Transfer the lawsuit to the District of Delaware, which the Court granted on March 29, 2024, and the Court transferred the lawsuit to the District of Delaware on the same day.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Elaine Wang, et al. v. deSouza, et al. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Michael Warner, et al. v. deSouza, et al. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;were voluntarily dismissed on April 29, 2024, and May 1, 2024, respectively. On May 1, 2024, Michael Warner sent a litigation demand to our Board of Directors requesting that a civil action for monetary damages be brought by the Board of Directors on behalf of Illumina against officers and directors involved with the GRAIL acquisition. On July 30, 2024, the Board unanimously determined that it was in the best interest of the Company and its shareholders to defer a final decision on the demand given, among other things, the pending stockholder lawsuits described herein and the similarity of issues raised in the demand and those lawsuits. Our Board will monitor the stockholder lawsuits and revisit the demand as warranted as the lawsuits progress. On June 3, 2024, Elaine Wang made requests to inspect certain books and records under Delaware law and the Company sent a production of documents in response to that demand. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 21, 2024, an additional stockholder, Jane Davidson, sent a litigation demand to our Board of Directors requesting that a civil action for breaches of fiduciary duty, indemnification, contribution and other appropriate claims be brought by the Board of Directors on behalf of Illumina against officers and directors involved with the GRAIL acquisition. On October 29, 2024, the Board unanimously determined that it was in the best interest of the Company and its shareholders to defer a final decision on the demand given, among other things, the pending stockholder lawsuits described herein and the similarity of issues raised in the demand and those lawsuits. Our Board will monitor the stockholder lawsuits and revisit the demand as warranted as the lawsuits progress.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:113%"&gt;Securities Class Actions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Securities Class Actions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 11, 2023, the first of three securities class action complaints was filed against Illumina and certain of its current and former executive officers in the United States District Court for the Southern District of California. The first-filed case is captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kangas v. Illumina, Inc. et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., the second-filed case is captioned&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Roy v. Illumina, Inc. et al.,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and the third-filed case is captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Louisiana Sheriffs&#x2019; Pension &amp;amp; Relief Fund v. Illumina, Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (collectively, the Actions). The complaints generally allege, among other things, that defendants made materially false and misleading statements and omitted material facts relating to Illumina&#x2019;s acquisition of GRAIL. The complaints seek unspecified damages, interest, fees, and costs. On January 9, 2024, four movants filed motions to consolidate the Actions and to appoint a lead plaintiff (Lead Plaintiff Motions). On April 11, 2024, the Court issued an order consolidating the Actions into a single action (captioned in re Illumina, Inc. Securities Litigation No. 23-cv-2082-LL-MMP), and appointed Universal-Investment-Gesellschaft mbH, UI BVK Kapitalverwaltungsgesellschaft mbH, and ACATIS Investment Kapitalverwaltungsgesellschaft mbH as lead plaintiffs (the Lead Plaintiffs). On June 21, 2024, the Lead Plaintiffs filed their consolidated amended complaint. The complaint alleges that Illumina and GRAIL and certain of their current and former directors and officers violated Sections 10(b) and 20(a) of the Securities Exchange Act and SEC Rule 10b-5 in connection with Illumina&#x2019;s acquisition of GRAIL. On September 13, 2024, the Lead Plaintiffs filed a second amended consolidated complaint. On November 12, 2024, the Company and other defendants filed a motion to dismiss the second amended consolidated complaint. On December 20, 2024, the Lead Plaintiffs filed their opposition to the motion to dismiss. The defendants&#x2019; final reply brief was filed on February 3, 2025. No hearing date has been set.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;State Securities Class Actions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On February 2, 2024, the first of two additional securities class actions was filed against Illumina, certain of its officers and directors, and several other individuals and entities in the Superior Court of the State of California, County of San Mateo, captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loren Scott Mar v. Illumina, et al. and Scott Zerzanek v. Illumina, Inc. et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Both complaints generally allege, among other things, that defendants made materially false and misleading statements and omitted material facts in the November 2020 and February 2021 registration statements and prospectus relating to Illumina&#x2019;s acquisition of GRAIL. The complaints seek unspecified damages, interest, fees, and costs. On March 29, 2024, the parties to the actions filed a Joint Stipulation to Consolidate the actions and to appoint co-lead counsel for plaintiffs, which the Court granted on April 5, 2024. On August 12, 2024, the Plaintiffs filed their consolidated complaint. On September 6, 2024, Illumina and the other named defendants filed a motion to stay the litigation. On October 4, 2024, the plaintiffs opposed the motion to stay. At a hearing held on December 6, 2024, the Court declined to stay the litigation. The defendants&#x2019; demurrer is due February 28, 2025. Plaintiffs&#x2019; oppositions to the demurrer are due April 30, 2025, and defendants&#x2019; final reply briefs are due May 30, 2025. A hearing is set for June 20, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In light of the fact that the lawsuits are in an early stage, we cannot predict the ultimate outcome of the suits. We deny the allegations in the complaints and intend to vigorously defend the litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;DOJ Civil Investigative Demand&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 18, 2024, we received a civil investigative demand (CID) from the U.S. Department of Justice, requiring production of certain documents and information in the course of a False Claims Act investigation to determine whether there is or has been a violation of 31 U.S.C. &#xa7; 3729. The False Claims Act investigation concerns allegations that the Company caused the submission of false claims to Medicare and other federal government programs because it misrepresented its compliance with cybersecurity requirements to the Food and Drug Administration and other federal agencies that purchase its devices. The Company is cooperating with the government. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Books and Records Action&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2024, a stockholder filed a complaint in the Delaware Court of Chancery captioned Pavers and Road Builders Benefit Funds v. Illumina, Inc. seeking to inspect certain books and records related to the GRAIL transaction, including certain materials and minutes from meetings of our Board of Directors, which have been withheld because the Company contends they are non-responsive to the request or subject to the attorney-client privilege. Illumina previously provided documents to the stockholder in response to a demand made by letter under Delaware law, but the stockholder seeks additional and unredacted materials through this action. On March 11, 2024, Illumina filed an answer to the complaint, denying that the stockholder was entitled to inspection. We deny that the stockholder is entitled to review the documents and intend to vigorously defend the litigation. The trial took place on June 7, 2024. On July 16, 2024, the Court issued a decision requiring the Company to produce certain additional documents to plaintiff. On July 26, 2024, the stockholder filed a motion seeking in camera review of certain documents that the Company maintains are not subject to the Court&#x2019;s July 16, 2024 order to produce documents. The Court granted the motion on August 19, 2024, and the Company filed the documents for in camera review on August 29, 2024. On October 7, 2024, the Court ruled that the Company need not produce the documents subject to the motion for in camera review because they are privileged under the attorney opinion work product doctrine. On December 11, 2024, the Court entered its final order and judgment. On December 23, 2024, the plaintiff in this action filed a derivative complaint, described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;BGI Genomics Co. Ltd. and its Affiliates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously disclosed, we were engaged in litigation in various U.S. jurisdictions with BGI Genomics Co. Ltd (BGI) and certain of its affiliates, including Complete Genomics, Inc. (CGI) since June of 2019. On July 14, 2022, we entered into a Settlement and License Agreement with BGI and CGI (the Agreement). Pursuant to the terms of the Agreement, we agreed to pay CGI a one time payment of $325&#160;million. We allocated the $325&#160;million payment on a relative fair value basis, resulting in $180&#160;million capitalized as an intangible asset in 2022 for the value of the license, which is amortized over a period of 6.5 years on a straight-line basis, $150&#160;million allocated to the release of past damages claimed, and a $5&#160;million gain for damages awarded to us. The fair value of the license was estimated using a discounted cash flow model, which included assumptions for projected revenues covered by the license, an estimated royalty rate and a discount rate. The fair value of the past damages claimed was estimated based on applicable historical revenues and an estimated royalty rate. These inputs represent a Level 3 measurement because they are supported by little or no market activity and reflect our own assumptions in measuring fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <ilmn:DiscontinuedOperationPercentOfInterestDisposedOf contextRef="c-55" decimals="3" id="f-1312" unitRef="number">0.855</ilmn:DiscontinuedOperationPercentOfInterestDisposedOf>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-383" decimals="-6" id="f-1313" unitRef="usd">432000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-384" decimals="-6" id="f-1314" unitRef="usd">481000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:LitigationSettlementGain contextRef="c-384" decimals="-6" id="f-1315" unitRef="usd">489000000</us-gaap:LitigationSettlementGain>
    <us-gaap:LitigationSettlementLoss contextRef="c-384" decimals="-6" id="f-1316" unitRef="usd">8000000</us-gaap:LitigationSettlementLoss>
    <ilmn:LitigationSettlementFinePercentageRate
      contextRef="c-385"
      decimals="3"
      id="f-1317"
      unitRef="number">0.055</ilmn:LitigationSettlementFinePercentageRate>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="c-386"
      decimals="INF"
      id="f-1318"
      unitRef="lawsuit">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <ilmn:CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions
      contextRef="c-387"
      decimals="INF"
      id="f-1319"
      unitRef="movant">4</ilmn:CommitmentsAndContingenciesNumberOfMovantsFiledMotionsConsolidateActions>
    <ilmn:CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions
      contextRef="c-388"
      decimals="INF"
      id="f-1320"
      unitRef="lawsuit">2</ilmn:CommitmentsAndContingenciesNumberOfAdditionalSecuritiesClassActions>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-389" decimals="-6" id="f-1321" unitRef="usd">325000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-389" decimals="-6" id="f-1322" unitRef="usd">325000000</us-gaap:PaymentsForLegalSettlements>
    <ilmn:LossContingencyLicenseGrantedIntangibleAssets contextRef="c-390" decimals="-6" id="f-1323" unitRef="usd">180000000</ilmn:LossContingencyLicenseGrantedIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-391" id="f-1324">P6Y6M</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <ilmn:PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed contextRef="c-389" decimals="-6" id="f-1325" unitRef="usd">150000000</ilmn:PaymentsForLegalSettlementsAmountAllocatedToReleaseOfPastDamagesClaimed>
    <us-gaap:FormerGainContingencyRecognizedInCurrentPeriod contextRef="c-392" decimals="-6" id="f-1326" unitRef="usd">5000000</us-gaap:FormerGainContingencyRecognizedInCurrentPeriod>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1327">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10.  INCOME TAXES&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss before income taxes summarized by region was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loss before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes reconciles to the amount computed by applying the federal statutory rate to loss before income taxes as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and other credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of R&amp;amp;D expense capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of net operating losses on GILTI, U.S. foreign tax credits, and Pillar Two global minimum top-up tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual of European Commission fine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of acquisition related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected to account for the global intangible low-taxed income (GILTI) as a period cost in our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of foreign operations primarily represents the difference between the actual provision for income taxes for our legal entities that operate in jurisdictions that have statutory tax rates that differ from the U.S. federal statutory tax rate of 21%. The most significant tax benefits from foreign operations were from our earnings in Singapore, which had a statutory tax rate of 17% in 2024. The impact of foreign operations also includes the impacts of GILTI, U.S. foreign tax credits, and the Pillar Two global minimum top-up tax of non-U.S. earnings before the tax impact of net operating losses, and uncertain tax positions related to foreign items.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of R&amp;amp;D expense capitalization is primarily the income tax expense impact of capitalizing research and development expenses for tax purposes on GILTI and the utilization of the U.S. foreign tax credits. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of net operating losses on GILTI, U.S. foreign tax credits, and the Pillar Two global minimum top-up tax is primarily the income tax expense impact of GRAIL pre-acquisition net operating losses on GILTI, the utilization of the U.S. foreign tax credits, and the Pillar Two global minimum top-up tax.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The impact of acquisition related items includes the income tax expense impact of transaction costs, acquisition related compensation, and changes to the contingent value rights associated with the GRAIL acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of deferred tax assets and liabilities were as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;189&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized U.S. R&amp;amp;D expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;181&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;112&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance on deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(251)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased intangible amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;558&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence, including operating results and forecasted ranges of future taxable income. Based on the available evidence as of December&#160;29, 2024, we were not able to conclude it is more likely than not certain deferred tax assets will be realized. Therefore, a valuation allowance of $278 million was recorded against certain U.S. and foreign deferred tax assets. &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;29, 2024, we had net operating loss carryforwards for federal and state tax purposes of $74&#160;million and $1,872 million, respectively, which will begin to expire in 2036 and 2025, respectively, unless utilized prior. We also had federal and state tax credit carryforwards of $140 million and $239 million, which will begin to expire in 2031 and 2027, respectively, unless utilized prior.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to Section&#160;382 and 383 of the Internal Revenue Code, utilization of net operating losses and credits may be subject to annual limitations in the event of any significant future changes in its ownership structure. These annual limitations may result in the expiration of net operating losses and credits prior to utilization. The deferred tax assets as of December&#160;29, 2024 are net of any previous limitations due to Section&#160;382 and 383.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our manufacturing operations in Singapore operate under various tax holidays and incentives, which will begin to expire in 2028. These tax holidays and incentives resulted in a $33 million, $75 million, and $56 million decrease to the provision for income taxes in 2024, 2023, and 2022, respectively. These tax holidays and incentives resulted in a decrease in diluted loss per share of $0.20, $0.47, and $0.35, in 2024, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;29, 2024, we asserted that $1,806 million of foreign earnings would not be indefinitely reinvested, and accordingly, recorded a deferred tax liability of $24 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gross amount of our uncertain tax positions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the balance of uncertain tax positions as of December&#160;29, 2024 and December&#160;31, 2023, was $202&#160;million and $156&#160;million, respectively, of net unrecognized tax benefits that, if recognized, would reduce the effective income tax rate in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any interest and penalties related to uncertain tax positions are reflected in the provision for income taxes. We recognized expense of $6&#160;million and $2&#160;million in 2024 and 2023, respectively, and income of $3&#160;million in 2022, related to potential interest and penalties on uncertain tax positions. We recorded a liability for potential interest and penalties of $13&#160;million and $6&#160;million as of December&#160;29, 2024 and December&#160;31, 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Tax years 1997 to 2023 remain subject to future examination by the major tax jurisdictions in which we are subject to tax. The Internal Revenue Service completed an examination of the U.S. Corporation Income Tax Returns for tax years 2017, 2018, and 2020. Given the uncertainty of potential adjustments from examination as well as the potential expiration of the statute of limitations, it is reasonably possible that the balance of unrecognized tax benefits could change significantly over the next 12 months. Due to the number of years remaining that are subject to examination, we are unable to estimate the full range of possible adjustments to the balance of gross unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-1328">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss before income taxes summarized by region was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loss before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-6" id="f-1329" unitRef="usd">-1834000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-12" decimals="-6" id="f-1330" unitRef="usd">-1735000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-13" decimals="-6" id="f-1331" unitRef="usd">-4942000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-6" id="f-1332" unitRef="usd">655000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-12" decimals="-6" id="f-1333" unitRef="usd">618000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-13" decimals="-6" id="f-1334" unitRef="usd">606000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-1335" unitRef="usd">-1179000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-12" decimals="-6" id="f-1336" unitRef="usd">-1117000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-13" decimals="-6" id="f-1337" unitRef="usd">-4336000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1338">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1339" unitRef="usd">6000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1340" unitRef="usd">-5000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1341" unitRef="usd">-11000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1342" unitRef="usd">18000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1343" unitRef="usd">6000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1344" unitRef="usd">27000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1345" unitRef="usd">137000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1346" unitRef="usd">77000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1347" unitRef="usd">75000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1348" unitRef="usd">161000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1349" unitRef="usd">78000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1350" unitRef="usd">91000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1351" unitRef="usd">-59000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1352" unitRef="usd">-13000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1353" unitRef="usd">40000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1354" unitRef="usd">-56000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1355" unitRef="usd">-26000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1356" unitRef="usd">-47000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1357" unitRef="usd">-2000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1358" unitRef="usd">5000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1359" unitRef="usd">-16000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1360" unitRef="usd">-117000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1361" unitRef="usd">-34000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1362" unitRef="usd">-23000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1363" unitRef="usd">44000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1364" unitRef="usd">44000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1365" unitRef="usd">68000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1366">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes reconciles to the amount computed by applying the federal statutory rate to loss before income taxes as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and other credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of R&amp;amp;D expense capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of net operating losses on GILTI, U.S. foreign tax credits, and Pillar Two global minimum top-up tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual of European Commission fine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of acquisition related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-6" id="f-1367" unitRef="usd">-248000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-12" decimals="-6" id="f-1368" unitRef="usd">-235000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-13" decimals="-6" id="f-1369" unitRef="usd">-911000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="-6" id="f-1370" unitRef="usd">-38000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-12" decimals="-6" id="f-1371" unitRef="usd">-16000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-13" decimals="-6" id="f-1372" unitRef="usd">-9000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-1" decimals="-6" id="f-1373" unitRef="usd">32000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-12" decimals="-6" id="f-1374" unitRef="usd">42000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-13" decimals="-6" id="f-1375" unitRef="usd">46000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-6" id="f-1376" unitRef="usd">29000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-12" decimals="-6" id="f-1377" unitRef="usd">48000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-13" decimals="-6" id="f-1378" unitRef="usd">62000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment contextRef="c-1" decimals="-6" id="f-1379" unitRef="usd">52000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment contextRef="c-12" decimals="-6" id="f-1380" unitRef="usd">86000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment contextRef="c-13" decimals="-6" id="f-1381" unitRef="usd">87000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount contextRef="c-1" decimals="-6" id="f-1382" unitRef="usd">90000000</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount contextRef="c-12" decimals="-6" id="f-1383" unitRef="usd">61000000</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount contextRef="c-13" decimals="-6" id="f-1384" unitRef="usd">60000000</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-6" id="f-1385" unitRef="usd">3000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-12" decimals="-6" id="f-1386" unitRef="usd">-50000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-13" decimals="-6" id="f-1387" unitRef="usd">-81000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-6" id="f-1388" unitRef="usd">16000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-12" decimals="-6" id="f-1389" unitRef="usd">31000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-13" decimals="-6" id="f-1390" unitRef="usd">20000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <ilmn:EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine contextRef="c-1" decimals="-6" id="f-1391" unitRef="usd">-99000000</ilmn:EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine>
    <ilmn:EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine contextRef="c-12" decimals="-6" id="f-1392" unitRef="usd">3000000</ilmn:EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine>
    <ilmn:EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine contextRef="c-13" decimals="-6" id="f-1393" unitRef="usd">96000000</ilmn:EffectiveIncomeTaxRateReconciliationAccrualOfPotentialFine>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses contextRef="c-1" decimals="-6" id="f-1394" unitRef="usd">308000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses contextRef="c-12" decimals="-6" id="f-1395" unitRef="usd">149000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses contextRef="c-13" decimals="-6" id="f-1396" unitRef="usd">822000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses>
    <ilmn:EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount contextRef="c-1" decimals="-6" id="f-1397" unitRef="usd">46000000</ilmn:EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount>
    <ilmn:EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount contextRef="c-12" decimals="-6" id="f-1398" unitRef="usd">-8000000</ilmn:EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount>
    <ilmn:EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount contextRef="c-13" decimals="-6" id="f-1399" unitRef="usd">27000000</ilmn:EffectiveIncomeTaxRateReconciliationAcquisitionsRelatedItemsAmount>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-1" decimals="-6" id="f-1400" unitRef="usd">9000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-12" decimals="-6" id="f-1401" unitRef="usd">1000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-13" decimals="-6" id="f-1402" unitRef="usd">-5000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-1403" unitRef="usd">44000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-12" decimals="-6" id="f-1404" unitRef="usd">44000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-13" decimals="-6" id="f-1405" unitRef="usd">68000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1406">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of deferred tax assets and liabilities were as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;189&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized U.S. R&amp;amp;D expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;181&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;112&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance on deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(251)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased intangible amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;558&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-4" decimals="-6" id="f-1407" unitRef="usd">189000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-6" id="f-1408" unitRef="usd">392000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-4" decimals="-6" id="f-1409" unitRef="usd">252000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-5" decimals="-6" id="f-1410" unitRef="usd">211000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther contextRef="c-4" decimals="-6" id="f-1411" unitRef="usd">40000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther contextRef="c-5" decimals="-6" id="f-1412" unitRef="usd">49000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-4" decimals="-6" id="f-1413" unitRef="usd">34000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-5" decimals="-6" id="f-1414" unitRef="usd">15000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-4" decimals="-6" id="f-1415" unitRef="usd">181000000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-5" decimals="-6" id="f-1416" unitRef="usd">158000000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="c-4" decimals="-6" id="f-1417" unitRef="usd">42000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="c-5" decimals="-6" id="f-1418" unitRef="usd">115000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <ilmn:DeferredTaxAssetsOperatingLeaseLiabilities contextRef="c-4" decimals="-6" id="f-1419" unitRef="usd">112000000</ilmn:DeferredTaxAssetsOperatingLeaseLiabilities>
    <ilmn:DeferredTaxAssetsOperatingLeaseLiabilities contextRef="c-5" decimals="-6" id="f-1420" unitRef="usd">146000000</ilmn:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-4" decimals="-6" id="f-1421" unitRef="usd">17000000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-5" decimals="-6" id="f-1422" unitRef="usd">4000000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsInvestments contextRef="c-4" decimals="-6" id="f-1423" unitRef="usd">23000000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsInvestments contextRef="c-5" decimals="-6" id="f-1424" unitRef="usd">7000000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-4" decimals="-6" id="f-1425" unitRef="usd">63000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-5" decimals="-6" id="f-1426" unitRef="usd">56000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="-6" id="f-1427" unitRef="usd">953000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="-6" id="f-1428" unitRef="usd">1153000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-6" id="f-1429" unitRef="usd">278000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-6" id="f-1430" unitRef="usd">251000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-4" decimals="-6" id="f-1431" unitRef="usd">675000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-5" decimals="-6" id="f-1432" unitRef="usd">902000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-4" decimals="-6" id="f-1433" unitRef="usd">35000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-5" decimals="-6" id="f-1434" unitRef="usd">734000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <ilmn:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets contextRef="c-4" decimals="-6" id="f-1435" unitRef="usd">57000000</ilmn:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets>
    <ilmn:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets contextRef="c-5" decimals="-6" id="f-1436" unitRef="usd">88000000</ilmn:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-4" decimals="-6" id="f-1437" unitRef="usd">25000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-5" decimals="-6" id="f-1438" unitRef="usd">25000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="-6" id="f-1439" unitRef="usd">117000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-5" decimals="-6" id="f-1440" unitRef="usd">847000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-4" decimals="-6" id="f-1441" unitRef="usd">558000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-5" decimals="-6" id="f-1442" unitRef="usd">55000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-6" id="f-1443" unitRef="usd">278000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards contextRef="c-393" decimals="-6" id="f-1444" unitRef="usd">74000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-394" decimals="-6" id="f-1445" unitRef="usd">1872000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-395" decimals="-6" id="f-1446" unitRef="usd">140000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-394" decimals="-6" id="f-1447" unitRef="usd">239000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount contextRef="c-396" decimals="-6" id="f-1448" unitRef="usd">33000000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount contextRef="c-397" decimals="-6" id="f-1449" unitRef="usd">75000000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount contextRef="c-398" decimals="-6" id="f-1450" unitRef="usd">56000000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare
      contextRef="c-396"
      decimals="2"
      id="f-1451"
      unitRef="usdPerShare">0.20</us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare>
    <us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare
      contextRef="c-397"
      decimals="2"
      id="f-1452"
      unitRef="usdPerShare">0.47</us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare>
    <us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare
      contextRef="c-398"
      decimals="2"
      id="f-1453"
      unitRef="usdPerShare">0.35</us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries contextRef="c-399" decimals="-6" id="f-1454" unitRef="usd">1806000000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-399" decimals="-6" id="f-1455" unitRef="usd">24000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-1456">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gross amount of our uncertain tax positions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-6" id="f-1457" unitRef="usd">210000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-33" decimals="-6" id="f-1458" unitRef="usd">153000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-19" decimals="-6" id="f-1459" unitRef="usd">131000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-6" id="f-1460" unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-12" decimals="-6" id="f-1461" unitRef="usd">27000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-13" decimals="-6" id="f-1462" unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-6" id="f-1463" unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-12" decimals="-6" id="f-1464" unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-13" decimals="-6" id="f-1465" unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-6" id="f-1466" unitRef="usd">23000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-12" decimals="-6" id="f-1467" unitRef="usd">42000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-13" decimals="-6" id="f-1468" unitRef="usd">42000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-1" decimals="-6" id="f-1469" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-12" decimals="-6" id="f-1470" unitRef="usd">10000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-13" decimals="-6" id="f-1471" unitRef="usd">29000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-6" id="f-1472" unitRef="usd">232000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-6" id="f-1473" unitRef="usd">210000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-33" decimals="-6" id="f-1474" unitRef="usd">153000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-4" decimals="-6" id="f-1475" unitRef="usd">202000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-5" decimals="-6" id="f-1476" unitRef="usd">156000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-1" decimals="-6" id="f-1477" unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-12" decimals="-6" id="f-1478" unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-13" decimals="-6" id="f-1479" unitRef="usd">-3000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-4" decimals="-6" id="f-1480" unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-5" decimals="-6" id="f-1481" unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="c-1" id="f-1482">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11.  EMPLOYEE BENEFIT PLANS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retirement Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a 401(k) savings plan covering substantially all of our employees in the United States. Our contributions to the plan are discretionary. During 2024, 2023, and 2022, we made matching contributions of $34 million, $36 million, and $30 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Illumina, Inc. Deferred Compensation Plan (the Plan) allows senior level employees to contribute up to 60% of their base salary and 100% of their variable cash compensation, and members of the board of directors to contribute up to 100% of their director fees and equity awards. Under the Plan, we credit the participants&#x2019; contributions with earnings that reflect the performance of certain independent investment funds. On a discretionary basis, we may also make employer contributions to participant accounts in any amount determined by us. The vesting schedules of employer contributions are at the sole discretion of the Compensation Committee. However, all employer contributions shall become 100% vested upon the occurrence of the participant&#x2019;s disability, death or retirement or a change in control of Illumina. The benefits under this plan are unsecured. Participants are generally eligible to receive payment of their vested benefit at the end of their elected deferral period or after termination of their employment for any reason or at a later date to comply with the restrictions of Section&#160;409A. &lt;/span&gt;&lt;/div&gt;We established a rabbi trust for the benefit of the participants under the Plan and have included the assets of the rabbi trust in other assets in the consolidated balance sheets. As of December&#160;29, 2024 and December&#160;31, 2023, the assets of the trust were $70 million and $61 million, respectively, and our liabilities, included in accrued liabilities, were $65 million and $59 million, respectively. Changes in the values of the assets held by the trust are recorded in other expense, net, and changes in the values of the deferred compensation liabilities are recorded in operating expense.</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-1" decimals="-6" id="f-1483" unitRef="usd">34000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-12" decimals="-6" id="f-1484" unitRef="usd">36000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-13" decimals="-6" id="f-1485" unitRef="usd">30000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <ilmn:DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent
      contextRef="c-400"
      decimals="INF"
      id="f-1486"
      unitRef="number">0.60</ilmn:DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeBaseSalaryPercent>
    <ilmn:DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent
      contextRef="c-400"
      decimals="INF"
      id="f-1487"
      unitRef="number">1</ilmn:DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent>
    <ilmn:DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent
      contextRef="c-401"
      decimals="INF"
      id="f-1488"
      unitRef="number">1</ilmn:DeferredCompensationPlanMaximumAnnualContributionsPerEmployeeOtherCompensationPercent>
    <ilmn:DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents
      contextRef="c-1"
      decimals="INF"
      id="f-1489"
      unitRef="number">1</ilmn:DeferredCompensationArrangementWithIndividualVestingPercentSpecifiedEvents>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-4" decimals="-6" id="f-1490" unitRef="usd">70000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-5" decimals="-6" id="f-1491" unitRef="usd">61000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent contextRef="c-4" decimals="-6" id="f-1492" unitRef="usd">65000000</us-gaap:DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent contextRef="c-5" decimals="-6" id="f-1493" unitRef="usd">59000000</us-gaap:DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1494">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:98.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #ffb441;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#666666;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12.  SEGMENT AND GEOGRAPHIC INFORMATION&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reportable Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;29, 2024, we have one reportable segment, Core Illumina. Prior to the Spin-Off of GRAIL, on June&#160;24, 2024, our reportable segments included both Core Illumina and GRAIL. See note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_40" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2. GRAIL Spin-Off&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for details. We continue to disclose certain historical information for GRAIL prior to the Spin-Off. Segment information is consistent with how our Chief Operating Decision Maker (CODM), who is our Chief Executive Officer, reviews financial information, makes operating decisions, allocates resources, and assesses performance. We also consider the way budgets and forecasts are prepared and reviewed and the basis on which executive compensation is determined.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Core Illumina: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Core Illumina&#x2019;s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina sells products and provides services to GRAIL, and vice versa, in accordance with contractual agreements between the entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;GRAIL: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GRAIL is a healthcare company focused on early detection of multiple cancers. Prior to the Spin-Off of GRAIL into a separate, independent public company, GRAIL was required to be held and operated separately and independently from Illumina pursuant to the transitional measures ordered by the European Commission. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our CODM allocates resources and evaluates business performance based on revenues and net income (loss). Net income (loss) is used in the annual budgeting and monthly forecasting processes and to monitor and assess budgeted/forecasted versus actual results. Our CODM does not evaluate segments using asset information. The accounting policies for segments are the same as those described in the summary of significant accounting policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present selected financial information with respect to segments for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.043%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.422%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.848%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core Illumina:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,424&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible impairment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal contingency and settlement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core Illumina income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GRAIL:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated other expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;346&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated provision for income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"&gt;Core Illumina revenue for 2024, 2023, and 2022 included intercompany revenue of $15 million, $26 million, and $24 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"&gt;GRAIL operating expenses are inclusive of cost of revenue, research and development, selling and marketing, general and administrative, and goodwill and intangible impairment for the comparative periods prior to the Spin-Off on June&#160;24, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core Illumina&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GRAIL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core Illumina&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GRAIL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Geographic Data&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets, consisting of property and equipment and operating lease right-of-use assets, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to note &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i64df1cccf2dd452496bdff4e9d30a288_94" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;3. Revenue&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for revenue by geographic area.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1495"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1496">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our CODM allocates resources and evaluates business performance based on revenues and net income (loss). Net income (loss) is used in the annual budgeting and monthly forecasting processes and to monitor and assess budgeted/forecasted versus actual results. Our CODM does not evaluate segments using asset information. The accounting policies for segments are the same as those described in the summary of significant accounting policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present selected financial information with respect to segments for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.043%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.422%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.848%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core Illumina:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,424&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;988&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible impairment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal contingency and settlement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core Illumina income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GRAIL:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated other expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;346&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated provision for income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"&gt;Core Illumina revenue for 2024, 2023, and 2022 included intercompany revenue of $15 million, $26 million, and $24 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"&gt;GRAIL operating expenses are inclusive of cost of revenue, research and development, selling and marketing, general and administrative, and goodwill and intangible impairment for the comparative periods prior to the Spin-Off on June&#160;24, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core Illumina&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GRAIL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core Illumina&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GRAIL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-402" decimals="-6" id="f-1497" unitRef="usd">4332000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-403" decimals="-6" id="f-1498" unitRef="usd">4438000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-404" decimals="-6" id="f-1499" unitRef="usd">4553000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue contextRef="c-402" decimals="-6" id="f-1500" unitRef="usd">1424000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-403" decimals="-6" id="f-1501" unitRef="usd">1582000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-404" decimals="-6" id="f-1502" unitRef="usd">1446000000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-402" decimals="-6" id="f-1503" unitRef="usd">988000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-403" decimals="-6" id="f-1504" unitRef="usd">1030000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-404" decimals="-6" id="f-1505" unitRef="usd">1004000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-402" decimals="-6" id="f-1506" unitRef="usd">638000000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-403" decimals="-6" id="f-1507" unitRef="usd">648000000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-404" decimals="-6" id="f-1508" unitRef="usd">677000000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-402" decimals="-6" id="f-1509" unitRef="usd">262000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-403" decimals="-6" id="f-1510" unitRef="usd">600000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-404" decimals="-6" id="f-1511" unitRef="usd">326000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-402" decimals="-6" id="f-1512" unitRef="usd">3000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-403" decimals="-6" id="f-1513" unitRef="usd">6000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-404" decimals="-6" id="f-1514" unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-402" decimals="-6" id="f-1515" unitRef="usd">456000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-403" decimals="-6" id="f-1516" unitRef="usd">-20000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-404" decimals="-6" id="f-1517" unitRef="usd">-619000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:NetIncomeLoss contextRef="c-402" decimals="-6" id="f-1518" unitRef="usd">1473000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-403" decimals="-6" id="f-1519" unitRef="usd">552000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-404" decimals="-6" id="f-1520" unitRef="usd">481000000</us-gaap:NetIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-405" decimals="-6" id="f-1521" unitRef="usd">55000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-406" decimals="-6" id="f-1522" unitRef="usd">93000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-407" decimals="-6" id="f-1523" unitRef="usd">55000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingExpenses contextRef="c-405" decimals="-6" id="f-1524" unitRef="usd">2360000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-406" decimals="-6" id="f-1525" unitRef="usd">1714000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-407" decimals="-6" id="f-1526" unitRef="usd">4712000000</us-gaap:OperatingExpenses>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-405" decimals="-6" id="f-1527" unitRef="usd">-346000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-406" decimals="-6" id="f-1528" unitRef="usd">-48000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-407" decimals="-6" id="f-1529" unitRef="usd">-157000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-405" decimals="-6" id="f-1530" unitRef="usd">44000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-406" decimals="-6" id="f-1531" unitRef="usd">44000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-407" decimals="-6" id="f-1532" unitRef="usd">68000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-408" decimals="-6" id="f-1533" unitRef="usd">-1000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-409" decimals="-6" id="f-1534" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-410" decimals="-6" id="f-1535" unitRef="usd">-3000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-1536" unitRef="usd">-1223000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-6" id="f-1537" unitRef="usd">-1161000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-6" id="f-1538" unitRef="usd">-4404000000</us-gaap:NetIncomeLoss>
    <us-gaap:CostOfRevenue contextRef="c-411" decimals="-6" id="f-1539" unitRef="usd">15000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-412" decimals="-6" id="f-1540" unitRef="usd">26000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-413" decimals="-6" id="f-1541" unitRef="usd">24000000</us-gaap:CostOfRevenue>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-402" decimals="-6" id="f-1542" unitRef="usd">280000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-403" decimals="-6" id="f-1543" unitRef="usd">273000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-404" decimals="-6" id="f-1544" unitRef="usd">240000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-405" decimals="-6" id="f-1545" unitRef="usd">74000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-406" decimals="-6" id="f-1546" unitRef="usd">159000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-407" decimals="-6" id="f-1547" unitRef="usd">154000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-6" id="f-1548" unitRef="usd">354000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-12" decimals="-6" id="f-1549" unitRef="usd">432000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-13" decimals="-6" id="f-1550" unitRef="usd">394000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-402" decimals="-6" id="f-1551" unitRef="usd">137000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-403" decimals="-6" id="f-1552" unitRef="usd">183000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-404" decimals="-6" id="f-1553" unitRef="usd">262000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-405" decimals="-6" id="f-1554" unitRef="usd">5000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-406" decimals="-6" id="f-1555" unitRef="usd">13000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-407" decimals="-6" id="f-1556" unitRef="usd">24000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-408" decimals="-6" id="f-1557" unitRef="usd">0</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-409" decimals="-6" id="f-1558" unitRef="usd">-1000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-410" decimals="-6" id="f-1559" unitRef="usd">0</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-1" decimals="-6" id="f-1560" unitRef="usd">142000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-12" decimals="-6" id="f-1561" unitRef="usd">195000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-13" decimals="-6" id="f-1562" unitRef="usd">286000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock contextRef="c-1" id="f-1563">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets, consisting of property and equipment and operating lease right-of-use assets, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 29,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Singapore&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dddddd;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dddddd;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dddddd;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets contextRef="c-414" decimals="-6" id="f-1564" unitRef="usd">750000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-415" decimals="-6" id="f-1565" unitRef="usd">1040000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-416" decimals="-6" id="f-1566" unitRef="usd">279000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-417" decimals="-6" id="f-1567" unitRef="usd">298000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-418" decimals="-6" id="f-1568" unitRef="usd">124000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-419" decimals="-6" id="f-1569" unitRef="usd">136000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-420" decimals="-6" id="f-1570" unitRef="usd">81000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-421" decimals="-6" id="f-1571" unitRef="usd">77000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-4" decimals="-6" id="f-1572" unitRef="usd">1234000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-5" decimals="-6" id="f-1573" unitRef="usd">1551000000</us-gaap:NoncurrentAssets>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-422" id="f-1574">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;On November 6, 2024, Frances Arnold, a member of our Board of Directors, entered in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on February 27, 2026 and provides for the sale of up to 120 shares.&lt;/span&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-423" id="f-1575">November 6, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-423" id="f-1576">Frances Arnold</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-423" id="f-1577">Board of Directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-423" id="f-1578">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrExpirationDate contextRef="c-423" id="f-1579">February 27, 2026</ecd:TrdArrExpirationDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-424"
      decimals="INF"
      id="f-1580"
      unitRef="shares">120</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-425" id="f-1581">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;On November 7, 2024, Jakob Wedel, our Chief Strategy and Corporate Development Officer, entered in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on May 29, 2026 and provides for the sale of up to 3,182 shares.&lt;/span&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-426" id="f-1582">November 7, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-426" id="f-1583">Jakob Wedel</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-426" id="f-1584">Chief Strategy and Corporate Development Officer</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-426" id="f-1585">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrExpirationDate contextRef="c-426" id="f-1586">May 29, 2026</ecd:TrdArrExpirationDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-427"
      decimals="INF"
      id="f-1587"
      unitRef="shares">3182</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-428" id="f-1588">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;On November 8, 2024, Scott Davies, our Interim General Counsel, entered in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on December 16, 2025 and provides for the sale of up to 3,301 shares.&lt;/span&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-429" id="f-1589">November 8, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-429" id="f-1590">Scott Davies</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-429" id="f-1591">Interim General Counsel</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-429" id="f-1592">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrExpirationDate contextRef="c-429" id="f-1593">December 16, 2025</ecd:TrdArrExpirationDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-430"
      decimals="INF"
      id="f-1594"
      unitRef="shares">3301</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-431" id="f-1595">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;On November 13, 2024, Patricia Leckman, our Chief People Officer, entered in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on November 14, 2025 and provides for the sale of up to 1,615 shares.&lt;/span&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-432" id="f-1596">November 13, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-432" id="f-1597">Patricia Leckman</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-432" id="f-1598">Chief People Officer</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-432" id="f-1599">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrExpirationDate contextRef="c-432" id="f-1600">November 14, 2025</ecd:TrdArrExpirationDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-433"
      decimals="INF"
      id="f-1601"
      unitRef="shares">1615</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-434" id="f-1602">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-434" id="f-1603">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-434" id="f-1604">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-1609">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
